PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kanomata, N; Matsuura, S; Nomura, T; Kurebayashi, J; Mori, T; Kitawaki, J; Moriya, T				Kanomata, Naoki; Matsuura, Shiro; Nomura, Tsunehisa; Kurebayashi, Junichi; Mori, Taisuke; Kitawaki, Jo; Moriya, Takuya			Preparation of a novel antiserum to aromatase with high affinity and specificity: Its clinicopathological significance on breast cancer tissue	PLOS ONE			English	Article							IMMUNOHISTOCHEMICAL LOCALIZATION; MONOCLONAL-ANTIBODY; ENDOCRINE THERAPY; HUMAN-PLACENTA; IN-SITU; EXPRESSION; CYTOCHROME-P-450; METAANALYSIS; TRANSCRIPTS; TAMOXIFEN	Aromatase inhibitors have been widely used for the endocrine treatment of estrogen-dependent breast cancer in postmenopausal patients. However, clinicopathological studies of aromatase have been limited due to unsatisfactory specificity and/or restricted availability of anti-aromatase antibodies. Here, we have generated a polyclonal antiserum with high affinity and specificity for human aromatase using a monoclonal antibody tagged immunoaffinity chromatography on an industrial production scale. Our preliminary immunohistochemical analysis of 221 invasive breast cancer cases indicated that 87.3% (193/221) had at least 5% aromatase positive cells. The histoscore for aromatase was inversely correlated with pT (p = 0.019), pN (p = 0.001), stage (p < 0.001), histologic grade (p = 0.003), lymphatic infiltration (p < 0.001), venous infiltration (p < 0.001), and Ki-67 index (p < 0.001). However, cancer aromatase expression was independent of estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor 2 statuses. This antiserum will be applicable to clinicopathological examination of aromatase in addition to ER and PgR for an appropriate use of aromatase inhibitor on the treatment of breast cancer. Further studies on the relationship between Aromatase inhibitors have been widely used for the endocrine treatment of estrogen-dependent breast cancer in postmenopausal patients. However, clinicopathological studies of aromatase have been limited due to unsatisfactory specificity and/or restricted availability of anti-aromatase antibodies. Here, we have generated a polyclonal antiserum with high affinity and specificity for human aromatase using a monoclonal antibody tagged immunoaffinity chromatography on an industrial production scale. Our preliminary immunohistochemical analysis of 221 invasive breast cancer cases indicated that 87.3% (193/221) had at least 5% aromatase positive cells. The histoscore for aromatase was inversely correlated with pT (p = 0.019), pN (p = 0.001), stage (p < 0.001), histologic grade (p = 0.003), lymphatic infiltration (p < 0.001), venous infiltration (p < 0.001), and Ki-67 index (p < 0.001). However, cancer aromatase expression was independent of estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor 2 statuses. This antiserum will be applicable to clinicopathological examination of aromatase in addition to ER and PgR for an appropriate use of aromatase inhibitor on the treatment of breast cancer. Further studies on the relationship between aromatase expression and aromatase inhibitors are warranted.	[Kanomata, Naoki; Moriya, Takuya] Kawasaki Med Sch, Dept Pathol, Kurashiki, Okayama, Japan; [Matsuura, Shiro] LSI Medience Corp, Corp Planning Dept, Tokyo, Japan; [Nomura, Tsunehisa; Kurebayashi, Junichi] Kawasaki Med Sch, Dept Breast & Thyroid Surg, Kurashiki, Okayama, Japan; [Mori, Taisuke; Kitawaki, Jo] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Obstet & Gynecol, Kyoto, Japan	Kawasaki Medical School; Kawasaki Medical School; Kyoto Prefectural University of Medicine	Kanomata, N (corresponding author), Kawasaki Med Sch, Dept Pathol, Kurashiki, Okayama, Japan.	kanomata_7@med.kawasaki-m.ac.jp	Moriya, Takuya/AAM-6974-2020	Kanomata, Naoki/0000-0002-0172-4524	Shiro Matsuura is an employee of LSI Medience Corporation, Tokyo, Japan; Grants-in-Aid for Scientific Research [15K10726] Funding Source: KAKEN	Shiro Matsuura is an employee of LSI Medience Corporation, Tokyo, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Shiro Matsuura is an employee of LSI Medience Corporation, Tokyo, Japan. The specific roles of this author are articulated in the 'author contributions' section. There was no additional external funding received for this study.	Berstein LM, 1996, J CANCER RES CLIN, V122, P495, DOI 10.1007/BF01187162; BULUN SE, 1993, J CLIN ENDOCR METAB, V77, P1622, DOI 10.1210/jc.77.6.1622; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082; CHEN S, 1986, BIOCHEM BIOPH RES CO, V135, P713, DOI 10.1016/0006-291X(86)90987-3; Chen SA, 1998, FRONT BIOSCI-LANDMRK, V3, P922; Cuzick J, 2013, LANCET, V381, P1827, DOI 10.1016/S0140-6736(13)60140-3; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; ESTEBAN JM, 1992, AM J PATHOL, V140, P337; Geisler J, 2010, J STEROID BIOCHEM, V118, P237, DOI 10.1016/j.jsbmb.2009.10.010; Harada N, 1997, J STEROID BIOCHEM, V61, P175; Honma N, 2006, J CLIN ENDOCR METAB, V91, P607, DOI 10.1210/jc.2005-1967; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; KITAWAKI J, 1992, ENDOCRINOLOGY, V130, P2751, DOI 10.1210/en.130.5.2751; Kitawaki J, 1996, ANTICANCER RES, V16, P91; Kitawaki J, 1997, BIOL REPROD, V57, P514, DOI 10.1095/biolreprod57.3.514; KITAWAKI J, 1989, ENDOCRINOLOGY, V124, P1417, DOI 10.1210/endo-124-3-1417; Lykkesfeldt AE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-185; Miki Y, 2007, J STEROID BIOCHEM, V106, P97, DOI 10.1016/j.jsbmb.2007.05.007; Miki Y, 2007, CANCER RES, V67, P3945, DOI 10.1158/0008-5472.CAN-06-3105; MILLER WR, 1982, CANCER RES, V42, P3365; PEREL E, 1982, CANCER RES, V42, P3369; SASANO H, 1994, HUM PATHOL, V25, P530, DOI 10.1016/0046-8177(94)90127-9; Sasano H, 2005, J STEROID BIOCHEM, V95, P35, DOI 10.1016/j.jsbmb.2005.04.027; Sasano H, 1998, BREAST CANC RES T S1, V49, pS109; Sasieni PD, 2011, BRIT J CANCER, V105, P460, DOI 10.1038/bjc.2011.250; Sobin L, 2009, TNM CLASSIFICATION M; TAMURA T, 1992, J ENDOCRINOL, V135, P589, DOI 10.1677/joe.0.1350589; Utsumi T, 1996, J CLIN ENDOCR METAB, V81, P2344, DOI 10.1210/jc.81.6.2344; WASHIDA N, 1985, FED PROC, V44, P861; YOSHIDA N, 1991, BIOCHEMISTRY-US, V30, P3003, DOI 10.1021/bi00226a004; Zhang ZH, 2002, BREAST CANCER RES TR, V74, P47, DOI 10.1023/A:1016022314608	31	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177439	10.1371/journal.pone.0177439	http://dx.doi.org/10.1371/journal.pone.0177439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489882	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100075
J	Sadler, E; Porat, T; Marshall, I; Hoang, U; Curcin, V; Wolfe, CDA; McKevitt, C				Sadler, Euan; Porat, Talya; Marshall, Iain; Hoang, Uy; Curcin, Vasa; Wolfe, Charles D. A.; McKevitt, Christopher			Shaping innovations in long-term care for stroke survivors with multimorbidity through stakeholder engagement	PLOS ONE			English	Article							SELF-MANAGEMENT PROGRAMS; RISK-FACTORS; PREVALENCE; RECOVERY; EFFICACY; PATIENT; TRENDS	Background Stroke, like many long-term conditions, tends to be managed in isolation of its associated risk factors and multimorbidity. With increasing access to clinical and research data there is the potential to combine data from a variety of sources to inform interventions to improve healthcare. A 'Learning Health System' (LHS) is an innovative model of care which transforms integrated data into knowledge to improve healthcare. The objective of this study is to develop a process of engaging stakeholders in the use of clinical and research data to co-produce potential solutions, informed by a LHS, to improve long-term care for stroke survivors with multimorbidity. Methods We used a stakeholder engagement study design informed by co-production principles to engage stakeholders, including service users, carers, general practitioners and other health and social care professionals, service managers, commissioners of services, policy makers, third sector representatives and researchers. Over a 10 month period we used a range of methods including stakeholder group meetings, focus groups, nominal group techniques (priority setting and consensus building) and interviews. Qualitative data were recorded, transcribed and analysed thematically. Results 37 participants took part in the study. The concept of how data might drive intervention development was difficult to convey and understand. The engagement process led to four priority areas for needs for data and information being identified by stakeholders: 1) improving continuity of care; 2) improving management of mental health consequences; 3) better access to health and social care; and 4) targeting multiple risk factors. These priorities informed preliminary design interventions. The final choice of intervention was agreed by consensus, informed by consideration of the gap in evidence and local service provision, and availability of robust data. This shaped a co-produced decision support tool to improve secondary prevention after stroke for further development. Conclusions Stakeholder engagement to identify data-driven solutions is feasible but requires resources. While a number of potential interventions were identified, the final choice rested not just on stakeholder priorities but also on data availability. Further work is required to evaluate the impact and implementation of data-driven interventions for long-term stroke survivors.	[Sadler, Euan; Porat, Talya; Marshall, Iain; Hoang, Uy; Curcin, Vasa; Wolfe, Charles D. A.] Kings Coll London, Fac Life Sci & Med, Div Hlth & Social Care Res, London, England; [Sadler, Euan] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Implementat Sci, Kings Improvement Sci,Hlth Serv & Populat Res Dep, London, England; [Wolfe, Charles D. A.; McKevitt, Christopher] Kings Coll Hosp NHS Fdn Trust, Natl Inst Hlth Res Collaborat Leadership Appl Hlt, London, England; [Wolfe, Charles D. A.; McKevitt, Christopher] Kings Coll London, London, England; [Wolfe, Charles D. A.; McKevitt, Christopher] Guys & St Thomas NHS Fdn Trust & Kings Coll Londo, Biomed Res Ctr, Natl Inst Hlth Res, London, England	University of London; King's College London; University of London; King's College London; King's College Hospital NHS Foundation Trust; University of London; King's College London; University of London; King's College London	Sadler, E (corresponding author), Kings Coll London, Fac Life Sci & Med, Div Hlth & Social Care Res, London, England.; Sadler, E (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Implementat Sci, Kings Improvement Sci,Hlth Serv & Populat Res Dep, London, England.	euan.sadler@kcl.ac.uk	mckevitt, christopher/AAN-7271-2021; Hoang, Uy/AAD-9445-2022	Hoang, Uy/0000-0002-8428-5140; Curcin, Vasa/0000-0002-8308-2886; Sadler, Euan/0000-0003-3827-224X; Marshall, Iain/0000-0003-2594-2654; MCKEVITT, CHRISTOPHER/0000-0002-5290-4613	National Institute for Health Research (NIHR); Care South London at King's College Hospital NHS Foundation Trust [NIHR CLAHRC-2013-10022]; MRC [MR/N015185/1] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Care South London at King's College Hospital NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	There search was funded by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College Hospital NHS Foundation Trust (award number NIHR CLAHRC-2013-10022), Prof Charles DA Wolfe (stroke themelead), http://www.nihr.ac.uk/about-us/how-we-are-managed/our-structure/infrastructure/ collaborations-for-leadership-in-applied-health-research-and-care.htm. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, S LONDON STROK UNPUB; Bamford David, 2013, J Health Organ Manag, V27, P548; Batalden M, 2016, BMJ QUAL SAF, V25, P509, DOI 10.1136/bmjqs-2015-004315; Bovaird T, 2007, PUBLIC ADMIN REV, V67, P846, DOI 10.1111/j.1540-6210.2007.00773.x; Boyle D, 2006, ASPECTS COPRODUCTION; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chen RL, 2014, J NEUROL NEUROSUR PS, V85, P1294, DOI 10.1136/jnnp-2013-306413; Crandall W, 2011, INFLAMM BOWEL DIS, V17, P450, DOI 10.1002/ibd.21394; Curcin V, 2016, EMBEDDING DATA PROVE; Dawes M, 2010, FAM PRACT, V27, P1, DOI 10.1093/fampra/cmp106; Delaney BC, 2012, ANN FAM MED, V10, P54, DOI 10.1370/afm.1313; Ellis G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005066.pub2; Forster A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001919.pub3; Fortin M, 2006, QUAL LIFE RES, V15, P83, DOI 10.1007/s11136-005-8661-z; Fraccaro P, 2015, JMIR MED INF, V3, DOI 10.2196/medinform.3503; Glynn LG, 2011, FAM PRACT, V28, P516, DOI 10.1093/fampra/cmr013; Governance International, 2013, ACH CIT OUTC; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003437.pub3; Heaton J, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0383-9; Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285; Intercollegiate Stroke Working Party, 2016, NAT CLIN GUID STROK; Jones F, 2011, DISABIL REHABIL, V33, P797, DOI 10.3109/09638288.2010.511415; Kendall E, 2007, SOC SCI MED, V64, P735, DOI 10.1016/j.socscimed.2006.09.012; Kenning C, 2013, SAGE OPEN MED, V1, DOI 10.1177/2050312113510001; Kirkevold M, 2012, INT J NURS STUD, V49, P386, DOI 10.1016/j.ijnurstu.2011.10.006; Korpershoek C, 2011, J ADV NURS, V67, P1876, DOI 10.1111/j.1365-2648.2011.05659.x; Lager KE, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009103.pub2; Lawrence M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120902; Lennon S, 2013, CLIN REHABIL, V27, P867, DOI 10.1177/0269215513481045; MacKay-Lyons M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008656.pub2; Marshall IJ, 2013, STROKE, V44, P1809, DOI 10.1161/STROKEAHA.111.000655; Mason B, 2016, BMJ SUPPORT PALLIAT, V6, P60, DOI 10.1136/bmjspcare-2013-000639; McKevitt C, 2011, STROKE, V42, P1398, DOI 10.1161/STROKEAHA.110.598839; McKevitt C, 2010, HEALTH EXPECT, V13, P86, DOI 10.1111/j.1369-7625.2009.00573.x; Morris RL, 2011, CHRONIC ILLN, V7, P147, DOI 10.1177/1742395310393365; National Audit Office, 2010, DEP HLTH PROGR IMPR; NIHR, 2015, GOING EXTR MIL IMPR; Olsen L., 2007, LEARNING HEALTHCARE, DOI DOI 10.17226/; Ottmann G, 2011, SYST PRACT ACT RES, V24, P413, DOI 10.1007/s11213-011-9192-x; Pawson R., 1997, REALIST EVALUATION; Pollock A, 2014, INT J STROKE, V9, P313, DOI 10.1111/j.1747-4949.2012.00942.x; Reeve J, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-112; Roshanov PS, 2011, IMPLEMENT SCI, V6, DOI [10.1186/1748-5908-6-92, 10.1186/1748-5908-6-88]; Smith SM, 2016, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006560.pub3, 10.1002/14651858.CD006560.pub4]; Smith SM, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X514756; Social Care Institute of Excellence, 2015, SCIE GUID, V51; Starks H, 2015, QUAL LIFE RES, V24, P1097, DOI 10.1007/s11136-014-0810-9; Su P, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0352-9; Wallace E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h176; Warner G, 2015, DISABIL REHABIL, V37, P2141, DOI 10.3109/09638288.2014.996674; Wherton J, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0271-8; Wolfe CDA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001033; Wolfe CDA, 2010, STROKE, V41, P2470, DOI 10.1161/STROKEAHA.110.588046; Young J, 2003, REV CLIN GERONTOL, V13, P55	54	12	12	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177102	10.1371/journal.pone.0177102	http://dx.doi.org/10.1371/journal.pone.0177102			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475606	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000400649500047
J	Yi, K; Hatayama, N; Hirai, S; Qu, N; Hayashi, S; Kawata, S; Nagahori, K; Naito, M; Itoh, M				Yi, Kai; Hatayama, Naoyuki; Hirai, Shuichi; Qu, Ning; Hayashi, Shogo; Kawata, Shinichi; Nagahori, Kenta; Naito, Munekazu; Itoh, Masahiro			Development of heterotopic transplantation of the testis with the epididymis to evaluate an aspect of testicular immunology in rats	PLOS ONE			English	Article							HEART-TRANSPLANTATION; ADULT-RATS; MICE; MODEL; CRYPTORCHIDISM; INFILTRATION; VASECTOMY; TISSUE; SPERM	Transplantation of testicular cells and tissues has been studied for the investigation of immunology of the testis, which is an immunologically privileged organ. However, reports of transplant of the testis at organ level have been extremely limited because of technical difficulties of the orthotopic testis transplantation (OTT) in experimental animals. In the present study, we developed a new and simple model of the heterotopic testis transplantation (HTT), which is donor testis transplantation into the cervical region of recipients, in a syngeneic model in rats [donor Lewis (LEW) graft to LEW recipient]. The duration of HTT was significantly shorter and success rate higher than that of OTT. To histologically evaluate HTT, the local immune responses were compared among the syngeneic model, an acute rejection allogeneic model [donor Augustus Copenhagen Irish (ACI) graft to LEW recipient] and a chronic rejection allogeneic model (donor F344 graft to LEW recipient) at postoperative day 3. We found that allogeneic ACI grafts resulted in mild and not severe orchitic lesions, whereas immune responses of allogeneic F344 grafts seemed intact and were not significantly different from those of syngeneic LEW grafts. These results suggest that our new operative procedure will be useful in future for the investigation of the testicular immunology.	[Yi, Kai; Hatayama, Naoyuki; Qu, Ning; Hayashi, Shogo; Kawata, Shinichi; Nagahori, Kenta; Itoh, Masahiro] Tokyo Med Univ, Dept Anat, Tokyo, Japan; [Hatayama, Naoyuki; Hirai, Shuichi; Naito, Munekazu] Aichi Med Univ, Dept Anat, Aichi, Japan	Tokyo Medical University; Aichi Medical University	Hatayama, N (corresponding author), Tokyo Med Univ, Dept Anat, Tokyo, Japan.; Hatayama, N (corresponding author), Aichi Med Univ, Dept Anat, Aichi, Japan.	naoyuki@tokyo-med.ac.jp	Hayashi, Shogo/K-7268-2015; HIRAI, SHUICHI/AAQ-6081-2020; Qu, Ning/X-1827-2019	Hayashi, Shogo/0000-0003-0302-7658; 	JSPS KAKENHI [15K08159]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Author Mashahiro Itoh received funding from JSPS KAKENHI (15K08159). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTWEIN JE, 1972, ENDOCRINOLOGY, V91, P312, DOI 10.1210/endo-91-1-312; Bergh A, 2001, BIOL REPROD, V64, P13, DOI 10.1095/biolreprod64.1.13; Fuse H., 1993, International Urology and Nephrology, V25, P491; Ghabriel MN, 2002, REPRODUCTION, V123, P389, DOI 10.1530/reprod/123.3.389; GILBERT P, 1986, UROL INT, V41, P145, DOI 10.1159/000281184; GOLDSTEIN M, 1983, BIOL REPROD, V28, P971, DOI 10.1095/biolreprod28.4.971; HEAD JR, 1985, TRANSPLANTATION, V40, P269, DOI 10.1097/00007890-198509000-00010; HERON I, 1971, ACTA PATH MICRO IM A, VA 79, P366; Honaramooz A, 2002, NATURE, V418, P778, DOI 10.1038/nature00918; Itoh M, 2005, J REPROD IMMUNOL, V67, P57, DOI 10.1016/j.jri.2005.06.007; JEGOU B, 1983, J ANDROL, V4, P88; JEGOU B, 1983, J REPROD FERTIL, V69, P137, DOI 10.1530/jrf.0.0690137; JOHNSEN S G, 1970, Hormones (Basel), V1, P2, DOI 10.1159/000178170; Johnson L, 1996, BIOL REPROD, V54, P948, DOI 10.1095/biolreprod54.5.948; KAZEEM AA, 1988, SCAND J IMMUNOL, V27, P149, DOI 10.1111/j.1365-3083.1988.tb02333.x; LEE S, 1971, TRANSPLANT P, V3, P586; Li JH, 2010, REPRODUCTION, V139, P447, DOI 10.1530/REP-08-0464; MADDOCKS S, 1990, J REPROD IMMUNOL, V18, P9, DOI 10.1016/0165-0378(90)90021-W; Marco ML, 2006, NEPHROL DIAL TRANSPL, V21, P3082, DOI 10.1093/ndt/gfl451; Martins PNA, 2008, MICROSURG, V28, P565, DOI 10.1002/micr.20544; McDonald SW, 2000, INT REV CYTOL, V199, P295, DOI 10.1016/S0074-7696(00)99006-5; MCDONALD SW, 1991, J ANAT, V176, P35; Naito M, 2008, AM J REPROD IMMUNOL, V59, P55, DOI 10.1111/j.1600-0897.2007.00556.x; Nakao A, 2002, ACTA MED OKAYAMA, V56, P69; Nunes Sergio Ibañez, 2013, Rev. Col. Bras. Cir., V40, P60; Okuno M, 2014, J ORTHOP RES, V32, P928, DOI 10.1002/jor.22614; PARADYSZ JM, 1981, TRANSPLANT P, V13, P1120; Rodriguez-Sosa JR, 2010, REPRODUCTION, V139, P227, DOI 10.1530/REP-09-0176; Schlatt S, 2002, REPRODUCTION, V124, P339, DOI 10.1530/rep.0.1240339; Song YH, 2007, BIOL REPROD, V76, P598, DOI 10.1095/biolreprod.106.058032; Spanjol J, 2011, COLLEGIUM ANTROPOL, V35, P87; STERNBERGER NH, 1987, P NATL ACAD SCI USA, V84, P8169, DOI 10.1073/pnas.84.22.8169; Su LL, 2011, J ENDOCRINOL, V209, P337, DOI 10.1530/JOE-10-0474; Tan Fu-qing, 2006, Zhejiang Da Xue Xue Bao Yi Xue Ban, V35, P297; TODO S, 1988, TRANSPLANT P, V20, P215; TUNG KSK, 1970, AM J PATHOL, V60, P313; Visser AJ, 2003, BJU INT, V92, P200, DOI 10.1046/j.1464-410X.2003.04307.x; Winnall WR, 2011, J LEUKOCYTE BIOL, V90, P133, DOI 10.1189/jlb.1010557; Zhang WX, 2005, CHINESE MED J-PEKING, V118, P850	39	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177067	10.1371/journal.pone.0177067	http://dx.doi.org/10.1371/journal.pone.0177067			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475594	Green Submitted, Green Published, gold			2022-12-27	WOS:000400649500040
J	Bader, M; Schroger, E; Grimm, S				Bader, Maria; Schroeger, Erich; Grimm, Sabine			How regularity representations of short sound patterns that are based on relative or absolute pitch information establish over time: An EEG study	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; EVENT-RELATED POTENTIALS; MEMORY-TRACE FORMATION; INDEPENDENT COMPONENT ANALYSIS; MISMATCH NEGATIVITY; INVOLUNTARY ATTENTION; COMPLEX-SOUND; HUMAN BRAIN; REPETITION SUPPRESSION; FEATURE CONJUNCTIONS	The recognition of sound patterns in speech or music (e.g., a melody that is played in different keys) requires knowledge about pitch relations between successive sounds. We investigated the formation of regularity representations for sound patterns in an event-related potential (ERP) study. A pattern, which consisted of six concatenated 50 ms tone segments differing in fundamental frequency, was presented 1, 2, 3, 6, or 12 times and then replaced by another pattern by randomly changing the pitch of the tonal segments (roving standard paradigm). In an absolute repetition condition, patterns were repeated identically, whereas in a transposed condition, only the pitch relations of the tonal segments of the patterns were repeated, while the entire patterns were shifted up or down in pitch. During ERP measurement participants were not informed about the pattern repetition rule, but were instructed to discriminate rarely occurring targets of lower or higher sound intensity. EPRs for pattern changes (mismatch negativity, MMN; and P3a) and for pattern repetitions (repetition positivity, RP) revealed that the auditory system is able to rapidly extract regularities from unfamiliar complex sound patterns even when absolute pitch varies. Yet, enhanced RP and P3a amplitudes, and improved behavioral performance measured in a post-hoc test, in the absolute as compared with the transposed condition suggest that it is more difficult to encode patterns without absolute pitch information. This is explained by dissociable processing of standards and deviants as well as a back propagation mechanism to early sensory processing stages, which is effective after less repetitions of a standard stimulus for absolute pitch.	[Bader, Maria; Schroeger, Erich; Grimm, Sabine] Univ Leipzig, Inst Psychol, Leipzig, Germany	Leipzig University	Bader, M (corresponding author), Univ Leipzig, Inst Psychol, Leipzig, Germany.	maria.bader@uni-leipzig.de	Grimm, Sabine/AAO-1547-2021; Schröger, Erich/C-3079-2009	Schröger, Erich/0000-0002-8321-6629; Grimm, Sabine/0000-0002-9071-5944	German Research Foundation [GR 3412/2-1]; German Research Foundation (DFG); Leipzig University	German Research Foundation(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	The study was funded by the German Research Foundation (www.dfg.de) with the project number GR 3412/2-1. Furthermore we acknowledged support from the German Research Foundation (DFG) and the Leipzig University within the program of Open Access Publishing. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 1999, NEUROREPORT, V10, P2429, DOI 10.1097/00001756-199908020-00038; Alho K, 1998, PSYCHOPHYSIOLOGY, V35, P211, DOI 10.1111/1469-8986.3520211; Alho K, 1997, NEUROREPORT, V8, P3233, DOI 10.1097/00001756-199710200-00010; ALHO K, 1993, NEUROREPORT, V4, P391, DOI 10.1097/00001756-199304000-00012; Alho K, 1996, PSYCHOPHYSIOLOGY, V33, P369, DOI 10.1111/j.1469-8986.1996.tb01061.x; Baldeweg T, 2004, SCHIZOPHR RES, V69, P203, DOI 10.1016/j.schres.2003.09.009; Baldeweg T, 2007, J PSYCHOPHYSIOL, V21, P204, DOI 10.1027/0269-8803.21.34.204; Barascud N, 2016, P NATL ACAD SCI USA, V113, pE616, DOI 10.1073/pnas.1508523113; Bendixen A, 2008, BIOL PSYCHOL, V78, P231, DOI 10.1016/j.biopsycho.2008.03.005; Bendixen A, 2007, J COGNITIVE NEUROSCI, V19, P1664, DOI 10.1162/jocn.2007.19.10.1664; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bizley JK, 2013, NAT REV NEUROSCI, V14, P693, DOI 10.1038/nrn3565; Carral V, 2005, NEUROREPORT, V16, P301, DOI 10.1097/00001756-200502280-00020; Cooper RJ, 2013, INT J PSYCHOPHYSIOL, V88, P74, DOI 10.1016/j.ijpsycho.2013.02.003; Costa-Faidella J, 2011, J NEUROSCI, V31, P18590, DOI 10.1523/JNEUROSCI.2599-11.2011; Costa-Faidella J, 2011, PSYCHOPHYSIOLOGY, V48, P774, DOI 10.1111/j.1469-8986.2010.01144.x; COWAN N, 1993, J EXP PSYCHOL LEARN, V19, P909, DOI 10.1037/0278-7393.19.4.909; Cycowicz YM, 1998, BRAIN COGNITION, V36, P30, DOI 10.1006/brcg.1997.0955; Debener S, 2005, COGNITIVE BRAIN RES, V22, P309, DOI 10.1016/j.cogbrainres.2004.09.006; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dowling W. J., 1981, PSYCHOMUSICOLOGY, V1, P30, DOI [10.1037/h0094275, DOI 10.1037/H0094275]; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Escera C, 2001, EUR J NEUROSCI, V14, P877, DOI 10.1046/j.0953-816x.2001.01707.x; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Friston K., 2005, PHILOS T R SOC LON B, V360, P815; Garrido MI, 2008, NEUROIMAGE, V42, P936, DOI 10.1016/j.neuroimage.2008.05.018; Garrido MI, 2009, NEUROIMAGE, V48, P269, DOI 10.1016/j.neuroimage.2009.06.034; Gomes H, 1997, PSYCHOPHYSIOLOGY, V34, P712, DOI 10.1111/j.1469-8986.1997.tb02146.x; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; Horvath J, 2001, COGNITIVE BRAIN RES, V12, P131, DOI 10.1016/S0926-6410(01)00038-6; Horvath J, 2008, BIOL PSYCHOL, V79, P139, DOI 10.1016/j.biopsycho.2008.04.001; Huotilainen M, 2001, INT J PSYCHOPHYSIOL, V41, P226; Katayama J, 1996, EVOKED POTENTIAL, V100, P555, DOI 10.1016/S0168-5597(96)95171-0; Kiesel A, 2008, PSYCHOPHYSIOLOGY, V45, P250, DOI 10.1111/j.1469-8986.2007.00618.x; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Langers DRM, 2007, NEUROIMAGE, V34, P264, DOI 10.1016/j.neuroimage.2006.09.002; LEVITIN DJ, 1994, PERCEPT PSYCHOPHYS, V56, P414, DOI 10.3758/BF03206733; Macmillan N. A., 1991, DETECTION THEORY USE; McDermott JH, 2011, P NATL ACAD SCI USA, V108, P1188, DOI 10.1073/pnas.1004765108; Miller J, 1998, PSYCHOPHYSIOLOGY, V35, P99, DOI 10.1111/1469-8986.3510099; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1993, NEUROREPORT, V4, P503; Neuloh G, 2004, NEUROREPORT, V15, P2471, DOI 10.1097/00001756-200411150-00008; Nikjeh DA, 2009, EAR HEARING, V30, P432, DOI 10.1097/AUD.0b013e3181a61bf2; Novitski N, 2004, COGNITIVE BRAIN RES, V20, P26, DOI 10.1016/j.cogbrainres.2003.12.011; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PAAVILAINEN P, 1993, BIOL PSYCHOL, V37, P23, DOI 10.1016/0301-0511(93)90025-4; Pannese A, 2015, BRAIN TOPOGR, V28, P411, DOI 10.1007/s10548-014-0368-4; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Plantinga J, 2005, COGNITION, V98, P1, DOI 10.1016/j.cognition.2004.09.008; Rahne T, 2008, J NEUROSCI METH, V172, P74, DOI 10.1016/j.jneumeth.2008.04.006; Roeber U, 2003, CLIN NEUROPHYSIOL, V114, P341, DOI 10.1016/S1388-2457(02)00377-2; Romero R, 1996, PHYSIOL BEHAV, V59, P517, DOI 10.1016/0031-9384(95)02099-3; Rushby JA, 2005, CLIN NEUROPHYSIOL, V116, P2363, DOI 10.1016/j.clinph.2005.06.008; SAARINEN J, 1992, NEUROREPORT, V3, P1149, DOI 10.1097/00001756-199212000-00030; Saffran JR, 2003, DEVELOPMENTAL SCI, V6, P35, DOI 10.1111/1467-7687.00250; Saffran JR, 2001, DEV PSYCHOL, V37, P74, DOI 10.1037//0012-1649.37.1.74; SAMS M, 1983, BIOL PSYCHOL, V17, P41, DOI 10.1016/0301-0511(83)90065-0; Schindler A, 2013, CEREB CORTEX, V23, P2987, DOI 10.1093/cercor/bhs289; Schonwiesner M, 2002, NEUROIMAGE, V17, P1144, DOI 10.1006/nimg.2002.1250; Schroger E, 1996, J COGNITIVE NEUROSCI, V8, P527, DOI 10.1162/jocn.1996.8.6.527; Schroger E, 1998, BEHAV RES METH INS C, V30, P131, DOI 10.3758/BF03209423; Schroger E, 1998, COGNITIVE BRAIN RES, V7, P71, DOI 10.1016/S0926-6410(98)00013-5; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; SCHROGER E, 1994, PSYCHOPHYSIOLOGY, V31, P175, DOI 10.1111/j.1469-8986.1994.tb01037.x; Shinn-Cunningham BG, 2008, TRENDS COGN SCI, V12, P182, DOI 10.1016/j.tics.2008.02.003; Sussman E, 1998, BRAIN RES, V793, P95, DOI 10.1016/S0006-8993(98)00164-4; Tervaniemi M, 2000, NEUROSCI LETT, V290, P66, DOI 10.1016/S0304-3940(00)01290-8; Urbach TP, 2006, BIOL PSYCHOL, V72, P333, DOI 10.1016/j.biopsycho.2005.11.012; Verleger R, 1997, PSYCHOPHYSIOLOGY, V34, P131, DOI 10.1111/j.1469-8986.1997.tb02125.x; Von Ehrenfels C, 1937, PSYCHOL REV, V44, P521, DOI 10.1037/h0056968; Wallentin M, 2010, LEARN INDIVID DIFFER, V20, P188, DOI 10.1016/j.lindif.2010.02.004; Widmann A, 2015, J NEUROSCI METH, V250, P34, DOI 10.1016/j.jneumeth.2014.08.002; Winkler I, 1996, J COGNITIVE NEUROSCI, V8, P403, DOI 10.1162/jocn.1996.8.5.403; Zatorre RJ, 2003, NAT NEUROSCI, V6, P692, DOI 10.1038/nn1085	76	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176981	10.1371/journal.pone.0176981	http://dx.doi.org/10.1371/journal.pone.0176981			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472146	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500109
J	Berbasova, T; Nallur, S; Sells, T; Smith, KD; Gordon, PB; Tausta, SL; Strobel, SA				Berbasova, Tetyana; Nallur, Sunitha; Sells, Taylor; Smith, Kathryn D.; Gordon, Patricia B.; Tausta, Susan Lori; Strobel, Scott A.			Fluoride export (FEX) proteins from fungi, plants and animals are 'single barreled' channels containing one functional and one vestigial ion pore	PLOS ONE			English	Article							TOXICITY; RESISTANCE; ORGANISMS; GENOME; MODEL; WATER	The fluoride export protein (FEX) in yeast and other fungi provides tolerance to fluoride (F-), an environmentally ubiquitous anion. FEX efficiently eliminates intracellular fluoride that otherwise would accumulate at toxic concentrations. The FEX homolog in bacteria, Fluc, is a 'double-barreled' channel formed by dimerization of two identical or similar subunits. FEX in yeast and other eukaryotes is a monomer resulting from covalent fusion of the two subunits. As a result, both potential fluoride pores are created from different parts of the same protein. Here we identify FEX proteins from two multicellular eukaryotes, a plant Arabidopsis thaliana and an animal Amphimedon queenslandica, by demonstrating significant fluoride tolerance when these proteins are heterologously expressed in the yeast Saccharomyces cerevisiae. Residues important for eukaryotic FEX function were determined by phylogenetic sequence alignment and functional analysis using a yeast growth assay. Key residues of the fluoride channel are conserved in only one of the two potential fluoride-transporting pores. FEX activity is abolished upon mutation of residues in this conserved pore, suggesting that only one of the pores is functional. The same topology is conserved for the newly identified FEX proteins from plant and animal. These data suggest that FEX family of fluoride channels in eukaryotes are 'single-barreled' transporters containing one functional pore and a second non-functional vestigial remnant of a homologous gene fusion event.	[Berbasova, Tetyana; Nallur, Sunitha; Sells, Taylor; Smith, Kathryn D.; Tausta, Susan Lori; Strobel, Scott A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Berbasova, Tetyana; Nallur, Sunitha; Sells, Taylor; Smith, Kathryn D.; Tausta, Susan Lori; Strobel, Scott A.] Yale Univ, Chem Biol Inst, West Haven, CT 06520 USA; [Gordon, Patricia B.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA	Yale University; Yale University; Fred Hutchinson Cancer Center	Strobel, SA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.; Strobel, SA (corresponding author), Yale Univ, Chem Biol Inst, West Haven, CT 06520 USA.	scott.strobel@yale.edu	Tausta, Lori/GXH-7773-2022	Tausta, Lori/0000-0003-0720-1182	National Institutes of Health [GM022778]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM022778 (to SAS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalakova NI, 2011, J EVOL BIOCHEM PHYS+, V47, P393, DOI 10.1134/S002209301105001X; Akers HF, 2004, AUST DENT J, V49, P61, DOI 10.1111/j.1834-7819.2004.tb00051.x; Ayoob S, 2006, CRIT REV ENV SCI TEC, V36, P433, DOI 10.1080/10643380600678112; Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; Barbier O, 2010, CHEM-BIOL INTERACT, V188, P319, DOI 10.1016/j.cbi.2010.07.011; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Camargo JA, 2003, CHEMOSPHERE, V50, P251, DOI 10.1016/S0045-6535(02)00498-8; Cametti M, 2009, CHEM COMMUN, P2809, DOI 10.1039/b902069a; Fawell J., 2006, FLUORIDE DRINKING WA; Fernandez R, 2016, YEAST, V33, P549, DOI 10.1002/yea.3178; Gazzano E, 2010, CURR MED CHEM, V17, P2431, DOI 10.2174/092986710791698503; Golicnik M, 2010, ACTA CHIM SLOV, V57, P272; HORNER JM, 1995, AGR ECOSYST ENVIRON, V52, P205, DOI 10.1016/0167-8809(94)00533-K; Jha SK, 2009, CHEMOSPHERE, V76, P353, DOI 10.1016/j.chemosphere.2009.03.044; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Last NB, 2016, ELIFE, V5, DOI 10.7554/eLife.18767; Lee ST, 2014, J AGR FOOD CHEM, V62, P7345, DOI 10.1021/jf500563h; Li SS, 2013, P NATL ACAD SCI USA, V110, P19018, DOI 10.1073/pnas.1310439110; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Pulyaevskaya MA, 2011, RUSS J PLANT PHYSL+, V58, P589, DOI 10.1134/S1021443711040108; Ram A, 2014, FLUORIDE, V47, P49; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Smith KD, 2015, J BIOL CHEM, V290, P19874, DOI 10.1074/jbc.M115.651976; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stockbridge RB, 2015, NATURE, V525, P548, DOI 10.1038/nature14981; Stockbridge RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6120; Stockbridge RB, 2012, P NATL ACAD SCI USA, V109, P15289, DOI 10.1073/pnas.1210896109; Stockbridge RB, 2013, ELIFE, V2; Strunecka A, 2007, CURR SIGNAL TRANSD T, V2, P190, DOI 10.2174/157436207781745300; Vithanage M, 2015, ENVIRON CHEM LETT, V13, P131, DOI 10.1007/s10311-015-0496-4; Weinstein L.H., 2004, FLUORIDES ENV; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yang Y, 2016, PLANT SOIL, V402, P179, DOI 10.1007/s11104-015-2787-8	34	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177096	10.1371/journal.pone.0177096	http://dx.doi.org/10.1371/journal.pone.0177096			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472134	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500134
J	Curtis, KA; Hanson, DL; Price, KA; Owen, SM				Curtis, Kelly A.; Hanson, Debra L.; Price, Krystin Ambrose; Owen, S. Michele			Performance characteristics of an antibody-based multiplex kit for determining recent HIV-1 infection	PLOS ONE			English	Article							HOMOSEXUAL-MEN; LYMPHADENOPATHY SYNDROME; CONTINUING RISK; AVIDITY; ASSAYS; SEROCONVERSION; VACCINE; TRIALS	The availability of reliable laboratory methods for determining recent HIV infection is vital for accurate estimation of population-based incidence. The mean duration of recent infection (MDRI) and false recent rate (FRR) are critical parameters for HIV incidence assays, as they impact HIV incidence estimates and provide a measure of assay performance. The HIV-1 Multiplex assay is an in-house developed, magnetic bead-based assay that measures virus-specific antibody levels and avidity to multiple analytes. To ensure quality control and to facilitate transfer of the assay to external laboratories or testing facilities, the in-house assay has been adapted and produced in kit form. Here, we describe the performance characteristics of the multiplex kit and demonstrate the stability of the kit components over a one-year period. Two statistical methods were employed to estimate the MDRI of the individual analytes and five different algorithms, combining multiple analyte values. The MDRI estimates for the individual analytes and five algorithms were all between 200 and 300 days post-seroconversion, with no notable difference between the two statistical approaches. All five algorithms exhibited a 0% FRR with specimens from long-term, subtype B HIV-1-infected individuals. The assay parameters described in this study provide the necessary tools to implement the HIV-1 multiplex assay and improves the utility of the assay for field use.	[Curtis, Kelly A.; Hanson, Debra L.; Price, Krystin Ambrose; Owen, S. Michele] Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Ctr Dis Control, Atlanta, GA 30329 USA; [Curtis, Kelly A.; Hanson, Debra L.; Price, Krystin Ambrose; Owen, S. Michele] Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Ctr Prevent, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Curtis, KA (corresponding author), Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Ctr Dis Control, Atlanta, GA 30329 USA.; Curtis, KA (corresponding author), Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Ctr Prevent, Atlanta, GA 30329 USA.	czv2@cdc.gov			CDC intramural funding; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention	CDC intramural funding; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The research study was supported through CDC intramural funding and by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have not received any additional external funding for this work.	Brookmeyer R, 2013, JAIDS-J ACQ IMM DEF, V63, pS233, DOI 10.1097/QAI.0b013e3182986fdf; Brookmeyer R, 2013, AM J EPIDEMIOL, V177, P264, DOI 10.1093/aje/kws436; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Celum CL, 2001, J INFECT DIS, V183, P23, DOI 10.1086/317658; Cousins MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101043; Cousins MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027211; Curtis KA, 2016, AIDS RES HUM RETROV, V32, P561, DOI [10.1089/aid.2015.0247, 10.1089/AID.2015.0247]; Curtis KA, 2014, AIDS RES HUM RETROV, V30, P1099, DOI 10.1089/aid.2014.0105; Curtis KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107153; Curtis KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077765; Curtis KA, 2012, AIDS RES HUM RETROV, V28, P188, DOI [10.1089/aid.2011.0037, 10.1089/AID.2011.0037]; Curtis KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064201; Duong YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114947; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; FISHBEIN DB, 1985, JAMA-J AM MED ASSOC, V254, P930, DOI 10.1001/jama.254.7.930; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hanson DL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152327; Hauser A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098038; Incidence Assay Critical Path Working G, 2011, PLOS MED, V8; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; KAPLAN JE, 1992, J ACQ IMMUN DEF SYND, V5, P565; KAPLAN JE, 1987, JAMA-J AM MED ASSOC, V257, P335, DOI 10.1001/jama.257.3.335; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Keating SM, 2012, J CLIN MICROBIOL, V50, P3968, DOI 10.1128/JCM.01454-12; Konikoff J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082772; Laeyendecker O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078818; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; Longosz AF, 2014, AIDS, V28, P1227, DOI 10.1097/QAD.0000000000000221; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; Mei JV, 2011, JAIDS-J ACQ IMM DEF, V58, P482, DOI 10.1097/QAI.0b013e318230dd77; Moyo S, 2015, VIRUSES-BASEL, V7, P5508, DOI 10.3390/v7102887; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Rawal BD, 2003, JAIDS-J ACQ IMM DEF, V33, P349, DOI 10.1097/00126334-200307010-00009; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; Sharma Usha K, 2012, AIDS Res Hum Retroviruses, V28, P532, DOI 10.1089/AID.2011.0332; STEVENS J, 1986, APPL MULTIVARIATE ST; Suligoi B, 2003, JAIDS-J ACQ IMM DEF, V32, P424, DOI 10.1097/00126334-200304010-00012; UNAIDS Reference Group, 2006, WKLY EPIDEMIOL REC, V81, P40; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176593	10.1371/journal.pone.0176593	http://dx.doi.org/10.1371/journal.pone.0176593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472089	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500057
J	Liu, WT; Wu, HT; Juang, JN; Wisniewski, A; Lee, HC; Wu, D; Lo, YL				Liu, Wen-Te; Wu, Hau-tieng; Juang, Jer-Nan; Wisniewski, Adam; Lee, Hsin-Chien; Wu, Dean; Lo, Yu-Lun			Prediction of the severity of obstructive sleep apnea by anthropometric features via support vector machine	PLOS ONE			English	Article							FAT DISTRIBUTION; BODY-FAT; POSTMENOPAUSAL WOMEN; ADULTS; GENDER; PREVALENCE; OBESITY; IMPACT; INDEX; RATIO	To develop an applicable prediction for obstructive sleep apnea (OSA) is still a challenge in clinical practice. We apply a modern machine learning method, the support vector machine to establish a predicting model for the severity of OSA. The support vector machine was applied to build up a prediction model based on three anthropometric features (neck circumference, waist circumference, and body mass index) and age on the first database. The established model was then valided independently on the second database. The anthropometric features and age were combined to generate powerful predictors for OSA. Following the common practice, we predict if a subject has the apnea-hypopnea index greater then 15 or not as well as 30 or not. Dividing by genders and age, for the AHI threhosld 15 (respectively 30), the cross validation and testing accuracy for the prediction were 85.3% and 76.7% (respectively 83.7% and 75.5%) in young female, while the negative likelihood ratio for the AHI threhosld 15 (respectively 30) for the cross validation and testing were 0.2 and 0.32 (respectively 0.06 and 0.1) in young female. The more accurate results with lower negative likelihood ratio in the younger patients, especially the female subgroup, reflect the potential of the proposed model for the screening purpose and the importance of approaching by different genders and the effects of aging.	[Liu, Wen-Te] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Pulm Med, New Taipei, Taiwan; [Liu, Wen-Te] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Liu, Wen-Te] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Liu, Wen-Te; Juang, Jer-Nan] Natl Cheng Kung Univ, Dept Engn Sci, Tainan, Taiwan; [Liu, Wen-Te; Lee, Hsin-Chien] Taipei Med Univ, Taipei Med Univ Hosp, Sleep Sci Ctr, Taipei, Taiwan; [Liu, Wen-Te; Lee, Hsin-Chien; Wu, Dean] Taipei Med Univ, Shuang Ho Hosp, Sleep Ctr, New Taipei, Taiwan; [Wu, Hau-tieng; Wisniewski, Adam] Univ Toronto, Dept Math, Toronto, ON, Canada; [Lee, Hsin-Chien] Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, New Taipei, Taiwan; [Lee, Hsin-Chien] Taipei Med Univ, Coll Med, Sch Med, Dept Psychiat & Med Humanities, Taipei, Taiwan; [Wu, Dean] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan; [Wu, Dean] Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan; [Lo, Yu-Lun] Chang Gung Univ, Chang Gung Mem Hosp, Healthcare Ctr, Sch Med,Dept Thorac Med, Taoyuan, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; National Cheng Kung University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Shuang Ho Hospital; University of Toronto; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Chang Gung Memorial Hospital; Chang Gung University	Lo, YL (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Healthcare Ctr, Sch Med,Dept Thorac Med, Taoyuan, Taiwan.	lo3043@cgmh.org.tw		lee, hsin-chien/0000-0002-7557-8259; Wu, Hau-Tieng/0000-0002-0253-3156				Banhiran Wish, 2014, Journal of the Medical Association of Thailand, V97, P644; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Caixexa JAD, 2015, SLEEP BREATH, V19, P231, DOI 10.1007/s11325-014-1001-1; Deurenberg P, 1999, INT J OBESITY, V23, P537, DOI 10.1038/sj.ijo.0800868; Edwards BA, 2014, SLEEP, V37, P1227, DOI 10.5665/sleep.3844; Gibson GJ, 2005, BRIT MED BULL, V72, P49, DOI 10.1093/bmb/ldh044; Golbidi S, 2012, LUNG, V190, P113, DOI 10.1007/s00408-011-9340-1; Hastie T., 2009, UNSUPERVISED LEARNIN; Iber C., 2007, AASM MANUAL SCORING; Kapur V, 1999, SLEEP, V22, P749, DOI 10.1093/sleep/22.6.749; Katz SL, 2014, J CLIN SLEEP MED, V10, P1303, DOI 10.5664/jcsm.4284; Lee RWW, 2010, SLEEP, V33, P1075, DOI 10.1093/sleep/33.8.1075; Leger D, 2012, SLEEP MED REV, V16, P455, DOI 10.1016/j.smrv.2011.10.001; Li KK, 2000, LARYNGOSCOPE, V110, P1689, DOI 10.1097/00005537-200010000-00022; Lim YH, 2014, ANN OTO RHINOL LARYN, V123, P517, DOI 10.1177/0003489414526134; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Manber R, 2003, SLEEP, V26, P163; Mazzuca E, 2014, J SLEEP RES, V23, P13, DOI 10.1111/jsr.12088; McNicholas Walter T, 2008, Proc Am Thorac Soc, V5, P154, DOI 10.1513/pats.200708-118MG; Medicine PMTFotAAoS, 2007, J CLIN SLEEP MED JCS, V3, P737; MILLMAN RP, 1995, CHEST, V107, P362, DOI 10.1378/chest.107.2.362; Mirrakhimov AE, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-10; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Ogretmenoglu O, 2005, LARYNGOSCOPE, V115, P1493, DOI 10.1097/01.mlg.0000172204.82314.c3; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Ralls FM, 2012, CURR OPIN PULM MED, V18, P568, DOI 10.1097/MCP.0b013e328358be05; Simpson L, 2010, SLEEP, V33, P467, DOI 10.1093/sleep/33.4.467; Subramanian S, 2012, SLEEP BREATH, V16, P1091, DOI 10.1007/s11325-011-0607-9; Tremollieres FA, 1996, AM J OBSTET GYNECOL, V175, P1594, DOI 10.1016/S0002-9378(96)70111-4; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; Whittle AT, 1999, THORAX, V54, P323, DOI 10.1136/thx.54.4.323; Wysocki J, 2015, FOLIA MORPHOL WARSZ; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young Terry, 2009, WMJ, V108, P246	34	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176991	10.1371/journal.pone.0176991	http://dx.doi.org/10.1371/journal.pone.0176991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472141	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500110
J	Ma, YC; Liu, RL; Lv, HQ; Han, JQ; Zhong, DX; Zhang, XM				Ma, Yucheng; Liu, Ruiling; Lv, Hongqiang; Han, Jiuqiang; Zhong, Dexing; Zhang, Xinman			A computational method for prediction of matrix proteins in endogenous retroviruses	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; LARGE WHITE-PIG; REPLICATION-COMPETENT; NUCLEOTIDE-SEQUENCE; HUMAN-CELLS; MOLECULAR CLONES; MINIATURE SWINE; DNA-SEQUENCE; IN-VIVO; IDENTIFICATION	Human endogenous retroviruses (HERVs) encode active retroviral proteins, which may be involved in the progression of cancer and other diseases. Matrix protein (MA), in groupspecific antigen genes (gag) of retroviruses, is associated with the virus envelope glycoproteins in most mammalian retroviruses and may be involved in virus particle assembly, transport and budding. However, the amount of annotated MAs in ERVs is still at a low level so far. No computational method to predict the exact start and end coordinates of MAs in gags has been proposed yet. In this paper, a computational method to identify MAs in ERVs is proposed. A divide and conquer technique was designed and applied to the conventional prediction model to acquire better results when dealing with gene sequences with various lengths. Initiation sites and termination sites were predicted separately and then combined according to their intervals. Three different algorithms were applied and compared: weighted support vector machine (WSVM), weighted extreme learning machine (WELM) and random forest (RF). G-mean (geometric mean of sensitivity and specificity) values of initiation sites and termination sites under 5-fold cross validation generated by random forest models are 0.9869 and 0.9755 respectively, highest among the algorithms applied. Our prediction models combine RF & WSVM algorithms to achieve the best prediction results. 98.4% of all the collected ERV sequences with complete MAs (125 in total) could be predicted exactly correct by the models. 94,671 HERV sequences from 118 families were scanned by the model, 104 new putative MAs were predicted in human chromosomes. Distributions of the putative MAs and optimizations of model parameters were also analyzed. The usage of our predicting method was also expanded to other retroviruses and satisfying results were acquired.	[Ma, Yucheng; Liu, Ruiling; Lv, Hongqiang; Han, Jiuqiang; Zhong, Dexing; Zhang, Xinman] Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian, Peoples R China	Xi'an Jiaotong University	Liu, RL; Lv, HQ (corresponding author), Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian, Peoples R China.	meggie@mail.xjtu.edu.cn; hongqianglv@mail.xjtu.edu.cn		Ma, Yucheng/0000-0002-9498-3452	National Natural Science Foundation of Shaanxi Province [2012JQ8042]; China Postdoctoral Science Foundation [2015M580851]	National Natural Science Foundation of Shaanxi Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grant from National Natural Science Foundation of Shaanxi Province (No. 2012JQ8042) at http://www.sninfo.gov.cn and by grant from China Postdoctoral Science Foundation (No. 2015M580851) at http://chinapostdoctor.org.cn The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahi YS, 2016, MBIO, V7, DOI 10.1128/mBio.01985-16; Akiyoshi DE, 1998, J VIROL, V72, P4503, DOI 10.1128/JVI.72.5.4503-4507.1998; Anai Y, 2012, J VIROL, V86, P8634, DOI 10.1128/JVI.00280-12; Barbulescu M, 1999, CURR BIOL, V9, P861, DOI 10.1016/S0960-9822(99)80390-X; BARTMAN T, 1995, J VIROL, V69, P3224, DOI 10.1128/JVI.69.5.3224-3228.1995; Bartosch B, 2004, J VIROL, V78, P13880, DOI 10.1128/JVI.78.24.13880-13890.2004; Bartosch B, 2002, J GEN VIROL, V83, P2231, DOI 10.1099/0022-1317-83-9-2231; Beck-Engeser GB, 2015, J GEN VIROL, V96, P3396, DOI 10.1099/jgv.0.000271; Boller K, 1997, J VIROL, V71, P4581, DOI 10.1128/JVI.71.6.4581-4588.1997; Breiman L, 1992, SUBMODEL SELECTION E, P291; Cingoz O, 2012, J VIROL, V86, P328, DOI 10.1128/JVI.06022-11; COPELAND NG, 1988, J VIROL, V62, P479, DOI 10.1128/JVI.62.2.479-487.1988; Cornelis G, 2015, P NATL ACAD SCI USA, V112, pE487, DOI 10.1073/pnas.1417000112; Cui Y, 2013, BIOCHEM BIOPH RES CO, V431, P221, DOI 10.1016/j.bbrc.2012.12.131; Czauderna F, 2000, J VIROL, V74, P4028, DOI 10.1128/JVI.74.9.4028-4038.2000; de Parseval N, 2001, VIROLOGY, V279, P558, DOI 10.1006/viro.2000.0737; Deng YM, 2000, TRANSPLANTATION, V70, P1010, DOI 10.1097/00007890-200010150-00004; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Escalera-Zamudio M, 2015, J VIROL, V89, P5180, DOI 10.1128/JVI.03452-14; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Griffiths DJ, 2002, J VIROL, V76, P7094, DOI 10.1128/JVI.76.14.7094-7102.2002; Hanger JJ, 2000, J VIROL, V74, P4264, DOI 10.1128/JVI.74.9.4264-4272.2000; HERR W, 1984, J VIROL, V49, P471, DOI 10.1128/JVI.49.2.471-478.1984; Herring C, 2001, J VIROL, V75, P12252, DOI 10.1128/JVI.75.24.12252-12265.2001; Hirschl S, 2007, VIRUS RES, V123, P211, DOI 10.1016/j.virusres.2006.08.010; Ho TK, 1995, RANDOM DECISION FORE, V271, P278; Huang GB, 2011, INT J MACH LEARN CYB, V2, P107, DOI 10.1007/s13042-011-0019-y; Huder JB, 2002, J VIROL, V76, P7607, DOI 10.1128/JVI.76.15.7607-7615.2002; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Jung WY, 2010, ANIM GENET, V41, P89, DOI 10.1111/j.1365-2052.2009.01953.x; Kim HS, 2001, AIDS RES HUM RETROV, V17, P1665, DOI 10.1089/088922201753342086; Kim NY, 2009, VIRUS GENES, V39, P210, DOI 10.1007/s11262-009-0377-7; Krach U, 2001, J VIROL, V75, P5465, DOI 10.1128/JVI.75.12.5465-5472.2001; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; LOWER R, 1993, P NATL ACAD SCI USA, V90, P4480, DOI 10.1073/pnas.90.10.4480; Ma YY, 2010, COMP IMMUNOL MICROB, V33, P323, DOI 10.1016/j.cimid.2008.10.007; Machnik G, 2014, FOLIA BIOL-PRAGUE, V60, P35; Marsh AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040158; Martin J, 2004, NATURE, V432, P988, DOI 10.1038/nature03187; Mayer J, 1999, NAT GENET, V21, P257, DOI 10.1038/6766; Mendoza R, 2011, J VIROL, V85, P9247, DOI 10.1128/JVI.05137-11; Miller AD, 2008, J VIROL, V82, P6862, DOI 10.1128/JVI.00397-08; Monde K, 2012, J VIROL, V86, P11194, DOI 10.1128/JVI.00301-12; Niebert M, 2002, J VIROL, V76, P2714, DOI 10.1128/JVI.76.6.2714-2720.2002; Onions D, 2011, VACCINE, V29, P7117, DOI 10.1016/j.vaccine.2011.05.071; ONO M, 1986, J VIROL, V60, P589, DOI 10.1128/JVI.60.2.589-598.1986; POLICASTRO PF, 1989, J VIROL, V63, P4136, DOI 10.1128/JVI.63.10.4136-4147.1989; Pothlichet J, 2006, INT J CANCER, V119, P1869, DOI 10.1002/ijc.22066; Pothlichet J, 2006, INT J CANCER, V119, P815, DOI 10.1002/ijc.21935; PRATS AC, 1989, J MOL BIOL, V205, P363, DOI 10.1016/0022-2836(89)90347-1; Preuss T, 2006, J VIROL, V80, P10258, DOI 10.1128/JVI.01140-06; Reis BS, 2013, CLIN CANCER RES, V19, P6112, DOI 10.1158/1078-0432.CCR-12-3580; Scherer SE, 2006, NATURE, V440, P346, DOI 10.1038/nature04569; Scobie L, 2004, J VIROL, V78, P2502, DOI 10.1128/JVI.78.5.2502-2509.2004; Shimode S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08164; Sperber GO, 2007, NUCLEIC ACIDS RES, V35, P4964, DOI 10.1093/nar/gkm515; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Sugimoto J, 2001, GENOMICS, V72, P137, DOI 10.1006/geno.2001.6473; Summers MF, 2009, P NATL ACAD SCI USA, P11364; Suntsova M, 2015, CELL MOL LIFE SCI, V72, P3653, DOI 10.1007/s00018-015-1947-6; Tang HB, 2015, GENOME ANNOUNC, V3; Tian F, 2009, AMINO ACIDS, V36, P535, DOI 10.1007/s00726-008-0116-8; Tonjes RR, 1997, VIROLOGY, V233, P280, DOI 10.1006/viro.1997.8614; Tonjes RR, 1999, J VIROL, V73, P9187; Triviai I, 2014, P NATL ACAD SCI USA, V111, P8595, DOI 10.1073/pnas.1401215111; Turner G, 2001, CURR BIOL, V11, P1531, DOI 10.1016/S0960-9822(01)00455-9; vanderKuyl AC, 1997, J VIROL, V71, P3666, DOI 10.1128/JVI.71.5.3666-3676.1997; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Villesen Palle, 2004, Retrovirology, V1, P32, DOI 10.1186/1742-4690-1-32; Voisset C, 2000, AIDS RES HUM RETROV, V16, P731, DOI 10.1089/088922200308738; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Wu HL, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0238-0; Wu TY, 2005, J VIROL, V79, P9677, DOI 10.1128/JVI.79.15.9677-9684.2005; Xiang SL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-228; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yoshikawa R, 2015, VIRUS RES, V196, P128, DOI 10.1016/j.virusres.2014.11.020; Yu SL, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/482568	78	2	2	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176909	10.1371/journal.pone.0176909	http://dx.doi.org/10.1371/journal.pone.0176909			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472185	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500095
J	Tanaka, T; Terai, Y; Ashihara, K; Fujiwara, S; Tanaka, Y; Sasaki, H; Tsunetoh, S; Ohmichi, M				Tanaka, Tomohito; Terai, Yoshito; Ashihara, Keisuke; Fujiwara, Satoe; Tanaka, Yoshimichi; Sasaki, Hiroshi; Tsunetoh, Satoshi; Ohmichi, Masahide			The efficacy of the cyclin-dependent kinase 4/6 inhibitor in endometrial cancer	PLOS ONE			English	Article							CDK4/6 INHIBITION; CELL-CYCLE; PD 0332991; PALBOCICLIB; PD-0332991; EXPRESSION; PD0332991; PROTEIN	Background PD-0332991, the selective cyclin-dependent kinase 4/6 inhibitor palbociclib, causes cell cycle arrest by inhibiting phosphorylation of retinoblastoma (Rb) protein. The aim of this study was to evaluate the therapeutic potential of PD-0332991 in endometrial cancer. Methods and findings Four human endometrial cancer cell lines, ECC, HEC1A, HEC108 and TEN, were treated with PD-0332991 and their function was evaluated. In vivo, the therapeutic efficacy was evaluated in a model of subcutaneous endometrial cancer. An immunohistochemical analysis was performed in 337 endometrial cancer specimens. A proliferation assay revealed that 2 of the 4 cell lines that expressed Rb were sensitive to PD-0332991 with an IC50 of 0.65 mu M ( HEC1A) and 0.58 mu M( HEC108), respectively. Both cell lines had G0/G1 cell cycle arrest after treatment with PD-0332991 according to flow cytometry. In vivo, PD-0332991 had anti-tumoral efficacy with a reduction in the activity of Ki67 and phosphorylation of Rb. Immunohistochemical analyses revealed that the positive rate of Rb was 67.7%, however, there was no significant relationship between the expression levels of Rb and the tumor grade. Conclusions PD-0332991 had therapeutic potential against endometrial cancer cell lines expressing Rb protein. Our immunohistochemical analysis revealed that approximately 70% of patients with endometrial cancer might have therapeutic indications for PD-0332991. Of note, the tumor grade had no impact on the indications for treatment.	[Tanaka, Tomohito; Terai, Yoshito; Ashihara, Keisuke; Fujiwara, Satoe; Tanaka, Yoshimichi; Sasaki, Hiroshi; Tsunetoh, Satoshi; Ohmichi, Masahide] Osaka Med Coll, Dept Obstet & Gynecol, Takatsuki, Osaka, Japan	Osaka Medical College	Tanaka, T (corresponding author), Osaka Med Coll, Dept Obstet & Gynecol, Takatsuki, Osaka, Japan.	gyn123@osaka-med.ac.jp		tanaka, tomohito/0000-0003-4210-701X	JSPS KAKENHI [25462621]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a JSPS KAKENHI Grant, Number 25462621 (to Y. Terai).	BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Bollard J, 2016, GUT; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Caldon CE, 2006, J CELL BIOCHEM, V97, P261, DOI 10.1002/jcb.20690; Comstock CES, 2013, ONCOGENE, V32, P5481, DOI 10.1038/onc.2013.83; Creasman WT., 2007, CLIN GYNECOLOGIC ONC; DeMichele A, 2015, CLIN CANCER RES, V21, P995, DOI 10.1158/1078-0432.CCR-14-2258; Ferrandina G, 2005, GYNECOL ONCOL, V98, P383, DOI 10.1016/j.ygyno.2005.04.024; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Flaherty KT, 2012, CLIN CANCER RES, V18, P568, DOI 10.1158/1078-0432.CCR-11-0509; Fry DW, 2004, MOL CANCER THER, V3, P1427; Hirahatake K, 1997, J SURG ONCOL, V65, P82, DOI 10.1002/(SICI)1096-9098(199706)65:2<82::AID-JSO3>3.0.CO;2-J; Iglesias DA, 2011, GYNECOLOGIC ONCOLOGY; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Konecny GE, 2011, CLIN CANCER RES, V17, P1591, DOI 10.1158/1078-0432.CCR-10-2307; Leonard JP, 2012, BLOOD, V119, P4597, DOI 10.1182/blood-2011-10-388298; MORROW CP, 1991, GYNECOL ONCOL, V40, P55, DOI 10.1016/0090-8258(91)90086-K; Parrish KE, 2015, J PHARMACOL EXP THER, V355, P264, DOI 10.1124/jpet.115.228213; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Silververg SG, 2003, TUMOURS BREAST FEMAL; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Turner NC, 2015, N ENGL J MED; Vaughn DJ, 2015, CANCER-AM CANCER SOC, V121, P1463, DOI 10.1002/cncr.29213; Wiedemeyer WR, 2010, P NATL ACAD SCI USA, V107, P11501, DOI 10.1073/pnas.1001613107; Yang BY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155145	28	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177019	10.1371/journal.pone.0177019	http://dx.doi.org/10.1371/journal.pone.0177019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472136	Green Submitted, gold, Green Published			2022-12-27	WOS:000400648500120
J	Willkomm, L; Gehlert, S; Jacko, D; Schiffer, T; Bloch, W				Willkomm, Lena; Gehlert, Sebastian; Jacko, Daniel; Schiffer, Thorsten; Bloch, Wilhelm			p38 MAPK activation and H3K4 trimethylation is decreased by lactate in vitro and high intensity resistance training in human skeletal muscle	PLOS ONE			English	Article							LENGTHENING CONTRACTIONS; HISTONE MODIFICATIONS; SIGNALING PATHWAYS; GENE-EXPRESSION; EXERCISE; RECRUITMENT; RESPONSES; COMPLEXES; CELLS; PHOSPHORYLATION	Exercise induces adaptation of skeletal muscle by acutely modulating intracellular signaling, gene expression, protein turnover and myogenic activation of skeletal muscle stem cells (Satellite cells, SCs). Lactate (La)-induced metabolic stimulation alone has been shown to modify SC proliferation and differentiation. Although the mechanistic basis remains elusive, it was demonstrated that La affects signaling via p38 mitogen activated protein kinase (p38 MAPK) which might contribute to trimethylation of histone 3 lysine 4 (H3K4me3) known to regulate satellite cell proliferation and differentiation. We investigated the effects of La on p38 MAPK and H3K4me3 in a model of activated SCs. Differentiating C2C12 myoblasts were treated with La (20 mM) and samples analysed using qRT-PCR, immunofluorescence, and western blotting. We determined a reduction of p38 MAPK phosphorylation, decreased H3K4me3 and reduced expression of Myf5, myogenin, and myosin heavy chain (MHC) leading to decreased differentiation of La-treated C2C12 cells after 5 days of repeated La treatment. We further investigated whether this regulatory pathway would be affected in human skeletal muscle by the application of two different resistance exercise regimes (RE) associated with distinct metabolic demands and blood La accumulation. Muscle biopsies were obtained 15, 30 min, 1, 4, and 24 h post exercise after moderate intensity RE (STD) vs. high intensity RE (HIT). Consistent with in vitro results, reduced p38 phosphorylation and blunted H3K4me3 were also observed upon metabolically demanding HIT RE in human skeletal muscle. Our data provide evidence that La-accumulation acutely affects p38 MAPK signaling, gene expression and thereby cell differentiation and adaptation in vitro, and likely in vivo.	[Willkomm, Lena; Gehlert, Sebastian; Jacko, Daniel; Bloch, Wilhelm] German Sport Univ Cologne, Dept Mol & Cellular Sports Med, Inst Cardiovasc Res & Sports Med, Cologne, Germany; [Schiffer, Thorsten] German Sport Univ Cologne, Outpatient Clin Sports Traumatol, Cologne, Germany; [Willkomm, Lena] Bayer Pharma AG, Cross Indicat Platform, Dis Genom, Wuppertal, Germany	German Sport University Cologne; German Sport University Cologne; Bayer AG; Bayer Healthcare Pharmaceuticals	Gehlert, S (corresponding author), German Sport Univ Cologne, Dept Mol & Cellular Sports Med, Inst Cardiovasc Res & Sports Med, Cologne, Germany.	gehlert@dshs-koeln.de	Gehlert, Sebastian/P-7687-2016; Gehlert, Sebastian/AAU-7086-2021	Gehlert, Sebastian/0000-0001-6940-3084; 	Federal Institute of Sport Science (BISp) [IIA1-507070103-09-10]	Federal Institute of Sport Science (BISp)	The human study was funded by the Federal Institute of Sport Science (BISp), Project # IIA1-507070103-09-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburg TM, 2007, J APPL PHYSIOL, V103, P1752, DOI 10.1152/japplphysiol.00496.2007; Aziz A, 2010, EPIGENETICS-US, V5, P691, DOI 10.4161/epi.5.8.13045; Baker JS, 2010, J NUTR METAB, V2010, DOI 10.1155/2010/905612; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Beltman JGM, 2004, EUR J APPL PHYSIOL, V92, P485, DOI 10.1007/s00421-004-1105-6; Bergman BC, 1999, J APPL PHYSIOL, P87; BIGLANDRITCHIE B, 1976, J PHYSIOL-LONDON, V260, P267, DOI 10.1113/jphysiol.1976.sp011515; Buitrago S, 2013, J STRENGTH COND RES, V27, P1091, DOI 10.1519/JSC.0b013e318260ec77; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; Gehlert S, 2014, PFLUGERS ARCH; Gibala M, 2009, APPL PHYSIOL NUTR ME, V34, P428, DOI 10.1139/H09-046; Godin R, 2010, J PHYSIOL-LONDON, V588, P4073, DOI 10.1113/jphysiol.2010.195925; Hashimoto T, 2008, MED SCI SPORT EXER, V40, P486, DOI [10.1249/MSS.0b013e31815fcb04, 10.1249/mss.0b013e31815fcb04]; Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hunter GR, 2003, J STRENGTH COND RES, V17, P76, DOI 10.1519/00124278-200302000-00013; JACOBS I, 1981, ACTA PHYSIOL SCAND, V111, P465, DOI 10.1111/j.1748-1716.1981.tb06764.x; JACOBS I, 1982, MED SCI SPORT EXER, V14, P457, DOI 10.1249/00005768-198206000-00009; JACOBS I, 1983, J APPL PHYSIOL, V55, P365, DOI 10.1152/jappl.1983.55.2.365; Kadi F, 2000, HISTOCHEM CELL BIOL, V113, P99, DOI 10.1007/s004180050012; KARLSSON J, 1971, ACTA PHYSIOL SCAND, P1; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Krustrup P, 2004, PFLUG ARCH EUR J PHY, V449, P56, DOI 10.1007/s00424-004-1304-3; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lagally KM, 2002, MED SCI SPORT EXER, V34, P552, DOI 10.1097/00005768-200203000-00025; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; Martineau LC, 2001, J APPL PHYSIOL, V91, P693, DOI 10.1152/jappl.2001.91.2.693; Mcgee SL, 2011, J APPL PHYSIOL, V110, P258, DOI 10.1152/japplphysiol.00979.2010; McGee SL, 2009, J PHYSIOL-LONDON, V587, P5951, DOI 10.1113/jphysiol.2009.181065; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Mendler AN, 2012, INT J CANCER, V131, P633, DOI 10.1002/ijc.26410; Milovanova TN, 2008, MOL CELL BIOL, V28, P6248, DOI 10.1128/MCB.00795-08; Moller AB, 2013, PFLUG ARCH EUR J PHY, V465, P1785, DOI 10.1007/s00424-013-1318-9; NARDONE A, 1988, J PHYSIOL-LONDON, V395, P363, DOI 10.1113/jphysiol.1988.sp016924; Petrella JK, 2006, AM J PHYSIOL-ENDOC M, V291, pE937, DOI 10.1152/ajpendo.00190.2006; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Szivak TK, 2013, J STRENGTH COND RES, V27, P748, DOI 10.1519/JSC.0b013e318259e009; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Tannerstedt J, 2009, J APPL PHYSIOL, V106, P1412, DOI 10.1152/japplphysiol.91243.2008; Tesch P, 1980, Acta Physiol Scand Suppl, V480, P1; Thornton MK, 2002, MED SCI SPORT EXER, V34, P715, DOI 10.1249/00005768-200204000-00024; Widegren U, 1998, FASEB J, V12, P1379, DOI 10.1096/fasebj.12.13.1379; Willkomm L, 2014, STEM CELL RES, V12, P742, DOI 10.1016/j.scr.2014.03.004	50	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176609	10.1371/journal.pone.0176609	http://dx.doi.org/10.1371/journal.pone.0176609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467493	Green Published, gold, Green Submitted			2022-12-27	WOS:000400647000061
J	Niewieczerzal, S; Sulkowska, JI				Niewieczerzal, Szymon; Sulkowska, Joanna I.			Knotting and unknotting proteins in the chaperonin cage: Effects of the excluded volume	PLOS ONE			English	Article							MONTE-CARLO SIMULATIONS; STRUCTURE-BASED MODELS; FOLDING MECHANISMS; TOPOLOGICAL FRUSTRATION; MOLECULAR-DYNAMICS; ESCHERICHIA-COLI; IN-VITRO; CONFINEMENT; KNOTS; THERMODYNAMICS	Molecular dynamics simulations are used to explore the effects of chaperonin-like cages on knotted proteins with very low sequence similarity, different depths of a knot but with a similar fold, and the same type of topology. The investigated proteins are VirC2, DndE and MJ0366 with two depths of a knot. A comprehensive picture how encapsulation influences folding rates is provided based on the analysis of different cage sizes and temperature conditions. Neither of these two effects with regard to knotted proteins has been studied by means of molecular dynamics simulations with coarse-grained structure-based models before. We show that encapsulation in a chaperonin is sufficient to self-tie and untie small knotted proteins ( VirC2, DndE), for which the equilibrium process is not accessible in the bulk solvent. Furthermore, we find that encapsulation reduces backtracking that arises from the destabilisation of nucleation sites, smoothing the free energy landscape. However, this effect can also be coupled with temperature rise. Encapsulation facilitates knotting at the early stage of folding and can enhance an alternative folding route. Comparison to unknotted proteins with the same fold shows directly how encapsulation influences the free energy landscape. In addition, we find that as the size of the cage decreases, folding times increase almost exponentially in a certain range of cage sizes, in accordance with confinement theory and experimental data for unknotted proteins.	[Niewieczerzal, Szymon; Sulkowska, Joanna I.] Univ Warsaw, Ctr New Technol, Banacha 2c, PL-02097 Warsaw, Poland; [Sulkowska, Joanna I.] Univ Warsaw, Dept Chem, Pasteura 1, PL-02093 Warsaw, Poland	University of Warsaw; University of Warsaw	Sulkowska, JI (corresponding author), Univ Warsaw, Ctr New Technol, Banacha 2c, PL-02097 Warsaw, Poland.; Sulkowska, JI (corresponding author), Univ Warsaw, Dept Chem, Pasteura 1, PL-02093 Warsaw, Poland.	jsulkowska@cent.uw.edu.pl		Sulkowska, Joanna/0000-0003-2452-0724	National Science Centre [2012/07/E/NZ1/01900]; European Molecular Biology Organization (EMBO) [2057]	National Science Centre(National Science Centre, Poland); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This work was supported by National Science Centre 2012/07/E/NZ1/01900, https://ncn.gov.pI/?language=en and European Molecular Biology Organization (EMBO) Installation Grant 2057. JIS is a principal investigator of both grants.; This work was supported by National Science Centre 2012/07/E/NZ1/01900 and EMBO Installation Grant 2057.	Andersson FI, 2009, FEBS J, V276, P2625, DOI 10.1111/j.1742-4658.2009.06990.x; Beccara SA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003002; Best RB, 2013, P NATL ACAD SCI USA, V110, P17874, DOI 10.1073/pnas.1311599110; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Cheung MS, 2006, J MOL BIOL, V357, P632, DOI 10.1016/j.jmb.2005.12.048; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; D'Adamo G, 2015, MACROMOLECULES, V48, P6337, DOI 10.1021/acs.macromol.5b01323; Dai L, 2016, MACROMOLECULES; Dai L, 2015, MACROMOLECULES, V48, P2812, DOI 10.1021/acs.macromol.5b00280; Ewing B, 1997, PROGR KNOT THEORY RE, V56, P51; FREYD P, 1985, B AM MATH SOC, V12, P239, DOI 10.1090/S0273-0979-1985-15361-3; Gosavi S, 2006, J MOL BIOL, V357, P986, DOI 10.1016/j.jmb.2005.11.074; Grosberg AY, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.217801; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hu W, 2012, CELL RES, V22, P1203, DOI 10.1038/cr.2012.66; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jamroz M, 2014, NUCLEIC ACIDS RES; Jarmolinska AI, 2016, KNOTTED MEM IN PRESS; Jewett AI, 2004, P NATL ACAD SCI USA, V101, P13192, DOI 10.1073/pnas.0400720101; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; King NP, 2010, P NATL ACAD SCI USA, V107, P20732, DOI 10.1073/pnas.1007602107; Klimov DK, 2002, P NATL ACAD SCI USA, V99, P8019, DOI 10.1073/pnas.072220699; KONIARIS K, 1991, J CHEM PHYS, V95, P2873, DOI 10.1063/1.460889; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lammert H, 2009, PROTEINS, V77, P881, DOI 10.1002/prot.22511; Li WF, 2012, P NATL ACAD SCI USA, V109, P17789, DOI 10.1073/pnas.1201807109; Lim NCH, 2015, J MOL BIOL, V427, P248, DOI 10.1016/j.jmb.2014.09.007; Lin PK, 2012, MACROMOLECULES, V45, P2920, DOI 10.1021/ma202695e; Lu J, 2009, P NATL ACAD SCI USA, V106, P9643, DOI 10.1073/pnas.0812199106; Mallam AL, 2012, NAT CHEM BIOL, V8, P147, DOI 10.1038/nchembio.742; Mallam AL, 2010, P NATL ACAD SCI USA, V107, P8189, DOI 10.1073/pnas.0912161107; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Micheletti C, 2014, ACS MACRO LETT, V3, P876, DOI 10.1021/mz500402s; Mittal J, 2008, P NATL ACAD SCI USA, V105, P20233, DOI 10.1073/pnas.0807742105; Najafi S, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4934541; Noel JK, 2013, J PHYS CHEM LETT, V4, P3570, DOI 10.1021/jz401842f; Noel JK, 2010, P NATL ACAD SCI USA, V107, P15403, DOI 10.1073/pnas.1009522107; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Ping G, 2003, J CHEM PHYS, V118, P8042, DOI 10.1063/1.1564053; Przytycki J.H., 1988, KOBE J MATH, V4, P115; Rathore N, 2006, BIOPHYS J, V90, P1767, DOI 10.1529/biophysj.105.071076; Shea JE, 1999, P NATL ACAD SCI USA, V96, P12512, DOI 10.1073/pnas.96.22.12512; Sulkowska JI, 2013, BIOCHEM SOC T, V41, P523, DOI 10.1042/BST20120342; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, pE1715, DOI 10.1073/pnas.1205918109; Sulkowska JI, 2009, P NATL ACAD SCI USA, V106, P3119, DOI 10.1073/pnas.0811147106; Sulkowska JI, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.058106; Takagi F, 2003, P NATL ACAD SCI USA, V100, P11367, DOI 10.1073/pnas.1831920100; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; VANGIESSEN AE, 1995, J CHEM PHYS, V102, P9069, DOI 10.1063/1.468855; Wallin S, 2007, J MOL BIOL, V368, P884, DOI 10.1016/j.jmb.2007.02.035; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Wu X, 2015, ADV EXP MED BIOL, V827, P93, DOI 10.1007/978-94-017-9245-5_8; Yang D, 2013, P NATL ACAD SCI USA, V110, pE4298, DOI 10.1073/pnas.1318862110	55	16	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176744	10.1371/journal.pone.0176744	http://dx.doi.org/10.1371/journal.pone.0176744			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489858	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314100030
J	Liu, WC; Ren, J; Zhang, JL; Song, XH; Liu, SL; Chi, XY; Chen, Y; Wen, ZH; Li, JM; Chen, W				Liu, Weicen; Ren, Jun; Zhang, Jinlong; Song, Xiaohong; Liu, Shuling; Chi, Xiangyang; Chen, Yi; Wen, Zhonghua; Li, Jianmin; Chen, Wei			Identification and characterization of a neutralizing monoclonal antibody that provides complete protection against Yersinia pestis	PLOS ONE			English	Article							CAPSULAR ANTIGEN; VACCINE; PURIFICATION; EFFICACY; STRAIN; VIRUS	Yersinia pestis (Y. pestis) has caused an alarming number of deaths throughout recorded human history, and novel prophylactics and therapeutics are necessary given its potential as a bioweapon. Only one monoclonal antibody has been identified to date that provides complete protection against Y. pestis. Here, we describe a second novel murine monoclonal antibody (F2H5) that provided complete protection against Y. pestis 141 infection when administered prophylactically to Balb/c mice (100 mu g intravenously). We humanized F2H5, characterized its ability to bind to the Y. pestis F1 protein and further characterized the neutralizing epitope using computational and experimental approaches. While Western blot results suggested a linear epitope, peptide mapping using ELISA failed to identify an epitope, suggesting a conformational epitope instead. We adopted a computational approach based on Residue Contact Frequency to predict the site of antigen-antibody interaction and defined the F2H5/F1 binding site computationally. Based on computational approach, we determined that residues G(104)E(105)N(106) in F1 were critical to F2H5 binding and that CDRH2 and CDRH3 of F2H5 interacted with F1. Our results show that combining computational approach and experimental approach can effectively identify epitopes.	[Liu, Weicen; Ren, Jun; Zhang, Jinlong; Song, Xiaohong; Liu, Shuling; Chi, Xiangyang; Chen, Yi; Wen, Zhonghua; Li, Jianmin; Chen, Wei] Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing, Peoples R China		Chen, W (corresponding author), Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, 20 FengTai Dongdajie St, Beijing, Peoples R China.	lijmqz@126.com; cw0226@foxmail.com	zhang, jin/GXV-9154-2022; LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022		National Natural Science Foundation of China [81172980]; State Project For Essential Drug Research and Development [2013ZX09304103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Project For Essential Drug Research and Development	This work was supported by the National Natural Science Foundation of China (grant no.81172980) to WC and the State Project For Essential Drug Research and Development (grant no. 2013ZX09304103) to JML.	Anderson GW, 1997, AM J TROP MED HYG, V56, P471, DOI 10.4269/ajtmh.1997.56.471; Andrews GP, 1996, INFECT IMMUN, V64, P2180, DOI 10.1128/IAI.64.6.2180-2187.1996; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P89; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chichester JA, 2009, VACCINE, V27, P3471, DOI 10.1016/j.vaccine.2009.01.050; Chua CL, 2014, J VIROL METHODS, V195, P126, DOI 10.1016/j.jviromet.2013.10.015; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Erova TE, 2013, CLIN VACCINE IMMUNOL, V20, P227, DOI 10.1128/CVI.00597-12; Galimand M, 2006, ANTIMICROB AGENTS CH, V50, P3233, DOI 10.1128/AAC.00306-06; Huang SS, 2014, INT J NANOMED, V9, P813, DOI 10.2147/IJN.S56260; Hwang H, 2014, PROTEINS, V82, P57, DOI 10.1002/prot.24354; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Mazumdar S, 2009, MABS-AUSTIN, V1, P531, DOI 10.4161/mabs.1.6.10195; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Qi ZZ, 2012, CLIN VACCINE IMMUNOL, V19, P1746, DOI 10.1128/CVI.00455-12; Quenee LE, 2010, VACCINE, V28, P1870, DOI 10.1016/j.vaccine.2009.11.076; Ren J, 2009, VACCINE, V27, P7436, DOI 10.1016/j.vaccine.2009.07.015; RUSSELL P, 1995, VACCINE, V13, P1551, DOI 10.1016/0264-410X(95)00090-N; Sofer-Podesta C, 2009, INFECT IMMUN, V77, P1561, DOI 10.1128/IAI.00856-08; Subramanian GM, 2005, CLIN INFECT DIS, V41, P12, DOI 10.1086/430708; Tharakaraman K, 2013, P NATL ACAD SCI USA, V110, pE1555, DOI 10.1073/pnas.1303645110; Vorontsov E D, 1990, Biomed Sci, V1, P391; Vreven T, 2015, J MOL BIOL, V427, P3031, DOI 10.1016/j.jmb.2015.07.016; Wang T, 2008, PROTEIN EXPRES PURIF, V61, P7, DOI 10.1016/j.pep.2008.05.003; Xiao XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013047; Xu Jun-jie, 2005, Weishengwu Xuebao, V45, P947; Zhang J, 2013, PROCEEDINGS OF THE 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE FOR ENGINEERING SOLUTIONS (CIES), P29, DOI 10.1109/CIES.2013.6611725	27	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177012	10.1371/journal.pone.0177012	http://dx.doi.org/10.1371/journal.pone.0177012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486528	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000034
J	Thomas, FM; Vesk, PA				Thomas, Freya M.; Vesk, Peter A.			Are trait-growth models transferable? Predicting multi-species growth trajectories between ecosystems using plant functional traits	PLOS ONE			English	Article							SPECIES-AREA CURVES; LEAF TRAITS; TREE GROWTH; DEMOGRAPHIC RATES; BAYESIAN MEASURES; RESPONSES; HEIGHT; DISTRIBUTIONS; RESTORATION; PERFORMANCE	Plant functional traits are increasingly used to generalize across species, however few examples exist of predictions from trait-based models being evaluated in new species or new places. Can we use functional traits to predict growth of unknown species in different areas? We used three independently collected datasets, each containing data on heights of individuals from non-resprouting species over a chronosquence of time-since-fire sites from three ecosystems in south-eastern Australia. We examined the influence of specific leaf area, woody density, seed size and leaf nitrogen content on three aspects of plant growth; maximum relative growth rate, age at maximum growth and asymptotic height. We tested our capacity to perform out-of-sample prediction of growth trajectories between ecosystems using species functional traits. We found strong trait-growth relationships in one of the datasets; whereby species with low SLA achieved the greatest asymptotic heights, species with high leaf-nitrogen content achieved relatively fast growth rates, and species with low seed mass reached their time of maximum growth early. However these same growth-trait relationships did not hold across the two other datasets, making accurate prediction from one dataset to another unachievable. We believe there is evidence to suggest that growth trajectories themselves may be fundamentally different between ecosystems and that trait-height- growth relationships may change over environmental gradients.	[Thomas, Freya M.; Vesk, Peter A.] Univ Melbourne, Sch Biosci, ARC Ctr Excellence Environm Decis, Melbourne, Vic, Australia	University of Melbourne	Thomas, FM (corresponding author), Univ Melbourne, Sch Biosci, ARC Ctr Excellence Environm Decis, Melbourne, Vic, Australia.	freyamthomas@gmail.com	Vesk, Peter/AAG-9970-2020	Vesk, Peter/0000-0003-2008-7062	Australian Postgraduate Award, a Holsworth Wildlife Research Scholarship; Australian Research Council Centre of Excellence in Environmental Decisions (CEED); CEED	Australian Postgraduate Award, a Holsworth Wildlife Research Scholarship; Australian Research Council Centre of Excellence in Environmental Decisions (CEED)(Australian Research Council); CEED	FMT is supported by an Australian Postgraduate Award, a Holsworth Wildlife Research Scholarship and top up from Australian Research Council Centre of Excellence in Environmental Decisions (CEED). PAV is supported by CEED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2014, P NATL ACAD SCI USA, V111, P740, DOI 10.1073/pnas.1315179111; Beven K, 2002, P ROY SOC A-MATH PHY, V458, P2465, DOI 10.1098/rspa.2002.0986; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cordlandwehr V, 2013, J ECOL, V101, P662, DOI 10.1111/1365-2745.12091; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Cunningham SA, 1999, ECOL MONOGR, V69, P569, DOI 10.1890/0012-9615(1999)069[0569:EDILSA]2.0.CO;2; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; Diaz S, 2016, NATURE, V529, P167, DOI 10.1038/nature16489; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Falster DS, 2008, AM NAT, V172, P299, DOI 10.1086/589889; Falster DS, 2005, OIKOS, V111, P57, DOI 10.1111/j.0030-1299.2005.13383.x; Falster DS, 2005, J ECOL, V93, P521, DOI 10.1111/j.0022-0477.2005.00992.x; Fonseca CR, 2000, J ECOL, V88, P964, DOI 10.1046/j.1365-2745.2000.00506.x; Funk JL, 2013, ECOLOGY, V94, P1893, DOI 10.1890/12-1602.1; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; HARRIS GP, 1994, FRESHWATER BIOL, V32, P143, DOI 10.1111/j.1365-2427.1994.tb00874.x; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; Herault B, 2010, J APPL ECOL, V47, P821, DOI 10.1111/j.1365-2664.2010.01826.x; Hooten MB, 2015, ECOL MONOGR, V85, P3, DOI 10.1890/14-0661.1; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; King DA, 2005, FUNCT ECOL, V19, P445, DOI 10.1111/j.1365-2435.2005.00982.x; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; Kobayashi K, 2000, AGRON J, V92, P345, DOI 10.1007/s100870050043; Kobe RK, 1999, ECOLOGY, V80, P187, DOI 10.1890/0012-9658(1999)080[0187:LGPATT]2.0.CO;2; Kunstler G, 2016, NATURE, V529, P204, DOI 10.1038/nature16476; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Martinez-Garza C, 2013, FOREST ECOL MANAG, V303, P35, DOI 10.1016/j.foreco.2013.03.046; Martinez-Vilalta J, 2010, J ECOL, V98, P1462, DOI 10.1111/j.1365-2745.2010.01718.x; May F, 2013, PERSPECT PLANT ECOL, V15, P304, DOI 10.1016/j.ppees.2013.08.002; Mayfield MM, 2013, AM J BOT, V100, P1356, DOI 10.3732/ajb.1200461; Mlambo MC, 2014, BIODIVERS CONSERV, V23, P781, DOI 10.1007/s10531-014-0618-5; Moles AT, 2006, OIKOS, V113, P91, DOI 10.1111/j.0030-1299.2006.14194.x; Muir AM, 2014, AUST J BOT, V62, P369, DOI 10.1071/BT14117; Olden JD, 2000, ECOSCIENCE, V7, P501, DOI 10.1080/11956860.2000.11682622; Paine CET, 2015, J ECOL, V103, P978, DOI 10.1111/1365-2745.12401; Paine CET, 2012, METHODS ECOL EVOL, V3, P245, DOI 10.1111/j.2041-210X.2011.00155.x; Pickering CM, 2013, INCREASING RESILIENC, P94; Plummer M., 2011, JAGS VERSION 3 3 0 U; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Ruger N, 2012, FUNCT ECOL, V26, P759, DOI 10.1111/j.1365-2435.2012.01981.x; Sandel B, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00175.1; Schwilk DW, 2011, J ECOL, V99, P970, DOI 10.1111/j.1365-2745.2011.01828.x; Specht RL., 1970, AUSTR ENV, P44; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sterck FJ, 2006, AM NAT, V167, P758, DOI 10.1086/503056; Su YS, 2015, SYSTEMREQUIREMENTS; Thomas SC, 1996, AM J BOT, V83, P556, DOI 10.2307/2445913; Thomas SC, 1999, ECOLOGY, V80, P1607; Tjorve E, 2003, J BIOGEOGR, V30, P827, DOI 10.1046/j.1365-2699.2003.00877.x; Tjorve E, 2010, J THEOR BIOL, V267, P417, DOI 10.1016/j.jtbi.2010.09.008; Tjorve E, 2009, J BIOGEOGR, V36, P1435, DOI 10.1111/j.1365-2699.2009.02101.x; Vesk PA, 2001, J APPL ECOL, V38, P897, DOI 10.1046/j.1365-2664.2001.00646.x; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Wilfahrt PA, 2014, FOREST ECOL MANAG, P1; Williams NSG, 2015, PERSPECT PLANT ECOL, V17, P78, DOI 10.1016/j.ppees.2014.10.002; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x	63	14	15	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176959	10.1371/journal.pone.0176959	http://dx.doi.org/10.1371/journal.pone.0176959			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486535	Green Published, gold			2022-12-27	WOS:000401314000031
J	Liu, T; Liang, YC; Chu, GX				Liu, Tao; Liang, Yongchao; Chu, Guixin			Nitrapyrin addition mitigates nitrous oxide emissions and raises nitrogen use efficiency in plastic-film-mulched drip-fertigated cotton field	PLOS ONE			English	Article							NITRIFICATION INHIBITORS; N2O EMISSIONS; NITRIC-OXIDE; SOIL; WHEAT; DENITRIFICATION; CROP; FLUXES; CORN	Nitrification inhibitors (NIs) have been used extensively to reduce nitrogen losses and increase crop nitrogen nutrition. However, information is still scant regarding the influence of NIs on nitrogen transformation, nitrous oxide (N2O) emission and nitrogen utilization in plastic-film-mulched calcareous soil under high frequency drip-fertigated condition. Therefore, a field trial was conducted to evaluate the effect of nitrapyrin (2-chloro-6-(trichloromethyl)-pyridine) on soil mineral nitrogen (N) transformation, N2O emission and nitrogen use efficiency (NUE) in a drip-fertigated cotton-growing calcareous field. Three treatments were established: control (no N fertilizer), urea (225 kg N ha(-1)) and urea+nitrapyrin (225 kg N ha(-1) +2.25 kg nitrapyrin ha(-1)). Compared with urea alone, urea plus nitrapyrin decreased the average N2O emission fluxes by 6.6-21.8% in June, July and August significantly in a drip-fertigation cycle. Urea application increased the seasonal cumulative N2O emission by 2.4 kg N ha(-1) compared with control, and nitrapyrin addition significantly mitigated the seasonal N2O emission by 14.3% compared with urea only. During the main growing season, the average soil ammonium nitrogen (NH4+-N) concentration was 28.0% greater and soil nitrate nitrogen (NO3--N) concentration was 13.8% less in the urea+nitrapyrin treatment than in the urea treatment. Soil NO3--N and water-filled pore space (WFPS) were more closely correlated than soil NH4+-N with soil N2O fluxes under drip-fertigated condition (P<0.001). Compared with urea alone, urea plus nitrapyrin reduced the seasonal N2O emission factor (EF) by 32.4% while increasing nitrogen use efficiency by 10.7%. The results demonstrated that nitrapyrin addition significantly inhibited soil nitrification and maintained more NH4+-N in soil, mitigated N2O losses and improved nitrogen use efficiency in plastic-film-mulched calcareous soil under high frequency drip-fertigated condition.	[Liu, Tao; Chu, Guixin] Shihezi Univ, Coll Agr, Xinjiang Prod & Construct Grp, Key Lab Oasis Ecoagr, Shihezi, Peoples R China; [Liang, Yongchao] Zhejiang Univ, Coll Environm & Resource Sci, Key Lab Environm Remediat & Ecol Hlth, Minist Educ, Hangzhou, Zhejiang, Peoples R China	Shihezi University; Zhejiang University	Chu, GX (corresponding author), Shihezi Univ, Coll Agr, Xinjiang Prod & Construct Grp, Key Lab Oasis Ecoagr, Shihezi, Peoples R China.; Liang, YC (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Key Lab Environm Remediat & Ecol Hlth, Minist Educ, Hangzhou, Zhejiang, Peoples R China.	ycliang@zju.edu.cn; chuguixinshzu@163.com	Liang, Yongchao/S-9281-2019; Liang, Yongchao/D-5809-2012	Liang, Yongchao/0000-0002-0501-2823; Liang, Yongchao/0000-0002-0501-2823	Natural Science Foundation of China (NSFC) entitled "The response of N2O emission and soil nitrification-denireification key processing microbial molecular ecological mechanism on nitrapyrin in drip irrigation cropland" P. R. China [41461064]; National Key Basic Research Support Foundation of China (NKBRSF) entitled "Soil Microbial Community Structure in Paddy-upland Crop Rotation System in Relation to Efficient Nitrogen Use in Paddy Field" [2015C6150502]; 12th Five-Year Key Programs for Science and Technology Development of China entitled "Study of Key Technologies for Alleviating Obstacle Factors and Improving Productivity of Low-yield Cropland" [2012BAD05B06]	Natural Science Foundation of China (NSFC) entitled "The response of N2O emission and soil nitrification-denireification key processing microbial molecular ecological mechanism on nitrapyrin in drip irrigation cropland" P. R. China; National Key Basic Research Support Foundation of China (NKBRSF) entitled "Soil Microbial Community Structure in Paddy-upland Crop Rotation System in Relation to Efficient Nitrogen Use in Paddy Field"; 12th Five-Year Key Programs for Science and Technology Development of China entitled "Study of Key Technologies for Alleviating Obstacle Factors and Improving Productivity of Low-yield Cropland"	Our work was supported by three resources of funding; they were: The Natural Science Foundation of China (NSFC) entitled "The response of N2O emission and soil nitrification-denireification key processing microbial molecular ecological mechanism on nitrapyrin in drip irrigation cropland" (approved no. 41461064), P. R. China; The National Key Basic Research Support Foundation of China (NKBRSF) entitled "Soil Microbial Community Structure in Paddy-upland Crop Rotation System in Relation to Efficient Nitrogen Use in Paddy Field" (approved no. 2015C6150502); The 12th Five-Year Key Programs for Science and Technology Development of China entitled "Study of Key Technologies for Alleviating Obstacle Factors and Improving Productivity of Low-yield Cropland" (approved no. 2012BAD05B06).	Abalos D, 2014, SCI TOTAL ENVIRON, V490, P880, DOI 10.1016/j.scitotenv.2014.05.065; AULAKH MS, 1984, SOIL BIOL BIOCHEM, V16, P351, DOI 10.1016/0038-0717(84)90031-2; Bateman EJ, 2005, BIOL FERT SOILS, V41, P379, DOI 10.1007/s00374-005-0858-3; Bhatia A, 2010, AGR ECOSYST ENVIRON, V136, P247, DOI 10.1016/j.agee.2010.01.004; BRONSON KF, 1992, SOIL SCI SOC AM J, V56, P161, DOI 10.2136/sssaj1992.03615995005600010025x; Brown L, 2001, ATMOS ENVIRON, V35, P1439, DOI 10.1016/S1352-2310(00)00361-7; CRAWFORD DM, 1993, PLANT SOIL, V149, P59, DOI 10.1007/BF00010763; DAVIDSON EA, 1986, APPL ENVIRON MICROB, V52, P1287, DOI 10.1128/AEM.52.6.1287-1292.1986; Di HJ, 2012, SOIL USE MANAGE, V28, P54, DOI 10.1111/j.1475-2743.2011.00373.x; Ding WX, 2007, SCI TOTAL ENVIRON, V373, P501, DOI 10.1016/j.scitotenv.2006.12.026; DUXBURY JM, 1982, NATURE, V298, P462, DOI 10.1038/298462a0; FRENEY JR, 1993, FERT RES, V34, P37, DOI 10.1007/BF00749958; HUBER DM, 1977, BIOSCIENCE, V27, P523, DOI 10.2307/1297812; Lin S, 2011, ATMOS ENVIRON, V45, P1775, DOI 10.1016/j.atmosenv.2011.01.003; Liu CY, 2014, ATMOS ENVIRON, V96, P201, DOI 10.1016/j.atmosenv.2014.07.040; Liu CY, 2010, PLANT SOIL, V332, P123, DOI 10.1007/s11104-009-0278-5; [刘涛 Liu Tao], 2011, [土壤, Soils], V43, P758; Lopez NI, 2003, SOIL BIOL BIOCHEM, V35, P1609, DOI 10.1016/j.soilbio.2003.08.005; Lu R.K, 2000, ANAL METHOD SOIL AGR; Majumdar D, 2002, AGR ECOSYST ENVIRON, V91, P283, DOI 10.1016/S0167-8809(01)00223-7; Maljanen M, 2003, SOIL BIOL BIOCHEM, V35, P689, DOI 10.1016/S0038-0717(03)00085-3; Maljanen M, 2007, SOIL BIOL BIOCHEM, V39, P914, DOI 10.1016/j.soilbio.2006.11.001; Merino P, 2005, SOIL USE MANAGE, V21, P53, DOI 10.1079/SUM2005292; Merino P, 2012, SOIL TILL RES, V123, P29, DOI 10.1016/j.still.2012.03.005; Parkin TB, 2010, AGR ECOSYST ENVIRON, V136, P81, DOI 10.1016/j.agee.2009.11.014; Pihlatie M, 2004, NUTR CYCL AGROECOSYS, V70, P135, DOI 10.1023/B:FRES.0000048475.81211.3c; Ravishankara A. R., 2009, Science (Washington), V326, P123, DOI 10.1126/science.1176985; Scheer C, 2009, PLANT SOIL, V314, P273, DOI 10.1007/s11104-008-9728-8; Scheer C, 2008, SOIL BIOL BIOCHEM, V40, P290, DOI 10.1016/j.soilbio.2007.08.007; SKIBA U, 1993, SOIL BIOL BIOCHEM, V25, P1527, DOI 10.1016/0038-0717(93)90007-X; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sun H, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/169680; SWEZEY AW, 1962, AGRON J, V54, P532, DOI 10.2134/agronj1962.00021962005400060020x; Velthof GL, 2002, NUTR CYCL AGROECOSYS, V62, P249, DOI 10.1023/A:1021259107244; Vilain G, 2014, NUTR CYCL AGROECOSYS, V98, P169, DOI 10.1007/s10705-014-9604-2; Weiske A, 2001, BIOL FERT SOILS, V34, P109, DOI 10.1007/s003740100386; Wolt JD, 2004, NUTR CYCL AGROECOSYS, V69, P23, DOI 10.1023/B:FRES.0000025287.52565.99; Xiong Wu, 2013, Acta Pedologica Sinica, V50, P743; Zaman M, 2009, SOIL BIOL BIOCHEM, V41, P1270, DOI 10.1016/j.soilbio.2009.03.011; Zhang M, 2015, AGR ECOSYST ENVIRON, V201, P43, DOI 10.1016/j.agee.2014.12.003; Zhang Q., 2010, CHIN J ECOAGRIC, p[18, 7]; Zheng XH, 2000, CHEMOSPHERE GLOBAL C, V2, P204; Zou JW, 2010, ENVIRON POLLUT, V158, P631, DOI 10.1016/j.envpol.2009.08.026; Zou JW, 2005, ATMOS ENVIRON, V39, P4755, DOI 10.1016/j.atmosenv.2005.04.028	44	17	23	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176305	10.1371/journal.pone.0176305	http://dx.doi.org/10.1371/journal.pone.0176305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481923	Green Published, gold, Green Submitted			2022-12-27	WOS:000401313700009
J	Bridge, K; Revill, C; Macrae, F; Bailey, M; Yuldasheva, N; Wheatcroft, S; Butlin, R; Foster, R; Scott, DJ; Gils, A; Ariens, R				Bridge, Katherine; Revill, Charlotte; Macrae, Fraser; Bailey, Marc; Yuldasheva, Nadira; Wheatcroft, Stephen; Butlin, Roger; Foster, Richard; Scott, D. Julian; Gils, Ann; Ariens, Robert			Inhibition of plasmin-mediated TAFI activation may affect development but not progression of abdominal aortic aneurysms	PLOS ONE			English	Article							FIBRINOLYSIS INHIBITOR; DEFICIENT MICE; INTRALUMINAL THROMBUS; OPEN REPAIR; MORTALITY; OSTEOPONTIN; MEN	Objective Thrombin-activatable fibrinolysis inhibitor (TAFI) reduces the breakdown of fibrin clots through its action as an indirect inhibitor of plasmin. Studies in TAFI-deficient mice have implicated a potential role for TAFI in Abdominal Aortic Aneurysm (AAA) disease. The role of TAFI inhibition on AAA formation in adult ApoE-/- mice is unknown. The aim of this paper was to investigate the effects of TAFI inhibition on AAA development and progression. Methods Using the Angiotensin II model of AAA, male ApoE-/- mice were infused with Angiotensin II 750ng/kg/min with or without a monoclonal antibody inhibitor of plasmin-mediated activation of TAFI, MA-TCK26D6, or a competitive small molecule inhibitor of TAFI, UK-396082. Results Inhibition of TAFI in the Angiotensin II model resulted in a decrease in the mortality associated with AAA rupture (from 40.0% to 16.6% with MA-TCK26D6 (log-rank Mantel Cox test p = 0.16), and 8.3% with UK-396082 (log-rank Mantel Cox test p = 0.05)). Inhibition of plasmin- mediated TAFI activation reduced the incidence of AAA from 52.4% to 30.0%. However, late treatment with MA-TCK26D6 once AAA were already established had no effect on the progression of AAA in this model. Conclusions The formation of intra-mural thrombus is responsible for the dissection and early rupture in the angiotensin II model of AAA, and this process can be prevented through inhibition of TAFI. Late treatment with a TAFI inhibitor does not prevent AAA progression. These data may indicate a role for inhibition of plasmin-mediated TAFI activation in the early stages of AAA development, but not in its progression.	[Bridge, Katherine; Macrae, Fraser; Bailey, Marc; Yuldasheva, Nadira; Wheatcroft, Stephen; Scott, D. Julian; Ariens, Robert] Univ Leeds, Leeds Inst Cardiovasc & Metab Res, Div Cardiovasc & Diabet Res, Thrombosis & Tissue Repair Grp, Leeds, W Yorkshire, England; [Bridge, Katherine; Bailey, Marc; Scott, D. Julian] Leeds Gen Infirm, Leeds Vasc Inst, Leeds, W Yorkshire, England; [Revill, Charlotte; Butlin, Roger; Foster, Richard] Univ Leeds, Sch Chem, Leeds, W Yorkshire, England; [Gils, Ann] Univ Leuven, KU Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Therapeut & Diagnost Antibodies, Leuven, Belgium	University of Leeds; Leeds General Infirmary; University of Leeds; University of Leeds; KU Leuven	Ariens, R (corresponding author), Univ Leeds, Leeds Inst Cardiovasc & Metab Res, Div Cardiovasc & Diabet Res, Thrombosis & Tissue Repair Grp, Leeds, W Yorkshire, England.	r.a.s.ariens@leeds.ac.uk	Macrae, Fraser/AAN-8377-2021; Yuldasheva, Dr. Nadira Yusupovna/GXM-9013-2022; Butlin, Roger/F-7709-2013	Yuldasheva, Dr. Nadira Yusupovna/0000-0001-6213-6358; Bailey, Marc/0000-0001-5038-1970; Macrae, Fraser/0000-0002-7092-0422; Ariens, Robert/0000-0002-6310-5745; Foster, Richard/0000-0002-2361-3884; Butlin, Roger/0000-0003-4736-0954	Clinical Research Training Fellowship from the British Heart Foundation [FS/12/26/29395]; British Heart Foundation [FS/12/26/29395] Funding Source: researchfish	Clinical Research Training Fellowship from the British Heart Foundation; British Heart Foundation(British Heart Foundation)	This work was funded by a Clinical Research Training Fellowship from the British Heart Foundation (ref. FS/12/26/29395) awarded to Katherine Bridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Bailey MA, 2013, J VASC SURG, V57, P1512, DOI 10.1016/j.jvs.2012.12.030; Bouma BN, 2006, ANN MED, V38, P378, DOI 10.1080/07853890600852898; Brady AR, 2001, ARTERIOSCL THROM VAS, V21, P1203, DOI 10.1161/hq0701.091999; Bridge KI, 2014, THROMB HAEMOSTASIS, V112, P901, DOI 10.1160/TH14-02-0184; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Buelens K, 2010, J THROMB HAEMOST, V8, P1302, DOI 10.1111/j.1538-7836.2010.03816.x; Bunnage ME, 2007, J MED CHEM, V50, P6095, DOI 10.1021/jm0702433; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Dubis J, 2014, BLOOD COAGUL FIBRIN, V25, P226, DOI 10.1097/MBC.0000000000000028; Foley JH, 2013, J THROMB HAEMOST, V11, P306, DOI 10.1111/jth.12216; Folkesson M, 2011, ATHEROSCLEROSIS, V218, P294, DOI 10.1016/j.atherosclerosis.2011.05.002; Gils A, 2005, J THROMB HAEMOST, V3, P2745, DOI 10.1111/j.1538-7836.2005.01629.x; Hobbs SD, 2007, J VASC SURG, V46, P682, DOI 10.1016/j.jvs.2007.05.057; Lederle FA, 2011, CIRCULATION, V124, P1097, DOI 10.1161/CIRCULATIONAHA.111.052365; Lindholt JS, 2001, J VASC SURG, V34, P611, DOI 10.1067/mva.2001.119040; Parry DJ, 2009, BRIT J SURG, V96, P870, DOI 10.1002/bjs.6632; Schultz G, 2010, ARTERIOSCL THROM VAS, V30, P1363, DOI 10.1161/ATVBAHA.109.202259; Scott DJA, 2011, ARTERIOSCL THROM VAS, V31, P3004, DOI 10.1161/ATVBAHA.111.236786; Semeraro F, 2013, J THROMB HAEMOST, V11, P2137, DOI 10.1111/jth.12431; Sidloff D, 2014, CIRCULATION, V129, P747, DOI 10.1161/CIRCULATIONAHA.113.005457; Vercauteren E, 2011, BLOOD, V117, P4615, DOI 10.1182/blood-2010-08-303677; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; Wyseure T, 2015, BLOOD, V125, P1325, DOI 10.1182/blood-2014-07-588319	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177117	10.1371/journal.pone.0177117	http://dx.doi.org/10.1371/journal.pone.0177117			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472123	Green Published, gold			2022-12-27	WOS:000400648500138
J	Gadoev, J; Asadov, D; Harries, AD; Parpiev, N; Tayler-Smith, K; Isaakidis, P; Ali, E; Hinderaker, SG; Ogtay, G; Ramsay, A; Jalolov, A; Dara, M				Gadoev, Jamshid; Asadov, Damin; Harries, Anthony D.; Parpiev, Nargiza; Tayler-Smith, Katie; Isaakidis, Petros; Ali, Engy; Hinderaker, Sven Gudmund; Ogtay, Gozalov; Ramsay, Andrew; Jalolov, Avazbek; Dara, Masoud			Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RELAPSE; REINFECTION	Background In Uzbekistan, despite stable and relatively high tuberculosis treatment success rates, relatively high rates of recurrent tuberculosis have recently been reported. Recurrent tuberculosis is when a patient who was treated for pulmonary tuberculosis and cured, later develops the disease again. This requires closer analysis to identify possible causes and recommend interventions to improve the situation. Using countrywide data, this study aimed to analyse trends in recurrent tuberculosis cases and describe their associations with socio-demographic and clinical factors. Method Countrywide retrospective cohort study comparing recurrent tuberculosis patients with all new tuberculosis patients registered within the NTP between January 2006 and December 2010 using routinely collected data. Determinants studied were baseline characteristics and treatment outcomes. Results Of 107,380 registered patients during the period January 2006 and December 2010, 9358 (8.7%) were recurrent cases. Between 2006 and 2008, the number of recurrent cases per annum increased from 1530 to 2081, then fell slightly thereafter from 2081 to 1888 cases. The proportion of all notified cases during this period increased from 6.5% to 9.9%. Factors associated with recurrent tuberculosis included age (35-55 years old), having smear positive pulmonary tuberculosis, residing in certain areas of Uzbekistan, having particular comorbidities (including chronic obstructive pulmonary disease and HIV), and being unemployed, a pensioner or disabled. Recurrent tuberculosis patients also had a higher likelihood of having an unfavourable treatment outcome Conclusion Despite signs of declining national tuberculosis notifications between 2006 and 2010, the relative proportion of recurrent cases appears to have increased. These findings, together with the identification of possible risk factors associated with recurrent tuberculosis, highlight various areas where Uzbekistan needs to focus its tuberculosis control efforts, particularly in light of the country's rapidly emerging multi drug resistant tuberculosis epidemic.	[Gadoev, Jamshid] World Hlth Org Country Off Uzbekistan, Tashkent, Uzbekistan; [Asadov, Damin] State Post Grad Inst Med Educ, Tashkent, Uzbekistan; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London, England; [Parpiev, Nargiza] Republican Specialized Sci Pract Med Ctr Phthisio, Tashkent, Uzbekistan; [Tayler-Smith, Katie; Isaakidis, Petros; Ali, Engy] MSF Luxembourg, Operat Ctr Brussels, Operat Res Unit, Luxembourg, Luxembourg; [Hinderaker, Sven Gudmund] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Ogtay, Gozalov; Dara, Masoud] WHO Reg Off Europe Joint TB HIV & Hepatitis Progr, Copenhagen, Denmark; [Ramsay, Andrew] World Bank, UNDP, UNICEF, Geneva, Switzerland; [Ramsay, Andrew] World Hlth Org, WHO Special Programme Res & Training Trop Dis TDR, Geneva, Switzerland; [Ramsay, Andrew] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Jalolov, Avazbek] Minist Hlth Republ Uzbekistan, Tashkent, Uzbekistan	World Health Organization; University of London; London School of Hygiene & Tropical Medicine; Doctors Without Borders; University of Bergen; The World Bank; World Health Organization; University of St Andrews	Gadoev, J (corresponding author), World Hlth Org Country Off Uzbekistan, Tashkent, Uzbekistan.	gadoevj@who.int		Gadoev, Jamshid/0000-0003-3998-5786; Asadov, Damin/0000-0003-2192-1418; Isaakidis, Petros/0000-0002-7881-1554	USAID in Uzbekistan; National Tuberculosis programme; WHO Country Office in Uzbekistan	USAID in Uzbekistan(United States Agency for International Development (USAID)); National Tuberculosis programme; WHO Country Office in Uzbekistan	This research was conducted through the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR) and "Partnership project for TB control" funded by USAID in Uzbekistan. The specific SORT IT programme which resulted in this publication was jointly developed and implemented by: WHO-TDR, WHO Regional Office for Europe, Republican DOTS center, Uzbekistan, the Operational Research Unit (LUXOR), Medecins Sans Frontieres, Brussels Operational Center, Luxembourg; the Centre for Operational Research, International Union Against Tuberculosis and Lung Disease, France; The Union South-East Asia Regional Office, New Delhi, India; Centre for International Health, University of Bergen, Norway. We also appreciate the active involvement of the National Tuberculosis programme and WHO Country Office in Uzbekistan and support provided during the study.	[Anonymous], 2014, ORDER MOH REPUBLIC U; Cox H, 2006, PLOS MED, V3, P1836, DOI 10.1371/journal.pmed.0030384; Cynthia R, 2001, CLIN INFECT DIS, V33, P1762; d'Arc Lyra B. J., 2008, INT J EPIDEMIOL, V37, P841; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Didilescu C, 2000, Pneumologia, V49, P247; El Sahly HM, 2004, INT J TUBERC LUNG D, V8, P333; Gadoev J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128907; Garcia V. D., 2002, ARCH INTERN MED, V162, P1873; Gulrez S. A., 2012, LUNG INDIA, V29, P147; Hovitz D. J, 2014, CURR HIV-AIDS REP, V11, P168; Hung CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124822; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P1360, DOI 10.1164/rccm.200408-1081OC; Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705; Kumar A, 2013, TROP MED INT HEALTH, V18, P636, DOI 10.1111/tmi.12084; Millet JP, 2009, J EPIDEMIOL COMMUN H, V63, P799, DOI 10.1136/jech.2008.077560; Millet JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064898; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Murray J, 2014, EUROPEAN RESP J S58, V44, P4546; Quy HTW, 2003, INT J TUBERC LUNG D, V7, P631; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Sanghani RN, 2013, THORAX, V68, P202, DOI 10.1136/thoraxjnl-2012-202976; Shu CC, 2010, MEDICINE, V89, P53, DOI 10.1097/MD.0b013e3181cafcd3; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Thomas A, 2005, INT J TUBERC LUNG D, V9, P556; Ulmasova DJ, 2013, EUROSURVEILLANCE, V18, P5, DOI 10.2807/1560-7917.ES2013.18.42.20609; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; World Health Organization, 2013, DEFINITIONS REPORTIN; Yusupova S., 2016, PUBLIC HLTH PANORAMA, V2, P1	29	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176473	10.1371/journal.pone.0176473	http://dx.doi.org/10.1371/journal.pone.0176473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472053	Green Published, Green Accepted, gold			2022-12-27	WOS:000400648500048
J	Jackwood, MW; Lee, DH				Jackwood, Mark W.; Lee, Dong-Hun			Different evolutionary trajectories of vaccine-controlled and non-controlled avian infectious bronchitis viruses in commercial poultry	PLOS ONE			English	Article							RNA VIRUS; SEROTYPE	To determine the genetic and epidemiological relationship of infectious bronchitis virus (IBV) isolates from commercial poultry to attenuated live IBV vaccines we conducted a phylogenetic network analysis on the full-length S1 sequence for Arkansas (Ark), Massachusetts (Mass) and Delmarva/1639 (DMV/1639) type viruses isolated in 2015 from clinical cases by 3 different diagnostic laboratories. Phylogenetic network analysis of Ark isolates showed two predominant groups linked by 2 mutations, consistent with subpopulations found in commercial vaccines for this IBV type. In addition, a number of satellite groups surrounding the two predominant populations were observed for the Ark type virus, which is likely due to mutations associated with the nature of this vaccine to persist in flocks. The phylogenetic network analysis of Mass-type viruses shows two groupings corresponding to different manufacturers vaccine sequences. No satellite groups were observed for Masstype viruses, which is consistent with no persistence of this vaccine type in the field. At the time of collection, no vaccine was being used for the DMV/1639 type viruses and phylogenetic network analysis showed a dispersed network suggesting no clear change in genetic distribution. Selection pressure analysis showed that the DMV/1639 and Mass-type strains were evolving under negative selection, whereas the Ark type viruses had evolved under positive selection. This data supports the hypothesis that live attenuated vaccine usage does play a role in the genetic profile of similar IB viruses in the field and phylogenetic network analysis can be used to identify vaccine and vaccine origin isolates, which is important for our understanding of the role live vaccines play in the evolutionary trajectory of those viruses.	[Jackwood, Mark W.] Univ Georgia, Coll Vet Med, Poultry Diagnost & Res Ctr, Dept Populat Hlth, Athens, GA 30602 USA; [Lee, Dong-Hun] USDA ARS, US Natl Poultry Res Ctr, Southeast Poultry Res Lab, Athens, GA 30613 USA	University System of Georgia; University of Georgia; United States Department of Agriculture (USDA)	Jackwood, MW (corresponding author), Univ Georgia, Coll Vet Med, Poultry Diagnost & Res Ctr, Dept Populat Hlth, Athens, GA 30602 USA.	mjackwoo@uga.edu	Lee, Dong-hun/H-5082-2019					Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Holmes EC, 2009, ANNU REV ECOL EVOL S, V40, P353, DOI 10.1146/annurev.ecolsys.110308.120248; Jackwood MW, 2012, INFECT GENET EVOL, V12, P1305, DOI 10.1016/j.meegid.2012.05.003; Jackwood MW, 2013, DIS POULTRY, P139, DOI DOI 10.1002/9781119421481.CH4; KANT A, 1992, J GEN VIROL, V73, P591, DOI 10.1099/0022-1317-73-3-591; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Lee CW, 2000, AVIAN DIS, V44, P650, DOI 10.2307/1593106; Lee CW, 2001, VIRUS RES, V80, P33, DOI 10.1016/S0168-1702(01)00345-8; Leyson C, 2016, VIROLOGY, V498, P218, DOI 10.1016/j.virol.2016.08.030; Lim TH, 2011, INFECT GENET EVOL, V11, P678, DOI 10.1016/j.meegid.2011.01.007; McKinley ET, 2008, VACCINE, V26, P1274, DOI 10.1016/j.vaccine.2008.01.006; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Moore KM, 1997, ARCH VIROL, V142, P2249, DOI 10.1007/s007050050239; Roh HJ, 2013, AVIAN DIS, V57, P248, DOI 10.1637/10459-112812-Reg.1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]	17	32	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176709	10.1371/journal.pone.0176709	http://dx.doi.org/10.1371/journal.pone.0176709			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472110	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500065
J	Leem, AY; Han, CH; Ahn, CM; Lee, SH; Kim, JY; Chun, EM; Yoo, KH; Jung, JY				Leem, Ah Young; Han, Chang Hoon; Ahn, Chul Min; Lee, Sang Haak; Kim, Jae Yeol; Chun, Eun Mi; Yoo, Kwang Ha; Jung, Ji Ye		Korean Smoking Cessation Study Grp	Factors associated with stage of change in smoker in relation to smoking cessation based on the Korean National Health and Nutrition Examination Survey II-V	PLOS ONE			English	Article							NICOTINE DEPENDENCE; TOBACCO USE; PHYSICAL-ACTIVITY; FAGERSTROM TEST; UNITED-STATES; ADULTS; DEPRESSION; SAMPLE; READINESS; BEHAVIORS	Despite a decrease in incidence, smoking remains the most serious public health problem worldwide. Identification of the factors contributing to changes in willingness to quit smoking may aid the development of strategies that encourage smoking cessation. Pooled cross-sectional data from 11,924 smokers from the Korean National Health and Nutrition Examination Survey II-V were analyzed. The stages of change in smoking cessation were categorized as pre-contemplation, contemplation, and preparation. Baseline characteristics, socioeconomic factors, quality of life, psychological status, and smoking-related factors were compared between groups. The smokers were grouped as follows: 32.4% pre-contemplation, 54.4% contemplation, and 13.1% preparation. The proportion of smokers in the pre-contemplation group decreased (from 37.4% to 28.4%) from 2001 to 2012, while the proportion in the preparation group increased (from 6.4% to 18.1%). Compared with the preparation group, after adjusting for confounding factors, the pre-contemplation group was older [>= 65 years-old; odds ratio (OR) = 1.40], more often single (OR = 1.38), less educated (elementary school or lower; OR = 1.93), less physically active in terms of walking (OR = 1.38) or performing strengthening exercises (OR = 1.61), smoked more heavily (>= 20 cigarettes per day; OR = 4.75), and had a lower prevalence of chronic disease (OR = 0.76). Moreover, smokers who had never received education on smoking cessation were less willing to quit than those who had (OR = 0.44). In Korean smokers, the stages of change for smoking cessation were associated with age, education, marital status, chronic diseases, physical activity, and participation in smoking cessation programs.	[Leem, Ah Young; Jung, Ji Ye] Yonsei Univ, Severance Hosp, Coll Med, Inst Chest Dis,Dept Internal Med,Div Pulmonol, Seoul, South Korea; [Han, Chang Hoon] Natl Hlth Insurance Serv Ilsan Hosp, Dept Internal Med, Div Pulmonol, Koyang, South Korea; [Ahn, Chul Min] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Internal Med,Div Pulmonol, Seoul, South Korea; [Lee, Sang Haak] Catholic Univ Korea, St Pauls Hosp, Coll Med, Dept Internal Med,Div Pulmonol Crit Care & Sleep, Seoul, South Korea; [Kim, Jae Yeol] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Chun, Eun Mi] Ewha Womans Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul, South Korea; [Yoo, Kwang Ha] Konkuk Univ, Sch Med, Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; National Health Insurance Service; Yonsei University; Yonsei University Health System; Catholic University of Korea; Chung Ang University; Chung Ang University Hospital; Ewha Womans University; Konkuk University; Konkuk University Medical Center	Jung, JY (corresponding author), Yonsei Univ, Severance Hosp, Coll Med, Inst Chest Dis,Dept Internal Med,Div Pulmonol, Seoul, South Korea.	STOPYES@yuhs.ac	Jung, Ji Ye/AAB-4993-2021	Leem, Ah Young/0000-0001-5165-3704; Jung, Ji Ye/0000-0003-1589-4142	Yonsei University College of Medicine [6-2014-0158]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant from Yonsei University College of Medicine (6-2014-0158). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a faculty research grant of Yonsei University College of Medicine for (6-2014-0158). We thank to all members of the Korean Smoking Cessation Study Group: Jae Jeong Shim (Korea University), Tae Hoon Jung (Kyoungpook National University), Yeong Hun Choe (Chonbuk National University), Hyo-Jeong Lim (Veterans Health Service Medical Center), Yong C. Lee(Chonbuk National University), Jinyoung An (Chungbuk National University), Kyeong-Cheol Shin (Yeungnam University), Jae Woo Jung (Chung-Ang University), Yeon Mok Oh (Univeristy of Ulsan), Hyoung Kyu Yoon (Catholic University of Korea), Ki Uk Kim (Pusan National University), Yu -Il Kim (Chonnam National University), Yu Jin Kim (Gachon University), Jae Yeol Kim (Chung-Ang University), Ju Ock Kim (Chungnam National University), Huijung Kim (Wonkwang University), Ju Ock Na (Soonchunhyang University), Jeong-Seon Ryu (Inha University), Won-Yeon Lee (Yonsei University), Myung Jae Park (KyungHee University), Young Sik Park (Seoul National University), Joo Hun Park (Ajou University), Hye Jung Park (Yonsei University), Ji Young Seo (Sungkyunkwan University), and Choon Hee Sohn (Dong-A University)	ANDA RF, 1990, JAMA-J AM MED ASSOC, V264, P1541, DOI 10.1001/jama.264.12.1541; Anderson JE, 2002, CHEST, V121, P932, DOI 10.1378/chest.121.3.932; Ben Taleb Z, 2016, NICOTINE TOBACCO RES; BOYLE RG, 1995, ADDICT BEHAV, V20, P443, DOI 10.1016/0306-4603(95)00013-3; Breslau N, 2004, BIOL PSYCHIAT, V55, P69, DOI 10.1016/S0006-3223(03)00317-2; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P1069; Cahill K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004492.pub4; Campbell S, 2013, INT J ENV RES PUB HE, V10, P1562, DOI 10.3390/ijerph10041562; Cho Hong-Jun, 2014, J Prev Med Public Health, V47, P129, DOI 10.3961/jpmph.2014.47.3.129; Daoud N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1950-8; Galil AGD, 2016, INT J CARDIOL, V221, P1004, DOI 10.1016/j.ijcard.2016.07.041; DICLEMENTE CC, 1991, J CONSULT CLIN PSYCH, V59, P295, DOI 10.1037/0022-006X.59.2.295; Etter JF, 2005, DRUG ALCOHOL DEPEN, V77, P259, DOI 10.1016/j.drugalcdep.2004.08.015; Etter JF, 2002, ADDICTION, V97, P1171, DOI 10.1046/j.1360-0443.2002.00198.x; Etter JF, 1999, ADDICTION, V94, P1881, DOI 10.1046/j.1360-0443.1999.9412188113.x; Fagerstrom K, 2012, NICOTINE TOB RES, V14, P1467, DOI 10.1093/ntr/nts018; Jamal A, 2014, MMWR-MORBID MORTAL W, V63, P1108; Jhun HJ, 2006, J KOREAN MED SCI, V21, P843, DOI 10.3346/jkms.2006.21.5.843; Kim DS, 2005, AM J RESP CRIT CARE, V172, P842, DOI 10.1164/rccm.200502-259OC; Laforge RG, 1999, PREV MED, V28, P61, DOI 10.1006/pmed.1998.0384; Levy David T, 2004, J Public Health Manag Pract, V10, P338; Loprinzi PD, 2016, J PHYS ACT HEALTH, V13, P1, DOI 10.1123/jpah.2014-0605; Luh DL, 2015, PREV SCI, V16, P301, DOI 10.1007/s11121-014-0471-5; Mbulo L, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150146; National Center for Chronic Disease Prevention and Health Promo- tion (U.S.) Office on Smoking and Health, 2014, HLTH CONSMOK 50 YE; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; PROCHASKA JO, 1988, J CONSULT CLIN PSYCH, V56, P520, DOI 10.1037/0022-006X.56.4.520; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; PROCHASKA JO, 1991, CLIN CHEST MED, V12, P727; PROCHASKA JO, 1985, ADDICT BEHAV, V10, P395, DOI 10.1016/0306-4603(85)90036-X; Schumann A, 2005, PSYCHOL ADDICT BEHAV, V19, P3, DOI 10.1037/0893-164X.19.1.3; Stanton CA, 2016, PREV MED, V92, P160, DOI 10.1016/j.ypmed.2016.04.008; Teychenne M, 2008, PREV MED, V46, P397, DOI 10.1016/j.ypmed.2008.01.009; VELICER WF, 1992, PSYCHOL BULL, V111, P23, DOI 10.1037/0033-2909.111.1.23; VELICER WF, 1995, PREV MED, V24, P401, DOI 10.1006/pmed.1995.1065; Wewers ME, 2003, PREV MED, V36, P710, DOI 10.1016/S0091-7435(03)00044-6; Zwar Nicolas, 2005, Aust Fam Physician, V34, P461	37	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176294	10.1371/journal.pone.0176294	http://dx.doi.org/10.1371/journal.pone.0176294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472051	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500035
J	Masubuchi, Y; Nakagawa, Y; Medina, J; Nagasawa, M; Kojima, I; Rasenick, MM; Inagaki, T; Shibata, H				Masubuchi, Yosuke; Nakagawa, Yuko; Medina, Johan; Nagasawa, Masahiro; Kojima, Itaru; Rasenick, Mark M.; Inagaki, Takeshi; Shibata, Hiroshi			T1R3 homomeric sweet taste receptor regulates adipogenesis through G alpha s-mediated microtubules disassembly and Rho activation in 3T3-L1 cells	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE-FACTOR; ADIPOCYTE DIFFERENTIATION; PROTEIN; TRANSCRIPTION; MODULATION; G-ALPHA(S); DYNAMICS; GROWTH; ACTIN	We previously reported that 3T3-L1 cells express a functional sweet taste receptor possibly as a T1R3 homomer that is coupled to Gs and negatively regulates adipogenesis by a G alpha s-mediated but cAMP-independent mechanism. Here, we show that stimulation of this receptor with sucralose or saccharin induced disassembly of the microtubules in 3T3-L1 preadipocytes, which was attenuated by overexpression of the dominant-negative mutant of G alpha s (G alpha s-G226A). In contrast, overexpression of the constitutively active mutant of G alpha s (G alpha sQ227L) as well as treatment with cholera toxin or isoproterenol but not with forskolin caused disassembly of the microtubules. Sweetener-induced microtubule disassembly was accompanied by activation of RhoA and Rho-associated kinase (ROCK). This was attenuated with by knockdown of GEF-H1, a microtubule-localized guanine nucleotide exchange factor for Rho GTPase. Furthermore, overexpression of the dominant-negative mutant of RhoA (RhoA-T19N) blocked sweetener-induced dephosphorylation of Akt and repression of PPAR. and C/EBP alpha in the early phase of adipogenic differentiation. These results suggest that the T1R3 homomeric sweet taste receptor negatively regulates adipogenesis through G alpha s-mediated microtubule disassembly and consequent activation of the Rho/ROCK pathway.	[Masubuchi, Yosuke; Nakagawa, Yuko; Medina, Johan; Nagasawa, Masahiro; Kojima, Itaru; Inagaki, Takeshi; Shibata, Hiroshi] Gunma Univ, Inst Mol & Cellular Regulat, Dept Mol & Cellular Biol, 3-39-15 Showa Machi, Maebashi, Gunma, Japan; [Rasenick, Mark M.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA; [Rasenick, Mark M.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Rasenick, Mark M.] Jesse Brown VA Med Ctr, Chicago, IL USA	Gunma University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Shibata, H (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Dept Mol & Cellular Biol, 3-39-15 Showa Machi, Maebashi, Gunma, Japan.	hshibata@gunma-u.ac.jp	Inagaki, Takeshi/J-8802-2013	Inagaki, Takeshi/0000-0003-1711-8286	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP26461325]; USPHS-NIH grant [AT009169]; US Veterans Administration Merit award [BX001149]; National Center for Complementary & Integrative Health [R01AT009169] Funding Source: NIH RePORTER; Veterans Affairs [IK6BX004475, I01BX001149] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); USPHS-NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Veterans Administration Merit award; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Japan Society for the Promotion of Science (JSPS) (https.//www.jsps.go.jp/) KAKENHI Grant Number JP26461325. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MMR is supported by USPHS-NIH grant AT009169 and US Veterans Administration Merit award BX001149.; This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number JP26461325. M.M.R. is supported by USPHS-NIH grant AT009169 and US Veterans Administration Merit award BX001149. We are grateful to Dr. Michiyuki Matsuda for Raichu1237X and Dr. Takashi Matozaki for the expression plasmids for RhoA. We also thank to Dr. Howard Green for 3T3-L1 cells.	Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Bryan BA, 2005, MOL CELL BIOL, V25, P11089, DOI 10.1128/MCB.25.24.11089-11101.2005; DJIAN P, 1985, J CELL PHYSIOL, V124, P554, DOI 10.1002/jcp.1041240327; Fischer-Posovszky P, 2012, MOL CELL ENDOCRINOL, V358, P135, DOI 10.1016/j.mce.2012.03.018; Hara Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001227; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; Horii T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005809; JONES DT, 1987, J BIOL CHEM, V262, P14241; Kanda T, 2005, FASEB J, V19, P169, DOI 10.1096/fj.05-4197fje; Kim JJ, 2009, DIABETES, V58, P1275, DOI 10.2337/db08-1001; Kojima I, 2011, DIABETES METAB J, V35, P451, DOI 10.4093/dmj.2011.35.5.451; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Laffitte A, 2014, CURR OPIN CLIN NUTR, V17, P379, DOI 10.1097/MCO.0000000000000058; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Liu LB, 2007, DIABETES, V56, P1977, DOI 10.2337/db06-1100; Magun R, 1996, ENDOCRINOLOGY, V137, P3590, DOI 10.1210/en.137.8.3590; Masubuchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054500; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Noda K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110446; Noguchi M, 2007, J BIOL CHEM, V282, P29574, DOI 10.1074/jbc.M705972200; Roper SD, 2007, PFLUG ARCH EUR J PHY, V454, P759, DOI 10.1007/s00424-007-0247-x; Sarma T, 2015, J BIOL CHEM, V290, P10045, DOI 10.1074/jbc.M114.630632; Schappi JM, 2014, BBA-BIOMEMBRANES, V1838, P674, DOI 10.1016/j.bbamem.2013.08.026; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Tomiyama K, 1995, BIOCHEM BIOPH RES CO, V212, P263; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Yu JZ, 2009, J BIOL CHEM, V284, P10462, DOI 10.1074/jbc.M809166200; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352; Yun SJ, 2008, BIOCHEM BIOPH RES CO, V371, P138, DOI 10.1016/j.bbrc.2008.04.029	32	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176841	10.1371/journal.pone.0176841	http://dx.doi.org/10.1371/journal.pone.0176841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472098	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500083
J	Sevic, I; Ledesma, MMGL; Flichman, DM; Campos, RH				Sevic, Ina; Lopez Ledesma, Maria Mora Gonzalez; Martin Flichman, Diego; Hector Campos, Rodolfo			HBV DNA genome co-transfection procedure for the evaluation of relative fitness	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CORE PROMOTER; ANTIGEN	Hepatitis B virus (HBV) has a high mutation rate and exists as a mixture of genetically different but closely related variants. We present a HBV DNA co-transfection fitness assay and use it to evaluate the relative fitness of different HBV variants in two scenarios: seroconversion process and occupation of an ecological niche. In the seroconversion experiment, subgenotype D1 (sgtD1) deletion (1763-1770) had significantly lower fitness comparing with both sgtD1 wild type and sgtD1mut G1896A, while, in the case of occupation of ecological niche experiment, the results showed the same relative fitness between all of the genotype combinations, except F1b-F4. In this case sgtF1b clearly overgrow sgtF4, which is in accordance with the observation that F1b is the most prevalent in the new infections in Argentina. In summary, we present a method aimed to evaluate HBV viral fitness which improve the analysis of the relative frequency of viral variants during the HBV infection process.	[Sevic, Ina; Lopez Ledesma, Maria Mora Gonzalez; Martin Flichman, Diego; Hector Campos, Rodolfo] Univ Buenos Aires, Fac Farm Bioguim, Dept Microbiol Inmunol & Biotecnol Catedra Virol, Buenos Aires, DF, Argentina; [Sevic, Ina; Lopez Ledesma, Maria Mora Gonzalez; Martin Flichman, Diego; Hector Campos, Rodolfo] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Campos, RH (corresponding author), Univ Buenos Aires, Fac Farm Bioguim, Dept Microbiol Inmunol & Biotecnol Catedra Virol, Buenos Aires, DF, Argentina.; Campos, RH (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina.	rcampos@ffyb.uba.ar	Sevic, Ina/ABF-2898-2021	Sevic, Ina/0000-0002-4920-5096; Gonzalez Lopez Ledesma, Maria Mora/0000-0002-2189-8388	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP2015-0595C0]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT2014-1672]; UBACyT [20020130100505BA]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); UBACyT	This work was supported by: Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP2015-0595C0], Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT2014-1672] and UBACyT [20020130100505BA 2014-2017].	Andino R, 2015, VIROLOGY, V479, P46, DOI 10.1016/j.virol.2015.03.022; Rodrigo MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159509; Domingo E, 2000, REV SCI TECH OIE, V19, P55, DOI 10.20506/rst.19.1.1210; Domingo E, 2007, VIRUS RES, V127, P131, DOI 10.1016/j.virusres.2007.02.001; Fischer SF, 2006, WORLD J GASTROENTERO, V12, P6054, DOI 10.3748/wjg.v12.i37.6054; Gao S, 2015, WORLD J HEPATOL, V7, P1086, DOI 10.4254/wjh.v7.i8.1086; Geng Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002657; Jammeh S, 2008, J GEN VIROL, V89, P901, DOI 10.1099/vir.0.83468-0; Ledesma MMGL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121436; Ledesma MMGL, 2011, INT J INFECT DIS, V15, pE314, DOI 10.1016/j.ijid.2010.12.009; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Moriyama K, 1997, J GEN VIROL, V78, P1479, DOI 10.1099/0022-1317-78-6-1479; Pezzano SC, 2011, CLIN MICROBIOL INFEC, V17, P223, DOI 10.1111/j.1469-0691.2010.03283.x; Sallam TA, 2002, J MED VIROL, V68, P328, DOI 10.1002/jmv.10207; Sede M, 2014, J VIRAL HEPATITIS, V21, P650, DOI 10.1111/jvh.12196; Sozzi V, 2016, J VIROL	16	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175543	10.1371/journal.pone.0175543	http://dx.doi.org/10.1371/journal.pone.0175543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472081	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500012
J	Echternach, M; Burk, F; Koberlein, M; Selamtzis, A; Dollinger, M; Burdumy, M; Richter, B; Herbst, CT				Echternach, Matthias; Burk, Fabian; Koeberlein, Marie; Selamtzis, Andreas; Doellinger, Michael; Burdumy, Michael; Richter, Bernhard; Herbst, Christian Thomas			Laryngeal evidence for the first and second passaggio in professionally trained sopranos	PLOS ONE			English	Article							VOCAL FOLD ADDUCTION; REGISTER TRANSITIONS; TRACT; PITCH; VOICE; VIDEOKYMOGRAPHY; MECHANISMS; RESONANCES; PHONATION; ACOUSTICS	Introduction Due to a lack of empirical data, the current understanding of the laryngeal mechanics in the passaggio regions (i.e., the fundamental frequency ranges where vocal registration events usually occur) of the female singing voice is still limited. Material and methods In this study the first and second passaggio regions of 10 professionally trained female classical soprano singers were analyzed. The sopranos performed pitch glides from A3 (f(o) = 220 Hz) to A4 (f(o) = 440 Hz) and from A4 (f(o) = 440 Hz) to A5 (f(o) = 880 Hz) on the vowel [i:]. Vocal fold vibration was assessed with trans-nasal high speed videoendoscopy at 20,000 fps, complemented by simultaneous electroglottographic (EGG) and acoustic recordings. Register breaks were perceptually rated by 12 voice experts. Voice stability was documented with the EGG-based sample entropy. Glottal opening and closing patterns during the passaggi were analyzed, supplemented with open quotient data extracted from the glottal area waveform. Results In both the first and the second passaggio, variations of vocal fold vibration patterns were found. Four distinct patterns emerged: smooth transitions with either increasing or decreasing durations of glottal closure, abrupt register transitions, and intermediate loss of vocal fold contact. Audible register transitions (in both the first and second passaggi) generally coincided with higher sample entropy values and higher open quotient variance through the respective passaggi. Conclusions Noteworthy vocal fold oscillatory registration events occur in both the first and the second passaggio even in professional sopranos. The respective transitions are hypothesized to be caused by either (a) a change of laryngeal biomechanical properties; or by (b) vocal tract resonance effects, constituting level 2 source-filter interactions.	[Echternach, Matthias; Burk, Fabian; Koeberlein, Marie; Richter, Bernhard] Univ Freiburg, Fac Med, Med Ctr, Inst Musicians Med, Freiburg, Germany; [Selamtzis, Andreas] Royal Tech Univ, Mus Acoust, Lindstedtsvagen 24, Stockholm, Sweden; [Doellinger, Michael] Univ Hosp Erlangen, Div Phoniatr & Pediat Audiol, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Waldstr 1, Erlangen, Germany; [Burdumy, Michael] Univ Freiburg, Fac Med, Med Ctr, Dept Med Phys, Freiburg, Germany; [Herbst, Christian Thomas] Univ Vienna, Dept Cognit Biol, Lab Bioacoust, Althanstr 14, Vienna, Austria	University of Freiburg; Royal Institute of Technology; University of Erlangen Nuremberg; University of Freiburg; University of Vienna	Herbst, CT (corresponding author), Univ Vienna, Dept Cognit Biol, Lab Bioacoust, Althanstr 14, Vienna, Austria.	herbst@ccrma.stanford.edu	Burdumy, Michael/M-6212-2017	Burdumy, Michael/0000-0003-4577-5515; Echternach, Matthias/0000-0003-0095-5360; Herbst, Christian/0000-0001-9095-3953; Doellinger, Michael/0000-0003-2717-4820; Selamtzis, Andreas/0000-0003-2995-1363	Deutsche Forschungsgemeinschaft (DFG) [Ec409/1-1, Ri1050/4-3, DO 1247/8-1]; Austrian Academy of Sciences; Swedish Research Council (Vetenskapsradet) [2010-4565, 2013-0642]; German Research Foundation (DFG); University of Freiburg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Austrian Academy of Sciences; Swedish Research Council (Vetenskapsradet)(Swedish Research Council); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	Matthias Echternach (grant Ec409/1-1), Bernhard Richter (grant Ri1050/4-3) and Michael Dollinger (grant DO 1247/8-1) are supported by the Deutsche Forschungsgemeinschaft (DFG). Christian T. Herbst's contribution was supported by an APART grant received from the Austrian Academy of Sciences. Andreas Selamtzis's contribution was supported by the Swedish Research Council (Vetenskapsradet) Contracts No. 2010-4565 and 2013-0642. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing. All fundings had no role in the study, at all. There are no financial interests of the authors in relation to the work.; Matthias Echternach (grant Ec409/1-1), Bernhard Richter (grant Ri1050/ 43) and Michael Dollinger (grant DO 1247/8-1) are supported by the Deutsche Forschungsgemeinschaft (DFG). Christian T. Herbsts contribution was supported by an APART grant received from the Austrian Academy of Sciences. Andreas Selamtzis contribution was supported by the Swedish Research Council (Vetenskapsradet) Contracts No. 20104565 and 20130642. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing. The authors thank Sten Ternstrom, PhD, (KTH Stockholm, Sweden) for his help in integration of the sample entropy, Manfred Nusseck (Institute of Musicians'Medicine, Freiburg, Germany) for statistical help and the twelve raters for their willingness to participate in this study.	BERKE GS, 1993, J VOICE, V7, P123, DOI 10.1016/S0892-1997(05)80341-8; Berry DA, 2001, J PHONETICS, V29, P431, DOI 10.1006/jpho.2001.0148; Bresch E, 2010, J ACOUST SOC AM, V128, pEL335, DOI 10.1121/1.3499700; Bruton A, 2000, PHYSIOTHERAPY, V86, P94, DOI [10.1016/S0031-9406(05)61211-4, DOI 10.1016/S0031-9406(05)61211-4, 10.1016/s0031-9406(05)61211-4]; Bunch M, 2000, J VOICE, V14, P363, DOI 10.1016/S0892-1997(00)80081-8; Castellengo M, 2004, P INT S MUS AC; Colton R H, 1972, Folia Phoniatr (Basel), V24, P337; Colton R H, 1973, Folia Phoniatr (Basel), V25, P62; Echternach M, 2016, J VOICE; Echternach M, 2010, UNTERSUCHUNGEN REGIS; Echternach M, 2010, UNTERSUCHUNG ANAL ST, P97; Echternach M, 2014, J VOICE, V28, p262e1; Echternach M, 2008, LOGOP PHONIATR VOCO, V33, P67, DOI 10.1080/14015430701875653; Echternach M, 2016, LOGOP PHONIATR VOCO, V41, P1, DOI 10.3109/14015439.2014.936499; Echternach M, 2015, J ACOUST SOC AM, V137, P2586, DOI 10.1121/1.4919356; Echternach M, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2012.02.003; Echternach M, 2012, J VOICE, V26, P440, DOI 10.1016/j.jvoice.2011.03.004; Echternach M, 2011, J VOICE, V25, P670, DOI 10.1016/j.jvoice.2010.09.008; Echternach M, 2011, J VOICE, V25, P663, DOI 10.1016/j.jvoice.2010.01.013; Echternach M, 2011, J ACOUST SOC AM, V129, P3955, DOI 10.1121/1.3589249; Echternach M, 2010, J VOICE, V24, P133, DOI 10.1016/j.jvoice.2008.06.004; Fant G., 1960, ACOUSTIC THEORY SPEE; Garcia M, 1841, ESCULAPE, V3, P105; Hampala V, 2016, J VOICE, V30, P161, DOI 10.1016/j.jvoice.2015.03.018; Henrich Nathalie, 2006, Logoped Phoniatr Vocol, V31, P3; Henrich N, 2011, J ACOUST SOC AM, V129, P1024, DOI 10.1121/1.3518766; Herbst CT, 2011, J ACOUST SOC AM, V129, P2253, DOI 10.1121/1.3552874; Herbst CT, 2010, J ACOUST SOC AM, V128, P3070, DOI 10.1121/1.3493423; HIRANO M, 1970, FOLIA PHONIATR, V22, P1, DOI 10.1159/000263363; Hollien H, 1983, STOCKH MUS AC C SMAC, P27; Inwald EC, 2011, J VOICE, V25, P576, DOI 10.1016/j.jvoice.2010.04.004; Joliveau E, 2004, NATURE, V427, P116, DOI 10.1038/427116a; Kochis-Jennings KA, 2012, J VOICE, V26, P182, DOI 10.1016/j.jvoice.2010.11.002; Large J, 1968, NATS B, V24, P12; Large J, 1972, NATS B, V28, P18; Lehfeldt C, 1835, HDB PHYSL MENSCHEN V; Merkel CL, 1863, ANATOMIE PHYSL MENSC; Miller D., 2000, REGISTERS SINGING EM; MILLER DG, 1993, J VOICE, V7, P206, DOI 10.1016/S0892-1997(05)80328-5; Miller R., 1986, STRUCTURE SINGING; Muller J., 1840, HDB PHYSIOLOGIE MENS; Nadoleczny M, 1923, UNTERSUCHUNGEN KUNST; Neumann K, 2005, FOLIA PHONIATR LOGO, V57, P308, DOI 10.1159/000087084; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Roubeau B, 2009, J VOICE, V23, P425, DOI 10.1016/j.jvoice.2007.10.014; RUBIN HENRY J., 1960, LARYNGOSCOPE, V70, P1305; Seidner W, 2004, DIE SANGERSTIMME; Selamtzis A, 2014, J ACOUST SOC AM, V136, P2773, DOI 10.1121/1.4896466; Sonninen A, 1999, J VOICE, V13, P319, DOI 10.1016/S0892-1997(99)80039-3; SUNDBERG J, 1975, ACUSTICA, V32, P89; Sundberg J, 2001, Logoped Phoniatr Vocol, V26, P26, DOI 10.1080/140154301300109107; Sundberg J, 1999, LOGOP PHONIATR VOCO, V24, P76; Sundberg J., 1987, SCI SINGING VOICE; Sundberg J, 2009, J VOICE, V23, P546, DOI 10.1016/j.jvoice.2008.02.003; Svec JG, 2008, J ACOUST SOC AM, V123, P347, DOI 10.1121/1.2804939; Svec JG, 1999, J ACOUST SOC AM, V106, P1523, DOI 10.1121/1.427149; Svec JG, 1996, J VOICE, V10, P201, DOI 10.1016/S0892-1997(96)80047-6; Titze IR, 2008, J ACOUST SOC AM, V123, P2733, DOI 10.1121/1.2832337; Titze IR, 2015, J ACOUST SOC AM, V137, P3005, DOI 10.1121/1.4919349; Titze IR, 2014, J ACOUST SOC AM, V135, P2091, DOI 10.1121/1.4868355; Titze IR, 2009, J ACOUST SOC AM, V126, P1530, DOI 10.1121/1.3160296; Titze IR, 1994, PRINCIPLES VOICE PRO; Titze IR, 1988, J VOICE, V2, P183, DOI [10.1016/S0892-1997(88)80075-4, DOI 10.1016/S0892-1997(88)80075-4]; Tokuda IT, 2010, J ACOUST SOC AM, V127, P1528, DOI 10.1121/1.3299201; Van den Berg JW, 1963, NATS B, V20, P16; Vennard W., 1967, SINGING MECH TECHNIC; Zanartu M, 2011, J ACOUST SOC AM, V129, P326, DOI 10.1121/1.3514536	68	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175865	10.1371/journal.pone.0175865	http://dx.doi.org/10.1371/journal.pone.0175865			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467509	Green Published, Green Submitted, gold			2022-12-27	WOS:000400647000027
J	Seo, Y; Kim, YS; Lee, KE; Park, TH; Kim, Y				Seo, Yoona; Kim, Yoo-Sun; Lee, Kyung Eun; Park, Tai Hyun; Kim, Yuri			Anti-cancer stemness and anti-invasive activity of bitter taste receptors, TAS2R8 and TAS2R10, in human neuroblastoma cells	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PROTEIN-COUPLED RECEPTORS; GENE-EXPRESSION; TUMOR-METASTASIS; BETA-CAROTENE; WILLOW BARK; IN-VITRO; CANCER; DIFFERENTIATION; MOLECULES	Neuroblastoma (NB) originates from immature neuronal cells and currently has a poor clinical outcome. NB cells possess cancer stem cells (CSCs) characteristics that facilitate the initiation of a tumor, as well as its metastasis. Human bitter taste receptors, referred to as TAS2Rs, are one of five types of basic taste receptors and they belong to a family of G-protein coupled receptors. The recent finding that taste receptors are expressed in non-gustatory tissues suggest that they mediate additional functions distinct from taste perception. While it is generally admitted that the recognition of bitter tastes may be associated with a self-defense system to prevent the ingestion of poisonous food compounds, this recognition may also serve as a disease-related function in the human body. In particular, the anti-cancer stemness and invasion effects of TAS2Rs on NB cells remain poorly understood. In the present study, endogenous expression of TAS2R8 and TAS2R10 in SK-N-BE(2) C and SH-SY5Y cells was examined. In addition, higher levels of TAS2R8 and TAS2R10 expression were investigated in more differentiated SY5Y cells. Both TAS2Rs were up-regulated following the induction of neuronal cell differentiation by retinoic acid. In addition, ectopic transfection of the two TAS2Rs induced neurite elongation in the BE(2) C cells, and down-regulated CSCs markers (including DLK1, CD133, Notch1, and Sox2), and suppressed self-renewal characteristics. In particular, TAS2RS inhibited tumorigenicity. Furthermore, when TAS2Rs was over-expressed, cell migration, cell invasion, and matrix metalloproteinases activity were inhibited. Expression levels of hypoxia-inducible factor-1 alpha, a well-known regulator of tumor metastasis, as well as its downstream targets, vascular endothelial growth factor and glucose transporter-1, were also suppressed by TAS2Rs. Taken together, these novel findings suggest that TAS2Rs targets CSCs by suppressing cancer stemness characteristics and NB cell invasion, thereby highlighting the chemotherapeutic potential of bitter taste receptors.	[Seo, Yoona; Kim, Yoo-Sun; Lee, Kyung Eun; Kim, Yuri] Ewha Womans Univ, Dept Nutr Sci & Food Management, Seoul, South Korea; [Park, Tai Hyun] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea	Ewha Womans University; Seoul National University (SNU)	Kim, Y (corresponding author), Ewha Womans Univ, Dept Nutr Sci & Food Management, Seoul, South Korea.	yuri.kim@ewha.ac.kr	Park, Tai Hyun/C-6529-2013	Seo, Yoona/0000-0001-7510-2501	Brain Korea 21 Plus [22A20130012143]	Brain Korea 21 Plus	This work was supported by the Brain Korea 21 Plus (Project No. 22A20130012143). The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-12; American Cancer Society, 2016, CANC FACTS FIGURES 2; Avau B, 2016, ACTA PHYSIOL, V216, P407, DOI 10.1111/apha.12621; Begum A, 2012, CANCER LETT, V318, P26, DOI 10.1016/j.canlet.2011.11.032; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Behrens M, 2009, RESULTS PROBL CELL D, V47, P203, DOI 10.1007/400_2008_5; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Catapano LA, 2007, BBA-BIOMEMBRANES, V1768, P976, DOI 10.1016/j.bbamem.2006.09.025; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chen K, 2013, ACTA PHARMACOL SIN, V34, P732, DOI 10.1038/aps.2013.27; CICCARONE V, 1989, CANCER RES, V49, P219; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Das S, 2003, MOL CELL BIOCHEM, V253, P31, DOI 10.1023/A:1026093016148; Dehkordi O, 2012, BRAIN RES, V1475, P1, DOI 10.1016/j.brainres.2012.07.038; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Foster SR, 2014, PHARMACOL THERAPEUT, V142, P41, DOI 10.1016/j.pharmthera.2013.11.004; Gaida MM, 2016, ONCOTARGET, V7, P12623, DOI 10.18632/oncotarget.7206; Garcia-Esparcia P, 2013, J NEUROPATH EXP NEUR, V72, P524, DOI 10.1097/NEN.0b013e318294fd76; Hussein D, 2006, MOL CANCER THER, V5, P2241, DOI 10.1158/1535-7163.MCT-06-0145; Jaggupilli A, 2016, INT J BIOCHEM CELL B, V77, P184, DOI 10.1016/j.biocel.2016.03.005; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Kamijo T, 2012, PEDIATR RES, V71, P511, DOI 10.1038/pr.2011.54; Kaur S, 2014, J CANCER RES THER, V10, P846, DOI 10.4103/0973-1482.139264; Kim SY, 2010, NEUROCHEM INT, V56, P437, DOI 10.1016/j.neuint.2009.11.019; Kim Y, 2009, CANCER RES, V69, P9271, DOI 10.1158/0008-5472.CAN-09-1605; Kong CS, 2014, PHYTOTHER RES, V28, P1246, DOI 10.1002/ptr.5126; Krishnakumar N., 2011, PREV NUTR FOOD SCI, V1, P223, DOI DOI 10.1016/J.BIONUT.2011.09.003; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lee HA, 2013, ONCOL REP, V30, P1869, DOI 10.3892/or.2013.2643; Lee YH, 2015, NEOPLASMA, V62, P230, DOI 10.4149/neo_2015_028; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Lim JY, 2014, BIOCHEM BIOPH RES CO, V450, P1475, DOI 10.1016/j.bbrc.2014.07.021; Lu P, 2017, J GEN PHYSIOL, V149, P181, DOI 10.1085/jgp.201611637; Lynch JR, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050707; Mahller YY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004235; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Navarro G, 2016, NEUROPHARMACOLOGY, V104, P161, DOI 10.1016/j.neuropharm.2015.07.024; Orsmark-Pietrast C, 2013, EUR RESPIR J, V42, P65, DOI 10.1183/09031936.00077712; Park S, 2013, BIOSCI BIOTECH BIOCH, V77, P722, DOI 10.1271/bbb.120763; Priya ES, 2014, NEUROL SCI, V35, P163, DOI 10.1007/s10072-013-1462-1; Puppo M, 2008, MOL CANCER THER, V7, P1974, DOI 10.1158/1535-7163.MCT-07-2059; Rask-Andersen M, 2014, ANNU REV PHARMACOL, V54, P9, DOI 10.1146/annurev-pharmtox-011613-135943; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roomi MW, 2009, ONCOL REP, V21, P1323, DOI 10.3892/or_00000358; Shaik FA, 2016, INT J BIOCHEM CELL B, V77, P197, DOI 10.1016/j.biocel.2016.03.011; Singh N, 2014, BIOCHEM BIOPH RES CO, V446, P499, DOI 10.1016/j.bbrc.2014.02.140; Singh N, 2011, BIOCHEM BIOPH RES CO, V406, P146, DOI 10.1016/j.bbrc.2011.02.016; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Stetler-Stevenson W G, 2001, Surg Oncol Clin N Am, V10, P383; Sugiura Y, 1998, CANCER RES, V58, P2209; Tsai YP, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-102; Ueno Y, 2011, BIOSCI BIOTECH BIOCH, V75, P1188, DOI 10.1271/bbb.100893; Upadhyaya J, 2010, BIOCHEM BIOPH RES CO, V398, P331, DOI 10.1016/j.bbrc.2010.06.097; Vegezzi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107732; Wiener A, 2012, NUCLEIC ACIDS RES, V40, pD413, DOI 10.1093/nar/gkr755; Wolfle U, 2015, PHYTOTHER RES, V29, P1494, DOI 10.1002/ptr.5400; Xiang ZL, 2011, CLIN CANCER RES, V17, P5463, DOI 10.1158/1078-0432.CCR-10-3096; Xu L, 2010, CLIN EXP METASTAS, V27, P241, DOI 10.1007/s10585-010-9322-3; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Yu B, 2017, J ETHNOPHARMACOL, V195, P71, DOI 10.1016/j.jep.2016.11.049; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219; Zhang YS, 2010, MOL NUTR FOOD RES, V54, P127, DOI 10.1002/mnfr.200900323; Zhou Q, 2002, BREAST CANCER RES TR, V75, P107, DOI 10.1023/A:1019698807564	67	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e176851	10.1371/journal.pone.0176851	http://dx.doi.org/10.1371/journal.pone.0176851			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467517	Green Published, Green Submitted, gold			2022-12-27	WOS:000400647000079
J	Hiremath, SV; Tyler-Kabara, EC; Wheeler, JJ; Moran, DW; Gaunt, RA; Collinger, JL; Foldes, ST; Weber, DJ; Chen, WD; Boninger, ML; Wang, W				Hiremath, Shivayogi V.; Tyler-Kabara, Elizabeth C.; Wheeler, Jesse J.; Moran, Daniel W.; Gaunt, Robert A.; Collinger, Jennifer L.; Foldes, Stephen T.; Weber, Douglas J.; Chen, Weidong; Boninger, Michael L.; Wang, Wei			Human perception of electrical stimulation on the surface of somatosensory cortex	PLOS ONE			English	Article							MOTOR	Recent advancement in electrocorticography (ECoG)-based brain-computer interface technology has sparked a new interest in providing somatosensory feedback using ECoG electrodes, i.e., cortical surface electrodes. We conducted a 28-day study of cortical surface stimulation in an individual with arm paralysis due to brachial plexus injury to examine the sensation produced by electrical stimulation of the somatosensory cortex. A high-density ECoG grid was implanted over the somatosensory and motor cortices. Stimulation through cortical surface electrodes over the somatosensory cortex successfully elicited arm and hand sensations in our participant with chronic paralysis. There were three key findings. First, the intensity of perceived sensation increased monotonically with both pulse amplitude and pulse frequency. Second, changing pulse width changed the type of sensation based on qualitative description provided by the human participant. Third, the participant could distinguish between stimulation applied to two neighboring cortical surface electrodes, 4.5 mm center-to-center distance, for three out of seven electrode pairs tested. Taken together, we found that it was possible to modulate sensation intensity, sensation type, and evoke sensations across a range of locations from the fingers to the upper arm using different stimulation electrodes even in an individual with chronic impairment of somatosensory function. These three features are essential to provide effective somatosensory feedback for neuroprosthetic applications.	[Hiremath, Shivayogi V.; Tyler-Kabara, Elizabeth C.; Gaunt, Robert A.; Collinger, Jennifer L.; Foldes, Stephen T.; Weber, Douglas J.; Chen, Weidong; Boninger, Michael L.; Wang, Wei] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Hiremath, Shivayogi V.; Collinger, Jennifer L.; Foldes, Stephen T.; Weber, Douglas J.; Wang, Wei] Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Hiremath, Shivayogi V.] Temple Univ, Dept Phys Therapy, Philadelphia, PA 19122 USA; [Tyler-Kabara, Elizabeth C.; Gaunt, Robert A.; Collinger, Jennifer L.; Weber, Douglas J.; Boninger, Michael L.; Wang, Wei] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Tyler-Kabara, Elizabeth C.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Tyler-Kabara, Elizabeth C.; Boninger, Michael L.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Wheeler, Jesse J.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Collinger, Jennifer L.; Foldes, Stephen T.; Boninger, Michael L.] Dept Vet Affairs Med Ctr, Pittsburgh, PA USA; [Foldes, Stephen T.] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Chen, Weidong] Zhejiang Univ, Qiushi Acad Adv Studies, Hangzhou, Zhejiang, Peoples R China; [Wang, Wei] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Wang, Wei] Washington Univ, Mallinckrodt Inst Radiol, Sch Med, St Louis, MO USA; [Wang, Wei] Barnes Jewish Hosp, St Louis, MO 63110 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); Barrow Neurological Institute; Phoenix Children's Hospital; Zhejiang University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)	Wang, W (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA.; Wang, W (corresponding author), Ctr Neural Basis Cognit, Pittsburgh, PA USA.; Wang, W (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA.; Wang, W (corresponding author), Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA USA.; Wang, W (corresponding author), Washington Univ, Mallinckrodt Inst Radiol, Sch Med, St Louis, MO USA.; Wang, W (corresponding author), Barnes Jewish Hosp, St Louis, MO 63110 USA.	wei.wang@wustl.edu	Tyler-Kabara, Elizabeth/H-4930-2013; Hiremath, Shivayogi V./X-8758-2019; Foldes, Stephen/Y-4304-2019; Hiremath, Shivayogi/AAV-5752-2020	Tyler-Kabara, Elizabeth/0000-0003-3286-1094; Hiremath, Shivayogi V./0000-0002-9708-1411; Foldes, Stephen/0000-0002-2061-3790; Gaunt, Robert/0000-0001-6202-5818; Boninger, Michael/0000-0001-6966-919X; Collinger, Jennifer/0000-0002-4517-5395	University of Pittsburgh Medical Center (UPMC); UPMC Rehabilitation Institute; National Institutes of Health (NIH) [3R01NS05025605S1, 8KL2TR000146]; Paralyzed Veterans of America Research Foundation (PVA) [3039]	University of Pittsburgh Medical Center (UPMC); UPMC Rehabilitation Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paralyzed Veterans of America Research Foundation (PVA)	This work was supported by the University of Pittsburgh Medical Center (UPMC), UPMC Rehabilitation Institute, the National Institutes of Health (NIH) (Grants 3R01NS05025605S1 and 8KL2TR000146), and Paralyzed Veterans of America Research Foundation (PVA#3039). The funders had no role in the preparation of this article.; We would like to first thank our study participant for the invaluable dedication and effort that made this study possible. We would like to thank Dr. Daniel S. Rizzuto from the University of Pennsylvania for sharing his experience with using Blackrock Stimulator for their research. We would like to thank Dr. Donald Crammond for intra-operative brain mapping and electrode impedance testing. We would also like to thank Ms. Debbie Harrington, our clinical research coordinator, for her great effort in participant recruitment, clinical data management, and study coordination. This work was supported by the University of Pittsburgh Medical Center (UPMC), UPMC Rehabilitation Institute, the National Institutes of Health (NIH) (Grants 3R01NS050256-0551 and 8KL2TR000146), and Paralyzed Veterans of America Research Foundation (PVA#3039). The funders had no role in the preparation of this article.	Bensmaia SJ, 2014, NAT REV NEUROSCI, V15, P313, DOI 10.1038/nrn3724; Borchers S, 2012, NAT REV NEUROSCI, V13, P63, DOI 10.1038/nrn3140; Brodmann K, 1909, VERGLEICHENDE LOKALI; Collinger JL, 2014, CTS-CLIN TRANSL SCI, V7, P52, DOI 10.1111/cts.12086; Cronin J, 2016, IEEE T HAPTICS; Dadarlat MC, 2015, NAT NEUROSCI, V18, P138, DOI 10.1038/nn.3883; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; Flesher SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8083; Gardner E.P., 2000, PRINCIPLES NEURAL SC, P411; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; GORDON B, 1990, ELECTROEN CLIN NEURO, V75, P371, DOI 10.1016/0013-4694(90)90082-U; Johnson LA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036021; MacDonald DB, 2015, BRAIN MAPPING ENCY R, P871; MCCREERY DB, 1990, IEEE T BIO-MED ENG, V37, P996, DOI 10.1109/10.102812; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; ODOHERTY JE, 2012, SYSTEMS MAN CYBERN A, V20, P85, DOI DOI 10.1109/TNSRE.2011.2166807; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Penfield W, 1950, CEREBRAL CORTEX MAN; RASMUSSEN T, 1947, FED PROC, V6, P184; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Tabot GA, 2013, P NATL ACAD SCI USA, V110, P18279, DOI 10.1073/pnas.1221113110; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055344; Wheeler J, 2013, SOC NEUROSCIENCE; Yanagisawa T, 2011, ANN NEUROLOGY	27	50	52	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176020	10.1371/journal.pone.0176020	http://dx.doi.org/10.1371/journal.pone.0176020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489913	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100013
J	Kakkanat, A; Phan, MD; Lo, AW; Beatson, SA; Schembri, MA				Kakkanat, Asha; Minh-Duy Phan; Lo, Alvin W.; Beatson, Scott A.; Schembri, Mark A.			Novel genes associated with enhanced motility of Escherichia coli ST131	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; ELONGATION-FACTOR-P; REGULATOR-C QSEBC; FLAGELLAR EXPRESSION; SWARMING MOTILITY; PROTEIN; OPERON; FLHDC; BIOGENESIS; BACTERIA	Uropathogenic Escherichia coli (UPEC) is the cause of similar to 75% of all urinary tract infections (UTIs) and is increasingly associated with multidrug resistance. This includes UPEC strains from the recently emerged and globally disseminated sequence type 131 (ST131), which is now the dominant fluoroquinolone-resistant UPEC clone worldwide. Most ST131 strains are motile and produce H4-type flagella. Here, we applied a combination of saturated Tn5 mutagenesis and transposon directed insertion site sequencing (TraDIS) as a high throughput genetic screen and identified 30 genes associated with enhanced motility of the reference ST131 strain EC958. This included 12 genes that repress motility of E. coli K-12, four of which (lrhA, ihfA, ydiV, lrp) were confirmed in EC958. Other genes represented novel factors that impact motility, and we focused our investigation on characterisation of the mprA, hemK and yjeA genes. Mutation of each of these genes in EC958 led to increased transcription of flagellar genes (flhD and fliC), increased expression of the FliC flagellin, enhanced flagella synthesis and a hyper-motile phenotype. Complementation restored all of these properties to wild-type level. We also identified Tn5 insertions in several intergenic regions (IGRs) on the EC958 chromosome that were associated with enhanced motility; this included flhDC and EC958_1546. In both of these cases, the Tn5 insertions were associated with increased transcription of the downstream gene(s), which resulted in enhanced motility. The EC958_1546 gene encodes a phage protein with similarity to esterase/deacetylase enzymes involved in the hydrolysis of sialic acid derivatives found in human mucus. We showed that over-expression of EC958_1546 led to enhanced motility of EC958 as well as the UPEC strains CFT073 and UTI89, demonstrating its activity affects the motility of different UPEC strains. Overall, this study has identified and characterised a number of novel factors associated with enhanced UPEC motility.	[Kakkanat, Asha; Minh-Duy Phan; Lo, Alvin W.; Beatson, Scott A.; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Kakkanat, Asha; Minh-Duy Phan; Lo, Alvin W.; Beatson, Scott A.; Schembri, Mark A.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Beatson, Scott A.] Univ Queensland, Australian Ctr Ecogen, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Schembri, MA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.; Schembri, MA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	m.schembri@uq.edu.au	Schembri, Mark A/C-7262-2009; Beatson, Scott/B-6985-2013; Phan, Minh-Duy/I-9147-2012	Schembri, Mark A/0000-0003-4863-9260; Beatson, Scott/0000-0002-1806-3283; Kakkanat, Asha/0000-0002-2492-1424; Phan, Minh-Duy/0000-0002-3426-1044	National Health and Medical Research Council (NHMRC) of Australia [GNT1067455]; NHMRC Senior Research Fellowship [GNT1106930]; NHMRC Career Development Fellowship [GNT1090456]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the National Health and Medical Research Council (NHMRC) of Australia (GNT1067455). MAS is supported by an NHMRC Senior Research Fellowship (GNT1106930) and SAB by an NHMRC Career Development Fellowship (GNT1090456).	Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Allsopp LP, 2010, INFECT IMMUN, V78, P1659, DOI 10.1128/IAI.01010-09; AMSLER CD, 1993, J BACTERIOL, V175, P6238, DOI 10.1128/JB.175.19.6238-6244.1993; Arshad M, 2016, J INFECT DIS, V213, P1330, DOI 10.1093/infdis/jiv584; Balestrino D, 2005, J BACTERIOL, V187, P2870, DOI 10.1128/JB.187.8.2870-2880.2005; Barker CS, 2004, J BACTERIOL, V186, P7529, DOI 10.1128/JB.186.22.7529-7537.2004; Bearson SMD, 2011, FOODBORNE PATHOG DIS, V8, P725, DOI 10.1089/fpd.2010.0796; Behshad E, 2006, BIOCHEMISTRY-US, V45, P12639, DOI 10.1021/bi061328t; Bien J, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/681473; Bogomolnaya LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111513; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Clarke MB, 2005, MOL MICROBIOL, V58, P441, DOI 10.1111/j.1365-2958.2005.04819.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deditius JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135351; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Duan QD, 2013, J BASIC MICROB, V53, P1, DOI [10.1002/jobm.201100335, 10.1002/jobm.201370001]; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Fahrner KA, 2015, J BACTERIOL, V197, P3087, DOI 10.1128/JB.00455-15; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; GIVSKOV M, 1995, MOL MICROBIOL, V15, P445, DOI 10.1111/j.1365-2958.1995.tb02258.x; GLICK BR, 1979, EUR J BIOCHEM, V97, P23, DOI 10.1111/j.1432-1033.1979.tb13081.x; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Hadjifrangiskou M, 2012, J BACTERIOL, V194, P6195, DOI 10.1128/JB.01012-12; Hadjifrangiskou M, 2011, MOL MICROBIOL, V80, P1516, DOI 10.1111/j.1365-2958.2011.07660.x; Hancock SJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01740-16; Heurgue-Hamard V, 2002, EMBO J, V21, P769, DOI 10.1093/emboj/21.4.769; Hung CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034220; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Kakkanat A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16149; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; Ko M, 2000, J BACTERIOL, V182, P4670, DOI 10.1128/JB.182.16.4670-4672.2000; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lehnen D, 2002, MOL MICROBIOL, V45, P521, DOI 10.1046/j.1365-2958.2002.03032.x; Lehti TA, 2012, MICROBIOL-SGM, V158, P1444, DOI 10.1099/mic.0.056499-0; Li BQ, 2012, NUCLEIC ACIDS RES, V40, P11073, DOI 10.1093/nar/gks869; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; LOMOVSKAYA O, 1995, J BACTERIOL, V177, P2328, DOI 10.1128/jb.177.9.2328-2334.1995; LOMOVSKAYA O, 1992, P NATL ACAD SCI USA, V89, P8938, DOI 10.1073/pnas.89.19.8938; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; MARTINEZ E, 1988, GENE, V68, P159, DOI 10.1016/0378-1119(88)90608-7; Michel E, 1998, FEMS MICROBIOL LETT, V169, P341, DOI 10.1016/S0378-1097(98)00498-4; Phan MD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003834; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Nakahigashi K, 2002, P NATL ACAD SCI USA, V99, P1473, DOI 10.1073/pnas.032488499; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Nubling S, 2014, INT J MED MICROBIOL, V304, P269, DOI 10.1016/j.ijmm.2013.10.008; ORSKOV F, 1992, CAN J MICROBIOL, V38, P699, DOI 10.1139/m92-115; Patrick JE, 2012, MOL MICROBIOL, V83, P14, DOI 10.1111/j.1365-2958.2011.07917.x; Petty NK, 2014, P NATL ACAD SCI USA, V111, P5694, DOI 10.1073/pnas.1322678111; Pichon C, 2009, CELL MICROBIOL, V11, P616, DOI 10.1111/j.1462-5822.2008.01278.x; Reiss DJ, 2011, J BIOL CHEM, V286, P44726, DOI 10.1074/jbc.M111.290684; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Sanchez-Torres V, 2011, APPL MICROBIOL BIOT, V90, P651, DOI 10.1007/s00253-010-3074-5; Schubert HL, 2003, BIOCHEMISTRY-US, V42, P5592, DOI 10.1021/bi034026p; SHIN S, 1995, J BACTERIOL, V177, P4696, DOI 10.1128/jb.177.16.4696-4702.1995; Simms AN, 2008, INFECT IMMUN, V76, P4833, DOI 10.1128/IAI.00630-08; Simms AN, 2008, J BACTERIOL, V190, P3747, DOI 10.1128/JB.01870-07; Sivick KE, 2010, INFECT IMMUN, V78, P568, DOI 10.1128/IAI.01000-09; Smith TG, 2009, ADV APPL MICROBIOL, V67, P257, DOI 10.1016/S0065-2164(08)01008-3; Soutourina O, 1999, J BACTERIOL, V181, P7500, DOI 10.1128/JB.181.24.7500-7508.1999; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Steenbergen SM, 2009, J BACTERIOL, V191, P7134, DOI 10.1128/JB.01000-09; STOJILJKOVIC I, 1994, J MOL BIOL, V236, P531, DOI 10.1006/jmbi.1994.1163; Subashchandrabose S, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.UTI-0015-2012; Takaya A, 2012, MOL MICROBIOL, V83, P1268, DOI 10.1111/j.1365-2958.2012.08007.x; Tomoyasu T, 2003, MOL MICROBIOL, V48, P443, DOI 10.1046/j.1365-2958.2003.03437.x; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Ulett GC, 2006, MICROBIOL-SGM, V152, P2101, DOI 10.1099/mic.0.28607-0; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Vimr Eric R, 2013, ISRN Microbiol, V2013, P816713, DOI 10.1155/2013/816713; Wang XX, 2011, ISME J, V5, P1517, DOI 10.1038/ismej.2011.27; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wright KJ, 2005, INFECT IMMUN, V73, P7657, DOI 10.1128/IAI.73.11.7657-7668.2005; Xiong A, 2000, ANTIMICROB AGENTS CH, V44, P2905, DOI 10.1128/AAC.44.10.2905-2907.2000; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Yona-Nadler C, 2003, MICROBIOL-SGM, V149, P877, DOI 10.1099/mic.0.25970-0; Zou SB, 2012, J BACTERIOL, V194, P413, DOI 10.1128/JB.05864-11	94	23	23	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176290	10.1371/journal.pone.0176290j	http://dx.doi.org/10.1371/journal.pone.0176290j			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489862				2022-12-27	WOS:000401314100020
J	Nay, JJ				Nay, John J.			Predicting and understanding law-making with word vectors and an ensemble model	PLOS ONE			English	Article								Out of nearly 70,000 bills introduced in the U.S. Congress from 2001 to 2015, only 2,513 were enacted. We developed a machine learning approach to forecasting the probability that any bill will become law. Starting in 2001 with the 107th Congress, we trained models on data from previous Congresses, predicted all bills in the current Congress, and repeated until the 113th Congress served as the test. For prediction we scored each sentence of a bill with a language model that embeds legislative vocabulary into a high-dimensional, semantic-laden vector space. This language representation enables our investigation into which words increase the probability of enactment for any topic. To test the relative importance of text and context, we compared the text model to a context-only model that uses variables such as whether the bill's sponsor is in the majority party. To test the effect of changes to bills after their introduction on our ability to predict their final outcome, we compared using the bill text and meta-data available at the time of introduction with using the most recent data. At the time of introduction context-only predictions outperform text-only, and with the newest data text-only outperforms context-only. Combining text and context always performs best. We conducted a global sensitivity analysis on the combined model to determine important variables predicting enactment.	[Nay, John J.] Vanderbilt Univ, Sch Engn, 221 Kirkland Hall, Nashville, TN 37235 USA; [Nay, John J.] Vanderbilt Law Sch, Program Law & Innovat, Nashville, TN 37203 USA	Vanderbilt University; Vanderbilt University	Nay, JJ (corresponding author), Vanderbilt Univ, Sch Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.; Nay, JJ (corresponding author), Vanderbilt Law Sch, Program Law & Innovat, Nashville, TN 37203 USA.	john.j.nay@gmail.com						ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; [Anonymous], 2012, P 2012 C N AM CHAPT; Bengio Y, 2001, ADV NEUR IN, V13, P932; Breiman L, 1996, MACH LEARN, V24, P49; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Chan K., 2000, SENSITIVITY ANAL; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gerrish S. M., 2011, P ICML; Martin T, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16), P683, DOI 10.1145/2872427.2883001; Mikolov T., 2013, ADV NEURAL INF PROCE, P3111; Nay JJ, 2016, P 2016 EMNLP WORKSH, P49; Pujol G., 2014, SENSITIVITY SENSITIV; Rehurek R., 2010, P LREC 2010 WORKSH N; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Stewart C, 2011, C COMM ASS 103 112 C; Stewart III C, 2016, C COMM ASS 103 113 C; Taddy M, 2015, PROCEEDINGS OF THE 53RD ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL) AND THE 7TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (IJCNLP), VOL 2, P45; van dL MJ, 2007, STAT APPL GENETICS M, V6; Wang E, 2010, ADV NEURAL INFORM PR, P2370; Wilkerson J, 2015, AM J POLIT SCI, V59, P943, DOI 10.1111/ajps.12175	21	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176999	10.1371/journal.pone.0176999	http://dx.doi.org/10.1371/journal.pone.0176999			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489868	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100043
J	Fujita, M; Sato, Y; Nagashima, K; Takahashi, S; Hata, A				Fujita, Misuzu; Sato, Yasunori; Nagashima, Kengo; Takahashi, Sho; Hata, Akira			Impact of geographic accessibility on utilization of the annual health check-ups by income level in Japan: A multilevel analysis	PLOS ONE			English	Article							MEASURING SPATIAL ACCESSIBILITY; CATCHMENT-AREA METHOD; BREAST-CANCER STAGE; ETHNIC DISPARITIES; MEDICAL-CARE; ACCESS; MAMMOGRAPHY; INEQUALITIES; DETERMINANTS	Although both geographic accessibility and socioeconomic status have been indicated as being important factors for the utilization of health care services, their combined effect has not been evaluated. The aim of this study was to reveal whether an income-dependent difference in the impact of geographic accessibility on the utilization of government-led annual health check-ups exists. Existing data collected and provided by Chiba City Hall were employed and analyzed as a retrospective cohort study. The subjects were 166,966 beneficiaries of National Health Insurance in Chiba City, Japan, aged 40 to 74 years. Of all subjects, 54,748 (32.8%) had an annual health check-up in fiscal year 2012. As an optimal index of geographic accessibility has not been established, five measures were calculated: travel time to the nearest health care facility, density of health care facilities (number facilities within a 30-min walking distance from the district of residence), and three indices based on the two-step floating catchment area method. Three-level logistic regression modeling with random intercepts for household and district of residence was performed. Of the five measures, density of health care facilities was the most compatible according to Akaike's information criterion. Both low density and low income were associated with decreased utilization of the health check-ups. Furthermore, a linear relationship was observed between the density of facilities and utilization of the health check-ups in all income groups and its slope was significantly steeper among subjects with an equivalent income of 0.00 yen than among those with equivalent income of 1.01-2.00 million yen (p = 0.028) or 2.01 million yen or more (p = 0.040). This result indicated that subjects with lower incomes were more susceptible to the effects of geographic accessibility than were those with higher incomes. Thus, better geographic accessibility could increase the health check-up utilization and also decrease the income-related disparity of utilization.	[Fujita, Misuzu; Hata, Akira] Chiba Univ, Grad Sch Med, Dept Publ Hlth, Chiba, Chiba, Japan; [Sato, Yasunori; Nagashima, Kengo] Chiba Univ, Grad Sch Med, Dept Global Clin Res, Chiba, Chiba, Japan; [Takahashi, Sho] Chiba Univ Hosp, Clin Res Ctr, Chiba, Chiba, Japan	Chiba University; Chiba University; Chiba University	Fujita, M (corresponding author), Chiba Univ, Grad Sch Med, Dept Publ Hlth, Chiba, Chiba, Japan.	fujitam@chiba-u.jp	Nagashima, Kengo/I-1726-2013; Nagashima, Kengo/I-4258-2019	Nagashima, Kengo/0000-0003-4529-9045; Nagashima, Kengo/0000-0003-4529-9045; Fujita, Misuzu/0000-0001-5308-4744; Sato, Yasunori/0000-0002-7189-5126	Japan Society for the Promotion of Science KAKENHI [26460826]; Chiba Foundation for Health Promotion and Disease Prevention	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Chiba Foundation for Health Promotion and Disease Prevention	This work was supported by a Japan Society for the Promotion of Science KAKENHI grant (http://.jsps.go.jp/j-grantsinad, Number 26460826, Received author: MF) and Chiba Foundation for Health Promotion and Disease Prevention (http://www.kenko-chiba.or.jp/cyousa/ cyousakenkyuu.html, Received author: MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WHIT PAP REP ANN HLT; Cooper LA, 2002, J GEN INTERN MED, V17, P477, DOI 10.1046/j.1525-1497.2002.10633.x; Coughlin SS, 2008, SOC SCI MED, V66, P260, DOI 10.1016/j.socscimed.2007.09.009; Crawford SM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000410; Diderichsen F, 2012, SCAND J PUBLIC HEALT, V40, P10, DOI 10.1177/1403494812457732; Elkin EB, 2010, MED CARE, V48, P349, DOI 10.1097/MLR.0b013e3181ca3ecb; Elting LS, 2009, AM J PREV MED, V37, P102, DOI 10.1016/j.amepre.2009.03.017; Fransen K, 2015, HEALTH PLACE, V32, P65, DOI 10.1016/j.healthplace.2015.01.002; Fujita M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151690; Gentil J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-351; Grad FP, 2002, B WORLD HEALTH ORGAN, V80, P981; Hadley J, 2007, JAMA-J AM MED ASSOC, V297, P1073, DOI 10.1001/jama.297.10.1073; Henry KA, 2014, J WOMENS HEALTH, V23, P664, DOI 10.1089/jwh.2013.4668; Hirai Hiroshi, 2012, Curr Gerontol Geriatr Res, V2012, P701583, DOI 10.1155/2012/701583; Hu RS, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-35; Huisman M, 2005, LANCET, V365, P493, DOI 10.1016/S0140-6736(05)17867-2; Khan-Gates JA, 2015, WOMEN HEALTH ISS, V25, P482, DOI 10.1016/j.whi.2015.05.010; Lian M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043000; Luo W, 2009, HEALTH PLACE, V15, P1100, DOI 10.1016/j.healthplace.2009.06.002; Marchick J, 2005, CANCER-AM CANCER SOC, V103, P1571, DOI 10.1002/cncr.20915; Matsuyama Y, 2014, COMMUNITY DENT ORAL, V42, P122, DOI 10.1111/cdoe.12074; McGrail MR, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-50; Meade MA, 2015, DISABIL REHABIL, V37, P632, DOI 10.3109/09638288.2014.938176; Meersman SC, 2009, CANCER CAUSE CONTROL, V20, P1469, DOI 10.1007/s10552-009-9373-4; Miwa Makiko, 2006, Int J Health Geogr, V5, P25, DOI 10.1186/1476-072X-5-25; Rahman Selina, 2009, Int J Canc Prev, V2, P403; Sasaki S, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-4; Shone LP, 2005, PEDIATRICS, V115, pE697, DOI 10.1542/peds.2004-1726; van Doorslaer E, 2006, CAN MED ASSOC J, V174, P177, DOI 10.1503/cmaj.050584	29	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177091	10.1371/journal.pone.0177091	http://dx.doi.org/10.1371/journal.pone.0177091			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UM	28486522	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000043
J	Lee, JY; Rahman, A; Azam, H; Kim, HS; Kwon, MJ				Lee, Ju Yeon; Rahman, Arifur; Azam, Hossain; Kim, Hyung Seok; Kwon, Man Jae			Characterizing nutrient uptake kinetics for efficient crop production during Solanum lycopersicum var. cerasiforme Alef. growth in a closed indoor hydroponic system	PLOS ONE			English	Article							FRUIT-QUALITY; TOMATO PLANTS; YIELD; PHOSPHATE; COPPER	A balanced nutrient supply is essential for the healthy growth of plants in hydroponic systems. However, the commonly used electrical conductivity (EC)-based nutrient control for plant cultivation can provide amounts of nutrients that are excessive or inadequate for proper plant growth. In this study, we investigated the kinetics of major and minor nutrient uptake in a nutrient solution during the growth of tomato (Solanum lycopersicum var. cerasiforme Alef.) in a closed hydroponic system. The concentrations of major and minor ions in the nutrient solution were determined by various analytical methods including inductively coupled plasma-optical emission spectroscopy (ICP-OES), ion chromatography (IC), ion specific electrodes, and/or colorimetric methods. The concentrations of the individual nutrient ions were compared with changes in the EC. The EC of the nutrient solution varied according to the different growth stages of tomato plants. Variation in the concentrations of NO3-, SO42-, Mg2+, Ca2+, and K+ was similar to the EC variation. However, in the cases of PO43-, Na+, Cl-, dissolved Fe and Mn, Cu2+, and Zn2+, variation did not correspond with that of EC. These ions were generally depleted (to 0 mg L-1) during tomato growth, suggesting that these specific ions should be monitored individually and their supply increased. Nutrient uptake rates of major ions increased gradually at different growth stages until harvest (from < 3 mg L-1 d(-1) to > 15 mg L-1 d(-1)). Saturation indices determined by MINEQL+ simulation and a mineral precipitation experiment demonstrated the potential for amorphous calcium phosphate precipitation, which may facilitate the abiotic adsorptive removal of dissolved Fe, dissolved Mn, Cu2+, and Zn2+.	[Lee, Ju Yeon; Kim, Hyung Seok; Kwon, Man Jae] Korea Inst Sci & Technol, Kangnung, South Korea; [Lee, Ju Yeon; Kwon, Man Jae] Korea Univ, Seoul, South Korea; [Rahman, Arifur] George Washington Univ, Civil & Environm Engn, Washington, DC USA; [Azam, Hossain] Manhattan Coll, Civil & Environm Engn, Riverdale, NY USA	Korea Institute of Science & Technology (KIST); Korea University; George Washington University; Manhattan College	Kwon, MJ (corresponding author), Korea Inst Sci & Technol, Kangnung, South Korea.; Kwon, MJ (corresponding author), Korea Univ, Seoul, South Korea.	mkwon@kist.re.kr			KIST Open Research Program [2E25701]; National Research Council of Science & Technology (NST) by the Korean Government (MSIP) [CRC-15-01-KIST]; National Research Foundation of Korea - Korean Government (MEST)	KIST Open Research Program; National Research Council of Science & Technology (NST) by the Korean Government (MSIP); National Research Foundation of Korea - Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	MJK and HSK were supported by the KIST Open Research Program (grant number, 2E25701)(http://www.kist.re.kr) and a National Research Council of Science & Technology (NST) grant by the Korean Government (MSIP) (grant number, CRC-15-01-KIST)(http://www.nst.re.kr/nst/index.jsp). JYL was partially supported by a National Research Foundation of Korea Grant funded by the Korean Government (MEST) (2015, University-Institute Cooperation Program)(http://www.nrf.re.kr/nrf_eng_cms/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams P., 1986, THE TOMATO CROP, P281, DOI DOI 10.1007/978-94-009-3137-4_7; Albano JP, 2001, HORTSCIENCE, V36, P313, DOI 10.21273/HORTSCI.36.2.313; Arellano-Jimenez MJ, 2009, J PHYS CHEM SOLIDS, V70, P390, DOI 10.1016/j.jpcs.2008.11.001; Bamsey M, 2012, SENSORS-BASEL, V12, P13349, DOI 10.3390/s121013349; Botrini L, 2000, HORTSCIENCE, V35, P1220, DOI 10.21273/HORTSCI.35.7.1220; Bugbee B, 2004, ACTA HORTIC, P99, DOI 10.17660/ActaHortic.2004.648.12; Cao XD, 2004, ENVIRON POLLUT, V131, P435, DOI 10.1016/j.envpol.2004.03.003; Cao XD, 2009, J HAZARD MATER, V164, P555, DOI 10.1016/j.jhazmat.2008.08.034; Caruso G, 2011, SCI HORTIC-AMSTERDAM, V129, P479, DOI 10.1016/j.scienta.2011.04.020; Christie E., 2014, THESIS; Corami A, 2007, J HAZARD MATER, V146, P164, DOI 10.1016/j.jhazmat.2006.12.003; De Borba BM, 2014, J CHROMATOGR A, V1369, P131, DOI 10.1016/j.chroma.2014.10.027; Gales Jr M.E., 1966, J AM WATER WORK ASS, V58, P1363, DOI DOI 10.1002/J.1551-8833.1966.TB01703.X; Girard J.E, 2014, PRINCIPLES ENV CHEM, V3rd; Hartz TK, 1999, J AM SOC HORTIC SCI, V124, P199, DOI 10.21273/JASHS.124.2.199; Kelton N, 2007, AQUAT SCI, V69, P86, DOI 10.1007/s00027-006-0869-7; Komosa A, 2015, J PLANT NUTR, V38, P355, DOI 10.1080/01904167.2014.934466; Lee Seongtae, 2011, [Korean Journal of Soil Science & Fertilizer, 한국토양비료학회지(Korean Journal of Soil Science and Fertilizer)], V44, P767; Nakano Y, 2010, J JPN SOC HORTIC SCI, V79, P47, DOI 10.2503/jjshs1.79.47; Rhine ED, 1998, SOIL SCI SOC AM J, V62, P473, DOI 10.2136/sssaj1998.03615995006200020026x; Satti SME, 1996, J PLANT NUTR, V19, P705, DOI 10.1080/01904169609365154; Savvas D, 2002, SCI HORTIC-AMSTERDAM, V96, P267, DOI 10.1016/S0304-4238(02)00054-7; Schwarz D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00625; Somrani S, 2005, J SOLID STATE CHEM, V178, P1337, DOI 10.1016/j.jssc.2004.11.029; STENSVAND A, 1992, GARTENBAUWISSENSCHAF, V57, P193; Trejo-Tellez L.I., 2012, NUTR SOLUTIONS HYDRO; Turan M., 1999, IMPROVED CROP QUALIT, P229; Zekki H, 1996, J AM SOC HORTIC SCI, V121, P1082, DOI 10.21273/JASHS.121.6.1082	28	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177041	10.1371/journal.pone.0177041	http://dx.doi.org/10.1371/journal.pone.0177041			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486501	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314000036
J	Ong, CT; Tsai, CF; Wong, YS; Chen, SCC				Ong, Cheung-Ter; Tsai, Ching-Fang; Wong, Yi-Sin; Chen, Solomon Chih-Cheng			Epidemiology of brain abscess in Taiwan: A 14-year population-based cohort study	PLOS ONE			English	Article							MANAGEMENT	Brain abscess (BA) is a severe neurological emergency, which remains a challenge for physicians despite medical advancements. The purpose of this study is to describe the epidemiology of BA in Taiwan and to investigate potential factors affecting the survival of patients with BA. By using the Taiwan National Health Insurance Research Database, we identified hospitalized patients with a discharge diagnosis of pyogenic BA (324.X) between 2000 and 2013. The incidence and in-hospital mortality of BA were calculated based on both age and sex. A total of 6027 BA cases were identified. The overall incidence of BA was 1.88 (95% CI: 1.83-1.93) per 100,000 person-years and increased with age, from 0.58 per 100,000 person-years in individuals aged 0-14 years to 4.67 per 100,000 person-years in those over 60 years of age. The male-to-female incidence ratio was 2.37 (95% CI: 2.24-2.50), with a mountain-shaped distribution across ages peaking at 40-44 years. The in-hospital mortality also increased with age, from 4.22% (95% CI: 2.54-6.97) at 0-14 years to 17.34% (95% CI: 15.79-19.02) in individuals over 60 years of age, without a gender difference (11.9% for males, 12.5% for females). Age, stroke, septicemia, pneumonia, meningitis, and hepatitis were associated with increased risk of in-hospital mortality. There was a male predominance for BA, and both the incidence and in-hospital mortality rates increased with age. Infection-related disease such as septicemia, pneumonia and meningitis were important factors associated with in-hospital mortality. In addition to the original treatment of BA, we suggest paying close attention to potential infections to improve the outcome of BA patients.	[Ong, Cheung-Ter] Ditmanson Med Fdn, Dept Neurol, Chiayi Christian Hosp, Chiayi, Taiwan; [Ong, Cheung-Ter] Chung Jen Jr Coll Nursing Hlth Sci & Management, Dept Nursing, Chiayi, Taiwan; [Tsai, Ching-Fang; Chen, Solomon Chih-Cheng] Ditmanson Med Fdn, Chiayi Christian Hosp, Dept Med Res, Chiayi, Taiwan; [Wong, Yi-Sin] Ditmanson Med Fdn, Chiayi Christian Hosp, Dept Family Med, Chiayi, Taiwan; [Chen, Solomon Chih-Cheng] Taipei Med Univ, Sch Med, Dept Pediat, Taipei, Taiwan	Chia-Yi Christian Hospital; Chia-Yi Christian Hospital; Chia-Yi Christian Hospital; Taipei Medical University	Ong, CT (corresponding author), Ditmanson Med Fdn, Dept Neurol, Chiayi Christian Hosp, Chiayi, Taiwan.; Ong, CT (corresponding author), Chung Jen Jr Coll Nursing Hlth Sci & Management, Dept Nursing, Chiayi, Taiwan.	ctong98@yahoo.com.tw		Ong, Cheung-Ter/0000-0003-1814-4371				BELLER AJ, 1973, J NEUROL NEUROSUR PS, V36, P757, DOI 10.1136/jnnp.36.5.757; Brouwer MC, 2014, NEW ENGL J MED, V371, P447, DOI 10.1056/NEJMra1301635; Brouwer MC, 2014, NEUROLOGY, V82, P806, DOI 10.1212/WNL.0000000000000172; Carpenter J, 2007, EUR J CLIN MICROBIOL, V26, P1, DOI 10.1007/s10096-006-0236-6; Cartes-Zumelzu FW, 2004, AM J NEURORADIOL, V25, P1310; Datto JP, 2015, NEURAL REGEN RES, V10, P1533, DOI 10.4103/1673-5374.165213; Hakan T, 2006, J INFECTION, V52, P359, DOI 10.1016/j.jinf.2005.07.019; Helweg-Larsen J, BMC INFEC DIS, V12, P332; Kuo CF, 2011, BRIT J DERMATOL, V165, P1273, DOI 10.1111/j.1365-2133.2011.10595.x; Kuo CY, 2015, IRAN J PUBLIC HEALTH, V44, P470; Lai CH, 2010, NEUROEPIDEMIOLOGY, V35, P66, DOI 10.1159/000311012; Landriel F, 2012, ACTA NEUROCHIR, V154, P903, DOI 10.1007/s00701-012-1299-z; Lu CH, 2002, QJM-INT J MED, V95, P501, DOI 10.1093/qjmed/95.8.501; Mathisen GE, 1997, CLIN INFECT DIS, V25, P763, DOI 10.1086/515541; MCCLELLAND CJ, 1978, J NEUROL NEUROSUR PS, V41, P1043, DOI 10.1136/jnnp.41.11.1043; Menon S, 2008, J MED MICROBIOL, V57, P1259, DOI 10.1099/jmm.0.47814-0; Nathoo N, 2011, WORLD NEUROSURG, V75, P716, DOI 10.1016/j.wneu.2010.11.043; NICOLOSI A, 1991, NEUROEPIDEMIOLOGY, V10, P122, DOI 10.1159/000110257; Ong CT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122350; Shachor-Meyouhas Y, 2010, ACTA PAEDIATR, V99, P1163, DOI 10.1111/j.1651-2227.2010.01780.x; Sharma R, 2009, INFECTION, V37, P39, DOI 10.1007/s15010-008-7359-x; Shoko T, 2010, J AM COLL SURGEONS, V211, P338, DOI 10.1016/j.jamcollsurg.2010.04.010; STRANDGAARD S, 1973, BMJ-BRIT MED J, V1, P507, DOI 10.1136/bmj.1.5852.507; Tsou TP, 2009, J MICROBIOL IMMUNOL, V42, P405; Wutzler S, 2009, J AM COLL SURGEONS, V209, P75, DOI 10.1016/j.jamcollsurg.2009.03.015; Zhang C, 2014, BMC INFEC DIS	26	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176705	10.1371/journal.pone.0176705	http://dx.doi.org/10.1371/journal.pone.0176705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486477	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000023
J	Shiju, S; Sriram, K				Shiju, S.; Sriram, K.			Hypothesis driven single cell dual oscillator mathematical model of circadian rhythms	PLOS ONE			English	Article							SUPRACHIASMATIC-NUCLEUS; GENE-EXPRESSION; MICE LACKING; COUPLED OSCILLATORS; MOLECULAR ANALYSIS; FEEDBACK LOOPS; MUTANT MICE; CLOCK; PACEMAKER; DROSOPHILA	Molecular mechanisms responsible for 24 h circadian oscillations, entrainment to external cues, encoding of day length and the time-of-day effects have been well studied experimentally. However, it is still debated from the molecular network point of view whether each cell in suprachiasmatic nuclei harbors two molecular oscillators, where one tracks dawn and the other tracks dusk activities. A single cell dual morning and evening oscillator was proposed by Daan et al., based on the molecular network that has two sets of similar non-redundant per1/cry1 and per2/cry2 circadian genes and each can independently maintain their endogenous oscillations. Understanding of dual oscillator dynamics in a single cell at molecular level may provide insight about the circadian mechanisms that encodes day length variations and its response to external zeitgebers. We present here a realistic dual oscillator model of circadian rhythms based on the series of hypotheses proposed by Daan et al., in which they conjectured that the circadian genes per1/cry1 track dawn while per2/cry2 tracks dusk and they together constitute the morning and evening oscillators (dual oscillator). Their hypothesis also provides explanations about the encoding of day length in terms of molecular mechanisms of per/cry expression. We frame a minimal mathematical model with the assumption that per1 acts a morning oscillator and per2 acts as an evening oscillator and to support and interpret this assumption we fit the model to the experimental data of per1/per2 circadian temporal dynamics, phase response curves (PRC's), and entrainment phenomena under various light-dark conditions. We also capture different patterns of splitting phenomena by coupling two single cell dual oscillators with neuropeptides vasoactive intestinal polypeptide (VIP) and arginine vasopressin (AVP) as the coupling agents and provide interpretation for the occurrence of splitting in terms of ME oscillators, though they are not required to explain the morning and evening oscillators. The proposed dual oscillator model based on Daan's hypothesis supports per1 and per2 playing the role of morning and evening oscillators respectively and this may be the first step towards the understanding of the core molecular mechanism responsible for encoding the day length.	[Shiju, S.; Sriram, K.] Indraprastha Inst Informat Technol Delhi, Ctr Computat Biol, New Delhi, India	Indraprastha Institute of Information Technology Delhi	Sriram, K (corresponding author), Indraprastha Inst Informat Technol Delhi, Ctr Computat Biol, New Delhi, India.	sriramk@iiitd.ac.in		S, Shiju/0000-0002-9715-1029	Department of Science & Technology, Ministry of Science and Technology, Government of India (DST) cognitive neuroscience [SR/CSI/299/2012]	Department of Science & Technology, Ministry of Science and Technology, Government of India (DST) cognitive neuroscience	This work is supported by the Department of Science & Technology, Ministry of Science and Technology, Government of India (DST) cognitive neuroscience grant,SR/CSI/299/2012. (KS received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the DST cognitive neuroscience grant, SR/CSI/299/2012 from the Department of Science and Technology, INDIA.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Becker-Weimann S, 2004, BIOPHYS J, V87, P3023, DOI 10.1529/biophysj.104.040824; Bodenstein C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002697; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Carr AJF, 2003, CURR BIOL, V13, P1543, DOI 10.1016/S0960-9822(03)00619-5; Challet E, 2003, J NEUROSCI RES, V72, P629, DOI 10.1002/jnr.10616; DAAN S, 1978, J THEOR BIOL, V70, P297, DOI 10.1016/0022-5193(78)90378-8; Daan S, 2002, J BIOL RHYTHM, V17, P107, DOI 10.1177/074873002129002375; Daan S, 2001, J BIOL RHYTHM, V16, P105, DOI 10.1177/074873001129001809; de la Iglesia HO, 2004, MOL BRAIN RES, V127, P121, DOI 10.1016/j.molbrainres.2004.05.018; DeWoskin D, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0076; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Ermentrout, 2002, SIMULATING ANALYZING, Vvol. 14; Forger DB, 2004, J THEOR BIOL, V230, P533, DOI 10.1016/j.jtbi.2004.04.041; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Geier F, 2005, J BIOL RHYTHM, V20, P83, DOI 10.1177/0748730404269309; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hastings M, 2001, J BIOL RHYTHM, V16, P117, DOI 10.1177/074873001129001818; Helfrich-Forster C, 2009, J BIOL RHYTHM, V24, P259, DOI 10.1177/0748730409339614; Hughes AT, 2004, J NEUROSCI, V24, P3522, DOI 10.1523/JNEUROSCI.5345-03.2004; ILLNEROVA H, 1987, Journal of Biological Rhythms, V2, P95, DOI 10.1177/074873048700200202; Indic P, 2008, J R SOC INTERFACE, V5, P873, DOI 10.1098/rsif.2007.1248; Kalsbeek A, 2012, NEUROBIOLOGY CIRCADI, V199, P5; Kulasiri D, 2008, MATH MODEL NAT PHENO, V3, P1, DOI 10.1051/mmnp:2008053; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Leloup JC, 1999, J BIOL RHYTHM, V14, P433, DOI 10.1177/074873099129000948; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Maywood ES, 2003, J NEUROENDOCRINOL, V15, P329, DOI 10.1046/j.1365-2826.2003.00971.x; Mirsky HP, 2009, P NATL ACAD SCI USA, V106, P11107, DOI 10.1073/pnas.0904837106; Nuesslein-Hildesheim B, 2000, EUR J NEUROSCI, V12, P2856, DOI 10.1046/j.1460-9568.2000.00173.x; Oda GA, 2002, J BIOL RHYTHM, V17, P76, DOI 10.1177/074873002129002357; Oda GA, 2000, J BIOL RHYTHM, V15, P246, DOI 10.1177/074873040001500306; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Oster H, 2002, CHRONOBIOL INT, V19, P507, DOI 10.1081/CBI-120004210; Pendergast JS, 2010, J NEUROSCI, V30, P12179, DOI 10.1523/JNEUROSCI.2607-10.2010; PICKARD GE, 1982, SCIENCE, V215, P1119, DOI 10.1126/science.7063843; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Pittendrigh CS, 1966, LIFE SCI SPACE RES, V5, P122; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Punia S, 2012, AM J PHYSIOL-ENDOC M, V303, pE762, DOI 10.1152/ajpendo.00513.2011; Quintero JE, 2003, J NEUROSCI, V23, P8070; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Romijn HJ, 1997, EUR J NEUROSCI, V9, P2613, DOI 10.1111/j.1460-9568.1997.tb01691.x; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; Ruoff P, 2005, J THEOR BIOL, V237, P41, DOI 10.1016/j.jtbi.2005.03.030; Ruoff P, 2001, J THEOR BIOL, V209, P29, DOI 10.1006/jtbi.2000.2239; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Schroder S, 2012, J BIOL RHYTHM, V27, P79, DOI 10.1177/0748730411429659; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; SHINOHARA K, 1993, J NEUROSCI, V13, P793; Steinlechner S, 2002, J BIOL RHYTHM, V17, P202, DOI 10.1177/07430402017003003; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; TOMINAGA K, 1992, NEUROREPORT, V3, P809, DOI 10.1097/00001756-199209000-00022; VANDENPOL AN, 1980, J COMP NEUROL, V191, P661, DOI 10.1002/cne.901910410; Yan L, 2005, J NEUROSCI, V25, P9017, DOI 10.1523/JNEUROSCI.2538-05.2005; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	65	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177197	10.1371/journal.pone.0177197	http://dx.doi.org/10.1371/journal.pone.0177197			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486525	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000056
J	Yun, LF; Wang, XF; Fan, HQ; Li, XP				Yun, Lifen; Wang, Xifu; Fan, Hongqiang; Li, Xiaopeng			A reliable facility location design model with site-dependent disruption in the imperfect information context	PLOS ONE			English	Article							SUPPLY CHAIN; SENSOR DEPLOYMENT; NETWORK DESIGN; RISK; SURVEILLANCE; SYSTEMS	This paper proposes a reliable facility location design model under imperfect information with site-dependent disruptions; i.e., each facility is subject to a unique disruption probability that varies across the space. In the imperfect information contexts, customers adopt a realistic "trial-and-error" strategy to visit facilities; i.e., they visit a number of pre-assigned facilities sequentially until they arrive at the first operational facility or give up looking for the service. This proposed model aims to balance initial facility investment and expected long-term operational cost by finding the optimal facility locations. A nonlinear integer programming model is proposed to describe this problem. We apply a linearization technique to reduce the difficulty of solving the proposed model. A number of problem instances are studied to illustrate the performance of the proposed model. The results indicate that our proposed model can reveal a number of interesting insights into the facility location design with site-dependent disruptions, including the benefit of backup facilities and system robustness against variation of the loss-of-service penalty.	[Yun, Lifen; Wang, Xifu] Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China; [Fan, Hongqiang] Beijing Univ Posts & Telecommun, Sch Modern Post, Beijing, Peoples R China; [Fan, Hongqiang; Li, Xiaopeng] Univ S Florida, Dept Civil & Environm Engn, Tampa, FL 33620 USA	Beijing Jiaotong University; Beijing University of Posts & Telecommunications; State University System of Florida; University of South Florida	Fan, HQ (corresponding author), Beijing Univ Posts & Telecommun, Sch Modern Post, Beijing, Peoples R China.; Fan, HQ (corresponding author), Univ S Florida, Dept Civil & Environm Engn, Tampa, FL 33620 USA.	fanbjtu@gmail.com		Li, Xiaopeng/0000-0002-5264-3775; Fan, Hong-Qiang/0000-0001-9398-7251	National Natural Science Foundation of China [71601014]; Fundamental Research Funds for the Central Universities [2016JBM026]; US National Science Foundation [1541130, 1558889, 1638355]; Directorate For Engineering [1634738] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); US National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research is supported in part by National Natural Science Foundation of China (71601014) to LY, the Fundamental Research Funds for the Central Universities (2016JBM026) to LY, and the US National Science Foundation (1541130, 1558889 and 1638355) to XL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported in part by National Natural Science Foundation of China #71601014, the Fundamental Research Funds for the Central Universities #2016JBM026, and the US National Science Foundation #1541130, #1558889 and #1638355.	An S, 2015, TRANSPORT RES E-LOG, V82, P199, DOI 10.1016/j.tre.2015.07.006; An S, 2013, TRANSPORT RES B-METH, V54, P1, DOI 10.1016/j.trb.2013.03.002; Bai Y, 2015, ENERGIES, V8, P1468, DOI 10.3390/en8021468; Baillieul J, 2007, P IEEE, V95, P9, DOI 10.1109/JPROC.2006.887290; Berman O, 2009, DECISION SCI, V40, P845, DOI 10.1111/j.1540-5915.2009.00253.x; Berry J, 2006, J WATER RES PLAN MAN, V132, P218, DOI 10.1061/(ASCE)0733-9496(2006)132:4(218); Birenbaum I., 2009, FHWAHOP08059; Chen Q, 2011, TRANSPORT RES B-METH, V45, P991, DOI 10.1016/j.trb.2011.04.004; Cui JX, 2016, TRANSPORT RES E-LOG, V95, P143, DOI 10.1016/j.tre.2016.09.009; Cui TT, 2010, OPER RES, V58, P998, DOI 10.1287/opre.1090.0801; D'Amico E, 2002, CHEM WEEK, V164, P10; Daskin M. S., 2011, NETWORK DISCRETE LOC; Daskin MS, 2002, ANN OPER RES, V110, P83, DOI 10.1023/A:1020763400324; Drezner Z, 1995, FACILITY LOCATION SU; Hurricane Sandy Rebuilding Task Force (HSRTF), 2013, HURR SAND REB TASK F; Li XP, 2012, OPER RES, V60, P1183, DOI 10.1287/opre.1120.1082; Li XP, 2011, TRANSPORT RES B-METH, V45, P218, DOI 10.1016/j.trb.2010.04.005; Lu ZQ, 2007, COMPUT OPER RES, V34, P299, DOI 10.1016/j.cor.2005.03.002; Marufuzzaman M, 2014, TRANSPORT RES E-LOG, V69, P122, DOI 10.1016/j.tre.2014.06.008; Melkote S, 2001, TRANSPORT RES A-POL, V35, P515, DOI 10.1016/S0965-8564(00)00005-7; Qureshi MA, 2002, TRANSPORT RES REC, P212; Schewe P.F., 2004, PHYS TODAY, V57, P9; Schiff A. J., 2004, International Journal of Critical Infrastructures, V1, P100, DOI 10.1504/IJCIS.2004.003799; Shen ZJM, 2003, TRANSPORT SCI, V37, P40, DOI 10.1287/trsc.37.1.40.12823; Shu J, 2005, OPER RES, V53, P48, DOI 10.1287/opre.1040.0140; Snyder LV, 2005, TRANSPORT SCI, V39, P400, DOI 10.1287/trsc.1040.0107; Wang Y, 2012, J ZHEJIANG UNIV-SC A, V13, P782, DOI 10.1631/jzus.A1200137; Weber A., 1929, A WEBERS THEORY LOCA; Yu HS, 2009, OMEGA-INT J MANAGE S, V37, P788, DOI 10.1016/j.omega.2008.05.006; Yun LF, 2015, TRANSPORT RES B-METH, V81, P596, DOI 10.1016/j.trb.2014.10.010; Zhang Y, 2016, TRANSPORT RES B-METH, V83, P151, DOI 10.1016/j.trb.2015.11.009	32	7	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177104	10.1371/journal.pone.0177104	http://dx.doi.org/10.1371/journal.pone.0177104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UM	28486564	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314000044
J	Fan, YY; Jonas, JB; Wang, YX; Chen, CX; Wei, WB				Fan, Yuan Yuan; Jonas, Jost B.; Wang, Ya Xing; Chen, Chang Xi; Wei, Wen Bin			Horizontal and vertical optic disc rotation. The Beijing Eye Study	PLOS ONE			English	Article							PARAPAPILLARY GAMMA ZONE; COHERENCE TOMOGRAPHY; INTRACHOROIDAL CAVITATION; PATHOLOGICAL MYOPIA; NERVE; THICKNESS; TILT; PREVALENCE; GLAUCOMA; FUNDUS	Purpose To measure the optic disc rotation around the vertical and horizontal disc axis and to evaluate associations with general and ocular parameters. Design Population-based study Methods In the Beijing Eye Study, 3468 participants (mean age: 64.6 +/- 9.8 years; range: 50-93 years) underwent an ophthalmological examination which included spectral-domain optical coherence tomography (OCT) with enhanced depth imaging. Using the OCT images, we determined the amount of the rotation of the optic disc (defined as Bruch's membrane opening (BMO)) around the vertical axis and horizontal axis. Results Optic disc rotation measurements were available for 3037 (87.6%) individuals. In multivariate analysis, larger optic disc rotation around the vertical axis (range:-4.90(omicron) to 41.0(omicron)) was associated (regression coefficient r:0.27) with high axial myopia (axial length >= 26.5 mm) (P<0.001;standardized regression coefficient beta beta:0.09), longer disc-fovea distance (P = 0.001;beta: 0.09) and wider parapapillary beta/gamma zone (P<0.001;beta0.12). Larger optic disc rotation around the horizontal axis (range:-7.10(omicron) to 26.4(omicron)) was associated (r:0.32) with high axial myopia (P = 0.001;beta:0.08), larger optic disc-fovea angle (P<0.001; beta:0.13), thinner superior nasal retinal nerve fiber layer (RNFL) thickness (P<0.001;beta:0.19) and thicker inferior nasal RNFL thickness (P<0.001;beta:0.17). Conclusions Vertical optic disc rotation was associated with highly myopic axial elongation, increased disc-fovea distance and development or enlargement of parapapillary, Bruch's membrane free, gamma zone, while macular Bruch's membrane length is not affected. Horizontal optic disc rotation was associated with inferior dislocation of the fovea, in addition to a thinner superior nasal RNFL and thicker inferior nasal RNFL. The latter association may be taken into account in the interpretation of RNFL thickness profiles.	[Fan, Yuan Yuan; Wei, Wen Bin] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Fan, Yuan Yuan; Wei, Wen Bin] Beijing Ophthalmol & Visual Sci Key Lab, Beijing Key Lab Intraocular Tumor Diag & Treatmen, Beijing, Peoples R China; [Jonas, Jost B.; Wang, Ya Xing; Chen, Chang Xi] Capital Med Univ, Beijing Tongren Hosp, Beijing Key Lab Ophthalmol & Visual Sci, Beijing Inst Ophthalmol,Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Capital Medical University; Ruprecht Karls University Heidelberg	Wei, WB (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China.; Wei, WB (corresponding author), Beijing Ophthalmol & Visual Sci Key Lab, Beijing Key Lab Intraocular Tumor Diag & Treatmen, Beijing, Peoples R China.	tr_weiwenbin@163.com	wang, YA XING/K-9671-2016; wei, wei/HHR-8613-2022	wang, YA XING/0000-0003-2749-7793; Jonas, Jost/0000-0003-2972-5227; Fan, yuanyuan/0000-0002-4620-0484	State Natural Sciences Fund [81041018]; Natural Sciences Fund of Beijing government [7092021, 7112031]	State Natural Sciences Fund(National Natural Science Foundation of China (NSFC)); Natural Sciences Fund of Beijing government	This study was supported by State Natural Sciences Fund (81041018) and the Natural Sciences Fund of Beijing government (7092021; 7112031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Choi JA, 2014, INVEST OPHTH VIS SCI, V55, P4991, DOI 10.1167/iovs.14-14663; Dai Y, 2015, INVEST OPHTH VIS SCI, V56, P7076, DOI 10.1167/iovs.14-16033; Dai Y, 2015, RETINA-J RET VIT DIS, V35, P655, DOI 10.1097/IAE.0000000000000358; Demer JL, 2016, INVEST OPHTH VIS SCI, V57, P1826, DOI 10.1167/iovs.15-18718; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hosseini H, 2013, AM J OPHTHALMOL, V156, P737, DOI 10.1016/j.ajo.2013.05.036; Jonas J. B., 2017, RETINA; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P2942; Jonas JB, 2000, PROG RETIN EYE RES, V19, P1, DOI 10.1016/S1350-9462(99)00002-6; Jonas JB, 1997, OPHTHALMOLOGY, V104, P1934, DOI 10.1016/S0161-6420(97)30004-9; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P531, DOI 10.1007/BF02169200; Jonas JB, 1997, AM J OPHTHALMOL, V124, P488, DOI 10.1016/S0002-9394(14)70864-5; Jonas JB, 2016, INVEST OPHTH VIS SCI, V57, P4373, DOI 10.1167/iovs.16-19885; Jonas JB, 2016, INVEST OPHTH VIS SCI, V57, P1791, DOI 10.1167/iovs.15-18529; Jonas JB, 2016, INVEST OPHTH VIS SCI, V57, P396, DOI 10.1167/iovs.15-18263; Jonas JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136833; Jonas JB, 2014, ACTA OPHTHALMOL, V92, pE470, DOI 10.1111/aos.12372; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Jonas RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141771; Jonas RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138701; Law SK, 2010, ARCH OPHTHALMOL-CHIC, V128, P141, DOI 10.1001/archophthalmol.2009.340; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; Nangia V, 2010, OPHTHALMOLOGY, V117, P693, DOI 10.1016/j.ophtha.2009.09.037; Ohno-Matsui K, 2012, AM J OPHTHALMOL, V154, P382, DOI 10.1016/j.ajo.2012.02.010; Ohno-Matsui K, 2011, INVEST OPHTH VIS SCI, V52, P9644, DOI 10.1167/iovs.11-8597; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; Paunescu LA, 2004, INVEST OPHTH VIS SCI, V45, P1716, DOI 10.1167/iovs.03-0514; QUIGLEY HA, 1990, ARCH OPHTHALMOL-CHIC, V108, P51, DOI 10.1001/archopht.1990.01070030057028; Reis ASC, 2012, OPHTHALMOLOGY, V119, P738, DOI 10.1016/j.ophtha.2011.09.054; Reis F., 2015, J GLAUCOMA, V24, P45; Takasaki H, 2013, JPN J OPHTHALMOL, V57, P34, DOI 10.1007/s10384-012-0193-9; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; Vongphanit J, 2002, AM J OPHTHALMOL, V133, P679, DOI 10.1016/S0002-9394(02)01339-9; Wang XF, 2016, INVEST OPHTH VIS SCI, V57, P5825, DOI 10.1167/iovs.16-20560; Wang XF, 2016, INVEST OPHTH VIS SCI, V57, P2452, DOI 10.1167/iovs.15-18986; Wang YZ, 2011, P IEEE INT FREQ CONT, P428; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Wojtkowski M, 2005, OPHTHALMOLOGY, V112, P1734, DOI 10.1016/j.ophtha.2005.05.023; Xu L, 2006, OPHTHALMOLOGY, V113, P747, DOI 10.1016/j.ophtha.2006.01.026; Yan YN, 2015, OPHTHALMOLOGY, V122, P1873, DOI 10.1016/j.ophtha.2015.05.031; Yokoyama Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099138	43	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0175749	10.1371/journal.pone.0175749	http://dx.doi.org/10.1371/journal.pone.0175749			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481929	Green Published, gold, Green Submitted			2022-12-27	WOS:000401313700005
J	van der Linden, M; Hooghe, M; de Vroome, T; Van Laar, C				van der Linden, Meta; Hooghe, Marc; de Vroome, Thomas; Van Laar, Colette			Extending trust to immigrants: Generalized trust, cross-group friendship and anti-immigrant sentiments in 21 European societies	PLOS ONE			English	Article							INTERGROUP CONTACT; ETHNIC DIVERSITY; PREJUDICE; ATTITUDES; RADIUS; RECONCILIATION; DISCRIMINATION; CONSEQUENCES; COUNTRIES; EDUCATION	The aim of this study is twofold. First, we expand on the literature by testing whether generalized trust is negatively related to anti-immigrant sentiments in Europe. Second, we examine to what extent the relation between generalized trust and anti-immigrant sentiments is dependent upon cross-group friendships. We apply multilevel linear regression modeling to representative survey data enriched with levels of ethnic diversity covering 21 European countries. Results show that both generalized trust and cross-group friendship are negatively related to anti-immigrant sentiments. However, there is a negligible positive relation between generalized trust and cross-group friendship (r =.10), and we can clearly observe that they operate independently from one another. Hence, trusting actors are not more likely to form more cross-group friendships, and cross-group friendship do not lead to the development of more generalized trust. Instead, the findings show that generalized trust leads immigrants too to be included in the radius of trusted others and, as a consequence, the benign effects of generalized trust apply to them as well. We conclude that the strength of generalized trust is a form of generalization, beyond the confines of individual variations in intergroup experiences.	[van der Linden, Meta; Hooghe, Marc] Univ Leuven, Ctr Citizenship & Democracy, Leuven, Belgium; [de Vroome, Thomas] Univ Utrecht, European Res Ctr Migrat & Ethn Relat, Utrecht, Netherlands; [Van Laar, Colette] Univ Leuven, Ctr Social & Cultural Psychol, Leuven, Belgium	KU Leuven; Utrecht University; KU Leuven	van der Linden, M (corresponding author), Univ Leuven, Ctr Citizenship & Democracy, Leuven, Belgium.	meta.vanderlinden@kuleuven.be		Van Laar, Colette/0000-0002-8113-1242; van der Linden, Meta/0000-0003-3944-3354	European Research Council, ERC [ERC-2011-ADG]	European Research Council, ERC(European Research Council (ERC))	The authors acknowledge the funding by the European Research Council, ERC Advanced Grant Linkage between citizens and the state. Grant number: ERC-2011-ADG, and URL: https://erc.europa.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport G. W., 1954, NATURE PREJUDICE; Bar-Tal D, 2000, POLIT PSYCHOL, V21, P351, DOI 10.1111/0162-895X.00192; Bauer PC, 2015, EUR SOCIOL REV, V31, P397, DOI 10.1093/esr/jcu096; Bekkers R, 2012, POLIT BEHAV, V34, P225, DOI 10.1007/s11109-011-9165-x; Brown R, 2005, ADV EXP SOC PSYCHOL, V37, P255, DOI 10.1016/S0065-2601(05)37005-5; Carvacho H, 2013, EUR J SOC PSYCHOL, V43, P272, DOI 10.1002/ejsp.1961; Christ O, 2014, P NATL ACAD SCI USA, V111, P3996, DOI 10.1073/pnas.1320901111; Citrin J, 2008, POLIT STUD-LONDON, V56, P33, DOI 10.1111/j.1467-9248.2007.00716.x; Coenders M, 1998, EUR SOCIOL REV, V14, P405, DOI 10.1093/oxfordjournals.esr.a018247; Coenders M, 2008, J ETHN MIGR STUD, V34, P1, DOI 10.1080/13691830701708809; Davies K, 2011, PERS SOC PSYCHOL REV, V15, P332, DOI 10.1177/1088868311411103; Delhey J, 2011, AM SOCIOL REV, V76, P786, DOI 10.1177/0003122411420817; Ekici T, 2015, SOC INDIC RES, V122, P105, DOI 10.1007/s11205-014-0674-y; Freitag M, 2009, EUR J POLIT RES, V48, P782, DOI 10.1111/j.1475-6765.2009.00849.x; Fukuyama F., 1995, TRUST SOCIAL VIRTUES; Glanville JL, 2013, SOC FORCES, V92, P545, DOI 10.1093/sf/sot079; Green E.G.T., 2013, OXFORD HDB POLITICAL, P852, DOI DOI 10.1093/OXFORDHB/9780199760107.013.0026; Hardin Russell, 2002, RUSSELL SAGE FDN SER; Hardin Russell, 2006, TRUST; Hewstone M, 2015, J SOC ISSUES, V71, P417, DOI 10.1111/josi.12120; Hooghe M, 2008, INT MIGR REV, V42, P476, DOI 10.1111/j.1747-7379.2008.00132.x; Hooghe M, 2015, ETHNIC RACIAL STUD, V38, P38, DOI 10.1080/01419870.2013.800572; Hooghe M, 2009, COMP POLIT STUD, V42, P198, DOI 10.1177/0010414008325286; Kenworthy JB, 2016, J CONFLICT RESOLUT, V60, P1041, DOI 10.1177/0022002714564427; Levin S, 2003, GROUP PROCESS INTERG, V6, P76, DOI 10.1177/1368430203006001013; LYNN P, 2003, INT J SOCIAL RES MET, V0006; Meuleman B, 2009, SOC SCI RES, V38, P352, DOI 10.1016/j.ssresearch.2008.09.006; Nadler A, 2015, EUR REV SOC PSYCHOL, V26, P93, DOI 10.1080/10463283.2015.1106712; Nussbaum M.C., 2012, NEW RELIG INTOLERANC; OROURKE KH, 2006, EUR J POLIT EC, V0022; Paxton P, 2015, SOC PSYCHOL QUART, V78, P194, DOI 10.1177/0190272515582177; Pettigrew TF, 1998, ANNU REV PSYCHOL, V49, P65, DOI 10.1146/annurev.psych.49.1.65; Pettigrew TF, 2010, SAGE HDB PREJUDICE S, P599, DOI [10.4135/9781446200919.n36, DOI 10.4135/9781446200919.N36]; Pettigrew TR, 2006, J SOC ISSUES, V62, P615, DOI 10.1111/j.1540-4560.2006.00477.x; Putnam RD., 2000, BOWLING ALONE COLLAP; Putnam RD, 2007, SCAND POLIT STUD, V30, P137, DOI 10.1111/j.1467-9477.2007.00176.x; Reeskens T, 2008, SOC INDIC RES, V85, P515, DOI 10.1007/s11205-007-9100-z; Reeskens T, 2013, SOC INDIC RES, V114, P703, DOI 10.1007/s11205-012-0169-7; Scheepers P, 2002, EUR SOCIOL REV, V18, P17, DOI 10.1093/esr/18.1.17; Schmid K, 2014, PSYCHOL SCI, V25, P665, DOI 10.1177/0956797613508956; Schneider SL, 2008, EUR SOCIOL REV, V24, P53, DOI 10.1093/esr/jcm034; Semyonov M, 2006, AM SOCIOL REV, V71, P426, DOI 10.1177/000312240607100304; Simmel G, 1992, GESAMTAUSGABE 11 SOZ; Sztompka P., 1999, TRUST; Tam T, 2009, PERS SOC PSYCHOL B, V35, P45, DOI 10.1177/0146167208325004; Torpe L, 2011, SOC INDIC RES, V103, P481, DOI 10.1007/s11205-010-9713-5; Tropp L. R., 2008, IMPROVING INTERGROUP, P91, DOI [10.1002/9781444303117.ch7, DOI 10.1002/9781444303117.CH7]; Uslaner E., 2002, MORAL FDN TRUST; Uslaner Eric, 2012, SEGREGATION MISTRUST; van der Meer T, 2014, ANNU REV SOCIOL, V40, P459, DOI 10.1146/annurev-soc-071913-043309; van Hoorn A, 2015, J CROSS CULT PSYCHOL, V46, P269, DOI 10.1177/0022022114551053; van Ingen E, 2015, POLIT PSYCHOL, V36, P277, DOI 10.1111/pops.12105; Vonofakou C., 2008, IMPROVING INTERGROUP, P107, DOI [DOI 10.1002/9781444303117.CH8, 10.1002/9781444303117.ch8]; WAGNER U, 1995, EUR J SOC PSYCHOL, V25, P41, DOI 10.1002/ejsp.2420250105; Welch MR, 2005, SOCIOL INQ, V75, P453, DOI 10.1111/j.1475-682X.2005.00132.x; Zick A., 2011, INTOLERANCE PREJUDIC; Zick A, 2008, J SOC ISSUES, V64, P233, DOI 10.1111/j.1540-4560.2008.00559.x	57	23	23	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177369	10.1371/journal.pone.0177369	http://dx.doi.org/10.1371/journal.pone.0177369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481925	Green Published, Green Submitted, gold			2022-12-27	WOS:000401313700055
J	Zwerenz, R; Becker, J; Gerzymisch, K; Siepmann, M; Holme, M; Kiwus, U; Sporl-Donch, S; Beutel, ME				Zwerenz, Ruediger; Becker, Jan; Gerzymisch, Katharina; Siepmann, Martin; Holme, Martin; Kiwus, Ulrich; Spoerl-Doench, Sieglinde; Beutel, Manfred E.			Evaluation of a transdiagnostic psychodynamic online intervention to support return to work: A randomized controlled trial	PLOS ONE			English	Article							MEDICAL REHABILITATION; INTERNET; ANXIETY; PARTICIPATION; PSYCHOTHERAPY; DISORDERS; EMPLOYEES; ABILITY; HEALTH; CARE	Objectives Given their flexibility, online interventions may be useful as an outpatient treatment option to support vocational reintegration after inpatient rehabilitation. To that purpose we devised a transdiagnostic psychodynamic online intervention to facilitate return to work, focusing on interpersonal conflicts at the workplace often responsible for work-related stress. Research design and methods In a randomized controlled trial, we included employed patients from cardiologic, psychosomatic and orthopedic rehabilitation with work-related stress or need for support at intake to inpatient rehabilitation after they had given written consent to take part in the study. Following discharge, maladaptive interpersonal interactions at the workplace were identified via weekly blogs and processed by written therapeutic comments over 12 weeks in the intervention group (IG). The control group (CG) received an augmented treatment as usual condition. The main outcome, subjective prognosis of gainful employment (SPE), and secondary outcomes (psychological complaints) were assessed by means of online questionnaires before, at the end of aftercare (3 months) and at follow-up (12 months). We used ITT analyses controlling for baseline scores and medical group. Results N = 319 patients were enrolled into IG and N = 345 into CG. 77% of the IG logged in to the webpage (CG 74%) and 65% of the IG wrote blogs. Compared to the CG, the IG reported a significantly more positive SPE at follow-up. Measures of depression, anxiety and psychosocial stressors decreased from baseline to follow-up, whereas the corresponding scores increased in the CG. Correspondingly, somatization and psychological quality of life improved in the IG. Conclusions Psychodynamic online aftercare was effective to enhance subjective prognosis of future employment and improved psychological complaints across a variety of chronic physical and psychological conditions, albeit with small effect sizes.	[Zwerenz, Ruediger; Becker, Jan; Gerzymisch, Katharina; Beutel, Manfred E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Mainz, Germany; [Siepmann, Martin] Carl Gustav Carus Tech Univ, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Dresden, Germany; [Holme, Martin] Clin Weser, German Statutory Pens Insurance Rehabil Ctr Ortho, Bad Pyrmont, Germany; [Kiwus, Ulrich] Clin Wetterau, German Statutory Pens Insurance Rehabil Ctr Cardi, Bad Nauheim, Germany; [Spoerl-Doench, Sieglinde] Haus Franken GmbH, Clin Prevent & Rehabil Cardiovasc Dis, Bad Neustadt an der Saale, Germany; [Siepmann, Martin] Rhon Klinikum AG, Clin Psychosomat Med Bad Neustadt, Bad Neustadt an der Saale, Germany	Johannes Gutenberg University of Mainz; Technische Universitat Dresden; Rhon-Klinikum AG	Zwerenz, R (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Mainz, Germany.	ruediger.zwerenz@unimedizin-mainz.de	Becker, Jan/AAU-4951-2021	Becker, Jan/0000-0002-2125-5323; Zwerenz, Rudiger/0000-0003-1491-0905	German Statutory Pension insurance (Deutsche Rentenversicherung-Bund) [0423/00-40-65-50-25]	German Statutory Pension insurance (Deutsche Rentenversicherung-Bund)	The study was funded by the German Statutory Pension insurance (Deutsche Rentenversicherung-Bund; grant number: 0423/00-40-65-50-25) [http://www.deutsche-rentenversicherung.de]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews G, 2010, PLOS ONE, V5; Bethge M, 2009, DISABIL REHABIL, V31, P1692, DOI 10.1080/09638280902751949; Beutel ME, 2006, INT J GROUP PSYCHOTH, V56, P285, DOI 10.1521/ijgp.2006.56.3.285; Beutel ME, 2005, DISABIL REHABIL, V27, P891, DOI 10.1080/09638280500030464; Beutel ME, 2004, Z KL PSYCH PSYCHOTH, V33, P110, DOI 10.1026/1616-3443.33.2.110; Burger W, 2009, REHABILITATION, V48, P211, DOI 10.1055/s-0029-1231062; Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Corp IBM, 2014, IBM SPSS STAT WIND V; Cuijpers Pim, 2009, Cognitive Behaviour Therapy, V38, P66, DOI 10.1080/16506070802694776; Deutsche Rentenversicherung Bund. Reha-Bericht 2013, 2013, REH BER 2013 MED BER; Dumitru RC, 2007, INT J PUBLIC HEALTH, V52, P275, DOI 10.1007/s00038-007-6067-0; Ebert D, 2013, PSYCHOTHER PSYCHOSOM, V82, P246, DOI 10.1159/000345967; Ebert DD, 2014, SCANDINAVIAN J WORK; Frees B., 2015, MEDIA PERSPEKTIVEN, P366; Hillert A, 2007, PRAXIS KLIN VERHALTE, V77, P147; Johansson R., 2012, PLOS ONE, V7; Johansson R, 2013, PSYCHODYNAMIC PSYCHI, V41, P385; Johansson R, 2013, PEERJ, V1, DOI 10.7717/peerj.102; Joyce S, 2015, PSYCHOL MED, P1; Kobelt A, 2004, PSYCHOTHER PSYCH MED, V54, P58, DOI 10.1055/s-2003-812612; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Lehr D, 2016, HLTH WORK, P257, DOI [10.1007/978-3-319-32331-2_19, DOI 10.1007/978-3-319-32331-2_19]; Linder J, 2009, INT J REHABIL RES, V32, P20, DOI 10.1097/MRR.0b013e328306351d; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lowe B, 2006, PSYCHOSOMATICS, V47, P62, DOI 10.1176/appi.psy.47.1.62; Luborsky L., 1984, PRINCIPLES PSYCHOANA; Mittag O, 2003, Rehabilitation (Stuttg), V42, P169; MURPHY LJ, 1998, BRIT J GUID COUNS, V26, P21, DOI DOI 10.1080/03069889808253835; Muschalla B, 2013, OCCUP MED-OXFORD, V63, P415, DOI 10.1093/occmed/kqt072; Muschalla B, 2014, J AM BOARD FAM MED, V27, P486, DOI 10.3122/jabfm.2014.04.130308; Pennebaker J.W., 2007, FDN HLTH PSYCHOL, P263, DOI DOI 10.1093/OXFORDHB/9780195342819.013.0018; Plous S., 2011, RES RANDOMIZER VERSI; Rockelein E, 2011, BUNDESGESUNDHEITSBLA, V54, P436, DOI 10.1007/s00103-011-1239-8; Schaarschmidt U., 2008, ARBEITSBEZOGENES VER; Sibold M, 2011, REHABILITATION, V50, P363, DOI 10.1055/s-0031-1271815; SPERA SP, 1994, ACAD MANAGE J, V37, P722, DOI 10.2307/256708; Spitzer RL, 2002, MANUAL KOMPLETTVERSI, V2; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Streibelt M, 2011, REHABILITATION, V50, P160, DOI 10.1055/s-0031-1275721; Thiart H, 2015, SCAND J WORK ENV HEA, V41, P164, DOI 10.5271/sjweh.3478; Wang MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096025; Zimmermann L, 2011, MENTAL HLTH PATTERNS; Zwerenz R, 2004, Rehabilitation (Stuttg), V43, P10; Zwerenz R, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-26	46	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176513	10.1371/journal.pone.0176513	http://dx.doi.org/10.1371/journal.pone.0176513			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481893	Green Published, gold, Green Submitted			2022-12-27	WOS:000401313700011
J	Chaffee, BW; Couch, ET; Gansky, SA				Chaffee, Benjamin W.; Couch, Elizabeth T.; Gansky, Stuart A.			Trends in characteristics and multi-product use among adolescents who use electronic cigarettes, United States 2011-2015	PLOS ONE			English	Article							HIGH-SCHOOL-STUDENTS; POLY-TOBACCO USE; YOUNG-ADULTS; SMOKING; PRODUCTS; MIDDLE; REASONS; HARM; ASSOCIATIONS; PERCEPTIONS	Objectives Evaluate trends from 2011-2015 in electronic cigarette (e-cigarette) use among U.S. adolescents, grades 6-12, including prevalence and associations with past month use of cigarettes and other tobacco products, cigarette smoking intensity, quit attempts, and quit contemplation. Methods Five consecutive waves from the National Youth Tobacco Survey (N = 101,011) were used to estimate the grade-and race/ethnicity-standardized prevalence of past month use of e-cigarettes and nine non e-cigarette tobacco products. We assessed linear trends by year and compared outcomes (e.g., tobacco use, smoking intensity) by e-cigarette past month use. Results Past month e-cigarette use rose sharply from 2011-2015. In all years and both sexes, e-cigarette past month use and ever use were positively associated with use of cigarettes and other tobacco products, with past month e-cigarette use reaching 52% in 2015 among individuals who used >= 1 non e-cigarette tobacco product in the past month. Meanwhile, from 2011-2015, the population of adolescent past month e-cigarette users increasingly encompassed adolescents who were not past month users of other products (females: 19.0% to 41.7%; males: 11.1% to 36.7%) or had never used other products (females: 7.1% to 13.5%; males: 6.7% to 15.0%). Among male (but not female) past month cigarette users, there was a statistically significant positive association between past month e-cigarette use and daily cigarette smoking but not in all individual years. Past month e-cigarette use among past month cigarette smokers was not associated with cigarette quit attempts or quit contemplation, with no temporal trend. Conclusion Adolescent past month e-cigarette use is associated with past month use of other tobacco but not with cigarette quit attempts or quit contemplation among cigarette users. Over five years, the average characteristics of U.S. adolescents who use e-cigarettes have shifted, increasingly including more adolescents who do not use non e-cigarette tobacco products.	[Chaffee, Benjamin W.; Couch, Elizabeth T.; Gansky, Stuart A.] Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, Div Oral Epidemiol & Dent Publ Hlth, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Chaffee, BW (corresponding author), Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, Div Oral Epidemiol & Dent Publ Hlth, San Francisco, CA 94143 USA.	benjamin.chaffee@ucsf.edu			United States National Cancer Institute and Food and Drug Administration Center for Tobacco Products [P50 CA180890]; United States National Center for Advancing Translational Sciences [KL2 TR000143]; NATIONAL CANCER INSTITUTE [P50CA180890] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR051895] Funding Source: NIH RePORTER	United States National Cancer Institute and Food and Drug Administration Center for Tobacco Products; United States National Center for Advancing Translational Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The United States National Cancer Institute and Food and Drug Administration Center for Tobacco Products (P50 CA180890, support to BWC ETC SAG, website: www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/AbouttheCenterforTobaccoProducts/default.htm) and the United States National Center for Advancing Translational Sciences (KL2 TR000143, support to BWC, website: ncats.nih.gov/) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Amrock SM, 2015, NICOTINE TOB RES, V17, P330, DOI 10.1093/ntr/ntu156; Apelberg BJ, 2014, AM J PREV MED, V47, pS4, DOI 10.1016/j.amepre.2014.04.013; Arrazola R. A., 2010, Morbidity and Mortality Weekly Report, V59, P1063; Arrozola RA, 2015, MMWR-MORBID MORTAL W, V64, P381; Babineau K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126419; Barrington-Trimis JL, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0379; Barrington-Trimis JL, 2016, J ADOLESCENT HEALTH, V59, P75, DOI 10.1016/j.jadohealth.2016.03.019; Benowitz Neal L, 2014, Ann Am Thorac Soc, V11, P231, DOI 10.1513/AnnalsATS.201312-433PS; Berg CJ, 2015, SUBST USE MISUSE, V50, P79, DOI 10.3109/10826084.2014.958857; BMOA, 1831, DEEM TOB PROD SUBJ F; Bunnell RE, 2015, NICOTINE TOB RES, V17, P228, DOI 10.1093/ntr/ntu166; Cobb C., 2015, TOB REGUL SCI, V1, P129, DOI [10.18001/TRS.1.2.3, DOI 10.18001/TRS.1.2.3]; Cooper M, 2016, AM J HEALTH BEHAV, V40, P108, DOI 10.5993/AJHB.40.1.12; Corey CG, 2015, MMWR-MORBID MORTAL W, V64, P1066, DOI 10.15585/mmwr.mm6438a2; Creamer MR, 2016, AM J HEALTH BEHAV, V40, P117, DOI 10.5993/AJHB.40.1.13; Czoli CD, 2015, J ADOLESCENT HEALTH, V57, P123, DOI 10.1016/j.jadohealth.2015.03.006; de Andrade Marisa, 2013, BMJ, V347, pf7473, DOI 10.1136/bmj.f7473; Dutra LM, 2014, JAMA PEDIATR, V168, P684, DOI 10.1001/jamapediatrics.2013.5488; Gmel G, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14271; Goniewicz ML, 2016, INT J PUBLIC HEALTH, V61, P189, DOI 10.1007/s00038-015-0756-x; Hartmann-Boyce Jamie, 2016, Cochrane Database Syst Rev, V9, pCD010216, DOI 10.1002/14651858.CD010216.pub3; Hildick-Smith GJ, 2015, J ADOLESCENT HEALTH, V57, P574, DOI 10.1016/j.jadohealth.2015.07.020; Hughes K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1618-4; Johnston LD, 2015, MONITORING FUTURE NA; Kalkhoran S, 2016, LANCET RESP MED, V4, P116, DOI 10.1016/S2213-2600(15)00521-4; Kalkhoran S, 2015, JAMA INTERN MED, V175, P1671, DOI 10.1001/jamainternmed.2015.4209; Kaufman AR, 2015, PREV MED, V81, P251, DOI 10.1016/j.ypmed.2015.08.026; Kong G, 2015, NICOTINE TOB RES, V17, P847, DOI 10.1093/ntr/ntu257; Kowitt SD, 2015, INT J ENV RES PUB HE, V12, P14477, DOI 10.3390/ijerph121114477; Latimer LA, 2014, NICOTINE TOB RES, V16, P519, DOI 10.1093/ntr/ntt174; Lauterstein Dana, 2014, Curr Drug Abuse Rev, V7, P29; Lee S, 2014, J ADOLESCENT HEALTH, V54, P684, DOI 10.1016/j.jadohealth.2013.11.003; Leventhal AM, 2015, JAMA-J AM MED ASSOC, V314, P700, DOI 10.1001/jama.2015.8950; Li J, 2015, ADDICT BEHAV, V45, P245, DOI 10.1016/j.addbeh.2015.02.006; Lippert AM, 2015, AM J HEALTH PROMOT, V29, P374, DOI 10.4278/ajhp.131120-QUAN-595; Moore G, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007072; Neff LJ, 2015, MMWR-MORBID MORTAL W, V64, P1061, DOI 10.15585/mmwr.mm6438a1; Office on Smoking and Health, 2015, 2014 NAT YOUTH TOB S; Okuyemi Kolawole S, 2002, Nicotine Tob Res, V4 Suppl 2, pS103; Primack BA, 2015, JAMA PEDIATR, V169, P1018, DOI 10.1001/jamapediatrics.2015.1742; Richtel M., 2014, NY TIMES; Robertson L, 2016, NICOTINE TOB RES, V18, P943, DOI 10.1093/ntr/ntv167; RUBIN DB, 1987, J AM STAT ASSOC, V82, P543, DOI 10.2307/2289460; Saddleson ML, 2016, DRUG ALCOHOL DEPEN, V162, P92, DOI 10.1016/j.drugalcdep.2016.02.043; Schneider S, 2016, NICOTINE TOB RES, V18, P647, DOI 10.1093/ntr/ntv193; Sect Tobacco Control, 2015, PEDIATRICS, V136, P1018, DOI 10.1542/peds.2015-3222; Singh T, 2016, MMWR-MORBID MORTAL W, V65, P361, DOI 10.15585/mmwr.mm6514a1; Soneji S, 2016, TOB CONTROL, V25, P174, DOI 10.1136/tobaccocontrol-2014-051638; Stanwick R, 2015, PAED CHILD HEALT-CAN, V20, P101, DOI 10.1093/pch/20.2.101; Suris JC, 2015, DRUG ALCOHOL DEPEN, V153, P140, DOI 10.1016/j.drugalcdep.2015.05.034; Sutfin EL, 2013, DRUG ALCOHOL DEPEN, V131, P214, DOI 10.1016/j.drugalcdep.2013.05.001; Tomar SL, 1998, AM J PUBLIC HEALTH, V88, P20, DOI 10.2105/AJPH.88.1.20; Villanti AC, 2016, NICOTINE TOB RES; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wills TA, 2016, TOB CONTROL, V25, pE52, DOI 10.1136/tobaccocontrol-2015-052349; Wills TA, 2017, TOB CONTROL, V26, P534, DOI 10.1136/tobaccocontrol-2016-053116; Wills TA, 2015, PEDIATRICS, V135, pE43, DOI 10.1542/peds.2014-0760; Witt MB, 2009, P SECT SURV RES METH; Zhong JM, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13050465	59	36	36	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177073	10.1371/journal.pone.0177073	http://dx.doi.org/10.1371/journal.pone.0177073			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475634	Green Submitted, Green Published, gold			2022-12-27	WOS:000400649500042
J	Haslacher, H; Ratzinger, F; Perkmann, T; Batmyagmar, D; Nistler, S; Scherzer, TM; Ponocny-Seliger, E; Pilger, A; Gerner, M; Scheichenberger, V; Kundi, M; Endler, G; Wagner, OF; Winker, R				Haslacher, Helmuth; Ratzinger, Franz; Perkmann, Thomas; Batmyagmar, Delgerdalai; Nistler, Sonja; Scherzer, Thomas M.; Ponocny-Seliger, Elisabeth; Pilger, Alexander; Gerner, Marlene; Scheichenberger, Vanessa; Kundi, Michael; Endler, Georg; Wagner, Oswald F.; Winker, Robert			A combination of routine blood analytes predicts fitness decrement in elderly endurance athletes	PLOS ONE			English	Article							OXIDATIVE STRESS; PHYSICAL-EXERCISE; MARATHON RACE; OXYGEN-UPTAKE; RUNNERS; MYELOPEROXIDASE; PERFORMANCE; TIME; PARAMETERS	Endurance sports are enjoying greater popularity, particularly among new target groups such as the elderly. Predictors of future physical capacities providing a basis for training adaptations are in high demand. We therefore aimed to estimate the future physical performance of elderly marathoners (runners/bicyclists) using a set of easily accessible standard laboratory parameters. To this end, 47 elderly marathon athletes underwent physical examinations including bicycle ergometry and a blood draw at baseline and after a three-year follow-up period. In order to compile a statistical model containing baseline laboratory results allowing prediction of follow-up ergometry performance, the cohort was subgrouped into a model training (n = 25) and a test sample (n = 22). The model containing significant predictors in univariate analysis ( alanine aminotransferase, urea, folic acid, myeloperoxidase and total cholesterol) presented with high statistical significance and excellent goodness of fit (R-2 = 0.789, ROC-AUC = 0.951 +/- 0.050) in the model training sample and was validated in the test sample (ROC-AUC = 0.786 +/- 0.098). Our results suggest that standard laboratory parameters could be particularly useful for predicting future physical capacity in elderly marathoners. It hence merits further research whether these conclusions can be translated to other disciplines or age groups.	[Haslacher, Helmuth; Ratzinger, Franz; Perkmann, Thomas; Batmyagmar, Delgerdalai; Gerner, Marlene; Scheichenberger, Vanessa; Wagner, Oswald F.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Batmyagmar, Delgerdalai; Kundi, Michael] Med Univ Vienna, Dept Publ Hlth, Vienna, Austria; [Nistler, Sonja; Scherzer, Thomas M.; Winker, Robert] Hlth & Prevent Ctr, Sanatorium Hera, Vienna, Austria; [Ponocny-Seliger, Elisabeth] Empir Res, Vienna, Austria; [Pilger, Alexander] Med Univ Vienna, Inst Occupat Med, Vienna, Austria; [Endler, Georg] Gruppenpraxis Labors At, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Haslacher, H (corresponding author), Med Univ Vienna, Dept Lab Med, Vienna, Austria.	helmuth.haslacher@meduniwien.ac.at	Perkmann, Thomas/F-3074-2012; Haslacher, Helmuth/D-4233-2013	Haslacher, Helmuth/0000-0003-4605-2503; Perkmann, Thomas/0000-0002-7976-0285	Austrian National Bank [14511, 12979]	Austrian National Bank	This trial was supported by the Anniversary Fund of the Austrian National Bank (No. 14511, No. 12979), https://www.oenb.at/en/About-Us/Research-Promotion/The-OeNBAnniversary-Fund.html. Moreover, authors EP and GE are currently affiliated with commercial companies. However, neither these companies nor the funder (Austrian National Bank), who inter alia provided support in the form of salaries for authors (EP, DB), did have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banfi G, 2012, ADV CLIN CHEM, V56, P1, DOI 10.1016/B978-0-12-394317-0.00015-7; Beck BR, 2016, J SCI MED SPORT; Bobbert T, 2012, INT J SPORTS MED, V33, P244, DOI 10.1055/s-0031-1291251; Bohm H, 1978, OST ARZTEZTG, V33, P333; Dahlquist DT, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0093-8; Del Coso J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057602; Durstine JL, 2001, SPORTS MED, V31, P1033, DOI 10.2165/00007256-200131150-00002; Gill JMR, 2008, SPORTS MED, V38, P807, DOI 10.2165/00007256-200838100-00002; Haslacher H, 2012, INT J SPORTS MED, V33, P1034, DOI 10.1055/s-0032-1304637; Haslacher H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157695; Haslacher H, 2015, J SPORT EXERCISE PSY, V37, P637, DOI 10.1123/jsep.2015-0111; Haslacher H, 2015, NEUROPSYCHOBIOLOGY, V71, P168, DOI 10.1159/000381350; Heil DP, 2001, EUR J APPL PHYSIOL, V85, P374, DOI 10.1007/s004210100442; Henrotin Y, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-92; Herrmann M, 2003, CLIN CHEM LAB MED, V41, P1518, DOI 10.1515/CCLM.2003.233; Hessel E, 2000, CLIN CHIM ACTA, V298, P145, DOI 10.1016/S0009-8981(00)00295-3; HIKIDA RS, 1983, J NEUROL SCI, V59, P185, DOI 10.1016/0022-510X(83)90037-0; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; HOUMARD JA, 1994, ARTERIOSCLER THROMB, V14, P325, DOI 10.1161/01.ATV.14.3.325; Ke CY, 2016, INT J MED SCI, V13, P147, DOI 10.7150/ijms.13746; KIENS B, 1989, J CLIN INVEST, V83, P558, DOI 10.1172/JCI113918; Knechtle B, 2011, CLINICS, V66, P287, DOI 10.1590/S1807-59322011000200018; Kobayashi Y, 2005, RES Q EXERCISE SPORT, V76, P450; Kratz A, 2002, AM J CLIN PATHOL, V118, P856, DOI 10.1092/BTWQ5YMYVQ67QK9L; Lepers R, 2012, AGE, V34, P773, DOI 10.1007/s11357-011-9271-z; Lippi G, 2015, CLIN CHEM LAB MED, V53, P469, DOI 10.1515/cclm-2014-0850; Lippi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112892; Londeree BR, 1997, MED SCI SPORT EXER, V29, P837, DOI 10.1097/00005768-199706000-00016; Mairbaurl H, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00332; MATTER M, 1987, CLIN SCI, V72, P415, DOI 10.1042/cs0720415; Midgley AW, 2007, SPORTS MED, V37, P857, DOI 10.2165/00007256-200737100-00003; Midgley AW, 2006, SPORTS MED, V36, P117, DOI 10.2165/00007256-200636020-00003; Misra M, 2014, HAND CLINIC, V124, P373, DOI 10.1016/B978-0-444-59602-4.00025-3; Nauseef WM, 2014, CELL MICROBIOL, V16, P1146, DOI 10.1111/cmi.12312; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Pettersson J, 2008, BRIT J CLIN PHARMACO, V65, P253, DOI 10.1111/j.1365-2125.2007.03001.x; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Sanchis-Gomar F, 2014, BIOCHEM MEDICA, V24, P68, DOI 10.11613/BM.2014.009; Schwabe K, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093470; Shin KA, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003657; Suzuki K, 2003, MED SCI SPORT EXER, V35, P348, DOI 10.1249/01.MSS.0000048861.57899.04; Till ES, 2016, J STRENGTH COND RES, V30, P512, DOI 10.1519/JSC.0000000000001152; Tilley BJ, 2015, BRIT J SPORT MED, V49, P1504, DOI 10.1136/bjsports-2015-095100; Van Remoortel H, 2017, TRANSFUSION, V57, P451, DOI 10.1111/trf.13893; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Williams C, 1983, Br J Sports Med, V17, P152; Williams PT, 2009, MED SCI SPORT EXER, V41, P523, DOI 10.1249/MSS.0b013e31818c1752; Winker R, 2010, WIEN KLIN WOCHENSCHR, V122, P704, DOI 10.1007/s00508-010-1485-z; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200	49	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177174	10.1371/journal.pone.0177174	http://dx.doi.org/10.1371/journal.pone.0177174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475643	Green Published, gold, Green Submitted			2022-12-27	WOS:000400649500053
J	Koziel, JA; Frana, TS; Ahn, H; Glanville, TD; Nguyen, LT; van Leeuwen, J				Koziel, Jacek A.; Frana, Timothy S.; Ahn, Heekwon; Glanville, Thomas D.; Nguyen, Lam T.; van Leeuwen, J. (Hans)			Efficacy of NH3 as a secondary barrier treatment for inactivation of Salmonella Typhimurium and methicillin-resistant Staphylococcus aureus in digestate of animal carcasses: Proof-of-concept	PLOS ONE			English	Article							SWINE MANURE; ANAEROBIC-DIGESTION; AMMONIA TOXICITY; BACTERIA; PATHOGENS; RISK; PH; CONTAMINATION; DISINFECTION; ENVIRONMENT	Managing the disposal of infectious animal carcasses from routine and catastrophic disease outbreaks is a global concern. Recent research suggests that burial in lined and aerated trenches provides the rapid pathogen containment provided by burial, while reducing air and water pollution potential and the length of time that land is taken out of agricultural production. Survival of pathogens in the digestate remains a concern, however. A potential answer is a `dual'-barrier approach in which ammonia is used as a secondary barrier treatment to reduce the risk of pathogen contamination when trench liners ultimately leak. Results of this study showed that the minimum inhibitory concentration (MIC) of NH3 is 0.1 M (similar to 1,468 NH3-N mg/L), and 0.5 M NH3 (similar to 7,340 NH3-N mg/L) for ST4232 & MRSA43300, respectively at 24 h and pH = 9 +/- 0.1 and inactivation was increased by increasing NH3 concentration and/or treatment time. Results for digestate treated with NH3 were consistent with the MICs, and both pathogens were completely inactivated within 24 h.	[Koziel, Jacek A.; Glanville, Thomas D.; Nguyen, Lam T.; van Leeuwen, J. (Hans)] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA; [Koziel, Jacek A.; van Leeuwen, J. (Hans)] Iowa State Univ, Dept Civil Construct & Environm Engn, Ames, IA 50011 USA; [Koziel, Jacek A.; van Leeuwen, J. (Hans)] Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA; [Frana, Timothy S.] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [Ahn, Heekwon] Chungnam Natl Univ, Dept Anim Biosyst Sci, Daejeon, South Korea	Iowa State University; Iowa State University; Iowa State University; Iowa State University; Chungnam National University	Koziel, JA (corresponding author), Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA.; Koziel, JA (corresponding author), Iowa State Univ, Dept Civil Construct & Environm Engn, Ames, IA 50011 USA.; Koziel, JA (corresponding author), Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA.	koziel@iastate.edu	Koziel, Jacek A./B-5483-2014	Koziel, Jacek A./0000-0002-2387-0354; Ahn, Heekwon/0000-0002-3487-0640	National Institute of Animal Science [PJ90713006]; Korea Rural Development Administration	National Institute of Animal Science(National Institute of Animal Science, Republic of Korea); Korea Rural Development Administration(Rural Development Administration (RDA), Republic of Korea)	This work was supported by Republic of Korea Rural Development Administration through a grant from the National Institute of Animal Science (Project title: Development of environmentally friendly live stock mortality disposal system using aerobic digestion. Project no.: PJ90713006). The under had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by Republic of Korea Rural Development Administration through a grant from the National Institute of Animal Science (Project Title: Development of environmentally friendly livestock mortality disposal system using aerobic digestion. Project no.: PJ90713006, PI Prof. Thomas Glanville). The authors gratefully acknowledge Brad Bearson at the USDA-ARS, National Laboratory for Agriculture and the Environment, Ames, IA for providing Salmonella enterica ser. Typhimurium strain BSX 8 (chi 4232). The authors also would like to thank ISU, VDPAM for providing methicillin-resistant Staphylococcus aureus - ATCC 43300 strain and conducting the microbiological analysis. Special thanks to Joann Kinyon and Susan Cramer for their support with microbiological analyses. Special thanks to Dr. Susan Lamont and the staff of the ISU Poultry Research and Teaching facility for their assistance with raising and euthanizing poultry (IACUC log #4-03-5425-G).	ALBERTSON OE, 1961, J WATER POLLUT CON F, V33, P978; Anderson TC, 2016, MULTISTATE OUTBREAK; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Animal and Plant Health Inspection Service, 2005, NAT AN HLTH EM MAN S; [Anonymous], 2005, STANDARD METHODS EXA; Bell C, 2002, SALMONELLA PRACTICAL; Bendinelli M, 2002, STAPHYLOCOCCUS AUREU; Bolder NM, 1997, TRENDS FOOD SCI TECH, V8, P221, DOI 10.1016/S0924-2244(97)01040-6; Borgmann U, 1997, ENVIRON POLLUT, V95, P325, DOI 10.1016/S0269-7491(96)00138-8; Brglez B, 2009, METHODS DISPOSAL POU, P333; Brooks JP, 2014, WATER RES, V57, P96, DOI 10.1016/j.watres.2014.03.017; Cabello F, 1993, BIOL SALMONELLA; Carrel M, 2014, INFECT CONT HOSP EP, V35, P190, DOI 10.1086/674860; Casey JA, 2013, JAMA INTERN MED, V173, P1980, DOI 10.1001/jamainternmed.2013.10408; Cohen ML, 2000, NATURE, V406, P762, DOI 10.1038/35021206; Council for Agricultural Science and Technology (CAST), 2008, 40 CAST; Dahms C, 2014, GMS HYG INFECT CONTR, V9, DOI 10.3205/dgkh000241; EMERSON K, 1975, J FISH RES BOARD CAN, V32, P2379, DOI 10.1139/f75-274; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Fasina FO, 2015, ONDERSTEPOORT J VET, V82, DOI 10.4102/ojvr.v82i1.986; Fischer J, 2016, VET MICROBI IN PRESS; Ganidi N, 2009, BIORESOURCE TECHNOL, V100, P5546, DOI 10.1016/j.biortech.2009.06.024; Guan TY, 2003, J ENVIRON QUAL, V32, P383, DOI 10.2134/jeq2003.0383; Guerra B, 2014, VET MICROBIOL, V171, P290, DOI 10.1016/j.vetmic.2014.02.001; Gwyther CL, 2012, WASTE MANAGE, V32, P933, DOI 10.1016/j.wasman.2011.10.031; Hansen KH, 1998, WATER RES, V32, P5, DOI 10.1016/S0043-1354(97)00201-7; Hatcher SM, 2016, SCI TOTAL ENVIRON, V565, P1028, DOI 10.1016/j.scitotenv.2016.05.083; Himathongkham S, 1999, FEMS MICROBIOL LETT, V171, P179, DOI 10.1111/j.1574-6968.1999.tb13430.x; Himathongkham S, 1999, FEMS MICROBIOL LETT, V178, P251, DOI 10.1111/j.1574-6968.1999.tb08684.x; Himathongkham S, 2001, J FOOD PROTECT, V64, P1817, DOI 10.4315/0362-028X-64.11.1817; Huong VTL, 2016, EPIDEMIOL INFECT, V144, P35, DOI 10.1017/S0950268815000990; Ip Y.K., 2001, Fish Physiology, V20, P109; Kawakami VM, 2016, MMWR-MORBID MORTAL W, V65, P379, DOI 10.15585/mmwr.mm6514a4; Kim HS, 2012, GEOSCI J, V16, P479, DOI 10.1007/s12303-012-0036-1; Kleiner D, 1998, B I PASTEUR, V96, P257, DOI 10.1016/S0020-2452(99)80006-2; Koziel JA, 2017, WASTE MANAG IN PRESS; Leejeerajumnean A, 2000, LETT APPL MICROBIOL, V30, P385, DOI 10.1046/j.1472-765X.2000.00734.x; Mendez JM, 2004, WATER SCI TECHNOL, V50, P67, DOI 10.2166/wst.2004.0536; Metcalf Eddy, 2005, WASTEWATER ENG TREAT; Michitsch R, 2015, J ENVIRON QUAL, V44, P1355, DOI 10.2134/jeq2015.01.0034; Mohaibes M, 2004, BIORESOURCE TECHNOL, V95, P245, DOI 10.1016/j.biortech.2004.02.022; Mohammed AN, 2016, PARASITOL RES, V115, P3889, DOI 10.1007/s00436-016-5154-7; Mohler VL, 2009, VET CLIN N AM-FOOD A, V25, P37, DOI 10.1016/j.cvfa.2008.10.009; Muller T, 2006, CURR MICROBIOL, V52, P400, DOI 10.1007/s00284-005-0370-x; Niebuhr SE, 2003, J FOOD PROTECT, V66, P874, DOI 10.4315/0362-028X-66.5.874; Nutsch A, 2010, WILEY HDB SCI TECHNO, P1959; Persoons D, 2009, EMERG INFECT DIS, V15, P452, DOI 10.3201/eid1503.080696; REDDY KR, 1975, SOIL BIOL BIOCHEM, V7, P87, DOI 10.1016/0038-0717(75)90004-8; Sahlstrom L, 2003, BIORESOURCE TECHNOL, V87, P161, DOI 10.1016/S0960-8524(02)00168-2; Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12; Sparks Companies Inc, 2002, LIV MORT METH DISP T; SPROTT GD, 1984, J BIOL CHEM, V259, P2602; Tajkarli-Ni M, 2008, INT J FOOD MICROBIOL, V122, P23, DOI 10.1016/j.ijfoodmicro.2007.11.040; TAYLOR BL, 1983, TRENDS BIOCHEM SCI, V8, P438, DOI 10.1016/0968-0004(83)90030-0; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Tenuta M, 2002, PHYTOPATHOLOGY, V92, P255, DOI 10.1094/PHYTO.2002.92.3.255; Ugwuanyi JO, 2006, J CHEM TECHNOL BIOT, V81, P1641, DOI 10.1002/jctb.1574; WARD RL, 1977, APPL ENVIRON MICROB, V33, P860, DOI 10.1128/AEM.33.4.860-864.1977; WARREN KS, 1962, NATURE, V195, P47, DOI 10.1038/195047a0; Williams AP, 2009, BIORESOURCE TECHNOL, V100, P4032, DOI 10.1016/j.biortech.2009.03.018	60	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176825	10.1371/journal.pone.0176825	http://dx.doi.org/10.1371/journal.pone.0176825			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475586	Green Published, gold, Green Submitted			2022-12-27	WOS:000400649500016
J	de Bruin, EC; Whiteley, JL; Corcoran, C; Kirk, PM; Fox, JC; Armisen, J; Lindemann, JPO; Schiavon, G; Ambrose, HJ; Kohlmann, A				de Bruin, Elza C.; Whiteley, Jessica L.; Corcoran, Claire; Kirk, Pauline M.; Fox, Jayne C.; Armisen, Javier; Lindemann, Justin P. O.; Schiavon, Gaia; Ambrose, Helen J.; Kohlmann, Alexander			Accurate detection of low prevalence AKT1 E17K mutation in tissue or plasma from advanced cancer patients	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; BREAST-CANCER; DNA; AZD5363	Personalized healthcare relies on accurate companion diagnostic assays that enable the most appropriate treatment decision for cancer patients. Extensive assay validation prior to use in a clinical setting is essential for providing a reliable test result. This poses a challenge for low prevalence mutations with limited availability of appropriate clinical samples harboring the mutation. To enable prospective screening for the low prevalence AKT1 E17K mutation, we have developed and validated a competitive allele-specific TaqMan((R)) PCR (castPCR(TM) ) assay for mutation detection in formalin-fixed paraffin embedded (FFPE) tumor tissue. Analysis parameters of the castPCR(TM) assay were established using an FFPE DNA reference standard and its analytical performance was assessed using 338 breast cancer and gynecological cancer FFPE samples. With recent technical advances for minimally invasive mutation detection in circulating tumor DNA (ctDNA), we subsequently also evaluated the OncoBEAM(TM) assay to enable plasma specimens as additional diagnostic opportunity for AKT1 E17K mutation testing. The analysis performance of the OncoBEAM(TM) test was evaluated using a novel AKT1 E17K ctDNA reference standard consisting of sheared genomic DNA spiked into human plasma. Both assays are employed at centralized testing laboratories operating according to quality standards for prospective identification of the AKT1 E17K mutation in ER+breast cancer patients in the context of a clinical trial evaluating the AKT inhibitor AZD5363 in combination with endocrine (fulvestrant) therapy.	[de Bruin, Elza C.; Whiteley, Jessica L.; Corcoran, Claire; Kirk, Pauline M.; Fox, Jayne C.; Kohlmann, Alexander] AstraZeneca, Innovat Med & Early Dev, Personalised Healthcare & Biomarkers, Cambridge, England; [Armisen, Javier] Horizon Discovery Ltd, Cambridge, England; [Lindemann, Justin P. O.; Ambrose, Helen J.] AstraZeneca, Innovat Med & Early Dev, Early Clin Dev, Cambridge, England; [Schiavon, Gaia] AstraZeneca, Innovat Med & Early Dev, Translat Sci, Cambridge, England	AstraZeneca; AstraZeneca; AstraZeneca	de Bruin, EC (corresponding author), AstraZeneca, Innovat Med & Early Dev, Personalised Healthcare & Biomarkers, Cambridge, England.	elza.de-bruin@astrazeneca.com		Lindemann, Justin/0000-0003-1531-9754	AstraZeneca	AstraZeneca(AstraZeneca)	This work was funded by AstraZeneca. AstraZeneca provided support in the form of salaries for authors ECB, JLW, CC, PMK, JCF, JPOL, GS, HJA, AK. Horizon Discovery Ldt provided support in the form of salary for author JA. The specific roles of these authors are articulated in the "Author Contributions" section. AstraZeneca and Horizon Discovery Ldt did not have any role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript.; We thank Claire Routley from Mudskipper Business Ltd, who provided editorial assistance funded by AstraZeneca. AZD5363 is discovered by AstraZeneca subsequent to a collaboration with Astex Therapeutics and its collaboration with the Institute of Cancer Research and Cancer Research Technology Ltd.	Anderson S, 2012, ARCH PATHOL LAB MED, V136, P1385, DOI 10.5858/arpa.2011-0505-OA; Benlloch S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089518; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen WW, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.28; Davies BR, 2015, MOL CANCER THER, V14, P2441, DOI 10.1158/1535-7163.MCT-15-0230; Davies BR, 2012, MOL CANCER THER, V11, P873, DOI 10.1158/1535-7163.MCT-11-0824-T; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Diaz IM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166354; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; EMA, 2011, REFL PAP METH ISS AS; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Gainor JF, 2014, CLIN CANCER RES, V20, P2587, DOI 10.1158/1078-0432.CCR-13-3132; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Higgins MJ, 2012, CLIN CANCER RES, V18, P3462, DOI 10.1158/1078-0432.CCR-11-2696; Hiley Crispin T, 2014, Clin Med (Lond), V14 Suppl 6, ps33, DOI 10.7861/clinmedicine.14-6-s33; Jahr S, 2001, CANCER RES, V61, P1659; Kim MS, 2008, BRIT J CANCER, V98, P1533, DOI 10.1038/sj.bjc.6604212; Lebofsky R, 2015, MOL ONCOL, V9, P783, DOI 10.1016/j.molonc.2014.12.003; McInerney Peter, 2014, Mol Biol Int, V2014, P287430, DOI 10.1155/2014/287430; Meldrum Cliff, 2011, Clin Biochem Rev, V32, P177; Mouliere F, 2015, P NATL ACAD SCI USA, V112, P3178, DOI 10.1073/pnas.1501321112; O'Donnell P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-210; Ribas R, 2015, MOL CANCER THER, V14, P2035, DOI 10.1158/1535-7163.MCT-15-0143; Rudolph M, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2626-1; Sacher AG, 2016, JAMA ONCOL, V2, P1014, DOI 10.1001/jamaoncol.2016.0173; Sherwood JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150197; Sherwood JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100566; Shoji K, 2009, BRIT J CANCER, V101, P145, DOI 10.1038/sj.bjc.6605109; Tamura K, 2016, CANCER CHEMOTH PHARM, V77, P787, DOI 10.1007/s00280-016-2987-9	31	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175779	10.1371/journal.pone.0175779	http://dx.doi.org/10.1371/journal.pone.0175779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472036	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500017
J	Gencay, M; Hubner, K; Gohl, P; Seffner, A; Weizenegger, M; Neofytos, D; Batrle, R; Woeste, A; Kim, HS; Westergaard, G; Reinsch, C; Brill, E; Thuy, PTT; Hoang, BH; Sonderup, M; Spearman, CW; Pabinger, S; Gautier, J; Brancaccio, G; Fasano, M; Santantonio, T; Gaeta, GB; Nauck, M; Kaminski, WE				Gencay, Mikael; Huebner, Kirsten; Gohl, Peter; Seffner, Anja; Weizenegger, Michael; Neofytos, Dionysios; Batrle, Richard; Woeste, Andreas; Kim, Hyon-suk; Westergaard, Gaston; Reinsch, Christine; Brill, Eva; Pham Thi Thu Thuy; Hoang, Bui Huu; Sonderup, Mark; Spearman, C. Wendy; Pabinger, Stephan; Gautier, Jeremie; Brancaccio, Giuseppina; Fasano, Massimo; Santantonio, Teresa; Gaeta, Giovanni B.; Nauck, Markus; Kaminski, Wolfgang E.			Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population	PLOS ONE			English	Article							MAJOR HYDROPHILIC REGION; GENE VARIANTS; DETERMINANT VARIANTS; VIRUS; HBSAG; GENOTYPES; RESISTANCE; MUTANTS; EPIDEMIOLOGY; FREQUENCY	The diversity of the hepatitis B surface antigen (HBsAg) has a significant impact on the performance of diagnostic screening tests and the clinical outcome of hepatitis B infection. Neutralizing or diagnostic antibodies against the HBsAg are directed towards its highly conserved major hydrophilic region (MHR), in particular towards its "a" determinant subdomain. Here, we explored, on a global scale, the genetic diversity of the HBsAg MHR in a large, multi-ethnic cohort of randomly selected subjects with HBV infection from four continents. A total of 1553 HBsAg positive blood samples of subjects originating from 20 different countries across Africa, America, Asia and central Europe were characterized for amino acid variation in the MHR. Using highly sensitive ultra-deep sequencing, we found 72.8% of the successfully sequenced subjects (n = 1391) demonstrated amino acid sequence variation in the HBsAg MHR. This indicates that the global variation frequency in the HBsAg MHR is threefold higher than previously reported. The majority of the amino acid mutations were found in the HBV genotypes B (28.9%) and C (25.4%). Collectively, we identified 345 distinct amino acid mutations in the MHR. Among these, we report 62 previously unknown mutations, which extends the worldwide pool of currently known HBsAg MHR mutations by 22%. Importantly, topological analysis identified the "a" determinant upstream flanking region as the structurally most diverse subdomain of the HBsAg MHR. The highest prevalence of "a" determinant region mutations was observed in subjects from Asia, followed by the African, American and European cohorts, respectively. Finally, we found that more than half (59.3%) of all HBV subjects investigated carried multiple MHR mutations. Together, this worldwide ultra-deep sequencing based genotyping study reveals that the global prevalence and structural complexity of variation in the hepatitis B surface antigen have, to date, been significantly underappreciated.	[Gencay, Mikael; Neofytos, Dionysios; Batrle, Richard; Westergaard, Gaston] Roche Diagnost Int Ltd, Rotkreuz, Germany; [Huebner, Kirsten; Gohl, Peter; Brill, Eva; Nauck, Markus; Kaminski, Wolfgang E.] Bioscientia Inst Med Diagnost, Ingelheim, Germany; [Seffner, Anja; Weizenegger, Michael] MVZ Labor Dr Limbach & Kollegen GbR, Dept Mol Genet & Microbiol, Heidelberg, Germany; [Woeste, Andreas] Roche Diagnost GmbH, Penzberg, Germany; [Kim, Hyon-suk] Yonsei Univ, Severance Hosp, Coll Med, Dept Lab Med, Seoul, South Korea; [Reinsch, Christine] Roche Diagnost GmbH, Mannheim, Germany; [Pham Thi Thu Thuy] Medic Med Ctr, Hepatol Dept, Ho Chi Minh City, Vietnam; [Hoang, Bui Huu] Ho Chi Minh City Univ, Med Ctr, Gastroenterol Dept, Ho Chi Minh City, Vietnam; [Sonderup, Mark; Spearman, C. Wendy] Univ Cape Town, Div Hepatol, Cape Town, South Africa; [Sonderup, Mark; Spearman, C. Wendy] Univ Cape Town, Dept Med, Cape Town, South Africa; [Sonderup, Mark; Spearman, C. Wendy] Groote Schuur Hosp, Cape Town, South Africa; [Pabinger, Stephan] AIT, Hlth & Environm Dept, Mol Diagnost, Vienna, Austria; [Gautier, Jeremie] Cerba Specimen Serv, St Ouen Aumone, France; [Brancaccio, Giuseppina; Gaeta, Giovanni B.] Univ Naples 2, Infect Dis & Viral Hepatitis Unit, Naples, Italy; [Fasano, Massimo; Santantonio, Teresa] Univ Foggia, Dept Clin & Expt Med, Infect Dis Unit, Foggia, Italy	Roche Holding; Yonsei University; Yonsei University Health System; Roche Holding; Vietnam National University Hochiminh City; University of Cape Town; University of Cape Town; University of Cape Town; Austrian Institute of Technology (AIT); Universita della Campania Vanvitelli; University of Foggia	Nauck, M; Kaminski, WE (corresponding author), Bioscientia Inst Med Diagnost, Ingelheim, Germany.	markus.nauck@bioscientia.de; wolfgang.kaminski@bioscientia.de	Sonderup, Mark W/H-8582-2015; Kim, Hyon-Suk/R-4113-2017; Spearman, C.Wendy/R-8173-2019; Neofytos, Dionysios/ABE-2214-2020; Gaeta, Giovanni/AAQ-4294-2021	Sonderup, Mark W/0000-0001-7128-8329; Kim, Hyon-Suk/0000-0001-5662-7740; Neofytos, Dionysios/0000-0001-6970-2869; Crisanti, Andrea/0000-0002-2406-4426; Brancaccio, Giuseppina/0000-0001-5643-0139; Pabinger, Stephan/0000-0001-9876-5965; Spearman, Catherine Wendy/0000-0003-3199-301X	Roche Diagnostics	Roche Diagnostics	The study was sponsored by Roche Diagnostics, who were involved in the study design, data collection, interpretation, and analysis. Editorial support was provided by Kim Brown, Roche Diagnostics International Ltd.	Al-Qudari AY, 2016, SAUDI J GASTROENTERO, V22, P133, DOI 10.4103/1319-3767.167186; Alvarado-Mora MV, 2013, ANTIVIR THER, V18, P459, DOI 10.3851/IMP2599; Amini-Bavil-Olyaee S, 2009, AIDS, V23, P268, DOI 10.1097/QAD.0b013e3283224316; Avellon A, 2006, J MED VIROL, V78, P24, DOI 10.1002/jmv.20516; Bian T, 2013, J VIROL, V87, P12196, DOI 10.1128/JVI.02127-13; Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760; Caligiuri P, 2016, WORLD J GASTROENTERO, V22, P145, DOI 10.3748/wjg.v22.i1.145; Chiou HL, 1997, J GEN VIROL, V78, P2639, DOI 10.1099/0022-1317-78-10-2639; Chong-Jin O, 1999, J INFECT DIS, V179, P259, DOI 10.1086/314553; Coleman PF, 2006, J MED VIROL, V78, pS56, DOI 10.1002/jmv.20609; Croagh CMN, 2015, WORLD J HEPATOL, V7, P289, DOI 10.4254/wjh.v7.i3.289; Davaalkham D, 2007, ARCH VIROL, V152, P575, DOI 10.1007/s00705-006-0863-3; Flanagan E, 2014, INTERN MED J, V44, P709, DOI 10.1111/imj.12465; Gededzha MP, 2016, J MED VIROL, V88, P1560, DOI 10.1002/jmv.24502; Hollinger FB, 2007, J VIRAL HEPATITIS, V14, P11, DOI 10.1111/j.1365-2893.2007.00910.x; Hou JL, 2001, HEPATOLOGY, V34, P1027, DOI 10.1053/jhep.2001.28708; Hsu HY, 2013, J INFECT DIS, V207, P1047, DOI 10.1093/infdis/jis943; Hsu HY, 2010, J INFECT DIS, V201, P1192, DOI 10.1086/651378; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054486; Kim KH, 2014, CLIN MOL HEPATOL, V20, P251, DOI 10.3350/cmh.2014.20.3.251; Larralde O, 2013, MED MICROBIOL IMMUN, V202, P207, DOI 10.1007/s00430-012-0283-9; Liao CC, 2015, BIOMED J, V38, P250, DOI 10.4103/2319-4170.143485; Lieshout-Krikke RW, 2014, EUR J CLIN MICROBIOL, V33, P69, DOI 10.1007/s10096-013-1930-9; Ma Q, 2012, J MED VIROL, V84, P198, DOI 10.1002/jmv.23183; Mallory MA, 2011, J VIROL METHODS, V177, P31, DOI 10.1016/j.jviromet.2011.06.009; Mohamed S, 2014, AIDS, V28, P1315, DOI 10.1097/QAD.0000000000000267; Neumann-Fraune M, 2014, INTERVIROLOGY, V57, P232, DOI 10.1159/000361076; Neumann-Fraune M, 2013, J MED VIROL, V85, P775, DOI 10.1002/jmv.23530; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Leone FGPY, 2008, J CLIN VIROL, V42, P381, DOI 10.1016/j.jcv.2008.01.018; Pollicino T, 2014, J HEPATOL, V61, P408, DOI 10.1016/j.jhep.2014.04.041; Powell EA, 2016, J GEN VIROLOGY; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Rodriguez-Frias F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037874; Salpini R, 2015, HEPATOLOGY, V61, P823, DOI 10.1002/hep.27604; Sayan M, 2012, JPN J INFECT DIS, V65, P495, DOI 10.7883/yoken.65.495; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Seddigh-Tonekaboni S, 2000, J MED VIROL, V60, P113, DOI 10.1002/(SICI)1096-9071(200002)60:2<113::AID-JMV2>3.0.CO;2-0; Servant-Delmas A, 2010, TRANSFUSION, V50, P2607, DOI 10.1111/j.1537-2995.2010.02725.x; Shi WF, 2013, INFECT GENET EVOL, V16, P355, DOI 10.1016/j.meegid.2013.03.021; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; Song BC, 2005, J MED VIROL, V76, P194, DOI 10.1002/jmv.20354; Sticchi L, 2013, HUM VACC IMMUNOTHER, V9, P568, DOI 10.4161/hv.23236; Sunbul M, 2014, WORLD J GASTROENTERO, V20, P5427, DOI 10.3748/wjg.v20.i18.5427; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Teo CG, 2010, ANTIVIR THER, V15, P445, DOI 10.3851/IMP1556; Verheyen J, 2012, J CLIN VIROL, V54, P279, DOI 10.1016/j.jcv.2012.04.010; WALLACE LA, 1994, J INFECT DIS, V170, P1300, DOI 10.1093/infdis/170.5.1300; Wu CC, 2012, J VIROL, V86, P4658, DOI 10.1128/JVI.06353-11; Yamani LN, 2015, J CLIN MICROBIOL, V53, P3165, DOI 10.1128/JCM.00602-15; Yang YL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-82; Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009297	53	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0172101	10.1371/journal.pone.0172101	http://dx.doi.org/10.1371/journal.pone.0172101			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472040	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500001
J	Hassan, KA; Fagerlund, A; Elbourne, LDH; Voros, A; Kroeger, JK; Simm, R; Tourasse, NJ; Finke, S; Henderson, PJF; Okstad, OA; Paulsen, IT; Kolsto, AB				Hassan, Karl A.; Fagerlund, Annette; Elbourne, Liam D. H.; Voros, Aniko; Kroeger, Jasmin K.; Simm, Roger; Tourasse, Nicolas J.; Finke, Sarah; Henderson, Peter J. F.; Okstad, Ole Andreas; Paulsen, Ian T.; Kolsto, Anne-Brit			The putative drug efflux systems of the Bacillus cereus group	PLOS ONE			English	Article							MULTIDRUG TRANSPORTER; ABC TRANSPORTER; GENE-EXPRESSION; RESISTANCE; SUBTILIS; THURINGIENSIS; VIRULENCE; ANTHRACIS; PUMP; OVEREXPRESSION	The Bacillus cereus group of bacteria includes seven closely related species, three of which, B. anthracis, B. cereus and B. thuringiensis, are pathogens of humans, animals and/or insects. Preliminary investigations into the transport capabilities of different bacterial lineages suggested that genes encoding putative efflux systems were unusually abundant in the B. cereus group compared to other bacteria. To explore the drug efflux potential of the B. cereus group all putative efflux systems were identified in the genomes of prototypical strains of B. cereus, B. anthracis and B. thuringiensis using our Transporter Automated Annotation Pipeline. More than 90 putative drug efflux systems were found within each of these strains, accounting for up to 2.7% of their protein coding potential. Comparative analyses demonstrated that the efflux systems are highly conserved between these species; 70-80% of the putative efflux pumps were shared between all three strains studied. Furthermore, 82% of the putative efflux system proteins encoded by the prototypical B. cereus strain ATCC 14579 (type strain) were found to be conserved in at least 80% of 169 B. cereus group strains that have high quality genome sequences available. However, only a handful of these efflux pumps have been functionally characterized. Deletion of individual efflux pump genes from B. cereus typically had little impact to drug resistance phenotypes or the general fitness of the strains, possibly because of the large numbers of alternative efflux systems that may have overlapping substrate specificities. Therefore, to gain insight into the possible transport functions of efflux systems in B. cereus, we undertook large-scale qRT-PCR analyses of efflux pump gene expression following drug shocks and other stress treatments. Clustering of gene expression changes identified several groups of similarly regulated systems that may have overlapping drug resistance functions. In this article we review current knowledge of the small molecule efflux pumps encoded by the B. cereus group and suggest the likely functions of numerous uncharacterised pumps.	[Hassan, Karl A.; Elbourne, Liam D. H.; Paulsen, Ian T.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW, Australia; [Hassan, Karl A.; Henderson, Peter J. F.] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England; [Hassan, Karl A.; Henderson, Peter J. F.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Fagerlund, Annette; Voros, Aniko; Kroeger, Jasmin K.; Simm, Roger; Tourasse, Nicolas J.; Finke, Sarah; Okstad, Ole Andreas; Kolsto, Anne-Brit] Univ Oslo, Sch Pharm, Lab Microbial Dynam LaMDa, Sect Pharmaceut Biosci, Oslo, Norway; [Kroeger, Jasmin K.] Albert Ludwigs Univ, Inst Pharmazeut Biol & Biotechnol, Freiburg, Germany; [Finke, Sarah; Okstad, Ole Andreas; Kolsto, Anne-Brit] Univ Oslo, Fac Math & Nat Sci, CIME, N-0316 Oslo, Norway; [Fagerlund, Annette] Nofima, PB210, N-1431 As, Norway; [Simm, Roger] Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway; [Tourasse, Nicolas J.] Univ Bordeaux 2, CNRS, INSERM, ARNA Lab,UMR5320, 146 Rue Leo Saignat, Bordeaux, France	Macquarie University; University of Leeds; University of Leeds; University of Oslo; University of Freiburg; University of Oslo; Nofima; University of Oslo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Paulsen, IT (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW, Australia.; Kolsto, AB (corresponding author), Univ Oslo, Sch Pharm, Lab Microbial Dynam LaMDa, Sect Pharmaceut Biosci, Oslo, Norway.; Kolsto, AB (corresponding author), Univ Oslo, Fac Math & Nat Sci, CIME, N-0316 Oslo, Norway.	ian.paulsen@mq.edu.au; a.b.koisto@farmasi.uio.no	Henderson, Peter JF/Q-1907-2018; Elbourne, Liam/G-6150-2011; Okstad, Ole Andreas/ABE-4202-2020; Simm, Roger/AAN-8965-2020; Paulsen, Ian/K-3832-2012; Hassan, Karl/B-2802-2013	Elbourne, Liam/0000-0002-9784-0959; Simm, Roger/0000-0001-5187-2456; Fagerlund, Annette/0000-0001-7146-4265; Paulsen, Ian/0000-0001-9015-9418; Okstad, Ole Andreas/0000-0001-9351-8535; Hassan, Karl/0000-0003-2031-9679; Kroeger, Jasmin Kaori/0000-0002-7747-3223; Henderson, Peter/0000-0002-9187-0938	Norwegian Research Council [183421]; Australian National Health and Medical Research Council [1060895]; Australian Academy of Science [247634]; Macquarie University [9201401563]; Marie Slowdoska Curie Research Fellowship; Leverhulme Trust; EU BacMT; ATENS	Norwegian Research Council(Research Council of NorwayEuropean Commission); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Academy of Science; Macquarie University; Marie Slowdoska Curie Research Fellowship; Leverhulme Trust(Leverhulme Trust); EU BacMT; ATENS	This research was funded by the Norwegian Research Council (FUGE II Program, Project ID 183421) to ABK and OAO, an Australian National Health and Medical Research Council Project Grant (1060895) to ITP, KAH and PJFH, an Australian Academy of Science Grant (247634) and a Research Development Grant from Macquarie University to KAH and LDHE (9201401563). KAH thanks the EU for the award of a Marie Slowdoska Curie Research Fellowship and PJFH thanks the Leverhulme Trust for an Emeritus Research Fellowship. Consortium collaborations between laboratories (ABK, PJFH, ITP) are funded by the EU BacMT and ATENS initiatives.; This research was funded by the Norwegian Research Council (FUGE II Program, Project ID 183421) to ABK and OAO, an Australian National Health and Medical Research Council Project Grant (1060895) to ITP, KAH and PJFH, an Australian Academy of Science Grant (247634) and a Research Development Grant from Macquarie University to KAH and LDHE (9201401563). KAH thanks the EU for the award of a Marie Slowdoska Curie Research Fellowship and PJFH thanks the Leverhulme Trust for an Emeritus Research Fellowship. Consortium collaborations between laboratories (ABK, PJFH, ITP) are funded by the EU BacMT and ATENS initiatives.	Agaisse H, 1999, MOL MICROBIOL, V32, P1043, DOI 10.1046/j.1365-2958.1999.01419.x; AHMED M, 1995, J BACTERIOL, V177, P3904, DOI 10.1128/jb.177.14.3904-3910.1995; Auger S, 2006, APPL ENVIRON MICROB, V72, P937, DOI 10.1128/AEM.72.1.937-941.2006; Bechet M, 2012, APPL MICROBIOL BIOT, V95, P593, DOI 10.1007/s00253-012-4181-2; Bottone E. J., 2003, Clinical Microbiology Newsletter, V25, P49, DOI 10.1016/S0196-4399(03)80005-3; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; CAMPBELL NRC, 1992, BRIT J CLIN PHARMACO, V33, P115, DOI 10.1111/j.1365-2125.1992.tb04010.x; Caro-Astorga Joaquin, 2014, Front Microbiol, V5, P745, DOI 10.3389/fmicb.2014.00745; Doganay Mehmet, 2015, Recent Pat Antiinfect Drug Discov, V10, P10; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Ehling-Schulz M, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-20; Elbourne LDH, 2017, NUCLEIC ACIDS RES, V45, pD320, DOI 10.1093/nar/gkw1068; Espinasse S, 2004, J BACTERIOL, V186, P3108, DOI 10.1128/JB.186.10.3108-3116.2004; Espinasse S, 2002, J BACTERIOL, V184, P5848, DOI 10.1128/JB.184.21.5848-5854.2002; Fuangthong M, 2003, J BACTERIOL, V185, P6348, DOI 10.1128/JB.185.21.6348-6357.2003; Galian C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019677; Ganas P, 2007, MICROBIOL-SGM, V153, P1546, DOI 10.1099/mic.0.2006/004234-0; Gelis-Jeanvoine S, 2016, RES MICROBIOL; Hassan KA, 2015, MBIO, V6, DOI 10.1128/mBio.01982-14; Hassan KA, 2013, P NATL ACAD SCI USA, V110, P20254, DOI 10.1073/pnas.1317052110; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Hoggard SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021763; Hoton FM, 2005, MICROBIOL-SGM, V151, P2121, DOI 10.1099/mic.0.28069-0; Hotta K, 2010, MICROBIOL-SGM, V156, P1918, DOI 10.1099/mic.0.039404-0; Huang JZ, 2004, ANTIMICROB AGENTS CH, V48, P909, DOI 10.1128/AAC.48.3.909-917.2004; Jack DL, 2000, J BACTERIOL, V182, P2311, DOI 10.1128/JB.182.8.2311-2313.2000; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Khattar ZA, 2009, J BACTERIOL, V191, P7063, DOI 10.1128/JB.00892-09; Klee SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010986; Kristoffersen SM, 2007, J BACTERIOL, V189, P5302, DOI 10.1128/JB.00239-07; Kristoffersen SM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r30; Kroeger JK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01063; Kumano M, 2003, ANTIMICROB AGENTS CH, V47, P432, DOI 10.1128/AAC.47.1.432-435.2003; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Leendertz FH, 2004, NATURE, V430, P451, DOI 10.1038/nature02722; Li X, 2015, J IND MICROBIOL BIOT, V42, P93, DOI 10.1007/s10295-014-1527-z; Lim CK, 2013, APPL ENVIRON MICROB, V79, P3141, DOI 10.1128/AEM.03101-12; Lopez D, 2009, GENE DEV, V23, P1631, DOI 10.1101/gad.1813709; Muller RT, 2015, BIOL CHEM, V396, P1083, DOI 10.1515/hsz-2015-0150; Ohki R, 1997, J BACTERIOL, V179, P1423, DOI 10.1128/jb.179.4.1423-1427.1997; PAULSEN IT, 1995, J BACTERIOL, V177, P2827, DOI 10.1128/jb.177.10.2827-2833.1995; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poole K, 2000, ANTIMICROB AGENTS CH, V44, P2595, DOI 10.1128/AAC.44.10.2595-2599.2000; Priest F.G., 1993, BACILLUS SUBTILIS OT; PRIEST FG, 1988, J GEN MICROBIOL, V134, P1847; Radchenko M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8995; Reilman E, 2014, NUCLEIC ACIDS RES, V42, P11393, DOI 10.1093/nar/gku832; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Serizawa M, 2005, MICROBIOL-SGM, V151, P1769, DOI 10.1099/mic.0.27619-0; Serizawa M, 2010, ANTIMICROB AGENTS CH, V54, P2787, DOI 10.1128/AAC.01405-09; Simm R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036720; Soukas A, 2000, GENE DEV, V14, P963; Torres C, 2009, BBA-BIOMEMBRANES, V1788, P615, DOI 10.1016/j.bbamem.2008.12.012; Tsuge K, 2001, ANTIMICROB AGENTS CH, V45, P3566, DOI 10.1128/AAC.45.12.3566-3573.2001; Turillazzi S, 2006, J AM SOC MASS SPECTR, V17, P376, DOI 10.1016/j.jasms.2005.11.017; Varela MF, 1995, MOL MEMBR BIOL, V12, P313, DOI 10.3109/09687689509072433; Voros A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103326; Wijman JGE, 2007, APPL ENVIRON MICROB, V73, P1481, DOI 10.1128/AEM.01781-06; Woolridge DP, 1997, J BIOL CHEM, V272, P8864; Zwick ME, 2012, GENOME RES, V22, P1512, DOI 10.1101/gr.134437.111	64	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176188	10.1371/journal.pone.0176188	http://dx.doi.org/10.1371/journal.pone.0176188			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472044	gold, Green Published			2022-12-27	WOS:000400648500027
J	Hovhannisyan, N; Dhilly, M; Fidalgo, M; Fillesoye, F; Guillouet, S; Sola, B; Barre, L				Hovhannisyan, Narinee; Dhilly, Martine; Fidalgo, Martin; Fillesoye, Fabien; Guillouet, Stephane; Sola, Brigitte; Barre, Louisa			[F-18] Fludarabine-PET in a murine model of multiple myeloma	PLOS ONE			English	Article							EMISSION-TOMOGRAPHY PET; LYMPHOMA; THERAPY	Purpose Multiple myeloma (MM) is a haematological malignancy that affects plasma cells in the bone marrow. Recently, [F-18] fludarabine has been introduced as an innovative PET radiotracer for imaging lymphoma. It demonstrated a great potential for accurate imaging of lymphoproliferative disorders. With the goal to question the usefulness of [F-18] fludarabine-PET in other haematological diseases, an in vivo MM model was investigated. Methods RPMI8226-GFP-Luc MM cells expressing the green fluorescent protein (GFP) as well as the luciferase reporter (Luc) were derived from the parental RPMI8226 cells. They were injected subcutaneously into the flank of nude mice. Myeloma tumour growth was followed using bioluminescence-based imaging (BLI) and characterised by immunohistochemistry (IHC). The tumour specificity of [F-18] fludarabine was evaluated and compared to [F-18]FDG. Results The tumoural uptake of [F-18] FDG was greater than that of [F-18] fludarabine. However, the quantitative data extracted from IHC stainings were in better agreement with [F-18] fludarabine, when compared to [F-18] FDG. The relationship between the tumoural uptake of [F-18]labelled tracers and the BLI quantitative data was also in favour of [F-18] fludarabine. Conclusion Our results suggest that [F-18] fludarabine-PET might represent an alternative and perhaps more specific modality for MM imaging when compared to [F-18] FDG. Nevertheless, more investigations are required to extend this conclusion to humans.	[Hovhannisyan, Narinee; Dhilly, Martine; Fillesoye, Fabien; Guillouet, Stephane; Barre, Louisa] GIP Cyceron, CEA, DRF I2BM, LDM TEP Grp, Caen, France; [Hovhannisyan, Narinee; Dhilly, Martine; Fillesoye, Fabien; Guillouet, Stephane; Barre, Louisa] Normandie Univ, UNICAEN, CHU Caen, CNRS,CEA,ISTCT LDM TEP Grp, Caen, France; [Fidalgo, Martin; Sola, Brigitte] Normandie Univ, UNICAEN, UNIROUEN, INSERM UMR1245, Caen, France	CEA; Universite de Caen Normandie; CEA; Centre National de la Recherche Scientifique (CNRS); CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie	Hovhannisyan, N (corresponding author), GIP Cyceron, CEA, DRF I2BM, LDM TEP Grp, Caen, France.; Hovhannisyan, N (corresponding author), Normandie Univ, UNICAEN, CHU Caen, CNRS,CEA,ISTCT LDM TEP Grp, Caen, France.	hovhannisyan@cyceron.fr		Sola, Brigitte/0000-0001-7278-9651	French National Agency [ANR-11-LABEX-0018-01]; Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)	French National Agency(French National Research Agency (ANR)); Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)(French Atomic Energy Commission)	This research was supported by a grant from the French National Agency for Research called "Investissements d'Avenir" ANR-11-LABEX-0018-01, by the Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA).	Caers J, 2014, HAEMATOLOGICA, V99, P629, DOI 10.3324/haematol.2013.091918; Chantepie S, 2015, BLOOD, V126, P3917; Dhilly M, 2014, MOL IMAGING BIOL, V16, P118, DOI 10.1007/s11307-013-0659-2; Gallamini A, 2014, CANCERS, V6, P1821, DOI 10.3390/cancers6041821; Gandhi V, 2002, CLIN PHARMACOKINET, V41, P93, DOI 10.2165/00003088-200241020-00002; Gaudichon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107009; Guillouet S, 2014, MOL IMAGING BIOL, V16, P28, DOI 10.1007/s11307-013-0657-4; Hovhannisyan N, 2016, MOL PHARMACEUT, V13, P2136, DOI 10.1021/acs.molpharmaceut.6b00050; Hovhannisyan N, 2015, EJNMMI RES, V5, DOI 10.1186/s13550-015-0101-7; Luckerath K, 2015, ONCOTARGET, V6, P8418; Mesguich C, 2016, THERANOSTICS, V6, P287, DOI 10.7150/thno.14400; Mihailovic J, 2015, SEMIN NUCL MED, V45, P16, DOI 10.1053/j.semnuclmed.2014.08.002; Rozemuller H, 2008, HAEMATOL-HEMATOL J, V93, P1049, DOI 10.3324/haematol.12349	13	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177125	10.1371/journal.pone.0177125	http://dx.doi.org/10.1371/journal.pone.0177125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472196	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500140
J	Kremers, RMW; Kleinegris, MC; Ninivaggi, M; de Laat, B; ten Cate, H; Koek, GH; Wagenvoord, RJ; Hemker, HC				Kremers, Romy M. W.; Kleinegris, Marie-Claire; Ninivaggi, Marisa; de Laat, Bas; ten Cate, Hugo; Koek, Ger H.; Wagenvoord, Rob J.; Hemker, H. Coenraad			Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; CONVENTIONAL COAGULATION TESTS; HEPATITIS-C PATIENTS; PROTEIN-C; VENOUS THROMBOEMBOLISM; CLINICAL CONSEQUENCES; PLASMA; DISEASE; COAGULOPATHY; INHIBITION	Impaired coagulation factor synthesis in cirrhosis causes a reduction of most pro-and anticoagulant factors. Cirrhosis patients show no clear bleeding or thrombotic phenotype, although they are at risk for both types of hemostatic event. Thrombin generation (TG) is a global coagulation test and its outcome depends on underlying pro-and anticoagulant processes (prothrombin conversion and thrombin inactivation). We quantified the prothrombin conversion and thrombin inactivation during TG in 30 healthy subjects and 52 Child-Pugh (CP-) A, 15 CP-B and 6 CP-C cirrhosis patients to test the hypothesis that coagulation is rebalanced in liver cirrhosis patients. Both prothrombin conversion and thrombin inactivation are reduced in cirrhosis patients. The effect on pro-and anticoagulant processes partially cancel each other out and as a result TG is comparable at 5 pM tissue factor between healthy subjects and patients. This supports the hypothesis of rebalanced hemostasis, as TG in cirrhosis patients remains within the normal range, despite large changes in prothrombin conversion and thrombin inactivation. Nevertheless, in silico analysis shows that normalization of either prothrombin conversion or thrombin inactivation to physiological levels, by for example the administration of prothrombin complex concentrates would cause an elevation of TG, whereas the normalization of both simultaneously maintains a balanced TG. Therefore, cirrhosis patients might require adapted hemostatic treatment.	[Kremers, Romy M. W.; Ninivaggi, Marisa; de Laat, Bas; Wagenvoord, Rob J.; Hemker, H. Coenraad] Maastricht Univ, Cardiovasc Res Inst Maastricht, Synapse Res Inst, Maastricht, Netherlands; [Kremers, Romy M. W.; Kleinegris, Marie-Claire; de Laat, Bas; ten Cate, Hugo] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands; [Koek, Ger H.] Maastricht Univ, Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Kremers, RMW (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Synapse Res Inst, Maastricht, Netherlands.; Kremers, RMW (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands.	r.kremers@thrombin.com	de Laat-Kremers, Romy MW/E-1253-2016; Cate, Hugo ten/AAM-4000-2021	de Laat-Kremers, Romy MW/0000-0001-6526-0338; ten Cate, Hugo/0000-0001-7796-4463	CTMM, the Center for translational Molecular Medicine, project INCOAG [01C-201]; Dutch Heart Foundation; Center for Translational and Molecular Medicine, program INCOAG; Netherlands Heart Foundation	CTMM, the Center for translational Molecular Medicine, project INCOAG; Dutch Heart Foundation(Netherlands Heart Foundation); Center for Translational and Molecular Medicine, program INCOAG; Netherlands Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of CTMM, the Center for translational Molecular Medicine (http://www.ctmm.ni), project INCOAG (grant 01C-201), and supported by the Dutch Heart Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank J. Crombag measuring plasma fibrinogen levels, P. Kluskens for the plasma and serum prothrombin measurements and Thrombinoscope by for providing thrombomodulin. This work was supported by a grant from the Center for Translational and Molecular Medicine, program INCOAG and the Netherlands Heart Foundation (patient samples).	Bechmann LP, 2011, LIVER INT, V31, P1064, DOI 10.1111/j.1478-3231.2011.02548.x; Chaireti R, 2014, THROMB RES, V134, P455, DOI 10.1016/j.thromres.2014.05.012; Chandler WL, 2014, BLOOD COAGUL FIBRINO; Choi HS, 2009, J GASTROEN HEPATOL, V24, pA94; CHURCH FC, 1986, ANAL BIOCHEM, V157, P77, DOI 10.1016/0003-2697(86)90198-3; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Delahousse B, 2010, THROMB HAEMOSTASIS, V104, P741, DOI 10.1160/TH10-01-0040; DOWNING MR, 1978, BIOCHEMISTRY-US, V17, P2649, DOI 10.1021/bi00606a030; Esmon CT, 1999, HAEMATOLOGICA, V84, P363; Gangadharan B, 2007, CLIN CHEM, V53, P1792, DOI 10.1373/clinchem.2007.089144; Gatt A, 2010, J THROMB HAEMOST, V8, P1994, DOI 10.1111/j.1538-7836.2010.03937.x; Groeneveld D, 2014, THROMB RES, V134, P753, DOI 10.1016/j.thromres.2014.07.010; Hemker HC, 2013, THROMB RES, V131, P3, DOI 10.1016/j.thromres.2012.10.011; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; HENDRIX H, 1983, J BIOL CHEM, V258, P3637; Ho AS, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-58; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; JESTY J, 1986, J BIOL CHEM, V261, P313; Kleinegris MC, 2014, J THROMB HAEMOST, V12, P1647, DOI 10.1111/jth.12706; Kremers RMW, 2015, J THROMB HAEMOST, V13, P437, DOI 10.1111/jth.12798; Kremers RMW, 2016, THROMB HAEM IN PRESS; Kremers RMW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141491; Kremers RMW, 2014, THROMB HAEMOSTASIS, V112, P486, DOI 10.1160/TH14-02-0172; Lisman T, 2007, DIGEST SURG, V24, P250, DOI 10.1159/000103655; Lisman T, 2011, LIVER INT, V31, P1063, DOI 10.1111/j.1478-3231.2011.02489.x; Lisman T, 2010, BLOOD, V116, P878, DOI 10.1182/blood-2010-02-261891; Lisman T, 2010, J HEPATOL, V52, P355, DOI 10.1016/j.jhep.2009.12.001; Mann KG, 2012, J THROMB HAEMOST, V10, P1463, DOI 10.1111/j.1538-7836.2012.04799.x; Marlar R A, 1981, Ann N Y Acad Sci, V370, P303, DOI 10.1111/j.1749-6632.1981.tb29743.x; MOR E, 1993, SURG GYNECOL OBSTET, V176, P219; Northup PG, 2008, J THROMB HAEMOST, V6, P2; Northup PG, 2006, AM J GASTROENTEROL, V101, P1524, DOI 10.1111/j.1572-0241.2006.00588.x; OHISHI R, 1993, THROMB HAEMOSTASIS, V70, P423; Potze W, 2014, HEPATOLOGY; Potze W, 2013, BRIT J HAEMATOL, V163, P666, DOI 10.1111/bjh.12593; Potze W, 2013, BRIT J HAEMATOL, V162, P819, DOI 10.1111/bjh.12462; Senzolo M, 2012, J THROMB HAEMOST, V10, P1823, DOI 10.1111/j.1538-7836.2012.04824.x; Sharara AI, 2001, NEW ENGL J MED, V345, P669, DOI 10.1056/NEJMra003007; Sogaard KK, 2009, AM J GASTROENTEROL, V104, P96, DOI 10.1038/ajg.2008.34; Stellingwerff M, 2012, SEMIN THROMB HEMOST, V38, P244, DOI 10.1055/s-0032-1302440; THALER E, 1975, BRIT J HAEMATOL, V31, P233, DOI 10.1111/j.1365-2141.1975.tb00853.x; Tripodi A, 2007, ALIMENT PHARM THERAP, V26, P141, DOI 10.1111/j.1365-2036.2007.03369.x; Tripodi A, 2005, HEPATOLOGY, V41, P553, DOI 10.1002/hep.20569; Tripodi A, 2007, J HEPATOL, V46, P727, DOI 10.1016/j.jhep.2007.01.015; Tripodi A, 2006, HEPATOLOGY, V44, P440, DOI 10.1002/hep.21266; Tripodi A, 2013, J HEPATOL, V59, P265, DOI 10.1016/j.jhep.2013.03.036; Tripodi A, 2012, INTERN EMERG MED, V7, P139, DOI 10.1007/s11739-011-0528-4; Tripodi A, 2010, HEPATOLOGY, V52, P249, DOI 10.1002/hep.23653; Westerkamp AC, 2009, HPB, V11, P453, DOI 10.1111/j.1477-2574.2009.00078.x; Youngwon N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/856754	50	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177020	10.1371/journal.pone.0177020	http://dx.doi.org/10.1371/journal.pone.0177020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472132	gold, Green Submitted, Green Published			2022-12-27	WOS:000400648500121
J	Matsuura, M; Hirasawa, K; Murata, H; Nakakura, S; Kiuchi, Y; Asaoka, R				Matsuura, Masato; Hirasawa, Kazunori; Murata, Hiroshi; Nakakura, Shunsuke; Kiuchi, Yoshiaki; Asaoka, Ryo			Using CorvisST tonometry to assess glaucoma progression	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CENTRAL CORNEAL THICKNESS; GOLDMANN APPLANATION TONOMETER; OCULAR HYPERTENSION TREATMENT; INTRAOCULAR-PRESSURE; VISUAL-FIELD; BIOMECHANICAL PROPERTIES; BLOOD-FLOW; TONO-PEN; DEFORMATION	Purpose To investigate the utility of the Corneal Visualization Scheimpflug Technology instrument (CST) to assess the progression of visual field (VF) damage in primary open angle glaucoma patients. Method A total of 75 eyes from 111 patients with primary open-angle glaucoma were investigated. All patients underwent at least nine VF measurements with the Humphrey Field Analyzer, CST measurements, axial length (AL), central corneal thickness (CCT) and intraocular pressure (IOP) with Goldmann applanation tonometry (GAT). Mean total deviation (mTD) progression rates of the eight VFs, excluding the first VF, were calculated and the association between progression rate and the other listed measurements was analyzed using linear regression, and the optimal to describe mTD progression rate was selected based on the second order bias corrected Akaike Information Criterion (AICc) index. Results VF progression was described best in a model that included CST parameters as well as other ocular measurements. The optimal linear model to describe mTD progression rate was given by the equation: -8.9-0.068 x mean GAT + 0.68 x A1 time + 0.31 x A2 time -0.39 x A2 length- 1.26 x highest deformation amplitude. Conclusion CST measurements are useful when assessing VF progression in glaucoma patients. In particular, careful consideration should be given to patients where: (i) an eye is observed to be applanated fast in the first and second applanations, (ii) the applanated area is wide in the second applanation and (iii) the indentation is deep at the maximum deformation, since these eyes appear to be at greater risk of VF progression.	[Matsuura, Masato; Hirasawa, Kazunori; Murata, Hiroshi; Asaoka, Ryo] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Hirasawa, Kazunori] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Orthopt & Visual Sci, Kanagawa, Japan; [Nakakura, Shunsuke] Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan; [Kiuchi, Yoshiaki] Hiroshima Univ, Dept Ophthalmol & Visual Sci, Hiroshima, Japan	University of Tokyo; Kitasato University; Hiroshima University	Asaoka, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.	rasaoka-tky@umin.ac.jp		Hirasawa, Kazunori/0000-0001-5100-005X	Japan Science and Technology Agency (JST)-CREST; Ministry of Education, Culture, Sports, Science and Technology of Japan [26462679]	Japan Science and Technology Agency (JST)-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	All the funding supported this work are Japan Science and Technology Agency (JST)-CREST and Grant 26462679 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. There was no additional external funding received for this study.	Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Asaoka R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140385; Bengtsson B, 2009, ARCH OPHTHALMOL-CHIC, V127, P1610, DOI 10.1001/archophthalmol.2009.297; Bhan A, 2002, INVEST OPHTH VIS SCI, V43, P1389; BROWN RH, 1994, CONTROL CLIN TRIALS, V15, P299; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; De Moraes CG, 2012, AM J OPHTHALMOL, V154, P702, DOI 10.1016/j.ajo.2012.04.015; Ehlers N, 1975, ACTA OPHTHALMOL S, V32; Ewing JA, 1889, HYSTERESIS RELATION, P502; Feltgen N, 2001, BRIT J OPHTHALMOL, V85, P85, DOI 10.1136/bjo.85.1.85; FORBES M, 1974, ARCH OPHTHALMOL-CHIC, V91, P134, DOI 10.1001/archopht.1974.03900060140012; Foster PJ, 1998, OPHTHALMOLOGY, V105, P969, DOI 10.1016/S0161-6420(98)96021-3; Fujino Y, INVEST OPHT IN PRESS; Garway-Heath DF, 2015, LANCET, V385, P1295, DOI 10.1016/S0140-6736(14)62111-5; Gordon MO, 2007, OPHTHALMOLOGY, V114, P10, DOI 10.1016/j.ophtha.2006.08.031; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Gunvant P, 2004, BRIT J OPHTHALMOL, V88, P518, DOI 10.1136/bjo.2003.019331; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; HOLMIN C, 1982, ACTA OPHTHALMOL, V60, P267; HOLMIN C, 1988, ACTA OPHTHALMOL, V66, P170; Inoue K, 2003, JPN J OPHTHALMOL, V47, P129, DOI 10.1016/S0021-5155(02)00667-6; JAY JL, 1988, BRIT J OPHTHALMOL, V72, P881, DOI 10.1136/bjo.72.12.881; Jonas JB, 2005, INVEST OPHTH VIS SCI, V46, P1275, DOI 10.1167/iovs.04-0851; Jung Y, 2016, OPHTHALMOLOGY, V123, P959, DOI 10.1016/j.ophtha.2015.12.043; Kaminski S, 1998, ACTA OPHTHALMOL SCAN, V76, P78, DOI 10.1034/j.1600-0420.1998.760114.x; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kim YW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159663; Koprowski R, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-150; Kotecha A, 2005, BRIT J OPHTHALMOL, V89, P1572, DOI 10.1136/bjo.2005.075580; Kotecha A, 2006, INVEST OPHTH VIS SCI, V47, P5337, DOI 10.1167/iovs.06-0557; KRAKAU CET, 1985, ACTA OPHTHALMOL, V63, P19; Lascaratos G, 2014, INTRAOCULAR PRESSURE; Lee JM, 2014, INVEST OPHTH VIS SCI, V55, P2228, DOI 10.1167/iovs.13-12261; Lesk MR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1568, DOI 10.1001/archopht.124.11.1568; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Lichter PR, 2001, OPHTHALMOLOGY, V108, P1943, DOI 10.1016/S0161-6420(01)00873-9; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; Medeiros FA, 2005, ARCH OPHTHALMOL-CHIC, V123, P1351, DOI 10.1001/archopht.123.10.1351; Medeiros FA, 2013, OPHTHALMOLOGY, V120, P1533, DOI 10.1016/j.ophtha.2013.01.032; MIGDAL C, 1994, OPHTHALMOLOGY, V101, P1651; Musch DC, 2009, OPHTHALMOLOGY, V116, P200, DOI 10.1016/j.ophtha.2008.08.051; NIELSEN CB, 1985, ACTA OPHTHALMOL, V63, P351; Pajic B, 2010, CURR MED RES OPIN, V26, P2213, DOI 10.1185/03007995.2010.508702; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ritch R, 1996, Trans Am Ophthalmol Soc, V94, P381; Salvetat ML, 2015, J GLAUCOMA, V24, P568, DOI 10.1097/IJG.0000000000000133; Shah S, 1999, OPHTHALMOLOGY, V106, P2154, DOI 10.1016/S0161-6420(99)90498-0; Shimmyo M, 2003, AM J OPHTHALMOL, V136, P603, DOI 10.1016/S0002-9394(03)00424-0; Singh K, 2011, INVEST OPHTH VIS SCI, V52, P8927, DOI 10.1167/iovs.11-7854; Spry PGD, 2000, INVEST OPHTH VIS SCI, V41, P2192; Stodtmeister R, 1998, ACTA OPHTHALMOL SCAN, V76, P319, DOI 10.1034/j.1600-0420.1998.760313.x; Taketani Y, 2015, INVEST OPHTH VIS SCI, V56, P4076, DOI 10.1167/iovs.14-16341; Tibshirani RJ, 2012, ANN STAT, V40, P1198, DOI 10.1214/12-AOS1003; Tonnu PA, 2005, BRIT J OPHTHALMOL, V89, P851, DOI 10.1136/bjo.2004.056622; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Wang W, 2015, INVEST OPHTH VIS SCI, V56, P5557, DOI 10.1167/iovs.15-16926; Wang XF, 2016, INVEST OPHTH VIS SCI, V57, P2452, DOI 10.1167/iovs.15-18986; Wang YX, 2015, OPHTHALMOLOGY, V122, P2022, DOI 10.1016/j.ophtha.2015.06.005; Wells AP, 2008, INVEST OPHTH VIS SCI, V49, P3262, DOI 10.1167/iovs.07-1556; WHITACRE MM, 1993, AM J OPHTHALMOL, V115, P592, DOI 10.1016/S0002-9394(14)71455-2; WHITACRE MM, 1993, SURV OPHTHALMOL, V38, P1, DOI 10.1016/0039-6257(93)90053-A; Wolfs RC, 1997, AM J OPHTHALMOL, V123, P767, DOI 10.1016/S0002-9394(14)71125-0; Zhong YS, 2011, CORNEA, V30, P861, DOI 10.1097/ICO.0b013e3182000c27	65	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176380	10.1371/journal.pone.0176380	http://dx.doi.org/10.1371/journal.pone.0176380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472062	gold, Green Submitted, Green Published			2022-12-27	WOS:000400648500042
J	Mauer, J; Peltomaki, M; Poblete, S; Gompper, G; Fedosov, DA				Mauer, Johannes; Peltomaeki, Matti; Poblete, Simon; Gompper, Gerhard; Fedosov, Dmitry A.			Static and dynamic light scattering by red blood cells: A numerical study	PLOS ONE			English	Article							DISSIPATIVE PARTICLE DYNAMICS; DIFFUSING-WAVE SPECTROSCOPY; SIMULATIONS; MODEL; FLOW; MACROMOLECULES; APPROXIMATION; CYTOSKELETON; SUSPENSIONS; MECHANICS	Light scattering is a well-established experimental technique, which gains more and more popularity in the biological field because it offers the means for non-invasive imaging and detection. However, the interpretation of light-scattering signals remains challenging due to the complexity of most biological systems. Here, we investigate static and dynamic scattering properties of red blood cells (RBCs) using two mesoscopic hydrodynamics simulation methods-multi-particle collision dynamics and dissipative particle dynamics. Light scattering is studied for various membrane shear elasticities, bending rigidities, and RBC shapes (e.g., biconcave and stomatocyte). Simulation results from the two simulation methods show good agreement, and demonstrate that the static light scattering of a diffusing RBC is not very sensitive to the changes in membrane properties and moderate alterations in cell shapes. We also compute dynamic light scattering of a diffusing RBC, from which dynamic properties of RBCs such as diffusion coefficients can be accessed. In contrast to static light scattering, the dynamic measurements can be employed to differentiate between the biconcave and stomatocytic RBC shapes and generally allow the differentiation based on the membrane properties. Our simulation results can be used for better understanding of light scattering by RBCs and the development of new non-invasive methods for blood-flow monitoring.	[Fedosov, Dmitry A.] Forschungszentrum Julich, Inst Complex Syst, Theoret Soft Matter & Biophys, D-52425 Julich, Germany; Forschungszentrum Julich, Inst Adv Simulat, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich	Fedosov, DA (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Theoret Soft Matter & Biophys, D-52425 Julich, Germany.	d.fedosov@fz.juelich.de	Fedosov, Dmitry/G-4110-2013; Gompper, Gerhard/I-4886-2012	Fedosov, Dmitry/0000-0001-7469-9844; Gompper, Gerhard/0000-0002-8904-0986	FP7-PEOPLE-ITN LAPASO "Label-free particle sorting"; Alexander von Humboldt Foundation	FP7-PEOPLE-ITN LAPASO "Label-free particle sorting"; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We acknowledge the FP7-PEOPLE-2013-ITN LAPASO "Label-free particle sorting" for financial support. D.A.F. acknowledges funding by the Alexander von Humboldt Foundation.	Allen M.P., 1991, COMPUTER SIMULATION; Arifler D, 2014, BIOMED OPT EXPRESS, V5, P485, DOI 10.1364/BOE.5.000485; Belau M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3503398; Berne B. J., 2000, DYNAMIC LIGHT SCATTE; Bi L, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.5.055001; Born M., 1959, PRINCIPLES OPTICS; BROCHARD F, 1975, J PHYS-PARIS, V36, P1035, DOI 10.1051/jphys:0197500360110103500; Cordasco D, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4871300; DELATORRE JG, 1994, BIOPHYS J, V67, P530, DOI 10.1016/S0006-3495(94)80512-0; Dhont, 1996, INTRO DYNAMICS COLLO; Discher DE, 1998, BIOPHYS J, V75, P1584, DOI 10.1016/S0006-3495(98)74076-7; DRAINE BT, 1994, J OPT SOC AM A, V11, P1491, DOI 10.1364/JOSAA.11.001491; Dunn A K, 1997, J Biomed Opt, V2, P262, DOI 10.1117/12.275219; ESPANOL P, 1995, EUROPHYS LETT, V30, P191, DOI 10.1209/0295-5075/30/4/001; Evans E.A., 1980, MECH THERMODYNAMICS; Fedosov DA, 2014, BIOMECH MODEL MECHAN, V13, P239, DOI 10.1007/s10237-013-0497-9; Fedosov DA, 2011, P NATL ACAD SCI USA, V108, P11772, DOI 10.1073/pnas.1101210108; Fedosov DA, 2010, BIOPHYS J, V98, P2215, DOI 10.1016/j.bpj.2010.02.002; Freund JB, 2014, ANNU REV FLUID MECH, V46, P67, DOI 10.1146/annurev-fluid-010313-141349; FUJIME S, 1985, BIOPHYS CHEM, V23, P1, DOI 10.1016/0301-4622(85)80059-4; de la Torre JG, 2007, J PHYS CHEM B, V111, P955, DOI 10.1021/jp0647941; Gompper G, 2009, ADV POLYM SCI, V221, P1, DOI 10.1007/12_2008_5; Gompper G, 1996, J PHYS I, V6, P1305, DOI 10.1051/jp1:1996246; He JP, 2004, J OPT SOC AM A, V21, P1953, DOI 10.1364/JOSAA.21.001953; HOOGERBRUGGE PJ, 1992, EUROPHYS LETT, V19, P155, DOI 10.1209/0295-5075/19/3/001; Huang CC, 2010, J COMPUT PHYS, V229, P168, DOI 10.1016/j.jcp.2009.09.024; Ihle T, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.066706; Ihle T, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.020201; ITZYKSON C, 1986, NUCL PHYS B, V275, P580, DOI 10.1016/0550-3213(86)90576-6; Kim Y, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.040501; Kruger T, 2011, COMPUT MATH APPL, V61, P3485, DOI 10.1016/j.camwa.2010.03.057; KUNZ D, 1983, COLLOID POLYM SCI, V261, P635, DOI 10.1007/BF01415033; Lanotte L, 2016, P NATL ACAD SCI USA, V113, P13289, DOI 10.1073/pnas.1608074113; Li J, 2008, OPT LETT, V33, P2233, DOI 10.1364/OL.33.002233; Lim J, 2011, BIOMED OPT EXPRESS, V2, P2784, DOI 10.1364/BOE.2.002784; Liu T, 2012, MACROMOL CHEM PHYS, V213, P1697, DOI 10.1002/macp.201200154; Lu JQ, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1897397; MAEDA T, 1985, MACROMOLECULES, V18, P2430, DOI 10.1021/ma00154a016; Malevanets A, 1999, J CHEM PHYS, V110, P8605, DOI 10.1063/1.478857; Meinke MC, 2011, ADV OPTICAL FLOW CYT, P95; Nikitin SY, 2013, QUANTUM ELECTRON+, V43, P90, DOI 10.1070/QE2013v043n01ABEH014968; Ninck M, 2010, BIOMED OPT EXPRESS, V1, P1502, DOI 10.1364/BOE.1.001502; Noguchi H, 2005, P NATL ACAD SCI USA, V102, P14159, DOI 10.1073/pnas.0504243102; Noguchi H, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016706; Okubo T, 1996, COLLOID POLYM SCI, V274, P93, DOI 10.1007/BF00663441; Park Y, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3524509; Park Y, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3369966; Park YK, 2010, P NATL ACAD SCI USA, V107, P1289, DOI 10.1073/pnas.0910785107; Pecora R, 2000, J NANOPART RES, V2, P123, DOI 10.1023/A:1010067107182; Peltomaki M, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3701265; Peng ZL, 2014, J FLUID MECH, V742, P96, DOI 10.1017/jfm.2014.14; Poblete S, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.033314; Tsinopoulos SV, 1999, APPL OPTICS, V38, P5499, DOI 10.1364/AO.38.005499; Turlier H, 2016, NAT PHYS, V12, P513, DOI [10.1038/nphys3621, 10.1038/NPHYS3621]; TYCKO DH, 1985, APPL OPTICS, V24, P1355, DOI 10.1364/AO.24.001355; Zohdi TI, 2006, J R SOC INTERFACE, V3, P823, DOI 10.1098/rsif.2006.0139	56	10	10	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176799	10.1371/journal.pone.0176799	http://dx.doi.org/10.1371/journal.pone.0176799			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472125	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500073
J	Niegowska, M; Delitala, A; Pes, GM; Delitala, G; Sechi, LA				Niegowska, Magdalena; Delitala, Alessandro; Pes, Giovanni Mario; Delitala, Giuseppe; Sechi, Leonardo A.			Increased seroreactivity to proinsulin and homologous mycobacterial peptides in latent autoimmune diabetes in adults	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; TCF7L2 GENE; TYPE-1; ASSOCIATION; LADA; EXPRESSION; EPITOPES; CHILDREN; NIRAD; TITER	Latent Autoimmune Diabetes in Adults (LADA) is a slowly progressing form of immune-mediated diabetes that combines phenotypical features of type 2 diabetes (T2D) with the presence of islet cell antigens detected in type 1 diabetes (T1D). Heterogeneous clinical picture have led to the classification of patients based on the levels of antibodies against glutamic acid decarboxylase 65 (GADA) that correlate with clinical phenotypes closer to T1D or T2D when GADA titers are high or low, respectively. To date, LADA etiology remains elusive despite numerous studies investigating on genetic predisposition and environmental risk factors. To our knowledge, this is the first study aimed at evaluation of a putative role played by Mycobacterium avium subsp. paratuberculosis (MAP) as an infective agent in LADA pathogenesis. MAP is known to cause chronic enteritis in ruminants and has been associated with autoimmune disorders in humans. We analyzed seroreactivity of 223 Sardinian LADA subjects and 182 healthy volunteers against MAP-derived peptides and their human homologs of proinsulin and zinc transporter 8 protein. A significantly elevated positivity for MAP/proinsulin was detected among patients, with the highest prevalence in the 32-41year- old T1D-like LADA subgroup, supporting our hypothesis of a possible MAP contribution in the development of autoimmunity.	[Niegowska, Magdalena; Sechi, Leonardo A.] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Delitala, Alessandro] Univ Sassari, Azienda Osped, Sassari, Italy; [Pes, Giovanni Mario; Delitala, Giuseppe] Univ Sassari, Dept Clin & Expt Med, Sassari, Italy	University of Sassari; University of Sassari; University of Sassari	Sechi, LA (corresponding author), Univ Sassari, Dept Biomed Sci, Sassari, Italy.	sechila@uniss.it	Pes, Giovanni Mario/AAH-3340-2019; Delitala, Alessandro/AAH-2697-2020; Sechi, Leonardo Antonio/Y-3109-2018; Delitala, Alessandro/L-3194-2016	Pes, Giovanni Mario/0000-0003-3265-2823; Delitala, Alessandro/0000-0003-1729-8969; sechi, leonardo antonio/0000-0003-0566-2049				Atreya R, 2014, INT J MED MICROBIOL, V304, P858, DOI 10.1016/j.ijmm.2014.07.006; Barros CMAR, 2014, GENET MOL RES, V13, P7889, DOI 10.4238/2014.September.29.1; Carlsson S, 2007, DIABETES CARE, V30, P3040, DOI 10.2337/dc07-0718; Cervin C, 2008, DIABETES, V57, P1433, DOI 10.2337/db07-0299; Delitala AP, 2016, ENDOCR RES, V41, P207, DOI 10.3109/07435800.2015.1136934; Delitala AP, 2015, J DIABETES, V7, P68, DOI 10.1111/1753-0407.12137; Desai M, 2007, DIABETOLOGIA, V50, P68, DOI 10.1007/s00125-006-0513-z; Di Gaetano C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091237; Falorni A, 2002, ANN NY ACAD SCI, V958, P99; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Guglielmi C, 2012, DIABETES-METAB RES, V28, P40, DOI 10.1002/dmrr.2345; Hawa MI, 2013, DIABETES CARE, V36, P908, DOI 10.2337/dc12-0931; Hermon-Taylor J, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-15; Hjort R, 2015, DIABETOLOGIA, V58, P2525, DOI 10.1007/s00125-015-3711-8; Liao Yu, 2012, Front Med, V6, P243, DOI 10.1007/s11684-012-0201-y; Lofvenborg JE, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.36; Lukacs K, 2012, DIABETOLOGIA, V55, P689, DOI 10.1007/s00125-011-2378-z; Maioli M, 2010, EUR J ENDOCRINOL, V163, P541, DOI 10.1530/EJE-10-0427; Masala S, 2014, PLOS ONE, V15; Masala S, 2015, PEDIATR DIABETES, V16, P189, DOI 10.1111/pedi.12269; Masala S, 2014, ACTA DIABETOL, V51, P577, DOI 10.1007/s00592-014-0558-2; Masala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063371; Masala S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026931; Niegowska M, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5842701; Niegowska M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22266; Niegowska M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133497; Ostergaard JA, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0780-0; Patel D, 2006, INFECT IMMUN, V74, P2849, DOI 10.1128/IAI.74.5.2849-2855.2006; Pes GM, 2016, INTERN EMERG MED, V11, P561, DOI 10.1007/s11739-015-1352-z; Pettersen E, 2010, DIABETES, V59, P302, DOI 10.2337/db09-0923; Rasouli B, 2014, EUR J ENDOCRINOL, V171, P535, DOI 10.1530/EJE-14-0403; Rasuoli B, 2016, DIABET MED; Redondo MJ, 2013, DIABETES, V62, P339, DOI 10.2337/db12-1171; Rosu V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004386; Sardu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032487; Savic D, 2011, GENOME RES, V21, P1417, DOI 10.1101/gr.123745.111; Shin MK, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv031; Stenstrom G, 2002, AM J EPIDEMIOL, V156, P787, DOI 10.1093/aje/kwf115; Tanaka S, 2005, VET PATHOL, V42, P579, DOI 10.1354/vp.42-5-579; Weber P, 2011, Adv Gerontol, V24, P312; Zampetti S, 2010, DIABETIC MED, V27, P701, DOI 10.1111/j.1464-5491.2010.02997.x; Zampetti S, 2012, J CLIN ENDOCR METAB, V97, P3759, DOI 10.1210/jc.2012-2037	42	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176584	10.1371/journal.pone.0176584	http://dx.doi.org/10.1371/journal.pone.0176584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472070	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500055
J	Sayre, EC; Guermazi, A; Esdaile, JM; Kopec, JA; Singer, J; Thorne, A; Nicolaou, S; Cibere, J				Sayre, Eric C.; Guermazi, Ali; Esdaile, John M.; Kopec, Jacek A.; Singer, Joel; Thorne, Anona; Nicolaou, Savvas; Cibere, Jolanda			Associations between MRI features versus knee pain severity and progression: Data from the Vancouver Longitudinal Study of Early Knee Osteoarthritis	PLOS ONE			English	Article							SUBCHONDRAL BONE; EPIDEMIOLOGY; POPULATION; BIOMARKERS; ARTHRITIS; OUTCOMES; THERAPY; HEALTH; DAMAGE; JOINT	Objective To determine associations between features of osteoarthritis (OA) on MRI and knee pain severity and knee pain progression. Design Baseline, 3.3- and 7.5-year assessments were performed for 122 subjects with baseline knee pain (age 40-79), sample-weighted for population (with knee pain) representativeness. MRIs were scored for: osteophytes (0: absent to 3: large); cartilage (0: normal to 4: full thickness defect; 0/1 collapsed); subchondral sclerosis (0: none to 3:>50% of site), subchondral cyst (0: absent to 3: severe), bone marrow lesions (0: none to 3:>= 50% of site); and meniscus (0: normal to 3: maceration/resection), in 6-8 regions each. Per feature, scores were averaged across regions. Effusion/synovitis (0: absent to 3: severe) was analyzed as >= 2 vs. <2. Linear models predicted WOMAC knee pain severity (0-100), and binary models predicted 10+ (minimum perceptible clinical improvement [ MPCI]) and 20+ (minimum clinically important difference [ MCID]) increases. Models were adjusted for age, sex, BMI (and follow-up time for longitudinal models). Results Pain severity was associated with osteophytes (7.17 per unit average; 95% CI = 3.19, 11.15) and subchondral sclerosis (11.03; 0.68, 21.39). MPCI-based pain increase was associated with osteophytes (odds ratio per unit average 3.20; 1.36, 7.55), subchondral sclerosis (5.69; 1.06, 30.44), meniscal damage (1.68; 1.08, 2.61) and effusion/synovitis >= 2 (2.25; 1.07, 4.71). MCID-based pain increase was associated with osteophytes ( 3.79; 1.41, 10.20) and cartilage defects ( 2.42; 1.24, 4.74). Conclusions Of the features investigated, only osteophytes were consistently associated with pain cross-sectionally and longitudinally in all models. This suggests an important role of bone in early knee osteoarthritis.	[Sayre, Eric C.; Esdaile, John M.; Kopec, Jacek A.; Cibere, Jolanda] Arthrit Res Canada, Richmond, BC, Canada; [Guermazi, Ali] Boston Univ, Sch Med, Radiol, Boston, MA 02215 USA; [Esdaile, John M.; Cibere, Jolanda] Univ British Columbia, Med, Vancouver, BC, Canada; [Esdaile, John M.] Univ Calgary, Med, Calgary, AB, Canada; [Esdaile, John M.] Univ Queensland, Sch Med, St Lucia, Qld, Australia; [Kopec, Jacek A.; Singer, Joel; Thorne, Anona] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Nicolaou, Savvas] Univ British Columbia, Radiol, Vancouver, BC, Canada	Arthritis Research Canada; Boston University; University of British Columbia; University of Calgary; University of Queensland; University of British Columbia; University of British Columbia	Sayre, EC (corresponding author), Arthrit Res Canada, Richmond, BC, Canada.	esayre@arthritisresearch.ca		Nicolaou, Savvas/0000-0002-4203-6605	Canadian Institutes of Health Research [89890, 89997]; Canadian Arthritis Network [01-MNO-09N]; The Arthritis Society [TAS04/0063, INS-12-027]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network; The Arthritis Society	This cohort study was funded by grants from the Canadian Institutes of Health Research (#89890, #89997), the Canadian Arthritis Network (01-MNO-09N), and The Arthritis Society (TAS04/0063). Dr. Cibere was supported by an Investigator Award from The Arthritis Society (INS-12-027).	Ai F, 2010, J HUAZHONG U SCI-MED, V30, P248, DOI 10.1007/s11596-010-0223-0; Baert IAC, 2014, KNEE SURG SPORT TR A, V22, P2013, DOI 10.1007/s00167-013-2434-y; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bilgici A, 2010, TURK J RHEUMATOL, V25, P184, DOI 10.5152/tjr.2010.26; Chopra A, 2008, BEST PRACT RES CL RH, V22, P583, DOI 10.1016/j.berh.2008.07.001; Cibere J, 2011, OSTEOARTHR CARTILAGE, V19, P683, DOI 10.1016/j.joca.2011.02.008; Cibere J, 2010, ARTHRIT CARE RES, V62, P1691, DOI 10.1002/acr.20314; Cibere J, 2009, ARTHRITIS RHEUM-US, V60, P1372, DOI 10.1002/art.24473; Cotofana S, 2013, OSTEOARTHR CARTILAGE, V21, P1214, DOI 10.1016/j.joca.2013.04.001; Disler DG, 1996, AM J ROENTGENOL, V167, P127, DOI 10.2214/ajr.167.1.8659356; Ehrich EW, 2000, J RHEUMATOL, V27, P2635; Engelhardt M, 2003, DEUT Z SPORTMED, V54, P171; Galvan-Tejada JI, P SPIE; Guermazi A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5339; Hernandez-Molina G, 2008, ANN RHEUM DIS, V67, P43, DOI 10.1136/ard.2007.070565; Hunter DJ, 2013, OSTEOARTHR CARTILAGE, V21, P1170, DOI 10.1016/j.joca.2013.05.017; Hunter DJ, 2011, OSTEOARTHR CARTILAGE, V19, P557, DOI 10.1016/j.joca.2010.10.029; Ip S, 2011, J RHEUMATOL, V38, P1079, DOI 10.3899/jrheum.100587; Javaid MK, 2012, ARTHRITIS RHEUM-US, V64, P3246, DOI 10.1002/art.34594; Javaid MK, 2010, OSTEOARTHR CARTILAGE, V18, P323, DOI 10.1016/j.joca.2009.11.002; Joubert J, 2007, SAMJ S AFR MED J, V97, P683; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kim HA, 2011, OSTEOARTHR CARTILAGE, V19, P1422, DOI 10.1016/j.joca.2011.09.002; Kopec JA, 2007, J RHEUMATOL, V34, P386; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Link TM, 2009, J BONE JOINT SURG AM, V91A, P30, DOI 10.2106/JBJS.H.01313; Lo GH, 2009, OSTEOARTHR CARTILAGE, V17, P1562, DOI 10.1016/j.joca.2009.06.006; Niethammer TR, 2015, AM J SPORT MED, V43, P1172, DOI 10.1177/0363546515573935; Ratzlaff C, 2013, OSTEOARTHR CARTILAGE, V21, P806, DOI 10.1016/j.joca.2013.03.007; Sowers M, 2011, J BONE JOINT SURG AM, V93A, P241, DOI 10.2106/JBJS.I.00667; Stefanik JJ, 2015, OSTEOARTHR CARTILAGE, V23, P565, DOI 10.1016/j.joca.2014.12.023; Tubach F, 2005, ANN RHEUM DIS, V64, P29, DOI 10.1136/ard.2004.022905; White AG, 2008, J OCCUP ENVIRON MED, V50, P998, DOI 10.1097/JOM.0b013e3181715111; Wildi LM, 2010, ANN RHEUM DIS, V69, P2118, DOI 10.1136/ard.2009.127993; Yusuf E, 2011, ANN RHEUM DIS, V70, P60, DOI 10.1136/ard.2010.131904; Zhai G, 2007, CLIN RHEUMATOL, V26, P75, DOI 10.1007/s10067-006-0248-8	37	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176833	10.1371/journal.pone.0176833	http://dx.doi.org/10.1371/journal.pone.0176833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472071	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500080
J	Lomax, DR; Falkingham, PL; Schweigert, G; Jimenez, AP				Lomax, Dean R.; Falkingham, Peter L.; Schweigert, Guenter; Jimenez, Alejandro P.			An 8.5 m long ammonite drag mark from the Upper Jurassic Solnhofen Lithographic Limestones, Germany	PLOS ONE			English	Article							FRANCONIAN ALB; TRACE	Trackways and tracemakers preserved together in the fossil record are rare. However, the co-occurrence of a drag mark, together with the dead animal that produced it, is exceptional. Here, we describe an 8.5 m long ammonite drag mark complete with the preserved ammonite shell (Subplanites rueppellianus) at its end. Previously recorded examples preserve ammonites with drag marks of < 1 m. The specimen was recovered from a quarry near Solnhofen, southern Germany. The drag mark consists of continuous parallel ridges and furrows produced by the ribs of the ammonite shell as it drifted just above the sediment surface, and does not reflect behaviour of the living animal.	[Lomax, Dean R.] Univ Manchester, Sch Earth & Environm Sci, Manchester, Lancs, England; [Falkingham, Peter L.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England; [Schweigert, Guenter] Staatl Museum Nat Kunde, Stuttgart, Germany; [Jimenez, Alejandro P.] CosmoCaixa Museum, Barcelona, Spain	University of Manchester; Liverpool John Moores University	Lomax, DR (corresponding author), Univ Manchester, Sch Earth & Environm Sci, Manchester, Lancs, England.	dean.lomax@manchester.ac.uk	Falkingham, Peter/AFM-8750-2022	Falkingham, Peter/0000-0003-1856-8377; Lomax, Dean/0000-0001-6985-3966				Abel O., 1930, Palaeobiologica Wien, V3, P371; Barthel K. W., 1964, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V4, P37; Barthel K.W., 1978, BLICK ERDGESCHICHTE; Barthel KW., 1990, STUDY MESOZOIC PALAE; Boucot A.J., 2010, FOSSIL BEHAV COMPEND; Dzulynski S, 1962, CONNECTICUT ACADEMY, V42, P57; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; Fernandez V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064978; Fursich FT, 2007, NEUES JAHRB GEOL P-A, V245, P45, DOI 10.1127/0077-7749/2007/0245-0045; GAILLARD C, 1977, Eclogae Geologicae Helvetiae, V70, P701; Hastings AK, 2015, PALAIOS, V30, P446, DOI 10.2110/palo.2014.062; Keupp H., 2015, SOLNHOFEN FENSTER JU, P218; Keupp H, 2007, NEUES JAHRB GEOL P-A, V245, P3, DOI 10.1127/0077-7749/2007/0245-0003; Kolb A., 1961, Geologische Blaetter fuer Nordost-Bayern, V11, P1; Kolb A., 1967, GEOLOGISCHE BL TTER, V17, P21; Landman NH, 2007, CEPHALOPODS PRESENT AND PAST: NEW INSIGHTS AND FRESH PERSPECTIVES, P396, DOI 10.1007/978-1-4020-6806-5_18; Lomax DR, 2012, ICHNOS, V19, P175, DOI 10.1080/10420940.2012.702704; Maeda H, 1996, AMMONOID PALEOBIOLOG; Neto de Carvalho C, 2015, COMUN GEOL, V103, P39; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; Rothpletz A., 1909, ABH K BAYER AKAD W 2, V24, P311; Schweigert G., 2015, SOLNHOFEN FENSTER JU, P57; Schweigert G, 2007, NEUES JAHRB GEOL P-A, V245, P117, DOI 10.1127/0077-7749/2007/0245-0117; Schweigert G, 2016, ICHNOS, V23, P71, DOI 10.1080/10420940.2015.1126585; Seilacher A., 1963, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1963, P593; Seilacher A., 1976, Neues Jb Geol Paleont Abh, V152, P307; Seilacher A., 2007, TRACE FOSSIL ANAL; Seilacher A, 2008, PALAEOGEOGR PALAEOCL, V270, P252, DOI 10.1016/j.palaeo.2008.07.011; Selden PA, 2012, EVOLUTION OF FOSSIL ECOSYSTEMS, 2ND EDITION, P1, DOI 10.1201/b15128; Summesberger H, 1999, ADVANCING RESEARCH ON LIVING AND FOSSIL CEPHALOPODS, P335; TRUSHEIM F., 1934, PALAE ONT ZEITSCHR, V16, P1; Vallon LH, 2015, ANN SOC GEOL POL, V85, P527; Vallon LH, 2015, ANN SOC GEOL POL, V85, P433; Varricchio DJ, 2007, P ROY SOC B-BIOL SCI, V274, P1361, DOI 10.1098/rspb.2006.0443; Viohl G, 2015, SOLNHOFEN FENSTER JU, P78	35	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0175426	10.1371/journal.pone.0175426	http://dx.doi.org/10.1371/journal.pone.0175426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489915	gold, Green Published, Green Accepted			2022-12-27	WOS:000401314100007
J	Pascual, M; Rives, B; Schunter, C; Macpherson, E				Pascual, Marta; Rives, Borja; Schunter, Celia; Macpherson, Enrique			Impact of life history traits on gene flow: A multispecies systematic review across oceanographic barriers in the Mediterranean Sea	PLOS ONE			English	Review							PELAGIC LARVAL DURATION; LOBSTER PALINURUS-ELEPHAS; MARINE PROTECTED AREAS; POPULATION-STRUCTURE; INTERANNUAL VARIABILITY; PARACENTROTUS-LIVIDUS; MITOCHONDRIAL-DNA; ATLANTIC-OCEAN; CRAMBE-CRAMBE; FISH LARVAE	Background Marine species can demonstrate strong genetic differentiation and population structure despite the hypothesis of open seas and high connectivity. Some suggested drivers causing the genetic breaks are oceanographic barriers and the species' biology. We assessed the relevance of seven major oceanographic fronts on species connectivity while considering their dispersal capacity and life strategy. Methods We systematically reviewed the scientific articles reporting population genetic differentiation along the Mediterranean Sea and across the Atlantic-Mediterranean transition. We retained those considering at least one sampling locality at each side of an oceanographic front, and at least two localities with no-front between them to correctly assess the effect of the front. To estimate the impact of life history characteristics affecting connectivity we considered the planktonic larval duration (PLD) and adult life strategy. Results Oceanographic barriers in the Mediterranean Sea seem to reduce gene flow globally; however, this effect is not homogeneous considering the life history traits of the species. The effect of the oceanographic fronts reduces gene flow in highly mobile species with PLD larger than 2-4 weeks. Benthic sessile species and/or with short PLD (< 2 weeks) have more significant genetic breaks between localities than species with higher motility; however, genetic differentiation occurs independently of the presence of a front. Conclusion Genetic connectivity is important for populations to recover from anthropogenic or natural impacts. We show that species with low mobility, mostly habitat-formers, have high genetic differentiation but low gene flow reduction mediated by the front, therefore, considering the importance of these species, we emphasize the vulnerability of the Mediterranean ecosystems and the necessity of protection strategies based on the whole ecosystem.	[Pascual, Marta; Rives, Borja] Univ Barcelona, Dept Genet Microbiol & Stat IrBio, Diagonal 643, Barcelona, Spain; [Schunter, Celia] King Abdullah Univ Sci & Technol, KEEP, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia; [Schunter, Celia] King Abdullah Univ Sci & Technol, Div Appl Math & Comp Sci, Thuwal, Saudi Arabia; [Macpherson, Enrique] CSIC, CEAB, Car Acc Cala St Francesc 14, Blanes, Girona, Spain	University of Barcelona; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Pascual, M (corresponding author), Univ Barcelona, Dept Genet Microbiol & Stat IrBio, Diagonal 643, Barcelona, Spain.	martapascual@ub.edu	Pascual, Marta/ABG-3782-2020; Pascual, Marta/M-7626-2015; Schunter, Celia/F-2507-2016; Macpherson, Enrique/J-8982-2012	Pascual, Marta/0000-0002-6189-0612; Pascual, Marta/0000-0002-6189-0612; Schunter, Celia/0000-0003-3620-2731; Macpherson, Enrique/0000-0003-4849-4532	Ministerio de Economia y Competitividad [CTM2013-48163]; Generalitat de Catalunya [2014SGR-336, 2014SGR-120]	Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by project CTM2013-48163 from Ministerio de Economia y Competitividad. MP and EM are part of the research groups 2014SGR-336 and 2014SGR-120 of the Generalitat de Catalunya.	Almany GR, 2013, CURR BIOL, V23, P626, DOI 10.1016/j.cub.2013.03.006; Anderson MJ, 2008, PERMANOVA PRIMER GUI, P214; Arizmendi-Mejia R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119585; Artegiani A, 1997, J PHYS OCEANOGR, V27, P1492, DOI 10.1175/1520-0485(1997)027<1492:TASGCP>2.0.CO;2; Astraldi M, 1999, PROG OCEANOGR, V44, P65, DOI 10.1016/S0079-6611(99)00021-X; Babbucci M, 2010, MOL PHYLOGENET EVOL, V56, P1040, DOI 10.1016/j.ympev.2010.05.014; Baguette M, 2013, BIOL REV, V88, P310, DOI 10.1111/brv.12000; Balbin R, 2014, J MARINE SYST, V138, P70, DOI 10.1016/j.jmarsys.2013.07.004; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Bell JJ, 2008, BIOL CONSERV, V141, P2807, DOI 10.1016/j.biocon.2008.08.017; Berline L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111978; Blanquer A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-13; Boero F, 2015, REND LINCEI-SCI FIS, V26, P3, DOI 10.1007/s12210-014-0340-y; Bradbury IR, 2010, P ROY SOC B-BIOL SCI, V277, P3725, DOI 10.1098/rspb.2010.0985; Buonomo R, 2017, MOL ECOL, V26, P766, DOI 10.1111/mec.13960; Cabanellas-Reboredo Miguel, 2009, Marine Biodiversity Records, V2, pe126, DOI 10.1017/S1755267209001274; Calderon I, 2012, MAR BIOL, V159, P187, DOI 10.1007/s00227-011-1799-z; Calderon I, 2007, MOL ECOL, V16, P1799, DOI 10.1111/j.1365-294X.2007.03276.x; Carreras C, 2017, SCI REP, V7; Carreras-Carbonell J, 2006, MOL ECOL, V15, P3527, DOI 10.1111/j.1365-294X.2006.03003.x; Casado-Amezua P, 2012, MOL ECOL, V21, P3671, DOI 10.1111/j.1365-294X.2012.05655.x; Cebrian E, 2003, MAR POLLUT BULL, V46, P1273, DOI 10.1016/S0025-326X(03)00190-5; Cerrano C, 2010, BIODIVERS CONSERV, V19, P153, DOI 10.1007/s10531-009-9712-5; Charrier G, 2006, MOL PHYLOGENET EVOL, V38, P742, DOI 10.1016/j.ympev.2005.08.002; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; COMA R, 1995, MAR ECOL PROG SER, V117, P173, DOI 10.3354/meps117173; Cordero D, 2014, MOL PHYLOGENET EVOL, V71, P274, DOI 10.1016/j.ympev.2013.11.003; De Innocentiis S, 2004, FISHERIES SCI, V70, P852, DOI 10.1111/j.1444-2906.2004.00879.x; Dubois M, 2016, GLOBAL ECOL BIOGEOGR, V25, P503, DOI 10.1111/geb.12431; Fernandez V, 2005, PROG OCEANOGR, V66, P321, DOI 10.1016/j.pocean.2004.07.010; Galarza JA, 2009, CAN J FISH AQUAT SCI, V66, P1478, DOI 10.1139/F09-098; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Garcia-Lafuente J, 2006, DEEP-SEA RES PT II, V53, P1182, DOI 10.1016/j.dsr2.2006.04.011; Garcia-Rubies A, 2017, MANAGEMENT MARINE PR; GARCIARUBIES A, 1995, MAR BIOL, V124, P35, DOI 10.1007/BF00349144; Gonzalez-Gordillo JI, 2001, SCI MAR, V65, P275, DOI 10.3989/scimar.2001.65n4275; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Garcia-Merchan VH, 2012, MOL PHYLOGENET EVOL, V62, P664, DOI 10.1016/j.ympev.2011.11.009; Jahnke M, 2016, MAR ENVIRON RES, V117, P54, DOI 10.1016/j.marenvres.2016.04.004; Kaplan DM, 2009, MAR ECOL PROG SER, V377, P213, DOI 10.3354/meps07825; Lleonart J, 2003, SCI MAR, V67, P37, DOI 10.3989/scimar.2003.67s137; Lopez S, 1998, MAR ECOL PROG SER, V172, P239, DOI 10.3354/meps172239; Luiz OJ, 2013, P NATL ACAD SCI USA, V110, P16498, DOI 10.1073/pnas.1304074110; Macpherson E, 2006, MAR ECOL PROG SER, V327, P257, DOI 10.3354/meps327257; Magris RA, 2014, BIOL CONSERV, V170, P207, DOI 10.1016/j.biocon.2013.12.032; Maltagliati F, 2016, MAR ECOL-EVOL PERSP, V37, P492, DOI 10.1111/maec.12261; Marie AD, 2016, SCI REP, V6; Millot C, 2005, HANDB ENVIRON CHEM, V5, P29, DOI 10.1007/b107143; Mokhtar-Jamai K, 2011, MOL ECOL, V20, P3291, DOI 10.1111/j.1365-294X.2011.05176.x; Mokhtar-Jamai K, 2013, ECOL EVOL, V3, P1765, DOI 10.1002/ece3.588; Olsen EM, 2013, 18 EUR MAR BOARD; Palero F, 2008, MOL PHYLOGENET EVOL, V48, P708, DOI 10.1016/j.ympev.2008.04.022; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Pascual M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29892; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Perez-Ruzafa A, 2006, BIOL CONSERV, V129, P244, DOI 10.1016/j.biocon.2005.10.040; Pineda MC, 2016, PEERJ, V4, DOI 10.7717/peerj.2158; Preacher K.J., 2001, CALCULATION CHI SQUA; Raventos N, 2001, MAR BIOL, V138, P1115; Renault L, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC007924; Reuschel S, 2010, MOL PHYLOGENET EVOL, V55, P765, DOI 10.1016/j.ympev.2010.03.021; Ribeiro PMA, 2008, DISPERSAL CONNECTIVI; Riginos C, 2011, ECOGRAPHY, V34, P566, DOI 10.1111/j.1600-0587.2010.06511.x; Rio MH, 2007, J MARINE SYST, V65, P484, DOI 10.1016/j.jmarsys.2005.02.006; Rius M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035815; Rossi V, 2014, GEOPHYS RES LETT, V41, P2883, DOI 10.1002/2014GL059540; SABATES A, 1990, MAR ECOL PROG SER, V59, P75, DOI 10.3354/meps059075; Sabates A, 2007, PROG OCEANOGR, V74, P355, DOI 10.1016/j.pocean.2007.04.017; Sabates A, 2001, SCI MAR, V65, P77, DOI 10.3989/scimar.2001.65s177; SABATES A, 1990, DEEP-SEA RES, V37, P1085, DOI 10.1016/0198-0149(90)90052-W; Sahyoun R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167441; Salat J, 1996, SCI MAR, V60, P21; Sales M, 2015, NEW METHOD RESTORING; Schunter C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0556; Schunter C, 2011, MOL ECOL, V20, P5167, DOI 10.1111/j.1365-294X.2011.05355.x; Schunter C, 2011, J EXP MAR BIOL ECOL, V401, P126, DOI 10.1016/j.jembe.2011.01.021; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; Selkoe KA, 2016, MAR ECOL PROG SER, V554, P1, DOI 10.3354/meps11792; Selkoe KA, 2014, MOL ECOL, V23, P3064, DOI 10.1111/mec.12804; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; Shanks AL, 2003, ECOL APPL, V13, pS159; Shanks AL, 2009, BIOL BULL-US, V216, P373; Simion P, 2017, CURR BIOL RUPRECHT K, V432, P618; Siokou-Frangou I, 2010, BIOGEOSCIENCES, V7, P1543, DOI 10.5194/bg-7-1543-2010; Stat Soft. Inc, 2007, STATISTICA DAT AN SO; Tarjuelo I, 2004, MOL ECOL, V13, P3125, DOI 10.1111/j.1365-294X.2004.02306.x; Theocharis A, 1999, PROG OCEANOGR, V44, P469, DOI 10.1016/S0079-6611(99)00041-5; Thibaut T, 2005, MAR POLLUT BULL, V50, P1472, DOI 10.1016/j.marpolbul.2005.06.014; Thibaut T, 2016, CRYPTOGAMIE ALGOL, V37, P233, DOI 10.7872/crya/v37.iss4.2016.233; TINTORE J, 1988, J PHYS OCEANOGR, V18, P1384, DOI 10.1175/1520-0485(1988)018<1384:ASOAID>2.0.CO;2; Uriz MJ, 1998, MAR ECOL PROG SER, V167, P137, DOI 10.3354/meps167137; Villanueva R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165334; Wang IJ, 2010, MOL ECOL, V19, P2605, DOI 10.1111/j.1365-294X.2010.04715.x; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Zitari-Chatti R, 2009, GENETICA, V136, P439, DOI 10.1007/s10709-008-9344-9; Zulliger DE, 2009, MAR BIOL, V156, P597, DOI 10.1007/s00227-008-1111-z	98	89	91	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176419	10.1371/journal.pone.0176419	http://dx.doi.org/10.1371/journal.pone.0176419			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489878	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314100023
J	Asli, A; Brouillette, E; Ster, C; Ghinet, MG; Brzezinski, R; Lacasse, P; Jacques, M; Malouin, F				Asli, Abdelhamid; Brouillette, Eric; Ster, Celine; Ghinet, Mariana Gabriela; Brzezinski, Ryszard; Lacasse, Pierre; Jacques, Mario; Malouin, Francois			Antibiofilm and antibacterial effects of specific chitosan molecules on Staphylococcus aureus isolates associated with bovine mastitis	PLOS ONE			English	Article							INTRAMAMMARY INFECTIONS; ESCHERICHIA-COLI; MILK; MODE; OIL; HAMAMELITANNIN; COMBINATION; ANTIBIOTICS; PREVENTION; RESISTANCE	Staphylococcus aureus is one of the major pathogens causing bovine intramammary infections (IMIs) and mastitis. Mastitis is the primary cause for the use of antibiotics in dairy farms but therapeutic failure is often observed. One of the reasons for the lack of effectiveness of antibiotic therapy despite the observed susceptibility of bacterial isolates in vitro are bacterial biofilms. In this study, we used chitosan of well-defined molecular weight (0.4-0.6, 1.3, 2.6 and 4.0 kDa) and investigated their antibiofilm and antibacterial activities in in vitro and in vivo models related to S. aureus IMIs. A chitosan of at least 6 units of glucosamine was necessary for maximum antibacterial activity. The 2.6 and 4.0 kDa forms were able to prevent biofilm production by the biofilm hyperproducer strain S. aureus 2117 and a bovine MRSA (methicillin-resistant S. aureus). The intramammary administration of the 2.6 kDa chitosan showed no adverse effects in mice or in cows, as opposed to the slight inflammatory effect observed in mammary glands with the 4.0 kDa derivative. The 2.6 kDa chitosan killed bacteria embedded in pre-established biofilms in a dose-dependent manner with a > 3 log10 reduction in CFU at 4 mg/ml. Also, the 2.6 kDa chitosan could prevent the persistence of the internalized MRSA into the mammary epithelial cell line MAC-T. An in vitro checkerboard assay showed that the 2.6 kDa chitosan produced a synergy with the macrolide class of antibiotics (e.g., tilmicosin) and reduced the MIC of both molecules by 2-8 times. Finally, the intramammary administration of the 2.6 kDa chitosan alone (P<0.01) or in combination with tilmicosin (P<0.0001) reduced the colonization of mammary glands in a murine IMI model. Our results suggest that the use of chitosan alone or in combination with a low dose of a macrolide could help reduce antibiotic use in dairy farms.	[Asli, Abdelhamid; Brouillette, Eric; Ster, Celine; Ghinet, Mariana Gabriela; Brzezinski, Ryszard; Malouin, Francois] Univ Sherbrooke, Fac Sci, Dept Biol, CEVDM, Sherbrooke, PQ, Canada; [Asli, Abdelhamid; Brouillette, Eric; Ster, Celine; Lacasse, Pierre; Jacques, Mario; Malouin, Francois] Univ Montreal, Canadian Bovine Mastitis & Milk Qual Res Network, Montreal, PQ, Canada; [Asli, Abdelhamid; Brouillette, Eric; Ster, Celine; Lacasse, Pierre; Jacques, Mario; Malouin, Francois] Univ Montreal, Regrp Rech Lait Qualite Optimale Op Lait, Montreal, PQ, Canada; [Lacasse, Pierre] Agr & Agri Food Canada, Sherbrooke Res & Dev Ctr, Sherbrooke, PQ, Canada; [Jacques, Mario] Univ Montreal, Fac Med Vet, Dept Pathol & Microbiol, St Hyacinthe, PQ, Canada	University of Sherbrooke; Universite de Montreal; Universite de Montreal; Agriculture & Agri Food Canada; Universite de Montreal	Malouin, F (corresponding author), Univ Sherbrooke, Fac Sci, Dept Biol, CEVDM, Sherbrooke, PQ, Canada.	francois.malouin@usherbrooke.ca	Lacasse, Pierre/AAS-3143-2020; Ster, Céline/AAT-2620-2020; Lacasse, Pierre/B-5084-2013; Jacques, Mario/D-4901-2015	Malouin, Francois/0000-0001-5031-345X	FRQNT, les Fonds de Recherche du Quebec, Nature et Technologies (St-Hyacinthe, Quebec, Canada)	FRQNT, les Fonds de Recherche du Quebec, Nature et Technologies (St-Hyacinthe, Quebec, Canada)	This research was supported by a contribution from the Dairy Research Cluster initiative [Dairy Farmers of Canada (Ottawa, ON, Canada), Agriculture and AgriFood Canada (Ottawa, ON, Canada), and the Canadian Dairy Commission (Ottawa, ON, Canada)] through the Canadian Bovine Mastitis and Milk Quality Research Network (St-Hyacinthe, QC, Canada). AA received a studentship from Op+Lait, le Regroupement de recherche pour un lait de qualite optimale supported by the FRQNT, les Fonds de Recherche du Quebec, Nature et Technologies (St-Hyacinthe, Quebec, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 1999, APMIS, V107, P425, DOI 10.1111/j.1699-0463.1999.tb01576.x; Aarestrup FM, 1995, ACTA VET SCAND, V36, P475; Aitken SL, 2011, J MAMMARY GLAND BIOL, V16, P291, DOI 10.1007/s10911-011-9230-4; Anderson KL, 2006, J DAIRY SCI, V89, P4551, DOI 10.3168/jds.S0022-0302(06)72504-8; Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; Bhatnagar A, 2009, ADV COLLOID INTERFAC, V152, P26, DOI 10.1016/j.cis.2009.09.003; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; BOUCHER I, 1992, APPL MICROBIOL BIOT, V38, P188, DOI 10.1007/BF00174466; Brouillette E, 2004, VET MICROBIOL, V101, P253, DOI 10.1016/j.vetmic.2004.04.008; Cafiso V, 2007, FEMS IMMUNOL MED MIC, V51, P220, DOI 10.1111/j.1574-695X.2007.00298.x; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Chung YC, 2008, BIORESOURCE TECHNOL, V99, P2806, DOI 10.1016/j.biortech.2007.06.044; Clinical and Laboratory Standards Institute, 2006, M100S16 CLIN LAB STA; Cobrado L, 2013, J ANTIMICROB CHEMOTH, V68, P126, DOI 10.1093/jac/dks376; Cobrado L, 2012, J ANTIMICROB CHEMOTH, V67, P1159, DOI 10.1093/jac/dks007; Costa E, 2014, PATHOGENS, V3, P908, DOI 10.3390/pathogens3040908; Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cui HY, 2016, BIOFOULING, V32, P215, DOI 10.1080/08927014.2015.1134516; Cui HY, 2016, FOOD CONTROL, V61, P92, DOI 10.1016/j.foodcont.2015.09.034; Cui HY, 2015, FOOD CONTROL, V56, P128, DOI 10.1016/j.foodcont.2015.03.026; De Vliegher S, 2012, J DAIRY SCI, V95, P1025, DOI 10.3168/jds.2010-4074; Decker EM, 2005, J PERIODONTAL RES, V40, P373, DOI 10.1111/j.1600-0765.2005.00817.x; Dodane V, 1998, PHARM SCI TECHNOL TO, V1, P246, DOI 10.1016/S1461-5347(98)00059-5; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; Fournier C, 2008, RES VET SCI, V85, P439, DOI 10.1016/j.rvsc.2008.01.010; Fox LK, 2005, VET MICROBIOL, V107, P295, DOI 10.1016/j.vetmic.2005.02.005; Geary U, 2012, J DAIRY SCI, V95, P3662, DOI 10.3168/jds.2011-4863; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Islam M.M., 2011, J ADV SCI RES, V2, P63; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kim Y, 2009, BIOCHEM BIOPH RES CO, V379, P324, DOI 10.1016/j.bbrc.2008.12.053; Klein RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120514; Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012; Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Liu XF, 2001, J APPL POLYM SCI, V79, P1324; Ma Y, 2000, J DAIRY SCI, V83, P264, DOI 10.3168/jds.S0022-0302(00)74873-9; MCEWEN SA, 1991, J DAIRY SCI, V74, P2128, DOI 10.3168/jds.S0022-0302(91)78385-9; Melchior MB, 2006, VET J, V171, P398, DOI 10.1016/j.tvjl.2005.01.006; Mitchell G, 2012, J ANTIMICROB CHEMOTH, V67, P559, DOI 10.1093/jac/dkr510; Mu HB, 2014, INT J MOL SCI, V15, P22296, DOI 10.3390/ijms151222296; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Orhan G, 2005, J CLIN MICROBIOL, V43, P140, DOI 10.1128/JCM.43.1.140-143.2005; Osteras O, 2006, J DAIRY SCI, V89, P1010, DOI 10.3168/jds.S0022-0302(06)72167-1; Otto M., 2012, ANNU REV MED, V64, P1; Otto M, 2014, INT J MED MICROBIOL, V304, P164, DOI 10.1016/j.ijmm.2013.11.019; Pitkala A, 2004, J DAIRY SCI, V87, P2433, DOI 10.3168/jds.S0022-0302(04)73366-4; Prashanth KVH, 2007, TRENDS FOOD SCI TECH, V18, P117, DOI 10.1016/j.tifs.2006.10.022; Quintero-Villegas MI, 2013, J AGR FOOD CHEM, V61, P2748, DOI 10.1021/jf400103g; Raafat D, 2008, APPL ENVIRON MICROB, V74, P3764, DOI 10.1128/AEM.00453-08; Raafat D, 2009, MICROB BIOTECHNOL, V2, P186, DOI 10.1111/j.1751-7915.2008.00080.x; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; Rainard P, 2003, CLIN DIAGN LAB IMMUN, V10, P272, DOI 10.1128/CDLI.10.2.272-277.2003; Reyher KK, 2011, J DAIRY SCI, V94, P1616, DOI 10.3168/jds.2010-3180; Riekerink RGMO, 2008, J DAIRY SCI, V91, P1366, DOI 10.3168/jds.2007-0757; Saber A, 2010, EUR J PHARM SCI, V39, P110, DOI 10.1016/j.ejps.2009.11.003; Silva-Dias A, 2014, MED MICROBIOL IMMUN, V203, P25, DOI 10.1007/s00430-013-0311-4; Tarsi R, 1997, J DENT RES, V76, P665, DOI 10.1177/00220345970760020701; Tenhagen BA, 2006, J DAIRY SCI, V89, P2542, DOI 10.3168/jds.S0022-0302(06)72330-X; Thompson AK, 2006, J DAIRY SCI, V89, P410, DOI 10.3168/jds.S0022-0302(06)72105-1; Tin S, 2009, INT J BIOL SCI, V5, P153; Tokura S., 1996, NEW MACROMOLECULAR A, P199, DOI DOI 10.1007/978-3-642-80289-8_21; Varum K.M., 2005, VERSATILITY, P625; Veh KA, 2015, J DAIRY SCI, V98, P155, DOI 10.3168/jds.2014-8044; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Vinsova J, 2011, CURR PHARM DESIGN, V17, P3596, DOI 10.2174/138161211798194468; Yadav MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119564; Zheng LY, 2003, CARBOHYD POLYM, V54, P527, DOI 10.1016/j.carbpol.2003.07.009	71	43	45	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176988	10.1371/journal.pone.0176988	http://dx.doi.org/10.1371/journal.pone.0176988			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486482	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000033
J	Chao, WC; Lin, CH; Liao, TL; Chen, YM; Chen, DY; Chen, HH				Chao, Wen-Cheng; Lin, Ching-Heng; Liao, Tsai-Ling; Chen, Yi-Ming; Chen, Der-Yuan; Chen, Hsin-Hua			Association between a history of mycobacterial infection and the risk of newly diagnosed Sjogren's syndrome: A nationwide, population-based case-control study	PLOS ONE			English	Article							TUBERCULOSIS; BRONCHIECTASIS; SUSCEPTIBILITY; SIGNATURES; THERAPY; DISEASE; TAIWAN	Objective To address the association between a history of tuberculosis (TB) or nontuberculous mycobacterial (NTM) infection and the risk of newly diagnosed Sjogren's syndrome (SS). Methods Using a nationwide, population-based, claims dataset, and after excluding those who had rheumatoid arthritis or systemic lupus erythematosus, we identified 5,751 newly diagnosed SS cases during 2007-2012, and compared them to 86,265 non-SS controls matched (1: 15) for age, sex, and the year of first SS diagnosis date. The association between the risk of incident SS and a history of mycobacterial infection, including TB and NTM, was quantified by calculating odds ratios (ORs) with 95% confidence intervals (CIs) using conditional logistic regression analysis after adjustment for Charlson comorbidity index (CCI) and bronchiectasis. Results The mean age was 55 +/- 14 years, and the proportion of female gender was 87.8% in both newly diagnosed SS cases andnon-SS controls. An association was observed between NTM infection (OR, 11.24; 95% CI, 2.37-53.24) and incident SS, but not between TB infection and incident SS (OR, 1.29; 95% CI, 0.97-1.71) after adjustment for CCI and bronchiectasis. The association between NTM and SS risk was remarkably strong among those aged between 45 and 65 years (OR, 39.24; 95% CI, 3.97-387.75) and those without bronchiectasis (OR, 39.98; 95% CI, 3.83-376.92). Conclusion The study reveals a significant association of newly diagnosed SS with a history NTM infection, especially among individuals aged 40-65 years or those without bronchiectasis.	[Chao, Wen-Cheng; Lin, Ching-Heng; Liao, Tsai-Ling; Chen, Yi-Ming; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chao, Wen-Cheng] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Chao, Wen-Cheng] Natl Changhua Univ Educ, Dept Business Adm, Changhua, Taiwan; [Liao, Tsai-Ling; Chen, Yi-Ming; Chen, Der-Yuan; Chen, Hsin-Hua] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Liao, Tsai-Ling; Chen, Yi-Ming; Chen, Der-Yuan; Chen, Hsin-Hua] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Yi-Ming; Chen, Der-Yuan; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Yi-Ming; Chen, Der-Yuan; Chen, Hsin-Hua] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Der-Yuan; Chen, Hsin-Hua] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Changhua University of Education; National Chung Hsing University; National Chung Hsing University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Chung Shan Medical University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, HH (corresponding author), Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan.	dychen@vghtc.gov.tw; shc5555@hotmail.com	Chen, Yi-Ming/AAV-3806-2021	Chen, Yi-Ming/0000-0001-7593-3065; Chao, Wen-Cheng/0000-0001-9631-8934	Taichung Veterans General Hospital, Taiwan [TCVGH-1057329D, TCVGH-105G213, TCVGH-NHRI10505, TCVGH-1057308C, TCVGH-FCU1058202]	Taichung Veterans General Hospital, Taiwan	This study was supported in part by grants from Taichung Veterans General Hospital, Taiwan (TCVGH-1057329D,TCVGH-105G213, TCVGH-NHRI10505, TCVGH-1057308C, TCVGH-FCU1058202). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Chan ED, 2013, SEMIN RESP CRIT CARE, V34, P110, DOI 10.1055/s-0033-1333573; Chang YS, 2014, CLIN RHEUMATOL, V33, P377, DOI 10.1007/s10067-013-2408-y; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chien JY, 2013, J ANTIMICROB CHEMOTH, V68, P1910, DOI 10.1093/jac/dkt103; Chu HQ, 2014, ARCH MED SCI, V10, P661, DOI 10.5114/aoms.2014.44857; Cronan MR, 2016, IMMUNITY, V45, P861, DOI 10.1016/j.immuni.2016.09.014; Danley Joshua, 2014, Ann Am Thorac Soc, V11, P908, DOI 10.1513/AnnalsATS.201312-422OC; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Elkington P, 2016, TRENDS IMMUNOLOGY; Firestein Gary S., 2013, KELLEYS TXB RHEUMATO, P1169; Friedland JS, 2014, NEW ENGL J MED, V371, P1354, DOI 10.1056/NEJMcibr1408663; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Jordan TS, 2010, RESPIROLOGY, V15, P623, DOI 10.1111/j.1440-1843.2010.01749.x; Jou R, 2009, INT J TUBERC LUNG D, V13, P1142; Kakumanu P, 2008, ARTHRITIS RHEUM-US, V58, P1576, DOI 10.1002/art.23514; Ko JM, 2013, ACTA RADIOL, V54, P412, DOI 10.1177/0284185113475796; Konttinen YT, 2012, J AUTOIMMUN, V39, P49, DOI 10.1016/j.jaut.2012.01.004; Liao TL, 2015, EMERG INFECT DIS, V21, P1387, DOI 10.3201/eid2108.141846; Lo HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-915; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Mavragani CP, 2012, J AUTOIMMUN, V39, P354, DOI 10.1016/j.jaut.2012.05.011; Mavragani CP, 2010, J AUTOIMMUN, V35, P225, DOI 10.1016/j.jaut.2010.06.012; Mavragani CP, 2010, AUTOIMMUN REV, V9, pA305, DOI 10.1016/j.autrev.2009.11.004; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mirsaeidi M, 2015, INT J MYCOBACT, V4, P92, DOI 10.1016/j.ijmyco.2015.05.002; National Health Insurance Administration Ministry of Health and Welfare Taiwan ROC, 2014, NATL HLTH INSURANCE; Nezos A, 2015, J AUTOIMMUN, V63, P47, DOI 10.1016/j.jaut.2015.07.002; Olate S, 2014, INT J CLIN EXP MED, V7, P1140; Peri Y, 2012, BEST PRACT RES CL RH, V26, P105, DOI 10.1016/j.berh.2012.01.012; Root-Bernstein R, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0407-3; Sandhya P, 2016, CURRENT RHEUMATOLOGY; Shoda H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22486; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wallace RJ, 1997, AM J RESP CRIT CARE, V156, pS1, DOI 10.1164/ajrccm.156.2.atsstatement	35	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176549	10.1371/journal.pone.0176549	http://dx.doi.org/10.1371/journal.pone.0176549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486537	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314000015
J	Vejrikova, I; Eloranta, AP; Vejrik, L; Smejkal, M; Cech, M; Sajdlova, Z; Frouzova, J; Kiljunen, M; Peterka, J				Vejrikova, Ivana; Eloranta, Anttl P.; Vejrik, Lukas; Smejkal, Marek; Cech, Martin; sajdlova, Zuzana; Frouzova, Jaroslava; Kiljunen, Mikko; Peterka, Jlri			Macrophytes shape trophic niche variation among generalist fishes	PLOS ONE			English	Article							ROACH RUTILUS-RUTILUS; PERCH PERCA-FLUVIATILIS; SCARDINIUS-ERYTHROPHTHALMUS; STABLE-ISOTOPES; INDIVIDUAL SPECIALIZATION; STRUCTURAL COMPLEXITY; POPULATION-DYNAMICS; COMMUNITY STRUCTURE; PISCIVOROUS PERCH; PREY REFUGES	Generalist species commonly have a fundamental role in ecosystems as they can integrate spatially distinct habitats and food-web compartments, as well as control the composition, abundance and behavior of organisms at different trophic levels. Generalist populations typically consist of specialized individuals, but the potential for and hence degree of individual niche variation can be largely determined by habitat complexity. We compared individual niche variation within three generalist fishes between two comparable lakes in the Czech Republic differing in macrophyte cover, i.e. macrophyte-rich Milada and macrophyte-poor Most. We tested the hypothesis that large individual niche variation among generalist fishes is facilitated by the presence of macrophytes,which provides niches and predation shelter for fish and their prey items. Based on results from stable nitrogen (delta N-15) and carbon (delta C-13) isotopic mixing models, perch (Perca fluviatilis L.) and rudd (Scardinius erythrophthalmus (L.)) showed larger individual variation (i.e., variance) in trophic position in Milada as compared to Most, whereas no significant between-lake differences were observed for roach (Rutilus rutilus (L.)). Contrary to our hypothesis, all the three species showed significantly lower individual variation in the relative reliance on littoral food resources in Milada than in Most. Rudd relied significantly more whereas perch and roach relied less on littoral food resources in Milada than in Most, likely due to prevalent herbivory by rudd and prevalent zooplanktivory by perch and roach in the macrophyte-rich Milada as compared to macrophyte-poor Most. Our study demonstrates how the succession of macrophyte vegetation, via its effects on the physical and biological complexity of the littoral zone and on the availability of small prey fish and zooplankton, can strongly influence individual niche variation among generalist fishes with different ontogenetic trajectories, and hence the overall foodweb structures in lake ecosystems.	[Vejrikova, Ivana; Vejrik, Lukas; Smejkal, Marek; Cech, Martin; sajdlova, Zuzana; Frouzova, Jaroslava; Peterka, Jlri] Czech Acad Sci, Biol Ctr, Inst Hydrobiol, Sadkach 7, Ceske Budejovice, Czech Republic; [Vejrikova, Ivana] Univ South Bohemia Ceske Budejovice, Fac Sci, Branisovska 31, Ceske Budejovice, Czech Republic; [Eloranta, Anttl P.] Norwegian Inst Nat Res, Trondheim, Norway; [Kiljunen, Mikko] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Norwegian Institute Nature Research; University of Jyvaskyla	Peterka, J (corresponding author), Czech Acad Sci, Biol Ctr, Inst Hydrobiol, Sadkach 7, Ceske Budejovice, Czech Republic.	j.peterka@yahoo.com	Frouzova, Jaroslava/F-8518-2014; Peterka, Jiří/C-7218-2014; Vejřík, Lukáš/E-1607-2017; Eloranta, Antti Pekka/AAA-1426-2020; Šmejkal, Marek/E-1269-2017; Sajdlova, Zuzana/R-1383-2018; Vejříková, Ivana/E-1624-2017; Čech, Martin/C-5797-2014	Frouzova, Jaroslava/0000-0003-4876-4985; Vejřík, Lukáš/0000-0001-8911-9128; Šmejkal, Marek/0000-0002-7887-6411; Vejříková, Ivana/0000-0001-9113-2815; Čech, Martin/0000-0003-1350-4286; Eloranta, Antti/0000-0002-8893-0135	(CEKOPOT) of the Ministry of Education, Youth and Sports [CZ.1.07/2.3.00/20.0204]; Norwegian Financial Mechanism [7F14316, MSMT-28477/2014, LM2015075]; (SoWa Research Infrastructure) of the programme "Projects of Large Infrastructure for Research, Development, and Innovations" of the Ministry of Education, Youth and Sports from University of South Bohemia [158/2016/P]	(CEKOPOT) of the Ministry of Education, Youth and Sports; Norwegian Financial Mechanism; (SoWa Research Infrastructure) of the programme "Projects of Large Infrastructure for Research, Development, and Innovations" of the Ministry of Education, Youth and Sports from University of South Bohemia	The study was supported by projects No. CZ.1.07/2.3.00/20.0204 (CEKOPOT) of the Ministry of Education, Youth and Sports, No. 7F14316 of the Norwegian Financial Mechanism 2009-2014 under contract number MSMT-28477/2014, No. LM2015075 (SoWa Research Infrastructure) of the programme "Projects of Large Infrastructure for Research, Development, and Innovations" of the Ministry of Education, Youth and Sports, and No.158/2016/P from University of South Bohemia.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Blabolil P, 2016, FISH RES, V173, P80, DOI 10.1016/j.fishres.2015.05.022; Bode A, 2006, MAR ECOL PROG SER, V318, P89, DOI 10.3354/meps318089; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; Castanheira MF, PLOS ONE, V8; CEN, 2015, EN14757; Craig FG, 2000, PERCID FISHES SYSTEM; DENNISON WC, 1993, BIOSCIENCE, V43, P86, DOI 10.2307/1311969; DIEHL S, 1988, OIKOS, V53, P207, DOI 10.2307/3566064; DIEHL S, 1992, ECOLOGY, V73, P1646, DOI 10.2307/1940017; Duncan A., 1993, COMP RESERVOIR LIMNO, P153; Estlander S, 2010, J FISH BIOL, V77, P241, DOI 10.1111/j.1095-8649.2010.02682.x; Feyrer F, 2003, ENVIRON BIOL FISH, V67, P277, DOI 10.1023/A:1025839132274; FRANCE R, 1995, CAN J FISH AQUAT SCI, V52, P651, DOI 10.1139/f95-065; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Gerking SD., 2014, FEEDING ECOLOGY FISH; Grenouillet G, 2001, J FISH BIOL, V59, P939; Hargeby A, 2005, FRESHWATER BIOL, V50, P2053, DOI 10.1111/j.1365-2427.2005.01446.x; Hayden B, 2015, FRESHWATER BIOL, V60, P1000, DOI 10.1111/fwb.12564; Horppila J, 2009, J FISH BIOL, V75, P1230, DOI 10.1111/j.1095-8649.2009.02359.x; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jarolim O, 2010, HYDROBIOLOGIA, V654, P253, DOI 10.1007/s10750-010-0398-1; Jeppesen E, 2000, FRESHWATER BIOL, V45, P201, DOI 10.1046/j.1365-2427.2000.00675.x; Jeppesen E., 1992, STRUCTURING ROLE SUB; Kapuscinski KL, 2012, HYDROBIOLOGIA, V693, P169, DOI 10.1007/s10750-012-1106-0; Kratina P, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00121.1; Lacoul P, 2006, ENVIRON REV, V14, P89, DOI 10.1139/a06-001; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; LODGE DM, 1991, AQUAT BOT, V41, P195, DOI 10.1016/0304-3770(91)90044-6; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; McMeans BC, 2016, ECOL MONOGR, V86, P4, DOI 10.1890/15-0288.1; Mittelbach GG, 2014, CAN J FISH AQUAT SCI, V71, P927, DOI 10.1139/cjfas-2013-0558; NEWMAN RM, 1991, J N AM BENTHOL SOC, V10, P89, DOI 10.2307/1467571; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Olin M, 2002, J FISH BIOL, V60, P593, DOI 10.1006/jfbi.2002.1876; Persson A, 1999, CAN J FISH AQUAT SCI, V56, P70, DOI 10.1139/cjfas-56-1-70; Persson L, 2000, ECOLOGY, V81, P1058; PERSSON L, 1990, ECOLOGY, V71, P44, DOI 10.2307/1940246; Persson L., 1988, P203; PERSSON L, 1995, ECOLOGY, V76, P70, DOI 10.2307/1940632; PERSSON L, 1991, J FISH BIOL, V38, P281, DOI 10.1111/j.1095-8649.1991.tb03114.x; PERSSON L, 1991, BEHAV ECOL SOCIOBIOL, V28, P101; PERSSON L, 1993, OIKOS, V68, P12, DOI 10.2307/3545304; PERSSON L, 1987, ENVIRON BIOL FISH, V19, P235, DOI 10.1007/BF00005353; PIMM SL, 1978, NATURE, V275, P542, DOI 10.1038/275542a0; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; PREJS A, 1978, EKOL POL-POL J ECOL, V26, P429; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; Schindler DE, 2002, OIKOS, V98, P177, DOI 10.1034/j.1600-0706.2002.980201.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; SCHRIVER P, 1995, FRESHWATER BIOL, V33, P255, DOI 10.1111/j.1365-2427.1995.tb01166.x; Specziar A, 2009, J FISH BIOL, V75, P247, DOI 10.1111/j.1095-8649.2009.02283.x; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Takimoto G, 2013, ECOL RES, V28, P675, DOI 10.1007/s11284-012-0943-7; Vasek M, 2004, INT REV HYDROBIOL, V89, P352, DOI 10.1002/iroh.200410734; Vasek M, 2008, FOLIA ZOOL, V57, P324; Vasek M, 2006, INT REV HYDROBIOL, V91, P178, DOI 10.1002/iroh.200510835; Vejrik L, 2016, FRESHWATER BIOL, V61, P899, DOI 10.1111/fwb.12753; Vejrikova I, 2016, SCI REP-UK, V6, DOI 10.1038/srep39600; Warfe DM, 2006, OECOLOGIA, V150, P141, DOI 10.1007/s00442-006-0505-1; WINFIELD IJ, 1986, J FISH BIOL, V29, P37, DOI 10.1111/j.1095-8649.1986.tb04997.x	68	15	17	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177114	10.1371/journal.pone.0177114	http://dx.doi.org/10.1371/journal.pone.0177114			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486550	Green Accepted, Green Published, gold			2022-12-27	WOS:000401314000046
J	Gutierrez-Camino, A; Martin-Guerrero, I; de Andoin, NG; Sastre, A; Baneres, AC; Astigarraga, I; Navajas, A; Garcia-Orad, A				Gutierrez-Camino, Angela; Martin-Guerrero, Idoia; Garcia de Andoin, Nagore; Sastre, Ana; Carbone Baneres, Ana; Astigarraga, Itziar; Navajas, Aurora; Garcia-Orad, Africa			Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population	PLOS ONE			English	Article							CHILDHOOD; RISK; 10Q21.2; 7P12.2; 14Q11.2; ARID5B; LOCI; CEBPE	The locus CDKN2A/B (9p21.3), which comprises the tumor suppressors genes CDKN2A and CDKN2B and the long noncoding RNA (lncRNA) known as ANRIL (or CDKN2B-AS), was associated with childhood acute lymphoblastic leukemia (ALL) susceptibility in several genome wide association studies (GWAS). However, the variants associated in the diverse studies were different. Recently, new and independent SNPs deregulating the locus function were also identified in association with ALL risk. This diversity in the results may be explained because different variants in each population could alter CDKN2A/B locus function through diverse mechanisms. Therefore, the aim of this study was to determine whether the annotated risk variants in the CDKN2A/B locus affect the susceptibility of B cell precursor ALL (B-ALL) in our Spanish population and explore if other SNPs altering additional regulatory mechanisms could be also involved. We analyzed the four SNPs proposed by GWAs and two additional SNPs in miRNA binding sites in 217 pediatric patients with B-ALL and 330 healthy controls. The SNPs rs2811712, rs3731249, rs3217992 and rs2811709 were associated with B-ALL susceptibility in our Spanish population. ALL subtypes analyses showed that rs2811712 was associated with B-hyperdiploid ALL. These results provide evidence for the influence of genetic variants at CDKN2A/B locus with the risk of developing BALL.	[Gutierrez-Camino, Angela; Martin-Guerrero, Idoia; Garcia-Orad, Africa] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, UPV EHU, Leioa, Spain; [Garcia de Andoin, Nagore] Univ Hosp Donostia, Dept Pediat, San Sebastian, Spain; [Garcia de Andoin, Nagore] BioDonostia Hlth Res Inst, San Sebastian, Spain; [Sastre, Ana] Univ Hosp La Paz, Dept Oncohematol, Madrid, Spain; [Carbone Baneres, Ana] Univ Hosp Miguel Servet, Dept Pediat, Zaragoza, Spain; [Astigarraga, Itziar] Univ Hosp Cruces, Dept Pediat, Baracaldo, Spain; [Astigarraga, Itziar; Navajas, Aurora; Garcia-Orad, Africa] BioCruces Hlth Res Inst, Baracaldo, Spain	University of Basque Country; University Hospital Donostia; Instituto de Investigacion Sanitaria Biodonostia; Hospital Universitario La Paz; Miguel Servet University Hospital; Hospital Universitario Cruces	Garcia-Orad, A (corresponding author), Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, UPV EHU, Leioa, Spain.; Garcia-Orad, A (corresponding author), BioCruces Hlth Res Inst, Baracaldo, Spain.	africa.garciaorad@ehu.eus	Gutierrez-Camino, Angela/AAM-2032-2020; Astigarraga, I/I-1215-2014; Martin-Guerrero, Idoia/AAF-3446-2020	Gutierrez-Camino, Angela/0000-0002-8679-6868; Astigarraga, I/0000-0002-5012-0137; Garcia.Orad, Africa/0000-0002-5575-3080; Martin-Guerrero, Idoia/0000-0002-0098-1908	Basque Government [IT661-13, IT989-16]; UPV/EHU [UFI11/35]; pre-doctoral grant from the Basque Government	Basque Government(Basque Government); UPV/EHU; pre-doctoral grant from the Basque Government	This study was funded by the Basque Government (IT661-13, IT989-16), UPV/EHU (UFI11/35). AGC was supported by a pre-doctoral grant from the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 1995, J ROYAL STAT; Boon RA, 2016, J AM COLL CARDIOL, V67, P1214, DOI 10.1016/j.jacc.2015.12.051; Chokkalingam AP, 2013, CANCER CAUSE CONTROL, V24, P1789, DOI 10.1007/s10552-013-0256-3; Gong J, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav029; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Gutierrez-Camino A, 2013, J CANCER RES CLIN, V139, P1879, DOI 10.1007/s00432-013-1512-3; Hungate EA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10635; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lopez-Lopez E, 2013, JNCI-J NATL CANCER I, V105, P1512, DOI 10.1093/jnci/djt229; Meseure D, 2016, MOL CANC RES; Migliorini G, 2013, BLOOD, V122, P3298, DOI 10.1182/blood-2013-03-491316; Orsi L, 2012, LEUKEMIA, V26, P2561, DOI 10.1038/leu.2012.148; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Pastorczak A, 2011, LEUKEMIA RES, V35, P1534, DOI 10.1016/j.leukres.2011.07.034; Prasad RB, 2010, BLOOD, V115, P1765, DOI 10.1182/blood-2009-09-241513; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Sambrook J, 2001, PREPARATION ANAL EUK, V1, P4; Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585; Sullivan KM, 2009, PUBLIC HEALTH REP, V124, P471, DOI 10.1177/003335490912400320; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Vijayakrishnan J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15065; Vijayakrishnan J, 2010, LEUKEMIA LYMPHOMA, V51, P1870, DOI 10.3109/10428194.2010.511356; Walsh KM, 2015, CANCER RES, V75, P4884, DOI 10.1158/0008-5472.CAN-15-1105; Xu H, 2013, J NATL CANC I; Xu H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8553	26	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177421	10.1371/journal.pone.0177421	http://dx.doi.org/10.1371/journal.pone.0177421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481918	gold, Green Published, Green Submitted			2022-12-27	WOS:000401313700061
J	Lee, KH				Lee, Kyun Ho			Numerical comparison of exhaust plume flow behaviors of small monopropellant and bipropellant thrusters	PLOS ONE			English	Article							MONTE-CARLO; SIMULATION	In general, a space propulsion system has a crucial role in the normal mission operations of a spacecraft. Depending on the types and number of propellants, a monopropellant and a bipropellant thrusters are mostly utilized for low thrust liquid rocket engines. As the plume gas flow exhausted from these small thrusters expands freely in a vacuum space environment along all directions, adverse effects of the plume impingement onto the spacecraft surfaces can dramatically reduce the function and performance of a spacecraft. Thus, the purpose of the present study is to investigate and compare the major differences of the plume gas flow behaviors numerically between the small monopropellant and bipropellant thrusters. To ensure efficient numerical calculations, the whole physical domain was divided into three different subdomains depending on the flow conditions, and then the appropriate numerical methods were combined and applied for each subdomain sequentially. With the present analysis results, the plume gas behaviors including the density, the overall temperature and the separation of the chemical species are compared and discussed between the monopropellant and the bipropellant thrusters. Consequently, the present results are expected to provide useful information on selecting the appropriate propulsion system, which can be very helpful for actual engineers practically during the design process.	[Lee, Kyun Ho] Sejong Univ, Dept Aerosp Engn, Seoul, South Korea	Sejong University	Lee, KH (corresponding author), Sejong Univ, Dept Aerosp Engn, Seoul, South Korea.	khlee0406@sejong.ac.kr		Lee, Kyun Ho/0000-0002-0703-1323	Space Core Technology Development Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MSIP) [NRF-2013M1A3A3A02042426]	Space Core Technology Development Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MSIP)	This research is supported by the Space Core Technology Development Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (MSIP) (NRF-2013M1A3A3A02042426). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerojet Rocketdyne, 2016, MON ROCK ENG; Airbus Safran Launchers GmbH, 2016, 4 N BIPR THRUST; Amri R, 2011, ACTA ASTRONAUT, V69, P485, DOI 10.1016/j.actaastro.2011.05.008; Bird GA, 1992, MOL GAS DYNAMICS DIR; BORGNAKKE C, 1975, J COMPUT PHYS, V18, P405, DOI 10.1016/0021-9991(75)90094-7; BOYD ID, 1990, J PROPUL POWER, V6, P121, DOI 10.2514/3.23232; CHUNG CH, 1995, J PROPUL POWER, V11, P64, DOI 10.2514/3.23841; Dettleff G., 1991, PROG AEROSP SCI, V28, P1, DOI [10.1016/0376-0421(91)90008-R, DOI 10.1016/0376-0421(91)90008-R]; Furlani TR, 1989, 24 THERM C FLUID DYN; Grabe M, 2014, SPAC PROP C 2014 COL; Grabe M, 2008, 16 STAB DGLR S AACH; Jang YH, 2016, J KOREAN SOC AERONA, V44, P333, DOI 10.5139/JKSAS.2016.44.4.333; Lee KH, 2009, T JPN SOC AERONAUT S, V52, P135, DOI 10.2322/tjsass.52.135; LEGGE H, 1986, J SPACECRAFT ROCKETS, V23, P357, DOI 10.2514/3.25812; McBride B.J., 1996, COMPUTER PROGRAM CAL; Shershnev A, 2015, MICROFLUID NANOFLUID, V19, P105, DOI 10.1007/s10404-015-1553-9; Tang ZY, 2014, INT J NUMER METH FL, V76, P95, DOI 10.1002/fld.3924; Trinks H, 1983, 18 THERM C FLUID DYN; Wu J, 2016, VACUUM, V128, P166, DOI 10.1016/j.vacuum.2016.03.020; Yan F., 2003, THESIS	20	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176423	10.1371/journal.pone.0176423	http://dx.doi.org/10.1371/journal.pone.0176423			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481892	Green Published, Green Submitted, gold			2022-12-27	WOS:000401313700010
J	Carballo, A; Murillo, R; Jakubowska, A; Herrero, S; Williams, T; Caballero, P				Carballo, Arkaitz; Murillo, Rosa; Jakubowska, Agata; Herrero, Salvador; Williams, Trevor; Caballero, Primitivo			Co-infection with iflaviruses influences the insecticidal properties of Spodoptera exigua multiple nucleopolyhedrovirus occlusion bodies: Implications for the production and biosecurity of baculovirus insecticides	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; PICORNA-LIKE VIRUS; LEPIDOPTERA-NOCTUIDAE; GENOME SEQUENCE; RNA VIRUS; MICRORNAS; SUSCEPTIBILITY; INFECTIONS; DIVERSITY; INCREASES	Biological insecticides based on Spodoptera exigua multiple nucleopolyhedrovirus (SeMNPV) can efficiently control S. exigua larvae on field and greenhouse crops in many parts of the world. Spanish wild populations and laboratory colonies of S. exigua are infected by two iflaviruses (SeIV-1 and SeIV-2). Here we evaluated the effect of iflavirus co-infection on the insecticidal characteristics of SeMNPV occlusion bodies (OBs). Overall, iflavirus co-inoculation consistently reduced median lethal concentrations (LC50) for SeMNPV OBs compared to larvae infected with SeMNPV alone. However, the speed of kill of SeMNPV was similar in the presence or absence of the iflaviruses. A reduction of the weight gain (27%) associated with iflavirus infection resulted in a 30% reduction in total OB production per larva. Adult survivors of SeMNPV OB inoculation were examined for covert infection. SeMNPV DNA was found to be present at a high prevalence in all SeIV-1 and SeIV-2 co-infection treatments. Interestingly, co-inoculation of SeMNPV with SeIV-2 alone or in mixtures with SeIV-1 resulted in a significant increase in the SeMNPV load of sublethally infected adults, suggesting a role for SeIV-2 in vertical transmission or reactivation of sublethal SeMNPV infections. In conclusion, iflaviruses are not desirable in insect colonies used for large scale baculovirus production, as they may result in diminished larval growth, reduced OB production and, depending on their host-range, potential risks to non-target Lepidoptera.	[Carballo, Arkaitz; Murillo, Rosa; Caballero, Primitivo] CSIC Gobierno Navarra, Inst Agrobiotecnol, Navarra, Spain; [Carballo, Arkaitz; Murillo, Rosa; Caballero, Primitivo] Univ Publ Navarra, Dept Prod Agr, Navarra, Spain; [Jakubowska, Agata; Herrero, Salvador] Univ Valencia, Dept Genet, Valencia, Spain; [Williams, Trevor] Inst Ecol AC, Xalapa, Veracruz, Mexico	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; University of Valencia; Instituto de Ecologia - Mexico	Caballero, P (corresponding author), CSIC Gobierno Navarra, Inst Agrobiotecnol, Navarra, Spain.; Caballero, P (corresponding author), Univ Publ Navarra, Dept Prod Agr, Navarra, Spain.; Williams, T (corresponding author), Inst Ecol AC, Xalapa, Veracruz, Mexico.	trevor.inecol@gmail.com; pcm92@unavarra.es	Caballero, Primitivo/D-5063-2009; Williams, Trevor/ABG-3961-2020; Herrero, Salvador/J-5767-2013; Williams, Trevor/F-1447-2011; Herrero, Salva/ABE-5123-2020; Murillo, Rosa/G-5506-2010	Caballero, Primitivo/0000-0003-0065-9625; Herrero, Salvador/0000-0001-5690-2108; Williams, Trevor/0000-0003-3414-3440; Herrero, Salva/0000-0001-5690-2108; Murillo, Rosa/0000-0001-9535-0000	Spanish Ministerio de Cienciae Innovacion [AGL2011-30352-C02-01]; Ministerio de Economoia y Competitividad	Spanish Ministerio de Cienciae Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economoia y Competitividad	This study was funded by the Spanish Ministerio de Cienciae Innovacion, project number AGL2011-30352-C02-01. AC received a student scholarship from the Ministerio de Economoia y Competitividad.	Asgari S, 2015, CURR OPIN INSECT SCI, V8, P104, DOI 10.1016/j.cois.2014.12.008; Berenyi O, 2006, APPL ENVIRON MICROB, V72, P2414, DOI 10.1128/AEM.72.4.2414-2420.2006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caballero P., 1992, Biocontrol Science and Technology, V2, P35, DOI 10.1080/09583159209355215; Caballero P, 2009, REV COLOMB ENTOMOL, V35, P105; CABI, 2016, CROP PROT COMP INT; Cabodevilla O, 2011, BIOL CONTROL, V56, P184, DOI 10.1016/j.biocontrol.2010.10.007; Chen YP, 2012, INSECT PATHOLOGY, 2ND EDITION, P133, DOI 10.1016/B978-0-12-384984-7.00005-1; Choi JY, 2012, J ASIA-PAC ENTOMOL, V15, P259, DOI 10.1016/j.aspen.2012.01.006; Cory JS, 2003, ANNU REV ECOL EVOL S, V34, P239, DOI 10.1146/annurev.ecolsys.34.011802.132402; Crawley M.J., 1993, GLIM ECOLOGISTS; Eberle KE, 2012, INTEGRATED PEST MANAGEMENT, P281, DOI 10.1079/9781845938086.0281; Eilenberg J, 2015, J INSECTS FOOD FEED, V1, P87, DOI 10.3920/JIFF2014.0022; Elvira S, 2010, J ECON ENTOMOL, V103, P17, DOI 10.1603/EC09246; Farrar RR, 1998, ENVIRON ENTOMOL, V27, P1289, DOI 10.1093/ee/27.6.1289; Francis B, 1993, NUMERICAL ALGORITHMS; Fuxa JR, 2001, APPL ENVIRON MICROB, V67, P5166, DOI 10.1128/AEM.67.11.5166-5170.2001; Geng P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092107; Graham RI, 2012, ECOL LETT, V15, P993, DOI 10.1111/j.1461-0248.2012.01820.x; HIMENO M, 1974, J INVERTEBR PATHOL, V23, P164, DOI 10.1016/0022-2011(74)90180-3; HUGHES PR, 1981, J INVERTEBR PATHOL, V37, P154, DOI 10.1016/0022-2011(81)90069-0; Hussain M, 2014, J INSECT PHYSIOL, V70, P151, DOI 10.1016/j.jinsphys.2014.08.003; Ikeda M, 2013, VIROLOGY, V435, P1, DOI 10.1016/j.virol.2012.10.016; Jakubowska AK, 2016, PEERJ, V4, DOI 10.7717/peerj.1687; Jakubowska AK, 2014, J INVERTEBR PATHOL, V121, P56, DOI 10.1016/j.jip.2014.06.009; Jakubowska AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003379; Junglen S, 2013, CURR OPIN MICROBIOL, V16, P507, DOI 10.1016/j.mib.2013.06.005; Kariithi Henry M, 2013, Insects, V4, P287, DOI 10.3390/insects4030287; Kaya, 1993, INSECT PATHOLOGY; Kemp EM, 2011, J INVERTEBR PATHOL, V107, P202, DOI 10.1016/j.jip.2011.05.015; Lacey LA, 2015, J INVERTEBR PATHOL, V132, P1, DOI 10.1016/j.jip.2015.07.009; Magholli Z, 2013, J PLANT DIS PROTECT, V120, P173, DOI 10.1007/BF03356471; Mehrabadi M, 2015, J VIROL, V89, P8182, DOI 10.1128/JVI.00802-15; Millan-Leiva A, 2012, J INVERTEBR PATHOL, V109, P127, DOI 10.1016/j.jip.2011.10.009; Mordecai GJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34983; Moscardi F, 2011, MICROBES AND MICROBIAL TECHNOLOGY: AGRICULTURAL AND ENVIRONMENTAL APPLICATIONS, P415, DOI 10.1007/978-1-4419-7931-5_16; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167; Singh J, 2010, VIROLOGY, V407, P120, DOI 10.1016/j.virol.2010.07.033; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; SMITS PH, 1987, ENTOMOL EXP APPL, V43, P73, DOI 10.1007/BF00350378; Sundararajan K. T., 2012, P IEEE INT S HIGH PE, P1; Szelei J, 2011, J INVERTEBR PATHOL, V106, P394, DOI 10.1016/j.jip.2010.12.009; Tapparel C, 2013, INFECT GENET EVOL, V14, P282, DOI 10.1016/j.meegid.2012.10.016; VAIL PV, 1983, J INVERTEBR PATHOL, V41, P179, DOI 10.1016/0022-2011(83)90217-3; VAIL PV, 1983, J INVERTEBR PATHOL, V41, P171, DOI 10.1016/0022-2011(83)90216-1; van Oers MM, 2010, INSECT VIROLOGY, P231; Vilaplana L, 2010, EVOL ECOL, V24, P147, DOI 10.1007/s10682-009-9296-2; Virto C, 2017, J APPL ENTOMOL; Virto C, 2014, J INVERTEBR PATHOL, V122, P22, DOI 10.1016/j.jip.2014.07.007; Virto C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070932; Wang CH, 1999, J INVERTEBR PATHOL, V74, P62, DOI 10.1006/jipa.1999.4842; Wu P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165865; Xu PJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004490; Yuan H, 2017, J INVERTEBR PATHOL, V144, P65, DOI 10.1016/j.jip.2017.01.011; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0; Zheng XL, 2011, J ENTOMOL RES SOC, V13, P39	57	22	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177301	10.1371/journal.pone.0177301	http://dx.doi.org/10.1371/journal.pone.0177301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475633	Green Published, gold			2022-12-27	WOS:000400649500062
J	James, S; Bell, OA; Nazli, MAM; Pearce, RE; Spencer, J; Tyrrell, K; Paine, PJ; Heaton, TJ; Anderson, S; Da Lio, M; Gurney, K				James, Sebastian; Bell, Olivia A.; Nazli, Muhammed A. M.; Pearce, Rachel E.; Spencer, Jonathan; Tyrrell, Katie; Paine, Phillip J.; Heaton, Timothy J.; Anderson, Sean; Da Lio, Mauro; Gurney, Kevin			Target-distractor synchrony affects performance in a novel motor task for studying action selection	PLOS ONE			English	Article							OPTIMAL DECISION-MAKING; EYE-HAND COORDINATION; BASAL GANGLIA; VISUAL-SEARCH; SUPERIOR COLLICULUS; CORTICAL MECHANISMS; NEURONAL-ACTIVITY; ARM MOVEMENTS; TRACKING; CORTEX	The study of action selection in humans can present challenges of task design since our actions are usually defined by many degrees of freedom and therefore occupy a large action-space. While saccadic eye-movement offers a more constrained paradigm for investigating action selection, the study of reach-and-grasp in upper limbs has often been defined by more complex scenarios, not easily interpretable in terms of such selection. Here we present a novel motor behaviour task which addresses this by limiting the action space to a single degree of freedom in which subjects have to track (using a stylus) a vertical coloured target line displayed on a tablet computer, whilst ignoring a similarly oriented distractor line in a different colour. We ran this task with 55 subjects and showed that, in agreement with previous studies, the presence of the distractor generally increases the movement latency and directional error rate. Further, we used two distractor conditions according to whether the distractor's location changes asynchronously or synchronously with the location of the target. We found that the asynchronous distractor yielded poorer performance than its synchronous counterpart, with significantly higher movement latencies and higher error rates. We interpret these results in an action selection framework with two actions (move left or right) and competing 'action requests' offered by the target and distractor. As such, the results provide insights into action selection performance in humans and supply data for directly constraining future computational models therein.	[James, Sebastian; Bell, Olivia A.; Nazli, Muhammed A. M.; Pearce, Rachel E.; Spencer, Jonathan; Tyrrell, Katie; Gurney, Kevin] Univ Sheffield, Dept Psychol, Adapt Behav Res Grp, Sheffield, S Yorkshire, England; [James, Sebastian; Anderson, Sean; Gurney, Kevin] Univ Sheffield, Insigne Inst Insilico Med, Sheffield, S Yorkshire, England; [Anderson, Sean] Univ Sheffield, Dept Automat Control Syst Engn, Sheffield, S Yorkshire, England; [Da Lio, Mauro] Univ Trento, Dept Ind Engn, Trento, Italy; [Paine, Phillip J.; Heaton, Timothy J.] Univ Sheffield, Sch Math & Stat, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Trento; University of Sheffield	Gurney, K (corresponding author), Univ Sheffield, Dept Psychol, Adapt Behav Res Grp, Sheffield, S Yorkshire, England.; Gurney, K (corresponding author), Univ Sheffield, Insigne Inst Insilico Med, Sheffield, S Yorkshire, England.	k.gurney@sheffield.ac.uk	Heaton, Timothy J/AFJ-8295-2022; Heaton, Tim/AAF-5132-2022; James, Sebastian/B-2932-2019	Heaton, Timothy J/0000-0002-9994-142X; James, Sebastian/0000-0003-0208-0588; Anderson, Sean/0000-0002-7452-5681; Da Lio, Mauro/0000-0002-6619-9484; Tyrrell, Katie/0000-0002-3333-415X	EC FP7 project NoTremor-Virtual, Physiological and Computational Neuromuscular Models for the Predictive Treatment of Parkinson's Disease [610391]	EC FP7 project NoTremor-Virtual, Physiological and Computational Neuromuscular Models for the Predictive Treatment of Parkinson's Disease	This work was partially funded by the EC FP7 project NoTremor-Virtual, Physiological and Computational Neuromuscular Models for the Predictive Treatment of Parkinson's Disease, Grant Agreement No. 610391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially funded by the EC FP7 project NoTremor-Virtual, Physiological and Computational Neuromuscular Models for the Predictive Treatment of Parkinson's Disease, Grant Agreement No. 610391.	Antoniades C, 2013, VISION RES, V84, P1, DOI 10.1016/j.visres.2013.02.007; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; BIGUER B, 1982, EXP BRAIN RES, V46, P301; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bompas A, 2011, J NEUROSCI, V31, P12501, DOI 10.1523/JNEUROSCI.2234-11.2011; Carey DP, 2000, CURR BIOL, V10, pR416, DOI 10.1016/S0960-9822(00)00508-X; Carpenter RHS, 2004, CURR BIOL, V14, P1576, DOI 10.1016/j.cub.2004.08.058; Castiello U, 1999, TRENDS COGN SCI, V3, P264, DOI 10.1016/S1364-6613(99)01346-7; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Da Lio M, NOTREMOR D LINE TRAC; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Elsner B, 2001, J EXP PSYCHOL HUMAN, V27, P229, DOI 10.1037/0096-1523.27.1.229; FISK JD, 1985, EXP BRAIN RES, V60, P159; FORTIER PA, 1989, J NEUROPHYSIOL, V62, P198, DOI 10.1152/jn.1989.62.1.198; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gibson J.J., 1986, ECOLOGICAL APPROACH; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Gribble PL, 2002, EXP BRAIN RES, V145, P372, DOI 10.1007/s00221-002-1122-9; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Gurney K, 2001, BIOL CYBERN, V84, P411, DOI 10.1007/PL00007985; HALLETT M, 1975, J NEUROL NEUROSUR PS, V38, P1154, DOI 10.1136/jnnp.38.12.1154; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Haruno M, 2005, J NEUROPHYSIOL, V94, P4244, DOI 10.1152/jn.00404.2005; HIRSCH J, 1989, VISION RES, V29, P1095, DOI 10.1016/0042-6989(89)90058-8; Hocherman S, 2004, COGNITIVE BRAIN RES, V21, P77, DOI 10.1016/j.cogbrainres.2004.05.008; HOFFMAN DS, 1986, J NEUROSCI, V6, P3309; Houghton G, 1996, VIS COGN, V3, P119, DOI 10.1080/713756733; Houghton George, 1994, P53; Houk JC, 2007, PHILOS T R SOC B, V362, P1573, DOI 10.1098/rstb.2007.2063; Howard LA, 1997, EXP BRAIN RES, V113, P144, DOI 10.1007/BF02454150; Humphries MD, 2002, NETWORK-COMP NEURAL, V13, P131, DOI 10.1088/0954-898X/13/1/305; Iglewicz B., 1993, DETECT HANDLE OUTLIE, V16, P1; JACKSON SR, 1995, EXP BRAIN RES, V102, P519; Jax SA, 2007, J EXP PSYCHOL HUMAN, V33, P425, DOI 10.1037/0096-1523.33.2.425; JONAS JB, 1992, GRAEF ARCH CLIN EXP, V230, P505, DOI 10.1007/BF00181769; KALASKA JF, 1983, EXP BRAIN RES, V51, P247; Maes P., 1990, Robotics and Autonomous Systems, V6, P49, DOI 10.1016/S0921-8890(05)80028-4; Maes P., 1989, DYNAMICS ACTION SELE; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; Meegan DV, 1999, J EXP PSYCHOL HUMAN, V25, P1347, DOI 10.1037/0096-1523.25.5.1347; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Moschovakis AK, 1996, PROG NEUROBIOL, V50, P133, DOI 10.1016/S0301-0082(96)00034-2; MOSCHOVAKIS AK, 1994, ANNU REV NEUROSCI, V17, P465; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Neggers SFW, 2001, J NEUROPHYSIOL, V86, P961, DOI 10.1152/jn.2001.86.2.961; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; PRABLANC C, 1979, BIOL CYBERN, V35, P113, DOI 10.1007/BF00337436; PRATT J, 1994, HUM MOVEMENT SCI, V13, P245, DOI 10.1016/0167-9457(94)90039-6; R Core Team, 2021, R LANGUAGE ENV STAT; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Reppert TR, 2015, J NEUROSCI, V35, P15369, DOI 10.1523/JNEUROSCI.2621-15.2015; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Roseberry TK, 2016, CELL, V164, P526, DOI 10.1016/j.cell.2015.12.037; SASLOW MG, 1967, J OPT SOC AM, V57, P1024, DOI 10.1364/JOSA.57.001024; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Snyder LH, 2002, J NEUROPHYSIOL, V87, P2279, DOI 10.1152/jn.00854.2001; Song JH, 2008, VISION RES, V48, P853, DOI 10.1016/j.visres.2007.12.015; Song JH, 2007, J VISION, V7, DOI 10.1167/7.5.2; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; TIPPER SP, 1992, J EXP PSYCHOL HUMAN, V18, P891, DOI 10.1037/0096-1523.18.4.891; Tipper SP, 1998, PHILOS T R SOC B, V353, P1385, DOI 10.1098/rstb.1998.0292; Tipper SP, 1997, VIS COGN, V4, P1, DOI 10.1080/713756749; Tipper SP, 2001, EXP BRAIN RES, V136, P241, DOI 10.1007/s002210000577; TRUMBO D, 1963, Percept Mot Skills, V16, P649; TRUMBO D, 1968, J EXP PSYCHOL, V77, P397, DOI 10.1037/h0025935; Waszak F, 2005, EXP BRAIN RES, V162, P346, DOI 10.1007/s00221-004-2183-8; WATERS P, 1981, BRAIN RES, V207, P189, DOI 10.1016/0006-8993(81)90692-2; Watson RW, 1997, MED BIOL ENG COMPUT, V35, P141, DOI 10.1007/BF02534145; Welsh TN, 2004, Q J EXP PSYCHOL-A, V57, P1031, DOI 10.1080/02724980343000666; ZARZECKI P, 1991, SOMATOSENS MOT RES, V8, P313, DOI 10.3109/08990229109144755	79	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176945	10.1371/journal.pone.0176945	http://dx.doi.org/10.1371/journal.pone.0176945			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475622	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000400649500030
J	Dzieciolowska, S; Drapeau, P; Armstrong, GAB				Dzieciolowska, Stefania; Drapeau, Pierre; Armstrong, Gary Alan Barclay			Augmented quantal release of acetylcholine at the vertebrate neuromuscular junction following tdp-43 depletion	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; WHITE MUSCLE-FIBERS; EMBRYONIC RED; MOTOR-NEURON; RNA TARGETS; IN-VIVO; ZEBRAFISH; ALS; DYSFUNCTION; MODEL	TAR DNA binding protein (TDP-43) is a 43 kD, predominately nuclear, protein involved in RNA metabolism. Of clinical significance is that the majority of amyotrophic lateral sclerosis (ALS) patients display abnormal accumulation of misfolded TDP-43 in the cytoplasm, which is coincident with a loss of nuclear localization in the afflicted regions of the central nervous system. Little is known about defects that arise in loss-of-function models, in particular synaptic defects that arise at the neuromuscular junction (NMJ). In this report, we examined abnormalities arising at the NMJ following depletion of tdp-43 using a previously characterized mutant tardbp (encoding tdp-43) zebrafish line containing a premature stop codon (Y220X) that results in an unstable and degraded protein. Homozygous tardbp(Y220X/Y220X) zebrafish do not produce tdp-43 but develop normally due to expression of an alternative splice variant of tardbpl (tardbp paralog). Using an antisense morpholino oligonucleotide to knockdown expression of the tardbpl in tardbp(Y220X/Y220X) embryos, we examined locomotor defects, NMJ structural abnormalities and release of quantal synaptic vesicles at the NMJ. As in previous reports, larvae depleted of tdp-43 display reduced survival, gross morphological defects and severely impaired locomotor activity. These larvae also displayed an increased number of orphaned pre- and postsynaptic NMJ markers but surprisingly, we observed a significant increase (3.5 times) in the frequency of quantal acetylcholine release at the NMJ in larvae depleted of tdp-43. These results indicate that reduced TDP-43 levels alter quantal vesicle release at the NMJ during vertebrate development and may be relevant for understanding synaptic dysfunction in ALS.	[Dzieciolowska, Stefania; Drapeau, Pierre; Armstrong, Gary Alan Barclay] CRCHUM, Montreal, PQ, Canada; [Dzieciolowska, Stefania; Drapeau, Pierre; Armstrong, Gary Alan Barclay] CRCHUM, Dept Neurosci, Montreal, PQ, Canada; [Dzieciolowska, Stefania] McGill Univ, Integrated Neurosci Program, Montreal, PQ, Canada; [Armstrong, Gary Alan Barclay] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University; McGill University	Armstrong, GAB (corresponding author), CRCHUM, Montreal, PQ, Canada.; Armstrong, GAB (corresponding author), CRCHUM, Dept Neurosci, Montreal, PQ, Canada.; Armstrong, GAB (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	gary.ab.armstrong@gmail.com		Armstrong, Gary/0000-0003-4613-8817	Weston Brain Institute, grant [RR130306]; Muscular Dystrophy Association, grant [351000]; Canadian Institutes of Health Research	Weston Brain Institute, grant; Muscular Dystrophy Association, grant(Muscular Dystrophy Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Weston Brain Institute, grant # RR130306 (http // westonbraininstitute.ca/) (GA); Muscular Dystrophy Association, grant #351000 (https:// www.mda.org/) (GA); Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (PD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KT, 2016, DEV NEUROBIOL, V76, P916, DOI 10.1002/dneu.22366; Armstrong GAB, 2013, J NEUROSCI, V33, P1741, DOI 10.1523/JNEUROSCI.4003-12.2013; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buss RR, 2002, J NEUROPHYSIOL, V87, P1244, DOI 10.1152/jn.00659.2001; Buss RR, 2000, J NEUROPHYSIOL, V84, P1545, DOI 10.1152/jn.2000.84.3.1545; Cui YW, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-42; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Frey D, 2000, J NEUROSCI, V20, P2534; Hewamadduma CAA, 2013, HUM MOL GENET, V22, P2376, DOI 10.1093/hmg/ddt082; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kleopa KA, 2004, GLIA, V47, P346, DOI 10.1002/glia.20043; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; McGown A, 2013, ANN NEUROL, V73, P246, DOI 10.1002/ana.23780; Moon Y, 2010, NEUROREPORT, V21, P1135, DOI 10.1097/WNR.0b013e32834051c7; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nguyen PV, 1999, J NEUROPHYSIOL, V81, P2852, DOI 10.1152/jn.1999.81.6.2852; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Schmid B, 2013, P NATL ACAD SCI USA, V110, P4986, DOI 10.1073/pnas.1218311110; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Walker AK, 2015, ACTA NEUROPATHOL, V130, P643, DOI 10.1007/s00401-015-1460-x; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584	28	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177005	10.1371/journal.pone.0177005	http://dx.doi.org/10.1371/journal.pone.0177005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472174	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500114
J	Fan, XG; Wu, HY; Li, GL; Yuan, H; Zhang, HC; Li, YJ; Xie, XX; Chen, N				Fan, Xiaoguang; Wu, Heyun; Li, Guoliang; Yuan, Hui; Zhang, Hongchao; Li, Yanjun; Xie, Xixian; Chen, Ning			Improvement of uridine production of Bacillus subtilis by atmospheric and room temperature plasma mutagenesis and high-throughput screening	PLOS ONE			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; PYR MESSENGER-RNA; TRANSCRIPTIONAL ATTENUATION; REGULATORY PROTEIN; ETHANOL-PRODUCTION; METABOLIC FLUXES; BINDING-SITE; WILD-TYPE; MUTANT; RESIDUES	In the present study, a novel breeding strategy of atmospheric and room temperature plasma (ARTP) mutagenesis was used to improve the uridine production of engineered Bacillus subtilis TD12np. A high-throughput screening method was established using both resistant plates and 96-well microplates to select the ideal mutants with diverse phenotypes. Mutant F126 accumulated 5.7 and 30.3 g/L uridine after 30 h in shake-flask and 48 h in fed-batch fermentation, respectively, which represented a 4.4- and 8.7-fold increase over the parent strain. Sequence analysis of the pyrimidine nucleotide biosynthetic operon in the representative mutants showed that proline 1016 and glutamate 949 in the large subunit of B. subtilis carbamoyl phosphate synthetase were of importance for the allosteric regulation caused by uridine 5'- monophosphate. The proposed mutation method with efficient high-throughput screening assay was proved to be an appropriate strategy to obtain uridine-overproducing strain.	[Fan, Xiaoguang; Wu, Heyun; Li, Guoliang; Yuan, Hui; Zhang, Hongchao; Li, Yanjun; Xie, Xixian; Chen, Ning] Tianjin Univ Sci & Technol, Natl & Local United Engn Lab Metab Control Fermen, Tianjin, Peoples R China; [Fan, Xiaoguang; Li, Yanjun; Xie, Xixian; Chen, Ning] Tianjin Univ Sci & Technol, Key Lab Microbial Engn China Light Ind, Tianjin, Peoples R China; [Fan, Xiaoguang; Wu, Heyun; Li, Guoliang; Yuan, Hui; Zhang, Hongchao; Li, Yanjun; Xie, Xixian; Chen, Ning] Tianjin Univ Sci & Technol, Coll Biotechnol, Tianjin, Peoples R China	Tianjin University Science & Technology; Tianjin University Science & Technology; Tianjin University Science & Technology	Xie, XX; Chen, N (corresponding author), Tianjin Univ Sci & Technol, Natl & Local United Engn Lab Metab Control Fermen, Tianjin, Peoples R China.; Xie, XX; Chen, N (corresponding author), Tianjin Univ Sci & Technol, Key Lab Microbial Engn China Light Ind, Tianjin, Peoples R China.; Xie, XX; Chen, N (corresponding author), Tianjin Univ Sci & Technol, Coll Biotechnol, Tianjin, Peoples R China.	xixianxie@tust.edu.cn; ningch@tust.edu.cn			Key Technologies Research and Development Program of Tianjin [16YEZCSY00770]; Innovation Fund for Youth of Tianjin University of Science and Technology [2015LG19]; Tianjin Municipal Science and Technology Commission [15JCTPJC62800]; Dr. Rui Ban from Tianjin University; Dr. Leonardo Rios from Joint BioEnergy Institute	Key Technologies Research and Development Program of Tianjin; Innovation Fund for Youth of Tianjin University of Science and Technology; Tianjin Municipal Science and Technology Commission; Dr. Rui Ban from Tianjin University; Dr. Leonardo Rios from Joint BioEnergy Institute	This work was supported by Key Technologies Research and Development Program of Tianjin (16YEZCSY00770), Innovation Fund for Youth of Tianjin University of Science and Technology (2015LG19) and Tianjin Municipal Science and Technology Commission (15JCTPJC62800). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the generous support of Dr. Rui Ban from Tianjin University and Dr. Leonardo Rios from Joint BioEnergy Institute.	ASAHI S, 1995, BIOSCI BIOTECH BIOCH, V59, P2123, DOI 10.1271/bbb.59.2123; ASAHI S, 1995, BIOSCI BIOTECH BIOCH, V59, P915, DOI 10.1271/bbb.59.915; ASAHI S, 1994, BIOSCI BIOTECH BIOCH, V58, P1399, DOI 10.1271/bbb.58.1399; Bonner ER, 2001, NUCLEIC ACIDS RES, V29, P4851, DOI 10.1093/nar/29.23.4851; Braxton BL, 1999, BIOCHEMISTRY-US, V38, P1394, DOI 10.1021/bi982097w; CERVERA J, 1993, J BIOL CHEM, V268, P12504; Cervera J, 1996, BIOCHEMISTRY-US, V35, P7247, DOI 10.1021/bi952549u; Chen XC, 2013, BIOPROC BIOSYST ENG, V36, P1851, DOI 10.1007/s00449-013-0959-6; Cheng KG, 2016, CHEM BIOL DRUG DESIG; CZERWINSKI RM, 1995, BIOCHEMISTRY-US, V34, P13920, DOI 10.1021/bi00042a025; Delannay S, 1999, J MOL BIOL, V286, P1217, DOI 10.1006/jmbi.1999.2561; Dobolyi A, 2011, CURR TOP MED CHEM, V11, P1058, DOI 10.2174/156802611795347618; Dong HN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121612; Fang MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077046; Hobl B, 2007, MICROBIOL-SGM, V153, P693, DOI 10.1099/mic.0.2006/003772-0; Iglesias LE, 2015, BIOTECHNOL ADV, V33, P412, DOI 10.1016/j.biotechadv.2015.03.009; Jiang T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149101; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Li HG, 2013, BIORESOURCE TECHNOL, V137, P254, DOI 10.1016/j.biortech.2013.03.084; Li XY, 2015, BIORESOURCE TECHNOL, V177, P134, DOI 10.1016/j.biortech.2014.11.051; Long Q, 2014, J BIOTECHNOL, V192, P323, DOI 10.1016/j.jbiotec.2014.03.028; Lu Y, 1996, J BACTERIOL, V178, P7206, DOI 10.1128/jb.178.24.7206-7211.1996; Lu Y, 1996, P NATL ACAD SCI USA, V93, P14462, DOI 10.1073/pnas.93.25.14462; Moffatt Barbara A, 2002, Arabidopsis Book, V1, pe0018, DOI 10.1199/tab.0018; QUINN CL, 1991, J BIOL CHEM, V266, P9113; RUBIO V, 1991, BIOCHEMISTRY-US, V30, P1068, DOI 10.1021/bi00218a027; Sauer U, 1997, NAT BIOTECHNOL, V15, P448, DOI 10.1038/nbt0597-448; Sauer U, 1996, APPL ENVIRON MICROB, V62, P3687, DOI 10.1128/AEM.62.10.3687-3696.1996; Savacool HK, 2002, J BACTERIOL, V184, P2521, DOI 10.1128/JB.184.9.2521-2528.2002; Stapleton MA, 1996, BIOCHEMISTRY-US, V35, P14352, DOI 10.1021/bi961183y; Sun JD, 2015, BIOTECHNOL APPL BIOC, V62, P287, DOI 10.1002/bab.1267; Switzer RL, 1999, PROG NUCLEIC ACID RE, V62, P329; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P6305, DOI 10.1021/bi970503q; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Wang L, 2015, ANN MICROBIOL, V65, P2009, DOI 10.1007/s13213-015-1039-8; Watanabe T, 2011, BIORESOURCE TECHNOL, V102, P1844, DOI 10.1016/j.biortech.2010.09.087; Zhang X, 2014, APPL MICROBIOL BIOT, V98, P5387, DOI 10.1007/s00253-014-5755-y; Zhu H, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0237-1	38	21	24	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176545	10.1371/journal.pone.0176545	http://dx.doi.org/10.1371/journal.pone.0176545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472077	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500051
J	Liversage, K				Liversage, Kiran			First evidence of biogenic habitat from tubeworms providing a near-absolute habitat requirement for high-intertidal Ulva macroalgae	PLOS ONE			English	Article							NEW-SOUTH-WALES; TIDAL ALGAL COMMUNITY; NATURAL COMMUNITIES; NULL HYPOTHESIS; BOULDER FIELDS; WAVE-EXPOSURE; ROCKY SHORES; DISTURBANCE; PATTERNS; FACILITATION	Disturbances in ecological systems can cause new resources to become available and can free the resources held by strongly competitive species. In intertidal boulder fields, wave-action causes disturbance by overturning boulders and freeing space for re-colonisation. In this study, mensurative experiments showed that boulder disturbance may also cause new biogenic-habitat resources to become available, if pre-disturbance boulders originally had tubeworm encrustations on their undersides. On the high-shore of a South Australian rocky coast, a small proportion of boulders had extensive encrustations of serpulid and spirorbid worm-tubes on their uppersides, and were likely to have recently been overturned, as spirorbid tubeworms are almost always only underneath boulders while living. Ulva macroalgae was absent from all boulders, except those with worm-tubes, where up to 61% Ulva cover was observed. Many boulders with tubes did not, however, have much algae, and this was likely caused by grazing. While limpets were seldom observed attached to tube encrustations, snails such as Nerita atramentosa and Bembicium nanum were equally abundant on and off tubes. N. atramentosa was likely the main grazer, as its densities were negatively correlated with Ulva cover. The mechanism causing association of Ulva and worm-tubes is unknown, but may be related to retention of moisture or algal spores within the complex topography of the tubes. Alternatively, some tubes may still have been living and providing nutrients for Ulva from excretory products. This study takes the first step towards understanding a very distinct habitat requirement which allows an important alga to persist in the hostile environment of the rocky-intertidal high shore.	[Liversage, Kiran] Govt South Australia, Dept Environm Water & Nat Resources, Mt Gambier, SA, Australia		Liversage, K (corresponding author), Govt South Australia, Dept Environm Water & Nat Resources, Mt Gambier, SA, Australia.	kiran.liversage@gmail.com		Liversage, Kiran/0000-0001-9971-0907				ADDESSI L, 1994, ECOL APPL, V4, P786, DOI 10.2307/1942008; Airoldi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022985; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V214, P137, DOI 10.3354/meps214137; Bracken MES, 2004, ECOLOGY, V85, P2828, DOI 10.1890/03-0651; Bulleri F, 2016, FUNCT ECOL, V30, P70, DOI 10.1111/1365-2435.12528; Bulleri F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033825; Callow M. E., 2002, BIOFOULING, V18, P229, DOI [DOI 10.1080/08927010290014908), DOI 10.1080/08927010290014908]; CANHAM CD, 1990, CAN J FOREST RES, V20, P620, DOI 10.1139/x90-084; Chapman MG, 1996, J EXP MAR BIOL ECOL, V196, P213, DOI 10.1016/0022-0981(95)00131-X; Chapman MG, 2003, J MAR BIOL ASSOC UK, V83, P415, DOI 10.1017/S0025315403007276h; Chapman MG, 2002, AUSTRAL ECOL, V27, P211, DOI 10.1046/j.1442-9993.2002.01172.x; Chapperon C, 2013, ECOL RES, V28, P407, DOI 10.1007/s11284-013-1030-4; CHILTON NB, 1984, MAR BIOL, V83, P163, DOI 10.1007/BF00394724; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Davison IR, 1996, J PHYCOL, V32, P197, DOI 10.1111/j.0022-3646.1996.00197.x; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; DENNY MW, 1987, J EXP MAR BIOL ECOL, V113, P231, DOI 10.1016/0022-0981(87)90103-1; DETHIER MN, 1984, ECOL MONOGR, V54, P99, DOI 10.2307/1942457; FARRELL TM, 1991, ECOL MONOGR, V61, P95, DOI 10.2307/1943001; FOSTER MS, 1990, HYDROBIOLOGIA, V192, P21, DOI 10.1007/BF00006225; Guo D, 2002, J ECOL, V90, P338, DOI 10.1046/j.1365-2745.2001.00667.x; HARLIN MM, 1977, MAR BIOL, V40, P33, DOI 10.1007/BF00390625; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; JAMES RJ, 1994, J EXP MAR BIOL ECOL, V181, P105, DOI 10.1016/0022-0981(94)90107-4; KENSLER CB, 1967, J ANIM ECOL, V36, P391, DOI 10.2307/2921; Knight-Jones EW, 2002, J NAT HIST, V36, P1397, DOI 10.1080/00222930110052454; Kotta J, 2006, HELGOLAND MAR RES, V60, P106, DOI 10.1007/s10152-006-0027-6; Kupriyanova EK, 2001, OCEANOGR MAR BIOL, V39, P1; LITTLER MM, 1980, BOT MAR, V23, P161, DOI 10.1515/botm.1980.23.3.161; Liversage K, 2012, THESIS; Liversage Kiran, 2015, Pacific Conservation Biology, V21, P234, DOI 10.1071/PC15017; Liversage K, 2015, P EST ACAD SCI, V64, P53, DOI 10.3176/proc.2015.1.07; Liversage K, 2014, MAR ECOL PROG SER, V505, P131, DOI 10.3354/meps10755; Liversage K, 2013, MOLLUSCAN RES, V33, P24, DOI 10.1080/13235818.2012.754145; MARION GM, 1991, SOIL SCI SOC AM J, V55, P235, DOI 10.2136/sssaj1991.03615995005500010040x; MCGUINNESS KA, 1986, J EXP MAR BIOL ECOL, V104, P97, DOI 10.1016/0022-0981(86)90099-7; MCGUINNESS KA, 1984, J BIOGEOGR, V11, P439, DOI 10.2307/2844807; MCGUINNESS KA, 1987, OECOLOGIA, V71, P409, DOI 10.1007/BF00378715; McIntire EJB, 2014, NEW PHYTOL, V201, P403, DOI 10.1111/nph.12478; Moore CG, 1998, AQUAT CONSERV, V8, P645, DOI 10.1002/(SICI)1099-0755(199809/10)8:5<645::AID-AQC295>3.0.CO;2-G; Nicastro KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047382; ROBERTSON GP, 1993, OECOLOGIA, V96, P451, DOI 10.1007/BF00320501; ROBLES C, 1982, OECOLOGIA, V54, P23, DOI 10.1007/BF00541103; Schumacher JF, 2007, BIOFOULING, V23, P55, DOI 10.1080/08927010601136957; SHANKS AL, 1986, OECOLOGIA, V69, P420, DOI 10.1007/BF00377065; Soliveres S, 2015, BIOL REV, V90, P297, DOI 10.1111/brv.12110; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; SOUSA WP, 1979, ECOL MONOGR, V49, P227, DOI 10.2307/1942484; Swain G, 2006, BIOFOULING, V22, P425, DOI 10.1080/08927010601037163; Taylor RB, 1998, LIMNOL OCEANOGR, V43, P600, DOI 10.4319/lo.1998.43.4.0600; Thomsen MS, 2010, INTEGR COMP BIOL, V50, P158, DOI 10.1093/icb/icq042; Thomsen MS, 2005, ESTUAR COAST SHELF S, V62, P63, DOI 10.1016/j.ecss.2004.08.007; TILMAN D, 1985, AM NAT, V125, P827, DOI 10.1086/284382; TURNER T, 1983, AM NAT, V121, P729, DOI 10.1086/284098; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P97, DOI 10.1016/S0022-0981(00)00181-7; UNDERWOOD AJ, 1984, J EXP MAR BIOL ECOL, V75, P71, DOI 10.1016/0022-0981(84)90024-8; UNDERWOOD AJ, 1981, OECOLOGIA, V48, P221, DOI 10.1007/BF00347968; UNDERWOOD AJ, 1983, OECOLOGIA, V56, P202, DOI 10.1007/BF00379692; UNDERWOOD AJ, 1978, OECOLOGIA, V33, P185, DOI 10.1007/BF00344847; UNDERWOOD AJ, 1990, AUST J ECOL, V15, P365, DOI 10.1111/j.1442-9993.1990.tb01464.x; UNDERWOOD AJ, 1980, OECOLOGIA, V46, P201, DOI 10.1007/BF00540127; Underwood AJ, 1993, SPECIES DIVERSITY EC, P38; Wernberg T, 2008, J SEA RES, V59, P237, DOI 10.1016/j.seares.2008.02.005; WILLIAMSON JE, 1994, OECOLOGIA, V99, P16, DOI 10.1007/BF00317078; Wright JT, 2016, BIOL INVASIONS, V18, P3163, DOI 10.1007/s10530-016-1206-2	71	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176952	10.1371/journal.pone.0176952	http://dx.doi.org/10.1371/journal.pone.0176952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467512	Green Published, gold, Green Submitted			2022-12-27	WOS:000400647000090
J	Chen, M; Zhang, Y; Zheng, PS				Chen, Mei; Zhang, Yuan; Zheng, Peng-Sheng			Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis	PLOS ONE			English	Article							CARDIOLIPIN; EXPRESSION; HPV	Tafazzin (TAZ) is often aberrantly expressed in some cancers, including rectal cancer and thyroid neoplasms. However, the function of TAZ in cervical cancer cells remains unknown. This study aims to explore the expression and function of TAZ in cervical cancer cells. Here, we determined the expression of TAZ protein in normal cervical tissue (NC, n = 27), high-grade squamous intraepithelial lesions (HSIL, n = 26) and squamous cervical carcinoma (SCC, n = 41) by immunohistochemistry, the expression of TAZ protein gradually increased from NC to HSIL to SCC. TAZ was overexpressed or down-regulated in cervical cancer cells by stably transfecting a TAZ-expressing plasmid or a shRNA plasmid targeting TAZ. In vitro, the cell growth curves and MTT assays showed that TAZ may promote the growth and viability of cervical cancer cells. In vivo, xenografts experiment showed that TAZ may increase tumor-forming ability. The percentage of apoptosis cells analyzed by FACS and TUNEL assays consistently showed that TAZ inhibits apoptosis in cervical cancer cells. Furthermore, the Cleaved Caspase 9 and Cleaved Caspase 3 were down-regulated by TAZ in cervical cancer cells. Taken together, this study demonstrated that TAZ is overexpressed in cervical cancer and may promote tumorigenicity of cervical cancer cells and inhibit apoptosis.	[Chen, Mei; Zhang, Yuan; Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Reprod Med, Med Coll, Xian, Peoples R China; [Zheng, Peng-Sheng] Minist Educ Peoples Republ China, Sect Canc Res, Key Lab Environm & Genes Related Dis, Xian, Peoples R China	Xi'an Jiaotong University; Ministry of Education, China	Zheng, PS (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Reprod Med, Med Coll, Xian, Peoples R China.; Zheng, PS (corresponding author), Minist Educ Peoples Republ China, Sect Canc Res, Key Lab Environm & Genes Related Dis, Xian, Peoples R China.	zpsheng@mail.xjtu.edu.cn			National Natural Science Foundation of China [81472728, 81672910]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant to Prof. Peng-Sheng Zheng from the National Natural Science Foundation of China (no. 81472728 and no. 81672910).; This work was supported by a grant to Prof. Peng-Sheng Zheng from the National Natural Science Foundation of China (No. 81472728 and No. 81672910).	Bosch FX, 2008, BRIT J CANCER, V98, P15, DOI 10.1038/sj.bjc.6604146; Brentnall M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-32; Chevillard S, 2004, CLIN CANCER RES, V10, P6586, DOI 10.1158/1078-0432.CCR-04-0053; Eiben GL, 2003, VIRAL IMMUNOL, V16, P111, DOI 10.1089/088282403322017866; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jin MF, 2015, ONCOL LETT, V10, P857, DOI 10.3892/ol.2015.3319; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kirwin SM, 2014, MOL GENET METAB, V111, P26, DOI 10.1016/j.ymgme.2013.11.006; Liu XY, 2015, CLADISTICS, V31, P18, DOI 10.1111/cla.12071; Pathak S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098317; Saavedra K, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-13; Sigurdsson K., 2007, LAEKNABLADID, V93, P21; Sigurdsson Kristjan, 2007, Laeknabladid, V93, P821; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Wang HY, 2015, ONCOTARGET, V6, P20711, DOI 10.18632/oncotarget.4133; Wang H, 2015, EURASIP J WIREL COMM, DOI 10.1186/s13638-015-0270-0; Wang T., 2016, INT J DISTRIB SENS N, V2016, P1, DOI DOI 10.1007/S11010-015-2651-4; Wang YD, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.272; Wilson LD, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-25; Wu XL, 2013, CARCINOGENESIS, V34, P1660, DOI 10.1093/carcin/bgt102; Xi RC, 2011, ONKOLOGIE, V34, P428, DOI 10.1159/000331132; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Zhang SD, 2016, ONCOL LETT, V11, P1223, DOI 10.3892/ol.2015.3999	27	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177171	10.1371/journal.pone.0177171	http://dx.doi.org/10.1371/journal.pone.0177171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489874	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314100052
J	Okeyo-Owuor, T; Benesh, E; Bibbey, S; Reid, M; Halabi, J; Sutcliffe, S; Moley, K				Okeyo-Owuor, Theresa; Benesh, Emily; Bibbey, Scott; Reid, Michaela; Halabi, Jacques; Sutcliffe, Siobhan; Moley, Kelle			Exposure to maternal obesogenic diet worsens some but not all pre-cancer phenotypes in a murine genetic model of prostate cancer	PLOS ONE			English	Article							NEUROENDOCRINE DIFFERENTIATION; HIGH-FAT; TUMOR-CELLS; PROGRESSION; PHOSPHORYLATION; EXPRESSION; CARCINOMA; OBESITY; RISK; H3	Prostate cancer research has been predominantly focused on adult exposures and risk factors. However, because the prostate develops during gestation and early life, exposure to external factors, such as obesity, during development could affect the prostate cancer progression in adults. Our previous work demonstrated that exposure to a high fat/high sugar (HF/HS) diet during gestation and until weaning stimulated prostate hyperplasia and altered the Pten/Akt pathway in adult mice fed a normal diet after weaning. Here, we asked whether maternal exposure to HF/HS would worsen prostate phenotypes in mice lacking Pten, a widely accepted driver of prostate cancer. We found that, at six weeks of age, both Chow (control)-and HF/HS-exposed Pten knockout mice showed evidence of murine PIN that included ducts with central comedo necrosis but that the HF/HS exposure did not influence murine PIN progression. The Pten knockout mice exposed to HF/HS in utero had significantly more mitotic cells than Pten knockouts exposed to Chow diet. In the Pten null background, the maternal HF/HS diet enhanced proliferation but did not have an additive effect on Akt activation. We observed neuroendocrine differentiation in Pten knockout mice, a phenotype that had not been previously described in this model.	[Okeyo-Owuor, Theresa; Benesh, Emily; Reid, Michaela; Halabi, Jacques; Moley, Kelle] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Bibbey, Scott] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Sutcliffe, Siobhan] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Moley, K (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.	moleyk@wudosis.wustl.edu		Sutcliffe, Siobhan/0000-0002-4613-8107	NCI [U54 CA155496]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the NCI grant U54 CA155496 awarded to KHM. The funders had no role in the study.	ABRAHAMSSON PA, 1987, PATHOL RES PRACT, V182, P298, DOI 10.1016/S0344-0338(87)80065-1; Benesh EC, 2013, SCI REP-UK, V3, DOI 10.1038/srep03466; BOSTWICK DG, 1994, AM J SURG PATHOL, V18, P1240, DOI 10.1097/00000478-199412000-00007; Bostwick DG, 2002, J UROLOGY, V168, P1204, DOI 10.1016/S0022-5347(05)64626-5; Boudoures AL, 2016, REPRODUCTION, V151, P261, DOI 10.1530/REP-15-0419; Cox ME, 1999, CANCER RES, V59, P3821; de Assis S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2058; Ekbom A, 1998, SEMIN CANCER BIOL, V8, P237, DOI 10.1006/scbi.1998.0073; Esakky P, 2013, REPROD SCI, V20, P238, DOI 10.1177/1933719112452939; Freedland SJ, 2007, EPIDEMIOL REV, V29, P88, DOI 10.1093/epirev/mxm006; Grigore AD, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00037; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hilakivi-Clarke L, 2001, J NUTR, V131, p154S, DOI 10.1093/jn/131.1.154S; HilakiviClarke L, 1997, P NATL ACAD SCI USA, V94, P9372, DOI 10.1073/pnas.94.17.9372; Komiya A, 2009, INT J UROL, V16, P37, DOI 10.1111/j.1442-2042.2008.02175.x; Kwon OJ, 2016, STEM CELL RES, V16, P682, DOI 10.1016/j.scr.2016.04.009; LOEB LA, 1994, CANCER RES, V54, P5059; Lu ZH, 2007, AM J PATHOL, V171, P667, DOI 10.2353/ajpath.2007.061138; Nielsen PS, 2013, MODERN PATHOL, V26, P404, DOI 10.1038/modpathol.2012.188; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Roberts JA, 2013, KOREAN J PATHOL, V47, P307, DOI 10.4132/KoreanJPathol.2013.47.4.307; Saben JL, 2016, CELL REP, V16, P1, DOI 10.1016/j.celrep.2016.05.065; Sagnak L, 2011, CLIN GENITOURIN CANC, V9, P73, DOI 10.1016/j.clgc.2011.07.003; Schiller JS, 2010, VITAL HLTH STAT, V10, P2012; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SHIBATA K, 1990, EUR J BIOCHEM, V192, P87, DOI 10.1111/j.1432-1033.1990.tb19199.x; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sun Y, 2009, AM J TRANSL RES, V1, P148; Surwit RS, 1998, P NATL ACAD SCI USA, V95, P4061, DOI 10.1073/pnas.95.7.4061; Sutcliffe S, 2013, NAT REV CANCER, V13, P208, DOI 10.1038/nrc3434; Suwa T, 2002, TOXICOL PATHOL, V30, P228, DOI 10.1080/019262302753559560; TRICHOPOULOS D, 1990, LANCET, V335, P939, DOI 10.1016/0140-6736(90)91000-Z; TRICHOPOULOS D, 1995, EPIDEMIOLOGY, V6, P347; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu CY, 2007, J BIOL CHEM, V282, P3571, DOI 10.1074/jbc.M608487200; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Zhong S, 2016, PROSTATE CANCER P D, V19, P122, DOI 10.1038/pcan.2015.64	37	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0175764	10.1371/journal.pone.0175764	http://dx.doi.org/10.1371/journal.pone.0175764			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489892	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314100009
J	Takeuchi, H; Kawanaka, H; Fukuyama, S; Kubo, N; Hiroshige, S; Yano, T				Takeuchi, Hideya; Kawanaka, Hirohumi; Fukuyama, Seiichi; Kubo, Nobuhide; Hiroshige, Shoji; Yano, Tokujiro			Comparison of the prognostic values of preoperative inflammation-based parameters in patients with breast cancer	PLOS ONE			English	Article							C-REACTIVE PROTEIN; COLORECTAL-CANCER; LYMPHOCYTE; CARCINOMA; RATIO; NEUTROPHIL; SURVIVAL; COUNTS	Peripheral blood-derived inflammation-based markers, including C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-tolymphocyte ratio (PLR) are indicators of prognosis in various malignant tumors. The present study aimed to identify the inflammation-based parameters that are most suitable for predicting outcomes in patients with breast cancer. Two hundred ninety-six patients who underwent surgery for localized breast cancer were reviewed retrospectively. The association between clinicopathological factors and inflammation-based parameters were investigated. Univariate and multivariate Cox regression analyses were performed to identify independent prognostic indicators associated with disease-free survival (DFS). The NLR level correlated significantly with tumor size (P< 0.05). The PLR level correlated with the expression of estrogen receptor and lymph node involvement (P< 0.05). Univariate analysis revealed that lower CRP and PLR values as well as tumor size, lymph node involvement, and nuclear grade were significantly associated with superior DFS (CRP: P< 0.01; PLR, tumor size, lymph node involvement, and nuclear grade: P< 0.05). On multivariate analysis, CRP (hazard ratio [HR]: 2.85, 95% confidence interval [CI]: 1.03-7.88, P< 0.05), PLR (HR: 2.61, 95% CI: 1.07-6.36, P< 0.05) and nuclear grade (HR: 3.066, 95% CI: 1.26-7.49, P< 0.05) were significant prognostic indicators of DFS in patients with breast cancer. Neither LMR nor NLR significantly predicted DFS. Both preoperative CRP and PLR values were independently associated with poor prognosis in patients with breast carcinoma; these were superior to other inflammation-based scores in terms of prognostic ability.	[Takeuchi, Hideya; Kawanaka, Hirohumi; Fukuyama, Seiichi; Kubo, Nobuhide; Hiroshige, Shoji; Yano, Tokujiro] Natl Hosp Org, Beppu Med Ctr, Dept Surg, Beppu, Oita, Japan; [Kawanaka, Hirohumi] Natl Hosp Org, Beppu Med Ctr, Clin Res Inst, Beppu, Oita, Japan		Takeuchi, H (corresponding author), Natl Hosp Org, Beppu Med Ctr, Dept Surg, Beppu, Oita, Japan.	t3996a@yahoo.co.jp						Alexandrakis MG, 2002, RESP MED, V96, P553, DOI 10.1053/rmed.2002.1328; Asahi Y, 1996, JPN J CANCER RES, V87, P451, DOI 10.1111/j.1349-7006.1996.tb00245.x; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; BAIN B, 1984, J CLIN PATHOL, V37, P188, DOI 10.1136/jcp.37.2.188; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Drukker CA, 2013, INT J CANCER, V133, P929, DOI 10.1002/ijc.28082; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hashimoto K, 2005, CANCER-AM CANCER SOC, V103, P1856, DOI 10.1002/cncr.20976; Hiraoka K, 2006, BRIT J CANCER, V94, P275, DOI 10.1038/sj.bjc.6602934; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Noh H, 2013, J BREAST CANCER, V16, P55, DOI 10.4048/jbc.2013.16.1.55; Nozoe T, 2001, AM J SURG, V182, P197, DOI 10.1016/S0002-9610(01)00684-5; OWNBY HE, 1983, CANCER, V52, P126, DOI 10.1002/1097-0142(19830701)52:1<126::AID-CNCR2820520123>3.0.CO;2-Y; Peterson JE, 2012, ANGIOGENESIS, V15, P265, DOI 10.1007/s10456-012-9259-z; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Takeuchi H, 2016, ADV BREAST CANC RES, V5, P49; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Wang D, 2013, ONCOTARGETS THER, V6, P211, DOI 10.2147/OTT.S41711; Wei XL, 2014, LEUKEMIA RES, V38, P694, DOI 10.1016/j.leukres.2014.03.013; Yamanaka T, 2007, ONCOLOGY-BASEL, V73, P215, DOI 10.1159/000127412	24	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177137	10.1371/journal.pone.0177137	http://dx.doi.org/10.1371/journal.pone.0177137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489884	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314100050
J	Cheng, Y; Zheng, SF; Pan, CT; Yuan, MK; Chang, LB; Yao, YU; Zhao, MW; Liang, JH				Cheng, Yong; Zheng, Shufeng; Pan, Chung-Ting; Yuan, Mengke; Chang, Libin; Yao, Yuou; Zhao, Mingwei; Liang, Jianhong			Analysis of aqueous humor concentrations of cytokines in retinoblastoma	PLOS ONE			English	Article							GROWTH-FACTOR; INFLAMMATORY CYTOKINES; PROTEOMIC ANALYSIS; INDUCIBLE PROTEIN; CELL-GROWTH; IN-VIVO; CANCER; VEGF; PHOSPHORYLATION; PATHWAY	To investigate the components of the aqueous humor (AH) in patients with retinoblastoma (RB). We collected 0.1 ml AH of 35 children with RB and 20 patients with congenital cataracts as controls. Multiplex enzyme-linked immunosorbent assays (ELISAs) and Luminex xMAP technology were used to assess 45 cytokines/chemokines, matrix metalloproteinases ( MMPs), and acute-phase proteins in the identification cohort. The concentrations of IL-6, IL-7, IL-8, IFN-gamma, PIGF-1, VEGF-A, beta-NGF, HGF, EGF and FGF-2 were significantly higher in the AH of patients with RB than those in the control group (P<0.05). The study showed that the higher levels of IP-10, IL-6, IL-7, IL-8, IFN-gamma, PIGF-1, VEGF-A, beta-NGF, HGF, EGF and FGF-2 in AH may be associated with RB. Our findings may facilitate a better understanding of the molecular pathways of tumors and solid molecular targets for new strategies for therapy and the earlier diagnosis of RB.	[Cheng, Yong; Yao, Yuou; Zhao, Mingwei; Liang, Jianhong] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Cheng, Yong; Yao, Yuou; Zhao, Mingwei; Liang, Jianhong] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Cheng, Yong; Yao, Yuou; Zhao, Mingwei; Liang, Jianhong] Beijing Key Lab Diag & Therapy Retinal & Choroid, Beijing, Peoples R China; [Zheng, Shufeng] Tradit Chinese Med Hosp Yulin, Eye Hosp, Yulin, Shaanxi, Peoples R China; [Pan, Chung-Ting] Peking Univ, Dept Ophthalmol, Int Hosp, Beijing, Peoples R China; [Yuan, Mengke] Beijing Shunyi Airport Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Chang, Libin] Beijing Jingmei Grp Gen Hosp, Dept Ophthalmol, Beijing, Peoples R China	Peking University; Peking University	Zhao, MW; Liang, JH (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing, Peoples R China.; Zhao, MW; Liang, JH (corresponding author), Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China.; Zhao, MW; Liang, JH (corresponding author), Beijing Key Lab Diag & Therapy Retinal & Choroid, Beijing, Peoples R China.	zhaomingwei@medmail.com.cn; drjianhongliang@163.com						Alberti L, 2004, INT J CANCER, V111, P653, DOI 10.1002/ijc.20287; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Cebulla CM, 2008, INVEST OPHTH VIS SCI, V49, P5215, DOI 10.1167/iovs.07-1668; Chen DM, 2009, J VIROL, V83, P722, DOI 10.1128/JVI.01517-08; Chen H, 2016, MOL VIS, V22, P1005; Chiang CW, 2014, J HIGH ENERGY PHYS, DOI [10.1007/JHEP09(2014)006, 10.1186/1750-2187-9-6]; Chintagumpala M, 2007, ONCOLOGIST, V12, P1237, DOI 10.1634/theoncologist.12-10-1237; Chu L, 2015, MOL VIS, P2418; Crawford Y, 2009, CELL TISSUE RES, V335, P261, DOI 10.1007/s00441-008-0675-8; Dong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125329; El-Gohary A, 2016, J CLIN LAB ANAL, V30, P1135, DOI 10.1002/jcla.21993; Feng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068149; Fortunato P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-504; Guo J, 2005, J BIOL CHEM, V280, P35992, DOI 10.1074/jbc.M504583200; Hadjistilianou T, 2012, CLIN EXP OPHTHALMOL, V40, pE8, DOI 10.1111/j.1442-9071.2011.02711.x; Jeong YH, 2015, J CLIN MICROBIOL, V53, P504, DOI 10.1128/JCM.02758-14; KRAUSE U, 1970, OPHTHALMOLOGICA, V160, P280, DOI 10.1159/000306003; Kvanta A, 1996, EXP EYE RES, V63, P511, DOI 10.1006/exer.1996.0141; Laveti Durgaprasad, 2013, Inflammation & Allergy Drug Targets, V12, P349; Leshem Y, 2002, J CELL PHYSIOL, V191, P173, DOI 10.1002/jcp.10089; Luo WJ, 2016, INT J OPHTHALMOL-CHI, V9, P937, DOI 10.18240/ijo.2016.07.01; Miao H, 2012, MOL VIS, V18, P574; Niki T, 2015, INT HEART J, V56, P269, DOI 10.1536/ihj.14-300; Ozcan Altan Atakan, 2004, International Ophthalmology, V25, P19, DOI 10.1023/B:INTE.0000018524.48581.79; Pavlakovic Helena, 2001, Angiogenesis, V4, P259, DOI 10.1023/A:1016045012466; Qu H, 2016, INT IMMUNOPHARMACOL, V40, P203, DOI 10.1016/j.intimp.2016.08.017; Richardson MR, 2009, MOL VIS, V15, P2740; Saryeddine L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165876; Sauer A, 2016, GRAEF ARCH CLIN EXP, V254, P1013, DOI 10.1007/s00417-016-3313-2; SCHWEIGERER L, 1995, J MOL MED-JMM, V73, P497; Shields CL, 2006, OPHTHALMOLOGY, V113, P2276, DOI 10.1016/j.ophtha.2006.06.018; SHIELDS JA, 1991, RETINA-J RET VIT DIS, V11, P232, DOI 10.1097/00006982-199111020-00009; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Snoussi K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-283; Sohn HJ, 2011, AM J OPHTHALMOL, V152, P686, DOI 10.1016/j.ajo.2011.03.033; Stacker SA, 2013, CHIN J CANCER, V32, P297, DOI 10.5732/cjc.012.10319; Tai WY, 2010, MOL PHARMACEUT, V7, P543, DOI 10.1021/mp9002514; To Chi-ho, 2002, Clin Exp Optom, V85, P335; Traine PG, 2016, OCUL ONCOL PATHOL, V2, P128, DOI 10.1159/000441528; Urashima M, 1996, BLOOD, V88, P2219, DOI 10.1182/blood.V88.6.2219.bloodjournal8862219; Visciano C, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/705169; Vujosevic S, 2016, ACTA OPHTHALMOL, V94, P56, DOI 10.1111/aos.12812; Wang B, 2014, J OCUL PHARMACOL TH, V30, P587, DOI 10.1089/jop.2013.0241; Wykosky Jill, 2011, Chin J Cancer, V30, P5; Xin GH, 2012, INT J OPHTHALMOL-CHI, V5, P440, DOI 10.3980/j.issn.2222-3959.2012.04.07	46	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177337	10.1371/journal.pone.0177337	http://dx.doi.org/10.1371/journal.pone.0177337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486560	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000071
J	McCoy, SI; Fahey, C; Rao, A; Kapologwe, N; Njau, PF; Bautista-Arredondo, S				McCoy, Sandra I.; Fahey, Carolyn; Rao, Aarthi; Kapologwe, Ntuli; Njau, Prosper F.; Bautista-Arredondo, Sergio			Pilot study of a multi-pronged intervention using social norms and priming to improve adherence to antiretroviral therapy and retention in care among adults living with HIV in Tanzania	PLOS ONE			English	Article							INHIBITOR THERAPY; BEHAVIOR; METAANALYSIS	Background Interventions incorporating constructs from behavioral economics and psychology have the potential to enhance HIV 'treatment as prevention' (TasP) strategies. To test this hypothesis, we evaluated an intervention to improve antiretroviral therapy (ART) adherence based on the concepts of social norms and priming. Methods We used tools from marketing research and patient-centered design to develop a combination intervention that included visual feedback about clinic-level retention in care, a self- relevant prime, and useful take-home items with the priming image. The intervention was implemented at two HIV primary clinics in Shinyanga, Tanzania in 2-week intervals for six months. We conducted a quasi-experimental pilot study with a random sample of exposed and unexposed adult patients living with HIV infection (PLHIV) to compare retention and the proportion of patients with medication possession ratio (MPR) >= 95% after six months. Intervention acceptability was determined with a convenience sample of 405 PLHIV at baseline (n = 189) and endline (n = 216). Results Medical records were reviewed for 438 PLHIV (320 intervention, 118 standard of care). In adjusted analyses, PLHIV exposed to the intervention were significantly more likely to be in care after 6 months (87% vs. 79%, adjusted odds ratio (ORa) = 1.73, 95% CI: 1.08, 2.78, p<0.05) and were more likely to achieve MPR >= 95% (70% vs. 59%, OR = 1.51, 95% CI: 0.96, 2.37, p = 0.07). The intervention was associated with increases in staff support of treatment goals (100% vs. 95%, p = 0.01) and life goals (66% vs. 50%, p<0.01), the perceived likelihood of other patients' adherence (54% vs. 32%, p<0.01), support from other patients (71% vs. 60%, p = 0.03), and being very satisfied with care (53% vs. 35%, p<0.01). Conclusions This novel intervention has the potential to improve the clinic experience, short-term retention in care, and ART adherence. Future studies are needed to expand the generalizability of the approach and evaluate effectiveness on clinical outcomes.	[McCoy, Sandra I.; Fahey, Carolyn] Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94720 USA; [Rao, Aarthi] CVS Hlth, Enterprise Prod Innovat, Woonsocket, RI USA; [Kapologwe, Ntuli] Minist Hlth Community Dev Gender Elderly & Childr, Reg Med Off, Shinyanga, Tanzania; [Njau, Prosper F.] Minist Hlth Community Dev Gender Elderly & Childr, Prevent Mother Child HIV Transmiss Programme, Dar Es Salaam, Tanzania; [Bautista-Arredondo, Sergio] Natl Inst Publ Hlth, Hlth Econ Dept, Cuernavaca, Morelos, Mexico	University of California System; University of California Berkeley; Instituto Nacional de Salud Publica	McCoy, SI (corresponding author), Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94720 USA.	smccoy@berkeley.edu	Bautista-Arredondo, Sergio/N-7305-2016	Bautista-Arredondo, Sergio/0000-0001-8910-3011; Fahey, Carolyn A./0000-0001-9865-2397; MCCOY, SANDRA/0000-0002-4764-9195	Bill & Melinda Gates Foundation; National Institute of Mental Health [K01MH094246];  [OPP1118511]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD073964] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This publication is based on research funded in part by a Grand Challenges Explorations grant to SIM (Award Number OPP1118511), an initiative of the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/). The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. SIM is supported by Award Number K01MH094246 from the National Institute of Mental Health (www.nimh.nih.gov). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bezabhe WM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003361; Birnbach DJ, 2013, J HOSP INFECT, V85, P79, DOI 10.1016/j.jhin.2013.06.008; Caceres CF, 2010, JAIDS-J ACQ IMM DEF, V54, P204, DOI 10.1097/QAI.0b013e3181d61def; Chaiyachati KH, 2014, AIDS, V28, pS187, DOI 10.1097/QAD.0000000000000252; Codagnone C, 2014, J EPIDEMIOL COMMUN H, V68, P909, DOI 10.1136/jech-2014-203948; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; DELBECQ AL, 1971, J APPL BEHAV SCI, V7, P466, DOI 10.1177/002188637100700404; Dolan P, 2012, J ECON PSYCHOL, V33, P264, DOI 10.1016/j.joep.2011.10.009; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Galarraga O, 2013, AIDS BEHAV; Greenland S, 2000, INT J EPIDEMIOL, V29, P1102, DOI 10.1093/oxfordjournals.ije.a019909; Hallsworth M, 2016, LANCET; Hong SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056307; IDEO. org, 2016, FIELD GUID HUM CTR D; Kahana SY, 2013, AIDS BEHAV, V17, P41, DOI 10.1007/s10461-012-0159-4; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Martin S., 2012, HARVARD BUSINESS REV; McMahon JH, 2011, CLIN INFECT DIS, V52, P493, DOI 10.1093/cid/ciq167; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) CF International, 2013, TANZ HIV AIDS MAL IN; Oyserman D, 2010, COUNS PSYCHOL, V38, P1001, DOI 10.1177/0011000010374775; Oyserman D, 2009, J CONSUM PSYCHOL, V19, P250, DOI 10.1016/j.jcps.2009.05.008; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pettifor A, 2012, AIDS BEHAV, V16, P1729, DOI 10.1007/s10461-012-0240-z; Rao A, 2016, 21 INT AIDS C AIDS 2; Rao A, 2015, FOSTERING BEHAV CHAN; RAO JNK, 1981, J AM STAT ASSOC, V76, P221, DOI 10.2307/2287815; RICHARDSONKLAVEHN A, 1988, ANNU REV PSYCHOL, V39, P475, DOI 10.1146/annurev.ps.39.020188.002355; Susnstein CR, 2008, NUDGE IMPROVING DECI; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; UNAIDS, 2014, GAP REP; UNAIDS, 2014, 90 90 90 AMB TREATM; Walton GM, 2014, CURR DIR PSYCHOL SCI, V23, P73, DOI 10.1177/0963721413512856	37	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177394	10.1371/journal.pone.0177394	http://dx.doi.org/10.1371/journal.pone.0177394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UM	28486553	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314000078
J	Alsop, J; Medin, J; Cornelissen, C; Vormfelde, SV; Ziemssen, T				Alsop, Jonathan; Medin, Jennie; Cornelissen, Christian; Vormfelde, Stefan Viktor; Ziemssen, Tjalf			Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL	PLOS ONE			English	Article							REMITTING MULTIPLE-SCLEROSIS; INTRAMUSCULAR INTERFERON; CLINICAL-RELEVANCE; ORAL FINGOLIMOD; BETA THERAPY; DOUBLE-BLIND; FREEDOMS II; DISEASE; NATALIZUMAB; COHORT	Background This study compared outcomes following fingolimod or BRACE treatments (beta-interferons/glatiramer acetate) in patients with active MS (>= 1 relapse in the previous year) following previous BRACE treatment. Methods and findings Patients with active MS who previously received BRACE were identified from German prospective, observational studies, PANGAEA and PEARL. A novel methodology was developed to compare outcomes between propensity-score-matched cohorts (3: 1 ratio) from the independent single-arm studies. Patients in PANGAEA (n = 1287) experienced 48% fewer relapses per year than those in PEARL (n = 429; annualized relapse rate ratio: 0.52; p < 0.001). The risk of 3-month or 6-month confirmed disability progression (CDP) was reduced in PANGAEA versus PEARL (3-month: 37% reduction; hazard ratio [HR], 0.63; p < 0.001; 6-month: 47% reduction; HR, 0.53; p < 0.001). A higher proportion of patients in PANGAEA (n = 1234) than PEARL (n = 401) were free from relapses and 3-month (65.7% vs 38.7%; p < 0.001) or 6-month (68.2% vs 39.2%; p < 0.001) CDP. The probability of confirmed disability improvement was higher in PANGAEA (n = 1163) than PEARL (n = 372; 3-month: 175% increase; HR, 2.75; p < 0.001; 6-month: 126% increase; HR, 2.26; p < 0.001). Patients in PANGAEA (n = 149) were less likely than those in PEARL (n = 307) to have taken sick leave (proportion with 0 days off work: 62.4% vs 44.6%; p = 0.0005). For change in disease severity from baseline (assessed by clinicians using the Clinical Global Impressions scale; PANGAEA, n = 1207; PEARL, n = 427), a larger proportion of patients had subjective improvement and a smaller proportion had worsening status in PANGAEA than PEARL (improvement: 28.2% vs 15.2%; worsening: 16.4% vs 30.4%; p < 0.0001). Conclusions Fingolimod appears to be more effective than BRACE in improving clinical and physician-/patient-reported outcomes in individuals with active MS.	[Alsop, Jonathan] Numerus Ltd, Wokingham, England; [Medin, Jennie] Novartis Pharma AG, Basel, Switzerland; [Cornelissen, Christian; Vormfelde, Stefan Viktor] Novartis Pharma GmbH, Nurnberg, Germany; [Ziemssen, Tjalf] Tech Univ Dresden, Carl Gustav Carus Univ Clin, Ctr Clin Neurosci, Dresden, Germany	Novartis; Novartis; Technische Universitat Dresden	Ziemssen, T (corresponding author), Tech Univ Dresden, Carl Gustav Carus Univ Clin, Ctr Clin Neurosci, Dresden, Germany.	Tjalf.Ziemssen@uniklinikum-dresden.de	Ziemssen, Tjalf/J-2017-2019	Ziemssen, Tjalf/0000-0001-8799-8202; Vormfelde, Stefan/0000-0003-4046-745X; Cornelissen, Christian/0000-0001-7983-657X	Novartis Pharma GmbH, Nuremberg, Germany; Novartis Pharma AG, Basel, Switzerland; Novartis Pharma GmbH; Novartis Pharma	Novartis Pharma GmbH, Nuremberg, Germany; Novartis Pharma AG, Basel, Switzerland; Novartis Pharma GmbH; Novartis Pharma	The funders (Novartis Pharma GmbH and Novartis Pharma AG) had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The design of the study and the collection, analysis and interpretation of data were funded by Novartis Pharma GmbH, Nuremberg, Germany. The writing of the manuscript was funded by Novartis Pharma AG, Basel, Switzerland. Novartis Pharma GmbH provided support in the form of salaries for two authors [CC, SVV (at the time of manuscript preparation)]. Novartis Pharma AG provided support in the form of salaries for one author [JM]. One author was employed by Numerus [JA] which received funding from Novartis Pharma GmbH and Novartis Pharma AG to conduct the data analysis. The specific roles of these authors are articulated in the 'author contributions' section.; The authors take full responsibility for the content of the paper. The authors thank Dr Colin Glen, Dr Anne-Marie Couto and Dr Gemma Carter of Oxford PharmaGenesis, Oxford, UK for medical writing support, editorial assistance and collation and incorporation of comments from all authors (funded by Novartis Pharma AG, Basel, Switzerland).	Agashivala N, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-138; [Anonymous], 2008, VAL PAT REG CLIN RES; Barbin L, 2016, NEUROLOGY, V86, P771, DOI 10.1212/WNL.0000000000002395; Baroncini D, 2016, MULT SCLER J, V22, P1315, DOI 10.1177/1352458516650736; Bergvall N, 2014, MULT SCLER J, V20, P117; Bergvall N, 2013, NEUROLOGY S7, V80; Bergvall N, 2014, CURR MED RES OPIN, V30, P1461, DOI 10.1185/03007995.2014.915802; Bergvall N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088472; Bergvall N, 2013, CURR MED RES OPIN, V29, P1647, DOI 10.1185/03007995.2013.847411; Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0; Busner Joan, 2007, Psychiatry (Edgmont), V4, P28; Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3; Carruthers RL, 2014, MULT SCLER J, V20, P1381, DOI 10.1177/1352458514535282; Castillo-Trivino T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016664; Cohen JA, 2013, J NEUROL, V260, P2023, DOI 10.1007/s00415-013-6932-0; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; De Stefano N, 2014, CNS DRUGS, V28, P147, DOI 10.1007/s40263-014-0140-z; Derwenskus J, 2011, MT SINAI J MED, V78, P161, DOI 10.1002/msj.20239; Devonshire V, 2012, LANCET NEUROL, V11, P420, DOI 10.1016/S1474-4422(12)70056-X; European Medicines Agency, 2014, GIL EPAR PROD INF; European Medicines Agency, 2013, TYS EPAR PROD INF; Filippi M, 2005, J NEUROL, V252, pV16, DOI 10.1007/s00415-005-5004-5; Fusco C, 2001, NEUROLOGY, V57, P1976, DOI 10.1212/WNL.57.11.1976; Haase R, 2016, THER ADV NEUROL DISO, V9, P250, DOI 10.1177/1756285616634247; He A, 2015, JAMA NEUROL, V72, P405, DOI 10.1001/jamaneurol.2014.4147; Kalincik T, 2015, ANN NEUROL, V77, P425, DOI 10.1002/ana.24339; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS34; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS5; Koch-Henriksen N, 2016, MULTIPLE SCLEROSIS; Kutzelnigg A, 2014, HAND CLINIC, V122, P15, DOI 10.1016/B978-0-444-52001-2.00002-9; Multiple Sclerosis International Federation, 2013, ATL OF MS DAT; Orme M, 2007, VALUE HEALTH, V10, P54, DOI 10.1111/j.1524-4733.2006.00144.x; Portaccio E, 2008, EUR NEUROL, V59, P131, DOI 10.1159/000111875; Portaccio E, 2006, MULT SCLER J, V12, P281, DOI 10.1191/135248506ms1278oa; Prosperini L, 2014, DEGENER NEUROL NEURO, V4, P75, DOI 10.2147/DNND.S42734; Reese JP, 2011, EUR NEUROL, V66, P311, DOI 10.1159/000331043; Rice GP, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002002; Pereira VCS, 2012, ARQ NEURO-PSIQUIAT, V70, P774, DOI 10.1590/S0004-282X2012001000005; Sobocki P, 2007, MULT SCLER J, V13, P1054, DOI 10.1177/1352458507077941; Sorensen H T, 1997, Int J Risk Saf Med, V10, P1, DOI 10.3233/JRS-1997-10101; Spelman T, 2013, MULT SCLER J, V19, P514; Vormfelde SV, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.4473; Ziemssen T, BMC MED, V14, P81; Ziemssen T, 2016, J NEUROL, V263, P1053, DOI 10.1007/s00415-015-7986-y; Ziemssen T, 2016, J NEUROL, V263, P784, DOI 10.1007/s00415-016-8058-7; Ziemssen T, 2015, MULT SCLER RELAT DIS, V4, P460, DOI 10.1016/j.msard.2015.07.007; Ziemssen T, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0342-0; Ziemssen T, 2014, J NEUROL, V261, P2101, DOI 10.1007/s00415-014-7446-0; Ziemssen T, 2013, J NEURAL TRANSM, V120, pS61, DOI 10.1007/s00702-013-1041-x; Zwibel HL, 2006, ACTA NEUROL SCAND, V113, P378, DOI 10.1111/j.1600-0404.2006.00627.x	53	15	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0173353	10.1371/journal.pone.0173353	http://dx.doi.org/10.1371/journal.pone.0173353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475587	Green Submitted, Green Published, gold			2022-12-27	WOS:000400649500002
J	Ohta, M; Midorikawa, T; Hikihara, Y; Sakamoto, S; Kawakami, Y; Fukunaga, T; Kanehisa, H				Ohta, Megumi; Midorikawa, Taishi; Hikihara, Yuki; Sakamoto, Shizuo; Kawakami, Yasuo; Fukunaga, Tetsuo; Kanehisa, Hiroaki			Body mass-to-waist ratio strongly correlates with skeletal muscle volume in children	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; HIP RATIO; PREDICTION; INDEX; CIRCUMFERENCE; FAT; VALIDATION; ADIPOSITY; GIRTH	Purpose We hypothesized that body mass-to-waist ratio is strongly associated with the total-body skeletal muscle volume (SMV) in children. The purpose of the present study was to examine this hypothesis. Methods By using magnetic resonance imaging, total-body SMV (SMVMRI) was determined in 70 boys and 53 girls aged 6 to 12 years. Waist was measured at each of the level of umbilicus (Wumb) and the minimum circumference (Wmin), and the ratio of body mass to each of the two measured values was calculated (BM/Wumb and BM/Wmin, respectively). A single regression analysis was used to examine the relationships between SMVMRI and either BM/Wumb or BM/Wmin. On the basis of the obtained regression equations, SMVMRI was estimated and referred to as SMVBM/Wumb or SMVBM/Wmin. Results In both boys and girls, SMVMRI was highly correlated to BM/Wumb (r = 0.937 for boys and r = 0.939 for girls, P < 0.0001) and BM/Wmin (r = 0.915 and 0.942, P < 0.0001). R-2 and the standard error of estimate for SMVBM/Wumb were 0.878 and 706.2 cm(3), respectively, in boys and 0.882 and 825.3 cm(3), respectively, in girls, and those for SMVBM/Wmin were 0.837 and 814.0 cm(3), respectively, in boys and 0.888 and 804.1 cm(3), respectively, in girls. In both boys and girls, there were no significant differences between SMVMRI and either SMVBM/Wumb or SMVBM/Wmin, without systematic errors in Band-Altman plots. There was no significant effect of model on the absolute values of the residuals in both boys and girls. Conclusion The current results indicate that body mass-to-waist ratio can be a convenient outcome measure for assessing the total-body skeletal muscle volume in children.	[Ohta, Megumi] Chukyo Univ, Sch Int Liberal Studies, Toyota, Aichi, Japan; [Midorikawa, Taishi] JF Oberlin Univ, Coll Hlth & Welf, Machida, Tokyo, Japan; [Hikihara, Yuki] Chiba Inst Technol, Fac Engn, Narashino, Chiba, Japan; [Sakamoto, Shizuo; Kawakami, Yasuo] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Fukunaga, Tetsuo; Kanehisa, Hiroaki] Natl Inst Fitness & Sports Kanoya, Kanoya, Kagoshima, Japan	Chukyo University; Chiba Institute of Technology; Waseda University; National Institute Fitness & Sports Kanoya	Ohta, M (corresponding author), Chukyo Univ, Sch Int Liberal Studies, Toyota, Aichi, Japan.	m-ohta@lets.chukyo-u.ac.jp	Kawakami, Yasuo/AAH-3075-2022; Kawakami, Yasuo/AFM-0651-2022	Kawakami, Yasuo/0000-0003-0588-4039; Kawakami, Yasuo/0000-0003-0588-4039	JSPS KAKENHI [18800054, 22700623, 24680069]; Grants-in-Aid for Scientific Research [16K01601, 16H01870] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided by JSPS KAKENHI Grant Number 18800054, 22700623 and 24680069 [https://kaken.nii.ac.jp/].	Abe T, 2003, BRIT J SPORT MED, V37, P436, DOI 10.1136/bjsm.37.5.436; Abe T, 2014, J CLIN GERONTOL GERI, V5, P58, DOI 10.1016/j.jcgg.2014.01.006; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Corvalan C, 2010, AM J CLIN NUTR, V91, P166, DOI 10.3945/ajcn.2009.27547; Goran MI, 1998, INT J OBESITY, V22, P549, DOI 10.1038/sj.ijo.0800624; Hubert H, 2009, J SCI MED SPORT, V12, P449, DOI 10.1016/j.jsams.2008.05.002; KANEHISA H, 1994, INT J SPORTS MED, V15, P420, DOI 10.1055/s-2007-1021081; Kim J, 2006, AM J CLIN NUTR, V84, P1014, DOI 10.1093/ajcn/84.5.1014; Lee RC, 2000, AM J CLIN NUTR, V72, P796, DOI 10.1093/ajcn/72.3.796; Midorikawa T, 2009, BRIT J NUTR, V101, P72, DOI 10.1017/S000711450899440X; Midorikawa T, 2015, BRIT J NUTR, V114, P1209, DOI 10.1017/S0007114515002585; Nakatani M, 2016, EUR J APPL PHYSIOL, V116, P2125, DOI 10.1007/s00421-016-3464-1; Poortmans JR, 2005, MED SCI SPORT EXER, V37, P316, DOI 10.1249/01.MSS.0000152804.93039.CE; Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929; Sijtsma A, 2014, CLIN NUTR, V33, P311, DOI 10.1016/j.clnu.2013.05.010; Sisson SB, 2009, OBESITY, V17, P2075, DOI 10.1038/oby.2009.132; Taylor RW, 2000, AM J CLIN NUTR, V72, P490; Taylor RW, 1998, AM J CLIN NUTR, V67, P44, DOI 10.1093/ajcn/67.1.44; Wang J, 2003, AM J CLIN NUTR, V77, P379, DOI 10.1093/ajcn/77.2.379; Yang CR, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7678613	21	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177155	10.1371/journal.pone.0177155	http://dx.doi.org/10.1371/journal.pone.0177155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475638	Green Published, Green Submitted, gold			2022-12-27	WOS:000400649500052
J	Tolosana, R; Vera-Rodriguez, R; Fierrez, J; Morales, A; Ortega-Garcia, J				Tolosana, Ruben; Vera-Rodriguez, Ruben; Fierrez, Julian; Morales, Aythami; Ortega-Garcia, Javier			Benchmarking desktop and mobile handwriting across COTS devices: The e-BioSign biometric database	PLOS ONE			English	Article							SIGNATURE VERIFICATION; USER AUTHENTICATION	This paper describes the design, acquisition process and baseline evaluation of the new e-BioSign database, which includes dynamic signature and handwriting information. Data is acquired from 5 different COTS devices: three Wacom devices (STU-500, STU-530 and DTU-1031) specifically designed to capture dynamic signatures and handwriting, and two general purpose tablets (Samsung Galaxy Note 10.1 and Samsung ATIV 7). For the two Samsung tablets, data is collected using both pen stylus and also the finger in order to study the performance of signature verification in a mobile scenario. Data was collected in two sessions for 65 subjects, and includes dynamic information of the signature, the full name and alpha numeric sequences. Skilled forgeries were also performed for signatures and full names. We also report a benchmark evaluation based on e-BioSign for person verification under three different real scenarios: 1) intra-device, 2) inter-device, and 3) mixed writing-tool. We have experimented the proposed benchmark using the main existing approaches for signature verification: feature-and time functions-based. As a result, new insights into the problem of signature biometrics in sensor-interoperable scenarios have been obtained, namely: the importance of specific methods for dealing with device interoperability, and the necessity of a deeper analysis on signatures acquired using the finger as the writing tool. This e-BioSign public database allows the research community to: 1) further analyse and develop signature verification systems in realistic scenarios, and 2) investigate towards a better understanding of the nature of the human handwriting when captured using electronic COTS devices in realistic conditions.	[Tolosana, Ruben; Vera-Rodriguez, Ruben; Fierrez, Julian; Morales, Aythami; Ortega-Garcia, Javier] Univ Autonoma Madrid, ATVS, Biometr & Data Pattern Analyt BiDA Lab, Madrid, Spain	Autonomous University of Madrid	Tolosana, R (corresponding author), Univ Autonoma Madrid, ATVS, Biometr & Data Pattern Analyt BiDA Lab, Madrid, Spain.	ruben.tolosana@uam.es	Vera-Rodriguez, Ruben/D-1272-2014; Moreno, Aythami/ABF-8166-2021; Morales, Aythami/L-2529-2013; Tolosana, Ruben/ABE-9297-2021; Ortega-Garcia, Javier/J-7065-2012	Vera-Rodriguez, Ruben/0000-0002-6338-8511; Morales, Aythami/0000-0002-7268-4785; Tolosana, Ruben/0000-0002-9393-3066; Ortega-Garcia, Javier/0000-0003-0557-1948	MINECO/FEDER [TEC2015-70627-R]; Cecabank e-BioFirma2 Contract; FPU Fellowship from Spanish MECD	MINECO/FEDER; Cecabank e-BioFirma2 Contract; FPU Fellowship from Spanish MECD(German Research Foundation (DFG))	This work has been supported by project TEC2015-70627-R MINECO/FEDER and by Cecabank e-BioFirma2 Contract. Ruben Tolosana is supported by a FPU Fellowship from Spanish MECD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco-Gonzalo R, 2014, IET BIOMETRICS, V3, P139, DOI 10.1049/iet-bmt.2013.0044; Dessimoz D, 2007, FORENSIC SCI INT, V167, P154, DOI 10.1016/j.forsciint.2006.06.037; Diaz M, 2018, IEEE T CYBERNETICS, V48, P228, DOI 10.1109/TCYB.2016.2630419; Drotar P, 2016, ARTIF INTELL MED, V67, P39, DOI 10.1016/j.artmed.2016.01.004; Drotar P, 2015, IEEE T NEUR SYS REH, V23, P508, DOI 10.1109/TNSRE.2014.2359997; Dumas B, 2005, P 3 COST 275 WORKSH, P59; Fierrez J, 2010, PATTERN ANAL APPL, V13, P235, DOI 10.1007/s10044-009-0151-4; Fierrez-Aguilar J., 2006, THESIS; Galbally J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069897; Garcia-Salicetti S, 2003, P 4 INT C AUD VID BA; Gomez M, 2015, 2ND ACM INTERNATIONAL CONFERENCE ON MOBILE SOFTWARE ENGINEERING AND SYSTEMS MOBILESOFT 2015, P1, DOI 10.1109/MobileSoft.2015.8; Guest R, 2006, PATTERN RECOGN LETT, V27, P1098, DOI 10.1016/j.patrec.2005.12.008; Humm A, 2009, IEEE T SYST MAN CY A, V39, P25, DOI 10.1109/TSMCA.2008.2007978; Impedovo D, 2008, IEEE T SYST MAN CY C, V38, P609, DOI 10.1109/TSMCC.2008.923866; Jain AK, 2016, PATTERN RECOGN LETT, V79, P80, DOI 10.1016/j.patrec.2015.12.013; Kholmatov A, 2009, PATTERN ANAL APPL, V12, P227, DOI 10.1007/s10044-008-0118-x; Martinez-Diaz M, 2015, SIGNATURE FEATURES E, P1375; Martinez-Diaz M, 2015, SIGNATURE DATABASES, P1367; Martinez-Diaz M, 2016, IEEE T HUM-MACH SYST, V46, P607, DOI 10.1109/THMS.2015.2504101; Martinez-Diaz M, 2014, IET BIOMETRICS, V3, P267, DOI 10.1049/iet-bmt.2013.0081; Martinez-Diaz M, 2013, IEEE ACCESS, V1, P596, DOI 10.1109/ACCESS.2013.2281773; Meng WZ, 2015, IEEE COMMUN SURV TUT, V17, P1268, DOI 10.1109/COMST.2014.2386915; O'Reilly C, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00150; Ortega-Garcia J, 2003, IEE P-VIS IMAGE SIGN, V150, P395, DOI 10.1049/ip-vis:20031078; Ortega-Garcia J, 2010, IEEE T PATTERN ANAL, V32, P1097, DOI 10.1109/TPAMI.2009.76; Plamondon R, 2014, PATTERN RECOGN LETT, V35, P225, DOI 10.1016/j.patrec.2012.06.004; Tolosana R, 2015, P 7 IEEE INT WORKSH; Tolosana R, 2015, P 3 INT WORKSH BIOM; Tolosana R, 2015, IEEE ACCESS, V3, P478, DOI 10.1109/ACCESS.2015.2431493; Vera-Rodriguez R., 2015, P 3 INT WORKSH BIOM; Yeung DY, 2004, LECT NOTES COMPUT SC, V3072, P16; Zhang DD, 2013, INT SERIES ASIAN STU, P7	32	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176792	10.1371/journal.pone.0176792	http://dx.doi.org/10.1371/journal.pone.0176792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475590	gold, Green Submitted, Green Published			2022-12-27	WOS:000400649500015
J	Andersson, T; Magnuson, A; Bryngelsson, IL; Frobert, O; Henriksson, KM; Edvardsson, N; Poci, D				Andersson, Tommy; Magnuson, Anders; Bryngelsson, Ing-Liss; Frobert, Ole; Henriksson, Karin M.; Edvardsson, Nils; Poci, Dritan			Patients with atrial fibrillation and outcomes of cerebral infarction in those with treatment of warfarin versus no warfarin with references to CHA(2)DS(2)-VASc score, age and sex - A Swedish nationwide observational study with 48 433 patients	PLOS ONE			English	Article							RISK STRATIFICATION SCHEMES; STROKE RISK; PREDICTING STROKE; ORAL ANTICOAGULATION; ISCHEMIC-STROKE; BENEFIT; VALIDATION; THROMBOEMBOLISM; MORTALITY; REGISTRY	Aims There is controversy in the guidelines as to whether patients with atrial fibrillation and a low risk of stroke should be treated with anticoagulation, especially those with a CHA(2)DS(2)-VASc score of 1 point. Methods In a retrospective, nationwide cohort study, we used the Swedish National Patient Registry, the National Prescribed Drugs Registry, the Swedish Registry of Education and the Population and Housing Census Registry. 48 433 patients were identified between 1 January 2006 and 31 December 2008 with incident atrial fibrillation who were divided in age categories, sex and a CHA(2)DS(2)-VASc score of 0, 1, 2 and >= 3 and they were included in a time-varying analysis of warfarin treatment versus no treatment. The primary end-point was cerebral infarction and stroke, and patients were followed until 31 December 2009. Results Patients with 1 point from the CHA(2)DS(2)-VASc score showed the following adjusted hazard ratios (HR) with a 95% confidence interval: men 65-74 years 0.46 (0.25-0.83), men < 65 years 1.11 (0.56-2.23) and women < 65 years 2.13 (0.94-4.82), where HR < 1 indicates protection with warfarin. In patients < 65 years and 2 points, HR in men was 0.35 (0.18-0.69) and in women 1.84 (0.86-3.94) while, in women with at least 3 points, HR was 0.31 (0.16-0.59). In patients 65-74 years and 2 points, HR in men was 0.37 (0.23-0.59) and in women 0.39 ( 0.21-0.73). Categories including age >= 65 years or >= 3 points showed a statistically significant protection from warfarin. Conclusions Our results support that treatment with anticoagulation may be considered in all patients with an incident atrial fibrillation diagnosis and an age of 65 years and older, i.e. also when the CHA(2)DS(2)-VASc score is 1.	[Andersson, Tommy; Frobert, Ole; Poci, Dritan] Orebro Univ, Fac Hlth, Dept Cardiol, Orebro, Sweden; [Magnuson, Anders] Orebro Univ, Sch Med Sci, Clin Epidemiol & Biostat, Orebro, Sweden; [Bryngelsson, Ing-Liss] Orebro Univ, Dept Occupat & Environm Med, Orebro, Sweden; [Henriksson, Karin M.] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Edvardsson, Nils] Sahlgrens Univ Hosp, Sahlgrenska Acad, Gothenburg, Sweden	Orebro University; Orebro University; Orebro University; Uppsala University; Sahlgrenska University Hospital; University of Gothenburg	Andersson, T (corresponding author), Orebro Univ, Fac Hlth, Dept Cardiol, Orebro, Sweden.	catronius1970@yahoo.se	Poci, Dritan/B-4577-2009; Poci, Dritan/AAD-7067-2021	Frobert, Ole/0000-0002-5846-345X	Research Committee of orebro University [0LL 2012-265231]; AstraZeneca RD Molndal; orebro Heart Foundation	Research Committee of orebro University; AstraZeneca RD Molndal(AstraZeneca); orebro Heart Foundation	The study was supported by a grant from the Research Committee of orebro University (0LL 2012-265231), AstraZeneca R&D Molndal and the orebro Heart Foundation. AstraZeneca provided support in the form of salary for one author [KMH, at the time an employee of AstraZeneca] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the author contribution section.	Andersson T, 2013, EUR HEART J, V34, P1061, DOI 10.1093/eurheartj/ehs469; [Anonymous], 2010, KODN PAT SLUTNV 2008; Chao TF, 2015, J AM COLL CARDIOL, V65, P635, DOI 10.1016/j.jacc.2014.11.046; Coppens M, 2013, EUR HEART J, V34, P170, DOI 10.1093/eurheartj/ehs314; Friberg L, 2013, J Intern Med, V274, P461, DOI 10.1111/joim.12114; Friberg L, 2006, EUR HEART J, V27, P1954, DOI 10.1093/eurheartj/ehl146; Friberg L, 2015, J AM COLL CARDIOL, V65, P225, DOI 10.1016/j.jacc.2014.10.052; Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488; Friberg L, 2012, CIRCULATION, V125, P2298, DOI 10.1161/CIRCULATIONAHA.111.055079; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Hijazi Z, 2013, EUR HEART J, V34, P1475, DOI 10.1093/eurheartj/eht024; Hohnloser SH, 2007, J AM COLL CARDIOL, V50, P2156, DOI 10.1016/j.jacc.2007.07.076; Huang D, 2014, PACE, V37, P1442, DOI 10.1111/pace.12445; Kirchhof P., 2016, EUR HEART J; Leong DP, 2013, EUR HEART J, V34, P1027, DOI 10.1093/eurheartj/eht044; Lip GYH, 2015, J AM COLL CARDIOL, V65, P1385, DOI 10.1016/j.jacc.2015.01.044; Lip GYH, 2010, STROKE, V41, P2731, DOI 10.1161/STROKEAHA.110.590257; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Nielsen PB, 2015, THROMB HAEMOSTASIS, V113, P1170, DOI 10.1160/TH15-03-0210; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Sato H, 2006, STROKE, V37, P447, DOI 10.1161/01.STR.0000198839.61112.ee; Savino JA, 2016, CIRCULATION, V133, P1504, DOI 10.1161/CIRCULATIONAHA.115.016715; Sjalander S, 2014, EUROPACE, V16, P631, DOI 10.1093/europace/eut333; Sjolander M, 2015, STROKE, V46, P2220, DOI 10.1161/STROKEAHA.115.009718; Wieloch M, 2011, EUR HEART J, V32, P2282, DOI 10.1093/eurheartj/ehr134	28	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176846	10.1371/journal.pone.0176846	http://dx.doi.org/10.1371/journal.pone.0176846			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472091	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500084
J	Hayashida, T; Tsuchiya, K; Kikuchi, Y; Oka, S; Gatanaga, H				Hayashida, Tsunefusa; Tsuchiya, Kiyoto; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki			Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressors	PLOS ONE			English	Article							TREATMENT-NAIVE PATIENTS; REVERSE-TRANSCRIPTASE; ULTRA-DEEP; CORECEPTOR USAGE; TYPE-1 TROPISM; V3 REGION; IN-VIVO; POPULATION; MUTATIONS; AIDS	Objective The association between emergence of CXCR4-tropic HIV-1 variants (X4 variants) and disease progression of HIV-1 infection has been reported. However, it is not known whether the emergence of X4 variants is the cause or result of HIV-1 disease progression. We tried to answer this question. Design HIV-1 env sequences around the V3 region were analyzed in serially stocked samples in order to determine whether X4 variants emerged before or after the fall in CD4+ T-cell count. Methods The study subjects were five HIV-1-infected hemophiliac slow progressors. Deep sequencing around the HIV-1 env V3 region was conducted in duplicate. Tropism was predicted by geno2pheno [coreceptor] 2.5 with cutoff value of false positive ratio at <5%. When X4 variant was identified in the latest stocked sample before the introduction of antiretroviral therapy, we checked viral genotype in previously stocked samples to determine the time of emergence of X4 variants. Results Emergence of X4 variants was noted in two of the five patients when their CD4+ T-cell counts were still high. The rate of decrease of CD4+ T-cell count or of rise of HIV-1 load accelerated significantly after the emergence of X4 variants in these two cases. Phylogenetic analysis showed that these X4 variants emerged from CCR5-tropic HIV-1 viruses with several amino acid changes in the V3 region. Conclusions The emergence of X4 variants preceded HIV-1 disease progression in two hemophiliac slow progressors.	[Hayashida, Tsunefusa; Tsuchiya, Kiyoto; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Oka, Shinichi; Gatanaga, Hiroyuki] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	National Center for Global Health & Medicine - Japan; Kumamoto University	Gatanaga, H (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.; Gatanaga, H (corresponding author), Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan.	higatana@acc.ncgm.go.jp	Tsuchiya, Kiyoto/L-8650-2013	Tsuchiya, Kiyoto/0000-0002-8233-6653	Grant for National Center for Global Health and Medicine [28-SI-1102]; Japan Agency for Medical Research and Development (AMED) [AIDS-H26]	Grant for National Center for Global Health and Medicine; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by a Grant for National Center for Global Health and Medicine [28-SI-1102]; and a Grant from the Japan Agency for Medical Research and Development (AMED) [AIDS-H26]), which were received by HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Archer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049602; Armenia D, 2012, J INFECT DIS, V205, P557, DOI 10.1093/infdis/jir821; Bunnik EM, 2007, J VIROL, V81, P525, DOI 10.1128/JVI.01983-06; Bunnik EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002106; CORNELISSEN M, 1995, J VIROL, V69, P1810, DOI 10.1128/JVI.69.3.1810-1818.1995; Delobel P, 2007, J CLIN MICROBIOL, V45, P1572, DOI 10.1128/JCM.02090-06; Delobel P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021655; FENYO EM, 1989, AIDS, V3, pS5, DOI 10.1097/00002030-198901001-00002; Fisher R, 2012, J VIROL, V86, P6231, DOI 10.1128/JVI.06541-11; Gibson RM, 2014, ANTIMICROB AGENTS CH, V58, P2167, DOI 10.1128/AAC.02710-13; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Hayashida T, 2016, J ANTIMICROB CHEMOTH, V71, P2760, DOI 10.1093/jac/dkw224; Hazenberg MD, 2003, AIDS, V17, P1419, DOI 10.1097/00002030-200307040-00001; Hedskog C, 2013, AIDS RES HUM RETROV, V29, P1237, DOI [10.1089/aid.2012.0349, 10.1089/AID.2012.0349]; Ida S, 1997, AIDS RES HUM RETROV, V13, P1597, DOI 10.1089/aid.1997.13.1597; JI JP, 1994, VIROLOGY, V199, P323, DOI 10.1006/viro.1994.1130; Knoepfel SA, 2011, J VIROL METHODS, V171, P329, DOI 10.1016/j.jviromet.2010.11.016; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Lee GQ, 2013, AIDS RES HUM RETROV, V29, P979, DOI [10.1089/aid.2012.0338, 10.1089/AID.2012.0338]; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Messiaen P, 2012, VIROLOGY, V426, P7, DOI 10.1016/j.virol.2012.01.002; Ministry of Health Labour And Welfare, 2016, NAT SURV COAG DIS 20; Mohamed S, 2014, AIDS, V28, P1315, DOI 10.1097/QAD.0000000000000267; Mortier V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080259; Naganawa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003206; Naif HM, 2013, INFECT DIS REP, V5, P26, DOI 10.4081/idr.2013.s1.e6; Poon AFY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002753; Pou C, 2014, CLIN INFECT DIS, V59, P578, DOI 10.1093/cid/ciu287; Poveda E, 2012, AIDS REV, V14, P208; PRATT RD, 1995, J INFECT DIS, V172, P851, DOI 10.1093/infdis/172.3.851; Raymond S, 2011, AIDS, V25, P1668, DOI 10.1097/QAD.0b013e3283498305; Raymond S, 2010, AIDS, V24, P2305, DOI 10.1097/QAD.0b013e32833e50bb; Saliou A, 2011, ANTIMICROB AGENTS CH, V55, P2831, DOI 10.1128/AAC.00091-11; Shepherd JC, 2008, J INFECT DIS, V198, P1104, DOI 10.1086/591623; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Telenti A, 2014, NATURE, V511, P537, DOI 10.1038/nature13517; TERSMETTE M, 1989, LANCET, V1, P983; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Tsuchiya K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02389; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Verhofstede C, 2012, CURR OPIN HIV AIDS, V7, P432, DOI 10.1097/COH.0b013e328356f6f2; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Yin L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-108	45	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177033	10.1371/journal.pone.0177033	http://dx.doi.org/10.1371/journal.pone.0177033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472121	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500125
J	Hinz, L; Ahles, A; Ruprecht, B; Kuster, B; Engelhardt, S				Hinz, Laura; Ahles, Andrea; Ruprecht, Benjamin; Kuester, Bernhard; Engelhardt, Stefan			Two serines in the distal C-terminus of the human beta(1)-adrenoceptor determine beta-arrestin2 recruitment	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; BETA-ARRESTIN-BINDING; BIOSENSORS REVEAL; KINASE-A; PHOSPHORYLATION; ACTIVATION; INTERNALIZATION; VARIANTS; ADRENOCEPTORS; PHARMACOLOGY	G protein-coupled receptors (GPCRs) undergo phosphorylation at several intracellular residues by G protein-coupled receptor kinases. The resulting phosphorylation pattern triggers arrestin recruitment and receptor desensitization. The exact sites of phosphorylation and their function remained largely unknown for the human beta(1)-adrenoceptor (ADRB1), a key GPCR in adrenergic signal transduction and the target of widely used drugs such as beta-blockers. The present study aimed to identify the intracellular phosphorylation sites in the ADRB1 and to delineate their function. The human ADRB1 was expressed in HEK293 cells and its phosphorylation pattern was determined by mass spectrometric analysis before and after stimulation with a receptor agonist. We identified a total of eight phosphorylation sites in the receptor's third intracellular loop and C-terminus. Analyzing the functional relevance of individual sites using phosphosite-deficient receptor mutants we found phosphorylation of the ADRB1 at Ser461/Ser462 in the distal part of the C-terminus to determine beta-arrestin2 recruitment and receptor internalization. Our data reveal the phosphorylation pattern of the human ADRB1 and the site that mediates recruitment of beta-arrestin2.	[Hinz, Laura; Ahles, Andrea; Engelhardt, Stefan] Tech Univ Munich, Inst Pharmacol & Toxicol, Munich, Germany; [Ruprecht, Benjamin; Kuester, Bernhard] Tech Univ Munich, Chair Prote & Bioanalyt, Freising Weihenstephan, Germany; [Ruprecht, Benjamin; Kuester, Bernhard] Ctr Prot Sci Munich CIPSM, Freising Weihenstephan, Germany; [Kuester, Bernhard] German Canc Consortium DKTK, Heidelberg, Germany; [Kuester, Bernhard] German Canc Res Ctr, Heidelberg, Germany; [Kuester, Bernhard] Tech Univ Munich, Bavarian Biomol Mass Spectrometry Ctr, Freising Weihenstephan, Germany; [Engelhardt, Stefan] German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Ahles, A; Engelhardt, S (corresponding author), Tech Univ Munich, Inst Pharmacol & Toxicol, Munich, Germany.; Engelhardt, S (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany.	andrea.ahles@tum.de; stefan.engelhardt@tum.de	Engelhardt, Stefan/AAA-9329-2019	Engelhardt, Stefan/0000-0001-5378-8661	Deutsche Forschungsgemeinschaft (DEG); Bundesministerium fOr Bildung und Forschung (BMBF); Otto-Hess-Scholarship from the German Cardiac Society (DGK)	Deutsche Forschungsgemeinschaft (DEG)(German Research Foundation (DFG)); Bundesministerium fOr Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Otto-Hess-Scholarship from the German Cardiac Society (DGK)	The research was supported by grants of the Deutsche Forschungsgemeinschaft (DEG) and the Bundesministerium fOr Bildung und Forschung (BMBF). Laura Hinz received the Otto-Hess-Scholarship from the German Cardiac Society (DGK).	Ahles A, 2015, J BIOL CHEM, V290, P1760, DOI 10.1074/jbc.M114.607333; Ahles A, 2014, PHARMACOL REV, V66, P598, DOI 10.1124/pr.113.008219; Alvarez-Curto E, 2016, J BIOL CHEM, V291, P27147, DOI 10.1074/jbc.M116.754887; ANDERSSON L, 1986, ANAL BIOCHEM, V154, P250, DOI 10.1016/0003-2697(86)90523-3; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Chen Q, 2014, ARRESTINS PHARM THER; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Eichel K, 2016, NAT CELL BIOL, V18, P303, DOI 10.1038/ncb3307; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Evans BA, 2010, BRIT J PHARMACOL, V159, P1022, DOI 10.1111/j.1476-5381.2009.00602.x; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Gardner LA, 2004, J BIOL CHEM, V279, P21135, DOI 10.1074/jbc.M313652200; Gavi S, 2007, ENDOCRINOLOGY, V148, P2653, DOI 10.1210/en.2006-1569; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Hakalahti AE, 2013, MOL PHARMACOL, V83, P129, DOI 10.1124/mol.112.080440; Insel PA, 2007, BBA-BIOMEMBRANES, V1768, P994, DOI 10.1016/j.bbamem.2006.09.029; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kettenbach AN, 2011, ANAL CHEM, V83, P7635, DOI 10.1021/ac201894j; Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Laporte SA, 2002, J BIOL CHEM, V277, P9247, DOI 10.1074/jbc.M108490200; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Lefkowitz RJ, 2013, ANGEW CHEM INT EDIT, V52, P6366, DOI 10.1002/anie.201301924; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liang W, 2003, J BIOL CHEM, V278, P39773, DOI 10.1074/jbc.M304482200; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; McCrink KA, 2016, PHARMACOGENOMICS, V17, P1611, DOI 10.2217/pgs-2016-0094; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Nooh MM, 2014, J BIOL CHEM, V289, P2277, DOI 10.1074/jbc.M113.513481; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Orpana AK, 2012, ANAL CHEM, V84, P2081, DOI 10.1021/ac300040j; Ostermaier MK, 2014, CURR OPIN STRUC BIOL, V29, P143, DOI 10.1016/j.sbi.2014.07.006; Patel PA, 2008, CIRC J, V72, P1725, DOI 10.1253/circj.CJ-08-0734; Prihandoko R, 2016, MOL PHARMACOL, V89, P505, DOI 10.1124/mol.115.101949; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Ruprecht B, 2016, PROTEOMICS, V16, P1447, DOI 10.1002/pmic.201500523; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Smith JS, 2016, J BIOL CHEM; Tilley DG, 2009, J BIOL CHEM, V284, P20375, DOI 10.1074/jbc.M109.005793; VANBIESEN T, 1995, NATURE, V376, P781, DOI 10.1038/376781a0; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Zindel D, 2015, MOL PHARMACOL, V87, P349, DOI 10.1124/mol.114.095422	49	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176450	10.1371/journal.pone.0176450	http://dx.doi.org/10.1371/journal.pone.0176450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472170	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500047
J	Kim, GR; Choi, JS; Han, BK; Ko, EY; Ko, ES; Hahn, SY				Kim, Ga Ram; Choi, Ji Soo; Han, Boo-Kyung; Ko, Eun Young; Ko, Eun Sook; Hahn, Soo Yeon			Combination of shear-wave elastography and color Doppler: Feasible method to avoid unnecessary breast excision of fibroepithelial lesions diagnosed by core needle biopsy	PLOS ONE			English	Article							PHYLLODES TUMORS; HISTOLOGICAL FEATURES; US; FIBROADENOMA; SPECIFICITY; PROGRESSION; SONOGRAPHY	Background We evaluated shear-wave elastography (SWE) and color Doppler ultrasonography (US) features for fibroepithelial lesions (FELs), and to evaluate their utility to differentiate fibroadenomas (FAs) and phyllodes tumors (PTs). Methods This retrospective study included 67 FELs pathologically confirmed (49 FAs, 18 PTs). B-mode US, SWE and color Doppler US were performed for each lesion. Mean elasticity (E-mean), maximum elasticity (E-max), and vascularity were determined by SWE and Doppler US. Diagnostic performances were calculated to differentiate FAs and PTs. Equivocal FELs diagnosed by core needle biopsy (CNB) were further analyzed. Results Median E-mean and E-max were significantly lower for FAs than PTs (E-mean, 15.7 vs. 66.7 kPa; E-max, 21.0 vs. 76.7 kPa, P<0.01). Low vascularity (0-1 vessel flow) on color Doppler US were more frequent in FAs than in PTs (P<0.01). SWE showed significantly higher specificities (E-mean >43.9 kPa, 89.8%; E-max >46.1 kPa, 79.6%) than B-mode US (42.9%) (P<0.01) for differentiating PTs from FAs. Other diagnostic values of SWE and overall diagnostic values of Doppler US were not significantly different from B-mode US (P>0.05). The combination of SWE and Doppler US with 'E-mean>43.9 kPa or high vascularity (>= 2 vessel flows)' showed a higher area under the curve (0.786 vs. 0.687) and higher diagnostic values than B-mode US (sensitivity, 100 vs. 94.4%; specificity, 57.1 vs. 42.9%; positive predictive value, 46.2 vs. 37.8%; negative predictive value, 100 vs. 95.5%), without statistical significance (P>0.05). Of the 30 equivocal FELs, all lesions with 'E-mean <= 43.9 kPa and low vascularity (0-1 vessel flow)' (23.3%, 7/30) were finally confirmed as FAs by excision. Conclusion FAs have a tendency to have less stiffness and lower vascularity than PTs. Combined SWE and color Doppler US may help patients with equivocal FELs diagnosed by CNB avoid unnecessary excision.	[Kim, Ga Ram; Choi, Ji Soo; Han, Boo-Kyung; Ko, Eun Young; Ko, Eun Sook; Hahn, Soo Yeon] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Radiol, Seoul, South Korea; [Kim, Ga Ram] Inha Univ, Inha Univ Hosp, Dept Radiol, Incheon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Inha University; Inha University Hospital	Choi, JS (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Radiol, Seoul, South Korea.	jisoo.choi@samsung.com						Adamietz BR, 2011, ULTRASCHALL MED, V32, P67, DOI 10.1055/s-0031-1282024; Bae JS, 2017, EUR RADIOL, V27, P7, DOI 10.1007/s00330-016-4359-6; Ben hassouna J, 2006, AM J SURG, V192, P141, DOI 10.1016/j.amjsurg.2006.04.007; BENNETT BM, 1972, BIOMETRICS, V28, P793, DOI 10.2307/2528763; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Blanco AJ, 1999, EUR RADIOL, V9, P356, DOI 10.1007/s003300050680; Chao TC, 2003, EUR RADIOL, V13, P88, DOI 10.1007/s00330-002-1370-x; Chao TC, 2002, ULTRASOUND OBST GYN, V20, P64, DOI 10.1046/j.1469-0705.2002.00736.x; Choi JS, 2016, EUR RADIOL, V26, P3542, DOI 10.1007/s00330-015-4201-6; Choi J, 2012, PATHOL INT, V62, P120, DOI 10.1111/j.1440-1827.2011.02761.x; Ciatto S, 2007, BREAST CANCER RES TR, V101, P291, DOI 10.1007/s10549-006-9289-6; D'Orsi CJ., 2013, ACR BI RADS ATLAS BR; Duman L, 2016, BREAST CARE, V11, P123, DOI 10.1159/000444377; Jacklin RK, 2006, J CLIN PATHOL, V59, P454, DOI 10.1136/jcp.2005.025866; Jacobs TW, 2005, AM J CLIN PATHOL, V124, P342, DOI 10.1309/5N2C4N5XCV8XW8JL; Karim RZ, 2013, J CLIN PATHOL, V66, P496, DOI 10.1136/jclinpath-2012-201082; KEELAN PA, 1992, HUM PATHOL, V23, P1048, DOI 10.1016/0046-8177(92)90268-8; Kim EK, 2008, AM J ROENTGENOL, V190, P1209, DOI 10.2214/AJR.07.3259; Kuijper A, 2002, J PATHOL, V197, P575, DOI 10.1002/path.1161; Lee AHS, 2007, HISTOPATHOLOGY, V51, P336, DOI 10.1111/j.1365-2559.2007.02786.x; Lee SH, 2014, RADIOLOGY, V273, P61, DOI 10.1148/radiol.14132443; Li LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085257; MCNICHOLAS MMJ, 1993, AM J ROENTGENOL, V161, P765, DOI 10.2214/ajr.161.4.8372754; Mishra SP, 2013, ISRN SURG, V2013, DOI [DOI 10.1155/2013/361469, 10.1155/2013/361469]; NOGUCHI S, 1995, CANCER, V76, P1779, DOI 10.1002/1097-0142(19951115)76:10<1779::AID-CNCR2820761015>3.0.CO;2-0; Ozdemir A, 2001, J ULTRAS MED, V20, P1091; Ozdemir A, 2001, J ULTRAS MED, V20, P1102; Park HL, 2012, J BREAST CANCER, V15, P224, DOI 10.4048/jbc.2012.15.2.224; Raza S, 1997, RADIOLOGY, V203, P164, DOI 10.1148/radiology.203.1.9122386; Resetkova E, 2010, BREAST J, V16, P573, DOI 10.1111/j.1524-4741.2010.01013.x; ROWELL MD, 1993, AM J SURG, V165, P376, DOI 10.1016/S0002-9610(05)80849-9; Simsir A, 2012, DIAGN CYTOPATHOL, V40, P262, DOI 10.1002/dc.21630; Skerl K, 2015, CLIN RADIOL, V70, P1421, DOI 10.1016/j.crad.2015.08.010; Tan PH, 2013, J CLIN PATHOL, V66, P465, DOI 10.1136/jclinpath-2012-201078; Wiratkapun C, 2014, DIAGN INTERV RADIOL, V20, P27, DOI 10.5152/dir.2013.13133; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	36	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175380	10.1371/journal.pone.0175380	http://dx.doi.org/10.1371/journal.pone.0175380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472030	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500010
J	Rame, M; Caudal, D; Schenker, E; Svenningsson, P; Spedding, M; Jay, TM; Godsil, BP				Rame, Marion; Caudal, Dorian; Schenker, Esther; Svenningsson, Per; Spedding, Michael; Jay, Therese M.; Godsil, Bill P.			Clozapine counteracts a ketamine-induced depression of hippocampal-prefrontal neuroplasticity and alters signaling pathway phosphorylation	PLOS ONE			English	Article							METHYL-D-ASPARTATE; NMDA RECEPTOR BLOCKADE; FUNCTIONAL CONNECTIVITY; SYNAPTIC PLASTICITY; PSYCHOTIC SYMPTOMS; AMPA-RECEPTOR; CORTEX; RAT; DOPAMINE; STRESS	Single sub-anesthetic doses of ketamine can exacerbate the symptoms of patients diagnosed with schizophrenia, yet similar ketamine treatments rapidly reduce depressive symptoms in major depression. Acute doses of the atypical antipsychotic drug clozapine have also been shown to counteract ketamine-induced psychotic effects. In the interest of understanding whether these drug effects could be modeled with alterations in neuroplasticity, we examined the impact of acutely-administered ketamine and clozapine on in vivo long-term potentiation (LTP) in the rat's hippocampus-to-prefrontal cortex (H-PFC) pathway. We found that a low dose of ketamine depressed H-PFC LTP, whereas animals that were co-administrated the two drugs displayed LTP that was similar to a saline-treated control. To address which signaling molecules might mediate such effects, we also examined phosphorylation and total protein levels of GSK3 beta, GluA1, TrkB, ERK, and mTOR in prefrontal and hippocampal sub-regions. Among the statistically significant effects that were detected (a) both ketamine and clozapine increased the phosphorylation of Ser9-GSK3 beta throughout the prefrontal cortex and of Ser2481-mTOR in the dorsal hippocampus (DH), (b) clozapine increased the phosphorylation of Ser831-GluA1 throughout the prefrontal cortex and of Ser845-GluA1 in the ventral hippocampus, (c) ketamine treatment increased the phosphorylation of Thr202/ Tyr204-ERK in the medial PFC (mPFC), and (d) clozapine treatment was associated with decreases in the phosphorylation of Tyr705-TrkB in the DH and of Try816-TrkB in the mPFC. Further analyses involving phosphorylation effect sizes also suggested Ser831-GluA1 in the PFC displayed the highest degree of clozapine-responsivity relative to ketamine. These results provide evidence for how ketamine and clozapine treatments affect neuroplasticity and signaling pathways in the stress-sensitive H-PFC network. They also demonstrate the potential relevance of H-PFC pathway neuroplasticity for modeling ketamine-clozapine interactions in regards to psychosis.	[Rame, Marion; Jay, Therese M.; Godsil, Bill P.] Ctr Psychiat & Neurosci, INSERM, Lab Physiopathol Malad Psychiat, UMR S894, Paris, France; [Rame, Marion; Jay, Therese M.; Godsil, Bill P.] Sorbonne Paris Cite, Univ Paris Descartes, Paris, France; [Caudal, Dorian; Svenningsson, Per] Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Stockholm, Sweden; [Schenker, Esther; Spedding, Michael] Inst Rech Servier, Croissy Sur Seine, France; [Spedding, Michael] Spedding Res Solut SAS, Le Vesinet, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Servier; Institut de Recherches Internationales Servier	Godsil, BP (corresponding author), Ctr Psychiat & Neurosci, INSERM, Lab Physiopathol Malad Psychiat, UMR S894, Paris, France.; Godsil, BP (corresponding author), Sorbonne Paris Cite, Univ Paris Descartes, Paris, France.	bp.godsil@gmail.com	Spedding, Michael/AAE-7342-2019; Jay, Therese M/G-2297-2015; Svenningsson, Per JL/K-5210-2014	Spedding, Michael/0000-0002-1248-8221; Jay, Therese M/0000-0002-2468-1141; Caudal, Dorian/0000-0003-4288-3801; Godsil, Bill/0000-0001-7248-4292	Innovative Medicines Initiative Joint Undertaking (IMI) [115008]; INSERM; University Paris Descartes; La Fondation Deniker; Servier	Innovative Medicines Initiative Joint Undertaking (IMI); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris Descartes; La Fondation Deniker; Servier(Servier)	The research leading to these results was carried out as part of the Innovative Medicines Initiative Joint Undertaking (IMI) under Grant Agreement No 115008. IMI is a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations. http://www.newmeds-europe.com/. The Karolinska Institute and Servier were partners in NEWMEDS and Servier was subcontracting TMJ. Part of the present study was financed as in-cash-contributions by Servier. These in-cash contributions went to TMJ and PS. Additional support came from grants from INSERM, University Paris Descartes, and La Fondation Deniker. The funders provided support in the form of salaries for authors MR, DC, and BPG. ES is a full-time employee of Servier. MS was a full-time employee of Servier and is now a consultant (Spedding Research Solutions SAS). The specific roles of these authors are articulated in the 'author contributions' section.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Adler CM, 1999, AM J PSYCHIAT, V156, P1646, DOI 10.1176/ajp.156.10.1646; Ahs F, 2015, NEUROIMAGE, V122, P262, DOI 10.1016/j.neuroimage.2015.07.051; Amargos-Bosch M, 2006, INT J NEUROPSYCHOPH, V9, P565, DOI 10.1017/S1461145705005900; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beurel E, 2011, MOL PSYCHIATR, V16, P1068, DOI 10.1038/mp.2011.47; Blot K, 2015, CEREB CORTEX, V25, P1348, DOI 10.1093/cercor/bht329; Bunzow JR, 1991, CLONING GENE HUMAN D; Carreno FR, 2016, MOL PSYCHIATR, V21, P1298, DOI 10.1038/mp.2015.176; Caudal D, 2016, CELLULAR MOL NEUROBI; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Chen L, 2002, J NEUROPHYSIOL, V87, P2324, DOI 10.1152/jn.2002.87.5.2324; Coe R., 2002, STUPID WHAT EFFECT S; Corcoran C, 2003, SCHIZOPHRENIA BULL, V29, P671, DOI 10.1093/oxfordjournals.schbul.a007038; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Duman RS, 2012, NEUROPHARMACOLOGY, V62, P35, DOI 10.1016/j.neuropharm.2011.08.044; Duncan GE, 1998, BRAIN RES, V812, P65, DOI 10.1016/S0006-8993(98)00926-3; Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873; Gao WJ, 2007, J NEUROPHYSIOL, V97, P1196, DOI 10.1152/jn.00400.2006; Gass N, 2014, NEUROPSYCHOPHARMACOL, V39, P895, DOI 10.1038/npp.2013.290; Godsil BP, 2013, EUR NEUROPSYCHOPHARM, V23, P1165, DOI 10.1016/j.euroneuro.2012.10.018; Grimm O, 2015, PSYCHOPHARMACOLOGY, V232, P4231, DOI 10.1007/s00213-015-4022-y; Hadley JA, 2014, NEUROPSYCHOPHARMACOL, V39, P1020, DOI 10.1038/npp.2013.305; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Hudson MR, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.51; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; JAY TM, 1995, EUR J NEUROSCI, V7, P247, DOI 10.1111/j.1460-9568.1995.tb01060.x; Jin J, 2015, SCI REPORTS, P5; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kamiyama H, 2011, NEUROSCIENCE, V177, P159, DOI 10.1016/j.neuroscience.2010.12.012; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; Kole MHP, 2002, EUR J NEUROSCI, V16, P807, DOI 10.1046/j.1460-9568.2002.02136.x; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Kubota T, 1996, NEUROSCI LETT, V211, P21, DOI 10.1016/0304-3940(96)12709-9; Kubota T, 1999, CAN J ANAESTH, V46, P388, DOI 10.1007/BF03013235; LAHTI AC, 1995, NEUROPSYCHOPHARMACOL, V13, P9, DOI 10.1016/0893-133X(94)00131-I; Li J, 2014, NEUROPSYCHOPHARMACOL, V39, P1635, DOI 10.1038/npp.2014.10; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Liu RJ, 2013, NEUROPSYCHOPHARMACOL, V38, P2268, DOI 10.1038/npp.2013.128; Llado-Pelfort L, 2016, EUR NEUROPSYCHOPHARM, V26, P614, DOI 10.1016/j.euroneuro.2015.11.015; Lopez JF, 1999, BIOL PSYCHIAT, V46, P1461, DOI 10.1016/S0006-3223(99)00266-8; Lorrain DS, 2003, NEUROSCIENCE, V117, P697, DOI 10.1016/S0306-4522(02)00652-8; Luckenbaugh DA, 2014, J AFFECT DISORDERS, V159, P56, DOI 10.1016/j.jad.2014.02.017; MACDONALD JF, 1991, J PHYSIOL-LONDON, V432, P483, DOI 10.1113/jphysiol.1991.sp018396; Mailliet F, 2008, EXP NEUROL, V211, P593, DOI 10.1016/j.expneurol.2008.02.030; Malhotra AK, 1997, NEUROPSYCHOPHARMACOL, V17, P141; Malhotra AK, 1997, BIOL PSYCHIAT, V42, P664, DOI 10.1016/S0006-3223(96)00546-X; Matsumoto M, 2008, BRAIN RES, V1195, P50, DOI 10.1016/j.brainres.2007.12.010; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Naughton M, 2014, J AFFECT DISORDERS, V156, P24, DOI 10.1016/j.jad.2013.11.014; Nelson CL, 2002, PSYCHOPHARMACOLOGY, V161, P168, DOI 10.1007/s00213-002-1004-7; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Popp S., 2016, F1000RESEARCH, V5; Qi HS, 2009, NEUROPHARMACOLOGY, V56, P37, DOI 10.1016/j.neuropharm.2008.06.068; Rocher C, 2004, CEREB CORTEX, V14, P224, DOI 10.1093/cercor/bhg122; Rocher C, 2003, ACUTE LOW DOSE CLOZA; Roh MS, 2007, EXP MOL MED, V39, P353, DOI 10.1038/emm.2007.39; Rotarska-Jagiela A, 2010, SCHIZOPHR RES, V117, P21, DOI 10.1016/j.schres.2010.01.001; Rubinstein M, 2001, J NEUROSCI, V21, P3756, DOI 10.1523/JNEUROSCI.21-11-03756.2001; Schwarz AJ, 2013, NEUROSCIENCE, V228, P243, DOI 10.1016/j.neuroscience.2012.10.032; Sebban C, 2002, BRIT J PHARMACOL, V135, P65, DOI 10.1038/sj.bjp.0704451; Sebban C, 1999, BRIT J PHARMACOL, V128, P1055, DOI 10.1038/sj.bjp.0702893; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Svenningsson P, 2000, P NATL ACAD SCI USA, V97, P1856, DOI 10.1073/pnas.97.4.1856; Swerdlow NR, 1998, PSYCHOPHARMACOLOGY, V140, P75, DOI 10.1007/s002130050741; Troyano-Rodriguez E, 2014, BIOL PSYCHIAT, V76, P937, DOI 10.1016/j.biopsych.2014.05.019; Varese F, 2012, SCHIZOPHRENIA B; Wedzony K, 2000, J PHYSIOL PHARMACOL, V51, P205; Yuen EY, 2010, P NATL ACAD SCI USA, V107, P22308, DOI 10.1073/pnas.1010025108; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhang H, 2013, MOL PSYCHIATR, V18, P471, DOI 10.1038/mp.2012.80; Zheng WH, 2012, BRAIN RES, V1470, P145, DOI 10.1016/j.brainres.2012.06.032; Zhou YA, 2008, SCHIZOPHR RES, V100, P120, DOI 10.1016/j.schres.2007.11.039	79	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177036	10.1371/journal.pone.0177036	http://dx.doi.org/10.1371/journal.pone.0177036			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472198	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500126
J	Riley, ME; Griffen, BD				Riley, Megan E.; Griffen, Blaine D.			Habitat-specific differences alter traditional biogeographic patterns of life history in a climate-change induced range expansion	PLOS ONE			English	Article							MANGROVE TREE CRAB; BERGMANNS RULE; EVOLUTION; TEMPERATURE; RESPONSES; SIZE; PREDATION; CONSEQUENCES; GRADIENT; ECOLOGY	Range shifts and expansions resulting from global climate change have the potential to create novel communities with unique plant-animal interactions. Organisms expanding their range into novel biotic and abiotic environments may encounter selection pressures that alter traditional biogeographic patterns of life history traits. Here, we used field surveys to examine latitudinal patterns of life history traits in a broadly distributed ectotherm (mangrove tree crab Aratus pisonii) that has recently experienced a climate change-induced range expansion into a novel habitat type. Additionally, we conducted laboratory and field experiments to investigate characteristics associated with these life history traits (e.g. fecundity, offspring quality, and potential selection pressures). We compared these characteristics in native mangrove habitats in which the species has historically dwelled and novel salt marsh habitats into which the species has recently expanded its range. Consistent with traditional biogeographic concepts (i.e. Bergmann's clines), size at maturity and mean body size of reproductive females increased with latitude within the native habitat. However, they decreased significantly in novel habitats at the highest latitudes of the species' range, which was consistent with habitat-specific differences in both biotic (predation) and abiotic (temperature) selection pressures. Although initial maternal investment (egg volume and weight) did not differ between habitats, fecundity was lower in novel habitats as a result of differences in size at reproduction. Offspring quality, as measured by larval starvation resistance, was likewise diminished in novel habitats relative to native habitats. These differences in off-spring quality may have enduring consequences for species success and persistence in novel habitats. Life history characteristics such as those investigated here are fundamental organismal traits; consequently, understanding the potential impacts of climate change responses on latitudinal patterns of these traits is key to understanding climate change impacts on natural systems.	[Riley, Megan E.; Griffen, Blaine D.] Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Griffen, Blaine D.] Univ South Carolina, Sch Earth Ocean & Environm, Marine Sci Program, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia	Riley, ME (corresponding author), Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	riley.megan.e@gmail.com	Griffen, Blaine/AAC-6384-2021		National Science Foundation [OCE-1129166]; Smithsonian Institution Predoctoral Fellowship; Slocum-Lunz Foundation; University of South Carolina SPARC Graduate Research Fellowship	National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution Predoctoral Fellowship(Smithsonian Institution); Slocum-Lunz Foundation; University of South Carolina SPARC Graduate Research Fellowship	This research was supported by a National Science Foundation grant to BG (OCE-1129166), a Smithsonian Institution Predoctoral Fellowship to MR, a Slocum-Lunz Foundation grant to MR, and a University of South Carolina SPARC Graduate Research Fellowship to MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2003, AM NAT, V162, P332; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; BEEVER JW, 1979, OECOLOGIA, V43, P317, DOI 10.1007/BF00344958; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; Chapperon C, 2011, GLOBAL CHANGE BIOL, V17, P1740, DOI 10.1111/j.1365-2486.2010.02356.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chuang A, 2016, GLOBAL CHANGE BIOL, V22, P494, DOI 10.1111/gcb.13107; CONDE JE, 1989, ESTUAR COAST SHELF S, V28, P639, DOI 10.1016/0272-7714(89)90051-6; D'Odorico P, 2013, GLOBAL ECOL BIOGEOGR, V22, P364, DOI 10.1111/geb.12000; Diamond SE, 2010, AM NAT, V175, P1, DOI 10.1086/648602; Erickson AA, 2003, J EXP MAR BIOL ECOL, V289, P123, DOI 10.1016/S0022-0981(03)00039-X; Griffen BD, 2014, OECOLOGIA, V174, P121, DOI 10.1007/s00442-013-2751-3; Gutowsky LFG, 2012, FISHERIES MANAG ECOL, V19, P78, DOI 10.1111/j.1365-2400.2011.00831.x; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hartnoll RG, 2001, HYDROBIOLOGIA, V449, P111, DOI 10.1023/A:1017597104367; Hassall C, 2014, GLOBAL CHANGE BIOL, V20, P475, DOI 10.1111/gcb.12340; Hildrew Alan G., 2007, P326; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; HINES AH, 1982, MAR BIOL, V69, P309, DOI 10.1007/BF00397496; Horne CR, 2015, ECOL LETT, V18, P327, DOI 10.1111/ele.12413; Jannett FJ, 2007, AM MIDL NAT, V158, P168, DOI 10.1674/0003-0031(2007)158[168:NREOMS]2.0.CO;2; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Kilada R, 2012, CAN J FISH AQUAT SCI, V69, P1728, DOI 10.1139/cjfas-2012-0254; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; le Roux PC, 2008, GLOBAL CHANGE BIOL, V14, P2950, DOI 10.1111/j.1365-2486.2008.01687.x; Lurgi M, 2012, PHILOS T R SOC B, V367, P2913, DOI 10.1098/rstb.2012.0238; Manyak-Davis A, 2013, AM NAT, V182, P347, DOI 10.1086/671170; Merila J, 2014, EVOL APPL, V7, P1, DOI 10.1111/eva.12137; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pedraza-Garcia M, 2012, CRUSTACEANA, V85, P635, DOI 10.1163/156854012X643924; PETERSON CH, 1994, MAR ECOL PROG SER, V111, P289, DOI 10.3354/meps111289; Phillips BL, 2010, ECOLOGY, V91, P1617, DOI 10.1890/09-0910.1; Pitt NR, 2010, MAR FRESHWATER RES, V61, P963, DOI 10.1071/MF09225; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Prowse TAA, 2015, J ANIM ECOL, V84, P299, DOI 10.1111/1365-2656.12273; Ray C., 1960, J MORPHOL, V106, P88; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Riley ME, 2014, SOUTHEAST NAT, V13, pN43, DOI 10.1656/058.013.0405; Riley ME, 2014, AQUAT BIOL, V20, P35, DOI 10.3354/ab00543; Sanford E, 2006, ECOLOGY, V87, P2882, DOI 10.1890/0012-9658(2006)87[2882:LTGFAT]2.0.CO;2; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Vogt G, 2012, ZOOL ANZ, V251, P1, DOI 10.1016/j.jcz.2011.05.003; Walsh MR, 2009, EVOLUTION, V63, P3201, DOI 10.1111/j.1558-5646.2009.00785.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WARNER GF, 1967, J ZOOL, V153, P321, DOI 10.1111/j.1469-7998.1967.tb04066.x; Watt C, 2010, OIKOS, V119, P89, DOI 10.1111/j.1600-0706.2009.17959.x; Williams AA, 2014, SOUTHEAST NAT, V13, P56, DOI 10.1656/058.013.0104; WILSON KA, 1989, B MAR SCI, V44, P263	55	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176263	10.1371/journal.pone.0176263	http://dx.doi.org/10.1371/journal.pone.0176263			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472189	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500032
J	De Gregorio, PR; Michavila, G; Muller, LR; Borges, CD; Pomares, MF; de Sa, ELS; Pereira, C; Vincent, PA				Romina De Gregorio, Priscilla; Michavila, Gabriela; Muller, Lenise Ricciardi; Borges, Clarissa de Souza; Fernanda Pomares, Maria; Sacco de Sa, Enilson Luiz; Pereira, Claudio; Andrea Vincent, Paula			Beneficial rhizobacteria immobilized in nanofibers for potential application as soybean seed bioinoculants	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIA; NITROGEN-FIXATION; AZOSPIRILLUM-BRASILENSE; POLY(VINYL ALCOHOL); PLANT; ENCAPSULATION; BACTERIA; INOCULATION; IMPROVEMENT; NODULATION	Seed inoculation with plant growth promoting rhizobacteria (PGPR) is an ideal tool to supply the soil with a high density of beneficial microorganisms. However, maintaining viable microorganisms is a major problem during seed treatment and storage. In this work, an evaluation was made of the effect of bacterial immobilization in nanofibers on the stability (viability and maintenance of beneficial properties) of two potential PGPR, Pantoea agglomerans ISIB55 and Burkholderia caribensis ISIB40. Moreover, the impact of soybean seed coating with nanofiber-immobilized rhizobacteria on bacterial survival during seed storage and on germination and plant growth parameters was determined. Bacterial nanoimmobilization and subsequent seed coating with nanofiber-immobilized rhizobacteria were carried out by electrospinning. The results demonstrate that this technique successfully immobilized P. agglomerans ISIB55 and B. caribensis ISIB40 because it did not affect the viability or beneficial properties of either rhizobacteria. Seed coating with nanofiber-immobilized rhizobacteria improved P. agglomerans ISIB55 and B. caribensis ISIB40 survival on seeds stored for 30 days and contributed to the successful colonization of both bacteria on the plant root. Moreover, seed coating with P. agglomerans ISIB55 increased germination, length and dry weight of the root. Furthermore, seed coating with B. caribensis ISIB40 increased leaf number and dry weight of the shoot. Therefore, the technique applied in the present work to coat seeds with nanofiber-immobilized PGPR could be considered a promising eco-friendly approach to improve soybean production using a microbial inoculant.	[Romina De Gregorio, Priscilla; Michavila, Gabriela; Fernanda Pomares, Maria; Andrea Vincent, Paula] UNT, CONICET, Inst Super Invest Biol INSIBIO, Chacabuco 461, San Miguel De Tucuman, Argentina; [Romina De Gregorio, Priscilla; Michavila, Gabriela; Fernanda Pomares, Maria; Andrea Vincent, Paula] UNT, Fac Bioquim Quim & Farm, Inst Quim Biol Dr Bernabe Bloj, Chacabuco 461, Porto Alegre, RS, Brazil; [Muller, Lenise Ricciardi; Pereira, Claudio] Tecnano Prod & Serv Ltda, Rua Washington Luiz 675, Porto Alegre, RS, Brazil; [Borges, Clarissa de Souza; Sacco de Sa, Enilson Luiz] Univ Fed Rio Grande do Sul, Fac Agron, Dept Solos, Ave Bento Goncalves 7712, Porto Alegre, RS, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman; Universidade Federal do Rio Grande do Sul	Vincent, PA (corresponding author), UNT, CONICET, Inst Super Invest Biol INSIBIO, Chacabuco 461, San Miguel De Tucuman, Argentina.; Vincent, PA (corresponding author), UNT, Fac Bioquim Quim & Farm, Inst Quim Biol Dr Bernabe Bloj, Chacabuco 461, Porto Alegre, RS, Brazil.	pvincent@fbqf.unt.edu.ar	de Sá, Enilson Luiz Saccol/AAE-1486-2019; De Gregorio, Priscilla/AAC-9013-2022	de Sá, Enilson Luiz Saccol/0000-0002-7796-0857; De Gregorio, Priscilla Romina/0000-0002-9697-0911	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPGyT) [PICT 2991, PICT 2222]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 0972]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [FAPERGS 16/2013 - TECNOVA/RS, 1433-2551/14-8]; CONICET; CNPq	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPGyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by grants PICT 2991 and PICT 2222 from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPGyT), PIP 0972 from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil) and FAPERGS 16/2013 - TECNOVA/RS, 1433-2551/14-8 from the Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS). PRD and GM were recipients of a fellowship from CONICET. LM is a Tecnano Ltda. technician. CSB was a recipient of a fellowship from CNPq. MFP and PAV are Career Investigators from CONICET. ELS is Associate professor at the Federal University of Rio Grande do Sul. CP is Tecnano Ltda. Researcher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesemoye AO, 2009, MICROB ECOL, V58, P921, DOI 10.1007/s00248-009-9531-y; Ahmed A, 2014, POL J MICROBIOL, V63, P261; Albareda M, 2009, F CROP RES, V113, P325; Ali N, 2010, SOYBEAN: BOTANY, PRODUCTION AND USES, P345, DOI 10.1079/9781845936440.0345; Amalraj L., 2013, J PLANT PHYSL PATHOL, V1; Asghar HN, 2002, BIOL FERT SOILS, V35, P231, DOI 10.1007/s00374-002-0462-8; Atefan M., 2008, ANALELE STIINTIFICE, V3, P105; Bashan Y, 2002, BIOL FERT SOILS, V35, P359, DOI 10.1007/s00374-002-0481-5; Bashan Y, 1999, APPL MICROBIOL BIOT, V51, P262, DOI 10.1007/s002530051391; Bashan Y, 2014, PLANT SOIL, V378, P1, DOI 10.1007/s11104-013-1956-x; Beneduzi A, 2012, GENET MOL BIOL, V35, P1044, DOI 10.1590/S1415-47572012000600020; Benizri E, 2001, BIOCONTROL SCI TECHN, V11, P557, DOI 10.1080/09583150120076120; Castaneda L., 2014, J RES UPDAT POLYM SC, V3, P33, DOI [10.6000/1929-5995.2014.03.01.5, DOI 10.6000/1929-5995.2014.03.01.5]; Castanheira EG, 2013, J CLEAN PROD, V54, P49, DOI 10.1016/j.jclepro.2013.05.026; Cavalett O, 2010, J CLEAN PROD, V18, P55, DOI 10.1016/j.jclepro.2009.09.008; Chen WM, 2003, J BACTERIOL, V185, P7266, DOI 10.1128/JB.185.24.7266-7272.2003; Chiarini L, 2006, TRENDS MICROBIOL, V14, P277, DOI 10.1016/j.tim.2006.04.006; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Damasceno R, 2013, CAN J MICROBIOL, V59, P716, DOI 10.1139/cjm-2013-0508; Datta C, 2000, MICROBIOL RES, V155, P123, DOI 10.1016/S0944-5013(00)80047-6; Deaker R, 2004, SOIL BIOL BIOCHEM, V36, P1275, DOI 10.1016/j.soilbio.2004.04.009; Deaker R, 2007, SOIL BIOL BIOCHEM, V39, P573, DOI 10.1016/j.soilbio.2006.09.005; Deaker R, 2012, AGRICULTURE-BASEL, V2, P38, DOI 10.3390/agriculture2010038; Denardin ND, 2000, WORLD J MICROB BIOT, V16, P215, DOI 10.1023/A:1008914223467; Fernandes PI, 2009, PESQUI AGROPECU BRAS, V44, P1184, DOI 10.1590/S0100-204X2009000900017; Figueiredo MVB, 2008, WORLD J MICROB BIOT, V24, P1187, DOI 10.1007/s11274-007-9591-4; Frickmann H, 2014, EUR J MICROBIOL IMMU, V4, P106, DOI 10.1556/EuJMI.4.2014.2.3; Fung WY, 2011, J AGR FOOD CHEM, V59, P8140, DOI 10.1021/jf2009342; Garret RD, 2013, ENVIRON RES LETT, V8, P1; GHOLAMI A, 2009, WORLD ACAD SCI ENG T, V49, P19; Gui-Bo Y, 2010, J BIOMED MATER RES A, V93A, P158, DOI 10.1002/jbm.a.32496; Hartmann A, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P115, DOI 10.1007/0-387-30745-1_6; HUME DJ, 1992, CAN J MICROBIOL, V38, P588, DOI 10.1139/m92-097; John RP, 2011, CRIT REV BIOTECHNOL, V31, P211, DOI 10.3109/07388551.2010.513327; Tomas MSJ, 2015, EUR J PHARM SCI, V79, P87, DOI 10.1016/j.ejps.2015.08.010; Kan GZ, 2015, MOL GENET GENOMICS, V290, P2147, DOI 10.1007/s00438-015-1066-y; Koberg M, 2011, BIORESOURCE TECHNOL, V102, P1073, DOI 10.1016/j.biortech.2010.08.055; Krishnamoorthy V, 2016, NEW J CHEM, V40, P3268, DOI 10.1039/c5nj03008k; Lin QQ, 2012, SENSOR ACTUAT B-CHEM, V161, P967, DOI 10.1016/j.snb.2011.11.074; Linu M. S., 2009, International Journal of Agricultural Research, V4, P79; Lopez-Rubio A, 2009, BIOMACROMOLECULES, V10, P2823, DOI 10.1021/bm900660b; Lupwayi NZ, 2000, FIELD CROP RES, V65, P259, DOI 10.1016/S0378-4290(99)00091-X; Martins LMV, 2003, BIOL FERT SOILS, V38, P333, DOI 10.1007/s00374-003-0668-4; Mohite B, 2013, J SOIL SCI PLANT NUT, V13, P638, DOI 10.4067/S0718-95162013005000051; O'Callaghan M., 2012, Agronomy New Zealand, V42, P149; O'Callaghan M, 2016, APPL MICROBIOL BIOT, V100, P5729, DOI 10.1007/s00253-016-7590-9; Oteino N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00745; Pajak J, 2010, CHEMIK, V64, P523; Pan YL, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0109-7; Parra-Cota FI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088094; Paungfoo-Lonhienne C, 2014, MICROB BIOTECHNOL, V7, P142, DOI 10.1111/1751-7915.12105; Raj N, 2004, INT J PEST MANAGE, V50, P41, DOI 10.1080/09670870310001626365; Raju NS, 1999, J SCI FOOD AGR, V79, P206, DOI 10.1002/(SICI)1097-0010(199902)79:2&lt;206::AID-JSFA167&gt;3.0.CO;2-Y; Roy B. D., 2013, African Journal of Agricultural Research, V8, P349; Saharan BC, 2011, LIFE SCI MED RES, V21, P1, DOI DOI 10.4172/2157-7471.1000266; Salalha W, 2006, NANOTECHNOLOGY, V17, P4675, DOI 10.1088/0957-4484/17/18/025; Santoro MV, 2015, PLANT BIOLOGY, V17, P1218, DOI 10.1111/plb.12351; Sayyed R. Z., 2005, Indian Journal of Biotechnology, V4, P484; Silini-Cherif H, 2012, Pak J Biol Sci, V15, P267, DOI 10.3923/pjbs.2012.267.276; Tortora ML, 2011, ARCH MICROBIOL, V193, P275, DOI 10.1007/s00203-010-0672-7; Ulzen J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01770; Vejan P, 2016, MOLECULES, V21, DOI 10.3390/molecules21050573; Verma S, 2012, FOLIA MICROBIOL, V57, P525, DOI 10.1007/s12223-012-0163-0; Wang HS, 2009, RECENT PAT NANOTECH, V3, P21, DOI 10.2174/187221009787003285; Wang SD, 2014, MATER RES EXPRESS, V1, DOI 10.1088/2053-1591/1/2/025406; Wang X, 2013, CATAL COMMUN, V31, P37, DOI 10.1016/j.catcom.2012.11.009; WEAVER RW, 1974, AGRON J, V66, P233, DOI 10.2134/agronj1974.00021962006600020015x; Yates RJ, 2004, SOIL BIOL BIOCHEM, V36, P1319, DOI 10.1016/j.soilbio.2004.04.013; Zhang CX, 2005, EUR POLYM J, V41, P423, DOI 10.1016/j.eurpolymj.2004.10.027; Zhou GC, 2013, APPL MICROBIOL BIOT, V97, P4065, DOI 10.1007/s00253-012-4638-3	70	42	43	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176930	10.1371/journal.pone.0176930	http://dx.doi.org/10.1371/journal.pone.0176930			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472087	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500099
J	Sheen, YS; Liao, YH; Lin, MH; Chen, JS; Liau, JY; Liang, CW; Chang, YL; Chu, CY				Sheen, Yi-Shuan; Liao, Yi-Hua; Lin, Ming-Hsien; Chen, Jau-Shiuh; Liau, Jau-Yu; Liang, Cher-Wei; Chang, Yih-Leong; Chu, Chia-Yu			Clinicopathological features and prognosis of patients with de novo versus nevus-associated melanoma in Taiwan	PLOS ONE			English	Article							MALIGNANT-MELANOMA; MELANOCYTIC NEVUS; PRECURSOR	Studies surveying melanomas associated with melanocytic nevi in Asia are rare. In this study, we examined whether nevus-associated melanomas differ from de novo melanomas in terms of their associations with clinical factors, histologic characteristics, and patient survival in Taiwan. Using data on cancer cases obtained from the Department of Pathology archives and the Cancer Registry of National Taiwan University Hospital, we conducted a retrospective analysis of 103 consecutive melanoma patients who were diagnosed between 2010 and 2015 and received follow-up through November 2016. Approximately 17.5% of the melanomas in question were associated with a nevus. In patients under 65 years of age, non-acral lentiginous melanomas were significantly associated with a higher percentage of nevus-associated melanomas. The superficial spreading subtype, younger patient age, thinner tumor, intermittent solar exposure, and early stage were significant predictors of a melanoma being histologically associated with a nevus. The appearance of a nevus associated with a melanoma predicted better recurrence-free survival compared with de novo melanomas. Although acral lentiginous melanomas (70.9%) constituted the most common histologic subtype, only 9.6% of the acral lentiginous melanomas were associated with a nevus. Furthermore, there was no statistically significant difference between the nevus-associated and de novo acral lentiginous melanomas with regard to clinicopathological factors and survival. In conclusion, nevus-associated melanomas were uncommon among acral lentiginous melanomas. Relatedly, because over half of all melanomas in Asians are acral lentiginous melanomas, Asians are less likely than Caucasians to have nevus-associated melanomas.	[Sheen, Yi-Shuan; Chang, Yih-Leong] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei, Taiwan; [Sheen, Yi-Shuan; Liao, Yi-Hua; Chen, Jau-Shiuh; Chu, Chia-Yu] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Sheen, Yi-Shuan; Liao, Yi-Hua; Chen, Jau-Shiuh; Chu, Chia-Yu] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Lin, Ming-Hsien] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Lin, Ming-Hsien] Natl Taiwan Univ Hosp, Dept Surg, Hsinchu Branch, Hsinchu, Taiwan; [Liau, Jau-Yu; Liang, Cher-Wei; Chang, Yih-Leong] Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chang, YL (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei, Taiwan.; Chu, CY (corresponding author), Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan.; Chu, CY (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.; Chang, YL (corresponding author), Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan.	ntuhylc@gmail.com; chiayu@ntu.edu.tw	Sheen, Yi-Shuan/HGA-1172-2022	LIANG, CHER-WEI/0000-0001-8903-6082; Sheen, Yi-Shuan/0000-0002-8743-7496; Chen, Jau-Shiuh/0000-0002-5701-0109; CHANG, YIH-LEONG/0000-0001-5309-0554; LIAO, YI-HUA/0000-0002-4434-3780; CHU, CHIA-YU/0000-0002-9370-3279	Ministry of Science and Technology of Taiwan [MOST 103-2314-B-002-065-MY3, MOST 104-2314-B-002-116-MY3]; National Taiwan University Hospital [NTUH 105-M3349, 106-M3737]; National Taiwan University Hospital Hsin-Chu Branch [HCH 105-029]; Department of Medical Research of National Taiwan University Hospital	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University); National Taiwan University Hospital Hsin-Chu Branch; Department of Medical Research of National Taiwan University Hospital	This study was supported by grants MOST 103-2314-B-002-065-MY3 (CYC) and MOST 104-2314-B-002-116-MY3 (YSS) from the Ministry of Science and Technology of Taiwan (http://www.most.gov.tw), by grants NTUH 105-M3349 and "NTUH" 106-M3737 (YSS) from the National Taiwan University Hospital (https://www.ntuh.gov.tw) and by grants HCH 105-029 (MHL) from the National Taiwan University Hospital Hsin-Chu Branch.; We are grateful for the statistical assistance provided by the Taiwan Clinical Trial Bioinformatics and Statistical Center, Training Center, and Pharmacogenomics Laboratory (which was founded by the National Research Program for Biopharmaceuticals (NRPB) at the Ministry of Science and Technology of Taiwan; MOST 103-2325-B-002-033). The authors also wish to acknowledge the support provided by the Department of Medical Research of National Taiwan University Hospital.	ACKERMAN AB, 1988, HISTOPATHOLOGY, V13, P241, DOI 10.1111/j.1365-2559.1988.tb02036.x; Al-Jamal MS, 2014, DERMATOL SIN, V32, P217, DOI 10.1016/j.dsi.2014.09.001; BAER SC, 1995, CANCER, V76, P2242, DOI 10.1002/1097-0142(19951201)76:11<2242::AID-CNCR2820761110>3.0.CO;2-I; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Betti R, 2014, J EUR ACAD DERMATOL, V28, P1738, DOI 10.1111/jdv.12395; Bevona C, 2003, ARCH DERMATOL, V139, P1620, DOI 10.1001/archderm.139.12.1620; Chang John Wen-Cheng, 2010, Chang Gung Med J, V33, P602; Chen YJ, 1999, J AM ACAD DERMATOL, V41, P945, DOI 10.1016/S0190-9622(99)70251-3; Cormier JN, 2006, ARCH INTERN MED, V166, P1907, DOI 10.1001/archinte.166.17.1907; Cymerman RM, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw121; Duman N, 2015, DERMATOPATHOLOGY, V2, P46, DOI 10.1159/000375490; Fernandez LP, 2009, EXP DERMATOL, V18, P634, DOI 10.1111/j.1600-0625.2009.00846.x; FRIEDMAN RJ, 1983, ARCH DERMATOL, V119, P455, DOI 10.1001/archderm.119.6.455; Green A, 1999, CANCER CAUSE CONTROL, V10, P21, DOI 10.1023/A:1008872014889; Haenssle HA, 2015, JAMA DERMATOL, P1; Harley S, 1996, AM J DERMATOPATH, V18, P137, DOI 10.1097/00000372-199604000-00005; Jung HJ, 2013, JAMA DERMATOL, V149, P1281, DOI 10.1001/jamadermatol.2013.5853; Kaddu S, 2002, MELANOMA RES, V12, P271, DOI 10.1097/00008390-200206000-00011; Lin WM, 2015, J AM ACAD DERMATOL, V72, P54, DOI 10.1016/j.jaad.2014.09.028; Lv JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31432; Mervic L, 2012, ACTA DERMATOVEN ALP, V21, P27, DOI 10.2478/v10162-012-0008-1; Minagawa A, 2016, NEW ENGL J MED, V374, P2404, DOI 10.1056/NEJMc1512354; REINTGEN DS, 1982, JAMA-J AM MED ASSOC, V248, P1856, DOI 10.1001/jama.248.15.1856; RHODES AR, 1983, J AM ACAD DERMATOL, V9, P563, DOI 10.1016/S0190-9622(83)70171-4; Shain AH, 2015, NEW ENGL J MED, V373, P1926, DOI 10.1056/NEJMoa1502583; Sheen YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147431; Sheen YS, 2015, J INVEST DERMATOL, V135, P1065, DOI 10.1038/jid.2014.480; Shitara D, 2014, AM J CLIN PATHOL, V142, P485, DOI 10.1309/AJCP4L5CJGKTJVDD; Smoller BR, 2006, MODERN PATHOL, V19, pS34, DOI 10.1038/modpathol.3800508; Togawa Y, 2010, INT J DERMATOL, V49, P1362, DOI 10.1111/j.1365-4632.2010.04602.x; Tzen CY, 2014, DERMATOL SIN, V32, P7, DOI 10.1016/j.dsi.2013.05.005; Weatherhead SC, 2007, BRIT J DERMATOL, V156, P72, DOI 10.1111/j.1365-2133.2006.07570.x	32	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177126	10.1371/journal.pone.0177126	http://dx.doi.org/10.1371/journal.pone.0177126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472158	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500141
J	Yan, DP; Lu, YZ; Zhou, M; Chen, SP; Levy, D				Yan, Danping; Lu, Yongzhong; Zhou, Min; Chen, Shiping; Levy, David			Empirically characteristic analysis of chaotic PID controlling particle swarm optimization	PLOS ONE			English	Article							ALGORITHM; SEARCH	Since chaos systems generally have the intrinsic properties of sensitivity to initial conditions, topological mixing and density of periodic orbits, they may tactfully use the chaotic ergodic orbits to achieve the global optimum or their better approximation to given cost functions with high probability. During the past decade, they have increasingly received much attention from academic community and industry society throughout the world. To improve the performance of particle swarm optimization (PSO), we herein propose a chaotic proportional integral derivative (PID) controlling PSO algorithm by the hybridization of chaotic logistic dynamics and hierarchical inertia weight. The hierarchical inertia weight coefficients are determined in accordance with the present fitness values of the local best positions so as to adaptively expand the particles' search space. Moreover, the chaotic logistic map is not only used in the substitution of the two random parameters affecting the convergence behavior, but also used in the chaotic local search for the global best position so as to easily avoid the particles' premature behaviors via the whole search space. Thereafter, the convergent analysis of chaotic PID controlling PSO is under deep investigation. Empirical simulation results demonstrate that compared with other several chaotic PSO algorithms like chaotic PSO with the logistic map, chaotic PSO with the tent map and chaotic catfish PSO with the logistic map, chaotic PID controlling PSO exhibits much better search efficiency and quality when solving the optimization problems. Additionally, the parameter estimation of a nonlinear dynamic system also further clarifies its superiority to chaotic catfish PSO, genetic algorithm (GA) and PSO.	[Yan, Danping; Zhou, Min] Huazhong Univ Sci & Technol, Coll Publ Adm, Wuhan, Hubei, Peoples R China; [Yan, Danping] Huazhong Univ Sci & Technol, Nontradit Secur Ctr, Wuhan, Hubei, Peoples R China; [Lu, Yongzhong] Huazhong Univ Sci & Technol, Sch Software Engn, Wuhan, Hubei, Peoples R China; [Chen, Shiping] Commonwealth Sci & Ind Res Org, Data61, Marsfield, NSW, Australia; [Levy, David] Univ Sydney, Sch Elect & Informat Engn, Sydney, NSW, Australia	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney	Lu, YZ (corresponding author), Huazhong Univ Sci & Technol, Sch Software Engn, Wuhan, Hubei, Peoples R China.	yongzhonglu@hust.edu.cn	Levy, David/GPS-4945-2022; Chen, Shiping/Q-8611-2019	Chen, Shiping/0000-0002-4603-0024	National 985 Project of Non-traditional Security at Huazhong University of Science and Technology - Fundamental Research Funds for the Central Universities [HUST: 2016AA016]	National 985 Project of Non-traditional Security at Huazhong University of Science and Technology - Fundamental Research Funds for the Central Universities	This work is supported by National 985 Project of Non-traditional Security at Huazhong University of Science and Technology, and is also funded by the Fundamental Research Funds for the Central Universities, HUST: 2016AA016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by National 985 Project of Non-traditional Security at Huazhong University of Science and Technology, and is also funded by the Fundamental Research Funds for the Central Universities, HUST: 2016AA016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHARA K, 1990, PHYS LETT A, V144, P333, DOI 10.1016/0375-9601(90)90136-C; Anderssen RS., 1972, OPTIMIZATION, P1; Auger A, 2005, IEEE C EVOL COMPUTAT, P1777; Cai JJ, 2007, ENERG CONVERS MANAGE, V48, P645, DOI 10.1016/j.enconman.2006.05.020; Chuang LY, 2011, EXPERT SYST APPL, V38, P14555, DOI 10.1016/j.eswa.2011.05.027; Chuang LY, 2011, APPL MATH COMPUT, V217, P6900, DOI 10.1016/j.amc.2011.01.081; CVIJOVIC D, 1995, SCIENCE, V267, P664, DOI 10.1126/science.267.5198.664; DEKKERS A, 1991, MATH PROGRAM, V50, P367, DOI 10.1007/BF01594945; Du WB, 2017, IEEE T CIRCUITS-II, V64, P467, DOI 10.1109/TCSII.2016.2595597; Eberhart RC, 1996, P 6 INT S MICR HUM S, P39; Gandomi AH, 2013, COMMUN NONLINEAR SCI, V18, P327, DOI 10.1016/j.cnsns.2012.07.017; Goldberg D.E., 1989, GENETIC ALGORITHMS S; HENON M, 1976, COMMUN MATH PHYS, V50, P69, DOI 10.1007/BF01608556; Hong WC, 2009, ENERG CONVERS MANAGE, V50, P105, DOI 10.1016/j.enconman.2008.08.031; Ji MJ, 2004, CHAOS SOLITON FRACT, V21, P933, DOI 10.1016/j.chaos.2003.12.032; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Li B, 1998, CYBERNET SYST, V29, P409, DOI 10.1080/019697298125678; Liu B, 2005, CHAOS SOLITON FRACT, V25, P1261, DOI 10.1016/j.chaos.2004.11.095; Liu Y, 2007, NEUROCOMPUTING, V70, P672, DOI 10.1016/j.neucom.2006.10.002; Lorenz E. N., 1993, ESSENCE CHAOS; Lu YZ, 2016, APPL INTELL, V44, P793, DOI 10.1007/s10489-015-0726-2; Lu YZ, 2015, INFORM SCIENCES, V297, P21, DOI 10.1016/j.ins.2014.11.017; Lu Z, 2003, CHAOS SOLITON FRACT, V18, P819, DOI 10.1016/S0960-0779(03)00033-X; Niu B, 2017, IEEE ACM T COMPUT BI, V14, P4, DOI 10.1109/TCBB.2015.2459690; Qin QD, 2016, IEEE T CYBERNETICS, V46, P2238, DOI 10.1109/TCYB.2015.2474153; Suganthan P.N., 2005, TECHNICAL REPORT; Wang JZ, 2011, EXPERT SYST APPL, V38, P8151, DOI 10.1016/j.eswa.2010.12.158; Wang Y, 2010, ROBOT CIM-INT MANUF, V26, P212, DOI 10.1016/j.rcim.2009.05.003; Xu WX, 2013, INFORM SCIENCES, V218, P85, DOI 10.1016/j.ins.2012.06.003; Zhang QK, 2017, INFORM SCIENCES, V394, P273, DOI 10.1016/j.ins.2017.01.038	30	2	2	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176359	10.1371/journal.pone.0176359	http://dx.doi.org/10.1371/journal.pone.0176359			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472050	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500040
J	Madni, SHH; Abd Latiff, MS; Abdullahi, M; Abdulhamid, SM; Usman, MJ				Madni, Syed Hamid Hussain; Abd Latiff, Muhammad Shafie; Abdullahi, Mohammed; Abdulhamid, Shafi'i Muhammad; Usman, Mohammed Joda			Performance comparison of heuristic algorithms for task scheduling in IaaS cloud computing environment	PLOS ONE			English	Article							MIN-MIN ALGORITHM; INDEPENDENT TASKS; RESOURCE-MANAGEMENT; TAXONOMY; SIMULATION; TOOLKIT	Cloud computing infrastructure is suitable for meeting computational needs of large task sizes. Optimal scheduling of tasks in cloud computing environment has been proved to be an NP-complete problem, hence the need for the application of heuristic methods. Several heuristic algorithms have been developed and used in addressing this problem, but choosing the appropriate algorithm for solving task assignment problem of a particular nature is difficult since the methods are developed under different assumptions. Therefore, six rule based heuristic algorithms are implemented and used to schedule autonomous tasks in homogeneous and heterogeneous environments with the aim of comparing their performance in terms of cost, degree of imbalance, makespan and throughput. First Come First Serve (FCFS), Minimum Completion Time (MCT), Minimum Execution Time (MET), Max-min, Min-min and Sufferage are the heuristic algorithms considered for the performance comparison and analysis of task scheduling in cloud computing.	[Madni, Syed Hamid Hussain; Abd Latiff, Muhammad Shafie; Abdullahi, Mohammed] Univ Teknol Malaysia, Fac Comp, Skudai, Johor, Malaysia; [Madni, Syed Hamid Hussain] Fed Urdu Univ Arts Sci & Technol, Dept Comp Sci, G-7-1, Islamabad, Pakistan; [Abdullahi, Mohammed] Ahmadu Bello Univ, Dept Math, Zaria, Kaduna State, Nigeria; [Abdulhamid, Shafi'i Muhammad] Fed Univ Technol, Dept Cyber Secur Sci, Minna, Niger State, Nigeria; [Usman, Mohammed Joda] Bauchi State Univ, Dept Math, Gadau, Nigeria	Universiti Teknologi Malaysia; Federal Urdu University of Arts Science & Technology; Ahmadu Bello University	Abdulhamid, SM (corresponding author), Fed Univ Technol, Dept Cyber Secur Sci, Minna, Niger State, Nigeria.	shafii.abdulhamid@futminna.edu.ng	Madni, Syed Hamid Hussain/AAF-6434-2019; Madni, Hamid/AIC-1780-2022; Abdullahi, Mohammed/AAN-9860-2020; Abdulhamid, Shafi'i Muhammad/J-4288-2016; Abdullahi, Mohammed/Y-3519-2019; Abd Latiff, Muhammad Shafie/P-1648-2015; Abdullahi, Mohammed/GRF-6308-2022	Madni, Syed Hamid Hussain/0000-0002-3816-1382; Madni, Hamid/0000-0002-3816-1382; Abdullahi, Mohammed/0000-0001-7844-9527; Abdulhamid, Shafi'i Muhammad/0000-0001-9196-9447; Abdullahi, Mohammed/0000-0002-0214-6340; Abd Latiff, Muhammad Shafie/0000-0002-0741-2257; Abdullahi, Mohammed/0000-0001-7844-9527				Ab Rahman NH, 2015, COMPUT SECUR, V49, P45, DOI 10.1016/j.cose.2014.11.006; Abdulhamid S.I.M., 2014, ARPN J ENG APPL SCI, V9; Abdulhamid S. M., 2014, J THEORETICAL APPL I, V63; Abdulhamid S. M., 2017, CLOUD WORKLOADS HPC2; Abdulhamid SM, 2018, NEURAL COMPUT APPL, V29, P279, DOI 10.1007/s00521-016-2448-8; Abdulhamid SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158102; Abdulhamid SM, 2017, CLOUD WORKLOADS NASA; Abdullahi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158229; Abdullahi M, 2016, FUTURE GENER COMP SY, V56, P640, DOI 10.1016/j.future.2015.08.006; Achar R, 2012, EM APPL INF TECHN EA; Aissi H, 2005, OPER RES LETT, V33, P634, DOI 10.1016/j.orl.2004.12.002; Akilandeswari P., 2016, INDIAN J SCI TECHNOL, V9, P1; Bansal N, 2016, ADV INTELL SYST, V433, P619, DOI 10.1007/978-81-322-2755-7_64; Barquet AL, 2013, COMPUT SIST, V17, P401; Beheshti Z., 2013, INT J ADV SOFT COMPU, V5, P1; Beloglazov A., 2010, 8 INT WORKSH MIDDL G; Braun TD, 2001, J PARALLEL DISTR COM, V61, P810, DOI 10.1006/jpdc.2000.1714; Buyya R, 2002, CONCURR COMP-PRACT E, V14, P1175, DOI 10.1002/cpe.710; BUYYA R, 2009, HIGH PERF COMP SIM 2; Calheiros RN, 2011, SOFTWARE PRACT EXPER, V41, P23, DOI 10.1002/spe.995; Cao Y, 2013, FUTURE INFORM COMMUN, P81; Chen Huankai, 2013, PAR COMP TECHN PARCO; Cui YF, 2011, ADV MATER RES-SWITZ, V271-273, P552, DOI 10.4028/www.scientific.net/AMR.271-273.552; Dasgupta K, 2013, PROC TECH, V10, P340, DOI 10.1016/j.protcy.2013.12.369; Devipriya S., 2013, GREEN COMP COMM CONS; Dong ZQ, 2015, J CLOUD COMPUT-ADV S, V4, DOI 10.1186/s13677-015-0031-y; Du Kim H, 2003, INT C GRID COOP COMP; Foster I., 2008, GRID COMP ENV WORKSH; Gabi D., 2016, NEURAL COMPUT APPL, V30, P1; Gandomi AH, 2013, ELSEV INSIGHT, P1; Gani A, 2014, J NETW COMPUT APPL, V43, P84, DOI 10.1016/j.jnca.2014.04.009; Gorbenko A, 2012, INT J AUTOM COMPUT, V9, P429, DOI 10.1007/s11633-012-0664-y; Gupta Harshit, 2016, ARXIV160602007; Han H, 2013, EM INT DAT WEB TECHN; He XS, 2003, J COMPUT SCI TECH-CH, V18, P442, DOI 10.1007/BF02948918; He ZT, 2013, ADV MAT RES; Higashino W. A., 2015, FUTURE GENERATION CO; Hung Pham Phuoc, 2014, COMP MAN TEL COMMANT; IBARRA OH, 1977, J ACM, V24, P280, DOI 10.1145/322003.322011; Iqbal S, 2016, J NETW COMPUT APPL, V74, P98, DOI 10.1016/j.jnca.2016.08.016; Khan S, 2014, COMP COMM CONTR TECH; Lakra AV, 2015, PROCEDIA COMPUT SCI, V48, P107, DOI 10.1016/j.procs.2015.04.158; Li FF, 2013, APPL MECH MATER, V263-266, P1892, DOI 10.4028/www.scientific.net/AMM.263-266.1892; Li Kun, 2011, CHIN C CHINAGRID 201; Li X, 2009, CLOUD COMP 2009 CLOU; Li Xiaofang, 2014, COMP CONS CONTR IS3C; Lin WW, 2014, SOFTWARE PRACT EXPER, V44, P163, DOI 10.1002/spe.2163; Liu C-Y, 2014, DISTR COMP APPL BUS; Lizheng Guo, 2012, Journal of Networks, V7, P547, DOI 10.4304/jnw.7.3.547-553; Madni S.H.H, 2016, CLUSTER COMPUT, V20, P1; Madni S.H.H., 2016, INDIAN J SCI TECHNOL, V9; Madni SHH, 2016, J NETW COMPUT APPL, V68, P173, DOI 10.1016/j.jnca.2016.04.016; Maheswaran M, 1999, J PARALLEL DISTR COM, V59, P107, DOI 10.1006/jpdc.1999.1581; Mao Y, 2014, P INT C COMP SCI INF; Mehrotra P, 2013, CONCURRENCY COMPUTAT; Mell P., 2011, NATL I STAND TECHNOL, DOI DOI 10.6028/NIST.SP.800-145; Ming G, 2012, RECENT ADV COMPUTER, P217; Mondal B, 2012, PROC TECH, V4, P783, DOI 10.1016/j.protcy.2012.05.128; MULLERMERBACH H, 1981, EUR J OPER RES, V8, P1, DOI 10.1016/0377-2217(81)90024-2; Munir Ehsan Ullah, 2007, Information Technology Journal, V6, P1166; Mustafa S, 2015, COMPUT ELECTR ENG, V47, P186, DOI 10.1016/j.compeleceng.2015.07.021; Netjinda N, 2014, J SUPERCOMPUT, V68, P1579, DOI 10.1007/s11227-014-1126-9; Patel G, 2015, PROCEDIA COMPUT SCI, V57, P545, DOI 10.1016/j.procs.2015.07.385; Raghavan S, 2015, EL DES COMP NETW AUT; Raju IRK., 2016, INDIAN J SCI TECHNOL, V9, P1; Razaque A., 2016, 2016 IEEE LONG ISL S; Rimal BP, 2010, COMPUT COMMUN NETW S, P21, DOI 10.1007/978-1-84996-241-4_2; Sadeqi S, 2016, BOOK EXTENDED ABSTRA, P192; Shengjun Xue, 2014, Journal of Software, V9, P466, DOI 10.4304/jsw.9.2.466-473; Sindhu S, 2011, COMM COM INF SC, V169, P79; Sindhu S, 2013, COMP COMM TECHN ICCC; Singh, 2016, INT J FOUND COMPUT S, V6, P65, DOI [10.5121/ijfcst.2016.6106, DOI 10.5121/IJFCST.2016.6106]; Tabak EK, 2014, IEEE T PARALL DISTR, V25, P1244, DOI 10.1109/TPDS.2013.107; Tawfeek M. A., 2013, COMP ENG SYST ICCES; Tchernykh A, 2016, J GRID COMPUT, V14, P5, DOI 10.1007/s10723-015-9340-0; Teena Mathew, 2014, ADV COMP COMM INF IC; Thomas A, 2015, PROCEDIA COMPUT SCI, V46, P913, DOI 10.1016/j.procs.2015.02.162; Tingting Wang, 2014, DEP AUT SEC COMP DAS; Tsai JT, 2013, COMPUT OPER RES, V40, P3045, DOI 10.1016/j.cor.2013.06.012; Tsai MY, 2011, COMM COM INF SC, V261, P496; Wang G, 2013, APPL MECH MATER, V303-306, P2429, DOI 10.4028/www.scientific.net/AMM.303-306.2429; Wang WJ, 2013, J SUPERCOMPUT, V66, P783, DOI 10.1007/s11227-013-0890-2; Wu M-Y, 2000, SEGMENTED MIN MIN ST; Wu XN, 2013, PROCEDIA COMPUT SCI, V17, P1162, DOI 10.1016/j.procs.2013.05.148; Zhan JF, 2013, IEEE T COMPUT, V62, P2155, DOI 10.1109/TC.2012.103; Zhang Q, 2010, J INTERNET SERV APPL, V1, P7, DOI 10.1007/s13174-010-0007-6; Zhang Y, 2015, INT J GRID DISTRIB, V8, P269, DOI 10.14257/ijgdc.2015.8.6.26; Zhao LF, 2014, APPL MECH MAT; Zhu Y, 2013, INF MAN INN MAN IND; Zuo LY, 2015, IEEE ACCESS, V3, P2687, DOI 10.1109/ACCESS.2015.2508940	91	63	63	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176321	10.1371/journal.pone.0176321	http://dx.doi.org/10.1371/journal.pone.0176321			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467505	Green Published, gold, Green Submitted			2022-12-27	WOS:000400647000048
J	Murakami, Y; Ito, M; Ohsawa, I				Murakami, Yayoi; Ito, Masafumi; Ohsawa, Ikuroh			Molecular hydrogen protects against oxidative stress-induced SH-SY5Y neuroblastoma cell death through the process of mitohormesis	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; RICH SALINE; RAT MODEL; MICE; APOPTOSIS; INJURY; MITOCHONDRIA; INHALATION; RADICALS; DAMAGE	Inhalation of molecular hydrogen (H-2) gas ameliorates oxidative stress-induced acute injuries in the brain. Consumption of water nearly saturated with H-2 also prevents chronic neurodegenerative diseases including Parkinson's disease in animal and clinical studies. However, the molecular mechanisms underlying the remarkable effect of a small amount of H-2 remain unclear. Here, we investigated the effect of H-2 on mitochondria in cultured human neuroblastoma SH-SY5Y cells. H-2 increased the mitochondrial membrane potential and the cellular ATP level, which were accompanied by a decrease in the reduced glutathione level and an increase in the superoxide level. Pretreatment with H-2 suppressed H2O2-induced cell death, whereas post-treatment did not. Increases in the expression of anti-oxidative enzymes underlying the Nrf2 pathway in H-2-treated cells indicated that mild stress caused by H-2 induced increased resistance to exacerbated oxidative stress. We propose that H-2 functions both as a radical scavenger and a mitohormetic effector against oxidative stress in cells.	[Murakami, Yayoi; Ohsawa, Ikuroh] Tokyo Metropolitan Inst Gerontol, Biol Proc Aging, Tokyo, Japan; [Ito, Masafumi] Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology	Ohsawa, I (corresponding author), Tokyo Metropolitan Inst Gerontol, Biol Proc Aging, Tokyo, Japan.	iohsawa@tmig.or.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [24500882, 16H03267]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI (https://www.jsps.go.jp/english/e-grants/) Grant Number 24500882 and 16H03267 for IO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028536; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P990, DOI 10.1101/pdb.prot5648; Chuai YH, 2012, BIOCHEM J, V442, P49, DOI 10.1042/BJ20111786; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; HALLIWELL B, 1987, FASEB J, V1, P358, DOI 10.1096/fasebj.1.5.2824268; Hayashida K, 2014, CIRCULATION, V130, P2173, DOI 10.1161/CIRCULATIONAHA.114.011848; Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001; Hugyecz M, 2011, BRAIN RES, V1404, P31, DOI 10.1016/j.brainres.2011.05.068; Ichihara M, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0035-1; Igarashi T, 2016, SCI REP-UK, V6, DOI 10.1038/srep31190; Iketani M, 2016, PREADMINISTRATION HY; Iketani M, 2016, CURR NEUROPHARMACOL; Iuchi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep18971; Kamimura N, 2011, OBESITY, V19, P1396, DOI 10.1038/oby.2011.6; Kawamura T, 2013, AM J PHYSIOL-LUNG C, V304, pL646, DOI 10.1152/ajplung.00164.2012; Kawamura T, 2011, SURGERY, V150, P240, DOI 10.1016/j.surg.2011.05.019; Li JJ, 2012, BRAIN RES, V1486, P103, DOI 10.1016/j.brainres.2012.09.031; Ludovico P, 2014, FEMS YEAST RES, V14, P33, DOI 10.1111/1567-1364.12070; Oharazawa H, 2010, INVEST OPHTH VIS SCI, V51, P487, DOI 10.1167/iovs.09-4089; Ohno K, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/353152; Ohsawa I, 1999, EUR J NEUROSCI, V11, P1907, DOI 10.1046/j.1460-9568.1999.00601.x; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohta S, 2015, METHOD ENZYMOL, V555, P289, DOI 10.1016/bs.mie.2014.11.038; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Sato Y, 2008, BIOCHEM BIOPH RES CO, V375, P346, DOI 10.1016/j.bbrc.2008.08.020; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Seppet E, 2009, INT J MOL SCI, V10, P2252, DOI 10.3390/ijms10052252; Shimada S, 2016, ARTIF ORGANS; Terasaki Y, 2011, AM J PHYSIOL-LUNG C, V301, pL415, DOI 10.1152/ajplung.00008.2011; Texel SJ, 2011, ANTIOXID REDOX SIGN, V14, P1519, DOI 10.1089/ars.2010.3569; Yonamine R, 2013, ANESTHESIOLOGY, V118, P105, DOI 10.1097/ALN.0b013e318275146d	33	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176992	10.1371/journal.pone.0176992	http://dx.doi.org/10.1371/journal.pone.0176992			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467497	Green Published, gold, Green Submitted			2022-12-27	WOS:000400647000093
J	Baotic, A; Stoeger, AS				Baotic, Anton; Stoeger, Angela S.			Sexual dimorphism in African elephant social rumbles	PLOS ONE			English	Article							SOURCE-FILTER THEORY; LOXODONTA-AFRICANA; VOCAL COMMUNICATION; BODY-SIZE; LARYNX; CALLS; CUES; RECOGNITION; DISTANCE; BEHAVIOR	This study used the source and filter theory approach to analyse sex differences in the acoustic features of African elephant (Loxodonta africana) low-frequency rumbles produced in social contexts ('social rumbles'). Permuted discriminant function analysis revealed that rumbles contain sufficient acoustic information to predict the sex of a vocalizing individual. Features primarily related to the vocalizer's size, i.e. fundamental frequency variables and vocal tract resonant frequencies, differed significantly between the sexes. Yet, controlling for age and size effects, our results indicate that the pronounced sexual size dimorphism in African elephants is partly, but not exclusively, responsible for sexual differences in social rumbles. This provides a scientific foundation for future work investigating the perceptual and functional relevance of specific acoustic characteristics in African elephant vocal sexual communication.	[Baotic, Anton; Stoeger, Angela S.] Univ Vienna, Dept Cognit Biol, Mammal Commun Lab, Vienna, Austria	University of Vienna	Stoeger, AS (corresponding author), Univ Vienna, Dept Cognit Biol, Mammal Commun Lab, Vienna, Austria.	angela.stoeger-horwath@univie.ac.at	Baotic, Anton/AAC-3924-2021	Baotic, Anton/0000-0002-7881-857X; Stoeger, Angela S/0000-0002-6714-8291	FWF Austrian Science Fund [P26448]	FWF Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by the FWF Austrian Science Fund, grant number P26448, Project description: (http://pf.fwf.ac.at/en/ research-in-practice/project-finder?search% 5Bwhat%5D=P26448&search%5Bpromotion_ category_id%5D%5B%5D=&search%5Bcall%5D= &search%5Bproject_number%5D=&search% 5Bdecision_board_ids%5D=&search%5Bproject_ title%5D=&search%5Blead_frstname%5D= &search%5Blead_lastname%5D=&search% 5Bresearch_place_kind%5D%5B%5D=&search% 5Binstitute_name%5D=&search%5Bstart_date%5D=&search%5Bend_date%5D=&search% 5Bgrant_years%5D%5B%5D=&search% 5Bstatus_id%5D=&search%5Bscience_discipline_ id%5D=&search%5Bper_page%5D=10#search-results.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all participating institutions. We thank Sean Hensman and the Rory Hensman Elephant Research Unit (Adventures with Elephants), Brett Mitchel (Pilanesberg Back Safaris), Andre Kotze (Elephant Whisperers), Dr. Debbie Young (African Elephant Research Unit, Knysna Elephant Park and Addo Elephant Back Safaris), Dr. Harald Schwammer (Vienna Zoo) and Dr. Florian Sicks (Tierpark Berlin) for enabling and supporting our research at their institutions. We further thank our long-term collaborator Matthias Zeppelzauer for developing the annotation and contour analyses tool, and Dr. Michael Stachowitsch for editing the text. We are grateful to Prof. Tecumseh Fitch and Prof. Thomas Bugnyar for strongly supporting our research at the Department of Cognitive Biology. This project was supported by the FWF Austrian Science Fund (P26448).	[Anonymous], 1997, ANIMAL BEHAV, V53, P229; Baotic A, 2014, BIOACOUSTICS, V23, P15, DOI 10.1080/09524622.2013.798744; Barelli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082748; BECKFORD NS, 1985, ANN OTO RHINOL LARYN, V94, P634, DOI 10.1177/000348948509400622; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Briefer E, 2011, APPL ANIM BEHAV SCI, V133, P175, DOI 10.1016/j.applanim.2011.05.012; Charif RA, 2005, BEHAV ECOL SOCIOBIOL, V57, P327, DOI 10.1007/s00265-004-0867-5; Charlton BD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12739; Charlton BD, 2013, CURR BIOL, V23, pR1035, DOI 10.1016/j.cub.2013.10.069; Charlton BD, 2012, ANIM COGN, V15, P999, DOI 10.1007/s10071-012-0527-5; Charlton BD, 2011, BIOL LETTERS, V7, P71, DOI 10.1098/rsbl.2010.0582; Charlton BD, 2009, ANIM BEHAV, V78, P893, DOI 10.1016/j.anbehav.2009.06.029; Dabbs JM, 1999, PERS INDIV DIFFER, V27, P801, DOI 10.1016/S0191-8869(98)00272-4; Darwin C., 1871, DESCENT MAN SELCTION; Fairbairn DJ., 1997, ANNU REV ECOL SYST, V28, P659; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; Frey R, 2003, ZOOL ANZ, V242, P33, DOI 10.1078/0044-5231-00086; Frey R, 2007, J ANAT, V210, P131, DOI 10.1111/j.1469-7580.2006.00684.x; Gahr M, 2007, ADV GENET, V59, P67, DOI 10.1016/S0065-2660(07)59003-6; Ganswindt A, 2005, HORM BEHAV, V47, P83, DOI 10.1016/j.yhbeh.2004.09.002; Herbst CT, 2013, J EXP BIOL, V216, P4054, DOI 10.1242/jeb.091009; Kelley D. B., 2002, BEHAV ENDOCRINOLOGY, P289; King LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010346; LEE PC, 1995, J ZOOL, V236, P29, DOI 10.1111/j.1469-7998.1995.tb01782.x; Lee Phyllis C., 2011, P260; Leighty KA, 2008, ANIM BEHAV, V76, P1601, DOI 10.1016/j.anbehav.2008.06.022; Leong KM, 2003, HORM BEHAV, V43, P433, DOI 10.1016/S0018-506X(03)00025-4; Lueders Imke, 2012, P503; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; MCCOWAN B, 1995, J COMP PSYCHOL, V109, P242, DOI 10.1037/0735-7036.109.3.242; McPherson FJ, 2012, ANIM REPROD SCI, V131, P109, DOI 10.1016/j.anireprosci.2012.02.007; MITANI JC, 1994, ETHOLOGY, V96, P233, DOI 10.1111/j.1439-0310.1994.tb01012.x; Morisaka T, 2005, J MAMMAL, V86, P541, DOI 10.1644/1545-1542(2005)86[541:EOANOT]2.0.CO;2; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; O'Connell-Rodwell CE, 2011, ETHOL ECOL EVOL, V23, P388, DOI 10.1080/03949370.2011.598569; Ortolani A, 2005, ZOO BIOL, V24, P311, DOI 10.1002/zoo.20053; Palacios V, 2015, BEHAVIOUR, V152, P593, DOI 10.1163/1568539X-00003244; Payne KB, 2003, AFR J ECOL, V41, P99, DOI 10.1046/j.1365-2028.2003.00421.x; Pfefferle D, 2006, ANIM BEHAV, V72, P43, DOI 10.1016/j.anbehav.2005.08.021; POOLE JH, 1987, BEHAVIOUR, V102, P283, DOI 10.1163/156853986X00171; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Poole Joyce H., 1994, P331; Poole Joyce H., 2011, P125; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Rendall D, 2005, J ACOUST SOC AM, V117, P944, DOI 10.1121/1.1848011; Rendall D, 1996, ANIM BEHAV, V51, P1007, DOI 10.1006/anbe.1996.0103; SCHNEIDE.R, 1967, Z WISS ZOOL ABT A, V175, P1; Shannon G, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-62; Shoshani J., TRENDS ECOLOGY EVOLU, V13, P480; Shrader AM, 2006, J ZOOL, V270, P40, DOI 10.1111/j.1469-7998.2006.00108.x; Soltis J, 2005, ANIM BEHAV, V70, P579, DOI 10.1016/j.anbehav.2004.11.015; Soltis J., 2013, EVOLUTION EMOTIONAL, P105, DOI 10.1093/acprof:oso/9780199583560.003.0007; Soltis J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089403; Soltis J, 2011, J ACOUST SOC AM, V129, P1059, DOI 10.1121/1.3531798; Soltis J, 2010, ZOO BIOL, V29, P192, DOI 10.1002/zoo.20251; Stoeger AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048907; Stoeger AS, 2011, J ACOUST SOC AM, V130, P1700, DOI 10.1121/1.3605538; Stoeger-Horwath AS, 2007, J ACOUST SOC AM, V121, P3922, DOI 10.1121/1.2722216; Sukumar R, 2003, STATURAL GROWTH ELEP, P409; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Taylor AM, 2008, J ACOUST SOC AM, V123, P2903, DOI 10.1121/1.2896962; Thompson ME, 2010, AFR J ECOL, V48, P654, DOI 10.1111/j.1365-2028.2009.01161.x; Thompson ME, 2010, AFR J ECOL, V48, P224, DOI 10.1111/j.1365-2028.2009.01106.x; Titze IR, 2011, J SPEECH LANG HEAR R, V54, P520, DOI 10.1044/1092-4388(2010/09-0284); Titze IR, 1994, PRINCIPLES VOICE PRO; Todd NE, 2010, ANAT REC, V293, P62, DOI 10.1002/ar.21011; Townsend SW, 2012, BIOL LETTERS, V8, P179, DOI 10.1098/rsbl.2011.0844; VanDerMerwe NJ, 1995, ONDERSTEPOORT J VET, V62, P245; Venables WN., 2002, MODERN APPL STAT S 4; Youlatos D, 2015, DEV PRIMATOL-PROG PR, P133, DOI 10.1007/978-1-4939-1957-4_6; Zeppelzauer Matthias, 2015, BMC Research Notes, V8, P409, DOI 10.1186/s13104-015-1370-y; Zeppelzauer M, 2015, BIOACOUSTICS, V24, P13, DOI 10.1080/09524622.2014.906321; ZIELINSKI WJ, 1993, ANIM BEHAV, V45, P873, DOI 10.1006/anbe.1993.1108	74	17	17	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177411	10.1371/journal.pone.0177411	http://dx.doi.org/10.1371/journal.pone.0177411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UN	28489908	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314100073
J	Bethoney, ND; Zhao, LZ; Chen, CS; Stokesbury, KDE				Bethoney, N. David; Zhao, Liuzhi; Chen, Changsheng; Stokesbury, Kevin D. E.			Identification of persistent benthic assemblages in areas with different temperature variability patterns through broad-scale mapping	PLOS ONE			English	Article							SEA SCALLOP; PLACOPECTEN-MAGELLANICUS; GEORGES BANK; FISHERY-MANAGEMENT; CLOSED AREAS; ATLANTIC; USA; RECRUITMENT; MORTALITY; IMPACT	Ecosystem-based management is a place-based approach that considers the relationships between system parts. Due to the complexity of ecosystems in the marine environment it is often difficult to define these relationships in space and time. Maps illustrate spatial concepts. Here we promote ecosystem-based spatial thinking by layering datasets from a larger project that mapped benthic fauna, substrate characteristics, and oceanic conditions on monthly, annual and decadal time scales along the U.S. continental shelf. By combining maps of persistent benthic megafauna and bottom temperature variability over approximately 90,000 km(2), we identified wide spread benthic animal assemblages and regional disparity in temperature variability. From a broad-scale perspective the locations of the assemblage appear to be related to sea scallop population dynamics and indicate potential regional differences in climate change resiliency. These findings offer information on a scale that correlates with marine spatial planning, and could be used as a starting point for further investigation. To spur additional analysis and facilitate their linkage to other datasets, these datasets are available through public, online data portals. Overall, this study demonstrates how the growth of maps from single to multiple elements can help promote and facilitate the multifactor, ecosystem-based thinking needed to support regional ocean planning.	[Bethoney, N. David; Zhao, Liuzhi; Chen, Changsheng; Stokesbury, Kevin D. E.] Univ Massachusetts Dartmouth, Sch Marine Sci & Technol, New Bedford, MA 02740 USA	University of Massachusetts System; University Massachusetts Dartmouth	Bethoney, ND (corresponding author), Univ Massachusetts Dartmouth, Sch Marine Sci & Technol, New Bedford, MA 02740 USA.	nbethoney@umassd.edu			Nature Conservancy from a Gordon and Betty Moore Foundation	Nature Conservancy from a Gordon and Betty Moore Foundation	Funding for this research came through The Nature Conservancy from a Gordon and Betty Moore Foundation(https://www.moore.org/) grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CF, 2008, ICES J MAR SCI, V65, P995, DOI 10.1093/icesjms/fsn053; Beardsley RC, 2013, J GEOPHYS RES-OCEANS, V118, P6030, DOI 10.1002/2013JC008862; Bethoney ND, 2016, MAR ECOL PROG SER, V547, P137, DOI 10.3354/meps11666; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; Chen CS, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007054; Cogan CB, 2009, ICES J MAR SCI, V66, P2033, DOI 10.1093/icesjms/fsp214; Collie JS, 1997, MAR ECOL PROG SER, V155, P159, DOI 10.3354/meps155159; Fogarty MJ, 2014, CAN J FISH AQUAT SCI, V71, P479, DOI 10.1139/cjfas-2013-0203; Hampton RE, 2014, INTRO BIOL STAT, P129; Hare JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146756; Harris BP, 2010, CONT SHELF RES, V30, P1840, DOI 10.1016/j.csr.2010.08.011; Hart D.R., 2004, NMFSNE189 NOAA; Hart DR, 2006, MAR ECOL PROG SER, V306, P209, DOI 10.3354/meps306209; Kleisner KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149220; Levesque MM, 2016, J SHELLFISH RES, V35, P295, DOI 10.2983/035.035.0204; Levin PS, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0275; Li Y, 2015, PROG OCEANOGR, V134, P123, DOI 10.1016/j.pocean.2015.01.003; Link J, 2008, J MARINE SYST, V74, P453, DOI 10.1016/j.jmarsys.2008.03.007; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Marino MC, 2009, MAR ECOL PROG SER, V382, P59, DOI 10.3354/meps08011; Mayr E, 1997, THIS IS BIOL SCI LIV, P207; Murawski SA, 2000, B MAR SCI, V66, P775; New England Fisheries Management Council, 2011, OMN ESS FISH HAB EFH; Northeast Regional Planning Body, 2016, NE OC PLAN; O'Leary JK, 2017, BIOSCIENCE, V67, P208, DOI 10.1093/biosci/biw161; Stokesbury KDE, 2006, MAR ECOL PROG SER, V307, P85, DOI 10.3354/meps307085; Stokesbury KDE, 2007, MAR ECOL PROG SER, V349, P151, DOI 10.3354/meps07113; Stokesbury KDE, 2016, DEV AQUAC FISH SCI, V40, P719; Sun YF, 2013, J GEOPHYS RES-OCEANS, V118, P2685, DOI 10.1002/jgrc.20207; Van Wyngaarden M, 2017, EVOL APPL, V10, P102, DOI 10.1111/eva.12432; Young AM, 2002, MAR BIOL, V140, P1059, DOI 10.1007/s00227-002-0780-2	31	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177333	10.1371/journal.pone.0177333	http://dx.doi.org/10.1371/journal.pone.0177333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489873	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100062
J	Rodriguez-Molinero, A; Galvez-Barron, C; Narvaiza, L; Minarro, A; Ruiz, J; Valldosera, E; Gonzalo, N; Ng, T; Sanguino, MJ; Yuste, A				Rodriguez-Molinero, Alejandro; Galvez-Barron, Cesar; Narvaiza, Leire; Minarro, Antonio; Ruiz, Jorge; Valldosera, Esther; Gonzalo, Natalia; Ng, Thalia; Jesus Sanguino, Maria; Yuste, Antonio			A two-question tool to assess the risk of repeated falls in the elderly	PLOS ONE			English	Article							DWELLING OLDER-PEOPLE; MOBILITY ASSESSMENT; COMMUNITY; POPULATION; INJURIES; FRAILTY; HOME	Introduction Older adults' perception of their own risk of fall has never been included into screening tools. The goal of this study was to evaluate the predictive validity of questions on subjects' self-perception of their own risk of fall. Methods This prospective study was conducted on a probabilistic sample of 772 Spanish community-dwelling older adults, who were followed-up for a one year period. At a baseline visit, subjects were asked about their recent history of falls (question 1: "Have you fallen in the last 6 months?"), as well as on their perception of their own risk of fall by using two questions (question 2: "Do you think you may fall in the next few months?" possible answers: yes/no; question 3: "What is the probability that you fall in the next few months?" possible answers: low/intermediate/high). The follow-up consisted of quarterly telephone calls, where the number of falls occurred in that period was recorded. Results A short questionnaire built with questions 1 and 3 showed 70% sensitivity (95% CI: 56%-84%), 72% specificity (95% CI: 68%-76%) and 0.74 area under the ROC curve (95% CI: 0.66-0.82) for prediction of repeated falls in the subsequent year. Conclusions The estimation of one's own risk of fall has predictive validity for the occurrence of repeated falls in older adults. A short questionnaire including a question on perception of one's own risk of fall and a question on the recent history of falls had good predictive validity.	[Rodriguez-Molinero, Alejandro; Galvez-Barron, Cesar; Ruiz, Jorge; Valldosera, Esther; Gonzalo, Natalia; Ng, Thalia; Jesus Sanguino, Maria; Yuste, Antonio] Fundacio Privada St Antoni Abat, Consorci Sanitari Garraf, Barcelona, Spain; [Narvaiza, Leire] Ctr Salut Mental Garraf, Parc Sanitari Sant Joan de Deu, Barcelona, Spain; [Minarro, Antonio] Univ Barcelona, Fac Biol, Dept Genet Microbiol & Stat, Barcelona, Spain	University of Barcelona	Rodriguez-Molinero, A (corresponding author), Fundacio Privada St Antoni Abat, Consorci Sanitari Garraf, Barcelona, Spain.	rodriguez.molinero@gmail.com	Gálvez-Barrón, César/AAD-6192-2021; Miñarro, Antonio/G-1740-2015	Gálvez-Barrón, César/0000-0001-5333-3317; Miñarro, Antonio/0000-0001-7747-5299; Rodriguez-Molinero, Alejandro/0000-0002-9678-2654	European Commission within the 6th Framework Programme [IST-2005-045215]; Sociedad Espanola de Geriatria y Gerontologia	European Commission within the 6th Framework Programme(European Commission); Sociedad Espanola de Geriatria y Gerontologia	This work was supported by the European Commission within the 6th Framework Programme (project CAALYX: IST-2005-045215) and the Sociedad Espanola de Geriatria y Gerontologia.	[Anonymous], 2014, R LANG ENV STAT COMP; de la Iglesia J.M., 2005, ATEN PRIM, V35, P14, DOI [10.1157/13071040, DOI 10.1157/13071040]; Faber MJ, 2006, PHYS THER, V86, P944, DOI 10.1093/ptj/86.7.944; Galvez-Barron C, 2013, AGING CLIN EXP RES, V25, P591, DOI 10.1007/s40520-013-0130-x; Ganz DA, 2005, J AM GERIATR SOC, V53, P2190, DOI 10.1111/j.1532-5415.2005.00509.x; Gill TM, 2001, ANN INTERN MED, V135, P313, DOI 10.7326/0003-4819-135-5-200109040-00007; Gonzalez-Montalvo JI, 1993, VALORACION PACIENTE, P73; Hajian-Tilaki K, 2014, J BIOMED INFORM, V48, P193, DOI 10.1016/j.jbi.2014.02.013; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kojima G, 2015, J AM MED DIR ASSOC, V16, P1027, DOI 10.1016/j.jamda.2015.06.018; Lin MR, 2004, J AM GERIATR SOC, V52, P1343, DOI 10.1111/j.1532-5415.2004.52366.x; Lumley T., 2014, SURVEY ANAL COMPLEX; LUUKINEN H, 1994, J CLIN EPIDEMIOL, V47, P843, DOI 10.1016/0895-4356(94)90187-2; Medical Research Council, 1981, 45 MED RES COUNC HER; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Papachristou E, 2017, J AM MED DIR ASSOC, V18, P152, DOI 10.1016/j.jamda.2016.08.020; Perell KL, 2001, J GERONTOL A-BIOL, V56, pM761, DOI 10.1093/gerona/56.12.M761; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Rapp K, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-105; Rodriguez-Molinero Alejandro, 2015, Rev Esp Geriatr Gerontol, V50, P274, DOI 10.1016/j.regg.2015.05.005; Russell MA, 2008, AGE AGEING, V37, P634, DOI 10.1093/ageing/afn129; Scott V, 2007, AGE AGEING, V36, P130, DOI 10.1093/ageing/afl165; Shumway-Cook A, 2009, PHYS THER, V89, P324, DOI 10.2522/ptj.20070107; Tinetti ME, 1998, J GERONTOL A-BIOL, V53, pM112, DOI 10.1093/gerona/53A.2.M112; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Verghese J, 2002, J AM GERIATR SOC, V50, P1572, DOI 10.1046/j.1532-5415.2002.50415.x	27	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176703	10.1371/journal.pone.0176703	http://dx.doi.org/10.1371/journal.pone.0176703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UN	28489888	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100028
J	Zhou, DY; Tang, YC; Jiang, W				Zhou, Deyun; Tang, Yongchuan; Jiang, Wen			A modified belief entropy in Dempster-Shafer framework	PLOS ONE			English	Article							EVIDENTIAL REASONING APPROACH; RELIABILITY-ANALYSIS; CLASSIFICATION RULE; ATTRIBUTE WEIGHTS; HIERARCHY PROCESS; PROBABILITY; UNCERTAINTY; SPECIFICITY; DEPENDENCE; ALGORITHM	How to quantify the uncertain information in the framework of Dempster-Shafer evidence theory is still an open issue. Quite a few uncertainty measures have been proposed in Dempster-Shafer framework, however, the existing studies mainly focus on the mass function itself, the available information represented by the scale of the frame of discernment (FOD) in the body of evidence is ignored. Without taking full advantage of the information in the body of evidence, the existing methods are somehow not that efficient. In this paper, a modified belief entropy is proposed by considering the scale of FOD and the relative scale of a focal element with respect to FOD. Inspired by Deng entropy, the new belief entropy is consistent with Shannon entropy in the sense of probability consistency. What's more, with less information loss, the new measure can overcome the shortage of some other uncertainty measures. A few numerical examples and a case study are presented to show the efficiency and superiority of the proposed method.	[Zhou, Deyun; Tang, Yongchuan; Jiang, Wen] Northwestern Polytech Univ, Sch Elect & Informat, Xian, Shaanxi, Peoples R China	Northwestern Polytechnical University	Tang, YC; Jiang, W (corresponding author), Northwestern Polytech Univ, Sch Elect & Informat, Xian, Shaanxi, Peoples R China.	tangyongchuan@mail.nwpu.edu.cn; jiangwen@nwpu.edu.cn	Tang, Yongchuan/G-8970-2019	Tang, Yongchuan/0000-0003-2568-9628	National Natural Science Foundation of China [61671384]; Natural Science Basic Research Plan in Shaanxi Province of China [2016JM6018]; Fund of SAST [SAST2016083]; Innovation Foundation for Doctor Dissertation of Northwestern Polytechnical University [CX201705]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Plan in Shaanxi Province of China; Fund of SAST; Innovation Foundation for Doctor Dissertation of Northwestern Polytechnical University	We declare that the work is partially supported by National Natural Science Foundation of China (Grant No. 61671384), Natural Science Basic Research Plan in Shaanxi Province of China (Grant No. 2016JM6018), the Fund of SAST (Grant No. SAST2016083) and the Innovation Foundation for Doctor Dissertation of Northwestern Polytechnical University (Grant No. CX201705). There was no additional external funding received for this study.	Cao SJ, 2015, APPL MATH COMPUT, V261, P141, DOI 10.1016/j.amc.2015.03.046; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Chen ZQ, 2014, ENTROPY-SWITZ, V16, P5416, DOI 10.3390/e16105416; Chen ZQ, 2014, APPL MATH COMPUT, V242, P462, DOI 10.1016/j.amc.2014.05.105; Chin KS, 2015, COMPUT IND ENG, V87, P150, DOI 10.1016/j.cie.2015.04.016; Conti PL, 2017, COMMUN STAT-THEOR M, V46, P967, DOI 10.1080/03610926.2015.1010005; DEMPSTER AP, 1967, ANN MATH STAT, V38, P325, DOI 10.1214/aoms/1177698950; Deng XY, 2016, INFORM SCIENCES, V340, P250, DOI 10.1016/j.ins.2016.01.033; Deng Y., 2012, J INF COMPUT SCI, V9, P2421; Deng Y, 2016, CHAOS SOLITON FRACT, V91, P549, DOI 10.1016/j.chaos.2016.07.014; Deng Y, 2017, J COMPUT ANAL APPL, V22, P201; Deng Y, 2015, APPL INTELL, V43, P530, DOI 10.1007/s10489-015-0661-2; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Denoeux T, 2013, IEEE T KNOWL DATA EN, V25, P119, DOI 10.1109/TKDE.2011.201; Du WS, 2016, INFORM SCIENCES, V364, P91, DOI 10.1016/j.ins.2016.05.011; DUBOIS D, 1985, INT J GEN SYST, V10, P279, DOI 10.1080/03081078508934893; Fan XF, 2006, PATTERN RECOGN LETT, V27, P366, DOI 10.1016/j.patrec.2005.08.025; Feller W., 1957, INTRO PROBABILITY TH; Frikha A, 2015, EUR J OPER RES, V241, P133, DOI 10.1016/j.ejor.2014.08.024; Fu C, 2015, EUR J OPER RES, V246, P886, DOI 10.1016/j.ejor.2015.05.042; Fu C, 2015, COMPUT IND ENG, V81, P109, DOI 10.1016/j.cie.2014.12.031; George T, 1996, INT J GEN SYST, V24, P407, DOI 10.1080/03081079608945130; HAN DQ, 2016, KNOWL-BASED SYST, V110, P210, DOI DOI 10.1016/J.KN0SYS.2016.07.029; Hohle U, 1982, P 12 IEEE INT S MULT; Jiang W, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016641820; Jiang W, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16091509; Jiang W, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/5769061; Jiang W, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/3878634; Jiang W, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016644579; Khodabandeh M, 2014, INT J GEN SYST, V43, P610, DOI 10.1080/03081079.2014.896353; Klir G.J., 1992, UNCERTAIN ARTIFICAIA, P138; Klir G. J., 1991, INT J GEN SYST, V18, P155, DOI DOI 10.1080/03081079008935135; Liu WR, 2006, ARTIF INTELL, V170, P909, DOI 10.1016/j.artint.2006.05.002; LIU ZG, 2016, PATTERN RECOGN, V52, P85, DOI DOI 10.1016/J.PATC0G.2015.10.001; Liu ZG, 2014, PATTERN RECOGN, V47, P2532, DOI 10.1016/j.patcog.2014.01.011; Liu ZG, 2013, PATTERN RECOGN, V46, P834, DOI 10.1016/j.patcog.2012.10.001; Ma JB, 2016, INFORM SCIENCES, V333, P10, DOI 10.1016/j.ins.2015.11.011; Ma JB, 2015, INT J APPROX REASON, V59, P20, DOI 10.1016/j.ijar.2015.01.003; PAWLAK Z, 1982, INT J COMPUT INF SCI, V11, P341, DOI 10.1007/BF01001956; Pezzulo G, 2014, P COGN SCI SOC, V26; Sabahi F, 2014, INT J APPROX REASON, V55, P1383, DOI 10.1016/j.ijar.2013.12.003; Sabahi F, 2013, INFORM SCIENCES, V244, P60, DOI 10.1016/j.ins.2013.03.020; Sankaran PG, 2017, COMMUN STAT-THEOR M, V46, P805, DOI 10.1080/03610926.2015.1006779; Schubert J, 2011, INT J APPROX REASON, V52, P449, DOI 10.1016/j.ijar.2010.10.004; Shafer G.A., 1976, MATH THEORY EVIDENCE; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Smets P, 2005, INT J APPROX REASON, V40, P181, DOI 10.1016/j.ijar.2005.04.001; SMETS P, 1994, ARTIF INTELL, V66, P191, DOI 10.1016/0004-3702(94)90026-4; Su XY, 2016, APPL INTELL, V44, P634, DOI 10.1007/s10489-015-0723-5; Su XY, 2015, RISK ANAL, V35, P1296, DOI 10.1111/risa.12347; Su XY, 2015, INT J INTELL SYST, V30, P441, DOI 10.1002/int.21695; Su XY, 2012, ENG FAIL ANAL, V26, P164, DOI 10.1016/j.engfailanal.2012.07.009; Tang YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160416; Wang YM, 2007, EXPERT SYST APPL, V32, P336, DOI 10.1016/j.eswa.2005.11.029; Wang YM, 2009, EXPERT SYST APPL, V36, P8421, DOI 10.1016/j.eswa.2008.10.052; Wen ML, 2016, FUZZY OPTIM DECIS MA, V15, P491, DOI 10.1007/s10700-016-9235-y; YAGER RR, 1995, IEEE T SYST MAN CYB, V25, P1221, DOI 10.1109/21.398683; YAGER RR, 1983, INT J GEN SYST, V9, P249, DOI 10.1080/03081078308960825; YANG Y, 2016, KNOWL-BASED SYST, V94, P114, DOI DOI 10.1016/J.KN0SYS.2015.11.014; Yang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147799; Yuan K, 2015, SENSORS, V16, P1; Yuan KJ, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2205-6; Zadeh L.A., 1986, AI MAG, V7, P85, DOI DOI 10.1609/AIMAG.V7I2.542; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhang MJ, 2017, EUR J OPER RES, V257, P1005, DOI 10.1016/j.ejor.2016.08.028; Zhou DY, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/4512383; Zhou K, 2015, KNOWL-BASED SYST, V74, P69, DOI 10.1016/j.knosys.2014.11.010	68	30	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176832	10.1371/journal.pone.0176832	http://dx.doi.org/10.1371/journal.pone.0176832			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481914	gold, Green Submitted, Green Published			2022-12-27	WOS:000401313700018
J	Cook, J; Lewandowsky, S; Ecker, UKH				Cook, John; Lewandowsky, Stephan; Ecker, Ullrich K. H.			Neutralizing misinformation through inoculation: Exposing misleading argumentation techniques reduces their influence	PLOS ONE			English	Article							CLIMATE-CHANGE; CONTINUED INFLUENCE; MEDIA COVERAGE; FALSE BALANCE; SCIENCE; POLARIZATION; VACCINE; CONSTRUCTION; CONTROVERSY; VALIDATION	Misinformation can undermine a well-functioning democracy. For example, public misconceptions about climate change can lead to lowered acceptance of the reality of climate change and lowered support for mitigation policies. This study experimentally explored the impact of misinformation about climate change and tested several pre-emptive interventions designed to reduce the influence of misinformation. We found that false-balance media coverage (giving contrarian views equal voice with climate scientists) lowered perceived consensus overall, although the effect was greater among free-market supporters. Likewise, misinformation that confuses people about the level of scientific agreement regarding anthropogenic global warming (AGW) had a polarizing effect, with free-market supporters reducing their acceptance of AGW and those with low free-market support increasing their acceptance of AGW. However, we found that inoculating messages that (1) explain the flawed argumentation technique used in the misinformation or that (2) highlight the scientific consensus on climate change were effective in neutralizing those adverse effects of misinformation. We recommend that climate communication messages should take into account ways in which scientific content can be distorted, and include pre-emptive inoculation messages.	[Cook, John] George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA; [Cook, John; Lewandowsky, Stephan; Ecker, Ullrich K. H.] Univ Western Australia, Sch Psychol Sci, Perth, WA, Australia; [Lewandowsky, Stephan] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Lewandowsky, Stephan] Univ Bristol, Cabot Inst, Bristol, Avon, England	George Mason University; University of Western Australia; University of Bristol; University of Bristol	Cook, J (corresponding author), George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA.; Cook, J (corresponding author), Univ Western Australia, Sch Psychol Sci, Perth, WA, Australia.	jcook20@gmu.edu	Ecker, Ullrich K H/A-2043-2010; Lewandowsky, Stephan/L-4272-2019	Ecker, Ullrich K H/0000-0003-4743-313X; Lewandowsky, Stephan/0000-0003-1655-2013; Cook, John/0000-0001-8488-6766	Australian Research Council; Royal Society; Psychonomics Society	Australian Research Council(Australian Research Council); Royal Society(Royal Society of London); Psychonomics Society	Support was provided by the Australian Research Council, the Royal Society, and the Psychonomics Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae J, 2006, PUBLIC RELAT REV, V32, P144, DOI 10.1016/j.pubrev.2006.02.007; Banas JA, 2013, HUM COMMUN RES, V39, P184, DOI 10.1111/hcre.12000; Banas JA, 2010, COMMUN MONOGR, V77, P281, DOI 10.1080/03637751003758193; Bedford D, 2010, J GEOGR, V109, P159, DOI 10.1080/00221341.2010.498121; Berrens RP, 2003, POLIT ANAL, V11, P1, DOI 10.1093/pan/11.1.1; Boykoff MT, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/2/024002; Boykoff MT, 2004, GLOBAL ENVIRON CHANG, V14, P125, DOI 10.1016/j.gloenvcha.2003.10.001; Brehm J.W., 1966, THEORY PSYCHOL REACT; Carrillo-Santisteve P, 2012, CLIN MICROBIOL INFEC, V18, P50, DOI 10.1111/j.1469-0691.2012.03982.x; CDC, 2017, MEASL CAS OUTBR; Chigwedere P, 2008, JAIDS-J ACQ IMM DEF, V49, P410, DOI 10.1097/QAI.0b013e31818a6cd5; Clarke CE, 2008, SCI COMMUN, V30, P77, DOI 10.1177/1075547008320262; Compton J., 2013, SAGE HDB PERSUASION, V2nd ed, P220; Cook J., 2016, OXFORD ENCY CLIMATE; Cook J, 2014, REPORTS NATL CTR SCI, V34; Cook J, 2015, MAKING SENSE CLIMATE; Cook J, 2014, J GEOSCI ED, V62, P296, DOI [DOI 10.5408/13-071.1, 10.5408/13-071.1]; Cook J, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/4/048002; Cook J, 2016, TOP COGN SCI, V8, P160, DOI 10.1111/tops.12186; Cook J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024024; Deryugina T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151469; Diethelm P, 2009, EUR J PUBLIC HEALTH, V19, P2, DOI 10.1093/eurpub/ckn139; Dixon GN, 2013, SCI COMMUN, V35, P358, DOI 10.1177/1075547012458290; Dunlap RE, 2016, ENVIRONMENT, V58, P4, DOI 10.1080/00139157.2016.1208995; DURYEA EJ, 1983, J SCHOOL HEALTH, V53, P250, DOI 10.1111/j.1746-1561.1983.tb01139.x; Ecker UKH, 2017, J APPL RES MEMORY CO; Ecker UKH, 2014, PROCESSING INACCURATE INFORMATION: THEORETICAL AND APPLIED PERSPECTIVES FROM COGNITIVE SCIENCE AND THE EDUCATIONAL SCIENCES, P13; Ecker UKH, 2010, MEM COGNITION, V38, P1087, DOI 10.3758/MC.38.8.1087; Elsasser SW, 2012, AM BEHAV SCI; Gardner MN, 2006, AM J PUBLIC HEALTH, V96, P222, DOI 10.2105/AJPH.2005.066654; Heath Y, 2006, ENVIRON BEHAV, V38, P48, DOI 10.1177/0013916505277998; HOAGLIN DC, 1986, J AM STAT ASSOC, V81, P991, DOI 10.2307/2289073; Jensen C., 1998, MANY CLIMATE RESEARC; Johnson TJ, 2009, J COMPUT-MEDIAT COMM, V15, P60, DOI 10.1111/j.1083-6101.2009.01492.x; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; Koehler DJ, 2016, J EXP PSYCHOL-APPL, V22, P24, DOI 10.1037/xap0000073; Kortenkamp KV, 2015, SCI COMMUNICATION; Kowalski P, 2009, TEACH PSYCHOL, V36, P153, DOI 10.1080/00986280902959986; Leiserowitz A., 2015, CLIMATE CHANGE AM MI; Lewandowsky S, 2005, PSYCHOL SCI, V16, P190, DOI 10.1111/j.0956-7976.2005.00802.x; Lewandowsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075637; Lewandowsky S, 2013, NAT CLIM CHANGE, V3, P399, DOI [10.1038/nclimate1720, 10.1038/NCLIMATE1720]; Lewandowsky S, 2013, PSYCHOL SCI, V24, P622, DOI 10.1177/0956797612457686; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Luntz F., 2002, ENV CLEANER SAFER HE; Maibach E, 2014, EARTHS FUTURE, V2, P295, DOI 10.1002/2013EF000226; Majumder MS, 2015, JAMA PEDIATR, V169, P494, DOI 10.1001/jamapediatrics.2015.0384; Malka A, 2009, FEATURING SKEPTICS N; Malka A, 2009, RISK ANAL, V29, P633, DOI 10.1111/j.1539-6924.2009.01220.x; McCright AM, 2016, TOP COGN SCI, V8, P76, DOI 10.1111/tops.12171; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; McCuin JL, 2014, J GEOL EDUC, V62, P445, DOI [DOI 10.5408/13-068.1, 10.5408/13-068.1]; MCGUIRE WJ, 1962, PUBLIC OPIN QUART, V26, P24, DOI 10.1086/267068; Miller CH, 2013, HUM COMMUN RES, V39, P127, DOI 10.1111/j.1468-2958.2012.01438.x; Muller A, 2008, J COMPUT ASSIST LEAR, V24, P144, DOI 10.1111/j.1365-2729.2007.00248.x; Muller DA, 2008, RAISING COGNITIVE LO; NCES, 2009, DIG ED STUD 2008; Niederdeppe J, 2014, PUBLIC OPIN QUART, V78, P634, DOI 10.1093/poq/nfu026; Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2; OHANIAN R, 1990, J ADVERTISING, V19, P39, DOI 10.1080/00913367.1990.10673191; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Painter J., 2013, CLIMATE CHANGE MEDIA; PFAU M, 1992, COMMUN MONOGR, V59, P213, DOI 10.1080/03637759209376266; Richter T, 2009, J PERS SOC PSYCHOL, V96, P538, DOI 10.1037/a0014038; Smith MJ, 2008, PEDIATRICS, V121, pE836, DOI 10.1542/peds.2007-1760; Smith N, 2012, RISK ANAL, V32, P1021, DOI 10.1111/j.1539-6924.2012.01801.x; Stenhouse N, 2013, B AM METEOROLOGICAL; Stocking SH, 2009, PUBLIC UNDERST SCI, V18, P23, DOI 10.1177/0963662507079373; Tippett CD, 2010, INT J SCI MATH EDUC, V8, P951, DOI 10.1007/s10763-010-9203-x; van der Linden S, 2017, GLOB CHALL, V1, DOI 10.1002/gch2.201600008; van der Linden SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118489; Walker J., 1998, DRAFT GLOBAL CLIMATE; Wood MLM, 2007, HUM COMMUN RES, V33, P357, DOI 10.1111/j.1468-2958.2007.00303.x; Zimmerman M., 2009, EOS T AM GEOPHYS UN, V99, P22, DOI DOI 10.1029/2009EO030002	77	272	274	10	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0175799	10.1371/journal.pone.0175799	http://dx.doi.org/10.1371/journal.pone.0175799			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475576	Green Published, gold			2022-12-27	WOS:000400649500005
J	Vegter, EL; Ovchinnikova, ES; Sillje, HHW; Meems, LMG; van der Pol, A; van der Velde, AR; Berezikov, E; Voors, AA; de Boer, RA; van der Meer, P				Vegter, Eline L.; Ovchinnikova, Ekaterina S.; Sillje, Herman H. W.; Meems, Laura M. G.; van der Pol, Atze; van der Velde, A. Rogier; Berezikov, Eugene; Voors, Adriaan A.; de Boer, Rudolf A.; van der Meer, Peter			Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; BIOMARKERS; HYPERTENSION; PROGRESSION; DISEASE; INJURY; KINASE	Introduction We recently identified a set of plasma microRNAs (miRNAs) that are downregulated in patients with heart failure in comparison with control subjects. To better understand their meaning and function, we sought to validate these circulating miRNAs in 3 different well-established rat and mouse heart failure models, and correlated the miRNAs to parameters of cardiac function. Methods The previously identified let-7i-5p, miR-16-5p, miR-18a-5p, miR-26b-5p, miR-27a-3p, miR30e-5p, miR-199a-3p, miR-223-3p, miR-423-3p, miR-423-5p and miR-652-3p were measured by means of quantitative real time polymerase chain reaction (qRT-PCR) in plasma samples of 8 homozygous TGR(mREN2)27 (Ren2) transgenic rats and 8 (control) Sprague-Dawley rats, 6 mice with angiotensin II-induced heart failure (AngII) and 6 control mice, and 8 mice with ischemic heart failure and 6 controls. Circulating miRNA levels were compared between the heart failure animals and healthy controls. Results Ren2 rats, AngII mice and mice with ischemic heart failure showed clear signs of heart failure, exemplified by increased left ventricular and lung weights, elevated end-diastolic left ventricular pressures, increased expression of cardiac stress markers and reduced left ventricular ejection fraction. All miRNAs were detectable in plasma from rats and mice. No significant differences were observed between the circulating miRNAs in heart failure animals when compared to the healthy controls (all P>0.05) and no robust associations with cardiac function could be found. Conclusions The previous observation that miRNAs circulate in lower levels in human patients with heart failure could not be validated in well-established rat and mouse heart failure models. These results question the translation of data on human circulating miRNA levels to experimental models, and vice versa the validity of experimental miRNA data for human heart failure.	[Vegter, Eline L.; Ovchinnikova, Ekaterina S.; Sillje, Herman H. W.; Meems, Laura M. G.; van der Pol, Atze; van der Velde, A. Rogier; Voors, Adriaan A.; de Boer, Rudolf A.; van der Meer, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Ovchinnikova, Ekaterina S.; Berezikov, Eugene] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands	University of Groningen; University of Groningen	van der Meer, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	p.van.der.meer@umcg.nl	de Boer, Rudolf/ABE-9879-2020; Meems, Laura M.G./J-7979-2016; Berezikov, Eugene/D-3363-2013; Voors, Adriaan/ABE-6784-2020	Meems, Laura M.G./0000-0001-8627-7139; Berezikov, Eugene/0000-0002-1145-2884; van der Pol, Atze/0000-0003-1182-5051	Innovational Research Incentives Scheme Program of the Netherlands Organization for Scientific Research (NWO VIDI) [917.13.350]; Netherlands Heart Foundation: Approaching Heart Failure By Translational Research Of RNA Mechanisms (ARENA) [2011-11]; Netherlands CardioVascular Research Initiative; Netherlands Heart Foundation; Dutch Federation of University Medical Centres; Netherlands Organization for Health Research and Development; Royal Netherlands Academy of Sciences	Innovational Research Incentives Scheme Program of the Netherlands Organization for Scientific Research (NWO VIDI); Netherlands Heart Foundation: Approaching Heart Failure By Translational Research Of RNA Mechanisms (ARENA); Netherlands CardioVascular Research Initiative; Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Federation of University Medical Centres; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Royal Netherlands Academy of Sciences	This study is supported by the Innovational Research Incentives Scheme Program of the Netherlands Organization for Scientific Research (NWO VIDI, grant 917.13.350 to Dr. de Boer). This study was further subsidized by a grant from the Netherlands Heart Foundation: Approaching Heart Failure By Translational Research Of RNA Mechanisms (ARENA, 2011-11). We also acknowledge the support from the Netherlands CardioVascular Research Initiative: the Netherlands Heart Foundation, Dutch Federation of University Medical Centres, the Netherlands Organization for Health Research and Development and the Royal Netherlands Academy of Sciences.	Akat KM, 2014, P NATL ACAD SCI USA, V111, P11151, DOI 10.1073/pnas.1401724111; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bernardo BC, 2014, FASEB J, V28, P5097, DOI 10.1096/fj.14-253856; Booij HG, 2016, CARDIOVASC RES, V111, P217, DOI 10.1093/cvr/cvw161; Cannon MV, 2015, EMBO MOL MED, V7, P1229, DOI 10.15252/emmm.201404669; de Boer RA, 2004, J MOL MED, V82, P678, DOI 10.1007/s00109-004-0579-3; Deddens JC, 2016, J CARDIOVASC TRANSL, V9, P291, DOI 10.1007/s12265-016-9705-1; Dickinson BA, 2013, EUR J HEART FAIL, V15, P650, DOI 10.1093/eurjhf/hft018; Emanueli C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154274; Kaneko M, 2016, BIOMARKERS, V11, P1; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Ovchinnikova ES, 2016, EUR J HEART FAIL, V18, P414, DOI 10.1002/ejhf.332; Piubelli Chiara, 2014, Cells, V3, P802, DOI 10.3390/cells3030802; Romaine SPR, 2015, HEART, V101, P921, DOI 10.1136/heartjnl-2013-305402; Schlosser K, 2015, CHEST, V148, P481, DOI 10.1378/chest.14-2169; Shah R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153691; Sopel MJ, 2011, LAB INVEST, V91, P565, DOI 10.1038/labinvest.2010.190; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tijsen AJ, 2014, CARDIOVASC RES, V104, P61, DOI 10.1093/cvr/cvu184; Vegter EL, 2017, CLIN RES CARDIOL; Vegter EL, 2016, INT J CARDIOL, V224, P231, DOI 10.1016/j.ijcard.2016.09.010; Vegter EL, 2016, EUR J HEART FAIL, V18, P457, DOI 10.1002/ejhf.495; Yu LL, 2013, CIRC-HEART FAIL, V6, P107, DOI 10.1161/CIRCHEARTFAILURE.112.971168; Zolk O, 1998, CARDIOVASC RES, V39, P242, DOI 10.1016/S0008-6363(98)00081-9	25	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177242	10.1371/journal.pone.0177242	http://dx.doi.org/10.1371/journal.pone.0177242			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475616	Green Published, gold, Green Submitted			2022-12-27	WOS:000400649500056
J	Blythe, DAJ; Nikulin, VV				Blythe, Duncan A. J.; Nikulin, Vadim V.			Long-range temporal correlations in neural narrowband time-series arise due to critical dynamics	PLOS ONE			English	Article							NEURONAL AVALANCHES; HUMAN BRAIN; OSCILLATIONS; NOISE; NETWORKS; EEG	We show theoretically that the hypothesis of criticality as a theory of long-range fluctuation in the human brain may be distinguished from the theory of passive filtering on the basis of macroscopic neuronal signals such as the electroencephalogram, using novel theory of narrowband amplitude time-series at criticality. Our theory predicts the division of critical activity into meta-universality classes. As a consequence our analysis shows that experimental electroencephalography data favours the hypothesis of criticality in the human brain.	[Blythe, Duncan A. J.] Zalando SE, Zalando Res, Berlin, Germany; [Nikulin, Vadim V.] Charite, Dept Neurol, Neurophys Grp, Berlin, Germany; [Nikulin, Vadim V.] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Nikulin, Vadim V.] Natl Res Univ, Ctr Cognit & Decis Making, Higher Sch Econ, Moscow, Russia	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; HSE University (National Research University Higher School of Economics)	Blythe, DAJ (corresponding author), Zalando SE, Zalando Res, Berlin, Germany.; Nikulin, VV (corresponding author), Charite, Dept Neurol, Neurophys Grp, Berlin, Germany.; Nikulin, VV (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany.; Nikulin, VV (corresponding author), Natl Res Univ, Ctr Cognit & Decis Making, Higher Sch Econ, Moscow, Russia.	duncanblythe@gmail.com; vadim.nikulin@charite.de	Nikulin, Vadim V/A-6050-2014	Nikulin, Vadim V/0000-0001-6082-3859	DFG [GRK 1589/1]; Russian Academic Excellence Project '5-100'	DFG(German Research Foundation (DFG)); Russian Academic Excellence Project '5-100'(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation)	DAJB was supported by a grant from the training group DFG, GRK 1589/1 'Sensory Computation in Neural Systems'; VVN acknowledges support from the Russian Academic Excellence Project '5-100'.; We thank Daniel Bartz for a critical reading of the manuscript. Financial support; DAJB was supported by a grant from the training group DFG, GRK 1589/1 'Sensory Computation in Neural Systems'; VVN acknowledges support from the Russian Academic Excellence Project `5-100'.	Abry P., 1998, J TIME SER ANAL, V19, P253, DOI DOI 10.1111/1467-9892.00090; Amblard P. O., 2013, SEMIN C, V28, P65; Arviv O, 2015, J NEUROSCI, V35, P13927, DOI 10.1523/JNEUROSCI.0477-15.2015; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Bedard C, 2009, BIOPHYS J, V96, P2589; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beggs JM, 2008, PHILOS T R SOC A, V366, P329, DOI 10.1098/rsta.2007.2092; Billingsley P, 1995, WILEY SERIES PROBABI; Blythe DAJ, 2014, NEUROIMAGE, V99, P377, DOI 10.1016/j.neuroimage.2014.05.041; Buzsaki G., 2006, RHYTHMS BRAIN; Dehghani N, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00302; Eurich CW, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.066137; Foldiak P, 1995, HDB BRAIN THEORY NEU, V1, P1064; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; Giraitis L, 2000, J MULTIVARIATE ANAL, V72, P183, DOI 10.1006/jmva.1999.1865; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Griffiths, 1999, INTRO ELECTRODYNAMIC, V3; Hardstone R, 2012, SCALE FREE DYNAMICS, P75; JENSEN HJ, 1989, PHYS REV B, V40, P7425, DOI 10.1103/PhysRevB.40.7425; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; KASDIN NJ, 1995, P IEEE, V83, P802, DOI 10.1109/5.381848; Kristoufek L, 2014, PHYSICA A, V402, P291, DOI 10.1016/j.physa.2014.01.058; Kuntz MC, 2000, PHYS REV B, V62, P11699, DOI 10.1103/PhysRevB.62.11699; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Marinucci D, 2000, STOCH PROC APPL, V86, P103, DOI 10.1016/S0304-4149(99)00088-5; Mehta AP, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.046139; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; Nikulin VV, 2011, NEUROIMAGE, V55, P1528, DOI 10.1016/j.neuroimage.2011.01.057; Nikulin VV, 2005, NEUROSCIENCE, V130, P549, DOI 10.1016/j.neuroscience.2004.10.007; Nikulin VV, 2004, CLIN NEUROPHYSIOL, V115, P1896, DOI 10.1016/j.clinph.2004.03.019; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Palva JM, 2013, P NATL ACAD SCI USA, V110, P3585, DOI 10.1073/pnas.1216855110; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Podobnik B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.084102; Poil SS, 2012, J NEUROSCI, V32, P9817, DOI 10.1523/JNEUROSCI.5990-11.2012; Rea W, 2009, ARXIV09010762; Ribeiro TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014129; Robinson PM, 1995, ANN STAT, V23, P1630, DOI 10.1214/aos/1176324317; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; Shriki O, 2013, J NEUROSCI, V33, P7079, DOI 10.1523/JNEUROSCI.4286-12.2013; Srinivasan R, 1996, BRAIN TOPOGR, V8, P355, DOI 10.1007/BF01186911; Taqqu MS, 1975, PROBAB THEORY REL, V31, P287; Weron R, 2002, PHYSICA A, V312, P285, DOI 10.1016/S0378-4371(02)00961-5; Zebende GF, 2011, PHYSICA A, V390, P1677, DOI 10.1016/j.physa.2010.12.038	48	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175628	10.1371/journal.pone.0175628	http://dx.doi.org/10.1371/journal.pone.0175628			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472078	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500013
J	Froese, JG; Smith, CS; Durr, PA; McAlpine, CA; van Klinken, RD				Froese, Jens G.; Smith, Carl S.; Durr, Peter A.; McAlpine, Clive A.; van Klinken, Rieks D.			Modelling seasonal habitat suitability for wide-ranging species: Invasive wild pigs in northern Australia	PLOS ONE			English	Article							BOAR SUS-SCROFA; FERAL PIGS; BAYESIAN NETWORKS; PASTURE DISTRIBUTION; EXPERT KNOWLEDGE; UNCERTAINTY; JUDGMENTS; SELECTION; TEMPERATURE; POPULATIONS	Invasive wildlife often causes serious damage to the economy and agriculture as well as environmental, human and animal health. Habitat models can fill knowledge gaps about species distributions and assist planning to mitigate impacts. Yet, model accuracy and utility may be compromised by small study areas and limited integration of species ecology or temporal variability. Here we modelled seasonal habitat suitability for wild pigs, a widespread and harmful invader, in northern Australia. We developed a resource-based, spatially-explicit and regional-scale approach using Bayesian networks and spatial pattern suitability analysis. We integrated important ecological factors such as variability in environmental conditions, breeding requirements and home range movements. The habitat model was parameterized during a structured, iterative expert elicitation process and applied to a wet season and a dry season scenario. Model performance and uncertainty was evaluated against independent distributional data sets. Validation results showed that an expert-averaged model accurately predicted empirical wild pig presences in northern Australia for both seasonal scenarios. Model uncertainty was largely associated with different expert assumptions about wild pigs' resource-seeking home range movements. Habitat suitability varied considerably between seasons, retracting to resource-abundant rainforest, wetland and agricultural refuge areas during the dry season and expanding widely into surrounding grassland floodplains, savanna woodlands and coastal shrubs during the wet season. Overall, our model suggested that suitable wild pig habitat is less widely available in northern Australia than previously thought. Mapped results may be used to quantify impacts, assess risks, justify management investments and target control activities. Our methods are applicable to other wide-ranging species, especially in data-poor situations.	[Froese, Jens G.; Smith, Carl S.] Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia; [Froese, Jens G.; McAlpine, Clive A.] Univ Queensland, Sch Earth & Environm Sci, St Lucia, Qld, Australia; [Froese, Jens G.; van Klinken, Rieks D.] CSIRO Hlth & Biosecur, Dutton Pk, Qld, Australia; [Durr, Peter A.] CSIRO, Australian Anim Hlth Lab, East Geelong, Vic, Australia	University of Queensland; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Froese, JG (corresponding author), Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia.; Froese, JG (corresponding author), Univ Queensland, Sch Earth & Environm Sci, St Lucia, Qld, Australia.; Froese, JG (corresponding author), CSIRO Hlth & Biosecur, Dutton Pk, Qld, Australia.	jens.froese@uq.net.au	Durr, Peter/O-2948-2014; van Klinken, Rieks D/B-1772-2009; Smith, Carl/G-9991-2017; Froese, Jens/P-3215-2015	Durr, Peter/0000-0003-0851-5300; van Klinken, Rieks D/0000-0002-7578-8977; Smith, Carl/0000-0003-3823-2432; Froese, Jens/0000-0001-5920-6431; McAlpine, Clive/0000-0003-0457-8144	Australian Postgraduate Award; Commonwealth Scientific and Industrial Research Organisation (CSIRO)/The University of Queensland "integrated Natural Resource Management scholarship'' [Q13/00325]; CSIRO Human Ethics Committee [075/13]	Australian Postgraduate Award(Australian Government); Commonwealth Scientific and Industrial Research Organisation (CSIRO)/The University of Queensland "integrated Natural Resource Management scholarship''; CSIRO Human Ethics Committee	This research was funded by an Australian Postgraduate Award and a Commonwealth Scientific and Industrial Research Organisation (CSIRO)/The University of Queensland "integrated Natural Resource Management scholarship'' (Q13/00325). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge foremost the contributions of our panel of wild pig experts, without whom this research would not have been possible. In particular, thank you Jim Mitchell, Justin Perry, Col Dollery, Andrew Hartwig, Scott Middleton and Tim Kerlin for kindly participating in elicitation interviews. Expert elicitation work was approved by the CSIRO Human Ethics Committee (Project 075/13). We also thank the Balkanu Cape York Development Corporation,Queensland Parks and Wildlife Service and Northern Australia Quarantine Strategy who shared data; Russell Richards and Justin Perry who helped with R analyses and Justine Murray who helped with expert elicitation.	Alexander N., 2016, OPEN HLTH DATA, V4, P1, DOI DOI 10.5334/OHD.24; [Anonymous], 1996, MANAGING VERTEBRATE; Australian Bureau of Agricultural and Resource Economics and Sciences, 2011, GUID LAND US MAPP AU; Barrios-Garcia MN, 2012, BIOL INVASIONS, V14, P2283, DOI 10.1007/s10530-012-0229-6; Beale R., 2008, ONE BIOSECURITY WORK; Beck JL, 2009, MODELS FOR PLANNING WILDLIFE CONSERVATION IN LARGE LANDSCAPES, P251, DOI 10.1016/B978-0-12-373631-4.00010-1; Bengsen AJ, 2014, MAMMAL REV, V44, P135, DOI 10.1111/mam.12011; Bosch J, 2014, SPAN J AGRIC RES, V12, P984, DOI 10.5424/sjar/2014124-5717; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Cain J, 2001, PLANNING IMPROVEMENT; Caley P, 1997, WILDLIFE RES, V24, P77, DOI 10.1071/WR94075; CALEY P, 1993, WILDLIFE RES, V20, P625, DOI 10.1071/WR9930625; Choquenot D, 1998, J ANIM ECOL, V67, P887, DOI 10.1046/j.1365-2656.1998.6760887.x; Choquenot D, 2003, J ANIM ECOL, V72, P14, DOI 10.1046/j.1365-2656.2003.00676.x; Cowled BD, 2007, SPATIAL PREDICTIVE M; Cowled B, 2008, PREV VET MED, V87, P197, DOI 10.1016/j.prevetmed.2008.03.012; Cowled BD, 2009, WILDLIFE RES, V36, P242, DOI 10.1071/WR08115; *DEP ENV WAT RES, 2007, AUSTR NAT VEG SUMM A; Department of Agriculture and Fisheries, 2015, ANN PEST DISTR SURV; Department of the Environment, 2015, THREAT AB PLAN PRED; Dexter N, 1999, WILDLIFE RES, V26, P755, DOI 10.1071/WR98075; Dexter N, 1998, WILDLIFE RES, V25, P547, DOI 10.1071/WR97119; Dexter N, 2015, ECOL EVOL, V5, P2036, DOI 10.1002/ece3.1489; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fenton NE, 2007, IEEE T KNOWL DATA EN, V19, P1420, DOI [10.1109/TKDE.2007.1073, 10.1109/TKDE.2007.1068]; Fox I. D., 2001, VEGETATION AUSTR TRO; Franklin J, 2010, DIVERS DISTRIB, V16, P321, DOI 10.1111/j.1472-4642.2010.00641.x; Guerschman JP, 2009, REMOTE SENS ENVIRON, V113, P928, DOI 10.1016/j.rse.2009.01.006; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; HONE J, 1990, AUST WILDLIFE RES, V17, P131; Hone J., 2012, APPL POPULATION COMM; Hone J., 2007, WILDLIFE DAMAGE CONT; HUNSAKER C, 2001, SPATIAL UNCERTAINTY; Jackson HB, 2015, GLOBAL ECOL BIOGEOGR, V24, P52, DOI 10.1111/geb.12233; Jones DA, 2009, AUST METEOROL OCEAN, V58, P233, DOI 10.22499/2.5804.003; Kramer-Schadt S, 2007, MAMMAL REV, V37, P1, DOI 10.1111/j.1365-2907.2007.00097.x; Krull CR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146765; Kuhnert PM, 2010, ECOL LETT, V13, P900, DOI 10.1111/j.1461-0248.2010.01477.x; Landuyt D, 2013, ENVIRON MODELL SOFTW, V46, P1, DOI 10.1016/j.envsoft.2013.03.011; Marcot BG, 2001, FOREST ECOL MANAG, V153, P29, DOI 10.1016/S0378-1127(01)00452-2; Marcot BG, 2006, ECOL SOC, V11; Marcot BG, 2012, ECOL MODEL, V230, P50, DOI 10.1016/j.ecolmodel.2012.01.013; Martin AE, 2012, ECOL APPL, V22, P2277, DOI 10.1890/11-2224.1; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; McBride MF, 2012, METHODS ECOL EVOL, V3, P906, DOI 10.1111/j.2041-210X.2012.00221.x; McBride MF, 2012, DIVERS DISTRIB, V18, P782, DOI 10.1111/j.1472-4642.2012.00884.x; McClure ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133771; McGarigal K, 2016, LANDSCAPE ECOL, V31, P1161, DOI 10.1007/s10980-016-0374-x; Mitchell J, 2009, WILDLIFE RES, V36, P110, DOI 10.1071/WR06066; Mitchell J, 1982, VERTEBRATE PESTS QUE; Mitchell J., 2010, EXPT RES QUANTIFY EN; Mitchell J. D., 2002, THESIS; Morelle K, 2015, EUR J WILDLIFE RES, V61, P45, DOI 10.1007/s10344-014-0872-6; Morrison ML., 2006, WILDLIFE HABITAT REL; Murray JV, 2012, GLOBAL CHANGE BIOL, V18, P1738, DOI 10.1111/j.1365-2486.2011.02621.x; Murray JV, 2009, J APPL ECOL, V46, P842, DOI 10.1111/j.1365-2664.2009.01671.x; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Perera AH, 2012, EXPERT KNOWLEDGE AND ITS APPLICATION IN LANDSCAPE ECOLOGY, P1, DOI 10.1007/978-1-4614-1034-8; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Smith C, 2012, DIVERS DISTRIB, V18, P818, DOI 10.1111/j.1472-4642.2011.00871.x; Smith CS, 2007, BIOL CONSERV, V139, P333, DOI 10.1016/j.biocon.2007.06.025; Speirs-Bridge A, 2010, RISK ANAL, V30, P512, DOI 10.1111/j.1539-6924.2009.01337.x; Stephens PA, 2015, J APPL ECOL, V52, P1, DOI 10.1111/1365-2664.12383; Tantipisanuh N, 2014, ECOL APPL, V24, P1705, DOI 10.1890/13-1882.1; Turner M., 2015, LANDSCAPE ECOLOGY TH, DOI [10.1007/978-1-4939-2794-4, DOI 10.1007/978-1-4939-2794-4]; Uusitalo L, 2007, ECOL MODEL, V203, P312, DOI 10.1016/j.ecolmodel.2006.11.033; van Klinken RD, 2015, CABI INVASIVE SER, V7, P171, DOI 10.1079/9781780643946.0171; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Venette RC, 2010, BIOSCIENCE, V60, P349, DOI 10.1525/bio.2010.60.5.5; Weber MM, 2016, ECOGRAPHY; West P., 2008, ASSESSING INVASIVE A; Wilhere GF, 2012, J WILDLIFE MANAGE, V76, P1298, DOI 10.1002/jwmg.366; WILSON G, 1992, PEST ANIMALS AUSTR S; Wurster CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043538; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0	80	13	13	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177018	10.1371/journal.pone.0177018	http://dx.doi.org/10.1371/journal.pone.0177018			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472113	gold, Green Submitted, Green Published			2022-12-27	WOS:000400648500119
J	Hernandez-Jimenez, M; Pena-Martinez, C; Godino, MD; Diaz-Guzman, J; Moro, MA; Lizasoain, I				Hernandez-Jimenez, Macarena; Pena-Martinez, Carolina; del Carmen Godino, Maria; Diaz-Guzman, Jaime; Angeles Moro, Maria; Lizasoain, Ignacio			Test repositioning for functional assessment of neurological outcome after experimental stroke in mice	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; ISCHEMIC-STROKE; MOTOR DEFICITS; RODENT MODELS; RATS; INFARCTION; BRAIN; VALIDATION; DEPRESSION; OCCLUSION	Stroke is a cerebrovascular pathology for which the only approved treatment is fibrinolysis. Several studies have focused on the development of new drugs but none has led to effective therapies to date, due, among others, to the difficulty to evaluate clinical deficits in experimental animal models. The present study aims to explore the applicability of known behavioral tests not commonly used in ischemia for the neurological assessment of mice after experimental stroke in different brain areas. A total of 225 CD1 male mice were randomly assigned to permanent middle cerebral artery occlusion by ligature (pMCAO) or permanent anterior cerebral artery occlusion by photothrombosis (pACAO) models. Modified neuroseverity score, footprint test, forced swim test and elevated plus maze were performed. Under these experimental conditions, modified neuroseverity score showed neurological impairment early after experimental stroke in both models. By contrast, the footprint test and the elevated plus maze detected short-term neurological deterioration in the pMCAO model but not in the pACAO model. Furthermore, the forced swim test identified depression-like behavior in mice after ischemia only when the left hemisphere was affected. In conclusion, we propose the repositioning of known neurobehavioral tests, but not commonly used in the stroke field, for the fast detection of neurological impairments early after ischemia, and even specific to discriminate the territory affected by arterial occlusion as well as the hemisphere where brain damage occurs. All these findings may prove useful to improve the experimental design of neuroprotective drugs in order to bridge the gap between experimental studies and clinical trials.	[Hernandez-Jimenez, Macarena; Pena-Martinez, Carolina; del Carmen Godino, Maria; Angeles Moro, Maria; Lizasoain, Ignacio] Univ Complutense, Fac Med, Dept Farmacol, Unidad Invest Neurovasc, Madrid, Spain; [Hernandez-Jimenez, Macarena; Pena-Martinez, Carolina; del Carmen Godino, Maria; Diaz-Guzman, Jaime; Angeles Moro, Maria; Lizasoain, Ignacio] Inst Invest Hosp 12 Octubre i 12, Madrid, Spain; [Hernandez-Jimenez, Macarena; Pena-Martinez, Carolina; del Carmen Godino, Maria; Angeles Moro, Maria; Lizasoain, Ignacio] Inst Univ Invest Neuroquirn, Madrid, Spain; [Diaz-Guzman, Jaime] Hosp Univ 12 Octubre, Serv Neurol, Madrid, Spain	Complutense University of Madrid; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre	Hernandez-Jimenez, M; Lizasoain, I (corresponding author), Univ Complutense, Fac Med, Dept Farmacol, Unidad Invest Neurovasc, Madrid, Spain.; Hernandez-Jimenez, M; Lizasoain, I (corresponding author), Inst Invest Hosp 12 Octubre i 12, Madrid, Spain.; Hernandez-Jimenez, M; Lizasoain, I (corresponding author), Inst Univ Invest Neuroquirn, Madrid, Spain.	macarenh@ucm.es; ignacio.lizasoain@med.ucm.es	Moro, María Ángeles/K-6396-2014; Lizasoain, Ignacio/K-9844-2014	Moro, María Ángeles/0000-0003-1010-8237; Lizasoain, Ignacio/0000-0002-6028-7379; Hernandez Jimenez, Macarena/0000-0003-3329-3965	Spanish Ministry of Economy and Competitiveness [SAF2014-52225, 5AF2015-68632-R]; Fondo Europeo de Desarrollo Regional (FEDER) "Una manera de hacer Europa" RETICS INVICTUS PLUS [RD16/0019/0009]; Instituto de Salud Carlos III	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER) "Una manera de hacer Europa" RETICS INVICTUS PLUS; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by grants from Spanish Ministry of Economy and Competitiveness SAF2014-52225 (IL) and 5AF2015-68632-R (MAM), and from Instituto de Salud Carlos III and cofinanced by Fondo Europeo de Desarrollo Regional (FEDER) "Una manera de hacer Europa" RETICS INVICTUS PLUS RD16/0019/0009 (IL).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboix A, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-30; Bhogal SK, 2004, STROKE, V35, P794, DOI 10.1161/01.STR.0000117237.98749.26; Carter RJ, 1999, J NEUROSCI, V19, P3248; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Chen JR, 2008, J ANAT, V213, P249, DOI 10.1111/j.1469-7580.2008.00948.x; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; DeVries AC, 2001, NEUROSCI BIOBEHAV R, V25, P325, DOI 10.1016/S0149-7634(01)00017-3; Dorr A, 2007, NEUROIMAGE, V35, P1409, DOI 10.1016/j.neuroimage.2006.12.040; Engels AS, 2007, PSYCHOPHYSIOLOGY, V44, P352, DOI 10.1111/j.1469-8986.2007.00518.x; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; GARCIA JH, 1995, STROKE, V26, P636, DOI 10.1161/01.STR.26.4.636; Hackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35; Hernandez-Jimenez M, 2013, STROKE, V44, P2333, DOI 10.1161/STROKEAHA.113.001715; Hossmann KA, 2008, NEUROPHARMACOLOGY, V55, P257, DOI 10.1016/j.neuropharm.2007.12.004; James ML, 2009, STROKE, V40, P632, DOI 10.1161/STROKEAHA.108.530402; Lee HY, 2012, MED BIOL ENG COMPUT, V50, P937, DOI 10.1007/s11517-012-0933-5; Livingston-Thomas JM, 2015, BEHAV BRAIN RES, V294, P102, DOI 10.1016/j.bbr.2015.07.053; Macrae IM, 2011, BRIT J PHARMACOL, V164, P1062, DOI 10.1111/j.1476-5381.2011.01398.x; Manwani B, 2011, BRAIN BEHAV IMMUN, V25, P1689, DOI 10.1016/j.bbi.2011.06.015; MATSUNO H, 1993, J PHARMACOL TOX MET, V29, P165, DOI 10.1016/1056-8719(93)90068-P; Nagano K, 2015, J PHYS THER SCI, V27, P357, DOI 10.1589/jpts.27.357; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Peng CG, 2015, NEURAL REGEN RES, V10, P1477, DOI 10.4103/1673-5374.165520; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; ROBINSON RG, 1984, BRAIN, V107, P81, DOI 10.1093/brain/107.1.81; Rosell A, 2013, TRANSL STROKE RES, V4, P297, DOI 10.1007/s12975-012-0234-1; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Sugimoto H, 2014, BEHAV BRAIN RES, V272, P100, DOI 10.1016/j.bbr.2014.06.048; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; TITIANOVA EB, 1995, J REHABIL RES DEV, V32, P236; Vahid-Ansari F, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.124; Winter B, 2005, BIOL PSYCHIAT, V57, P1166, DOI 10.1016/j.biopsych.2005.02.010; Zarruk JG, 2011, REV NEUROLOGIA, V53, P607, DOI 10.33588/rn.5310.2011016; Zhu J, 2015, J PERIODONTAL RES, V50, P683, DOI 10.1111/jre.12251	36	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176770	10.1371/journal.pone.0176770	http://dx.doi.org/10.1371/journal.pone.0176770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472090	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500070
J	Pennekamp, F; Griffiths, JI; Fronhofer, EA; Garnier, A; Seymour, M; Altermatt, F; Petchey, OL				Pennekamp, Frank; Griffiths, Jason I.; Fronhofer, Emanuel A.; Garnier, Aurelie; Seymour, Mathew; Altermatt, Florian; Petchey, Owen L.			Dynamic species classification of microorganisms across time, abiotic and biotic environments-A sliding window approach	PLOS ONE			English	Article							IMAGE-ANALYSIS; PHENOTYPIC PLASTICITY; SMALL WORLDS; ECOLOGY; DIVERSITY; IDENTIFICATION; COMMUNITIES; TEMPERATURE; EVOLUTION; PREDATION	The development of video-based monitoring methods allows for rapid, dynamic and accurate monitoring of individuals or communities, compared to slower traditional methods, with far reaching ecological and evolutionary applications. Large amounts of data are generated using video-based methods, which can be effectively processed using machine learning (ML) algorithms into meaningful ecological information. ML uses user defined classes (e.g. species), derived from a subset (i.e. training data) of video-observed quantitative features (e.g. phenotypic variation), to infer classes in subsequent observations. However, phenotypic variation often changes due to environmental conditions, which may lead to poor classification, if environmentally induced variation in phenotypes is not accounted for. Here we describe a framework for classifying species under changing environmental conditions based on the random forest classification. A sliding window approach was developed that restricts temporal and environmentally conditions to improve the classification. We tested our approach by applying the classification framework to experimental data. The experiment used a set of six ciliate species to monitor changes in community structure and behavior over hundreds of generations, in dozens of species combinations and across a temperature gradient. Differences in biotic and abiotic conditions caused simplistic classification approaches to be unsuccessful. In contrast, the sliding window approach allowed classification to be highly successful, as phenotypic differences driven by environmental change, could be captured by the classifier. Importantly, classification using the random forest algorithm showed comparable success when validated against traditional, slower, manual identification. Our framework allows for reliable classification in dynamic environments, and may help to improve strategies for long-term monitoring of species in changing environments. Our classification pipeline can be applied in fields assessing species community dynamics, such as eco-toxicology, ecology and evolutionary ecology.	[Pennekamp, Frank; Fronhofer, Emanuel A.; Garnier, Aurelie; Altermatt, Florian; Petchey, Owen L.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Griffiths, Jason I.] Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Fronhofer, Emanuel A.; Seymour, Mathew; Altermatt, Florian] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Uberlandstr 133, CH-8600 Dubendorf, Switzerland; [Seymour, Mathew] Bangor Univ, Sch Biol Sci, Mol Ecol & Fisheries Genet Lab, Deiniol Rd, Bangor LL57 2UW, Gwynedd, Wales	University of Zurich; University of Sheffield; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Bangor University	Pennekamp, F (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	frank.pennekamp@ieu.uzh	Fronhofer, Emanuel A./AAY-3186-2021; Seymour, Mat/AAT-2716-2020; Garnier, Aurelie/AAJ-2073-2021; Pennekamp, Frank/ABD-3597-2020; Fronhofer, Emanuel A./J-9784-2013; Petchey, Owen/D-8851-2011	Fronhofer, Emanuel A./0000-0002-2219-784X; Pennekamp, Frank/0000-0003-0679-1045; Fronhofer, Emanuel A./0000-0002-2219-784X; Petchey, Owen/0000-0002-7724-1633; Altermatt, Florian/0000-0002-4831-6958; Garnier, Aurelie/0000-0002-3712-4301; seymour, mathew/0000-0002-3654-4857	Swiss National Science Foundation [31003A_159498, 31003A_135622, PP00P3_150698]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation 31003A_159498 to OLP and Swiss National Science Foundation 31003A_135622 and PP00P3_150698 to FA.; The data used in this study was collected in a joint effort of the Altermatt and Petchey groups, University of Zurich. We thank Roman Alther, Yves Choffat, Pravin Ganesanandamoorthy, Suzanne Greene, Katherine Horgan, Thomas Massie, Elvira M achler, Gian-Marco Palamara and Mikael Pontarp for their help in collecting the experimental data. We also thank S3IT at University of Zurich for adapting the tracking functionality of the R package BEMOVI to the ScienceCloud computing infrastructure and assistance in processing the video raw data. FP and OLP were financially supported by Swiss National Science Foundation Grant 31003A_159498, FA received funding by the Swiss National Science Foundation Grants 31003A_135622 and PP00P3_150698.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Altermatt F, 2015, METHODS ECOL EVOL, V6, P218, DOI 10.1111/2041-210X.12312; Amaral AL, 2008, ANAL BIOANAL CHEM, V391, P1321, DOI 10.1007/s00216-008-1845-y; Amaral AL, 2004, ENVIRONMETRICS, V15, P381, DOI 10.1002/env.652; Atkinson D, 2003, P ROY SOC B-BIOL SCI, V270, P2605, DOI 10.1098/rspb.2003.2538; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bell JL, 2008, J PLANKTON RES, V30, P1351, DOI 10.1093/plankt/fbn092; Benton TG, 2007, TRENDS ECOL EVOL, V22, P516, DOI 10.1016/j.tree.2007.08.003; Bi HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127121; Biard T, 2016, NATURE, V532, P504, DOI 10.1038/nature17652; Blumenshine SC, 2000, ECOLOGY, V81, P374, DOI 10.1890/0012-9658(2000)081[0374:GOFPAB]2.0.CO;2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cadotte MW, 2005, ADV ECOLOGICAL RES; Carrara F, 2015, METHODS ECOL EVOL, V6, P895, DOI 10.1111/2041-210X.12363; Carrara F, 2015, ECOLOGY, V96, P1340, DOI 10.1890/14-1324.1; Culverhouse PF, 2006, MAR ECOL PROG SER, V312, P297, DOI 10.3354/meps312297; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Depraetere M, 2012, ECOL INDIC, V13, P46, DOI 10.1016/j.ecolind.2011.05.006; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; Gao ZK, 2016, EPL-EUROPHYS LETT, V116, DOI 10.1209/0295-5075/116/50001; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35622; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Hammill E, 2010, AM NAT, V176, P723, DOI 10.1086/657040; Harrison XA, 2015, PEERJ, V3, DOI 10.7717/peerj.1114; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Jiang L, 2004, OIKOS, V106, P217, DOI 10.1111/j.0030-1299.2004.13056.x; Jiang L, 2004, J ANIM ECOL, V73, P569, DOI 10.1111/j.0021-8790.2004.00830.x; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Kotsiantis S., 2006, GESTS INT T COMPUTER, V30, P25, DOI DOI 10.1007/978-0-387-09823-4_45; Kuhl HS, 2013, TRENDS ECOL EVOL, V28, P432, DOI 10.1016/j.tree.2013.02.013; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; KUSCH J, 1993, OECOLOGIA, V96, P354, DOI 10.1007/BF00317505; Leary DJ, 2009, J ANIM ECOL, V78, P1143, DOI 10.1111/j.1365-2656.2009.01586.x; MacLeod N, 2010, NATURE, V467, P154, DOI 10.1038/467154a; Mayumi Oshiro Thais, 2012, Machine Learning and Data Mining in Pattern Recognition. Proceedings 8th International Conference, MLDM 2012, P154, DOI 10.1007/978-3-642-31537-4_13; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Ozgul A, 2009, SCIENCE, V325, P464, DOI 10.1126/science.1173668; Pennekamp F, 2015, ECOL EVOL, V5, P2584, DOI 10.1002/ece3.1529; Pennekamp F, 2014, EVOLUTION, V68, P2319, DOI 10.1111/evo.12428; Pennekamp F, 2013, METHODS ECOL EVOL, V4, P483, DOI 10.1111/2041-210X.12036; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Peters DPC, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00295.1; Pons M N, 2000, Adv Biochem Eng Biotechnol, V66, P133; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Quinn G.P., 2002, EXPT DESIGN DATA ANA; R Core Team, 2021, R LANGUAGE ENV STAT; Russo D, 2016, ECOL INDIC, V66, P598, DOI 10.1016/j.ecolind.2016.02.036; Seymour M, 2015, OIKOS, V124, P908, DOI 10.1111/oik.02354; Soleymani A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145345; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604; Swinnen KRR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098881; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Travis J, 2014, P NATL ACAD SCI USA, V111, P581, DOI 10.1073/pnas.1305853111; Vrijenhoek RC, 2009, DEEP-SEA RES PT II, V56, P1713, DOI 10.1016/j.dsr2.2009.05.016; Weinstein BG, 2015, METHODS ECOL EVOL, V6, P357, DOI 10.1111/2041-210X.12320	61	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176682	10.1371/journal.pone.0176682	http://dx.doi.org/10.1371/journal.pone.0176682			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472193	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000400648500064
J	Signes-Pastor, AJ; Woodside, JV; McMullan, P; Mullan, K; Carey, M; Karagas, MR; Meharg, AA				Signes-Pastor, Antonio J.; Woodside, Jayne V.; McMullan, Paul; Mullan, Karen; Carey, Manus; Karagas, Margaret R.; Meharg, Andrew A.			Levels of infants' urinary arsenic metabolites related to formula feeding and weaning with rice products exceeding the EU inorganic arsenic standard	PLOS ONE			English	Article							GEOGRAPHICAL VARIATION; EXPOSURE; SAMPLES; SPECIATION; HEALTH; WHITE; FOODS	Early childhood inorganic arsenic (i-As) exposure is of particular concern since it may adversely impact on lifetime health outcomes. Infants' urinary arsenic (As) metabolites were analysed in 79 infants by inductively coupled plasma D mass spectrometric detection (ICICP- MS) to evaluate i-As exposure pre-and post-weaning. Levels of i-As in rice-based weaning and infants' foods were also determined to relate to urinary As levels. Higher As levels, especially of monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA), were found in urine from formula fed infants compared to those breastfed. Urine from infants post-weaning consuming rice-products resulted in higher urinary MMA and DMA compared to the paired pre-weaning urine samples. The European Union (EU) has regulated i-As in rice since 1 st January 2016. Comparing infants' rice-based foods before and after this date, little change was found. Nearly of the rice-based products specifically marketed for infants and young children contained i-As over the 0.1 mg/kg EU limit. Efforts should be made to provide low i-As rice and rice-based products consumed by infants and young children that do not exceed the maximum i-As level to protect this vulnerable subpopulation.	[Signes-Pastor, Antonio J.; Woodside, Jayne V.; Carey, Manus; Meharg, Andrew A.] Queens Univ Belfast, Inst Global Food Secur, David Keir Bldg, Belfast, Antrim, North Ireland; [Signes-Pastor, Antonio J.; Karagas, Margaret R.] Dartmouth Coll, Geisel Sch Med, Dept Epidemiol, 1 Med Ctr Dr,7927 Rubin Bldg, Lebanon, NH 03755 USA; [Woodside, Jayne V.; McMullan, Paul; Mullan, Karen] Royal Victoria Hosp, UKCRC Ctr Excellence Publ Hlth, Inst Clin Sci B, Belfast, Antrim, North Ireland	Queens University Belfast; Dartmouth College	Signes-Pastor, AJ (corresponding author), Queens Univ Belfast, Inst Global Food Secur, David Keir Bldg, Belfast, Antrim, North Ireland.; Signes-Pastor, AJ (corresponding author), Dartmouth Coll, Geisel Sch Med, Dept Epidemiol, 1 Med Ctr Dr,7927 Rubin Bldg, Lebanon, NH 03755 USA.	antonio.j.signes-pastor@dartmouth.edu	Meharg, Andrew Alexander/F-8182-2014; Signes-Pastor, Antonio/N-9700-2019; Carey, Manus/K-8180-2015	Meharg, Andrew Alexander/0000-0003-2019-0449; Signes-Pastor, Antonio/0000-0003-4898-2480; Mullan, Karen R/0000-0002-6355-1964; Carey, Manus/0000-0002-1065-4943; Woodside, Jayne/0000-0002-5691-4659	Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme [PIEF-GA-2013-622096]; Metabolic Unit Research funds (charitable funds) Belfast Health and Social Care Trust	Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme(European Commission); Metabolic Unit Research funds (charitable funds) Belfast Health and Social Care Trust	This work was funded by a Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (PIEF-GA-2013-622096) and the Metabolic Unit Research funds (charitable funds) Belfast Health and Social Care Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a Marie Curie Intra-European Fellowship within the 7<SUP>th</SUP> European Community Framework Programme (PIEF-GA-2013-622096) and the Metabolic Unit Research funds (charitable funds) Belfast Health and Social Care Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carey M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131608; Carignan CC, 2015, ENVIRON HEALTH PERSP, V123, P500, DOI 10.1289/ehp.1408789; Da Sacco L, 2013, J GEOCHEM EXPLOR, V131, P45, DOI 10.1016/j.gexplo.2012.11.014; EFSA. European Food Safety Authority, 2009, SCI OP ARS FOOD EFS; Fangstrom B, 2008, ENVIRON HEALTH PERSP, V116, P963, DOI 10.1289/ehp.11094; Farzan SF, 2013, TOXICOL APPL PHARM, V272, P384, DOI 10.1016/j.taap.2013.06.030; FDA, 2016, FDA PROC LIM IN ARS; Hinwood AL, 2002, ENVIRON RES, V88, P219, DOI 10.1006/enrs.2002.4339; IARC, 2004, INT AG RES CANC MON; Jackson BP, 2012, ENVIRON HEALTH PERSP, V120, P623, DOI 10.1289/ehp.1104619; Jackson BP, 2012, PURE APPL CHEM, V84, P215, DOI 10.1351/PAC-CON-11-09-17; Karagas MR, 2016, JAMA PEDIATR, V170, P609, DOI 10.1001/jamapediatrics.2016.0120; Kordas K, 2016, ENVIRON RES, V147, P16, DOI 10.1016/j.envres.2016.01.022; Ljung K, 2011, FOOD CHEM, V127, P943, DOI 10.1016/j.foodchem.2011.01.062; Lovebom HSkroder, 2016, TOXICOL SCI, P1; Meharg AA, 2014, ENVIRON POLLUT, V194, P181, DOI 10.1016/j.envpol.2014.07.031; Meharg AA, 2008, ENVIRON POLLUT, V152, P746, DOI 10.1016/j.envpol.2008.01.043; Meharg AA, 2008, ENVIRON SCI TECHNOL, V42, P1051, DOI 10.1021/es702212p; Munera-Picazo S, 2014, J FOOD SCI, V79, pT122, DOI 10.1111/1750-3841.12310; Nermell B, 2008, ENVIRON RES, V106, P212, DOI 10.1016/j.envres.2007.08.005; NI Water, 2013, DRINK WAT QUAL ANN R, V67; R Code Team, 2015, LANG ENV STAT COMP; Rivera-Nunez Z, 2010, INT J HYG ENVIR HEAL, V213, P259, DOI 10.1016/j.ijheh.2010.03.003; Rodriguez-Barranco M., 2016, CORTEX, V4; Sanchez TR, 2016, ENVIRON RES, V147, P537, DOI 10.1016/j.envres.2016.02.009; Signes-Pastor AJ, 2016, EXPO HEAL, P4; Signes-Pastor AJ, 2016, FOOD CHEM, V202, P356, DOI 10.1016/j.foodchem.2016.01.117; Signes-Pastor AJ, 2016, FOOD CHEM, V191, P128, DOI 10.1016/j.foodchem.2014.11.078; Vahter M, 2002, TOXICOLOGY, V181, P211, DOI 10.1016/S0300-483X(02)00285-8; Vahter M, 2009, ANNU REV NUTR, V29, P381, DOI 10.1146/annurev-nutr-080508-141102; Williams PN, 2007, ENVIRON SCI TECHNOL, V41, P6854, DOI 10.1021/es070627i	32	26	27	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176923	10.1371/journal.pone.0176923	http://dx.doi.org/10.1371/journal.pone.0176923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472079	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500098
J	Wu, BH; Kou, XX; Zhang, C; Zhang, YM; Cui, Z; Wang, XD; Liu, Y; Liu, DW; Zhou, YH				Wu, Bo-Hai; Kou, Xiao-Xing; Zhang, Ci; Zhang, Yi-Mei; Cui, Zhen; Wang, Xue-Dong; Liu, Yan; Liu, Da-Wei; Zhou, Yan-Heng			Stretch force guides finger-like pattern of bone formation in suture	PLOS ONE			English	Article							RAPID PALATAL EXPANSION; MIDPALATAL SUTURE; CRANIAL SUTURES; MAXILLARY EXPANSION; TRANSCRIPTIONAL REGULATION; CIRCUMMAXILLARY SUTURES; CRANIOFACIAL SUTURES; STRAIN; RATS; OSTEOGENESIS	Mechanical tension is widely applied on the suture to modulate the growth of craniofacial bones. Deeply understanding the features of bone formation in expanding sutures could help us to improve the outcomes of clinical treatment and avoid some side effects. Although there are reports that have uncovered some biological characteristics, the regular pattern of sutural bone formation in response to expansion forces is still unknown. Our study was to investigate the shape, arrangement and orientation of new bone formation in expanding sutures and explore related clinical implications. The premaxillary sutures of rat, which histologically resembles the sutures of human beings, became wider progressively under stretch force. Micro-CT detected new bones at day 3. Morphologically, these bones were forming in a finger-like pattern, projecting from the maxillae into the expanded sutures. There were about 4 finger-like bones appearing on the selected micro-CT sections at day 3 and this number increased to about 18 at day 7. The average length of these projections increased from 0.14 mm at day 3 to 0.81 mm at day 7. The volume of these bony protuberances increased to the highest level of 0.12 mm(3) at day 7. HE staining demonstrated that these finger-like bones had thick bases connecting with the maxillae and thin fronts stretching into the expanded suture. Nasal sections had a higher frequency of finger-like bones occuring than the oral sections at day 3 and day 5. Masson-stained sections showed stretched fibers embedding into maxillary margins. Osteocalcin-positive osteoblasts changed their shapes from cuboidal to spindle and covered the surfaces of finger-like bones continuously. Alizarin red S and calcein deposited in the inner and outer layers of finger-like bones respectively, which showed that longer and larger bones formed on the nasal side of expanded sutures compared with the oral side. Interestingly, these finger-like bones were almost paralleling with the direction of stretch force. Inclined force led to inclined finger-like bones formation and deflection of bilateral maxillae. Additionally, heavily compressive force caused fracture of finger-like bones in the sutures. These data together proposed the special finger-like pattern of bone formation in sutures guided by stretch force, providing important implications for maxillary expansion.	[Wu, Bo-Hai; Kou, Xiao-Xing; Zhang, Ci; Zhang, Yi-Mei; Cui, Zhen; Wang, Xue-Dong; Liu, Yan; Liu, Da-Wei; Zhou, Yan-Heng] Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, Beijing, Peoples R China; [Wu, Bo-Hai; Kou, Xiao-Xing; Zhang, Ci; Zhang, Yi-Mei; Cui, Zhen; Wang, Xue-Dong; Liu, Yan; Liu, Da-Wei; Zhou, Yan-Heng] Peking Univ, Sch & Hosp Stomatol, Ctr Craniofacial Stem Cell Res & Regenerat, Beijing, Peoples R China	Peking University; Peking University	Liu, DW; Zhou, YH (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, Beijing, Peoples R China.; Liu, DW; Zhou, YH (corresponding author), Peking Univ, Sch & Hosp Stomatol, Ctr Craniofacial Stem Cell Res & Regenerat, Beijing, Peoples R China.	liudawei@bjmu.edu.cn; yanhengzhou@vip.163.com	, 许开源 18362929861 赛德阳光口腔/AFX-1820-2022; Zhou, Yanheng/ABG-5432-2021; Liu, Dawei/AAD-3130-2019	Zhou, Yanheng/0000-0002-5610-9967; Kou, Xiaoxing/0000-0001-9680-0077	International Science & Technology Cooperation Program of China [2015DFB30040]; National Science Foundation of China [81300897, 81300850, 81470717]; Beijing Municipal Natural Science Foundation [7152156]	International Science & Technology Cooperation Program of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by International Science & Technology Cooperation Program of China no. 2015DFB30040 (YZ), the National Science Foundation of China no. 81300897 (XK), no. 81571815 (YL), no. 81300850 (XW), no. 81470717 (YZ), the Beijing Municipal Natural Science Foundation no. 7152156 (YL).	Borke JL, 2003, ANN PLAS SURG, V51, P499, DOI 10.1097/01.SAP.0000067964.14122.3E; Borke JL, 2003, CLEFT PALATE-CRAN J, V40, P284, DOI 10.1597/1545-1569(2003)040<0284:NTROCB>2.0.CO;2; BURSTONE CHARLES J., 1959, JOUR DENTAL RES, V38, P534, DOI 10.1177/00220345590380031501; Byron CD, 2004, ANAT REC PART A, V279A, P676, DOI 10.1002/ar.a.20055; Chang HN, 1996, ARCH ORAL BIOL, V41, P985, DOI 10.1016/S0003-9969(96)00041-6; CLEALL J F, 1965, Angle Orthod, V35, P23; Cray J, 2014, J MORPHOL, V275, P342, DOI 10.1002/jmor.20218; Cray J, 2011, J ANAT, V218, P471, DOI 10.1111/j.1469-7580.2011.01358.x; Cray J, 2011, ANAT REC, V294, P676, DOI 10.1002/ar.21345; Cray J, 2010, AM J PHYS ANTHROPOL, V143, P473, DOI 10.1002/ajpa.21367; Ghoneima A, 2011, AM J ORTHOD DENTOFAC, V140, P510, DOI 10.1016/j.ajodo.2010.10.024; Gurel HG, 2010, ANGLE ORTHOD, V80, P5, DOI 10.2319/011209-22.1; Hermann CD, 2016, J DENT RES, V95, P846, DOI 10.1177/0022034516643315; Hou B, 2007, BONE, V40, P1483, DOI 10.1016/j.bone.2007.01.019; KAMBARA T, 1977, AM J ORTHOD DENTOFAC, V71, P249, DOI 10.1016/0002-9416(77)90187-7; Kariya T, 2015, J CELL BIOCHEM, V116, P12, DOI 10.1002/jcb.24863; Kobayashi ET, 1999, J DENT RES, V78, P1495, DOI 10.1177/00220345990780090301; Kopher RA, 2003, J BONE MINER RES, V18, P521, DOI 10.1359/jbmr.2003.18.3.521; LATHAM RA, 1971, J ANAT, V108, P31; Liu SSY, 2011, AM J ORTHOD DENTOFAC, V139, P446, DOI 10.1016/j.ajodo.2009.03.056; Liu SSY, 2010, EUR J ORTHODONT, V32, P371, DOI 10.1093/ejo/cjp103; Liu WT, 2015, AM J ORTHOD DENTOFAC, V148, P641, DOI 10.1016/j.ajodo.2015.04.038; Mao JJ, 2002, J DENT RES, V81, P810, DOI 10.1177/154405910208101203; Mao JJ, 2003, ANGLE ORTHOD, V73, P128; Mao JJ, 2003, FRONT BIOSCI-LANDMRK, V8, pA10, DOI 10.2741/917; Meikle MC, 2007, J DENT RES, V86, P12, DOI 10.1177/154405910708600103; MELSEN B, 1982, AM J ORTHOD DENTOFAC, V82, P329, DOI 10.1016/0002-9416(82)90467-5; MURRAY JMG, 1971, J DENT RES, V50, P1654, DOI 10.1177/00220345710500065101; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; PRITCHARD JJ, 1956, J ANAT, V90, P73; Shibazaki R, 2007, PLAST RECONSTR SURG, V119, P2167, DOI 10.1097/01.prs.0000260705.70329.38; Sun ZY, 2011, AM J ORTHOD DENTOFAC, V139, DOI 10.1016/j.ajodo.2009.12.029; Takahashi I, 1996, BONE, V18, P341, DOI 10.1016/8756-3282(96)00012-9; Takenouchi H, 2014, ARCH ORAL BIOL, V59, P414, DOI 10.1016/j.archoralbio.2014.01.010; Vardimon AD, 1998, AM J ORTHOD DENTOFAC, V113, P488, DOI 10.1016/S0889-5406(98)70259-8; Vardimon AD, 1998, AM J ORTHOD DENTOFAC, V113, P371, DOI 10.1016/S0889-5406(98)80006-1; Wu YD, 2007, CLEFT PALATE-CRAN J, V44, P482, DOI 10.1597/06-122.1; Yu Jack C, 2004, Semin Pediatr Neurol, V11, P249, DOI 10.1016/j.spen.2004.10.002; Yu JC, 2009, PLAST RECONSTR SURG, V123, p83S, DOI 10.1097/PRS.0b013e318191c029; Yu JC, 2003, CLEFT PALATE-CRAN J, V40, P409, DOI 10.1597/1545-1569(2003)040<0409:AFAOHC>2.0.CO;2; Yu JC, 2001, J CRANIOFAC SURG, V12, P391, DOI 10.1097/00001665-200107000-00018; ZAHROWSKI JJ, 1992, ANGLE ORTHOD, V62, P197	42	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177159	10.1371/journal.pone.0177159	http://dx.doi.org/10.1371/journal.pone.0177159			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472133	Green Submitted, gold, Green Published			2022-12-27	WOS:000400648500147
J	Anastasi, E; Ekanem, E; Hill, O; Oluwakemi, AA; Abayomi, O; Bernasconi, A				Anastasi, Erin; Ekanem, Ekanem; Hill, Olivia; Oluwakemi, Agnes Adebayo; Abayomi, Oluwatosin; Bernasconi, Andrea			Unmasking inequalities: Sub-national maternal and child mortality data from two urban slums in Lagos, Nigeria tells the story	PLOS ONE			English	Article							PERINATAL-MORTALITY	Introduction Nigeria has one of the highest maternal mortality ratios in the world as well as high perinatal mortality. Unfortunately, the country does not have the resources to assess this critical indicator with the conventional health information system and measuring its progress toward the goal of ending preventable maternal deaths is almost impossible. Me A decins Sans Frontieres (MSF) conducted a cross-sectional study to assess maternal and perinatal mortality in Makoko Riverine and Badia East, two of the most vulnerable slums of Lagos. Materials and methods The study was a cross-sectional, community-based household survey. Nearly 4,000 households were surveyed. The sisterhood method was utilized to estimate maternal mortality and the preceding births technique was used to estimate newborn and child mortality. Questions regarding health seeking behavior were posed to female interviewees and self-reported data were collected. Results Data was collected from 3963 respondents for a total of 7018 sisters ever married. The maternal mortality ratio was calculated at 1,050/100,000 live births (95% CI: 894-1215), and the lifetime risk of maternal death at 1: 18. The neonatal mortality rate was extracted from 1967 pregnancies reported and was estimated at 28.4/1,000; infant mortality at 43.8/1,000 and under-five mortality at 103/1,000. Living in Badia, giving birth at home and belonging to the Egun ethnic group were associated with higher perinatal mortality. Half of the last pregnancies were reportedly delivered in private health facilities. Proximity to home was the main influencing factor (32.4%) associated with delivery at the health facility. Discussion The maternal mortality ratio found in these urban slum populations within Lagos is extremely high, compared to the figure estimated for Lagos State of 545 per 100,000 live births. Urgent attention is required to address these neglected and vulnerable neighborhoods. Efforts should be invested in obtaining data from poor, marginalized, and hard-to-reach populations in order to identify pockets of marginalization needing additional resources and tailored approaches to guarantee equitable treatment and timely access to quality health services for vulnerable groups. This study demonstrates the importance of sub-regional, disaggregated data to identify and redress inequities that exist among poor, remote, vulnerable populations-as in the urban slums of Lagos.	[Anastasi, Erin] UN, Populat Fund, New York, NY 10017 USA; [Anastasi, Erin; Hill, Olivia; Oluwakemi, Agnes Adebayo; Abayomi, Oluwatosin; Bernasconi, Andrea] Doctors Borders, Operat Ctr Barcelona, Barcelona, Spain; [Ekanem, Ekanem] Univ Lagos, Dept Community Hlth & Primary Care, Coll Med, Lagos, Nigeria; [Abayomi, Oluwatosin] Turquoise Zeta Consult, Lagos, Nigeria; [Bernasconi, Andrea] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Bernasconi, Andrea] Univ Basel, Basel, Switzerland	United Nations Population Fund; University of Lagos; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Bernasconi, A (corresponding author), Doctors Borders, Operat Ctr Barcelona, Barcelona, Spain.; Bernasconi, A (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Bernasconi, A (corresponding author), Univ Basel, Basel, Switzerland.	doigb2@yahoo.it						Abosede O A, 2009, Nig Q J Hosp Med, V19, P69; Adimora G N, 2007, Niger J Clin Pract, V10, P19; Aguirre Alejandro, 1994, Genus, V50, P151; Ahman E, 2007, NEONATAL PERINATAL M; [Anonymous], 2014, COUNTD 2015 FULF HLT; BICEGO G, 1989, INT J EPIDEMIOL, V18, pS20, DOI 10.1093/ije/18.Supplement_2.S20; Daramola A O, 2004, Niger Postgrad Med J, V11, P274; Ekure EN, 2004, NIGER J PAEDIAT, V31, P14, DOI DOI 10.4314/NJP.V31I1.12082; Fawole AO, 2011, INT J GYNECOL OBSTET, V114, P37, DOI 10.1016/j.ijgo.2011.01.013; Graham W, 1989, Mothers Child, V8, P1; Hanley JA, 1996, STUD FAMILY PLANN, V27, P220, DOI 10.2307/2137955; HILL AG, 1990, POP STUD-J DEMOG, V44, P317, DOI 10.1080/0032472031000144616; National Population Commission [ Nigeria]. ORC Macro, 2004, ORC MACR NIG DEM HLT; NJOKANMA OF, 1994, J TROP PEDIATRICS, V40, P78, DOI 10.1093/tropej/40.2.78; NPC/Nigeria, 2014, NIG DEM HLTH SURV 20; OWA JA, 1995, TROP GEOGR MED, V47, P86; Oye-Adeniran BA, 2011, J OBSTET GYNAECOL, V31, P315, DOI 10.3109/01443615.2011.561381; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization. United Nations Children's Fund, 1997, SIST METH EST MAT MO; Ziraba Abdhalah Kasiira, 2009, Reprod Health, V6, P6, DOI 10.1186/1742-4755-6-6	20	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177190	10.1371/journal.pone.0177190	http://dx.doi.org/10.1371/journal.pone.0177190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489890	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100055
J	Ghosh, PK; Debu, DT; French, DA; Herzog, JB				Ghosh, Pijush K.; Debu, Desalegn T.; French, David A.; Herzog, Joseph B.			Calculated thickness dependent plasmonic properties of gold nanobars in the visible to near-infrared light regime	PLOS ONE			English	Article							OPTICAL-PROPERTIES; FIELD ENHANCEMENT; SINGLE; POLARIZATION; SCATTERING; RESONANCE; SHAPE; SIZE; NANOPARTICLES; MORPHOLOGY	Metallic, especially gold, nanostructures exhibit plasmonic behavior in the visible to nearinfrared light range. In this study, we investigate optical enhancement and absorption of gold nanobars with different thicknesses for transverse and longitudinal polarizations using finite element method simulations. This study also reports on the discrepancy in the resonance wavelengths and optical enhancement of the sharp-corner and round-corner nanobars of constant length 100 nm and width 60 nm. The result shows that resonance amplitude and wavelength have strong dependences on the thickness of the nanostructure as well as the sharpness of the corners, which is significant since actual fabricated structure often have rounded corners. Primary resonance mode blue-shifts and broadens as the thickess increases due to decoupling of charge dipoles at the surface for both polarizations. The broadening effect is characterized by measuring the full width at half maximum of the spectra. We also present the surface charge distribution showing dipole mode oscillations at resonance frequency and multimode resonance indicating different oscillation directions of the surface charge based on the polarization direction of the field. Results of this work give insight for precisely tuning nanobar structures for sensing and other enhanced optical applications.	[Ghosh, Pijush K.; Debu, Desalegn T.; French, David A.; Herzog, Joseph B.] Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA; [Ghosh, Pijush K.] Univ Arkansas, Dept Elect Engn, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Herzog, JB (corresponding author), Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA.	jbherzog@uark.edu	Debu, Desalegn T./ABC-2805-2020; Herzog, Joseph/I-5389-2019	Herzog, Joseph/0000-0003-2441-6169	Arkansas Biosciences Institute	Arkansas Biosciences Institute	Support was provided by Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000 [http://arbiosciences.org]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey GP, 2016, P SOC PHOTO-OPT INS; Catchpole KR, 2008, OPT EXPRESS, V16, P21793, DOI 10.1364/OE.16.021793; Chen HJ, 2013, CHEM SOC REV, V42, P2679, DOI 10.1039/c2cs35367a; Choy T. C., 2015, EFFECTIVE MEDIUM THE, V165; Dai H, 2012, OPT EXPRESS, V20, pA502, DOI 10.1364/OE.20.00A502; Derkacs D, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2336629; Ekinci Y, 2008, J APPL PHYS, V104, DOI 10.1063/1.2999370; Farahani JN, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.017402; Fernandez-Lopez C, 2015, ACS APPL MATER INTER, V7, P12530, DOI 10.1021/am5087209; Ferry VE, 2010, OPT EXPRESS, V18, pA237, DOI 10.1364/OE.18.00A237; Giannini R, 2015, J PHYS CHEM C, V119, P6138, DOI 10.1021/jp509245u; Giannini V, 2010, OPT EXPRESS, V18, P2797, DOI 10.1364/OE.18.002797; Herzog JB, 2014, NANO LETT, V14, P499, DOI 10.1021/nl403510u; Herzog JB, 2013, NANO LETT, V13, P1359, DOI 10.1021/nl400363d; Huang YJ, 2011, NANOSCALE, V3, P3228, DOI 10.1039/c1nr10336a; Huang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23159; Jain PK, 2010, CHEM PHYS LETT, V487, P153, DOI 10.1016/j.cplett.2010.01.062; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Knight MW, 2012, NANO LETT, V12, P6000, DOI 10.1021/nl303517v; Kooij ES, 2006, PHYS CHEM CHEM PHYS, V8, P3349, DOI 10.1039/b518389h; Kreibig U., 2013, OPTICAL PROPERTIES M; Langhammer C, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2734550; Li XF, 2011, OPT EXPRESS, V19, pA888, DOI 10.1364/OE.19.00A888; Macpherson HA, 2012, ACS NANO, V6, P8940, DOI 10.1021/nn3029502; Massa E, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/063013; Mokkapati S, 2012, J APPL PHYS, V112, DOI 10.1063/1.4747795; Muhlschlegel P, 2005, SCIENCE, V308, P1607, DOI 10.1126/science.1111886; Muskens OL, 2007, OPT EXPRESS, V15, P17736, DOI 10.1364/OE.15.017736; Ozhikandathil J, 2014, SENSORS-BASEL, V14, P10497, DOI 10.3390/s140610497; Pillai S, 2007, J APPL PHYS, V101, DOI 10.1063/1.2734885; Polavarapu L, 2015, CRYSTENGCOMM, V17, P3727, DOI 10.1039/c5ce00112a; Polavarapu L, 2013, NANOSCALE, V5, P4355, DOI 10.1039/c3nr01244a; Qiu YH, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/18/185107; Raziman TV, 2013, OPT EXPRESS, V21, P21500, DOI 10.1364/OE.21.021500; Saylor C, 2015, J NANOPHOTONICS, V9, DOI 10.1117/1.JNP.9.093053; Schuck PJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.017402; Shao L, 2015, PHYS CHEM CHEM PHYS, V17, P10861, DOI 10.1039/c5cp00715a; Shiohara A, 2014, NANOSCALE, V6, P9817, DOI 10.1039/c4nr02648a; Song M, 2012, OPT EXPRESS, V20, P22290, DOI 10.1364/OE.20.022290; Sonnichsen C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.077402; Wang F, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.206806; Wiley BJ, 2007, NANO LETT, V7, P1032, DOI 10.1021/nl070214f; Wissert MD, 2011, OPT EXPRESS, V19, P3686, DOI 10.1364/OE.19.003686; Wu J, 2014, NANO-MICRO LETT, V6, P372, DOI 10.1007/s40820-014-0011-7; Zhang SP, 2011, NANO LETT, V11, P1657, DOI 10.1021/nl200135r	46	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177463	10.1371/journal.pone.0177463	http://dx.doi.org/10.1371/journal.pone.0177463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486554	gold, Green Published			2022-12-27	WOS:000401314000080
J	Ruijsbroek, A; Wong, A; Kunst, AE; van den Brink, C; van Oers, HAM; Droomers, M; Stronks, K				Ruijsbroek, Annemarie; Wong, Albert; Kunst, Anton E.; van den Brink, Carolien; van Oers, Hans A. M.; Droomers, Mariel; Stronks, Karien			The impact of urban regeneration programmes on health and health-related behaviour: Evaluation of the Dutch District Approach 6.5 years from the start	PLOS ONE			English	Article							RENEWAL PROGRAM; NEW-DEAL; NEIGHBORHOOD; INEQUALITIES	Background Large-scale regeneration programmes to improve the personal conditions and living circumstances in deprived areas may affect health and the lifestyle of the residents. Previous evaluations concluded that a large-scale urban regeneration programme in the Netherlands had some positive effects within 3.5 years. The aim of the current study was to evaluate the effects at the longer run. Methods With a quasi-experimental research design we assessed changes in the prevalence of general health, mental health, physical activity, overweight, obesity, and smoking between the pre-intervention (2003-04-mid 2008) and intervention period (mid 2008-2013-14) in 40 deprived target districts and comparably deprived control districts. We used the Difference-in-Difference (DiD) to assess programme impact. Additionally, we stratified analyses by sex and by the intensity of the regeneration programme. Results Changes in health and health related behaviours from pre-intervention to the intervention period were about equally large in the target districts as in control districts. DiD impact estimates were inconsistent and not statistically significant. Sex differences in DiD estimates were not consistent or significant. Furthermore, DiD impact estimates were not consistently larger in target districts with more intensive intervention programmes. Conclusion We found no evidence that this Dutch urban regeneration programme had an impact in the longer run on self-reported health and related behaviour at the area level.	[Ruijsbroek, Annemarie; Wong, Albert; van den Brink, Carolien; van Oers, Hans A. M.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Kunst, Anton E.; Droomers, Mariel; Stronks, Karien] Univ Amsterdam, AMC, Amsterdam, Netherlands; [van Oers, Hans A. M.] Univ Tilburg, Fac Social Sci, Tranzo, Tilburg, Netherlands	Netherlands National Institute for Public Health & the Environment; University of Amsterdam; Academic Medical Center Amsterdam; Tilburg University	Ruijsbroek, A (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.	annemarie.ruijsbroek@RIVM.nl		van Oers, Hans/0000-0003-4063-2240; Stronks, Karien/0000-0002-0921-2232; Kunst, Anton/0000-0002-3313-5273				[Anonymous], 2008, CLOS GAP GEN HLTH EQ; Batty E., 2010, NEW DEAL COMMUNITIES, V7; Colla S., 2013, EVALUATIE DIENSTEN O; Droomers M, 2016, HEALTH PLACE, V41, P50, DOI 10.1016/j.healthplace.2016.07.003; Droomers M, 2014, PREV MED, V61, P122, DOI 10.1016/j.ypmed.2014.01.009; Egan M, 2013, AM J PUBLIC HEALTH, V103, pE47, DOI 10.2105/AJPH.2013.301275; Jalaludin B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-521; Jongeneel-Grimen B, 2016, J EPIDEMIOL COMMUN H, V70, P967, DOI 10.1136/jech-2015-207016; Kelaher M, 2010, HEALTH PLACE, V16, P861, DOI 10.1016/j.healthplace.2010.04.011; Kramer D, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-36; Lawless P, 2012, PLAN THEORY PRACT, V13, P509, DOI 10.1080/14649357.2012.728003; Lawless P, 2010, URBAN STUD, V47, P257, DOI 10.1177/0042098009348324; Mehdipanah R, 2014, J EPIDEMIOL COMMUN H, V68, P811, DOI 10.1136/jech-2013-203434; Mehdipanah R, 2013, HEALTH PLACE, V23, P9, DOI 10.1016/j.healthplace.2013.04.009; Pearson S, 2010, IMPROVING HLTH OUTCO; Perenboom R OK, 2000, PGVGZ99067 TNO; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Stafford M., 2008, J EPIDEMIOL COMMUNIT, V62, P1603; Stronks K, 2015, NED TIJDSCHR GENEES, V158, pA7989; Wagenmakers R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-141; Walthery P, 2015, J EPIDEMIOL COMMUN H, V69, P762, DOI 10.1136/jech-2014-204362; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; Whitehead M, 1991, GEOL FORENINGAN STOC; Whitehead M, 2007, J EPIDEMIOL COMMUN H, V61, P473, DOI 10.1136/jech.2005.037242	25	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177262	10.1371/journal.pone.0177262	http://dx.doi.org/10.1371/journal.pone.0177262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UM	28486487	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314000065
J	Tian, HF; Zhang, Y; Shi, Y; Li, XJ; Sun, Q; Liu, L; Zhao, D; Xu, BH				Tian, Huifang; Zhang, Yong; Shi, Yan; Li, Xiujuan; Sun, Qiang; Liu, Li; Zhao, Dong; Xu, Baohong			Epidemiological and aetiological characteristics of hand, foot, and mouth disease in Shijiazhuang City, Hebei province, China, 2009-2012	PLOS ONE			English	Article							ENTEROVIRUS 71 INFECTION; COXSACKIEVIRUS A6; GENETIC-CHARACTERIZATION; CHILDREN; RECOMBINATION; PATTERNS; MALAYSIA; A16; OUTBREAK; JAPAN	Large outbreaks of hand, foot, and mouth disease (HFMD) have repeatedly occurred in mainland of China since 2007. In this study, we investigated the epidemiological and aetiological characteristics of HFMD in Shijiazhuang City, one of the biggest northern cities of China. A total of 57,173 clinical HFMD cases, including 911 severe and 32 fatal cases, were reported in Shijiazhuang City during 2009-2012. The disease incidence peaked during March-July, with a small increase in the number of cases observed in November of each year. Seventeen potential HFMD-causing enterovirus serotypes were detected, with the most frequent serotypes being EV-A71 and CV-A16. CV-A10 was also a frequently detected causative serotype, and was associated with the second largest number of severe HFMD cases, following EV-A71. Phylogenetic analysis revealed that all EV-A71, CV-A16 and CV-A10 strains from Shijiazhuang City had co-evolved and co-circulated with those from other Chinese provinces. Our findings underscore the need for enhanced surveillance and molecular detection for HFMD, and suggest that EV-A71 vaccination may be an effective intervention strategy for HFMD prevention and vaccines against CV-A10 and CV-A16 are also urgently needed.	[Tian, Huifang; Shi, Yan; Li, Xiujuan; Liu, Li; Zhao, Dong; Xu, Baohong] Shijiazhuang Ctr Dis Control & Prevent, Shijiazhuang, Hebei Province, Peoples R China; [Zhang, Yong; Sun, Qiang] Natl Hlth & Family Planning Commiss China, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China; [Zhang, Yong; Sun, Qiang] Natl Hlth & Family Planning Commiss China, Key Lab Med Virol, Beijing, Peoples R China; [Zhang, Yong; Sun, Qiang] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Sun, Qiang] Chinese Acad Sci, State Key Lab Mol Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Tian, HF (corresponding author), Shijiazhuang Ctr Dis Control & Prevent, Shijiazhuang, Hebei Province, Peoples R China.	fang45530@126.com	li, xiu/GXV-1745-2022	Zhang, Yong/0000-0002-2692-5437	National Natural Science Foundation of China [81672070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (project no. 81672070).	Bian LL, 2015, EXPERT REV ANTI-INFE, V13, P1061, DOI 10.1586/14787210.2015.1058156; Cardosa MJ, 1999, LANCET, V354, P987, DOI 10.1016/S0140-6736(98)11032-2; Chan YF, 2012, TROP BIOMED, V29, P451; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chen L, 2012, MOL MED REP, V5, P1001, DOI 10.3892/mmr.2012.742; Cui AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061451; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; Gaunt E, 2015, J GEN VIROL, V96, P1067, DOI 10.1099/vir.0.000062; Guan HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142733; Gui JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139109; Han JF, 2014, J INFECTION, V69, P303, DOI 10.1016/j.jinf.2014.03.015; He YQ, 2013, J CLIN MICROBIOL, V51, P3560, DOI 10.1128/JCM.01231-13; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hu YF, 2011, J CLIN MICROBIOL, V49, P2426, DOI 10.1128/JCM.00007-11; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Huang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08904; Iwai M, 2009, JPN J INFECT DIS, V62, P254; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Laga AC, 2016, J CUTANEOUS PATHOLOG; Letsas Konstantinos P, 2007, J Infect, V54, pe75, DOI 10.1016/j.jinf.2006.04.006; Lim CT, 2015, EPIDEMIOL INFECT, P1; Linsuwanon P, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-16; Liu WY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096051, 10.1371/journal.pone.0088077]; Liu WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131311; Liu XL, 2014, ARCH VIROL, V159, P2497, DOI 10.1007/s00705-014-2067-6; LIU Y, 2011, PLOS GENET, V7, DOI DOI 10.1371/JOURNAL.PONE.0063447; Liu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117626; Ni H, 2012, J CLIN VIROL, V54, P342, DOI DOI 10.1016/J.JCV; Oberste MS, 2006, J GEN VIROL, V87, P119, DOI 10.1099/vir.0.81179-0; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Qiaoyun F, 2012, ARCH VIROL; Schuffenecker I, 2011, J CLIN VIROL, V50, P50, DOI 10.1016/j.jcv.2010.09.019; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Takahashi S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001958; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teoh HL, 2016, JAMA NEUROL, V73, P300, DOI 10.1001/jamaneurol.2015.4388; Tian HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084233; Tian XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090379; Urashima M, 2003, JPN J INFECT DIS, V56, P48; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; Wang JF, 2013, GEOSPATIAL HEALTH, V7, P381, DOI 10.4081/gh.2013.95; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang Y, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0308-2; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yan JJ, 2000, J CLIN VIROL, V17, P13, DOI 10.1016/S1386-6532(00)00067-6; Zeng HR, 2015, SCI REP-UK, V5, DOI 10.1038/srep10550; Zhang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17291; Zhang Y, 2013, BIOMED ENVIRON SCI, V26, P875, DOI 10.3967/bes2013.015; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhuang DF, 2014, INT J ENVIRON HEAL R, V24, P1, DOI 10.1080/09603123.2013.769206	56	14	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176604	10.1371/journal.pone.0176604	http://dx.doi.org/10.1371/journal.pone.0176604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486500	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314000017
J	Buege, M; Koehler, T; Heiderhoff, R; Papenheim, M; Wang, S; Schleiting, H; Arnold, WH; Foerst, JR; Seyfarth, M; Tiroch, K; Riedl, T; Vorpahl, M				Buege, Michael; Koehler, Till; Heiderhoff, Ralf; Papenheim, Marc; Wang, Si; Schleiting, Heinrich; Arnold, Wolfgang H.; Foerst, Jason R.; Seyfarth, Melchior; Tiroch, Klaus; Riedl, Thomas; Vorpahl, Marc			Minor defects of the luminal integrity in arterial introducer eSheaths after transcatheter aortic valve implantation	PLOS ONE			English	Article							HYDROPHILIC POLYMER EMBOLISM; COMPLICATIONS; REPLACEMENT	Background Medical devices such as implant delivery systems are commonly used during minimally invasive procedures in the cardiovascular system. These devices often have lubricious polymer coatings to reduce friction between the device and blood vessels but coatings may separate and potentially cause serious injuries to patients. Methods Lubricious coated eSheaths for transcatheter heart valve implantation were assessed for luminal integrity at the proximal, medial and distal part. We assessed the number, depths and area of luminal trails using environmental scanning electron microscope (ESEM), white light interferometry (WLI) and optical profilometry using area scale fractal complexity (asfc) as surface parameters. A total of 15 eSheaths were retrieved and analyzed after successful femoral transcatheter Sapien 3 implantation in patients (23 mm valve- 14F eSheath, 26 mm valve- 14F eSheath and 29 mm valve- 16F eSheath, n = 5 for each group). Unused eSheaths (14F and 16F) served as controls (n = 5 for each group). Results ESEM revealed significantly greater number of trails after TAVR passage with the 23 mm, 26 mm and 29 mm valves compared to unused control 14F and 16F eSheaths (13.9 +/- 3.1, 14.2 +/- 2.3, 15.8 +/- 1.7 vs. 0.08 +/- 0.1 and 1.0 +/- 0.5 [ n]; p <= 0.0001 for all comparisons). Similarly, WLI showed minor, but significantly greater areas of luminal defects after 23 mm, 26 mm and 29 mm valve implantation vs. 14F and 16F unused controls (7.5 +/- 0.9, 10.3 +/- 1.1, 10.4 +/- 1.4 vs. 4.1 +/- 0.4 and 2.2 +/- 0.4 [ mu m2], p = 0.0081). Likewise, the 3D-surface-measurement showed comparable results after implantation of the 23 mm, 26 mm and 29 mm valves vs. 14F and 16F unused control eSheaths (79.5 +/- 6.3, 105.9 +/- 5.3, 98.8 +/- 4.8 vs. 5.1 +/- 2.8 and 5.6 +/- 0.5 [asfc] p = 0.0001). Conclusion Measurable defects of the luminal layer occur during balloon expandable TAVR using 14F and 16F eSheaths though this is likely clinically insignificant. Further clinical investigations including a prospective assessment of minor peripheral embolization are needed to fully address the impact of this luminal defects.	[Buege, Michael; Koehler, Till; Schleiting, Heinrich; Seyfarth, Melchior; Vorpahl, Marc] Univ Witten Herdecke, HELIOS Klinikum Wuppertal, Dept Cardiol, ZFKM, Wuppertal, Germany; [Heiderhoff, Ralf; Papenheim, Marc; Wang, Si; Riedl, Thomas] Univ Wuppertal, Sch Elect Informat & Media Engn, Wuppertal, Germany; [Arnold, Wolfgang H.] Witten Herdecke Univ, Sch Dent, Fac Hlth, Dept Biol & Mat Sci Dent, Witten, Germany; [Foerst, Jason R.] Virginia Tech, Carilion Roanoke Mem Hosp, Dept Cardiol, Carilion Sch Med, Roanoke, VA USA; [Tiroch, Klaus] Heart Ctr Bodensee, Dept Cardiol, Constance, Germany; [Tiroch, Klaus] Witten Herdecke Univ, Witten, Germany	Helios Kliniken; Witten Herdecke University; University of Wuppertal; Virginia Polytechnic Institute & State University	Vorpahl, M (corresponding author), Univ Witten Herdecke, HELIOS Klinikum Wuppertal, Dept Cardiol, ZFKM, Wuppertal, Germany.	marc.vorpahl@helios-kliniken.de	Riedl, Thomas/P-5375-2014; Riedl, Thomas/P-8922-2019	Riedl, Thomas/0000-0003-1084-316X; Riedl, Thomas/0000-0003-1084-316X	HELIOS research grant	HELIOS research grant	This work was supported in part by a HELIOS research grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold WH, 2015, HEAD FACE MED, V11, DOI 10.1186/s13005-015-0089-2; Bizhang M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153250; Borz B, 2014, CATHETER CARDIO INTE, V83, pE227, DOI 10.1002/ccd.25390; Hayashida K, 2011, JACC-CARDIOVASC INTE, V4, P851, DOI 10.1016/j.jcin.2011.03.019; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI [10.1016/j.jacc.2012.09.001, 10.1093/ejcts/ezs533]; Koehler T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/572681; Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mehta RI, 2015, HUM PATHOL, V46, P191, DOI 10.1016/j.humpath.2014.09.011; Reardon MJ, 2016, JAMA CARDIOL, V1, P945, DOI 10.1001/jamacardio.2016.2257; Sanon S, 2014, CATHETER CARDIO INTE, V83, P1152, DOI 10.1002/ccd.25353; Siegmann S., 1997, 1 UN THERM SPRAY C T, P665; Van Mieghem NM, 2012, AM J CARDIOL, V110, P1361, DOI 10.1016/j.amjcard.2012.06.042; Vorpahl M, 2014, EUROINTERVENTION, V10, P833, DOI 10.4244/EIJV10I7A143; Yazdani SK, 2011, EUROINTERVENTION, V7, P835, DOI 10.4244/EIJV7I7A131	15	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176893	10.1371/journal.pone.0176893	http://dx.doi.org/10.1371/journal.pone.0176893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481954	Green Published, gold, Green Submitted			2022-12-27	WOS:000401313700021
J	D'Amour, S; Harris, LR				D'Amour, Sarah; Harris, Laurence R.			Perceived face size in healthy adults	PLOS ONE			English	Article							IMPLICIT BODY REPRESENTATIONS; ANOREXIA-NERVOSA; IMAGE DISTORTIONS; PERCEPTION; DISTURBANCES; ACCURACY; SELF	Perceptual body size distortions have traditionally been studied using subjective, qualitative measures that assess only one type of body representation-the conscious body image. Previous research on perceived body size has typically focused on measuring distortions of the entire body and has tended to overlook the face. Here, we present a novel psychophysical method for determining perceived body size that taps into implicit body representation. Using a two-alternative forced choice (2AFC), participants were sequentially shown two life-size images of their own face, viewed upright, upside down, or tilted 90 degrees. In one interval, the width or length dimension was varied, while the other interval contained an undistorted image. Participants reported which image most closely matched their own face. An adaptive staircase adjusted the distorted image to hone in on the image that was equally likely to be judged as matching their perceived face as the accurate image. When viewed upright or upside down, face width was overestimated and length underestimated, whereas perception was accurate for the on-side views. These results provide the first psychophysically robust measurements of how accurately healthy participants perceive the size of their face, revealing distortions of the implicit body representation independent of the conscious body image.	[D'Amour, Sarah; Harris, Laurence R.] York Univ, Dept Psychol, Ctr Vis Res, Toronto, ON, Canada	York University - Canada	D'Amour, S (corresponding author), York Univ, Dept Psychol, Ctr Vis Res, Toronto, ON, Canada.	saod16@yorku.ca	Harris, Laurence/AAT-9549-2021	Harris, Laurence/0000-0002-7154-8757	Natural Sciences and Engineering Council of Canada (NSERC); PGS-D3 NSERC graduate scholarship; NSERC CREATE grant	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); PGS-D3 NSERC graduate scholarship; NSERC CREATE grant	This work was supported by the Natural Sciences and Engineering Council of Canada (NSERC) grant to LRH. SD was supported by a PGS-D3 NSERC graduate scholarship and an NSERC CREATE grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Natural Sciences and Engineering Council of Canada (NSERC) grant to LRH. SD was supported by a PGS-D3 NSERC graduate scholarship and an NSERC CREATE grant.	Apps MAJ, 2015, CEREB CORTEX, V25, P46, DOI 10.1093/cercor/bht199; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRODIE DA, 1989, PERCEPT MOTOR SKILL, V69, P723, DOI 10.2466/pms.1989.69.3.723; Brooks KR, 2016, FRONT NEUROSCI, V10, P1; BRUCH H, 1962, PSYCHOSOM MED, V24, P187, DOI 10.1097/00006842-196203000-00009; Cardini F, 2011, J COGNITIVE NEUROSCI, V23, P503, DOI 10.1162/jocn.2010.21484; Cash TF, 1997, INT J EAT DISORDER, V22, P107, DOI 10.1002/(SICI)1098-108X(199709)22:2&lt;107::AID-EAT1&gt;3.0.CO;2-J; Coetzee V, 2009, PERCEPTION, V38, P1700, DOI 10.1068/p6423; Cooper EA, 2012, J VISION, V12, DOI 10.1167/12.5.8; COOPER PJ, 1987, INT J EAT DISORDER, V6, P485, DOI 10.1002/1098-108X(198707)6:4<485::AID-EAT2260060405>3.0.CO;2-O; Eshkevari E, 2012, PSYCHOL MED, V42, P819, DOI 10.1017/S0033291711002091; Farrell C, 2005, EUR EAT DISORD REV, V13, P75, DOI 10.1002/erv.622; Frassinetti F, 2008, J COGNITIVE NEUROSCI, V20, P1507, DOI 10.1162/jocn.2008.20067; Fuentes CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076805; Fuentes CT, 2013, ACTA PSYCHOL, V144, P344, DOI 10.1016/j.actpsy.2013.06.012; Fuentes CT, 2013, J NEUROL NEUROSUR PS, V84, P201, DOI 10.1136/jnnp-2012-304001; Gardner RM, 2014, PSYCHIAT RES, V219, P407, DOI 10.1016/j.psychres.2014.06.029; Gardner RM, 2010, PERS INDIV DIFFER, V49, P794, DOI 10.1016/j.paid.2010.07.001; Gardner RM, 2010, PERS INDIV DIFFER, V48, P107, DOI 10.1016/j.paid.2009.08.017; Gardner RM, 1996, J CLIN PSYCHOL, V52, P3, DOI 10.1002/(SICI)1097-4679(199601)52:1<3::AID-JCLP1>3.0.CO;2-X; Gardner RM, 2004, BEHAV RES METH INS C, V36, P89, DOI 10.3758/BF03195553; GLEGHORN AA, 1987, J PSYCHOPATHOL BEHAV, V9, P203, DOI 10.1007/BF00960575; Green D., 1966, SOCIETY, V1, P521, DOI [10.1901/jeab.1969.12-475, DOI 10.1901/JEAB.1969.12-475]; Hrabosky JI, 2009, BODY IMAGE, V6, P155, DOI 10.1016/j.bodyim.2009.03.001; KEETON WP, 1990, J PERS ASSESS, V54, P213, DOI 10.1207/s15327752jpa5401&2_21; Keizer A, 2014, NEUROPSYCHOLOGIA, V62, P26, DOI 10.1016/j.neuropsychologia.2014.07.003; Keyes H, 2010, BRAIN COGNITION, V72, P244, DOI 10.1016/j.bandc.2009.09.006; Leopold DA, 2010, J COMP PSYCHOL, V124, P233, DOI 10.1037/a0019460; Linkenauger SA, 2015, J EXP PSYCHOL GEN, V144, P103, DOI 10.1037/xge0000028; Linkenauger SA, 2009, PSYCHOL SCI, V20, P1373, DOI 10.1111/j.1467-9280.2009.02447.x; Longo MR, 2017, Q J EXP PSYCHOL, V70, P378, DOI 10.1080/17470218.2016.1143956; Longo MR, 2015, ACTA PSYCHOL, V160, P77, DOI 10.1016/j.actpsy.2015.07.002; Longo MR, 2015, COGNITION, V142, P230, DOI 10.1016/j.cognition.2015.05.024; Longo MR, 2015, EUR PSYCHOL, V20, P6, DOI 10.1027/1016-9040/a000198; Longo MR, 2012, ACTA PSYCHOL, V141, P164, DOI 10.1016/j.actpsy.2012.07.015; Longo MR, 2012, J EXP PSYCHOL HUMAN, V38, P9, DOI 10.1037/a0025428; Longo MR, 2011, J EXP PSYCHOL HUMAN, V37, P720, DOI 10.1037/a0021921; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; Macmillan NA, 2005, DETECTION THEORY USE; Mai S, 2015, BIOL PSYCHOL, V108, P105, DOI 10.1016/j.biopsycho.2015.03.013; Mancini F, 2011, PSYCHOL SCI, V22, P325, DOI 10.1177/0956797611398496; Mancini F, 2011, NEUROPSYCHOLOGIA, V49, P1194, DOI 10.1016/j.neuropsychologia.2010.12.040; McCabe Marita P, 2006, Body Image, V3, P163, DOI 10.1016/j.bodyim.2006.01.004; Mohr HM, 2011, NEUROIMAGE, V56, P1822, DOI 10.1016/j.neuroimage.2011.02.069; MOLINARI E, 1995, PERCEPT MOTOR SKILL, V81, P23, DOI 10.2466/pms.1995.81.1.23; Mussap AJ, 2008, BODY IMAGE, V5, P80, DOI 10.1016/j.bodyim.2007.07.003; NELSON CL, 1993, ADDICT BEHAV, V18, P503, DOI 10.1016/0306-4603(93)90067-J; Pazzaglia M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9834340; Peterson M, 2003, AM J HEALTH BEHAV, V27, P355, DOI 10.5993/AJHB.27.4.7; PROBST M, 1995, BEHAV RES THER, V33, P985, DOI 10.1016/0005-7967(95)00037-X; Sand L, 2011, BODY IMAGE, V8, P275, DOI 10.1016/j.bodyim.2011.03.004; Saulton A, 2015, EXP BRAIN RES, V233, P1471, DOI 10.1007/s00221-015-4221-0; SLADE PD, 1973, PSYCHOL MED, V3, P188, DOI 10.1017/S0033291700048510; Smeets MAM, 1997, BRIT J CLIN PSYCHOL, V36, P263, DOI 10.1111/j.2044-8260.1997.tb01412.x; Stephen ID, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01223; Stice E, 2002, J PSYCHOSOM RES, V53, P985, DOI 10.1016/S0022-3999(02)00488-9; Sturman D, 2017, INDEPENDENT AFTEREFF, P1; THOMPSON JK, 1988, INT J EAT DISORDER, V7, P521, DOI 10.1002/1098-108X(198807)7:4<521::AID-EAT2260070410>3.0.CO;2-H; Thompson JK, 1996, BODY IMAGE EATING DI, P49; Thompson P, 2012, I-PERCEPTION, V3, P765, DOI 10.1068/i0554; Urdapilleta I, 2010, PSYCHOL SPORT EXERC, V11, P568, DOI 10.1016/j.psychsport.2010.06.006; VITOUSEK K, 1994, J ABNORM PSYCHOL, V103, P137, DOI 10.1037/0021-843X.103.1.137; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828	64	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177349	10.1371/journal.pone.0177349	http://dx.doi.org/10.1371/journal.pone.0177349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481928	gold, Green Published, Green Submitted			2022-12-27	WOS:000401313700054
J	McNamee, LM; Walsh, MJ; Ledley, FD				McNamee, Laura M.; Walsh, Michael Jay; Ledley, Fred D.			Timelines of translational science: From technology initiation to FDA approval	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; DRUG DISCOVERY; PHARMACEUTICAL INNOVATION; NON-A; HEPATITIS; LESSONS; CANCER; GENOME; TRENDS; RATES	While timelines for clinical development have been extensively studied, there is little data on the broader path from initiation of research on novel drug targets, to approval of drugs based on this research. We examined timelines of translational science for 138 drugs and biologicals approved by the FDA from 2010-2014 using an analytical model of technology maturation. Research on targets for 102 products exhibited a characteristic (S-curve) maturation pattern with exponential growth between statistically defined technology initiation and established points. The median initiation was 1974, with a median of 25 years to the established point, 28 years to first clinical trials, and 36 years to FDA approval. No products were approved before the established point, and development timelines were significantly longer when the clinical trials began before this point (11.5 vs 8.5 years, p<0.0005). Technological maturation represents the longest stage of translation, and significantly impacts the efficiency of drug development.	[McNamee, Laura M.; Walsh, Michael Jay; Ledley, Fred D.] Bentley Univ, Ctr Integrat Sci & Ind, Dept Nat & Appl Sci, Waltham, MA 02452 USA; [Ledley, Fred D.] Bentley Univ, Dept Management, Waltham, MA USA	Bentley University; Bentley University	McNamee, LM (corresponding author), Bentley Univ, Ctr Integrat Sci & Ind, Dept Nat & Appl Sci, Waltham, MA 02452 USA.	lmcnamee@bentley.edu			National Biomedical Research Foundation	National Biomedical Research Foundation	This work was funded by a grant from the National Biomedical Research Foundation.; This work was funded by a grant from the National Biomedical Research Foundation. All three authors were involved in the conception of this work, data collection, data analysis, and manuscript preparation. The authors report no competing interests. The authors are indebted to our undergraduate researchers Ashley Rossi and Cory Kalin for their contributions to this work.	BRADLEY DW, 1985, GASTROENTEROLOGY, V88, P773, DOI 10.1016/0016-5085(85)90150-7; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Christensen C., 2013, INNOVATORS DILEMMA N; Christensen Clayton M., 2003, INNOVATORS DILEMMA R; Cockburn IM, 1998, J IND ECON, V46, P157; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; DiMasi JA, 2004, PHARMACOECONOMICS, V22, P1, DOI 10.2165/00019053-200422002-00002; DiMasi JA, 2002, PHARMACOECONOMICS, V20, P1, DOI 10.2165/00019053-200220003-00001; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; DROUIN JN, 1979, CAN J PHYSIOL PHARM, V57, P375, DOI 10.1139/y79-056; Eder J, 2014, NAT REV DRUG DISCOV, V13, P577, DOI 10.1038/nrd4336; Eichler HG, 2011, NAT REV DRUG DISCOV, V10, P495, DOI [10.1038/nrd3501, 10.1038/nrd3348]; Foster R. N., 1986, INNOVATION ATTACKERS; Gibbs JB, 2000, SCIENCE, V287, P1969, DOI 10.1126/science.287.5460.1969; Goldman M, 2014, NATURE REV DRUG DISC; GOODCHILD MC, 1976, J MED GENET, V13, P417, DOI 10.1136/jmg.13.6.417; Guedj I., 2004, 10933 NBER; Kaitin KI, 2011, CLIN PHARMACOL THER, V89, P183, DOI 10.1038/clpt.2010.286; Kotz J., 2012, SCIBX, V5, P15; Ledley F, 2013, GENE THERAPY; Lipinski CA, 2012, ADV DRUG DELIVER REV, V64, P4, DOI 10.1016/j.addr.2012.09.019; McNamee L, PLOS ONE IN PRESS; McNamee LM, 2012, NAT BIOTECHNOL, V30, P937, DOI 10.1038/nbt.2389; Miklos GLG, 2005, NAT BIOTECHNOL, V23, P535, DOI 10.1038/nbt0505-535; MULLER E, 1965, P SOC EXP BIOL MED, V119, P1191; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Woodcock J, 2013, CLIN PHARMACOL THER, V94, P297, DOI 10.1038/clpt.2013.88; Woodcock J, 2008, ANNU REV MED, V59, P1, DOI 10.1146/annurev.med.59.090506.155819	33	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177371	10.1371/journal.pone.0177371	http://dx.doi.org/10.1371/journal.pone.0177371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481922	gold, Green Published, Green Submitted			2022-12-27	WOS:000401313700056
J	Weller, SA; Latham, J				Weller, Simon A.; Latham, Jennie			High stringency evaluation of the inactivation / exclusion efficacy of a MALDI-TOF MS chemical extraction method, with filtration of extract through 0.1 mu m filters, on Bacillus anthracis Vollum vegetative cells and spores	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; MASS-SPECTROMETRY; IDENTIFICATION; RESISTANCE	A previous report indicated that a formic acid chemical extraction method for the preparation of protein extracts for matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF MS) identification, with filtration of extracts through 0.2 mu m regenerated cellulose (RC) filters, would not reliably inactivate or exclude Bacillus anthracis Vollum cells or spores when tested under high stringency conditions. B. anthracis was recovered from 13/36 extracts (3/18 from vegetative cell extracts and 10/18 from bacterial spore extracts). In this paper we report the repetition of this study but with the substitution of the 0.2 mu m, regenerated cellulose, filters with 0.1 mu m polyvinylidene fluoride (PVDF) filters. Experiments were conducted under the same high stringency post-treatment viability test methods (100% of resulting protein content; 7 days Luria (L)-broth and a further 7 days L-agar plate incubation; or 7 days L-agar plate only incubation). B. anthracis was not recovered from any of 18 replicates generated from high concentrations of vegetative cells (10(7) to 10(8) cfu), but a single B. anthracis colony was recovered from one of 18 replicates generated from high concentrations of bacterial spores (10(8) cfu), using a post-treatment viability culture method of 7 days on L-agar plate only. We discuss our results in the context of other similar studies and also a requirement to develop standardised post-treatment viability test methods.	[Weller, Simon A.; Latham, Jennie] Minist Def, Def & Sci Technol Lab, CBR Div, Salisbury, Wilts, England	Defence Science & Technology Laboratory	Weller, SA (corresponding author), Minist Def, Def & Sci Technol Lab, CBR Div, Salisbury, Wilts, England.	sweller@dstl.gov.uk		Weller, Simon/0000-0001-9286-2991	Biological Evaluation & Detection Group (CBR Division, Dstl) Capability Development funding	Biological Evaluation & Detection Group (CBR Division, Dstl) Capability Development funding	This study was funded using Biological Evaluation & Detection Group (CBR Division, Dstl) Capability Development funding. The authorising officer of this funding approved submission of this manuscript but had no role in study design, data collection, or analysis. The views in this paper may not reflect those of the UK Ministry of Defence.	ABSHIRE RL, 1980, APPL ENVIRON MICROB, V39, P695, DOI 10.1128/AEM.39.4.695-701.1980; Carrera M, 2007, J APPL MICROBIOL, V102, P303, DOI 10.1111/j.1365-2672.2006.03111.x; Centers for Disease Control and Prevention, 2014, REP POT EXP ANTHR; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; Daltonics B., 2011, REVISION, V2, P157; Dauphin LA, 2009, J MICROBIOL METH, V76, P212, DOI 10.1016/j.mimet.2008.10.009; Department of Defense, 2015, REV COMM REP IN SHIP; Federal Select Agent Program, 2016, REV FSAP POL STAT IN; Lasch P, 2016, TRENDS ANAL CHEM, V85, P133; Lasch P, 2008, ANAL CHEM, V80, P2026, DOI 10.1021/ac701822j; Millipore Merck, 2014, USER GUIDE ULTRAFREE; Parsons TM., 2013, J BIOTERR BIODEF, VS3, P009, DOI [10.4172/2157-2526.S3-009, DOI 10.4172/2157-2526.S3-009]; Redmond C, 2004, MICROBIOL-SGM, V150, P355, DOI 10.1099/mic.0.26681-0; Russell AD, 1999, J HOSP INFECT, V43, pS57, DOI 10.1016/S0195-6701(99)90066-X; Schulthess B, 2013, J CLIN MICROBIOL, V51, P1834, DOI 10.1128/JCM.02654-12; Thermo Scientific, 2009, TECH TIP 40; Tracz DM, 2016, J CLIN MICROBIOL, V54, P764, DOI 10.1128/JCM.02709-15; Varughese EA, 2007, J MICROBIOL METH, V71, P66, DOI 10.1016/j.mimet.2007.07.011; Weller SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143870; Zeus Industrial Products Inc, 2017, CHEM RES CHART PVDF	20	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177294	10.1371/journal.pone.0177294	http://dx.doi.org/10.1371/journal.pone.0177294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481931	Green Published, gold, Green Submitted			2022-12-27	WOS:000401313700049
J	Gomes, A; van der Wijk, L; Proost, JH; Sinha, B; Touw, DJ				Gomes, Anna; van der Wijk, Lars; Proost, Johannes H.; Sinha, Bhanu; Touw, Daan J.			Pharmacokinetic modeling of gentamicin in treatment of infective endocarditis: Model development and validation of existing models	PLOS ONE			English	Article							AMINOGLYCOSIDES; NEPHROTOXICITY; THERAPY	Gentamicin shows large variations in half-life and volume of distribution (Vd) within and between individuals. Thus, monitoring and accurately predicting serum levels are required to optimize effectiveness and minimize toxicity. Currently, two population pharmacokinetic models are applied for predicting gentamicin doses in adults. For endocarditis patients the optimal model is unknown. We aimed at: 1) creating an optimal model for endocarditis patients; and 2) assessing whether the endocarditis and existing models can accurately predict serum levels. We performed a retrospective observational two-cohort study: one cohort to parameterize the endocarditis model by iterative two-stage Bayesian analysis, and a second cohort to validate and compare all three models. The Akaike Information Criterion and the weighted sum of squares of the residuals divided by the degrees of freedom were used to select the endocarditis model. Median Prediction Error (MDPE) and Median Absolute Prediction Error (MDAPE) were used to test all models with the validation dataset. We built the endocarditis model based on data from the modeling cohort (65 patients) with a fixed 0.277 L/h/70kg metabolic clearance, 0.698 (+/- 0.358) renal clearance as fraction of creatinine clearance, and Vd 0.312 (+/- 0.076) L/kg corrected lean body mass. External validation with data from 14 validation cohort patients showed a similar predictive power of the endocarditis model (MDPE -1.77%, MDAPE 4.68%) as compared to the intensive-care (MDPE -1.33%, MDAPE 4.37%) and standard (MDPE -0.90%, MDAPE 4.82%) models. All models acceptably predicted pharmacokinetic parameters for gentamicin in endocarditis patients. However, these patients appear to have an increased Vd, similar to intensive care patients. Vd mainly determines the height of peak serum levels, which in turn correlate with bactericidal activity. In order to maintain simplicity, we advise to use the existing intensive-care model in clinical practice to avoid potential underdosing of gentamicin in endocarditis patients.	[Gomes, Anna; Sinha, Bhanu] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [van der Wijk, Lars; Touw, Daan J.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Proost, Johannes H.; Touw, Daan J.] Univ Groningen, Dept Pharmacokinet Toxicol & Targeting, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Touw, DJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.; Touw, DJ (corresponding author), Univ Groningen, Dept Pharmacokinet Toxicol & Targeting, Groningen, Netherlands.	d.t.touw@umcg.nl		Sinha, Bhanu/0000-0003-1634-0010; Leggas, Markos/0000-0003-4314-4533; Touw, Daniel/0000-0002-1429-4789; Gomes, Anna/0000-0001-5989-2072	INTERREG [202085]	INTERREG	This work was supported by INTERREG project EurHealth- 1Health; project number 202085; URL http://www.eurhealth-1health.eu/nl/nieuws/: AG BS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay ML, 1999, CLIN PHARMACOKINET, V36, P89, DOI 10.2165/00003088-199936020-00001; Bassetti M, 2013, INT J CARDIOL, V168, P5033, DOI 10.1016/j.ijcard.2013.07.225; Bennett JE, 2015, MANDELL DOUGLAS BENN; Cahill TJ, 2016, LANCET, V387, P882, DOI 10.1016/S0140-6736(15)00067-7; CHENNAVASIN P, 1982, EUR J CLIN PHARMACOL, V22, P91, DOI 10.1007/BF00606431; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coenradie S, 2016, NVVZ; Eisen DP, 2009, J INFECTION, V58, P332, DOI 10.1016/j.jinf.2009.03.006; ELSAYED YM, 1994, J CLIN PHARM THER, V19, P267, DOI 10.1111/j.1365-2710.1994.tb00686.x; Evers N, 1995, THER DRUG MONIT, V17, P424; Girard P, 2005, COMP ESTIMATION METH, P14; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Hoen B, 2013, NEW ENGL J MED, V368, P1425, DOI 10.1056/NEJMcp1206782; Kirkpatrick CMJ, 1999, BRIT J CLIN PHARMACO, V47, P637; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; MATSUMOTO JY, 1980, ANTIMICROB AGENTS CH, V18, P944, DOI 10.1128/AAC.18.6.944; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; NICOLAU DP, 1995, ANTIMICROB AGENTS CH, V39, P650, DOI 10.1128/AAC.39.3.650; Nishimura RA, 2014, CIRCULATION, V129, pE521, DOI 10.1161/CIR.0000000000000031; Proost JH, 2006, PHARM RES-DORDR, V23, P2748, DOI 10.1007/s11095-006-9116-0; ROSELLROVIRA ML, 1994, AM J HOSP PHARM, V51, P1429, DOI 10.1093/ajhp/51.11.1429; Rybak MJ, 1999, ANTIMICROB AGENTS CH, V43, P1549, DOI 10.1128/AAC.43.7.1549; SCHWARTZ SN, 1978, J INFECT DIS, V138, P499, DOI 10.1093/infdis/138.4.499; SHEINER LB, 1981, J PHARMACOKINET BIOP, V9, P503, DOI 10.1007/BF01060893; Tam VH, 1999, ANN PHARMACOTHER, V33, P600, DOI 10.1345/aph.18316; Turnidge J, 2003, INFECT DIS CLIN N AM, V17, P503, DOI 10.1016/S0891-5520(03)00057-6; van Lent-Evers NAEM, 1999, THER DRUG MONIT, V21, P63, DOI 10.1097/00007691-199902000-00010; Verhagen DWM, 2003, NETH J MED, V61, P421; Vogkou CT, 2016, EUR J CLIN MICROBIOL, V35, P1227, DOI 10.1007/s10096-016-2660-6; VONREYN CF, 1981, ANN INTERN MED, V94, P505, DOI 10.7326/0003-4819-94-4-505; Zaske D., 1987, APPL PHARMACOKINETIC	33	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177324	10.1371/journal.pone.0177324	http://dx.doi.org/10.1371/journal.pone.0177324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475651	gold, Green Published, Green Submitted			2022-12-27	WOS:000400649500064
J	Casaroli, G; Galbusera, F; Jonas, R; Schlager, B; Wilke, HJ; Villa, T				Casaroli, Gloria; Galbusera, Fabio; Jonas, Rene; Schlager, Benedikt; Wilke, Hans-Joachim; Villa, Tomaso			A novel finite element model of the ovine lumbar intervertebral disc with anisotropic hyperelastic material properties	PLOS ONE			English	Article							ISSLS PRIZE WINNER; SHEEP; FAILURE; MECHANICS; FIBROSUS; SPINE; CALF	The Ovine spine is an accepted model to investigate the biomechanical behaviour of the human lumbar one. Indeed, the use of animal models for in vitro studies is necessary to investigate the mechanical behaviour of biological tissue, but needs to be reduced for ethical and social reasons. The aim of this study was to create a finite element model of the lumbar intervertebral disc of the sheep that may help to refine the understanding of parallel in vitro experiments and that can be used to predict when mechanical failure occurs. Anisotropic hyperelastic material properties were assigned to the annulus fibrosus and factorial optimization analyses were performed to find out the optimal parameters of the ground substance and of the collagen fibers. For the ground substance of the annulus fibrosus the investigation was based on experimental data taken from the literature, while for the collagen fibers tensile tests on annulus specimens were conducted. Flexibility analysis in flexion-extension, lateral bending and axial rotation were conducted. Different material properties for the anterior, lateral and posterior regions of the annulus were found. The posterior part resulted the stiffest region in compression whereas the anterior one the stiffest region in tension. Since the flexibility outcomes were in a good agreement with the literature data, we considered this model suitable to be used in conjunction with in vitro and in vivo tests to investigate the mechanical behaviour of the ovine lumbar disc.	[Casaroli, Gloria; Villa, Tomaso] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Lab Biol Struct Mech LaBS, Milan, Italy; [Galbusera, Fabio; Villa, Tomaso] IRCCS Ist Ortoped Galeazzi, Milan, Italy; [Jonas, Rene; Schlager, Benedikt; Wilke, Hans-Joachim] Univ Ulm, Ctr Musculoskeletal Res zmfu, Inst Orthopaed Res & Biomech, Ulm, Germany	Polytechnic University of Milan; IRCCS Istituto Ortopedico Galeazzi; Ulm University	Casaroli, G (corresponding author), Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Lab Biol Struct Mech LaBS, Milan, Italy.	gloria.casaroli@polimi.it	Galbusera, Fabio/J-8618-2016; Wilke, Hans-Joachim/M-6440-2014	Galbusera, Fabio/0000-0003-1826-9190; Wilke, Hans-Joachim/0000-0001-6007-8844; VILLA, TOMASO MARIA TOBIA/0000-0003-2663-6755; Schlager, Benedikt/0000-0003-2371-851X				Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; Ayturk UM, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007632; Badyal DK, 2014, INDIAN J PHARMACOL, V46, P257, DOI 10.4103/0253-7613.132153; Beckstein JC, 2008, SPINE, V33, pE166, DOI 10.1097/BRS.0b013e318166e001; Berger-Roscher N, 1976, SPINE PHILA PA 1976; Casaroli G, 2017, MATERIALS, V10, DOI 10.3390/ma10010031; CASSIDY JJ, 1989, CONNECT TISSUE RES, V23, P75, DOI 10.3109/03008208909103905; Cortes DH, 2014, J BIOMECH, V47, P2088, DOI 10.1016/j.jbiomech.2013.12.021; Ebara S, 1996, TENSILE PROPERTIES N, P452; Eberlein R., 2001, COMPUT METHOD BIOMEC, V4, P209, DOI [DOI 10.1080/10255840108908005, 10.1080/10255840108908005]; Elliott DM, 2001, J BIOMECH ENG-T ASME, V123, P256, DOI 10.1115/1.1374202; Freeman AL, 2013, J BIOMECH, V46, P1714, DOI 10.1016/j.jbiomech.2013.03.034; Galbusera F, 2011, EUR SPINE J, V20, P563, DOI 10.1007/s00586-010-1586-4; Holzapfel GA, 2005, BIOMECH MODEL MECHAN, V3, P125, DOI 10.1007/s10237-004-0053-8; Isaacs JL, 2014, J MECH BEHAV BIOMED, V40, P75, DOI 10.1016/j.jmbbm.2014.08.012; Kasra M, 2004, Technol Health Care, V12, P333; Kettler A, 2007, EUR SPINE J, V16, P2186, DOI 10.1007/s00586-007-0485-9; Little JP, 2010, J MECH BEHAV BIOMED, V3, P146, DOI 10.1016/j.jmbbm.2009.09.002; Lovati AB, 2016, CALCIFIED TISSUE INT, V99, P209, DOI 10.1007/s00223-016-0140-8; Malandrino A, 2011, COMPUT METHOD BIOMEC, P1; Noailly J, 2011, BIOMECH MODEL MECHAN, V10, P203, DOI 10.1007/s10237-010-0227-5; Reid JE, 2002, CLIN BIOMECH, V17, P312, DOI 10.1016/S0268-0033(02)00009-8; Reitmaier S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0650; Reitmaier S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069610; Reutlinger C, 2014, J MECH BEHAV BIOMED, V30, P279, DOI 10.1016/j.jmbbm.2013.11.019; Schmidt H, 2013, J BIOMECH, V46, P2513, DOI 10.1016/j.jbiomech.2013.06.038; Schmidt H, 2013, J MECH BEHAV BIOMED, V17, P229, DOI 10.1016/j.jmbbm.2012.09.010; Schmidt H, 2010, J BIOMECH, V43, P1849, DOI 10.1016/j.jbiomech.2010.03.035; Schollum ML, 2008, SPINE, V33, P2702, DOI 10.1097/BRS.0b013e31817bb92c; SKAGGS DL, 1994, SPINE, V19, P1310, DOI 10.1097/00007632-199406000-00002; SLATER R, 1988, J ORTHOPAED RES, V6, P138, DOI 10.1002/jor.1100060118; Vena Pasquale, 2005, Computer Methods in Biomechanics and Biomedical Engineering, V8, P7, DOI 10.1080/10255840500062914; Veres SP, 2010, SPINE, V35, P1897, DOI 10.1097/BRS.0b013e3181d9b69e; Veres SP, 2010, EUR SPINE J, V19, P1468, DOI 10.1007/s00586-010-1383-0; Wade KR, 2014, SPINE, V39, P1018, DOI 10.1097/BRS.0000000000000262; Wilke H-J, 1997, ARE SHEEP SPINES VAL, P2365; Wilke HJ, 1996, J ORTHOPAED RES, V14, P500, DOI 10.1002/jor.1100140321; Wilke HJ, 1997, ANAT RECORD, V247, P542, DOI 10.1002/(SICI)1097-0185(199704)247:4<542::AID-AR13>3.0.CO;2-P; YAMAMURO T, 1990, J BONE JOINT SURG BR, V72, P889, DOI 10.1302/0301-620X.72B5.2211778	39	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177088	10.1371/journal.pone.0177088	http://dx.doi.org/10.1371/journal.pone.0177088			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472100	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500132
J	Coskran, TM; Jiang, ZJ; Klaunig, JE; Mager, DL; Obert, L; Robertson, A; Tsinoremas, N; Wang, ZM; Gosink, M				Coskran, Timothy M.; Jiang, Zhijie; Klaunig, James E.; Mager, Dixie L.; Obert, Leslie; Robertson, Andrew; Tsinoremas, Nicholas; Wang, Zemin; Gosink, Mark			Induction of endogenous retroelements as a potential mechanism for mouse-specific drug-induced carcinogenicity	PLOS ONE			English	Article							PEROXISOME PROLIFERATOR WY-14,643; ACTIVATED RECEPTOR-ALPHA; GENE-EXPRESSION; EPIGENETIC REGULATION; RETROVIRAL ELEMENTS; ADAPTIVE IMMUNITY; INDUCED-TUMORS; LIVER-TUMORS; CANCER-RISK; PPAR-ALPHA	A number of chemical compounds have been shown to induce liver tumors in mice but not in other species. While several mechanisms for this species-specific tumorigenicity have been proposed, no definitive mechanism has been established. We examined the effects of the nongenotoxic rodent hepatic carcinogen, WY-14,643, in male mice from a high liver tumor susceptible strain (C3H/HeJ), and from a low tumor susceptible strain (C57BL/6). WY-14,643, a PPAR alpha activator induced widespread increases in the expression of some endogenous retroelements, namely members of LTR and LINE elements in both strains. The expression of a number of known retroviral defense genes was also elevated. We also demonstrated that basal immune-mediated viral defense was elevated in C57BL/6 mice (the resistant strain) and that WY-14,643 further activated those immuno-defense processes. We propose that the previously reported > 100X activity of retroelements in mice drives mouse-specific tumorigenicity. We also propose that C57BL/6's competent immune to retroviral activation allows it to remove cells before the activation of these elements can result in significant chromosomal insertions and mutation. Finally, we showed that WY-14,643 treatment induced gene signatures of DNA recombination in the sensitive C3H/HeJ strain.	[Coskran, Timothy M.; Robertson, Andrew; Gosink, Mark] Pfizer Inc, Drug Safety Res & Dev, Groton, CT 06340 USA; [Jiang, Zhijie; Tsinoremas, Nicholas] Univ Miami, Dept Comp Sci, Miami, FL USA; [Klaunig, James E.; Wang, Zemin] Indiana Univ, Environm Hlth, Bloomington, IN USA; [Mager, Dixie L.] BC Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada; [Obert, Leslie] GlaxoSmithKline plc, King Of Prussia, PA USA	Pfizer; University of Miami; Indiana University System; Indiana University Bloomington; British Columbia Cancer Agency; GlaxoSmithKline	Gosink, M (corresponding author), Pfizer Inc, Drug Safety Res & Dev, Groton, CT 06340 USA.	Mark.M.Gosink@Pfizer.com		Mager, Dixie/0000-0002-5955-2550; Gosink, Mark/0000-0003-3009-3941; Klaunig, James/0000-0002-4736-2223	Pfizer	Pfizer(Pfizer)	Pfizer provided support in the form of salaries for authors MG, TC, AR & LO and paid the sequencing costs, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Bhan U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009896; Bloom DC, 2010, BBA-GENE REGUL MECH, V1799, P246, DOI 10.1016/j.bbagrm.2009.12.001; BROWN LP, 1990, MUTAT RES, V244, P67, DOI 10.1016/0165-7992(90)90110-6; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Cloonan SM, 2013, CURR OPIN MICROBIOL, V16, P327, DOI 10.1016/j.mib.2013.05.005; Corton JC, 2014, CRIT REV TOXICOL, V44, P1, DOI 10.3109/10408444.2013.835784; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Douville RN, 2010, CYTOKINE, V52, P108, DOI 10.1016/j.cyto.2010.04.010; Dragan Y, 1998, TOXICOL SCI, V41, P3; Duperray A, 2015, INTERNATIONAL IMMUNO; Friedrich A, 2011, REGUL TOXICOL PHARM, V60, P225, DOI 10.1016/j.yrtph.2011.04.001; Goldsworthy TL, 2002, TOXICOL PATHOL, V30, P97, DOI 10.1080/01926230252824770; Nunez NG, 2012, CANCER RES, V72, P592, DOI 10.1158/0008-5472.CAN-11-0534; Hakre S, 2011, CURR OPIN HIV AIDS, V6, P19, DOI 10.1097/COH.0b013e3283412384; Herquel B, 2013, NAT STRUCT MOL BIOL, V20, P339, DOI 10.1038/nsmb.2496; Holsapple MP, 2006, TOXICOL SCI, V89, P51, DOI 10.1093/toxsci/kfj001; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Isenberg JS, 1997, CARCINOGENESIS, V18, P1511, DOI 10.1093/carcin/18.8.1511; Iyer SS, 2010, J IMMUNOL, V185, P6599, DOI 10.4049/jimmunol.1002041; Kaer K, 2013, GENE, V518, P231, DOI 10.1016/j.gene.2013.01.008; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kinnier CV, 2011, TRANSPL IMMUNOL, V24, P83, DOI 10.1016/j.trim.2010.11.004; Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372; Koturbash I, 2011, TOXICOL MECH METHOD, V21, P289, DOI 10.3109/15376516.2011.557881; Kremer D, 2013, ANN NEUROL, V74, P721, DOI 10.1002/ana.23970; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; LOVE BA, 1992, CAN J CARDIOL, V8, P347; Lu MY, 2011, CELL DEATH DIFFER, V18, P925, DOI 10.1038/cdd.2010.160; Maksakova IA, 2008, CELL MOL LIFE SCI, V65, P3329, DOI 10.1007/s00018-008-8494-3; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Marsili G, 2012, CYTOKINE GROWTH F R, V23, P255, DOI 10.1016/j.cytogfr.2012.06.001; Meyer U, 2014, BIOL PSYCHIAT, V75, P307, DOI 10.1016/j.biopsych.2013.07.011; Morimura K, 2006, CARCINOGENESIS, V27, P1074, DOI 10.1093/carcin/bgi329; Niller HH, 2011, ADV EXP MED BIOL, V711, P82; Norris PJ, 2006, AIDS RES HUM RETROV, V22, P757, DOI 10.1089/aid.2006.22.757; Pantry SN, 2009, SEMIN CANCER BIOL, V19, P153, DOI 10.1016/j.semcancer.2009.02.010; Park S, 2013, J IMMUNOL, V191, P4358, DOI 10.4049/jimmunol.1301170; Perron H, 2010, CLIN REV ALLERG IMMU, V39, P51, DOI 10.1007/s12016-009-8170-x; Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V625, P62, DOI 10.1016/j.mrfmmm.2007.05.004; Pogribny IP, 2012, CANC LETT; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Richardson SR, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0061-2014; Sobieszczyk ME, 2011, CURR OPIN HIV AIDS, V6, P427, DOI 10.1097/COH.0b013e3283497155; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; Sturgill D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-320; Swenberg J A, 1992, IARC Sci Publ, P477; TAKATSUKI A, 1969, APPL MICROBIOL, V18, P660, DOI 10.1128/AEM.18.4.660-667.1969; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vazquez-Torres A, 2004, J IMMUNOL, V172, P6202, DOI 10.4049/jimmunol.172.10.6202; Waldschmidt I, 2013, VET IMMUNOL IMMUNOP, V155, P30, DOI 10.1016/j.vetimm.2013.05.017; Wang ZM, 2015, TOXICOL SCI, V147, P549, DOI 10.1093/toxsci/kfv151; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Yu P, 2012, IMMUNITY, V37, P867, DOI 10.1016/j.immuni.2012.07.018; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	56	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176768	10.1371/journal.pone.0176768	http://dx.doi.org/10.1371/journal.pone.0176768			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472135	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500069
J	Delea, TE; Weycker, D; Atwood, M; Neame, D; Alvarez, FP; Forget, E; Langley, JM; Chit, A				Delea, Thomas E.; Weycker, Derek; Atwood, Mark; Neame, Dion; Alvarez, Fabian P.; Forget, Evelyn; Langley, Joanne M.; Chit, Ayman			Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada	PLOS ONE			English	Article							SEROGROUP-C; EPIDEMIOLOGY; CHILDREN; IMPACT	Background Public health programs to prevent invasive meningococcal disease (IMD) with monovalent serogroup C meningococcal conjugate vaccine (MCV-C) and quadrivalent meningococcal conjugate vaccines (MCV-4) in infancy and adolescence vary across Canadian provinces. This study evaluated the cost-effectiveness of various vaccination strategies against IMD using current and anticipated future pricing and recent epidemiology. Methods A cohort model was developed to estimate the clinical burden and costs (CAN$2014) of IMD in the Canadian population over a 100-year time horizon for three strategies: (1) MCVC in infants and adolescents (MCV-C/C); (2) MCV-C in infants and MCV-4 in adolescents (MCV-C/4); and (3) MCV-4 in infants (2 doses) and adolescents (MCV-4/4). The source for IMD incidence was Canadian surveillance data. The effectiveness of MCV-C was based on published literature. The effectiveness of MCV-4 against all vaccination regimens was assumed to be the same as for MCV-C regimens against serogroup C. Herd effects were estimated by calibration to estimates reported in prior analyses. Costs were from published sources. Vaccines prices were projected to decline over time reflecting historical procurement trends. Results Over the modeling horizon there are a projected 11,438 IMD cases and 1,195 IMD deaths with MCV-C/C; expected total costs are $597.5 million. MCV-C/4 is projected to reduce cases of IMD by 1,826 (16%) and IMD deaths by 161 (13%). Vaccination costs are increased by $32 million but direct and indirect IMD costs are projected to be reduced by $46 million. MCV-C/4 is therefore dominant vs. MCV-C/C in the base case. Cost-effectiveness of MCV-4/4 was $111,286 per QALY gained versus MCV-C/4 (2575/206 IMD cases/ deaths prevented; incremental costs $68 million). Conclusions If historical trends in Canadian vaccines prices continue, use of MCV-4 instead of MCV-C in adolescents may be cost-effective. From an economic perspective, switching to MCV-4 as the adolescent booster should be considered.	[Delea, Thomas E.; Weycker, Derek; Atwood, Mark] Policy Anal Inc PAI, Brookline, MA 02445 USA; [Neame, Dion] Sanofi Pasteur, Toronto, ON, Canada; [Alvarez, Fabian P.] Sanofi Pasteur, Lyon, France; [Forget, Evelyn] Univ Manitoba, Fac Med, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Langley, Joanne M.] Dalhousie Univ, Canadian Ctr Vaccinol, Halifax, NS, Canada; [Langley, Joanne M.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Langley, Joanne M.] Dalhousie Univ, Dept Community Hlth, Halifax, NS, Canada; [Langley, Joanne M.] Dalhousie Univ, Dept Epidemiol, Halifax, NS, Canada; [Chit, Ayman] Sanofi Pasteur, Swiftwater, PA USA; [Chit, Ayman] Univ Toronto, Lesli Dan Fac Pharm, Toronto, ON, Canada	Policy Analysis Inc; Sanofi-Aventis; University of Manitoba; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Sanofi-Aventis; University of Toronto	Delea, TE (corresponding author), Policy Anal Inc PAI, Brookline, MA 02445 USA.	tdelea@pai2.com	Alvarez, Fabian P./AAD-6455-2020	Alvarez, Fabian P./0000-0003-3085-6275; Langley, Joanne/0000-0003-3270-7345	Sanofi Pasteur; Canadian Institutes of Health Research-GlaxoSmithKline Chair in Pediatric Vaccinology at Dalhousie University, Halifax, Canada; Policy Analysis Inc. (PAI)	Sanofi Pasteur; Canadian Institutes of Health Research-GlaxoSmithKline Chair in Pediatric Vaccinology at Dalhousie University, Halifax, Canada(Canadian Institutes of Health Research (CIHR)); Policy Analysis Inc. (PAI)	Funding for this research was provided by Sanofi Pasteur to Policy Analysis Inc. (PAI). Mark Atwood, Thomas Delea, and Derek Weycker are employed by PAI. Ayman Chit, Dion Neame, and Fabian Alvarez are employed by Sanofi Pasteur. J Langley holds the Canadian Institutes of Health Research-GlaxoSmithKline Chair in Pediatric Vaccinology at Dalhousie University, Halifax, Canada. Sanofi Pasteur was provided a review of the study research plan and study manuscript; model development and estimation, analyses, and all final decisions related to analytics and the manuscript were made by study authors. Policy Analysis Inc. (PAI) provided support in the form of salaries for authors TED, DW and MA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Sanofi Pasteur provided support in the form of salaries for authors DN, FPA and AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bauch CT, 2009, MED DECIS MAKING, V29, P557, DOI 10.1177/0272989X09334419; Bogaert D, 2005, CLIN INFECT DIS, V40, P899, DOI 10.1086/428351; Campbell H, 2009, VACCINE, V27, pB20, DOI 10.1016/j.vaccine.2009.04.067; Canadian Agency for Drugs and Technologies in Health (CADTH), 2017, GUID EC EV HLTH TECH; Caro JJ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-130; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; De Wals P, 2007, VACCINE, V25, P5433, DOI 10.1016/j.vaccine.2007.04.071; De Wals P, 2011, PEDIATR INFECT DIS J, V30, P566, DOI 10.1097/INF.0b013e31820e8638; Erickson LJ, 2001, CLIN INFECT DIS, V33, P737, DOI 10.1086/322587; Government of Canada, 2015, LAND US MAP IST METR; Hepkema H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065036; Ladhani SN, 2015, CLIN INFECT DIS, V60, P578, DOI 10.1093/cid/ciu881; Larrauri A, 2005, VACCINE, V23, P4097, DOI 10.1016/j.vaccine.2005.03.045; Li YA, 2014, CANADA COMMUNICABLE, V40; National Advisory Committee on Immunization (NACI), 2009, Can Commun Dis Rep, V35, P1; National Advisory Committee on Immunization (NACI), 2015, UPD QUADR MEN VACC A; Novartis Vaccines and Diagnostics Inc, 2014, NOV VACC DIAGN INC P; Ortega-Sanchez IR, 2008, CLIN INFECT DIS, V46, P1, DOI 10.1086/524041; Pitman R, 2012, MED DECIS MAKING, V32, P712, DOI 10.1177/0272989X12454578; Public Health Agency of Canada, 2012, INV MEN DIS IMD; Public Health Agency of Canada, 2002, ENH SURV INV MEN DIS; Public Health Ontario Partners for Health, 2013, MONTHL INF DIS SURV, V2, P1; Rocchi A, 2008, VALUE HEALTH, V11, P771, DOI 10.1111/j.1524-4733.2007.00298.x; Sadarangani M, 2015, CLIN INFECT DIS, V60, pE27, DOI 10.1093/cid/civ028; Sadarangani M, 2014, CLIN INFECT DIS, V59, P1208, DOI 10.1093/cid/ciu597; Sanofi Pasteur Limited, 2012, SAN PAST LTD PROD MO; Shepard CW, 2005, PEDIATRICS, V115, P1220, DOI 10.1542/peds.2004-2514; Statistics Canada, 2015, CONS PRIC IND HLTH P; Statistics of Kalimantan Barat Province, 2014, POP CENS PROV 2014; Stovall SH, 2002, PEDIATR INFECT DIS J, V21, P366, DOI 10.1097/00006454-200205000-00003; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Van Vlaenderen I, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-25; World Bank, 2014, GLOB PURCH POW PAR R; World Bank, 2014, GDP PER CAP; World Health Organization, 2014, COST EFF STRAT PLANN; Wormsbecker AE, 2015, VACCINE, V33, P5678, DOI 10.1016/j.vaccine.2015.08.023	36	7	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175721	10.1371/journal.pone.0175721	http://dx.doi.org/10.1371/journal.pone.0175721			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472165	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500015
J	Griffiths, SR; Rowland, JA; Briscoe, NJ; Lentini, PE; Handasyde, KA; Lumsden, LF; Robert, KA				Griffiths, Stephen R.; Rowland, Jessica A.; Briscoe, Natalie J.; Lentini, Pia E.; Handasyde, Kathrine A.; Lumsden, Linda F.; Robert, Kylie A.			Surface reflectance drives nest box temperature profiles and thermal suitability for target wildlife	PLOS ONE			English	Article							POSSUMS TRICHOSURUS-VULPECULA; SOUTH-EASTERN AUSTRALIA; BAT BOXES; PIPISTRELLUS-PYGMAEUS; CONSERVATION EFFORTS; BODY-TEMPERATURE; ROOST SELECTION; BIRDS; MICROCLIMATE; SIZE	Thermal properties of tree hollows play a major role in survival and reproduction of hollow-dependent fauna. Artificial hollows (nest boxes) are increasingly being used to supplement the loss of natural hollows; however, the factors that drive nest box thermal profiles have received surprisingly little attention. We investigated how differences in surface reflectance influenced temperature profiles of nest boxes painted three different colors (dark-green, light-green, and white: total solar reflectance 5.9%, 64.4%, and 90.3% respectively) using boxes designed for three groups of mammals: insectivorous bats, marsupial gliders and brushtail possums. Across the three different box designs, dark-green (low reflectance) boxes experienced the highest average and maximum daytime temperatures, had the greatest magnitude of variation in daytime temperatures within the box, and were consistently substantially warmer than light-green boxes (medium reflectance), white boxes (high reflectance), and ambient air temperatures. Results from biophysical model simulations demonstrated that variation in diurnal temperature profiles generated by painting boxes either high or low reflectance colors could have significant ecophysiological consequences for animals occupying boxes, with animals in dark-green boxes at high risk of acute heat-stress and dehydration during extreme heat events. Conversely in cold weather, our modelling indicated that there are higher cumulative energy costs for mammals, particularly smaller animals, occupying light-green boxes. Given their widespread use as a conservation tool, we suggest that before boxes are installed, consideration should be given to the effect of color on nest box temperature profiles, and the resultant thermal suitability of boxes for wildlife, particularly during extremes in weather. Managers of nest box programs should consider using several different colors and installing boxes across a range of both orientations and shade profiles (i.e., levels of canopy cover), to ensure target animals have access to artificial hollows with a broad range of thermal profiles, and can therefore choose boxes with optimal thermal conditions across different seasons.	[Griffiths, Stephen R.; Robert, Kylie A.] La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia; [Rowland, Jessica A.; Briscoe, Natalie J.; Lentini, Pia E.; Handasyde, Kathrine A.] Univ Melbourne, Sch Biosci, Parkville, Vic, Australia; [Lumsden, Linda F.] Arthur Rylah Inst Environm Res, Dept Environm Land Water & Planning, Heidelberg, Vic, Australia	La Trobe University; University of Melbourne; Arthur Rylah Institute for Environmental Research (ARI)	Griffiths, SR (corresponding author), La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia.	s.griffiths@latrobe.edu.au	Rowland, Jessica A/Q-9851-2019; Lentini, Pia/H-3254-2019; Rowland, Jessica/HHN-8649-2022; Griffiths, Stephen/AAT-9401-2020; Robert, Kylie/C-5181-2009; Li, Mengqi/AAG-6804-2021	Rowland, Jessica A/0000-0001-9831-681X; Rowland, Jessica/0000-0001-9831-681X; Griffiths, Stephen/0000-0003-3882-3654; Robert, Kylie/0000-0002-8554-8440; Lumsden, Lindy/0000-0002-4967-4626; Briscoe, Natalie/0000-0003-0049-8956; Lentini, Pia/0000-0002-3520-3460	Holsworth Wildlife Research Endowment; Parks Victoria Research Partners Panel [RPP1314P18]; Normal Wettenhall Foundation; Department of Environment, Land, Water and Planning's Communities for Nature; Australian Government's National Environmental Science Program Threatened Species Recovery Hub; Australian Government Research Training Program Scholarship	Holsworth Wildlife Research Endowment; Parks Victoria Research Partners Panel; Normal Wettenhall Foundation; Department of Environment, Land, Water and Planning's Communities for Nature; Australian Government's National Environmental Science Program Threatened Species Recovery Hub(Australian Government); Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This study was funded by the Holsworth Wildlife Research Endowment (grant to SRG), the Parks Victoria Research Partners Panel (grant RPP1314P18 to SRG and KAR), the Normal Wettenhall Foundation (grant to SRG) and the Department of Environment, Land, Water and Planning's Communities for Nature (grant to SRG and PEL). PEL and NJB are supported by the Australian Government's National Environmental Science Program Threatened Species Recovery Hub. SRG is supported by an Australian Government Research Training Program Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sonja Dechian, Robert Bender, John Salisbury, Michael Bajer, Peter Rowland, Susan Pepper and Kristin Semmens for assistance during fieldwork, and Casey Visintin for drafting the CAD nest box diagrams. SRG is supported by an Australian Government Research Training Program Scholarship. PEL and NJB are supported by the Australian Government's National Environmental Science Program Threatened Species Recovery Hub.	Amat-Valero M, 2014, INT J BIOMETEOROL, V58, P1983, DOI 10.1007/s00484-014-0801-0; [Anonymous], 1999, WALKERS MAMMALS WORL; [Anonymous], 2013, BAT HOUSE BUILDERS H; Ardia DR, 2006, J FIELD ORNITHOL, V77, P339, DOI 10.1111/j.1557-9263.2006.00064.x; ASCHOFF J, 1981, COMP BIOCHEM PHYS A, V69, P611, DOI 10.1016/0300-9629(81)90145-6; Australian Bureau of Meteorology, 2016, CLIM DAT ONL; Bartonicka T, 2007, ACTA CHIROPTEROL, V9, P517, DOI 10.3161/1733-5329(2007)9[517:IOTMOB]2.0.CO;2; Beckschafer P, 2013, IFOREST, V6, P228, DOI [10.3832/ifor0957-006, 10.3832/ifor0968-006]; Berthier K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036028; Beyer GL, 2006, WILDLIFE RES, V33, P161, DOI 10.1071/WR04109; Bondarenco A, 2014, NATURWISSENSCHAFTEN, V101, P679, DOI 10.1007/s00114-014-1202-2; Boyles JG, 2008, FUNCT ECOL, V22, P632, DOI 10.1111/j.1365-2435.2008.01423.x; Brittingham MC, 2000, WILDLIFE SOC B, V28, P197; Bronner GN, 1999, S AFR J ZOOL, V34, P1; Catry I, 2011, BIOL CONSERV, V144, P1111, DOI 10.1016/j.biocon.2010.12.030; Clinchy M, 2004, MOL ECOL, V13, P195, DOI 10.1046/j.1365-294X.2003.02029.x; Currie SE, 2015, AM J PHYSIOL-REG I, V308, pR34, DOI 10.1152/ajpregu.00341.2014; DAWSON TJ, 1970, AM J PHYSIOL, V218, P1233, DOI 10.1152/ajplegacy.1970.218.4.1233; DAWSON TJ, 1969, COMP BIOCHEM PHYSIOL, V28, P401, DOI 10.1016/0010-406X(69)91353-X; Doty AC, 2016, J THERM BIOL, V60, P162, DOI 10.1016/j.jtherbio.2016.07.015; Fitzpatrick MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136677; Flaquer C, 2006, BIOL CONSERV, V128, P223, DOI 10.1016/j.biocon.2005.09.030; Fokidis HB, 2005, SOUTHEAST NAT, V4, P447, DOI 10.1656/1528-7092(2005)004[0447:TUONBT]2.0.CO;2; Franks A., 2003, NEST BOXES WILDLIFE; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Fukui D, 2010, MAMM STUDY, V35, P99, DOI 10.3106/041.035.0207; Geiser F, 2000, J COMP PHYSIOL B, V170, P153, DOI 10.1007/s003600050270; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geosciences Australia, 2004, GEOD COAST 100K 2004; Gibbons P, 2002, BIOL CONSERV, V103, P1, DOI 10.1016/S0006-3207(01)00109-4; Gibbons P., 2002, TREE HOLLOWS WILDLIF, DOI [10.1071/9780643090033, DOI 10.1071/9780643090033]; Glorioso BM, 2014, HERPETOL CONSERV BIO, V9, P609; Goldingay RL, 2015, AUST MAMMAL, V37, P225, DOI 10.1071/AM14040; Goldingay RL, 2015, RESTOR ECOL, V23, P482, DOI 10.1111/rec.12208; Goldingay RL, 2009, WILDLIFE RES, V36, P81, DOI 10.1071/WR08064; Harley Dan K.P., 2004, P318; HAVERA SP, 1979, J WILDLIFE MANAGE, V43, P251, DOI 10.2307/3800666; Hodgkison S, 2007, BIOL CONSERV, V135, P576, DOI 10.1016/j.biocon.2006.11.001; Holloway JC, 2000, J ZOOL, V252, P389, DOI 10.1017/S0952836900000133; HUEY RB, 1991, AM NAT, V137, pS91, DOI 10.1086/285141; Isaac JL, 2008, WILDLIFE RES, V35, P441, DOI 10.1071/WR08016; Kavanagh RP, 2007, AUSTRAL ECOL, V32, P635, DOI 10.1111/j.1442-9993.2007.01746.x; Kearney M, 2011, AUSTRAL ECOL, V36, P297, DOI 10.1111/j.1442-9993.2010.02150.x; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kerth G, 2001, OECOLOGIA, V126, P1, DOI 10.1007/s004420000489; Kunz TH, 2003, BAT ECOLOGY, P3; Lambrechts MM, 2010, ACTA ORNITHOL, V45, P1, DOI 10.3161/000164510X516047; Le Roux DS, 2016, FOREST ECOL MANAG, V366, P135, DOI 10.1016/j.foreco.2016.02.017; Le Roux DS, 2016, RESTOR ECOL, V24, P252, DOI 10.1111/rec.12303; Lentini PE, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0371; LICHT P, 1967, J MAMMAL, V48, P52, DOI 10.2307/1378169; Lindenmayer DB, 2011, ECOL MONOGR, V81, P557, DOI 10.1890/11-0279.1; Lindenmayer D, 2016, RESTOR ECOL, V24, P244, DOI 10.1111/rec.12306; Lindenmayer DB, 2009, BIOL CONSERV, V142, P33, DOI 10.1016/j.biocon.2008.09.026; Lourenco SI, 2004, BIOL CONSERV, V119, P237, DOI 10.1016/j.biocon.2003.11.006; Mainwaring MC, 2015, J NAT CONSERV, V25, P17, DOI 10.1016/j.jnc.2015.02.007; Mainwaring MC, 2011, ARDEA, V99, P167, DOI 10.5253/078.099.0206; Manning AD, 2013, ANIM CONSERV, V16, P395, DOI 10.1111/acv.12006; Mathewson PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072863; MCCOMB W C, 1981, Wildlife Society Bulletin, V9, P261; MCCOMB WC, 1982, AM MIDL NAT, V107, P163, DOI 10.2307/2425197; MCCOMB WC, 1981, J WILDLIFE MANAGE, V45, P284, DOI 10.2307/3807906; Mclean JA, 1999, FUNCT ECOL, V13, P360, DOI 10.1046/j.1365-2435.1999.00321.x; Mering ED, 2014, WILDLIFE SOC B, V38, P741, DOI 10.1002/wsb.461; MOLLER AP, 1989, OIKOS, V56, P421, DOI 10.2307/3565628; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Nussear KE, 2000, HERPETOL J, V10, P119; Porter WP, 2009, P NATL ACAD SCI USA, V106, P19666, DOI 10.1073/pnas.0907321106; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rhodes M, 2007, J MAMMAL, V88, P1252, DOI 10.1644/06-MAMM-A-374R1.1; Roads and Traffic Authority, 2011, BIOD GUID PROT MAN B; ROBINSON KW, 1957, J CELL COMPAR PHYSL, V49, P455, DOI 10.1002/jcp.1030490306; Rowland JA, 2017, BIOL CONSERV, V209, P341, DOI 10.1016/j.biocon.2017.02.006; Rueegger N, 2016, ACTA CHIROPTEROL, V18, P279, DOI 10.3161/15081109ACC2016.18.1.017; Speakman J, 1997, P NUTR SOC, V56, P1119, DOI 10.1079/PNS19970115; SPEAKMAN JR, 1994, J ZOOL, V233, P318, DOI 10.1111/j.1469-7998.1994.tb08593.x; The State of Victoria Department of Environment, 2017, PLANN SCHEM URB GROW; Turbill C, 2008, J COMP PHYSIOL B, V178, P597, DOI 10.1007/s00360-007-0249-1; vandenOord QGW, 1995, NEW ZEAL VET J, V43, P328, DOI 10.1080/00480169./1995.35914; Velky M, 2010, J ORNITHOL, V151, P147, DOI 10.1007/s10336-009-0436-9; Webb JK, 1997, BIOL CONSERV, V81, P21, DOI 10.1016/S0006-3207(96)00160-7; Wendlandt W.W., 1966, REFLECTANCE SPECTROS; Wiebe KL, 2011, J FIELD ORNITHOL, V82, P239, DOI 10.1111/j.1557-9263.2011.00327.x; Wiebe KL, 2001, AUK, V118, P412, DOI 10.1642/0004-8038(2001)118[0412:MOTCNI]2.0.CO;2; Willis CKR, 2007, BEHAV ECOL SOCIOBIOL, V62, P97, DOI 10.1007/s00265-007-0442-y	85	31	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176951	10.1371/journal.pone.0176951	http://dx.doi.org/10.1371/journal.pone.0176951			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472147	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500101
J	Hur, M; Koo, CH; Lee, HC; Park, SK; Kim, M; Kim, WH; Kim, JT; Bahk, JH				Hur, Min; Koo, Chang-Hoon; Lee, Hyung-Chul; Park, Sun-Kyung; Kim, Minkyung; Kim, Won Ho; Kim, Jin-Tae; Bahk, Jae-Hyon			Preoperative aspirin use and acute kidney injury after cardiac surgery: A propensity-score matched observational study	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ACUTE-RENAL-FAILURE; BYPASS GRAFT-SURGERY; ANTIPLATELET THERAPY; MYOCARDIAL-INFARCTION; RISK-FACTORS; MORTALITY; ASSOCIATION; CLOPIDOGREL; MANAGEMENT	Background The association between preoperative aspirin use and postoperative acute kidney injury (AKI) in cardiovascular surgery is unclear. We sought to evaluate the effect of preoperative aspirin use on postoperative AKI in cardiac surgery. Methods A total of 770 patients who underwent cardiovascular surgery under cardiopulmonary bypass were reviewed. Perioperative clinical parameters including preoperative aspirin administration were retrieved. We matched 108 patients who took preoperative aspirin continuously with patients who stopped aspirin more than 7 days or did not take aspirin for the month before surgery. The parameters used in the matching included variables related to surgery type, patient's demographics, underlying medical conditions and preoperative medications. Results In the first seven postoperative days, 399 patients (51.8%) developed AKI, as defined by the Kidney Disease Improving Global Outcomes (KDIGO) criteria and 128 patients (16.6%) required hemodialysis. Most patients took aspirin 100 mg once daily (n = 195, 96.5%) and the remaining 75 mg once daily. Multivariable analysis showed that preoperative maintenance of aspirin was independently associated with decreased incidence of postoperative AKI (odds ratio [OR] 0.46, 95% confidence interval [CI] 0.21-0.98, P = 0.048; after propensity score matching: OR 0.39, 95% CI 0.22-0.67, P = 0.001). Preoperative maintenance of aspirin was associated with less incidence of AKI defined by KDIGO both in the entire and matched cohort (n = 44 [40.7%] vs. 69 [63.9%] in aspirin and non-aspirin group, respectively in matched sample, relative risk [RR] 0.64, 95% CI 0.49, 0.83, P = 0.001). Preoperative aspirin was associated with decreased postoperative hospital stay after matching (12 [9-18] days vs. 16 [10-25] in aspirin and non-aspirin group, respectively, P = 0.038). Intraoperative estimated or calculated blood loss using hematocrit difference and estimated total blood volume showed no difference according to aspirin administration in both entire and matched cohort. Conclusions Preoperative low dose aspirin administration without discontinuation was protective against postoperative AKI defined by KDIGO criteria independently in both entire and matched cohort. Preoperative aspirin was also associated with decreased hemodialysis requirements and decreased postoperative hospital stay without increasing bleeding. However, differences in AKI and hospital stay were not associated with in-hospital mortality.	[Hur, Min; Koo, Chang-Hoon; Lee, Hyung-Chul; Park, Sun-Kyung; Kim, Minkyung; Kim, Won Ho; Kim, Jin-Tae; Bahk, Jae-Hyon] Seoul Natl Univ Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Koo, Chang-Hoon] CHA Univ, CHA Bundang Med Ctr, Dept Anesthesiol & Pain Med, Seongnam Si, Kyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Pochon Cha University	Kim, WH (corresponding author), Seoul Natl Univ Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea.	wonhokim.ane@gmail.com	Lee, Hyung-chul/AAP-7101-2021; KIM, JIN TAE/D-5734-2012; Kim, Won Ho/S-8671-2019; Lee, Hyung-Chul/U-1910-2019; Park, Sun/GSD-9620-2022; Kim, Jin-Tae/T-7983-2019	KIM, JIN TAE/0000-0002-3738-0081; Kim, Won Ho/0000-0003-1748-1296; Lee, Hyung-Chul/0000-0003-0048-7958; Kim, Jin-Tae/0000-0002-3738-0081; Bahk, Jae-Hyon/0000-0002-3082-5244				Ahn HJ, 2016, ANESTH ANALG, V122, P186, DOI 10.1213/ANE.0000000000000974; Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Bellomo R, 2008, INT J ARTIF ORGANS, V31, P166, DOI 10.1177/039139880803100210; Berger JS, 2008, AM J MED, V121, P43, DOI 10.1016/j.amjmed.2007.10.002; Berger JS, 2009, AM J CARDIOL, V104, p44C, DOI 10.1016/j.amjcard.2009.06.015; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Butterworth JF, 2013, MORGAN MIKHAILS CLIN, P1168; Bybee KA, 2005, CIRCULATION, V112, pI286, DOI 10.1161/CIRCULATIONAHA.104.522805; Cao LH, 2012, ANN SURG, V255, P399, DOI 10.1097/SLA.0b013e318234313b; Chao CT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001251; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Dacey LJ, 2000, ANN THORAC SURG, V70, P1986, DOI 10.1016/S0003-4975(00)02133-0; Deng Y, 2015, ANN SURG, V262, P1150, DOI 10.1097/SLA.0000000000000951; Dunning J, 2008, EUR J CARDIO-THORAC, V34, P73, DOI 10.1016/j.ejcts.2008.02.024; Engelman DT, 1999, J THORAC CARDIOV SUR, V118, P866, DOI 10.1016/S0022-5223(99)70056-5; FERRARIS VA, 1988, ANN THORAC SURG, V45, P71, DOI 10.1016/S0003-4975(10)62401-0; Gaffney AM, 2015, CURR OPIN ANESTHESIO, V28, P50, DOI 10.1097/ACO.0000000000000154; Goldhammer JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134670; Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Jacob M, 2011, CIRCULATION, V123, P577, DOI 10.1161/CIRCULATIONAHA.110.957373; Kim DH, 2009, J THORAC CARDIOV SUR, V138, P1377, DOI 10.1016/j.jtcvs.2009.07.027; Kim WH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001867; Kim WH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000273; Kim WH, 2013, J CARDIOTHOR VASC AN, V27, P1158, DOI 10.1053/j.jvca.2013.04.007; Kulik A, 2010, CIRCULATION, V122, P2680, DOI 10.1161/CIRCULATIONAHA.110.978007; Kulik A, 2009, EXPERT OPIN DRUG SAF, V8, P169, DOI [10.1517/14740330902797081, 10.1517/14740330902797081 ]; Lapsia V, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.06.021; Levine GN, 2016, CIRCULATION, V134, pE123, DOI 10.1161/CIR.0000000000000404; Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798; Morawski W, 2005, J THORAC CARDIOV SUR, V130, P791, DOI 10.1016/j.jtcvs.2005.02.041; Parolari A, 2012, ANN THORAC SURG, V93, P584, DOI 10.1016/j.athoracsur.2011.09.073; Scrascia G, 2014, ARTIF ORGANS, V38, P101, DOI 10.1111/aor.12127; Shin SR, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2985148; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Sun JCJ, 2008, EUR HEART J, V29, P1057, DOI 10.1093/eurheartj/ehn104; Sun JCJ, 2010, AM HEART J, V160, P1178, DOI 10.1016/j.ahj.2010.07.035; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Thomas ME, 2015, KIDNEY INT, V87, P62, DOI 10.1038/ki.2014.328; Tran H, 2004, JAMA-J AM MED ASSOC, V292, P1867, DOI 10.1001/jama.292.15.1867; Wijeysundera DN, 2007, JAMA-J AM MED ASSOC, V297, P1801, DOI 10.1001/jama.297.16.1801; Xiao FC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116311; Yoo S, 2017, ANESTH ANALG, V124, P35, DOI 10.1213/ANE.0000000000001632	45	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177201	10.1371/journal.pone.0177201	http://dx.doi.org/10.1371/journal.pone.0177201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472145	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500152
J	Inagaki, T; Watanabe, T; Tsuchikawa, S				Inagaki, Tetsuya; Watanabe, Tomoko; Tsuchikawa, Satoru			The effect of path length, light intensity and co-added time on the detection limit associated with NIR spectroscopy of potassium hydrogen phthalate in aqueous solution	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; TRANSMISSION SPECTROSCOPY; GLUCOSE; CALIBRATION; WATER; REGRESSION; SUGAR	Near infrared (NIR) spectroscopy is a common means of non-invasively determining the concentrations of organic compounds in relatively transparent aqueous solutions. Rigorous determination for limit of detection (LOD) is of importance for the application use of NIR spectroscopy. The work reported herein determined the LOD with the analysis of potassium hydrogen phthalate (KHP) in water with partial least square (PLS) calibration in the range of 6300 - 5800 cm (-1) between the two strong absorption bands of water, in which the C-H overtone bands of KHP are located. A comparison of the LOD estimated when using various condition (path length, aperture and co-added scan times) showed that the lowest LOD for KHP obtained with a fiber optic cable attachment equipped NIR spectrometer is approximately 150 ppm.	[Inagaki, Tetsuya; Watanabe, Tomoko; Tsuchikawa, Satoru] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan	Nagoya University	Inagaki, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan.	inatetsu@agr.nagoya-u.ac.jp						Allegrini F, 2014, ANAL CHEM, V86, P7858, DOI 10.1021/ac501786u; Amerov AK, 2004, APPL SPECTROSC, V58, P1195, DOI 10.1366/0003702042336136; [Anonymous], 1999, ISO8245; Chang CW, 2001, SOIL SCI SOC AM J, V65, P480, DOI 10.2136/sssaj2001.652480x; CHOPPIN GR, 1978, J MOL STRUCT, V45, P39, DOI 10.1016/0022-2860(78)87057-4; CHUNG HI, 1995, APPL BIOCHEM BIOTECH, V50, P109, DOI 10.1007/BF02783448; Ding Q, 2000, APPL SPECTROSC, V54, P1047, DOI 10.1366/0003702001950553; Giangiacomo R, 2006, FOOD CHEM, V96, P371, DOI 10.1016/j.foodchem.2005.02.051; Griffiths PR., 2007, FOURIER TRANSFORM IN, V2nd ed.; HAALAND DM, 1988, ANAL CHEM, V60, P1193, DOI 10.1021/ac00162a020; Hazen KH, 1998, APPL SPECTROSC, V52, P1597, DOI 10.1366/0003702981943103; Hazen KH, 1998, ANAL CHIM ACTA, V371, P255, DOI 10.1016/S0003-2670(98)00318-3; Jensen PS, 2002, APPL SPECTROSC, V56, P1600, DOI 10.1366/000370202321115878; Le LMM, 2014, TALANTA, V119, P361, DOI 10.1016/j.talanta.2013.10.060; Mauer LJ, 2009, J AGR FOOD CHEM, V57, P3974, DOI 10.1021/jf900587m; Meyer T, 2006, NIR NEWS, V7, P12; Olivieri AC, 2015, ANAL CHIM ACTA, V868, P10, DOI 10.1016/j.aca.2015.01.017; Olivieri AC, 2014, CHEM REV, V114, P5358, DOI 10.1021/cr400455s; Pearson EJ, 2014, GEOCHEM GEOPHY GEOSY, V15, P292, DOI 10.1002/2013GC004928; Rambla FJ, 1997, ANAL CHIM ACTA, V344, P41, DOI 10.1016/S0003-2670(97)00032-9; Raposo F, 2016, TRAC-TREND ANAL CHEM, V77, P167, DOI 10.1016/j.trac.2015.12.006	21	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176920	10.1371/journal.pone.0176920	http://dx.doi.org/10.1371/journal.pone.0176920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472128	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500097
J	Rudra, S; Kalra, A; Kumar, A; Joe, W				Rudra, Shalini; Kalra, Aakshi; Kumar, Abhishek; Joe, William			Utilization of alternative systems of medicine as health care services in India: Evidence on AYUSH care from NSS 2014	PLOS ONE			English	Article							TRADITIONAL MEDICINE	AYUSH, an acronym for Ayurveda, Yoga and Naturopathy, Unani, Siddha, Sowa-Rigpa and Homeopathy represents the alternative systems of medicine recognized by the Government of India. Understanding the patterns of utilization of AYUSH care has been important for various reasons including an increased focus on its mainstreaming and integration with biomedicine-based health care system. Based on a nationally representative health survey 2014, we present an analysis to understand utilization of AYUSH care across socioeconomic and demographic groups in India. Overall, 6.9% of all patients seeking outpatient care in the reference period of last two weeks have used AYUSH services without any significant differentials across rural and urban India. Importantly, public health facilities play a key role in provisioning of AYUSH care in rural areas with higher utilization in Chhattisgarh, Kerala and West Bengal. Use of AYUSH among middle-income households is lower when compared with poorer and richer households. We also find that low-income households display a greater tendency for AYUSH self-medication. AYUSH care utilization is higher among patients with chronic diseases and also for treating skin-related and musculo-skeletal ailments. Although the overall share of AYUSH prescription drugs in total medical expenditure is only about 6% but the average expenditure for drugs on AYUSH and allopathy did not differ hugely. The discussion compares our estimates and findings with other studies and also highlights major policy issues around mainstreaming of AYUSH care.	[Rudra, Shalini] Observer Res Fdn, New Delhi, India; [Kalra, Aakshi; Kumar, Abhishek; Joe, William] Delhi Univ, Populat Res Ctr, Inst Econ Growth, North Campus, Delhi, India	University of Delhi	Joe, W (corresponding author), Delhi Univ, Populat Res Ctr, Inst Econ Growth, North Campus, Delhi, India.	william@iegindia.org		Joe, William/0000-0003-3282-658X				Abraham L, 2005, INDIAN SYSTEMS MED I; Ahmad S S, 2007, INT J ALTERN MED, V6, P1; Bannerman RH, 1988, TRADITIONAL MED HLTH; BHARDWAJ SM, 1975, SOC SCI MED, V9, P603, DOI 10.1016/0037-7856(75)90174-2; BHATIA JC, 1975, SOC SCI MED, V9, P15, DOI 10.1016/0037-7856(75)90153-5; Chandra Shailaja, 2012, Ayu, V33, P461, DOI 10.4103/0974-8520.110504; Das J, 2016, AM ECON REV, V106, P3765, DOI 10.1257/aer.20151138; Ebrahimnejad H, 2009, ROY ASIAT SOC BOOKS, P1; Elwell-Sutton TM, 2013, HEALTH POLICY PLANN, V28, P467, DOI 10.1093/heapol/czs077; Erreygers G, 2009, J HEALTH ECON, V28, P504, DOI 10.1016/j.jhealeco.2008.02.003; Gautham Meenakshi, 2011, Indian J Med Res, V134, P627, DOI 10.4103/0971-5916.90987; George A, 2013, SOC SCI MED, V96, P297, DOI 10.1016/j.socscimed.2013.01.022; Gopichandran Vijayaprasad, 2012, Indian J Med Ethics, V9, P272; Government of India, 2015, KEY IND SOC CONS IND; Greene H., 2003, ECONOMETRIC ANAL; Harilal M. S., 2009, ECON POLIT WEEKLY, V44, P44; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Herman PM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001046; Jaggi OP., 2000, MED INDIA MODERN PER; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jeffery R., 1988, POLITICS HLTH INDIA; Kumar C, 2011, PUBLIC PRIVATE DICHO; Kumar Deepak, 2010, INDIAN HIST REV, V37; Kumar Deepak, 2001, DIS MED INDIA HIST O; Lakshmi JK, 2015, HEALTH POLICY PLANN, V30, P1067, DOI 10.1093/heapol/czu096; Mahal A, 2001, HNP DISCUSSION PAPER; Mazumdar PG, 2007, J BIOSOC SCI, V39, P819, DOI 10.1017/S0021932007002106; Ministry of Textiles Government of India, 2015, ANN REP 2014 15; Mira Sadgopal, 2009, Economic and Political Weekly, V44, P52; Mohanan M, 2015, JAMA PEDIATR, V169, P349, DOI 10.1001/jamapediatrics.2014.3445; Mukherjee PK, 2012, J ETHNOPHARMACOL, V143, P424, DOI 10.1016/j.jep.2012.07.036; Mushtaq Muhammad Umair, 2009, Indian J Community Med, V34, P6, DOI 10.4103/0970-0218.45369; National Rural Health Mission, 2005, INDIAN J PUBLIC HLTH, V49, P175; NEUMANN AK, 1971, SOC SCI MED, V5, P137, DOI 10.1016/0037-7856(71)90094-1; Oyebode O, 2016, USE TRADITIONAL MED; Patwardhan Bhushan, 2015, J Ayurveda Integr Med, V6, P147, DOI 10.4103/0975-9476.166389; Planning Commission of India, 2011, REP STEER COMM AYUSH; Powell-Jackson T, 2016, SCIENCE, V354, P34, DOI 10.1126/science.aai8652; Priya R., 2010, STATUS ROLE AYUSH LO; RAMESH A, 1981, SOC SCI MED-MED GEOG, V15, P69, DOI 10.1016/0160-8002(81)90017-4; Raut B, 2011, INT J RES AYURVEDA P, V2, P876; Rohde J.E., 1995, RURAL PRIVATE PRACTI; Ruchika Nandha, 2013, International Journal of Green Pharmacy, V7, P173, DOI 10.4103/0973-8258.120184; Samal J, 2015, J INTERCULT ETHNOPHA, V4, P348, DOI 10.5455/jice.20151101093011; Schensul SL, 2006, SOC SCI MED, V62, P2774, DOI 10.1016/j.socscimed.2005.11.003; Sheehan Helen E, 2009, Indian J Med Ethics, V6, P138; Shyam Ashtekar, 2001, Economic and Political Weekly, V36, P448; Singh P, 2005, INDIAN J MED RES, V122, P137; Sivaramakrishnan K., 2006, OLD POTIONS NEW BOTT; Song F, 1991, HLTH POLICY PLAN, V6, P64; Srinivasan P, 1995, World Health Forum, V16, P190; Sujatha V., 2009, Economic and Political Weekly, V44, P76; Sujatha V., 2009, Economic and Political Weekly, V44, P35; Sunil Amrith, 2007, Economic and Political Weekly, V42, P114; Thorsen RS, 2016, HEALTH POLICY PLANN, V31, P314, DOI 10.1093/heapol/czv060; Vaidya A D B National Commission on Macroeconomics and Health, 2005, EFF INT IND SYST MED; VANDEVEN WPMM, 1981, J ECONOMETRICS, V17, P229, DOI 10.1016/0304-4076(81)90028-2; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; World Health Organization, 2013, WHO TRAD MED STRAT 2; World Health Organization, 2000, US	60	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176916	10.1371/journal.pone.0176916	http://dx.doi.org/10.1371/journal.pone.0176916			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472197	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500096
J	Scott, A; Chambers, D; Goyder, E; O'Cathain, A				Scott, Anne; Chambers, Duncan; Goyder, Elizabeth; O'Cathain, Alicia			Socioeconomic inequalities in mortality, morbidity and diabetes management for adults with type 1 diabetes: A systematic review	PLOS ONE			English	Review							PITTSBURGH EPIDEMIOLOGY; GLYCEMIC CONTROL; SEVERE HYPOGLYCEMIA; BLOOD-GLUCOSE; RISK-FACTORS; YOUNG-ADULTS; COMPLICATIONS; POPULATION; PEOPLE; HEALTH	Aims To systematically review the evidence of socioeconomic inequalities for adults with type 1 diabetes in relation to mortality, morbidity and diabetes management. Methods We carried out a systematic search across six relevant databases and included all studies reporting associations between socioeconomic indicators and mortality, morbidity, or diabetes management for adults with type 1 diabetes. Data extraction and quality assessment was undertaken for all included studies. A narrative synthesis was conducted. Results A total of 33 studies were identified. Twelve cohort, 19 cross sectional and 2 case control studies met the inclusion criteria. Regardless of healthcare system, low socioeconomic status was associated with poorer outcomes. Following adjustments for other risk factors, socioeconomic status was a statistically significant independent predictor of mortality in 9/10 studies and morbidity in 8/10 studies for adults with type 1 diabetes. There appeared to be an association between low socioeconomic status and some aspects of diabetes management. Although only 3 of 16 studies made adjustments for confounders and other risk factors, poor diabetes management was associated with lower socioeconomic status in 3/3 of these studies. Conclusions Low socioeconomic status is associated with higher levels of mortality and morbidity for adults with type 1 diabetes even amongst those with access to a universal healthcare system. The association between low socioeconomic status and diabetes management requires further research given the paucity of evidence and the potential for diabetes management to mitigate the adverse effects of low socioeconomic status.	[Scott, Anne; Chambers, Duncan; Goyder, Elizabeth; O'Cathain, Alicia] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England	University of Sheffield	Scott, A (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England.	anne.scott@sheffield.ac.uk		Chambers, Duncan/0000-0002-0154-0469; Goyder, Elizabeth/0000-0003-3691-1888	Economic and Social Research Council [ES/1022740/1]; ESRC; NIHR School for Public Health Research (SPHR); NIHR SPHR	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NIHR School for Public Health Research (SPHR); NIHR SPHR	This work was supported by the Economic and Social Research Council (http:// www.esre.ac.uk/) [Grant No: ES/1022740/1]. AS was awarded a full time PhD studentship from the ESRC. The research was supported by the NIHR School for Public Health Research (SPHR) (http:// sphr.nihr.ac.uk/). AS received a salary funded by the NIHR SPHR during 2016 to carry out the current review. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. NIHR SPHR is a collaboration between: the Universities of Sheffield, Bristol, Cambridge, Exeter, UCL; The London School of Hygiene and Tropical Medicine; the LiLaC collaboration between the Universities of Liverpool and Lancaster and Fuse: The Centre for Translational Research in Public Health, a collaboration between Newcastle, Durham, Northumbria, Sunderland and Teesside Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-6; Anderson SG, 2014, PRIM CARE DIABETES, V8, P65, DOI 10.1016/j.pcd.2013.08.004; Booth A, 2016, SYSTEMATIC APPROACHE; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; Butalia S, 2013, DIABETIC MED, V30, P567, DOI 10.1111/dme.12127; Carstairs V., 1991, DEPRIVATION HLTH SCO; CASP, 2013, 12 QUEST HELP YOU MA; Chaturvedi N, 1996, DIABETES CARE, V19, P423, DOI 10.2337/diacare.19.5.423; Cortina S, 2010, PEDIATR DIABETES, V11, P337, DOI 10.1111/j.1399-5448.2009.00593.x; DCCT Research Group, 1989, NEW ENGL J MED, V329, P977; Forssas E, 2003, EUR J PUBLIC HEALTH, V13, P38, DOI 10.1093/eurpub/13.1.38; Forssas E, 2012, EUR J PUBLIC HEALTH, V22, P305, DOI 10.1093/eurpub/ckr044; Forssas E, 2010, SCAND J PUBLIC HEALT, V38, P691, DOI 10.1177/1403494810376427; Gnavi R, 2004, INT J EPIDEMIOL, V33, P864, DOI 10.1093/ije/dyh089; Grintsova O, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-43; HARRIS MI, 1993, DIABETES CARE, V16, P1116, DOI 10.2337/diacare.16.8.1116; HEPBURN DA, 1994, DIABETIC MED, V11, P578, DOI 10.1111/j.1464-5491.1994.tb02039.x; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Johansen K., 1986, PRACTICAL DIABETES, V3, P93; Karter AJ, 2000, DIABETES CARE, V23, P477, DOI 10.2337/diacare.23.4.477; Kibbey KJ, 2013, DIABETIC MED, V30, P878, DOI 10.1111/dme.12227; Leese GP, 2003, DIABETES CARE, V26, P1176, DOI 10.2337/diacare.26.4.1176; Lievre M, 2005, DIABETES METAB, V31, P41, DOI 10.1016/S1262-3636(07)70165-9; LLOYD CE, 1993, DIABETES RES CLIN PR, V21, P187, DOI 10.1016/0168-8227(93)90068-G; Mackenbach JP, 2012, SOC SCI MED, V75, P761, DOI 10.1016/j.socscimed.2012.02.031; Matsushima M, 1996, DIABETOLOGIA, V39, P710; Moher David, 2009, Open Med, V3, pe123; Muhlhauser I, 1998, DIABETOLOGIA, V41, P1139, DOI 10.1007/s001250051043; Muhlhauser I, 1998, DIABETOLOGIA, V41, P1274, DOI 10.1007/s001250051065; Muhlhauser I, 2000, DIABETIC MED, V17, P727, DOI 10.1046/j.1464-5491.2000.00372.x; Nadas J, 2009, ACTA DIABETOL, V46, P159, DOI 10.1007/s00592-008-0065-4; National Institute for Health and Care Excellence, 2008, CONT SUBC INS INF TR; Osan JK, 2016, INTERN MED J, V46, P332, DOI 10.1111/imj.12991; Pedersen-Bjergaard U, 2004, DIABETES-METAB RES, V20, P479, DOI 10.1002/dmrr.482; Perros P, 1998, DIABETES RES CLIN PR, V39, P23, DOI 10.1016/S0168-8227(97)00109-5; Rawshani A, 2015, DIABETES CARE, V38, P1518, DOI 10.2337/dc15-0145; Ricci-Cabello I, 2010, HEALTH SOC CARE COMM, V18, P572, DOI 10.1111/j.1365-2524.2010.00960.x; Robinson N, 1998, DIABETIC MED, V15, P205, DOI 10.1002/(SICI)1096-9136(199803)15:3<205::AID-DIA519>3.0.CO;2-#; ROBINSON N, 1984, DIABETES METAB, V10, P245; Rossing P, 1996, BRIT MED J, V313, P779; Sastre Julia, 2012, Endocrinol Nutr, V59, P539, DOI 10.1016/j.endonu.2012.07.003; Sawka AM, 2007, CAN J DIABETES, V31, P233, DOI DOI 10.1016/S1499-2671(07)13010-0; Secrest AM, 2011, ANN EPIDEMIOL, V21, P374, DOI 10.1016/j.annepidem.2011.02.007; Secrest AM, 2011, ANN EPIDEMIOL, V21, P367, DOI 10.1016/j.annepidem.2011.02.011; Simmons JH, 2013, DIABETES CARE, V36, P3573, DOI 10.2337/dc12-2643; Townsend PP., 1988, HLTH DEPRIVATION INE; Unwin N, 1996, DIABETIC MED, V13, P72, DOI 10.1002/(SICI)1096-9136(199601)13:1<72::AID-DIA21>3.3.CO;2-K; Weinstock RS, 2013, J CLIN ENDOCR METAB, V98, P3411, DOI 10.1210/jc.2013-1589; Whitehead M, 1997, BRIT MED J, V315, P1006, DOI 10.1136/bmj.315.7114.1006; WHO, 2014, HLTH WORLDS AD 2 CHA; Wood J, 2013, DIABETES TECHNOL THE, V15, pA25; Zgibor JC, 2000, DIABETES CARE, V23, P472, DOI 10.2337/diacare.23.4.472	52	34	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177210	10.1371/journal.pone.0177210	http://dx.doi.org/10.1371/journal.pone.0177210			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489876	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000401314100056
J	Wang, K; Chen, X; Zhu, YF				Wang, Kai; Chen, Xi; Zhu, Yuefei			Random domain name and address mutation (RDAM) for thwarting reconnaissance attacks	PLOS ONE			English	Article								Network address shuffling is a novel moving target defense (MTD) that invalidates the address information collected by the attacker by dynamically changing or remapping the host's network addresses. However, most network address shuffling methods are limited by the limited address space and rely on the host's static domain name to map to its dynamic address; therefore these methods cannot effectively defend against random scanning attacks, and cannot defend against an attacker who knows the target's domain name. In this paper, we propose a network defense method based on random domain name and address mutation (RDAM), which increases the scanning space of the attacker through a dynamic domain name method and reduces the probability that a host will be hit by an attacker scanning IP addresses using the domain name system (DNS) query list and the time window methods. Theoretical analysis and experimental results show that RDAM can defend against scanning attacks and worm propagation more effectively than general network address shuffling methods, while introducing an acceptable operational overhead.	[Wang, Kai; Chen, Xi; Zhu, Yuefei] Zhengzhou Informat Sci & Technol Inst, Dept Network Engn, Zhengzhou, Henan, Peoples R China	PLA Information Engineering University	Wang, K (corresponding author), Zhengzhou Informat Sci & Technol Inst, Dept Network Engn, Zhengzhou, Henan, Peoples R China.	quanjiaokk@163.com			National Natural Science Foundation of China [61271252]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (nos. 61271252). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shaer E., 2012, P INT C SECURITY PRI, P310, DOI DOI 10.1007/978-3-642-36883-7_19; [Anonymous], 2009, NAT CYB LEAP YEAR SU; Antonatos S, 2007, COMPUT NETW, V51, P3471, DOI 10.1016/j.comnet.2007.02.006; Atighetchi M, 2003, ISORC 2003: SIXTH IEEE INTERNATIONAL SYMPOSIUM ON OBJECT-ORIENTED REAL-TIME DISTRIBUTED COMPUTING, PROCEEDINGS, P183; Bailey M, 2005, IEEE SECUR PRIV, V3, P26, DOI 10.1109/MSP.2005.106; Cai GL, 2016, INT CONF ADV COMMUN, P185, DOI 10.1109/ICACT.2016.7423322; Cai JY, 2009, LECT NOTES COMPUT SC, V5609, P7, DOI 10.1007/978-3-642-02882-3_2; Carroll TE, 2014, IEEE ICC, P701, DOI 10.1109/ICC.2014.6883401; Chen Z, 2008, IEEE T INF FOREN SEC, V4, P530; Clark A, 2013, IEEE DECIS CONTR P, P678, DOI 10.1109/CDC.2013.6759960; Crouse M., 2015, P 2 ACM WORKSHOP MOV, P21, DOI [DOI 10.1145/2808475.2808480, 10.1145/2808475.2808480]; Dunlop M, 2012, IEEE SECUR PRIV, V10, P35, DOI 10.1109/MSP.2012.28; Dunlop M, 2011, 2011 - MILCOM 2011 MILITARY COMMUNICATIONS CONFERENCE, P1321, DOI 10.1109/MILCOM.2011.6127486; Green M., 2015, P 2 ACM WORKSHOP MOV, P31, DOI DOI 10.1145/2808475.2808484; Holz T., 2008, P 1 US WORKSH LARG S; Jafarian Jafar Haadi, 2015, 2015 IEEE Conference on Computer Communications (INFOCOM). Proceedings, P738, DOI 10.1109/INFOCOM.2015.7218443; Jafarian J. H., 2012, P 1 WORKSH HOT TOP S, P127, DOI DOI 10.1145/2342441.2342467; Jafarian J. H. H., 2014, P 1 ACM WORKSHOP MOV, P69, DOI DOI 10.1109/DSN.2014.35; Jafarian JH, 2015, IEEE T INF FOREN SEC, V10, P2562, DOI 10.1109/TIFS.2015.2467358; Kampanakis P., 2014, P 15 IEEE INT S WORL, P1, DOI DOI 10.1109/WOWMOM.2014.6918979; Kewley D, 2001, DISCEX'01: DARPA INFORMATION SURVIVABILITY CONFERENCE & EXPOSITION II, VOL I, PROCEEDINGS, P176, DOI 10.1109/DISCEX.2001.932214; Lantz B., 2010, P 9 ACM SIGCOMM WORK, P19, DOI [DOI 10.1145/1868447.1868466, 10.1145/1868447.1868466]; Li P, 2008, IEEE COMMUN SURV TUT, V10, P20, DOI 10.1109/COMST.2008.4483668; Luo Y., 2015, 2012 4 INT C COMPUTA, P1, DOI [10.1371/journal.pone.0136045, DOI 10.1371/JOURNAL.PONE.0136045]; Luo YB, 2015, 2015 IEEE TRUSTCOM/BIGDATASE/ISPA, VOL 1, P263, DOI [10.1109/Trustcom-2015.383, 10.1109/Trustcom.2015.383]; MacFarland D.C., 2015, PROC 2015 ACM WORKSH, P37, DOI DOI 10.1145/2808475.2808485; Okhravi Hamed, 2014, Research in Attacks, Intrusions and Defenses. 17th International Symposium (RAID 2014). Proceedings: LNCS 8688, P405, DOI 10.1007/978-3-319-11379-1_20; Okhravi H, 2012, INT J CRIT INFR PROT, V5, P30, DOI 10.1016/j.ijcip.2012.01.002; Parno B, 2007, ACM SIGCOMM COMP COM, V37, P289, DOI 10.1145/1282427.1282413; Pongracz Gergely, 2013, 2013 Second European Workshop on Software Defined Networks (EWSDN), P62, DOI 10.1109/EWSDN.2013.17; Shang YL, 2016, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2016/08/083403; Shang YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30521; Shang YL, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.042804; Shannon C, 2004, IEEE SECUR PRIV, V2, P46, DOI 10.1109/MSP.2004.59; Shin S, 2010, 26TH ANNUAL COMPUTER SECURITY APPLICATIONS CONFERENCE (ACSAC 2010), P151; Sifalakis M, 2005, IEEE ICC, P1518; Sohail A, 2014, 2014 INTERNATIONAL CONFERENCE ON COMPUTER, COMMUNICATIONS, AND CONTROL TECHNOLOGY (I4CT), P75, DOI 10.1109/I4CT.2014.6914149; Wang HX, 2014, COMPUT COMMUN, V46, P10, DOI 10.1016/j.comcom.2014.03.009; Waters B., 2004, P 11 ACM C COMP COMM, P246; Weaver Nicholas, 2003, P 2003 ACM WORKSH RA, P11, DOI DOI 10.1145/948187.948190; Xu J., 2014, P 1 ACM WORKSHOP MOV, P97, DOI DOI 10.1145/2663474.2663486; Zhuang R., 2015, P 2 ACM WORKSHOP MOV, P11, DOI DOI 10.1145/2808475.2808478; Zhuang R., 2014, P ACM C COMPUTER COM, P31, DOI DOI 10.1145/2663474.2663479; Zou C.C., 2002, P 9 ACM C COMPUTER C, P138, DOI 10.1145/586110.586130; Zou CC, 2006, PERFORM EVALUATION, V63, P700, DOI 10.1016/j.peva.2005.07.032	45	7	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177111	10.1371/journal.pone.0177111	http://dx.doi.org/10.1371/journal.pone.0177111			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489910	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100049
J	Aboalroub, AA; Bachman, AB; Zhang, ZM; Keramisanou, D; Merkler, DJ; Gelis, I				Aboalroub, Adam A.; Bachman, Ashleigh B.; Zhang, Ziming; Keramisanou, Dimitra; Merkler, David J.; Gelis, Ioannis			Acetyl group coordinated progression through the catalytic cycle of an arylalkylamine N-acetyltransferase	PLOS ONE			English	Article							1.8 ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; DROSOPHILA-MELANOGASTER; STRUCTURAL-ANALYSIS; GNAT SUPERFAMILY; BIOCHEMICAL-CHARACTERIZATION; SUBSTRATE-BINDING; PINEAL-GLAND; ENZYME; PROTEIN	The transfer of an acetyl group from acetyl-CoA to an acceptor amine is a ubiquitous biochemical transformation catalyzed by Gcn5-related N-acetyltransferases (GNATs). Although it is established that the reaction proceeds through a sequential ordered mechanism, the role of the acetyl group in driving the ordered formation of binary and ternary complexes remains elusive. Herein, we show that CoA and acetyl-CoA alter the conformation of the substrate binding site of an arylalkylamine N-acetyltransferase (AANAT) to facilitate interaction with acceptor substrates. However, it is the presence of the acetyl group within the catalytic funnel that triggers high affinity binding. Acetyl group occupancy is relayed through a conserved salt bridge between the P-loop and the acceptor binding site, and is manifested as differential dynamics in the CoA and acetyl-CoA-bound states. The capacity of the acetyl group carried by an acceptor to promote its tight binding even in the absence of CoA, but also its mutually exclusive position to the acetyl group of acetyl-CoA underscore its importance in coordinating the progression of the catalytic cycle.	[Aboalroub, Adam A.; Bachman, Ashleigh B.; Zhang, Ziming; Keramisanou, Dimitra; Merkler, David J.; Gelis, Ioannis] Univ S Florida, Dept Chem, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Gelis, I (corresponding author), Univ S Florida, Dept Chem, Tampa, FL 33620 USA.	igelis@usf.edu	Zhang, ziming/HGA-8604-2022		University of South Florida; National Institute of Health [R15-GM107864]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM107864] Funding Source: NIH RePORTER	University of South Florida; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I.G. would like to thank the University of South Florida for internal funds. D.J.M. acknowledges the National Institute of Health for support (R15-GM107864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboalroub AA, 2017, BIOMOL NMR ASSIGN, V11, P105, DOI 10.1007/s12104-017-9729-8; ARENDT J, 1995, NATO ADV SCI INST SE, V277, P165; Battistini MR, BM IAANAT3 EXPRESSIO; Bewley MC, 2006, P NATL ACAD SCI USA, V103, P2063, DOI 10.1073/pnas.0511008103; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brodbeck D, 1998, DNA CELL BIOL, V17, P621, DOI 10.1089/dna.1998.17.621; Burk DL, 2003, PROTEIN SCI, V12, P426, DOI 10.1110/ps.0233503; Chen JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep31425; Cheng KC, 2012, BIOCHEM J, V446, P395, DOI 10.1042/BJ20120520; COON SL, 1995, SCIENCE, V270, P1681, DOI 10.1126/science.270.5242.1681; Dai FY, 2010, J BIOL CHEM, V285, P19553, DOI 10.1074/jbc.M109.096743; De Angelis J, 1998, J BIOL CHEM, V273, P3045, DOI 10.1074/jbc.273.5.3045; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dempsey DR, 2015, INSECT BIOCHEM MOLEC, V66, P1, DOI 10.1016/j.ibmb.2015.10.003; Dempsey DR, 2015, BIOCHEMISTRY-US, V54, P2644, DOI 10.1021/acs.biochem.5b00113; Dempsey DR, 2014, BIOCHEMISTRY-US, V53, P7777, DOI 10.1021/bi5006078; Dorfmueller HC, 2012, ACTA CRYSTALLOGR D, V68, P1019, DOI 10.1107/S0907444912019592; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Filippova EV, 2011, PROTEINS, V79, P2566, DOI 10.1002/prot.23062; Freiburger LA, 2011, NAT STRUCT MOL BIOL, V18, P288, DOI 10.1038/nsmb.1978; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Han Q, 2012, P NATL ACAD SCI USA, V109, P11669, DOI 10.1073/pnas.1206828109; Hegde SS, 2007, BIOCHEMISTRY-US, V46, P7187, DOI 10.1021/bi700256z; Hickman AB, 1999, MOL CELL, V3, P23, DOI 10.1016/S1097-2765(00)80171-9; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; Hung MN, 2006, J BACTERIOL, V188, P5606, DOI 10.1128/JB.00306-06; Hurtado-Guerrero R, 2008, BIOCHEM J, V415, P217, DOI 10.1042/BJ20081000; Khalil EM, 1998, J BIOL CHEM, V273, P30321, DOI 10.1074/jbc.273.46.30321; KLEIN DC, 1970, SCIENCE, V169, P1093, DOI 10.1126/science.169.3950.1093; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; Klein DC, 2006, CHRONOBIOL INT, V23, P5, DOI 10.1080/07420520500545839; Klein DC, 1996, TRENDS ENDOCRIN MET, V7, P106, DOI 10.1016/1043-2760(96)00033-1; Kramer KJ, 2001, TETRAHEDRON, V57, P385, DOI 10.1016/S0040-4020(00)00949-2; Liszczak G, 2013, NAT STRUCT MOL BIOL, V20, P1098, DOI 10.1038/nsmb.2636; Majorek KA, 2013, J BIOL CHEM, V288, P30223, DOI 10.1074/jbc.M113.501353; Maksimoska J, 2014, BIOCHEMISTRY-US, V53, P3415, DOI 10.1021/bi500380f; Mun S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10484; Norris AL, 2013, PROTEIN SCI, V22, P916, DOI 10.1002/pro.2273; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Oda K, 2010, J BIOL CHEM, V285, P1446, DOI 10.1074/jbc.M109.022277; Osanai-Futahashi M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2312; Peneff C, 2001, J BIOL CHEM, V276, P16328, DOI 10.1074/jbc.M009988200; Sloley BD, 2004, NEUROTOXICOLOGY, V25, P175, DOI 10.1016/S0161-813X(03)00096-2; Ud-Din AIMS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071018; Vetting MW, 2008, PROTEIN SCI, V17, P1781, DOI 10.1110/ps.035899.108; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zilberman-Peled B, 2006, BRAIN RES, V1073, P220, DOI 10.1016/j.brainres.2005.12.028	50	6	6	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177270	10.1371/journal.pone.0177270	http://dx.doi.org/10.1371/journal.pone.0177270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486510	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314000068
J	Dananche, C; Gustin, MP; Cassier, P; Loeffert, ST; Thibaudon, M; Benet, T; Vanhems, P				Dananche, Cedric; Gustin, Marie-Paule; Cassier, Pierre; Loeffert, Sophie Tiphaine; Thibaudon, Michel; Benet, Thomas; Vanhems, Philippe			Evaluation of hirst-type spore trap to monitor environmental fungal load in hospital	PLOS ONE			English	Article							DEMOLITION; AIR; INFECTION	The main purpose was to validate the use of outdoor-indoor volumetric impaction sampler with Hirst-type spore traps (HTSTs) to continuously monitor fungal load in order to prevent invasive fungal infections during major structural work in hospital settings. For 4 weeks, outdoor fungal loads were quantified continuously by 3 HTSTs. Indoor air was sampled by both HTST and viable impaction sampler. Results were expressed as particles/m(3) (HTST) or colony-forming units (CFU)/m(3) (biocollector). Paired comparisons by day were made with Wilcoxon's paired signed-rank test or paired Student's t-test as appropriate. Paired airborne spore levels were correlated 2 by 2, after log-transformation with Pearson's cross-correlation. Concordance was calculated with kappa coefficient (k). Median total fungal loads (TFLs) sampled by the 3 outdoor HTSTs were 3,025.0, 3,287.5 and 3,625.0 particles/m(3) (P = 0.6, 0.6 and 0.3). -Concordance between Aspergillaceae fungal loads (AFLs, including Aspergillus spp. + Penicillium spp.) was low (k = 0.2). A low positive correlation was found between TFLs sampled with outdoor HTST and indoor HTST with applying a 4-hour time lag, r = 0.30, 95% CI (0.23-0.43), P<0.001. In indoor air, Aspergillus spp. were detected by the viable impaction sampler on 63.1% of the samples, whereas AFLs were found by HTST-I on only 3.6% of the samples. Concordance between Aspergillus spp. loads and AFLs sampled with the 2 methods was very low (k = 0.1). This study showed a 4-hour time lag between increase of outdoor and indoor TFLs, possibly due to insulation and aeraulic flow of the building. Outdoor HTSTs may permit to quickly identify (after 48 hours) time periods with high outdoor fungal loads. An identified drawback is that a too low sample area read did not seem to enable detection of Aspergillaceae spores efficiently. Indoor HTSTs may not be recommended at this time, and outdoor HTSTs need further study. Air sampling by viable impaction sampler remains the reference tool for quantifying fungal contamination of indoor air in hospitals.	[Dananche, Cedric; Loeffert, Sophie Tiphaine; Benet, Thomas; Vanhems, Philippe] Hosp Civils Lyon, Grp Hosp Ctr, Unite Hyg Epidemiol & Prevent, Lyon, France; [Dananche, Cedric; Gustin, Marie-Paule; Loeffert, Sophie Tiphaine; Benet, Thomas; Vanhems, Philippe] ENS Lyon, CNRS, UMR5308, Inserm U1111,CIRI,Lab Pathogenes Emergents,Fdn Me, Lyon, France; [Gustin, Marie-Paule] Univ Claude Bernard Lyon 1, Fac Pharm, ISPB, Dept Sante Publ, Villeurbanne, France; [Cassier, Pierre] Hosp Civils Lyon, Grp Hosp Ctr, Lab Biol Securite Environm, Lyon, France; [Thibaudon, Michel] European Aerobiol Soc, Brussieu, France; [Thibaudon, Michel] Reseau Natl Surveillance Aerobiol, Brussieu, France	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Dananche, C (corresponding author), Hosp Civils Lyon, Grp Hosp Ctr, Unite Hyg Epidemiol & Prevent, Lyon, France.; Dananche, C (corresponding author), ENS Lyon, CNRS, UMR5308, Inserm U1111,CIRI,Lab Pathogenes Emergents,Fdn Me, Lyon, France.	cedric.dananche@chu-lyon.fr		Dananche, Cedric/0000-0002-0791-6391				Araujo Ricardo, 2010, Air Quality, P357; Bouza E, 2002, J HOSP INFECT, V52, P234, DOI 10.1053/jhin.2002.1316; Cabral JPS, 2010, SCI TOTAL ENVIRON, V408, P4285, DOI 10.1016/j.scitotenv.2010.07.005; Chang CC, 2008, INTERN MED J, V38, P538, DOI 10.1111/j.1445-5994.2008.01727.x; Cheng SM, 2001, AM J INFECT CONTROL, V29, P321, DOI 10.1067/mic.2001.118410; European Committee for Standardization, 168682015 CENTS; Fernandez-Rodriguez S, 2014, FUNGAL ECOL, V7, P16, DOI 10.1016/j.funeco.2013.11.004; HIRST JM, 1952, ANN APPL BIOL, V39, P257, DOI 10.1111/j.1744-7348.1952.tb00904.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Lacey M.E., 2007, AIR SPORA MANUAL CAT; Levetin E, 2004, CURR ALLERGY ASTHM R, V4, P376, DOI 10.1007/s11882-004-0088-z; Munoz P, 2001, CLIN MICROBIOL INFEC, V7, P38, DOI 10.1111/j.1469-0691.2001.tb00008.x; Nesa D, 2001, J HOSP INFECT, V47, P149, DOI 10.1053/jhin.2000.0883; Sehulster Lynne, 2003, MMWR Recomm Rep, V52, P1; Stern MA, 1999, INDOOR BUILT ENVIRON, V8, P40, DOI 10.1177/1420326X9900800104; STREIFEL AJ, 1983, APPL ENVIRON MICROB, V46, P375, DOI 10.1128/AEM.46.2.375-378.1983	16	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177263	10.1371/journal.pone.0177263	http://dx.doi.org/10.1371/journal.pone.0177263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486534	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000066
J	Karadagi, A; Johansson, H; Zemack, H; Salipalli, S; Mork, LM; Kannisto, K; Jorns, C; Gramignoli, R; Strom, S; Stokkeland, K; Ericzon, BG; Jonigk, D; Janciauskiene, S; Nowak, G; Ellis, ECS				Karadagi, Ahmad; Johansson, Helene; Zemack, Helen; Salipalli, Sandeep; Mork, Lisa-Mari; Kannisto, Kristina; Jorns, Carl; Gramignoli, Roberto; Strom, Stephen; Stokkeland, Knut; Ericzon, Bo-Goran; Jonigk, Danny; Janciauskiene, Sabina; Nowak, Greg; Ellis, Ewa C. S.			Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expression	PLOS ONE			English	Article							LIVER-DISEASE; HEPATOCYTE TRANSPLANTATION; DEFICIENCY; ADULTS; MICE; RNA	The main goal of the therapy with purified human plasma alpha1-antitrypsin (A1AT) is to increase A1AT levels and to prevent lungs from elastolytic activity in patients with PiZZ (Glu(342)Lys) A1AT deficiency-related emphysema. Potential hepatic gains of this therapy are unknown. Herein, we investigated the effect of A1AT therapy on SERPINA1 (gene encoding A1AT) expression. The expression of SERPINA1 was determined in A1AT or A1AT plus Oncostatin M (OSM) treated primary human hepatocytes isolated from liver tissues from A1AT deficient patients and control liver tissues. In addition, SERPINA1 mRNA was assessed in lung tissues from PiZZ emphysema patients with and without A1AT therapy, and in adherent human peripheral blood mononuclear cells (PBMC) isolated from healthy PiMM donors. In a dose-dependent manner purified A1AT lowered SERPINA1 expression in hepatocytes. This latter effect was more prominent in hepatocytes stimulated with OSM. Although it did not reach statistical significance (P = 0.0539)-analysis of lung tissues showed lower SERPINA1 expression in PiZZ emphysema patients receiving augmentation therapy relative to those without therapy. Finally, exogenously added purified A1AT (1mg/ml) reduced SERPINA1 expression in naive as well as in lipopolysaccharide (LPS)-stimulated human adherent PBMCs. Exogenous A1AT protein reduces its own endogenous expression. Hence, augmentation with native M-A1AT protein and a parallel reduction in expression of dysfunctional mutant Z-A1AT may be beneficial for PiZZ liver, and this motivates further studies.	[Karadagi, Ahmad; Johansson, Helene; Zemack, Helen; Mork, Lisa-Mari; Jorns, Carl; Ericzon, Bo-Goran; Nowak, Greg; Ellis, Ewa C. S.] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Div Transplantat Surg, Stockholm, Sweden; [Salipalli, Sandeep; Janciauskiene, Sabina] Hannover Med Sch, German Ctr Lung Res DZL, Dept Resp Med, Res Endstage & Obstruct Lung Dis Hannover BREATH, Hannover, Germany; [Kannisto, Kristina; Gramignoli, Roberto; Strom, Stephen] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden; [Stokkeland, Knut] Visby Hosp, Dept Med, Visby, Sweden; [Stokkeland, Knut] Karolinska Inst, Dept Med, Gastroenterol & Hepatol Unit, Stockholm, Sweden; [Jonigk, Danny] Hannover Med Sch, Inst Pathol, Hannover, Germany	Karolinska Institutet; Karolinska University Hospital; Hannover Medical School; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Hannover Medical School	Ellis, ECS (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Div Transplantat Surg, Stockholm, Sweden.	ewa.ellis@ki.se	Jorns, Carl/AAE-6925-2021; gramignoli, roberto/AAD-8669-2019; Ellis, Ewa C S/D-5370-2014; Johansson, Helene/AGR-5090-2022; Ericzon, Bo-Goran/AAH-5328-2020; Gramignoli, Roberto/AAK-5387-2020	Jorns, Carl/0000-0001-7727-8113; Ellis, Ewa C S/0000-0002-3057-5337; Gramignoli, Roberto/0000-0003-3362-4170; Johansson, Helene/0000-0001-5519-0401; Karadagi, Ahmad/0000-0002-1360-938X	Swedish research council; German Center for Lung Research (DZL); Stockholm county council; ALF; Treatments of the future	Swedish research council(Swedish Research CouncilEuropean Commission); German Center for Lung Research (DZL); Stockholm county council(Stockholm County Council); ALF; Treatments of the future	This work was supported by the Swedish research council (Vetenskapsradet), Project research grant - Treatments of the future, E. Ellis 2013-2015 and by the German Center for Lung Research (DZL), S. Janciauskiene and D. Jonigk. It was also supported by Stockholm county council (Stockholms Lans Landsting), ALF 2015, E. Ellis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal N, 2016, AM J RESP CRIT CARE, V193, P1065, DOI 10.1164/rccm.201510-2062LE; Amer Thoracic Soc European Respir, 2003, AM J RESP CRIT CARE, V168, P818, DOI 10.1164/rccm.168.7.818; Bartels CL, 2009, AM J TRANSL RES, V1, P406; BERG NO, 1972, NEW ENGL J MED, V287, P1264, DOI 10.1056/NEJM197212212872502; Carey EJ, 2013, LIVER TRANSPLANT, V19, P1370, DOI 10.1002/lt.23744; CRYSTAL RG, 1990, J CLIN INVEST, V85, P1343, DOI 10.1172/JCI114578; ERIKSSON S, 1987, ACTA MED SCAND, V221, P461; Frenzel E, 2014, J IMMUNOL, V192, P5354, DOI 10.4049/jimmunol.1400378; Gramignoli R, 2012, CELL TRANSPLANT, V21, P1245, DOI 10.3727/096368911X600939; Izykowski N, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0933-6; Jedicke N, 2014, HEPATOLOGY, V59, P2299, DOI 10.1002/hep.27024; Jonigk D, 2011, METHODS MOL BIOL, V755, P67, DOI 10.1007/978-1-61779-163-5_5; Jonigk D, 2011, AM J PATHOL, V178, P599, DOI 10.1016/j.ajpath.2010.10.032; Jorns C, 2012, J INTERN MED, V272, P201, DOI 10.1111/j.1365-2796.2012.02574.x; Kleinman H K, 2001, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1002s00; LARSSON C, 1978, ACTA MED SCAND, V204, P345, DOI 10.1111/j.0954-6820.1978.tb08452.x; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Nguyen TM, 2012, J LIPID RES, V53, P1598, DOI 10.1194/jlr.M026823; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Piitulainen E, 2003, EUR J CLIN PHARMACOL, V59, P151, DOI 10.1007/s00228-003-0589-z; Rudnick DA, 2004, HEPATOLOGY, V39, P1048, DOI 10.1002/hep.20118; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; Strom SC, 1997, TRANSPLANTATION, V63, P559, DOI 10.1097/00007890-199702270-00014; Sveger T., 1976, N ENGL J MED; Teckman JH, 2015, EXPERT REV GASTROENT, V9, P261, DOI 10.1586/17474124.2014.943187; Theophile K, 2008, DIAGN MOL PATHOL, V17, P101, DOI 10.1097/PDM.0b013e318163f26e	26	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177279	10.1371/journal.pone.0177279	http://dx.doi.org/10.1371/journal.pone.0177279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486562	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314000070
J	Liu, W; Wang, HL; Zhu, B; Yin, CQ; Chen, SY; Li, J; Yu, XA; Azietaku, JT; An, MR; Gao, XM; Chang, YX				Liu, Wei; Wang, Huilin; Zhu, Bo; Yin, Chengqian; Chen, Shuyang; Li, Jin; Yu, Xie-an; Azietaku, John Teye; An, Mingrui; Gao, Xiu-mei; Chang, Yan-xu			An activity-integrated strategy of the identification, screening and determination of potential neuraminidase inhibitors from Radix Scutellariae	PLOS ONE			English	Article							BAICALENSIS GEORGI; MASS-SPECTROMETRY; INFLUENZA; VIRUS; FLAVONOIDS; RHABDOMYOSARCOMA; INFECTION; BARBATA	Small molecules isolated from herbal medicines (HMs) were identified as the potential neuraminidase inhibitors which are effective in influenza prevention and treatment. Unfortunately, current available screen methods of small molecules isolated from HMs are inefficient and insensitive. Here a novel Ultra Performance Liquid Chromatography coupled with diode-array detectors and auto-fraction collector / time-of-flight mass spectrometry (UPLC-DAD-FC/Q-TOF-MS) screening method with high efficiency was developed and validated to separate, collect, enrich, identify and quantify potential neuraminidase inhibitors from Radix Scutellariae. The results showed that 26 components with neuraminidase inhibitory activity were identified from Radix Scutellariae extracts. It was also found that the influence of origins on the quality of RS was more than that of cultivated time on the basis of the concentration of the effective components. These results brought novel insights into quality evaluation of Radix Scutellariae. It was demonstrated that new activity-integrated strategy was a suitable technique for the identification, screening and determination of potential neuraminidase inhibitors in herbal medicine and will provide novel potential strategies in other drug screening from herbal medicine.	[Liu, Wei; Wang, Huilin; Li, Jin; Yu, Xie-an; Azietaku, John Teye; Gao, Xiu-mei; Chang, Yan-xu] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Liu, Wei; Wang, Huilin; Li, Jin; Yu, Xie-an; Azietaku, John Teye; Gao, Xiu-mei; Chang, Yan-xu] Tianjin Univ Tradit Chinese Med, Tianjin Key Lab Phytochem & Pharmaceut Anal, Tianjin, Peoples R China; [Zhu, Bo; Yin, Chengqian; Chen, Shuyang] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [An, Mingrui] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine; Boston University; University of Michigan System; University of Michigan	Gao, XM; Chang, YX (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China.; Gao, XM; Chang, YX (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin Key Lab Phytochem & Pharmaceut Anal, Tianjin, Peoples R China.	gaoxiumei@tjutcm.edu.cn; Tcmcyx@126.com	Liu, Wei/E-8826-2018	Liu, Wei/0000-0003-1792-6048; Yin, Chengqian/0000-0003-4247-6245; Yu, Xie-an/0000-0003-2918-7369; Li, Jin/0000-0003-3094-4777	National Natural Science Foundation of China [81374050]; National Science and Technology Support Program Projects [2014BA105B01]; PCSIRT [IRT-14R41]; State the Science & Technology Commission of MOST of China [2014ZX09304307001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program Projects; PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); State the Science & Technology Commission of MOST of China	This research was supported by National Natural Science Foundation of China (81374050), National Science and Technology Support Program Projects (2014BA105B01), and PCSIRT (IRT-14R41) and State the Science & Technology Commission of MOST of China (2014ZX09304307001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2015, ANTIVIR RES, V114, P57, DOI 10.1016/j.antiviral.2014.12.006; Apea-Bah FB, 2009, J MED PLANTS RES, V3, P736; Cuong TD, 2015, BIOORG MED CHEM LETT, V25, P1129, DOI 10.1016/j.bmcl.2014.12.055; Dai ZJ, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-150; Guo Shan-shan, 2009, Yaoxue Xuebao, V44, P1348; Han J, 2007, J CHROMATOGR B, V848, P355, DOI 10.1016/j.jchromb.2006.10.061; He HZ, 2012, J PHARMACEUT BIOMED, V62, P196, DOI 10.1016/j.jpba.2011.12.025; Hour MJ, 2013, ALTERN MED, V2013, P1; Huang S. H., 2015, J MICROBIOL IMMUNOL; Liu GZ, 2009, J CHROMATOGR A, V1216, P4809, DOI 10.1016/j.chroma.2009.04.021; Lohani M, 2013, NAT PROD COMMUN, V8, P1415; Lu XH, 2014, VIROLOGY, V454, P169, DOI 10.1016/j.virol.2014.02.011; Nakano T, 2014, J INFECT CHEMOTHER, V20, P401, DOI 10.1016/j.jiac.2014.01.012; Patel M, 2013, J GENE MED, V15, P51, DOI 10.1002/jgm.2695; Rakers C, 2014, BIOORG MED CHEM LETT, V24, P4312, DOI 10.1016/j.bmcl.2014.07.010; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Seo ON, 2013, J FUNCT FOODS, V5, P1741, DOI 10.1016/j.jff.2013.07.020; Tian L, 2011, J ETHNOPHARMACOL, V137, P534, DOI 10.1016/j.jep.2011.06.002; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wang HL, 2013, J CHROMATOGR A, V1315, P107, DOI 10.1016/j.chroma.2013.09.052; Yi T, 2015, LWT-FOOD SCI TECHNOL, V62, P194, DOI 10.1016/j.lwt.2015.01.003; Zhang ML, 2015, J BIOL CHEM, V290, P310, DOI 10.1074/jbc.M114.606277; Zhu B, 2016, ONCOGENE, V35, P4212, DOI 10.1038/onc.2015.486; Zhu B, 2015, BRIT J CANCER, V112, P227, DOI 10.1038/bjc.2014.471; Zhu HY, 2015, ANTIVIR RES, V113, P62, DOI 10.1016/j.antiviral.2014.11.003	25	4	5	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0175751	10.1371/journal.pone.0175751	http://dx.doi.org/10.1371/journal.pone.0175751			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486473	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000005
J	Powers, AK; Davis, EM; Kaplan, SA; Gross, JB				Powers, Amanda K.; Davis, Erin M.; Kaplan, Shane A.; Gross, Joshua B.			Cranial asymmetry arises later in the life history of the blind Mexican cavefish, Astyanax mexicanus	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; GEOMETRIC MORPHOMETRICS; FACIAL ATTRACTIVENESS; SEXUAL SELECTION; MICRO-CT; EVOLUTION; FISH; HANDEDNESS; ZEBRAFISH; SYMMETRY	As a consequence of adaptation to the cave environment, the blind Mexican cavefish, Astyanax mexicanus, has evolved several cranial aberrations including changes to bone sizes, shapes and presence of numerous lateral asymmetries. Prior studies of cranial asymmetry in cavefish focused strictly on adult specimens. Thus, the extent to which these asymmetries emerge in adulthood, or earlier in the life history of cavefish, was unknown. We performed a geometric morphometric analysis of shape variation in the chondrocranium and osteocranium across life history in two distinct cavefish populations and surface-dwelling fish. The cartilaginous skull in juveniles was bilaterally symmetric and chondrocranial shape was conserved in all three populations. In contrast, bony skull shapes segregated into significantly distinct groups in adults. Cavefish demonstrated significant asymmetry for the bones surrounding the collapsed eye orbit, and the opercle bone posterior to the eye orbit. Interestingly, we discovered that cavefish also exhibit directional "bends" in skull shape, almost always biased to the left. In sum, this work reveals that asymmetric craniofacial aberrations emerge later in the cavefish life history. These abnormalities may mirror asymmetries in the lateral line sensory system, reflect a 'handedness' in cavefish swimming behavior, or evolve through neutral processes.	[Powers, Amanda K.; Davis, Erin M.; Kaplan, Shane A.; Gross, Joshua B.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati	Gross, JB (corresponding author), Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45220 USA.	grossja@ucmail.uc.edu		Gross, Joshua/0000-0002-0032-1053	US National Institute of Health [NIDCR R01-DE025033]; US National Science Foundation [DEB-1457630]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025033] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was funded by the US National Institute of Health (NIDCR R01-DE025033) and the US National Science Foundation (DEB-1457630) awarded to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2007, DEVELOPMENT, V134, P3133, DOI 10.1242/dev.002709; Alvarez J., 1947, SLP Rev Soc Mexicana Hist nat, V8, P215; Alvarez J., 1946, AN ESCUELA NATION CIENC BIOL MEXICO, V4, P263; Atukorala ADS, 2015, BIOL MEXICAN CAVEFIS, P208; Bandyopadhyay PR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01128; Cardini A, 2007, ZOOMORPHOLOGY, V126, P121, DOI 10.1007/s00435-007-0036-2; Cashmore L, 2008, J ANTHROPOL SCI, V86, P7; Coombs S., 1989, MECHANOSENSORY LATER, P3, DOI DOI 10.1007/978-1-4612-3560-6_1; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Dufton M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050308; Finnerty JR, 2003, INT J DEV BIOL, V47, P523; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Griscom L., 1937, MONOGRAPHIC STUDY RE; Gross JB, 2016, SYMMETRY-BASEL, V8, DOI 10.3390/sym8110118; Gross JB, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0716-y; Gross JB, 2016, BIOLOGY AND EVOLUTION OF THE MEXICAN CAVEFISH, P193, DOI 10.1016/B978-0-12-802148-4.00010-4; Gross JB, 2014, GENETICS, V196, P1303, DOI 10.1534/genetics.114.161661; Gross JB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-105; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hernandez LP, 2002, INTEGR COMP BIOL, V42, P222, DOI 10.1093/icb/42.2.222; Hinaux H, 2011, ZEBRAFISH, V8, P155, DOI 10.1089/zeb.2011.0713; Holdsworth DW, 2002, TRENDS BIOTECHNOL, V20, pS34, DOI 10.1016/S0167-7799(02)02004-8; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; Jamniczky HA, 2015, EVOL BIOL, V42, P260, DOI 10.1007/s11692-015-9318-7; Jeffery WR, 2009, ANNU REV GENET, V43, P25, DOI 10.1146/annurev-genet-102108-134216; Jeffery WR, 2001, DEV BIOL, V231, P1, DOI 10.1006/dbio.2000.0121; JOLLIE M, 1975, J MORPHOL, V147, P61, DOI 10.1002/jmor.1051470106; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; Kimmel CB, 2003, DEVELOPMENT, V130, P1339, DOI 10.1242/dev.00338; Klingenberg CP, 2015, SYMMETRY-BASEL, V7, P843, DOI 10.3390/sym7020843; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Kowalko JE, 2013, P NATL ACAD SCI USA, V110, P16933, DOI 10.1073/pnas.1317192110; Levy J, 1977, Ann N Y Acad Sci, V299, P264, DOI 10.1111/j.1749-6632.1977.tb41913.x; Mitchell R.W., 1977, MEXICAN EYELESS CHAR; MOLLER AP, 1994, EVOLUTION, V48, P658, DOI 10.2307/2410476; Morgan TH, 1923, AM NAT, V57, P269, DOI 10.1086/279921; NORBERG RA, 1978, PHILOS T R SOC B, V282, P325, DOI 10.1098/rstb.1978.0014; Oest ME, 2008, BIRTH DEFECTS RES B, V83, P582, DOI 10.1002/bdrb.20177; Piotrowski T, 1996, DEVELOPMENT, V123, P345; Potthoff T., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P35; Pouilly M, 2003, J FISH BIOL, V63, P490, DOI 10.1046/j.1095-8649.2003.00171.x; Powder KE, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0020-8; Reboleira ASPS, 2012, ZOOTAXA, P33; Retaux S, 2016, BIOLOGY AND EVOLUTION OF THE MEXICAN CAVEFISH, P227, DOI 10.1016/B978-0-12-802148-4.00012-8; Savriama Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-280; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Schemmel C., 1980, ETHOLOGY, V53, P9; SCHEMMEL CHRISTIAN, 1967, Z MORPHOL TIERE, V61, P255, DOI 10.1007/BF00400988; SCHILLING TF, 1994, DEVELOPMENT, V120, P483; Sharma S, 2009, J COMP PHYSIOL A, V195, P225, DOI 10.1007/s00359-008-0400-9; Smith DR, 1997, J EVOLUTION BIOL, V10, P551; Speder P, 2007, CURR OPIN GENET DEV, V17, P351, DOI 10.1016/j.gde.2007.05.008; Stewart TA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-8; TEYKE T, 1990, BRAIN BEHAV EVOLUT, V35, P23, DOI 10.1159/000115853; Thomas F, 1998, CAN J ZOOL, V76, P931, DOI 10.1139/cjz-76-5-931; Tokita M, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2015.0481; Tomkins JL, 2002, ELS; Valdez-Moreno ME, 2003, P BIOL SOC WASH, V116, P341; Wilkens H, 2001, ENVIRON BIOL FISH, V62, P251, DOI 10.1023/A:1011897805681; Windsor SP., 2014, FLOW SENSING AIR WAT, P103, DOI 10.1007/978-3-642-41446-6_4; XIA Y, 1994, MAGNET RESON MED, V31, P273, DOI 10.1002/mrm.1910310306; Yamamato Y., 2015, BIOL MEXICAN CAVEFIS, P175; Yamamoto Y, 2003, EVOL DEV, V5, P435, DOI 10.1046/j.1525-142X.2003.03050.x; Yoshizawa M, 2010, CURR BIOL, V20, P1631, DOI 10.1016/j.cub.2010.07.017; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	67	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177419	10.1371/journal.pone.0177419	http://dx.doi.org/10.1371/journal.pone.0177419			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486546	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000079
J	Dantas, RCC; Silva, RTE; Ferreira, ML; Goncalves, IR; Araujo, BF; de Campos, PA; Royer, S; Batistao, DWD; Gontijo, PP; Ribas, RM				Cavalcanti Dantas, Raquel Cristina; Tavares e Silva, Rebecca; Ferreira, Melina Lorraine; Goncalves, Iara Rossi; Araujo, Bruna Fuga; de Campos, Paola Amaral; Royer, Sabrina; da Fonseca Batistao, Deivid William; Gontijo-Filho, Paulo Pinto; Ribas, Rosineide Marques			Molecular epidemiological survey of bacteremia by multidrug resistant Pseudomonas aeruginosa: the relevance of intrinsic resistance mechanisms	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; INTENSIVE-CARE-UNIT; CARBAPENEM-RESISTANCE; ANTIMICROBIAL RESISTANCE; RISK-FACTORS; EFFLUX PUMPS; INFECTIONS; OUTBREAK; SURVEILLANCE; ANTIBIOTICS	The bacterial factors associated with bacteremia by multidrug-resistant and extensively drug-resistant P. aeruginosa, including overexpression of efflux pumps, AmpC overproduction, and loss/alteration of the OprD porin in isolates that are non-Metallo-beta-Lactamase producing were analyzed in a retrospective study. Molecular analyses included strain typing by Pulsed Field Gel Electrophoresis and identification of key genes via qualitative and quantitative PCR-based assays. Previous use of carbapenems and tracheostomy was independently associated with the development of bacteremia by extensively drug-resistant and multidrug-resistant strains of P. aeruginosa. A high consumption of antimicrobials was observed, and 75.0% of the isolates contained amplicons with the bla(SPM-1) and bla(VIM) genes. Of the 47 non-Metallo-beta-Lactamase isolates, none had another type of carbapenemase. However, the isolates exhibited high rates of hyperproduction of AmpC, loss of the OprD porin (71.4%) and the presence of MexABOprM (57.1%) and MexXY (64.3%). This study suggests that in non-Metallo-beta-Lactamase isolates, the association of intrinsic resistance mechanisms could contributes to the expression of multidrug-resistant/extensively drug-resistant phenotypes.	[Cavalcanti Dantas, Raquel Cristina; Ferreira, Melina Lorraine; Goncalves, Iara Rossi; Araujo, Bruna Fuga; de Campos, Paola Amaral; Royer, Sabrina; Gontijo-Filho, Paulo Pinto; Ribas, Rosineide Marques] Univ Fed Uberlandia, Lab Mol Microbiol, Inst Biomed Sci, Uberlandia, MG, Brazil; [Tavares e Silva, Rebecca] Univ Fed Uberlandia, Lab Trypanosomatids Mol Biol, Inst Biomed Sci, Uberlandia, MG, Brazil; [da Fonseca Batistao, Deivid William] Univ Fed Uberlandia, Sch Med, Uberlandia, MG, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia	Dantas, RCC (corresponding author), Univ Fed Uberlandia, Lab Mol Microbiol, Inst Biomed Sci, Uberlandia, MG, Brazil.	raquelc.dantas@hotmail.com	Goncalves, Iara/GRO-4035-2022; ribas, Rosineide m/D-2461-2018; Batistão, Deivid William da Fonseca/V-7770-2018; Gonçalves, Iara Rossi/AAJ-6326-2020	ribas, Rosineide m/0000-0001-9295-6832; Batistão, Deivid William da Fonseca/0000-0002-4928-3473; Gonçalves, Iara Rossi/0000-0001-5594-7099; Campos, Paola Amaral de/0000-0001-9384-7582; Dantas, Raquel/0000-0002-4605-1773	FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We thank FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) for the financial support and scholarships.	Cortes JA, 2009, BRAZ J INFECT DIS, V13, P99, DOI 10.1590/S1413-86702009000200005; Alhazmi A, 2015, INT J BIOL, P7; Arakawa Y, 2000, J CLIN MICROBIOL, V38, P40; Askoura M, 2011, LIBYAN J MED, V6, DOI 10.3402/ljm.v6i0.5870; Bonomo RA, 2006, CLIN INFECT DIS, V43, pS49, DOI 10.1086/504477; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Cezario RC, 2009, ENFERM INFEC MICR CL, V27, P269, DOI 10.1016/j.eimc.2008.09.009; Cholley P, 2011, J CLIN MICROBIOL, V49, P2578, DOI 10.1128/JCM.00102-11; Climaco E., 2011, THESIS; Clinical and Laboratory Standards Institute, 2022, PERFORMANCE STANDARD; Clinical and Laboratory Standards Institute (CLSI), 2010, M100S20 CLSI; CLSI, 2009, M100S19 CLSI; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dunne WM, 2005, J CLIN MICROBIOL, V43, P5945, DOI 10.1128/JCM.43.12.5945-5949.2005; Furtado GHC, 2007, INT J ANTIMICROB AG, V30, P315, DOI 10.1016/j.ijantimicag.2007.05.017; Fuste E, 2013, J MED MICROBIOL, V62, P1317, DOI 10.1099/jmm.0.058354-0; Gales AC, 2003, J ANTIMICROB CHEMOTH, V52, P699, DOI 10.1093/jac/dkg416; Gales AC, 2012, DIAGN MICR INFEC DIS, V73, P354, DOI 10.1016/j.diagmicrobio.2012.04.007; Galetti R., THESIS, P49; Franco MRG, 2010, CLINICS, V65, P825, DOI 10.1590/S1807-59322010000900002; Gulen TA, 2015, INT J INFECT DIS, V38, P32, DOI [10.1016/j.ijid.2015.06.014, 10.1016/j.ijid.2015.06.01]; Haak H, 2010, ANTIMICROBIAL RESISTANCE IN DEVELOPING COUNTRIES, P283, DOI 10.1007/978-0-387-89370-9_16; Khuntayaporn P, 2013, MICROBIOL IMMUNOL, V57, P170, DOI 10.1111/1348-0421.12021; Laupland KB, 2005, J INFECT DIS, V192, P1606, DOI 10.1086/444469; Lee Y, 2012, INT J ANTIMICROB AG, V40, P168, DOI 10.1016/j.ijantimicag.2012.04.004; Lemmen SW, 2000, INFECTION, V28, P384, DOI 10.1007/s150100070010; Lepper PM, 2002, ANTIMICROB AGENTS CH, V46, P2920, DOI 10.1128/AAC.46.9.2920-2925.2002; Levin AS, 1999, CLIN INFECT DIS, V28, P1008, DOI 10.1086/514732; Lister Philip D, 2002, Am J Pharmacogenomics, V2, P235, DOI 10.2165/00129785-200202040-00003; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Liu QQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11715; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Livermore DM, 2001, J ANTIMICROB CHEMOTH, V47, P247, DOI 10.1093/jac/47.3.247; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Meyer E, 2003, INFECTION, V31, P208, DOI 10.1007/s15010-003-3201-7; Moreira MR, 2013, REV SOC BRAS MED TRO, V46, P39, DOI 10.1590/0037-868216722013; Neves PR, 2008, 11 C BRAS CONTR INF, V12, P30; Neves PR, 2010, THESIS; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Olmsted R. N., 1996, APIC INFECT CONTROL, pA1; Pai H, 2001, ANTIMICROB AGENTS CH, V45, P480, DOI 10.1128/AAC.45.2.480-484.2001; Pereira de Cassia, 2013, THESIS; Goncalves DCPS, 2009, REV SOC BRAS MED TRO, V42, P411, DOI 10.1590/S0037-86822009000400010; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porto JP, 2013, REV SOC BRAS MED TRO, V46, P713, DOI 10.1590/0037-8682-0199-2013; Porto JP, 2012, REV SOC BRAS MED TRO, V45, P475, DOI 10.1590/S0037-86822012005000003; Quale J, 2006, ANTIMICROB AGENTS CH, V50, P1633, DOI 10.1128/AAC.50.5.1633-1641.2006; Sader H S, 2001, Braz J Infect Dis, V5, P200; Sader HS, 2005, CLIN MICROBIOL INFEC, V11, P73, DOI 10.1111/j.1469-0691.2004.01031.x; Samonis G, 2014, INFECTION, V42, P721, DOI 10.1007/s15010-014-0635-z; Santos KV, 2011, J CHEMOTHERAPY, V23, P135, DOI 10.1179/joc.2011.23.3.135; Tacconelli E, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12427; Tuon FF, 2012, BRAZ J INFECT DIS, V16, P351, DOI 10.1016/j.bjid.2012.06.009; Van der Bij AK, 2012, CLIN MICROBIOL INFEC, V18, pE369, DOI 10.1111/j.1469-0691.2012.03969.x; Van der Bij AK, 2011, INT J ANTIMICROB AG, V37, P513, DOI 10.1016/j.ijantimicag.2011.02.010; Vitkauskiene A, 2010, MEDICINA-LITHUANIA, V46, P490, DOI 10.3390/medicina46070071; WHO, 2015, ANT RES; WHO, 2000, COLL CTR DRUGS STAT; Woodford N, 2010, METHODS MOL BIOL, V642, P181, DOI 10.1007/978-1-60327-279-7_14; Xavier DE, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-217; Zavascki AP, 2004, INFECT CONT HOSP EP, V25, P805, DOI 10.1086/503487	63	19	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176774	10.1371/journal.pone.0176774	http://dx.doi.org/10.1371/journal.pone.0176774			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481953	Green Published, Green Submitted, gold			2022-12-27	WOS:000401313700016
J	Palumbo, PJ; Wilson, EA; Piwowar-Manning, E; McCauley, M; Gamble, T; Kumwenda, N; Makhema, J; Kumarasamy, N; Chariyalertsak, S; Hakim, JG; Hosseinipour, MC; Melo, MG; Godbole, SV; Pilotto, JH; Grinsztejn, B; Panchia, R; Chen, YQ; Cohen, MS; Eshleman, SH; Fogel, JM				Palumbo, Philip J.; Wilson, Ethan A.; Piwowar-Manning, Estelle; McCauley, Marybeth; Gamble, Theresa; Kumwenda, Newton; Makhema, Joseph; Kumarasamy, Nagalingeswaran; Chariyalertsak, Suwat; Hakim, James G.; Hosseinipour, Mina C.; Melo, Marineide G.; Godbole, Sheela V.; Pilotto, Jose H.; Grinsztejn, Beatriz; Panchia, Ravindre; Chen, Ying Q.; Cohen, Myron S.; Eshleman, Susan H.; Fogel, Jessica M.			Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052	PLOS ONE			English	Article							RESOLUTION MELTING ASSAY; ENV GENE; EVOLUTION; PREVENTION; INFECTION; RATES	Higher HIV diversity has been associated with virologic outcomes in children on antiretroviral treatment (ART). We examined the association of HIV diversity with virologic outcomes in adults from the HPTN 052 trial who initiated ART at CD4 cell counts of 350-550 cells/mm(3). A high resolution melting (HRM) assay was used to analyze baseline (pre-treatment) HIV diversity in six regions in the HIV genome (two in gag, one in pol, and three in env) from 95 participants who failed ART. We analyzed the association of HIV diversity in each genomic region with baseline (pre-treatment) factors and three clinical outcomes: time to virologic suppression after ART initiation, time to ART failure, and emergence of HIV drug resistance at ART failure. After correcting for multiple comparisons, we did not find any association of baseline HIV diversity with demographic, laboratory, or clinical characteristics. For the 18 analyses performed for clinical outcomes evaluated, there was only one significant association: higher baseline HIV diversity in one of the three HIV env regions was associated with longer time to ART failure (p = 0.008). The HRM diversity assay may be useful in future studies exploring the relationship between HIV diversity and clinical outcomes in individuals with HIV infection.	[Palumbo, Philip J.; Piwowar-Manning, Estelle; Eshleman, Susan H.; Fogel, Jessica M.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Wilson, Ethan A.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [McCauley, Marybeth] FHI 360, Sci Facilitat Dept, Washington, DC USA; [Gamble, Theresa] FHI 360, Sci Facilitat Dept, Durham, NC USA; [Kumwenda, Newton] Johns Hopkins Project, Coll Med, Blantyre, Malawi; [Makhema, Joseph] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Kumarasamy, Nagalingeswaran] VHS, YRGCARE Med Ctr, CART CRS, Madras, Tamil Nadu, India; [Chariyalertsak, Suwat] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand; [Hakim, James G.] Univ Zimbabwe, Dept Med, Harare, Zimbabwe; [Hosseinipour, Mina C.] Univ North Carolina Chapel Hill, Div Infect Dis, Chapel Hill, NC USA; [Hosseinipour, Mina C.] UNC Project Malawi, Inst Global Hlth & Infect Dis, Lilongwe, Malawi; [Melo, Marineide G.] Hosp Nossa Senhora Conceicao, Serv Infectol, Porto Alegre, RS, Brazil; [Godbole, Sheela V.] Natl AIDS Res Inst ICMR, Pune, Maharashtra, India; [Pilotto, Jose H.] Hosp Geral Nova Iguacu, Rio De Janeiro, Brazil; [Pilotto, Jose H.] Fiocruz MS, Lab AIDS Imunol Mol IOC, Rio De Janeiro, Brazil; [Grinsztejn, Beatriz] Fiocruz MS, Inst Nacl Infectol Evandro Chagas INI, Rio De Janeiro, Brazil; [Panchia, Ravindre] Univ Witwatersrand, Perinatal HIV Res Unit, Soweto HPTN CRS, Soweto, South Africa; [Chen, Ying Q.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Cohen, Myron S.] Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC USA	Johns Hopkins University; Fred Hutchinson Cancer Center; FHI 360; University of Malawi; Botswana-Harvard AIDS Institute Partnership; Chiang Mai University; University of Zimbabwe; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; University of Witwatersrand; Fred Hutchinson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Eshleman, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	seshlem@jhmi.edu	Kumwenda, Newton/ADL-6890-2022; Godbole, Sheela/K-4177-2017; Godbole, Sheela/ABG-4942-2020; Pilotto, Jose Henrique/AAD-9773-2019; Kumarasasmy, Nagalingeswaran/AAB-7348-2021	Pilotto, Jose Henrique/0000-0003-0521-8597; Godbole, Sheela/0000-0001-6537-9064; Chen, Ying Qing/0000-0002-2726-3391; Palumbo, Philip/0000-0002-6394-6878; Kumwenda, Newton/0000-0003-2622-4339	Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases (NIAID); Office of AIDS Research of the U.S. National Institutes of Health (NIH) [UM1-AI068613, UM1-AI068617, UM1-AI068619]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069436, UM1AI069456, UM1AI068613, UM1AI069476, UM1AI069432, UM1AI069453, UM1AI069399, UM1AI069423] Funding Source: NIH RePORTER	Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases (NIAID); Office of AIDS Research of the U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the grants from the Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases (NIAID); and by the Office of AIDS Research of the U.S. National Institutes of Health (NIH) [UM1-AI068613 (Eshleman); UM1-AI068617 (Donnell); and UM1-AI068619 (Cohen/El-Sadr)]. Study drugs used in HPTN 052 were donated by Abbott Laboratories, Boehringer-Ingelheim Pharmaceuticals, Inc, Bristol-Myers Squibb, Gilead Sciences, Inc., GlaxoSmithKline/ViiV Healthcare, and Merck & Co., Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081213; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cousins MM, 2013, J MOL DIAGN, V15, P130, DOI 10.1016/j.jmoldx.2012.08.008; Cousins MM, 2012, J CLIN MICROBIOL, V50, P3054, DOI 10.1128/JCM.01460-12; Cousins MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027211; Eshleman SH, 2007, AIDS, V21, P1165, DOI 10.1097/QAD.0b013e32810fd72e; Fogel JM, VIROLOGIC OUTC UNPUB; Ganeshan S, 1997, J VIROL, V71, P663, DOI 10.1128/JVI.71.1.663-677.1997; James MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057350; James MM, 2012, PEDIATR INFECT DIS J, V31, pE222, DOI 10.1097/INF.0b013e3182678c3f; James MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018642; Joos B, 2005, J VIROL, V79, P9026, DOI 10.1128/JVI.79.14.9026-9037.2005; Keele BF, 2010, CURR OPIN HIV AIDS, V5, P327, DOI 10.1097/COH.0b013e32833a0b9b; Kitrinos KM, 2005, J VIROL, V79, P10627, DOI 10.1128/JVI.79.16.10627-10637.2005; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Mani I, 2002, J VIROL, V76, P10745, DOI 10.1128/JVI.76.21.10745-10755.2002; Markham RB, 1998, P NATL ACAD SCI USA, V95, P12568, DOI 10.1073/pnas.95.21.12568; Piantadosi A, 2009, AIDS, V23, P579, DOI 10.1097/QAD.0b013e328328f76e; Rachinger A, 2012, AIDS, V26, P1517, DOI 10.1097/QAD.0b013e328354f539; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Sagar M, 2003, J VIROL, V77, P12921, DOI 10.1128/JVI.77.23.12921-12926.2003; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Towler WI, 2010, AIDS RES HUM RETROV, V26, P913, DOI 10.1089/aid.2009.0259; Williamson S, 2003, MOL BIOL EVOL, V20, P1318, DOI 10.1093/molbev/msg144; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537	26	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177281	10.1371/journal.pone.0177281	http://dx.doi.org/10.1371/journal.pone.0177281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481902	Green Submitted, Green Published, gold			2022-12-27	WOS:000401313700047
J	Wasitthankasem, R; Vichaiwattana, P; Siripon, N; Posuwan, N; Auphimai, C; Klinfueng, S; Thaneskongtong, N; Vuthitanachot, V; Saiyatha, S; Thongmai, C; Suwanpatoomlerd, S; Sochoo, S; Pongsuwan, N; Poovorawan, K; Tangkijvanich, P; Vongpunsawad, S; Poovorawan, Y				Wasitthankasem, Rujipat; Vichaiwattana, Preeyaporn; Siripon, Nipaporn; Posuwan, Nawarat; Auphimai, Chompoonut; Klinfueng, Sirapa; Thaneskongtong, Napha; Vuthitanachot, Viboonsak; Saiyatha, Supapith; Thongmai, Chaiwat; Suwanpatoomlerd, Sarawut; Sochoo, Saowakon; Pongsuwan, Natnada; Poovorawan, Kittiyod; Tangkijvanich, Pisit; Vongpunsawad, Sompong; Poovorawan, Yong			Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence	PLOS ONE			English	Article							RISK-FACTORS; BLOOD-DONORS; NORTHERN THAILAND; HCV INFECTION; UNITED-STATES; PREVALENCE; CLASSIFICATION; EPIDEMIOLOGY; DIVERSITY; GENOTYPES	Improved awareness of the hepatitis C virus (HCV) transmission has contributed to the overall decline in the HCV infection rate in some developing countries including Thailand. Chronic HCV infection in some rural Thai communities, however, presents a challenge in the efforts to treat and manage HCV-related diseases. Published and unpublished studies have suggested an unusually high incidence of HCV infection in a Thai province of Phetchabun compared to elsewhere in Thailand. To determine the magnitude of HCV infection and identify potential factors contributing to the higher rate of HCV infection in this province, we performed a population-based study in Phetchabun (n = 1667) and the neighboring Khon Kaen province (n = 1410) where HCV prevalence is much lower. Individuals between 30 and 64 years old completed detailed questionnaires designed to identify HCV risk factors and provided blood samples for anti-HCV antibody screening. The anti-HCV seropositive rates were 15.5% (259/1667) in Phetchabun and 3.6% (51/1410) in Khon Kaen. Positive samples were subsequently genotyped for HCV core gene sequence and assessed for the hepatitis B virus surface antigen (HBsAg) and human immunodeficiency virus antigen/antibody (HIV Ag/Ab). More individuals in Phetchabun possessed the combined presence of HBsAg (5.0%) and HIV Ag/Ab (0.4%) than those in Khon Kaen (3.9% HBsAg and 0.0% HIV Ag/Ab). While male gender, intravenous drug use (IVDU) and tattoos were significant HCV risk factors in both provinces (p < 0.05), education less than high school and agriculturerelated occupation were additionally associated with HCV in Phetchabun. HCV genotypes 6, 3, and 1 were identified in similar frequency in both provinces. We estimated that prevalence of HCV seropositivity and viremic carriers were higher in Phetchabun (143 and 111 per 1000) than in Khon Kaen (34 and 22 per 1000). Finally, we derived a simple risk factorbased scoring system as a useful preclinical tool to screen individuals at risk of chronic HCV infection prior to intervention. Knowledge gained from this study will assist in HCV screening and promote access to anti-viral treatment in high-risk groups.	[Wasitthankasem, Rujipat; Vichaiwattana, Preeyaporn; Siripon, Nipaporn; Posuwan, Nawarat; Auphimai, Chompoonut; Klinfueng, Sirapa; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok, Thailand; [Thaneskongtong, Napha; Vuthitanachot, Viboonsak] Chumpae Hosp, Khon Kaen, Thailand; [Saiyatha, Supapith; Thongmai, Chaiwat] Phetchabun Prov Publ Hlth Off, Phetchabun, Thailand; [Suwanpatoomlerd, Sarawut; Sochoo, Saowakon; Pongsuwan, Natnada] Lomkao Crown Prince Hosp, Lom Kao, Phetchabun, Thailand; [Poovorawan, Kittiyod] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Tangkijvanich, Pisit] Chulalongkorn Univ, Fac Med, Dept Biochem, Res Unit Hepatitis & Liver Canc, Bangkok, Thailand	Chulalongkorn University; Mahidol University; Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok, Thailand.	yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	vongpunsawad, sompong/0000-0001-7520-8728; Poovorawan, Kittiyod/0000-0001-7016-7605	National Research Council of Thailand (NRCT); National Research University Project, Office of Higher Education Commission [NRU-59-002-HR]; Research Chair Grant from the National Science and Technology Development Agency, Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093]; Outstanding Professor of Thailand Research Fund [DPG5480002]; Ratchadaphiseksomphot Endowment Fund for Postdoctoral Fellowship; Center of Excellence in Clinical Virology, Chulalongkorn University [GCE58- 014-30-004]; King Chulalongkorn Memorial Hospital	National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); National Research University Project, Office of Higher Education Commission; Research Chair Grant from the National Science and Technology Development Agency, Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Outstanding Professor of Thailand Research Fund; Ratchadaphiseksomphot Endowment Fund for Postdoctoral Fellowship; Center of Excellence in Clinical Virology, Chulalongkorn University(Chulalongkorn University); King Chulalongkorn Memorial Hospital(Chulalongkorn University)	This work was supported by the National Research Council of Thailand (NRCT), the National Research University Project, Office of Higher Education Commission (NRU-59-002-HR), the Research Chair Grant from the National Science and Technology Development Agency, Chulalongkorn University Centenary Academic Development Project (CU56-HR01), Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530093) the Outstanding Professor of Thailand Research Fund (DPG5480002), Ratchadaphiseksomphot Endowment Fund for Postdoctoral Fellowship to Rujipat Wasitthankasem, the Center of Excellence in Clinical Virology, Chulalongkorn University (GCE58- 014-30-004) and King Chulalongkorn Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkarathamrongsin S, 2010, J MED VIROL, V82, P257; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Buathong R, 2013, WEEKLY EPIDEMIOLOGIC, V44, pS47; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Engle RE, 2014, TRANSFUSION, V54, P2833, DOI 10.1111/trf.12682; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Ishida T, 2002, J CLIN VIROL, V24, P31, DOI 10.1016/S1386-6532(01)00222-0; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; Jatapai A, 2010, AM J TROP MED HYG, V83, P433, DOI 10.4269/ajtmh.2010.09-0749; Lu L, 2007, J GEN VIROL, V88, P1505, DOI 10.1099/vir.0.82604-0; Luksamijarulkul Pipat, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P147; Luksamijarulkul Pipat, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P272; Meffre C, 2010, J MED VIROL, V82, P546, DOI 10.1002/jmv.21734; MELLOR J, 1995, J GEN VIROL, V76, P2493, DOI 10.1099/0022-1317-76-10-2493; Morisco F, 2017, J MED VIROL, V89, P291, DOI 10.1002/jmv.24635; Omland Lars Haukali, 2013, Clin Epidemiol, V5, P163, DOI 10.2147/CLEP.S43926; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Poovorawan K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163095; Posuwan N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150499; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Rangsin R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136555; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Songsivilai S, 1997, AM J TROP MED HYG, V57, P66, DOI 10.4269/ajtmh.1997.57.66; Sunanchaikarn S, 2007, ASIAN PAC J ALLERGY, V25, P175; Tanwandee Tawesak, 2006, J Med Assoc Thai, V89 Suppl 5, pS79; Thaikruea L, 2004, TRANSFUSION, V44, P1433, DOI 10.1111/j.1537-2995.2004.04073.x; Verachai Viroj, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P849; Wasitthankasem R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152451; Wasitthankasem R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126764; WHO, 2016, HEP C	33	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177022	10.1371/journal.pone.0177022	http://dx.doi.org/10.1371/journal.pone.0177022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475637	gold, Green Submitted, Green Published			2022-12-27	WOS:000400649500036
J	Couch, CE; Movius, MA; Jolles, AE; Gorman, ME; Rigas, JD; Beechler, BR				Couch, Claire E.; Movius, Morgan A.; Jolles, Anna E.; Gorman, M. Elena; Rigas, Johanna D.; Beechler, Brianna R.			Serum biochemistry panels in African buffalo: Defining reference intervals and assessing variability across season, age and sex	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; DEER DAMA-DAMA; CHEMISTRY VALUES; BLOOD PARAMETERS; SYNCERUS-CAFFER; HEMATOLOGY; CATTLE; COINFECTIONS; ASSOCIATIONS; SPECIFICITY	Serum biochemical parameters can be utilized to evaluate the physiological status of an animal, and relate it to the animal's health. In order to accurately interpret individual animal biochemical results, species-specific reference intervals (RI) must be established. Reference intervals for biochemical parameters differ between species, and physiological differences including reproductive status, nutritional resource availability, disease status, and age affect parameters within the same species. The objectives of this study were to (1) establish RI for biochemical parameters in managed African buffalo (Syncerus caffer), (2) assess the effects of age, sex, pregnancy, and season on serum biochemistry values, and (3) compare serum biochemistry values from a managed herd to a free-ranging buffalo herd and to values previously published for captive (zoo) buffalo. Season profoundly affected all biochemistry parameters, possibly due to changes in nutrition and disease exposure. Age also affected all biochemical parameters except gamma glutamyl transferase and magnesium, consistent with patterns seen in cattle. Sex and reproductive status had no detectable effects on the parameters that were measured. The biochemical profiles of managed buffalo were distinct from those observed in the free-ranging herd and captive buffalo. Biochemical differences between buffalo from captive, managed, and free-ranging populations may be related to nutritional restriction or lack of predation in the context of management or captivity. The reference intervals provided in this study, in addition to the seasonal and age-related patterns observed, provide a foundation for health investigations that may inform management strategies in this ecologically and economically important species.	[Couch, Claire E.; Jolles, Anna E.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR USA; [Movius, Morgan A.; Jolles, Anna E.; Gorman, M. Elena; Beechler, Brianna R.] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA; [Rigas, Johanna D.] Utah State Univ, Sch Vet Med, Logan, UT 84322 USA	Oregon State University; Oregon State University; Utah System of Higher Education; Utah State University	Beechler, BR (corresponding author), Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA.	brianna.beechler@oregonstate.edu	Beechler, Brianna R/H-7972-2019	Beechler, Brianna R/0000-0002-9711-4340; Jolles, Anna/0000-0003-3074-9912	USDA-NIFA AFRI [2013-67015-21291]; UK Biotechnology and Biological Sciences Research Council [BB/L011085/1]; BBSRC [BB/L011085/1] Funding Source: UKRI	USDA-NIFA AFRI(United States Department of Agriculture (USDA)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	All data collection was funded by USDA-NIFA AFRI grant # 2013-67015-21291and by the UK Biotechnology and Biological Sciences Research Council grant # BB/L011085/1 as part of the joint USDA-NSF-NIH-BBSRC Ecology and Evolution of Infectious Diseases program. Coauthor Morgan Movius had travel and a stipend for fieldwork provided by the Oregon State University College of Veterinary Medicine Summer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alberghina D, 2011, J VET DIAGN INVEST, V23, P111, DOI 10.1177/104063871102300119; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; [Anonymous], 2009, AB VETSCAN OP MAN; [Anonymous], 2001, VETSCAN LARG AN PROF; Barton K., 2016, MUMIN MULTIMODEL INF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beechler BR, 2015, TRANSBOUND EMERG DIS, V62, P24, DOI 10.1111/tbed.12197; Beechler BR, 2009, J WILDLIFE DIS, V45, P57, DOI 10.7589/0090-3558-45.1.57; Beechler BR, 2012, PHYSIOL BIOCHEM ZOOL, V85, P255, DOI 10.1086/665276; Borjesson DL, 2009, J WILDLIFE DIS, V36, P294; BRAUN JP, 1995, REV MED VET-TOULOUSE, V146, P615; Broughton H, J ZOO WILDL IN PRESS; Budischak SA, 2015, MOL ECOL RESOUR, V15, P1112, DOI 10.1111/1755-0998.12382; BUSH M, 1981, J WILDLIFE DIS, V17, P135, DOI 10.7589/0090-3558-17.1.135; Casas-Diaz E, 2008, J WILDLIFE DIS, V44, P965, DOI 10.7589/0090-3558-44.4.965; Constable P, 1998, J ZOO WILDLIFE MED, V29, P435; Cozzi G, 2011, J DAIRY SCI, V94, P3895, DOI 10.3168/jds.2010-3687; Cross PC, 2009, J APPL ECOL, V46, P467, DOI 10.1111/j.1365-2664.2008.01589.x; Cross PC, 2005, ANIM BEHAV, V69, P499, DOI 10.1016/j.anbehav.2004.08.006; Dayger CA, 2013, HORM BEHAV, V64, P748, DOI 10.1016/j.yhbeh.2013.09.003; DOORNENBAL H, 1988, CAN J VET RES, V52, P99; ENGLISH AW, 1981, J WILDLIFE DIS, V17, P289, DOI 10.7589/0090-3558-17.2.289; Ezenwa VO, 2015, SCIENCE, V347, P175, DOI 10.1126/science.1261714; Ezenwa VO, 2009, AFR J ECOL, V47, P476, DOI 10.1111/j.1365-2028.2008.00960.x; Geffre A, 2011, VET CLIN PATH, V40, P107, DOI 10.1111/j.1939-165X.2011.00287.x; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gorsich EE, 2015, J WILDLIFE DIS, V51, P9, DOI 10.7589/2013-12-334; Gorsich Erin E., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P124, DOI 10.1016/j.ijppaw.2014.05.003; Gurgoze SY, 2010, J EQUINE VET SCI, V30, P569, DOI 10.1016/j.jevs.2010.09.006; Henrichs B., 2014, THESIS; Henrichs B, 2016, J ANIM ECOL, V85, P1025, DOI 10.1111/1365-2656.12535; Horn PS, 1998, CLIN CHEM, V44, P622; Hoste H, 2005, SMALL RUMINANT RES, V60, P141, DOI 10.1016/j.smallrumres.2005.06.008; Huber D, 1997, J WILDLIFE DIS, V33, P790, DOI 10.7589/0090-3558-33.4.790; Husakova T, 2014, ANIMAL, V8, P1448, DOI 10.1017/S1751731114001256; Jolles AE, 2015, PARASITE IMMUNOL, V37, P255, DOI 10.1111/pim.12153; Kale VP, 2012, J AM ASSOC LAB ANIM, V51, P475; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Le Boedec K, 2016, VET CLIN PATH, V45, P648, DOI 10.1111/vcp.12390; LINCOLN SD, 1990, J AM VET MED ASSOC, V197, P1471; LOCHMILLER R L, 1984, Journal of Wildlife Diseases, V20, P134; Maceda-Veiga A, 2015, SCI TOTAL ENVIRON, V514, P322, DOI 10.1016/j.scitotenv.2015.02.004; MARLER R J, 1975, Journal of Wildlife Diseases, V11, P97; Michel AL, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i2.453; Miller L D, 1989, J Vet Diagn Invest, V1, P219; Miller M, 2010, J ZOO WILDLIFE MED, V41, P404, DOI 10.1638/2009-0001.1; Moen R, 2010, J WILDLIFE DIS, V46, P13, DOI 10.7589/0090-3558-46.1.13; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Perez JM, 2015, J WILDLIFE DIS, V51, P148, DOI 10.7589/2014-01-008; Poljicak-Milas N, 2004, EUR J WILDLIFE RES, V50, P7, DOI 10.1007/s10344-003-0003-2; RODGERS JD, 1983, EXP GERONTOL, V18, P39, DOI 10.1016/0531-5565(83)90049-9; Ryan S. J., 2005, Koedoe, V48, P117; Ryan SJ, 2006, J WILDLIFE MANAGE, V70, P764, DOI 10.2193/0022-541X(2006)70[764:RAHSOA]2.0.CO;2; Ryan SJ, 2012, J WILDLIFE MANAGE, V76, P1499, DOI 10.1002/jwmg.407; Schmidt DA, 2011, J ZOO WILDLIFE MED, V42, P33, DOI 10.1638/2009-0218.1; Sinclair A.R.E., 1977, AFRICAN BUFFALO STUD; South African National Parks, 2006, AV MONTHL SEAS TEMP; Spaan RS., 2016, THESIS; Spears JW, 2000, P NUTR SOC, V59, P587, DOI 10.1017/S0029665100000835; Stockham SL., 2008, FUNDAMENTALS CLIN PA, V2; Sullivan K, 2010, ZOO BIOL, V29, P457, DOI 10.1002/zoo.20278; TSUCHIYA N, 1995, EXP ANIM TOKYO, V43, P671; Tukey JW, 1977, EXPLORATORY DATA ANA; VAHALA J, 1993, COMP BIOCHEM PHYS B, V106, P47, DOI 10.1016/0305-0491(93)90005-P; Van Hooft P, 2001, THESIS; Yokus B, 2006, BIOL TRACE ELEM RES, V109, P255, DOI 10.1385/BTER:109:3:255	67	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176830	10.1371/journal.pone.0176830	http://dx.doi.org/10.1371/journal.pone.0176830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472180	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500079
J	Goda, H; Yamaoka, H; Nakayama-Imaohji, H; Kawata, H; Horiuchi, I; Fujita, Y; Nagao, T; Tada, A; Terada, A; Kuwahara, T				Goda, Hisataka; Yamaoka, Hitoshi; Nakayama-Imaohji, Haruyuki; Kawata, Hiroyuki; Horiuchi, Isanori; Fujita, Yatsuka; Nagao, Tamiko; Tada, Ayano; Terada, Atsushi; Kuwahara, Tomomi			Microbicidal effects of weakly acidified chlorous acid water against feline calicivirus and Clostridium difficile spores under protein-rich conditions	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; NOSOCOMIAL PATHOGENS; CHLORINE DIOXIDE; SODIUM-CHLORITE; CONTAMINATION; SURFACES; NOROVIRUS; DISINFECTION; GLUTATHIONE; SANITIZERS	Sanitation of environmental surfaces with chlorine based-disinfectants is a principal measure to control outbreaks of norovirus or Clostridium difficile. The microbicidal activity of chlorine-based disinfectants depends on the free available chlorine (FAC), but their oxidative potential is rapidly eliminated by organic matter. In this study, the microbicidal activities of weakly acidified chlorous acid water (WACAW) and sodium hypochlorite solution (NaClO) against feline calcivirus (FCV) and C. difficile spores were compared in protein-rich conditions. WACAW inactivated FCV and C. difficile spores better than NaClO under all experimental conditions used in this study. WACAW above 100 ppm FAC decreased FCV >4 log(10) within 30 sec in the presence of 0.5% each of bovine serum albumin (BSA), polypeptone or meat extract. Even in the presence of 5% BSA, WACAW at 600 ppm FAC reduced FCV >4 log(10) within 30 sec. Polypeptone inhibited the virucidal activity of WACAW against FCV more so than BSA or meat extract. WACAW at 200 ppm FAC decreased C. difficile spores >3 log(10) within 1 min in the presence of 0.5% polypeptone. The microbicidal activity of NaClO was extensively diminished in the presence of organic matter. WACAW recovered its FAC to the initial level after partial neutralization by sodium thiosulfate, while no restoration of the FAC was observed in NaClO. These results indicate that WACAW is relatively stable under organic matter-rich conditions and therefore may be useful for treating environmental surfaces contaminated by human excretions.	[Goda, Hisataka; Yamaoka, Hitoshi; Kawata, Hiroyuki; Horiuchi, Isanori; Fujita, Yatsuka] Honbu Sankei Co Ltd, Chuou Ku, 2-2-53 Shiromi, Osaka, Japan; [Yamaoka, Hitoshi; Nakayama-Imaohji, Haruyuki; Tada, Ayano; Kuwahara, Tomomi] Kagawa Univ, Fac Med, Dept Microbiol, 1750-1 Miki, Kagawa, Japan; [Nagao, Tamiko] Shikoku Univ, Fac Nursing, Ojin Cho, Furukawa, Tokushima, Japan; [Terada, Atsushi] Nihon Univ, Dept Vet Med, Fujisawa, Kanagawa, Japan	Kagawa University; Nihon University	Kuwahara, T (corresponding author), Kagawa Univ, Fac Med, Dept Microbiol, 1750-1 Miki, Kagawa, Japan.	tomomi@med.kagawa-u.ac.jp			Kagawa University; Honbu Sankei Co. Ltd.	Kagawa University; Honbu Sankei Co. Ltd.	This study was supported by the collaboration research fund between Kagawa University and Honbu Sankei Co. Ltd. The study design, data collection and analysis, decision to publish or preparation of the manuscript was done under discussion between Kagawa University and Honbu Sankei Co. Ltd.	[Anonymous], 1998, ENCY ENV ANAL REMEDI; Barker J, 2004, J HOSP INFECT, V58, P42, DOI 10.1016/j.jhin.2004.04.021; Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067/mic.2002.130391; BUTTERFIELD C. T., 1948, JOUR AMER WATER WORKS ASSOC, V40, P1305; Castillo A, 1999, J FOOD PROTECT, V62, P580, DOI 10.4315/0362-028X-62.6.580; Chitnis V, 2004, AM J INFECT CONTROL, V32, P306, DOI 10.1016/j.ajic.2003.10.007; Cohen S. H., 2013, INFECT CONT HOSP EP, V31, P423; Dancer SJ, 2009, J HOSP INFECT, V73, P378, DOI 10.1016/j.jhin.2009.03.030; Dubberke ER, 2014, INFECT CONTROL HO S2, V35, P48; Evans MR, 2002, EPIDEMIOL INFECT, V129, P355, DOI 10.1017/S0950268802007446; Gagnon GA, 2005, WATER RES, V39, P1809, DOI 10.1016/j.watres.2005.02.004; Gordon G., 1972, PROGR INORGANIC CHEM, P201; HAAS CN, 1980, J WATER POLLUT CON F, V52, P1976; Horiuchi I, 2015, BIOCONTROL SCI, V20, P43, DOI 10.4265/bio.20.43; Ingram PR, 2004, FREE RADICAL RES, V38, P739, DOI 10.1080/10715760410001712773; Ingram PR, 2003, ARCH BIOCHEM BIOPHYS, V410, P121, DOI 10.1016/S0003-9861(02)00659-8; Japan Food Hygiene Association, 2015, STAND METH AN FOOD S; Kampf G, 2004, CLIN MICROBIOL REV, V17, P863, DOI 10.1128/CMR.17.4.863-893.2004; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kumar M, 2006, J FOOD PROTECT, V69, P1571, DOI 10.4315/0362-028X-69.7.1571; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; Ling ML, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0099-7; Liu PB, 2010, APPL ENVIRON MICROB, V76, P394, DOI 10.1128/AEM.01729-09; MacCannell T, 2011, STAND PREV CONTR NOR; Moberg L, 2000, ANAL CHIM ACTA, V29, P123; Okabayashi T, 2008, J CLIN MICROBIOL, V46, P1985, DOI 10.1128/JCM.00305-08; Otter JA, 2011, INFECT CONT HOSP EP, V32, P687, DOI 10.1086/660363; Park GW, 2010, J FOOD PROTECT, V73, P2232, DOI 10.4315/0362-028X-73.12.2232; Richardson S.D., 1998, ENCY ENV ANAL REMEDI, V3, P1398; Richardson SD, 1998, FOOD TECHNOL-CHICAGO, V52, P58; RIDENOUR GM, 1946, AM J PUBLIC HEALTH, V36, P639; Sehulster Lynne, 2003, MMWR Recomm Rep, V52, P1; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Stopforth JD, 2008, J FOOD PROTECT, V71, P625, DOI 10.4315/0362-028X-71.3.625; Todd ECD, 2008, J FOOD PROTECT, V71, P2582, DOI 10.4315/0362-028X-71.12.2582; Van Aken B, 2011, WATER SCI TECHNOL, V64, P1226, DOI 10.2166/wst.2011.684; Verani M, 2014, AM J INFECT CONTROL, V42, P758, DOI 10.1016/j.ajic.2014.03.026; Weber DJ, 2010, AM J INFECT CONTROL, V38, pS25, DOI 10.1016/j.ajic.2010.04.196; Yamaoka H, 2016, LETT APPL MICROBIOL, V62, P47, DOI 10.1111/lam.12506; Young SB, 2003, J APPL MICROBIOL, V95, P54, DOI 10.1046/j.1365-2672.2003.01960.x	40	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176718	10.1371/journal.pone.0176718	http://dx.doi.org/10.1371/journal.pone.0176718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472060	gold, Green Submitted, Green Published			2022-12-27	WOS:000400648500066
J	Huang, JF; Yeh, ML; Huang, CF; Huang, CI; Tsai, PC; Tai, CM; Yang, HL; Dai, CY; Hsieh, MH; Chen, SC; Yu, ML; Chuang, WL				Huang, Jee-Fu; Yeh, Ming-Lun; Huang, Chung-Feng; Huang, Ching-I; Tsai, Pei-Chien; Tai, Chi-Ming; Yang, Hua-Ling; Dai, Chia-Yen; Hsieh, Meng-Hsuan; Chen, Shinn-Chern; Yu, Ming-Lung; Chuang, Wan-Long			Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ASIA-PACIFIC REGION; CHRONIC HEPATITIS-C; BODY-MASS INDEX; FRAGMENT LEVELS; SCORING SYSTEM; RISK-FACTORS; ASSOCIATION; BIOMARKERS; GUIDELINES	Background & aims Identification of disease severity remains a challenge in the management of non-alcoholic steatohepatitis (NASH). Cytokeratin-18 (CK18), is a recently developed non-invasive bio-marker for NASH. We aimed to assess the performance of CK18 in disease severity prediction among Taiwanese NASH patients. Methods A total of 76 biopsy-proven NASH patients ( 54 males, age = 41.0 +/- 13.5 years) were consecutively recruited. The optimal cutoff values of CK18 for each stage of fibrosis were correlated with their histopathological manifestations. Results There were 23 (30.3%) patients of Metavir fibrosis stage 0 (F0), 32 (42.1%) patients of F1, 14 (18.4%) patients of F2, and 7 (9.2%) patients of F3-4, respectively. The CK18 levels among those patients of F0, F1, F2, F3-4 were 86.7 +/- 75.6 U/L, 122.4 +/- 123.8 U/L, 160.7 +/- 120.4 U/L, and 507.3 +/- 343 U/L, respectively (trend for P < 0.001). The adjusted optimal cutoff value for F2 prediction was 312.5 U/L, yielding the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and the accuracy of 96.4%, 28.6%, 77.9%, 75%, and 77.6%, respectively (P = 0.009). For the prediction of advanced fibrosis (F3-4), the adjusted optimal cutoff value was 374.5 U/L, yielding the sensitivity, specificity, PPV, NPV, and the accuracy of 97.1%, 54.1%, 95.7%, 66.7%, and 77.6%, respectively (P = 0.003). Among those patients without hyperuricemia, the PPV, NPV, and accuracy of CK18 reached 100%, 95.8%, and 96%, respectively (P < 0.001). Conclusions CK18 combined with uric acid measurement is a promising non-invasive biomarker for prediction of disease severity in NASH patients.	[Huang, Jee-Fu; Yeh, Ming-Lun; Huang, Chung-Feng; Huang, Ching-I; Tsai, Pei-Chien; Yang, Hua-Ling; Dai, Chia-Yen; Hsieh, Meng-Hsuan; Chen, Shinn-Chern; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan; [Huang, Jee-Fu; Tai, Chi-Ming; Dai, Chia-Yen; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan; [Huang, Jee-Fu; Yeh, Ming-Lun; Huang, Chung-Feng; Dai, Chia-Yen; Hsieh, Meng-Hsuan; Chen, Shinn-Chern; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ, Coll Med, Fac Internal Med, Kaohsiung, Taiwan; [Tai, Chi-Ming] I Shou Univ, E Da hosp, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; E-Da Hospital; I Shou University	Huang, JF; Chuang, WL (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan.; Huang, JF; Chuang, WL (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan.; Huang, JF; Chuang, WL (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Internal Med, Kaohsiung, Taiwan.	jf71218@gmail.com; waloch@cc.kmu.edu.tw	Dai, Chia-Yen/V-6560-2019; Yu, Ming-Lung/AAZ-4306-2020; Huang, Jee-Fu/AAX-4622-2020; Hsieh, Meng Hsuan/AAY-7973-2021; Chuang, Wan-Long/ABF-7427-2021	Dai, Chia-Yen/0000-0003-2296-3054; Yu, Ming-Lung/0000-0001-8145-1900; Huang, Jee-Fu/0000-0002-2752-7051; Chuang, Wan-Long/0000-0002-2376-421X; Tsai, Pei-Chien/0000-0002-5044-6727; Hsieh, Meng-Hsuen/0000-0001-9739-3901	Ministry of Science and Techology, Taiwan [NSC 98WFD2100412, 99-2314-B-037-040-MY3, 101-2325-B-037-003]; Kaohsiung Medical University Hospital [KMUH-102-2R05]	Ministry of Science and Techology, Taiwan; Kaohsiung Medical University Hospital	This study was supported partly by grants from The Ministry of Science and Techology, Taiwan (NSC 98WFD2100412, 99-2314-B-037-040-MY3, 101-2325-B-037-003) and Kaohsiung Medical University Hospital (KMUH-102-2R05).; This study was supported partly by grants from The Ministry of Science and Technology, Taiwan (NSC 98WFD2100412, 99-2314-B-037-040-MY3, 101-2325-B-037-003) and Kaohsiung Medical University Hospital (KMUH-102-2R05). The authors thank serum processing help from Taiwan Liver Research Foundation (TLRF). The foundation did not influence how the study was conducted or the approval of the manuscript.	Alkhouri N, 2011, EXPERT REV GASTROENT, V5, P201, DOI [10.1586/EGH.11.6, 10.1586/egh.11.6]; [Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Chalasani N, 2010, GASTROENTEROLOGY, V139, P1567, DOI 10.1053/j.gastro.2010.07.057; Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Chitturi S, 2007, J GASTROEN HEPATOL, V22, P778, DOI 10.1111/j.1440-1746.2007.05001.x; de Oliveira EP, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-12; Diab DL, 2008, CLIN GASTROENTEROL H, V6, P1249, DOI 10.1016/j.cgh.2008.07.016; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Feldstein AE, 2013, AM J GASTROENTEROL, V108, P1526, DOI 10.1038/ajg.2013.168; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Hasegawa Y, 2015, DIGEST DIS, V33, P715, DOI 10.1159/000439076; Hsiao PJ, 2007, J GASTROEN HEPATOL, V22, P2118, DOI 10.1111/j.1440-1746.2006.04698.x; Hsieh MH, 2007, JPN J INFECT DIS, V60, P377; Huang JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139796; Jazwinski AB, 2012, J VIRAL HEPATITIS, V19, P278, DOI 10.1111/j.1365-2893.2011.01546.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Kramer G, 2004, CANCER RES, V64, P1751, DOI 10.1158/0008-5472.CAN-03-2455; Leung JCF, 2017, HEPATOLOGY, V65, P54, DOI 10.1002/hep.28697; Liu CJ, 2012, J GASTROEN HEPATOL, V27, P1555, DOI 10.1111/j.1440-1746.2012.07222.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Shen JY, 2012, J HEPATOL, V56, P1363, DOI 10.1016/j.jhep.2011.12.025; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; Wang JH, 2009, J GASTROENTEROL, V44, P439, DOI 10.1007/s00535-009-0017-y; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Wong RJ, 2014, J COMMUN HEALTH, V39, P437, DOI 10.1007/s10900-013-9792-8; Zafrani ES, 2004, VIRCHOWS ARCH, V444, P3, DOI 10.1007/s00428-003-0943-7	28	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0174394	10.1371/journal.pone.0174394	http://dx.doi.org/10.1371/journal.pone.0174394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472039	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500003
J	Levy, G; Peled, Y; From, A; Fainberg, I; Barak, S; Aviram, A; Krissi, H				Levy, Gil; Peled, Yoav; From, Anat; Fainberg, Irena; Barak, Sarit; Aviram, Amir; Krissi, Haim			Outcome of vaginal mesh reconstructive surgery in multiparous compared with grand multiparous women: Retrospective long-term follow-up	PLOS ONE			English	Article							PELVIC ORGAN PROLAPSE; RANDOMIZED CONTROLLED-TRIAL; FLOOR; QUESTIONNAIRE	We aimed to compare the long-term surgical outcome and complications of multiparous and grand multiparous women undergoing reconstructive surgery with vaginal mesh implants for repair of pelvic organ prolapse. This retrospective, long-term follow-up (28.17 +/- 20.7 months) comprised 113 women who underwent surgical reconstructive surgery with vaginal polypropylene mesh in a high parity rate population medical center. The women were divided into 2 groups (multiparous and grand multiparous) and each group was evaluated for objective and subjective surgical outcome. Patient demographics and surgical data were retrieved from electronic medical records. Outcome measure included POP-Q exam as objective outcome and validated Pelvic Floor Distress Inventory questionnaire (PFDI) to assess subjective outcome. Average age of patients was 62 +/- 7.9 (range 42-83) years. Average parity was 5.6 +/- 3.1 (range 1-14). There were 54 (47.7%) multiparous women and 59 (52.3%) grand multiparous women. The grand multiparous women were younger than the multiparous women and had a significantly higher degree of prolapse. At the last follow-up, the only significant difference was related to symptoms of an overactive bladder. In conclusion, long-term follow-up demonstrates that vaginal mesh surgery in grand multiparous women offers anatomical and subjective cure rates comparable to multiparous women.	[Levy, Gil; Fainberg, Irena; Barak, Sarit] Mayanei HaYeshua Med Ctr, Dept Obstet & Gynecol, Div Female Pelv Med, Bnei Braq, Israel; [Peled, Yoav; From, Anat; Aviram, Amir; Krissi, Haim] Helen Schneider Hosp Women, Beilinson Hosp, Rabin Med Ctr, Dept Obstet & Gynecol,Rogynecol Unit, Petah Tiqwa, Israel; [Peled, Yoav; Aviram, Amir; Krissi, Haim] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Krissi, H (corresponding author), Helen Schneider Hosp Women, Beilinson Hosp, Rabin Med Ctr, Dept Obstet & Gynecol,Rogynecol Unit, Petah Tiqwa, Israel.; Krissi, H (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	haimkr@clalit.org.il	Levy, Gil/AAX-9431-2020					Ashok K, 2012, WORLD J UROL, V30, P487, DOI 10.1007/s00345-011-0808-7; Barber MD, 2013, INT UROGYNECOL J, V24, P1783, DOI 10.1007/s00192-013-2169-9; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Chaliha C, 2009, CURR OPIN OBSTET GYN, V21, P474, DOI 10.1097/GCO.0b013e328332a84e; Dannecker C, 2000, J PERINAT MED, V28, P175, DOI 10.1515/JPM.2000.025; Feiner B, 2010, INT UROGYNECOL J, V21, P203, DOI 10.1007/s00192-009-1012-9; Jelovsek JE, 2007, LANCET, V369, P1027, DOI 10.1016/S0140-6736(07)60462-0; Kisli E, 2006, TOHOKU J EXP MED, V210, P365, DOI 10.1620/tjem.210.365; Lowenstein L, 2012, FEMALE PELVIC MED RE, V18, P329, DOI 10.1097/SPV.0b013e31827268fa; Lunardelli Jacqueline Leme, 2009, Rev. Col. Bras. Cir., V36, P210; Maher C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004014.pub3; Maher C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004014.pub5; Maher C, 2011, INT UROGYNECOL J, V22, P1593, DOI 10.1007/s00192-011-1465-5; Moore RD, 2010, INT UROGYNECOL J, V21, P545, DOI 10.1007/s00192-009-1071-y; Nguyen JN, 2008, OBSTET GYNECOL, V111, P891, DOI 10.1097/AOG.0b013e31816a2489; Nieminen K, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.030; Rudnicki M, 2016, BJOG-INT J OBSTET GY, V123, P136, DOI 10.1111/1471-0528.13628; Smith FJ, 2010, OBSTET GYNECOL, V116, P1096, DOI 10.1097/AOG.0b013e3181f73729; Svihrova V, 2014, EUR J OBSTET GYN R B, V182, P22, DOI 10.1016/j.ejogrb.2014.08.024; Weber AM, 2005, OBSTET GYNECOL, V106, P615, DOI 10.1097/01.AOG.0000175832.13266.bb	20	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176666	10.1371/journal.pone.0176666	http://dx.doi.org/10.1371/journal.pone.0176666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472172	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500060
J	Stanikova, D; Buzga, M; Krumpolec, P; Skopkova, M; Surova, M; Ukropcova, B; Ticha, L; Petrasova, M; Gabcova, D; Huckova, M; Piskorova, L; Bozensky, J; Mokan, M; Ukropec, J; Zavacka, I; Klimes, I; Stanik, J; Gasperikova, D				Stanikova, Daniela; Buzga, Marek; Krumpolec, Patrik; Skopkova, Martina; Surova, Martina; Ukropcova, Barbara; Ticha, Lubica; Petrasova, Miroslava; Gabcova, Dominika; Huckova, Miroslava; Piskorova, Lucie; Bozensky, Jan; Mokan, Marian; Ukropec, Jozef; Zavacka, Ivona; Klimes, Iwar; Stanik, Juraj; Gasperikova, Daniela			Genetic analysis of single-minded 1 gene in early-onset severely obese children and adolescents	PLOS ONE			English	Article							MELANOCORTIN-4 RECEPTOR GENE; FOOD-INTAKE; INSULIN SENSITIVITY; GLUCOSE-TOLERANCE; MORBID-OBESITY; UNITED-STATES; PIMA-INDIANS; WEB SERVER; SIM1 GENE; MUTATIONS	Background Inactivating mutations of the hypothalamic transcription factor singleminded1 (SIM1) have been shown as a cause of early-onset severe obesity. However, to date, the contribution of SIM1 mutations to the obesity phenotype has only been studied in a few populations. In this study, we screened the functional regions of SIM1 in severely obese children of Slovak and Moravian descent to determine if genetic variants within SIM1 may influence the development of obesity in these populations. Methods The SIM1 promoter region, exons and exon-intron boundaries were sequenced in 126 unrelated obese children and adolescents (2-18 years of age) and 41 adult lean controls of Slovak and Moravian origin. Inclusion criteria for the children and adolescents were a body mass index standard deviation score higher than 2 SD for an appropriate age and sex, and obesity onset at less than 5 years of age. The clinical phenotypes of the SIM1 variant carriers were compared with clinical phenotypes of 4 MC4R variant carriers and with 27 unrelated SIM1 and MC4R mutation negative obese controls that were matched for age and gender. Results Seven previously described SIM1 variants and one novel heterozygous variant p.D134N were identified. The novel variant was predicted to be pathogenic by 7 in silico software analyses and is located at a highly conserved position of the SIM1 protein. The p.D134N variant was found in an 18 year old female proband (BMI 44.2kg/m(2); +7.5 SD), and in 3 obese family members. Regardless of early onset severe obesity, the proband and her brother (age 16 years) did not fulfill the criteria of metabolic syndrome. Moreover, the variant carriers had significantly lower preferences for high sugar (p = 0.02) and low fat, low carbohydrate, high protein (p = 0.02) foods compared to the obese controls. Conclusions We have identified a novel SIM1 variant, p. D134N, in 4 obese individuals from a single pedigree which is also associated with lower preference for certain foods.	[Stanikova, Daniela; Krumpolec, Patrik; Skopkova, Martina; Surova, Martina; Ukropcova, Barbara; Gabcova, Dominika; Huckova, Miroslava; Klimes, Iwar; Stanik, Juraj; Gasperikova, Daniela] Slovak Acad Sci, Biomed Res Ctr, Inst Expt Endocrinol, Lab Diabet & Metab Disorders, Bratislava, Slovakia; [Stanikova, Daniela; Ticha, Lubica; Stanik, Juraj] Comenius Univ, Med Fac, Dept Pediat, Bratislava, Slovakia; [Stanikova, Daniela] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, Leipzig, Germany; [Buzga, Marek] Univ Ostrava, Fac Med, Dept Physiol & Pathophysiol, Ostrava, Czech Republic; [Ukropcova, Barbara] Comenius Univ, Fac Med, Inst Pathophysiol, Bratislava, Slovakia; [Petrasova, Miroslava] Safarik Univ, Med Fac, Dept Pediat, Kosice, Slovakia; [Piskorova, Lucie; Bozensky, Jan] Vitkovice Hosp, Dept Pediat, Ostrava, Czech Republic; [Mokan, Marian] Comenius Univ, Jessenius Med Fac, Dept Internal Med, Martin, Slovakia; [Zavacka, Ivona] Univ Ostrava, Fac Med, Dept Biomed Sci, Ostrava, Czech Republic; [Stanik, Juraj] Univ Leipzig, Univ Hosp Children & Adolescents, Ctr Pediat Res Leipzig, Leipzig, Germany	Slovak Academy of Sciences; Comenius University Bratislava; Leipzig University; University of Ostrava; Comenius University Bratislava; University of Pavol Jozef Safarik Kosice; University Hospital Ostrava; Comenius University Bratislava; University of Ostrava; Leipzig University	Gasperikova, D (corresponding author), Slovak Acad Sci, Biomed Res Ctr, Inst Expt Endocrinol, Lab Diabet & Metab Disorders, Bratislava, Slovakia.	daniela.gasperikova@savba.sk	Ukropec, Jozef/AAI-5590-2020; Gasperikova, Daniela/E-7824-2018; Stanik, Juraj/AAQ-6217-2021; Ukropec, Jozef/D-5960-2018; Závacká, Ivona/D-8782-2014; Buzga, Marek/D-6288-2014; Ukropcova, Barbara/E-7644-2018; Buzga, Marek/ABC-1449-2021; Ukropcova, Barbara/ABE-6186-2020; Skopkova, Martina/AAO-1640-2021; Skopkova, Martina/B-4176-2014	Gasperikova, Daniela/0000-0002-5725-6424; Stanik, Juraj/0000-0002-0538-1274; Ukropec, Jozef/0000-0001-8401-6621; Buzga, Marek/0000-0002-9554-737X; Ukropcova, Barbara/0000-0002-3309-7713; Skopkova, Martina/0000-0001-7927-9777; Petrasova, Miroslava/0000-0003-4156-7073	Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic; Slovak Academy of Sciences [VEGA 2/0166/14]; European Regional Development Fund [Transendogen/26240220051]; ESPE (European Society of Pediatric Endocrinology) Research Fellowship	Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic; Slovak Academy of Sciences(Slovak Academy of Sciences); European Regional Development Fund(European Commission); ESPE (European Society of Pediatric Endocrinology) Research Fellowship	1. Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and the Slovak Academy of Sciences - VEGA 2/0166/14, www.vega.sav.sk recieved by DaG; 2. Research&Development Operational Program funded by the European Regional Development Fund - Transendogen/26240220051 recieved by IK; 3. JS was supported by ESPE (European Society of Pediatric Endocrinology) Research Fellowship.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Bonnefond A, 2013, J CLIN INVEST, V123, P3037, DOI 10.1172/JCI68035; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S6; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Faivre L, 2002, J MED GENET, V39, P594, DOI 10.1136/jmg.39.8.594; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Geiselman PJ, 1998, PHYSIOL BEHAV, V63, P919, DOI 10.1016/S0031-9384(97)00542-8; Geistanger A, 2008, CLIN CHEM, V54, P1379, DOI 10.1373/clinchem.2008.103556; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Holder JL, 2000, HUM MOL GENET, V9, P101; Hossain MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep32453; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kobzova J., 2004, Central European Journal of Public Health, V12, P126; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; Kublaoui BM, 2006, ENDOCRINOLOGY, V147, P4542, DOI 10.1210/en.2006-0453; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Melchior C, 2012, HORM RES PAEDIAT, V78, P237, DOI 10.1159/000343816; Michaud JL, 2000, MECH DEVELOP, V90, P253, DOI 10.1016/S0925-4773(99)00328-7; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Montagne L, 2014, OBESITY, V22, P2621, DOI 10.1002/oby.20886; Ramachandrappa S, 2013, J CLIN INVEST, V123, P3042, DOI 10.1172/JCI68016; REAVEN GM, 1993, J CLIN ENDOCR METAB, V76, P44, DOI 10.1210/jc.76.1.44; Retnakaran R, 2009, DIABETIC MED, V26, P1198, DOI 10.1111/j.1464-5491.2009.02841.x; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Swarbrick MM, 2011, OBESITY, V19, P2394, DOI 10.1038/oby.2011.79; Tapia LU, 2013, NUTR HOSP, V28, P1552, DOI 10.3305/nh.2013.28.5.6735; Thearle MS, 2012, DIABETES, V61, P250, DOI 10.2337/db11-0708; Traurig M, 2009, DIABETES, V58, P1682, DOI 10.2337/db09-0028; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Xi D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081087; Yang C, 2006, J NEUROSCI, V26, P7116, DOI 10.1523/JNEUROSCI.0672-06.2006; Yeo GSH, 2003, HUM MOL GENET, V12, P561, DOI 10.1093/hmg/ddg057; Zegers D, 2014, INTJ OBESITY LOND, V38, P1000; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	46	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177222	10.1371/journal.pone.0177222	http://dx.doi.org/10.1371/journal.pone.0177222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472148	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500153
J	Vidal, T; Calado, AJ; Moita, MT; Cunha, MR				Vidal, Tania; Calado, Antonio Jose; Moita, Maria Teresa; Cunha, Marina R.			Phytoplankton dynamics in relation to seasonal variability and upwelling and relaxation patterns at the mouth of Ria de Aveiro (West Iberian Margin) over a four-year period	PLOS ONE			English	Article							NW-SPAIN; COMMUNITY STRUCTURE; CLIMATE-CHANGE; PHYSICAL OCEANOGRAPHY; COASTAL LAGOON; COOP-WEST; PORTUGAL; PENINSULA; ASSEMBLAGES; CHLOROPHYLL	From June 2004 to December 2007, samples were weekly collected at a fixed station located at the mouth of Ria de Aveiro (West Iberian Margin). We examined the seasonal and inter-annual fluctuations in composition and community structure of the phytoplankton in relation to the main environmental drivers and assessed the influence of the oceano-graphic regime, namely changes in frequency and intensity of upwelling events, over the dynamics of the phytoplankton assemblage. The samples were consistently handled and a final subset of 136 OTUs (taxa with relative abundance > 0.01%) was subsequently submitted to various multivariate analyses. The phytoplankton assemblage showed significant changes at all temporal scales but with an overriding importance of seasonality over longer-(inter-annual) or shorter-term fluctuations (upwelling-related). Sea-surface temperature, salinity and maximum upwelling index were retrieved as the main driver of seasonal change. Seasonal signal was most evident in the fluctuations of chlorophyll a concentration and in the high turnover from the winter to spring phytoplankton assemblage. The seasonal cycle of production and succession was disturbed by upwelling events known to disrupt thermal stratification and induce changes in the phytoplankton assemblage. Our results indicate that both the frequency and intensity of physical forcing were important drivers of such variability, but the outcome in terms of species composition was highly dependent on the available local pool of species and the timing of those events in relation to the seasonal cycle. We conclude that duration, frequency and intensity of upwelling events, which vary seasonally and inter-annually, are paramount for maintaining long-term phytoplankton diversity likely by allowing unstable coexistence and incorporating species turnover at different scales. Our results contribute to the understanding of the complex mechanisms of coastal phytoplankton dynamics in relation to changing physical forcing which is fundamental to improve predictability of future prospects under climate change.	[Vidal, Tania; Calado, Antonio Jose; Cunha, Marina R.] Univ Aveiro, Dept Biol, Campus Univ Santiago, Aveiro, Portugal; [Vidal, Tania; Cunha, Marina R.] Univ Aveiro, CESAM, Campus Univ Santiago, Aveiro, Portugal; [Vidal, Tania; Moita, Maria Teresa] IPMA, IP Portuguese Inst Ocean & Atmosphere, Lisbon, Portugal; [Calado, Antonio Jose] Univ Aveiro, GeoBioTec, Campus Univ Santiago, Aveiro, Portugal; [Moita, Maria Teresa] Univ Algarve, CCMAR, Campus Gambelas, Faro, Portugal	Universidade de Aveiro; Universidade de Aveiro; Instituto Portugues do Mar e da Atmosfera; Universidade de Aveiro; Universidade do Algarve	Vidal, T (corresponding author), Univ Aveiro, Dept Biol, Campus Univ Santiago, Aveiro, Portugal.; Vidal, T (corresponding author), Univ Aveiro, CESAM, Campus Univ Santiago, Aveiro, Portugal.; Vidal, T (corresponding author), IPMA, IP Portuguese Inst Ocean & Atmosphere, Lisbon, Portugal.	taniavidal@ua.pt	Calado, António José/D-6263-2015; Cunha, Marina R/B-7644-2008; Calado, António José/AAC-8269-2019; Vidal, Tânia/B-7566-2014; Calixto de Jesus Moita Garnel, Maria Teresa/M-4039-2013	Calado, António José/0000-0002-9711-0593; Cunha, Marina R/0000-0001-8833-6980; Calado, António José/0000-0002-9711-0593; Vidal, Tânia/0000-0002-2846-1306; Calixto de Jesus Moita Garnel, Maria Teresa/0000-0002-8995-7516	Portuguese Foundation for Science and Technology (FCT, Portugal) [SFRH/BPD/ 94562/2013]; FEDER funds; national funds; CESAM [UID/AMB/50017]; FCT/MEC through national funds; FEDER; Fundação para a Ciência e a Tecnologia [UID/AMB/50017/2013] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT, Portugal)(Portuguese Foundation for Science and Technology); FEDER funds(European Commission); national funds; CESAM; FCT/MEC through national funds; FEDER(European Commission); Fundação para a Ciência e a Tecnologia	The Portuguese Foundation for Science and Technology (FCT, Portugal) financed Tania Vidal (SFRH/BPD/ 94562/2013) by individual research grants. This study was supported by FEDER funds through the programme COMPETE and by national funds. We would like to thank to European Project SI MCLAVE and HABSPOT. Thanks are due, for the financial support to CESAM (UID/AMB/50017), to FCT/MEC through national funds, and the co-funding by the FEDER, within the PT2020 Partnership Agreement and Compete 2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, ESTUAR COAST SHELF S, V56, P869, DOI 10.1016/S0272-7714(02)00309-8; Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Aristegui J, 2005, SEA GLOBAL COASTAL O, V14B, P879; Bakun A., 1973, COASTAL UPWELLING IN; Bode A, 1998, SCI MAR, V62, P319; Bode A, 2015, MAR ENVIRON RES, V110, P81, DOI 10.1016/j.marenvres.2015.07.017; Bode Antonio, 1994, Scientia Marina, V58, P131; BROWN PC, 1986, J PLANKTON RES, V8, P55, DOI 10.1093/plankt/8.1.55; Casabella N, 2014, J SEA RES, V93, P23, DOI 10.1016/j.seares.2014.01.013; Casas B, 1997, ESTUAR COAST SHELF S, V44, P767, DOI 10.1006/ecss.1996.0155; Casas B., 1995, THESIS; Cerejo M, 2007, MAR ENVIRON RES, V63, P313, DOI 10.1016/j.marenvres.2006.10.005; Cermeno P, 2006, ESTUAR COAST SHELF S, V67, P251, DOI 10.1016/j.ecss.2005.11.027; Chavez FP, 2009, PROG OCEANOGR, V83, P80, DOI 10.1016/j.pocean.2009.07.032; CHISHOLM SW, 1991, LIMNOL OCEANOGR, V36, pU1507; Churro CI, 2009, DIATOM RES, V24, P35; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cloern JE, 2005, MAR ECOL PROG SER, V285, P11, DOI 10.3354/meps285011; Cuadrado MMS, 2002, 21 ANN S EUR ASS REM, P87; da Silva JF, 2002, HYDROBIOLOGIA, V475, P379, DOI 10.1023/A:1020347610968; Dias JM, 1999, OCEANOL ACTA, V22, P473, DOI 10.1016/S0399-1784(00)87681-1; DORMAN CE, 1995, J GEOPHYS RES-OCEANS, V100, P16029, DOI 10.1029/95JC00964; Du XN, 2014, ESTUAR COAST, V37, P299, DOI 10.1007/s12237-013-9679-z; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Escalera L, 2010, HARMFUL ALGAE, V9, P312, DOI 10.1016/j.hal.2009.12.002; Estrada M, 2008, UNITY DIVERSITY REFL, P191; Estrada M, 1985, INT S UPW AR W AFR B, P379; Fehling J, 2006, MAR ECOL PROG SER, V323, P91, DOI 10.3354/meps323091; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; FIUZA AFD, 1982, OCEANOL ACTA, V5, P31; Freon P, 2009, PROG OCEANOGR, V83, P97, DOI 10.1016/j.pocean.2009.07.034; Goebel NL, 2013, ECOL MODEL, V264, P37, DOI 10.1016/j.ecolmodel.2012.11.008; Gorley C.K., 2006, GETTING STARTED PRIM; Harris GP., 1986, PHYTOPLANKTON ECOLOG; HOLM-HANSEN OSMUND, 1965, J CONS CONS PERMS INTE EXPLOR MER, V30, P3; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Kudela Raphael, 2005, Oceanography, V18, P184; LAMBSHEAD PJD, 1983, J NAT HIST, V17, P859, DOI 10.1080/00222938300770671; Lamont T, 2014, DEEP-SEA RES PT I, V90, P1, DOI 10.1016/j.dsr.2014.03.003; Largier JL, 2006, DEEP-SEA RES PT II, V53, P2833, DOI 10.1016/j.dsr2.2006.08.018; Lassiter AM, 2006, DEEP-SEA RES PT II, V53, P3063, DOI 10.1016/j.dsr2.2006.07.013; Legendre L, 1996, MAR ECOL PROG SER, V145, P179, DOI 10.3354/meps145179; Legendre L., 1981, ELSEVIER OCEANOGRAPH, V32, P191; Lemos RT, 2004, INT J CLIMATOL, V24, P511, DOI 10.1002/joc.1009; Lopes CB, 2007, ESTUAR COAST SHELF S, V71, P480, DOI 10.1016/j.ecss.2006.09.015; Lopes JF, 2014, J MARINE SYST, V129, P271, DOI 10.1016/j.jmarsys.2013.07.002; Lopes JF, 2009, ECOL MODEL, V220, P940, DOI 10.1016/j.ecolmodel.2008.11.024; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Margalef R., 1963, ADV FRONTIERS PLANT, P137; Margalef R., 1978, OECOLOGIA AQUATICA, V3, P97; Mercado JM, 2005, SCI MAR, V69, P451, DOI 10.3989/scimar.2005.69n4451; Moita M. T., 2001, ESTRUTURA VARIABILID; Moita MT, 2003, ACTA OECOL, V24, pS125, DOI 10.1016/S1146-609X(03)00011-0; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Palma S, 2010, HARMFUL ALGAE, V9, P294, DOI 10.1016/j.hal.2009.11.006; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Peliz A, 2005, DEEP-SEA RES PT I, V52, P621, DOI 10.1016/j.dsr.2004.11.005; Perez FF, 2010, GLOBAL CHANGE BIOL, V16, P1258, DOI 10.1111/j.1365-2486.2009.02125.x; Picado A, 2014, J SEA RES, V93, P2, DOI 10.1016/j.seares.2014.01.008; Pitcher GC, 2010, PROG OCEANOGR, V85, P5, DOI 10.1016/j.pocean.2010.02.002; PITCHER GC, 1991, PROG OCEANOGR, V28, P39, DOI 10.1016/0079-6611(91)90020-M; Poll WH, 2013, BIOGEOSCIENCES, V10, P4227; Prego R, 2007, ESTUAR COAST SHELF S, V73, P409, DOI 10.1016/j.ecss.2007.02.004; Relvas P, 2007, PROG OCEANOGR, V74, P149, DOI 10.1016/j.pocean.2007.04.021; Silva A, 2009, J SEA RES, V62, P238, DOI 10.1016/j.seares.2009.05.001; Smayda Theodore J., 2002, Harmful Algae, V1, P95, DOI 10.1016/S1568-9883(02)00010-0; Smayda TJ, 2001, J PLANKTON RES, V23, P447, DOI 10.1093/plankt/23.5.447; Stoecker DK, 1999, J EUKARYOT MICROBIOL, V46, P397, DOI 10.1111/j.1550-7408.1999.tb04619.x; Stoecker DK, 1997, MAR ECOL PROG SER, V152, P1, DOI 10.3354/meps152001; Trainer VL, 2010, PROG OCEANOGR, V85, P33, DOI 10.1016/j.pocean.2010.02.003; Tseng YF, 2014, BIOGEOSCIENCES, V11, P409, DOI 10.5194/bg-11-409-2014; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; Uusitalo L, 2013, ICES J MAR SCI, V70, P408, DOI 10.1093/icesjms/fss198; Vale P, 2008, HARMFUL ALGAE, V7, P11, DOI 10.1016/j.hal.2007.05.002; Varela M, 2008, MAR BIOL, V154, P483, DOI 10.1007/s00227-008-0943-x; Varkitzi I, 2010, HARMFUL ALGAE, V9, P304, DOI 10.1016/j.hal.2009.12.001; Venrick EL, 2009, J MAR RES, V67, P89, DOI 10.1357/002224009788597917; WALSH JJ, 1991, NATURE, V350, P53, DOI 10.1038/350053a0; Wang DW, 2015, NATURE, V518, P390, DOI 10.1038/nature14235; Wilkerson FP, 2006, DEEP-SEA RES PT II, V53, P3023, DOI 10.1016/j.dsr2.2006.07.007	82	30	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177237	10.1371/journal.pone.0177237	http://dx.doi.org/10.1371/journal.pone.0177237			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472179	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500154
J	Zlitni, A; Yin, M; Janzen, N; Chatterjee, S; Lisok, A; Gabrielson, KL; Nimmagadda, S; Pomper, MG; Foster, FS; Valliant, JF				Zlitni, Aimen; Yin, Melissa; Janzen, Nancy; Chatterjee, Samit; Lisok, Ala; Gabrielson, Kathleen L.; Nimmagadda, Sridhar; Pomper, Martin G.; Foster, F. Stuart; Valliant, John F.			Development of prostate specific membrane antigen targeted ultrasound microbubbles using bioorthogonal chemistry	PLOS ONE			English	Article							J591 ANTIBODY; MONOCLONAL-ANTIBODIES; PRECLINICAL EVALUATION; EXTRACELLULAR DOMAIN; SMALL MOLECULES; IN-VITRO; CANCER; PSMA; EXPRESSION; INHIBITORS	Prostate specific membrane antigen (PSMA) targeted microbubbles (MBs) were developed using bioorthogonal chemistry. Streptavidin-labeled MBs were treated with a biotinylated tetrazine (MBTz) and targeted to PSMA expressing cells using trans-cyclooctene (TCO)-functionalized anti-PSMA antibodies (TCO-anti-PSMA). The extent of MB binding to PSMA positive cells for two different targeting strategies was determined using an in vitro flow chamber. The initial approach involved pretargeting, where TCO-anti-PSMA was first incubated with PSMA expressing cells and followed by MBTz, which subsequently showed a 2.8 fold increase in the number of bound MBs compared to experiments performed in the absence of TCO-anti-PSMA. Using direct targeting, where TCO-anti-PSMA was linked to MBTz prior to initiation of the assay, a 5-fold increase in binding compared to controls was observed. The direct targeting approach was subsequently evaluated in vivo using a human xenograft tumor model and two different PSMA-targeting antibodies. The US signal enhancements observed were 1.6- and 5.9-fold greater than that for non-targeted MBs. The lead construct was also evaluated in a head-to-head study using mice bearing both PSMA positive or negative tumors in separate limbs. The human PSMA expressing tumors exhibited a 2-fold higher US signal compared to those tumors deficient in human PSMA. The results demonstrate both the feasibility of preparing PSMA-targeted MBs and the benefits of using bioorthogonal chemistry to create targeted US probes.	[Zlitni, Aimen; Janzen, Nancy; Valliant, John F.] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada; [Yin, Melissa; Foster, F. Stuart] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Chatterjee, Samit; Lisok, Ala; Gabrielson, Kathleen L.; Nimmagadda, Sridhar; Pomper, Martin G.] Johns Hopkins Med Inst, Russell H Morgan Dept Radiol & Radiol Sci, 600 N Wolfe St, Baltimore, MD 21205 USA; [Valliant, John F.] Ctr Probe Dev & Commercializat, Hamilton, ON, Canada; [Zlitni, Aimen] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA	McMaster University; University of Toronto; Johns Hopkins University; Johns Hopkins Medicine; McMaster University; Stanford University	Valliant, JF (corresponding author), McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada.; Foster, FS (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.; Valliant, JF (corresponding author), Ctr Probe Dev & Commercializat, Hamilton, ON, Canada.	stuart@sri.utoronto.ca; valliant@mcmaster.ca	Chatterjee, Samit/ABZ-2522-2022	Chatterjee, Samit/0000-0001-8176-3410; Zlitni, Aimen/0000-0002-4790-1573; Foster, F. Stuart/0000-0003-3972-8296; Nimmagadda, Sridhar/0000-0002-6413-7191	Natural Sciences and Engineering Research Council of Canada [227514]; Ontario Institute for Cancer Research [P.SI.015.8]; Canadian Cancer Society [703857]; Terry Fox Research Institute	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Institute for Cancer Research; Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Research Institute	This study was supported by the Natural Sciences and Engineering Research Council of Canada (# 227514), http://www.nserc-crsng.gc.ca./, recipient JFV; Ontario Institute for Cancer Research (# P.SI.015.8), https://oicr.on.ca/, recipient JFV; Canadian Cancer Society (# 703857), http://www.cancer.ca, recipients JFV and FSF; Terry Fox Research Institute, http://www.tfri.ca, recipient FSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elkacem L, 2015, EUR J RADIOL, V84, P1685, DOI 10.1016/j.ejrad.2015.03.016; Afshar-Oromieh A, 2014, EUR J NUCL MED MOL I, V41, P887, DOI 10.1007/s00259-013-2660-z; Banerjee SR, 2014, J MED CHEM, V57, P2657, DOI 10.1021/jm401921j; Barrett JA, 2013, J NUCL MED, V54, P380, DOI 10.2967/jnumed.112.111203; Canadian Cancer Society's Advisory Committee on Cancer Statistics, 2015, CANADIAN CANC STAT; Castanares MA, 2014, J NUCL MED, V55, P805, DOI 10.2967/jnumed.113.134031; Chang SS, 1999, CLIN CANCER RES, V5, P2674; Eder M, 2013, EUR J NUCL MED MOL I, V40, P819, DOI 10.1007/s00259-013-2374-2; El-Zaria ME, 2014, DALTON T, V43, P4950, DOI 10.1039/c3dt53189a; Elsasser-Beile U, 2009, J NUCL MED, V50, P606, DOI 10.2967/jnumed.108.058487; Fan XZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127419; Foss CA, 2005, CLIN CANCER RES, V11, P4022, DOI 10.1158/1078-0432.CCR-04-2690; Genady AR, 2016, J MED CHEM, V59, P2660, DOI 10.1021/acs.jmedchem.5b01881; Ghosh A, 2004, J CELL BIOCHEM, V91, P528, DOI 10.1002/jcb.10661; Haberkorn U, 2016, CLIN CANCER RES, V22, P9, DOI 10.1158/1078-0432.CCR-15-0820; Han M, 2001, Rev Urol, V3, P165; Hillier SM, 2009, CANCER RES, V69, P6932, DOI 10.1158/0008-5472.CAN-09-1682; Holland JP, 2010, J NUCL MED, V51, P1293, DOI 10.2967/jnumed.110.076174; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; ISRAELI RS, 1994, CANCER RES, V54, P1807; JAIN RK, 1988, CANCER RES, V48, P2641; Kaufmann S, 2015, UROL INT, V94, P319, DOI 10.1159/000365397; Kinoshita Y, 2006, WORLD J SURG, V30, P628, DOI 10.1007/s00268-005-0544-5; Lehr HA, 1997, INT J MICROCIRC, V17, P138, DOI 10.1159/000179221; Li Y, 2002, PROSTATE CANCER P D, V5, P36, DOI 10.1038/sj/pcan/4500543; Liu H, 1997, CANCER RES, V57, P3629; Liu H, 1998, CANCER RES, V58, P4055; Maurer T, 2016, NAT REV UROL, V13, P226, DOI 10.1038/nrurol.2016.26; Mottet N, 2016, EAU ESTRO SIOG GUIDE; Nakajima T, 2011, BIOCONJUGATE CHEM, V22, P1700, DOI 10.1021/bc2002715; Nguyen DP, 2016, MOL CANCER RES, V14, P1045, DOI 10.1158/1541-7786.MCR-16-0193; Norberg M, 1997, UROLOGY, V50, P562, DOI 10.1016/S0090-4295(97)00306-3; Osborne JR, 2013, UROL ONCOL-SEMIN ORI, V31, P144, DOI 10.1016/j.urolonc.2012.04.016; Pallwein L, 2008, EUR RADIOL, V18, P707, DOI 10.1007/s00330-007-0779-7; Pandit-Taskar N, 2015, CLIN CANCER RES, V21, P5277, DOI 10.1158/1078-0432.CCR-15-0552; Patri AK, 2004, BIOCONJUGATE CHEM, V15, P1174, DOI 10.1021/bc0499127; Perner S, 2007, HUM PATHOL, V38, P696, DOI 10.1016/j.humpath.2006.11.012; Regino CAS, 2009, CURR RADIOPHARM, V2, P9, DOI 10.2174/1874471010902010009; Roethke M, 2012, WORLD J UROL, V30, P213, DOI 10.1007/s00345-011-0675-2; Ross JS, 2003, CLIN CANCER RES, V9, P6357; Sanna V, 2011, MOL PHARMACEUT, V8, P748, DOI 10.1021/mp100360g; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smeenge M, 2012, BJU INT, V110, P942, DOI 10.1111/j.1464-410X.2012.11072.x; Smith-Jones PM, 2003, J NUCL MED, V44, P610; Sokoloff RL, 2000, PROSTATE, V43, P150; SU SL, 1995, CANCER RES, V55, P1441; Sweat SD, 1998, UROLOGY, V52, P637, DOI 10.1016/S0090-4295(98)00278-7; Troyer JK, 1997, PROSTATE, V30, P232, DOI 10.1002/(SICI)1097-0045(19970301)30:4<232::AID-PROS2>3.0.CO;2-N; Turkbey B, 2009, NAT REV UROL, V6, P191, DOI 10.1038/nrurol.2009.27; Tykvart J, 2014, PROSTATE, V74, P1674, DOI 10.1002/pros.22887; Vallabhajosula S, 2005, J NUCL MED, V46, P634; Wang LF, 2013, PROSTATE, V73, P1147, DOI 10.1002/pros.22663; Willmann JK, 2008, RADIOLOGY, V246, P508, DOI 10.1148/radiol.2462070536; Yang X, 2016, J MED CHEM, V59, P206, DOI 10.1021/acs.jmedchem.5b01268; Zhou J, 2005, NAT REV DRUG DISCOV, V4, P1015, DOI 10.1038/nrd1903; Zlitni A, 2014, ANGEW CHEM INT EDIT, V53, P6459, DOI 10.1002/anie.201402473	57	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176958	10.1371/journal.pone.0176958	http://dx.doi.org/10.1371/journal.pone.0176958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472168	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500103
J	Doubleday, ZA; Jones, AR; Deveney, MR; Ward, TM; Gillanders, BM				Doubleday, Zoe A.; Jones, Alice R.; Deveney, Marty R.; Ward, Tim M.; Gillanders, Bronwyn M.			Eight habitats, 38 threats and 55 experts: Assessing ecological risk in a multi-use marine region	PLOS ONE			English	Article							VULNERABILITY; ECOSYSTEM; STRESSORS; IMPACTS; MAP	Identifying the relative risk human activities pose to a habitat, and the ecosystem services they provide, can guide management prioritisation and resource allocation. Using a combination of expert elicitation to assess the probable effect of a threat and existing data to assess the level of threat exposure, we conducted a risk assessment for 38 human-mediated threats to eight marine habitats (totalling 304 threat-habitat combinations) in Spencer Gulf, Australia. We developed a score-based survey to collate expert opinion and assess the relative effect of each threat to each habitat, as well as a novel and independent measure of knowledge-based uncertainty. Fifty-five experts representing multiple sectors and institutions participated in the study, with 6 to 15 survey responses per habitat (n = 81 surveys). We identified key threats specific to each habitat; overall, climate change threats received the highest risk rankings, with nutrient discharge identified as a key local-scale stressor. Invasive species and most fishing-related threats, which are commonly identified as major threats to the marine environment, were ranked as low-tier threats to Spencer Gulf, emphasising the importance of regionally-relevant assessments. Further, we identified critical knowledge gaps and quantified uncertainty scores for each risk. Our approach will facilitate prioritisation of resource allocation in a region of increasing social, economic and environmental importance, and can be applied to marine regions where empirical data are lacking.	[Doubleday, Zoe A.; Jones, Alice R.; Gillanders, Bronwyn M.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Doubleday, Zoe A.; Jones, Alice R.; Gillanders, Bronwyn M.] Univ Adelaide, Environm Inst, Adelaide, SA, Australia; [Deveney, Marty R.; Ward, Tim M.] South Australian Res & Dev Inst & Marine Innovat, West Beach, SA, Australia	University of Adelaide; University of Adelaide	Doubleday, ZA; Gillanders, BM (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia.; Doubleday, ZA; Gillanders, BM (corresponding author), Univ Adelaide, Environm Inst, Adelaide, SA, Australia.	zoe.doubleday@adelaide.edu.au; bronwyn.gillanders@adelaide.edu.au	Doubleday, Zoe/N-9955-2013; Doubleday, Zoe/AAU-6278-2020; Gillanders, Bronwyn/B-4218-2013	Doubleday, Zoe/0000-0003-0045-6377; Jones, Alice/0000-0002-6157-2024; Gillanders, Bronwyn/0000-0002-7680-2240; Ward, Timothy Mark/0000-0002-9003-2772	Environment Institute; University of Adelaide; Spencer Gulf Ecosystem Development Initiative (SGEDI)	Environment Institute; University of Adelaide; Spencer Gulf Ecosystem Development Initiative (SGEDI)	Funding was provided by the Environment Institute, University of Adelaide and the consortia comprising the Spencer Gulf Ecosystem Development Initiative (SGEDI). https://www.adelaide.edu.au/environment/water/spencer-gulf/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Thomas Prowse, Phillip Casey, Sally Scrivens, Alice Mackay, Simon Goldsworthy, Fred Bailleul, Charlie Huveneers, Will Robbins, and Kathryn Wiltshire for their advice and input regarding method development and survey design. Funding was provided by the Environment Institute, University of Adelaide and the consortia comprising the Spencer Gulf Ecosystem Development Initiative (SGEDI). This project forms part of the SGEDI integrated marine management series of projects. The Spencer Gulf Ecosystem Development Initiative (SGEDI) is a collaboration between a broad range of industry investors, and the University of Adelaide, South Australian Research and Development Institute, a division of Primary Industries and Regions SA, and Flinders University. The program aims to reduce costs, aid development and answer environmental challenges for one of South Australia's leading economic development zones.	[Anonymous], 2013, PLOS ONE, DOI DOI 10.1371/JOURNAL.PONE.0079889; Ascough JC, 2008, ECOL MODEL, V219, P383, DOI 10.1016/j.ecolmodel.2008.07.015; Auguie B, 2017, GRIDEXTRA MISCELLANE; Batista MI, 2014, OCEAN COAST MANAGE, V102, P248, DOI 10.1016/j.ocecoaman.2014.09.020; Brown CJ, 2014, DIVERS DISTRIB, V20, P538, DOI 10.1111/ddi.12159; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Burgman M., 2005, RISKS DECISIONS CONS; Burgman MA., 2016, TRUSTING JUDGEMENTS; Chin A, 2010, GLOBAL CHANGE BIOL, V16, P1936, DOI 10.1111/j.1365-2486.2009.02128.x; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; de Chazal J, 2008, GLOBAL ENVIRON CHANG, V18, P508, DOI 10.1016/j.gloenvcha.2008.04.005; De Lange HJ, 2010, SCI TOTAL ENVIRON, V408, P3871, DOI 10.1016/j.scitotenv.2009.11.009; Doubleday ZA, 2013, AQUACULT ENV INTERAC, V3, P163, DOI 10.3354/aei00058; FAO, 2012, STAT WORLD FISH AQ 2; Gillanders B., 2016, SPENCER GULF ECOSYST; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Hijmans R. J., 2014, R PACKAGE VERSION; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; ISO, 2018, 310002018 ISO; Metcalf SJ, 2015, ECOL SOC, V20, DOI 10.5751/ES-07509-200235; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Murray CC, 2015, MAR POLICY, V58, P71, DOI 10.1016/j.marpol.2015.04.003; Pecl GT, 2014, CLIMATIC CHANGE, V127, P505, DOI 10.1007/s10584-014-1284-z; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Selkoe KA, 2009, CORAL REEFS, V28, P635, DOI 10.1007/s00338-009-0490-z; Shepherd SA, 2014, NATURAL HIST SPENCER; Smith SDP, 2015, ECOL APPL, V25, P717, DOI 10.1890/14-0366.1; Teck SJ, 2010, ECOL APPL, V20, P1402, DOI 10.1890/09-1173.1; Wiltshire KH, SARDI PUBLICATION, V468; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zhou SJ, 2008, FISH RES, V91, P56, DOI 10.1016/j.fishres.2007.11.007	33	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177393	10.1371/journal.pone.0177393	http://dx.doi.org/10.1371/journal.pone.0177393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489912	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100069
J	Montana, L; Caniglia, R; Galaverni, M; Fabbri, E; Ahmed, A; Bolfikova, BC; Czarnomska, SD; Galov, A; Godinho, R; Hindrikson, M; Hulva, P; Jedrzejewska, B; Jelencic, M; Kutal, M; Saarma, U; Skrbinsek, T; Randi, E				Montana, Luca; Caniglia, Romolo; Galaverni, Marco; Fabbri, Elena; Ahmed, Atidje; Bolfikova, Barbora Cerna; Czarnomska, Sylwia D.; Galov, Ana; Godinho, Raquel; Hindrikson, Maris; Hulva, Pavel; Jedrzejewska, Bogumila; Jelencic, Maja; Kutal, Miroslav; Saarma, Urmas; Skrbinsek, Tomaz; Randi, Ettore			Combining phylogenetic and demographic inferences to assess the origin of the genetic diversity in an isolated wolf population	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; CANIS-LUPUS; EVOLUTIONARY TREES; LARGE CARNIVORES; VARIABILITY; SOFTWARE; HISTORY; WOLVES; SIZE; POLYMORPHISM	The survival of isolated small populations is threatened by both demographic and genetic factors. Large carnivores declined for centuries in most of Europe due to habitat changes, overhunting of their natural prey and direct persecution. However, the current rewilding trends are driving many carnivore populations to expand again, possibly reverting the erosion of their genetic diversity. In this study we reassessed the extent and origin of the genetic variation of the Italian wolf population, which is expanding after centuries of decline and isolation. We genotyped wolves from Italy and other nine populations at four mtDNA regions (control-region, ATP6, COIII and ND4) and 39 autosomal microsatellites. Results of phylogenetic analyses and assignment procedures confirmed in the Italian wolves a second private mtDNA haplotype, which belongs to a haplogroup distributed mostly in southern Europe. Coalescent analyses showed that the unique mtDNA haplotypes in the Italian wolves likely originated during the late Pleistocene. ABC simulations concordantly showed that the extant wolf populations in Italy and in south-western Europe started to be isolated and declined right after the last glacial maximum. Thus, the standing genetic variation in the Italian wolves principally results from the historical isolation south of the Alps.	[Montana, Luca; Caniglia, Romolo; Galaverni, Marco; Fabbri, Elena; Randi, Ettore] ISPRA, Lab Genet, Bologna, Italy; [Ahmed, Atidje] Bulgarian Acad Sci, Inst Biodivers & Ecosyst Res, Sofia, Bulgaria; [Bolfikova, Barbora Cerna] Czech Univ Life Sci Prague, Fac Trop AgriSci, Prague, Czech Republic; [Czarnomska, Sylwia D.; Jedrzejewska, Bogumila] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Galov, Ana] Univ Zagreb, Dept Biol, Fac Sci, Zagreb, Croatia; [Godinho, Raquel] Univ Porto, CIBIO InBIO Ctr Invest Biodiversidade & Recursos, Campus Vairao, Vairao, Portugal; [Godinho, Raquel] Univ Porto, Fac Ciencias, Dept Biol, Oporto, Portugal; [Hindrikson, Maris] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia; [Hulva, Pavel] Charles Univ Prague, Dept Zool, Prague, Czech Republic; [Hulva, Pavel] Univ Ostrava, Dept Biol & Ecol, Ostrava, Czech Republic; [Jelencic, Maja] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Kutal, Miroslav; Skrbinsek, Tomaz] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Ecol, Brno, Czech Republic; [Kutal, Miroslav] Friends Earth Czech Republ, Olomouc Branch, Olomouc, Czech Republic; [Randi, Ettore] Aalborg Univ, Dept 18, Sect Environm Engn, Aalborg, Denmark	Italian Institute for Environmental Protection & Research (ISPRA); Bulgarian Academy of Sciences; Czech University of Life Sciences Prague; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; University of Zagreb; Universidade do Porto; Universidade do Porto; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Charles University Prague; University of Ostrava; University of Ljubljana; Mendel University in Brno; Aalborg University	Montana, L (corresponding author), ISPRA, Lab Genet, Bologna, Italy.	luca.montana@usherbrooke.ca	Saarma, Urmas/AAC-9813-2019; Kutal, Miroslav/B-9612-2014; Galov, Ana/AAC-4557-2020; Bolfikova, Barbora Cerna/I-6620-2019; Godinho, Raquel/L-6804-2013; Hindrikson, Maris/G-4573-2017	Saarma, Urmas/0000-0002-3222-571X; Kutal, Miroslav/0000-0003-3857-5419; Galov, Ana/0000-0002-3709-7286; Bolfikova, Barbora Cerna/0000-0001-8059-4889; Godinho, Raquel/0000-0002-4260-4799; Czarnomska, Sylwia/0000-0002-8081-0956; CANIGLIA, Romolo/0000-0002-3641-9490; Jedrzejewska, Bogumila/0000-0002-9652-0953; Montana, Luca/0000-0002-8869-6916; Skrbinsek, Tomaz/0000-0003-4435-7477; Hindrikson, Maris/0000-0001-8094-1860; Galaverni, Marco/0000-0002-2648-1506	Italian Ministry of Environment (MATTM); Italian Institute for Environmental Protection and Research (ISPRA); European Economic Area (EEA) and Norway; Estonian Ministry of Education and Research [IUT20-32]; Portuguese Foundation for Science and Technology [IF/564/2012]; BIOGEAST Biodiversity of East-European; Siberian large mammals on the level of genetic variation of populations, 7th Framework Programme [247652, 2096/7, UE/2011/2]	Italian Ministry of Environment (MATTM); Italian Institute for Environmental Protection and Research (ISPRA); European Economic Area (EEA) and Norway; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); BIOGEAST Biodiversity of East-European; Siberian large mammals on the level of genetic variation of populations, 7th Framework Programme	This project was supported by grants from Italian Ministry of Environment (MATTM) and the Italian Institute for Environmental Protection and Research (ISPRA). A grant from European Economic Area (EEA) and Norway was assigned for monitoring carnivore species of European importance in selected Natura 2000 sites. MH and US were supported by institutional research funding (IUT20-32) from the Estonian Ministry of Education and Research. RG was supported by the Portuguese Foundation for Science and Technology (IF/564/2012). US was supported by BIOGEAST Biodiversity of East-European and Siberian large mammals on the level of genetic variation of populations, 7th Framework Programme (contract nos. 247652 and no. 2096/7. PR UE/2011/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bartlett LJ, 2016, ECOGRAPHY, V39, P152, DOI 10.1111/ecog.01566; Beaumont MA, 2002, GENETICS, V162, P2025; Belkhir K, 2004, GENETIX 4 05 POPULAT, P2004; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Bjornerfeldt S, 2006, GENOME RES, V16, P990, DOI 10.1101/gr.5117706; Boggiano F, 2013, MAMM BIOL, V78, P374, DOI 10.1016/j.mambio.2013.06.001; BOITANI L, 1992, BIOL CONSERV, V61, P125, DOI 10.1016/0006-3207(92)91102-X; Boitani Luigi, 2003, P317; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Caniglia R, 2014, J MAMMAL, V95, P41, DOI 10.1644/13-MAMM-A-039; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; de Groot GA, 2015, MAMMAL REV, P1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fabbri E, 2014, MAMM BIOL, V79, P138, DOI 10.1016/j.mambio.2013.10.002; Fan ZX, 2016, GENOME RES, V26, P163, DOI 10.1101/gr.197517.115; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flower LOH, 2014, QUATERNARY SCI REV, V96, P188, DOI 10.1016/j.quascirev.2014.04.015; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Galaverni M, 2016, MAMMAL RES, V61, P13, DOI 10.1007/s13364-015-0247-8; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hindrikson M, 2016, BIOL REV; Hindrikson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075765; Hindrikson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046465; Hoban S, 2012, NAT REV GENET, V13, P110, DOI 10.1038/nrg3130; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Koblmu Eller S, 2016, J BIO GEOGR, P1; LACY R C, 1987, Conservation Biology, V1, P143, DOI 10.1111/j.1523-1739.1987.tb00023.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Leonard JA, 2005, MOL ECOL, V14, P9, DOI 10.1111/j.1365-294X.2004.02389.x; Leonard JA, 2007, CURR BIOL, V17, P1146, DOI 10.1016/j.cub.2007.05.072; Leonard JA, 2014, EVOL ECOL RES, V16, P461; Leonard JA, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P170; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Lohmueller KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002326; LONGMIRE JL, 1997, USE LYSIS BUFFER DNA; Lucchini V, 2004, MOL ECOL, V13, P523, DOI 10.1046/j.1365-294X.2004.02077.x; MECH LD, 1987, J MAMMAL, V68, P871, DOI 10.2307/1381570; Montana L, 2017, MAMM BIOL, V84, P30, DOI 10.1016/j.mambio.2017.01.005; Morey DF, 2014, J ARCHAEOL SCI, V52, P300, DOI 10.1016/j.jas.2014.08.015; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Palstra FP, 2012, ECOL EVOL, V2, P2357, DOI 10.1002/ece3.329; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pereira H.M., 2015, REWILDING EUROPEAN L; Perri A, 2016, J ARCHAEOL SCI, V68, P1, DOI 10.1016/j.jas.2016.02.003; Pilot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093828; Pilot M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-104; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Randi E, 2000, CONSERV BIOL, V14, P464, DOI 10.1046/j.1523-1739.2000.98280.x; Randi E, 2014, PLOS ONE, V9; Randi E, 2011, MAMMAL REV, V41, P99, DOI 10.1111/j.1365-2907.2010.00176.x; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandom C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3254; Sastre N, 2011, CONSERV GENET, V12, P701, DOI 10.1007/s10592-010-0177-6; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Silva PM., 2016, HIST DEMOGRAPHY DIFF; Skoglund P, 2011, MOL BIOL EVOL, V28, P1505, DOI 10.1093/molbev/msq342; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	73	20	20	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176560	10.1371/journal.pone.0176560	http://dx.doi.org/10.1371/journal.pone.0176560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UN	28489863	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100025
J	Cardoso, JMS; Guerreiro, SI; Lourenco, A; Alves, MM; Montemor, MF; Mira, NP; Leitao, JH; Carvalho, MFNN				Cardoso, Joao M. S.; Guerreiro, Soraia I.; Lourenco, Andreia; Alves, Marta M.; Fatima Montemor, M.; Mira, Nuno P.; Leitao, Jorge H.; Carvalho, M. Fernanda N. N.			Ag(I) camphorimine complexes with antimicrobial activity towards clinically important bacteria and species of the Candida genus	PLOS ONE			English	Article							SILVER NANOPARTICLES; RESISTANCE; TOXICITY; BIOFILMS; ALBICANS	The present work follows a previous report describing the antibacterial activity of silver camphorimine complexes of general formula [Ag(NO3)L]. The synthesis and demonstration of the antifungal and antibacterial activity of three novel [Ag(NO3) L] complexes (named 1, 2 and 3) is herein demonstrated. This work also shows for the first time that the previously studied complexes (named 4 to 8) also exert antifungal activity. The antibacterial activity of complexes was evaluated against Staphylococcus aureus, Pseudomonas aeruginosa, Burkholderia contaminans and Escherichia coli strains, while antifungal activity was tested against the Candida species C. albicans, C. glabrata, C. parapsilosis and C. tropicalis. The antimicrobial activity of the complexes ranged from very high (complex 4) to moderate (complex 6) or low (complex 8), depending on the structural and electronic characteristics of the camphorimine ligands. Notably, the highest antibacterial and anti-Candida activities do not coincide in the same complex and in some cases they were even opposite, as is the case of complex 4 which exhibits a high anti-bacterial and low antifungal activity. These distinct results suggest that the complexes may have different mechanisms against prokaryotic and eukaryotic cells. The antifungal activity of the Ag(I) camphorimine complexes (in particular of complex 1) was found to be very high (MIC = 2 mu g/mL) against C. parapsilosis, being also registered a prominent activity against C. tropicalis and C. glabrata. None of the tested compounds inhibited C. albicans growth, being this attributed to the ability of these yeast cells to mediate the formation of less toxic Ag nanoparticles, as confirmed by Scanning Electron Microscopy images. The high antibacterial and anti-Candida activities of the here studied camphorimine complexes, especially of complexes 1 and 7, suggests a potential therapeutic application for these compounds.	[Cardoso, Joao M. S.; Alves, Marta M.; Fatima Montemor, M.; Carvalho, M. Fernanda N. N.] Univ Lisbon, Ctr Quim Estrutural, Inst Super Tecn, Av Rovisco Pais, Lisbon, Portugal; [Guerreiro, Soraia I.; Lourenco, Andreia; Mira, Nuno P.; Leitao, Jorge H.] Univ Lisbon, iBB Inst Bioengn & Biosci, Inst Super Tecn, Av Rovisco Pais, Lisbon, Portugal; [Guerreiro, Soraia I.; Lourenco, Andreia; Mira, Nuno P.; Leitao, Jorge H.] Univ Lisbon, Dept Bioengn, Inst Super Tecn, Av Rovisco Pais, Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	Carvalho, MFNN (corresponding author), Univ Lisbon, Ctr Quim Estrutural, Inst Super Tecn, Av Rovisco Pais, Lisbon, Portugal.; Mira, NP; Leitao, JH (corresponding author), Univ Lisbon, iBB Inst Bioengn & Biosci, Inst Super Tecn, Av Rovisco Pais, Lisbon, Portugal.; Mira, NP; Leitao, JH (corresponding author), Univ Lisbon, Dept Bioengn, Inst Super Tecn, Av Rovisco Pais, Lisbon, Portugal.	nuno.mira@tecnico.ulisboa.pt; jorgeleitao@tecnico.ulisboa.pt; fcarvalho@ist.utl.pt	MONTEMOR, FATIMA/D-8976-2012; Mira, Nuno Pereira/E-2965-2012; Alves, Marta M./E-9716-2015; Leitão, Jorge H./A-5122-2012; Carvalho, MFNN/H-8162-2012	MONTEMOR, FATIMA/0000-0001-7835-6814; Mira, Nuno Pereira/0000-0001-7556-0385; Alves, Marta M./0000-0002-9679-4022; Leitão, Jorge H./0000-0001-8850-274X; Carvalho, MFNN/0000-0002-6825-1696	FCT-Fundacao para a Ciencia e Tecnologia [UID/QUI/00100/2013, UID/BIO/04565/2013, RECI/QEQ-QIN/0189/2012, PTDC/BIA-MIC/1615/2014]; Programa Operacional Regional de Lisboa [007317]; NMR Network (IST-UTL Node)	FCT-Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); Programa Operacional Regional de Lisboa; NMR Network (IST-UTL Node)	Financial support by FCT-Fundacao para a Ciencia e Tecnologia through projects UID/QUI/00100/2013, UID/BIO/04565/2013, RECI/QEQ-QIN/0189/2012 and partial contracts PTDC/BIA-MIC/1615/2014); Programa Operacional Regional de Lisboa 2020 (Project N. 007317) and the NMR Network (IST-UTL Node) for facilities are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support by FCT-Fundacao para a Ciencia e Tecnologia through projects UID/QUI/00100/2013, UID/BIO/04565/2013, RECI/QEQ-QIN/0189/2012 and partial contracts PTDC/BIA-MIC/1615/2014); Programa Operacional Regional de Lisboa 2020 (Project N. 007317) and the NMR Network (IST-UTL Node) for facilities are gratefully acknowledged.	Ahmed S, 2016, J ADV RES, V7, P17, DOI 10.1016/j.jare.2015.02.007; [Anonymous], M26A CLSI; Arendrup MC, 2012, CLIN MICROBIOL INFEC, V18, pE246, DOI 10.1111/j.1469-0691.2012.03880.x; Armarego WLF, 2009, PURIFICATION OF LABORATORY CHEMICALS, 6TH EDITION, P1; Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010; Brunetto PS, 2011, MATERIALS, V4, P355, DOI 10.3390/ma4020355; Cardoso JMS, 2017, J INORG BIOCHEM, V166, P55, DOI 10.1016/j.jinorgbio.2016.11.003; Cardoso JMS, 2016, DALTON T, V45, P7114, DOI 10.1039/c6dt00099a; Chai LYA, 2010, CRIT REV MICROBIOL, V36, P282, DOI 10.3109/1040841X.2010.489506; Chen WY, 2013, MOLECULES, V18, P5434, DOI 10.3390/molecules18055434; Coutinho CP, 2015, J MED MICROBIOL, V64, P927, DOI 10.1099/jmm.0.000094; Dorobantu LS, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-2984-7; Drake PL, 2005, ANN OCCUP HYG, V49, P575, DOI 10.1093/annhyg/mei019; Fernandes TA, 2015, POLYHEDRON, V87, P215, DOI 10.1016/j.poly.2014.11.020; Fernandes TA, 2014, J ORGANOMET CHEM, V760, P186, DOI 10.1016/j.jorganchem.2013.10.040; Fewtrell L., 2014, SILVER WATER DISINFE; Fromm KM, 2013, APPL ORGANOMET CHEM, V27, P683, DOI 10.1002/aoc.3047; Justino GC, 2016, RSC ADV, V6, P56249, DOI 10.1039/c6ra09627a; Klasen HJ, 2000, BURNS, V26, P117, DOI 10.1016/S0305-4179(99)00108-4; Lara HH, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0147-8; Maillard JY, 2013, CRIT REV MICROBIOL, V39, P373, DOI 10.3109/1040841X.2012.713323; McRee AE, 2015, J EXOT PET MED, V24, P240, DOI 10.1053/j.jepm.2015.04.015; Medici S, 2016, COORDIN CHEM REV, V327, P349, DOI 10.1016/j.ccr.2016.05.015; Mujahid M, 2016, J INORG BIOCHEM, V163, P53, DOI 10.1016/j.jinorgbio.2016.07.010; Obeng-Ofori D, 1998, INT J PEST MANAGE, V44, P203, DOI 10.1080/096708798228112; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Rauwel P, 2015, ADV MATER SCI ENG, V2015, DOI 10.1155/2015/682749; Rendosova M, 2017, J INORG BIOCHEM, V168, P1, DOI 10.1016/j.jinorgbio.2016.12.003; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Richau JA, 2000, J CLIN MICROBIOL, V38, P1651, DOI 10.1128/JCM.38.4.1651-1655.2000; Sanguinetti M, 2015, MYCOSES, V58, P2, DOI 10.1111/myc.12330; Silva S, 2013, MED MYCOL, V51, P178, DOI 10.3109/13693786.2012.700492; Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x; Silvestry-Rodriguez N, 2008, APPL ENVIRON MICROB, V74, P1639, DOI 10.1128/AEM.02237-07; Sokolova AS, 2015, EUR J MED CHEM, V105, P263, DOI 10.1016/j.ejmech.2015.10.010; Trofa D, 2008, CLIN MICROBIOL REV, V21, P606, DOI 10.1128/CMR.00013-08; Vazquez-Munoz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108876; Waghmare SR, 2015, 3 BIOTECH, V5, P33, DOI 10.1007/s13205-014-0196-y; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; 2008, EUR J CLIN MICROBIOL, V27, P1101, DOI DOI 10.1007/S10096-008-0552-0	40	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177355	10.1371/journal.pone.0177355	http://dx.doi.org/10.1371/journal.pone.0177355			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486529	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314000075
J	Hoppenbrouwers, T; Autar, ASA; Sultan, AR; Abraham, TE; van Cappellen, WA; Houtsmuller, AB; van Wamel, WJB; van Beusekom, HMM; van Neck, JW; de Maat, MPM				Hoppenbrouwers, Tamara; Autar, Anouchska S. A.; Sultan, Andi R.; Abraham, Tsion E.; van Cappellen, Wiggert A.; Houtsmuller, Adriaan B.; van Wamel, Willem J. B.; van Beusekom, Heleen M. M.; van Neck, Johan W.; de Maat, Moniek P. M.			In vitro induction of NETosis: Comprehensive live imaging comparison and systematic review	PLOS ONE			English	Review							NEUTROPHIL EXTRACELLULAR TRAPS; STEM-CELL TRANSPLANT; GROUP BOX 1; NADPH-OXIDASE; STREPTOCOCCUS-PNEUMONIAE; DNA TRAPS; ASPERGILLUS-FUMIGATUS; BACTERICIDAL ACTIVITY; MITOCHONDRIAL-DNA; NET FORMATION	Background Multiple inducers of in vitro Neutrophil Extracellular Trap (NET) formation (NETosis) have been described. Since there is much variation in study design and results, our aim was to create a systematic review of NETosis inducers and perform a standardized in vitro study of NETosis inducers important in (cardiac) wound healing. Methods In vitro NETosis was studied by incubating neutrophils with PMA, living and dead bacteria (S. aureus and E. coli), LPS, (activated) platelets (supernatant), glucose and calcium ionophore Ionomycin using 3-hour periods of time-lapse confocal imaging. Results PMA is a consistent and potent inducer of NETosis. Ionomycin also consistently resulted in extrusion of DNA, albeit with a process that differs from the NETosis process induced by PMA. In our standardized experiments, living bacteria were also potent inducers of NETosis, but dead bacteria, LPS, (activated) platelets (supernatant) and glucose did not induce NETosis. Conclusion Our systematic review confirms that there is much variation in study design and results of NETosis induction. Our experimental results confirm that under standardized conditions, PMA, living bacteria and Ionomycin all strongly induce NETosis, but real-time confocal imaging reveal different courses of events.	[Hoppenbrouwers, Tamara; van Neck, Johan W.] Erasmus MC, Dept Plast & Reconstruct Surg, Rotterdam, Netherlands; [Hoppenbrouwers, Tamara; Autar, Anouchska S. A.; de Maat, Moniek P. M.] Erasmus MC, Dept Hematol, Rotterdam, Netherlands; [Autar, Anouchska S. A.; van Beusekom, Heleen M. M.] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands; [Sultan, Andi R.; van Wamel, Willem J. B.] Erasmus MC, Dept Microbiol & Infect Dis, Rotterdam, Netherlands; [Abraham, Tsion E.; van Cappellen, Wiggert A.; Houtsmuller, Adriaan B.] Erasmus MC, Dept Pathol, Opt Imaging Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	de Maat, MPM (corresponding author), Erasmus MC, Dept Hematol, Rotterdam, Netherlands.	m.demaat@erasmusmc.nl	Hoppenbrouwers, Tamara/D-8616-2018	van Wamel, Willem/0000-0001-9145-9121; de Maat, Moniek/0000-0001-7749-334X; Hoppenbrouwers, Tamara/0000-0002-1764-9100	Trombosestichting [TSN2013-2]	Trombosestichting	This study was funded by the Trombosestichting: TSN2013-2 (https://www. trombosestichting.nI/, received by MPMdM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah DSA, 2012, INFECT IMMUN, V80, P768, DOI 10.1128/IAI.05730-11; Achouiti A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002987; Agraz-Cibrian JM, 2016, J INFECT DEV COUNTR, V10, P512, DOI 10.3855/jidc.7165; Akk A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00325; Akong-Moore K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042984; Al-Khafaji AB, 2016, MOL MED, V22, P621, DOI 10.2119/molmed.2016.00054; Aldabbous L, 2016, ARTERIOSCL THROM VAS, V36, P2078, DOI 10.1161/ATVBAHA.116.307634; Aleyd E, 2014, J IMMUNOL, V192, P2374, DOI 10.4049/jimmunol.1300261; Alfaro C, 2016, CLIN CANCER RES, V22, P3924, DOI 10.1158/1078-0432.CCR-15-2463; Amini P, 2016, EUR J IMMUNOL, V46, P178, DOI 10.1002/eji.201545615; Ammollo CT, 2016, J PHARMACOL EXP THER, V356, P305, DOI 10.1124/jpet.115.229823; Andzinski L, 2016, INT J CANCER, V138, P1982, DOI 10.1002/ijc.29945; Arai Y, 2014, BIOCHEM BIOPH RES CO, V443, P556, DOI 10.1016/j.bbrc.2013.12.007; Araujo CV, 2016, SHOCK, V45, P393, DOI 10.1097/SHK.0000000000000520; Awasthi D, 2016, FREE RADICAL BIO MED, V93, P190, DOI 10.1016/j.freeradbiomed.2016.01.004; Azevedo EPC, 2012, J BIOL CHEM, V287, P37206, DOI 10.1074/jbc.M112.369942; Bachiega TF, 2016, IMMUNOBIOLOGY, V221, P228, DOI 10.1016/j.imbio.2015.09.003; Barrientos L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00166; Basyreva Liliya Yu, 2016, Human Antibodies, V24, P39, DOI 10.3233/HAB-160293; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Bekeschus S, 2016, J LEUKOCYTE BIOL, V100, P791, DOI 10.1189/jlb.3A0415-165RR; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Biermann MHC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00557; Boneschansker L, 2016, INTEGR BIOL-UK, V8, P149, DOI 10.1039/c5ib00265f; Braian C, 2013, J INNATE IMMUN, V5, P591, DOI 10.1159/000348676; Branitzki-Heinemann K, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00518; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Braster Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163922; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V., 2010, JOVE-J VIS EXP, V36, P1724, DOI [10.3791/1724, DOI 10.3791/1724/J0VE.C0M/VIDE0/1724]; Brinkmann V, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00413; Brogden G, 2014, DEV COMP IMMUNOL, V44, P280, DOI 10.1016/j.dci.2014.01.003; Brogden G, 2012, FISH SHELLFISH IMMUN, V33, P1060, DOI 10.1016/j.fsi.2012.08.009; Byrd AS, 2016, J INFECT DIS, V213, P634, DOI 10.1093/infdis/jiv435; Bystrzycka W, 2016, CENT EUR J IMMUNOL, V41, P1, DOI 10.5114/ceji.2016.58811; Cacciotto C, 2016, CELL MICROBIOL, V18, P1751, DOI 10.1111/cmi.12613; Camicia G, 2014, SHOCK, V42, P286, DOI 10.1097/SHK.0000000000000221; Carestia A, 2016, J LEUKOCYTE BIOL, V99, P153, DOI 10.1189/jlb.3A0415-161R; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Chang A, 2011, MOL MICROBIOL, V79, P1629, DOI 10.1111/j.1365-2958.2011.07550.x; Chen XQ, 2016, NAT METHODS, V13, P1013, DOI [10.1038/NMETH.4031, 10.1038/nmeth.4031]; Chi H, 2016, DEV COMP IMMUNOL, V56, P7, DOI 10.1016/j.dci.2015.11.005; Chrysanthopoulou A, 2014, J PATHOL, V233, P294, DOI 10.1002/path.4359; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Clark SR, 2011, BLOOD, V117, P2033, DOI 10.1182/blood-2010-04-278887; Cogen AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008557; Cools-Lartigue J., 2013, J CLIN INVEST, V67484; Corsiero E, 2016, ANN RHEUM DIS, V75, P1866, DOI 10.1136/annrheumdis-2015-208356; Cortjens B, 2016, J PATHOL, V238, P401, DOI 10.1002/path.4660; Csomos K, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.200; de Buhr N, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12649; Demers M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1134073; Demers M, 2012, P NATL ACAD SCI USA, V109, P13076, DOI 10.1073/pnas.1200419109; Derre-Bobillot A, 2013, MOL MICROBIOL, V89, P518, DOI 10.1111/mmi.12295; Desai J, 2016, EUR J IMMUNOL, V46, P223, DOI 10.1002/eji.201545605; Doke M, 2016, MOL ORAL MICROBIOL; Dolgushin II, 2015, B EXP BIOL MED+, V159, P472, DOI 10.1007/s10517-015-2995-5; Domingo-Gonzalez R, 2016, AM J RESP CRIT CARE, V193, P186, DOI 10.1164/rccm.201501-0161OC; Douda DN, 2011, J IMMUNOL, V187, P1856, DOI 10.4049/jimmunol.1004201; Dubois AV, 2012, AM J RESP CELL MOL, V47, P80, DOI 10.1165/rcmb.2011-0380OC; Ermert D, 2009, J INNATE IMMUN, V1, P181, DOI 10.1159/000205281; Etulain J, 2015, BLOOD, V126, P242, DOI 10.1182/blood-2015-01-624023; Fadini GP, 2016, DIABETES, V65, P1061, DOI 10.2337/db15-0863; Farley K, 2012, J IMMUNOL, V189, P4574, DOI 10.4049/jimmunol.1201167; Farrera C, 2013, J IMMUNOL, V191, P2647, DOI 10.4049/jimmunol.1300436; Flores R, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00566; Floyd M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005987; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2012, ARTERIOSCL THROM VAS, V32, P1777, DOI 10.1161/ATVBAHA.111.242859; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gazendam RP, 2016, J IMMUNOL, V196, P1272, DOI 10.4049/jimmunol.1501811; Giaglis S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00565; Gogol M, 2016, ACTA BIOCHIM POL, V63, P167, DOI 10.18388/abp.2015_1163; Gondaira S, 2017, VET MICROBIOL, V199, P68, DOI 10.1016/j.vetmic.2016.12.022; Grinberg N, 2008, INFECT IMMUN, V76, P2802, DOI 10.1128/IAI.00051-08; Grund LZ, 2017, AUTOIMMUNITY, V50, P86, DOI 10.1080/08916934.2016.1261834; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Gupta AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097088; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Haase H, 2016, ARCH TOXICOL, V90, P543, DOI 10.1007/s00204-015-1484-y; Harrison S, 2011, AM J SPORT MED, V39, P729, DOI 10.1177/0363546511401576; Hasan R, 2013, INNATE IMMUN-LONDON, V19, P253, DOI 10.1177/1753425912458815; Hazeldine J, 2014, AGING CELL, V13, P690, DOI 10.1111/acel.12222; Hirschfeld J, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.33070; Hirschfeld J, 2015, INT J MED MICROBIOL, V305, P453, DOI 10.1016/j.ijmm.2015.04.002; Hoffmann JHO, 2016, EXP DERMATOL, V25, P895, DOI 10.1111/exd.13125; Hong WZ, 2009, J INNATE IMMUN, V1, P215, DOI 10.1159/000205937; Hopke A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005644; Imbert S, 2016, J ALLERGY CLIN IMMUN, V138, P860, DOI 10.1016/j.jaci.2016.02.026; Itakura A, 2013, AM J PHYSIOL-CELL PH, V305, pC348, DOI 10.1152/ajpcell.00108.2013; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jean S, 2016, INFECT IMMUN, V84, P2973, DOI 10.1128/IAI.00319-16; Jiang DS, 2016, STEM CELLS, V34, P2393, DOI 10.1002/stem.2417; Johnson JL, 2016, J BIOL CHEM, V291, P25965, DOI 10.1074/jbc.M116.741884; Joshi MB, 2016, SCI REP-UK, V6, DOI 10.1038/srep36362; Joshi MB, 2013, FEBS LETT, V587, P2241, DOI 10.1016/j.febslet.2013.05.053; Jovic S, 2016, MUCOSAL IMMUNOL, V9, P112, DOI 10.1038/mi.2015.43; Kawakami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084704; Kenno S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00879; Keshari RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048111; Keshari RS, 2012, CYTOM PART A, V81A, P238, DOI 10.1002/cyto.a.21178; Kirchner T, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/710239; Kirchner T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/849136; Kono M, 2016, CLIN EXP PHARMACOL P, V43, P915, DOI 10.1111/1440-1681.12612; Konstantinidis T, 2016, ANTIMICROB AGENTS CH, V60, P1040, DOI 10.1128/AAC.02063-15; Kraemer BF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002355; Krautgartner WD, 2008, MICRON, V39, P367, DOI 10.1016/j.micron.2007.03.007; Kulkarni R, 2016, AM J RESP CELL MOL, V55, P586, DOI 10.1165/rcmb.2015-0397OC; Kusunoki Y, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00227; Landoni VI, 2012, CLIN EXP IMMUNOL, V168, P153, DOI 10.1111/j.1365-2249.2012.04560.x; Lappann M, 2013, MOL MICROBIOL, V89, P433, DOI 10.1111/mmi.12288; Lee J, 2016, RHEUMATOLOGY OXFORD; Lippolis JD, 2006, VET IMMUNOL IMMUNOP, V113, P248, DOI 10.1016/j.vetimm.2006.05.004; Liu CL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3707; Liu SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep37252; Longstaff C, 2013, J BIOL CHEM, V288, P6946, DOI 10.1074/jbc.M112.404301; Lood C, 2016, RHEUMATOLOGY OXFORD; Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027; Ma YH, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-015-0903-z; Malachowa N, 2013, J IMMUNOL, V191, P6022, DOI 10.4049/jimmunol.1301821; Mangold A, 2015, CIRC RES, V116, P1182, DOI 10.1161/CIRCRESAHA.116.304944; Marin-Esteban V, 2012, INFECT IMMUN, V80, P1891, DOI 10.1128/IAI.00050-12; Martinod K, 2016, J THROMB HAEMOST, V14, P551, DOI 10.1111/jth.13239; Maugeri N, 2014, J THROMB HAEMOST, V12, P2074, DOI 10.1111/jth.12710; McInturff AM, 2012, BLOOD, V120, P3118, DOI 10.1182/blood-2012-01-405993; Menegazzi R, 2012, BLOOD, V119, P1214, DOI 10.1182/blood-2011-07-364604; Menegazzo L, 2015, ACTA DIABETOL, V52, P497, DOI 10.1007/s00592-014-0676-x; Meng W, 2012, CRIT CARE, V16, DOI 10.1186/cc11442; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Miyoshi A, 2016, PATHOBIOLOGY, V83, P243, DOI 10.1159/000444881; Mizurini DM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003869; Mori Y, 2012, J BIOL CHEM, V287, P10472, DOI 10.1074/jbc.M111.280321; Moussavi-Harami SF, 2016, INTEGR BIOL-UK, V8, P243, DOI 10.1039/c5ib00225g; Muller S, 2016, J INVEST DERMATOL, V136, P117, DOI 10.1038/JID.2015.361; Munafo DB, 2009, J INNATE IMMUN, V1, P527, DOI 10.1159/000235860; Nakazawa D, 2016, J AUTOIMMUN, V67, P19, DOI 10.1016/j.jaut.2015.08.018; Nakazawa D, 2012, ARTHRITIS RHEUM-US, V64, P3779, DOI 10.1002/art.34619; Neeli I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00038; Nishinaka Y, 2011, BIOCHEM BIOPH RES CO, V413, P75, DOI 10.1016/j.bbrc.2011.08.052; Noubouossie DF, 2017, BLOOD, V129, P1021, DOI 10.1182/blood-2016-06-722298; O'Donoghue AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075141; Oehmcke S, 2009, J INNATE IMMUN, V1, P225, DOI 10.1159/000203700; Okubo K, 2016, EBIOMEDICINE, V10, P204, DOI 10.1016/j.ebiom.2016.07.012; Ollier V., 2016, P 2016 IEEE SENS ARR, P1, DOI [10.1109/SAM.2016.7569694, DOI 10.1109/SAM.2016.7569694]; Palic D, 2007, DEV COMP IMMUNOL, V31, P805, DOI 10.1016/j.dci.2006.11.010; Palmer LJ, 2016, J PERIODONTAL RES, V51, P70, DOI 10.1111/jre.12284; Palmer LJ, 2012, J PERIODONTAL RES, V47, P439, DOI 10.1111/j.1600-0765.2011.01451.x; Palmer LJ, 2012, CLIN EXP IMMUNOL, V167, P261, DOI 10.1111/j.1365-2249.2011.04518.x; Papayannopoulos V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028526; Park J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1711; Parker H, 2012, J LEUKOCYTE BIOL, V92, P841, DOI 10.1189/jlb.1211601; Parker H, 2012, J LEUKOCYTE BIOL, V91, P369, DOI 10.1189/jlb.0711387; Patel S, 2010, NITRIC OXIDE-BIOL CH, V22, P226, DOI 10.1016/j.niox.2010.01.001; Pieterse E, 2016, SCI REP-UK, V6, DOI 10.1038/srep38229; Pieterse E, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00484; Pijanowski L, 2013, FISH SHELLFISH IMMUN, V34, P1244, DOI 10.1016/j.fsi.2013.02.010; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Pulze L, 2016, CLIN EXP IMMUNOL, V183, P469, DOI 10.1111/cei.12730; Aleman OR, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00277; Aleman OR, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/2908034; Razvina O, 2015, EXP MOL PATHOL, V98, P33, DOI 10.1016/j.yexmp.2014.11.009; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Rohm M, 2014, INFECT IMMUN, V82, P1766, DOI 10.1128/IAI.00096-14; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Savchenko AS, 2011, PATHOL INT, V61, P290, DOI 10.1111/j.1440-1827.2011.02651.x; Scapinello S, 2011, VET IMMUNOL IMMUNOP, V139, P113, DOI 10.1016/j.vetimm.2010.09.004; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Schneider AE, 2016, MOL IMMUNOL, V72, P37, DOI 10.1016/j.molimm.2016.02.011; Schorn C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00376; Schorn C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00277; Secundino I, 2016, J MOL MED, V94, P219, DOI 10.1007/s00109-015-1341-8; Seper A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003614; Sha LL, 2016, INNATE IMMUN-LONDON, V22, P658, DOI 10.1177/1753425916668981; Shimomura Y, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0177-9; Shishikura K, 2016, BRIT J PHARMACOL, V173, P319, DOI 10.1111/bph.13373; Sil P, 2017, INFLAMM RES, V66, P227, DOI 10.1007/s00011-016-1008-0; Sil P, 2017, J IMMUNOL, V198, P428, DOI 10.4049/jimmunol.1600766; Skopelja S, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88912; Sollberger G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157454; Stephan A, 2016, IMMUNOLOGY, V148, P420, DOI 10.1111/imm.12620; Su SB, 1996, J LEUKOCYTE BIOL, V59, P420, DOI 10.1002/jlb.59.3.420; Suzuki E, 2016, J IMMUNOL, V197, P4403, DOI 10.4049/jimmunol.1600383; Tadie JM, 2013, AM J PHYSIOL-LUNG C, V304, pL342, DOI 10.1152/ajplung.00151.2012; Tillack K, 2012, J IMMUNOL, V188, P3150, DOI 10.4049/jimmunol.1103414; Totani L, 2016, J THROMB HAEMOST, V14, P191, DOI 10.1111/jth.13173; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Van Avondt K, 2016, J IMMUNOL, V196, P3686, DOI 10.4049/jimmunol.1501650; van der Spek AH, 2016, ENDOCRINOLOGY, V157, P3293, DOI 10.1210/en.2016-1103; van Sorge NM, 2013, J BIOL CHEM, V288, P6417, DOI 10.1074/jbc.M112.448738; Ramos MV, 2016, J INNATE IMMUN, V8, P400, DOI 10.1159/000445770; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Vollger L, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160031; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; von Kockritz-Blickwede M, 2009, BLOOD, V114, P5245, DOI 10.1182/blood-2009-08-240713; Vong L, 2014, J IMMUNOL, V192, P1870, DOI 10.4049/jimmunol.1302286; Vorobjeva NV, 2016, IMMUNOBIOLOGY, V221, P208, DOI 10.1016/j.imbio.2015.09.005; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; Welin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069575; Wilson-Welder JH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01110; Wong SL, 2015, NAT MED; Yan HM, 2016, ARTERIOSCL THROM VAS, V36, P1660, DOI 10.1161/ATVBAHA.116.307786; Yan J, 2012, J IMMUNOL, V188, P2316, DOI 10.4049/jimmunol.1102683; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Yoo DG, 2014, IMMUNOL LETT, V160, P186, DOI 10.1016/j.imlet.2014.03.003; Yoo DG, 2014, J IMMUNOL, V192, P4728, DOI 10.4049/jimmunol.1301589; Young RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023637; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Yuen J, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00137; Zawrotniak M, 2015, ACTA BIOCHIM POL, V62, P465, DOI 10.18388/abp.2015_1055; Zhang H., 2016, INT J MOL SCI, V17; Zhang XH, 2016, MICROBIOL IMMUNOL, V60, P859, DOI 10.1111/1348-0421.12459; Zhao WP, 2015, J IMMUNOL METHODS, V423, P104, DOI 10.1016/j.jim.2015.04.027	214	106	108	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176472	10.1371/journal.pone.0176472	http://dx.doi.org/10.1371/journal.pone.0176472			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486563	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000012
J	Yamashita, H; Seto, Y; Takenaka, R; Okuma, K; Kiritooshi, T; Mori, K; Yamada, K; Fukuda, T; Kaminishi, M; Abe, O; Nakagawa, K				Yamashita, Hideomi; Seto, Yasuyuki; Takenaka, Ryousuke; Okuma, Kae; Kiritooshi, Tomoki; Mori, Kazuhiko; Yamada, Kazuhiko; Fukuda, Takashi; Kaminishi, Michio; Abe, Osamu; Nakagawa, Keiichi			Survival comparison between radical surgery and definitive chemoradiation in 267 esophageal squamous cell carcinomas in a single institution: A propensity-matched study	PLOS ONE			English	Article							PHASE-III TRIAL; THORACIC ESOPHAGUS; RADIATION-THERAPY; RANDOMIZED-TRIAL; CHEMORADIOTHERAPY; CANCER; CISPLATIN; PLUS; 5-FLUOROURACIL; FLUOROURACIL	Objective To compare radical surgery with definitive chemoradiation (CRT) for esophageal squamous cell carcinoma using propensity score (PS) matching at our single institution. Materials and methods A total of 386 consecutive, surgically treated and 243 CRT-treated cases between 2001 and 2014 were analyzed. PS was calculated using multivariable analysis (logistic regression) for pairs of variables such as treatment time, age, sex, primary tumor location, clinical stage, and clinical T-and N-stage for patients after excluding clinical T4 and M1 cases. According to PS, 133 surgically-treated and 134 CRT-treated cases were selected randomly by software. Results The patients' median age was 68 years in the CRT group and 71 years in the surgery group. Clinical stage II-III, T3, N0 (according to the 7th American Joint Committee on Cancer-2009), and upper plus middle thoracic esophageal disease were seen in 68%, 44%, 54%, and 59%, respectively, in the CRT group and 64%, 47%, 55%, and 64%, respectively, in the surgery group. The 3-and 5-year overall survival was 47.1% and 34.0% in the CRT group and 68.3% and 54.4% in the surgery group (p = 0.0019). The 3-and 5-year progression-free survival was 45.3% and 38.8% in the CRT group and 61.1% and 54.4% in the surgery group (p = 0.022). Conclusion CRT may be inferior to surgery in survival, although a selection bias for patients selected for a non-operative approach cannot be excluded, especially since surgery is the standard of care at this institution. A prospective randomized clinical trial will be necessary to draw a definite conclusion.	[Yamashita, Hideomi; Takenaka, Ryousuke; Okuma, Kae; Kiritooshi, Tomoki; Abe, Osamu; Nakagawa, Keiichi] Univ Tokyo Hosp, Dept Radiol, Tokyo, Japan; [Seto, Yasuyuki] Univ Tokyo Hosp, Dept Gastrointestinal Surg, Tokyo, Japan; [Mori, Kazuhiko] Mitui Mem Hosp, Dept Gastrointestinal Surg, Tokyo, Japan; [Yamada, Kazuhiko] Natl Ctr Global Hlth & Med, Dept Gastrointestinal Surg, Tokyo, Japan; [Fukuda, Takashi] Saitama Canc Ctr, Dept Gastrointestinal Surg, Saitama, Japan; [Kaminishi, Michio] Showa Gen Hosp, Dept Gastrointestinal Surg, Tokyo, Japan	University of Tokyo; University of Tokyo; National Center for Global Health & Medicine - Japan	Yamashita, H (corresponding author), Univ Tokyo Hosp, Dept Radiol, Tokyo, Japan.	yamachan07291973@yahoo.co.jp		Abe, Osamu/0000-0002-1180-2629				Ando N, 2003, J CLIN ONCOL, V21, P4592, DOI 10.1200/JCO.2003.12.095; Ando N, 2000, ANN SURG, V232, P225, DOI 10.1097/00000658-200008000-00013; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Best LMJ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011498.pub2; Bosset JF, 1997, NEW ENGL J MED, V337, P161, DOI 10.1056/NEJM199707173370304; Burmeister BH, 2005, LANCET ONCOL, V6, P659, DOI 10.1016/S1470-2045(05)70288-6; Conroy T, 2014, LANCET ONCOL, V15, P305, DOI 10.1016/S1470-2045(14)70028-2; Crosby T, 2017, BRIT J CANCER, V116, P709, DOI 10.1038/bjc.2017.21; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Fujita Hiromasa, 2002, Ann Thorac Cardiovasc Surg, V8, P328; Gebski V, 2007, LANCET ONCOL, V8, P226, DOI 10.1016/S1470-2045(07)70039-6; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Herskovic A, 2012, ANN ONCOL, V23, P1095, DOI 10.1093/annonc/mdr433; Hyder O, 2014, SURGERY, V155, P85, DOI 10.1016/j.surg.2013.06.001; Ishikura S, 2003, J CLIN ONCOL, V21, P2697, DOI 10.1200/JCO.2003.03.055; *JAP SOC ES DIS, 2002, COMPR REG ES CANC JA; Kato H, 2009, JPN J CLIN ONCOL, V39, P638, DOI 10.1093/jjco/hyp069; Kato K, 2011, INT J RADIAT ONCOL, V81, P684, DOI 10.1016/j.ijrobp.2010.06.033; Kelsen DP, 2005, SEMIN ONCOL, V32, pS6, DOI 10.1053/j.seminoncol.2005.04.025; Lin D, 2017, J THORAC DIS, V9, P318, DOI 10.21037/jtd.2017.02.19; Matsuda S, 2015, ANN SURG ONCOL, V22, P1866, DOI 10.1245/s10434-014-4337-7; Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Mu JW, 2016, J THORAC DIS, V8, P3588, DOI 10.21037/jtd.2016.12.42; MULLER JM, 1990, BRIT J SURG, V77, P845, DOI 10.1002/bjs.1800770804; National Comprehensive Cancer Network Panel Members, 2003, J NATL COMPR CANC NE, V1, P14; Nomura M, 2016, INT J CLIN ONCOL, V21, P890, DOI 10.1007/s10147-016-0963-3; Teoh AYB, 2013, ANN ONCOL, V24, P165, DOI 10.1093/annonc/mds206; Tepper J, 2008, J CLIN ONCOL, V26, P1086, DOI 10.1200/JCO.2007.12.9593; Urba SG, 2001, J CLIN ONCOL, V19, P305, DOI 10.1200/JCO.2001.19.2.305; Wobst A, 1998, ANN ONCOL, V9, P951, DOI 10.1023/A:1008273110272; Yamashita H, 2006, DIS ESOPHAGUS, V19, P15, DOI 10.1111/j.1442-2050.2006.00531.x	31	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177133	10.1371/journal.pone.0177133	http://dx.doi.org/10.1371/journal.pone.0177133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486551	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000048
J	Ye, LY; Wu, XJ; Wu, TW; Wu, QJ; Liu, Z; Liu, C; Li, S; Chen, T				Ye, Liangying; Wu, Xiaojing; Wu, Tongwei; Wu, Qijing; Liu, Zhao; Liu, Chuan; Li, Sen; Chen, Tao			Meta-analysis of laparoscopic vs. open resection of gastric gastrointestinal stromal tumors	PLOS ONE			English	Article							OPEN WEDGE RESECTION; SURGICAL STRATEGY; FOLLOW-UP; STOMACH; GIST; SURGERY; EXPERIENCE; OUTCOMES; IMPACT; LARGER	Background This meta-analysis compared laparoscopic surgery (LAP) and open resection (OPEN) for the treatment of gastric gastrointestinal stromal tumors (GISTs) with regard to feasibility and safety. Methods We searched PubMed, Embase, and Web of Science for studies published before March 2016 comparing the LAP and OPEN procedures for GISTs. RevMan 5.1 software was used for the meta-analysis. Results In total, 28 studies met the inclusion criteria for the meta-analysis. The mean tumor sizes in the OPEN and LAP groups were 4.54 and 5.67 cm. Compared with the OPEN patients, the LAP patients experienced shorter surgical times (P = 0.05), less blood loss (P< 0.01), earlier time to flatus (P< 0.01) and an oral diet (P< 0.01), and shorter hospital stays (P< 0.01). The LAP patients also exhibited a decrease in overall complications (P< 0.01). In addition, regarding the subgroup of larger GISTs (> 5 cm), the present study did not report significant differences in operation time (P = 0.93), postoperative complications (P = 0.30), or recurrence rate (P = 0.61) between the two groups, though LAP was associated with favorable results regarding blood loss (P = 0.03) and hospital stay (P< 0.01). Conclusions Compared with the OPEN procedure, the LAP procedure is associated with preferable short-term postoperative outcomes and does not compromise long-term oncological outcomes. For gastric GISTs >5 cm, no significant difference was detected between LAP and OPEN if patient selection and intraoperative decisions were carefully considered.	[Ye, Liangying; Wu, Xiaojing; Wu, Tongwei; Wu, Qijing; Liu, Zhao; Liu, Chuan] Southern Med Univ, Clin Med Coll 1, Guangzhou, Guangdong, Peoples R China; [Li, Sen] Southwest Med Univ, Dept Spinal Surg, Affiliated Tradit Chinese Med Hosp, Luzhou, Peoples R China; [Chen, Tao] Southern Med Univ, Dept Gen Surg, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southwest Medical University; Southern Medical University - China	Li, S (corresponding author), Southwest Med Univ, Dept Spinal Surg, Affiliated Tradit Chinese Med Hosp, Luzhou, Peoples R China.; Chen, T (corresponding author), Southern Med Univ, Dept Gen Surg, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.	senlimd@126.com; drchentao@163.com						Cai JQ, 2015, BMC SURG, V15, DOI 10.1186/s12893-015-0040-2; Catena F, 2008, J GASTROINTEST SURG, V12, P561, DOI 10.1007/s11605-007-0416-4; Dai Qiao-qiong, 2011, Zhonghua Wei Chang Wai Ke Za Zhi, V14, P603; De Vogelaere K, 2013, SURG ENDOSC, V27, P1546, DOI 10.1007/s00464-012-2622-8; de'Angelis N, 2015, SURG LAPARO ENDO PER, V25, P143, DOI 10.1097/SLE.0000000000000080; Goh BKP, 2010, WORLD J SURG, V34, P1847, DOI 10.1007/s00268-010-0590-5; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Hsiao CY, 2015, SURG ENDOSC, V29, P868, DOI 10.1007/s00464-014-3742-0; Ishikawa K, 2006, SURG LAPARO ENDO PER, V16, P82, DOI 10.1097/00129689-200604000-00005; Karakousis GC, 2011, ANN SURG ONCOL, V18, P1599, DOI 10.1245/s10434-010-1517-y; Kasetsermwiriya W, 2014, J LAPAROENDOSC ADV S, V24, P123, DOI 10.1089/lap.2013.0433; Kim IH, 2014, ANN SURG TREAT RES, V87, P298, DOI 10.4174/astr.2014.87.6.298; Kim KH, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-230; Lee PC, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-44; Lin JX, 2014, SURG ENDOSC, V28, P2577, DOI 10.1007/s00464-014-3506-x; Lukaszczyk J J, 1992, J Laparoendosc Surg, V2, P331, DOI 10.1089/lps.1992.2.331; Matthews BD, 2002, SURG ENDOSC, V16, P803, DOI 10.1007/s00464-001-8319-z; Melstrom LG, 2012, AM J CLIN ONCOL-CANC, V35, P451, DOI 10.1097/COC.0b013e31821954a7; Miettinen M, 1999, HUM PATHOL, V30, P1213, DOI 10.1016/S0046-8177(99)90040-0; Miettinen Markku, 2003, Polish Journal of Pathology, V54, P3; Mochizuki Y, 2006, SURG TODAY, V36, P341, DOI 10.1007/s00595-005-3164-7; Nguyen SQ, 2006, SURG ENDOSC, V20, P713, DOI 10.1007/s00464-005-0435-8; Nishimura J, 2007, SURG ENDOSC, V21, P875, DOI 10.1007/s00464-006-9065-z; Pelletier Jean-Sebastien, 2015, J Clin Med Res, V7, P289, DOI 10.14740/jocmr1547w; Piessen G, 2015, ANN SURG, V262, P831, DOI 10.1097/SLA.0000000000001488; Pitsinis V, 2007, HEPATO-GASTROENTEROL, V54, P606; Pucci MJ, 2012, SURG ENDOSC, V26, P3509, DOI 10.1007/s00464-012-2374-5; Severino BU, 2016, J MINIM ACCESS SURG, V12, P148, DOI 10.4103/0972-9941.169955; Shu ZB, 2013, CHINESE J CANCER RES, V25, P175, DOI 10.3978/j.issn.1000-9604.2013.02.03; Sista F, 2015, ANN ITAL CHIR, V86, P349; Takahashi T, 2015, SURG LAPARO ENDO PER, V25, P114, DOI 10.1097/SLE.0000000000000039; von Mehren M, 2014, J NATL COMPR CANC NE, V12, P853, DOI 10.6004/jnccn.2014.0080; Wan P, 2012, DIGEST SURG, V29, P243, DOI 10.1159/000341497; Wiebe N, 2006, J CLIN EPIDEMIOL, V59, P342, DOI 10.1016/j.jclinepi.2005.08.017; Wu JM, 2010, J LAPAROENDOSC ADV S, V20, P725, DOI 10.1089/lap.2010.0231; Xue Anwei, 2015, Zhonghua Wei Chang Wai Ke Za Zhi, V18, P1119; Yan Peng, 2015, Zhonghua Wei Chang Wai Ke Za Zhi, V18, P808	37	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177193	10.1371/journal.pone.0177193	http://dx.doi.org/10.1371/journal.pone.0177193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486486	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000055
J	Zhao, Y; Wu, KJ; Nguyen, C; Smbatyan, G; Melendez, E; Higuchi, Y; Chen, YB; Kahn, M				Zhao, Yi; Wu, Kaijin; Nguyen, Cu; Smbatyan, Goar; Melendez, Elisabeth; Higuchi, Yusuke; Chen, Yibu; Kahn, Michael			Small molecule p300/catenin antagonist enhances hematopoietic recovery after radiation	PLOS ONE			English	Article							CREB-BINDING PROTEIN; BETA-CATENIN; STEM-CELLS; SELF-RENEWAL; GAMMA-CATENIN; LONG-TERM; CBP; P300; DIFFERENTIATION; INHIBITION	There is currently no FDA approved therapeutic agent for ARS mitigation post radiation exposure. Here we report that the small molecule YH250, which specifically antagonizes p300/catenin interaction, stimulates hematopoiesis in lethally or sublethally irradiated mice. A single administration of YH250 24 hours post irradiation can significantly stimulate HSC proliferation, improve survival and accelerate peripheral blood count recovery. Our studies suggest that promotion of the expansion of the remaining HSC population via stimulation of symmetric non-differentiative proliferation is at least part of the mechanism of action.	[Zhao, Yi] Univ Southern Calif, Keck Sch Med, Dept Med, Los Angeles, CA USA; [Zhao, Yi; Higuchi, Yusuke; Kahn, Michael] Univ Southern Calif, Keck Sch Med, Ctr Mol Pathways & Drug Discovery, Los Angeles, CA 90007 USA; [Zhao, Yi; Higuchi, Yusuke; Kahn, Michael] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA; [Wu, Kaijin; Nguyen, Cu; Smbatyan, Goar; Melendez, Elisabeth; Higuchi, Yusuke; Kahn, Michael] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Res Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90007 USA; [Higuchi, Yusuke] Osaka Univ, Inst Sci & Ind Res, Dept Organ Fine Chem, Ibaraki, Osaka, Japan; [Chen, Yibu] Univ Southern Calif, Norris Med Lib, Bioinformat Serv Program, Los Angeles, CA USA; [Kahn, Michael] Univ Southern Calif, Keck Sch Med, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90007 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; Osaka University; University of Southern California; University of Southern California	Kahn, M (corresponding author), Univ Southern Calif, Keck Sch Med, Ctr Mol Pathways & Drug Discovery, Los Angeles, CA 90007 USA.	kahnm@usc.edu	Higuchi, Yusuke/I-1991-2018	Higuchi, Yusuke/0000-0002-5982-9660	USC Norris Comprehensive Cancer Center [P30 CA014089, NIH 1R01CM66161-01A1, 1R21N5074392-01, 1R21A1105057-01, NIH 1R01 HL112638-01]; USC Office of Research; Norris Medical Library; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER	USC Norris Comprehensive Cancer Center; USC Office of Research; Norris Medical Library; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support from USC Norris Comprehensive Cancer Center Support Grant P30 CA014089 (MK), NIH 1R01CM66161-01A1, 1R21N5074392-01, 1R21A1105057-01 and NIH 1R01 HL112638-01 (MK) is gratefully acknowledged. The bioinformatics software and computing resources used in the analysis are funded by the USC Office of Research and the Norris Medical Library. The funders had no role in study design, data collection; Support from USC Norris Comprehensive Cancer Center Support Grant P30 CA014089 (MK), NIH 1R01CA166161-01A1, 1R21N5074392-01, 1R21A1105057-01 and NIH 1R01 HL112638-01 (MK) is gratefully acknowledged. The bioinformatics software and computing resources used in the analysis are funded by the USC Office of Research and the Norris Medical Library.and analysis, decision to publish, or preparation of the manuscript.	Baba Y, 2005, IMMUNITY, V23, P599, DOI 10.1016/j.immuni.2005.10.009; Baba Y, 2006, J IMMUNOL, V177, P2294, DOI 10.4049/jimmunol.177.4.2294; Beckmann J, 2007, BLOOD, V109, P5494, DOI 10.1182/blood-2006-11-055921; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Chan WI, 2011, MOL CELL BIOL, V31, P5046, DOI 10.1128/MCB.05830-11; Chen TC, 2007, EXP HEMATOL, V35, P203, DOI 10.1016/j.exphem.2006.10.002; Dainiak N, 2011, DISASTER MED PUBLIC, V5, P183, DOI 10.1001/dmp.2011.73; Dainiak N, 2011, DISASTER MED PUBLIC, V5, P202, DOI 10.1001/dmp.2011.68; Descalzo S, 2015, SEMIN CELL DEV BIOL, V47-48, P101; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Fang F, 2014, STEM CELLS, V32, P1805, DOI 10.1002/stem.1705; Fukunaga Y, 2005, CELL STRUCT FUNCT, V30, P25, DOI 10.1247/csf.30.25; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Higuchi Y, 2016, CURR MOL PHARMACOL, V9, P272, DOI 10.2174/1874467208666150526155146; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Ito K, 2016, SCIENCE, V354, P1156, DOI 10.1126/science.aaf5530; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kahn M, 2011, FUTURE MED CHEM, V3, P1745, DOI [10.4155/FMC.11.126, 10.4155/fmc.11.126]; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim YM, CURR CANC DRUG TARGE; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Lei S., 2015, BLOOD, V126, P117; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Miyoshi H, 2017, J BIOCHEM, V161, P19, DOI 10.1093/jb/mvw070; Morisot S, 2006, MOL THER, V13, pS131, DOI 10.1016/j.ymthe.2006.08.403; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200; Schreck C, 2014, ANN NY ACAD SCI, V1310, P32, DOI 10.1111/nyas.12384; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; Thomas PD, 2016, CELL BIOL TOXICOL, V32, P61, DOI 10.1007/s10565-016-9318-0; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Van Camp J, 2014, STEM CELL REV REP, V10, P207, DOI 10.1007/s12015-013-9486-8; van Galen P, 2014, CELL STEM CELL, V14, P94, DOI 10.1016/j.stem.2013.11.021; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Wickline ED, 2011, J HEPATOL, V55, P1256, DOI 10.1016/j.jhep.2011.03.014; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yan D, 2011, P NATL ACAD SCI USA, V98, P14973; Zhang T, 2001, CANCER RES, V61, P8664; Zhao Y, 2016, ONCOGENE, V35, P3705, DOI 10.1038/onc.2015.438; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zhou JB, 2007, AM J PHYSIOL-HEART C, V292, pH270, DOI 10.1152/ajpheart.00576.2006	50	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177245	10.1371/journal.pone.0177245	http://dx.doi.org/10.1371/journal.pone.0177245			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486541	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314000063
J	Nie, J; Zhang, J; Gao, JS; Guo, LH; Zhou, H; Hu, YY; Zhu, CJ; Li, QF; Ma, XL				Nie, Ji; Zhang, Jing; Gao, Jinsheng; Guo, Linghong; Zhou, Hui; Hu, Yuanyuan; Zhu, Chenjing; Li, Qingfang; Ma, Xuelei			Diagnostic role of 18F-FDG PET/MRI in patients with gynecological malignancies of the pelvis: A systematic review and meta-analysis	PLOS ONE			English	Review							CONTRAST-ENHANCED PET/CT; WHOLE-BODY PET/CT; ENDOMETRIAL CANCER; CERVICAL-CARCINOMA; F-18-FDG PET/CT; COMPUTED-TOMOGRAPHY; MRI; ACCURACY; FUSION; RECURRENCE	Purpose The aim of this study was to assess the diagnostic performance of 18F-FDG Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for gynecological cancers of the pelvis, based on a systematic review and meta-analysis of published data. Methods We performed a comprehensive literature search of Pubmed and Embase for studies that evaluated the diagnosis of 18F-FDG PET/MRI for gynecological malignancies in the pelvis. Quality Assessment for Studies of Diagnostic Accuracy 2 (QUADAS 2) tool was used to access the quality of included studies. After testing heterogeneity of the pooled studies with I<^>2 and H<^>2 (calculated using metaan in Stata 12.0) we treated the data that extracted and transformation from the studies, based on DerSimonian-Laird method(Random-effects models), then back-transformation them to percentages and plotting to get the pooled sensitivity, specificity, likelihood ratios, and constructed summary receiver operating characteristics (SROC) curve. Results Eventually, 7 studies fulfilled our predefined inclusion criteria were included in our research. On patient-based assessment, the pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio and diagnostic odds ratio of 18F-FDG PET/MRI for diagnosis of gynecological malignancies were 0.95 (95% CI 0.86-0.99), 0.95 (95% CI 0.74-1.00), 7.51 (95% CI 2.29-24.59), 0.12 (95% CI 0.05-0.29) and 116.27 (95% CI 17.07-791.74), respectively. On lesion-based assessment, the pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio and the summary DOR were 0.89 (95% CI 0.84-0.93), 0.87 (95% CI 0.74-0.95), 6.99 (95% CI 3.30-14.79), 0.12 (95% CI 0.06-0.25) and 55.82 (95% CI 20.91-149.05), respectively. Conclusions Our meta-analysis indicated that 18F-FDG PET/MRI, combined the advantages of MRI and PET, may be a very promising diagnostic method to assess the primary tumor and nodal staging in patients with gynecological malignancies of the pelvis.	[Nie, Ji; Guo, Linghong; Zhou, Hui; Hu, Yuanyuan; Zhu, Chenjing; Li, Qingfang; Ma, Xuelei] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China; [Nie, Ji; Guo, Linghong; Zhou, Hui; Hu, Yuanyuan; Zhu, Chenjing; Li, Qingfang; Ma, Xuelei] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Peoples R China; [Zhang, Jing] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Peoples R China; [Gao, Jinsheng] Yilong Cty Peoples Hosp, Oncol Dept, Chengdu, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Ma, XL (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China.; Ma, XL (corresponding author), Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Peoples R China.	drmaxuelei@gmail.com						Amit A, 2013, CURR OPIN OBSTET GYN, V25, P17, DOI 10.1097/GCO.0b013e32835a7e96; Antonsen SL, 2013, GYNECOL ONCOL, V128, P300, DOI 10.1016/j.ygyno.2012.11.025; Beiderwellen K, 2015, EUR J NUCL MED MOL I, V42, P56, DOI 10.1007/s00259-014-2902-8; Bipat S, 2003, GYNECOL ONCOL, V91, P59, DOI 10.1016/S0090-8258(03)00409-8; Chung HH, 2006, GYNECOL ONCOL, V103, P165, DOI 10.1016/j.ygyno.2006.02.016; Dauwen H, 2013, GYNECOL ONCOL; Engelmann BE, 2014, SCAND J GASTROENTERO, V49, P191, DOI 10.3109/00365521.2013.863967; Folpe AL, 2000, CLIN CANCER RES, V6, P1279; Gatsonis C, 2007, EARLY INVASIVE CERVI, V245, P491; Grueneisen J, 2015, EUR J RADIOL, V84, P2097, DOI 10.1016/j.ejrad.2015.08.010; Grueneisen J, 2015, EUR J NUCL MED MOL I, V42, P1814, DOI 10.1007/s00259-015-3131-5; Grueneisen J, 2014, J NUCL MED, V55, P1930, DOI 10.2967/jnumed.114.146886; Heusch P, ROFO, V185, P1056; Heusch P, 2015, EUR J NUCL MED MOL I, V42, P42, DOI 10.1007/s00259-014-2885-5; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hollingworth W, 2006, ACAD RADIOL, V13, P803, DOI 10.1016/j.acra.2006.03.008; Imaoka I, 2006, RADIOGRAPHICS, V26, P1431, DOI 10.1148/rg.265045206; Iyer VR, 2010, AM J ROENTGENOL, V194, P311, DOI 10.2214/AJR.09.3522; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kinkel K, 2009, EUR RADIOL, V19, P1565, DOI 10.1007/s00330-009-1309-6; Kitajima K, 2014, CLIN IMAG, V38, P464, DOI 10.1016/j.clinimag.2014.02.006; Kitajima K, 2014, ANN NUCL MED, V28, P25, DOI 10.1007/s12149-013-0777-6; Kitajima K, 2013, EUR J RADIOL, V82, P1672, DOI 10.1016/j.ejrad.2013.05.005; Kubiessa K, 2014, EUR J NUCL MED MOL I, V41, P639, DOI 10.1007/s00259-013-2633-2; Lin WY, 2012, J CHIN MED ASSOC, V75, P203, DOI 10.1016/j.jcma.2012.04.004; Liu BJ, 2009, CHINESE MED J-PEKING, V122, P1749, DOI 10.3760/cma.j.issn.0366-6999.2009.15.006; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Nicolet V, 2000, RADIOGRAPHICS, V20, P1539, DOI 10.1148/radiographics.20.6.g00nv111539; Pace L, 2014, EUR J RADIOL, V83, P289, DOI 10.1016/j.ejrad.2013.11.002; Pui MH, 2004, CLIN IMAG, V28, P143, DOI 10.1016/S0899-7071(03)00116-5; Queiroz MA, 2015, EUR RADIOL, V25, P2222, DOI 10.1007/s00330-015-3657-8; Risum S, 2010, GYNECOL ONCOL, V116, P395, DOI 10.1016/j.ygyno.2009.12.008; Ryu SY, 2010, J KOREAN MED SCI, V25, P1029, DOI 10.3346/jkms.2010.25.7.1029; Sala E, 2013, RADIOLOGY, V266, P717, DOI 10.1148/radiol.12120315; Salaa E, 2010, EUR J RADIOL, V76, P367, DOI 10.1016/j.ejrad.2010.01.026; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Spencer JA, 2010, EUR RADIOL, V20, P25, DOI 10.1007/s00330-009-1584-2; SUBAK LL, 1995, OBSTET GYNECOL, V86, P43, DOI 10.1016/0029-7844(95)00109-5; Takekuma Munetaka, 2005, Int J Clin Oncol, V10, P177, DOI 10.1007/s10147-005-0489-6; Townsend DW, 2008, J NUCL MED, V49, P938, DOI 10.2967/jnumed.108.051276; von Schulthess GK, 2006, RADIOLOGY, V238, P405, DOI 10.1148/radiol.2382041977; Wetter A, 2013, INVEST RADIOL, V48, P256, DOI 10.1097/RLI.0b013e318282c654; Whiting P, 2008, J HEALTH SERV RES PO, V13, P57, DOI 10.1258/jhsrp.2008.008025; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	45	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0175401	10.1371/journal.pone.0175401	http://dx.doi.org/10.1371/journal.pone.0175401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481958	Green Published, gold, Green Submitted			2022-12-27	WOS:000401313700004
J	Verma, K; Ogonek, J; Varanasi, PR; Luther, S; Bunting, I; Thomay, K; Behrens, YL; Mischak-Weissinger, E; Hambach, L				Verma, Kriti; Ogonek, Justyna; Varanasi, Pavankumar Reddy; Luther, Susanne; Buenting, Ivonne; Thomay, Katrin; Behrens, Yvonne Lisa; Mischak-Weissinger, Eva; Hambach, Lothar			Human CD8+CD57-T-EMRA cells: Too young to be called "old"	PLOS ONE			English	Article							CD8(+) T-CELLS; EFFECTOR FUNCTIONS; TELOMERE LENGTH; MEMORY; DIFFERENTIATION; SUBSETS; LYMPHOCYTES; EXPRESSION; IDENTIFICATION; INFECTIONS	End-stage differentiation of antigen-specific T-cells may precede loss of immune responses against e.g. viral infections after allogeneic stem cell transplantation (SCT). Antigen-specific CD8+ T-cells detected by HLA/peptide multimers largely comprise CD45RA-/CCR7-effector memory (T-EM) and CD45RA+/CCR7-T-EMRA subsets. A majority of terminally differentiated T-cells is considered to be part of the heterogeneous T-EMRA subset. The senescence marker CD57 has been functionally described in memory T-cells mainly composed of central memory (T-CM) and T-EM cells. However, its role specifically in T-EMRA cells remained undefined. Here, we investigated the relevance of CD57 to separate human CD8+ T-EMRA cells into functionally distinct subsets. CD57-CD8+ T-EMRA cells isolated from healthy donors had considerably longer telomeres and showed significantly more BrdU uptake and IFN-gamma release upon stimulation compared to the CD57+ counterpart. Cytomegalovirus (CMV) specific T-cells isolated from patients after allogeneic SCT were purified into CD57+ and CD57-T-EMRA subsets. CMV specific CD57-T-EMRA cells had longer telomeres and a considerably higher CMV peptide sensitivity in BrdU uptake and IFN-gamma release assays compared to CD57 + T-EMRA cells. In contrast, CD57+ and CD57-T-EMRA cells showed comparable peptide specific cytotoxicity. Finally, CD57-CD8+ T-EMRA cells partially changed phenotypically into T-EM cells and gained CD57 expression, while CD57+ CD8+ T-EMRA cells hardly changed phenotypically and showed considerable cell death after in vitro stimulation. To the best of our knowledge, these data show for the first time that CD57 separates CD8+ T-EMRA cells into a terminally differentiated CD57+ population and a so far functionally undescribed "young" CD57-T-EMRA subset with high proliferative capacity and differentiation plasticity.	[Verma, Kriti; Ogonek, Justyna; Varanasi, Pavankumar Reddy; Luther, Susanne; Buenting, Ivonne; Mischak-Weissinger, Eva; Hambach, Lothar] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Verma, Kriti] Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany; [Thomay, Katrin; Behrens, Yvonne Lisa] Hannover Med Sch, Inst Human Genet, Hannover, Germany	Hannover Medical School; Hannover Medical School	Hambach, L (corresponding author), Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany.	hambach.lothar@mh-hannover.de	Varanasi, Pavankumar/AGP-6339-2022	Varanasi, Pavankumar/0000-0003-4658-0453; Verma, Kriti/0000-0002-7368-8171	German Federal Ministry of Education and Research [01EO1302]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (reference number: 01EO1302). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Bondanza A, 2011, BLOOD, V117, P6469, DOI 10.1182/blood-2010-11-320366; Borchers S, 2011, TRANSPL INFECT DIS, V13, P222, DOI 10.1111/j.1399-3062.2011.00626.x; Breckpot K, 2004, J IMMUNOL, V172, P2232, DOI 10.4049/jimmunol.172.4.2232; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Calarota Sandra A, 2013, Clin Dev Immunol, V2013, P637649, DOI 10.1155/2013/637649; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chattopadhyay PK, 2009, J LEUKOCYTE BIOL, V85, P88, DOI 10.1189/jlb.0208107; Geginat J, 2003, BLOOD, V101, P4260, DOI 10.1182/blood-2002-11-3577; Gerritsen B, 2016, IMMUNOL CELL BIOL, V94, P236, DOI 10.1038/icb.2015.118; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hombrink P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022523; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Lugli E, 2013, NAT PROTOC, V8, P33, DOI 10.1038/nprot.2012.143; Macchia I, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/726239; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; Mattis AE, 1997, J IMMUNOL METHODS, V204, P135, DOI 10.1016/S0022-1759(97)00047-1; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Rufer N, 2003, BLOOD, V102, P1779, DOI 10.1182/blood-2003-02-0420; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Scheinberg P, 2009, BLOOD, V114, P5071, DOI 10.1182/blood-2009-04-214684; van der Torren CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119595; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; Wang F, 2013, P NATL ACAD SCI USA, V110, pE1906, DOI 10.1073/pnas.1306639110	26	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177405	10.1371/journal.pone.0177405	http://dx.doi.org/10.1371/journal.pone.0177405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481945	Green Submitted, Green Published, gold			2022-12-27	WOS:000401313700058
J	Monroy, C; Meyer, M; Gerson, S; Hunnius, S				Monroy, Claire; Meyer, Marlene; Gerson, Sarah; Hunnius, Sabine			Statistical learning in social action contexts	PLOS ONE			English	Article							INFANTS; PREDICTION; PERCEPTION; MODEL	Sensitivity to the regularities and structure contained within sequential, goal-directed actions is an important building block for generating expectations about the actions we observe. Until now, research on statistical learning for actions has solely focused on individual action sequences, but many actions in daily life involve multiple actors in various interaction contexts. The current study is the first to investigate the role of statistical learning in tracking regularities between actions performed by different actors, and whether the social context characterizing their interaction influences learning. That is, are observers more likely to track regularities across actors if they are perceived as acting jointly as opposed to in parallel? We tested adults and toddlers to explore whether social context guides statistical learning and -if so-whether it does so from early in development. In a between-subjects eyetracking experiment, participants were primed with a social context cue between two actors who either shared a goal of playing together ('Joint' condition) or stated the intention to act alone ('Parallel' condition). In subsequent videos, the actors performed sequential actions in which, for certain action pairs, the first actor's action reliably predicted the second actor's action. We analyzed predictive eye movements to upcoming actions as a measure of learning, and found that both adults and toddlers learned the statistical regularities across actors when their actions caused an effect. Further, adults with high statistical learning performance were sensitive to social context: those who observed actors with a shared goal were more likely to correctly predict upcoming actions. In contrast, there was no effect of social context in the toddler group, regardless of learning performance. These findings shed light on how adults and toddlers perceive statistical regularities across actors depending on the nature of the observed social situation and the resulting effects.	[Monroy, Claire; Meyer, Marlene; Gerson, Sarah; Hunnius, Sabine] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Monroy, Claire] Ohio State Univ, Wexner Med Ctr, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA; [Meyer, Marlene] Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA; [Gerson, Sarah] Cardiff Univ, Sch Psychol, Cardiff, Wales	Radboud University Nijmegen; University System of Ohio; Ohio State University; University of Chicago; Cardiff University	Monroy, C (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.; Monroy, C (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA.	Claire.monroy@osumc.edu	Hunnius, Sabine/D-5834-2012	Monroy, Claire/0000-0002-5044-5185	Initial Training Network (ITN) of the People Marie Curie Actions-Seventh Research Programme (FP7) of the European Union [FP7ITN2011-289404]	Initial Training Network (ITN) of the People Marie Curie Actions-Seventh Research Programme (FP7) of the European Union	This work was supported by an Initial Training Network (ITN) of the People Marie Curie Actions-Seventh Research Programme (FP7) of the European Union (FP7ITN2011-289404). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abla D, 2008, J COGNITIVE NEUROSCI, V20, P952, DOI 10.1162/jocn.2008.20058; Abla D, 2009, NEUROSCI RES, V64, P185, DOI 10.1016/j.neures.2009.02.013; Ahlheim C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00273; Aslin RN, 1998, PSYCHOL SCI, V9, P321, DOI 10.1111/1467-9280.00063; Baldwin DA, 2001, CHILD DEV, V72, P708, DOI 10.1111/1467-8624.00310; Baldwin D, 2008, COGNITION, V106, P1382, DOI 10.1016/j.cognition.2007.07.005; Beier JS, 2012, CHILD DEV, V83, P486, DOI 10.1111/j.1467-8624.2011.01702.x; BRATMAN ME, 1992, PHILOS REV, V101, P327, DOI 10.2307/2185537; Canessa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042347; Centelles L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015749; Daum MM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00370; Emberson LL, 2013, COGNITION, V128, P82, DOI 10.1016/j.cognition.2012.12.006; Emberson LL, 2011, Q J EXP PSYCHOL, V64, P1021, DOI 10.1080/17470218.2010.538972; Eskenazi T, 2015, CORTEX, V70, P90, DOI 10.1016/j.cortex.2015.05.027; Fawcett C, 2015, INFANCY, V20, P115, DOI 10.1111/infa.12062; Fawcett C, 2013, DEVELOPMENTAL SCI, V16, P841, DOI 10.1111/desc.12074; Fiser J, 2001, PSYCHOL SCI, V12, P499, DOI 10.1111/1467-9280.00392; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Hauf P, 2008, PSYCHOL RES-PSYCH FO, V72, P203, DOI 10.1007/s00426-006-0101-3; Henderson AME, 2011, COGNITION, V121, P12, DOI 10.1016/j.cognition.2011.05.008; Hoehl S, 2014, SOC NEUROSCI-UK, V9, P300, DOI 10.1080/17470919.2014.884982; Hommel B, 1996, PSYCHOL RES-PSYCH FO, V59, P176, DOI 10.1007/BF00425832; Kirkham NZ, 2002, COGNITION, V83, pB35, DOI 10.1016/S0010-0277(02)00004-5; Klein AM, 2006, INFANT BEHAV DEV, V29, P535, DOI 10.1016/j.infbeh.2006.07.001; Krogh L, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00048, 10.3389/fpsyg.2012.00598]; Manera V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014594; Monroy C, J EXP CHILD IN PRESS; Neri P, 2006, NAT NEUROSCI, V9, P1186, DOI 10.1038/nn1759; Paulus M, 2012, DEV COGN NEUROS-NETH, V2, P90, DOI 10.1016/j.dcn.2011.05.006; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Prinz W., 1990, RELATIONSHIPS PERCEP, DOI DOI 10.1007/978-3-642-75348-0_7; Romberg AR, 2010, WIRES COGN SCI, V1, P906, DOI 10.1002/wcs.78; Ruffman T, 2012, BRIT J DEV PSYCHOL, V30, P87, DOI 10.1111/j.2044-835X.2011.02045.x; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Searle J, 1990, INTENTIONS COMMUN, V401; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Stahl AE, 2014, CHILD DEV, V85, P1821, DOI 10.1111/cdev.12247; Striano T, 2006, EUR J DEV PSYCHOL, V3, P289, DOI 10.1080/17405620600879779; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552; Turk-Browne NB, 2009, J COGNITIVE NEUROSCI, V21, P1934, DOI 10.1162/jocn.2009.21131; Verschoor S, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00201; Wu R, 2011, DEV PSYCHOL, V47, P1220, DOI 10.1037/a0024023	44	8	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177261	10.1371/journal.pone.0177261	http://dx.doi.org/10.1371/journal.pone.0177261			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475619	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000400649500057
J	Alghodaler, H; Jradi, H; Mohammad, NS; Bawazir, A				Alghodaler, Hussah; Jradi, Hoda; Mohammad, Najwa Samantha; Bawazir, Amen			Validation of a diabetes numeracy test in Arabic	PLOS ONE			English	Article							GLYCEMIC CONTROL; HEALTH LITERACY; SKILLS; SCALE	Background The prevalence of diabetes Mellitus in Saudi Arabia is 24%, ranking it among the top ten Worldwide. Diabetes education focuses on self-management and relies on numeracy skills. Poor numeracy may go unrecognized and it is important to have an assessment tool in Arabic to measure such a skill in diabetes care. Objectives To validate a 15-item Diabetes Numeracy Test (DNT-15) in the Arabic Language as a tool to assess the numeracy skills of patients with diabetes and to test its properties among Saudi patients with diabetes. Methods A 15-question Arabic-language test to assess diabetes numeracy among patients with diabetes on the basis of the diabetes numeracy test (DNT-15) was validated among a sample Arabic speaking Saudi patients with diabetes. Data collection included patients demographics, long-term glycemic control, diabetes type, duration, co-morbidities, and diabetes related knowledge questions. Internal reliability was assessed using Kuder-Richardson Formula 20 (KR-20). Results The average score of Arabic DNT-15 was 53.3% and took an average of 30 minutes to complete. The scores significantly correlated with education, income, HbA1c, and diabetes knowledge (p<0.05). Content Validity Ratio (CVR) of 0.75 and Content Validity Index (CVI) of 0.89 supported good content validity. The Arabic DNT-15 also had good internal reliability (KR20 = 0.90). Conclusion Patients with diabetes need numeracy skills to manage their disease. Level of education does not reflect level of numeracy, and low numeracy skills might be unnoticed by health care providers. The Arabic DNT-15 is a valid and reliable scale to identify Arabic speaking patients with difficulties in certain diabetes-related numeracy skills.	[Alghodaler, Hussah; Jradi, Hoda; Bawazir, Amen] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Coll Publ Hlth & Hlth Informat, Dept Community & Environm Hlth, Riyadh, Saudi Arabia; [Mohammad, Najwa Samantha] Al Faisal Univ, Sch Med, Riyadh, Saudi Arabia	King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Alfaisal University	Jradi, H (corresponding author), King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Coll Publ Hlth & Hlth Informat, Dept Community & Environm Hlth, Riyadh, Saudi Arabia.	Hoda.Jradi@gmail.com	Bawazir, Amen A/AAE-8993-2019	Bawazir, Amen A/0000-0002-6308-3136; Alghodaier, Hussah/0000-0002-7101-6769	King Abdullah International Medical Research Center [SP14/062]	King Abdullah International Medical Research Center	This research was funded by King Abdullah International Medical Research Center; Grant number SP14/062.	Abdelmoneim I, 2002, ABHA E MEDITERR HLTH; Al-Adsani AMS, 2009, DIABETES METAB, V35, P121, DOI 10.1016/j.diabet.2008.09.005; [Anonymous], DIABETES CARE J DIAB; Cavanaugh K, 2008, ANN INTERN MED, V148, P737, DOI 10.7326/0003-4819-148-10-200805200-00006; Estrada CA, 2004, AM J MED SCI, V328, P88, DOI 10.1097/00000441-200408000-00004; Fagerlin A, 2007, MED DECIS MAKING, V27, P672, DOI 10.1177/0272989x07304449; Fitzgerald JT, 1998, DIABETES CARE, V21, P706, DOI 10.2337/diacare.21.5.706; Golbeck AL, 2005, AM J PREV MED, V29, P375, DOI 10.1016/j.amepre.2005.06.012; Huizinga MM, 2008, OBESITY, V16, P1966, DOI 10.1038/oby.2008.294; Huizinga MM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-96; IDF, 2013, IDF DIABETES ATLAS, P160; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; Montori VM, 2005, J GEN INTERN MED, V20, P1071, DOI 10.1111/j.1525-1497.2005.051498.x; Musaiger AO, 2011, INT J ENV RES PUB HE, V8, P3637, DOI 10.3390/ijerph8093637; Osborn CY, 2010, J HEALTH COMMUN, V15, P146, DOI 10.1080/10810730.2010.499980; Osborn CY, 2009, DIABETES CARE, V32, P1614, DOI 10.2337/dc09-0425; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Rosas-Salazar C, 2013, CHEST, V144, P92, DOI 10.1378/chest.12-2693; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Wendling B. J., 2007, ASSESSMENT SERVICE B, V8; White Richard O, 2010, Diabetes Spectr, V23, P238, DOI 10.2337/diaspect.23.4.238; White RO, 2011, DIABETES TECHNOL THE, V13, P893, DOI 10.1089/dia.2011.0070; Wilkinson GS, 2002, JOPED, V5, P61; Zaugg Stephanie D, 2014, Clin Diabetes, V32, P152, DOI 10.2337/diaclin.32.4.152	24	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175442	10.1371/journal.pone.0175442	http://dx.doi.org/10.1371/journal.pone.0175442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472140	gold, Green Published			2022-12-27	WOS:000400648500011
J	Banu, S; Pholwat, S; Foongladda, S; Chinli, R; Boonlert, D; Ferdous, SS; Rahman, SMM; Rahman, A; Ahmed, S; Houpt, ER				Banu, Sayera; Pholwat, Suporn; Foongladda, Suporn; Chinli, Rattapha; Boonlert, Duangjai; Ferdous, Sara Sabrina; Rahman, S. M. Mazidur; Rahman, Arfatur; Ahmed, Shahriar; Houpt, Eric R.			Performance of TaqMan array card to detect TB drug resistance on direct specimens	PLOS ONE			English	Article							GENOTYPE(R) MTBDRPLUS ASSAY; XPERT MTB/RIF ASSAY; REAL-TIME PCR; MYCOBACTERIUM-TUBERCULOSIS; RIFAMPIN RESISTANCE; MDR-TB; DNA	Culture based phenotypic drug susceptibility testing (DST) for Mycobacterium tuberculosis (TB) is time consuming therefore rapid genotypic methods are increasingly being utilized. We previously developed and evaluated on TB isolates a rapid genotypic TaqMan array card (TAC) that detects mutations in several resistance-associated genes using dozens of primer pairs, probes, and high resolution melt analysis, with >96% accuracy versus Sanger sequencing. In this study we examined the performance of TAC on sputum, comparing results between 71 paired sputum and TB isolates of which 62 were MDR-TB. We also adapted the TAC to include wild-type probes and broadened coverage for rpoB and gyrA mutations. TAC was 89% successful at detecting wild-type or mutations within inhA, katG, rpoB, eis, gyrA, rplC, and pncA on smear positive sputa and 33% successful on smear negative sputa. The overall accuracy of these detections as compared to the TAC results of the paired isolate was 95% +/- 7 (average sensitivity 98% +/- 3; specificity 92% +/- 14). Accuracy of sputum TAC results versus phenotypic DST for isoniazid, rifampin, ofloxacin/moxifloxacin, and pyrazinamide was 85% +/- 12. This was similar to that of the isolate TAC results (accuracy 88% +/- 13), thus inaccuracies primarily reflected intrinsic genotypic-phenotypic discordance. The TAC is a rapid, modular, comprehensive, and accurate TB DST for the major first and second line TB drugs and could be used for supplemental testing of GeneXpert resistant smear positive sputum.	[Banu, Sayera; Ferdous, Sara Sabrina; Rahman, S. M. Mazidur; Rahman, Arfatur; Ahmed, Shahriar] Int Ctr Diarrhoeal Dis Res, Infect Dis Div, Mycobacteriol Lab, Dhaka, Bangladesh; [Pholwat, Suporn; Houpt, Eric R.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA; [Foongladda, Suporn; Chinli, Rattapha; Boonlert, Duangjai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand	International Centre for Diarrhoeal Disease Research (ICDDR); University of Virginia; Mahidol University	Houpt, ER (corresponding author), Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA.	erh6k@virginia.edu	Ahmed, Shahriar/A-3109-2019; Pholwat, Suporn/CAG-9380-2022; AHMED, SHAHRIAR/N-8532-2019; Rahman, Arfatur/AAC-1482-2022	Ahmed, Shahriar/0000-0002-8833-4130; AHMED, SHAHRIAR/0000-0002-8833-4130; Rahman, Arfatur/0000-0001-8749-0337; Rahman, Syed Mohammad Mazidur/0000-0003-2887-6250; Banu, Sayera/0000-0002-5121-1962	National Institute of Health (NIH) [R01 A1093358, K24 A1102972]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093358] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Health (NIH) grants R01 A1093358 and K24 A1102972 (to EH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous WK, 2005, J CLIN MICROBIOL, V43, P2471, DOI 10.1128/JCM.43.5.2471-2473.2005; Anek-vorapong R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-123; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Chakravorty S, 2011, J CLIN MICROBIOL, V49, P932, DOI 10.1128/JCM.02271-10; Clinical and Laboratory Standards Institute (CLSI), 2011, M24A2 CLSI; Foongladda S, 2016, INT J TUBERC LUNG D, V20, P1105, DOI 10.5588/ijtld.15.0896; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; Heysell SK, 2015, ANTIMICROB AGENTS CH, V59, P7104, DOI 10.1128/AAC.01117-15; Hillemann D, 2008, ANTIMICROB AGENTS CH, V52, P800, DOI 10.1128/AAC.01189-07; Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X; McAlister AJ, 2015, J CLIN MICROBIOL, V53, P1752, DOI 10.1128/JCM.03433-14; Meka VG, 2004, CLIN INFECT DIS, V39, P1010, DOI 10.1086/423841; Nikolayevskyy V, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-2; Pholwat S, 2015, MBIO, V6, DOI 10.1128/mBio.02273-14; Pholwat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057238; Prystowsky J, 2001, ANTIMICROB AGENTS CH, V45, P2154, DOI 10.1128/AAC.45.7.2154-2156.2001; Ramirez MV, 2010, J CLIN MICROBIOL, V48, P4003, DOI 10.1128/JCM.00812-10; Salamon H, 2015, J INFECT DIS, V211, pS50, DOI 10.1093/infdis/jiu816; Starks AM, 2015, INFECT DIS SOC AM S3, V61, pS141; Theron G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010705.pub2; Yadav RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072036; Yakrus MA, 2014, J CLIN MICROBIOL, V52, P1932, DOI 10.1128/JCM.00417-14	24	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177167	10.1371/journal.pone.0177167	http://dx.doi.org/10.1371/journal.pone.0177167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472124	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500149
J	Falda-Buscaiot, T; Hintzy, F; Rougier, P; Lacouture, P; Coulmy, N				Falda-Buscaiot, Thomas; Hintzy, Frederique; Rougier, Patrice; Lacouture, Patrick; Coulmy, Nicolas			Influence of slope steepness, foot position and turn phase on plantar pressure distribution during giant slalom alpine ski racing	PLOS ONE			English	Article							GROUND REACTION FORCES; SYSTEM; IMPACT; PLATE	The purpose of this study was to investigate the evolution of ground reaction force during alpine skiing turns. Specifically, this study investigated how turn phases and slope steepness affected the whole foot normal GRF pattern while performing giant slalom turns in a race-like setting. Moreover, the outside foot was divided into different plantar regions to see whether those parameters affected the plantar pressure distribution. Eleven skiers performed one giant slalom course at race intensity. Runs were recorded synchronously using a video camera in the frontal plane and pressure insoles under both feet's plantar surface. Turns were divided according to kinematic criteria into four consecutive phases: initiation, steering1, steering2 and completion; both steering phases being separated by the gate passage. Component of the averaged Ground Reaction Force normal to the ski's surface ((nGRF) over bar,/BW), and Pressure Time Integral relative to the entire foot surface (relPTI, %) parameters were calculated for each turn phases based on plantar pressure data. Results indicated that (nGRF) over bar under the total foot surface differed significantly depending on the slope (higher in steep sections vs. flat sections), and the turn phase (higher during steering2 vs. three other phases), although such modifications were observable only on the outside foot. Moreover, (nGRF) over bar under the outside foot was significantly greater than under the inside foot. RelPTI under different foot regions of the outside foot revealed a global shift from forefoot loading during initiation phase, toward heel loading during steering2 phase, but this was dependent on the slope studied. These results suggest a differentiated role played by each foot in alpine skiing turns: the outside foot has an active role in the turning process, while the inside foot may only play a role in stability.	[Falda-Buscaiot, Thomas; Hintzy, Frederique; Rougier, Patrice] Univ Savoie Mt Blanc, Lab Interuniv Biol Motricite, Chambery, France; [Falda-Buscaiot, Thomas] Cluster Sporaltec, Saint Etienne, France; [Lacouture, Patrick] Univ Poitiers, CNRS, Inst Pprime, Lab RoBioSS UPR 3346, Poitiers, France; Fed Francaise Ski, Dept Sportif & Sci, Annecy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Poitiers	Falda-Buscaiot, T (corresponding author), Univ Savoie Mt Blanc, Lab Interuniv Biol Motricite, Chambery, France.; Falda-Buscaiot, T (corresponding author), Cluster Sporaltec, Saint Etienne, France.	thomas.falda@univ-savoie.fr						Bentley JR, 2010, J STRENGTH COND RES, V24, P1414, DOI 10.1519/JSC.0b013e3181cb27e7; Chesnin KJ, 2000, GAIT POSTURE, V12, P128, DOI 10.1016/S0966-6362(00)00071-0; Federolf P, 2008, SCAND J MED SCI SPOR, V18, P790, DOI 10.1111/j.1600-0838.2007.00745.x; Forner Cordero A, 2004, J BIOMECH, V37, P1427, DOI 10.1016/j.jbiomech.2003.12.016; Fourchet F, 2012, GAIT POSTURE, V35, P685, DOI 10.1016/j.gaitpost.2011.12.004; Gilgien M, 2015, PLOS ONE, V10; Gilgien M, 2014, BRIT J SPORT MED, V48, P742, DOI 10.1136/bjsports-2013-092994; Gilgien M, 2013, SENSORS-BASEL, V13, P9821, DOI 10.3390/s130809821; Girard O, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036707; HINTERMEISTER RA, 1995, MED SCI SPORT EXER, V27, P315; Keranen T, 2010, 5 INT C SCI SKIING S; Kersting UG, 2010, EM SCI M ESM PROV RI, P55; Kroll J, 2010, MED SCI SPORT EXER, V42, P1545, DOI 10.1249/MSS.0b013e3181d299cf; Kroll J, 2015, 33 INT SOC BIOM SPOR; Lafontaine D, 1998, 16 INT S BIOM SPORTS; Lafontaine D, 1998, 6 EM SCI M BRISB AUS; Lamontagne M., 2001, 19 INT S BIOM SPORTS, P211; Luthi A., 2005, SCINCE SKIING, VIII, P96; Marginson V, 2001, J SPORT SCI, V19, P875, DOI 10.1080/026404101753113822; Melai T, 2011, GAIT POSTURE, V34, P379, DOI 10.1016/j.gaitpost.2011.06.005; Meyer F., 2011, BIOMECHANICAL ANAL A; Muller E, 2003, J SPORT SCI, V21, P679, DOI 10.1080/0264041031000140284; Nakazato K, 2013, SPORTS ENG, V16, P297, DOI 10.1007/s12283-013-0119-x; Nakazato K, 2011, J SPORT SCI MED, V10, P754; Niessen W, 1999, 26 INT S BIOM SPORTS; Petrone N, 2013, SPORTS ENG, V16, P265, DOI 10.1007/s12283-013-0133-z; Reid R.C, 2010, KINEMATIC KINETIC ST; Schaff P., 1997, SCI SKIING, V1st, P159; Scheiber P, 2006, 24 INT S BIOM SPORTS, P564; Senner V, 2016, POINT FORCE APPL TUR; Stoggl T, 2008, J SPORT SCI, V26, P1225, DOI 10.1080/02640410802027386; Stricker G, 2010, EUR J SPORT SCI, V10, P31, DOI 10.1080/17461390903108141; Supej M, 2008, J APPL BIOMECH, V24, P121, DOI 10.1123/jab.24.2.121; Supej M, 2015, INT J SPORT PHYSIOL, V10, P361, DOI 10.1123/ijspp.2014-0200; Yoneyama T, 2010, PROCEDIA ENGINEER, V2, P2901, DOI 10.1016/j.proeng.2010.04.085	35	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176975	10.1371/journal.pone.0176975	http://dx.doi.org/10.1371/journal.pone.0176975			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472092	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500107
J	Kitamura, S; Morisseau, C; Harris, TR; Inceoglu, B; Hammock, BD				Kitamura, Seiya; Morisseau, Christophe; Harris, Todd R.; Inceoglu, Bora; Hammock, Bruce D.			Occurrence of urea-based soluble epoxide hydrolase inhibitors from the plants in the order Brassicales	PLOS ONE			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE NAMPT; BENZYL ISOTHIOCYANATE; EPOXYEICOSATRIENOIC ACIDS; PENTADIPLANDRA-BRAZZEANA; DOCOSAHEXAENOIC ACID; INFLAMMATORY PAIN; POTENT INHIBITORS; BROCCOLI SPROUTS; MORINGA-OLEIFERA; BLOOD-PRESSURE	Recently, dibenzylurea-based potent soluble epoxide hydrolase (sEH) inhibitors were identified in Pentadiplandra brazzeana, a plant in the order Brassicales. In an effort to generalize the concept, we hypothesized that plants that produce benzyl glucosinolates and corresponding isothiocyanates also produce these dibenzylurea derivatives. Our overall aim here was to examine the occurrence of urea derivatives in Brassicales, hoping to find biologically active urea derivatives from plants. First, plants in the order Brassicales were analyzed for the presence of 1, 3-dibenzylurea (compound 1), showing that three additional plants in the order Brassicales produce the urea derivatives. Based on the hypothesis, three dibenzylurea derivatives with sEH inhibitory activity were isolated from maca (Lepidium meyenii) roots. Topical application of one of the identified compounds (compound 3, human sEH IC50 = 222 nM) effectively reduced pain in rat inflammatory pain model, and this compound was bioavailable after oral administration in mice. The biosynthetic pathway of these urea derivatives was investigated using papaya (Carica papaya) seed as a model system. Finally, a small collection of plants from the Brassicales order was grown, collected, extracted and screened for sEH inhibitory activity. Results show that several plants of the Brassicales order could be potential sources of urea-based sEH inhibitors.	[Kitamura, Seiya; Morisseau, Christophe; Harris, Todd R.; Inceoglu, Bora; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol & Hematol, Davis, CA 95616 USA; [Kitamura, Seiya; Morisseau, Christophe; Harris, Todd R.; Inceoglu, Bora; Hammock, Bruce D.] Univ Calif Davis, Ctr Comprehens Canc, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Hammock, BD (corresponding author), Univ Calif Davis, Dept Entomol & Hematol, Davis, CA 95616 USA.; Hammock, BD (corresponding author), Univ Calif Davis, Ctr Comprehens Canc, Davis, CA 95616 USA.	bdhammock@ucdavis.edu			National Institute of Environmental Health Sciences (NIEHS) [R01ES002710]; NIEHS Superfund Research Program grant [P42 ES04699]; Japan Student Services Organization; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002710, P42ES004699] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS Superfund Research Program grant; Japan Student Services Organization(Japan Student Services Organization); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partially funded by National Institute of Environmental Health Sciences (NIEHS, http://www.niehs.nih.gov/) grant R01ES002710, and NIEHS Superfund Research Program grant P42 ES04699. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. SK was financially supported by Japan Student Services Organization (http://www.jasso.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandan SK, 2011, BIOORG MED CHEM LETT, V21, P983, DOI 10.1016/j.bmcl.2010.12.042; Bahadoran Z, 2013, J MED FOOD, V16, P375, DOI 10.1089/jmf.2012.2559; Bahroun A, 1985, J SOC CHIMIQUE TUNIS, V2, P15; Barillari J, 2001, FITOTERAPIA, V72, P760, DOI 10.1016/S0367-326X(01)00320-3; BEETHAM JK, 1993, ARCH BIOCHEM BIOPHYS, V305, P197, DOI 10.1006/abbi.1993.1411; Bennett RN, 2004, J AGR FOOD CHEM, V52, P428, DOI 10.1021/jf030530p; Bennett RN, 2003, J AGR FOOD CHEM, V51, P3546, DOI 10.1021/jf0211480; Chen HX, 2012, NAT PROD RES, V26, P1016, DOI 10.1080/14786419.2010.535148; Clarke DB, 2010, ANAL METHODS-UK, V2, P310, DOI 10.1039/b9ay00280d; De Nicola GR, 2012, PHYTOCHEMISTRY, V73, P51, DOI 10.1016/j.phytochem.2011.09.006; Dragovich PS, 2013, BIOORG MED CHEM LETT, V23, P4875, DOI 10.1016/j.bmcl.2013.06.090; Eldrup AB, 2010, BIOORG MED CHEM LETT, V20, P571, DOI 10.1016/j.bmcl.2009.11.091; Engelen-Eigles G, 2006, J AGR FOOD CHEM, V54, P328, DOI 10.1021/jf051857o; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Fell RT, 2000, CR ACAD SCI II C, V3, P285, DOI 10.1016/S1387-1609(00)00123-7; Garofalo A, 2012, J MED CHEM, V55, P1189, DOI 10.1021/jm2013453; Gieling RG, 2012, J MED CHEM, V55, P5591, DOI 10.1021/jm300529u; GIL V, 1980, PHYTOCHEMISTRY, V19, P1369, DOI 10.1016/0031-9422(80)80176-2; Gill CIR, 2007, AM J CLIN NUTR, V85, P504, DOI 10.1093/ajcn/85.2.504; Goosen TC, 2001, J PHARMACOL EXP THER, V296, P198; Guedes AGP, 2013, VET ANAESTH ANALG, V40, P440, DOI 10.1111/vaa.12030; Gunzner-Toste J, 2013, BIOORG MED CHEM LETT, V23, P3531, DOI 10.1016/j.bmcl.2013.04.040; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hwang SH, 2007, J MED CHEM, V50, P3825, DOI 10.1021/jm070270t; Ikhlas AK, 2014, ENCY DIETARY SUPPLEM, P518; Imig JD, 2002, HYPERTENSION, V39, P690, DOI 10.1161/hy0202.103788; Inceoglu B, 2007, PROSTAG OTH LIPID M, V82, P42; Inceoglu B, 2006, LIFE SCI, V79, P2311, DOI 10.1016/j.lfs.2006.07.031; Inceoglu B, 2012, P NATL ACAD SCI USA, V109, P11390, DOI 10.1073/pnas.1208708109; Inceoglu B, 2008, P NATL ACAD SCI USA, V105, P18901, DOI 10.1073/pnas.0809765105; Intanon S, 2014, J AGR FOOD CHEM, V62, P7423, DOI 10.1021/jf5018687; Jones PD, 2005, ANAL BIOCHEM, V343, P66, DOI 10.1016/j.ab.2005.03.041; Kermanshai R, 2001, PHYTOCHEMISTRY, V57, P427, DOI 10.1016/S0031-9422(01)00077-2; Kim IH, 2007, J MED CHEM, V50, P5217, DOI 10.1021/jm070705c; Kim J, 2014, AM J PHYSIOL-RENAL, V307, pF971, DOI 10.1152/ajprenal.00256.2014; Kitamura S, 2016, J MED CHEM, V59, P4790, DOI 10.1021/acs.jmedchem.6b00173; Kitamura S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117438; Kleinwachter M, 2008, J AGR FOOD CHEM, V56, P11165, DOI 10.1021/jf802053n; la Buscato E, 2013, CHEMMEDCHEM, V8, P919, DOI 10.1002/cmdc.201300057; Lee GH, 2014, FOOD CHEM TOXICOL, V64, P225, DOI 10.1016/j.fct.2013.11.042; Lee MS, 1996, CHEM RES TOXICOL, V9, P1072, DOI 10.1021/tx950213f; Lehmann F, 2006, J MED CHEM, V49, P2232, DOI 10.1021/jm051121i; Li GQ, 2006, BIOORG MED CHEM LETT, V16, P2293, DOI 10.1016/j.bmcl.2006.01.028; Li GY, 2001, ECON BOT, V55, P255, DOI 10.1007/BF02864563; LIN WK, 1990, BIOCHEM BIOPH RES CO, V167, P977, DOI 10.1016/0006-291X(90)90619-X; Liu JY, 2013, EUR J PHARM SCI, V48, P619, DOI 10.1016/j.ejps.2012.12.013; Liu JY, 2011, TOXICOL APPL PHARM, V255, P200, DOI 10.1016/j.taap.2011.06.017; Lo Monte F, 2011, BIOORG MED CHEM LETT, V21, P5610, DOI 10.1016/j.bmcl.2011.06.131; Mithen R, 2010, PHYTOCHEMISTRY, V71, P2074, DOI 10.1016/j.phytochem.2010.09.017; Morisseau C, 1999, P NATL ACAD SCI USA, V96, P8849, DOI 10.1073/pnas.96.16.8849; Morisseau C, 2002, BIOCHEM PHARMACOL, V63, P1599, DOI 10.1016/S0006-2952(02)00952-8; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Morisseau C, 2010, J LIPID RES, V51, P3481, DOI 10.1194/jlr.M006007; Nakagawa Y, 2000, BIOORGAN MED CHEM, V8, P2663, DOI 10.1016/S0968-0896(00)00198-X; Nakamura Y, 2007, J AGR FOOD CHEM, V55, P4407, DOI 10.1021/jf070159w; Piacente S, 2002, J AGR FOOD CHEM, V50, P5621, DOI 10.1021/jf020280x; RAY AB, 1975, CHEM IND-LONDON, P517; Rose TE, 2010, J MED CHEM, V53, P7067, DOI 10.1021/jm100691c; Sahu S, 2011, J SULFUR CHEM, V32, P171, DOI 10.1080/17415993.2010.550294; Sashidhara KV, 2009, EUR J MED CHEM, V44, P432, DOI 10.1016/j.ejmech.2007.12.018; Schebb NH, 2011, ENVIRON SCI TECHNOL, V45, P3109, DOI 10.1021/es103650m; Schieber A, 2001, TRENDS FOOD SCI TECH, V12, P401, DOI 10.1016/S0924-2244(02)00012-2; Schmelzer KR, 2006, P NATL ACAD SCI USA, V103, P13646, DOI 10.1073/pnas.0605908103; Shen HC, 2012, J MED CHEM, V55, P1789, DOI 10.1021/jm201468j; Sofrata A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023045; TANG CS, 1971, PHYTOCHEMISTRY, V10, P117, DOI 10.1016/S0031-9422(00)90258-9; Tsopmo A, 1999, J NAT PROD, V62, P1435, DOI 10.1021/np990111f; Ulu A, 2008, J CARDIOVASC PHARM, V52, P314, DOI 10.1097/FJC.0b013e318185fa3c; Wagner K, 2011, J AGR FOOD CHEM, V59, P2816, DOI 10.1021/jf102559q; Wang HF, 2010, BIOORG MED CHEM LETT, V20, P392, DOI 10.1016/j.bmcl.2009.10.061; Wang L, 2012, AM J RESP CELL MOL, V46, P614, DOI 10.1165/rcmb.2011-0359OC; Watanabe T, 2006, ANAL CHIM ACTA, V559, P37, DOI 10.1016/j.aca.2005.11.049; WIXTROM RN, 1988, ANAL BIOCHEM, V169, P71, DOI 10.1016/0003-2697(88)90256-4; Wu LY, 2004, P NATL ACAD SCI USA, V101, P7094, DOI 10.1073/pnas.0402004101; Xu D, 2006, P NATL ACAD SCI USA, V103, P18733, DOI 10.1073/pnas.0609158103; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Zhang GD, 2014, P NATL ACAD SCI USA, V111, P11127, DOI 10.1073/pnas.1410432111; Zhang GD, 2013, P NATL ACAD SCI USA, V110, P6530, DOI 10.1073/pnas.1304321110	79	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176571	10.1371/journal.pone.0176571	http://dx.doi.org/10.1371/journal.pone.0176571			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472063	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500053
J	Luyten, P; Mayes, LC; Nijssens, L; Fonagy, P				Luyten, Patrick; Mayes, Linda C.; Nijssens, Liesbet; Fonagy, Peter			The parental reflective functioning questionnaire: Development and preliminary validation	PLOS ONE			English	Article							BORDERLINE PERSONALITY-DISORDER; MENTALIZATION-BASED TREATMENT; ATTACHMENT SECURITY; ANOREXIA-NERVOSA; MIND-MINDEDNESS; MENTAL STATES; INTERGENERATIONAL TRANSMISSION; CONSTRUCT-VALIDITY; INFANT ATTACHMENT; MOTHERS	This paper reports on three studies on the development and validation of the Parental Reflective Functioning Questionnaire (PRFQ), a brief, multidimensional self-report measure that assesses parental reflective functioning or mentalizing, that is, the capacity to treat the infant as a psychological agent. Study 1 investigated the factor structure, reliability, and relationships of the PRFQ with demographic features, symptomatic distress, attachment dimensions, and emotional availability in a socially diverse sample of 299 mothers of a child aged 0-3. In Study 2, the factorial invariance of the PRFQ in mothers and fathers was investigated in a sample of 153 first-time parents, and relationships with demographic features, symptomatic distress, attachment dimensions, and parenting stress were investigated. Study 3 investigated the relationship between the PRFQ and infant attachment classification as assessed with the Strange Situation Procedure (SSP) in a sample of 136 community mothers and their infants. Exploratory and confirmatory factor analyses suggested three theoretically consistent factors assessing pre-mentalizing modes, certainty about the mental states of the infant, and interest and curiosity in the mental states of the infant. These factors were generally related in theoretically expected ways to parental attachment dimensions, emotional availability, parenting stress, and infant attachment status in the SSP. Yet, at the same time, more research on the PRFQ is needed to further establish its reliability and validity.	[Luyten, Patrick; Nijssens, Liesbet] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium; [Luyten, Patrick; Fonagy, Peter] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Luyten, Patrick; Mayes, Linda C.] Yale Univ, Yale Child Study Ctr, Sch Med, New Haven, CT 06520 USA	KU Leuven; University of London; University College London; Yale University	Luyten, P (corresponding author), Katholieke Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium.; Luyten, P (corresponding author), UCL, Res Dept Clin Educ & Hlth Psychol, London, England.; Luyten, P (corresponding author), Yale Univ, Yale Child Study Ctr, Sch Med, New Haven, CT 06520 USA.	patrick.luyten@ppw.kuleuven.be		Fonagy, Peter/0000-0003-0229-0091	National Institute for Health Research Senior Investigator Award [NF-SI-0514-10157]; National Institute for Health Research [NF-SI-0514-10157] Funding Source: researchfish	National Institute for Health Research Senior Investigator Award; National Institute for Health Research(National Institute for Health Research (NIHR))	Peter Fonagy is in receipt of a National Institute for Health Research Senior Investigator Award (grant number NF-SI-0514-10157). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin RR., 1983, PARENTING STRESS IND; Ainsworth M.D.S., 1978, PATTERNS ATTACHMENT, DOI DOI 10.4324/9780203758045; Allen J.G., 2008, MENTALIZING CLIN PRA; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Arbuckle MH., 1999, AMOS STRUCTURAL EQUA; Arnott B, 2007, B MENNINGER CLIN, V71, P132, DOI 10.1521/bumc.2007.71.2.132; Ashton CK, 2015, J CAN ACAD CHILD ADO, V25, P35; Atzil S, 2012, J AM ACAD CHILD PSY, V51, P798, DOI 10.1016/j.jaac.2012.06.008; Bateman A, 2004, PSYCHOTHERAPY BORDER, DOI 10.1093/med:psych/9780198527664.001.0001; Bateman A, 2008, AM J PSYCHIAT, V165, P631, DOI 10.1176/appi.ajp.2007.07040636; Bateman A, 2008, J CLIN PSYCHOL, V64, P181, DOI 10.1002/jclp.20451; Bernier A, 2010, CHILD DEV, V81, P326, DOI 10.1111/j.1467-8624.2009.01397.x; Biringen Z, 2002, EMOTIONAL AVAILABILI; Bollen KA, 1989, STRUCTURAL EQUATIONS; BRETHERTON I, 1989, INF MENTAL HLTH J, V10, P203, DOI 10.1002/1097-0355(198923)10:3<203::AID-IMHJ2280100307>3.0.CO;2-8; Bronfman E., 1999, ATYPICAL MATERNAL BE; Byrne B.M., 2010, STRUCTURAL EQUATION, DOI DOI 10.4324/9781410600219; Camoirano A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00014; De Brock A.J.L.L., 1992, NIJMEEGSE OUDERLIJKE; DeWolff MS, 1997, CHILD DEV, V68, P571, DOI 10.2307/1132107; Diamond D, 2014, PERSONAL DISORD, V5, P428, DOI 10.1037/per0000065; Ensink K, 2010, PSYCHOANAL INQ, V30, P301, DOI 10.1080/07351690903206504; Fearon P, 2006, HDB MENTALIZATION BA; Fischer-Kern M, 2013, J NERV MENT DIS, V201, P202, DOI 10.1097/NMD.0b013e3182845c0a; FONAGY P, 1994, J CHILD PSYCHOL PSYC, V35, P231, DOI 10.1111/j.1469-7610.1994.tb01160.x; FONAGY P, 1991, INFANT MENT HEALTH J, V12, P201, DOI 10.1002/1097-0355(199123)12:3<201::AID-IMHJ2280120307>3.0.CO;2-7; Fonagy P, 1997, BRIT J DEV PSYCHOL, V15, P51, DOI 10.1111/j.2044-835X.1997.tb00724.x; Fonagy P, 2014, ROUTLEDGE HDB ATTACH, P31; Fonagy P., 2016, DEV PSYCHOPATHOL, P1, DOI [10.1002/9781119125556.devpsy317, DOI 10.1002/9781119125556.DEVPSY317]; Fonagy P., 1998, REFLECTIVE FUNCTIONI; Fonagy P., 2002, AFFECT REGULATION ME; Fonagy P., 2010, PSYCHODYNAMIC PSYCHO, P37; Fonagy P, 2007, J CHILD PSYCHOL PSYC, V48, P288, DOI 10.1111/j.1469-7610.2007.01727.x; Fonagy P, 2015, J PERS DISORD, V29, P575, DOI 10.1521/pedi.2015.29.5.575; Fonagy P, 2011, INFANT MENT HEALTH J, V32, P47, DOI 10.1002/imhj.20283; Fonagy P, 2009, DEV PSYCHOPATHOL, V21, P1355, DOI 10.1017/S0954579409990198; Fonagy P, 2009, J CHILD PSYCHOL PSYC, V50, P607, DOI 10.1111/j.1469-7610.2008.02025.x; Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350; FURROW D, 1992, J CHILD LANG, V19, P617, DOI 10.1017/S0305000900011594; George C., 1985, ADULT ATTACHME INTER; Goodman G, 2013, J PSYCHOTHER INTEGR, V23, P179, DOI 10.1037/a0032354; Goodman M, 2011, J AM ACAD CHILD PSY, V50, P536, DOI 10.1016/j.jaac.2011.02.013; Gordon I, 2010, BIOL PSYCHIAT, V68, P377, DOI 10.1016/j.biopsych.2010.02.005; Grienenberger J, 2005, ATTACH HUM DEV, V7, P299, DOI 10.1080/14616730500245963; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Katz LF, 1996, J FAM PSYCHOL, V10, P284, DOI 10.1037/0893-3200.10.3.284; Katznelson H, 2014, CLIN PSYCHOL REV, V34, P107, DOI 10.1016/j.cpr.2013.12.003; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Kochanska G, 2013, CHILD DEV, V84, P283, DOI 10.1111/j.1467-8624.2012.01852.x; Kuipers GS, 2012, CURR PSYCHIATRY REV, V8, P326, DOI 10.2174/157340012803520478; Kwon JW, 2009, BMC PUBLIC HEALTH, V9, P72; Kyte Z., 2008, SOCIAL COGNITION DEV, P201; Lange A, 2007, HANDLEIDING KORTE KL; Leckman JF, 1999, ACTA PSYCHIAT SCAND, V100, P1, DOI 10.1111/j.1600-0447.1999.tb10951.x; Leckman JF, 2007, DEV SCI PSYCHOANALYS, P89; Lemma A, 2011, PSYCHIATRY, V74, P41, DOI 10.1521/psyc.2011.74.1.41; Levy KN, 2011, CURR PSYCHIAT REP, V13, P50, DOI 10.1007/s11920-010-0169-8; Levy KN, 2005, REFLECTIVE FUNCTION; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Luyten P., 2012, HDB MENTALIZING MENT, P385; Luyten P, 2012, HDB MENTALIZING MENT, P43; Luyten P, 2015, PERSONAL DISORD, V6, P366, DOI 10.1037/per0000117; Luyten P, 2012, PSYCHOANAL PSYCHOTHE, V26, P121, DOI 10.1080/02668734.2012.678061; Main M, 1990, ATTACHMENT PRESCHOOL, P121; Meins E, 2003, CHILD DEV, V74, P1194, DOI 10.1111/1467-8624.00601; Meins E, 2002, CHILD DEV, V73, P1715, DOI 10.1111/1467-8624.00501; Meins E, 2001, J CHILD PSYCHOL PSYC, V42, P637, DOI 10.1111/1469-7610.00759; Meins E, 1998, INFANT BEHAV DEV, V21, P237, DOI 10.1016/S0163-6383(98)90004-2; Meins E, 2013, CHILD DEV, V84, P1777, DOI 10.1111/cdev.12061; Meins E, 2012, INFANCY, V17, P393, DOI 10.1111/j.1532-7078.2011.00087.x; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Oppenheim D, 2009, HDB INFANT MENTAL HL; Pajulo M, 2015, INFANT MENT HEALTH J, V36, P399, DOI 10.1002/imhj.21523; Paris R, 2015, CHILD ABUSE NEGLECT, V50, P206, DOI 10.1016/j.chiabu.2015.09.007; Pedersen SH, 2012, EUR EAT DISORD REV, V20, P303, DOI 10.1002/erv.2158; Rossouw TI, 2012, J AM ACAD CHILD PSY, V51, P1304, DOI 10.1016/j.jaac.2012.09.018; Rostad WL, 2016, J CHILD FAM STUD, V25, P2164, DOI 10.1007/s10826-016-0388-7; Ruffman T, 2002, CHILD DEV, V73, P734, DOI 10.1111/1467-8624.00435; Rutherford HJV, 2015, INFANT BEHAV DEV, V40, P54, DOI 10.1016/j.infbeh.2015.04.005; Rutherford HJV, 2013, INFANT BEHAV DEV, V36, P635, DOI 10.1016/j.infbeh.2013.06.008; Rutherford HJ, 2016, SOC NEUROSCI; Sadler L. S., 2006, HDB MENTALIZATION BA, P271, DOI DOI 10.1002/9780470712986.CH14; Schechter DS, 2006, INFANT MENT HEALTH J, V27, P429, DOI 10.1002/imhj.20101; Schiborr J, 2013, MEASUREMENT, V46, P2492, DOI 10.1016/j.measurement.2013.05.007; Sharp C, 2008, SOCIAL COGNITION DEV; Sharp C, 2008, SOC DEV, V17, P737, DOI 10.1111/j.1467-9507.2007.00457.x; Sharp C, 2011, J AM ACAD CHILD PSY, V50, P563, DOI 10.1016/j.jaac.2011.01.017; Skarderud F, 2007, EUR EAT DISORD REV, V15, P323, DOI 10.1002/erv.817; Skarderud F, 2007, EUR EAT DISORD REV, V15, P243, DOI 10.1002/erv.778; Skarderud F, 2007, EUR EAT DISORD REV, V15, P163, DOI 10.1002/erv.777; Slade A, 2005, ATTACH HUM DEV, V7, P269, DOI 10.1080/14616730500245906; Slade A, 2005, ATTACH HUM DEV, V7, P283, DOI 10.1080/14616730500245880; Slade A, 2007, ADDENDUM REFLECTIVE; Slade A., 2004, THESIS CITY U NEW YO; Slaughter V, 2008, INFANCY, V13, P640, DOI 10.1080/15250000802458807; Sroufe LA, 2005, ATTACH HUM DEV, V7, P349, DOI 10.1080/14616730500365928; Steele M, 2008, MIND MIND INFANT RES, P115, DOI DOI 10.1080/14616734.2010.501988; Suchman NE, 2010, ATTACH HUM DEV, V12, P483, DOI 10.1080/14616734.2010.501983; Twemlow SW, 2001, AM J PSYCHIAT, V158, P808, DOI 10.1176/appi.ajp.158.5.808; van Ijzendoorn MH, 1996, J CONSULT CLIN PSYCH, V64, P8, DOI 10.1037/0022-006X.64.1.8; van IJzendoorn MH, 1997, CHILD DEV, V68, P604; Verhage ML, 2016, PSYCHOL BULL, V142, P337, DOI 10.1037/bul0000038; Vliegen N, 2009, PARENT-SCI PRACT, V9, P228, DOI 10.1080/15295190902844514; Ward A, 2000, BRIT J MED PSYCHOL, V73, P35, DOI 10.1348/000711200160282; Winnicott D.W., 1956, PAEDIAT PSYCHOANALYS, P300	106	157	159	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176218	10.1371/journal.pone.0176218	http://dx.doi.org/10.1371/journal.pone.0176218			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472162	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500030
J	Ly, C; Doiron, B				Ly, Cheng; Doiron, Brent			Noise-enhanced coding in phasic neuron spike trains	PLOS ONE			English	Article							STOCHASTIC RESONANCE; SIGNAL TRANSMISSION; FIRE NEURONS; INPUT; OSCILLATIONS; BENEFITS; CURRENTS; SYSTEMS; SOUNDS; MODEL	The stochastic nature of neuronal response has lead to conjectures about the impact of input fluctuations on the neural coding. For the most part, low pass membrane integration and spike threshold dynamics have been the primary features assumed in the transfer from synaptic input to output spiking. Phasic neurons are a common, but understudied, neuron class that are characterized by a subthreshold negative feedback that suppresses spike train responses to low frequency signals. Past work has shown that when a low frequency signal is accompanied by moderate intensity broadband noise, phasic neurons spike trains are well locked to the signal. We extend these results with a simple, reduced model of phasic activity that demonstrates that a non-Markovian spike train structure caused by the negative feedback produces a noise-enhanced coding. Further, this enhancement is sensitive to the timescales, as opposed to the intensity, of a driving signal. Reduced hazard function models show that noise-enhanced phasic codes are both novel and separate from classical stochastic resonance reported in non-phasic neurons. The general features of our theory suggest that noise-enhanced codes in excitable systems with subthreshold negative feedback are a particularly rich framework to study.	[Ly, Cheng] Virginia Commonwealth Univ, Dept Stat Sci & Operat Res, Richmond, VA 23284 USA; [Doiron, Brent] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA; [Doiron, Brent] Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ly, C (corresponding author), Virginia Commonwealth Univ, Dept Stat Sci & Operat Res, Richmond, VA 23284 USA.	CLy@vcu.edu			Simons Foundation [355173, 32529MC]; National Science Foundation [DMS-1313225, DMS-1517082]; National Institutes of Health [R01NS070865, R01DC015139]	Simons Foundation; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Simons Foundation, https://www.simonsfoundation.org/,#355173 (CL); National Science Foundation, https://www.nsf.gov/index.jsp?div=DMS, #DMS-1313225 (BD); National Science Foundation, https://www.nsf.gov/div/index.jsp?dive=DMS,#DMS-1517082 (BD); National Institutes of Health, https://grants.nih.gov/grants/oer.htm, #R01NS070865 (BD); National Institutes of Health https://grants.nil.gov/grants/oer.htm, #R01DC015139 (BD); and Simons Foundation, https://www.simonsfoundation.org/, SCGB#32529MC (BD).	Barreiro AK, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011916; Benda J, 2010, J NEUROPHYSIOL, V104, P2806, DOI 10.1152/jn.00240.2010; Burkitt AN, 2001, NEURAL COMPUT, V13, P2639, DOI 10.1162/089976601317098475; Chacron MJ, 2005, NAT NEUROSCI, V8, P673, DOI 10.1038/nn1433; Chacron MJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.080601; Chacron MJ, 2001, J NEUROSCI, V21, P5328, DOI 10.1523/JNEUROSCI.21-14-05328.2001; Chen YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056822; Cox D. R., 1962, RENEWAL THEORY; Cox DR, 1966, STAT ANAL SERIES EVE; Dayan P, 2001, COMPUTATIONAL NEUROS; Desroches M, 2012, SIAM REV, V54, P211, DOI 10.1137/100791233; DeVille REL, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031105; DeVille REL, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2217013; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Gai Y, 2014, J NEUROPHYSIOL, V112, P802, DOI 10.1152/jn.00044.2013; Gai Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000825; Gai Y, 2009, J NEUROPHYSIOL, V102, P3447, DOI 10.1152/jn.00538.2009; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gao X, 2015, NEURON, V86, P292, DOI 10.1016/j.neuron.2015.03.004; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Goychuk I, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021104; Goychuk I, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.070601; HODGKIN AL, 1948, J PHYSIOL-LONDON, V107, P165, DOI 10.1113/jphysiol.1948.sp004260; HUDSON JL, 1979, J CHEM PHYS, V71, P1601, DOI 10.1063/1.438487; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; JUNG P, 1991, PHYS REV A, V44, P8032, DOI 10.1103/PhysRevA.44.8032; Kloeden PE., 2012, SPRINGER VERLAG, DOI [10.1007/978-3-642-57913-4, DOI 10.1007/978-3-642-57913-4]; Kramers H., 1940, PHYS UTRECHT, V1940, P284; Lindner B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021911; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; LONGTIN A, 1993, J STAT PHYS, V70, P309, DOI 10.1007/BF01053970; Lundstrom BN, 2008, NEURAL COMPUT, V20, P1239, DOI 10.1162/neco.2007.05-07-536; Lundstrom BN, 2009, J COMPUT NEUROSCI, V27, P277, DOI 10.1007/s10827-009-0142-x; Mapelli J, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00014; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; MCNAMARA B, 1989, PHYS REV A, V39, P4854, DOI 10.1103/PhysRevA.39.4854; O'Haver T., 2008, FAST SMOOTHING FUNCT; Plesser HE, 2000, NEURAL COMPUT, V12, P367, DOI 10.1162/089976600300015835; Prescott SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000198; Ratte S, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00452; Rinzel J., 1989, METHODS NEURONAL MOD, P135; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3097, DOI 10.1152/jn.00127.2002; RUSH ME, 1995, B MATH BIOL, V57, P899, DOI 10.1016/S0092-8240(95)80006-9; Shimokawa T, 1999, PHYS REV E, V59, P3427, DOI 10.1103/PhysRevE.59.3427; Slee SJ, 2005, J NEUROSCI, V25, P9978, DOI 10.1523/JNEUROSCI.2666-05.2005; St-Hilaire M, 2004, J COMPUT NEUROSCI, V16, P299, DOI 10.1023/B:JCNS.0000025690.02886.93; Svirskis G, 2002, J NEUROSCI, V22, P11019; Vanag VK, 2000, NATURE, V406, P389, DOI 10.1038/35019038; Vo T, 2010, J COMPUT NEUROSCI, V28, P443, DOI 10.1007/s10827-010-0226-7; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0	50	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176963	10.1371/journal.pone.0176963	http://dx.doi.org/10.1371/journal.pone.0176963			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472143	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500105
J	Ordelheide, AM; Bohm, A; Kempe-Teufel, D; Wagner, R; Machicao, F; Heni, M; Stefan, N; Fritsche, A; Haring, HU; Staiger, H				Ordelheide, Anna-Maria; Boehm, Anja; Kempe-Teufel, Daniela; Wagner, Robert; Machicao, Fausto; Heni, Martin; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald			Common variation in the sodium/glucose cotransporter 2 gene SLC5A2 does neither affect fasting nor glucose-suppressed plasma glucagon concentrations	PLOS ONE			English	Article							INSULIN SENSITIVITY; SGLT2; DAPAGLIFLOZIN; POLYMORPHISMS; INHIBITION	Aim Inhibition of sodium/glucose cotransporter 2 (SGLT2), the key transport protein in renal glucose reabsorption, promotes glucose excretion and represents a new concept in the therapy of type-2 diabetes. In addition, SGLT2 inhibition elevates circulating glucagon concentrations and enhances hepatic glucose production. Since SGLT2 is expressed in human pancreatic alpha-cells and regulates glucagon release, we tested whether common variants of the SGLT2 gene SLC5A2 associate with altered plasma glucagon concentrations in the fasting state and upon glucose challenge. Methods A study population of 375 healthy subjects at increased risk for type-2 diabetes, phenotyped by a 5-point oral glucose tolerance test (OGTT) and genotyped for recently described SLC5A2 tagging single nucleotide polymorphisms (SNPs), was selected for plasma glucagon measurements. Results After adjustment for gender, age, body mass index, and insulin sensitivity, the four tagging SNPs (rs9924771, rs3116150, rs3813008, rs9934336), tested separately or as genetic score, were neither significantly nor nominally associated with plasma glucagon concentrations at any time during the OGTT, with the inverse AUC of glucagon or the glucagon fold-change during the OGTT (p >= 0.2, all). Testing for genotype-related differences in the time course of the glucagon response using MANOVA did also not reveal any significant or nominal associations (p >= 0.5, all). Conclusion We could not obtain statistically significant evidence for a role of common SLC5A2 variants in the regulation of glucagon release in the fasting state or upon glucose challenge. Moreover, the reported nominal effects of individual SLC5A2 variants on fasting and post-challenge glucose levels may probably not be mediated by altered glucagon release.	[Ordelheide, Anna-Maria; Boehm, Anja; Kempe-Teufel, Daniela; Wagner, Robert; Machicao, Fausto; Heni, Martin; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald] Eberhard Karls Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Otfried Muller Str 10, Tubingen, Germany; [Ordelheide, Anna-Maria; Boehm, Anja; Kempe-Teufel, Daniela; Wagner, Robert; Machicao, Fausto; Heni, Martin; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald] German Ctr Diabet Res DZD, Otfried Muller Str 10, Tubingen, Germany; [Boehm, Anja; Kempe-Teufel, Daniela; Wagner, Robert; Heni, Martin; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich] Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Otfried Muller Str 10, Tubingen, Germany; [Machicao, Fausto; Staiger, Harald] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Expt Genet, Ingolstadter Landstr 1, Neuherberg, Germany; [Fritsche, Andreas] Univ Tubingen Hosp, Dept Internal Med, Div Nutr & Prevent Med, Otfried Muller Str 10, Tubingen, Germany; [Haering, Hans-Ulrich; Staiger, Harald] Eberhard Karls Univ Tubingen, Nterfac Ctr Pharmacogen & Pharma Res, Morgenstelle 8, Tubingen, Germany; [Staiger, Harald] Eberhard Karls Univ Tubingen, Dept Pharm & Biochem, Inst Pharmaceut Sci, Morgenstelle 8, Tubingen, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Staiger, H (corresponding author), Eberhard Karls Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Otfried Muller Str 10, Tubingen, Germany.; Staiger, H (corresponding author), German Ctr Diabet Res DZD, Otfried Muller Str 10, Tubingen, Germany.; Staiger, H (corresponding author), German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Expt Genet, Ingolstadter Landstr 1, Neuherberg, Germany.; Staiger, H (corresponding author), Eberhard Karls Univ Tubingen, Nterfac Ctr Pharmacogen & Pharma Res, Morgenstelle 8, Tubingen, Germany.; Staiger, H (corresponding author), Eberhard Karls Univ Tubingen, Dept Pharm & Biochem, Inst Pharmaceut Sci, Morgenstelle 8, Tubingen, Germany.	harald.staiger@med.uni-tuebingen.de	Wagner, Robert/B-3689-2012	Wagner, Robert/0000-0002-6120-0191; Stefan, Norbert/0000-0002-2186-9595; Heni, Martin/0000-0002-8462-3832; Staiger, Harald/0000-0002-9507-5333; Moller, Anja/0000-0002-5344-8533	Bundesministerium fur Bildung and Forschung (DE) [01G10925]	Bundesministerium fur Bildung and Forschung (DE)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung and Forschung (DE) (https//www.bmbf.de/) Grant number 01G10925. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonner C, 2015, NAT MED, V21, P512, DOI 10.1038/nm.3828; Crane RK, 1983, COMPREHENSIVE BIOCH, P43; Dusaulcy R, 2016, ENDOCRINOLOGY, V157, P536, DOI 10.1210/en.2015-1725; Enigk U, 2011, PHARMACOGENOMICS, V12, P1119, DOI [10.2217/PGS.11.69, 10.2217/pgs.11.69]; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Heikkinen S, 2007, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB29B03S77; Mather A, 2011, KIDNEY INT, V79, pS1, DOI 10.1038/ki.2010.509; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Merovci A, 2014, J CLIN INVEST, V124, P509, DOI 10.1172/JCI70704; Poulsen SB, 2015, CURR OPIN NEPHROL HY, V24, P463, DOI 10.1097/MNH.0000000000000152; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Vallon V, 2015, ANNU REV MED, V66, P255, DOI 10.1146/annurev-med-051013-110046; von Mering J, 1885, CENTRALBL MED WISS, V23, P531; Wagner R, 2016, DIABETES; Zimdahl H, 2017, PHARMACOGENET GENOM, V27, P135, DOI 10.1097/FPC.0000000000000268	15	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177148	10.1371/journal.pone.0177148	http://dx.doi.org/10.1371/journal.pone.0177148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472182	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500146
J	Park, YM; Pereira, RI; Erickson, CB; Swibas, TA; Cox-York, KA; Van Pelt, RE				Park, Young-Min; Pereira, Rocio I.; Erickson, Christopher B.; Swibas, Tracy A.; Cox-York, Kimberly A.; Van Pelt, Rachael E.			Estradiol-mediated improvements in adipose tissue insulin sensitivity are related to the balance of adipose tissue estrogen receptor alpha and beta in postmenopausal women	PLOS ONE			English	Article							GLUCOSE-HOMEOSTASIS; METABOLIC SYNDROME; ER-ALPHA; LIPOLYSIS; ADIPOCYTE; FAT; INFLAMMATION; EXPRESSION; CLEARANCE; MUSCLE	We recently demonstrated that short-term estradiol (E-2) treatment improved insulin-mediated suppression of lipolysis in postmenopausal women, but to a greater extent in those who were late compared to early postmenopausal. In this follow-up study we tested whether subcutaneous adipose tissue (SAT) expression of estrogen receptors (ER) alpha and beta differs between early and late postmenopausal women. We further tested whether the balance of ER alpha to ER beta in SAT determined the effect of E-2 on SAT insulin sensitivity. The present study included 35 women who were <= 6 years past menopause (EPM; n = 16) or >= 10 years past menopause (LPM; n = 19). Fasted SAT samples were taken following 1-week transdermal E-2 treatment or placebo (PL) in a random cross-over design. Samples were analyzed for nuclear/cytosolic protein content and mRNA expression using Western blot and qPCR, respectively. While ESR1 increased slightly (similar to 1.4-fold) following E-2 treatment in both groups, ER alpha and ER beta protein expression did not differ between groups at baseline or in response to E2. However, the balance of ER alpha/ER beta protein in the SAT nuclear fraction increased 10% in EPM compared to a 25% decrease in LPM women (group x treatment interaction, p<0.05). A greater proportion of ER alpha/ER beta protein in the nuclear fraction of SAT at baseline (placebo day) was associated with greater reduction in SAT insulin resistance (i.e., better suppression of lipolysis, EC50) in response to E-2 (r = -0.431, p<0.05). In conclusion, there do not appear to be differences in the proportion of adipose tissue ER alpha/ER beta protein in late, compared to early, postmenopausal women. However, the balance of ER alpha/ER beta may be important for E-2-mediated improvement in adipose tissue insulin sensitivity.	[Park, Young-Min; Erickson, Christopher B.; Swibas, Tracy A.; Van Pelt, Rachael E.] Univ Colorado Anschutz Med Campus, Dept Med, Div Geriatr Med, Aurora, CO 80045 USA; [Pereira, Rocio I.] Univ Colorado Anschutz Med Campus, Dept Med, Div Endocrinol Diabet & Metab, Aurora, CO USA; [Pereira, Rocio I.] Denver Hlth & Hosp Author, Denver, CO USA; [Cox-York, Kimberly A.] Colorado State Univ, Dept Nutr, Ft Collins, CO 80523 USA; [Van Pelt, Rachael E.] VA Eastern Colorado Hlth Care Syst, GRECC, Denver, CO 80220 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center; Colorado State University; Geriatric Research Education & Clinical Center	Van Pelt, RE (corresponding author), Univ Colorado Anschutz Med Campus, Dept Med, Div Geriatr Med, Aurora, CO 80045 USA.; Van Pelt, RE (corresponding author), VA Eastern Colorado Hlth Care Syst, GRECC, Denver, CO 80220 USA.	rachael.vanpelt@ucdenver.edu			National Institutes of Health [R01 DK088105, P50 HD073063, P30 DK048520, UL1 TR001082, T32 DK007446]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health: R01 DK088105, P50 HD073063, P30 DK048520, UL1 TR001082; all to RV; T32 DK007446 to KC.	Barros RPA, 2006, TRENDS MOL MED, V12, P425, DOI 10.1016/j.molmed.2006.07.004; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Barros RPA, 2009, AM J PHYSIOL-ENDOC M, V297, pE124, DOI 10.1152/ajpendo.00189.2009; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Coppack SW, 1999, AM J PHYSIOL-ENDOC M, V276, pE233, DOI 10.1152/ajpendo.1999.276.2.E233; Davis KE, 2013, MOL METAB, V2, P227, DOI 10.1016/j.molmet.2013.05.006; Dieudonne MN, 2004, AM J PHYSIOL-CELL PH, V286, pC655, DOI 10.1152/ajpcell.00321.2003; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Hevener AL, 2015, MOL CELL ENDOCRINOL, V418, P306, DOI 10.1016/j.mce.2015.05.020; Jackman MR, 2008, AM J PHYSIOL-REG I, V294, pR1117, DOI 10.1152/ajpregu.00808.2007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McInnes KJ, 2012, MENOPAUSE, V19, P1347, DOI 10.1097/gme.0b013e318258aad7; Morley TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8906; Park Y. M., 2017, TIME MENOPAUSE SKELE; Pedersen SB, 2004, J CLIN ENDOCR METAB, V89, P1869, DOI 10.1210/jc.2003-031327; Pedersen SB, 2001, MOL CELL ENDOCRINOL, V182, P27, DOI 10.1016/S0303-7207(01)00557-3; Pereira RI, 2015, J CLIN ENDOCR METAB, V100, P4456, DOI 10.1210/jc.2015-3084; Ribas V, 2010, AM J PHYSIOL-ENDOC M, V298, pE304, DOI 10.1152/ajpendo.00504.2009; Salpeter SR, 2006, DIABETES OBES METAB, V8, P538, DOI 10.1111/j.1463-1326.2005.00545.x; Stumvoll M, 2000, J CLIN ENDOCR METAB, V85, P3740, DOI 10.1210/jc.85.10.3740; Van Pelt RE, 2008, J CLIN ENDOCR METAB, V93, P484, DOI 10.1210/jc.2007-1657; Van Pelt RE, 2006, OBESITY, V14, P2163, DOI 10.1038/oby.2006.253; Van Pelt RE, 2003, AM J PHYSIOL-ENDOC M, V285, pE311, DOI 10.1152/ajpendo.00490.2002; Van Pelt RE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1023, DOI 10.1152/ajpendo.00467.2001	25	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176446	10.1371/journal.pone.0176446	http://dx.doi.org/10.1371/journal.pone.0176446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472101	Green Submitted, gold, Green Published			2022-12-27	WOS:000400648500046
J	Spielman, DJ; Zaidi, F; Zambrano, P; Khan, AA; Ali, S; Cheema, HMN; Nazli, H; Khan, RSA; Iqbal, A; Zia, MA; Ali, GM				Spielman, David J.; Zaidi, Fatima; Zambrano, Patricia; Khan, Asif Ali; Ali, Shaukat; Cheema, H. Masooma Naseer; Nazli, Hina; Khan, Rao Sohail Ahmad; Iqbal, Arshad; Zia, Muhammad Amir; Ali, Ghulam Muhammad			What are farmers really planting? Measuring the presence and effectiveness of Bt cotton in Pakistan	PLOS ONE			English	Article							YANGTZE-RIVER VALLEY; HELICOVERPA-ARMIGERA; EXPRESSION; PROTEIN; CRY1AC; RESISTANCE	Genetically modified, insect-resistant Bacillus thuringiensis (Bt) cotton is cultivated extensively in Pakistan. Past studies, however, have raised concerns about the prevalence of Bt cotton varieties possessing weak or nonperforming insect-resistance traits conferred by the cry gene. We examine this issue using data drawn from a representative sample of cotton- growing households that were surveyed in six agroclimatic zones spanning 28 districts in Pakistan in 2013, as well as measurements of Cry protein levels in cotton tissue samples collected from the sampled households' main fields. The resultant dataset combines information from 593 sampled households with corresponding plant tissue diagnostics from 70 days after sowing, as well as information from 589 sampled households with corresponding diagnostics from 120 days after sowing. Our analysis indicates that 11 percent of farmers believed they were cultivating Bt cotton when, in fact, the Cry toxin was not present in the tested tissue at 70 days after sowing (i.e., a Type I error). The analysis further indicates that 5 percent of farmers believed they were cultivating non-Bt cotton when, in fact, the Cry toxin was present in the tested tissue (i.e., a Type II error). In addition, 17 percent of all sampled farmers were uncertain whether or not they were cultivating Bt cotton. Overall, 33 percent of farmers either did not know or were mistaken in their beliefs about the presence of the cry gene in the cotton they cultivated. Results also indicate that toxic protein levels in the plant tissue samples occurred below threshold levels for lethality in a significant percentage of cases, although these measurements may also be affected by factors related to tissue sample collection, handling, storage, and testing procedures. Nonetheless, results strongly suggest wide variability both in farmers' beliefs and in gene expression. Such variability has implications for policy and regulation in Pakistan's transgenic cotton seed market.	[Spielman, David J.; Zaidi, Fatima; Zambrano, Patricia] Int Food Policy Res Inst, Environm & Prod Technol Div, Washington, DC 20036 USA; [Khan, Asif Ali] Muhammad Nawaz Shareef Univ Agr, Multan, Pakistan; [Khan, Asif Ali] Univ Agr Faisalabad, Off Res Innovat & Commercializat, Faisalabad, Pakistan; [Ali, Shaukat; Iqbal, Arshad; Zia, Muhammad Amir; Ali, Ghulam Muhammad] Pakistan Agr Res Council, Natl Inst Genom & Adv Biotechnol, Islamabad, Pakistan; [Cheema, H. Masooma Naseer] Univ Agr Faisalabad, Dept Plant Breeding & Genet, Faisalabad, Pakistan; [Nazli, Hina] Int Food Policy Res Inst, Pakistan Strategy Support Program, Islamabad, Pakistan; [Khan, Rao Sohail Ahmad] Univ Agr Faisalabad, Ctr Agr Biochem & Biotechnol, Faisalabad, Pakistan	CGIAR; International Food Policy Research Institute (IFPRI); University of Agriculture Faisalabad; National Agricultural Research Council - Pakistan; University of Agriculture Faisalabad; CGIAR; International Food Policy Research Institute (IFPRI); University of Agriculture Faisalabad	Spielman, DJ (corresponding author), Int Food Policy Res Inst, Environm & Prod Technol Div, Washington, DC 20036 USA.	d.spielman@cgiar.org	Cheema, H. Masooma Naseer/L-6918-2017; Asif, Ali/P-9684-2017; Khan, Rao Sohail Ahmad/AAA-6364-2019; Cheema, Hafiza Masooma Naseer/V-3865-2019	Cheema, H. Masooma Naseer/0000-0003-3285-0037; Asif, Ali/0000-0002-4474-164X; Khan, Rao Sohail Ahmad/0000-0002-1118-9000; Cheema, Hafiza Masooma Naseer/0000-0003-3285-0037; Spielman, David/0000-0002-6889-7358	Pakistan Strategy Support Program of the International Food Policy Research Institute; U.S. Agency for International Development; CGIAR Research Program on Policies, Institutions, and Markets	Pakistan Strategy Support Program of the International Food Policy Research Institute; U.S. Agency for International Development(United States Agency for International Development (USAID)); CGIAR Research Program on Policies, Institutions, and Markets(CGIAR)	This work was supported by the Pakistan Strategy Support Program of the International Food Policy Research Institute, with funding from the U.S. Agency for International Development, and by the CGIAR Research Program on Policies, Institutions, and Markets. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedullah, 2015, J AGR ECON, V66, P66, DOI 10.1111/1477-9552.12072; Adamczyk J. J. Jr., 2004, Journal of Cotton Science, V8, P17; Ali A, 2010, J AGR ECON, V61, P175, DOI 10.1111/j.1477-9552.2009.00227.x; Ali S, 2012, CURR SCI INDIA, V102, P1632; Ali S, 2010, PAK J BOT, V42, P1583; [Anonymous], 2015, DAWN; BARTON KA, 1987, PLANT PHYSIOL, V85, P1103, DOI 10.1104/pp.85.4.1103; Benedict JH, 1996, J ECON ENTOMOL, V89, P230, DOI 10.1093/jee/89.1.230; Cheema HM, 2015, J AGR SCI, V153, P1; *FAO, 2004, FERT US CROP PAK; Fuchs RL, 1990, ACS S SERIES, V432; Government of Punjab (Pakistan), 2015, COTT PEST SCOUT REP; Greenplate JT, 1999, J ECON ENTOMOL, V92, P1377, DOI 10.1093/jee/92.6.1377; Guo Wang-Zhen, 2001, Acta Genetica Sinica, V28, P668; Hayee A, 2004, CULTIVATION BT COTTO; Kouser S, 2014, ENVIRON DEV ECON, V19, P704, DOI 10.1017/S1355770X1300051X; Kranthi KR, 2005, CURR SCI INDIA, V89, P291; Liu YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23507; Ma X, 2016, J AGR EC IN PRESS; Maredia M, 2016, INT DEV WORKING PAPE, V246950; Monsanto, 2009, PINK BOLLW RES GM CO; Nazli H, 2012, BT COTTON ADOPTION W; Pemsl D, 2007, AGR SYST, V95, P28, DOI 10.1016/j.agsy.2007.02.013; Pemsl D, 2003, 7 INT CONS AGR BIOT; PERLAK FJ, 1990, BIO-TECHNOL, V8, P939, DOI 10.1038/nbt1090-939; Rana M. A., 2013, WORKING PAPER; Rana MA., 2010, THESIS; Rana MA., 2014, 19 PSSP INT FOOD POL; Rochester IJ, 2006, J COTTON SCI, V10, P252; Shan G, 2011, IMMUNOASSAYS AGR BIO; Showalter AM, 2009, BIOTECHNOLOGY AGR DE; Spielman D. J., 2015, AgBioForum, V18, P98; VAECK M, 1987, NATURE, V328, P33, DOI 10.1038/328033a0; Wan P, 2005, J ECON ENTOMOL, V98, P195, DOI 10.1603/0022-0493-98.1.195; Xia LanQin, 2005, Acta Agronomica Sinica, V31, P197; Xu NY, 2008, CROP PROT, V27, P1269, DOI 10.1016/j.cropro.2008.04.003; Zhao QC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110006	37	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176592	10.1371/journal.pone.0176592	http://dx.doi.org/10.1371/journal.pone.0176592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472094	gold, Green Submitted, Green Published			2022-12-27	WOS:000400648500056
J	Li, ZY; Jiang, J; Tian, L; Li, X; Chen, J; Li, ST; Li, CY; Yang, ZC				Li, Zhuoying; Jiang, Jie; Tian, Lang; Li, Xin; Chen, Jia; Li, Shentang; Li, Chunyun; Yang, Zuocheng			A plasma mir-125a-5p as a novel biomarker for Kawasaki disease and induces apoptosis in HUVECs	PLOS ONE			English	Article							CIRCULATING MICRORNAS; MYOCARDIAL-INFARCTION; CANCER; CELLS; MKK7; SUPPRESSION; EXPRESSION; DIAGNOSIS; SERUM; MIRNA	Background Kawasaki disease (KD) is a childhood systemic vasculitis that exhibits a specific preference for the coronary arteries. The aetiology remains unknown and there are no especially diagnostic tests. microRNAs (miRNAs) are 18 to 23 nucleotides non-coding RNAs that are negative regulator of gene expression and play a crucial role in the regulatory network of the genome. Recently, circulating miRNAs have been found presentation in human plasma and displayed some characteristics of the ideal biomarker. However, few researches explored differentially expressed miRNAs in the plasma of KD patients. Our study is to identify circulating miRNAs in KD plasma which can serve as potential biomarkers of KD diagnosis. Materials and methods The total of five pairs of acute KD and normal plasma samples were analyzed using ABI miRNAs TLDA Assay chip. Differentially expression of miR-125a-5p in plasma were confirmed by quantitative real-time PCR (qRT-PCR) in independent cohort (acute KD = 30, convalescent KD = 30 and healthy control = 32). After bioinformatics prediction, miR-125a-5p vector and inhibitor were transfected into HUVECs respectively, to observe MKK7 expression as a potential target gene. Flow cytometry was used to analyze apoptosis. The mRNA and protein levels of desired genes including MKK7, Caspase-3, Bax and Bcl2 were detected by qRT-PCR and western blotting. Results Eighteen miRNAs were differentially expressed in acute KD's plasma compared with healthy control. miR-125a-5p was significantly increased in plasma of KD patients (p = 0.000), but no variation between acute and convalescent KD (p = 0.357). Moreover, the results from the gain and loss functions of miR-125a-5p in HUVECs have shown that miR125a- 5p remarkably suppressed MKK7 expression, as a novel target gene. Importantly, miR-125a-5p also induced apoptosis in HUVECs through inhibition MKK7 levels to regulate Bax/Bcl2 pathway resulting to activate Caspase-3. Conclusion Our study indicated that the circulating miR-125a-5p levels in KD's plasma have remarkably evaluated compared with healthy individuals. miR-125a-5p might play a role in the development of KD by regulating target gene MKK7 to induce apoptosis in vascular endothelial cells. Therefore, our findings have suggested that detected miR-125a-5p levels in plasma could be used as a potential biomarker in early KD diagnosis.	[Li, Zhuoying; Jiang, Jie; Tian, Lang; Li, Xin; Chen, Jia; Li, Shentang; Li, Chunyun; Yang, Zuocheng] Cent S Univ, Xiangya Hosptial 3, Dept Pediat, Changsha, Hunan, Peoples R China	Central South University	Yang, ZC (corresponding author), Cent S Univ, Xiangya Hosptial 3, Dept Pediat, Changsha, Hunan, Peoples R China.	yang_zcr@126.com		Li, Zhuoying/0000-0002-2193-537X	Science and technology projects of Changsha City [kq1602042]; Hunan provincial Natural Science Foundation [2015JJ6111]	Science and technology projects of Changsha City; Hunan provincial Natural Science Foundation(Natural Science Foundation of Hunan Province)	This work was supported by grants from the Science and technology projects of Changsha City (No: kq1602042), and Hunan provincial Natural Science Foundation (No: 2015JJ6111), and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Barry SE, 2015, J CELL MOL MED, V19, P1606, DOI 10.1111/jcmm.12535; Bauters C, 2016, CARDIOLOGY, V133, P262, DOI 10.1159/000443204; Becker S, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0244-3; Bi Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040169; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Byun JY, 2009, CARCINOGENESIS, V30, P1880, DOI 10.1093/carcin/bgp235; Che P, 2014, AGING CELL, V13, P926, DOI 10.1111/acel.12252; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cui WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022988; Fan SJ, 2016, LEUKEMIA RES, V41, P62, DOI 10.1016/j.leukres.2015.11.016; Fukushima Y, 2011, CIRC J, V75, P336, DOI 10.1253/circj.CJ-10-0457; He WW, 2016, ONCOTARGET, V7, P6727, DOI 10.18632/oncotarget.6797; Huang YF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004020; Ju A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164259; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; Li Q, 2016, ATHEROSCLEROSIS, V254, P184, DOI 10.1016/j.atherosclerosis.2016.10.007; Lia D, 2010, J HYPERTENS, V28, P1646, DOI 10.1097/HJH.0b013e32833a4922; Maciejak A, 2016, MOL MED REP, V14, P2867, DOI 10.3892/mmr.2016.5566; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Parrizas M, 2016, BEST PRACT RES CL EN, V30, P591, DOI 10.1016/j.beem.2016.08.001; Rowley AH, 2011, ANNU REV MED, V62, P69, DOI 10.1146/annurev-med-042409-151944; Sanchez-Manubens J, 2014, J AUTOIMMUN, V48-49, P113, DOI 10.1016/j.jaut.2014.01.010; Shimizu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058159; Singh R, 2016, CANCER LETT, V381, P113, DOI 10.1016/j.canlet.2016.07.002; Singh S, 2016, INDIAN J PEDIATR, V83, P880, DOI 10.1007/s12098-016-2087-1; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tang RX, 2012, WORLD J GASTROENTERO, V18, P1485, DOI 10.3748/wjg.v18.i13.1485; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang J, 2011, MOL BIOL CELL, V22, P117, DOI 10.1091/mbc.E10-06-0492; Wang S, 2016, APOPTOSIS INT J PROG; Wang SY, 2017, APOPTOSIS, V22, P449, DOI 10.1007/s10495-016-1329-z; Zheng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077853; Zou HY, 2007, FEBS LETT, V581, P196, DOI 10.1016/j.febslet.2006.12.012	41	17	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175407	10.1371/journal.pone.0175407	http://dx.doi.org/10.1371/journal.pone.0175407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467514	Green Submitted, Green Published, gold			2022-12-27	WOS:000400647000014
J	Sekhar, DL; Murray-Kolb, LE; Kunselman, AR; Weisman, CS; Paul, IM				Sekhar, Deepa L.; Murray-Kolb, Laura E.; Kunselman, Allen R.; Weisman, Carol S.; Paul, Ian M.			Association between menarche and iron deficiency in non-anemic young women	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; US PRESCHOOL-CHILDREN; NATIONAL-HEALTH; CHILDBEARING AGE; ADOLESCENT; PREVALENCE; ANEMIA; SUPPLEMENTATION; FEMALES; RATIOS	Background The prevalence of iron deficiency (ID) among non-pregnant, reproductive-age US women significantly exceeds rates among males. In clinical practice ID screening relies on hemoglobin, a late-stage indicator of ID. As a single, low-cost laboratory test to diagnose ID before anemia develops is lacking, the study objective was to improve ID screening by identifying risk factors among non-anemic, iron-deficient reproductive age women. Methods Cross-sectional data were from the National Health and Nutrition Examination Survey (NHANES) 2003-2010. Hemoglobin identified non-anemic women. ID was defined using the body iron formula, requiring ferritin and transferrin receptor values. Logistic regression assessed the association of sociodemographic, behavioral, and reproductive risk factors in an anemia-based conceptual framework with non-anemic reproductive age women (12-49 years) with ID, as well as subsets of younger (12-21 years) and older (22-49 years) women, recognizing that risks may differ by age. Results Among 6216 women, 494 had ID (prevalence was 8.0%, 95% CI 7.3%, 8.6%). Among nonanemic younger women, 250 (8.7%, 95% CI 7.7%, 9.8%) had ID, compared to 244 (7.3%, 95% CI 6.4%, 8.2%) older women. Among younger women, menstruation for over 3 years was the only variable significantly associated with non-anemic ID (risk ratio 3.18, 95% CI 2.03, 4.96). No other significant risk factors were identified. Conclusion Menstrual years was the only risk factor significantly associated with ID among non-anemic younger women. The negative results suggest ID risk factors among non-anemic women may need to be considered separately from those associated with ID anemia.	[Sekhar, Deepa L.; Paul, Ian M.] Penn State Coll Med, Dept Pediat, Hershey, PA 17033 USA; [Murray-Kolb, Laura E.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Kunselman, Allen R.; Weisman, Carol S.; Paul, Ian M.] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Weisman, Carol S.] Penn State Coll Med, Dept Obstet & Gynecol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Sekhar, DL (corresponding author), Penn State Coll Med, Dept Pediat, Hershey, PA 17033 USA.	dsekhar@hmc.psu.edu	Paul, Ian/AAD-9813-2020	Paul, Ian/0000-0002-6344-8609	Eunice Kennedy Shriver National Institute of Child Health; Human Development of the National Institutes of Health under BIRCWH [K12HD055882]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055882] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Human Development of the National Institutes of Health under BIRCWH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Dr. Sekhar's research is supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under BIRCWH award number K12HD055882, "Career Development Program in Women's Health Research at Penn State." The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	[Anonymous], 1998, MMWR Recomm Rep, V47, P1; Bastos LS, 2015, CAD SAUDE PUBLICA, V31, P487, DOI [10.1590/0102-311X00175413, 10.1590/0102-311x00175413]; Beard J, 2004, ASSESSING IRON STATU, P77; Beck KL, 2014, NUTRIENTS, V6, P3747, DOI 10.3390/nu6093747; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; Blanton CA, 2013, BRIT J NUTR, V109, P906, DOI 10.1017/S0007114512002620; Bruinvels G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149881; Bruner AB, 1996, LANCET, V348, P992, DOI 10.1016/S0140-6736(96)02341-0; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P897; Cogswell ME, 2009, AM J CLIN NUTR, V89, P1334, DOI 10.3945/ajcn.2008.27151; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; FISHER KD, 1985, AM J CLIN NUTR, V42, P1318; Friedman AJ, 2012, J WOMENS HEALTH, V21, P1282, DOI 10.1089/jwh.2012.3713; Frith-Terhune AL, 2000, AM J CLIN NUTR, V72, P963; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; GRONER JA, 1986, J ADOLESCENT HEALTH, V7, P44, DOI 10.1016/S0197-0070(86)80094-8; Hagan JF, 2008, BRIGHT FUTURES GUIDE; Halterman JS, 2001, PEDIATRICS, V107, P1381, DOI 10.1542/peds.107.6.1381; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Killip S, 2007, AM FAM PHYSICIAN, V75, P671; Konofal E, 2008, PEDIATR NEUROL, V38, P20, DOI 10.1016/j.pediatrneurol.2007.08.014; Korn E. L., 1999, ANAL HLTH SURVEYS; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Lopez MAV, 2006, HAEMATOL-HEMATOL J, V91, P264; Lynch SR, 2011, J NUTR, V141, p763S, DOI 10.3945/jn.110.130609; Mei ZG, 2012, CLIN CHIM ACTA, V413, P1479, DOI 10.1016/j.cca.2012.05.022; Murray-Kolb LE, 2007, AM J CLIN NUTR, V85, P778, DOI 10.1093/ajcn/85.3.778; Murray-Kolb LE, 2011, J NUTR, V141, p747S, DOI 10.3945/jn.110.130658; Nead KG, 2004, PEDIATRICS, V114, P104, DOI 10.1542/peds.114.1.104; Nestel P., 2002, ADJUSTING HEMOGLOBIN; Peyrin-Biroulet L, 2015, AM J CLIN NUTR, V102, P1585, DOI 10.3945/ajcn.114.103366; Picchietti D, 2007, SLEEP MED, V8, P693, DOI 10.1016/j.sleep.2007.06.007; Sekhar DL, 2016, J WOMENS HEALTH, V25, P505, DOI 10.1089/jwh.2015.5449; Takala TI, 2003, CLIN CHEM LAB MED, V41, P203, DOI 10.1515/CCLM.2003.033; Wu Ann Chen, 2002, Pediatr Rev, V23, P171, DOI 10.1542/pir.23-5-171	35	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177183	10.1371/journal.pone.0177183	http://dx.doi.org/10.1371/journal.pone.0177183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486542	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000053
J	Kumari, A; Ray, K; Sadhna, S; Pandey, AK; Sreelakshmi, Y; Sharma, R				Kumari, Alka; Ray, Kamalika; Sadhna, Sadhna; Pandey, Arun Kumar; Sreelakshmi, Yellamaraju; Sharma, Rameshwar			Metabolomic homeostasis shifts after callus formation and shoot regeneration in tomato	PLOS ONE			English	Article							PLANT-GROWTH; NITRIC-OXIDE; ARABIDOPSIS-THALIANA; LIGNIN BIOSYNTHESIS; ROOT DEVELOPMENT; TOR PATHWAY; COMPLEX; TARGET; AUXIN; METABOLITES	Plants can regenerate from a variety of tissues on culturing in appropriate media. However, the metabolic shifts involved in callus formation and shoot regeneration are largely unknown. The metabolic profiles of callus generated from tomato (Solanum lycopersicum) cotyledons and that of shoot regenerated from callus were compared with the pct1-2 mutant that exhibits enhanced polar auxin transport and the shr mutant that exhibits elevated nitric oxide levels. The transformation from cotyledon to callus involved a major shift in metabolite profiles with denser metabolic networks in the callus. In contrast, the transformation from callus to shoot involved minor changes in the networks. The metabolic networks in pct1-2 and shr mutants were distinct from wild type and were rewired with shifts in endogenous hormones and metabolite interactions. The callus formation was accompanied by a reduction in the levels of metabolites involved in cell wall lignification and cellular immunity. On the contrary, the levels of monoamines were upregulated in the callus and regenerated shoot. The callus formation and shoot regeneration were accompanied by an increase in salicylic acid in wild type and mutants. The transformation to the callus and also to the shoot downregulated LST8 and upregulated TOR transcript levels indicating a putative linkage between metabolic shift and TOR signalling pathway. The network analysis indicates that shift in metabolite profiles during callus formation and shoot regeneration is governed by a complex interaction between metabolites and endogenous hormones.	[Kumari, Alka; Ray, Kamalika; Sadhna, Sadhna; Pandey, Arun Kumar; Sreelakshmi, Yellamaraju; Sharma, Rameshwar] Univ Hyderabad, Dept Plant Sci, Repository Tomato Genom Resources, Hyderabad, Andhra Prades, India	University of Hyderabad	Sharma, R (corresponding author), Univ Hyderabad, Dept Plant Sci, Repository Tomato Genom Resources, Hyderabad, Andhra Prades, India.	rameshwar.sharma@gmail.com	Pandey, Arun K/ABB-2179-2020	Sreelakshmi, Yellamaraju/0000-0003-3468-9136	Department of Biotechnology, Government of India, New Delhi [BT/PR11671/PBD/16/828/2008]	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India, New Delhi (Grant no. BT/PR11671/PBD/16/828/2008 to RS and YS.).	Al-Hammadi ASA, 2003, PLANT PHYSIOL, V133, P113, DOI 10.1104/pp.103.025478; Anzola JM, 2010, P NATL ACAD SCI USA, V107, P10308, DOI 10.1073/pnas.0913918107; Atta R, 2009, PLANT J, V57, P626, DOI 10.1111/j.1365-313X.2008.03715.x; BACKSHUSEMANN D, 1970, PROTOPLASMA, V70, P49, DOI 10.1007/BF01276841; Bahman F. N., 2012, International Journal of Agriculture and Crop Sciences (IJACS), V4, P17; Barrada A, 2015, INT J MOL SCI, V16, P19671, DOI 10.3390/ijms160819671; Berckmans RJ, 2011, BLOOD, V117, P3172, DOI 10.1182/blood-2010-06-290460; Caldana C, 2013, PLANT J, V73, P897, DOI 10.1111/tpj.12080; Capitani F, 2005, PLANTA, V220, P507, DOI 10.1007/s00425-004-1362-y; Cheng ZJ, 2013, PLANT PHYSIOL, V161, P240, DOI 10.1104/pp.112.203166; Correa-Aragunde N, 2006, J EXP BOT, V57, P581, DOI 10.1093/jxb/erj045; Correa-Aragunde N, 2004, PLANTA, V218, P900, DOI 10.1007/s00425-003-1172-7; De Bruyne L, 2014, MOL PLANT, V7, P943, DOI 10.1093/mp/ssu050; Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043; Fan MZ, 2012, CELL RES, V22, P1169, DOI 10.1038/cr.2012.63; Fares MA, 2015, TRENDS GENET, V31, P373, DOI 10.1016/j.tig.2015.04.008; Felix MA, 2015, NAT REV GENET, V16, P483, DOI 10.1038/nrg3949; Freschi L, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00398; GAUTHERET R., 1939, COMPT REND ACAD SCI [PARIS], V208, P118; Gomes AP, 2015, CURR OPIN BIOTECH, V34, P110, DOI 10.1016/j.copbio.2014.12.007; Gordon SP, 2007, DEVELOPMENT, V134, P3539, DOI 10.1242/dev.010298; Gupta SK, 2014, PLANT CELL ENVIRON, V37, P1688, DOI 10.1111/pce.12279; Haberlandt G., 1902, BER MAT NAT KI KAIS, V111, P69; Henriques R, 2014, J EXP BOT, V65, P2691, DOI 10.1093/jxb/eru049; Huang WL, 2012, PLANT CELL TISS ORG, V108, P257, DOI 10.1007/s11240-011-0038-0; Ikeda Y, 2006, PLANT CELL PHYSIOL, V47, P1443, DOI 10.1093/pcp/pcl023; Ikeuchi M, 2013, PLANT CELL, V25, P3159, DOI 10.1105/tpc.113.116053; Kareem A, 2015, CURR BIOL, V25, P1017, DOI 10.1016/j.cub.2015.02.022; Kharshiing EV, 2010, PLANT BIOLOGY, V12, P224, DOI 10.1111/j.1438-8677.2009.00267.x; Laplante M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011593; Leiber RM, 2010, PLANT CELL, V22, P1898, DOI 10.1105/tpc.109.073007; Li X, 2010, PLANT CELL, V22, P1620, DOI 10.1105/tpc.110.074161; Lommen A, 2012, METABOLOMICS, V8, P719, DOI 10.1007/s11306-011-0369-1; Mahmud I, 2014, ANAL BIOANAL CHEM, V406, P5997, DOI 10.1007/s00216-014-8002-6; Moreau M, 2012, PLANT CELL, V24, P463, DOI 10.1105/tpc.111.091306; Moreau M, 2010, ENZYMES, V27, P285, DOI 10.1016/S1874-6047(10)27015-4; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Navarova H, 2012, PLANT CELL, V24, P5123, DOI 10.1105/tpc.112.103564; Negi S, 2010, MOL PLANT, V3, P854, DOI 10.1093/mp/ssq033; Pacifici E, 2015, J EXP BOT, V66, P1113, DOI 10.1093/jxb/eru534; Pan XQ, 2010, NAT PROTOC, V5, P986, DOI 10.1038/nprot.2010.37; Lopez-Gresa MP, 2011, ENVIRON EXP BOT, V74, P216, DOI 10.1016/j.envexpbot.2011.06.003; PROTACIO CM, 1992, PLANT PHYSIOL, V98, P89, DOI 10.1104/pp.98.1.89; Pulianmackal AJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00142; Qiao M, 2012, PLANT J, V71, P14, DOI 10.1111/j.1365-313X.2012.04944.x; Radus I, 2001, ACTA PHYSIOL PLANT, V23, P103, DOI 10.1007/s11738-001-0029-6; Ramesh SA, 2015, NATURE COMMUNICATION, P6; Ren MZ, 2011, PLANT PHYSIOL, V155, P1367, DOI 10.1104/pp.110.169045; Renault H, 2011, PLANT CELL PHYSIOL, V52, P894, DOI 10.1093/pcp/pcr041; Rexin D, 2015, BIOCHEM J, V470, P1, DOI 10.1042/BJ20150505; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Sanz L, 2015, J EXP BOT, V66, P2857, DOI 10.1093/jxb/erv213; Schepetilnikov M, 2013, EMBO J, V32, P1087, DOI 10.1038/emboj.2013.61; Sebanek J, 2012, EXPT MORPHOGENESIS I, V18; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; Sugiyama M, 2015, J PLANT RES, V128, P349, DOI 10.1007/s10265-015-0706-y; Takahashi H, 2006, ANN BOT-LONDON, V98, P819, DOI 10.1093/aob/mcl162; Thimann KV, 1935, NATURE, V135, P101, DOI 10.1038/135101a0; Tikunov YM, 2012, METABOLOMICS, V8, P714, DOI 10.1007/s11306-011-0368-2; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Toubiana D, 2013, TRENDS BIOTECHNOL, V31, P29, DOI 10.1016/j.tibtech.2012.10.011; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vogel-Adghough D, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26366; Wagner A, 2007, BIOSYSTEMS, V88, P163, DOI 10.1016/j.biosystems.2006.06.002; Wang WF, 2014, CELL HOST MICROBE, V15, P401, DOI 10.1016/j.chom.2014.03.014; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xiong Y, 2014, PLANT PHYSIOL, V164, P499, DOI 10.1104/pp.113.229948; Zacares L, 2007, MOL PLANT MICROBE IN, V20, P1439, DOI 10.1094/MPMI-20-11-1439; Zhang YF, 2008, PLANT CELL TISS ORG, V93, P323, DOI 10.1007/s11240-008-9380-2	72	11	11	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176978	10.1371/journal.pone.0176978	http://dx.doi.org/10.1371/journal.pone.0176978			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481937	gold, Green Submitted, Green Published			2022-12-27	WOS:000401313700026
J	Ratnayake, M; Tselepi, M; Bloxham, R; Ploger, F; Reynard, LN; Loughlin, J				Ratnayake, Madhushika; Tselepi, Maria; Bloxham, Robert; Ploeger, Frank; Reynard, Louise N.; Loughlin, John			A consistent and potentially exploitable response during chondrogenesis of mesenchymal stem cells from osteoarthritis patients to the protein encoded by the susceptibility gene GDF5	PLOS ONE			English	Article							ALLELIC EXPRESSION; HUMAN CHONDROCYTES; CARTILAGE; DIFFERENTIATION; RECEPTORS; MUTATION; FACTOR-5; GROWTH; CDMP1; SNP	Osteoarthritis (OA) is a common joint disease characterised by the focal loss of the protective cartilage layer at the ends of the bones. It is painful, disabling, multifactorial and polygenic. The growth differentiation factor 5 gene GDF5 was one of the first reported OA susceptibility signals that showed consistent association to OA, with the transcript single nucleotide polymorphism (SNP) rs143383 demonstrating association in Asians and Europeans. The functional effect of the signal is reduced expression of the gene. The GDF5 protein is an extracellular matrix signalling molecule that is active during chondrogenesis and in mature chondrocytes. Due to the functional impact of the susceptibility, we previously assessed the effect of supplementing chondrocytes from OA patients with exogenous GDF5. Their response was highly discordant, precluding the application of GDF5 as a simple means of attenuating the genetic deficit. Since GDF5 is also active during development, we have now assessed the effect of exogenous GDF5 on bone marrow derived mesenchymal stem cells (MSCs) that are undergoing chondrogenesis during cartilage disc formation. MSCs from healthy donors and OA patients were studied and the effect of GDF5 was assessed by measuring the wet mass of the discs, by histological staining, and by monitoring the change in expression of anabolic, catabolic and hypertrophic protein-coding genes. The MSCs expressed the three principal GDF5 receptor genes and responded in a significantly anabolic manner (increase in wet mass, p = 0.0022; Bonferroni corrected p = 0.018) to a variant form of GDF5 that targets the most abundantly expressed receptor, BMPR-IA. GDF5 elicited significant (p < 0.05) changes in the expression of anabolic, catabolic and hypertrophic genes with several consistent effects in healthy donors and in OA patients. Our data implies that, unlike OA chondrocytes, OA MSCs do respond in a predictable, anabolic manner to GDF5, which could therefore provide a route to modulate the genetic deficit mediated by the rs143383 association signal.	[Ratnayake, Madhushika; Tselepi, Maria; Bloxham, Robert; Reynard, Louise N.; Loughlin, John] Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Ploeger, Frank] BioPharm GmbH, Heidelberg, Germany; [Ratnayake, Madhushika; Tselepi, Maria; Bloxham, Robert; Reynard, Louise N.; Loughlin, John] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Tselepi, M (corresponding author), Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.; Tselepi, M (corresponding author), Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England.	maria.tselepi@ncl.ac.uk		Loughlin, John/0000-0003-2018-3361; Reynard, Louise/0000-0002-6613-1797	Arthritis Research UK [19824, 20231]; Medical Research Council; Arthritis Research UK as part of the MRCArthritis Research UK Centre for Integrated Research into Musculoskeletal Ageing (CIMA) [JXR 10641]; European Unions Seventh Framework Program for research, technological development and demonstration [305815]; NIHR Newcastle Biomedical Research Centre; MRC [MR/K006312/1] Funding Source: UKRI; Medical Research Council [MR/K006312/1] Funding Source: researchfish; Versus Arthritis [20771, 20231, 19824] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK as part of the MRCArthritis Research UK Centre for Integrated Research into Musculoskeletal Ageing (CIMA)(Versus Arthritis); European Unions Seventh Framework Program for research, technological development and demonstration; NIHR Newcastle Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	This research was funded by Arthritis Research UK (http://www.arthritisresearchuk.org/; grant codes 19824 and 20231), by the Medical Research Council and Arthritis Research UK as part of the MRCArthritis Research UK Centre for Integrated Research into Musculoskeletal Ageing (CIMA; http://www.cimauk.org/; grant code JXR 10641), and by the European Unions Seventh Framework Program for research, technological development and demonstration under grant agreement No. 305815 (D-BOARD; http://cordis.europa.eu/project/rcn/105314_en.html). FP is an employee of the company Biopharm GmbH, which provided support in the form of salary for FP. None of the funders, including Biopharm, had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of FP and all authors are articulated in the author contributions section.; Patient tissue was provided by the Newcastle Bone and Joint Biobank supported by the NIHR Newcastle Biomedical Research Centre awarded to the Newcastle upon Tyne NHS Foundation Trust and Newcastle University. We thank the surgeons and research nurses at the Trust for providing us with access to these samples. We thank Sharon Watson for carrying out histological staining of our samples. We thank Lucy Gentles for her assistance with hip joint collection. We are grateful for Simon Partridge and Sotiria Toumpaniari for their assistance with MSC isolation from the femoral head of OA hips. We thank Fabio D'Agostino for his help with healthy donor MSC culture. We thank the patients for donating their tissue samples.	Bucher C, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/326828; Coleman CM, 2013, STEM CELLS DEV, V22, P1968, DOI 10.1089/scd.2012.0282; Enochson L, 2014, OSTEOARTHR CARTILAGE, V22, P566, DOI 10.1016/j.joca.2014.02.004; Francis-West PH, 1999, DEVELOPMENT, V126, P1305; Kasten P, 2010, BIOMATERIALS, V31, P3878, DOI 10.1016/j.biomaterials.2010.01.109; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374; Murphy MK, 2015, STEM CELLS, V33, P762, DOI 10.1002/stem.1890; Neagu M, 2005, ROMANIAN J BIOPHYS, V15, P1; Nishitoh H, 1996, J BIOL CHEM, V271, P21345, DOI 10.1074/jbc.271.35.21345; Oda T, 2016, BIOCHEM BIOPH RES CO, V479, P469, DOI 10.1016/j.bbrc.2016.09.085; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; Ratnayake M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086590; Reynard LN, 2014, HUM GENET, V133, P1059, DOI 10.1007/s00439-014-1447-z; Somoza RA, 2014, TISSUE ENG PART B-RE, V20, P596, DOI [10.1089/ten.teb.2013.0771, 10.1089/ten.TEB.2013.0771]; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; Tew SR, 2008, METHODS, V45, P2, DOI 10.1016/j.ymeth.2008.01.006; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	21	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176523	10.1371/journal.pone.0176523	http://dx.doi.org/10.1371/journal.pone.0176523			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481944	Green Submitted, Green Published, gold			2022-12-27	WOS:000401313700012
J	Ovejero, CA; Affranchino, JL; Gonzalez, SA				Ovejero, Cesar A.; Affranchino, Jose L.; Gonzalez, Silvia A.			Analysis of the functional compatibility of SIV capsid sequences in the context of the FIV gag precursor	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN INCORPORATION; MAJOR HOMOLOGY REGION; MATRIX PROTEIN; NUCLEOCAPSID PROTEIN; CRYOELECTRON MICROSCOPY; NUCLEAR IMPORT; ALPHA-HELIX; HIV-1; FELINE	The formation of immature lentiviral particles is dependent on the multimerization of the Gag polyprotein at the plasma membrane of the infected cells. One key player in the virus assembly process is the capsid (CA) domain of Gag, which establishes the protein-protein interactions that give rise to the hexagonal lattice of Gag molecules in the immature virion. To gain a better understanding of the functional equivalence between the CA proteins of simian and feline immunodeficiency viruses (SIV and FIV, respectively), we generated a series of chimeric FIV Gag proteins in which the CA-coding region was partially or totally replaced by its SIV counterpart. All the FIV Gag chimeras were found to be assembly-defective; however, all of them are able to interact with wild-type SIV Gag and be recruited into extracellular virus-like particles, regardless of the SIV CA sequences present in the chimeric FIV Gag. The results presented here markedly contrast with our previous findings showing that chimeric SIVs carrying FIV CA-derived sequences are assembly-competent. Overall, our data support the notion that although the SIV and FIV CA proteins share 51% amino acid sequence similarity and exhibit a similar organization, i.e., an N-terminal domain joined by a flexible linker to a C-terminal domain, their functional exchange between these different lentiviruses is strictly dependent on the context of the recipient Gag precursor.	[Ovejero, Cesar A.; Affranchino, Jose L.; Gonzalez, Silvia A.] Univ Belgrano, CONICET, Lab Virol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Gonzalez, SA (corresponding author), Univ Belgrano, CONICET, Lab Virol, Buenos Aires, DF, Argentina.	silvia.gonzalez@comunidad.ub.edu.ar		Affranchino, Jose/0000-0002-1287-9636; Gonzalez, Silvia Adriana/0000-0001-8744-0874	National Scientific and Technical Research Council of Argentina (CONICET) [PIP 0600]	National Scientific and Technical Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the National Scientific and Technical Research Council of Argentina (CONICET; www.conicet.gov.ar) Grant PIP 0600 to SAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all the authors are articulated in the author contributions' section.	Cerfoglio JCA, 2014, J GEN VIROL, V95, P2050, DOI 10.1099/vir.0.065151-0; Affranchino JL, 2014, VIRUSES-BASEL, V6, P264, DOI 10.3390/v6010264; Affranchino JL, 2010, VIRUS RES, V150, P153, DOI 10.1016/j.virusres.2010.03.012; Ako-Adjei D, 2005, J VIROL, V79, P13463, DOI 10.1128/JVI.79.21.13463-13472.2005; Bell NM, 2013, TRENDS MICROBIOL, V21, P136, DOI 10.1016/j.tim.2012.11.006; Bharat TAM, 2012, NATURE, V487, P385, DOI 10.1038/nature11169; Bowzard JB, 1998, J VIROL, V72, P9034, DOI 10.1128/JVI.72.11.9034-9044.1998; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Calistri A, 2009, J CELL PHYSIOL, V218, P175, DOI 10.1002/jcp.21587; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Chen K, 2013, J BIOL CHEM, V288, P1511, DOI 10.1074/jbc.M112.425140; Chukkapalli V, 2011, J MOL BIOL, V410, P512, DOI 10.1016/j.jmb.2011.04.015; CRAVEN RC, 1995, J VIROL, V69, P4213, DOI 10.1128/JVI.69.7.4213-4227.1995; de Marco A, 2010, J VIROL, V84, P11729, DOI 10.1128/JVI.01423-10; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Elder JH, 2010, CURR HIV RES, V8, P73, DOI 10.2174/157016210790416389; Esteva MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114299; Fassati A, 2012, VIRUS RES, V170, P15, DOI 10.1016/j.virusres.2012.09.012; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; GONZALEZ SA, 1993, VIROLOGY, V194, P548, DOI 10.1006/viro.1993.1293; Gonzalez SA, 1998, VIROLOGY, V240, P27, DOI 10.1006/viro.1997.8919; Gorelick RJ, 1999, VIROLOGY, V253, P259, DOI 10.1006/viro.1998.9513; Gres AT, 2015, SCIENCE, V349, P99, DOI 10.1126/science.aaa5936; Jacques DA, 2016, NATURE, V536, P349, DOI 10.1038/nature19098; Johnson MC, 2002, J VIROL, V76, P11177, DOI 10.1128/JVI.76.22.11177-11185.2002; Khwaja A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24957; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Liang C, 2003, J VIROL, V77, P1772, DOI 10.1128/JVI.77.3.1772-1783.2003; Liang C, 2002, J VIROL, V76, P11729, DOI 10.1128/JVI.76.22.11729-11737.2002; Logue EC, 2011, J VIROL, V85, P12950, DOI 10.1128/JVI.05384-11; Luttge BG, 2008, J VIROL, V82, P2106, DOI 10.1128/JVI.02337-07; MAMMANO F, 1994, J VIROL, V68, P4927, DOI 10.1128/JVI.68.8.4927-4936.1994; Manrique JM, 2003, J VIROL, V77, P10881, DOI 10.1128/JVI.77.20.10881-10888.2003; Manrique JM, 2008, VIROLOGY, V374, P273, DOI 10.1016/j.virol.2008.01.015; Manrique ML, 2004, VIROLOGY, V329, P157, DOI 10.1016/j.virol.2004.07.029; Manrique ML, 2004, VIROLOGY, V327, P83, DOI 10.1016/j.virol.2004.06.019; Manrique ML, 2001, VIRUS RES, V76, P103, DOI 10.1016/S0168-1702(01)00249-0; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; Muriaux D, 2010, RNA BIOL, V7, P744, DOI 10.4161/rna.7.6.14065; OLMSTED RA, 1989, P NATL ACAD SCI USA, V86, P8088, DOI 10.1073/pnas.86.20.8088; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Popov S, 2008, J VIROL, V82, P1389, DOI 10.1128/JVI.01912-07; Rauddi ML, 2011, AIDS RES HUM RETROV, V27, P303, DOI 10.1089/aid.2010.0137; Robinson BA, 2014, J VIROL, V88, P5718, DOI 10.1128/JVI.03609-13; Sandefur S, 2000, J VIROL, V74, P7238, DOI 10.1128/JVI.74.16.7238-7249.2000; Sanders-Beer BE, 2012, VIROLOGY, V422, P402, DOI 10.1016/j.virol.2011.11.003; Schur FKM, 2016, SCIENCE, V353, P506, DOI 10.1126/science.aaf9620; Schur FKM, 2015, NATURE, V517, P505, DOI 10.1038/nature13838; Sette P, 2016, CELL HOST MICROBE, V19, P336, DOI 10.1016/j.chom.2016.02.004; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tipper C, 2014, J VIROL, V88, P10289, DOI 10.1128/JVI.01388-14; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Zhang YQ, 1998, J VIROL, V72, P1782, DOI 10.1128/JVI.72.3.1782-1789.1998; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	60	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177297	10.1371/journal.pone.0177297	http://dx.doi.org/10.1371/journal.pone.0177297			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475623	Green Submitted, Green Published, gold			2022-12-27	WOS:000400649500059
J	Higuchi, T; Ishizaki, Y; Noritake, A; Yanagimoto, Y; Kobayashi, H; Nakamura, K; Kaneko, K				Higuchi, Takahiro; Ishizaki, Yuko; Noritake, Atsushi; Yanagimoto, Yoshitoki; Kobayashi, Hodaka; Nakamura, Kae; Kaneko, Kazunari			Spatiotemporal characteristics of gaze of children with autism spectrum disorders while looking at classroom scenes	PLOS ONE			English	Article							JOINT ATTENTION; RATING-SCALE; CHILDHOOD AUTISM; SOCIAL ATTENTION; PATTERNS; LANGUAGE	Children with autism spectrum disorders (ASD) who have neurodevelopmental impairments in social communication often refuse to go to school because of difficulties in learning in class. The exact cause of maladaptation to school in such children is unknown. We hypothesized that these children have difficulty in paying attention to objects at which teachers are pointing. We performed gaze behavior analysis of children with ASD to understand their difficulties in the classroom. The subjects were 26 children with ASD (19 boys and 7 girls; mean age, 8.6 years) and 27 age-matched children with typical development (TD) (14 boys and 13 girls; mean age, 8.2 years). We measured eye movements of the children while they performed free viewing of two movies depicting actual classes: a Japanese class in which a teacher pointed at cartoon characters and an arithmetic class in which the teacher pointed at geometric figures. In the analysis, we defined the regions of interest (ROIs) as the teacher's face and finger, the cartoon characters and geometric figures at which the teacher pointed, and the classroom wall that contained no objects. We then compared total gaze time for each ROI between the children with ASD and TD by two-way ANOVA. Children with ASD spent less gaze time on the cartoon characters pointed at by the teacher; they spent more gaze time on the wall in both classroom scenes. We could differentiate children with ASD from those with TD almost perfectly by the proportion of total gaze time that children with ASD spent looking at the wall. These results suggest that children with ASD do not follow the teacher's instructions in class and persist in gazing at inappropriate visual areas such as walls. Thus, they may have difficulties in understanding content in class, leading to maladaptation to school.	[Higuchi, Takahiro; Ishizaki, Yuko; Yanagimoto, Yoshitoki; Kobayashi, Hodaka; Kaneko, Kazunari] Kansai Med Univ, Dept Pediat, Hirakata, Osaka, Japan; [Noritake, Atsushi; Nakamura, Kae] Kansai Med Univ, Dept Physiol, Hirakata, Osaka, Japan	Kansai Medical University; Kansai Medical University	Ishizaki, Y (corresponding author), Kansai Med Univ, Dept Pediat, Hirakata, Osaka, Japan.	ishizaky@takii.kmu.ac.jp	Ishizaki, Yuko/AAM-9735-2020; Noritake, Atsushi/AAZ-7912-2020	Noritake, Atsushi/0000-0002-5081-6257	JSPS KAKENHI - Ministry of Education, Culture, Sports, Science and Technology, Japan [25461566]; JSPS KAKENHI [25461566]	JSPS KAKENHI - Ministry of Education, Culture, Sports, Science and Technology, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Number 25461566 (https://kaken.nii.ac.jp/ja/grant/KAKENHIPROJECT.25461566/) to Y.I. funded by the Ministry of Education, Culture, Sports, Science and Technology, Japan.; This work was supported by JSPS KAKENHI Grant Number 25461566. We thank Dr. Yasuko Nagao, Dr. Yuri Fuji, and Ms. Azusa Oshima for their assessment of the subjects' development. The authors declare no competing financial interests.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, Vxxxvii; Berney T., 2004, ADV PSYCHIAT TREATME, V10, P341, DOI [10.1192/apt.10.5.341, DOI 10.1192/APT.10.5.341]; Bruinsma Y, 2004, MENT RETARD DEV D R, V10, P169, DOI 10.1002/mrdd.20036; Charman T, 2003, PHILOS T R SOC B, V358, P315, DOI 10.1098/rstb.2002.1199; Chawarska K, 2012, J CHILD PSYCHOL PSYC, V53, P903, DOI 10.1111/j.1469-7610.2012.02538.x; Dawson G, 2004, DEV PSYCHOL, V40, P271, DOI 10.1037/0012-1649.40.2.271; Falck-Ytter T, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-28; Falck-Ytter T, 2012, J AUTISM DEV DISORD, V42, P2236, DOI 10.1007/s10803-012-1471-6; Ghaziuddin M, 2002, J AUTISM DEV DISORD, V32, P299, DOI 10.1023/A:1016330802348; Guillon Q, 2014, NEUROSCI BIOBEHAV R, V42, P279, DOI 10.1016/j.neubiorev.2014.03.013; Irwin JR, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00397; Ito H, 2012, RES AUTISM SPECT DIS, V6, P1265, DOI 10.1016/j.rasd.2012.04.002; Jones E. A., 2004, FOCUS AUTISM OTHER D, V19, P13, DOI DOI 10.1177/10883576040190010301; Kamio Y., 2006, SEISHINIGAKU, V48, P495; Keita L, 2011, BIOL PSYCHIAT, V70, P806, DOI 10.1016/j.biopsych.2011.07.031; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Koyama T, 2009, PSYCHIAT CLIN NEUROS, V63, P241, DOI 10.1111/j.1440-1819.2009.01931.x; Liberati A, 2017, PERCEPTION, DOI 10:1177/0301006616685976; LOVELAND KA, 1986, J AUTISM DEV DISORD, V16, P335, DOI 10.1007/BF01531663; McArthur D, 1996, J AUTISM DEV DISORD, V26, P481, DOI 10.1007/BF02172271; Parsons T., 2014, SCH SOC SOCIOLOGICAL, P35; PIAGET J, 1972, HUM DEV, V15, P1, DOI 10.1159/000271225; Pierce K, 2016, BIOL PSYCHIAT, V79, P657, DOI 10.1016/j.biopsych.2015.03.032; Pierce K, 2011, ARCH GEN PSYCHIAT, V68, P101, DOI 10.1001/archgenpsychiatry.2010.113; Riby D, 2009, J INTELL DISABIL RES, V53, P169, DOI 10.1111/j.1365-2788.2008.01142.x; Riby DM, 2013, J NEURODEVELOPMENTAL, V5, P1, DOI DOI 10.1186/1866-1955-5-13; SCHOPLER E, 1980, J AUTISM DEV DISORD, V10, P91, DOI 10.1007/BF02408436; Shic F, 2014, BIOL PSYCHIAT, V75, P231, DOI 10.1016/j.biopsych.2013.07.009; Shic F, 2011, BRAIN RES, V1380, P246, DOI 10.1016/j.brainres.2010.11.074; Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Tachimori H, 2003, PSYCHIAT CLIN NEUROS, V57, P113, DOI 10.1046/j.1440-1819.2003.01087.x; Wang S, 2015, NEURON, V88, P604, DOI 10.1016/j.neuron.2015.09.042; Wechsler D, 1974, WECHSLER INTELLIGENC; Whitby PJS, 2009, EDUC TRAIN DEV DISAB, V44, P551; Yi L, 2013, J VISION, V13, DOI 10.1167/13.10.5	35	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175912	10.1371/journal.pone.0175912	http://dx.doi.org/10.1371/journal.pone.0175912			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472111	gold, Green Submitted, Green Published			2022-12-27	WOS:000400648500018
J	Johansen, C; Rittig, AH; Mose, M; Bertelsen, T; Weimar, I; Nielsen, J; Andersen, T; Rasmussen, TK; Deleuran, B; Iversen, L				Johansen, Claus; Rittig, Anne Hald; Mose, Maike; Bertelsen, Trine; Weimar, Isabella; Nielsen, Jakob; Andersen, Thomas; Rasmussen, Tue Kruse; Deleuran, Bent; Iversen, Lars			STAT2 is involved in the pathogenesis of psoriasis by promoting CXCL11 and CCL5 production by keratinocytes	PLOS ONE			English	Article							CHRONIC PLAQUE PSORIASIS; SELF-DNA; SKIN; INFLAMMATION; TOFACITINIB; INHIBITION; MECHANISMS; EXPRESSION; BINDING; CELLS	The JAK/STAT signaling pathway is suggested to play an important role in the pathogenesis of psoriasis, and recently JAK/STAT inhibitors have shown promising results in psoriasis treatment. The present study aimed to characterize the role of STAT2 in psoriasis. We demonstrated an increased expression of STAT2 and an increased level of phosphorylated/activated STAT2 in lesional compared with nonlesional psoriatic skin. Gene silencing of STAT2 by siRNA in human keratinocytes revealed that upon IFN alpha stimulation CXCL11 and CCL5 were the only two cytokines, among 102 analyzed, found to be regulated through a STAT2-dependent mechanism. Moreover, the regulation of CXCL11 and CCL5 depended on IRF9, but not on STAT1 and STAT6. The CXCL11 and CCL5 expression was increased in lesional compared with nonlesional psoriatic skin, and analysis demonstrated positive correlation between the expression of CXCL11 and IFN gamma and between the expression of CCL5 and IFN gamma in lesional psoriatic skin. In contrast, no correlation between the expression of CXCL11 and IL-17A and the expression of CCL5 and IL-17A in lesional psoriatic skin was found. Our data suggest that STAT2 plays a role in the psoriasis pathogenesis by regulating the expression of CXCL11 and CCL5, and thereby attracting IFN gamma producing immune cells to the skin.	[Johansen, Claus; Rittig, Anne Hald; Mose, Maike; Bertelsen, Trine; Weimar, Isabella; Nielsen, Jakob; Iversen, Lars] Aarhus Univ Hosp, Dept Dermatol, Aarhus C, Denmark; [Andersen, Thomas; Rasmussen, Tue Kruse; Deleuran, Bent] Aarhus Univ, Dept Biomed, Aarhus C, Denmark	Aarhus University; Aarhus University	Johansen, C (corresponding author), Aarhus Univ Hosp, Dept Dermatol, Aarhus C, Denmark.	claus.johansen@clin.au.dk		Johansen, Claus/0000-0002-5665-5212; Iversen, Lars/0000-0003-1816-4508; Johansen, Claus/0000-0003-0240-5127; Deleuran, Bent/0000-0002-7079-1587	Danish Medical Research Council [10-093826]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Support was provided by the Danish Medical Research Council, grant number: 10-093826 [http//ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-Independent-research/the-council/the-danish-council-for-independent-research-merdical-sciences?set language=en&cl=en].The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres RM, 2013, EXP DERMATOL, V22, P323, DOI 10.1111/exd.12128; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Bissonnette R, 2015, BRIT J DERMATOL, V172, P1395, DOI 10.1111/bjd.13551; Chang BY, 2009, J IMMUNOL, V183, P2183, DOI 10.4049/jimmunol.0804063; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Eriksen KW, 2005, J INVEST DERMATOL, V125, P936, DOI 10.1111/j.0022-202X.2005.23864.x; Fink Karin, 2013, JAKSTAT, V2, pe27521, DOI 10.4161/jkst.27521; Fridman JS, 2011, J INVEST DERMATOL, V131, P1838, DOI 10.1038/jid.2011.140; Funding AT, 2007, J INVEST DERMATOL, V127, P2012, DOI 10.1038/sj.jid.5700821; Ghislain JJ, 2001, J INTERF CYTOK RES, V21, P379, DOI 10.1089/107999001750277853; Gilliet M, 2008, CURR OPIN IMMUNOL, V20, P401, DOI 10.1016/j.coi.2008.06.008; Gupta S, 1999, J IMMUNOL, V163, P3834; Hald A, 2013, BRIT J DERMATOL, V168, P302, DOI 10.1111/bjd.12049; Kjellerup RB, 2008, EXP DERMATOL, V17, P498, DOI 10.1111/j.1600-0625.2007.00672.x; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; KRAGBALLE K, 1985, BRIT J DERMATOL, V112, P263, DOI 10.1111/j.1365-2133.1985.tb04852.x; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Ludbrook VJ, 2016, BRIT J DERMATOL, V174, P985, DOI 10.1111/bjd.14399; Menter MA, 2016, J DRUGS DERMATOL, V15, P568; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nickoloff BJ, 2007, CLIN REV ALLERG IMMU, V33, P45, DOI 10.1007/s12016-007-0039-2; Nickoloff BJ, 2007, NAT MED, V13, P242, DOI 10.1038/nm0307-242; O'Shea JJ, 2005, CURR OPIN RHEUMATOL, V17, P305, DOI 10.1097/01.bor.0000160781.07174.db; Pfitzner E, 2004, CURR PHARM DESIGN, V10, P2839; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Punwani N, 2012, J AM ACAD DERMATOL, V67, P658, DOI 10.1016/j.jaad.2011.12.018; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Steen Hakan C, 2013, JAKSTAT, V2, pe25790, DOI 10.4161/jkst.25790; Van der Fits L, 2004, J INVEST DERMATOL, V122, P51, DOI 10.1046/j.0022-202X.2003.22113.x; Villanova F, 2014, COLD SPRING HARB PER, V4, P2157; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737	32	29	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176994	10.1371/journal.pone.0176994	http://dx.doi.org/10.1371/journal.pone.0176994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472186	Green Submitted, gold, Green Published			2022-12-27	WOS:000400648500111
J	Martinez-Canales, S; Cifuentes, F; Gregorio, MLD; Serrano-Oviedo, L; Galan-Moya, EM; Amir, E; Pandiella, A; Gyorffy, B; Ocana, A				Martinez-Canales, Sandra; Cifuentes, Francisco; De Rodas Gregorio, Miguel Lopez; Serrano-Oviedo, Leticia; Maria Galan-Moya, Eva; Amir, Eitan; Pandiella, Atanasio; Gyorffy, Balazs; Ocana, Alberto			Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumors	PLOS ONE			English	Article							INFILTRATING LYMPHOCYTES; CANCER	Background Most patients with early stage triple negative breast cancer (TNBC) receive adjuvant chemotherapy. Activation of the immune system is associated with tumor response and may help identify TNBC with favorable outcome. Methods Gene expression data were obtained from the GEO Dataset GDS2250/GSE3744. Affymetrix CEL files were downloaded and analyzed with Affymetrix Transcriptome Analysis Console 3.0. Functional genomics was implemented with David Bioinformatics Resources 6.8. Data contained at Oncomine were used to identify genes upregulated in basal-like cancer compared to normal breast tissue. Data contained at cBioportal were used to assess for molecular alterations. The KMPlotter online tool, METABRIC and GSE25066 datasets were used to associate gene signatures with clinical outcome. Results 1564 upregulated genes were identified as differentially expressed between normal and basal-like tumors. Of these, 16 genes associated with immune function were linked with clinical outcome. HLA-C, HLA-F, HLA-G and TIGIT were associated with both improved relapse-free survival (RFS) and overall survival (OS). The combination of HLA-F/TIGIT and HLA-C/HLA-F/TIGIT showed the most favorable outcome (HR for RFS 0.44, p< 0.001; HR for OS 0.22, p< 0.001; and HR for RFS 0.46, p< 0.001; HR for OS 0.15, p< 0.001; respectively). The association of HLA-C/HLA-F with outcome was confirmed using the METABRIC and GSE25066 datasets. No copy number alterations of these genes were identified. Conclusion We describe a gene signature associated with immune function and favorable outcome in basal-like breast cancer. Incorporation of this signature in prospective studies may help to stratify risk of early stage TNBC.	[Martinez-Canales, Sandra; Cifuentes, Francisco; De Rodas Gregorio, Miguel Lopez; Serrano-Oviedo, Leticia; Ocana, Alberto] Albacete Univ Hosp, Translat Res Unit, Albacete, Spain; [Martinez-Canales, Sandra; Cifuentes, Francisco; De Rodas Gregorio, Miguel Lopez; Serrano-Oviedo, Leticia; Ocana, Alberto] CIBERONC, Albacete, Spain; [Maria Galan-Moya, Eva; Ocana, Alberto] Univ Castilla La Mancha, CRIB, Albacete, Spain; [Amir, Eitan] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Pandiella, Atanasio] Univ Salamanca, CSIC, Canc Res Ctr, Salamanca, Spain; [Pandiella, Atanasio] Univ Salamanca, CSIC, CIBERONC, Salamanca, Spain; [Gyorffy, Balazs] MTA TTK Lendulet Canc Biomarker Res Grp, Budapest, Hungary; [Gyorffy, Balazs] Semmelweis Univ, Dept Pediat 2, Budapest, Hungary	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Universidad de Castilla-La Mancha; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University	Ocana, A (corresponding author), Albacete Univ Hosp, Translat Res Unit, Albacete, Spain.; Ocana, A (corresponding author), CIBERONC, Albacete, Spain.; Ocana, A (corresponding author), Univ Castilla La Mancha, CRIB, Albacete, Spain.	albertoo@sescam.jccm.es	Galan-Moya, Eva M/I-2912-2015; Gyorffy, Balazs/AAA-9135-2021; Lopez de Rodas Gregorio, Miguel/ABA-1757-2021; Lopez de Rodas Gregorio, Miguel/ABA-1769-2021; Amir, Eitan/L-6052-2019; Pandiella, Atanasio/O-5180-2014; Martinez Canales, Sandra/AAI-2732-2020	Galan-Moya, Eva M/0000-0001-5758-7592; Gyorffy, Balazs/0000-0002-5772-3766; Lopez de Rodas Gregorio, Miguel/0000-0002-6062-4064; Lopez de Rodas Gregorio, Miguel/0000-0002-6062-4064; Pandiella, Atanasio/0000-0002-4704-8971; Ocana, Alberto/0000-0002-1067-9630; Serrano Oviedo, Leticia/0000-0003-3876-2919; Martinez Canales, Sandra/0000-0002-4262-0262	Institute de Salud Carlos III [PI16/0121]; Diputacion de Albacete; CRIS Cancer Foundation; ACEPAIN; Institute de Salud Carlos III through the Spanish Cancer Centers Network Program [RD12/0036/0003]; European Community through the regional development funding program (FEDER)	Institute de Salud Carlos III(Instituto de Salud Carlos III); Diputacion de Albacete; CRIS Cancer Foundation; ACEPAIN; Institute de Salud Carlos III through the Spanish Cancer Centers Network Program; European Community through the regional development funding program (FEDER)	This study was supported in part by the Institute de Salud Carlos III (PI16/0121), ACEPAIN; Diputacion de Albacete and CRIS Cancer Foundation (to AO). BAE (Beca Ampliacion de Estudios) and Spanish Society of Medical Oncology (SEOM) to AO for his stay at Yale University. Ministry of Economy and Competitiveness of Spain (BFU2015-71371-R), the Institute de Salud Carlos III through the Spanish Cancer Centers Network Program (RD12/0036/0003) and CIBERONC, the scientific foundation of the AECC and the CRIS Foundation (to AP). The work carried out in our laboratories received support from the European Community through the regional development funding program (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2014, J CLIN ONCOL, V32, P2959, DOI 10.1200/JCO.2013.55.0491; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Blake SJ, 2016, CLIN CANCER RES, V13, P674; Chauvin JM, 2015, J CLIN INVEST, V125, P2046, DOI 10.1172/JCI80445; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Itoh M, 2014, BREAST CANCER RES TR, V143, P403, DOI 10.1007/s10549-013-2763-z; Mihaly Zsuzsanna, 2013, Microarrays (Basel), V2, P228, DOI 10.3390/microarrays2030228; Ocana A, 2017, ONCOTARGET; Ocana A, 2008, CLIN CANCER RES, V14, P961, DOI 10.1158/1078-0432.CCR-07-1630; Ocana A, 2015, J CLIN ONCOL, V33, P1298, DOI 10.1200/JCO.2014.59.7286; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Shin DS, 2015, CURR OPIN IMMUNOL, V33, P23, DOI 10.1016/j.coi.2015.01.006; Speiser DE, 2016, NAT REV IMMUNOL, V16, P500, DOI 10.1038/nri.2016.80	16	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175128	10.1371/journal.pone.0175128	http://dx.doi.org/10.1371/journal.pone.0175128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472085	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000400648500008
J	Lee, JS; Zakeri, IF; Butte, NF				Lee, Jong Soo; Zakeri, Issa F.; Butte, Nancy F.			Functional data analysis of sleeping energy expenditure	PLOS ONE			English	Article							METABOLIC-RATE; BODY-MASS; OBESITY; CHILDREN; DURATION; REGULARIZATION; CALORIMETER; OVERWEIGHT; PREDICTION; MODELS	Adequate sleep is crucial during childhood for metabolic health, and physical and cognitive development. Inadequate sleep can disrupt metabolic homeostasis and alter sleeping energy expenditure (SEE). Functional data analysis methods were applied to SEE data to elucidate the population structure of SEE and to discriminate SEE between obese and nonobese children. Minute-by-minute SEE in 109 children, ages 5-18, was measured in room respiration calorimeters. A smoothing spline method was applied to the calorimetric data to extract the true smoothing function for each subject. Functional principal component analysis was used to capture the important modes of variation of the functional data and to identify differences in SEE patterns. Combinations of functional principal component analysis and classifier algorithm were used to classify SEE. Smoothing effectively removed instrumentation noise inherent in the room calorimeter data, providing more accurate data for analysis of the dynamics of SEE. SEE exhibited declining but subtly undulating patterns throughout the night. Mean SEE was markedly higher in obese than non-obese children, as expected due to their greater body mass. SEE was higher among the obese than non-obese children (p<0.01); however, the weight-adjusted mean SEE was not statistically different (p>0.1, after post hoc testing). Functional principal component scores for the first two components explained 77.8% of the variance in SEE and also differed between groups (p = 0.037). Logistic regression, support vector machine or random forest classification methods were able to distinguish weight-adjusted SEE between obese and non-obese participants with good classification rates (62-64%). Our results implicate other factors, yet to be uncovered, that affect the weight-adjusted SEE of obese and non-obese children. Functional data analysis revealed differences in the structure of SEE between obese and non-obese children that may contribute to disruption of metabolic homeostasis.	[Lee, Jong Soo] Univ Massachusetts Lowell, Dept Math Sci, Lowell, MA 01854 USA; [Zakeri, Issa F.] Drexel Univ, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Butte, Nancy F.] Baylor Coll Med, Dept Pediat, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA	University of Massachusetts System; University of Massachusetts Lowell; Drexel University; Baylor College of Medicine; United States Department of Agriculture (USDA)	Lee, JS (corresponding author), Univ Massachusetts Lowell, Dept Math Sci, Lowell, MA 01854 USA.	jongsoo_lee@uml.edu			US Department of Agriculture/Agricultural Research Service [58-6250-0-008]; National Institutes of Health [R01 DK085163]	US Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by the US Department of Agriculture/Agricultural Research Service (https://www.ars.usda.gov). Cooperative Agreement No. 58-6250-0-008. NB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support was also provided by the National Institutes of Health (https://www.nih.gov), grant number R01 DK085163. NB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barati Z, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.117007; BREBBIA DR, 1965, SCIENCE, V150, P1621, DOI 10.1126/science.150.3703.1621; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; BROWN D, 1984, MED BIOL ENG COMPUT, V22, P333, DOI 10.1007/BF02442102; Butte NF, 2007, J NUTR, V137, P2660, DOI 10.1093/jn/137.12.2660; Butte NF, 2015, OBESITY, V23, P591, DOI 10.1002/oby.20994; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Chaput JP, 2016, EAT WEIGHT DISORD-ST, V21, P5, DOI 10.1007/s40519-015-0233-9; Chen XL, 2008, OBESITY, V16, P265, DOI 10.1038/oby.2007.63; CHILDS C, 1993, ARCH DIS CHILD, V68, P658, DOI 10.1136/adc.68.5.658; Cox DD, 2008, BIOMETRIKA, V95, P621, DOI 10.1093/biomet/asn021; CRAVEN P, 1979, NUMER MATH, V31, P377, DOI 10.1007/BF01437407; Dashti HS, 2015, ADV NUTR, V6, P648, DOI 10.3945/an.115.008623; DAUNCEY MJ, 1978, BRIT J NUTR, V39, P557, DOI 10.1079/BJN19780071; De Boor C, 2000, PRACTICAL GUIDE SPLI; Di CZ, 2009, ANN APPL STAT, V3, P458, DOI 10.1214/08-AOAS206; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; Eggermont PPB, 2009, SPRINGER SER STAT, P1, DOI 10.1007/b12285_1; Eubank R. L., 1999, NONPARAMETRIC REGRES; Fan JQ, 1998, J AM STAT ASSOC, V93, P1007, DOI 10.2307/2669845; Fatima Y, 2015, OBES REV, V16, P137, DOI 10.1111/obr.12245; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hirotsu C, 2015, SLEEP SCI, V8, P143, DOI 10.1016/j.slsci.2015.09.002; Hitchcock DB, 2006, J AM STAT ASSOC, V101, P211, DOI 10.1198/016214505000000673; Katayose Y, 2009, METABOLISM, V58, P920, DOI 10.1016/j.metabol.2009.02.025; Kuczmarski RJ, 2000, ADV DATA, V314, P1; Li A. M., 2003, Hong Kong Medical Journal, V9, P353; Magee L, 2012, SLEEP MED REV, V16, P231, DOI 10.1016/j.smrv.2011.05.005; MOON JK, 1995, J NUTR, V125, P220; MURGATROYD PR, 1987, BRIT J NUTR, V58, P347, DOI 10.1079/BJN19870104; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Quist JS, 2016, SLEEP MED REV, V29, P76, DOI 10.1016/j.smrv.2015.09.001; Ramsay JO, 2009, USE R, P1, DOI 10.1007/978-0-387-98185-7_1; Ramsay J.O., 2005, FUNCTIONAL DATA ANAL; Rencher AC, 2002, METHODS MULTIVARIATE; RUMPLER WV, 1990, AM J CLIN NUTR, V51, P147, DOI 10.1093/ajcn/51.2.147; Ruppert D, 2002, J COMPUT GRAPH STAT, V11, P735, DOI 10.1198/106186002853; Shang HL, 2014, ASTA-ADV STAT ANAL, V98, P121, DOI 10.1007/s10182-013-0213-1; Shen Q, 2004, STAT SINICA, V14, P1239; Shimizu I, 2016, HYPERTENS RES; Spaeth AM, 2015, OBESITY, V23, P2349, DOI 10.1002/oby.21198; Tokuyama K, 2009, J APPL PHYSIOL, V106, P640, DOI 10.1152/japplphysiol.90718.2008; Treuth MS, 1998, AM J PHYSIOL-ENDOC M, V275, pE12, DOI 10.1152/ajpendo.1998.275.1.E12; Treuth MS, 2000, AM J CLIN NUTR, V71, P893; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Viviani R, 2005, HUM BRAIN MAPP, V24, P109, DOI 10.1002/hbm.20074; Vsevolozhskaya OA, 2015, ENVIRON ECOL STAT, V22, P45, DOI 10.1007/s10651-014-0282-7; WAHBA G, 1985, ANN STAT, V13, P1378, DOI 10.1214/aos/1176349743; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wong WW, 1999, J CLIN ENDOCR METAB, V84, P906, DOI 10.1210/jc.84.3.906; Zakeri I, 2006, J NUTR, V136, P1371, DOI 10.1093/jn/136.5.1371; Zakeri I, 2008, J APPL PHYSIOL, V104, P1665, DOI 10.1152/japplphysiol.01163.2007; Zakeri IF, 2010, J APPL PHYSIOL, V108, P128, DOI 10.1152/japplphysiol.00729.2009; Zhang K, 2002, INT J OBESITY, V26, P376, DOI 10.1038/sj.ijo.0801922; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	57	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177286	10.1371/journal.pone.0177286	http://dx.doi.org/10.1371/journal.pone.0177286			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489875	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100057
J	Maierhofer, A; Flunkert, J; Dittrich, M; Muller, T; Schindler, D; Nanda, I; Haaf, T				Maierhofer, Anna; Flunkert, Julia; Dittrich, Marcus; Mueller, Tobias; Schindler, Detlev; Nanda, Indrajit; Haaf, Thomas			Analysis of global DNA methylation changes in primary human fibroblasts in the early phase following X-ray irradiation	PLOS ONE			English	Article							IONIZING-RADIATION; 5-HYDROXYMETHYLCYTOSINE; TISSUE; 5-METHYLCYTOSINE; SEQUENCES; PROTEINS; DAMAGE; SITES	Epigenetic alterations may contribute to the generation of cancer cells in a multi-step process of tumorigenesis following irradiation of normal body cells. Primary human fibroblasts with intact cell cycle checkpoints were used as a model to test whether X-ray irradiation with 2 and 4 Gray induces direct epigenetic effects (within the first cell cycle) in the exposed cells. ELISA-based fluorometric assays were consistent with slightly reduced global DNA methylation and hydroxymethylation, however the observed between-group differences were usually not significant. Similarly, bisulfite pyrosequencing of interspersed LINE-1 repeats and centromeric alpha-satellite DNA did not detect significant methylation differences between irradiated and non-irradiated cultures. Methylation of interspersed ALU repeats appeared to be slightly increased (one percentage point; p = 0.01) at 6 h after irradiation with 4 Gy. Single-cell analysis showed comparable variations in repeat methylation among individual cells in both irradiated and control cultures. Radiation-induced changes in global repeat methylation, if any, were much smaller than methylation variation between different fibroblast strains. Interestingly, alpha-satellite DNA methylation positively correlated with gestational age. Finally, 450K methylation arrays mainly targeting genes and CpG islands were used for global DNA methylation analysis. There were no detectable methylation differences in genic (promoter, 5' UTR, first exon, gene body, 3' UTR) and intergenic regions between irradiated and control fibroblast cultures. Although we cannot exclude minor effects, i.e. on individual CpG sites, collectively our data suggest that global DNA methylation remains rather stable in irradiated normal body cells in the early phase of DNA damage response.	[Maierhofer, Anna; Flunkert, Julia; Schindler, Detlev; Nanda, Indrajit; Haaf, Thomas] Julius Maximilians Univ, Inst Human Genet, Wurzburg, Germany; [Dittrich, Marcus; Mueller, Tobias] Julius Maximilians Univ, Dept Bioinformat, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Haaf, T (corresponding author), Julius Maximilians Univ, Inst Human Genet, Wurzburg, Germany.	thomas.haaf@uni-wuerzburg.de	Müller, Tobias/A-8952-2008		German Cancer Foundation [110805]	German Cancer Foundation	This work was supported by research grant 110805 from the German Cancer Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antwih DA, 2013, EPIGENETICS-US, V8, P839, DOI 10.4161/epi.25498; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Aypar U, 2011, MUTAT RES-FUND MOL M, V707, P24, DOI 10.1016/j.mrfmmm.2010.12.003; Bae JH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1229-6; BERNHARD EJ, 1995, RADIAT ENVIRON BIOPH, V34, P79, DOI 10.1007/BF01275210; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Chaudhry MA, 2012, DNA CELL BIOL, V31, P908, DOI 10.1089/dna.2011.1509; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; FRANKENBERGSCHWAGER M, 1990, RADIAT ENVIRON BIOPH, V29, P273, DOI 10.1007/BF01210408; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goetz W, 2011, RADIAT RES, V175, P575, DOI 10.1667/RR2390.1; HAAF T, 1995, PHARMACOL THERAPEUT, V65, P19, DOI 10.1016/0163-7258(94)00053-6; Haffner MC, 2011, ONCOTARGET, V2, P627; Hayden KE, 2013, MOL CELL BIOL, V33, P763, DOI 10.1128/MCB.01198-12; Holliday R, 2005, BIOCHEMISTRY-MOSCOW+, V70, P500, DOI 10.1007/s10541-005-0144-x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaup S, 2006, MUTAT RES-FUND MOL M, V597, P87, DOI 10.1016/j.mrfmmm.2005.06.032; Kinney SM, 2011, J BIOL CHEM, V286, P24685, DOI 10.1074/jbc.M110.217083; KOCHANEK S, 1993, EMBO J, V12, P1141, DOI 10.1002/j.1460-2075.1993.tb05755.x; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Koturbash I, 2005, BIOCHEM BIOPH RES CO, V337, P526, DOI 10.1016/j.bbrc.2005.09.084; Kovalchuk O, 2004, MUTAT RES-FUND MOL M, V548, P75, DOI 10.1016/j.mrfmmm.2003.12.016; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Lahtz Christoph, 2013, F1000Res, V2, P45, DOI 10.12688/f1000research.2-45.v1; Lahtz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044858; Lee Y, 2015, INT J RADIAT BIOL, V91, P142, DOI 10.3109/09553002.2015.969847; Liang HQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5048; MAITY A, 1994, RADIOTHER ONCOL, V31, P1, DOI 10.1016/0167-8140(94)90408-1; Pfeifer GP, 2014, CELL TISSUE RES, V356, P631, DOI 10.1007/s00441-014-1896-7; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Pogribny I, 2004, BIOCHEM BIOPH RES CO, V320, P1253, DOI 10.1016/j.bbrc.2004.06.081; Pogrlbny I, 2005, MOL CANCER RES, V3, P553, DOI 10.1158/1541-7786.MCR-05-0074; REIS RJS, 1982, P NATL ACAD SCI-BIOL, V79, P3949, DOI 10.1073/pnas.79.13.3949; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Schneider E, 2016, GENE, V592, P110, DOI 10.1016/j.gene.2016.07.058; SEYSCHAB H, 1993, HUM GENET, V92, P61, DOI 10.1007/BF00216146; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Spiers H, 2015, GENOME RES, V25, P338, DOI 10.1101/gr.180273.114; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Tawa R, 1998, J RADIAT RES, V39, P271, DOI 10.1269/jrr.39.271; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Wang X.D., 2014, J APPL MATH, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0090804; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; WEVRICK R, 1989, P NATL ACAD SCI USA, V86, P9394, DOI 10.1073/pnas.86.23.9394; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	52	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177442	10.1371/journal.pone.0177442	http://dx.doi.org/10.1371/journal.pone.0177442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489894	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100076
J	Marcella, TK; Gende, SM; Roby, DD; Allignol, A				Marcella, Timothy K.; Gende, Scott M.; Roby, Daniel D.; Allignol, Arthur			Disturbance of a rare seabird by ship-based tourism in a marine protected area	PLOS ONE			English	Article							MURRELET BRACHYRAMPHUS-BREVIROSTRIS; BAY NATIONAL-PARK; GLACIER BAY; KITTLITZS MURRELET; COMPETING RISKS; INFORMATION; CONSERVATION; DISTANCES; IMPACTS; PATTERN	Managers of marine protected areas (MPAs) must often seek ways to allow for visitation while minimizing impacts to the resources they are intended to protect. Using shipboard observers, we quantified the "zone of disturbance" for Kittlitz's and marbled murrelets (Brachyramphus brevirostris and B. marmoratus) exposed to large cruise ships traveling through Glacier Bay National Park, one of the largest MPAs in North America. In the upper reaches of Glacier Bay, where Kittlitz's murrelets predominated, binary logistic regression models predicted that 61% of all murrelets within 850 m perpendicular distance of a cruise ship were disturbed (defined as flushing or diving), whereas in the lower reaches, where marbled murrelets predominated, this percentage increased to 72%. Using survival analysis, murrelets in both reaches were found to react at greater distances when ships approached indirectly, presumably because of the ship's larger profile, suggesting murrelets responded to visual rather than audio cues. No management-relevant covariates (e.g., ship velocity, route distance from shore) were found to be important predictors of disturbance, as distance from ship to murrelet accounted for > 90% of the explained variation in murrelet response. Utilizing previously published murrelet density estimates from Glacier Bay, and applying an average empirical disturbance probability (68%) out to 850 m from a cruise ship's typical route, we estimated that a minimum of 9.8-19.6% of all murrelets in Glacier Bay are disturbed per ship entry. Whether these disturbance levels are inconsistent with Park management objectives, which include conserving wildlife as well as providing opportunities for visitation, depends in large part on whether disturbance events caused by cruise ships have impacts on murrelet fitness, which remains uncertain.	[Marcella, Timothy K.] Oregon State Univ, Dept Fisheries & Wildlife, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA; [Gende, Scott M.] Natl Pk Serv, Glacier Bay Field Stn, Juneau, AK USA; [Roby, Daniel D.] Oregon State Univ, US Geol Survey, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA; [Allignol, Arthur] Ulm Univ, Inst Stat, Ulm, Germany; [Marcella, Timothy K.] Quantum Spatial Inc, Corvallis, OR USA	Oregon State University; United States Department of the Interior; Oregon State University; United States Department of the Interior; United States Geological Survey; Ulm University	Gende, SM (corresponding author), Natl Pk Serv, Glacier Bay Field Stn, Juneau, AK USA.	scott_gende@nps.gov			National Park Service (NPS); Pacific Northwest Cooperative Ecosystems Studies Unit Task [J8W07100046]; USGS Oregon Cooperative Fish and Wildlife Research Unit; Oregon State University	National Park Service (NPS); Pacific Northwest Cooperative Ecosystems Studies Unit Task; USGS Oregon Cooperative Fish and Wildlife Research Unit; Oregon State University	Funding and logistical support was provided by the National Park Service (NPS), as part of the Pacific Northwest Cooperative Ecosystems Studies Unit Task Agreement No: J8W07100046 in cooperation with Oregon State University and the USGS Oregon Cooperative Fish and Wildlife Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding and logistical support was provided by the National Park Service (NPS), as part of the Pacific Northwest Cooperative Ecosystems Studies Unit Task Agreement No: J8W07100046, in cooperation with Oregon State University and the USGS-Oregon Cooperative Fish and Wildlife Research Unit. Additional logistical support was provided by the Holland America Line and Princess Cruises. We would like to acknowledge Dr. Michelle Antolos, Michelle Kissling, Kelsey Brasseur, Leslie Skora, Alishia Zyer, and Melissa Etheridge for their hard work in helping to collect, organize, analyze, and inspire this work. We are particularly grateful to the staff of Glacier Bay National Park and the residents of Gustavus, Alaska, who helped us work and live safely within the Park while completing this study.	Agness AM, 2008, AUK, V125, P346, DOI 10.1525/auk.2008.06203; Agness Alison M., 2013, Marine Ornithology, V41, P13; Allignol A, 2011, J STAT SOFTW, V38, P1; Arimitsu ML, 2007, P 4 GLAC BAY SCI S O, P102; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Bellefleur D, 2009, J ENVIRON MANAGE, V90, P531, DOI 10.1016/j.jenvman.2007.12.002; Bennett NJ, 2014, MAR POLICY, V44, P107, DOI 10.1016/j.marpol.2013.08.017; Beyersmann J., 2012, COMPETING RISKS MULT, DOI DOI 10.7326/0003-4819-153-6-201009210-00005; BirdLife International, 2014, SPEC FACTSH BRACH BR; Breslow NE, 1980, BIRDS N AM; Chatwin TA, 2013, WATERBIRDS, V36, P43, DOI 10.1675/063.036.0108; Christiansen F, 2015, J WILDLIFE MANAGE, V79, P1; Christiansen F, 2013, MAR ECOL PROG SER, V478, P239, DOI 10.3354/meps10163; COX DR, 1972, J R STAT SOC B, V34, P187; Cresswell W, 2000, P ROY SOC B-BIOL SCI, V267, P733, DOI 10.1098/rspb.2000.1064; de Wreede LC, 2011, J STAT SOFTW, V38, P1; Drew GS, 2008, AUK, V125, P178, DOI 10.1525/auk.2008.125.1.178; Fernandez-Juricic E, 2011, BEHAV ECOL, V22, P1304, DOI 10.1093/beheco/arr132; French SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017686; Gende SM, 2011, ECOL APPL, V21, P2232, DOI 10.1890/10-1965.1; Gerrodette T, 2011, MAR MAMMAL SCI, V27, pE101, DOI 10.1111/j.1748-7692.2010.00449.x; Harris K, 2012, ENVIRON MANAGE, V49, P44, DOI 10.1007/s00267-011-9754-9; Hoekman ST, 2013, NPSSEANNRR2013735; Hoyt E., 2011, MARINE PROTECTED ARE; Jansen JK, 2010, J WILDLIFE MANAGE, V74, P1186, DOI 10.2193/2008-192; Jones PJS, 2001, REV FISH BIOL FISHER, V11, P197, DOI 10.1023/A:1020327007975; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kirchhoff MD, 2014, CONDOR, V116, P24, DOI 10.1650/CONDOR-13-123.1; LIMA SL, 1994, J AVIAN BIOL, V25, P319, DOI 10.2307/3677279; Lukacs PM, 2010, CONDOR, V112, P455, DOI 10.1525/cond.2010.090204; Lusseau D, 2005, MAR ECOL PROG SER, V295, P265, DOI 10.3354/meps295265; Mathews EA, 2006, MAR MAMMAL SCI, V22, P167, DOI 10.1111/j.1748-7692.2006.00011.x; National Audubon Society, 2006, AM TOP 10 MOST END R; [National Park Service United States Department of the Interior], 2003, GLAC BAY NAT PARK PR; National Park Service, 2006, MAN POL 2006 GUID MA; NCH Software, 2014, WAVEPAD AUD ED V 4 5; Pennycuik C.J., 1987, P43; Piatt John F., 2011, Marine Ornithology, V39, P65; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Reisdorph SC, 2014, BIOGEOSCIENCES DISCU, V11, P13029; Reyes-Arriagada R, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00617-080213; Rodgers JA, 2002, CONSERV BIOL, V16, P216, DOI 10.1046/j.1523-1739.2002.00316.x; Ronconi RA, 2002, BIOL CONSERV, V108, P265, DOI 10.1016/S0006-3207(02)00126-X; Rosciano NG, 2013, REV BIOL MAR OCEANOG, V48, P165, DOI 10.4067/S0718-19572013000100014; Rossiter JS, 2014, MAR POLICY, V44, P196, DOI 10.1016/j.marpol.2013.08.022; Saracco James F., 2013, Northwestern Naturalist, V94, P187; Schwemmer P, 2011, ECOL APPL, V21, P1851, DOI 10.1890/10-0615.1; Sergeant CJ, 2017, NPSSEANNRTR20171375; Sergeant CJ, 2015, NPSSEANNRR20151076; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sirot E, 2006, ANIM BEHAV, V72, P373, DOI 10.1016/j.anbehav.2005.10.028; Venables WN., 2002, MODERN APPL STAT S 4; Webb KR, 2015, COAST MANAGE, V43, P67, DOI 10.1080/08920753.2014.989148; Williams ID, 2009, BIOL CONSERV, V142, P1066, DOI 10.1016/j.biocon.2008.12.029; Young C., 2014, Tourism in Marine Environments, V10, P5, DOI 10.3727/154427314X14056884441626; YOUNG IT, 1977, J HISTOCHEM CYTOCHEM, V25, P935, DOI 10.1177/25.7.894009	56	8	8	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176176	10.1371/journal.pone.0176176	http://dx.doi.org/10.1371/journal.pone.0176176			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489902	gold, Green Published			2022-12-27	WOS:000401314100017
J	Marini, M; Bendinelli, B; Assedi, M; Occhini, D; Castaldo, M; Fabiano, J; Petranelli, M; Migliolo, M; Monaci, M; Masala, G				Marini, Mirca; Bendinelli, Benedetta; Assedi, Melania; Occhini, Daniela; Castaldo, Maria; Fabiano, Jacopo; Petranelli, Marco; Migliolo, Mario; Monaci, Marco; Masala, Giovanna			Low back pain in healthy postmenopausal women and the effect of physical activity: A secondary analysis in a randomized trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; PRIMARY-CARE; RISK-FACTORS; EPIDEMIOLOGY; PREVALENCE; MUSCULOSKELETAL; EXERCISE; POPULATION; ADULTS; INTERVENTION	Epidemiological studies on the prevalence of musculoskeletal pain have consistently shown that this is a relevant health problem, with non-specific low back pain (LBP) being the most commonly reported in adult females. Conflicting data on the association between LBP symptoms and physical activity (PA) have been reported. Here, we investigated the prevalence of LBP and the effect of a 24-month non-specific PA intervention on changes in LBP prevalence in a series of Italian healthy postmenopausal women. We performed a secondary analysis in the frame of the DAMA trial, a factorial randomized intervention trial aimed to evaluate the ability of a 24-month intervention, based on moderate-intensity PA, and/or dietary modification, in reducing mammographic breast density in healthy postmenopausal women. The PA intervention included at least 1 hour/day of moderate PA and a more strenuous weekly activity, collective walks and theoretical group sessions. A self-administered pain questionnaire was administered at baseline and at the end of the intervention. The questionnaire was specifically structured to investigate the occurrence of musculoskeletal pain, the body localization, intensity and duration of the pain. Two hundred and ten women (102 randomized to PA intervention, 108 not receiving the PA intervention) filled out the questionnaires. At baseline LBP was present in 32.9% of the participants. Among women randomized to the PA intervention, LBP prevalence at follow up (21.6%) was lower than at baseline (33.3%) (p = 0.02), while in women who did not receive the PA intervention the LBP prevalence at baseline and follow up were 32.4% and 25.9%, respectively (p = 0.30). Overall, there was no significant between-group effect of PA intervention on LBP. Further studies are needed to understand the role of non-specific PA intervention, aimed to improve overall fitness, on LBP prevalence.	[Marini, Mirca; Fabiano, Jacopo; Monaci, Marco] Univ Florence, Sect Anat & Histol, Dept Expt & Clin Med, Florence, Italy; [Bendinelli, Benedetta; Assedi, Melania; Occhini, Daniela; Castaldo, Maria; Masala, Giovanna] Canc Res & Prevent Inst ISPO, Canc Risk Factors & Lifestyle Epidemiol, Florence, Italy; [Petranelli, Marco] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Migliolo, Mario] Florentine Sports Med Assoc FMSI CONI, Florence, Italy	University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Florence	Marini, M (corresponding author), Univ Florence, Sect Anat & Histol, Dept Expt & Clin Med, Florence, Italy.	mirca.marini@unifi.it	Masala, Giovanna/AAC-5474-2022	Masala, Giovanna/0000-0002-5758-9069; Bendinelli, Benedetta/0000-0002-4796-1517	Cancer Institute of Tuscany (ITT); Italian Ministry of Health (Programma Integrato Oncologia)	Cancer Institute of Tuscany (ITT); Italian Ministry of Health (Programma Integrato Oncologia)	The DAMA trial was funded by the Cancer Institute of Tuscany (ITT) and the Italian Ministry of Health (Programma Integrato Oncologia 2006).	Bachmann S, 2013, THER UMSCH, V70, P543, DOI 10.1024/0040-5930/a000444; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Bener A, 2014, ASIAN SPINE J, V8, P227, DOI 10.4184/asj.2014.8.3.227; Bingefors K, 2004, EUR J PAIN, V8, P435, DOI 10.1016/j.ejpain.2004.01.005; Bjorck-van Dijken C, 2008, J REHABIL MED, V40, P864, DOI 10.2340/16501977-0273; Bonezzi C, 2002, Minerva Anestesiol, V68, P607; Edmond SL, 2000, J RHEUMATOL, V27, P220; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gomes JL, 2015, EUR SPINE J, V24, P452, DOI 10.1007/s00586-015-3763-y; Gong GL, 2013, J CLIN NURS, V22, P1857, DOI 10.1111/jocn.12134; Gourmelen J., 2007, Annales de Readaptation et de Medecine Physique, V50, P640, DOI 10.1016/j.annrmp.2007.05.009; Grossschadl F, 2016, EUR J PUBLIC HEALTH, V26, P248, DOI 10.1093/eurpub/ckv163; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Hendrick P, 2011, EUR SPINE J, V20, P464, DOI 10.1007/s00586-010-1616-2; Heneweer H, 2011, EUR SPINE J, V20, P826, DOI 10.1007/s00586-010-1680-7; Heneweer H, 2009, PAIN, V143, P21, DOI 10.1016/j.pain.2008.12.033; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hussain SM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003963; Izzo R, 2015, EUR J RADIOL, V84, P746, DOI 10.1016/j.ejrad.2015.01.018; Jang JH, 2015, J PHYS THER SCI, V27, P725, DOI 10.1589/jpts.27.725; Juniper M, 2009, EXPERT OPIN PHARMACO, V10, P2581, DOI 10.1517/14656560903304063; Kamper SJ, 2014, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000335.PUB2; Kamper SJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000963.pub3; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; Krismer M, 2007, BEST PRACT RES CL RH, V21, P77, DOI 10.1016/j.berh.2006.08.004; Lizier DT, 2012, REV BRAS ANESTESIOL, V62, P838, DOI 10.1590/S0034-70942012000600008; Manchikanti L, 2014, NEUROMODULATION, V17, P3, DOI 10.1111/ner.12018; Masala G, 2014, TUMORI J, V100, P377, DOI 10.1700/1636.17890; Masiero S, 2010, ACTA PAEDIATR, V99, P1224, DOI 10.1111/j.1651-2227.2010.01770.x; Murphy S, 2014, IRISH J MED SCI, V183, P341, DOI 10.1007/s11845-013-1013-z; Notarnicola A, 2014, EUR J PHYS REHAB MED, V50, P59; Palli D, 2003, TUMORI, V89, P586, DOI 10.1177/030089160308900602; Ramond-Roquin A, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00073; Ribaud A., 2013, Annals of Physical and Rehabilitation Medicine, V56, P576, DOI 10.1016/j.rehab.2013.08.007; Saner J, 2015, MANUAL THER, V20, P672, DOI 10.1016/j.math.2015.02.005; Santos-Eggimann B, 2000, SPINE, V25, P2473, DOI 10.1097/00007632-200010010-00009; Schaller A, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0527-0; Steffens D, 2016, JAMA INTERN MED, V176, P199, DOI 10.1001/jamainternmed.2015.7431; Taylor JB, 2014, SPINE J, V14, P2299, DOI 10.1016/j.spinee.2014.01.026; van Middelkoop M, 2010, BEST PRACT RES CL RH, V24, P193, DOI 10.1016/j.berh.2010.01.002; van Tulder M, 2002, BEST PRACT RES CL RH, V16, P761, DOI 10.1053/berh.2002.0267; Waxman R, 2000, SPINE, V25, P2085, DOI 10.1097/00007632-200008150-00013; Wijnhoven HAH, 2006, CLIN J PAIN, V22, P717, DOI 10.1097/01.ajp.0000210912.95664.53; Zelman DC, 2005, J PAIN SYMPTOM MANAG, V29, P401, DOI 10.1016/j.jpainsymman.2004.06.018	45	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177370	10.1371/journal.pone.0177370	http://dx.doi.org/10.1371/journal.pone.0177370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489877	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314100068
J	Haeusermann, T; Greshake, B; Blasimme, A; Irdam, D; Richards, M; Vayena, E				Haeusermann, Tobias; Greshake, Bastian; Blasimme, Alessandro; Irdam, Darja; Richards, Martin; Vayena, Effy			Open sharing of genomic data: Who does it and why?	PLOS ONE			English	Article							CONSUMER PERCEPTIONS; HEALTH; BENEFITS; RISKS	We explored the characteristics and motivations of people who, having obtained their genetic or genomic data from Direct-To-Consumer genetic testing (DTC-GT) companies, voluntarily decide to share them on the publicly accessible web platform open SNP. The study is the first attempt to describe open data sharing activities undertaken by individuals without institutional oversight. In the paper we provide a detailed overview of the distribution of the demographic characteristics and motivations of people engaged in genetic or genomic open data sharing. The geographical distribution of the respondents showed the USA as dominant. There was no significant gender divide, the age distribution was broad, educational background varied and respondents with and without children were equally represented. Health, even though prominent, was not the respondents' primary or only motivation to be tested. As to their motivations to openly share their data, 86.05% indicated wanting to learn about themselves as relevant, followed by contributing to the advancement of medical research (80.30%), improving the predictability of genetic testing (76.02%) and considering it fun to explore genotype and phenotype data (75.51%). Whereas most respondents were well aware of the privacy risks of their involvement in open genetic data sharing and considered the possibility of direct, personal repercussions troubling, they estimated the risk of this happening to be negligible. Our findings highlight the diversity of DTC-GT consumers who decide to openly share their data. Instead of focusing exclusively on health-related aspects of genetic testing and data sharing, our study emphasizes the importance of taking into account benefits and risks that stretch beyond the health spectrum. Our results thus lend further support to the call for a broader and multi-faceted conceptualization of genomic utility.	[Haeusermann, Tobias; Blasimme, Alessandro; Vayena, Effy] Univ Zurich, EBPI, Hlth Ethics & Policy Lab, Zurich, Switzerland; [Haeusermann, Tobias; Irdam, Darja] Univ Cambridge, Dept Sociol, Cambridge, England; [Greshake, Bastian] Goethe Univ, Inst Cell Biol & Neurosci, Dept Appl Bioinformat, Frankfurt, Germany; [Richards, Martin] Univ Cambridge, Dept Psychol, Ctr Family Res, Cambridge, England	University of Zurich; University of Cambridge; Goethe University Frankfurt; University of Cambridge	Vayena, E (corresponding author), Univ Zurich, EBPI, Hlth Ethics & Policy Lab, Zurich, Switzerland.	effy.vayena@uzh.ch	Vayena, Effy/ABD-8272-2021; Blasimme, Alessandro/AAN-5814-2021; Greshake, Bastian/ABF-7171-2020	Vayena, Effy/0000-0003-1303-5467; Greshake, Bastian/0000-0002-9925-9623; Haeusermann, Tobias/0000-0002-5880-7873; Blasimme, Alessandro/0000-0001-5908-2002	University of Zurich's Priority Research Program; Swiss National Science Foundation	University of Zurich's Priority Research Program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the University of Zurich's Priority Research Program and the Swiss National Science Foundation.	Abbott A, 2012, NATURE, V486, P167, DOI 10.1038/486167a; Annas GJ, 2014, NEW ENGL J MED, V370, P985, DOI 10.1056/NEJMp1316367; [Anonymous], 2015, NAT BIOTECHNOL, V33, P435, DOI 10.1038/nbt0515-435a; Auffray C, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0265-4; Ball MP, 2014, GENOME MED, V6, DOI 10.1186/gm527; Bloss CS, 2011, NEW ENGL J MED, V364, P524, DOI 10.1056/NEJMoa1011893; Carere DA, 2016, GENETICS MED; Cheung C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166389; Christofides E, 2016, NEW GENET SOC, V35, P101, DOI 10.1080/14636778.2016.1162092; Chung MWH, 2016, J MED ETHICS, V42, P649, DOI 10.1136/medethics-2015-103057; Corpas M, 2016, FRONT LINE GENOMICS; Corpas M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1973-7; Critchley C, 2015, PUBLIC HEALTH GENOM, V18, P160, DOI 10.1159/000375441; Evans JP, 2009, GENET MED, V11, P568, DOI 10.1097/GIM.0b013e3181afbaed; Fernandez-Luque L, 2015, HEALTHC INFORM RES, V21, P67, DOI 10.4258/hir.2015.21.2.67; Global Alliance Genomics Hlth, 2016, SCIENCE, V352, P1278, DOI 10.1126/science.aaf6162; Gray SW, 2016, J CLIN ONCOL; Greshake B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089204; Hartung AM, 2016, THESIS; Heshka JT, 2008, GENET MED, V10, P19, DOI 10.1097/GIM.0b013e31815f524f; Humbert M., 2015, PROC 1 ENHANCING TEC, V2015, P99, DOI [10.1515/popets-2015-0020, DOI 10.1515/POPETS-2015-0020]; Laestadius L, 2016, GENETICS MED; Lapin V, 2016, HUM GENET, V135, P655, DOI 10.1007/s00439-016-1677-3; Lemke AA, 2010, PUBLIC HEALTH GENOM, V13, P368, DOI 10.1159/000276767; Lewin JH, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.11502; McGrath SP, 2016, PUBLIC HEALTH GENOM, V19, P116, DOI 10.1159/000444477; McGuire AL, 2008, GENET MED, V10, P46, DOI 10.1097/GIM.0b013e31815f1e00; Nelson B, 2016, CANCER CYTOPATHOL, V124, P159, DOI 10.1002/cncy.21706; Oliver JM, 2012, PUBLIC HEALTH GENOM, V15, P106, DOI 10.1159/000334718; Roberts J. S., 2017, PUBLIC HLTH GENOMICS; Roberts J Scott, 2013, Curr Genet Med Rep, V1, P182; Roberts JS, 2017, PUBLIC HEALTH GENOMI; Rothstein MA, 2016, J LAW MED ETHICS, V44, P161, DOI 10.1177/1073110516644207; Rotimi Charles N, 2003, Dev World Bioeth, V3, P151, DOI 10.1046/j.1471-8731.2003.00071.x; Royal CD, 2010, AM J HUM GENET, V86, P661, DOI 10.1016/j.ajhg.2010.03.011; Savage N, 2016, NATURE, P537; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Shih TH, 2008, FIELD METHOD, V20, P249, DOI 10.1177/1525822X08317085; Slavkovic A, 2015, CHANCE, V28, P37; Spector-Bagdady K, 2016, ANN EPIDEMIOL, V26, P515, DOI 10.1016/j.annepidem.2016.05.007; Sprenger Polly, 1999, WIRED; Trinidad SB, 2010, GENET MED, V12, P486, DOI 10.1097/GIM.0b013e3181e38f9e; Tubaro Paola, 2014, HYPOTHESIS END PRIVA; van der Wouden CH, 2016, ANN INTERN MED, V164, P513, DOI 10.7326/M15-0995; Vayena E, 2012, PUBLIC HEALTH GENOM, V15, P352, DOI 10.1159/000343792; Vayena E, 2015, J MED ETHICS, V41, P310, DOI 10.1136/medethics-2014-102026; Vayena E, 2014, PUBLIC HEALTH GENOM, V17, P158, DOI 10.1159/000360257; Vayena E, 2012, AM J PUBLIC HEALTH, V102, P2225, DOI 10.2105/AJPH.2012.300813; Wallis JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067332; Wicks P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g368; Wilbanks JT, 2016, NATURE; Zaaijer S, 2016, DEMOCRATIZING DNA FI	52	37	38	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177158	10.1371/journal.pone.0177158	http://dx.doi.org/10.1371/journal.pone.0177158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486511	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314000049
J	Hanoudi, S; Donato, M; Draghici, S				Hanoudi, Samer; Donato, Michele; Draghici, Sorin			Identifying biologically relevant putative mechanisms in a given phenotype comparison	PLOS ONE			English	Article							GENE SET ENRICHMENT; DIFFERENTIAL EXPRESSION; RNA-SEQ; R PACKAGE; PATHWAY; KEGG; RECONSTRUCTION; NETWORKS	A major challenge in life science research is understanding the mechanism involved in a given phenotype. The ability to identify the correct mechanisms is needed in order to understand fundamental and very important phenomena such as mechanisms of disease, immune systems responses to various challenges, and mechanisms of drug action. The current data analysis methods focus on the identification of the differentially expressed (DE) genes using their fold change and/or p-values. Major shortcomings of this approach are that: i) it does not consider the interactions between genes; ii) its results are sensitive to the selection of the threshold(s) used, and iii) the set of genes produced by this approach is not always conducive to formulating mechanistic hypotheses. Here we present a method that can construct networks of genes that can be considered putative mechanisms. The putative mechanisms constructed by this approach are not limited to the set of DE genes, but also considers all known and relevant gene-gene interactions. We analyzed three real datasets for which both the causes of the phenotype, as well as the true mechanisms were known. We show that the method identified the correct mechanisms when applied on microarray datasets from mouse. We compared the results of our method with the results of the classical approach, showing that our method produces more meaningful biological insights.	[Hanoudi, Samer; Donato, Michele; Draghici, Sorin] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Draghici, Sorin] Dept Obstet & Gynecol, Detroit, MI 48202 USA	Wayne State University	Draghici, S (corresponding author), Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA.; Draghici, S (corresponding author), Dept Obstet & Gynecol, Detroit, MI 48202 USA.	sorin@wayne.edu	Draghici, Sorin/B-3074-2013	Draghici, Sorin/0000-0002-0786-8377	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [RO1 DK089167]; National Institutes of Health, National Institute Of General Medical Sciences [STTR R42GM087013]; National Science Foundation [DBI-0965741]; Robert J. Sokol Endowment in Systems Biology; NIH [RO1 DK089167, STTR R42GM087013]; NSF [DBI-0965741]	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health, National Institute Of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Robert J. Sokol Endowment in Systems Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	This work has been partially supported by the following grants: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), RO1 DK089167, (https://www.nih.gov/), National Institutes of Health, National Institute Of General Medical Sciences STTR R42GM087013, (https://www.nih.gov/), National Science Foundation DBI-0965741 (to Sorin Draghici), (https://www.nsf.gov/index.jsp), and by the Robert J. Sokol Endowment in Systems Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.r This work has been partially supported by the following grants: NIH RO1 DK089167, NIH STTR R42GM087013, NSF DBI-0965741 (to Sorin Draghici, and by the Robert J. Sokol Endowment in Systems Biology. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of any of the funding agencies. We would like to thank Rebeca Tagett for her help in the preprocessing of the data.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ansari Sahar, 2017, Proc IEEE Inst Electr Electron Eng, V105, P482, DOI 10.1109/JPROC.2016.2531000; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bokanizad B, 2016, NUCLEIC ACIDS RES, V44, P5034, DOI 10.1093/nar/gkw429; Butte A J, 2000, Pac Symp Biocomput, P418; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chen C, 2012, AM J PHYSIOL-GASTR L, V302, pG407, DOI 10.1152/ajpgi.00314.2011; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Donato M, 2013, GENOME RES, V23, P1885, DOI 10.1101/gr.153551.112; Dong XR, 2016, SCI REP-UK, V6, DOI 10.1038/srep18871; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Efron B, 1993, INTRO BOOTSTRAP, P578; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Glaab E, 2012, BIOINFORMATICS, V28, pI451, DOI 10.1093/bioinformatics/bts389; Ha E, 2006, J PINEAL RES, V41, P67, DOI 10.1111/j.1600-079X.2006.00334.x; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Hartemink Alexander J, 2002, Pac Symp Biocomput, P437; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; Jin Lv, 2014, Genomics Proteomics & Bioinformatics, V12, P210, DOI 10.1016/j.gpb.2014.10.002; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Khatri PS, 2005, ENCY GENETICS GENOMI; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Killick R, 2014, J STAT SOFTW, V58, P1; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li J, 2011, BIOSTATISTICS; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Liu M, 2007, PLOS GENET, V3, P958, DOI 10.1371/journal.pgen.0030096; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mitrea C, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00278; Munoz EM, 2007, J NEUROCHEM, V102, P887, DOI 10.1111/j.1471-4159.2007.04605.x; Nguyen T, 2016, P IEEE, VPP, P1; Nicholson DJ, 2012, STUD HIST PHI PART C, V43, P152, DOI 10.1016/j.shpsc.2011.05.014; Pan KH, 2005, P NATL ACAD SCI USA, V102, P8961, DOI 10.1073/pnas.0502674102; Peliciari-Garcia RA, 2010, LIFE SCI, V87, P169, DOI 10.1016/j.lfs.2010.06.005; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Schurch NJ, 2016, RNA, V22, P839, DOI 10.1261/rna.053959.115; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; ter Linde JJM, 1999, J BACTERIOL, V181, P7409, DOI 10.1128/JB.181.24.7409-7413.1999; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Werhli AV, 2007, STAT APPL GENET MOL, V6; Zeng S, 2012, FASEB J, V26, P882, DOI 10.1096/fj.11-192997; Zhu J, 2004, CYTOGENET GENOME RES, V105, P363, DOI 10.1159/000078209; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	58	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176950	10.1371/journal.pone.0176950	http://dx.doi.org/10.1371/journal.pone.0176950			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486531	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314000029
J	Li, JL; Chen, TS; Yuan, CC; Zhao, GQ; Xu, M; Li, XY; Cao, J; Xing, LH				Li, Junlu; Chen, Tingsang; Yuan, Congcong; Zhao, Guoqiang; Xu, Min; Li, Xiaoyan; Cao, Jie; Xing, Lihua			Effect of intravenous immunoglobulin on the function of Treg cells derived from immunosuppressed mice with Pseudomonas aeruginosa pneumonia	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNOLOGICAL SELF-TOLERANCE; SEVERE SEPSIS; SEPTIC SHOCK; CYCLOPHOSPHAMIDE; PATHOGENESIS; INDUCTION; ARTHRITIS; RESPONSES; SURVIVAL	Aim The present study aimed to investigate the effect of intravenous immunoglobulin (IVIG) on regulatory T (Treg) cells derived from immunosuppressed mice with Pseudomonas aeruginosa (PA) pneumonia. Methods A total of 108 BALB/c mice were randomly divided into the following groups: control group (Control), immunosuppressed group (IS), PA pneumonia group (PA), PA pneumonia in immunosuppressed group (IS + PA), PA pneumonia with IVIG treatment in immunocompetent group (PA + IVIG) and PA pneumonia with IVIG treatment in immunosuppressed group (IS + PA + IVIG). Each group comprised 18 mice. The combined PA pneumonia in immunosuppressed model and the treatment models were established. The mice in each group were sacrificed at 4, 8, and 24 h time points. The general condition and pathological changes in the lung tissues of the mice were monitored. Reverse transcription-polymerase chain reaction was used to detect the forkhead box P3 (FOXP3) mRNA relative expression level in the lung tissues. The enzyme-linked immunosorbent assay was used to detect the serum concentration of active transforming growth factor beta (TGF-beta). Results No inflammatory response were exhibited in the lung tissues of the mice in Control group and IS group, while varying degrees of acute lung injury were revealed in the mice in PA group, IS + PA group, PA + IVIG group and IS + PA + IVIG group. Lung tissue injury was most apparent at the 8 h time point, and it indicated the greatest effect in IS + PA group. Whereas tissue damages were alleviated in PA + IVIG group and IS + PA + IVIG group compared with IS + PA group. In addition, tissue damage lessened in PA + IVIG group compared with PA group and IS + PA + IVIG group. FOXP3 mRNA expression levels in the lung tissues and the serum concentration of TGF-beta were lower in IS group, PA group, IS + PA group and IS + PA + IVIG group at the 4, 8 and 24 h time points, respectively compared with Control group. FOXP3 mRNA expression levels decreased in PA + IVIG group at the 4h time point and TGF-beta serum concentrations decreased at the 4 and 8h time points compared with Control group, and subsequently increased. Conclusions In the immunosuppred model with PA pneumonia, the immune system was greatly compromised. IVIG partially restored the immunosuppressed functions of Treg cells, suppressed the overactivated immune system and ameliorated the development of the disease.	[Li, Junlu; Chen, Tingsang; Yuan, Congcong; Li, Xiaoyan; Cao, Jie; Xing, Lihua] Zhengzhou Univ, Affiliated Hosp 1, Dept Resp Intens Care Unit RICU, Zhengzhou, Henan, Peoples R China; [Zhao, Guoqiang] Zhengzhou Univ, Sch Basic Med Sci, Zhengzhou, Henan, Peoples R China; [Xu, Min] Zhengzhou Univ, Affiliated Hosp 1, Dept Lab, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University	Xing, LH (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Resp Intens Care Unit RICU, Zhengzhou, Henan, Peoples R China.	Lihuaxingricu@163.com			Basic and advanced technology research of Henan Province Science and Technology Department [142 300 410 327]; Medical science and technology research project of Henan Provience [201403060]	Basic and advanced technology research of Henan Province Science and Technology Department; Medical science and technology research project of Henan Provience	Support was provided by Basic and advanced technology research of Henan Province Science and Technology Department, Number: 142 300 410 327; [http://xm.hnkjt.gov.cn/]; and Medical science and technology research project of Henan Provience 201403060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basta M, 2014, CLIN EXP IMMUNOL, V178, P111, DOI 10.1111/cei.12532; Cattepoel S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161826; Chen Tingsang, 2016, INT J RESP, V36, P445; Eibl MM, 2008, IMMUNOL ALLERGY CLIN, V28, P737, DOI 10.1016/j.iac.2008.06.004; Hill NS, 2001, NEW ENGL J MED, V344, P522, DOI 10.1056/NEJM200102153440711; Jing Gao, 2016, J HUAZHONG UNI SCI T, V36, P653; Kashima H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156643; Katz-Agranov N, 2015, AUTOIMMUN REV, V14, P651, DOI 10.1016/j.autrev.2015.04.003; Kaufman GN, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00469; Laupland KB, 2007, CRIT CARE MED, V35, P2686, DOI 10.1097/01.CCM.0000295312.13466.1C; Le DT, 2012, CANCER RES, V72, P3439, DOI 10.1158/0008-5472.CAN-11-3912; Lee SY, 2014, ARTHRITIS RHEUMATOL, V66, P1768, DOI 10.1002/art.38627; Lu PX, 2016, CENT EUR J IMMUNOL, V41, P143, DOI 10.5114/ceji.2016.60987; Manepalli S, 2013, J MED MICROBIOL, V62, P1747, DOI 10.1099/jmm.0.060004-0; Massoud AH, 2012, J ALLERGY CLIN IMMUN, V129, P1656, DOI 10.1016/j.jaci.2012.02.050; Odeh AN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155648; Radojcic V, 2010, CANCER IMMUNOL IMMUN, V59, P137, DOI 10.1007/s00262-009-0734-3; Restagno D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162109; Rodriguez A, 2005, SHOCK, V23, P298, DOI 10.1097/01.shk.0000157302.69125.f8; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; SCHEDEL I, 1991, CRIT CARE MED, V19, P1104, DOI 10.1097/00003246-199109000-00003; Schmidt A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148474; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Su ZQ, 2014, INT IMMUNOPHARMACOL, V22, P371, DOI 10.1016/j.intimp.2014.06.043; Tai X, 2013, IMMUNITY, V38, P1116, DOI 10.1016/j.immuni.2013.02.022; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Yayan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139836; Zuercher AW, 2016, AUTOIMMUN REV, V15, P781, DOI 10.1016/j.autrev.2016.03.018	29	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176843	10.1371/journal.pone.0176843	http://dx.doi.org/10.1371/journal.pone.0176843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481908	Green Submitted, Green Published, gold			2022-12-27	WOS:000401313700019
J	Park, HS; Lee, MK; Kim, SC; Yu, JH				Park, Hee-Soo; Lee, Mi-Kyung; Kim, Sun Chang; Yu, Jae-Hyuk			0000 The role of VosA/VelB-activated developmental gene vadA in Aspergillus nidulans	PLOS ONE			English	Article							SECONDARY METABOLISM; ASEXUAL SPORULATION; FILAMENTOUS FUNGI; CONIDIOPHORE DEVELOPMENT; SEXUAL DEVELOPMENT; VEA; EXPRESSION; STERIGMATOCYSTIN; CONIDIATION; FUMIGATUS	The filamentous fungus Aspergillus nidulans primarily reproduces by forming asexual spores called conidia, the integrity of which is governed by the NF-kappa B type velvet regulators VosA and VelB. The VosA-VelB hetero-complex regulates the expression of spore-specific structural and regulatory genes during conidiogenesis. Here, we characterize one of the VosA/VelB-activated developmental genes, called vadA, the expression of which in conidia requires activity of both VosA and VelB. VadA (AN5709) is predicted to be a 532-amino acid length fungal-specific protein with a highly conserved domain of unknown function (DUF) at the N-terminus. This DUF was found to be conserved in many Ascomycota and some Glomeromycota species, suggesting a potential evolutionarily conserved function of this domain in fungi. Deletion studies of vadA indicate that VadA is required for proper downregulation of brlA, fksA, and rodA, and for proper expression of tpsA and orlA during sporogenesis. Moreover, vadA null mutant conidia exhibit decreased trehalose content, but increased beta(1,3)-glucan levels, lower viability, and reduced tolerance to oxidative stress. We further demonstrate that the vadA null mutant shows increased production of the mycotoxin sterigmatocystin. In summary, VadA is a dual-function novel regulator that controls development and secondary metabolism, and participates in bridging differentiation and viability of newly formed conidia in A. nidulans.	[Park, Hee-Soo] Kyungpook Natl Univ, Inst Agr Sci & Technol, Sch Food Sci & Biotechnol, Daegu, South Korea; [Lee, Mi-Kyung; Yu, Jae-Hyuk] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Lee, Mi-Kyung; Yu, Jae-Hyuk] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea	Kyungpook National University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Korea Advanced Institute of Science & Technology (KAIST)	Yu, JH (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.; Yu, JH (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	jyu1@wisc.edu	Kim, Sun Chang/C-2026-2011; Yu, Jae-Hyuk/A-2343-2008; Park, Hee-Soo/AAC-6422-2019; Kim, Sun/GSN-4867-2022	Yu, Jae-Hyuk/0000-0002-6530-8407	Research Foundation of Korea (NRF) - Korea government (MSIP) [2016010945]; Intelligent Synthetic Biology Center of Global Frontier Project [2011-0031955]; National Research Foundation of Korea (NRF) grant [2016010945]; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology [2011-0031955]	Research Foundation of Korea (NRF) - Korea government (MSIP); Intelligent Synthetic Biology Center of Global Frontier Project; National Research Foundation of Korea (NRF) grant; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology	The work by HSP was supported by the National Research Foundation of Korea (NRF) grant to HSP founded by the Korea government (MSIP: No. 2016010945). This work was in part supported by the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031955) funded by the Ministry of Education, Science and Technology grants to SCK and JHY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Wendy Bedale of our institute for critically reviewing the manuscript. The work by HSP was supported by the National Research Foundation of Korea (NRF) grant to HSP founded by the Korea government (MSIP: No. 2016010945). This work was in part supported by the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031955) funded by the Ministry of Education, Science and Technology grants to SCK and JHY.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; ADAMS TH, 1990, MOL CELL BIOL, V10, P1815, DOI 10.1128/MCB.10.4.1815; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; ADRIANOPOULOS A, 1991, PLANT CELL, V3, P747, DOI 10.1105/tpc.3.8.747; Ahmed YL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001750; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bayram OS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001226; Bennett JW, 2010, ASPERGILLUS: MOLECULAR BIOLOGY AND GENOMICS, P1; Beyhan S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001614; BOYLAN MT, 1987, MOL CELL BIOL, V7, P3113, DOI 10.1128/MCB.7.9.3113; Calvo AM, 2004, APPL ENVIRON MICROB, V70, P4733, DOI 10.1128/AEM.70.8.4733-4739.2004; Casselton L, 2002, NAT REV GENET, V3, P683, DOI 10.1038/nrg889; de Vries RP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1151-0; Dhingra S, 2012, EUKARYOT CELL, V11, P1531, DOI 10.1128/EC.00222-12; Ebbole DJ, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P577; Gugnani HC, 2003, FRONT BIOSCI-LANDMRK, V8, pS346, DOI 10.2741/1002; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kato N, 2003, EUKARYOT CELL, V2, P1178, DOI 10.1128/EC.2.6.1178-1186.2003; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Kwon NJ, 2010, FUNGAL GENET BIOL, V47, P981, DOI 10.1016/j.fgb.2010.08.009; MARSHALL MA, 1991, MOL CELL BIOL, V11, P55, DOI 10.1128/MCB.11.1.55; Martinelli S D, 1994, Prog Ind Microbiol, V29, P33; MCKNIGHT GL, 1985, EMBO J, V4, P2093, DOI 10.1002/j.1460-2075.1985.tb03897.x; MIMS CW, 1988, PROTOPLASMA, V144, P132, DOI 10.1007/BF01637246; MIRABITO PM, 1989, CELL, V57, P859, DOI 10.1016/0092-8674(89)90800-3; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; Ni M, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P559; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Park Hee Soo, 2012, Methods Mol Biol, V944, P183, DOI 10.1007/978-1-62703-122-6_13; Park Hee-Soo, 2016, Microbiology and Biotechnology Letters, V44, P409, DOI 10.4014/mbl.1607.07007; Park HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10199; Park HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089883; Park HS, 2012, CURR OPIN MICROBIOL, V15, P669, DOI 10.1016/j.mib.2012.09.006; Park HS, 2012, MOL MICROBIOL, V86, P937, DOI 10.1111/mmi.12032; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roberts RG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001751; Samson R A, 1992, Biotechnology, V23, P355; Seo JA, 2003, GENETICS, V165, P1083; SEWALL TC, 1990, DEV BIOL, V138, P499, DOI 10.1016/0012-1606(90)90215-5; Shaaban MI, 2010, EUKARYOT CELL, V9, P1816, DOI 10.1128/EC.00189-10; TIMBERLAKE WE, 1990, ANNU REV GENET, V24, P5, DOI 10.1146/annurev.ge.24.120190.000253; WARING RB, 1989, GENE, V79, P119, DOI 10.1016/0378-1119(89)90097-8; Yu Jae-Hyuk, 2010, Mycobiology, V38, P229, DOI 10.4489/MYCO.2010.38.4.229; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	46	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177099	10.1371/journal.pone.0177099	http://dx.doi.org/10.1371/journal.pone.0177099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481894	gold, Green Submitted, Green Published			2022-12-27	WOS:000401313700033
J	Lee, JY; Lee, MK; Kim, NK; Chu, SH; Lee, DC; Lee, HS; Lee, JW; Jeon, JY				Lee, Jee-Yon; Lee, Mi-Kyung; Kim, Nam-Kyu; Chu, Sang-Hui; Lee, Duk-Chul; Lee, Hye-Sun; Lee, Ji-Won; Jeon, Justin Y.			Serum chemerin levels are independently associated with quality of life in colorectal cancer survivors: A pilot study	PLOS ONE			English	Article							FATIGUE; INFLAMMATION; CELLS; CHEMOATTRACTANT; STATISTICS; ADIPOKINE; SYMPTOMS; BEHAVIOR; LIGAND	Background Colorectal cancer (CRC) survivors are known to experience various symptoms that significantly affect their quality of life (QOL); therefore, it is important to identify clinical markers related with CRC survivor QOL. Here we investigated the relationship between serum chemerin levels, a newly identified proinflammatory adipokine, and QOL in CRC survivors. Methods A data of total of 110 CRC survivors were analysed in the study. Serum chemerin levels were measured with an enzyme immunoassay analyser. Functional Assessment of Cancer Therapy (FACT) scores were used as an indicator of QOL in CRC survivors. Results Weak but not negligible relationships were observed between serum chemerin levels and FACT-General (G) (r = -0.22, p<0.02), FACT-Colorectal cancer (C) (r = -0.23, p<0.02) and FACT-Fatigue (F) scores (r = -0.27, p<0.01) after adjusting for confounding factors. Both stepwise and enter method multiple linear regression analyses confirmed that serum chemerin levels were independently associated with FACT-G (stepwise: beta = -0.15, p<0.01; enter: beta = -0.12, p = 0.02), FACT-C (stepwise: beta = -0.19, p<0.01; enter; beta = -0.14, p = 0.02) and FACT-F scores (stepwise: beta = -0.23, p<0.01; enter: beta = -0.20, p<0.01). Conclusions Our results demonstrate a weak inverse relationship between serum chemerin and CRC survivor QOL. Although it is impossible to determine causality, our findings suggest that serum chemerin levels may have a significant association with CRC survivor QOL. Further prospective studies are required to confirm the clinical significance of our pilot study.	[Lee, Jee-Yon; Lee, Duk-Chul] Yonsei Univ, Coll Med, Dept Family Med, Seoul, South Korea; [Lee, Jee-Yon; Jeon, Justin Y.] CHA Univ, Coll Med, CHA Bundang Med Ctr, Dept Family Med, Seoul, South Korea; [Lee, Mi-Kyung] Yonsei Univ, Dept Sport & Leisure Studies, Sports Med Lab, 250 Seongsan Ro, Seoul, South Korea; [Kim, Nam-Kyu] Yonsei Univ, Dept Gen Surg, Coll Med, Seoul, South Korea; [Chu, Sang-Hui] Yonsei Univ, Coll Nursing, Nursing Policy Res Inst, Biobehav Res Ctr,Dept Clin Nursing Sci, Seoul, South Korea; [Lee, Hye-Sun] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Lee, Ji-Won] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Family Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jeon, JY (corresponding author), CHA Univ, Coll Med, CHA Bundang Med Ctr, Dept Family Med, Seoul, South Korea.; Lee, JW (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Family Med, Seoul, South Korea.	indi5645@yuhs.ac; jjeon@yonsei.ac.kr	; Lee, Hye Sun/J-2154-2015	CHU, Sang Hui/0000-0001-6877-5599; Jeon, Justin/0000-0001-7978-4271; LEE, JI WON/0000-0002-2666-4249; Kim, Nam-Kyu/0000-0003-0639-5632; Lee, Duk Chul/0000-0001-9166-1813; Lee, Hye Sun/0000-0001-6328-6948	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea [NRF-2013M3A9B6046416]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning, Republic of Korea (NRF-2013M3A9B6046416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning, Republic of Korea (NRF-2013M3A9B6046416).	Banas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058709; Berg V, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3215; Bower JE, 2007, BRAIN BEHAV IMMUN, V21, P863, DOI 10.1016/j.bbi.2007.03.013; Bower JE, 2013, J CLIN ONCOL, V31, P1656, DOI 10.1200/JCO.2012.46.2143; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Buechler C, 2014, CELLULAR MOL IMMUNOL; CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570; Dantzer R, 2008, PSYCHONEUROENDOCRINO, V33, P18, DOI 10.1016/j.psyneuen.2007.10.008; Dranse H., 2016, CHEMERIN SIGNALLING; Fung FY, 2013, LEUKEMIA RES, V37, P274, DOI 10.1016/j.leukres.2012.11.013; Garcia E., 2014, TUTORIAL CORRELATION, V6; Gobert AP, 2016, SCI REP-UK, V6, DOI 10.1038/srep39399; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kaneko K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3475; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Kulig P, 2011, J IMMUNOL, V187, P1403, DOI 10.4049/jimmunol.1002352; Lertkhachonsuk AA, 2013, LANCET ONCOL, V14, pE497, DOI 10.1016/S1470-2045(13)70350-4; Yang LY, 2006, WORLD J GASTROENTERO, V12, P6741, DOI 10.3748/wjg.v12.i42.6741; Maheshwari A, 2009, AM J PHYSIOL-GASTR L, V297, pG1, DOI 10.1152/ajpgi.90730.2008; Morant R, 1996, CANCER TREAT REV, V22, P117, DOI 10.1016/S0305-7372(96)90073-0; Mukaka MM, 2012, MALAWI MED J, V24, P69; Pachynski RK, 2012, J EXP MED, V209, P1427, DOI 10.1084/jem.20112124; Phipps E, 2008, J EVAL CLIN PRACT, V14, P254, DOI 10.1111/j.1365-2753.2007.00842.x; Rama D, 2011, CELL IMMUNOL, V271, P134, DOI 10.1016/j.cellimm.2011.06.016; Reyes-Gibby CC, 2008, LANCET ONCOL, V9, P777, DOI 10.1016/S1470-2045(08)70197-9; Rich T, 2005, CLIN CANCER RES, V11, P1757, DOI 10.1158/1078-0432.CCR-04-2000; Rigsbee L, 2012, AM J GASTROENTEROL, V107, P1740, DOI 10.1038/ajg.2012.287; Rourke JL, 2013, OBES REV, V14, P245, DOI 10.1111/obr.12009; Schubert C, 2007, BRAIN BEHAV IMMUN, V21, P413, DOI 10.1016/j.bbi.2006.11.004; Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023; Temple LK, 2005, DIS COLON RECTUM, V48, P1353, DOI 10.1007/s10350-004-0942-z; Vironen JH, 2006, DIS COLON RECTUM, V49, P568, DOI 10.1007/s10350-006-0513-6; Weigert J, 2010, INFLAMM BOWEL DIS, V16, P630, DOI 10.1002/ibd.21091; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176929	10.1371/journal.pone.0176929	http://dx.doi.org/10.1371/journal.pone.0176929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475614	Green Published, gold, Green Submitted			2022-12-27	WOS:000400649500029
J	Martinez, ME; Unkart, JT; Tao, L; Kroenke, CH; Schwab, R; Komenaka, I; Gomez, SL				Martinez, Maria Elena; Unkart, Jonathan T.; Tao, Li; Kroenke, Candyce H.; Schwab, Richard; Komenaka, Ian; Gomez, Scarlett Lin			Prognostic significance of marital status in breast cancer survival: A population-based study	PLOS ONE			English	Article							DIURNAL CORTISOL RHYTHM; SOCIAL SUPPORT; IMMIGRANT STATUS; BIRTHPLACE DATA; YOUNG-WOMEN; ASIAN WOMEN; ETHNICITY; QUALITY; CALIFORNIA; MORTALITY	Research shows that married cancer patients have lower mortality than unmarried patients but few data exist for breast cancer. We assessed total mortality associated with marital status, with attention to differences by race/ethnicity, tumor subtype, and neighborhood socioeconomic status (nSES). We included, from the population-based California Cancer Registry, women ages 18 and older with invasive breast cancer diagnosed between 2005 and 2012 with follow-up through December 2013. We estimated mortality rate ratios (MRR) and 95% confidence intervals (CI) for total mortality by nSES, race/ethnicity, and tumor subtype. Among 145,564 breast cancer cases, 42.7% were unmarried at the time of diagnosis. In multivariable-adjusted models, the MRR (95% CI) for unmarried compared to married women was 1.28 (1.24-1.32) for total mortality. Significant interactions were observed by race/ethnicity (P<0.001), tumor subtype (P<0.001), and nSES (P = 0.009). Higher MRRs were observed for non-Hispanic whites and Asians/Pacific Islanders than for blacks or Hispanics, and for HR+/HER2+ tumors than other subtypes. Assessment of interactive effect between marital status and nSES showed that unmarried women living in low SES neighborhoods had a higher risk of dying compared with married women in high SES neighborhoods (MRR = 1.60; 95% CI: 1.53-1.67). Unmarried breast cancer patients have higher total mortality than married patients; the association varies by race/ethnicity, tumor subtype, and nSES. Unmarried status should be further evaluated as a breast cancer prognostic factor. Identification of underlying causes of the marital status associations is needed to design interventions that could improve survival for unmarried breast cancer patients.	[Martinez, Maria Elena; Unkart, Jonathan T.; Schwab, Richard] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA; [Martinez, Maria Elena] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Unkart, Jonathan T.] Univ Calif San Diego, Dept Surg, San Diego, CA USA; [Tao, Li; Gomez, Scarlett Lin] Canc Prevent Inst Calif, Fremont, CA USA; [Kroenke, Candyce H.] Kaiser Permanente, Div Res, Oakland, CA USA; [Komenaka, Ian] Maricopa Cty Gen Hosp, Dept Surg, Phoenix, AZ USA; [Gomez, Scarlett Lin] Stanford Canc Inst, Palo Alto, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Cancer Prevention Institute of California; Kaiser Permanente; Maricopa County General Hospital; Stanford Cancer Institute	Martinez, ME (corresponding author), Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA.; Martinez, ME (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA.	e8martinez@ucsd.edu	Unkart, Jonathan/AAC-6098-2020; Komenaka, Ian/ABC-5161-2021; Schwab, Richard/AAX-9262-2020	Martinez, Maria Elena/0000-0002-6728-1834; Unkart, Jonathan/0000-0001-9041-5119	Specialized Cancer Center [CA023100-29]; Stanford Cancer Institute; California Department of Public Health [103885]; National Cancer Institute's Surveillance, Epidemiology and End Results Program [HHSN261201000140C]; Centers for Disease Control and Prevention's National Program of Cancer Registries [U58DP003862-01];  [HHSN261201000035C];  [HHSN261201000034C]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP003862] Funding Source: NIH RePORTER	Specialized Cancer Center; Stanford Cancer Institute; California Department of Public Health; National Cancer Institute's Surveillance, Epidemiology and End Results Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention's National Program of Cancer Registries(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); ; ; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Specialized Cancer Center Support Grant to the University of California San Diego Moores Cancer Center (CA023100-29) and the Stanford Cancer Institute. The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries, under agreement U58DP003862-01 awarded to the California Department of Public Health. The ideas and opinions expressed here in are those of the author (s) and endorsement by the State of California, Department of Public Health the National Cancer Institute, and the Centers for Disease Control and Prevention or their Contractors and Subcontractors is not intended nor should be inferred.; The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries, under agreement U58DP003862-01 awarded to the California Department of Public Health. The ideas and opinions expressed herein are those of the author (s) and endorsement by the State of California, Department of Public Health the National Cancer Institute and the Centers for Disease Control and Prevention or their Contractors and Subcontractors is not intended nor should be inferred.	Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Ali AA, 2014, AM J MANAG CARE, V20, P502; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bernstein L, 2011, JNCI-J NATL CANCER I, V103, P451, DOI 10.1093/jnci/djr046; Bhuyan SS, 2014, BREAST CANCER RES TR, V146, P221, DOI 10.1007/s10549-014-2992-9; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen DN, 2015, ONCOTARGET, V6, P12774, DOI 10.18632/oncotarget.3666; Chou AF, 2012, PSYCHO-ONCOLOGY, V21, P125, DOI 10.1002/pon.1863; Clegg LX, 2007, CANCER CAUSE CONTROL, V18, P177, DOI 10.1007/s10552-006-0089-4; Cluze C, 2012, ANN ONCOL, V23, P882, DOI 10.1093/annonc/mdr330; Elmore L, 2015, J SURG RES, V199, P90, DOI 10.1016/j.jss.2015.04.012; Epplein M, 2011, J CLIN ONCOL, V29, P406, DOI 10.1200/JCO.2010.30.6951; Gomez SL, 2006, CANCER CAUSE CONTROL, V17, P771, DOI 10.1007/s10552-006-0013-y; Gomez SL, 2016, CANCER-AM CANCER SOC, V122, P1618, DOI 10.1002/cncr.29885; Gomez SL, 2010, AM J PUBLIC HEALTH, V100, P861, DOI 10.2105/AJPH.2009.176651; Gomez SL, 2010, AM J PUBLIC HEALTH, V100, pS125, DOI 10.2105/AJPH.2009.163931; Gomez SL, 2005, CANCER CAUSE CONTROL, V16, P713, DOI 10.1007/s10552-005-0694-7; Gomez SL, 2004, ETHNIC DIS, V14, P292; Gomez SL, 2004, CANCER CAUSE CONTROL, V15, P243, DOI 10.1023/B:CACO.0000024244.91775.64; Gomez SL, 2003, AM J PUBLIC HEALTH, V93, P1685, DOI 10.2105/AJPH.93.10.1685; GOODWIN JS, 1987, JAMA-J AM MED ASSOC, V258, P3125, DOI 10.1001/jama.258.21.3125; Hawley ST, 2009, JNCI-J NATL CANCER I, V101, P1337, DOI 10.1093/jnci/djp271; Hinzey A, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0700-x; Keegan THM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-603; Keegan THM, 2010, CANCER EPIDEM BIOMAR, V19, P1208, DOI 10.1158/1055-9965.EPI-10-0021; Kravdal O, 2001, SOC SCI MED, V52, P357, DOI 10.1016/S0277-9536(00)00139-8; Kroenke CH, 2013, BREAST CANCER RES TR, V139, P515, DOI 10.1007/s10549-013-2477-2; Kroenke CH, 2013, BREAST CANCER RES TR, V137, P261, DOI 10.1007/s10549-012-2253-8; Kroenke CH, 2006, J CLIN ONCOL, V24, P1105, DOI 10.1200/JCO.2005.04.2846; Kroenke CH, 2016, PSYCHOONCOLOGY; Lai H, 1999, INT J BEHAV MED, V6, P150, DOI 10.1207/s15327558ijbm0602_4; Lutgendorf SK, 2011, PSYCHOSOM MED, V73, P724, DOI 10.1097/PSY.0b013e318235be76; Manzoli L, 2007, SOC SCI MED, V64, P77, DOI 10.1016/j.socscimed.2006.08.031; Martinez ME, 2016, CANCER-AM CANCER SOC, V122, P1570, DOI 10.1002/cncr.29886; Osborne C, 2005, BREAST CANCER RES TR, V93, P41, DOI 10.1007/s10549-005-3702-4; Parikh DA, 2015, INT J BREAST CANCER, V2015, DOI 10.1155/2015/835074; Patel K, 2014, J COMMUN HEALTH, V39, P943, DOI 10.1007/s10900-014-9834-x; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinquart M, 2010, CRIT REV ONCOL HEMAT, V75, P122, DOI 10.1016/j.critrevonc.2009.06.003; Rendall MS, 2011, DEMOGRAPHY, V48, P481, DOI 10.1007/s13524-011-0032-5; Ro A, 2015, SOC SCI MED, V144, P39, DOI 10.1016/j.socscimed.2015.09.001; Sephton SE, 2013, BRAIN BEHAV IMMUN, V30, pS163, DOI 10.1016/j.bbi.2012.07.019; Sephton SE, 2000, J NATL CANCER I, V92, P994, DOI 10.1093/jnci/92.12.994; Shelton RC, 2013, BREAST CANCER RES TR, V137, P817, DOI 10.1007/s10549-012-2370-4; Thompson AS, 2016, J MULTILING MULTICUL, V37, P115, DOI 10.1080/01434632.2015.1031136; U. S. Census Bureau, 2016, FAM LIV ARR; Waite LJ, 2003, POPUL DEV REV, V29, P255, DOI 10.1111/j.1728-4457.2003.00255.x; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yang J., 2014, DEV AREA BASED SOCIO; Yost K, 2001, CANCER CAUSE CONTROL, V12, P703, DOI 10.1023/A:1011240019516	50	47	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0175515	10.1371/journal.pone.0175515	http://dx.doi.org/10.1371/journal.pone.0175515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475579	Green Published, gold, Green Submitted			2022-12-27	WOS:000400649500003
J	Abdai, J; Terencio, CB; Miklosi, A				Abdai, Judit; Terencio, Cristina Bano; Miklosi, Adam			Novel approach to study the perception of animacy in dogs	PLOS ONE			English	Article							MOTION; CAUSALITY	Humans tend to perceive inanimate objects as animate based on simple motion cues. So far this perceptual bias has been studied mostly in humans by utilizing two-dimensional video and interactive displays. Considering its importance for survival, the perception of animacy is probably also widespread among animals, however two-dimensional displays are not necessarily the best approach to study the phenomenon in non-human species. Here we applied a novel method to study whether dogs recognize a dependent ( chasing-like) movement pattern performed by inanimate agents in live demonstration. We found that dogs showed more interest toward the agents that demonstrated the chasing-like motion, compared to those that were involved in the independent movement. We suggest that dogs spontaneously recognized the chasing-like pattern and thus they may have considered the interacting partners as animate agents. This methodological approach may be useful to test perceptual animacy in other non-human species.	[Abdai, Judit; Terencio, Cristina Bano; Miklosi, Adam] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Terencio, Cristina Bano] Univ Valencia, Valencia, Spain; [Miklosi, Adam] MTA ELTE Comparat Ethol Res Grp, Budapest, Hungary	Eotvos Lorand University; University of Valencia; MTA-ELTE Comparative Ethology Research Group	Abdai, J (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.	abdai.judit@gmail.com	Abdai, Judit/S-6287-2019	Abdai, Judit/0000-0003-1219-2858	Hungarian Academy of Sciences (Comparative Ethology Research Group) [MTA 01 031]	Hungarian Academy of Sciences (Comparative Ethology Research Group)	This research was supported by the Hungarian Academy of Sciences (Comparative Ethology Research Group, MTA 01 031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdai J, 2015, PLOS ONE, V10; Gergely A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072727; Atsumi T, 2015, ANIM COGN, V18, P1243, DOI 10.1007/s10071-015-0893-x; BASSILI JN, 1976, J PERS SOC PSYCHOL, V33, P680; Blakemore SJ, 2003, CEREB CORTEX, V13, P837, DOI 10.1093/cercor/13.8.837; Di Giorgio E., 2016, BEHAV BRAIN RES; Frankenhuis WE, 2013, COGNITION, V126, P224, DOI 10.1016/j.cognition.2012.10.001; Gao T, 2011, J EXP PSYCHOL HUMAN, V37, P669, DOI 10.1037/a0020735; Gao T, 2010, PSYCHOL SCI, V21, P1845, DOI 10.1177/0956797610388814; Gao T, 2009, COGNITIVE PSYCHOL, V59, P154, DOI 10.1016/j.cogpsych.2009.03.001; Goto K, 2002, ANIM COGN, V5, P119, DOI 10.1007/s10071-002-0139-6; Hauser MD, 1998, DEVELOPMENTAL SCI, V1, P31, DOI 10.1111/1467-7687.00009; Heberlein AS, 2004, P NATL ACAD SCI USA, V101, P7487, DOI 10.1073/pnas.0308220101; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Lunghi M, 2016, DEV SCI; Luo YY, 2009, COGNITIVE PSYCHOL, V58, P441, DOI 10.1016/j.cogpsych.2008.11.001; Mascalzoni E, 2010, P NATL ACAD SCI USA, V107, P4483, DOI 10.1073/pnas.0908792107; Meyerhoff HS, 2014, J EXP PSYCHOL HUMAN, V40, P702, DOI 10.1037/a0034846; Meyerhoff HS, 2013, J EXP PSYCHOL HUMAN, V39, P1003, DOI 10.1037/a0030839; Rochat P, 2004, PERCEPTION, V33, P355, DOI 10.1068/p3389; Rochat P., 1997, COGNIT DEV, V12, P537, DOI [10.1016/s0885-2014(97)90022-8, DOI 10.1016/S0885-2014(97)90022-8]; Rosa-Salva O, 2016, COGNITION, V157, P49, DOI 10.1016/j.cognition.2016.08.014; Scholl BJ, 2000, TRENDS COGN SCI, V4, P299, DOI 10.1016/S1364-6613(00)01506-0; Scholl BJ, 2013, SOCIAL PERCEPTION: DETECTION AND INTERPRETATION OF ANIMACY, AGENCY, AND INTENTION, P197; Tremoulet PD, 2006, PERCEPT PSYCHOPHYS, V68, P1047, DOI 10.3758/BF03193364; Tremoulet PD, 2000, PERCEPTION, V29, P943, DOI 10.1068/p3101; Tsutsumi S, 2012, PRIMATES, V53, P113, DOI 10.1007/s10329-011-0289-8; van Buren B, 2016, PSYCHON B REV, V23, P797, DOI 10.3758/s13423-015-0966-5	28	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177010	10.1371/journal.pone.0177010	http://dx.doi.org/10.1371/journal.pone.0177010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472117	Green Submitted, gold, Green Published			2022-12-27	WOS:000400648500115
J	Rosa, M; Roberts, CJ; Rodrigues, MA				Rosa, Monica; Roberts, Christopher J.; Rodrigues, Miguel A.			Connecting high-temperature and low-temperature protein stability and aggregation	PLOS ONE			English	Article							NUCLEATED-POLYMERIZATION MODEL; LUMRY-EYRING MODELS; COLD DENATURATION; ALPHA-CHYMOTRYPSINOGEN; NONNATIVE AGGREGATION; ACTIVATION-ENERGIES; COMPETING GROWTH; SHELF-LIFE; KINETICS; MECHANISMS	Protein aggregation is a long-standing problem for preservation of proteins in both laboratory settings and for commercial biotechnology products. It is well established that heating (cooling) can accelerate (slow) aggregation by populating (depopulating) unfolded or partially unfolded monomer states that are key intermediates in aggregation processes. However, there is a long-standing question of whether the same mechanism(s) that lead to aggregation under high-temperature stress are relevant for low-temperature stress such as in refrigerated or supercooled liquids. This report shows the first direct comparison of "hot" and "cold" aggregation kinetics and folding/unfolding thermodynamics, using bovine hemoglobin as a model system. The results suggest that the same mechanism for non-native aggregation holds from "hot" to "cold" temperatures, with an aggregation temperature-of-maximum-stability slightly below 0 degrees C. This highlights that sub-zero temperatures can induce cold-mediated aggregation, even in the absence of freezing stresses. From a practical perspective, the results suggests the possibility that cold-stress may be a useful alternative to heat-stress for extrapolating predictions of protein shelf life at refrigerated conditions, as well as providing a foundation for more mechanistic studies of cold-stress conditions in future work. A comparison between isochoric and isobaric methods is also briefly discussed.	[Rosa, Monica; Rodrigues, Miguel A.] Univ Lisbon, Ctr Quim Estrutural, Inst Super Tecn, Dept Chem Engn, Lisbon, Portugal; [Roberts, Christopher J.] Univ Delaware, Dept Chem & Biomol Engn, Newark, DE USA	Universidade de Lisboa; Instituto Superior Tecnico; University of Delaware	Rodrigues, MA (corresponding author), Univ Lisbon, Ctr Quim Estrutural, Inst Super Tecn, Dept Chem Engn, Lisbon, Portugal.	miguelrodrigues@tecnico.ulisboa.pt	Rodrigues, Miguel/H-9329-2012	Rodrigues, Miguel/0000-0001-9841-441X	Fundacao para a Ciencia e Tecnologia (Portugal) [PTDC/EQU-EQU/104318/2008, PTDC/QUI-BIQ/119677/2010, SFRH/BD/79046/2011, IF/01183/2013]; National Science Foundation [NSF-CBET1264329]; National Institute of Standards and Technology [NIST 70NANB12H239]; National Institutes of Health [R01 EB006006]	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); National Science Foundation(National Science Foundation (NSF)); National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Fundacao para a Ciencia e Tecnologia (Portugal) PTDC/EQU-EQU/104318/2008, PTDC/QUI-BIQ/119677/2010, SFRH/BD/79046/2011 and IF/01183/2013. CJR gratefully acknowledges support from the National Science Foundation (NSF-CBET1264329), National Institute of Standards and Technology (NIST 70NANB12H239), and National Institutes of Health (R01 EB006006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JM, 2008, BIOCHEMISTRY-US, V47, P2397, DOI 10.1021/bi7019244; Andrews JM, 2007, J PHYS CHEM B, V111, P7897, DOI 10.1021/jp070212j; Andrews JM, 2007, BIOCHEMISTRY-US, V46, P7558, DOI 10.1021/bi700296f; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; Bhatnagar BS, 2007, PHARM DEV TECHNOL, V12, P505, DOI 10.1080/10837450701481157; Brummitt RK, 2011, J PHARM SCI-US, V100, P2104, DOI 10.1002/jps.22447; CLELAND JL, 1993, CRIT REV THER DRUG, V10, P307; Debenedetti P.G., 1996, METASTABLE LIQUIDS C; Drenski MF, 2013, ANAL BIOCHEM, V437, P185, DOI 10.1016/j.ab.2013.02.014; Englander SW, 2014, P NATL ACAD SCI USA, V111, P15873, DOI 10.1073/pnas.1411798111; Franks F, 2003, BIOPHYS CHEM, V105, P251, DOI 10.1016/S0301-4622(03)00074-7; Hummer G, 1998, P NATL ACAD SCI USA, V95, P1552, DOI 10.1073/pnas.95.4.1552; Kayser V, 2011, J PHARM SCI-US, V100, P2526, DOI 10.1002/jps.22493; Lazar KL, 2010, MABS-AUSTIN, V2, P42, DOI 10.4161/mabs.2.1.10787; Lefebvre BG, 2003, BIOTECHNOL BIOENG, V82, P595, DOI 10.1002/bit.10607; Li Y, 2010, J PHARM SCI-US, V99, P645, DOI 10.1002/jps.21869; Li Y, 2009, J PHYS CHEM B, V113, P7020, DOI 10.1021/jp8083088; Pastore A, 2007, J AM CHEM SOC, V129, P5374, DOI 10.1021/ja0714538; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Roberts CJ, 2014, TRENDS BIOTECHNOL, V32, P372, DOI 10.1016/j.tibtech.2014.05.005; Roberts CJ, 2011, INT J PHARMACEUT, V418, P318, DOI 10.1016/j.ijpharm.2011.03.064; Roberts CJ, 2003, J PHARM SCI-US, V92, P1095, DOI 10.1002/jps.10377; Roberts CJ, 2003, J PHYS CHEM B, V107, P1194, DOI 10.1021/jp026827s; Rosa M, 2013, J PHYS CHEM B, V117, P8939, DOI 10.1021/jp4035369; Saluja A, 2014, PHARM RES; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; Seefeldt MB, 2004, PROTEIN SCI, V13, P2639, DOI 10.1110/ps.04891204; Szyperski T, 2006, EUR BIOPHYS J BIOPHY, V35, P363, DOI 10.1007/s00249-005-0028-4; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Wang W, 2013, AAPS J, V15, P840, DOI 10.1208/s12248-013-9485-3	31	31	32	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176748	10.1371/journal.pone.0176748	http://dx.doi.org/10.1371/journal.pone.0176748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472066	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500067
J	Ji, F; Mokoena, MP; Zhao, HY; Olaniran, AO; Shi, JR				Ji, Fang; Mokoena, Mduduzi P.; Zhao, Hongyan; Olaniran, Ademola O.; Shi, Jianrong			Development of an immunochromatographic strip test for the rapid detection of zearalenone in wheat from Jiangsu province, China	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; TANDEM MASS-SPECTROMETRY; MONOCLONAL-ANTIBODY; FOOD SAMPLES; AFLATOXIN B-1; OCHRATOXIN-A; T-2 TOXIN; DEOXYNIVALENOL; MYCOTOXINS; IMMUNOASSAY	A colloidal gold (ICS) test was developed for rapid detection of zearalenone (ZEN) in wheat samples. The mAb against ZEN was prepared in our laboratory and labelled with colloidal gold as a probe for the ICS test. The conditions were optimized and 30 nm colloidal gold nanoparticles were chosen for optimal performance. Millipore 135 was chosen as the NC membrane for its level of sensitivity. The optimum amount of coated antigen ZEN-OVA and anti-ZEN mAb was 0.5 mg/mL and 8 mu g/mL, respectively. The ICS test, which has a detection limit of 15 ng/mL for ZEN, could be completed in 5 min. Analysis of ZEN in 202 wheat samples over three consecutive years revealed that data obtained from the ICS test were in a good agreement with LC-MS/MS data. This result demonstrated that the ICS test could be used as a qualitative tool to screen on-site for ZEN.	[Ji, Fang; Zhao, Hongyan; Shi, Jianrong] Jiangsu Acad Agr Sci, Key Lab Control Technol & Standard Agroprod Safet, Key Lab Agroprod Safety Risk Evaluat Nanjing, Minist Agr,Inst Food Qual & Safety,Key Lab Food Q, Nanjing, Jiangsu, Peoples R China; [Ji, Fang; Mokoena, Mduduzi P.; Olaniran, Ademola O.] Univ KwaZulu Natal, Discipline Microbiol, Sch Life Sci, Westville Campus,Private Bag X54001, Durban, South Africa; [Ji, Fang; Shi, Jianrong] Collaborat Innovat Ctr Modern Grain Circulat & Sa, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; University of Kwazulu Natal	Shi, JR (corresponding author), Jiangsu Acad Agr Sci, Key Lab Control Technol & Standard Agroprod Safet, Key Lab Agroprod Safety Risk Evaluat Nanjing, Minist Agr,Inst Food Qual & Safety,Key Lab Food Q, Nanjing, Jiangsu, Peoples R China.; Shi, JR (corresponding author), Collaborat Innovat Ctr Modern Grain Circulat & Sa, Nanjing, Jiangsu, Peoples R China.	jianrong63@126.com	Shi, Jianrong/AAQ-1805-2020; Olaniran, Ademola Olufolahan/AAU-6836-2021; Shi, Jianrong/AAQ-3456-2020	Shi, Jianrong/0000-0003-3818-5074; Mokoena, Mduduzi/0000-0003-4620-0502; shi, jianrong/0000-0001-8650-248X	Special Fund for Agro-scientific Research in the Public Interest [201303088]; Natural Science Foundation of China [31271988]; Science and Technology Planning Project of Jiangsu Province [BE2014738]; Special Fund for Risk Assessment of China [GJFP201500702]; Jiangsu Agriculture Science and Technology [CX(14)2126]	Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Jiangsu Province; Special Fund for Risk Assessment of China; Jiangsu Agriculture Science and Technology	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (201303088), Natural Science Foundation of China (31271988), Science and Technology Planning Project of Jiangsu Province (BE2014738), Special Fund for Risk Assessment of China (GJFP201500702), Jiangsu Agriculture Science and Technology CX(14)2126.	Brenn-Struckhofova Z, 2007, ANAL CHEM, V79, P710, DOI 10.1021/ac061672w; Bucheli TD, 2008, J AGR FOOD CHEM, V56, P1029, DOI 10.1021/jf073082k; Cho YJ, 2005, J AGR FOOD CHEM, V53, P8447, DOI 10.1021/jf051681q; Cui L, 2013, FOOD CONTROL, V30, P469, DOI 10.1016/j.foodcont.2012.08.011; Delmulle BS, 2005, J AGR FOOD CHEM, V53, P3364, DOI 10.1021/jf0404804; GB/T, 2011, CHIN NCO MAX LEV MYC; Guo YC, 2010, ANAL CHEM, V82, P7550, DOI 10.1021/ac101020y; Huang ZB, 2012, FOOD CONTROL, V28, P7, DOI 10.1016/j.foodcont.2012.04.035; IARC, 1993, WHO IARC MONOGRAPHS, Va, P56; Ji F, 2014, FOOD CHEM, V157, P393, DOI 10.1016/j.foodchem.2014.02.058; Kharbikar LL, 2015, FOOD ADDIT CONTAM A, V32, P2075, DOI 10.1080/19440049.2015.1084652; KIESSLING KH, 1978, ACTA PHARMACOL TOX, V43, P285; Klotzel M, 2005, J AGR FOOD CHEM, V53, P8904, DOI 10.1021/jf051501c; Li PW, 2013, MASS SPECTROM REV, V32, P420, DOI 10.1002/mas.21377; Liu BH, 2008, ANAL CHEM, V80, P7029, DOI 10.1021/ac800951p; Liu J, 2012, FOOD CONTROL, V26, P88, DOI 10.1016/j.foodcont.2012.01.005; Minervini F, 2005, TOXICOLOGY, V210, P81, DOI 10.1016/j.tox.2005.01.007; Molinelli A, 2008, J AGR FOOD CHEM, V56, P2589, DOI 10.1021/jf800393j; Paek SH, 2000, METHODS, V22, P53, DOI 10.1006/meth.2000.1036; PALYUSIK M, 1980, ACTA VET ACAD SCI H, V28, P159; Romanazzo D, 2010, BIOSENS BIOELECTRON, V25, P2615, DOI 10.1016/j.bios.2010.04.029; Shephard GS, 2008, CHEM SOC REV, V37, P2468, DOI 10.1039/b713084h; Shim WB, 2006, J AGR FOOD CHEM, V54, P9728, DOI 10.1021/jf0620057; Shim WB, 2009, J AGR FOOD CHEM, V57, P4035, DOI 10.1021/jf900075h; Soleimany F, 2012, FOOD CHEM, V130, P1055, DOI 10.1016/j.foodchem.2011.07.131; Spanjer MC, 2008, FOOD ADDIT CONTAM A, V25, P472, DOI 10.1080/02652030701552964; Sulyok M, 2007, ANAL BIOANAL CHEM, V389, P1505, DOI 10.1007/s00216-007-1542-2; Sulyok M, 2006, RAPID COMMUN MASS SP, V20, P2649, DOI 10.1002/rcm.2640; Wang S, 2006, J AGR FOOD CHEM, V54, P2491, DOI 10.1021/jf0530401; Wang YK, 2013, FOOD CONTROL, V31, P180, DOI 10.1016/j.foodcont.2012.09.048; Xu Y, 2010, FOOD CHEM, V119, P834, DOI 10.1016/j.foodchem.2009.08.049; Zhang ZW, 2014, FOOD CHEM, V146, P314, DOI 10.1016/j.foodchem.2013.09.048; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.030	33	11	12	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0175282	10.1371/journal.pone.0175282	http://dx.doi.org/10.1371/journal.pone.0175282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489899	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100005
J	Meyer, L; Causse, R; Pernin, F; Scalone, R; Bailly, G; Chauvel, B; Delye, C; Le Corre, V				Meyer, Lucie; Causse, Romain; Pernin, Fanny; Scalone, Romain; Bailly, Geraldine; Chauvel, Bruno; Delye, Christophe; Le Corre, Valerie			New gSSR and EST-SSR markers reveal high genetic diversity in the invasive plant Ambrosia artemisiifolia L. and can be transferred to other invasive Ambrosia species	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; COMMON RAGWEED; POPULATION-STRUCTURE; CLIMATE-CHANGE; NULL ALLELES; R-PACKAGE; ASTERACEAE; LOCI; EUROPE; TESTS	Ambrosia artemisiifolia L., (common ragweed), is an annual invasive and highly troublesome plant species originating from North America that has become widespread across Europe. New sets of genomic and expressed sequence tag (EST) based simple sequence repeats (SSRs) markers were developed in this species using three approaches. After validation, 13 genomic SSRs and 13 EST-SSRs were retained and used to characterize the genetic diversity and population genetic structure of Ambrosia artemisiifolia populations from the native (North America) and invasive (Europe) ranges of the species. Analysing the mating system based on maternal families did not reveal any departure from complete allogamy and excess homozygosity was mostly due the presence of null alleles. High genetic diversity and patterns of genetic structure in Europe suggest two main introduction events followed by secondary colonization events. Cross-species transferability of the newly developed markers to other invasive species of the Ambrosia genus was assessed. Sixty-five percent and 75% of markers, respectively, were transferable from A. artemisiifolia to Ambrosia psilostachya and Ambrosia tenuifolia. 40% were transferable to Ambrosia trifida, this latter species being seemingly more phylogenetically distantly related to A. artemisiifolia than the former two.	[Meyer, Lucie; Causse, Romain; Pernin, Fanny; Chauvel, Bruno; Delye, Christophe; Le Corre, Valerie] Univ Bourgogne Franche Comte, INRA, AgroSup Dijon, Agroecol, Dijon, France; [Bailly, Geraldine] BASF France SAS, Sustainable Agr Dept, Ecully, France; [Scalone, Romain] Swedish Univ Agr Sci, Dept Crop Prod Ecol, Uppsala, Sweden	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; BASF; Swedish University of Agricultural Sciences	Le Corre, V (corresponding author), Univ Bourgogne Franche Comte, INRA, AgroSup Dijon, Agroecol, Dijon, France.	valerie.le-corre@dijon.inra.fr		Le Corre, Valerie/0000-0001-6515-7795	BASF France SAS; EU COST Action FM203; Carl Trygger Foundation for Scientific Research (CTS); Short Term Scientific Mission [COST-STSM-FA1203-21009, CTS 14.425]	BASF France SAS(BASF); EU COST Action FM203; Carl Trygger Foundation for Scientific Research (CTS); Short Term Scientific Mission	This work was funded by BASF France SAS. BASF France SAS provided support in the form of a research grant and of salaries for LM and GB. We also acknowledge support from EU COST Action FM203 "Sustainable management of Ambrosia artemisiifolia in Europe (SMARTER)" and from the Carl Trygger Foundation for Scientific Research (CTS). Part of the work was achieved thanks to the Short Term Scientific Mission COST-STSM-FA1203-21009 and the grant CTS 14.425 attributed to RS. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors supported by funders are articulated in the 'author contributions' section.	Abercrombie LG, 2009, MOL ECOL RESOUR, V9, P1375, DOI 10.1111/j.1755-0998.2009.02746.x; Alberto F, 2009, J HERED, V100, P394, DOI 10.1093/jhered/esn110; Baltisberger M, 2016, WILLDENOWIA, V46, P121, DOI 10.3372/wi.46.46110; BASSETT IJ, 1982, CAN J PLANT SCI, V62, P1003, DOI 10.4141/cjps82-148; BASSETT IJ, 1975, CAN J PLANT SCI, V55, P463, DOI 10.4141/cjps75-072; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; Chapman DS, 2016, GLOBAL CHANGE BIOL, V22, P3067, DOI 10.1111/gcb.13220; Chauvel B, 2006, J BIOGEOGR, V33, P665, DOI 10.1111/j.1365-2699.2005.01401.x; Chun YJ, 2010, NEW PHYTOL, V185, P1100, DOI 10.1111/j.1469-8137.2009.03129.x; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Ciappetta S, 2016, FLORA, V223, P106, DOI 10.1016/j.flora.2016.05.002; Cornuet JM, 1996, GENETICS, V144, P2001; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; DeFaveri J, 2013, MOL ECOL RESOUR, V13, P377, DOI 10.1111/1755-0998.12071; Delye C, 2002, PEST MANAG SCI, V58, P474, DOI 10.1002/ps.485; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Essl F, 2015, J ECOL, V103, P1069, DOI 10.1111/1365-2745.12424; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Falush D, 2003, GENETICS, V164, P1567; Falush D, PREPRINT; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Follak S, 2013, PRESLIA, V85, P41; Gaggiotti OE, 2010, MOL ECOL RESOUR, V10, P821, DOI 10.1111/j.1755-0998.2010.02873.x; Gaudeul M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017658; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Genton BJ, 2005, MOL ECOL NOTES, V5, P381, DOI 10.1111/j.1471-8286.2005.00934.x; Gladieux P, 2011, BIOL INVASIONS, V13, P933, DOI 10.1007/s10530-010-9880-y; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Haasl RJ, 2011, HEREDITY, V106, P158, DOI 10.1038/hdy.2010.21; Hodel RDGJ, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1600025; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; INSAUSTI P, 1995, OECOLOGIA, V103, P127, DOI 10.1007/BF00328433; Insausti P, 2006, AUSTRAL ECOL, V31, P828, DOI 10.1111/j.1442-9993.2006.01641.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kocis Tubic N, 2014, GENETIKA-BELGRADE, V46, P255, DOI 10.2298/GENSR1401255K; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Li XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031935; Lotterhos KE, 2014, MOL ECOL, V23, P2178, DOI 10.1111/mec.12725; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Malausa T, 2011, MOL ECOL RESOUR, V11, P638, DOI 10.1111/j.1755-0998.2011.02992.x; Martin MD, 2014, MOL ECOL, V23, P1701, DOI 10.1111/mec.12675; Meglecz E, 2014, MOL ECOL RESOUR, V14, P1302, DOI 10.1111/1755-0998.12271; MIAO B, 1995, PLANT SYST EVOL, V194, P241, DOI 10.1007/BF00982858; MULLIGAN GERALD A., 1957, CANADIAN JOUR BOT, V35, P779, DOI 10.1139/b57-064; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; Ortmans W, 2016, FLORA, V220, P134, DOI 10.1016/j.flora.2016.03.003; PAYNE WILLARD W., 1964, J ARNOLD ARBORETUM HARVARD UNIV, V45, P401; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Postolache D, 2014, PLANT MOL BIOL REP, V32, P750, DOI 10.1007/s11105-013-0688-7; Pritchard JK, 2000, GENETICS, V155, P945; Putman AI, 2014, ECOL EVOL, V4, P4399, DOI 10.1002/ece3.1305; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Rodriguez A., 2015, J BOT SOC BOT FRANCE, V71, P25; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Smith M, 2013, ENVIRON INT, V61, P115, DOI 10.1016/j.envint.2013.08.005; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WAGNER W. H., 1958, RHODORA, V60, P177; Ziska LH, 2003, J ALLERGY CLIN IMMUN, V111, P290, DOI 10.1067/mai.2003.53	63	15	18	4	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176197	10.1371/journal.pone.0176197	http://dx.doi.org/10.1371/journal.pone.0176197			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489870	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100018
J	Shrestha, SK; Cochran, A; Mengistu, A; Lamour, K; Castro-Rocha, A; Young-Kelly, H				Shrestha, Sandesh Kumar; Cochran, Alicia; Mengistu, Alemu; Lamour, Kurt; Castro-Rocha, Arturo; Young-Kelly, Heather			Genetic diversity, QoI fungicide resistance, and mating type distribution of Cercospora sojina-Implications for the disease dynamics of frogeye leaf spot on soybean	PLOS ONE			English	Article							POPULATIONS; YIELD; RACE	Frogeye leaf spot (FLS), caused by Cercospora sojina, causes significant damage to soybean in the U.S. One control strategy is the use of quinone outside inhibitor (QoI) fungicides. QoI resistant isolates were first reported in Tennessee (TN) in 2010. To investigate the disease dynamics of C. sojina, we collected 437 C. sojina isolates in 2015 from Jackson and Milan, TN and used 40 historical isolates collected from 2006-2009 from TN and ten additional states for comparison. A subset of 186 isolates, including historical isolates, were genotyped for 49 single nucleotide polymorphism (SNP) markers and the QoI resistance locus, revealing 35 unique genotypes. The genotypes clustered into three groups with two groups containing only sensitive isolates and the remaining group containing all resistant isolates and a dominant clonal lineage of 130 isolates. All 477 C. sojina isolates were genotyped for the QoI locus revealing 344 resistant and 133 sensitive isolates. All isolates collected prior to 2015 were QoI sensitive. Both mating type alleles (MAT1-1-1 and MAT1-2) were found in Jackson and Milan, TN and recovered from single lesions suggesting sexual recombination may play a role in the epidemiology of field populations. Analysis of C. sojina isolates using SNP markers proved useful to investigate population diversity and to elaborate on diversity as it relates to QoI resistance and mating type.	[Shrestha, Sandesh Kumar; Lamour, Kurt] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Cochran, Alicia; Young-Kelly, Heather] Univ Tennessee, Dept Entomol & Plant Pathol, Jackson, TN USA; [Mengistu, Alemu] ARS, USDA, Jackson, TN USA; [Castro-Rocha, Arturo] Univ Autonoma Cd Juarez, Dept Ciencias Quim Biol, Chihuahua, Mexico	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; United States Department of Agriculture (USDA); Universidad Autonoma de Ciudad Juarez	Young-Kelly, H (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Jackson, TN USA.	youngkelly@utk.edu		Lamour, Kurt/0000-0001-6407-8825				ATHOW K, 1952, PHYTOPATHOLOGY, V42, P660; ATHOW KL, 1962, PHYTOPATHOLOGY, V52, P712; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bradley CA, 2012, CAN J PLANT PATHOL, V34, P410, DOI 10.1080/07060661.2012.711775; Cruz C, 2009, PLANT HLTH PROGR, V10; DASHIELL KE, 1991, CROP PROT, V10, P465, DOI 10.1016/S0261-2194(91)80134-2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Grau CR, 2004, FUNGAL DIS SOYBEANS, P679; Groenewald M, 2008, PLANT PATHOL, V57, P25, DOI 10.1111/j.1365-3059.2007.01697.x; Hartwig E, 1990, UNIFORM SOYBEAN TEST; Kim H, 2013, PHYTOPATHOLOGY, V103, P1045, DOI 10.1094/PHYTO-09-12-0229-R; LAVIOLETTE FA, 1970, CROP SCI, V10, P418, DOI 10.2135/cropsci1970.0011183X001000040031x; Lehman SG, 1928, J AGRIC RES, V36, P0811; Mengistu A, 2012, PLANT HLTH PROGR, V10; Mengistu Alemu, 2002, Plant Disease, V86, P1272, DOI 10.1094/PDIS.2002.86.11.1272B; Mian MAR, 2008, CROP SCI, V48, P14, DOI 10.2135/cropsci2007.08.0432; Mian MAR, 1998, PLANT DIS, V82, P1017, DOI 10.1094/PDIS.1998.82.9.1017; Muller MF, 2016, PHYTOPATHOLOGY, V106, P1194, DOI 10.1094/PHYTO-02-16-0084-FI; Nei M., 2000, MOL EVOLUTION PHYLOG; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Phillips D, 1999, FROGEYE LEAF SPOT CO, P20; PHILLIPS DV, 1982, PHYTOPATHOLOGY, V72, P764, DOI 10.1094/Phyto-72-764; Pritchard JK, 2000, GENETICS, V155, P945; Sanogo S, 2001, PLANT DIS, V85, P773, DOI 10.1094/PDIS.2001.85.4.443A; Tamura K., 2013, MOL BIOL EVOL, P197, DOI DOI 10.1093/M0LBEV/MST197; Tu ND, 2013, BIOTECHNIQUES, V55, P69, DOI 10.2144/000114052; USDA, 2016, CROP PROD 2015 SUMM; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wrather JA, 2006, J NEMATOL, V38, P173; Yeh F.C., 1997, MOL BIOL BIOTECHNOL, V10, P295; Zeng F, 2015, PLANT DIS, V99, P544, DOI 10.1094/PDIS-05-14-0460-RE; Zhang G, 2014, PLANT HLTH PROG, V10; Zhang G, 2014, PHYTOPATHOLOGY; Zhang GR, 2012, PLANT DIS, V96, P767, DOI 10.1094/PDIS-10-11-0915-PDN	35	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177220	10.1371/journal.pone.0177220	http://dx.doi.org/10.1371/journal.pone.0177220			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486517	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314000059
J	Cao, JM; Zhou, J; Zhang, YF; Zou, YZ; Liu, XW				Cao, Jiamu; Zhou, Jing; Zhang, Yufeng; Zou, Yuezhang; Liu, Xiaowei			MoS2 nanosheets direct supported on reduced graphene oxide: An advanced electrocatalyst for hydrogen evolution reaction	PLOS ONE			English	Article							EFFICIENCY; ELECTRODES; REDUCTION; CATALYST; SITES	Molybdenum disulfide nanosheets/reduced graphene oxide (MoS2 NSs/rGO) nanohybrid as a highly effective catalyst for hydrogen evolution reaction (HER) have been successfully synthesized by a facile microwave-assisted method. The results clearly reveal that direct grown of MoS2 NSs on rGO have been achieved. Electrochemical tests show that the asprepared hybrid material exhibited excellent HER activity, with a small Tafel slope of 57 mV dec(-1), an overpotential of 130 mV and remarkable cycling stability. After analysis, the observed outstanding catalytic performance can be attributed to the uniform distribution of the MoS2 NSs, which are characterized by the presence of multiple active sites as well as the effective electron transport route provided by the conductive rGO substrate. Moreover, according to the classic theory, the mechanism governing of the catalytic HER on the MoS2 NSs/ rGO nanohybrid has been clarified.	[Cao, Jiamu; Zhou, Jing; Zhang, Yufeng; Zou, Yuezhang; Liu, Xiaowei] Harbin Inst Technol, Sch Astronaut, MEMS Ctr, Harbin, Peoples R China; [Zhang, Yufeng; Liu, Xiaowei] Minist Educ, Key Lab Microsyst & Microstruct Mfg, Harbin, Peoples R China	Harbin Institute of Technology	Zhang, YF (corresponding author), Harbin Inst Technol, Sch Astronaut, MEMS Ctr, Harbin, Peoples R China.; Zhang, YF (corresponding author), Minist Educ, Key Lab Microsyst & Microstruct Mfg, Harbin, Peoples R China.	yufeng_zhang@hit.edu.cn	Zhang, Yufeng/GZL-1973-2022		National Natural Science Foundation of China [61404037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work described in this paper was financially supported by the National Natural Science Foundation of China (No.61404037).	Bonde J, 2008, FARADAY DISCUSS, V140, P219, DOI 10.1039/b803857k; Cao JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161374; Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061; Chen WF, 2010, CARBON, V48, P1146, DOI 10.1016/j.carbon.2009.11.037; Du GD, 2010, CHEM COMMUN, V46, P1106, DOI 10.1039/b920277c; Hinnemann B, 2005, J AM CHEM SOC, V127, P5308, DOI 10.1021/ja0504690; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; Jin BW, 2016, ANGEW CHEM INT EDIT, V55, P12252, DOI 10.1002/anie.201605551; Karunadasa HI, 2010, NATURE, V464, P1329, DOI 10.1038/nature08969; Li F, 2015, J POWER SOURCES, V292, P15, DOI 10.1016/j.jpowsour.2015.04.173; Liang X, 2016, CERAM INT, V42, P12888, DOI 10.1016/j.ceramint.2016.05.055; Luo JS, 2014, SCIENCE, V345, P1593, DOI 10.1126/science.1258307; Ma CB, 2014, NANOSCALE, V6, P5624, DOI 10.1039/c3nr04975b; Ma FK, 2016, NANO ENERGY, V27, P466, DOI 10.1016/j.nanoen.2016.07.014; Ma LB, 2016, NANO ENERGY, V24, P139, DOI 10.1016/j.nanoen.2016.04.024; Shi Y, 2015, J AM CHEM SOC, V137, P7365, DOI 10.1021/jacs.5b01732; Suresh C, 2016, MATER LETT, V164, P417, DOI 10.1016/j.matlet.2015.11.052; Tang YJ, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201600116; THOMAS JG, 1961, T FARADAY SOC, V57, P1603, DOI 10.1039/tf9615701603; Tiwari AP, 2016, NANO ENERGY, V28, P366, DOI 10.1016/j.nanoen.2016.08.065; Turner JA, 2004, SCIENCE, V305, P972, DOI 10.1126/science.1103197; Walter MG, 2010, CHEM REV, V110, P6446, DOI 10.1021/cr1002326; Wang M, 2012, ENERG ENVIRON SCI, V5, P6763, DOI 10.1039/c2ee03309g; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/NNANO.2012.193, 10.1038/nnano.2012.193]; Wu WZ, 2014, NATURE, V514, P470, DOI 10.1038/nature13792; Xu SJ, 2015, J MATER CHEM A, V3, P16337, DOI 10.1039/c5ta02637g; Yan HH, 2016, CERAM INT, V42, P9327, DOI 10.1016/j.ceramint.2016.02.160; Yan SM, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4905656; Ye TN, 2015, NANO ENERGY, V15, P335, DOI 10.1016/j.nanoen.2015.04.033; Yu XL, 2016, APPL CATAL B-ENVIRON, V182, P504, DOI 10.1016/j.apcatb.2015.09.003; Zhang ZY, 2015, NANO ENERGY, V18, P196, DOI 10.1016/j.nanoen.2015.10.014; Zhou WJ, 2016, NANO ENERGY, V28, P29, DOI 10.1016/j.nanoen.2016.08.027; Zhou YC, 2015, NANO ENERGY, V16, P357, DOI 10.1016/j.nanoen.2015.07.008	33	15	15	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177258	10.1371/journal.pone.0177258	http://dx.doi.org/10.1371/journal.pone.0177258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481951	Green Published, gold, Green Submitted			2022-12-27	WOS:000401313700044
J	Dong, CX; Gao, MX; Guo, CW; Lin, L; Wu, DH; Zhang, LM				Dong, Chengxu; Gao, Meixiang; Guo, Chuanwei; Lin, Lin; Wu, Donghui; Zhang, Limin			The underlying processes of a soil mite metacommunity on a small scale	PLOS ONE			English	Article							TRADE-OFFS; BIODIVERSITY; DISPERSAL; ROLES; COLONIZATION; PATTERNS; FOREST	Metacommunity theory provides an understanding of how ecological processes regulate local community assemblies. However, few field studies have evaluated the underlying mechanisms of a metacommunity on a small scale through revealing the relative roles of spatial and environmental filtering in structuring local community composition. Based on a spatially explicit sampling design in 2012 and 2013, this study aims to evaluate the underlying processes of a soil mite metacommunity on a small spatial scale (50 m) in a temperate deciduous forest located at the Maoershan Ecosystem Research Station, Northeast China. Moran's eigenvector maps (MEMs) were used to model independent spatial variables. The relative importance of spatial (including trend variables, i.e., geographical coordinates, and broad-and fine-scale spatial variables) and environmental factors in driving the soil mite metacommunity was determined by variation partitioning. Mantel and partial Mantel tests and a redundancy analysis (RDA) were also used to identify the relative contributions of spatial and environmental variables. The results of variation partitioning suggested that the relatively large and significant variance was a result of spatial variables (including broad-and fine-scale spatial variables and trend), indicating the importance of dispersal limitation and autocorrelation processes. The significant contribution of environmental variables was detected in 2012 based on a partial Mantel test, and soil moisture and soil organic matter were especially important for the soil mite metacommunity composition in both years. The study suggested that the soil mite metacommunity was primarily regulated by dispersal limitation due to broad-scale and neutral biotic processes at a fine-scale and that environmental filtering might be of subordinate importance. In conclusion, a combination of metacommunity perspectives between neutral and species sorting theories was suggested to be important in the observed structure of the soil mite metacommunity at the studied small scale.	[Dong, Chengxu; Gao, Meixiang; Guo, Chuanwei; Lin, Lin; Zhang, Limin] Harbin Normal Univ, Coll Geog Sci, 1 Limin Econ Dev Dist, Harbin, Peoples R China; [Dong, Chengxu; Gao, Meixiang; Guo, Chuanwei; Lin, Lin; Zhang, Limin] Harbin Normal Univ, Coll Heilongjiang Prov, Key Lab Remote Sensing Monitoring Geog Environm, Harbin, Peoples R China; [Wu, Donghui] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun, Peoples R China	Harbin Normal University; Harbin Normal University; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS	Gao, MX (corresponding author), Harbin Normal Univ, Coll Geog Sci, 1 Limin Econ Dev Dist, Harbin, Peoples R China.; Gao, MX (corresponding author), Harbin Normal Univ, Coll Heilongjiang Prov, Key Lab Remote Sensing Monitoring Geog Environm, Harbin, Peoples R China.	gmx102@hotmail.com		Meixiang, Gao/0000-0002-5841-9918	National Natural Sciences Foundation of China [41471037, 41101049, 41371072, 41430857]; University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province [UNPYSCT-2015054]; Excellent Youth Scholars of Harbin Normal University, Chinese Academy of Sciences [DLSYQ2012004]; Excellent Youth Scholars of Northeast Institute of Geography and Agroecology, Chinese Academy of Sciences [DLSYQ2012004]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province; Excellent Youth Scholars of Harbin Normal University, Chinese Academy of Sciences; Excellent Youth Scholars of Northeast Institute of Geography and Agroecology, Chinese Academy of Sciences	This study was supported by the National Natural Sciences Foundation of China (Nos. 41471037, 41101049, 41371072, 41430857), University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province (No. UNPYSCT-2015054), Excellent Youth Scholars of Harbin Normal University and Excellent Youth Scholars of Northeast Institute of Geography and Agroecology, Chinese Academy of Sciences (No. DLSYQ2012004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ping He for her assistances with the experimental performing. We thank managers of the Maoershan Ecosystem Research Station for the convenience they provided. We also thank the anonymous reviewers. This study was supported by the National Natural Sciences Foundation of China (Nos. 41471037, 41101049, 41371072, 41430857), University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province (No. UNPYSCT-2015054), Excellent Youth Scholars of Harbin Normal University and Excellent Youth Scholars of Northeast Institute of Geography and Agroecology, Chinese Academy of Sciences (No. DLSYQ2012004).	Astrom J, 2011, OECOLOGIA, V167, P747, DOI 10.1007/s00442-011-2024-y; Balogh J., 1992, ORIBATID MITES GENER, V1; Behan-Pelletier VM, 1999, AGR ECOSYST ENVIRON, V74, P411, DOI 10.1016/S0167-8809(99)00046-8; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Bonthoux S, 2015, ECOL COMPLEX, V21, P39, DOI 10.1016/j.ecocom.2014.12.002; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brown JH, 2001, EVOLUTION, V55, P2137; Cadotte MW, 2007, ECOLOGY, V88, P823, DOI 10.1890/06-1117; Chalmandrier L, 2015, ECOLOGY, V96, P143, DOI 10.1890/13-2153.1; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Crawley MJ, 2001, SCIENCE, V291, P864, DOI 10.1126/science.291.5505.864; dos Santos AS, 2015, PERSPECT PLANT ECOL, V17, P96, DOI 10.1016/j.ppees.2015.01.002; Downing AS, 2014, ECOL LETT, V17, P1219, DOI 10.1111/ele.12327; Dray S., 2011, PACKFOR FORWARD SELE; Gan H., 2013, ORIBATID MITE COMMUN; Gao MX, 2014, SOIL BIOL BIOCHEM, V79, P68, DOI 10.1016/j.soilbio.2014.09.003; Gao MX, 2012, CHINESE GEOGR SCI, V22, P647, DOI 10.1007/s11769-012-0573-6; GHILAROV MS, 1984, PEDOBIOLOGIA, V27, P107; Gilpin M.E., 1991, METAPOPULATION DYNAM; Gong Z.T., 1999, SOIL-GERMANY, V31, P57, DOI [10.13758/j.cnki.tr.1999.02.001, DOI 10.13758/J.CNKI.TR.1999.02.001]; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Gronroos M, 2013, ECOL EVOL, V3, P4473, DOI 10.1002/ece3.834; Heino J, 2015, FRESHWATER BIOL, V60, P845, DOI 10.1111/fwb.12533; Hortal J, 2010, ECOGRAPHY, V33, P51, DOI 10.1111/j.1600-0587.2009.06428.x; Hubbell Stephen P., 2001, V32, pi; Ingimarsdottir M, 2012, OECOLOGIA, V170, P745, DOI 10.1007/s00442-012-2334-8; Jiang XJ, 2015, SOIL BIOL BIOCHEM, V81, P9, DOI 10.1016/j.soilbio.2014.10.025; Jimenez JJ, 2012, OIKOS, V121, P915, DOI 10.1111/j.1600-0706.2012.20428.x; Jocque M, 2010, GLOBAL ECOL BIOGEOGR, V19, P244, DOI 10.1111/j.1466-8238.2009.00510.x; Krantz G., 2009, MANUAL ACAROLOGY; Lao JC, 1998, HDB SOIL AGROCHEMIST; Legendre P. D., 2012, PCNM MEM SPATIAL EIG; Legendre P, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2728; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2002, OIKOS, V97, P237, DOI 10.1034/j.1600-0706.2002.970210.x; Lindstrom ES, 2012, ENV MICROBIOL REP, V4, P1, DOI 10.1111/j.1758-2229.2011.00257.x; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; MARINISSEN JCY, 1992, OECOLOGIA, V91, P371, DOI 10.1007/BF00317626; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Norton R.A., 1980, International Journal of Acarology, V6, P121; Ojala R, 2001, PEDOBIOLOGIA, V45, P443, DOI 10.1078/0031-4056-00098; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Pachepsky E, 2001, NATURE, V410, P923, DOI 10.1038/35073563; Sharma S, 2011, ECOGRAPHY, V34, P762, DOI 10.1111/j.1600-0587.2010.06811.x; Soininen J, 2012, ENV MICROBIOL REP, V4, P10, DOI 10.1111/j.1758-2229.2011.00308.x; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Virtanen L, 2012, EUR J PHYCOL, V47, P160, DOI 10.1080/09670262.2012.682610; Walter DE, 2001, MITES IN SOIL; WILSON DS, 1992, ECOLOGY, V73, P1984, DOI 10.2307/1941449; Winegardner AK, 2012, TRENDS ECOL EVOL, V27, P253, DOI 10.1016/j.tree.2012.01.007; Yin W., 1998, PICTORICAL KEYS SOIL; Yu DW, 2001, AM NAT, V158, P49, DOI 10.1086/320865	55	5	6	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176828	10.1371/journal.pone.0176828	http://dx.doi.org/10.1371/journal.pone.0176828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481906	Green Published, gold, Green Submitted			2022-12-27	WOS:000401313700017
J	Kee, JY; Han, YH; Kim, DS; Mun, JG; Park, SH; So, HS; Park, SJ; Park, R; Um, JY; Hong, SH				Kee, Ji-Ye; Han, Yo-Han; Kim, Dae-Seung; Mun, Jeong-Geon; Park, Seong-Hwan; So, Hong-Seob; Park, Sung-Joo; Park, Raekil; Um, Jae-Young; Hong, Seung-Heon			beta-Lapachone suppresses the lung metastasis of melanoma via the MAPK signaling pathway	PLOS ONE			English	Article							CELL-CYCLE; MATRIX METALLOPROTEINASES; INDUCED APOPTOSIS; CANCER; INDUCTION; ACTIVATION; INHIBITOR; PROLIFERATION; EXPRESSION; SELECTION	beta-Lapachone is a natural quinone compound from Lapacho trees, which has various pharmacological effects such as anti-bacterial, anti-fungal, anti-viral, and anti-inflammatory activities. However, the effect of beta-lapachone on metastasis of melanoma cells is unclear. In this study, beta-lapachone reduced cell viability of metastatic melanoma cancer cell lines B16F10 and B16BL6 through induction of apoptosis via the mitogen-activated protein kinase (MAPK) pathway. Additionally, flow cytometry results showed that beta-lapachone increased DNA content in the G0/G1 phase of the cell cycle. Analysis of the mechanisms of these events indicated that beta-lapachone regulated the expression of Bcl-2, Bcl-xL, and Bax, resulting in the activation of caspase-3, -8, -9, and poly-ADP-ribose polymerase (PARP). Moreover, the beta-lapachone-administered group showed significantly decreased lung metastasis in the experimental mouse model. In conclusion, our study demonstrates the inhibitory effect of beta-lapachone on lung metastasis of melanoma cells and provides a new insight into the role of beta-lapachone as a potential antitumor agent.	[Kee, Ji-Ye; Han, Yo-Han; Kim, Dae-Seung; Mun, Jeong-Geon; Park, Seong-Hwan; Hong, Seung-Heon] Wonkwang Univ, Wonkwang Oriental Med Res Inst, Dept Oriental Pharm, Coll Pharm, Iksan, Jeonbuk, South Korea; [Kee, Ji-Ye; So, Hong-Seob] Wonkwang Univ, Ctr Metab Funct Regulat, Iksan, South Korea; [Park, Sung-Joo] Wonkwang Univ, Dept Herbol, Coll Oriental Med, Iksan, Jeonbuk, South Korea; [Park, Raekil] Gwangju Inst Sci & Technol, Dept Biomed Sci & Engn, Gwangu, South Korea; [Um, Jae-Young] Kyung Hee Univ, Inst Korean Med, Dept Pharmacol, Coll Korean Med, Seoul, South Korea	Wonkwang University; Wonkwang University; Wonkwang University; Gwangju Institute of Science & Technology (GIST); Kyung Hee University	Hong, SH (corresponding author), Wonkwang Univ, Wonkwang Oriental Med Res Inst, Dept Oriental Pharm, Coll Pharm, Iksan, Jeonbuk, South Korea.	jooklim@wonkwang.ac.kr	Kee, Ji-Ye/V-5687-2019	Kee, Ji-Ye/0000-0002-9836-2127	National Research Foundation of Korea (NRF) [2015R1C1A1A02036733, 2011-0030130]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This study was supported by the National Research Foundation of Korea (NRF); Grant numbers: 2011-0030130, 2015R1C1A1A02036733.	Gomez-Sarosi LA, 2009, CANCER BIOL THER, V8, P1173, DOI 10.4161/cbt.8.12.8561; Banerji A, 2004, CANCER LETT, V211, P235, DOI 10.1016/j.canlet.2004.02.007; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bold RJ, 1997, SURG ONCOL, V6, P133, DOI 10.1016/S0960-7404(97)00015-7; Chi ZH, BMC CANC, P85; Choi YH, 2003, J BIOCHEM MOL BIOL, V36, P223; Cummins DL, 2006, MAYO CLIN PROC, V81, P500, DOI 10.4065/81.4.500; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Fidler IJ, 2002, DIFFERENTIATION, V70, P498, DOI 10.1046/j.1432-0436.2002.700904.x; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Hofmann UB, 1999, BRIT J CANCER, V81, P774, DOI 10.1038/sj.bjc.6690763; Huang LL, 1999, MOL MED, V5, P711, DOI 10.1007/BF03402095; Ishiguro T, 1996, CANCER RES, V56, P875; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261; Khasigov PZ, 2003, BIOCHEMISTRY-MOSCOW+, V68, P711, DOI 10.1023/A:1025051214001; Kim SO, 2007, BIOSCI BIOTECH BIOCH, V71, P2169, DOI 10.1271/bbb.70103; LI CJ, 1993, J BIOL CHEM, V268, P22463; LI CJ, 1995, CANCER RES, V55, P3712; Li JZ, 2014, TOXICOL APPL PHARM, V281, P285, DOI 10.1016/j.taap.2014.10.012; Lien YC, 2008, HISTOL HISTOPATHOL, V23, P1299, DOI 10.14670/HH-23.1299; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Macedo L, 2013, PHYTOMEDICINE, V21, P25, DOI 10.1016/j.phymed.2013.08.010; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; POSTE G, 1980, CANCER RES, V40, P1636; Serrone L, 2000, J EXP CLIN CANC RES, V19, P21; Sitonio MM, 2013, INFLAMM RES, V62, P107, DOI 10.1007/s00011-012-0557-0; Stadheim TA, 2002, LEUKEMIA RES, V26, P55, DOI 10.1016/S0145-2126(01)00099-6; Sun HP, 2012, PHYSIOLOGY, V27, P43, DOI 10.1152/physiol.00034.2011; TALMADGE JE, 1982, NATURE, V297, P593, DOI 10.1038/297593a0; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsuchiya T, 2008, HEPATO-GASTROENTEROL, V55, P930; Wells JM, 2015, MATRIX BIOL, V44-46, P122, DOI 10.1016/j.matbio.2015.01.016; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Woo HJ, 2006, J MED FOOD, V9, P161, DOI 10.1089/jmf.2006.9.161; Wuerzberger SM, 1998, CANCER RES, V58, P1876; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhang XM, 2001, CLIN EXP METASTAS, V18, P415, DOI 10.1023/A:1010960615370	43	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e01 76937	10.1371/journal.pone.0176937	http://dx.doi.org/10.1371/journal.pone.0176937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481901	Green Published, gold, Green Submitted			2022-12-27	WOS:000401313700024
J	Farquhar, M; Penfold, C; Benson, J; Lovick, R; Mahadeva, R; Howson, S; Burkin, J; Booth, S; Gilligan, D; Todd, C; Ewing, G				Farquhar, Morag; Penfold, Clarissa; Benson, John; Lovick, Roberta; Mahadeva, Ravi; Howson, Sophie; Burkin, Julie; Booth, Sara; Gilligan, David; Todd, Christopher; Ewing, Gail			Six key topics informal carers of patients with breathlessness in advanced disease want to learn about and why: MRC phase I study to inform an educational intervention	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OF-LIFE CARE; PALLIATIVE CARE; LUNG-CANCER; SUPPORT NEEDS; FAMILY CARERS; CAREGIVERS; END; PEOPLE; HEALTH	Introduction Breathlessness is a common symptom of advanced disease placing a huge burden on patients, health systems and informal carers (families and friends providing daily help and support). It causes distress and isolation. Carers provide complex personal, practical and emotional support yet often feel ill-prepared to care. They lack knowledge and confidence in their caring role. The need to educate carers and families about breathlessness is established, yet we lack robustly developed carer-targeted educational interventions to meet their needs. Methods We conducted a qualitative interview study with twenty five purposively-sampled patientcarer dyads living with breathlessness in advanced disease (half living with advanced cancer and half with advanced chronic obstructive pulmonary disease (COPD). We sought to identify carers' educational needs (including what they wanted to learn about) and explore differences by diagnostic group in order to inform an educational intervention for carers of patients with breathlessness in advanced disease. Results There was a strong desire among carers for an educational intervention on breathlessness. Six key topics emerged as salient for them: 1) understanding breathlessness, 2) managing anxiety, panic and breathlessness, 3) managing infections, 4) keeping active, 5) living positively and 6) knowing what to expect in the future. A cross-cutting theme was relationship management: there were tensions within dyads resulting from mismatched expectations related to most topics. Carers felt that knowledge-gains would not only help them to support the patient better, but also help them to manage their own frustrations, anxieties, and quality of life. Different drivers for education need were identified by diagnostic group, possibly related to differences in caring role duration and resulting impacts. Conclusion Meeting the educational needs of carers requires robustly developed and evaluated interventions. This study provides the evidence-base for the content of an educational intervention for carers of patients with breathlessness in advanced disease.	[Farquhar, Morag] Univ East Anglia, Sch Hlth Sci, Norwich, Norfolk, England; [Penfold, Clarissa; Benson, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Lovick, Roberta] Lay Carer Representat, Norwich, Norfolk, England; [Mahadeva, Ravi] Univ Cambridge, Dept Resp Med, Hosp NHS Trust, Cambridge, England; [Howson, Sophie] SK Nurses, St Ives, Cambs, England; [Burkin, Julie] Univ Cambridge, Hosp NHS Trust, Palliat Care Team, Cambridge, England; [Burkin, Julie] Univ Cambridge, Hosp NHS Trust, Palliat Care Team, Cambridge, England; [Booth, Sara; Gilligan, David] Univ Cambridge, Dept Oncol, Cambridge, England; [Todd, Christopher] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Ewing, Gail] Univ Cambridge, Ctr Family Res, Cambridge, England	University of East Anglia; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Manchester; University of Cambridge	Farquhar, M (corresponding author), Univ East Anglia, Sch Hlth Sci, Norwich, Norfolk, England.	mcf22@medschl.cam.ac.uk	Todd, Chris/A-7904-2010; Todd, Chris/AAD-8661-2022; Farquhar, Morag/C-5666-2015	Todd, Chris/0000-0001-6645-4505; Todd, Chris/0000-0001-6645-4505; Farquhar, Morag/0000-0001-7991-7679	Dimbleby Cancer Care; Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre	Dimbleby Cancer Care; Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR))	Dimbleby Cancer Care (study funder - no grant number allocated) http://www.dimblebycancercare.org/. The study was funded by Dimbleby Cancer Care. The funder provided support in the form of salaries for authors [CP, MF, GE], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section. SH was latterly employed by SKNurses, however SKNurses played no role in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are extremely grateful for the time and contribution of participating patients and informal carers. We thank CRN-Eastern, practices within Cambridgeshire and Peterborough CCG and clinical teams at Cambridge University Hospitals NHS Foundation Trust and Papworth for supporting participant recruitment. We thank Kevin Houghton for administrative support and Dimbleby Cancer Care for study funding. RM is supported by Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre.	Aoun SM, 2005, PALLIATIVE MED, V19, P551, DOI 10.1191/0269216305pm1053oa; Bee PE, 2009, J CLIN NURS, V18, P1379, DOI 10.1111/j.1365-2702.2008.02405.x; Bergs D, 2002, J CLIN NURS, V11, P613, DOI 10.1046/j.1365-2702.2002.00651.x; Boland JW, 2016, J PALLIAT MED, V19, P549, DOI 10.1089/jpm.2015.0355; Booth S, 2008, NAT CLIN PRACT ONCOL, V5, P90, DOI 10.1038/ncponc1034; Booth Sara, 2006, Palliat Support Care, V4, P287; Booth Sara, 2003, Palliat Support Care, V1, P337; Booth Sara, 2011, Curr Opin Support Palliat Care, V5, P77, DOI 10.1097/SPC.0b013e3283460c93; Boyle AH., 2009, SO ONLINE J NURSING, V9, P5; British Thoracic Society, 2006, BURD LUNG DIS; British Thoracic Society Pulmonary Rehabilitation Guideline Group, 2013, THORAX, V68, pS2; Bryant J, 2016, INT J CHRONIC OBSTR, V11, P1587, DOI 10.2147/COPD.S107571; Buckner L., 2015, VALUING CARERS 2015; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Candy B, 2011, COCHRANE DB SYST REV, V15; Caress AL, 2009, J CLIN NURS, V18, P479, DOI 10.1111/j.1365-2702.2008.02556.x; Corbin J M, 1984, Image J Nurs Sch, V16, P109; Corry M, 2015, J ADV NURS, V71, P718, DOI 10.1111/jan.12523; Cruz J, 2017, HEALTH SOC CARE COMM, V25, P11, DOI 10.1111/hsc.12292; Currow David C, 2008, Int J Chron Obstruct Pulmon Dis, V3, P753; Currow DC, 2010, J PAIN SYMPTOM MANAG, V39, P680, DOI 10.1016/j.jpainsymman.2009.09.017; Dudgeon DJ, 2001, J PAIN SYMPTOM MANAG, V21, P95, DOI 10.1016/S0885-3924(00)00258-X; Edmonds P, 2001, PALLIATIVE MED, V15, P287, DOI 10.1191/026921601678320278; Ewing G, 2004, PALLIATIVE MED, V18, P452, DOI 10.1191/0269216304pm905oa; Ewing G, 2017, J PAIN SYMPTOM MANAG, V53, P265, DOI 10.1016/j.jpainsymman.2016.08.015; Ewing G, 2013, PALLIATIVE MED, V27, P244, DOI 10.1177/0269216312440607; Farquhar M, 2016, ERS MONOGRAPH, V73; Farquhar M, 2014, BMJ SUPPORT PALLI S1, V4, pA8; Farquhar M, PALLIATIVE NURSING P; Farquhar M, 2016, J PAIN SYMPTOM MANAG, V52, P117, DOI 10.1016/j.jpainsymman.2015.12.341; Farquhar MC, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1304-6; Farquhar MC, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0194-2; Flemming K, 2016, PALL MED, V30, pS11; Fredman L, 2004, J AGING HEALTH, V16, P175, DOI 10.1177/0898264303262639; Funk L, 2010, PALLIATIVE MED, V24, P594, DOI 10.1177/0269216310371411; Gautun H, 2012, SCAND J PUBLIC HEALT, V40, P18, DOI 10.1177/1403494811425712; Gerrish K., 2008, PRIM HEALTH CARE RES, V9, P14; Goodridge D, 2008, RESP MED, V102, P885, DOI 10.1016/j.rmed.2008.01.007; Gore JM, 2000, THORAX, V55, P1000, DOI 10.1136/thorax.55.12.1000; Grant M, 2012, INT J NURS STUD, V49, P1459, DOI 10.1016/j.ijnurstu.2012.02.010; Gysels Marjolein H, 2009, Palliat Support Care, V7, P153, DOI 10.1017/S1478951509000200; Harding R, 2012, PALLIATIVE MED, V26, P7, DOI 10.1177/0269216311409613; Health and Safety Lab, 2009, PROJ MES MORT GREAT; Higginson IJ, 1999, J PUBLIC HEALTH MED, V21, P22, DOI 10.1093/pubmed/21.1.22; Howard C, 2010, PSYCHOL HEALTH MED, V15, P371, DOI 10.1080/13548506.2010.482142; Hudson Peter L, 2010, BMC Palliat Care, V9, P17, DOI 10.1186/1472-684X-9-17; Hynes G, 2012, J CLIN NURS, V21, P1068, DOI 10.1111/j.1365-2702.2011.03944.x; Malik FA, 2013, PALLIATIVE MED, V27, P647, DOI 10.1177/0269216313488812; Mansfield E, 2016, COPD J CHRONIC OBSTR; McPherson KM, 2014, INT J NURS STUD, V51, P418, DOI 10.1016/j.ijnurstu.2013.07.006; Morris SM, 2015, PALLIATIVE MED, V29, P487, DOI 10.1177/0269216314565706; MUERS MF, 1993, THORAX, V48, P339, DOI 10.1136/thx.48.4.339; Mularski Richard A, 2013, Ann Am Thorac Soc, V10, pS98, DOI 10.1513/AnnalsATS.201306-169ST; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray SA, 2004, PALLIATIVE MED, V18, P39, DOI 10.1191/0269216304pm837oa; Murray SA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2581; Northouse LL, 2006, RES NURS HEALTH, V29, P199, DOI 10.1002/nur.20128; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Ransom S, 2006, RES NURS HEALTH, V29, P190, DOI 10.1002/nur.20129; Ritchie J, 2002, ANAL QUALITATIVE DAT, P187; ROGERS A, 1986, TEACHING ADULTS; Rolls L, 2011, PALLIATIVE MED, V25, P650, DOI 10.1177/0269216310373165; Schumacher KL, 2000, RES NURS HEALTH, V23, P191, DOI 10.1002/1098-240X(200006)23:3<191::AID-NUR3>3.0.CO;2-B; Simpson A Catherine, 2010, Int J Chron Obstruct Pulmon Dis, V5, P141; Stajduhar KI, 2010, PALLIATIVE MED, V24, P573, DOI 10.1177/0269216310371412; Stajduhar KI, 2008, SOC SCI MED, V67, P1789, DOI 10.1016/j.socscimed.2008.09.012; Walsh K, 2007, BRIT J PSYCHIAT, V190, P142, DOI 10.1192/bjp.bp.106.023960	67	29	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177081	10.1371/journal.pone.0177081	http://dx.doi.org/10.1371/journal.pone.0177081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475655	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000400649500044
J	Gu, YF; Van Nostrand, JD; Wu, LY; He, ZL; Qin, YJ; Zhao, FJ; Zhou, JZ				Gu, Yunfu; Van Nostrand, Joy D.; Wu, Liyou; He, Zhili; Qin, Yujia; Zhao, Fang-Jie; Zhou, Jizhong			Bacterial community and arsenic functional genes diversity in arsenic contaminated soils from different geographic locations	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; PADDY SOILS; ABUNDANCE; METABOLISM; OXIDASE; RICE; MICROORGANISMS; RHIZOSPHERE; GROUNDWATER; SPECIATION	To understand how soil microbial communities and arsenic (As) functional genes respond to soil arsenic (As) contamination, five soils contaminated with As at different levels were collected from diverse geographic locations, incubated for 54 days under flooded conditions, and examined by both MiSeq sequencing of 16S rRNA gene amplicons and functional gene microarray (GeoChip 4.0). The results showed that both bacterial community structure and As functional gene structure differed among geographical locations. The diversity of As functional genes correlated positively with the diversity of 16S rRNA genes (P<0.05). Higher diversities of As functional genes and 16S rRNA genes were observed in the soils with higher available As. Soil pH, phosphate-extractable As, and amorphous Fe content were the most important factors in shaping the bacterial community structure and As transformation functional genes. Geographic location was also important in controlling both the bacterial community and As transformation functional potential. These findings provide insights into the variation of As transformation functional genes in soils contaminated with different levels of As at different geographic locations, and the impact of environmental As contamination on the soil bacterial community.	[Gu, Yunfu] Sichuan Agr Univ, Coll Resources Sci & Technol, Dept Microbiol, Chengdu, Peoples R China; [Van Nostrand, Joy D.; Wu, Liyou; He, Zhili; Qin, Yujia; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Zhao, Fang-Jie] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Zhao, Fang-Jie] Rothamsted Res, Sustainable Soil & Grassland Syst Dept, Harpenden, Herts, England; [Zhou, Jizhong] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing, Peoples R China; [Zhou, Jizhong] Lawrence Berkeley Natl Lab, Earth Sci Div, Berkeley, CA 94720 USA	Sichuan Agricultural University; University of Oklahoma System; University of Oklahoma - Norman; Nanjing Agricultural University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Tsinghua University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Zhou, JZ (corresponding author), Univ Oklahoma, Inst Environm Genom, Dept Microbiol & Plant Biol, Norman, OK 73019 USA.; Zhao, FJ (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China.; Zhao, FJ (corresponding author), Rothamsted Res, Sustainable Soil & Grassland Syst Dept, Harpenden, Herts, England.; Zhou, JZ (corresponding author), Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing, Peoples R China.; Zhou, JZ (corresponding author), Lawrence Berkeley Natl Lab, Earth Sci Div, Berkeley, CA 94720 USA.	fangjie.zhao@njau.edu.cn; jzhou@ou.edu	He, Zhili/C-2879-2012; Zhao, Fang-Jie/A-8339-2008; 吴, 昊/AAB-1620-2020	He, Zhili/0000-0001-8225-7333; Zhao, Fang-Jie/0000-0002-0164-169X; 				Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bhattacharya P, 2007, SCI TOTAL ENVIRON, V379, P109, DOI 10.1016/j.scitotenv.2007.02.037; Brammer H, 2009, ENVIRON INT, V35, P647, DOI 10.1016/j.envint.2008.10.004; Bruneel O, 2006, APPL ENVIRON MICROB, V72, P551, DOI 10.1128/AEM.72.1.551-556.2006; Bryan CG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-127; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Corsini A, 2011, APPL SOIL ECOL, V49, P99, DOI 10.1016/j.apsoil.2011.06.010; Dittmar J, 2010, ENVIRON SCI TECHNOL, V44, P2925, DOI 10.1021/es903117r; Duker AA, 2005, ENVIRON INT, V31, P631, DOI 10.1016/j.envint.2004.10.020; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Engel AS, 2013, FEMS MICROBIOL ECOL, V83, P745, DOI 10.1111/1574-6941.12030; Escudero LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078890; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Frankenberger WT, 1998, SOIL BIOL BIOCHEM, V30, P269, DOI 10.1016/S0038-0717(97)00102-8; Han YH, 2017, J HAZARD MATER, V321, P146, DOI 10.1016/j.jhazmat.2016.08.079; Hassan Z, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv026; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Hohmann C, 2010, ENVIRON SCI TECHNOL, V44, P94, DOI 10.1021/es900708s; Honschopp S, 1996, MICROBIOL RES, V151, P37, DOI 10.1016/S0944-5013(96)80053-X; Hornstrom E, 2002, HYDROBIOLOGIA, V470, P115, DOI 10.1023/A:1015619921119; Jackson CR, 2005, SOIL BIOL BIOCHEM, V37, P2319, DOI 10.1016/j.soilbio.2005.04.010; Jia Y, 2014, ENVIRON SCI TECHNOL, V48, P1001, DOI 10.1021/es403877s; Lami R, 2013, FEMS MICROBIOL ECOL, V84, P270, DOI 10.1111/1574-6941.12061; Lear G, 2007, APPL ENVIRON MICROB, V73, P1041, DOI 10.1128/AEM.01654-06; Li G, 2011, ENVIRON INT, V37, P1219, DOI 10.1016/j.envint.2011.05.007; Liang YT, 2011, ISME J, V5, P403, DOI 10.1038/ismej.2010.142; Lin HZ, 2014, J ENVIRON SCI HEAL A, V49, P1493, DOI 10.1080/10934529.2014.937168; Lombi E, 2000, WATER AIR SOIL POLL, V124, P319, DOI 10.1023/A:1005230628958; Macur RE, 2004, ENVIRON SCI TECHNOL, V38, P104, DOI 10.1021/es034455a; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; MCBRIDE BC, 1971, BIOCHEMISTRY-US, V10, P4312, DOI 10.1021/bi00799a024; Nemergut DR, 2004, APPL ENVIRON MICROB, V70, P1160, DOI 10.1128/AEM.70.2.1160-1168.2004; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Paez-Espino D, 2009, BIOMETALS, V22, P117, DOI 10.1007/s10534-008-9195-y; Perez-de-Mora A, 2006, SOIL BIOL BIOCHEM, V38, P327, DOI 10.1016/j.soilbio.2005.05.010; Poirel J, 2013, RES MICROBIOL, V164, P457, DOI 10.1016/j.resmic.2013.01.012; Qin J, 2006, P NATL ACAD SCI USA, V103, P2075, DOI 10.1073/pnas.0506836103; Reith F, 2012, ISME J, V6, P2107, DOI 10.1038/ismej.2012.48; Rosen BP, 1999, TRENDS MICROBIOL, V7, P207, DOI 10.1016/S0966-842X(99)01494-8; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Sheik CS, 2012, PLOS ONE, V6, P1; Spain AM, 2009, ISME J, V3, P992, DOI 10.1038/ismej.2009.43; Stroud JL, 2011, ENVIRON SCI TECHNOL, V45, P4262, DOI 10.1021/es104080s; Team RDC, 2005, R LANG ENV STAT COMP; Tu QC, 2014, MOL ECOL RESOUR, V14, P914, DOI 10.1111/1755-0998.12239; Turpeinen R, 2004, FEMS MICROBIOL ECOL, V47, P39, DOI 10.1016/S0168-6496(03)00232-0; van der Merwe JA, 2010, HYDROMETALLURGY, V104, P477, DOI 10.1016/j.hydromet.2010.01.017; WALSH LM, 1977, ENVIRON HEALTH PERSP, V19, P67, DOI 10.2307/3428453; WU JH, 1993, MOL MICROBIOL, V8, P615, DOI 10.1111/j.1365-2958.1993.tb01605.x; Xiao KQ, 2016, ENVIRON POLLUT, V211, P1, DOI 10.1016/j.envpol.2015.12.023; Xiong JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050507; Xiong JB, 2010, APPL ENVIRON MICROB, V76, P7277, DOI 10.1128/AEM.00500-10; Yan-Chu H., 1994, ARSENIC ENV 1, P17; Yang CL, 2015, ECOL ENG, V83, P176, DOI 10.1016/j.ecoleng.2015.06.018; Yin HQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14266; Zhang SY, 2015, ENVIRON SCI TECHNOL, V49, P4138, DOI 10.1021/acs.est.5b00028; Zhao FJ, 2013, ENVIRON SCI TECHNOL, V47, P7147, DOI 10.1021/es304977m; Zhao FJ, 2013, ENVIRON SCI TECHNOL, V47, P3957, DOI 10.1021/es304295n; Zhao FJ, 2010, ANNU REV PLANT BIOL, V61, P535, DOI 10.1146/annurev-arplant-042809-112152; Zhao MX, 2014, ISME J, V8, P2045, DOI 10.1038/ismej.2014.46; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996; Zhu YG, 2014, ANNU REV EARTH PL SC, V42, P443, DOI 10.1146/annurev-earth-060313-054942	66	41	41	13	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176696	10.1371/journal.pone.0176696	http://dx.doi.org/10.1371/journal.pone.0176696			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475654	Green Submitted, gold, Green Published			2022-12-27	WOS:000400649500012
J	Sato, M; Maufi, D; Mwingira, UJ; Leshabari, MT; Ohnishi, M; Honda, S				Sato, Miho; Maufi, Deogratias; Mwingira, Upendo John; Leshabari, Melkidezek T.; Ohnishi, Mayumi; Honda, Sumihisa			Measuring three aspects of motivation among health workers at primary level health facilities in rural Tanzania	PLOS ONE			English	Article							JOB-SATISFACTION; HUMAN-RESOURCES; CARE PROVIDERS; PUBLIC-SECTOR; PERFORMANCE; QUALITY; GHANA; DISTRICTS; DELIVERY; AFRICA	Background The threshold of 2.3 skilled health workers per 1,000 population, published in the World Health Report in 2006, has galvanized resources and efforts to attain high coverage of skilled birth attendance. With the inception of the Sustainable Development Goals (SDGs), a new threshold of 4.45 doctors, nurses, and midwives per 1,000 population has been identified. This SDG index threshold indicates the minimum density to respond to the needs of health workers to deliver a much broader range of health services, such as management of non-communicable diseases to meet the targets under Goal 3: Ensure healthy lives and promote well-being for all people of all ages. In the United Republic of Tanzania, the density of skilled health workers in 2012 was 0.5 per 1,000 population, which more than doubled from 0.2 per 1,000 in 2002. However, this showed that Tanzania still faced a critical shortage of skilled health workers. While training, deployment, and retention are important, motivation is also necessary for all health workers, particularly those who serve in rural areas. This study measured the motivation of health workers who were posted at government-run rural primary health facilities. Objectives We sought to measure three aspects of motivation-Management, Performance, and Individual Aspects-among health workers deployed in rural primary level government health facilities. In addition, we also sought to identify the job-related attributes associated with each of these three aspects. Two regions in Tanzania were selected for our research. In each region, we further selected two districts in which we carried out our investigation. The two regions were Lindi, where we carried out our study in the Nachingwea District and the Ruangwa District, and Mbeya, within which the Mbarali and Rungwe Districts were selected for research. All four districts are considered rural. Methods This cross-sectional study was conducted by administering a two-part questionnaire in the Kiswahili language. The first part was administered by a researcher, and contained questions for gaining socio-demographic and occupational information. The second part was a self-administered questionnaire that contained 45 statements used to measure three aspects of motivation among health workers. For analyzing the data, we performed multivariate regression analysis in order to evaluate the simultaneous effects of factors on the outcomes of the motivation scores in the three areas of Management, Performance, and Individual Aspects. Results Motivation was associated with marital status (p = 0.009), having a job description (p<0.001), and number of years in the current profession (<1 year: p = 0.043, >7 years: p = 0.042) for Management Aspects; having a job description (p<0.001) for Performance Aspects; and salary scale (p = 0.029) for Individual Aspects. Conclusion Having a clear job description motivates health workers. The existing Open Performance Review and Appraisal System, of which job descriptions are the foundation, needs to be institutionalized in order to effectively manage the health workforce in resource-limited settings.	[Sato, Miho; Ohnishi, Mayumi; Honda, Sumihisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Community Based Rehabil Sci, Nagasaki, Japan; [Sato, Miho] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Maufi, Deogratias] Presidents Off Reg Adm & Local Govt, Dodoma, Tanzania; [Mwingira, Upendo John] Minist Hlth, Neglected Trop Dis Programme, Community Dev Gender Elderly & Children, Dar Es Salaam, Tanzania; [Leshabari, Melkidezek T.] Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth & Social Sci, Dar Es Salaam, Tanzania	Nagasaki University; Nagasaki University; Muhimbili University of Health & Allied Sciences	Sato, M (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Community Based Rehabil Sci, Nagasaki, Japan.; Sato, M (corresponding author), Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan.	mihos@nagasaki-u.ac.jp	Honda, Sumihisa/V-7060-2019	mwingira, upendo/0000-0001-6852-6402	Regional Health Management Teams of the Lindi; Mbeya regions; Council Health Management Teams of the Nachingwea, Ruangwa, Mbarali; Rungwe District Councils; Foundation for Advanced Studies on International Development (FASID)	Regional Health Management Teams of the Lindi; Mbeya regions; Council Health Management Teams of the Nachingwea, Ruangwa, Mbarali; Rungwe District Councils; Foundation for Advanced Studies on International Development (FASID)	The authors would like to thank the following: the Regional Health Management Teams of the Lindi and Mbeya regions, the Council Health Management Teams of the Nachingwea, Ruangwa, Mbarali, and Rungwe District Councils for their support and assistance in implementing the study as well as their feedback on the preliminary results of the study, and the Council Health Management Team member or health professional in each study district who was assigned to guide and introduce the research team to each study health facility. The authors are also grateful for the time and cooperation rendered to us by all the health workers who participated in this study. Funding for this study was provided by the Foundation for Advanced Studies on International Development (FASID).; This study was carried out by the funding from the Foundation for Advanced Studies on International Development (FASID). There is no grant number. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyei-Baffour P, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-56; Agyepong IA, 2004, INT J HEALTH PLAN M, V19, P319, DOI 10.1002/hpm.770; [Anonymous], 2013, UNIVERSAL TRUTH HLTH; Baltussen R., 2006, COST EFF RESOUR ALLO, V4; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Bonenberger M, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-43; Bradley S, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-43; Chandler CIR, 2009, SOC SCI MED, V68, P2078, DOI 10.1016/j.socscimed.2009.03.007; De Brouwere V, 2009, REPROD HEALTH MATTER, V17, P32, DOI 10.1016/S0968-8080(09)33437-0; Dieleman M, 2006, HUM RESOUR HLTH, V4; Duysburgh E, 2013, TROP MED INT HEALTH, V18, P534, DOI 10.1111/tmi.12076; Franco LM, 2002, SOC SCI MED, V54, P1255, DOI 10.1016/S0277-9536(01)00094-6; Franco LM, 2000, 2 ABT ASS INC; Frimpong JA, 2011, TROP MED INT HEALTH, V16, P1225, DOI 10.1111/j.1365-3156.2011.02824.x; Garcia-Prado A., 2005, 3772 WORLD BANK; Government of Tanzania, 2015, BRN HEALTHC NKRA LAB; Hagopian A, 2009, HEALTH AFFAIR, V28, pW863, DOI 10.1377/hlthaff.28.5.w863; Harding R, 2014, PALLIATIVE MED, V28, P293, DOI 10.1177/0269216313498637; Henderson LN, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-18; Hongoro C, 2004, LANCET, V364, P1451, DOI 10.1016/S0140-6736(04)17229-2; Hornby P., 1988, MOTIVATION HLTH SERV; Jayasuriya R, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-156; Joint Learning Initiative, 2006, HLTH WORKFORCE AFRIC; King L A, 2006, Curationis, V29, P70; Kontodimopoulos N, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-164; Kruk ME, 2009, AM J PUBLIC HEALTH, V99, P1666, DOI 10.2105/AJPH.2008.146209; Lambdin BH, 2011, JAIDS-J ACQ IMM DEF, V57, pE33, DOI 10.1097/QAI.0b013e3182167e90; Lambrou P, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-26; Leshabari Melkidezek T, 2008, East Afr J Public Health, V5, P32; Manongi R, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-154; Manongi Rachel N, 2006, Hum Resour Health, V4, P6, DOI 10.1186/1478-4491-4-6; Mathauer I, 2006, HUM RESOUR HLTH, V4; Mbindyo P, 2009, IMPLEMENT SCI, V4; Mbindyo PM, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-40; Mccoy D, 2008, LANCET, V371, P675, DOI 10.1016/S0140-6736(08)60306-2; MSH/FPMD, 1998, HLTH FAM PLANN MAN T, V2015; Mubyazi GM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-48; Mutale W, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-8; Narasimhan V, 2004, LANCET, V363, P1469, DOI 10.1016/S0140-6736(04)16108-4; Nilseng J, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-78; NIMR, 2012, SIT AN EX TASK SHIFT; Organization WH, 2014, 3 GLOB FOR HUM RES H; Penn-Kekana L, NURSING STAFF DYNAMI; Picazo O, 2007, PET QSDS TEAM MOH U; Prytherch H, 2012, RURAL REMOTE HEALTH, V12; Prytherch H, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI [10.3402/gha.v5i0.19120, 10.3402/gha.v510.19120]; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Ryan RM, 2000, CONTEMP EDUC PSYCHOL, V25, P54, DOI 10.1006/ceps.1999.1020; Sararaks S, 1999, Med J Malaysia, V54, P310; Sato M, 2014, 3 GLOB S HLTH SYST R; Soeters R, 2006, B WORLD HEALTH ORGAN, V84, P884; Songstad NG, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-34; Stringhini S, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-53; Tache Stephanie, 2010, J Health Organ Manag, V24, P288; [USAID/PMI USAID], 2011, FY2011 MAL OP PLAN M; Wiedenmayer Karin A, 2015, J Pharm Policy Pract, V8, P13, DOI 10.1186/s40545-015-0032-8; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	58	9	9	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176973	10.1371/journal.pone.0176973	http://dx.doi.org/10.1371/journal.pone.0176973			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475644	Green Published, gold, Green Submitted			2022-12-27	WOS:000400649500033
J	Shen, XP; Bao, WJ; Yu, W; Liang, R; Nguyen, B; Liu, Y				Shen, Xiaopeng; Bao, Wenjing; Yu, Wei; Liang, Rui; Nguyen, Bao; Liu, Yu			An improved method with high sensitivity and low background in detecting low beta-galactosidase expression in mouse embryos	PLOS ONE			English	Article							MESP1; DIFFERENTIATION; CELLS	LacZ is widely used as a reporter in studies of gene expression patterns. beta-galactosidase, the product of LacZ gene, is usually detected by X-gal/FeCN staining. In X-gal/FeCN staining, beta-galactosidase catalyzes X-gal to produce blue precipitates, which indicate the expression patterns of the gene of interest. A newer LacZ detection method using S-gal/TNBT is more sensitive but plagued by high background. Here, we describe an improved procedure that combines advantageous steps from the two methods. By comparing with X-gal/FeCN and S-gal/TNBT methods in detecting the expression patterns of miR-322/503 and miR-451 at a series of developmental stages, the improved method showed higher sensitivity and lower background. Thus, the improved method could be an alternative way of beta-galactosidase staining in low gene expression situations.	[Shen, Xiaopeng; Yu, Wei; Liang, Rui; Nguyen, Bao; Liu, Yu] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Shen, Xiaopeng] Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China; [Bao, Wenjing] Liaoning Univ Tradit Chinese Med, Dept Med, Shenyang, Peoples R China	University of Houston System; University of Houston; Anhui Normal University; Liaoning University of Traditional Chinese Medicine	Shen, XP; Liu, Y (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.; Shen, XP (corresponding author), Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China.	shenxiaopeng_cn@ahnu.edu.cn; yliu54@uh.edu	Liang, Rui/AAI-2650-2019; Liu, Yu/F-2802-2015	Liang, Rui/0000-0002-4939-9281; Liu, Yu/0000-0002-1282-4897; Shen, Xiaopeng/0000-0002-6116-635X	University of Houston; American Heart Association grants [11SDG55260033, 16GRNT27760164]	University of Houston; American Heart Association grants(American Heart Association)	This work was supported by funds from the University of Houston (to YL) and American Heart Association grants 11SDG55260033 and 16GRNT27760164 (to YL).	BONNEROT C, 1993, METHOD ENZYMOL, V225, P451; COTSON S, 1958, PROC R SOC SER B-BIO, V148, P506, DOI 10.1098/rspb.1958.0042; GUGLIOTTA P, 1992, EUR J HISTOCHEM, V36, P143; Kishigami S, 2006, GENESIS, V44, P57, DOI 10.1002/gene.20186; Liang R, 2016, JOVE-J VIS EXP, DOI 10.3791/54078; LOJDA Z, 1970, HISTOCHEMISTRY, V22, P347; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Patrick DM, 2010, GENE DEV, V24, P1614, DOI 10.1101/gad.1942810; PEARSON B, 1963, LAB INVEST, V12, P1249; Peng XP, 2015, BBA-MOL BASIS DIS, V1852, P1490, DOI 10.1016/j.bbadis.2015.04.010; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1996, DEVELOPMENT, V122, P2769; Shen X, 2016, P NATL ACAD SCI; Soibam B, 2015, STEM CELLS, V33, P3254, DOI 10.1002/stem.2111; Stefanescu E, 1999, Rev Med Chir Soc Med Nat Iasi, V103, P182; STEVENS ME, 1989, EXP CELL RES, V183, P319, DOI 10.1016/0014-4827(89)90392-3; Sundararajan S, 2012, DEVELOPMENT, V139, P4484, DOI 10.1242/dev.078790; Trifonov S, 2016, ANAT SCI INT, V91, P56, DOI 10.1007/s12565-015-0300-3; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110	19	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176915	10.1371/journal.pone.0176915	http://dx.doi.org/10.1371/journal.pone.0176915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475610	Green Published, Green Submitted, gold			2022-12-27	WOS:000400649500027
J	Christodoulides, N; Van Dam, AR; Peterson, DA; Frandsen, RJN; Mortensen, UH; Petersen, B; Rasmussen, S; Normark, BB; Hardy, NB				Christodoulides, Nicholas; Van Dam, Alex R.; Peterson, Daniel A.; Frandsen, Rasmus John Normand; Mortensen, Uffe Hasbro; Petersen, Bent; Rasmussen, Simon; Normark, Benjamin B.; Hardy, Nate B.			Gene expression plasticity across hosts of an invasive scale insect species	PLOS ONE			English	Article							RUSSIAN WHEAT; PEA APHID; RNA-SEQ; PLANT; TRANSCRIPTOME; ADAPTATION; DETOXIFICATION; ANNOTATION; MECHANISMS; EVOLUTION	For plant-eating insects, we still have only a nascent understanding of the genetic basis of host-use promiscuity. Here, to improve that situation, we investigated host-induced gene expression plasticity in the invasive lobate lac scale insect, Paratachardina pseudolobata (Hemiptera: Keriidae). We were particularly interested in the differential expression of detoxification and effector genes, which are thought to be critical for overcoming a plant's chemical defenses. We collected RNA samples from P. pseudolobata on three different host plant species, assembled transcriptomes de novo, and identified transcripts with significant-host induced gene expression changes. Gene expression plasticity was pervasive, but the expression of most detoxification and effector genes was insensitive to the host environment. Nevertheless, some types of detoxification genes were more differentially expressed than expected by chance. Moreover, we found evidence of a trade-off between expression of genes involved in primary and secondary metabolism; hosts that induced lower expression of genes for detoxification induced higher expression of genes for growth. Our findings are largely consonant with those of several recently published studies of other plant-eating insect species. Thus, across plant-eating insect species, there may be a common set of gene expression changes that enable host-use promiscuity.	[Christodoulides, Nicholas; Hardy, Nate B.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Van Dam, Alex R.; Frandsen, Rasmus John Normand; Mortensen, Uffe Hasbro] Denmark Tech Univ, Dept Bioengn, Biosynthet Pathways Engn, Lyngby, Denmark; [Peterson, Daniel A.; Normark, Benjamin B.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Peterson, Daniel A.; Normark, Benjamin B.] Univ Massachusetts, Grad Program Organism & Evolutionary Biol, Amherst, MA 01003 USA; [Petersen, Bent; Rasmussen, Simon] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, Lyngby, Denmark; [Van Dam, Alex R.] Univ Puerto Rico, Dept Biol, Mayaguez, PR USA	Auburn University System; Auburn University; Technical University of Denmark; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Technical University of Denmark; University of Puerto Rico; University of Puerto Rico Mayaguez	Christodoulides, N (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	nzc0035@auburn.edu	Rasmussen, Simon/AAA-2308-2020; Rasmussen, Simon/G-6258-2016; Mortensen, Uffe/AAQ-1150-2021	Rasmussen, Simon/0000-0001-6323-9041; Rasmussen, Simon/0000-0001-6323-9041; Frandsen, Rasmus John Normand/0000-0002-3799-6062; Petersen, Bent/0000-0002-2472-8317	National Science foundation [DBI 1306489]; Alabama Agricultural Experiment Station	National Science foundation(National Science Foundation (NSF)); Alabama Agricultural Experiment Station	This work was supported by National Science foundation awarded to AVD. (DBI 1306489) https://www.nsf.gov/awardsearch/shotwAward?AWD_ID= 1306489. NC thanks the Auburn University Department of Entomology and Plant Pathology for research assistantship support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to Robin Giblin-Davis, William Kern, Ian Stocks, and Catherine Mannion for helping us find scale insects and learn the southern Florida flora. Thanks also to Mayrolin Garcia Morales for helping with the field work. NC thanks the Auburn University Department of Entomology and Plant Pathology for research assistantship support. We thank Marlene Dalgaard (DMAC) for use of their Qubit and Bioanalyzer. We thank Andrea Schreier for sample processing at UC Davis. We also thank Lutz Froenicke at UC Davis for advice on the sequencing scheme for this project. Funding: This work was supported by the National Science Foundation [DBI 1306489] awarded to AVD; and the Alabama Agricultural Experiment Station.	Adonizio AL, 2006, J ETHNOPHARMACOL, V105, P427, DOI 10.1016/j.jep.2005.11.025; Akhtar Y, 2012, IND CROP PROD, V37, P536, DOI [10.1016/j.indcrop.2011.07.033, 10.1016/j.indCrop.2011.07.033]; Alexa A, 2016, TOPGO ENRICHMENT ANA, V2; Alon M, 2012, INSECT BIOCHEM MOLEC, V42, P251, DOI 10.1016/j.ibmb.2011.12.007; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Bascompte J, 2007, APPL MATH, V101, P187; Bellafiore S, 2008, PLOS; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Brown CT, ARXIV201212034802, P1; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Celorio-Mancera MD, 2013, MOL ECOL, V22, P4884, DOI 10.1111/mec.12440; Cooper WR, 2010, ENVIRON ENTOMOL, V39, P223, DOI 10.1603/EN09079; Czosnek H, 2016, MANAGEMENT INSECT PE, P1, DOI [10.1007/978-3-319-24049-7, DOI 10.1007/978-3-319-24049-7]; Eyres I, 2016, MOL ECOL, V25, P4197, DOI 10.1111/mec.13771; Forister ML, 2014, P NATL ACAD SCI USA, V112, P1; Geldhof P, 2003, INT J PARASITOL, V33, P129, DOI 10.1016/S0020-7519(02)00260-6; Gilbert D, 2013, EVIDENTIALGENE MRNA; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Govind G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008735; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hardy NB, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0924; Harris MO, 2015, J EXP BOT, V66, P513, DOI 10.1093/jxb/eru465; Hoang K, 2015, MOL ECOL, V24, P5186, DOI 10.1111/mec.13388; Howard FW, 2014, CHAMBERLIN HEMIPTERA, P1; Iberkleid I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064586; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lukhele T, 2009, ISOLATION CHARACTERI; Mao WF, 2006, J CHEM ECOL, V32, P523, DOI 10.1007/s10886-005-9018-3; Melendez PA, 2006, PHYTOMEDICINE, V13, P272, DOI 10.1016/j.phymed.2004.11.009; Midiwo J, 1995, INT J; MILES PW, 1993, ENTOMOL EXP APPL, V67, P275, DOI 10.1007/BF02383437; Musacchia F, 2015, BIOINFORMATICS, V31, P2199, DOI 10.1093/bioinformatics/btv106; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; Pemberton RW, 2003, FLA ENTOMOL, V86, P353, DOI 10.1653/0015-4040(2003)086[0353:PFBCOT]2.0.CO;2; Pemberton RW, 2003, FLORIDA ENTOMOLOGIST, P373; Peng TF, 2016, INSECT BIOCHEM MOLEC, V75, P89, DOI 10.1016/j.ibmb.2016.06.002; Ragland GJ, 2015, MOL ECOL, V24, P2759, DOI 10.1111/mec.13191; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Ross L, 2012, LARGE POPULATION SIZ; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smith-Unna RD, 2015, BIORXIV, P21626; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Supek F, 1800, PLO E, V6; Vogel H, 2014, ANNU PLANT REV, V47, P197, DOI 10.1002/9781118472507.ch6; Volpicella M, 2011, CURR PROTEIN PEPT SC, V12, P386, DOI 10.2174/138920311796391098; Wang W, 2015, FASEB J, V29, P2032, DOI 10.1096/fj.14-266023; Will T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00336; Wybouw N, 2015, MOL ECOL, V24, P4647, DOI 10.1111/mec.13330; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	56	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176956	10.1371/journal.pone.0176956	http://dx.doi.org/10.1371/journal.pone.0176956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472112	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500102
J	Haaksma, ML; Vilela, LR; Marengoni, A; Calderon-Larranaga, A; Leoutsakos, JMS; Rikkert, MGMO; Melis, RJF				Haaksma, Miriam L.; Vilela, Lara R.; Marengoni, Alessandra; Calderon-Larranaga, Amaia; Leoutsakos, Jeannie-Marie S.; Rikkert, Marcel G. M. Olde; Melis, Rene J. F.			Comorbidity and progression of late onset Alzheimer's disease: A systematic review	PLOS ONE			English	Review							GENERAL MEDICAL HEALTH; FUNCTIONAL DECLINE; CO-MORBIDITY; COGNITIVE DECLINE; DEMENTIA; ILLNESS; CLASSIFICATION; MULTIMORBIDITY; ASSOCIATION; STRESS	Background Alzheimer's disease is a neurodegenerative syndrome characterized by multiple dimensions including cognitive decline, decreased daily functioning and psychiatric symptoms. This systematic review aims to investigate the relation between somatic comorbidity burden and progression in late-onset Alzheimer's disease (LOAD). Methods We searched four databases for observational studies that examined cross-sectional or longitudinal associations of cognitive or functional or neuropsychiatric outcomes with comorbidity in individuals with LOAD. From the 7966 articles identified originally, 11 studies were included in this review. The Newcastle-Ottawa quality assessment was used. The large variation in progression measures, comorbidity indexes and study designs hampered the ability to perform a meta-analysis. This review was registered with PROSPERO under DIO: 10.15124/CRD42015027046. Results Nine studies indicated that comorbidity burden was associated with deterioration in at least one of the three dimensions of LOAD examined. Seven out of ten studies investigating cognition found comorbidities to be related to decreased cognitive performance. Five out of the seven studies investigating daily functioning showed an association between comorbidity burden and decreased daily functioning. Neuropsychiatric symptoms (NPS) increased with increasing comorbidity burden in two out of three studies investigating NPS. Associations were predominantly found in studies analyzing the association cross-sectionally, in a time-varying manner or across short follow-up (<= 2 years). Rarely baseline comorbidity burden appeared to be associated with outcomes in studies analyzing progression over longer follow-up periods (>2 years). Conclusion This review provides evidence of an association between somatic comorbidities and multifaceted LOAD progression. Given that time-varying comorbidity burden, but much less so baseline comorbidity burden, was associated with the three dimensions prospectively, this relationship cannot be reduced to a simple cause-effect relation and is more likely to be dynamic. Therefore, both future studies and clinical practice may benefit from regarding comorbidity as a modifiable factor with a possibly fluctuating influence on LOAD.	[Haaksma, Miriam L.; Vilela, Lara R.; Rikkert, Marcel G. M. Olde; Melis, Rene J. F.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Geriatr Med, Nijmegen, Netherlands; [Haaksma, Miriam L.; Vilela, Lara R.; Rikkert, Marcel G. M. Olde; Melis, Rene J. F.] Radboud Univ Nijmegen, Radboudumc Alzheimer Ctr, Med Ctr, Nijmegen, Netherlands; [Marengoni, Alessandra; Calderon-Larranaga, Amaia] Karolinska Inst, Aging Res Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Marengoni, Alessandra; Calderon-Larranaga, Amaia] Stockholm Univ, Stockholm, Sweden; Univ Brescia, Dept Clin & Expt Sci, Brescia, Italy; [Calderon-Larranaga, Amaia] Miguel Servet Univ Hosp, Aragan Hlth Sci Inst, EpiChron Res Grp Chron Dis, IIS Aragan, Zaragoza, Spain; [Calderon-Larranaga, Amaia] Carlos III Hlth Inst, Red Invest Serv Salud Enfermedades Cron, Madrid, Spain; [Leoutsakos, Jeannie-Marie S.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD 21205 USA	Radboud University Nijmegen; Radboud University Nijmegen; Karolinska Institutet; Stockholm University; University of Brescia; Miguel Servet University Hospital; Johns Hopkins University	Melis, RJF (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Geriatr Med, Nijmegen, Netherlands.; Melis, RJF (corresponding author), Radboud Univ Nijmegen, Radboudumc Alzheimer Ctr, Med Ctr, Nijmegen, Netherlands.	rene.melis@radboudumc.nl	Haaksma, Miriam L/A-2772-2016; Calderón-Larrañaga, Amaia/ABC-6828-2021; Melis, René/J-5943-2012; Rikkert, Marcel Olde/D-9773-2012; Rikkert, M.G.M. Olde/H-8078-2014; Haaksma, Miriam/Q-5065-2019	Haaksma, Miriam L/0000-0002-3518-9152; Calderón-Larrañaga, Amaia/0000-0001-9064-9222; Melis, René/0000-0002-7863-4738; Rikkert, M.G.M. Olde/0000-0003-1397-1677; Haaksma, Miriam/0000-0002-3518-9152; marengoni, alessandra/0000-0002-4851-1825	NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aguero-Torres H, 1998, J AM GERIATR SOC, V46, P444, DOI 10.1111/j.1532-5415.1998.tb02464.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Aubert L, 2015, J AM GERIATR SOC, V63, P543, DOI 10.1111/jgs.13314; Baglietto-Vargas D, 2015, J NEUROCHEM, V134, P915, DOI 10.1111/jnc.13195; Boksay E, 2006, J AM GERIATR SOC, V54, P190; Boksay I, 2005, J AM GERIATR SOC, V53, P2235, DOI 10.1111/j.1532-5415.2005.00512_4.x; Carmichael O, 2010, ARCH NEUROL-CHICAGO, V67, P1370, DOI 10.1001/archneurol.2010.284; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coutu JP, 2017, NEUROBIOL AGING, V54, P1, DOI 10.1016/j.neurobiolaging.2017.02.005; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; Doraiswamy PM, 2002, J GERONTOL A-BIOL, V57, pM173, DOI 10.1093/gerona/57.3.M173; Duthie A, 2011, QJM-INT J MED, V104, P913, DOI 10.1093/qjmed/hcr118; FEENY D, 1995, PHARMACOECONOMICS, V7, P490, DOI 10.2165/00019053-199507060-00004; FEINSTEIN AR, 1970, J CHRON DIS, V23, P455, DOI 10.1016/0021-9681(70)90054-8; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Formiga F, 2009, J NUTR HEALTH AGING, V13, P423, DOI 10.1007/s12603-009-0078-x; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Gould CE, 2016, INT J GERIATRIC PSYC; Green C, 2016, ALZHEIMERS DEMENT, V12, P776, DOI 10.1016/j.jalz.2016.01.011; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jones JD, 2012, PARKINSONISM RELAT D, V18, P1073, DOI 10.1016/j.parkreldis.2012.06.004; Jyrkka J, 2011, PHARMACOEPIDEM DR S, V20, P514, DOI 10.1002/pds.2116; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kleisiaris C, 2015, EUR RESPIR J, V46, DOI 10.1183/13993003.congress-2015.PA2341; Lau DT, 2011, AM J ALZHEIMERS DIS, V26, P606, DOI 10.1177/1533317511432734; Laukka EJ, 2010, DEMENT GERIATR COGN, V29, P498, DOI 10.1159/000313978; Leoutsakos JMS, 2015, INT J GERIATR PSYCH, V30, P824, DOI 10.1002/gps.4221; Leoutsakos JMS, 2012, INT PSYCHOGERIATR, V24, P1561, DOI 10.1017/S104161021200049X; Liu-Seifert H, 2015, J ALZHEIMERS DIS, V47, P205, DOI 10.3233/JAD-142508; Liu-Seifert H, 2015, J ALZHEIMERS DIS, V43, P949, DOI 10.3233/JAD-140792; Lyketsos CG, 1999, J AM GERIATR SOC, V47, P487, DOI 10.1111/j.1532-5415.1999.tb07245.x; Malhotra RK, 2010, CLIN GERIATR MED, V26, P45, DOI 10.1016/j.cger.2009.11.001; Marengoni A, 2009, J INTERN MED, V265, P288, DOI 10.1111/j.1365-2796.2008.02017.x; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Melis RJF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084014; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Ooms S, 2016, CURRENT TREATMENT OP, V18, P1; Oosterveld SM, 2014, J ALZHEIMERS DIS, V42, P501, DOI 10.3233/JAD-140138; Panegyres Peter K, 2013, Am J Neurodegener Dis, V2, P300; Peavy GM, 2012, ALZ DIS ASSOC DIS, V26, P260, DOI 10.1097/WAD.0b013e3182389a9c; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Smith DJ, 2014, J CLIN PSYCHIAT, V75, P1202, DOI 10.4088/JCP.14m09147; Solomon A, 2011, INT J GERIATR PSYCH, V26, P1244, DOI 10.1002/gps.2670; Tekin S, 2001, AM J GERIAT PSYCHIAT, V9, P81, DOI 10.1176/appi.ajgp.9.1.81; Wells GA., 2015, NEWCASTLE OTTAWA SCA; Wickham S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105140; WILKINSON IM, 1980, BRIT J PSYCHIAT, V137, P558, DOI 10.1192/bjp.137.6.558; Zhao Y, 2008, BMC HEALTH SERV RES, V8, P1	50	53	53	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177044	10.1371/journal.pone.0177044	http://dx.doi.org/10.1371/journal.pone.0177044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472200	Green Submitted, gold, Green Published			2022-12-27	WOS:000400648500128
J	Wang, XQ; Song, F; Liu, YK				Wang, Xi-Qiao; Song, Fei; Liu, Ying-Kai			Hypertrophic scar regression is linked to the occurrence of endothelial dysfunction	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; FIBROBLAST-GROWTH; CELLS CONTRIBUTE; COLLAGEN; HYPOXIA; EXPRESSION; TISSUE	Most microvessels have been shown to become stenosed or completely occluded during hypertrophic scar progression. Here, we examined the morphology of capillary endothelial cells (ECs) and fibroblasts using immunofluorescence staining for CD31 and alpha-smooth muscle actin (alpha-SMA) and electron microscopy. In addition, ECs and fibroblasts were isolated from scar tissues, and the levels of transforming growth factor beta 1 (TGF-beta 1), platelet- derived growth factor (PDGF), endothelin 1 (ET-1), vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) were assayed using ELISAs. Furthermore, we assessed cell viability, total collagen production, and cell apoptosis in hypertrophic scar-derived fibroblasts cultured with EC-conditioned medium. Then, anti-TGF-beta 1, antiPDGF, anti-ET-1, anti-VEGF, and anti-bFGF neutralising antibodies were individually added to the EC medium to identify which growth factor plays a more important role in inhibiting fibroblasts biology. Our results showed microvessel lumen occlusion and EC atrophy during scar development, particularly in regressive scars (RSs). Additionally, EC growth factor secretion decreased and reached the lowest levels in RSs. Furthermore, based on the culture results, RS EC medium inhibited fibroblast viability and collagen production and induced apoptosis. Moreover, TGF-beta 1, PDGF, and bFGF played more important roles in these processes than VEGF and ET-1. The endothelial dysfunction occurring in hypertrophic scars contributes to fibroblast inhibition and scar regression, and reduced TGF-beta 1, PDGF, and bFGF levels play key roles during this process.	[Wang, Xi-Qiao; Song, Fei; Liu, Ying-Kai] Jiao Tong Univ, Ruijin Hosp, Burn Ctr, Med Sch, Shanghai, Peoples R China	Shanghai Jiao Tong University	Wang, XQ (corresponding author), Jiao Tong Univ, Ruijin Hosp, Burn Ctr, Med Sch, Shanghai, Peoples R China.	wxqiao2002@hotmail.com			National Natural Science Foundation of China [81671914]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 81671914), https://isisn.nsfc.gov.cn/egrantweb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner-Parzer SM, 2001, EXP CLIN ENDOCR DIAB, V109, pS166, DOI 10.1055/s-2001-18579; Belmadani S, 2008, AM J PHYSIOL-HEART C, V295, pH69, DOI 10.1152/ajpheart.00341.2008; CARLEY WW, 1992, AM J RESP CELL MOL, V7, P620, DOI 10.1165/ajrcmb/7.6.620; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Cohen Z, 1996, PROG NEUROBIOL, V50, P335, DOI 10.1016/S0301-0082(96)00033-0; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; FALANGA V, 1992, J SURG RES, V53, P515, DOI 10.1016/0022-4804(92)90099-L; Hirase T, 2012, AM J PHYSIOL-HEART C, V302, pH499, DOI 10.1152/ajpheart.00325.2011; Kose O, 2008, DERMATOL SURG, V34, P336, DOI 10.1111/j.1524-4725.2007.34067.x; Kopp J, 2005, J BIOL CHEM, V280, P21570, DOI 10.1074/jbc.m502071200; Kraling BM, 1998, IN VITRO CELL DEV-AN, V34, P308; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lario S, 2003, TRANSPLANTATION, V75, P1647, DOI 10.1097/01.TP.0000063128.86981.B2; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Li WH, 2009, BRAIN RES, V1287, P28, DOI 10.1016/j.brainres.2009.06.057; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Park JA, 2003, BIOCHEM BIOPH RES CO, V311, P247, DOI 10.1016/j.bbrc.2003.09.129; PELTONEN J, 1991, J INVEST DERMATOL, V97, P240, DOI 10.1111/1523-1747.ep12480289; PHILLIPS PG, 1995, AM J PHYSIOL-LUNG C, V268, pL789, DOI 10.1152/ajplung.1995.268.5.L789; Qing C, 2016, INT WOUND J, V13, P257, DOI 10.1111/iwj.12283; Reno F, 2003, WOUND REPAIR REGEN, V11, P331, DOI 10.1046/j.1524-475X.2003.11504.x; Rofstad EK, 2000, CANCER RES, V60, P4932; Salani D, 2000, AM J PATHOL, V157, P1537, DOI 10.1016/S0002-9440(10)64791-8; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Tabit CE, 2010, REV ENDOCR METAB DIS, V11, P61, DOI 10.1007/s11154-010-9134-4; TAN EML, 1995, BIOCHEM J, V310, P585, DOI 10.1042/bj3100585; Vane J R, 1992, J Physiol Pharmacol, V43, P195; Wang XQ, 2008, ENDOTHELIUM-J ENDOTH, V15, P113, DOI 10.1080/10623320802125169; Wang ZY, 2012, INT J LOW EXTR WOUND, V11, P271, DOI 10.1177/1534734612463698; Xi-Qiao W, 2009, MICROVASC RES, V77, P204, DOI 10.1016/j.mvr.2008.08.007; YOUNAI S, 1994, ANN PLAS SURG, V33, P148, DOI 10.1097/00000637-199408000-00005; Zhang LX, 2003, J SURG RES, V114, P262; Zheng JX, 2014, DERMATOL SURG, V40, P511, DOI 10.1111/dsu.12474; Zhu H, 2004, CELL PROLIFERAT, V37, P255, DOI 10.1111/j.1365-2184.2004.00310.x	34	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176681	10.1371/journal.pone.0176681	http://dx.doi.org/10.1371/journal.pone.0176681			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472181	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500063
J	Chen, YZ				Chen, Yuzhong			Scanning double-sided documents without incurring show-through by learning to fuse two complementary images using multilayer perceptron	PLOS ONE			English	Article								This paper presents a novel method for scanning duplex-printed documents without incurring the unwanted show-through artifact. The proposed method achieves the goal of eliminating the leaked-out reverse-side content by fusing a white backed scan image with a black backed scan image of the document. The fusion is accomplished using a multilayer perceptron having learned a fusion mapping from manually corrected document images. The main novel contributions of this work include (1) being the first to propose to accomplish the goal of show through free scanning by fusing a white backed scan image with a black backed scan image of the document; (2) proposing a learning approach using a multilayer perceptron to learn the fusion mapping from manually corrected scan images; and (3) proposing to use the pixel value histogram of reverse-side-printed area as well as the pixel value histogram of duplex-printed area to quantitatively indicate show through severity to facilitate objective comparison of the methods in consideration. The experiment results show that the proposed method is remarkably more powerful in eliminating show through than the two state-of-the-art methods in comparison.	[Chen, Yuzhong] Shandong Univ, Sch Mat Sci & Engn, Jinan, Peoples R China	Shandong University	Chen, YZ (corresponding author), Shandong Univ, Sch Mat Sci & Engn, Jinan, Peoples R China.	chenyz_sdu@163.com			Science and Technological Innovation Foundation of Shandong University	Science and Technological Innovation Foundation of Shandong University	The author would like to gratefully acknowledge the financial support of the Science and Technological Innovation Foundation of Shandong University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fan Z, 2011, United States Patent, Patent No. [7,965,421, 7965421]; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Knox K, 1998, U.S. Patent, Patent No. [5,832,137, 5832137]; Liu Q, 2013, IEEE CHIN SUMM INT C; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Merrikh-Bayat F, 2011, INT J DOC ANAL RECOG, V14, P319, DOI 10.1007/s10032-010-0131-7; Merrikh-Bayat F, 2010, LECT NOTES COMPUT SC, V6365, P482, DOI 10.1007/978-3-642-15995-4_60; MOLLER MF, 1993, NEURAL NETWORKS, V6, P525, DOI 10.1016/S0893-6080(05)80056-5; Raguram R, 2008, LECT NOTES COMPUT SC, V5303, P500, DOI 10.1007/978-3-540-88688-4_37; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Sharma G, 2001, IEEE T IMAGE PROCESS, V10, P736, DOI 10.1109/83.918567; Sharma G., 1998, U. S. Patent Application, Patent No. [09/200984, 09200984]; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; Tonazzini A, 2009, 10 INT C DOC AN REC; Tonazzini A, 2007, INT J DOC ANAL RECOG, V10, P17, DOI 10.1007/s10032-006-0015-z; Tuytelaars T., 2006, EUR C COMP VIS, V1, P404, DOI DOI 10.1007/11744023_32; Wu J, 2013, MEAS SCI REV, V13, P122, DOI 10.2478/msr-2013-0021	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176969	10.1371/journal.pone.0176969	http://dx.doi.org/10.1371/journal.pone.0176969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489900	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314100038
J	Currier, JS; Britto, P; Hoffman, RM; Brummel, S; Masheto, G; Joao, E; Santos, B; Aurpibul, L; Losso, M; Pierre, MF; Weinberg, A; Gnanashanmugam, D; Chakhtoura, N; Klingman, K; Browning, R; Coletti, A; Mofenson, L; Shapiro, D; Pilotto, J				Currier, Judith S.; Britto, Paula; Hoffman, Risa M.; Brummel, Sean; Masheto, Gaerolwe; Joao, Esau; Santos, Breno; Aurpibul, Linda; Losso, Marcelo; Pierre, Marie F.; Weinberg, Adriana; Gnanashanmugam, Devasena; Chakhtoura, Nahida; Klingman, Karin; Browning, Renee; Coletti, Anne; Mofenson, Lynne; Shapiro, David; Pilotto, Jose		1077HS PROMISE Team	Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 >= 400 cells/mm(3)	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV-1 INFECTION; CHILD TRANSMISSION; EFFICACY; PREVENTION; REGIMEN; MOTHERS; SAFETY	Background Health benefits of postpartum antiretroviral therapy (ART) for human immunodeficiency virus (HIV) positive women with high CD4+ T-counts have not been assessed in randomized trials. Methods Asymptomatic, HIV-positive, non-breastfeeding women with pre-ART CD4+ T-cell counts >= 400 cells/mm 3 started on ART during pregnancy were randomized up to 42 days after delivery to continue or discontinue ART. Lopinavir/ritonavir plus tenofovir/emtricitabine was the preferred ART regimen. The sample size was selected to provide 88% power to detect a 50% reduction from an annualized primary event rate of 2.07%. A post-hoc analysis evaluated HIV/AIDS-related and World Health Organization (WHO) Stage 2 and 3 events. All analyses were intent to treat. Results 1652 women from 52 sites in Argentina, Botswana, Brazil, China, Haiti, Peru, Thailand and the US were enrolled (1/2010-11/2014). Median age was 28 years and major racial categories were Black African (28%), Asian (25%) White (15%). Median entry CD4 count was 696 cells/mm(3) (IQR 575-869), median ART exposure prior to delivery was 19 weeks (IQR 13- 24) and 94% had entry HIV-1 RNA < 1000 copies/ml. After a median follow-up of 2.3 years, the primary composite endpoint rate was significantly lower than expected, and not significantly different between arms (continue arm 0.21/100 person years(py); discontinue 0.31/ 100 py, Hazard ratio (HR) 0.68, 95% CI: 0.19, 2.40). WHO Stage 2 and 3 events were significantly reduced with continued ART (2.08/100 py vs. 4.36/100 py in the discontinue arm; HR 0.48, 95% CI: 0.33, 0.70). Toxicity rates did not differ significantly between arms. Among women randomized to continue ART, 189/827 (23%) had virologic failure; of the 155 with resistance testing, 103 (66%) failed without resistance to their current regimen, suggesting non-adherence. Conclusions Overall, serious clinical events were rare among young HIV-positive post-partum women with high CD4 cell counts. Continued ART was safe and was associated with a halving of the rate of WHO 2/3 conditions. Virologic failure rates were high, underscoring the urgent need to improve adherence in this population.	[Currier, Judith S.; Hoffman, Risa M.] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Britto, Paula; Brummel, Sean; Shapiro, David] Harvard Univ, Ctr Biostat AIDS Res, TH Chan Sch Publ Hlth, Cambridge, MA 02138 USA; [Masheto, Gaerolwe] Botswana Harvard AIDS Partnership, Gaborone, Botswana; [Joao, Esau] Hosp Fed Serv Estado, Rio De Janeiro, Brazil; [Santos, Breno] Hosp Conceicao, Porto Alegre, RS, Brazil; [Aurpibul, Linda] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand; [Losso, Marcelo] Hosp JM Ramos Meija, HIV Unit, Buenos Aires, DF, Argentina; [Pierre, Marie F.] Ctr GHESKIO, Port Au Prince, Haiti; [Weinberg, Adriana] Univ Colorado Denver, Aurora, CO USA; [Chakhtoura, Nahida] NICHD, Washington, DC USA; [Gnanashanmugam, Devasena; Klingman, Karin; Browning, Renee] NIAID, NIH, Washington, DC USA; [Coletti, Anne] FHI360, Sci Facilitat, Durham, NC USA; [Mofenson, Lynne] Elizabeth Glaser Pediat AIDS Fdn, Washington, DC USA; [Pilotto, Jose] Inst Oswaldo Cruz, FIOCRUZ, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard T.H. Chan School of Public Health; Chiang Mai University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fundacao Oswaldo Cruz	Currier, JS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA.	jscurrier@mednet.ucla.edu	Aurpibul, Linda/AAA-6916-2021; Coutinho, Conrado Milani/I-2991-2019; Pilotto, Jose Henrique/AAD-9773-2019; Mofenson, Lynne/P-9631-2019	Coutinho, Conrado Milani/0000-0003-1966-0466; Pilotto, Jose Henrique/0000-0003-0521-8597; Mofenson, Lynne/0000-0002-2818-9808; Kreitchmann, Regis/0000-0002-1146-0497; SANTOS, BRENO/0000-0002-2888-2573; MONTALBAN, ESMELDA/0000-0002-7613-2857; Joao, Esau/0000-0002-2412-0627; Mursalin, Adi/0000-0002-1867-0868; Tongprasert, Fuanglada/0000-0001-7152-1952; Losso, Marcelo/0000-0002-4273-4833	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [UM1A1068632, UM1AI068616, UM1AI106716]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH); NIAID [5UM1AI068636]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068616, UM1AI069424, UM1AI069399, UM1AI069456, UM1AI069530, UM1AI106716, UM1AI068632, UM1AI068636] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1A1068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC) and UM1AI106716 (IMPAACT LC), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH). Overall support for the AIDS Clinical Trials Group (ACTG) was provided under NIAID Award Number 5UM1AI068636. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The NIH funders played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. Antiretroviral drugs were provided free of charge for this study by AbbVie, BristolMyers Squibb, Gilead Sciences, GlaxoSmithKlineNiiV, and Merck and Company. IMPACCT-http://impaactnetwork.org/. NIAID - https://www.niaid.nih.govi. NIH - https://wwwsiih.govt. NICHD - https://www.nichd.nih.gov/. NIMH - https://www.nimh.nih.gov/. ACTG - https:// actgnetwork.org/. AbbVie - www.abbvie.com/. BristolMyers Squibb - www.bms.com/. Gilead Sciences - www.gilead.com/. GlaxoSmithKlineNiiV - littps://www.gsk.com/ Merck and Company - www.merck.com/.	Adetokunboh OO, 2016, J INFECT PUBLIC HEAL, V9, P396, DOI 10.1016/j.jiph.2015.06.010; Cohan D, 2015, AIDS, V29, P183, DOI 10.1097/QAD.0000000000000531; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Coovadia HM, 2012, LANCET, V379, P221, DOI 10.1016/S0140-6736(11)61653-X; Coutsoudis A, 2013, LANCET, V381, P269, DOI 10.1016/S0140-6736(12)61807-8; COX DR, 1972, J R STAT SOC B, V34, P187; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Department of Health and Human Services (DHHS), 2012, PAN TREATM HIV INF P; Fisher R, 2012, J VIROL, V86, P6231, DOI 10.1128/JVI.06541-11; Govender T, 2014, J INFECTION, V68, pS57, DOI 10.1016/j.jinf.2013.09.015; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149527; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Matheson R, 2015, J INT AIDS SOC, V18, P50, DOI 10.7448/IAS.18.6.20286; Mbizvo M T, 2005, Cent Afr J Med, V51, P91; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0; Zheng Y, 2014, CLIN INFECT DIS, V59, P888, DOI 10.1093/cid/ciu367	21	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176009	10.1371/journal.pone.0176009	http://dx.doi.org/10.1371/journal.pone.0176009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489856	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314100011
J	Farris, DW; Cardona, A; Montes, C; Foster, D; Jaramillo, C				Farris, David W.; Cardona, Agustin; Montes, Camilo; Foster, David; Jaramillo, Carlos			Magmatic evolution of Panama Canal volcanic rocks: A record of arc processes and tectonic change	PLOS ONE			English	Article							AMERICAN LAND-BRIDGE; GEOCHEMICAL EVOLUTION; EARLY MIOCENE; COLLISION; COMPLEX; ORIGIN; SOUTH; CONSEQUENCES; TRANSITION; SUBDUCTION	Volcanic rocks along the Panama Canal present a world-class opportunity to examine the relationship between arc magmatism, tectonic forcing, wet and dry magmas, and volcanic structures. Major and trace element geochemistry of Canal volcanic rocks indicate a significant petrologic transition at 21-25 Ma. Oligocene Bas Obispo Fm. rocks have large negative Nb-Ta anomalies, low HREE, fluid mobile element enrichments, a THI of 0.88, and a H2Ocalc of >3 wt. %. In contrast, the Miocene Pedro Miguel and Late Basalt Fm. exhibit reduced Nb-Ta anomalies, flattened REE curves, depleted fluid mobile elements, a THI of 1.45, a H2Ocalc of < 1 wt. %, and plot in mid-ocean ridge/back-arc basin fields. Geochemical modeling of Miocene rocks indicates 0.5-0.1 kbar crystallization depths of hot (1100- 1190 degrees C) magmas in which most compositional diversity can be explained by fractional crystallization (F = 0.5). However, the most silicic lavas (Las Cascadas Fm.) require an additional mechanism, and assimilation-fractional-crystallization can reproduce observed compositions at reasonable melt fractions. The Canal volcanic rocks, therefore, change from hydrous basaltic pyroclastic deposits typical of mantle-wedge-derived magmas, to hot, dry bi-modal magmatism at the Oligocene-Miocene boundary. We suggest the primary reason for the change is onset of arc perpendicular extension localized to central Panama. High-resolution mapping along the Panama Canal has revealed a sequence of inward dipping maar-diatreme pyroclastic pipes, large basaltic sills, and bedded silicic ignimbrites and tuff deposits. These volcanic bodies intrude into the sedimentary Canal Basin and are cut by normal and subsequently strike-slip faults. Such pyroclastic pipes and basaltic sills are most common in extensional arc and large igneous province environments. Overall, the change in volcanic edifice form and geochemistry are related to onset of arc perpendicular extension, and are consistent with the idea that Panama arc crust fractured during collision with South America forming the observed Canal extensional zone.	[Farris, David W.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Cardona, Agustin] Univ Nacl Colombia, Medellin, Colombia; [Montes, Camilo] Yachay Tech Univ, Dept Geol Sci, San Jose De Urcuqui, Ecuador; [Foster, David] Univ Florida, Dept Geol Sci, Gainesville, FL USA; [Jaramillo, Carlos] Smithsonian Trop Res Inst, Unit 0948, APO, AA USA	State University System of Florida; Florida State University; Universidad Nacional de Colombia; State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian Tropical Research Institute	Farris, DW (corresponding author), Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA.	dwfarris@fsu.edu	Farris, David/AAK-5570-2020	Farris, David/0000-0002-8728-2746; jaramillo, carlos/0000-0002-2616-5079; Foster, David/0000-0002-5603-9372	National Science Foundation (NSF) PIRE [0966884]; NSF [DEB 0733725]; Smithsonian Institution; Panama Canal Authority; National Geographic; SENACYT; Ricardo Perez SA	National Science Foundation (NSF) PIRE; NSF(National Science Foundation (NSF)); Smithsonian Institution(Smithsonian Institution); Panama Canal Authority; National Geographic(National Geographic Society); SENACYT; Ricardo Perez SA	This contribution to the Panama Canal Project (PCP) was supported by National Science Foundation (NSF) PIRE grant 0966884 (OISE, EAR, DRL). Funding also came from NSF grant DEB 0733725, the Smithsonian Institution, the Panama Canal Authority, Mr. Mark Tupper, the National Geographic, SENACYT, and Ricardo Perez SA. Thanks go to the Panama Canal Authority, Ministerio de lndustria y Comercio, Odebretch for access and logistical help. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This contribution to the Panama Canal Project (PCP) was supported by National Science Foundation (NSF) PIRE grant 0966884 (OISE, EAR, DRL). Funding also came from NSF grant DEB-0733725, the Smithsonian Institution, the Panama Canal Authority, Mr. Mark Tupper, the National Geographic, SENACYT, and Ricardo Perez SA. Thanks go to the Panama Canal Authority, Ministerio de Industria y Comercio, Odebretch for access and logistical help.	Abratis M, 2001, GEOLOGY, V29, P127, DOI 10.1130/0091-7613(2001)029<0127:RCSWFA>2.0.CO;2; Arculus R.J., 1995, GEOPHYS MONOGR SER, P45; ARZI AA, 1978, TECTONOPHYSICS, V44, P173, DOI 10.1016/0040-1951(78)90069-0; Asimow PD, 1998, AM MINERAL, V83, P1127; Barat F, 2014, TECTONOPHYSICS, V622, P145, DOI 10.1016/j.tecto.2014.03.008; Bloch JI, 2016, NATURE, V533, P243, DOI 10.1038/nature17415; Buchs DM, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002901; Cassidy J, 2007, J VOLCANOL GEOTH RES, V159, P153, DOI 10.1016/j.jvolgeores.2006.06.007; DEFANT MJ, 1991, CONTRIB MINERAL PETR, V106, P309, DOI 10.1007/BF00324560; DEFANT MJ, 1992, J GEOL SOC LONDON, V149, P569, DOI 10.1144/gsjgs.149.4.0569; England P, 2004, GEOPHYS J INT, V156, P377, DOI 10.1111/j.1365-246X.2003.02132.x; Farris DW, 2011, GEOLOGY, V39, P1007, DOI 10.1130/G32237.1; Farris DW., GEOLOGICAL SOC AM AB, V45, P290; Fowler G. D., 2015, THESIS; Gazel E, 2015, NAT GEOSCI, V8, P321, DOI 10.1038/NGEO2392; Gazel E, 2011, LITHOS, V121, P117, DOI 10.1016/j.lithos.2010.10.008; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; Gill J., 1981, OROGENIC ANDESITES P; Giordano D., 2008, VISCOSITY MAGMATIC L, V271; Goss AR, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001163; GROVE TL, 1982, CONTRIB MINERAL PETR, V80, P160, DOI 10.1007/BF00374893; GROVE TL, 1984, J GEOPHYS RES, V89, P3253, DOI 10.1029/JB089iB05p03253; Hidalgo P. J., 2011, CONTRIBUTIONS MINERA; Hochstaedter AG, 2000, J GEOPHYS RES-SOL EA, V105, P495, DOI 10.1029/1999JB900125; Houghton BF, 1999, J VOLCANOL GEOTH RES, V91, P97, DOI 10.1016/S0377-0273(99)00058-X; Jamtveit B, 2004, GEOL SOC SPEC PUBL, V234, P233, DOI 10.1144/GSL.SP.2004.234.01.15; Kelemen P.B., 2007, TREATISE GEOCHEMISTR, V3, P1, DOI [10.1016/B0-08-043751-6/03035-8, DOI 10.1016/B0-08-043751-6/03035-8]; Kirby MX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002791; LEE JM, 1995, J GEOPHYS RES-SOL EA, V100, P17671, DOI 10.1029/95JB01685; Lorenz V., 1985, T GEOL SOC S AFR, V88, P459; Lorenz V, 2007, J VOLCANOL GEOTH RES, V159, P4, DOI 10.1016/j.jvolgeores.2006.06.019; Lutton R. J., 1970, 1 US ARM ENG WAT EXP; MacDonald D. F., 1915, SOME ENG PROBLEMS PA; MacFadden BJ, 2014, J GEOL, V122, P113, DOI 10.1086/675244; MacFadden BJ, 2010, J PALEONTOL, V84, P288, DOI 10.1666/09-064R.1; Molloy C, 2009, GEOL SOC AM BULL, V121, P1666, DOI 10.1130/B26447.1; Montes C., 2012, GEOLOGICAL SOC AM B; Mynhier K. N., 2015, THESIS; Peacock SM, 2001, GEOLOGY, V29, P299, DOI 10.1130/0091-7613(2001)029<0299:ATLPOD>2.0.CO;2; PEARCE JA, 1995, ANNU REV EARTH PL SC, V23, P251, DOI 10.1146/annurev.ea.23.050195.001343; PEARCE JA, 1984, J PETROL, V25, P956, DOI 10.1093/petrology/25.4.956; Perfit M. R., 1980, CHEM GEOL, V30, P1; Pratt TL, 2003, TECTONOPHYSICS, V368, P211, DOI 10.1016/S0040-1951(03)00159-8; Ramirez DA, 2016, GEOCHEM GEOPHY GEOSY, V17, P1758, DOI 10.1002/2016GC006289; Rockwell TK, 2010, TECTONICS, V29, DOI 10.1029/2009TC002571; Rollinson H.R, 1993, USING GEOCHEMICAL DA, P306; Rooney T. O., 2010, CONTRIBUTIONS MINERA; Rooney TO, 2015, GEOCHEM GEOPHY GEOSY, V16, P4178, DOI 10.1002/2015GC006150; RUDNICK RL, 1995, NATURE, V378, P571, DOI 10.1038/378571a0; Saginor I, 2013, GEOCHEM GEOPHY GEOSY, V14, P4504, DOI 10.1002/ggge.20259; SHERVAIS JW, 1982, EARTH PLANET SC LETT, V59, P101, DOI 10.1016/0012-821X(82)90120-0; Sisson TW, 1996, CONTRIB MINERAL PETR, V126, P81, DOI 10.1007/s004100050237; Smith IEM, 2006, J VOLCANOL GEOTH RES, V156, P315, DOI 10.1016/j.jvolgeores.2006.03.006; Stewart R. H., 1980, MISCELLANEOUS INVEST; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Svensen H, 2006, J GEOL SOC LONDON, V163, P671, DOI 10.1144/1144-764905-037; Svensen H, 2009, EARTH PLANET SC LETT, V277, P490, DOI 10.1016/j.epsl.2008.11.015; Syracuse EM, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001045; Tatsumi Y., 2005, GSA TODAY, V15; TAYLOR SR, 1995, REV GEOPHYS, V33, P241, DOI 10.1029/95RG00262; Wegner W, 2011, GEOL SOC AM BULL, V123, P703, DOI 10.1130/B30109.1; Whattam SA, 2012, LITHOS, V142, P226, DOI 10.1016/j.lithos.2012.02.017; White JDL, 2001, GEOLOGY, V29, P935, DOI 10.1130/0091-7613(2001)029<0935:IVCMFB>2.0.CO;2; Worner G, 2009, GEOL SOC AM MEM, V204, P183, DOI 10.1130/2009.1204(08); WOOD DA, 1980, EARTH PLANET SC LETT, V50, P11, DOI 10.1016/0012-821X(80)90116-8; Zimmer MM, 2010, J PETROL, V51, P2411, DOI 10.1093/petrology/egq062	66	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176010	10.1371/journal.pone.0176010	http://dx.doi.org/10.1371/journal.pone.0176010			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489866	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314100012
J	Lin, XL; Xu, Q; Tang, L; Sun, L; Han, T; Wang, LW; Xiao, XY				Lin, Xiao-Lin; Xu, Qi; Tang, Lei; Sun, Li; Han, Ting; Wang, Li-Wei; Xiao, Xiu-Ying			Regorafenib inhibited gastric cancer cells growth and invasion via CXCR4 activated Wnt pathway	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; CATENIN SIGNALING PATHWAY; DOUBLE-BLIND; DRUG-RESISTANCE; PLACEBO PLUS; CHEMOTHERAPY; ADENOCARCINOMA; OSTEOSARCOMA; ANGIOGENESIS; PROGRESSION	Aim Regorafenib is an oral small-molecule multi kinase inhibitor. Recently, several clinical trials have revealed that regorafenib has an anti-tumor activity in gastric cancer. However, only part of patients benefit from regorafenib, and the mechanisms of regorafenib's anti-tumor effect need further demonstrating. In this study, we would assess the potential anti-tumor effects and the underlying mechanisms of regorafenib in gastric cancer cells, and explore novel biomarkers for patients selecting of regorafenib. Methods The anti-tumor effects of regorafenib on gastric cancer cells were analyzed via cell proliferation and invasion. The underlying mechanisms were demonstrated using molecular biology techniques. Results We found that regorafenib inhibited cell proliferation and invasion at the concentration of 20 mu mol/L and in a dose dependent manner. The anti-tumor effects of regorafenib related to the decreased expression of CXCR4, and elevated expression and activation of CXCR4 could reverse the inhibition effect of regorafenib on gastric cancer cells. Further studies revealed that regorafenib reduced the transcriptional activity of Wnt/beta-Catenin pathway and led to decreased expression of Wnt pathway target genes, while overexpression and activation of CXCR4 could attenuate the inhibition effect of regorafenib on Wnt/beta-Catenin pathway. Conclusions Our findings demonstrated that regorafenib effectively inhibited cell proliferation and invasion of gastric cancer cells via decreasing the expression of CXCR4 and further reducing the transcriptional activity of Wnt/beta-Catenin pathway.	[Lin, Xiao-Lin; Xu, Qi; Tang, Lei; Sun, Li; Han, Ting; Wang, Li-Wei; Xiao, Xiu-Ying] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Oncol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Xiao, XY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Oncol, Shanghai, Peoples R China.	xiaoxiuying2002@163.com	HAN, TINGTING/GQZ-8692-2022	xiao, xiuying/0000-0002-9873-0380	National Natural Science Foundation of China [81101648]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81101648)	Bao W, 2011, GASTROENTEROLOGY, V141, P2076, DOI 10.1053/j.gastro.2011.08.050; Brenner B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157548; Burki TK, 2016, LANCET ONCOL, V17, pE323, DOI 10.1016/S1470-2045(16)30284-4; Calinescu AA, 2016, CLIN CANC RES; Chen DS, 2014, CLIN CANCER RES, V20, P3472, DOI 10.1158/1078-0432.CCR-13-2944; Chen L.T., 2017, CANC RES TREAT; Cristescu R, 2015, NAT MED, V21, P449, DOI 10.1038/nm.3850; Davis SL, 2013, DRUG TODAY, V49, P105, DOI 10.1358/dot.2013.49.2.1930525; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Fan DM, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0432-x; Fontanella R, 2016, CANCER LETT, V370, P100, DOI 10.1016/j.canlet.2015.10.018; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Gao DY, 2015, BIOMATERIALS, V67, P194, DOI 10.1016/j.biomaterials.2015.07.035; Garrido M, 2014, EXPERT REV ANTICANC, V14, P887, DOI 10.1586/14737140.2014.915194; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Guo ZJ, 2016, ONCOTARGET, V7, P20999, DOI 10.18632/oncotarget.8236; He HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071864; Ilson DH, 2014, LANCET, V383, P4, DOI 10.1016/S0140-6736(13)61892-9; Iwasa S, 2009, ANTICANCER RES, V29, P4751; Izumi D, 2016, INT J CANCER, V138, P1207, DOI 10.1002/ijc.29864; JANJIGIAN YY, 2015, J CLIN ONCOL S, V33; Jiang CM, 2017, BIOMED PHARMACOTHER, V86, P677, DOI 10.1016/j.biopha.2016.12.055; Jiang YY, 2016, ONCOGENE; Lee HJ, 2014, WORLD J GASTROENTERO, V20, P1681, DOI 10.3748/wjg.v20.i7.1681; Lee HJ, 2009, INT J ONCOL, V34, P473, DOI 10.3892/ijo_00000172; Li J, 2016, J CLIN ONCOL, V34, P1448, DOI 10.1200/JCO.2015.63.5995; Li J, 2015, LANCET ONCOL, V16, P619, DOI 10.1016/S1470-2045(15)70156-7; Lombardi L, 2013, CRIT REV ONCOL HEMAT, V88, P696, DOI 10.1016/j.critrevonc.2013.08.005; Nakamura T, 2015, ONCOTARGET, V6, P1008, DOI 10.18632/oncotarget.2826; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Pavlakis N, 2016, J CLIN ONCOL, V34, P2728, DOI 10.1200/JCO.2015.65.1901; Peng Y, 2017, CANCER LETT, V385, P117, DOI 10.1016/j.canlet.2016.10.035; Qiao JL, 2016, ONCOTARGET, V7, P46088, DOI 10.18632/oncotarget.10024; Riquelme I, 2015, ONCOTARGET, V6, P24750, DOI 10.18632/oncotarget.4990; Santos JC, 2016, CANC RES; Shah MA, 2010, JAMA-J AM MED ASSOC, V303, P1753, DOI 10.1001/jama.2010.553; Shirley M, 2015, DRUGS, V75, P1009, DOI 10.1007/s40265-015-0406-x; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6; Yi JH, 2012, BRIT J CANCER, V106, P1469, DOI 10.1038/bjc.2012.100; Yu J, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0340-8; Zhao SQ, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0103-8	46	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177335	10.1371/journal.pone.0177335	http://dx.doi.org/10.1371/journal.pone.0177335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489887	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314100063
J	Tenan, MS; Tweedell, AJ; Haynes, CA				Tenan, Matthew S.; Tweedell, Andrew J.; Haynes, Courtney A.			Analysis of statistical and standard algorithms for detecting muscle onset with surface electromyography	PLOS ONE			English	Article							BAYESIAN-ANALYSIS; R-PACKAGE; RECTIFICATION; EMG; ENTROPY; INPUT	The timing of muscle activity is a commonly applied analytic method to understand how the nervous system controls movement. This study systematically evaluates six classes of standard and statistical algorithms to determine muscle onset in both experimental surface electromyography (EMG) and simulated EMG with a known onset time. Eighteen participants had EMG collected from the biceps brachii and vastus lateralis while performing a biceps curl or knee extension, respectively. Three established methods and three statistical methods for EMG onset were evaluated. Linear envelope, Teager-Kaiser energy operator + linear envelope and sample entropy were the established methods evaluated while general time series mean/variance, sequential and batch processing of parametric and nonparametric tools, and Bayesian changepoint analysis were the statistical techniques used. Visual EMG onset (experimental data) and objective EMG onset (simulated data) were compared with algorithmic EMG onset via root mean square error and linear regression models for stepwise elimination of inferior algorithms. The top algorithms for both data types were analyzed for their mean agreement with the gold standard onset and evaluation of 95% confidence intervals. The top algorithms were all Bayesian changepoint analysis iterations where the parameter of the prior (p(0)) was zero. The best performing Bayesian algorithms were p(0) = 0 and a posterior probability for onset determination at 60-90%. While existing algorithms performed reasonably, the Bayesian changepoint analysis methodology provides greater reliability and accuracy when determining the singular onset of EMG activity in a time series. Further research is needed to determine if this class of algorithms perform equally well when the time series has multiple bursts of muscle activity.	[Tenan, Matthew S.; Tweedell, Andrew J.; Haynes, Courtney A.] US Army Res Lab, Human Res & Engn Directorate, Integrated Capabil Enhancement Branch, Aberdeen Proving Ground, MD 21010 USA	United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL)	Tenan, MS (corresponding author), US Army Res Lab, Human Res & Engn Directorate, Integrated Capabil Enhancement Branch, Aberdeen Proving Ground, MD 21010 USA.	matthew.s.tenan.civ@mail.mil		Tenan, Matthew/0000-0003-2215-0846				Addona V, 2010, JQAS, V6, P17; Almog M, 2016, J NEUROPHYSIOL, V116, P2180, DOI 10.1152/jn.00360.2016; BARRY D, 1993, J AM STAT ASSOC, V88, P309, DOI 10.1080/01621459.1993.10594323; Bennell K, 2010, MED SCI SPORT EXER, V42, P856, DOI 10.1249/MSS.0b013e3181c12771; Boonstra TW, 2010, J NEUROPHYSIOL, V104, P576, DOI 10.1152/jn.00258.2010; Box George E. P., 1979, ROBUSTNESS STAT, P201, DOI 10.1016/B978-0-12-438150-6.50018-2; Dakin CJ, 2014, J NEUROPHYSIOL, V112, P1685, DOI 10.1152/jn.00296.2014; Donges JF, 2015, CHAOS, V25, DOI 10.1063/1.4934554; Erdman C, 2007, J STAT SOFTW, V23, P1; Erdman C, 2008, BIOINFORMATICS, V24, P2143, DOI 10.1093/bioinformatics/btn404; Gao ZK, 2016, EPL-EUROPHYS LETT, V116, DOI 10.1209/0295-5075/116/50001; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35622; Halliday DM, 2010, J NEUROPHYSIOL, V103, P3547, DOI 10.1152/jn.00222.2010; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; Kaiser J. F., 1990, INT C AC SPEECH SIGN; Kaiser JF, 1993, INT C AC SPEECH SIGN; Killick R, 2014, J STAT SOFTW, V58, P1; Kortsch S, 2012, P NATL ACAD SCI USA, V109, P14052, DOI 10.1073/pnas.1207509109; Li XY, 2007, ANN BIOMED ENG, V35, P1532, DOI 10.1007/s10439-007-9320-z; LYONS K, 1983, PHYS THER, V63, P1597, DOI 10.1093/ptj/63.10.1597; PINCUS SM, 1991, J CLIN MONITOR, V7, P335, DOI 10.1007/BF01619355; Neto OP, 2010, J NEUROPHYSIOL, V103, P1093, DOI 10.1152/jn.00792.2009; R Core Team, 2013, R LANG ENV STAT COMP; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; ROSS GJ, 2015, J STAT SOFTW, V66, P1, DOI [DOI 10.18637/JSS.V066.I03, 10.18637/jss.v066.i03]; Socher R, 2011, P 28 INT C MACH LEAR; Solnik S, 2010, EUR J APPL PHYSIOL, V110, P489, DOI 10.1007/s00421-010-1521-8; Sutherland DH, 2001, GAIT POSTURE, V14, P61, DOI 10.1016/S0966-6362(01)00100-X; VANBOXTEL GJM, 1993, PSYCHOPHYSIOLOGY, V30, P405; Winter D, 2005, BIOMECHANICS MOTOR C; YAO YC, 1984, ANN STAT, V12, P1434, DOI 10.1214/aos/1176346802; Zhang X, 2012, J ELECTROMYOGR KINES, V22, P901, DOI 10.1016/j.jelekin.2012.06.005	33	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177312	10.1371/journal.pone.0177312	http://dx.doi.org/10.1371/journal.pone.0177312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489897	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100060
J	Deshmukh, M; Patole, S				Deshmukh, Mangesh; Patole, Sanjay			Antenatal corticosteroids for neonates born before 25 Weeks-A systematic review and meta-analysis	PLOS ONE			English	Review							RESPIRATORY-DISTRESS-SYNDROME; EXTREMELY PRETERM INFANTS; NEURODEVELOPMENTAL OUTCOMES; PREMATURE-INFANTS; PERIVENTRICULAR LEUKOMALACIA; GLUCOCORTICOID TREATMENT; RESEARCH NETWORK; WEEKS GESTATION; PERINATAL-CARE; FETAL LUNG	Background Efficacy of antenatal corticosteroids before 25 weeks of gestation is unclear. Objective To assess and compare neonatal outcomes following ANC exposure at 22, 23 and 24 weeks of gestation by conducting systematic review and meta-analysis. Methods A systematic review of randomised controlled trials (RCT) and non-RCTs reporting on neonatal outcomes after exposure to ANC up to 24(6) weeks of gestation using the Cochrane systematic review methodology. Databases Pubmed, CINAHL, Embase, Cochrane Central library, and online abstracts of conference proceedings including the Pediatric Academic Society (PAS) were searched in Feb 2017. Primary outcome was in-hospital mortality defined as death before discharge during the first admission. Secondary outcomes included severe intraventricular hemorrhage (IVH> grade III and IV)/or periventricular leukomalacia (PVL), necrotising enterocolitis (NEC > stage II) and chronic lung disease (CLD). Meta-analysis was performed using a random-effects model. The level of evidence (LOE) was summarised using the GRADE guidelines. Main results There were no RCTs; 8 high quality non-RCTs were included in the review. Meta-analysis showed reduction in mortality [N = 10109; OR = 0.47(0.39-0.56), p< 0.00001; LOE: Moderate] and severe IVH and PVL [N = 5084; OR = 0.71(0.61-0.82), p< 0.00001; LOE: Low] after exposure to ANC in neonates born < 25 weeks. There was no significant difference in CLD [N = 4649; OR = 1.19(0.85-1.65) p = 0.31; LOE: Low] and NEC [N = 5403; OR = 0.95 (0.76-1.19) p = 0.65; LOE: Low]. Mortality was comparable in neonates born at 22, 23 or 24 weeks. Conclusion Moderate to low quality evidence indicates that exposure to ANC is associated with reduction in mortality and IVH/or PVL in neonates born before 25 weeks.	[Deshmukh, Mangesh] St John God Hosp, Dept Neonatal Pediat, Subiaco, WA, Australia; [Deshmukh, Mangesh] Fiona Stanley Hosp, Dept Neonatal Pediat, Perth, WA, Australia; [Patole, Sanjay] King Edward Mem Hosp, Dept Neonatal Pediat, Perth, WA, Australia; [Patole, Sanjay] Univ Western Australia, Ctr Neonatal Res & Educ, Perth, WA, Australia	St John of God Health Care; King Edward Memorial Hospital; University of Western Australia	Deshmukh, M (corresponding author), St John God Hosp, Dept Neonatal Pediat, Subiaco, WA, Australia.	Mangesh.deshmukh@health.wa.gov.au		Deshmukh, Mangesh/0000-0002-7485-4776				Ancel PY, 2015, JAMA PEDIATR, V169, P230, DOI 10.1001/jamapediatrics.2014.3351; [Anonymous], 2016, Obstet Gynecol, V127, pe157, DOI 10.1097/AOG.0000000000001483; [Anonymous], 2015, Obstet Gynecol, V126, pe82, DOI 10.1097/AOG.0000000000001105; Antenatal Corticosteroids Clinical Practice Guidelines Panel, 2015, ANT CORT GIV WOM PRI; Bader D, 2010, PEDIATRICS, V125, P696, DOI 10.1542/peds.2009-1607; Bajwa NM, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13212; BALLARD PL, 1995, AM J OBSTET GYNECOL, V173, P254, DOI 10.1016/0002-9378(95)90210-4; Baud O, 1999, NEW ENGL J MED, V341, P1190, DOI 10.1056/NEJM199910143411604; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bolisetty S, 2014, PEDIATRICS, V133, P55, DOI 10.1542/peds.2013-0372; Bonanno C, 2012, OBSTET GYN CLIN N AM, V39, P47, DOI 10.1016/j.ogc.2011.12.006; Campbell DE, 2001, AM J PERINAT, V18, P117, DOI 10.1055/s-2001-14530; Canterino JC, 2001, OBSTET GYNECOL, V97, P135, DOI 10.1016/S0029-7844(00)01124-8; Carlo WA, 2011, JAMA-J AM MED ASSOC, V306, P2348, DOI 10.1001/jama.2011.1752; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gallagher K, 2016, ARCH DIS CHILD-FETAL, V101, P31, DOI 10.1136/archdischild-2014-308071; GONZALES LW, 1986, J CLIN ENDOCR METAB, V62, P678, DOI 10.1210/jcem-62-4-678; Guinsburg R, 2016, J MATERN-FETAL NEO M, V29, P1005, DOI 10.3109/14767058.2015.1031740; Guthrie Scott O, 2003, J Perinatol, V23, P278, DOI 10.1038/sj.jp.7210892; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P158, DOI 10.1016/j.jclinepi.2012.01.012; Haward MF, 2011, CLIN PERINATOL, V38, P471, DOI 10.1016/j.clp.2011.06.004; Hayes EJ, 2008, OBSTET GYNECOL, V111, P921, DOI 10.1097/AOG.0b013e318169ce2d; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Holsti A, 2016, ACTA PAEDIAT; Joan Crane AA, 2003, J OBSTET GYNAECOL CA, V25, P45; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; KARI MA, 1994, PEDIATRICS, V93, P730; KITCHENS CS, 1986, BLOOD, V67, P203; Lefebvre C ME, 2011, SEARCHING FOR STUDIE; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Lui K, 2006, MED J AUSTRALIA, V185, P495, DOI 10.5694/j.1326-5377.2006.tb00664.x; Manktelow BN, 2010, ARCH DIS CHILD-FETAL, V95, pF95, DOI 10.1136/adc.2009.170340; Mehler K, 2016, JAMA PEDIATR, V170, P671, DOI 10.1001/jamapediatrics.2016.0207; Mori R, 2011, J PEDIATR-US, V159, P110, DOI 10.1016/j.jpeds.2010.12.039; Mukerji A, 2015, PEDIATRICS, V136, P1132, DOI 10.1542/peds.2015-0944; OBrodovich HM, 1996, P ASSOC AM PHYSICIAN, V108, P345; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Park CK, 2016, OBSTET GYNECOL, V127, P715, DOI 10.1097/AOG.0000000000001355; Pignotti MS, 2008, PEDIATRICS, V121, pE193, DOI 10.1542/peds.2007-0513; Polk DH, 1997, AM J OBSTET GYNECOL, V176, P308, DOI 10.1016/S0002-9378(97)70490-3; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Roberts D., 2010, GREEN TOP GUIDELINE; Ruzek MC, 1999, J IMMUNOL, V162, P3527; SCHITTNY JC, 2008, FISHMANS PULMONARY D, P91; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tassani P, 1999, J CARDIOTHOR VASC AN, V13, P165, DOI 10.1016/S1053-0770(99)90081-2; Wapner RJ, 2013, SEMIN PERINATOL, V37, P410, DOI 10.1053/j.semperi.2013.06.024; Wells GA., 2015, NEWCASTLE OTTAWA SCA	50	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176090	10.1371/journal.pone.0176090	http://dx.doi.org/10.1371/journal.pone.0176090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486556	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314000007
J	Thiesen, HJ; Steinbeck, F; Maruschke, M; Koczan, D; Ziems, B; Hakenberg, OW				Thiesen, H. -J.; Steinbeck, F.; Maruschke, M.; Koczan, D.; Ziems, B.; Hakenberg, O. W.			Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VHL GENE; TUMOR AGGRESSIVENESS; POOR SURVIVAL; WHOLE-EXOME; CANCER; EXPRESSION; MUTATIONS; DISEASE; PATTERNS	Tumorigenic processes are understood to be driven by epi-/genetic and genomic alterations from single point mutations to chromosomal alterations such as insertions and deletions of nucleotides up to gains and losses of large chromosomal fragments including products of chromosomal rearrangements e.g. fusion genes and proteins. Overall comparisons of copy number alterations (CNAs) presented in 48 clear cell renal cell carcinoma (ccRCC) genomes resulted in ratios of gene losses versus gene gains between 26 ccRCC Fuhrman malignancy grades G1 (ratio 1.25) and 20 G3 (ratio 0.58). Gene losses and gains of 15762 CNA genes were mapped to 795 chromosomal cytoband loci including 280 KEGG path-ways. CNAs were classified according to their contribution to Fuhrman tumour gradings G1 and G3. Gene gains and losses turned out to be highly structured processes in ccRCC genomes enabling the subclassification and stratification of ccRCC tumours in a genome-wide manner. CNAs of ccRCC seem to start with common tumour related gene losses flanked by CNAs specifying Fuhrman grade G1 losses and CNA gains favouring grade G3 tumours. The appearance of recurrent CNA signatures implies the presence of causal mechanisms most likely implicated in the pathogenesis and disease-outcome of ccRCC tumours distinguishing lower from higher malignant tumours. The diagnostic quality of initial 201 genes (108 genes supporting G1 and 93 genes G3 phenotypes) has been successfully validated on published Swiss data (GSE19949) leading to a restricted CNA gene set of 171 CNA genes of which 85 genes favour Fuhrman grade G1 and 86 genes Fuhrman grade G3. Regarding these gene sets overall survival decreased with the number of G3 related gene losses plus G3 related gene gains. CNA gene sets presented define an entry to a gene-directed and pathway-related functional understanding of ongoing copy number alterations within and between individual ccRCC tumours leading to CNA genes of prognostic and predictive value.	[Thiesen, H. -J.; Steinbeck, F.; Koczan, D.] Univ Rostock, Inst Immunol, Rostock, Germany; [Maruschke, M.; Hakenberg, O. W.] Univ Rostock, Dept Urol, Rostock, Germany; [Maruschke, M.] HELIOS Hanseklinikum Stralsund, Dept Urol, Stralsund, Germany; [Ziems, B.] Steinbeis Ctr Proteome Anal, Rostock, Germany	University of Rostock; University of Rostock	Thiesen, HJ (corresponding author), Univ Rostock, Inst Immunol, Rostock, Germany.	hans-juergen.thiesen@med.uni-rostock.de			Research Executive Agency (IRSES grant) [269186]; German Federal Ministry of Education and Research (BMBF grant BioChancePLUS-2) [0313692A]	Research Executive Agency (IRSES grant); German Federal Ministry of Education and Research (BMBF grant BioChancePLUS-2)(Federal Ministry of Education & Research (BMBF))	The work has been supported by the Research Executive Agency (IRSES grant: 269186) and the German Federal Ministry of Education and Research (BMBF grant BioChancePLUS-2: 0313692A).	Adibi M, 2015, UROL ONCOL-SEMIN ORI, V33, P528, DOI 10.1016/j.urolonc.2015.10.003; Arai E, 2014, INT J CANCER, V135, P1330, DOI 10.1002/ijc.28768; Aron M, 2008, EUR UROL, V54, P133, DOI 10.1016/j.eururo.2007.12.001; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Beleut M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161514; Beleut M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-310; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bhatt JR, 2014, NAT REV UROL, V11, P517, DOI 10.1038/nrurol.2014.194; Brugarolas J, 2014, J CLIN ONCOL, V32, P1968, DOI 10.1200/JCO.2012.45.2003; Chen FJ, 2016, CELL REP, V14, P2476, DOI 10.1016/j.celrep.2016.02.024; Chen M, 2009, INT J CANCER, V125, P2342, DOI 10.1002/ijc.24642; Choueiri TK, 2008, J UROLOGY, V180, P860, DOI 10.1016/j.juro.2008.05.015; Chow WH, 1999, JAMA-J AM MED ASSOC, V281, P1628, DOI 10.1001/jama.281.17.1628; Cifola I, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-6; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dituri F, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/947858; Dondeti VR, 2012, CANCER RES, V72, P112, DOI 10.1158/0008-5472.CAN-11-1698; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gandolfi G, 2015, PIGMENT CELL MELANOM; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gerstung M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1814; Girgis AH, 2012, CANCER RES, V72, P5273, DOI 10.1158/0008-5472.CAN-12-0656; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gomez-Rueda H, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-015-0065-1; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Guinan P, 1997, CANCER, V80, P992, DOI 10.1002/(SICI)1097-0142(19970901)80:5<992::AID-CNCR26>3.0.CO;2-Q; Gunawan B, 2001, CANCER RES, V61, P7731; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Haddad AQ, 2015, NAT REV UROL, V12, P253, DOI 10.1038/nrurol.2015.71; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; Higgins JPT, 2006, THESCIENTIFICWORLDJO, V6, P502, DOI 10.1100/tsw.2006.109; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hoglund M, 2004, CANCER GENET CYTOGEN, V153, P1, DOI 10.1016/j.cancergencyto.2003.12.019; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kapur P, 2013, LANCET ONCOL, V14, P159, DOI 10.1016/S1470-2045(12)70584-3; Klatte T, 2009, J CLIN ONCOL, V27, P746, DOI 10.1200/JCO.2007.15.8345; Kondo K, 2002, GENE CHROMOSOME CANC, V34, P58, DOI 10.1002/gcc.10054; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; Krill-Burger JM, 2012, AM J PATHOL, V180, P2427, DOI 10.1016/j.ajpath.2012.01.044; Kroeger N, 2013, CANCER-AM CANCER SOC, V119, P1547, DOI 10.1002/cncr.27947; Kwiatkowski DJ, 2016, CLIN CANCER RES, V22, P2445, DOI 10.1158/1078-0432.CCR-15-2631; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee E, 2015, HUM PATHOL, V46, P1111, DOI 10.1016/j.humpath.2015.04.009; Maher ER, 2013, SEMIN CANCER BIOL, V23, P10, DOI 10.1016/j.semcancer.2012.06.003; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Maruschke M, 2011, UROL INT, V87, P205, DOI 10.1159/000328196; Maruschke M, 2011, BJU INT, V108, pE29, DOI 10.1111/j.1464-410X.2010.09794.x; Matsuda D, 2008, CANCER LETT, V272, P260, DOI 10.1016/j.canlet.2008.06.015; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Moore LE, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.14; Neumann HPH, 1998, J UROLOGY, V160, P1248, DOI 10.1016/S0022-5347(01)62509-6; Nguyen MM, 2006, J UROLOGY, V176, P2397, DOI 10.1016/j.juro.2006.07.144; Parker AS, 2005, UROLOGY, V65, P1090, DOI 10.1016/j.urology.2004.12.040; Patard JJ, 2009, BRIT J CANCER, V101, P1417, DOI 10.1038/sj.bjc.6605298; Patard JJ, 2008, INT J CANCER, V123, P395, DOI 10.1002/ijc.23496; Riazalhosseini Y, 2016, NAT REV NEPHROL, V12, P655, DOI 10.1038/nrneph.2016.133; Rini BI, 2006, BJU INT, V98, P756, DOI 10.1111/j.1464-410X.2006.06376.x; Rydzanicz M, 2013, CANCER LETT, V341, P111, DOI 10.1016/j.canlet.2013.08.006; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Scelo G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6135; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slomovitz BM, 2012, CLIN CANCER RES, V18, P5856, DOI 10.1158/1078-0432.CCR-12-0662; Soares MJ, 2009, MODERN PATHOL, V22, P744, DOI 10.1038/modpathol.2009.43; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; Toma MI, 2008, NEOPLASIA, V10, P634, DOI 10.1593/neo.08160; Van Poppel H, 2011, EUR UROL, V60, P662, DOI 10.1016/j.eururo.2011.06.040; vandenBerg A, 1997, GENE CHROMOSOME CANC, V19, P228, DOI 10.1002/(SICI)1098-2264(199708)19:4<228::AID-GCC4>3.0.CO;2-Z; Wang XY, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0044-0; Wei EY, 2015, NAT REV UROL, V12, P706, DOI 10.1038/nrurol.2015.260; Yao M, 2002, JNCI-J NATL CANCER I, V94, P1569; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937	81	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176659	10.1371/journal.pone.0176659	http://dx.doi.org/10.1371/journal.pone.0176659			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486536	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314000021
J	Ganmaa, D; Stuart, JJ; Sumberzul, N; Ninjin, B; Giovannucci, E; Kleinman, K; Holick, MF; Willett, WC; Frazier, LA; Rich-Edwards, JW				Ganmaa, Davaasambuu; Stuart, Jennifer J.; Sumberzul, Nyamjav; Ninjin, Boldbaatar; Giovannucci, Edward; Kleinman, Ken; Holick, Michael F.; Willett, Walter C.; Frazier, Lindsay A.; Rich-Edwards, Janet W.			Vitamin D supplementation and growth in urban Mongol school children: Results from two randomized clinical trials	PLOS ONE			English	Article							D DEFICIENCY; AGE-CHILDREN; DOUBLE-BLIND; WEIGHT; GIRLS; WOMEN; MILK	Background Symptomatic vitamin D deficiency is associated with slowed growth in children. It is unknown whether vitamin D repletion in children with asymptomatic serum vitamin D deficiency can restore normal growth. Objective We tested the impact of vitamin D-supplementation on serum concentrations of 25-hydroxy-vitamin D [25(OH) D] and short-term growth in Mongol children, with very low serum vitamin D levels in winter. Design We conducted two randomized, double-blind, placebo-controlled trials in urban school age children without clinical signs of rickets. The Supplementation Study was a 6-month intervention with an 800 IU vitamin D-3 supplement daily, compared with placebo, in 113 children aged 12-15 years. A second study, the Fortification Study, was a 7-week intervention with 710 ml of whole milk fortified with 300 IU vitamin D3 daily, compared with unfortified milk, in 235 children aged 9-11 years. Results At winter baseline, children had low vitamin D levels, with a mean (+/- SD) serum 25-hydroxy-vitamin D [25(OH) D] concentration of 7.3 (+/- 3.9) ng/ml in the Supplementation Study and 7.5 (+/- 3.8) ng/ml in the Fortification Study. The serum levels increased in both vitamin D groups by 19.8 (+/- 5.1) ng/ml in the Supplementation Study, and 19.7 (+/- 6.1) ng/ml in the Fortification Study. Multivariable analysis showed a 0.9 (+/- 0.3 SE) cm greater increase in height in the vitamin-D treated children, compared to placebo treated children, in the 6-month Supplementation Study (p = 0.003). Although the children in the 7-week Fortification Study intervention arm grew 0.2 (+/- 0.1) cm more, on average, than placebo children this difference was not statistically significant (p = 0.2). There were no significant effects of vitamin D supplements on differences in changes in weight or body mass index in either trial. For the Fortification Study, girls gained more weight than boys while taking vitamin D 3 (p-value for interaction = 0.03), but sex was not an effect modifier of the relationship between vitamin D3 and change in either height or BMI in either trial. Conclusions Correcting vitamin D deficiency in children with very low serum vitamin D levels using 800 IU of vitamin D3 daily for six months increased growth, at least in the short-term, whereas, in a shorter trial of 300 IU of D fortified milk daily for 7 weeks did not.	[Ganmaa, Davaasambuu; Giovannucci, Edward; Willett, Walter C.; Frazier, Lindsay A.; Rich-Edwards, Janet W.] Harvard Med Sch, Brigham & Womens Hosp, Channing Lab, Boston, MA USA; [Ganmaa, Davaasambuu; Giovannucci, Edward; Willett, Walter C.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Ganmaa, Davaasambuu; Sumberzul, Nyamjav; Ninjin, Boldbaatar] Hlth Sci Univ Mongolia, Ulaanbaatar, Mongolia; [Stuart, Jennifer J.; Giovannucci, Edward; Willett, Walter C.; Frazier, Lindsay A.; Rich-Edwards, Janet W.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Stuart, Jennifer J.; Rich-Edwards, Janet W.] Brigham & Womens Hosp, Connors Ctr Womens Hlth & Gender Biol, 75 Francis St, Boston, MA 02115 USA; [Kleinman, Ken] Harvard Pilgrim Hlth Care Inst, Populat Med, Boston, MA USA; [Kleinman, Ken] Harvard Med Sch, Boston, MA USA; [Holick, Michael F.] Boston Univ, Med Ctr, Dept Med, Endocrine Diabet & Nutr Sect, Boston, MA USA; [Frazier, Lindsay A.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Mongolian National University of Medical Sciences; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Boston University; Harvard University; Dana-Farber Cancer Institute	Ganmaa, D (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Channing Lab, Boston, MA USA.; Ganmaa, D (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA.; Ganmaa, D (corresponding author), Hlth Sci Univ Mongolia, Ulaanbaatar, Mongolia.	gdavaasa@hsph.harvard.edu		Nyamjav, Sumberzul/0000-0001-6818-6727; Stuart, Jennifer/0000-0003-2718-8827; Kleinman, Ken/0000-0002-5600-5834	National Heart, Lung, and Blood Institute [1K99HL089710-01A1]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded in part by National Heart, Lung, and Blood Institute (1K99HL089710-01A1) and by an anonymous funder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal KS, 2002, ARCH DIS CHILD; ALAHOUHALA M, 1988, ACTA PAEDIATR SCAND, V77, P89, DOI 10.1111/j.1651-2227.1988.tb10604.x; Bromage S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100592; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Du XQ, 2004, BRIT J NUTR, V92, P159, DOI 10.1079/BJN20041118; Ferrarezi DAF, 2012, METABOLISM, V61, P1413, DOI 10.1016/j.metabol.2012.03.018; Ganmaa D, 2008, ASIA PAC J CLIN NUTR, V17, P68; Ganmaa D, 2014, J STEROID BIOCHEM, V139, P1, DOI 10.1016/j.jsbmb.2013.09.011; Ganmaa D, 2012, AM J CLIN NUTR, V96, P391, DOI 10.3945/ajcn.112.034967; Gilbert-Diamond D, 2010, AM J CLIN NUTR, V92, P1446, DOI 10.3945/ajcn.2010.29746; Gipson RS, 1990, PRINCIPLES NUTR ASSE, P187; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Hatun S, 2005, J NUTR, V135, P218, DOI 10.1093/jn/135.2.218; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Hosseinpanah F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-519; Kremer R, 2009, J CLIN ENDOCR METAB, V94, P67, DOI 10.1210/jc.2008-1575; Kumar GT, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2975; MEHLS O, 1978, AM J CLIN NUTR, V31, P1927, DOI 10.1093/ajcn/31.10.1927; Rich-Edwards JW, 2011, AM J CLIN NUTR, V94, P578, DOI 10.3945/ajcn.110.008771; Rich-Edwards JW, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-28; Rovner AJ, 2007, AM J CLIN NUTR, V86, P1694; Schou AJ, 2003, ANN HUM BIOL, V30, P214, DOI 10.1080/0301446021000057629; Zittermann A, 2014, EUR J NUTR, V53, P367, DOI 10.1007/s00394-013-0634-3	23	23	23	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0175237	10.1371/journal.pone.0175237	http://dx.doi.org/10.1371/journal.pone.0175237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481882	Green Submitted, Green Published, gold			2022-12-27	WOS:000401313700003
J	Prieto, V; Ludwig, JM; Farris, AB; Nagaraju, GP; Lawal, TO; El-Rayes, B; Kim, HS				Prieto, Veronica; Ludwig, Johannes M.; Farris, Alton B.; Nagaraju, Ganji Purnachandra; Lawal, Taoreed O.; El-Rayes, Bassel; Kim, Hyun S.			Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study	PLOS ONE			English	Article							VX2 CARCINOMA; CELL-LINE; ANIMAL-MODELS; CHEMOEMBOLIZATION; IRINOTECAN; ANATOMY; TUMOR; IMPLANTATION; INJECTION; RESECTION	Rationale and objectives To develop a human metastatic colorectal cancer (mCRC) model in a rabbit liver. Materials and methods Immunosuppression in 4 adult New Zealand White rabbits weighing 3.5 to 4.5 kg was induced with daily subcutaneous injection of 15 mg/kg Cyclosporine A (CsA). On day 3 open mini-laparotomy was performed and 0.2 ml (1.8x10(5) cells) suspension of HCT-116 and HT-29 human CRC cells were injected into the left and right medial lobe respectively. On day 10 the CsA dose was reduced to 10 mg/kg daily maintenance dose. Rabbits were weighed weekly, closely monitored for CsA side effects (weight loss, gingival hyperplasia and gut modification). Rabbits were sacrificed 5, 6, 7, and 8 weeks after cells injection. Liver tumors were collected for histopathology and immunohistochemical analysis. Results HT-29 Tumor growth was observed in 3 rabbits (75%). Tumors measured 3, 4 and 6 mm after 5, 6 and 8 weeks respectively. Microscopically, tumors contained hyperchromatic, pleomorphic cells that stained for monoclonal carcinoembryonic antigen (CEA), polyclonal CEA, cytokeratin 20, vascular markers (CD31, CD34), and vascular endothelial growth factor (VEGF) by immunohistochemistry, supporting involvement by the poorly differentiated HT-29 colorectal cancer cell line. No gross tumor growth or microscopic viability was observed from HCT-116 cell injection. CsA extra-hepatic manifestations included minimal gum hyperplasia and decrease in gut motility in 3 rabbits (75%), which was treated with Azithromycin 15 mg/kg and Cisapride 0.5 mg/kg every 12 hours, respectively. Conclusion We successfully developed a human metastatic colon cancer model in immunosuppressed rabbit liver using HT-29 cells.	[Prieto, Veronica; Lawal, Taoreed O.] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Div Intervent Radiol & Image Guided Med, Atlanta, GA USA; [Ludwig, Johannes M.; Kim, Hyun S.] Yale Univ, Sch Med, Dept Diagnost Radiol, Div Intervent Radiol, New Haven, CT 06510 USA; [Farris, Alton B.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Nagaraju, Ganji Purnachandra; El-Rayes, Bassel] Emory Univ, Sch Med, Dept Hematol, Atlanta, GA USA; [Nagaraju, Ganji Purnachandra; El-Rayes, Bassel] Emory Univ, Sch Med, Dept Med Oncol, Atlanta, GA USA; [Kim, Hyun S.] Yale Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA	Emory University; Yale University; Emory University; Emory University; Emory University; Yale University	Kim, HS (corresponding author), Yale Univ, Sch Med, Dept Diagnost Radiol, Div Intervent Radiol, New Haven, CT 06510 USA.; Kim, HS (corresponding author), Yale Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA.	kevin.kim@yale.edu	Nagaraju, Purnachandra/D-4193-2011; el-rayes, bassel/ABD-2901-2021; Farris, Alton Brad/S-6041-2017	Nagaraju, Purnachandra/0000-0002-4989-5234; el-rayes, bassel/0000-0002-2661-5746; Farris, Alton Brad/0000-0001-5534-7763				Aravalli RN, 2015, J CLIN MED, V4, P1989, DOI 10.3390/jcm4121954; Aravalli RN, 2009, EUR RADIOL, V19, P1049, DOI 10.1007/s00330-008-1263-8; Bize P, 2016, RADIOLOGY, V280, P425, DOI 10.1148/radiol.2016150361; Blanco G, 2000, CURR EYE RES, V21, P740, DOI 10.1076/0271-3683(200009)21:3;1-R;FT740; Blanco PL, 2005, INVEST OPHTH VIS SCI, V46, P4376, DOI 10.1167/iovs.04-1103; Brouquet A, 2011, J CLIN ONCOL, V29, P1083, DOI 10.1200/JCO.2010.32.6132; Chen JH, 2004, LAB ANIM-UK, V38, P79, DOI 10.1258/00236770460734434; Choti MA, 2002, ANN SURG, V235, P759, DOI 10.1097/00000658-200206000-00002; de Jong GM, 2009, J SURG RES, V154, P167, DOI 10.1016/j.jss.2008.03.038; Duran R, 2016, THERANOSTICS, V6, P28, DOI 10.7150/thno.13137; EASTY DM, 1982, VIRCHOWS ARCH B, V39, P333, DOI 10.1007/BF02892859; Evans JP, 2016, CRIT REV ONCOL HEMAT, V98, P94, DOI 10.1016/j.critrevonc.2015.10.009; Eyol E, 2008, CLIN EXP METASTAS, V25, P273, DOI 10.1007/s10585-008-9142-x; Fiorentini G, 2012, ANTICANCER RES, V32, P1387; Geschwind JFH, 2000, J VASC INTERV RADIOL, V11, P1245, DOI 10.1016/S1051-0443(07)61299-8; Hong K, 2009, J VASC INTERV RADIOL, V20, P360, DOI 10.1016/j.jvir.2008.11.019; Hurst EW, 1933, J EXP MED, V58, P607, DOI 10.1084/jem.58.5.607; Kang SJ, 2013, BRIT J OPHTHALMOL, V97, P929, DOI 10.1136/bjophthalmol-2013-303343; Kang SJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/394730; Kawai K, 2013, ONCOL REP, V29, P464, DOI 10.3892/or.2012.2141; Lee DE, 2011, CARCINOGENESIS, V32, P629, DOI 10.1093/carcin/bgr008; Lee KH, 2009, J VASC INTERV RADIOL, V20, P113, DOI 10.1016/j.jvir.2008.09.033; Lin WY, 2002, J VET MED SCI, V64, P649, DOI 10.1292/jvms.64.649; Martin RCG, 2011, ANN SURG ONCOL, V18, P192, DOI 10.1245/s10434-010-1288-5; Martins PNA, 2007, LIVER INT, V27, P384, DOI 10.1111/j.1478-3231.2006.01414.x; Parvinian A, 2014, DIAGN INTERV RADIOL, V20, P335, DOI 10.5152/dir.2014.13415; Petre EN, 2015, HEMATOL ONCOL CLIN N, V29, P117, DOI 10.1016/j.hoc.2014.09.007; Robertson JHP, 2008, INT J EXP PATHOL, V89, P447, DOI 10.1111/j.1365-2613.2008.00605.x; Rous P, 1935, J EXP MED, V62, P523, DOI 10.1084/jem.62.4.523; Seo TS, 2001, INVEST RADIOL, V36, P186, DOI 10.1097/00004424-200103000-00008; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; STRAULI P, 1984, B CANCER, V71, P447; Sun JJ, 2012, ASIAN PAC J CANCER P, V13, P2823, DOI 10.7314/APJCP.2012.13.6.2823; Tam AL, 2014, ACTA RADIOL, V55, P1226, DOI 10.1177/0284185113514050; Van Cutsem E, 2009, ANN ONCOL, V20, P61, DOI 10.1093/annonc/mdp130; Virmani S, 2008, J VASC INTERV RADIOL, V19, P931, DOI 10.1016/j.jvir.2008.02.019; Vogel I, 1998, LANGENBECK ARCH SURG, V383, P466, DOI 10.1007/s004230050162; Zorzi D, 2006, J GASTROINTEST SURG, V10, P86, DOI 10.1016/j.gassur.2005.07.022	38	1	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177212	10.1371/journal.pone.0177212	http://dx.doi.org/10.1371/journal.pone.0177212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475639	gold, Green Published, Green Submitted			2022-12-27	WOS:000400649500054
J	Simpson, LA; Ambrosio, LJ; Baeza, JA				Simpson, Lunden Alice; Ambrosio, Louis John; Baeza, J. Antonio			A new species of Carcinonemertes, Carcinonemertes conanobrieni sp nov (Nemertea: Carcinonemertidae), an egg predator of the Caribbean spiny lobster, Panulirus argus	PLOS ONE			English	Article							N-SP NEMERTEA; CLIMATE-CHANGE; DISEASES; CRABS; DECAPODA; CALIFORNIA; CRUSTACEA; INFERENCE; PARASITES; ECOLOGY	A new species of nemertean worm belonging to the genus Carcinonemertes is described from egg masses of the Caribbean spiny lobster Panulirus argus from the Florida Keys, Florida, USA. This is the first species of Carcinonemertes reported to infect P. argus or any other lobster species in the greater Caribbean and western Atlantic Ocean. Carcinonemertes conanobrieni sp. nov. varies in body color from a translucent white to a pale orange, with males ranging in total body length from 2.35 to 12.71 mm and females ranging from 0.292 to 16.73 mm. Among the traits that separate this new species from previously described species in the genus Carcinonemertes are a relatively wide stylet basis, minimal sexual size dimorphism, and a unique mucus sheath decorated with external hooks. Also, juvenile worms were found to encyst themselves next to lobster embryos and female worms lay both long strings of eggs wound throughout the lobster's setae as well as spherical cases that are attached to lobster embryos. The stylet length and stylet basis remain unchanged throughout ontogeny for both male and female worms. Maximum likelihood and Bayesian inference phylogenetic analyses separated this newly described species from all other species of Carcinonemertes with available COI sequences. Carcinonemertes spp. are voracious egg predators and have been tied to the collapse of various crustacean fisheries. The formal description of this new species represents the first step to understand putative impacts of this worm on the population health of one of the most lucrative yet already depressed crustacean fisheries.	[Simpson, Lunden Alice; Ambrosio, Louis John; Baeza, J. Antonio] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Baeza, J. Antonio] Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL 34949 USA; [Baeza, J. Antonio] Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Larrondo, Coquimbo, Chile	Clemson University; Smithsonian Institution; Smithsonian National Museum of Natural History; Universidad Catolica del Norte	Baeza, JA (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.; Baeza, JA (corresponding author), Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL 34949 USA.; Baeza, JA (corresponding author), Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Larrondo, Coquimbo, Chile.	jbaezam@clemson.edu			Clemson University's Creative Inquiry (CI) program; Clemson University	Clemson University's Creative Inquiry (CI) program; Clemson University	We would like to thank Kyla Salomon for her support over the 2016 field season in the Florida Keys, as well as Clemson University's Creative Inquiry (CI) program for helping to fund her stay. This is Smithsonian Marine Station contribution number 1062.; All funding for this project came from a start-up grant from Clemson University, and there was no additional external funding received for this study.	Andrade SCS, 2012, CLADISTICS, V28, P141, DOI 10.1111/j.1096-0031.2011.00376.x; Baeza JA, 2016, BMC ZOOL, V1, DOI 10.1186/s40850-016-0006-6; Baeza JA., 2016, PEER J; Baker-Austin C, 2013, NAT CLIM CHANGE, V3, P73, DOI [10.1038/nclimate1628, 10.1038/NCLIMATE1628]; BOBES R, 1988, Revista de Investigaciones Marinas, V9, P97; Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029; CAMPBELL A, 1989, ZOOL J LINN SOC-LOND, V95, P257; Chollett I, 2012, MAR POLLUT BULL, V64, P956, DOI 10.1016/j.marpolbul.2012.02.016; Coe WR, 1902, AM NAT, V36, P431, DOI 10.1086/278150; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELDRED BONNIE, 1962, CRUSTACEANA, V3, P203, DOI 10.1163/156854062X00427; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gilman EL, 2008, AQUAT BOT, V89, P237, DOI 10.1016/j.aquabot.2007.12.009; Gomez del Prado-Rosas MC, 2003, ANALES I BIOL, V74, P1; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Humes Arthur Grover, 1942, ILLINOIS BIOL MONOGR, V18, P1; JMP, 1989, VERS 12; MCDERMOTT JJ, 1993, HYDROBIOLOGIA, V266, P57, DOI 10.1007/BF00013359; Messick GA, 1998, J CRUSTACEAN BIOL, V18, P533, DOI 10.2307/1549418; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Porter L, 2001, MAR FRESHWATER RES, V52, P1401, DOI 10.1071/MF01092; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruckelshaus M, 2013, MAR POLICY, V40, P154, DOI 10.1016/j.marpol.2013.01.009; Ruiz-Morenol D, 2012, DIS AQUAT ORGAN, V100, P249, DOI 10.3354/dao02488; Sadeghian PS, 2010, J NAT HIST, V44, P2395, DOI 10.1080/00222933.2010.505014; Santos C, 2006, J NAT HIST, V40, P915, DOI 10.1080/00222930600833842; Shields JD, 2011, J INVERTEBR PATHOL, V106, P79, DOI 10.1016/j.jip.2010.09.015; Shields JD, 2004, DIS AQUAT ORGAN, V59, P109, DOI 10.3354/dao059109; SHIELDS JD, 1992, J CRUSTACEAN BIOL, V12, P94, DOI 10.2307/1548723; SHIELDS JD, 1989, CAN J ZOOL, V67, P923, DOI 10.1139/z89-134; SHIELDS JD, 1990, FISH B-NOAA, V88, P279; Shields JD, 2001, J CRUSTACEAN BIOL, V21, P304, DOI 10.1651/0278-0372(2001)021[0304:OJNGNS]2.0.CO;2; Shields JD, 2007, J CRUSTACEAN BIOL, V27, P681, DOI 10.1651/S-2794.1; Shields Jeffrey D., 2006, P146, DOI 10.1002/9780470995969.ch5; Silva dos Fernandes Vieira R.H., 1989, Arquivos de Ciencias do Mar, V26, P1; Staudinger M. D., 2013, IMPACTS CLIMATE CHAN; Sundberg P, 2016, ZOOL SCRIPTA; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Weil E, 2009, CARIBB J SCI, V45, P221; WICKHAM DE, 1985, AM ZOOL, V25, P127; WICKHAM DE, 1980, BIOL BULL, V159, P247, DOI 10.2307/1541022; Wickham DE., 1996, P BIOL SOC WASH, V91, P197	49	7	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177021	10.1371/journal.pone.0177021	http://dx.doi.org/10.1371/journal.pone.0177021			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475595	Green Published, Green Submitted, gold			2022-12-27	WOS:000400649500035
J	Wu, CH; Yang, YW; Hung, SC; Kuo, KL; Wu, KD; Wu, VC; Hsieh, TC				Wu, Che-Hsiung; Yang, Ya-Wen; Hung, Szu-Chun; Kuo, Ko-Lin; Wu, Kwan-Dun; Wu, Vin-Cent; Hsieh, Tsung-Cheng		Natl Taiwan Univ Study Grp Acute	Ketoanalogues supplementation decreases dialysis and mortality risk in patients with anemic advanced chronic kidney disease	PLOS ONE			English	Article							LOW-PROTEIN-DIET; CHRONIC-RENAL-FAILURE; IMPROVES NUTRITIONAL-STATUS; NATIONAL-HEALTH INSURANCE; AMINO-ACID SUPPLEMENT; PREDIALYSIS PATIENTS; CONTROLLED-TRIAL; SERUM PHOSPHATE; TAIWAN; PROGRESSION	Background The benefit of alpha-Ketoanalogues (KA) supplementation for chronic kidney disease (CKD) patients that followed low-protein diet (LPD) remains undetermined. Methods We extracted longitudinal data for all CKD patients in the Taiwan National Health Insurance from January 1, 2000 through December 31, 2010. A total of 1483 patients with anemic advanced CKD treated with LPD, who started KA supplementation, were enrolled in this study. We analyzed the risks of end stage renal disease and all-cause mortality using Cox proportional hazard models with influential drugs as time-dependent variables. Results A total of 1113 events of initiating long-term dialysis and 1228 events of the composite outcome of long-term dialysis or death occurred in patients with advanced CKD after a mean follow-up of 1.57 years. Data analysis suggests KA supplementation is associated with a lower risk for long-term dialysis and the composite outcome when daily dosage is more than 5.5 tablets. The beneficial effect was consistent in subgroup analysis, independent of age, sex, and comorbidities. Conclusions Among advanced CKD patients that followed LPD, KA supplementation at an appropriate dosage may substantially reduce the risk of initiating long-term dialysis or of developing the composite outcome. KA supplementation represents an additional therapeutic strategy to slow the progression of CKD.	[Wu, Che-Hsiung; Hung, Szu-Chun; Kuo, Ko-Lin] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Div Nephrol, Taipei, Taiwan; [Wu, Che-Hsiung; Hsieh, Tsung-Cheng] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Wu, Che-Hsiung] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Yang, Ya-Wen] Natl Taiwan Univ Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Wu, Kwan-Dun; Wu, Vin-Cent] Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan	Tzu Chi University; Tzu Chi University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Hsieh, TC (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.; Wu, VC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan.	q91421028@ntu.edu.tw; tchsieh@mail.tcu.edu.tw		Hsieh, Tsung-Cheng/0000-0003-3024-8675; Wu, Che-Hsiung/0000-0001-6164-6655; YANG, YA-WEN/0000-0003-0412-584X; Kuo, Ko-Lin/0000-0002-7477-0388; WU, VIN-CENT/0000-0001-7935-0991				Aparicio M, 2012, J RENAL NUTR, V22, pS1, DOI 10.1053/j.jrn.2011.09.005; Bellizzi V, 2007, KIDNEY INT, V71, P245, DOI 10.1038/sj.ki.5001955; Brunori G, 2007, AM J KIDNEY DIS, V49, P569, DOI 10.1053/j.ajkd.2007.02.278; Buckley JP, 2015, EPIDEMIOLOGY, V26, P204, DOI 10.1097/EDE.0000000000000217; Chang JH, 2009, NEPHROLOGY, V14, P750, DOI 10.1111/j.1440-1797.2009.01115.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chauveau P, 2007, J RENAL NUTR, V17, P250, DOI 10.1053/j.jrn.2007.02.007; Chen JB C B, 2012, KIDNEY RES CLIN PRAC, pA24; Chen YR, 2013, NEPHROL DIAL TRANSPL, V28, P671, DOI 10.1093/ndt/gfs469; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Collins Allan J, 2014, Am J Kidney Dis, V63, pA7, DOI 10.1053/j.ajkd.2013.11.001; Cupisti A, 2014, KIDNEY BLOOD PRESS R, V39, P107, DOI 10.1159/000355784; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; de Zeeuw D, 2004, CIRCULATION, V110, P921, DOI 10.1161/01.CIR.0000139860.33974.28; DRUML W, 1986, INFUSIONSTHERAPIE, V13, P262; Eddington H, 2010, CLIN J AM SOC NEPHRO, V5, P2251, DOI 10.2215/CJN.00810110; Gao X, 2010, BRIT J NUTR, V103, P608, DOI 10.1017/S0007114509992108; Garneata L, 2016, J AM SOC NEPHROL, V27, P2164, DOI 10.1681/ASN.2015040369; Hiroshige K, 2001, NEPHROL DIAL TRANSPL, V16, P1856, DOI 10.1093/ndt/16.9.1856; HOSTETTER TH, 1986, KIDNEY INT, V30, P509, DOI 10.1038/ki.1986.215; Hsu TW, 2014, JAMA INTERN MED, V174, P347, DOI 10.1001/jamainternmed.2013.12700; Huang JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126668; Hwang SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2616, DOI 10.1093/ndt/gfq308; Hwang SJ, 2010, NEPHROLOGY, V15, P3, DOI 10.1111/j.1440-1797.2010.01304.x; Kasiske BL, 1998, AM J KIDNEY DIS, V31, P954, DOI 10.1053/ajkd.1998.v31.pm9631839; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; KING AJ, 1993, J AM SOC NEPHROL, V3, P1723; Kovesdy CP, 2013, AM J CLIN NUTR, V97, P1163, DOI 10.3945/ajcn.112.036418; Lai TS, 2013, CRIT CARE, V17, DOI 10.1186/cc13054; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; LEWIS NJW, 1993, PHARMACOECONOMICS, V4, P323, DOI 10.2165/00019053-199304050-00003; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Mircescu G, 2007, J RENAL NUTR, V17, P179, DOI 10.1053/j.jrn.2006.12.012; MITCH WE, 1984, NEW ENGL J MED, V311, P623, DOI 10.1056/NEJM198409063111002; MITCH WE, 1984, BIOCHEM J, V222, P579, DOI 10.1042/bj2220579; NATH KA, 1986, J CLIN INVEST, V78, P1199, DOI 10.1172/JCI112703; Ou SM, 2013, KIDNEY INT, V84, P198, DOI 10.1038/ki.2013.79; Prakash S, 2004, J RENAL NUTR, V14, P89, DOI 10.1053/j.jrn.2004.01.008; Scalone L, 2010, NEPHROL DIAL TRANSPL, V25, P907, DOI 10.1093/ndt/gfp572; Shiao C-C, 2015, NEPHROLOGY; Shih CJ, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0169-3; Teplan V, 2008, WIEN KLIN WOCHENSCHR, V120, P478, DOI 10.1007/s00508-008-0987-4; Voormolen N, 2007, NEPHROL DIAL TRANSPL, V22, P2909, DOI 10.1093/ndt/gfm286; Walser M, 1999, J AM SOC NEPHROL, V10, P110; Walser M, 1999, KIDNEY INT, V55, P771, DOI 10.1046/j.1523-1755.1999.055003771.x; WALSER M, 1993, KIDNEY INT, V43, P933, DOI 10.1038/ki.1993.131; WALSER M, 1992, J AM SOC NEPHROL, V2, P1178; Wang WJ, 2014, J BONE MINER RES, V29, P676, DOI 10.1002/jbmr.2061; Woo MJ, 2008, STAT MED, V27, P3805, DOI 10.1002/sim.3278; Wu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112257; Wu IW, 2009, NEPHROL DIAL TRANSPL, V24, P3426, DOI 10.1093/ndt/gfp259; Wu PC, 2015, CLIN PHARMACOL THER, V98, P442, DOI 10.1002/cpt.173; Wu VC, 2014, J CLIN EPIDEMIOL, V67, P1139, DOI 10.1016/j.jclinepi.2014.05.012; Wu VC, 2014, J AM SOC NEPHROL, V25, P595, DOI 10.1681/ASN.2013060610; Wu VC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030836; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406	56	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176847	10.1371/journal.pone.0176847	http://dx.doi.org/10.1371/journal.pone.0176847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475591	Green Submitted, Green Published, gold			2022-12-27	WOS:000400649500018
J	Frias, M; Rivero-Juarez, A; Tellez, F; Perez-Perez, M; Camacho, A; Machuca, I; Lorenzo-Moncada, S; Lopez-Lopez, P; Rivero, A				Frias, Mario; Rivero-Juarez, Antonio; Tellez, Francisco; Perez-Perez, Monserrat; Camacho, Angela; Machuca, Isabel; Lorenzo-Moncada, Sandra; Lopez-Lopez, Pedro; Rivero, Antonio		Grp Estudio Hepatitis Virales HEPA; SAEI	Spontaneous clearance of chronic hepatitis C is rare in HIV-infected patients after effective use of combination antiretroviral therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NATURAL-KILLER-CELLS; COINFECTION; HCV	Objective To evaluate the rate of spontaneous resolution of chronic hepatitis C (CHC) infection in a cohort of HIV-infected patients. Methods A retrospective analysis of 509 HIV-infected patients with chronic HCV infection was performed at two reference hospitals in Andalusia. The main variable of the study was spontaneous clearance of CHC, defined as a negative HCV RNA result after at least two previous quantitative measurements of HCV RNA separated by a minimum of 12 months. Results Of 509 patients, 3 (0.59%; 95% CI: 0.15%-1.6%) experienced spontaneous clearance of CHC. After combination antiretroviral therapy (cART) initiation, two of three cases experienced an increased CD4(+) count, coinciding with HCV viral clearance. All patients were IL28B CC carriers, 2 were co-infected with HCV genotype 3 (the HCV genotype of the remaining patient was not available). Conclusions Spontaneous clearance of CHC is a rare event in the context of HIV/HCV co-infected patients and may be associated with the effective use of cART and thus HIV suppression.	[Frias, Mario; Rivero-Juarez, Antonio; Camacho, Angela; Machuca, Isabel; Lopez-Lopez, Pedro; Rivero, Antonio] Hosp Univ Reina Sofia Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Infect Dis Unit, Cordoba, Spain; [Tellez, Francisco; Perez-Perez, Monserrat; Lorenzo-Moncada, Sandra] Hosp La Linea, AGS Campo Gibraltar, Infect Dis & Microbiol Unit, Cadiz, Spain	Hospital Universitario Reina Sofia - Cordoba	Rivero, A (corresponding author), Hosp Univ Reina Sofia Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Infect Dis Unit, Cordoba, Spain.	ariveror@gmail.com	Lopez, Pedro Lopez/AAL-5831-2021; Rivero-Juarez, Antonio/E-4528-2019; Rivero, Antonio/ABE-5294-2020; Espejo, Angela Camacho/AAM-9991-2021; Frias, Mario/AAL-6494-2021	Rivero-Juarez, Antonio/0000-0002-5813-6889; Tellez, Francisco/0000-0002-9997-6761; MACHUCA, ISABEL/0000-0003-3343-0085; Rivero, Antonio/0000-0001-5005-8268; Rivero Roman, Antonio/0000-0002-8643-4250	SPANISH AIDS Research Network (RIS) [RD16/0025/0034-ISCIII-FEDER]; Fundacion Progreso y Salud de la Junta de Andalucia [0187/2013]; Fundacion para la Investigacion en Salud del Institute de Salud Carlos III [RI15/01017]; Consejeria de Salud de la Junta de Andalucia [A-0025-2016]	SPANISH AIDS Research Network (RIS); Fundacion Progreso y Salud de la Junta de Andalucia(Junta de Andalucia); Fundacion para la Investigacion en Salud del Institute de Salud Carlos III; Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia)	This work was supported by the SPANISH AIDS Research Network (RIS) RD16/0025/0034-ISCIII-FEDER, Fundacion Progreso y Salud de la Junta de Andalucia (0187/2013), and Fundacion para la Investigacion en Salud del Institute de Salud Carlos III (RI15/01017). A.R is the recipient of a Research Support grant from the Consejeria de Salud de la Junta de Andalucia (A-0025-2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadei B, 2010, GASTROENTEROLOGY, V138, P1536, DOI 10.1053/j.gastro.2010.01.006; Chen JY, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.17; De Rosa Francesco G, 2006, J Infect, V53, pe215, DOI 10.1016/j.jinf.2006.01.023; Endo T, 2009, J MED VIROL, V81, P979, DOI 10.1002/jmv.21489; Falconer K, 2008, J CLIN VIROL, V41, P160, DOI 10.1016/j.jcv.2007.11.005; Fialaire P, 1999, J INFECT DIS, V180, P574, DOI 10.1086/314910; Goeser F, 2016, AIDS, V30, P355, DOI 10.1097/QAD.0000000000000963; Grint D, 2016, HIV MED; Guihot A, 2011, TRENDS IMMUNOL, V32, P131, DOI 10.1016/j.it.2010.12.002; Kim AY, 2006, PLOS MED, V3, P2324, DOI 10.1371/journal.pmed.0030492; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Lehmann M, 2004, J MED VIROL, V73, P387, DOI 10.1002/jmv.20103; Li Y, 2004, J LEUKOCYTE BIOL, V76, P1171, DOI 10.1189/jlb.0604372; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Stenkvist J, 2014, J HEPATOL, V61, P957, DOI 10.1016/j.jhep.2014.06.014; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199; Vergara S, 2007, CLIN INFECT DIS, V45, P969, DOI 10.1086/521857; Vispo E, 2014, AIDS, V28, P1473, DOI 10.1097/QAD.0000000000000275; You CR, 2014, WORLD J GASTROENTERO, V20, P13293, DOI 10.3748/wjg.v20.i37.13293; Zuniga EI, 2015, ANNU REV VIROL, V2, P573, DOI 10.1146/annurev-virology-100114-055226	22	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177141	10.1371/journal.pone.0177141	http://dx.doi.org/10.1371/journal.pone.0177141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472191	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500143
J	Hoeger, J; Simon, TP; Beeker, T; Marx, G; Haase, H; Schuerholz, T				Hoeger, Janine; Simon, Tim-Philipp; Beeker, Thorben; Marx, Gernot; Haase, Hajo; Schuerholz, Tobias			Persistent low serum zinc is associated with recurrent sepsis in critically ill patients - A pilot study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; IMMUNE FUNCTION; MURINE MODEL; DEFICIENCY; GUIDELINES; DAMAGE	Zinc is an essential trace element for both pathogens and hosts. Hypozincemia is a well known phenomenon in sepsis patients and represents the innate immune systems attempt to deprive pathogens of zinc. However little is known about course, restitution and prognostic value of serum zinc levels in sepsis patients. We performed a prospective observational single-center study set in a tertiary care university hospital intensive care unit. Serum zinc levels were singularly measured of healthy controls and sequentially of surgical sepsis patients and surgical patients over a 8-day period. Throughout the study period, we report significantly decreased serum zinc levels in surgical and surgical sepsis patients compared to healthy controls. Lower serum zinc levels in surgical sepsis patients were associated with a higher susceptibility to a recurrent sepsis episode. Furthermore, surgical sepsis patients with a higher number of organ dysfunctions and increased in-hospital mortality at day 28 and 90 showed lower serum zinc levels at admission. We report serum zinc levels as a promising biomarker in the diagnosis and evaluation of sepsis patients. However, it is still unclear whether these findings are caused by an over-amplified redistribution of zinc during acute-phase response, or whether the critically ill patients were zinc deficient before sepsis.	[Hoeger, Janine; Simon, Tim-Philipp; Beeker, Thorben; Marx, Gernot; Schuerholz, Tobias] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Intens Care & Intermediate Care, Aachen, Germany; [Haase, Hajo] Berlin Inst Technol, Dept Food Chem & Toxicol, Berlin, Germany; [Schuerholz, Tobias] Univ Rostock, Dept Anesthesiol & Intens Care, Rostock, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Technical University of Berlin; University of Rostock	Schuerholz, T (corresponding author), Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Intens Care & Intermediate Care, Aachen, Germany.; Schuerholz, T (corresponding author), Univ Rostock, Dept Anesthesiol & Intens Care, Rostock, Germany.	tobias.schuerholz@med.uni-rostock.de	Haase, Hajo/B-9280-2009	Haase, Hajo/0000-0002-1622-8718	B. Braun Melsungen GmbH; Adrenomed; Astellas Pharma; Bayer Health Care; Astra Zeneca; Astellas Pharma GmbH; German Research Council	B. Braun Melsungen GmbH; Adrenomed; Astellas Pharma(Astellas Pharmaceuticals); Bayer Health Care(Bayer AGBayer Healthcare Pharmaceuticals); Astra Zeneca(AstraZeneca); Astellas Pharma GmbH(Astellas Pharmaceuticals); German Research Council(German Research Foundation (DFG))	GM honoraria fees for consulting and research grants by B. Braun Melsungen GmbH and Adrenomed, lecture fees by B. Braun Melsungen GmbH. TPS received research grants and honoraria for lecture by B. Braun Melsungen. TS received honoraria for board membership by Astellas Pharma GmbH, lecture fees by Astellas Pharma, Bayer Health Care and Astra Zeneca and research grants by Bayer Health Care and Astellas Pharma GmbH. HH received research grants by the German Research Council, honoraria for lectures and development of educational presentations by Novartis Consumer Health and travel expenses by EU cost action TD 1304. This does not alter our adherence to PLOS ONE policies on sharing data and materials. All the other authors declare that they have no competing interests.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 2014, J INTENSIVE CARE MED, V29, P87, DOI 10.1177/0885066612467162; [Anonymous], 2009, CHEST; Besecker BY, 2011, AM J CLIN NUTR, V93, P1356, DOI 10.3945/ajcn.110.008417; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Garnacho-Montero J, 2003, CRIT CARE MED, V31, P2742, DOI 10.1097/01.CCM.0000098031.24329.10; Haase H, 2009, ANNU REV NUTR, V29, P133, DOI 10.1146/annurev-nutr-080508-141119; Hoeger J, 2015, BIOMETALS, V28, P693, DOI 10.1007/s10534-015-9858-4; Hofman Z, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0220-y; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Knoell DL, 2009, CRIT CARE MED, V37, P1380, DOI 10.1097/CCM.0b013e31819cefe4; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Mertens K, 2015, BRIT J ANAESTH, V114, P990, DOI 10.1093/bja/aev073; Nowak JE, 2012, PEDIATR CRIT CARE ME, V13, pE323, DOI 10.1097/PCC.0b013e31824fbd90; Pepersack T, 2001, ARCH GERONTOL GERIAT, V33, P243, DOI 10.1016/S0167-4943(01)00186-8; Rink L, 2000, J NUTR, V130, p1407S, DOI 10.1093/jn/130.5.1407S; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; SHANBHOGUE LKR, 1990, JPEN-PARENTER ENTER, V14, P287, DOI 10.1177/0148607190014003287; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; van Zanten ARH, 2014, JAMA-J AM MED ASSOC, V312, P514, DOI 10.1001/jama.2014.7698; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081	24	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176069	10.1371/journal.pone.0176069	http://dx.doi.org/10.1371/journal.pone.0176069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472045	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500023
J	Mwinyi, J; Bostrom, A; Fehrer, I; Othman, A; Waeber, G; Marti-Soler, H; Vollenweider, P; Marques-Vidal, P; Schioth, HB; von Eckardstein, A; Hornemann, T				Mwinyi, J.; Bostrom, A.; Fehrer, I.; Othman, A.; Waeber, G.; Marti-Soler, H.; Vollenweider, P.; Marques-Vidal, P.; Schioth, H. B.; von Eckardstein, A.; Hornemann, T.			Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus	PLOS ONE			English	Article							BIOMARKERS; NEUROPATHY; DISEASE	1-Deoxysphingolipids (1-deoxySLs) are atypical sphingolipids, which are formed in a side reaction during sphingolipid de-novo synthesis. Recently, we demonstrated that 1-deoxySLs are biomarkers for the prediction of T2DM in obese, non-diabetic patients. Here we investigated the relevance of 1-deoxySLs as long-term predictive biomarkers for the incidence of T2DM in an asymptomatic population. Here, we analyzed the plasma sphingoid base profile in a nested group of non-diabetic individuals (N = 605) selected from a population- based study including 5 year follow-up data (CoLaus study). 1-DeoxySLs at baseline were significantly elevated in individuals who developed T2DM during the follow-up (p<0.001), together with increased glucose (p<5.11E-14), triglycerides (p<0.001)and HOMA-IR indices (p<0.001). 1-Deoxy-sphinganine (1-deoxySA) and 1-deoxy-sphingosine (1-deoxySO) were predictive for T2DM, even after adjusting for fasting glucose levels in the binary regression analyses. The predictive value of the combined markers 1-deoxySA+ glucose were superior to glucose alone in normal-weight subjects (p<0.001) but decreased substantially with increasing BMI. Instead, plasma adiponectin and waist-to-hip ratio appeared to be better risk predictors for obese individuals (BMI>30kg/m(2)). In conclusion, elevated plasma 1-deoxySL levels are strong and independent risk predictors of future T2DM, especially for non-obese individuals in the general population.	[Mwinyi, J.; Schioth, H. B.] Uppsala Univ, Dept Neurosci Funct Pharmacol, Uppsala, Sweden; [Fehrer, I.; Othman, A.; von Eckardstein, A.; Hornemann, T.] Univ Zurich, Inst Clin Chem, Zurich, Switzerland; [Fehrer, I.; Othman, A.; von Eckardstein, A.; Hornemann, T.] Univ Hosp Zurich, Zurich, Switzerland; [Waeber, G.; Marti-Soler, H.; Vollenweider, P.; Marques-Vidal, P.] Univ Lausanne, Lausanne Univ Hosp CHUV, Dept Med, Lausanne, Switzerland; [Waeber, G.; Marti-Soler, H.; Vollenweider, P.; Marques-Vidal, P.] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland	Uppsala University; University of Zurich; University of Zurich; University Zurich Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Hornemann, T (corresponding author), Univ Zurich, Inst Clin Chem, Zurich, Switzerland.; Hornemann, T (corresponding author), Univ Hosp Zurich, Zurich, Switzerland.	thorsten.hornemann@usz.ch	Desai Boström (formerly Adrian E. Boström), Adrian Emmanuel/AAA-8872-2022; Colaus, PsyColaus/K-6607-2013; Marti-Soler, Helena/AAA-7659-2019; Schioth, Helgi/AAQ-7239-2020; Boström, Adrian/HCG-9089-2022; Othman, Alaa/AAE-5897-2019; Marques-Vidal, Pedro M/C-9449-2009	Desai Boström (formerly Adrian E. Boström), Adrian Emmanuel/0000-0001-8604-9638; Marti-Soler, Helena/0000-0002-7127-205X; Othman, Alaa/0000-0002-0092-5594; Marques-Vidal, Pedro M/0000-0002-4548-8500; Waeber, Gerard/0000-0003-4193-788X	Zurich Center of Integrated Human Physiology, University of Zurich (ZIHP); European Commission [305707]; Swiss National Foundation SNF [31003A_153390/1]; Hurka Foundation; Novartis Foundation; Rare Disease Initiative Zurich ("radiz", Clinical Research Priority Program for Rare Diseases, University of Zurich); GlaxoSmith Kline; Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation [33CSCO-122661, 33CS30-139468, 33CS30-148401]	Zurich Center of Integrated Human Physiology, University of Zurich (ZIHP); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Foundation SNF(Swiss National Science Foundation (SNSF)); Hurka Foundation; Novartis Foundation(Novartis); Rare Disease Initiative Zurich ("radiz", Clinical Research Priority Program for Rare Diseases, University of Zurich); GlaxoSmith Kline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the Zurich Center of Integrated Human Physiology, University of Zurich (ZIHP); the 7th Framework Program of the European Commission ("RESOLVE", Project number 305707); the Swiss National Foundation SNF (Project 31003A_153390/1); the Hurka Foundation; the Novartis Foundation and the Rare Disease Initiative Zurich ("radiz", Clinical Research Priority Program for Rare Diseases, University of Zurich) (TH). Further support was obtained from the Swedish Foundation for Medical Research (JM) and from the Swedish Research Council (HBS). The CoLaus study was and is supported by research grants from GlaxoSmith Kline, the Faculty of Biology and Medicine of Lausanne and the Swiss National Science Foundation (grants 33CSCO-122661, 33CS30-139468 and 33CS30-148401).	Bertea M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-84; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Dohrn MF, 2015, EUR J NEUROL, V22, P806, DOI 10.1111/ene.12663; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Fox TE, 2011, J LIPID RES, V52, P509, DOI 10.1194/jlr.M010595; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gorden DL, 2015, J LIPID RES, V56, P722, DOI 10.1194/jlr.P056002; Manchanayake J, 2011, J GASTROEN HEPATOL, V26, P510, DOI 10.1111/j.1440-1746.2010.06528.x; Nerpin E, 2008, DIABETES CARE, V31, P1550, DOI 10.2337/dc08-0369; Othman A, 2014, ATHEROSCLEROSIS, V235, pE16, DOI 10.1016/j.atherosclerosis.2014.05.015; Othman A, 2015, J CLIN LIPIDOL, V9, P568, DOI 10.1016/j.jacl.2015.03.011; Othman A, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2014-000073; Othman A, 2015, DIABETES, V64, P1035, DOI 10.2337/db14-1325; Wei N, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-161; Zuellig RA, 2014, DIABETES, V63, P1326, DOI 10.2337/db13-1042	15	32	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175776	10.1371/journal.pone.0175776	http://dx.doi.org/10.1371/journal.pone.0175776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472035	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000400648500016
J	Plaire, D; Puaud, S; Marsolier-Kergoat, MC; Elalouf, JM				Plaire, Delphine; Puaud, Simon; Marsolier-Kergoat, Marie-Claude; Elalouf, Jean-Marc			Comparative analysis of the sensitivity of metagenomic sequencing and PCR to detect a biowarfare simulant (Bacillus atrophaeus) in soil samples	PLOS ONE			English	Article							IDENTIFICATION; ANTHRACIS; AGENTS; SURROGATE; GENOME; AMPLIFICATION; BIOTERRORISM; INACTIVATION; BACTERIA; EFFICACY	To evaluate the sensitivity of high-throughput DNA sequencing for monitoring biowarfare agents in the environment, we analysed soil samples inoculated with different amounts of Bacillus atrophaeus, a surrogate organism for Bacillus anthracis. The soil samples considered were a poorly carbonated soil of the silty sand class, and a highly carbonated soil of the silt class. Control soil samples and soil samples inoculated with 10, 10(3), or 10(5) cfu were processed for DNA extraction. About 1% of the DNA extracts was analysed through the sequencing of more than 10(8) reads. Similar amounts of extracts were also studied for Bacillus atrophaeus DNA content by real-time PCR. We demonstrate that, for both soils, high-throughput sequencing is at least equally sensitive than real-time PCR to detect Bacillus atrophaeus DNA. We conclude that metagenomics allows the detection of less than 10 ppm of DNA from a biowarfare simulant in complex environmental samples.	[Plaire, Delphine; Marsolier-Kergoat, Marie-Claude; Elalouf, Jean-Marc] CNRS, Dept Hommes, Natures & Societes,Musee Homme, Ecoanthropol & Ethnobiol,UMR 7206, 17 Pl Trocadero & 11 Novembre, Paris, France; [Plaire, Delphine; Marsolier-Kergoat, Marie-Claude; Elalouf, Jean-Marc] Univ Paris Sud, Univ Paris Saclay, CNRS, Inst Integrat Biol Cell I2BC,IBITECS,CEA, Gif Sur Yvette, France; [Puaud, Simon] Sorbonne Univ, UPVD, Dept Prehistoire, MNHN,Musee Homme, 17 Pl Trocadero & 11 Novembre, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Elalouf, JM (corresponding author), CNRS, Dept Hommes, Natures & Societes,Musee Homme, Ecoanthropol & Ethnobiol,UMR 7206, 17 Pl Trocadero & 11 Novembre, Paris, France.; Elalouf, JM (corresponding author), Univ Paris Sud, Univ Paris Saclay, CNRS, Inst Integrat Biol Cell I2BC,IBITECS,CEA, Gif Sur Yvette, France.	jean-marc.elalouf@cea.fr	Elalouf, Jean-Marc/C-4351-2014	Elalouf, Jean-Marc/0000-0003-0151-6423	Commissariat a l'Energie atomique (CEA) [L0C1043ELAL0]; Joint Ministerial Program of Research and Development against Chemical, Biological, Radiological, Nuclear, and Explosive risks [A-NRBC-12-01]	Commissariat a l'Energie atomique (CEA)(French Atomic Energy Commission); Joint Ministerial Program of Research and Development against Chemical, Biological, Radiological, Nuclear, and Explosive risks	This work was supported by the Commissariat a l'Energie atomique (CEA, https://www.cea.fr) under grant L0C1043ELAL0 to JME; and by the Joint Ministerial Program of Research and Development against Chemical, Biological, Radiological, Nuclear, and Explosive risks (https://www.sgdsn.gouv.fr/site_rubrique102.html) under grant A-NRBC-12-01 to JME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoako KK, 2013, INT J FOOD MICROBIOL, V165, P319, DOI 10.1016/j.ijfoodmicro.2013.05.028; Aubert G., 1978, METHODES ANAL SOLS; Be NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073455; Belgrader P, 1999, SCIENCE, V284, P449, DOI 10.1126/science.284.5413.449; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bon C, 2012, P ROY SOC B-BIOL SCI, V279, P2825, DOI 10.1098/rspb.2012.0358; Buzard GS, 2012, FORENSIC SCI INT, V223, P292, DOI 10.1016/j.forsciint.2012.10.003; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; Direito SOL, 2012, FEMS MICROBIOL ECOL, V81, P111, DOI 10.1111/j.1574-6941.2012.01325.x; Dupuis M., 1963, B AFES, V3; Durighello E, 2014, ANAL CHEM, V86, P9394, DOI 10.1021/ac501840g; Eng C, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00491-15; Euler M, 2013, J CLIN MICROBIOL, V51, P1110, DOI 10.1128/JCM.02704-12; Frey KG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-96; Gibbons HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017836; Goransson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031068; Greenberg David L, 2010, Investig Genet, V1, P4, DOI 10.1186/2041-2223-1-4; Hall AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073845; He XH, 2007, J AGR FOOD CHEM, V55, P6897, DOI 10.1021/jf0707738; Higgins JA, 2003, BIOSENS BIOELECTRON, V18, P1115, DOI 10.1016/S0956-5663(02)00252-X; Howe AC, 2014, P NATL ACAD SCI USA, V111, P4904, DOI 10.1073/pnas.1402564111; Hurt RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102826; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Irenge LM, 2010, APPL MICROBIOL BIOT, V88, P1179, DOI 10.1007/s00253-010-2848-0; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Karlsson OE, 2013, BIOSECUR BIOTERROR, V11, pS146, DOI 10.1089/bsp.2012.0077; Kuske CR, 1998, APPL ENVIRON MICROB, V64, P2463; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Laporte J, 2015, J CLIN MICROBIOL, V53, P146, DOI 10.1128/JCM.02137-14; Lee J, 2015, J MICROBIOL METH, V115, P121, DOI 10.1016/j.mimet.2015.05.023; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim DV, 2005, CLIN MICROBIOL REV, V18, P583, DOI 10.1128/CMR.18.4.583-607.2005; Martelet A, 2015, ANAL CHEM, V87, P5553, DOI 10.1021/ac504508a; Meyer KM, 2014, J APPL MICROBIOL, V117, P1634, DOI 10.1111/jam.12648; Minogue TD, 2014, APPL ENVIRON MICROB, V80, P1322, DOI 10.1128/AEM.03478-13; Mirski T, 2014, ANN AGR ENV MED, V21, P224, DOI 10.5604/1232-1966.1108581; Munsell, 2015, MUNS SOIL COL BOOK; Olson Nathan D, 2012, BMC Res Notes, V5, P668, DOI 10.1186/1756-0500-5-668; Rachwal PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035971; Trask P. D., 1932, ORIGIN ENV SOURCE SE; Tufts JAM, 2014, WORLD J MICROB BIOT, V30, P1453, DOI 10.1007/s11274-013-1576-x; Tufts JAM, 2012, J AIR WASTE MANAGE, V62, P151, DOI 10.1080/10473289.2011.636862; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Ueda S, 2013, BIOCONTROL SCI, V18, P227, DOI 10.4265/bio.18.227; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Wattiau P, 2001, APPL MICROBIOL BIOT, V56, P816, DOI 10.1007/s002530100691; Weber DJ, 2003, JAMA-J AM MED ASSOC, V289, P1274, DOI 10.1001/jama.289.10.1274; Wilson WJ, 2002, MOL CELL PROBE, V16, P119, DOI 10.1006/mcpr.2001.0397	50	10	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177112	10.1371/journal.pone.0177112	http://dx.doi.org/10.1371/journal.pone.0177112			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472119	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500136
J	Revilla, M; Puig-Oliveras, A; Castello, A; Crespo-Piazuelo, D; Paludo, E; Fernandez, AI; Ballester, M; Folch, JM				Revilla, Manuel; Puig-Oliveras, Anna; Castello, Anna; Crespo-Piazuelo, Daniel; Paludo, Ediane; Fernandez, Ana I.; Ballester, Maria; Folch, Josep M.			A global analysis of CNVs in swine using whole genome sequence data and association analysis with fatty acid composition and growth traits	PLOS ONE			English	Article							COPY-NUMBER VARIATION; MEAT QUALITY; PIG GENOME; WIDE ASSOCIATION; PROSTATE-CANCER; EXPRESSION DATA; ADIPOSE-TISSUE; VARIANTS; IDENTIFICATION; METABOLISM	Copy number variations (CNVs) are important genetic variants complementary to SNPs, and can be considered as biomarkers for some economically important traits in domestic animals. In the present study, a genomic analysis of porcine CNVs based on next-generation sequencing data was carried out to identify CNVs segregating in an Iberian x Landrace backcross population and study their association with fatty acid composition and growth related traits. A total of 1,279 CNVs, including duplications and deletions, were detected, ranging from 106 to 235 CNVs across samples, with an average of 183 CNVs per sample. Moreover, we detected 540 CNV regions (CNVRs) containing 245 genes. Functional annotation suggested that these genes possess a great variety of molecular functions and may play a role in production traits in commercial breeds. Some of the identified CNVRs contained relevant functional genes (e.g., CLCA4, CYP4X1, GPAT2, MOGAT2, PLA2G2A and PRKG1, among others). The variation in copy number of four of them (CLCA4, GPAT2, MOGAT2 and PRKG1) was validated in 150 BC1_ LD (25% Iberian and 75% Landrace) animals by qPCR. Additionally, their contribution regarding backfat and intramuscular fatty acid composition and growth-related traits was analyzed. Statistically significant associations were obtained for CNVR112 (GPAT2) for the C18:2(n-6)/C18:3(n-3) ratio in backfat and carcass length, among others. Notably, GPATs are enzymes that catalyze the first step in the biosynthesis of both triglycerides and glycerophospholipids, suggesting that this CNVR may contribute to genetic variation in fatty acid composition and growth traits. These findings provide useful genomic information to facilitate the further identification of trait-related CNVRs affecting economically important traits in pigs.	[Revilla, Manuel; Puig-Oliveras, Anna; Castello, Anna; Crespo-Piazuelo, Daniel; Folch, Josep M.] UAB, Fac Vet, Dept Ciencia Anim & Dels Aliments, Bellaterra, Spain; [Revilla, Manuel; Puig-Oliveras, Anna; Castello, Anna; Crespo-Piazuelo, Daniel; Folch, Josep M.] UAB UB, Consorci CSIC, CRAG, IRTA,Plant & Anim Genom, Campus UAB, Bellaterra, Spain; [Paludo, Ediane] Santa Catarina State Univ, Dept Anim Sci, Lages, Santa Catarina, Brazil; [Fernandez, Ana I.] Inst Nacl Invest Tecnol Agraria Alimentaria INIA, Dept Genet Anim, Madrid, Spain; [Ballester, Maria] IRTA, Dept Genet & Millora Anim, Torre Marimon, Caldes De Montb, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; Universidade do Estado de Santa Catarina; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); IRTA	Revilla, M (corresponding author), UAB, Fac Vet, Dept Ciencia Anim & Dels Aliments, Bellaterra, Spain.; Revilla, M (corresponding author), UAB UB, Consorci CSIC, CRAG, IRTA,Plant & Anim Genom, Campus UAB, Bellaterra, Spain.	manuel.revilla@cragenomica.es	Folch, Josep M/I-4738-2015; Revilla, Manuel/U-9033-2018; Crespo-Piazuelo, Daniel/K-2280-2015; Ballester, Maria/E-7201-2016; Farré, Anna Castelló/K-9637-2015; Fernández, Ana Isabel/J-3265-2012	Folch, Josep M/0000-0003-3689-1303; Revilla, Manuel/0000-0002-0164-9317; Crespo-Piazuelo, Daniel/0000-0001-7896-2507; Ballester, Maria/0000-0002-5413-4640; Farré, Anna Castelló/0000-0001-8497-6251; Fernández, Ana Isabel/0000-0002-1509-5191	MICINN [AGL2014-56369-C2]; MINECO [AGL2011-29821-C02]; Formacio i Contractacio de Personal lnvestigador Novell (Fl-DGR) PhD grant from Generalitat Catalunya [ECO/1639/2013]; Personal lnvestigador en Formacion (PIE) PhD grant from the UniversitatAutonoma de Barcelona [458-01-1/2011]; Formacio i Contractacio de Personal lnvestigador Novell (FIDGR) PhD grant from Generalitat de Catalunya [ECO/1788/2014]; National Council of Scientific and Technological Development of Brazil (CNPq) [202243/2014-1]; Ramon y Cajal from the Spanish Ministry of Economy and Competitiveness. [RYC-2013-12573]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); MINECO(Spanish Government); Formacio i Contractacio de Personal lnvestigador Novell (Fl-DGR) PhD grant from Generalitat Catalunya; Personal lnvestigador en Formacion (PIE) PhD grant from the UniversitatAutonoma de Barcelona; Formacio i Contractacio de Personal lnvestigador Novell (FIDGR) PhD grant from Generalitat de Catalunya; National Council of Scientific and Technological Development of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ramon y Cajal from the Spanish Ministry of Economy and Competitiveness.	This work has been funded by the MICINN AGL2014-56369-C2 and MINECO AGL2011-29821-C02. MR was funded by a Formacio i Contractacio de Personal lnvestigador Novell (Fl-DGR) PhD grant from Generalitat Catalunya (ECO/1639/2013). APO was funded by a Personal lnvestigador en Formacion (PIE) PhD grant from the UniversitatAutonoma de Barcelona (458-01-1/2011), DCP by a Formacio i Contractacio de Personal lnvestigador Novell (FIDGR) PhD grant from Generalitat de Catalunya (ECO/1788/2014) and EP was funded by National Council of Scientific and Technological Development of Brazil (CNPq 202243/2014-1). MB was financially supported by a Ramon y Cajal contract (RYC-2013-12573) from the Spanish Ministry of Economy and Competitiveness.	Ahmadian M, 2007, FUTURE LIPIDOL, V2, P229, DOI 10.2217/17460875.2.2.229; Ballester M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080385; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Boeva V, 2011, BIOINFORMATICS, V27, P268, DOI 10.1093/bioinformatics/btq635; BUTT E, 1994, J BIOL CHEM, V269, P14509; Chen CY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-733; Conrad DF, 2007, NAT GENET, V39, pS30, DOI 10.1038/ng2042; COON MJ, 1992, FASEB J, V6, P669, DOI 10.1096/fasebj.6.2.1537454; Corominas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-843; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Dircks LK, 1997, BBA-LIPID LIPID MET, V1348, P17, DOI 10.1016/S0005-2760(97)00106-9; Duan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058640; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Fadista J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003916; Fan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062534; Fernandez AI, 2014, ANIM GENET, V45, P357, DOI 10.1111/age.12137; Fernandez AI, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-41; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gonzalez JR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-172; Grindflek E, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-4; Hurd Paul J., 2009, Briefings in Functional Genomics & Proteomics, V8, P174, DOI 10.1093/bfgp/elp013; Jiang JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-593; Jin GF, 2011, CARCINOGENESIS, V32, P1057, DOI 10.1093/carcin/bgr082; Kim JH, 2012, BIOINFORMATICS, V28, P1790, DOI 10.1093/bioinformatics/bts239; Kouba M, 2003, J ANIM SCI, V81, P1967; Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-725; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Liu WN, 2009, CANCER RES, V69, P2176, DOI 10.1158/0008-5472.CAN-08-3151; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuzaki H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r125; Molnar J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-761; Munoz M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-845; Murakami M, 2011, J BIOCHEM, V150, P233, DOI 10.1093/jb/mvr088; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Paudel Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1449-9; Paudel Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-449; Perez-Enciso M, 2000, J ANIM SCI, V78, P2525; Plog S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140050; Plog S, 2012, J HISTOCHEM CYTOCHEM, V60, P45, DOI 10.1369/0022155411426455; Pregibon D., 1992, GEN LINEAR MODELS ST; Puig-Oliveras A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099720; Ramayo-Caldas Y, 2012, J ANIM SCI, V90, P2883, DOI 10.2527/jas.2011-4900; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Sailani MR, 2013, GENOME RES, V23, P1410, DOI 10.1101/gr.147991.112; Sambrook J, 1989, MOL CLONING LAB MANU, pE3; Schiavo G, 2014, ANIM GENET, V45, P745, DOI 10.1111/age.12180; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subirana I, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-47; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Ventanas S, 2008, ANIMAL, V2, P621, DOI 10.1017/S1751731107001528; Wang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068683; Wang LG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12535; Wiedmann RT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133529; Wood JD, 2004, MEAT SCI, V66, P21, DOI 10.1016/S0309-1740(03)00022-6	60	23	26	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177014	10.1371/journal.pone.0177014	http://dx.doi.org/10.1371/journal.pone.0177014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472114	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500116
J	Stromvall, K; Thysell, E; Bergstrom, SH; Bergh, A				Stromvall, Kerstin; Thysell, Elin; Bergstrom, Sofia Halin; Bergh, Anders			Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CANCER PROGRESSION; PREMETASTATIC NICHE; PROMOTE TUMOR; EXTRACELLULAR VESICLES; CELL-PROLIFERATION; EXPRESSION; INVASION; ACTIVATION; MIGRATION	In order to grow and spread tumors need to interact with adjacent tissues. We therefore hypothesized that small but aggressive prostate cancers influence the rest of the prostate and regional lymph nodes differently than tumors that are more indolent. Poorly metastatic (Dunning AT1) or highly metastatic (Dunning MLL) rat prostate tumor cells were injected into the ventral prostate lobe of immunocompetent rats. After 10 days-when the tumors occupied about 30% of the prostate lobe and lymph node metastases were undetectable- the global gene expression in tumors, benign parts of the prostate, and regional iliac lymph nodes were examined to define tumor-induced changes related to preparation for future metastasis. The tumors induced profound effects on the gene expression profiles in the benign parts of the prostate and these were strikingly different in the two tumor models. Gene ontology enrichment analysis suggested that tumors with high metastatic capacity were more successful than less metastatic tumors in inducing tumor-promoting changes and suppressing anti-tumor immune responses in the entire prostate. Some of these differences such as altered angiogenesis, nerve density, accumulation of T-cells and macrophages were verified by immunohistochemistry. Gene expression alterations in the regional lymph nodes suggested decreased quantity and activation of immune cells in MLL-lymph nodes that were also verified by immunostaining. In summary, even when small highly metastatic prostate tumors can affect the entire tumor-bearing organ and pre-metastatic lymph nodes differently than less metastatic tumors. When the kinetics of these extratumoral influences (by us named TINT = tumor instructed normal tissue) are more precisely defined they could potentially be used as markers of disease aggressiveness and become therapeutic targets.	[Stromvall, Kerstin; Thysell, Elin; Bergstrom, Sofia Halin; Bergh, Anders] Umea Univ, Dept Med Biosci Pathol, Umea, Sweden	Umea University	Stromvall, K (corresponding author), Umea Univ, Dept Med Biosci Pathol, Umea, Sweden.	kerstin.stromvall@umu.se		Halin Bergstrom, Sofia/0000-0003-3475-3230	Swedish Research Council [Co257301]; Swedish Cancer Foundation, Umea University [130293]; Lion's Cancer Research Foundation; King Gustaf V and Queen Victoria's Foundation of Freemasons	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation, Umea University; Lion's Cancer Research Foundation; King Gustaf V and Queen Victoria's Foundation of Freemasons	This work was supported by grants from: Swedish Research Council, http://www.vr.se/ (AB), grant number Co257301; The Swedish Cancer Foundation, https://www.cancerfonden.se/ (AB), grant number 130293; The Lion's Cancer Research Foundation, Umea University, http://www.cancerforskningsfonden.se/ (KS, SHB); King Gustaf V and Queen Victoria's Foundation of Freemasons, https://www.frimurarordern.se/organisation/barmhartighetsverksamhet/frimurarstiftelsen/ (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2008, DIFFERENTIATION, V76, P717, DOI 10.1111/j.1432-0436.2008.00292.x; Achkova D, 2016, BIOCHEM SOC T, V44, P333, DOI 10.1042/BST20150245; Adamo HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141601; Adamo HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130076; Aichem A, 2016, INT J BIOCHEM CELL B, V79, P451, DOI 10.1016/j.biocel.2016.07.001; [Anonymous], 1979, STEREOLOGICAL METHOD; Barron DA, 2012, ENDOCR-RELAT CANCER, V19, pR187, DOI 10.1530/ERC-12-0085; Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Benezech C, 2014, BLOOD, V123, P3200, DOI 10.1182/blood-2013-03-489286; Bergstrom SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep31805; Bergstrom SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157280; Bhalla A, 2009, EUR J CLIN INVEST, V39, P74, DOI 10.1111/j.1365-2362.2009.02123.x; Bruyninx M, 1999, ENDOCRINOLOGY, V140, P4789, DOI 10.1210/en.140.10.4789; Buresh-Stiemke RA, 2012, DEV DYNAM, V241, P2005, DOI 10.1002/dvdy.23886; Cai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053388; Carosella ED, 2015, EUR UROL, V68, P267, DOI 10.1016/j.eururo.2015.02.032; Chen EC, 2015, GASTROENTEROLOGY, V149, P705, DOI 10.1053/j.gastro.2015.05.042; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Cochran AJ, 2015, CANCER J, V21, P39, DOI 10.1097/PPO.0000000000000094; D'Antonio KB, 2010, J UROLOGY, V183, P1604, DOI 10.1016/j.juro.2009.12.006; Dango S, 2008, LUNG CANCER, V60, P426, DOI 10.1016/j.lungcan.2007.11.015; Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039; Di Meo S, 2014, CLIN CANCER RES, V20, P585, DOI 10.1158/1078-0432.CCR-13-2240; Drake CG, 2010, NAT REV IMMUNOL, V10, P580, DOI 10.1038/nri2817; Duda DG, 2010, CANCER RES, V70, P5670, DOI 10.1158/0008-5472.CAN-10-0119; Dunne JC, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9096-3; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Fagiani E, 2013, CANCER LETT, V328, P18, DOI 10.1016/j.canlet.2012.08.018; Falasca Marco, 2015, Advances in Biological Regulation, V60, P88, DOI 10.1016/j.jbior.2015.10.003; Fu J, 2014, BIOCHEM BIOPH RES CO, V445, P314, DOI 10.1016/j.bbrc.2014.01.174; Fujita K, 2009, CANCER SCI, V100, P1047, DOI 10.1111/j.1349-7006.2009.01146.x; Gannon PO, 2006, PROSTATE, V66, P1710, DOI 10.1002/pros.20466; Garlanda C, 2013, SEMIN IMMUNOL, V25, P408, DOI 10.1016/j.smim.2013.10.019; Gitenay D, 2009, FUTURE ONCOL, V5, P993, DOI 10.2217/FON.09.67; Gong YX, 2014, CANCERS, V6, P1298, DOI 10.3390/cancers6031298; Gu JJ, 2016, INT J MOL MED, V37, P1587, DOI 10.3892/ijmm.2016.2580; Hagglof Christina, 2012, Cancers (Basel), V4, P531, DOI 10.3390/cancers4020531; Hagglof C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010747; Halin Sofia, 2011, Expert Opin Med Diagn, V5, P37, DOI 10.1517/17530059.2011.540009; Halin S, 2009, NEOPLASIA, V11, P177, DOI 10.1593/neo.81338; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Herroon MK, 2013, ONCOTARGET, V4, P2108, DOI 10.18632/oncotarget.1482; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Hirakawa S, 2009, CANCER SCI, V100, P983, DOI 10.1111/j.1349-7006.2009.01142.x; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Iguchi K, 2011, J ANDROL, V32, P144, DOI 10.2164/jandrol.110.011205; Ioachim HL, 1994, LYMPH NODE PATHOLOGY; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; Johansson A, 2010, AM J PATHOL, V177, P1031, DOI 10.2353/ajpath.2010.100070; Josefsson A, 2011, AM J PATHOL, V179, P1961, DOI 10.1016/j.ajpath.2011.06.005; Jung T, 2009, NEOPLASIA, V11, P1093, DOI 10.1593/neo.09822; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kirschmann DA, 2002, CANCER RES, V62, P4478; Knudsen BS, 2016, J MOL DIAGN, V18, P395, DOI 10.1016/j.jmoldx.2015.12.006; Koltai T, 2014, ONCOTARGETS THER, V7, P447, DOI 10.2147/OTT.S58622; Lai TH, 2008, PROSTATE, V68, P1341, DOI 10.1002/pros.20799; Lim SY, 2016, ONCOGENE, V35, P5735, DOI 10.1038/onc.2016.107; Liu Y, 2016, CANCER CELL, V30, P668, DOI 10.1016/j.ccell.2016.09.011; Louis I, 2003, BLOOD, V102, P1397, DOI 10.1182/blood-2003-01-0316; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Matsuda K, 2016, NEURON, V90, P752, DOI 10.1016/j.neuron.2016.04.001; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; McMahon BJ, 2015, ADV EXP MED BIOL, V867, P145, DOI 10.1007/978-94-017-7215-0_10; Morfoisse F, 2015, MOL CELL ONCOL, V2, DOI 10.1080/23723556.2015.1024821; Nilsson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140985; Nishan U, 2015, LIFE SCI, V143, P168, DOI 10.1016/j.lfs.2015.10.036; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; O'Neill ASG, 2013, IMMUNOLOGY, V138, P198, DOI 10.1111/imm.12042; Ogawa F, 2014, J CLIN INVEST, V124, P4882, DOI 10.1172/JCI73530; Pal SK, 2015, MOL CANCER THER, V14, P2896, DOI 10.1158/1535-7163.MCT-15-0367; Pan J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092815; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Pizzola C, 2016, CURR MOL PHARMACOL, V9, P217, DOI 10.2174/1874467208666150716120551; Place AE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2912; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rehman I, 2004, HUM PATHOL, V35, P1385, DOI 10.1016/j.humpath.2004.07.015; Rinderknecht M, 2008, J CELL PHYSIOL, V216, P347, DOI 10.1002/jcp.21494; Romanuik TL, 2009, AM J PATHOL, V175, P2264, DOI 10.2353/ajpath.2009.080868; Salazar N, 2013, CRIT REV EUKAR GENE, V23, P77, DOI 10.1615/CritRevEukaryotGeneExpr.2013006905; Sceneay J, 2013, CANCER METAST REV, V32, P449, DOI 10.1007/s10555-013-9420-1; Shaw A, 2007, J UROLOGY, V177, P832, DOI 10.1016/j.juro.2006.10.061; Shen PL, 2014, PROSTATE, V74, P946, DOI 10.1002/pros.22812; Sleeman JP, 2015, J MOL MED, V93, P1173, DOI 10.1007/s00109-015-1351-6; Sleeman JP, 2012, CANCER METAST REV, V31, P429, DOI 10.1007/s10555-012-9373-9; So T, 2006, INT J HEMATOL, V83, P1, DOI 10.1532/IJH97.05120; Stallone G, 2014, CANCER RES, V74, P4230, DOI 10.1158/0008-5472.CAN-14-0369; Sternberg IA, 2016, ANNU REV MED, V67, P119, DOI 10.1146/annurev-med-060413-112226; Tidehag V, 2014, EUR J CANCER, V50, P1829, DOI 10.1016/j.ejca.2014.03.278; Tomita Y, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28100; Trujillo KA, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/302894; Turnis ME, 2015, EUR J IMMUNOL, V45, P1892, DOI 10.1002/eji.201344413; Vainio P, 2012, PROSTATE, V72, P789, DOI 10.1002/pros.21487; Vainio P, 2011, ONCOTARGET, V2, P1176; Valverde LD, 2016, TUMOR BIOL, V37, P9233, DOI 10.1007/s13277-015-4763-6; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Weon JL, 2015, CURR OPIN CELL BIOL, V37, P1, DOI 10.1016/j.ceb.2015.08.002; Wiethe C, 2003, J IMMUNOL, V171, P4121, DOI 10.4049/jimmunol.171.8.4121; Wikstrom P, 2009, PROSTATE, V69, P799, DOI 10.1002/pros.20927; Yan L, 2014, ONCOGENE, V33, P157, DOI 10.1038/onc.2012.566; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702; Zang X, 2007, P NATL ACAD SCI USA, V104, P19458, DOI 10.1073/pnas.0709802104; Zhang J, 2010, JNCI-J NATL CANCER I, V102, P522, DOI 10.1093/jnci/djq044; Zhao P, 2016, ACTA BIOCH BIOPH SIN, V48, P266, DOI 10.1093/abbs/gmw001; Zhao S, 2016, CLIN CANC RES; Zundler S, 2015, CYTOKINE GROWTH F R, V26, P559, DOI 10.1016/j.cytogfr.2015.07.003	108	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176679	10.1371/journal.pone.0176679	http://dx.doi.org/10.1371/journal.pone.0176679			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472073	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500061
J	Tian, SQ; Liu, JJ; Yuan, WQ; Wang, YH; Ha, CZ; Liu, L; Li, QC; Yang, X; Sun, K				Tian, Shaoqi; Liu, Jiangjun; Yuan, Wanqing; Wang, Yuanhe; Ha, Chengzhi; Liu, Lun; Li, Qicai; Yang, Xu; Sun, Kang			Minimally invasive unicompartmental knee replacement: Midterm clinical outcome	PLOS ONE			English	Article							ARTHROPLASTY	Objective The purpose of this study was to explore the midterm clinical outcomes of unicompartmental knee replacement (UKR) for medial knee arthropathy through a minimally invasive approach (MIA). Methods From January 2006 to June 2010, 442 consecutive patients (485 knees) were included in the study. All patients underwent MIA-UKR with the mobile bearing Oxford phrase III prosthesis. The incision was made starting 1 cm medial to the medial pole of the patella and extending distally to the tibial tubercle. Radiographic evaluations include femorotibial angle (FTA) from coronal x-rays and rectified varus deformity angle, while clinical evaluations included Knee Society Score (KSS, clinical score and function score), the Western Ontario and McMaster Universities Arthritis Index (WOMAC) osteoarthritis index and visual analog scale (VAS) for pain. Patients followed-up at 1, 3, 6, 12 months after surgery and each year thereafter. Results Four hundreds and two patients completed the entire follow-up, 40 patients (45 knees) were lost to follow-up. The average follow-up time was 73.0 +/- 1.9 months. The mean length of the incisions was 5.0 +/- 0.2 cm. The average FTA decreased from 183.6 degrees +/- 5.1 degrees preoperatively to 174.3 degrees +/- 4.2 degrees postoperatively, and the mean rectified varus deformity angle was 9.3 degrees +/- 1.2 degrees. The KSS clinical score improved from 42.4 +/- 2.9 to 92.9 +/- 3.8, and the function score improved from 53.5 +/- 3.8 to 93.5 +/- 4.0. The WOMAC score improved from 47.5 +/- 3.1 preoperatively to 12.3 +/- 1.5 at the last evaluation. The VAS dropped from 7.8 +/- 1.9 preoperatively to 1.6 +/- 0.2 postoperatively. All clinical evaluations (KSS, WOMAC, VAS) were significantly different (p < 0.05) from pre and post-operative evaluations. The survival rate was 99.1% at 73 months, and the revision rate was 0.9%. Conclusion The midterm clinical outcomes of MIA-UKR are satisfactory in a Chinese patient population, which is a good surgical option for patients with medial arthropathy of the knee. However, longer-term follow-up studies should be performed in these patients.	[Tian, Shaoqi; Liu, Jiangjun; Yuan, Wanqing; Wang, Yuanhe; Ha, Chengzhi; Liu, Lun; Li, Qicai; Yang, Xu; Sun, Kang] Qingdao Univ, Affiliated Hosp, Dept Orthopaed, Qingdao, Peoples R China	Qingdao University	Tian, SQ; Sun, K (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Orthopaed, Qingdao, Peoples R China.	shaoqi99@aliyun.com; sunkang_qy@aliyun.corn						Arguello-Cuenca J M, 2012, Rev Esp Cir Ortop Traumatol, V56, P32, DOI 10.1016/j.recot.2011.08.007; Aslan Hakan, 2007, Acta Orthop Traumatol Turc, V41, P367; Bergeson AG, 2013, J ARTHROPLASTY, V28, P172, DOI 10.1016/j.arth.2013.01.005; Chatellard R, 2013, ORTHOP TRAUMATOL-SUR, V99, pS219, DOI 10.1016/j.otsr.2013.03.004; Faour-Martin O, 2013, INT ORTHOP, V37, P833, DOI 10.1007/s00264-013-1830-8; Goodfellow JW, 2006, UNICOMPARTMENTAL ART, P23; Goodfellow JW, 2006, UNICOMPARTMENTAL ART, P5; Gulati A, 2009, J BONE JOINT SURG BR, V91B, P896, DOI 10.1302/0301-620X.91B7.21914; Hamilton WG, 2010, J ARTHROPLASTY, V25, P735, DOI 10.1016/j.arth.2009.05.011; Heyse TJ, 2011, ARCH ORTHOP TRAUM SU, V131, P1287, DOI 10.1007/s00402-011-1274-9; Insall JN, 2006, SURG KNEE, P1527; Kim KT, 2015, CLIN ORTHOP SURG, V7, P199, DOI 10.4055/cios.2015.7.2.199; Kort NP, 2007, KNEE SURG SPORT TR A, V15, P356, DOI 10.1007/s00167-006-0204-9; KOZINN SC, 1989, J BONE JOINT SURG AM, V71A, P145, DOI 10.2106/00004623-198971010-00023; Kuipers BM, 2010, KNEE, V17, P48, DOI 10.1016/j.knee.2009.07.005; Lim HC, 2012, J BONE JOINT SURG BR, V94B, P1071, DOI 10.1302/0301-620X.94B8.29372; Lv HS., 2006, TOTAL JOINT ARTHROPL, P334; Maistrelli GL, 2006, J ORTHOP TRAUMATOL, V7, P51, DOI 10.1007/s10195-006-0122-0; O'Donnell TMP, 2013, J ARTHROPLASTY, V28, P33, DOI 10.1016/j.arth.2012.02.031; Pandit H, 2006, J BONE JOINT SURG BR, V88B, P54, DOI 10.1302/0301-620X.88B1.17114; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Robertsson O, 2001, J BONE JOINT SURG BR, V83B, P45, DOI 10.1302/0301-620X.83B1.10871; Romanowski MR, 2004, MIS OF THE HIP AND THE KNEE: A CLINICAL PERSPECTIVE, P123, DOI 10.1007/0-387-21715-0_7; Salvi AE, 2013, WORLD J ORTHOP, V4, P58, DOI 10.5312/wjo.v4.i2.58; Sebilo A, 2013, ORTHOP TRAUMATOL-SUR, V99, pS227, DOI 10.1016/j.otsr.2013.02.002; Tang Hengtao, 2012, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V26, P17; Thompson SAJ, 2013, J ARTHROPLASTY, V28, P1561, DOI 10.1016/j.arth.2013.02.034; TIBREWAL SB, 1984, J BONE JOINT SURG BR, V66, P523, DOI 10.1302/0301-620X.66B4.6746686; Weber P, 2013, KNEE SURG SPORT TR A, V21, P2453, DOI 10.1007/s00167-013-2370-x; Yoshida K, 2013, J ARTHROPLASTY, V28, P168, DOI 10.1016/j.arth.2013.08.019	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176082	10.1371/journal.pone.0176082	http://dx.doi.org/10.1371/journal.pone.0176082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472068	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500025
J	Wang, XH; Shults, NV; Suzuki, YJ				Wang, Xinhong; Shults, Nataliia V.; Suzuki, Yuichiro J.			Oxidative profiling of the failing right heart in rats with pulmonary hypertension	PLOS ONE			English	Article							RIGHT-VENTRICULAR FAILURE; ARTERIAL-HYPERTENSION; PROTEIN CARBONYLATION; MOLECULAR-MECHANISMS; HYPERTROPHY; SURVIVAL	Right heart failure is the major cause of death among patients with pulmonary arterial hypertension (PAH). Understanding the biology of the right ventricle (RV) should help developing new therapeutic strategies. Rats subjected to the injection of Sugen5416 (an inhibitors of vascular endothelial growth factor receptor) plus the ovalbumin immunization had increased pulmonary arterial pressure and severe vascular remodeling. RVs of these rats were hypertrophied and had severe cardiac fibrosis. No apoptosis was, however, detected. Metabolomics analysis revealed that oxidized glutathione, xanthine and uric acid had increased in PAH RVs, suggesting the production of reactive oxygen species by xanthine oxidase. PAH RVs were also found to have a 30-fold lower level of a-tocopherol nicotinate, consistent with oxidative stress decreasing antioxidants and also demonstrating for the first time that the nicotinate ester of vitamin E is endogenously expressed. Oxidative/nitrosative protein modifications including S-glutathionylation, S-nitrosylation and nitrotyrosine formation, but not protein carbonylation, were found to be increased in RVs of rats with PAH. Mass spectrometry identified that S-nitrosylated proteins include heat shock protein 90 and sarcoplasmic reticulum Ca2+-ATPase. These results demonstrate that RV failure is associated with the promotion of specific oxidative and nitrosative stress.	[Wang, Xinhong; Shults, Nataliia V.; Suzuki, Yuichiro J.] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA; [Wang, Xinhong] Fudan Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Shanghai, Peoples R China	Georgetown University; Fudan University	Suzuki, YJ (corresponding author), Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA.	ys82@georgetown.edu	Xinhong, Wang/P-7311-2019	Xinhong, Wang/0000-0001-5363-032X	National Institutes of Health [R01HL72844, R03AG047824]; National Natural Science Foundation of China [81201468]; Fudan University Fund [20520133217]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fudan University Fund	This work was supported in part by National Institutes of Health (R01HL72844 and R03AG047824) to YJS; and the National Natural Science Foundation of China (81201468) and Fudan University Fund (20520133217) to XW.	Alzoubi A, 2013, AM J PHYSIOL-HEART C, V304, pH1708, DOI 10.1152/ajpheart.00746.2012; ARAI M, 1994, CIRC RES, V74, P555, DOI 10.1161/01.RES.74.4.555; Benza RL, 2010, TRANSPLANTATION, V90, P298, DOI 10.1097/TP.0b013e3181e49b83; Boxt LM, 1999, RADIOL CLIN N AM, V37, P379, DOI 10.1016/S0033-8389(05)70100-7; Budev MM, 2003, SEMIN RESP CRIT CARE, V24, P233; Chemla D, 2002, EUR RESPIR J, V20, P1314, DOI 10.1183/09031936.02.00068002; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Delcroix M, 2010, EUR RESPIR REV, V19, P204, DOI 10.1183/09059180.00004910; Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488; Fishman AP, 2004, J AM COLL CARDIOL, V43, p2S, DOI 10.1016/j.jacc.2004.03.019; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Halliwell B., 2015, FREE RADICALS BIOL M; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Humbert M, 2010, EUR RESPIR J, V36, P549, DOI 10.1183/09031936.00057010; Ibrahim YF, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000520; Ikeda S, 2014, ARTERIOSCL THROM VAS, V34, P1260, DOI 10.1161/ATVBAHA.114.303320; Mizuno S, 2012, AM J RESP CELL MOL, V47, P679, DOI 10.1165/rcmb.2012-0077OC; Nauser Trenton D, 2003, Congest Heart Fail, V9, P155, DOI 10.1111/j.1527-5299.2002.01050.x; Nicolls Mark R, 2012, Pulm Circ, V2, P434, DOI 10.4103/2045-8932.105031; Qipshidze N, 2012, AM J PHYSIOL-HEART C, V302, pH688, DOI 10.1152/ajpheart.00777.2011; Rawat DK, 2014, HYPERTENSION, V64, P1266, DOI 10.1161/HYPERTENSIONAHA.114.03261; Reddy S, 2015, CIRCULATION, V132, P1734, DOI 10.1161/CIRCULATIONAHA.114.012975; Redout EM, 2007, CARDIOVASC RES, V75, P770, DOI 10.1016/j.cardiores.2007.05.012; Redout EM, 2010, AM J PHYSIOL-HEART C, V298, pH1038, DOI 10.1152/ajpheart.00097.2009; Runo JR, 2003, LANCET, V361, P1533, DOI 10.1016/S0140-6736(03)13167-4; Simonneau G, 2004, J AM COLL CARDIOL, V43, p5S, DOI 10.1016/j.jacc.2004.02.037; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Suzuki YJ, 2011, TEXTBOOK OF PULMONARY VASCULAR DISEASE, P1305, DOI 10.1007/978-0-387-87429-6_93; Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887; Sztrymf B, 2010, EUR RESPIR J, V35, P1286, DOI 10.1183/09031936.00070209; Tanonaka K, 2001, BIOCHEM BIOPH RES CO, V283, P520, DOI 10.1006/bbrc.2001.4801; Thenappan T, 2010, EUR RESPIR J, V35, P1079, DOI 10.1183/09031936.00072709; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Wong CM, 2008, CIRC RES, V102, P310, DOI 10.1161/CIRCRESAHA.107.159814	34	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176887	10.1371/journal.pone.0176887	http://dx.doi.org/10.1371/journal.pone.0176887			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472095	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500093
J	Zhang, YH; Dai, L; Liu, Y; Zhang, YH; Wang, SP				Zhang, Yunhua; Dai, Li; Liu, Ying; Zhang, YuHang; Wang, ShaoPeng			Identifying novel fruit-related genes in Arabidopsis thaliana based on the random walk with restart algorithm	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; ONE-CARBON METABOLISM; SEED-GERMINATION; SHORTEST-PATH; SPECIFICALLY INTERACTS; COMPUTATIONAL METHOD; IDENTIFICATION; NETWORK; PREDICTION; RECEPTOR	Fruit is essential for plant reproduction and is responsible for protection and dispersal of seeds. The development and maturation of fruit is tightly regulated by numerous genetic factors that respond to environmental and internal stimulation. In this study, we attempted to identify novel fruit-related genes in a model organism, Arabidopsis thaliana, using a computational method. Based on validated fruit-related genes, the random walk with restart (RWR) algorithm was applied on a protein-protein interaction (PPI) network using these genes as seeds. The identified genes with high probabilities were filtered by the permutation test and linkage tests. In the permutation test, the genes that were selected due to the structure of the PPI network were discarded. In the linkage tests, the importance of each candidate gene was measured from two aspects: (1) its functional associations with validated genes and (2) its similarity with validated genes on gene ontology (GO) terms and KEGG pathways. Finally, 255 inferred genes were obtained, subsequent extensive analysis of important genes revealed that they mainly contribute to ubiquitination (UBQ9, UBQ8, UBQ11, UBQ10), serine hydroxymethyl transfer (SHM7, SHM5, SHM6) or glycol-metabolism (HXKL2_ARATH, CSY5, GAPCP1), suggesting essential roles during the development and maturation of fruit in Arabidopsis thaliana.	[Zhang, Yunhua; Dai, Li] Anhui Agr Univ, Sch Resources & Environm, Hefei, Peoples R China; [Liu, Ying] Anhui Agr Univ, Sch Forestry & Landscape Architecture, Hefei, Peoples R China; [Zhang, YuHang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Wang, ShaoPeng] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China	Anhui Agricultural University; Anhui Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai University	Zhang, YH (corresponding author), Anhui Agr Univ, Sch Resources & Environm, Hefei, Peoples R China.	yunhua9681@163.com	Zhang, Yu-Hang/AAQ-9012-2021; Zhang, Yu-Hang/O-9774-2015	Zhang, Yu-Hang/0000-0003-3825-0796; Zhang, Yu-Hang/0000-0003-3825-0796; Zhang, Yunhua/0000-0001-5128-6385	Science Foundation of Anhui [1608085MC58]; Science and technology research projects [1604e0302006]	Science Foundation of Anhui; Science and technology research projects	This work was supported by the Science Foundation of Anhui (Grant No. 1608085MC58) and the Science and technology research projects (Grant No. 1604e0302006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by grants from the Science Foundation of Anhui (Grant No. 1608085MC58) and the Science and technology research projects (Grant No. 1604e0302006).	Agrawal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029302; Aloy P, 2003, BIOINFORMATICS, V19, P161, DOI 10.1093/bioinformatics/19.1.161; Andriotis VME, 2010, NEW PHYTOL, V185, P649, DOI 10.1111/j.1469-8137.2009.03113.x; Anoman AD, 2015, PLANT PHYSIOL, V169, P1619, DOI 10.1104/pp.15.00696; [Anonymous], 2005, P 5 INT WORKSH BIOIN, DOI DOI 10.1145/1134030.1134042; Avraham S, 2008, NUCLEIC ACIDS RES, V36, pD449, DOI 10.1093/nar/gkm908; Balanza V, 2016, DEVELOPMENT, V143, P3372, DOI 10.1242/dev.135202; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barkla BJ, 2014, J PROTEOMICS, V111, P128, DOI 10.1016/j.jprot.2014.03.006; Bueso E, 2014, PLANT PHYSIOL, V164, P999, DOI 10.1104/pp.113.232223; Bueso E, 2014, PLANT SCI, V215, P110, DOI 10.1016/j.plantsci.2013.11.004; CALLIS J, 1995, GENETICS, V139, P921; Chen JG, 2004, METHOD ENZYMOL, V389, P338; CHEN L, 2016, MOL GENET GENOMICS, V291, P2065, DOI DOI 10.1007/s00438-016-1240-x; Chen L, 2017, PLOS ONE; Chen L, 2017, AGR FOREST METEOROL, V233, P133, DOI 10.1016/j.agrformet.2016.11.012; Chen L, 2016, PROTEIN PEPTIDE LETT, V23, P1081, DOI 10.2174/0929866523666161021165506; Chen L, 2016, MOL GENET GENOMICS, V291, P913, DOI 10.1007/s00438-015-1157-9; Chen L, 2016, CURR BIOINFORM, V11, P51, DOI 10.2174/1574893611666151119220024; Chen L, 2016, J BIOMOL STRUCT DYN, V34, P664, DOI 10.1080/07391102.2015.1042915; Chen L, 2015, MOL BIOSYST, V11, P2541, DOI 10.1039/c5mb00276a; Dyson BC, 2014, ANN BOT-LONDON, V113, P643, DOI 10.1093/aob/mct298; El-Sharkawy I, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0746-z; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gene Ontology Consortium, 2015, Nucleic Acids Res, V43, pD1049, DOI 10.1093/nar/gku1179; Gormen T. H., 1990, INTRO ALGORITHMS; Gui TT, 2015, J COMPUT BIOL, V22, P63, DOI 10.1089/cmb.2014.0122; Guo W, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6132436; Ham B, 2013, IEEE T IMAGE PROCESS, V22, P2574, DOI 10.1109/TIP.2013.2253479; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang GH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166580; Jalali S, 2015, BIOINFORMATICS, V31, P2241, DOI 10.1093/bioinformatics/btv148; Jander G, 2004, PLANT J, V39, P465, DOI 10.1111/j.1365-313X.2004.02140.x; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jumhawan U, 2013, J AGR FOOD CHEM, V61, P7994, DOI 10.1021/jf401819s; Kawasaki T, 2005, PLANT J, V44, P258, DOI 10.1111/j.1365-313X.2005.02525.x; Kinoshita T, 2008, SEMIN CELL DEV BIOL, V19, P574, DOI 10.1016/j.semcdb.2008.07.018; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Lahaie N, 2016, J BIOL CHEM, V291, P7156, DOI 10.1074/jbc.M115.686907; Lasky JR, 2012, MOL ECOL, V21, P5512, DOI 10.1111/j.1365-294X.2012.05709.x; Leeggangers HACF, 2015, PHYSIOL PLANTARUM, V153, P318, DOI 10.1111/ppl.12231; Lemus Leticia, 2014, Cells, V3, P824, DOI 10.3390/cells3030824; Li M, 2011, PLANT BIOTECHNOL J, V9, P1002, DOI 10.1111/j.1467-7652.2011.00610.x; Li ZD, 2016, SCI REP-UK, V6, DOI 10.1038/srep25515; Liu JX, 2016, NEW PHYTOL, V211, P418, DOI 10.1111/nph.13915; Liu JH, 2013, PLANT CELL REP, V32, P129, DOI 10.1007/s00299-012-1347-4; Liu X, 2014, MOL BIOL REP, V41, P6253, DOI 10.1007/s11033-014-3506-x; Liu Y, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.42; Lugassi N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01114; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Matella NJ, 2005, J AGR FOOD CHEM, V53, P2268, DOI 10.1021/jf048285c; Meng HY, 2014, PLOS ONE, V9; Miao X., 2016, ADV EN ENV MAT SCI; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Pinto LVA, 2007, ANN BOT-LONDON, V100, P1175, DOI 10.1093/aob/mcm211; Pracharoenwattana I, 2005, PLANT CELL, V17, P2037, DOI 10.1105/tpc.105.031856; Quatrini L, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab2724; Ravi M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6334; Rizzo AA, 2014, BIOCHEMISTRY-US, V53, P5895, DOI 10.1021/bi500823h; Roeder Adrienne H K, 2006, Arabidopsis Book, V4, pe0075, DOI 10.1199/tab.0075; Roth U, 2006, J EXP BOT, V57, P4003, DOI 10.1093/jxb/erl170; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; SNAPE JW, 1971, HEREDITY, V27, P299, DOI 10.1038/hdy.1971.91; Su R, 2016, J MICROSC-OXFORD, V264, P127, DOI 10.1111/jmi.12421; Sun CW, 1997, PLANT MOL BIOL, V34, P745, DOI 10.1023/A:1005848828368; Wang BM, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/715639; Wang DK, 2015, J INTEGR PLANT BIOL, V57, P745, DOI 10.1111/jipb.12336; Wang SP, 2016, BBA-GEN SUBJECTS, V1860, P2716, DOI 10.1016/j.bbagen.2016.04.010; Wang WQ, 2015, PLANT PHYSIOL, V167, P1332, DOI 10.1104/pp.15.00045; Wei LY, 2017, ARTIF INTELL MED, V83, P67, DOI 10.1016/j.artmed.2017.03.001; Wei LY, 2017, IEEE T NANOBIOSCI, V16, P240, DOI 10.1109/TNB.2017.2661756; Wei LY, 2017, INFORM SCIENCES, V384, P135, DOI 10.1016/j.ins.2016.06.026; WEI LY, IEEE ACM TRANS COMPU, V16, P1264; Wei ZY, 2013, ARCH BIOCHEM BIOPHYS, V536, P87, DOI 10.1016/j.abb.2013.06.004; Yang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107202; Yang XY, 2011, PLANT CELL, V23, P1093, DOI 10.1105/tpc.110.082420; Yoshida H, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-14; Yuan F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/623121; Zeng XX, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005420; Zeng XX, 2017, IEEE ACM T COMPUT BI, V14, P687, DOI 10.1109/TCBB.2016.2520947; Zhang J, 2016, NEUROCOMPUTING, V217, P63, DOI 10.1016/j.neucom.2015.09.136; Zhang J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/450386; Zhang T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/870795; Zhang Y, 2010, BIOCHEM J, V430, P97, DOI 10.1042/BJ20100566; Zhu LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159519	88	15	15	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177017	10.1371/journal.pone.0177017	http://dx.doi.org/10.1371/journal.pone.0177017			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472169	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500118
J	Zhou, ZL; Cao, C; Cao, LD; Zheng, L; Xu, J; Li, FM; Huang, QL				Zhou, Zhao-Lu; Cao, Chong; Cao, Li-Dong; Zheng, Li; Xu, Jun; Li, Feng-Min; Huang, Qi-Liang			Evaporation kinetics of surfactant solution droplets on rice (Oryza sativa) leaves	PLOS ONE			English	Article							WATER DROPS; SESSILE; WETTABILITY; DYNAMICS; RATES	The dynamics of evaporating sessile droplets on hydrophilic or hydrophobic surfaces is widely studied, and many models for these processes have been developed based on experimental evidence. However, few research has been explored on the evaporation of sessile droplets of surfactant or pesticide solutions on target crop leaves. Thus, in this paper the impact of surfactant concentrations on contact angle, contact diameter, droplet height, and evolution of the droplets' evaporative volume on rice leaf surfaces have been investigated. The results indicate that the evaporation kinetics of surfactant droplets on rice leaves were influenced by both the surfactant concentrations and the hydrophobicity of rice leaf surfaces. When the surfactant concentration is lower than the surfactant CMC (critical micelle concentration), the droplet evaporation time is much longer than that of the high surfactant concentration. This is due to the longer existence time of a narrow wedge region under the lower surfactant concentration, and such narrow wedge region further restricts the droplet evaporation. Besides, our experimental data are shown to roughly collapse onto theoretical curves based on the model presented by Popov. This study could supply theoretical data on the evaporation of the adjuvant or pesticide droplets for practical applications in agriculture.	[Zhou, Zhao-Lu; Cao, Chong; Cao, Li-Dong; Zheng, Li; Xu, Jun; Li, Feng-Min; Huang, Qi-Liang] Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Integrated Pest Management Crops, Minist Agr, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs	Huang, QL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Integrated Pest Management Crops, Minist Agr, Beijing, Peoples R China.	qlhuang@ippcaas.cn	Huang, Qiliang/AAC-7178-2022	ZHENG, LI/0000-0002-5329-3762	National Natural Science Foundation of China (NSFC) [31471805, 31601673]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NSFC), no. 31471805, Prof. Qi-Liang Huang, and the National Natural Science Foundation of China (NSFC), no. 31601673, Dr. Chong Cao.	[Anonymous], 2007, MATLAB REF MAN; Barnes GT, 2008, AGR WATER MANAGE, V95, P339, DOI 10.1016/j.agwat.2007.12.003; BIRDI KS, 1993, J ADHES SCI TECHNOL, V7, P485, DOI 10.1163/156856193X00808; BIRDI KS, 1989, J PHYS CHEM-US, V93, P3702, DOI 10.1021/j100346a065; BOURGESMONNIER C, 1995, LANGMUIR, V11, P2820, DOI 10.1021/la00007a076; BREEZE VG, 1992, PESTIC SCI, V36, P101, DOI 10.1002/ps.2780360204; Calvert P, 2001, CHEM MATER, V13, P3299, DOI 10.1021/cm0101632; Carvalho FP, 2006, ENVIRON SCI POLICY, V9, P685, DOI 10.1016/j.envsci.2006.08.002; Chachalis D, 2001, WEED SCI, V49, P156, DOI 10.1614/0043-1745(2001)049[0156:COLSWC]2.0.CO;2; Choi CH, 2009, LANGMUIR, V25, P7561, DOI 10.1021/la803614h; Dash S, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.042402; Dash S, 2013, LANGMUIR, V29, P10785, DOI 10.1021/la402784c; Deegan RD, 2000, PHYS REV E, V62, P756, DOI 10.1103/PhysRevE.62.756; Doganci MD, 2011, J COLLOID INTERF SCI, V362, P524, DOI 10.1016/j.jcis.2011.06.060; Eral HB, 2013, COLLOID POLYM SCI, V291, P247, DOI 10.1007/s00396-012-2796-6; Gelderblom H, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.026306; Haynes W.M., 2014, CRC HDB CHEM PHYS, V95th ed.; HOLLOWAY P. J., 1970, Pesticide Science, V1, P156, DOI 10.1002/ps.2780010411; Hu H, 2002, J PHYS CHEM B, V106, P1334, DOI 10.1021/jp0118322; Huang J., 2000, FARM PESTICIDE USE R, P901; Huang Y, 2012, J AM CHEM SOC, V134, P17053, DOI 10.1021/ja304751k; Ivanova NA, 2011, CURR OPIN COLLOID IN, V16, P285, DOI 10.1016/j.cocis.2011.06.008; Ivanova N, 2010, COLLOID SURFACE A, V354, P143, DOI 10.1016/j.colsurfa.2009.07.030; Kerstiens G., 1996, J EXP BOT, V25, P41; Li QW, 2006, J PHYS CHEM B, V110, P13926, DOI 10.1021/jp061554c; Liu MJ, 2010, ACCOUNTS CHEM RES, V43, P368, DOI 10.1021/ar900205g; Mao BG, 2012, PLANTA, V235, P39, DOI 10.1007/s00425-011-1481-1; McHale G, 2005, LANGMUIR, V21, P11053, DOI 10.1021/la0518795; McHale G, 1998, J PHYS CHEM B, V102, P1964, DOI 10.1021/jp972552i; Nairn JJ, 2011, PEST MANAG SCI, V67, P1562, DOI 10.1002/ps.2213; PICKNETT RG, 1977, J COLLOID INTERF SCI, V61, P336, DOI 10.1016/0021-9797(77)90396-4; Pittoni PG, 2013, COLLOID SURFACE A, V432, P89, DOI 10.1016/j.colsurfa.2013.04.045; Popov YO, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036313; Priest C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.026103; Reyssat M, 2008, EPL, V81, P226; ROWAN SM, 1995, J PHYS CHEM-US, V99, P13268, DOI 10.1021/j100035a034; Semenov S, 2013, LANGMUIR, V29, P10028, DOI 10.1021/la401578v; SHANAHAN MER, 1994, INT J ADHES ADHES, V14, P201, DOI 10.1016/0143-7496(94)90031-0; Soboleva OA, 2003, COLLOID J+, V65, P89, DOI 10.1023/A:1022379210765; Starov V, 2010, ADV COLLOID INTERFAC, V161, P153, DOI 10.1016/j.cis.2010.04.001; Stauber JM, 2014, J FLUID MECH, V744, DOI 10.1017/jfm.2014.94; Stauber JM, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4935232; Stauber JM, 2015, LANGMUIR, V31, P3653, DOI 10.1021/acs.langmuir.5b00286; Tadmor R, 2011, SOFT MATTER, V7, P1577, DOI 10.1039/c0sm00775g; Tadmor R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.266101; Wang H, 2014, PLOS ONE, V9; WIRTH W, 1991, PESTIC SCI, V33, P411, DOI 10.1002/ps.2780330403; Xu L, 2010, T ASABE, V53, P13; Xu LY, 2011, PEST MANAG SCI, V67, P842, DOI 10.1002/ps.2122; Xu W, 2013, LANGMUIR, V29, P6032, DOI 10.1021/la400452e; Xu W, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.024504; Yu YS, 2012, J COLLOID INTERF SCI, V365, P254, DOI 10.1016/j.jcis.2011.09.007; Zhang XY, 2006, CHEMPHYSCHEM, V7, P2067, DOI 10.1002/cphc.200600229	53	14	17	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176870	10.1371/journal.pone.0176870	http://dx.doi.org/10.1371/journal.pone.0176870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472108	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500089
J	Shintyapina, AB; Vavilin, VA; Safronova, OG; Lyakhovich, VV				Shintyapina, Alexandra B.; Vavilin, Valentin A.; Safronova, Olga G.; Lyakhovich, Vyacheslav V.			The gene expression profile of a drug metabolism system and signal transduction pathways in the liver of mice treated with tert-butylhydroquinone or 3-(3'-tert-butyl-4'-hydroxyphenyl) propylthiosulfonate of sodium	PLOS ONE			English	Article							NF-KAPPA-B; CONSTITUTIVE ANDROSTANE RECEPTOR; ANTIOXIDANT-RESPONSIVE ELEMENT; HUMAN NEUROBLASTOMA-CELLS; ACTIVATED PROTEIN-KINASE; INDUCED APOPTOSIS; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASE; INFLAMMATORY RESPONSE; COORDINATE REGULATION	Tert-butylhydroquinone (tBHQ) is a highly effective phenolic antioxidant used in edible oils and fats in foods as well as in medicines and cosmetics. TBHQ has been shown to have both chemoprotective and carcinogenic effects. Furthermore, it has potential anti- inflammatory, antiatherogenic, and neuroprotective activities. TBHQ induces phase II detoxification enzymes via the Keap1/Nrf2/ARE mechanism, which contributes to its chemopreventive functions. Nonetheless, there is growing evidence that biological effects of tBHQ may be mediated by Nrf2-independent mechanisms related to various signaling cascades. Here, we studied changes in gene expression of phase I, II, and III drug metabolizing enzymes/transporters as well as protein levels and activities of cytochromes P450 (CYPs) elicited by tBHQ and its structural homolog TS-13 in the mouse liver. Next, we carried out gene expression analysis to identify signal transduction pathways modulated by the antioxidants. Mice received 100 mg/kg tBHQ or TS-13 per day or only vehicle. The liver was collected at 12 hours and after 7 days of the treatment. Protein and total RNA were extracted. Gene expression was analyzed using Mouse Drug Metabolism and Signal Transduction PathwayFinder RT2 Profiler (TM) PCR Arrays. A western blot analysis was used to measure protein levels and a fluorometric assay was employed to study activities of CYPs. Genes that were affected more than 1.5-fold by tBHQ or TS-13 treatment compared with vehicle were identified. Analysis of the gene expression data revealed changes in various genes that are important for drug metabolism, cellular defense mechanisms, inflammation, apoptosis, and cell cycle regulation. Novel target genes were identified, including xenobiotic metabolism genes encoding CYPs, phase II/III drug metabolizing enzymes/transporters. For Cyp1a2 and Cyp2b, we observed an increase in protein levels and activities during tBHQ or TS-13 treatment. Changes were found in the gene expression regulated by NF kappa B, androgen, retinoic acid, PI3K/AKT, Wnt, Hedgehog and other pathways. [GRAPHICS] .	[Shintyapina, Alexandra B.; Vavilin, Valentin A.; Safronova, Olga G.; Lyakhovich, Vyacheslav V.] Inst Mol Biol & Biophys, Novosibirsk, Russia; [Vavilin, Valentin A.; Lyakhovich, Vyacheslav V.] Novosibirsk State Univ, Novosibirsk, Russia	Novosibirsk State University	Shintyapina, AB (corresponding author), Inst Mol Biol & Biophys, Novosibirsk, Russia.	alexandra.shintyapina@gmail.com	Shintyapina, Alexandra/I-9853-2016; Shintyapina, Alexandra/J-8865-2017; Shintyapina, Alexandra/U-4814-2019; Safronova, Olga/G-5263-2017; Vavilin, Valentin A/K-6100-2012	Shintyapina, Alexandra/0000-0001-6253-6490; Safronova, Olga/0000-0002-7504-0168; Vavivilin, Valentin/0000-0002-9769-6512				Arinze IJ, 2005, J BIOL CHEM, V280, P9786, DOI 10.1074/jbc.M414006200; Auyeung DJ, 2003, MOL PHARMACOL, V63, P119, DOI 10.1124/mol.63.1.119; Bahia PK, 2012, J NEUROCHEM, V123, P182, DOI 10.1111/j.1471-4159.2012.07877.x; Barve A, 2008, J PHARM SCI-US, V97, P4528, DOI 10.1002/jps.21311; Bell KFS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8066; Bensasson RV, 2008, CHEM RES TOXICOL, V21, P805, DOI 10.1021/tx7002883; BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7; Cai YD, 2011, HEPATO-GASTROENTEROL, V58, P2071, DOI 10.5754/hge11155; EFSA, 2004, EFSA J, V84, P1, DOI [10.2903/j.efsa.2007.315, DOI 10.2903/J.EFSA.2007.315, DOI 10.2903/J.EFSA.2004.84]; Fung E, 2015, CLIN RES HEPATOL GAS, V39, pS69, DOI 10.1016/j.clinre.2015.05.017; Gharavi N, 2005, DRUG METAB DISPOS, V33, P365, DOI 10.1124/dmd.104.002253; Gharavi N, 2007, CURR DRUG METAB, V8, P1, DOI 10.2174/138920007779315035; GRISHANOVA AY, 1992, CYTOCHROME P-450 : BIOCHEMISTRY AND BIOPHYSICS, P525; HIROSE M, 1993, CARCINOGENESIS, V14, P2359, DOI 10.1093/carcin/14.11.2359; Ho LC, 2016, J MOL MED, V94, P933, DOI 10.1007/s00109-016-1403-6; Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321; Hu R, 2006, ARCH PHARM RES, V29, P911, DOI 10.1007/BF02973914; Ikeda H, 2002, BIOCHEM J, V364, P563, DOI 10.1042/BJ20011756; Ioannides C., 1996, CYTOCHROMES P450 MET; Jin W, 2014, ANN CLIN LAB SCI, V44, P151; Jin W, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/502564; Kang KW, 2001, MOL PHARMACOL, V59, P1147, DOI 10.1124/mol.59.5.1147; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; Kann S, 2005, TOXICOL SCI, V87, P365, DOI 10.1093/toxsci/kfi253; Kayampilly PP, 2010, ENDOCRINOLOGY, V151, P5030, DOI 10.1210/en.2010-0444; Kebenko M, 2015, CELL SIGNAL, V27, P373, DOI 10.1016/j.cellsig.2014.11.022; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Kohle C, 2007, BIOCHEM PHARMACOL, V73, P1853, DOI 10.1016/j.bcp.2007.01.009; Lee JM, 2001, J BIOL CHEM, V276, P20011, DOI 10.1074/jbc.M100734200; Li ST, 2014, BBA-MOL CELL BIOL L, V1841, P22, DOI 10.1016/j.bbalip.2013.09.004; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Li YS, 2013, GENET MOL RES, V12, P5433, DOI 10.4238/2013.November.11.5; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Lin W, 2008, BIOCHEM PHARMACOL, V76, P967, DOI 10.1016/j.bcp.2008.07.036; Liu H, 2008, P NATL ACAD SCI USA, V105, P15926, DOI 10.1073/pnas.0808346105; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo L, 2015, TOXICOL APPL PHARM, V288, P339, DOI 10.1016/j.taap.2015.08.006; Makia NL, 2014, MOL PHARMACOL, V86, P125, DOI 10.1124/mol.114.092585; Menegon S, 2016, TRENDS MOL MED, V22, P578, DOI 10.1016/j.molmed.2016.05.002; Menshchikova E, 2014, INFLAMM RES, V63, P729, DOI 10.1007/s00011-014-0746-0; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nair S, 2006, PHARM RES-DORDR, V23, P2621, DOI 10.1007/s11095-006-9099-x; NAKAGAWA Y, 1994, EUR J PHARM-ENVIRON, V270, P341, DOI 10.1016/0926-6917(94)90010-8; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; Namgaladze D, 2015, J BIOL CHEM, V290, P24484, DOI 10.1074/jbc.M115.678243; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nieva-Echevarria B, 2015, COMPR REV FOOD SCI F, V14, P67, DOI 10.1111/1541-4337.12121; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Okubo T, 2003, FOOD CHEM TOXICOL, V41, P679, DOI 10.1016/S0278-6915(03)00002-4; Oleynik AS, 2007, RUSS CHEM B+, V56, P1135, DOI 10.1007/s11172-007-0172-3; Petrick JS, 2007, DRUG METAB DISPOS, V35, P1806, DOI 10.1124/dmd.107.015974; Pickell L, 2005, BBA-GENE STRUCT EXPR, V1731, P104, DOI 10.1016/j.bbaexp.2005.09.002; Pokorny J., 2001, ANTIOXIDANTS FOOD PR; POLAND A, 1980, MOL PHARMACOL, V18, P571; Ramaswamy B, 2012, CANCER RES, V72, P5048, DOI 10.1158/0008-5472.CAN-12-1248; Reilly KB, 2004, J BIOL CHEM, V279, P9440, DOI 10.1074/jbc.M303857200; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; Rendic S, 2012, CHEM RES TOXICOL, V25, P1316, DOI 10.1021/tx300132k; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Rushmore TH, 2002, CURR DRUG METAB, V3, P481, DOI 10.2174/1389200023337171; Schreiber TD, 2006, DRUG METAB DISPOS, V34, P1096, DOI 10.1124/dmd.106.009662; Shi XJ, 2016, INT J MOL MED, V38, P123, DOI 10.3892/ijmm.2016.2605; Shindo S, 2007, BIOCHEM J, V401, P735, DOI 10.1042/BJ20061238; Shintyapina AB, 2014, B EXP BIOL MED+, V157, P473, DOI 10.1007/s10517-014-2594-x; Szrok S, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0533-3; Talalay P, 2000, BIOFACTORS, V12, P5, DOI 10.1002/biof.5520120102; TATA JR, 1969, SUBCELLULAR COMPONEN, P83; Vavilin V.A., 2014, J PHARM SCI RES, V6, P178; Winterbourn CC, 2004, JPN J INFECT DIS, V57, pS31; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Zagorski JW, 2013, TOXICOL SCI, V136, P63, DOI 10.1093/toxsci/kft172; Zhang D, 2007, DRUG METABOLISM DRUG, P123; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	74	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176939	10.1371/journal.pone.0176939	http://dx.doi.org/10.1371/journal.pone.0176939			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467491	Green Submitted, gold, Green Published			2022-12-27	WOS:000400647000088
J	Chiu, HT; Li, TC; Li, CI; Liu, CS; Lin, WY; Lin, CC				Chiu, Hsien-Tsai; Li, Tsai-Chung; Li, Chia-Ing; Liu, Chiu-Shong; Lin, Wen-Yuan; Lin, Cheng-Chieh			Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study	PLOS ONE			English	Article							LUNG-FUNCTION; STRESS HYPERGLYCEMIA; OXIDATIVE STRESS; ENDOTHELIAL-CELL; GLUCOSE; ASSOCIATION; OUTCOMES; HYPOGLYCEMIA; MANAGEMENT; APOPTOSIS	Background This study aims to examine the association between visit-to-visit glucose variability, which was measured by coefficient of variation (CV) of fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c), and risk of chronic obstructive pulmonary disease (COPD) in a large number of patients with type 2 diabetes with an average follow-up of 7.58 years. Methods We conducted a retrospective cohort study on 27,257 patients with type 2 diabetes who participated in the National Diabetes Case Management Program in Taiwan. Visit-to-visit variability in HbA1c and FPG at baseline and the incidence of COPD were analyzed using a modified Cox proportional hazards model considering competing risks. Results A total of 2,346 incident cases of COPD. Patients were grouped into tertiles of FPG-CV and HbA1c-CV. The incidence rates in the first, second, and third tertiles were 9.87, 11.06, and 13.19, respectively, for FPG-CV and 10.2, 11.81, and 12.07, for HbA1c-CV per 1000 person-years. After adjusting for age, gender, diabetes duration, treatment type, smoking, hypertension, hyperlipidemia, baseline FPG and HbA1c levels, and complications, both FPG-CV and HbA1c-CV were independently associated with COPD. The hazard ratios of COPD for the third terile compared with the first tertile of FPG-CV were 1.26 (95% confidence interval [CI]: 1.13-1.40). Moreover, the hazard ratios of COPD for the third and second tertiles compared with the first tertile of HbA1c-CV were 1.13 (1.02-1.25) and 1.13 (1.02-1.26), respectively. Conclusions Patients with FPG-CV higher than 34.6% or HbA1c-CV higher than 8.4% exhibited an increased risk of COPD. This finding confirmed the linear relationship of FPG-CV and HbA1c-CV to COPD. Visit-to-visit variability in FPG and HbA1c levels are strong predictors of COPD in patients with type 2 diabetes. Future studies should focus on lung dysfunction in diabetes, and adequate glucose control strategy in regular clinical practices must be established for COPD prevention.	[Chiu, Hsien-Tsai] China Med Univ, Dept Publ Hlth, Coll Publ Hlth, Taichung, Taiwan; [Chiu, Hsien-Tsai] China Med Univ Hosp, Big Data Ctr, Clin Res Outcome & Training Ctr, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Grad Inst Biostat, Coll Publ Hlth, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Dept Healthcare Adm, Coll Med & Hlth Sci, Taichung, Taiwan; [Li, Chia-Ing; Liu, Chiu-Shong; Lin, Wen-Yuan; Lin, Cheng-Chieh] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Li, Chia-Ing; Liu, Chiu-Shong; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Liu, Chiu-Shong; Lin, Wen-Yuan; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lin, CC (corresponding author), China Med Univ, Sch Med, Coll Med, Taichung, Taiwan.; Lin, CC (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.; Lin, CC (corresponding author), China Med Univ Hosp, Dept Family Med, Taichung, Taiwan.	cclin@mail.cmuh.org.tw	Lin, Cheng-Chieh/P-2564-2015	Lin, Cheng-Chieh/0000-0002-9625-6216	Bureau of National Health Insurance [D0H94-NH-1007]; Ministry of Science and Technology of Taiwan [NSC 101-2314-B-039 -017-MY3, NSC 102-2314-B-039-005-MY2, MOST 104-2314-B-039-016]; Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW-106-TDU-B-212-113004]; China Medical University Hospital [DMR-105-088]	Bureau of National Health Insurance; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Ministry of Health and Welfare Clinical Trial Center; China Medical University Hospital	This study was funded primarily by the Bureau of National Health Insurance (D0H94-NH-1007), the Ministry of Science and Technology of Taiwan (NSC 101-2314-B-039 -017-MY3 & NSC 102-2314-B-039-005-MY2 & MOST 104-2314-B-039-016), the Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW-106-TDU-B-212-113004), and China Medical University Hospital (DMR-105-088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Baker EH, 2006, THORAX, V61, P284, DOI 10.1136/thx.2005.051029; BUNN HF, 1976, J CLIN INVEST, V57, P1652, DOI 10.1172/JCI108436; Buscemi S, 2010, DIABETIC MED, V27, P872, DOI 10.1111/j.1464-5491.2010.03059.x; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Ceriello A, 2010, DIABETIC MED, V27, P862, DOI 10.1111/j.1464-5491.2010.02967.x; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chang CH, 2010, DIABETIC MED, V27, P636, DOI 10.1111/j.1464-5491.2010.03007.x; Davis TME, 2000, DIABETES RES CLIN PR, V50, P153, DOI 10.1016/S0168-8227(00)00166-2; Di Flaviani A, 2011, DIABETES CARE, V34, P1605, DOI 10.2337/dc11-0034; Ehrlich SF, 2010, DIABETES CARE, V33, P55, DOI 10.2337/dc09-0880; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Forgiarini LA, 2009, J BRAS PNEUMOL, V35, P788, DOI 10.1590/S1806-37132009000800011; Glaser S, 2015, RESPIRATION, V89, P253, DOI 10.1159/000369863; Goldman MD, 2003, DIABETES CARE, V26, P1915, DOI 10.2337/diacare.26.6.1915; Hsu PF, 2013, DIABETES CARE, V36, P894, DOI 10.2337/dc12-0916; IHNAT MA, 2007, AM J BIOCH BIOTECH, V3, P16; International Diabetes Federation, 2014, IDF DIAB ATL UPD POS; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Jiang YD, 2012, J FORMOS MED ASSOC, V111, P599, DOI 10.1016/j.jfma.2012.09.014; Kovatchev BP, 2006, DIABETES CARE, V29, P2433, DOI 10.2337/dc06-1085; LANGE P, 1989, EUR RESPIR J, V2, P14; Lawlor DA, 2004, DIABETOLOGIA, V47, P195, DOI 10.1007/s00125-003-1310-6; Li CI, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000367; Lin CH, 2013, J INTERN MED, V273, P102, DOI 10.1111/joim.12000; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Maurizi AR, 2013, DIABETES METAB RES R; McAlister FA, 2005, DIABETES CARE, V28, P810, DOI 10.2337/diacare.28.4.810; Mirrakhimov AE, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-132; Monnier L, 2008, DIABETES CARE, V31, pS150, DOI 10.2337/dc08-s241; Nalysnyk L, 2010, DIABETES OBES METAB, V12, P288, DOI 10.1111/j.1463-1326.2009.01160.x; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Piconi L, 2006, DIABETES-METAB RES, V22, P198, DOI 10.1002/dmrr.613; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Rogliani P, 2014, ACTA DIABETOL, V51, P933, DOI 10.1007/s00592-014-0584-0; Shih CJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000771; Tay J, 2015, ANNU REV NUTR, V35, P389, DOI 10.1146/annurev-nutr-121214-104422; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; VRACKO R, 1979, AM REV RESPIR DIS, V120, P973; Walter RE, 2003, AM J RESP CRIT CARE, V167, P911, DOI 10.1164/rccm.2203022	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177184	10.1371/journal.pone.0177184	http://dx.doi.org/10.1371/journal.pone.0177184			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489885	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314100053
J	Seher, A; Lagler, C; Stuhmer, T; Muller-Richter, UDA; Kubler, AC; Sebald, W; Muller, TD; Nickel, J				Seher, Axel; Lagler, Charlotte; Stuehmer, Thorsten; Mueller-Richter, Urs Dietmar Achim; Kuebler, Alexander Christian; Sebald, Walter; Mueller, Thomas Dieter; Nickel, Joachim			Utilizing BMP-2 muteins for treatment of multiple myeloma	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; SMAD SIGNALING PATHWAY; ACTIVIN-A; INDUCE APOPTOSIS; RECEPTOR; CELLS; ANTAGONISTS; DIFFERENTIATION; EXPRESSION; DISEASE	Multiple myeloma (MM) represents a haematological cancer characterized by the pathological hyper proliferation of antibody-producing B-lymphocytes. Patients typically suffer from kidney malfunction and skeletal disorders. In the context of MM, the transforming growth factor beta (TGF beta) member Activin A was recently identified as a promoter of both accompanying symptoms. Because studies have shown that (b) under bar one (m) under bar orphogenetic (p) under bar rotein (BMP)2-mediated activities are counteracted by Activin A, we analysed whether BMP2, which also binds to the Activin A receptors ActRII and ActRIIB but activates the alternative SMAD-1/5/8 pathway, can be used to antagonize Activin A activities, such as in the context of MM. Therefore three BMP2 derivatives were generated with modified binding activities for the type II (ActRIIB) and/or type I receptor (BMPRIA) showing either increased or decreased BMP2 activity. In the context of MM these BMP2 muteins show two functionalities since they act as a) an anti-proliferative/apoptotic agent against neoplastic B-cells, b) as a bone-formation promoting growth factor. The molecular basis of both activities was shown in two different cellular models to clearly rely on the properties of the investigated BMP2 muteins to compete for the binding of Activin A to the Activin type II receptors. The experimental outcome suggests new therapeutic strategies using BMP2 variants in the treatment of MMrelated pathologies.	[Seher, Axel; Lagler, Charlotte; Mueller-Richter, Urs Dietmar Achim; Kuebler, Alexander Christian] Univ Hosp Wurzburg, Dept Oral & Maxillofacial Plast Surg, Wurzburg, Germany; [Stuehmer, Thorsten] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany; [Sebald, Walter] Univ Wurzburg, Dept Physiol Chem 2, Theodor Boveri Inst, Bioctr, Wurzburg, Germany; [Mueller, Thomas Dieter] Univ Wurzburg, Dept Mol Plant Physiol & Biophys, Julius von Sachs Inst, Wurzburg, Germany; [Nickel, Joachim] Univ Hosp Wurzburg, Chair Tissue Engn & Regenerat Med, Wurzburg, Germany; [Nickel, Joachim] Fraunhofer IGB, Translat Ctr Wurzburg Regenerat Therapies Oncol &, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Muller, TD (corresponding author), Univ Wurzburg, Dept Mol Plant Physiol & Biophys, Julius von Sachs Inst, Wurzburg, Germany.; Nickel, J (corresponding author), Univ Hosp Wurzburg, Chair Tissue Engn & Regenerat Med, Wurzburg, Germany.; Nickel, J (corresponding author), Fraunhofer IGB, Translat Ctr Wurzburg Regenerat Therapies Oncol &, Wurzburg, Germany.	mueller@botanik.uni-wuerzburg.de; joachim.nickel@uni-wuerzburg.de	DA Müller-Richter, Urs/P-5864-2014; Kübler, Alexander/ABA-9297-2021	DA Müller-Richter, Urs/0000-0001-7869-7686; Mueller, Thomas/0000-0003-1862-7357	Deutsche Forschungsgemeinschaft [KFO 216]; University of Wuerzburg (funding program Open Access Publishing)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Wuerzburg (funding program Open Access Publishing)	This work was supported by the Deutsche Forschungsgemeinschaft (KFO 216) and the University of Wuerzburg (funding program Open Access Publishing).	Albers CE, 2012, BONE, V51, P401, DOI 10.1016/j.bone.2012.06.020; Anguiano A, 2009, J CLIN ONCOL, V27, P4197, DOI 10.1200/JCO.2008.19.1916; Aykul S, 2016, J BIOL CHEM, V291, P10792, DOI 10.1074/jbc.M115.713487; Bergsagel PL, 2001, ONCOGENE, V20, P5611, DOI 10.1038/sj.onc.1204641; Chantry AD, 2010, J BONE MINER RES, V25, P2357, DOI 10.1002/jbmr.142; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Choi YJ, 2012, MED ONCOL, V29, P582, DOI 10.1007/s12032-011-9852-9; DeLisi C, 1979, Cell Biophys, V1, P117; DELISI C, 1981, MOL IMMUNOL, V18, P507, DOI 10.1016/0161-5890(81)90128-0; DELISI C, 1981, NATURE, V289, P322, DOI 10.1038/289322a0; Dudaric L, 2013, COLLEGIUM ANTROPOL, V37, P1291; Fields SZ, 2013, EXPERT OPIN INV DRUG, V22, P87, DOI 10.1517/13543784.2013.738666; Fukuda N, 2006, ONCOGENE, V25, P3509, DOI 10.1038/sj.onc.1209393; Harousseau JL, 2009, NEW ENGL J MED, V360, P2645, DOI 10.1056/NEJMct0805626; Heinecke K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-59; Holien T, 2012, LEUKEMIA, V26, P1073, DOI 10.1038/leu.2011.263; Katagiri T, 2013, BIOL CHEM, V394, P703, DOI 10.1515/hsz-2012-0310; Kawamura C, 2000, BLOOD, V96, P2005, DOI 10.1182/blood.V96.6.2005.h8002005a_2005_2011; Kawamura C, 2002, LEUKEMIA LYMPHOMA, V43, P635, DOI 10.1080/10428190290012182; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420; Longo V, 2012, CANCER TREAT REV, V38, P787, DOI 10.1016/j.ctrv.2012.03.004; McCormack N, 2013, CELL SIGNAL, V25, P2856, DOI 10.1016/j.cellsig.2013.09.012; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; NISHIHARA T, 1993, BIOCHEM BIOPH RES CO, V197, P985, DOI 10.1006/bbrc.1993.2576; Olsen OE, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.16; Olsen OE, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0104-z; Park Y, 2010, MED ONCOL, V27, P1192, DOI 10.1007/s12032-009-9358-x; Piek E, 1999, J CELL PHYSIOL, V180, P141, DOI 10.1002/(SICI)1097-4652(199908)180:2<141::AID-JCP1>3.0.CO;2-I; Raje N, 2010, CURR OPIN MOL THER, V12, P586; Rajkumar SV, 2011, AM J HEMATOL, V86, P57, DOI 10.1002/ajh.21913; Ro TB, 2004, ONCOGENE, V23, P3024, DOI 10.1038/sj.onc.1207386; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Scullen T, 2013, LEUKEMIA, V27, P1715, DOI 10.1038/leu.2013.50; Sebald HJ, 2012, ACTA BIOMATER, V8, P3816, DOI 10.1016/j.actbio.2012.06.036; Seckinger A, 2009, ONCOGENE, V28, P3866, DOI 10.1038/onc.2009.257; Stuhmer T, 2010, BRIT J HAEMATOL, V149, P529, DOI 10.1111/j.1365-2141.2010.08126.x; Sugatani T, 2003, J CELL BIOCHEM, V90, P59, DOI 10.1002/jcb.10613; Terpos E, 2012, ANN ONCOL, V23, P2681, DOI 10.1093/annonc/mds068; URIST MR, 1979, P NATL ACAD SCI USA, V76, P1828, DOI 10.1073/pnas.76.4.1828; Vallet S, 2010, P NATL ACAD SCI USA, V107, P5124, DOI 10.1073/pnas.0911929107; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; WIEGEL FW, 1982, AM J PHYSIOL, V243, pR475, DOI 10.1152/ajpregu.1982.243.5.R475; You LT, 2002, INVEST OPHTH VIS SCI, V43, P72; Yu Nicole Y C, 2012, Front Biosci (Elite Ed), V4, P2647; Zipori D, 2001, J LEUKOCYTE BIOL, V69, P867	48	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0174884	10.1371/journal.pone.0174884	http://dx.doi.org/10.1371/journal.pone.0174884			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489849	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100004
J	Hagiwara, D; Sakai, K; Suzuki, S; Umemura, M; Nogawa, T; Kato, N; Osada, H; Watanabe, A; Kawamoto, S; Gonoi, T; Kamei, K				Hagiwara, Daisuke; Sakai, Kanae; Suzuki, Satoshi; Umemura, Myco; Nogawa, Toshihiko; Kato, Naoki; Osada, Hiroyuki; Watanabe, Akira; Kawamoto, Susumu; Gonoi, Tohru; Kamei, Katsuhiko			Temperature during conidiation affects stress tolerance, pigmentation, and trypacidin accumulation in the conidia of the airborne pathogen Aspergillus fumigatus	PLOS ONE			English	Article							BIOSYNTHESIS; MORPHOLOGY; VIRULENCE; PATHWAY; MELANIN; FUNGI; GENE	Asexual spores (conidia) are reproductive structures that play a crucial role in fungal distribution and survival. As fungal conidia are, in most cases, etiological agents of plant diseases and fungal lung disease, their stress resistance and interaction with their hosts have drawn increasing attention. In the present study, we investigated whether environmental temperature during conidiation affects the stress tolerance of the conidia of the human pathogenic fungus Aspergillus fumigatus. Conidia from a 25 degrees C culture showed a lower tolerance to heat (60 degrees C) and oxidative (H2O2) stresses and a marked resistance to ultraviolet radiation exposure, compared with those produced at 37 and 45 degrees C. The accumulation of trehalose was lower in the conidia from the 25 degrees C culture. Furthermore, the conidia from the 25 degrees C culture showed darker pigmentation and increased transcripts of dihydroxynaphthalene (DHN)melanin biosynthesis-related genes (i.e., pksP, arp1, and arp2). An RNA-sequencing analysis revealed that the transcription level of the trypacidin (tpc) gene cluster, which contains 13 genes, was sharply and coordinately activated in the conidia from the 25 degrees C culture. Accordingly, trypacidin was abundant in the conidia from the 25 degrees C culture, whereas there was little trypacidin in the conidia from the 37 degrees C culture. Taken together, these data show that the environmental temperature during conidiation affects conidial properties such as stress tolerance, pigmentation, and mycotoxin accumulation. To enhance our knowledge, we further explored the temperature-dependent production of DHN-melanin and trypacidin in clinical A. fumigatus isolates. Some of the isolates showed temperature-independent production of DHN-melanin and/or trypacidin, indicating that the conidia-associated secondary metabolisms differed among the isolates.	[Hagiwara, Daisuke; Sakai, Kanae; Watanabe, Akira; Kawamoto, Susumu; Gonoi, Tohru; Kamei, Katsuhiko] Chiba Univ, MMRC, Chuo Ku, 1-8-1 Inohana, Chiba, Japan; [Suzuki, Satoshi] Natl Food Res Inst, 2-1-12 Kan Nondai, Tsukuba, Ibaraki, Japan; [Umemura, Myco] Natl Inst Adv Ind Sci & Technol, Toyohira Ku, 17-2-1 Higashi Nijo, Sapporo, Hokkaido, Japan; [Nogawa, Toshihiko; Kato, Naoki; Osada, Hiroyuki] RIKEN, Ctr Sustainable Resource Sci, Wako, Saitama, Japan	Chiba University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; National Institute of Advanced Industrial Science & Technology (AIST); RIKEN	Hagiwara, D (corresponding author), Chiba Univ, MMRC, Chuo Ku, 1-8-1 Inohana, Chiba, Japan.	dhagi@chiba-u.jp	Osada, Hiroyuki/AAY-6254-2020; Osada, Hiroyuki/N-4305-2014; Umemura, Maiko/M-4092-2018; gonoi, tohru/AAC-5181-2021; Hagiwara, Daisuke/A-3488-2016; Kato, Naoki/D-4018-2017; Nogawa, Toshihiko/ABG-2652-2020; , gonoi/GRS-0648-2022; Nogawa, Toshihiko/C-4095-2017	Umemura, Maiko/0000-0001-8730-1380; gonoi, tohru/0000-0003-3655-7911; Hagiwara, Daisuke/0000-0003-1382-3914; Kato, Naoki/0000-0003-4410-4090; , gonoi/0000-0003-3655-7911; Nogawa, Toshihiko/0000-0003-1270-5270	Noda Institute for Science Research; Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) - MEXT, Japan; Agricultural chemical research foundation [1-328]; MEXT	Noda Institute for Science Research(Noda Institute for Scientific ResearchUemura Fund); Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) - MEXT, Japan; Agricultural chemical research foundation(Agricultural Chemical Research Foundation, Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Noda Institute for Science Research to DH. This work was also supported in part by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Special Budget for Research Project: The Project on Controlling Aspergillosis and the Related Emerging Mycoses, a Cooperative Research Grant of NEKKEN (2013), the National Bio Resource project for Pathogenic Microbes funded by the MEXT, Japan (http://www.nbrp.jp/), the Agricultural chemical research foundation (1-328 to DH), and a Grant-in-Aid for Scientific Research from MEXT (to DH).	ABBAS HK, 1995, PHYTOPATHOLOGY, V85, P677, DOI 10.1094/Phyto-85-677; Al-Bader N, 2010, INFECT IMMUN, V78, P3007, DOI 10.1128/IAI.00813-09; BALAN J, 1963, J ANTIBIOT, V16, P157; Bertolini P, 1997, PLANT PATHOL, V46, P432, DOI 10.1046/j.1365-3059.1997.d01-24.x; Braga G, 2015, CURR GENET, V61, P405, DOI 10.1007/s00294-015-0483-0; d'Enfert C, 1999, MOL MICROBIOL, V32, P471, DOI 10.1046/j.1365-2958.1999.01327.x; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; Fillinger S, 2001, MOL MICROBIOL, V39, P145, DOI 10.1046/j.1365-2958.2001.02223.x; Fuller KK, 2016, MBIO, V7, DOI [10.1128/mBio.01517-16, 10.1128/mbio.01517-16]; Gauthier T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029906; Geib E, 2016, CELL CHEM BIOL, V23, P587, DOI 10.1016/j.chembiol.2016.03.014; Hagiwara D, 2016, BIOSCI BIOTECH BIOCH, V80, P1667, DOI 10.1080/09168451.2016.1162085; Hagiwara D, 2014, FUNGAL GENET BIOL, V73, P138, DOI 10.1016/j.fgb.2014.10.011; Hagiwara D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080881; Heinekamp T, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00440; Hillmann F, 2015, ENVIRON MICROBIOL, V17, P2858, DOI 10.1111/1462-2920.12808; Jorgensen TR, 2011, FUNGAL GENET BIOL, V48, P544, DOI 10.1016/j.fgb.2011.01.005; Kowalski CH, 2016, MBIO, V7, DOI [10.1128/mBio.01515-16, 10.1128/mbio.01515-16]; Kwon-Chung KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003743; Low SY, 2011, FUNGAL BIOL-UK, V115, P625, DOI 10.1016/j.funbio.2011.03.006; Mattern DJ, 2015, APPL MICROBIOL BIOT, V99, P10151, DOI 10.1007/s00253-015-6898-1; MISAGHI IJ, 1978, PHYTOPATHOLOGY, V68, P29, DOI 10.1094/Phyto-68-29; Osherov N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00346; PHILLIPS DJ, 1982, PHYTOPATHOLOGY, V72, P1281, DOI 10.1094/Phyto-77-1281; Pihet M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-177; Rangel DEN, 2015, CURR GENET, V61, P383, DOI 10.1007/s00294-015-0477-y; Ruijter GJG, 2003, EUKARYOT CELL, V2, P690, DOI 10.1128/EC.2.4.690-698.2003; Sakamoto K, 2009, FUNGAL GENET BIOL, V46, P887, DOI 10.1016/j.fgb.2009.09.004; Sanchez JF, 2012, NAT PROD REP, V29, P351, DOI 10.1039/c2np00084a; Takahashi-Nakaguchi A, 2015, MED MYCOL, V53, P353, DOI 10.1093/mmy/myv003; Throckmorton K, 2016, ENVIRON MICROBIOL, V18, P246, DOI 10.1111/1462-2920.13007; Thywissen A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00096; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Umemura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084028; Van Waeyenberghe L, 2013, ENV MICROBIOL REP, V5, P819, DOI 10.1111/1758-2229.12082; Volling K, 2011, CELL MICROBIOL, V13, P1130, DOI 10.1111/j.1462-5822.2011.01605.x; Wyatt TT, 2013, ADV APPL MICROBIOL, V85, P43, DOI 10.1016/B978-0-12-407672-3.00002-2	37	36	38	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177050	10.1371/journal.pone.0177050	http://dx.doi.org/10.1371/journal.pone.0177050			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486558	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314000039
J	Noman, AM; Gee, CS; Isa, CR				Noman, Abu Hanifa Md.; Gee, Chan Sok; Isa, Che Ruhana			Does competition improve financial stability of the banking sector in ASEAN countries? An empirical analysis	PLOS ONE			English	Article							RISK-TAKING; PANEL-DATA; REVENUE DIVERSIFICATION; MARKET COMPETITION; REFORMS	This study examines the influence of competition on the financial stability of the commercial banks of Association of Southeast Asian Nation (ASEAN) over the 1990 to 2014 period. Panzar- Rosse H-statistic, Lerner index and Herfindahl-Hirschman Index (HHI) are used as measures of competition, while Z-score, non-performing loan (NPL) ratio and equity ratio are used as measures of financial stability. Two-step system Generalized Method of Moments (GMM) estimates demonstrate that competition measured by H-statistic is positively related to Z-score and equity ratio, and negatively related to non-performing loan ratio. Conversely, market power measured by Lerner index is negatively related to Z-score and equity ratio and positively related to NPL ratio. These results strongly support the competition-stability view for ASEAN banks. We also capture the non-linear relationship between competition and financial stability by incorporating a quadratic term of competition in our models. The results show that the coefficient of the quadratic term of H-statistic is negative for the Z-score model given a positive coefficient of the linear term in the same model. These results support the non-linear relationship between competition and financial stability of the banking sector. The study contains significant policy implications for improving the financial stability of the commercial banks.	[Noman, Abu Hanifa Md.; Gee, Chan Sok] Univ Malaya, Fac Business & Accountancy, Dept Finance & Banking, Kuala Lumpur, Malaysia; [Noman, Abu Hanifa Md.] Int Islamic Univ Chittagong, Fac Business Studies, Dept Business Adm, Chittagong, Bangladesh; [Isa, Che Ruhana] Univ Malaya, Fac Business & Accountancy, Dept Accountancy, Kuala Lumpur, Malaysia	Universiti Malaya; International Islamic University Chittagong (IIUC); Universiti Malaya	Noman, AM (corresponding author), Univ Malaya, Fac Business & Accountancy, Dept Finance & Banking, Kuala Lumpur, Malaysia.; Noman, AM (corresponding author), Int Islamic Univ Chittagong, Fac Business Studies, Dept Business Adm, Chittagong, Bangladesh.	kosiralam@yahoo.com	ISA, C.R./B-8360-2010; Noman, Abu Hanifa Md./ABC-1431-2021; Noman, Abu Hanifa Md/AAK-7552-2021	Noman, Abu Hanifa Md/0000-0002-2775-924X; Isa, Che Ruhana/0000-0001-7253-8123	UMRG, University of Malaya [RP001C-13SBS]	UMRG, University of Malaya	This paper is part of the research supported by UMRG research grant (RP001C-13SBS), University of Malaya.; This paper is part of the research supported by UMRG research grant (RP001C-13SBS), University of Malaya. Special thanks are due to the academic editor and two anonymous referees for their constructive comments and suggestions. We believe that the quality of the paper has substantially improved after addressing the comments and suggestions. The authors are also thankful to Michiel van Leuvensteijn, from the Netherlands' Bureau for Economic Policy Analysis, for his valuable suggestions in preparing the paper. However, the views reported in the article are personal.	Acharya VV, 2012, AM ECON J-MACROECON, V4, P184, DOI 10.1257/mac.4.2.184; Agoraki MEK, 2011, J FINANC STABIL, V7, P38, DOI 10.1016/j.jfs.2009.08.002; Allen F, 2004, J MONEY CREDIT BANK, V36, P453, DOI 10.1353/mcb.2004.0038; Allen F, 2000, COMP FINANCIAL SYSTE, P1; Allen F, 2011, REV FINANC STUD, V24, P983, DOI 10.1093/rfs/hhp089; Amidu M, 2013, REV DEV FINANC, V3, P152, DOI 10.1016/j.rdf.2013.08.002; Anginer D, 2014, J FINANC INTERMED, V23, P1, DOI 10.1016/j.jfi.2013.11.001; [Anonymous], 2001, BROOKINGS WHARTON PA; Apergis N, 2016, INT BUS REV, V25, P395, DOI 10.1016/j.ibusrev.2015.07.003; ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; ARELLANO M, 1995, J ECONOMETRICS, V68, P29, DOI 10.1016/0304-4076(94)01642-D; Asian Development Bank, 2013, PUBL STOCK; Barth J.R., 2006, RETHINKING BANK SUPE; Baum CF, 2003, STATA J, V3, P1, DOI 10.1177/1536867X0300300101; Baumol W. J., 1982, CONTESTABLE MARKETS; Beck T, 2006, J BANK FINANC, V30, P1581, DOI 10.1016/j.jbankfin.2005.05.010; Beck T, 2013, J FINANC INTERMED, V22, P218, DOI 10.1016/j.jfi.2012.07.001; Berger AN, 2009, J FINANC SERV RES, V35, P99, DOI 10.1007/s10693-008-0050-7; BERNHEIM BD, 1990, RAND J ECON, V21, P1, DOI 10.2307/2555490; Bikker JA, 2012, REV ECON STAT, V94, P1025, DOI 10.1162/REST_a_00210; Blundell R, 1998, J ECONOMETRICS, V87, P115, DOI 10.1016/S0304-4076(98)00009-8; Boyd JH, 2005, J FINANC, V60, P1329, DOI 10.1111/j.1540-6261.2005.00763.x; Caprio G, 2008, BANK REGULATIONS ARE; Chan S-G, 2015, J EC BUSINESS, V5; Cook Malcolm., 2008, BANKING REFORM SE AS; Corsetti G, 1999, JPN WORLD ECON, V11, P305, DOI 10.1016/S0922-1425(99)00019-5; Demirguc-Kunt A., 2010, WORLD BANK POLICY RE, P5499; Deniz A, 2012, WORLD BANK POLICY RE, V5981; DIAMOND DW, 1983, J POLIT ECON, V91, P401, DOI 10.1086/261155; Fang YW, 2014, J BANK FINANC, V39, P160, DOI 10.1016/j.jbankfin.2013.11.003; Fiordelisi F, 2014, J INT MONEY FINANC, V45, P1, DOI 10.1016/j.jimonfin.2014.02.008; Fu XQ, 2014, J BANK FINANC, V38, P64, DOI 10.1016/j.jbankfin.2013.09.012; Gochoco-Bautista MS, 1999, EYE ASIAN FINANCIAL, P1; Hadad MD, 2011, J BANK FINANC, V35, P1552, DOI 10.1016/j.jbankfin.2010.11.003; Jimenez G, 2007, FEDERAL RESERVE BANK, V2007-23; Jimenez G, 2010, DOES COMPETITION IMP; Jimenez G, 2013, J FINANC STABIL, V9, DOI 10.1016/j.jfs.2013.02.004; Jokipii T, 2008, J BANK FINANC, V32, P1440, DOI 10.1016/j.jbankfin.2007.12.001; Karim M. Z. A., 2001, ASEAN EC B, P289, DOI DOI 10.2307/25773688; Kasman S, 2015, ECON SYST, V39, P502, DOI 10.1016/j.ecosys.2014.12.003; Katib MN, 2000, SINGAP ECON REV, V44, P89; KEELEY MC, 1990, AM ECON REV, V80, P1183; Kishi M., 2001, PRUDENTIAL REGULATIO; Kwak, 2011, 13 BANKERS WALL STRE; Laeven L., 2005, WORKING PAPER; Laeven L, 2009, J FINANC ECON, V93, P259, DOI 10.1016/j.jfineco.2008.09.003; Lee CC, 2014, JPN WORLD ECON, V29, P18, DOI 10.1016/j.japwor.2013.11.002; Lee CC, 2014, J INT MONEY FINANC, V40, P204, DOI 10.1016/j.jimonfin.2013.09.001; Leon F., 2015, ETUDES DOCUMENTS; Lerner AP, 1933, REV ECON STUD, V1, P157; Leuvensteijn MV, 2007, 143 DNB; Liu H, 2013, EUR J FINANC, V19, P1, DOI 10.1080/1351847X.2011.633614; Liu H, 2012, APPL ECON, V44, P3627, DOI 10.1080/00036846.2011.579066; MARCUS AJ, 1984, J BANK FINANC, V8, P557, DOI 10.1016/S0378-4266(84)80046-1; Martinez-Miera D, 2010, REV FINANC STUD, V23, P3638, DOI 10.1093/rfs/hhq057; Merton HC., 1974, FINANCE, V29, P449; Moch N, 2013, J BANK FINANC, V37, P2908, DOI 10.1016/j.jbankfin.2013.04.029; Molyneux P, 2008, COMPETITION RISK S E; Nguyen M, 2012, J INT FINANC MARK I, V22, P897, DOI 10.1016/j.intfin.2012.05.008; PANZAR JC, 1987, J IND ECON, V35, P443, DOI 10.2307/2098582; Roodman D, 2009, STATA J, V9, P86, DOI 10.1177/1536867X0900900106; Roy A.D., 1952, ECONOMETRICA J ECONO, V20, P431, DOI [DOI 10.2307/1907413, 10.2307/1907413]; Saez L., 2004, J FINANC SERV RES, V25, P5, DOI [10.1023/B:FINA.0000008662.59653.33, DOI 10.1023/B:FINA.0000008662.59653.33]; Schaeck K, 2008, 932 NEW PERSP EMP EV; Schaeck K, 2014, FINANC MANAGE, V43, P215, DOI 10.1111/fima.12010; Schaeck K, 2009, J MONEY CREDIT BANK, V41, P711, DOI 10.1111/j.1538-4616.2009.00228.x; Shaffer S., 2004, J ECON BUS, V56, P287; Soedarmono W, 2013, J INT FINANC MARK I, V23, P196, DOI 10.1016/j.intfin.2012.09.009; Tabak BM, 2012, J BANK FINANC, V36, P3366, DOI 10.1016/j.jbankfin.2012.07.022; Teo Leslie E., 2000, FINANCIAL SECTOR CRI; Weill L, 2013, J INT FINANC MARK I, V26, P100, DOI 10.1016/j.intfin.2013.05.005; Williams J, 2002, FINANCIAL LIBERALISA; Xu B, 2013, BIS WORKING PAPERS; Yamanaka T., 2014, NEWSLETTER I INT MON; Yeyati EL, 2007, J BANK FINANC, V31, P1633, DOI 10.1016/j.jbankfin.2006.11.003	75	36	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176546	10.1371/journal.pone.0176546	http://dx.doi.org/10.1371/journal.pone.0176546			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UM	28486548	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000014
J	Trifiletti, DM; Sturz, VN; Showalter, TN; Lobo, JM				Trifiletti, Daniel M.; Sturz, Vanessa N.; Showalter, Timothy N.; Lobo, Jennifer M.			Towards decision-making using individualized risk estimates for personalized medicine: A systematic review of genomic classifiers of solid tumors	PLOS ONE			English	Review							21-GENE RECURRENCE SCORE; COST-EFFECTIVENESS ANALYSIS; POSITIVE BREAST-CANCER; EARLY-STAGE ESTROGEN; RT-PCR ASSAY; ONCOTYPE DX; ADJUVANT CHEMOTHERAPY; TREATMENT RECOMMENDATIONS; DISTANT RECURRENCE; CLINICAL-PRACTICE	Recent advances in the understanding of the genetic underpinnings of cancer offer the promise to customize cancer treatments to the individual through the use of genomic classifiers (GCs). At present, routine clinical utilization of GCs is uncommon and their current scope and status, in a broad sense, are unknown. As part of a registered review (PROSPERO 2014: CRD42014013371), we systematically reviewed the literature evaluating the utility of commercially available GCs by searching Ovid Medline (PubMed), EMBASE, the Cochrane Database of Systematic Reviews, and CINAHL on September 2, 2014. We excluded articles involving pediatric malignancies, non-solid or non-invasive cancers, hereditary risk of cancer, non-validated GCs, and GCs involving fewer than 3 biomarkers. A total of 3,625 studies were screened, but only 37 met the pre-specified inclusion criteria. Of these, 15 studies evaluated outcomes and clinical utility of GCs through clinical trials, and the remainder through the use of mathematical models. Most studies (29 of 37) were specific to hormone-receptor positive breast cancer, whereas only 4 studies evaluated GCs in non-breast cancer (prostate, colon, and lung cancers). GCs have spurred excitement across disciplines in recent decades. While there are several GCs that have been validated, the general quality of the data are weak. Further research, including prospective validation is needed, particularly in the non-breast cancer GCs.	[Trifiletti, Daniel M.; Showalter, Timothy N.] Univ Virginia, Sch Med, Dept Radiat Oncol, Charlottesville, VA 22908 USA; [Sturz, Vanessa N.; Lobo, Jennifer M.] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Lobo, JM (corresponding author), Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA.	jem4yb@virginia.edu	Lobo, Jennifer/AAK-6713-2021	Showalter, Timothy/0000-0003-1373-8496	American Society for Radiation Oncology Comparative Effectiveness Research Award	American Society for Radiation Oncology Comparative Effectiveness Research Award	This work was supported by an American Society for Radiation Oncology Comparative Effectiveness Research Award (T.N.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agendia, 2015, AG MIL; Agendia, 2015, AG COMP OV; Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; Chang JC, 2008, BREAST CANCER RES TR, V108, P233, DOI 10.1007/s10549-007-9590-z; Chen E, 2010, AM J MANAG CARE, V16, pE333; Cooperberg MR, 2015, EUR UROL, V67, P326, DOI 10.1016/j.eururo.2014.05.039; de Boer RH, 2013, MED J AUSTRALIA, V199, P205, DOI 10.5694/mja12.11334; Dinan MA, 2015, JAMA ONCOL, V1, P158, DOI 10.1001/jamaoncol.2015.43; Dowsett M, 2010, J CLIN ONCOL, V28, P1829, DOI 10.1200/JCO.2009.24.4798; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Garraway LA, 2013, J CLIN ONCOL, V31, P1803, DOI 10.1200/JCO.2013.49.4799; Goldstein LJ, 2008, J CLIN ONCOL, V26, P4063, DOI 10.1200/JCO.2007.14.4501; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hall PS, 2012, JNCI-J NATL CANCER I, V104, P56, DOI 10.1093/jnci/djr484; Hannouf MB, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-447; Hassett MJ, 2012, J CLIN ONCOL, V30, P2218, DOI 10.1200/JCO.2011.38.5740; Holt S, 2013, BRIT J CANCER, V108, P2250, DOI 10.1038/bjc.2013.207; Hornberger J, 2005, AM J MANAG CARE, V11, P313; Hornberger J, 2012, VALUE HEALTH, V15, P1014, DOI 10.1016/j.jval.2012.07.012; Hornberger J, 2011, J ONCOL PRACT, V7, pE38S, DOI 10.1200/JOP.2011.000303; Hunter DJ, 2016, NEW ENGL J MED, V375, P711, DOI 10.1056/NEJMp1608282; Iwamoto T, 2011, BREAST CANCER RES TR, V130, P155, DOI 10.1007/s10549-011-1706-9; Joh JE, 2011, ONCOLOGIST, V16, P1520, DOI 10.1634/theoncologist.2011-0045; Kelly CM, 2012, ONCOLOGIST, V17, P492, DOI 10.1634/theoncologist.2012-0007; Khoury MJ, 2011, CANCER EPIDEM BIOMAR, V20, P2105, DOI 10.1158/1055-9965.EPI-11-0481; Klang SH, 2010, VALUE HEALTH, V13, P381, DOI 10.1111/j.1524-4733.2010.00724.x; Knauer M, 2010, BRIT J CANCER, V103, P1788, DOI 10.1038/sj.bjc.6605916; Kok M, 2009, BREAST CANCER RES TR, V113, P275, DOI 10.1007/s10549-008-9939-y; Lamond NWD, 2012, BREAST CANCER RES TR, V133, P1115, DOI 10.1007/s10549-012-1989-5; Lee JJ, 2011, AM SURGEON, V77, P1364; Lund MJ, 2012, CANCER-AM CANCER SOC, V118, P788, DOI 10.1002/cncr.26180; Lyman GH, 2007, CANCER-AM CANCER SOC, V109, P1011, DOI 10.1002/cncr.22506; Maak M, 2013, ANN SURG, V257, P1053, DOI 10.1097/SLA.0b013e31827c1180; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Mislick K, 2014, CLINICOECONOMIC OUTC, V6, P37, DOI 10.2147/CEOR.S53142; NanoString Technologies, 2013, NANOSTRING LAUNCH IT; OncotypeDx, 2016, ONCOTYPEDX BREAST RE; Orucevic A, 2016, BREAST CANCER RES TR, V157, P427, DOI 10.1007/s10549-016-3833-9; Paulden M, 2013, VALUE HEALTH, V16, P729, DOI 10.1016/j.jval.2013.03.1625; PRNewswire, 2013, GENOMEDX BIOSC CLOS; PRNewswire, 2010, CLAR LAUNCH INS DX M; Rayhanabad JA, 2008, AM SURGEON, V74, P887; Reed SD, 2013, GENET MED, V15, P203, DOI 10.1038/gim.2012.119; Retel VP, 2013, EUR J CANCER, V49, P3773, DOI 10.1016/j.ejca.2013.08.001; Retel VP, 2010, EUR J CANCER, V46, P1382, DOI 10.1016/j.ejca.2010.02.035; Roth JA, 2014, ONCOLOGIST, V19, P466, DOI 10.1634/theoncologist.2013-0357; Sgroi DC, 2013, LANCET ONCOL, V14, P1067, DOI 10.1016/S1470-2045(13)70387-5; Simon R, 2006, PHARMACOGENOMICS J, V6, P166, DOI 10.1038/sj.tpj.6500349; Simonds NI, 2013, JNCI-J NATL CANCER I, V105, P929, DOI 10.1093/jnci/djt108; Tsoi DT, 2010, ONCOLOGIST, V15, P457, DOI 10.1634/theoncologist.2009-0275; Vanderlaan BF, 2011, AM J MANAG CARE, V17, P455; Ward S, 2013, HEALTH TECHNOL ASSES, P17; Yang M, 2012, CANCER-AM CANCER SOC, V118, P5163, DOI 10.1002/cncr.27443	53	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176388	10.1371/journal.pone.0176388	http://dx.doi.org/10.1371/journal.pone.0176388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486497	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000010
J	Verwaaijen, B; Wibberg, D; Krobber, M; Winkler, A; Zrenner, R; Bednarz, H; Niehaus, K; Grosch, R; Puhler, A; Schluter, A				Verwaaijen, Bart; Wibberg, Daniel; Kroebber, Magdalena; Winkler, Anika; Zrenner, Rita; Bednarz, Hanna; Niehaus, Karsten; Grosch, Rita; Puehler, Alfred; Schlueter, Andreas			The Rhizoctonia solani AG1-IB (isolate 7/3/14) transcriptome during interaction with the host plant lettuce (Lactuca sativa L.)	PLOS ONE			English	Article							CYANOVIRIN-N; SEQUENCE; PROTEIN; PATHOGEN; LECTIN; VISUALIZATION; ESTABLISHMENT; INFECTION; ALIGNMENT; TOXINS	The necrotrophic pathogen Rhizoctonia solani is one of the most economically important soil-borne pathogens of crop plants. Isolates of R. solani AG1-IB are the major pathogens responsible for bottom-rot of lettuce (Lactuca sativa L.) and are also responsible for diseases in other plant species. Currently, there is lack of information regarding the molecular responses in R. solani during the pathogenic interaction between the necrotrophic soilborne pathogen and its host plant. The genome of R. solani AG1-IB (isolate 7/3/14) was recently established to obtain insights into its putative pathogenicity determinants. In this study, the transcriptional activity of R. solani AG1-IB was followed during the course of its pathogenic interaction with the host plant lettuce under controlled conditions. Based on visual observations, three distinct pathogen-host interaction zones on lettuce leaves were defined which covered different phases of disease progression on tissue inoculated with the AG1-IB (isolate 7/3/14). The zones were defined as: Zone 1-symptomless, Zone 2-light brown discoloration, and Zone 3-dark brown, necrotic lesions. Differences in R. solani hyphae structure in these three zones were investigated by microscopic observation. Transcriptional activity within these three interaction zones was used to represent the course of R. solani disease progression applying high-throughput RNA sequencing (RNA-Seq) analysis of samples collected from each Zone. The resulting three transcriptome data sets were analyzed for their highest expressed genes and for differentially transcribed genes between the respective interaction zones. Among the highest expressed genes was a group of not previously described genes which were transcribed exclusively during early stages of interaction, in Zones 1 and 2. Previously described importance of up-regulation in R. solani agglutinin genes during disease progression could be further confirmed; here, the corresponding genes exhibited extremely high transcription levels. Most differentially higher expressed transcripts were found within Zone 2. In Zone 3, the zone with the strongest degree of interaction, gene transcripts indicative of apoptotic activity were highly abundant. The transcriptome data presented in this work support previous models of the disease and interaction cycle of R. solani and lettuce and may influence effective techniques for control of this pathogen.	[Verwaaijen, Bart; Wibberg, Daniel; Kroebber, Magdalena; Winkler, Anika; Bednarz, Hanna; Niehaus, Karsten; Puehler, Alfred; Schlueter, Andreas] Bielefeld Univ, Ctr Biotechnol, Bielefeld, Germany; [Verwaaijen, Bart; Zrenner, Rita; Grosch, Rita] Leibniz Inst Vegetable & Ornamental Crops IGZ, Grossbeeren, Germany	University of Bielefeld; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ)	Schluter, A (corresponding author), Bielefeld Univ, Ctr Biotechnol, Bielefeld, Germany.	aschluet@cebitec.uni-bielefeld.de	Zrenner, Rita/A-1593-2012; Grosch, Rita/HHM-5490-2022	Zrenner, Rita/0000-0002-1563-8942; Schluter, Andreas/0000-0003-4830-310X; Puhler, Alfred/0000-0003-4723-2960; Grosch, Rita/0000-0002-7179-5715	CUB Graduate Cluster 'Industrial Biotechnology'; Ministry of Innovation of North Rhine-Westphalia, Germany; Federal Ministry of Education and Research (BMBF) of the BonaRes program [FKZ 031A560D]; Resource Center for Microbial Bioinformatics BiGi within the German Network for Bioinformatics Infrastructure (de.NBI) [031A533]	CUB Graduate Cluster 'Industrial Biotechnology'; Ministry of Innovation of North Rhine-Westphalia, Germany; Federal Ministry of Education and Research (BMBF) of the BonaRes program(Federal Ministry of Education & Research (BMBF)); Resource Center for Microbial Bioinformatics BiGi within the German Network for Bioinformatics Infrastructure (de.NBI)	B.V. and D.W. acknowledge the receipt of a scholarship from the CUB Graduate Cluster 'Industrial Biotechnology', cofinanced by the Ministry of Innovation of North Rhine-Westphalia, Germany. A.S. acknowledges funding by the Federal Ministry of Education and Research (BMBF) in the frame of the BonaRes program (DiControl project: FKZ 031A560D). A.P. gratefully acknowledges funding by the Resource Center for Microbial Bioinformatics BiGi (Grant number 031A533) within the German Network for Bioinformatics Infrastructure (de.NBI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akileswaran L, 1999, APPL ENVIRON MICROB, V65, P415; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; ARMSTRONG JL, 1985, J BACTERIOL, V161, P39, DOI 10.1128/JB.161.1.39-46.1985; Bannwarth M, 2004, BIOCHEMISTRY-US, V43, P11683, DOI 10.1021/bi048609q; Blancard D, 2006, COLOR ATLAS DIS LETT; Boenisch MJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-110; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Candy L, 2001, BIOCHEM BIOPH RES CO, V282, P655, DOI 10.1006/bbrc.2001.4626; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davis R.M., 1997, STEMPHYLIUM LEAF SPO; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Garcia VG, 2006, SPAN J AGRIC RES, V4, P55; GOODWIN DC, 1995, BIOCHEMISTRY-US, V34, P5060, DOI 10.1021/bi00015a017; Grosch R, 2004, EUR J PLANT PATHOL, V110, P53, DOI 10.1023/B:EJPP.0000010137.69498.10; Hamshou M, 2010, FUNGAL BIOL-UK, V114, P34, DOI 10.1016/j.mycres.2009.10.002; Hamshou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033680; Hilker R, 2016, BIOINFORMATICS; Hilker R, 2014, BIOINFORMATICS, V30, P2247, DOI 10.1093/bioinformatics/btu205; Justesen A, 1996, GENE, V170, P131, DOI 10.1016/0378-1119(95)00875-6; Kadow KJ, 1937, DAMPING CONTROL EVAL; KELLENS JTC, 1990, J GEN MICROBIOL, V136, P2489, DOI 10.1099/00221287-136-12-2489; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koharudin LMI, 2008, STRUCTURE, V16, P570, DOI 10.1016/j.str.2008.01.015; Konopka JB, 2012, SCIENTIFICA, V2012, P631, DOI DOI 10.6064/2012/489208; Kwon SJ, 2009, PLANT J, V58, P235, DOI 10.1111/j.1365-313X.2008.03772.x; Lakshman DK, 2008, MYCOLOGIA, V100, P867, DOI 10.3852/08-065; Laluk Kristin, 2010, Arabidopsis Book, V8, pe0136, DOI 10.1199/tab.0136; Lazzari B, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S13; Liu TB, 2009, J ZHEJIANG UNIV-SC B, V10, P434, DOI 10.1631/jzus.B0920017; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oh IS, 2005, PLANT CELL, V17, P2832, DOI 10.1105/tpc.105.034819; Paulsrud P, 2002, APPL ENVIRON MICROB, V68, P2036, DOI 10.1128/AEM.68.4.2036-2039.2002; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Podobnik B, 2008, J MED CHEM, V51, P3480, DOI 10.1021/jm800030e; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Stodart BJ, 2007, MYCOL RES, V111, P891, DOI 10.1016/j.mycres.2007.05.008; Studier J, 1988, MOL BIOL EVOL; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Urban M, 2015, NUCLEIC ACIDS RES, V43, pD645, DOI 10.1093/nar/gku1165; van Driel KGA, 2008, EUKARYOT CELL, V7, P1865, DOI 10.1128/EC.00125-08; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Walton JD, 1996, PLANT CELL, V8, P1723, DOI 10.1105/tpc.8.10.1723; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Wibberg D, 2015, PLOS ONE, P1, DOI DOI 10.1371/JOURNAL.PONE.0144769; Wibberg D, 2014, FUNGAL BIOL-UK, V118, P800, DOI 10.1016/j.funbio.2014.06.007; Wibberg D, 2013, J BIOTECHNOL, V167, P142, DOI 10.1016/j.jbiotec.2012.12.010; Wu J, 2009, AUSTRALAS PLANT PATH, V38, P79, DOI 10.1071/AP08081; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Xue CY, 2002, PLANT CELL, V14, P2107, DOI 10.1105/tpc.003426; Yang YQ, 2011, RICE SCI, V18, P297, DOI 10.1016/S1672-6308(12)60008-0; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Yoshimoto K, 2010, FEBS LETT, V584, P1350, DOI 10.1016/j.febslet.2010.01.007; Zheng AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2427; Zhuang XF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-668	55	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177278	10.1371/journal.pone.0177278	http://dx.doi.org/10.1371/journal.pone.0177278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486484	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000069
J	Watanabe, Y; Wakayoshi, K; Nomura, T				Watanabe, Yasunori; Wakayoshi, Kohji; Nomura, Teruo			New evaluation index for the retainability of a swimmer's horizontal posture	PLOS ONE			English	Article							COMPETITIVE SWIMMERS; WET SUIT; BUOYANCY; VOLUME; DRAG	This study aims to investigate the effect of changes in buoyancy when a swimmer respires in a horizontal posture. We attempted to evaluate the levelness of swimmers' streamline posture by simultaneously measuring the lung capacity and buoyancy under water. The buoyancy was measured based on the changes in the vertical loads of the upper and lower limbs on the subjects' streamline posture under water. The horizontal x-axis as lung ventilation and the vertical y-axis as buoyancy forms a linear equation y = ax + b. The relation between hand (upper-limb) buoyancy and lung ventilation is defined as y = a1x + b1 and that between foot (lower-limb) buoyancy and lung ventilation as y = a2x + b2. Horizontal levelness was calculated as a ratio by dividing a2 by a1 using the inclination (a) values from these formulas for an underwater streamline posture. We defined this ratio as the breathing-balance (BB) ratio. Although the performance levels in the present study did not show any difference in the absolute quantity of air that humans can inhale in a streamline posture, the BB ratio was higher in a statistically significant manner in junior swimmers competing at international levels compared with the other groups of subjects (P < 0.001). This statistical difference in horizontal levelness, despite the absence of a noticeable difference in the absolute quantity of inhaled air, may be attributable to the way in which each person inhales and exhales air. Top-level junior swimmers that exhibited a high BB ratio might have inhaled in a way that would counteract the sinking of the lower limbs, for example, through abdominal respiration. When exhaling, on the other hand, they might have let out air gradually to mitigate the acceleration force involved in submerging the lower limbs.	[Watanabe, Yasunori] Sendai Univ, Fac Sports Sci, Sendai, Miyagi, Japan; [Wakayoshi, Kohji] Osaka Univ Econ, Fac Human Sci, Osaka, Japan; [Nomura, Teruo] Kyoto Inst Technol, Grad Sch Sci & Technol, Kyoto, Japan	Kyoto Institute of Technology	Watanabe, Y (corresponding author), Sendai Univ, Fac Sports Sci, Sendai, Miyagi, Japan.	ysn-watanabe@sendai-u.ac.jp			JSPS [JP23500761]; KOZUKI FOUNDATION	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KOZUKI FOUNDATION	This work was supported by JSPS Grant-in-Aid for Scientific Research C Grant Number JP23500761 (http://www.jsps.go.jp/english/e-grants/index.html) and KOZUKI FOUNDATION (http://www.kozuki-foundation.or.jp/jigyou/index-e.html).; We would like to thank Dr. Hideki Takagi, Professor of University of Tsukuba, for detailed comments, suggestions, and constant support. This work was supported by JSPS Grant-in-Aid for Scientific Research C Grant Number JP23500761 and KOZUKI FOUNDATION.	CAPELLI C, 1995, J APPL PHYSIOL, V78, P674, DOI 10.1152/jappl.1995.78.2.674; Carmody JF, 1965, NZ J PHYSICAL ED, V37, P15; Carter JEL, 1955, NZ J PHYS ED, V6, P14; Carter JEL, 1956, NZ J PHYSICAL ED, V8, P9; CHATARD JC, 1995, MED SCI SPORT EXER, V27, P580; Cordain L, 1991, Br J Sports Med, V25, P31; Cureton TK, 1933, BEACH POOL, V7, P282; GAGNON M, 1981, J BIOMECH, V14, P235, DOI 10.1016/0021-9290(81)90068-3; Hay JG, 1993, BIOMECHANICS SPORTS, V4th; Konin JG, 2005, ATHLETIC THERAPY TOD, V10, P30; Lynch SS, 2010, BRIT J SPORT MED, V44, P376, DOI 10.1136/bjsm.2009.066837; McLean SP, 1998, J SPORT SCI, V16, P373, DOI 10.1080/02640419808559365; McLean SP, 2000, RES Q EXERCISE SPORT, V71, P182, DOI 10.1080/02701367.2000.10608896; Nakashima M., 2007, J FLUID SCI TECHNOL, V2, P290, DOI [10.1299/jfst.2.290, DOI 10.1299/JFST.2.290, DOI 10.1299/jfst.2.290]; Rork R, 1937, RES QUART, V8, P19, DOI 10.1080/23267402.1937.10761845; TOUSSAINT HM, 1989, MED SCI SPORT EXER, V21, P325; Watanabe Y, 2014, SPORT MONT, V12, P98; Yanai T, 2004, J BIOMECH, V37, P605, DOI 10.1016/j.jbiomech.2003.10.004; Yanai T, 2001, J BIOMECH, V34, P235, DOI 10.1016/S0021-9290(00)00186-X; Zamparo P, 1996, EUR J APPL PHYSIOL O, V73, P195, DOI 10.1007/BF02425476	20	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177368	10.1371/journal.pone.0177368	http://dx.doi.org/10.1371/journal.pone.0177368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486565	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314000076
J	Chen, YH; Lee, YC; Tsai, YS; Guo, YC; Hsiao, CT; Tsai, PC; Huang, JA; Liao, YC; Soong, BW				Chen, Ying-Hao; Lee, Yi-Chung; Tsai, Yu-Shuen; Guo, Yuh-Cherng; Hsiao, Cheng-Tsung; Tsai, Pei-Chien; Huang, Jin-An; Liao, Yi-Chu; Soong, Bing-Wen			Unmasking adrenoleukodystrophy in a cohort of cerebellar ataxia	PLOS ONE			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; LATE-ONSET CEREBELLAR; ABCD1 GENE MUTATION; SPINOCEREBELLAR DEGENERATION; MISSENSE MUTATIONS; VARIANT; MRI; PROGRESSION; DIAGNOSIS; FORM	Adrenoleukodystrophy (ALD) is a rare and progressive neurogenetic disease that may manifest disparate symptoms. The present study aims at investigating the role of ataxic variant of ALD (AVALD) in patients with adult-onset cerebellar ataxia, as well as characterizing their clinical features that distinguish AVALD from other cerebellar ataxias. Mutations in the ATP binding cassette subfamily D member 1 gene (ABCD1) were ascertained in 516 unrelated patients with ataxia. The patients were categorized into three groups: molecularly unassigned hereditary ataxia (n = 118), sporadic ataxia with autonomic dysfunctions (n = 296), and sporadic ataxia without autonomic dysfunctions (n = 102). Brain MRIs were scrutinized for white matter hyperintensity (WMH) in the parieto-occipital lobes, frontal lobes, corticospinal tracts, pons, middle cerebellar peduncles and cerebellar hemispheres. Two ABCD1 mutations (p.S108L and p.P623fs) previously linked to cerebral ALD and adrenomyelo-neuropathy but not AVALD were identified. ALD accounts for 0.85% (1/118) of the patients with molecularly unassigned hereditary ataxia and 0.34% (1/296) of the patients with sporadic ataxia with autonomic dysfunctions. WMH in the corticospinal tracts and WMH in the cerebellar hemispheres were strongly associated with AVALD rather than other ataxias. To conclude, ALD accounts for approximately 0.39% (2/516) of adult-onset cerebellar ataxias. This study expands the mutational spectrum of AVALD and underscores the importance of considering ALD as a potential etiology of cerebellar ataxia.	[Chen, Ying-Hao; Lee, Yi-Chung; Liao, Yi-Chu; Soong, Bing-Wen] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Chen, Ying-Hao; Lee, Yi-Chung; Hsiao, Cheng-Tsung; Tsai, Pei-Chien; Liao, Yi-Chu; Soong, Bing-Wen] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei, Taiwan; [Lee, Yi-Chung; Tsai, Pei-Chien; Soong, Bing-Wen] Natl Yang Ming Univ, Brain Res Ctr, Taipei, Taiwan; [Tsai, Yu-Shuen] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei, Taiwan; [Guo, Yuh-Cherng] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Guo, Yuh-Cherng] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Guo, Yuh-Cherng] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Hsiao, Cheng-Tsung] Taipei Vet Gen Hosp, Div Neurol, Dept Internal Med, Taoyuan Branch, Taoyuan, Taiwan; [Hsiao, Cheng-Tsung] Natl Taiwan Univ, Grad Inst Physiol, Coll Med, Taipei, Taiwan; [Huang, Jin-An] Taichung Vet Gen Hosp, Neurol Inst, Taichung, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taipei Veterans General Hospital; National Taiwan University; Taichung Veterans General Hospital	Liao, YC; Soong, BW (corresponding author), Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan.; Liao, YC; Soong, BW (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei, Taiwan.; Soong, BW (corresponding author), Natl Yang Ming Univ, Brain Res Ctr, Taipei, Taiwan.	ycliao5@vghtpe.gov.tw; bwsoong@ym.edu.tw	Lee, Yi-Chung/GZK-7162-2022	Tsai, Pei-Chien/0000-0001-7303-0516; Liao, Yi-Chu/0000-0002-9644-2086; Lee, Yi-Chung/0000-0003-0102-164X; Huang, Jin-An/0000-0003-1275-059X	Ministry of Science & Technology, Taiwan, ROC [NSC102-2628-B-075-006-MY3, NSC103-2314-B-75-076-MY3, MOST 103-2314-B-010-049-MY3, MOST 104-2314-B-075-045-MY4]; Brain Research Center, National Yang-Ming University [104AC-B19]; High-Throughput Genome Analysis Core Facility and Bioinformatics Consortium of Taiwan of the National Core Facility Program for Biotechnology, Taiwan [NSC 101-2319-B-010-001]; Taipei Veterans General Hospital [V103C-109, V104C-061, V104C-079, V104E9-006, V105C-118, V105C-048]; Taiwan Ataxia Association; Hsu Tsung Pei Medical Research Fund	Ministry of Science & Technology, Taiwan, ROC; Brain Research Center, National Yang-Ming University; High-Throughput Genome Analysis Core Facility and Bioinformatics Consortium of Taiwan of the National Core Facility Program for Biotechnology, Taiwan; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Taiwan Ataxia Association; Hsu Tsung Pei Medical Research Fund	The research was supported by grants from the Ministry of Science & Technology, Taiwan, ROC (NSC102-2628-B-075-006-MY3, NSC103-2314-B-75-076-MY3 and MOST 103-2314-B-010-049-MY3, MOST 104-2314-B-075-045-MY4), the Brain Research Center, National Yang-Ming University (104AC-B19), the High-Throughput Genome Analysis Core Facility and Bioinformatics Consortium of Taiwan of the National Core Facility Program for Biotechnology, Taiwan (NSC 101-2319-B-010-001), and Taipei Veterans General Hospital (V103C-109, V104C-061, V104C-079, V104E9-006, V105C-118 and V105C-048), as well as research funds supported by the Taiwan Ataxia Association and the Hsu Tsung Pei Medical Research Fund.	Abele M, 2002, BRAIN, V125, P961, DOI 10.1093/brain/awf107; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Asheuer M, 2005, HUM MOL GENET, V14, P1293, DOI 10.1093/hmg/ddi140; Brusse E, 2007, CLIN GENET, V71, P12, DOI 10.1111/j.1399-0004.2006.00722.x; Burk K, 2005, ARCH NEUROL-CHICAGO, V62, P981, DOI 10.1001/archneur.62.6.981; Dunne E, 1999, ANN NEUROL, V45, P652, DOI 10.1002/1531-8249(199905)45:5<652::AID-ANA14>3.0.CO;2-M; Elenein RA, 2013, NEUROLOGY, V80, pE69, DOI 10.1212/WNL.0b013e3182815416; Fogel BL, 2006, NAT CLIN PRACT NEURO, V2, P629, DOI 10.1038/ncpneuro0319; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guo YC, 2014, NEUROLOGY, V83, P1554, DOI 10.1212/WNL.0000000000000909; Jayadev S, 2013, GENET MED, V15, P673, DOI 10.1038/gim.2013.28; Jung S, 2009, J MOV DISORD, V2, P91, DOI 10.14802/jmd.09025; Kang JW, 2014, YONSEI MED J, V55, P1157, DOI 10.3349/ymj.2014.55.4.1157; Kano S, 1998, J NEUROL SCI, V158, P187, DOI 10.1016/S0022-510X(98)00120-8; Kemp S, 2001, HUM MUTAT, V18, P499, DOI 10.1002/humu.1227; Kim JE, 2012, PARKINSONISM RELAT D, V18, P210, DOI 10.1016/j.parkreldis.2011.06.005; Klockgether T, 2010, LANCET NEUROL, V9, P94, DOI 10.1016/S1474-4422(09)70305-9; Ko CY, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.017; Kumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025094; KUSAKA H, 1992, J NEUROL, V239, P307, DOI 10.1007/BF00867585; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee YC, 2009, EUR J NEUROL, V16, P513, DOI 10.1111/j.1468-1331.2008.02524.x; Lee YC, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000068; Li JY, 2010, J NEUROL SCI, V290, P163, DOI 10.1016/j.jns.2009.12.002; Loes DJ, 2003, NEUROLOGY, V61, P369, DOI 10.1212/01.WNL.0000079050.91337.83; Manto M, 2009, CURR OPIN NEUROL, V22, P419, DOI 10.1097/WCO.0b013e32832b9897; MARSDEN CD, 1982, NEUROLOGY, V32, P1031, DOI 10.1212/WNL.32.9.1031; Matsukawa T, 2011, NEUROGENETICS, V12, P41, DOI 10.1007/s10048-010-0253-6; Mishra S, 2006, NEUROL INDIA, V54, P195; MIYAI I, 1990, J NEUROL NEUROSUR PS, V53, P623, DOI 10.1136/jnnp.53.7.623-a; Moseley ML, 1998, NEUROLOGY, V51, P1666, DOI 10.1212/WNL.51.6.1666; Moser HW, 2007, NAT CLIN PRACT NEURO, V3, P140, DOI 10.1038/ncpneuro0421; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Ochi H, 1996, Rinsho Shinkeigaku, V36, P1229; Ochi K, 1998, AM J NEURORADIOL, V19, P1904; Ogaki K, 2016, NEUROPATHOLOGY, V36, P64, DOI 10.1111/neup.12230; Park HJ, 2014, YONSEI MED J, V55, P676, DOI 10.3349/ymj.2014.55.3.676; Patel K, 2008, INT J INFECT DIS, V12, pE111, DOI 10.1016/j.ijid.2008.03.006; Perusi C, 1999, MOL CELL PROBE, V13, P179, DOI 10.1006/mcpr.1999.0232; Ramirez-Zamora A, 2015, MOVEMENT DISORD, V30, P614, DOI 10.1002/mds.26158; Ruano L, 2014, NEUROEPIDEMIOLOGY, V42, P174, DOI 10.1159/000358801; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Soong BW, 2001, ARCH NEUROL-CHICAGO, V58, P1105, DOI 10.1001/archneur.58.7.1105; Suda S, 2006, NEUROLOGY, V66, P144, DOI 10.1212/01.wnl.0000191329.34585.15; Suzuki Y, 2005, BRAIN DEV-JPN, V27, P353, DOI 10.1016/j.braindev.2004.09.008; Tan EK, 1999, CLIN NEUROL NEUROSUR, V101, P137, DOI 10.1016/S0303-8467(99)00028-1; Vianello M, 2005, EUR J NEUROL, V12, P912, DOI 10.1111/j.1468-1331.2005.01134.x; Watanabe H, 2002, BRAIN, V125, P1070, DOI 10.1093/brain/awf117; Wiesinger C, 2015, APPL CLIN GENET, V8, P109, DOI 10.2147/TACG.S49590; Yabe I, 2006, J NEUROL SCI, V249, P115, DOI 10.1016/j.jns.2006.05.064	51	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177296	10.1371/journal.pone.0177296	http://dx.doi.org/10.1371/journal.pone.0177296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481932	Green Published, gold, Green Submitted			2022-12-27	WOS:000401313700051
J	Lokhandwala, S; Waghela, SD; Bray, J; Sangewar, N; Charendoff, C; Martin, CL; Hassan, WS; Koynarski, T; Gabbert, L; Burrage, TG; Brake, D; Neilan, J; Mwangi, W				Lokhandwala, Shehnaz; Waghela, Suryakant D.; Bray, Jocelyn; Sangewar, Neha; Charendoff, Chloe; Martin, Cameron L.; Hassan, Wisam S.; Koynarski, Tsvetoslav; Gabbert, Lindsay; Burrage, Thomas G.; Brake, David; Neilan, John; Mwangi, Waithaka			Adenovirus-vectored novel African Swine Fever Virus antigens elicit robust immune responses in swine	PLOS ONE			English	Article							PROTEIN; ANTIBODY; CHALLENGE; IMMUNIZATION; REPLICATION; HOMOLOG; P-30; CD2V; PIGS; P54	African Swine Fever Virus (ASFV) is a high-consequence transboundary animal pathogen that often causes hemorrhagic disease in swine with a case fatality rate close to 100%. Lack of treatment or vaccine for the disease makes it imperative that safe and efficacious vaccines are developed to safeguard the swine industry. In this study, we evaluated the immunogenicity of seven adenovirus-vectored novel ASFV antigens, namely A151R, B119L, B602L, EP402R.PRR, B438L, K205R and A104R. Immunization of commercial swine with a cocktail of the recombinant adenoviruses formulated in adjuvant primed strong ASFV antigen-specific IgG responses that underwent rapid recall upon boost. Notably, most vaccinees mounted robust IgG responses against all the antigens in the cocktail. Most importantly and relevant to vaccine development, the induced antibodies recognized viral proteins from Georgia 2007/1 ASFV-infected cells by IFA and by western blot analysis. The recombinant adenovirus cocktail also induced ASFV-specific IFN-Y-secreting cells that were recalled upon boosting. Evaluation of local and systemic effects of the recombinant adenovirus cocktail post-priming and post-boosting in the immunized animals showed that the immunogen was well tolerated and no serious negative effects were observed. Taken together, these outcomes showed that the adenovirus-vectored novel ASFV antigen cocktail was capable of safely inducing strong antibody and IFN-Y+ cell responses in commercial swine. The data will be used for selection of antigens for inclusion in a multi-antigen prototype vaccine to be evaluated for protective efficacy.	[Lokhandwala, Shehnaz; Waghela, Suryakant D.; Bray, Jocelyn; Sangewar, Neha; Charendoff, Chloe; Martin, Cameron L.; Hassan, Wisam S.; Mwangi, Waithaka] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Koynarski, Tsvetoslav] Trakia Univ, Dept Anim Genet, Stara Zagora, Bulgaria; [Gabbert, Lindsay; Burrage, Thomas G.; Brake, David; Neilan, John] US Dept Homeland Secur, Plum Isl Anim Dis Ctr, Sci & Technol Directorate, Greenport, NY USA; [Lokhandwala, Shehnaz; Mwangi, Waithaka] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Texas A&M University System; Texas A&M University College Station; Trakia University; Kansas State University	Lokhandwala, S; Mwangi, W (corresponding author), Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA.; Lokhandwala, S; Mwangi, W (corresponding author), Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	shehnaz@vet.k-state.edu; wmwangi@vet.k-state.edu	Hassan, Wisam Salim/AFV-0948-2022; Koynarski, Tsvetoslav V/E-4800-2012	Hassan, Wisam Salim/0000-0001-8120-5224; Lokhandwala, Shehnaz/0000-0002-0873-8611	U. S. National Pork Board Award [13-176]	U. S. National Pork Board Award	This work was funded by U. S. National Pork Board Award # 13-176. Recipients: WM, SW, SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argilaguet JM, 2013, ANTIVIR RES, V98, P61, DOI 10.1016/j.antiviral.2013.02.005; Argilaguet JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040942; Borca MV, 1996, ARCH VIROL, V141, P301, DOI 10.1007/BF01718401; Cobbold C, 2001, J VIROL, V75, P7221, DOI 10.1128/JVI.75.16.7221-7229.2001; Costard S, 2009, PHILOS T R SOC B, V364, P2683, DOI 10.1098/rstb.2009.0098; Epifano C, 2006, J VIROL, V80, P11456, DOI 10.1128/JVI.01468-06; Epifano C, 2006, J VIROL, V80, P12260, DOI 10.1128/JVI.01323-06; Escribano JM, 2013, VIRUS RES, V173, P101, DOI 10.1016/j.virusres.2012.10.012; Gomez-Puertas P, 1998, VIROLOGY, V243, P461, DOI 10.1006/viro.1998.9068; Grubman MJ, 2012, FUTURE VIROL, V7, P767, DOI 10.2217/FVL.12.65; Gutierrez-Castaneda B, 2008, ARCH VIROL, V153, P2303, DOI 10.1007/s00705-008-0246-z; Kamen A, 2004, J GENE MED, V6, pS184, DOI 10.1002/jgm.503; Kay-Jackson PC, 2004, J GEN VIROL, V85, P119, DOI 10.1099/vir.0.19435-0; Keita D, 2010, ANTIVIR THER, V15, P727, DOI 10.3851/IMP1593; Lacasta A, 2014, J VIROL, V88, P13322, DOI 10.1128/JVI.01893-14; Lewis T, 2000, J VIROL, V74, P1275, DOI 10.1128/JVI.74.3.1275-1285.2000; Lokhandwala S, 2016, CLIN VACCINE IMMUNOL; Malogolovkin A, 2015, J GEN VIROL, V96, P866, DOI [10.1099/jgv.0.000490, 10.1099/jgv.0.000024]; Mulumba-Mfumu LK, 2015, TRANSBOUND EMERG DIS; Mwangi W, 2007, CLIN VACCINE IMMUNOL, V14, P304, DOI 10.1128/CVI.00363-06; Neilan JG, 2004, VIROLOGY, V319, P337, DOI 10.1016/j.virol.2003.11.011; O'Donnell V, 2015, J VIROL; ONISK DV, 1994, VIROLOGY, V198, P350, DOI 10.1006/viro.1994.1040; Patch JR, 2011, CLIN VACCINE IMMUNOL, V18, P280, DOI 10.1128/CVI.00417-10; Reis AL, 2007, J GEN VIROL, V88, P2426, DOI 10.1099/vir.0.82857-0; Rodriguez I, 2006, J VIROL, V80, P3157, DOI 10.1128/JVI.80.7.3157-3166.2006; RODRIGUEZ JM, 1993, J VIROL, V67, P5312; SCHLAFER DH, 1984, AM J VET RES, V45, P1361; SCOTT G.R, 1957, EAST AFRICAN AGRIC JOUR, V22, P168; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013	30	32	43	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e177007	10.1371/journal.pone.0177007	http://dx.doi.org/10.1371/journal.pone.0177007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481911	Green Submitted, gold, Green Published			2022-12-27	WOS:000401313700028
J	Lubitz, C; Ali, A; Zhan, TN; Heberle, C; White, C; Ito, Y; Miyauchi, A; Gazelle, GS; Kong, CY; Hur, C				Lubitz, Carrie; Ali, Ayman; Zhan, Tiannan; Heberle, Curtis; White, Craig; Ito, Yasuhiro; Miyauchi, Akira; Gazelle, G. Scott; Kong, Chung Yin; Hur, Chin			The thyroid cancer policy model: A mathematical simulation model of papillary thyroid carcinoma in The US population	PLOS ONE			English	Article							SONOGRAPHIC FEATURES; ACTIVE SURVEILLANCE; TUMOR SIZE; MICROCARCINOMA; RISK; NODULES; SURGERY	Background Thyroid cancer affects over 1/2 million people in the U.S. and the incidence of thyroid cancer has increased worldwide at a rate higher than any other cancer, while survival has remained largely unchanged. The aim of this research was to develop, calibrate and verify a mathematical disease model to simulate the natural history of papillary thyroid cancer, which will serve as a platform to assess the effectiveness of clinical and cancer control interventions. Methods Herein, we modeled the natural pre-clinical course of both benign and malignant thyroid nodules with biologically relevant health states from normal to detected nodule. Using established calibration techniques, optimal parameter sets for tumor growth characteristics, development rate, and detection rate were used to fit Surveillance Epidemiology and End Results (SEER) incidence data and other calibration targets. Results Model outputs compared to calibration targets demonstrating sufficient calibration fit and model validation are presented including primary targets of SEER incidence data and size distribution at detection of malignancy. Additionally, we show the predicted underlying benign and malignant prevalence of nodules in the population, the probability of detection based on size of nodule, and estimates of growth over time in both benign and malignant nodules. Conclusions This comprehensive model provides a dynamic platform employable for future comparative effectiveness research. Future model analyses will test and assess various clinical management strategies to improve patient outcomes related to thyroid cancer and optimize resource utilization for patients with thyroid nodules.	[Lubitz, Carrie; Ali, Ayman; Zhan, Tiannan; Heberle, Curtis; Kong, Chung Yin; Hur, Chin] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Lubitz, Carrie; Gazelle, G. Scott; Kong, Chung Yin; Hur, Chin] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Lubitz, Carrie] Massachusetts Gen Hosp, Dept Surg, Div Surg Oncol, Boston, MA 02114 USA; [White, Craig; Gazelle, G. Scott] Harvard Univ, PhD Program Hlth Policy, Grad Sch Arts & Sci, Cambridge, MA 02138 USA; [Ito, Yasuhiro; Miyauchi, Akira] Kuma Hosp, Dept Surg, Kobe, Hyogo, Japan; [Gazelle, G. Scott] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Hur, Chin] Massachusetts Gen Hosp, Dept Med, Div Gastroenterol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Kuma Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Lubitz, C (corresponding author), Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA.; Lubitz, C (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA.; Lubitz, C (corresponding author), Massachusetts Gen Hosp, Dept Surg, Div Surg Oncol, Boston, MA 02114 USA.	clubitz@mgh.harvard.edu		Zhan, Tiannan/0000-0003-4691-5284; Ali, Ayman/0000-0002-2791-2793; Miyauchi, Akira/0000-0003-0041-197X; Hur, Chin/0000-0002-2819-7576	National Institutes of Health/National Cancer Institute [K07-CA177900]; The Claflin Foundation at Massachusetts General Hospital; American Thyroid Association/ThyCa Research; NATIONAL CANCER INSTITUTE [K07CA177900] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Claflin Foundation at Massachusetts General Hospital; American Thyroid Association/ThyCa Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the National Institutes of Health/National Cancer Institute Grant (K07-CA177900, www.nihms.nih..gov/), The Claflin Foundation at Massachusetts General Hospital (www.ecor.mgh.harvard.edu), and the American Thyroid Association/ThyCa Research Grant (www. thyroid.org/professionals/research-grants/) for Dr. Carrie Lubitr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2016, THYROID; Alexander EK, 2012, NEW ENGL J MED, V367, P705, DOI 10.1056/NEJMoa1203208; [Anonymous], 2016, NAT CANC I NAT I HLT; Applewhite MK, 2016, WORLD J SURG, V40, P551, DOI 10.1007/s00268-015-3300-5; Aschebrook-Kilfoy B, 2013, CANCER EPIDEM BIOMAR, V22, P1252, DOI 10.1158/1055-9965.EPI-13-0242; Benzekry S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003800; BONDESON L, 1984, CANCER-AM CANCER SOC, V53, P1790, DOI 10.1002/1097-0142(19840415)53:8<1790::AID-CNCR2820530831>3.0.CO;2-9; Brito JP, 2016, THYROID, V26, P144, DOI 10.1089/thy.2015.0178; Chignola R, 2005, IEEE T BIO-MED ENG, V52, P808, DOI 10.1109/TBME.2005.845219; Control CfD, 2012, US LIF TABL 2012, P65; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.1; Durante C, 2015, JAMA-J AM MED ASSOC, V313, P926, DOI 10.1001/jama.2015.0956; FURMANCHUK AW, 1993, HISTOPATHOLOGY, V23, P319, DOI 10.1111/j.1365-2559.1993.tb01214.x; FURUYAKANAMORI L, 2016, J CLIN ONCOL; Giordano TJ, 2016, CURR OPIN ONCOL, V28, P1, DOI 10.1097/CCO.0000000000000248; Grogan RH, 2013, SURGERY, V154, P1436, DOI 10.1016/j.surg.2013.07.008; Gu WJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000841; HARACH HR, 1985, CANCER-AM CANCER SOC, V56, P531, DOI 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hay ID, 2002, WORLD J SURG, V26, P879, DOI 10.1007/s00268-002-6612-1; Ito Y, 2003, THYROID, V13, P381, DOI 10.1089/105072503321669875; Ito Y, 2010, WORLD J SURG, V34, P2333, DOI 10.1007/s00268-010-0712-0; Kamran SC, 2013, J CLIN ENDOCR METAB, V98, P564, DOI 10.1210/jc.2012-2968; Lai XJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148567; Leboulleux S, 2016, LANCET DIABETES ENDO, V4, P933, DOI 10.1016/S2213-8587(16)30180-2; Lubitz CC, 2016, J MOL DIAGN, V18, P100, DOI 10.1016/j.jmoldx.2015.08.003; Lubitz CC, 2014, CANCER-AM CANCER SOC, V120, P1345, DOI 10.1002/cncr.28562; Mandel Susan J, 2004, Endocr Pract, V10, P246; Miyauchi A, 2016, WORLD J SURG, V40, P516, DOI 10.1007/s00268-015-3392-y; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Popoveniuc G, 2012, MED CLIN N AM, V96, P329, DOI 10.1016/j.mcna.2012.02.002; Ramsey S, 2013, HEALTH AFFAIR, V32, P1143, DOI 10.1377/hlthaff.2012.1263; Reiners C, 2004, THYROID, V14, P926, DOI 10.1089/thy.2004.14.926; Society AC, 2016, AM CANC SOC CANC FAC; Stout NK, 2009, PHARMACOECONOMICS, V27, P533, DOI 10.2165/11314830-000000000-00000; Sugitani I, 2010, WORLD J SURG, V34, P1222, DOI 10.1007/s00268-009-0359-x; Wang LY, 2015, CANCER-AM CANCER SOC, V121, P4132, DOI 10.1002/cncr.29633; Wang TS, 2014, WORLD J SURG, V38, P2297, DOI 10.1007/s00268-014-2602-3; Wylie D, 2016, J PATHOL CLIN RES, V2, P93, DOI 10.1002/cjp2.38; Zhou LG, 2015, J ULTRAS MED, V34, P1003, DOI 10.7863/ultra.34.6.1003	40	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177068	10.1371/journal.pone.0177068	http://dx.doi.org/10.1371/journal.pone.0177068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481909	Green Submitted, Green Published, gold			2022-12-27	WOS:000401313700031
J	Wang, Y; Dai, W				Wang, Yan; Dai, Wu			Fine structure of mouthparts and feeding performance of Pyrrhocoris sibiricus Kuschakevich with remarks on the specialization of sensilla and stylets for seed feeding	PLOS ONE			English	Article							LABIAL TIP SENSILLA; STINK BUG; HETEROPTERA-PENTATOMIDAE; HEMIPTERA FULGOROMORPHA; ANTENNAL SENSILLA; SENSORY SYSTEMS; ULTRASTRUCTURE; MORPHOLOGY; BEHAVIOR; FOOD	Mouthpart structure and feeding behavior in the temperate firebug, Pyrrhocoris sibiricus Kuschakevich, an important pest that feeds on seeds of leguminous and gramineous plants, are described for the first time. Mouthparts were observed using scanning electron microscopy to examine the external morphology, distribution and abundance of sensilla on mouthparts. Feeding performance by adults on both seeds and shoots were observed using a binocular microscope. The four-segmented labium contains 3 types of sensilla trichodea, 3 types of sensilla basiconica, 1 type of sensilla placodea and 1 type of sensilla campaniformia. Among them, sensilla trichodea are most abundant. The tripartite apex of the labium consists of two lateral lobes and an apical plate. Each lateral lobe possesses a field of 12 thick-walled uniporous peg sensilla and long non-porous hair sensilla. The mandibular stylet tips have three central teeth and two pairs of lateral teeth, which may help in penetrating hard seed coats. A series of scale-like projections are present on the inner surface of the mandibular stylets. The externally smooth maxillary stylets interlock to form a larger food canal and a smaller salivary canal, and there are five tubercles near the tip of the right stylet. Cross-sections of the stylet fascicle show that each mandibular stylet has a dendritic canal. The adult feeding process involves several steps, including exploring and puncturing of the host epidermis, a probing phase, an engorgement phase, and removal of the mouthparts from the host tissue. The structure and function of the mouthparts are adapted for the seed feeding habits.	[Wang, Yan] Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China; [Dai, Wu] Northwest A&F Univ, Key Lab Plant Protect Resources & Pest Integrated, Minist Educ, Coll Plant Protect, Yangling, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Dai, W (corresponding author), Northwest A&F Univ, Key Lab Plant Protect Resources & Pest Integrated, Minist Educ, Coll Plant Protect, Yangling, Peoples R China.	daiwu@nwsuaf.edu.cn			National Natural Science Foundation of China [31572306, 31272343]; Chinese Universities Scientific Fund [YQ2013010]; West Light Foundation of the Chinese Academy of Sciences [2012DF06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Universities Scientific Fund; West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences)	Funding was provided by the National Natural Science Foundation of China (Nos. 31572306, 31272343), the Chinese Universities Scientific Fund (YQ2013010) and the West Light Foundation of the Chinese Academy of Sciences (2012DF06) to Wu Dai.	Ahmad I., 1987, Phytophaga, V1, P75; Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; Anderson WG, 2006, J ECON ENTOMOL, V99, P212, DOI 10.1603/0022-0493(2006)099[0212:CBHBMM]2.0.CO;2; Ave D, 1978, ENTOMOL EXP APPL, V24, P217; Backus E.A., 1985, P163; BACKUS EA, 1988, J INSECT PHYSIOL, V34, P151, DOI 10.1016/0022-1910(88)90045-5; Backus EA, 2005, ANNU REV ENTOMOL, V50, P125, DOI 10.1146/annurev.ento.49.061802.123310; BACKUS EA, 1983, J MORPHOL, V176, P3, DOI 10.1002/jmor.1051760102; Baker GT, 2008, INSECT SCI, V15, P271, DOI 10.1111/j.1744-7917.2008.00210.x; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Borjek J, 2006, POL J ENTOMOL, V75, P255; Boyd DW, 2003, ANN ENTOMOL SOC AM, V96, P667, DOI 10.1603/0013-8746(2003)096[0667:DEASMO]2.0.CO;2; BROMLEY AK, 1980, CELL TISSUE RES, V205, P493; Brozek Jolanta, 2006, Polskie Pismo Entomologiczne, V75, P239; Brozek J, 2014, EUR J ENTOMOL, V111, P275, DOI 10.14411/eje.2014.033; Brozek J, 2013, ZOOMORPHOLOGY, V132, P403, DOI 10.1007/s00435-013-0195-2; Brozek J, 2013, ZOOMORPHOLOGY, V132, P33, DOI 10.1007/s00435-012-0174-z; Chen HH, 2003, J BIOSCIENCES, V28, P743, DOI 10.1007/BF02708435; Chlond D., 2010, ZOOTAXA, V2476, P39; Cobben RH, 1978, EVOLUTIONARY TRENDS, P65; COHEN AC, 1990, ANN ENTOMOL SOC AM, V83, P1215, DOI 10.1093/aesa/83.6.1215; Depieri RA, 2010, REV BRAS ENTOMOL, V54, P584, DOI 10.1590/S0085-56262010000400008; Depieri RA, 2010, NEOTROP ENTOMOL, V39, P952, DOI 10.1590/S1519-566X2010000600017; Esquivel JF, 2011, ENTOMOL EXP APPL, V140, P163, DOI 10.1111/j.1570-7458.2011.01148.x; FAUCHEUX MJ, 1975, CR ACAD SCI D NAT, V281, P41; FEIR DOROTHY, 1963, ANN ENTOMOL SOC AMER, V56, P224; FOSTER S, 1983, CELL TISSUE RES, V230, P353; GAFFAL KP, 1981, INT J INSECT MORPHOL, V10, P1, DOI 10.1016/0020-7322(81)90008-8; Ge FR, 2016, ARTHROPOD STRUCT DEV, V45, P230, DOI 10.1016/j.asd.2016.01.005; Gullan PJ, 2005, INSECTS OUTLINE ENTO, P86; Hao YN, 2016, SCI REP-UK, V6, DOI 10.1038/srep38151; Hao YA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156640; HATFIELD LD, 1980, INT J INSECT MORPHOL, V9, P59, DOI 10.1016/0020-7322(80)90036-7; Henry Thomas J., 2009, P223, DOI 10.1002/9781444308211.ch10; Krenn Harald W., 2007, Arthropod Systematics & Phylogeny, V65, P7; Labandeira CC, 1997, ANNU REV ECOL SYST, V28, P153, DOI 10.1146/annurev.ecolsys.28.1.153; Liang XM, 2013, ARTHROPOD STRUCT DEV, V42, P495, DOI 10.1016/j.asd.2013.08.002; Lucini T, 2016, ANN ENTOMOL SOC AM, V109, P198, DOI 10.1093/aesa/sav156; MATOLIN S, 1987, ACTA ENTOMOL BOHEMOS, V84, P246; MCIVER S, 1984, J MORPHOL, V180, P19, DOI 10.1002/jmor.1051800104; Parveen S, 2015, ZOOTAXA, V4039, P359, DOI 10.11646/zootaxa.4039.2.9; Pei HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064290; Peregrine D.J., 1972, International J Insect Morph Embryol, V1, P241, DOI 10.1016/0020-7322(72)90032-3; Rani Pathipati Usha, 2005, International Journal of Tropical Insect Science, V25, P198, DOI 10.1079/IJT200577; Rani PU, 2009, ACTA ZOOL-STOCKHOLM, V90, P246, DOI 10.1111/j.1463-6395.2008.00346.x; RANI PU, 1995, INT J INSECT MORPHOL, V24, P119, DOI 10.1016/0020-7322(94)00020-Q; RATHORE Y. K., 1961, INDIAN JOUR ENTOMOL, V23, P163; Roitberg BD, 2005, NATURWISSENSCHAFTEN, V92, P431, DOI 10.1007/s00114-005-0013-x; SAXENA KN, 1963, J INSECT PHYSIOL, V9, P47, DOI 10.1016/0022-1910(63)90084-2; Schaefer CW, 2000, HETEROPTERA OF ECONOMIC IMPORTANCE, P3; Schaefer CW, 2000, HETEROPTERA OF ECONOMIC IMPORTANCE, P271; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; SCHOONHOVEN L M, 1972, Netherlands Journal of Zoology, V22, P343, DOI 10.1163/002829672X00149; Wang RR, 2013, MICRON, V44, P261, DOI 10.1016/j.micron.2012.07.003; Weirauch C, 2011, ANNU REV ENTOMOL, V56, P487, DOI 10.1146/annurev-ento-120709-144833; Zhang CN, 2016, ZOOL ANZ, V262, P20, DOI 10.1016/j.jcz.2016.03.011; Zhang SM, 1985, EC INSECT FAUNA CHIN, V50; Zhao LQ, 2010, MICRON, V41, P754, DOI 10.1016/j.micron.2010.06.001	58	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177209	10.1371/journal.pone.0177209	http://dx.doi.org/10.1371/journal.pone.0177209			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481941	Green Submitted, Green Published, gold			2022-12-27	WOS:000401313700041
J	Will, SE; Neumann-Schaal, M; Heydorn, RL; Bartling, P; Petersen, J; Schomburg, D				Will, Sabine Eva; Neumann-Schaal, Meina; Heydorn, Raymond Leopold; Bartling, Pascal; Petersen, Joern; Schomburg, Dietmar			The limits to growth - energetic burden of the endogenous antibiotic tropodithietic acid in Phaeobacter inhibens DSM 17395	PLOS ONE			English	Article							GALLAECIENSIS; BIOSYNTHESIS; ANGUILLARUM; ADAPTATION; CATABOLISM; PLASMIDS; PATHWAYS; STRAINS; REVEAL; MEMBER	Phaeobacter inhibens DSM 17395, a model organism for marine Roseobacter group, was studied for its response to its own antimicrobial compound tropodithietic acid (TDA). TDA biosynthesis is encoded on the largest extrachromosomal element of P. inhibens, the 262 kb plasmid, whose curation leads to an increased growth and biomass yield. In this study, the plasmid-cured strain was compared to the wild-type strain and to transposon mutants lacking single genes of the TDA biosynthesis. The data show that the growth inhibition of the wild-type strain can be mainly attributed to the TDA produced by P. inhibens itself. Oxygen uptake rates remained constant in all strains but the growth rate dropped in the wild-type which supports the recently proposed mode of TDA action. Metabolome analysis showed no metabolic alterations that could be attributed directly to TDA. Taken together, the growth of P. inhibens is limited by its own antibacterial compound due to a partial destruction of the proton gradient which leads to a higher energetic demand. The universal presence of TDA biosynthesis in genome-sequenced isolates of the genus Phaeobacter shows that there must be a high benefit of TDA for P. inhibens in its ecological niche despite the drawback on its metabolism.	[Will, Sabine Eva; Neumann-Schaal, Meina; Heydorn, Raymond Leopold; Schomburg, Dietmar] Tech Univ Carolo Wilhelmina Braunschweig, Dept Bioinformat & Biochem, Braunschweig, Germany; [Will, Sabine Eva; Neumann-Schaal, Meina; Heydorn, Raymond Leopold; Schomburg, Dietmar] Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig Integrated Ctr Syst Biol BRICS, Braunschweig, Germany; [Bartling, Pascal; Petersen, Joern] Leibniz Inst DSMZ German Collect Microorganisms &, Braunschweig, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Schomburg, D (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Dept Bioinformat & Biochem, Braunschweig, Germany.; Schomburg, D (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig Integrated Ctr Syst Biol BRICS, Braunschweig, Germany.	d.schomburg@tu-braunschweig.de	Neumann-Schaal, Meina/AAM-6389-2021	Heydorn, Raymond Leopold/0000-0002-2247-208X; Schomburg, Dietmar/0000-0002-3354-822X	Deutsche Forschungsgemeinschaft [SFB TRR 51]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft, SFB TRR 51 (www.dfg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger M, 2011, J BACTERIOL, V193, P6576, DOI 10.1128/JB.05818-11; Brock NL, 2014, CHEM COMMUN, V50, P5487, DOI 10.1039/c4cc01924e; Buddruhs N, 2013, INT J SYST EVOL MICR, V63, P4340, DOI 10.1099/ijs.0.053900-0; D'Alvise PW, 2016, APPL ENVIRON MICROB, V82, P502, DOI 10.1128/AEM.02992-15; D'Alvise PW, 2010, APPL ENVIRON MICROB, V76, P2366, DOI 10.1128/AEM.02717-09; Dannheim H, 2017, FEBS OPEN BIO; Druppel K, 2014, ENVIRON MICROBIOL, V16, P218, DOI 10.1111/1462-2920.12276; Frank O, 2014, STAND GENOMIC SCI, V9, DOI 10.4056/sigs.5179110; Grotkjaer T, 2016, SYST APPL MICROBIOL, V39, P180, DOI 10.1016/j.syapm.2016.01.005; Hensler M., 2015, THESIS; Michael V, 2016, ISME J, V10, P2498, DOI 10.1038/ismej.2016.30; Petersen J, 2013, APPL MICROBIOL BIOT, V97, P2805, DOI 10.1007/s00253-013-4746-8; Planas M, 2006, AQUACULTURE, V255, P323, DOI 10.1016/j.aquaculture.2005.11.039; Porsby CH, 2011, ANTIMICROB AGENTS CH, V55, P1332, DOI 10.1128/AAC.01222-10; Prado S, 2009, INT MICROBIOL, V12, P107, DOI 10.2436/20.1501.01.87; REUBER TL, 1993, CELL, V74, P269, DOI 10.1016/0092-8674(93)90418-P; Revelles O, 2005, J BACTERIOL, V187, P7500, DOI 10.1128/JB.187.21.7500-7510.2005; Ruiz-Ponte C, 1998, INT J SYST BACTERIOL, V48, P537, DOI 10.1099/00207713-48-2-537; Schneider K, 2010, BIOPROC BIOSYST ENG, V33, P541, DOI 10.1007/s00449-009-0367-0; Thole S, 2012, ISME J, V6, P2229, DOI 10.1038/ismej.2012.62; Trautwein K, 2016, ENVIRON MICROBIOL, V18, P4817, DOI 10.1111/1462-2920.13381; Wiegmann K, 2014, APPL ENVIRON MICROB, V80, P4725, DOI 10.1128/AEM.00719-14; Wilson MZ, 2016, P NATL ACAD SCI USA, V113, P1630, DOI 10.1073/pnas.1518034113; Zech H, 2013, PROTEOMICS, V13, P2869, DOI 10.1002/pmic.201200560; Zech H, 2013, PROTEOMICS, V13, P2851, DOI 10.1002/pmic.201200513; Zech H, 2009, PROTEOMICS, V9, P3677, DOI 10.1002/pmic.200900120; Zhao WJ, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-015-0617-z	27	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177295	10.1371/journal.pone.0177295	http://dx.doi.org/10.1371/journal.pone.0177295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481933	gold, Green Published, Green Submitted			2022-12-27	WOS:000401313700050
J	Cashman, CR; Hoke, A				Cashman, Christopher R.; Hoke, Ahmet			Deficiency of adaptive immunity does not interfere with Wallerian degeneration	PLOS ONE			English	Article							FACIAL MOTONEURON SURVIVAL; PERIPHERAL NERVOUS-SYSTEM; IMAGE-ANALYSIS; COMPLEMENT-SYSTEM; INNATE IMMUNITY; LYMPHOCYTES; INJURY; MICE; MACROPHAGES; MOUSE	Following injury, distal axons undergo the process of Wallerian degeneration, and then cell debris is cleared to create a permissive environment for axon regeneration. The innate and adaptive immune systems are believed to be critical for facilitating the clearance of myelin and axonal debris during this process. However, immunodeficient animal models are regularly used in transplantation studies investigating cell therapies to modulate the degenerative/regenerative response. Given the importance of the immune system in preparing a permissive environment for regeneration by clearing debris, animals lacking, in part or in full, a functional immune system may have an impaired ability to regenerate due to poor myelin clearance, and may, thus, be poor hosts to study modulators of regeneration and degeneration. To study this hypothesis, three different mouse models with impaired adaptive immunity were compared to wild type animals in their ability to degenerate axons and clear myelin debris one week following sciatic nerve transection. Immunofluorescent staining for axons and quantitation of axon density with nerve histomorphometry of the distal stump showed no consistent discrepancy between immunodeficient and wild type animals, suggesting axons tended to degenerate equally between the two groups. Debris clearance was assessed by macrophage density and relative myelin basic protein expression within the denervated nerve stump, and no consistent impairment of debris clearance was found. These data suggested deficiency of the adaptive immune system does not have a substantial effect on axon degeneration one week following axonal injury.	[Cashman, Christopher R.] Johns Hopkins Sch Med, MSTP MD PhD Program, Baltimore, MD USA; [Cashman, Christopher R.; Hoke, Ahmet] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Cashman, Christopher R.; Hoke, Ahmet] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Hoke, A (corresponding author), Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.; Hoke, A (corresponding author), Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	ahoke@jhmi.edu			Dr. Miriam and Sheldon G. Adelson Medical Research Foundation [113660]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Dr. Miriam and Sheldon G. Adelson Medical Research Foundation grant 113660 (CRC, AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Beahrs T, 2010, EXP NEUROL, V221, P225, DOI 10.1016/j.expneurol.2009.11.003; Berghoff M, 2005, MOL CELL NEUROSCI, V28, P118, DOI 10.1016/j.mcn.2004.09.001; BOSMA GC, 1988, J EXP MED, V167, P1016, DOI 10.1084/jem.167.3.1016; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chen P, 2015, ACTA NEUROPATHOL, V130, P1; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Ha GK, 2006, J NEUROIMMUNOL, V172, P1, DOI 10.1016/j.jneuroim.2005.10.012; Hirata K, 2002, MICROSC RES TECHNIQ, V57, P541, DOI 10.1002/jemt.10108; Huang Z, 2013, J NEUROL DISORD, V1, P1; Jones KJ, 2005, BRAIN BEHAV IMMUN, V19, P12, DOI 10.1016/j.bbi.2004.05.004; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; Kim SJ, 2003, ANN NY ACAD SCI, V987, P68, DOI 10.1111/j.1749-6632.2003.tb06034.x; Mietto BS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/251204; Miller NM, 2013, ASN NEURO, V5, DOI 10.1042/AN20120087; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nauta AJ, 2004, INT ARCH ALLERGY IMM, V134, P310, DOI 10.1159/000079261; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; Patzig J, 2011, J NEUROSCI, V31, P16369, DOI 10.1523/JNEUROSCI.4016-11.2011; Ramaglia V, 2008, MOL IMMUNOL, V45, P3865, DOI 10.1016/j.molimm.2008.06.018; Ramaglia V, 2009, PROG BRAIN RES, V175, P95, DOI 10.1016/S0079-6123(09)17507-6; Sanders VM, 2006, J NEUROIMMUNE PHARM, V1, P11, DOI 10.1007/s11481-005-9004-0; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuurman H. J., 1992, ILAR News, V34, P3; Serpe CJ, 2005, BRAIN BEHAV IMMUN, V19, P173, DOI 10.1016/j.bbi.2004.07.005; Serpe CJ, 2003, BRAIN BEHAV IMMUN, V17, P393, DOI 10.1016/S0889-1591(03)00028-X; Serpe CJ, 2002, BRAIN BEHAV IMMUN, V16, P808, DOI 10.1016/S0889-1591(02)00017-X; STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086; Vargas ME, 2010, P NATL ACAD SCI USA, V107, P11993, DOI 10.1073/pnas.1001948107; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; WINKELSTEIN JA, 1973, J PEDIATR-US, V82, P747, DOI 10.1016/S0022-3476(73)80062-9	35	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177070	10.1371/journal.pone.0177070	http://dx.doi.org/10.1371/journal.pone.0177070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475650	gold, Green Submitted, Green Published			2022-12-27	WOS:000400649500041
J	Deiner, K; Hull, JM; May, B				Deiner, Kristy; Hull, Joshua M.; May, Bernie			Range-wide phylogeographic structure of the vernal pool fairy shrimp (Branchinecta lynchi)	PLOS ONE			English	Article							GENETIC POPULATION-STRUCTURE; CALIFORNIA; DNA; RARE; CRUSTACEA; BRANCHIOPOD; LANDSCAPE; DIVERSITY; ANOSTRACA; SOFTWARE	Wetland habitats across the world are experiencing rapid modification and loss due to accelerating habitat conversion. Impacts to wetland habitats are particularly acute in California where up to 90% of wetland habitats have been modified or lost. Vernal pool ecosystems have therefore undergone a dramatic loss in habitat and along with them an entire endemic fauna is under threat of extinction. Recent efforts to conserve vernal pool habitat and associated species have involved restoration and creation of vernal pools as well as translocations of threatened species. The vernal pool fairy shrimp, Branchinecta lynchi, is one of several endemic and federally listed species being targeted for translocations. To guide reintroduction and conservation, detailed information on range-wide population structure and diversity is needed. We collected genetic data from two mitochondrial genes throughout the known extant range of B. lynchi to elucidate population structure and diversity of the species. We found support for phylogeographic structure throughout the range of B. lynch associated with isolated watersheds and vernal pool regions previously identified in the recovery plan for the species. The underlying mechanisms responsible for this broad pattern of genetic structure have yet to be identified. However, the evidence of only a few haplotypes being shared across the species range and patterns of isolation by distance within vernal pool regions suggests dispersal limitation may play a role. These results stress that conservation programs, at a minimum, should consider using individuals from regional populations as sources for reintroductions to maintain historical patterns of genetic differentiation. Additionally, because genetic structure is associated with vernal pool regions which are based on local hydrology and geology, translocations should proceed considering the distance between donor and recipient sites.	[Deiner, Kristy; May, Bernie] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Hull, Joshua M.] US Fish & Wildlife Serv, Sacramento Fish & Wildlife Off, Sacramento, CA USA	University of California System; University of California Davis; United States Department of the Interior; US Fish & Wildlife Service	Deiner, K (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	alpinedna@gmail.com	Hull, Joshua/ABD-5438-2020	Deiner, Kristy/0000-0001-9755-3223	U.S. Fish and Wildlife Services Cooperative [81420-9-J511]	U.S. Fish and Wildlife Services Cooperative	This work was supported by U.S. Fish and Wildlife Services Cooperative agreement grant (81420-9-J511), https://www.fws.gov/.	Aguilar A, 2012, CONSERV GENET, V13, P1577, DOI 10.1007/s10592-012-0405-3; Aguilar A, 2011, AQUAT SCI, V73, P15, DOI 10.1007/s00027-010-0155-6; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbour MG, 2005, PHYTOCOENOLOGIA, V35, P177, DOI 10.1127/0340-269X/2005/0035-0177; Bohonak A., 2005, FINAL REPORT CITY SA; Bohonak AJ, 1998, CAN J ZOOL, V76, P2049, DOI 10.1139/cjz-76-11-2049; Brochet AL, 2010, HYDROBIOLOGIA, V637, P255, DOI 10.1007/s10750-009-9975-6; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Dahl T., 1990, WETLANDS LOSSES US 1, P1; Davies CP, 1997, HYDROBIOLOGIA, V359, P149, DOI 10.1023/A:1003150517472; Deiner K, 2013, J FISH WILDL MANAG, V4, P134, DOI 10.3996/112012-JFWM-096; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; ENG LL, 1990, J CRUSTACEAN BIOL, V10, P247, DOI 10.2307/1548485; Eriksen CH, 1999, FAIRY SHRIMPS CALIFO; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Gordon SP, 2012, CONSERV GENET, V13, P117, DOI 10.1007/s10592-011-0269-y; Graham TB, 2008, HYDROBIOLOGIA, V600, P17, DOI 10.1007/s10750-007-9171-5; GRIGGS FT, 1983, BIOL CONSERV, V27, P171, DOI 10.1016/0006-3207(83)90087-3; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HOLLAND RF, 1981, AM NAT, V117, P24, DOI 10.1086/283684; Holland RF., 1978, GEOGRAPHIC EDAPHIC D; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Keeler-Wolf T, 1998, CALIFORNIA VERNAL PO, P1; Keeley JE, 1998, CHARACTERIZATION GLO; Kneitel JM, 2014, HYDROBIOLOGIA, V732, P71, DOI 10.1007/s10750-014-1845-1; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Machler E, 2014, FRESHW SCI, V33, P1174, DOI 10.1086/678128; McGlaughlin ME, 2015, CONSERV GENET, V16, P253, DOI 10.1007/s10592-014-0655-3; Meglecz E, 2005, ARCH HYDROBIOL, V164, P277, DOI 10.1127/0003-9136/2005/0164-0277; Nhiwatiwa T, 2011, FRESHWATER BIOL, V56, P1992, DOI 10.1111/j.1365-2427.2011.02630.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; QGIS Development Team, 2015, QGIS GEOGR INF SYST; Rains MC, 2008, WETLANDS, V28, P347, DOI 10.1672/07-132.1; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Santana QC, 2009, BIOTECHNIQUES, V46, P217, DOI 10.2144/000113085; Schwentner M, 2014, J ZOOL SYST EVOL RES, V52, P15, DOI 10.1111/jzs.12038; Schwentner M, 2012, ECOL EVOL, V2, P1605, DOI 10.1002/ece3.265; Shaffer HB, 2004, MOL ECOL, V13, P3033, DOI 10.1111/j.1365-294X.2004.02317.x; Simovich MA, 1997, J CRUSTACEAN BIOL, V17, P38, DOI 10.2307/1549460; Simovich MA, 2013, J CRUSTACEAN BIOL, V33, P730, DOI 10.1163/1937240X-00002164; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Soule M., 1987, VIABLE POPULATIONS C; TAJIMA F, 1989, GENETICS, V123, P597; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; USFWS, 2005, REC PLAN VERN POOL E; USFWS, 2007, VERN POOL FAIR SHRIM, P1; Vandergast AG, 2009, MOL ECOL RESOUR, V9, P767, DOI 10.1111/j.1755-0998.2009.02522.x; Wall AR, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.457.6822; Witham C, 2014, CHANGES DISTRIBUTION; Zwickl D. J, 2006, GENETIC ALGORITHM AP	57	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176266	10.1371/journal.pone.0176266	http://dx.doi.org/10.1371/journal.pone.0176266			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472088	Green Submitted, gold, Green Published			2022-12-27	WOS:000400648500033
J	Healy, EF				Healy, Eamonn F.			A prion-like mechanism for the propagated misfolding of SOD1 from in silico modeling of solvated near-native conformers	PLOS ONE			English	Article							HUMAN SUPEROXIDE-DISMUTASE; CU-ZN; PROTEINS; BINDING; AGGREGATION; DYNAMICS; ENERGY	A prion-like mechanism has been developed to explain the observed promotion of amyloid aggregation caused by conversion of structurally intact SOD1 to a misfolded form. Superoxide dismutase [Cu-Zn], or SOD1, is a homo-dimeric protein that functions as an antioxidant by scavenging for superoxide. The misfolding and aggregation of SOD1 is linked to inherited, or familial, amyotrophic lateral sclerosis (FALS), a progressive and fatal neurodegenerative disease. Aberrant SOD1 folding has also been strongly implicated in disease causation for sporadic ALS, or SALS, which accounts for similar to 90% of ALS cases. Studies have found that mutant, misfolded SOD1 can convert wtSOD1 in a prion-like fashion, and that misfolded wtSOD1 can be propagated by release and uptake of protein aggregates. Here it is demonstrated that enervating the SOD1 electrostatic loop can lead to an experimentally observed gain of interaction (GOI) responsible for the formation of SOD1 amyloid-like filaments. This enervation is caused in turn by the formation of transient, non-obligate oligomers between pathogenic SOD1 mutants and wt SOD1.	[Healy, Eamonn F.] St Edwards Univ, Dept Chem, Austin, TX 78704 USA		Healy, EF (corresponding author), St Edwards Univ, Dept Chem, Austin, TX 78704 USA.	healy@stedwards.edu	Healy, Eamonn/AAI-4331-2020	Healy, Eamonn/0000-0001-8479-7712	National Institute of General Medical Services [1K12GM102745]; Welch Foundation [BH-0018]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM102745] Funding Source: NIH RePORTER	National Institute of General Medical Services; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by the National Institute of General Medical Services (1K12GM102745) and the Welch Foundation (Grant# BH-0018).; The author wishes to acknowledge the support of the National Institute of General Medical Services (1K12GM102745), as well as Welch Foundation (Grant# BH-0018) for its continuing support of the Chemistry Department at St. Edward's University. The author also is particularly grateful to Luis Cervantes for his help in the preparation of this manuscript.	Antonyuk S, 2010, J MED CHEM, V53, P1402, DOI 10.1021/jm9017948; Banerjee V, 2016, ACS CHEM NEUROSCI, V7, P1595, DOI 10.1021/acschemneuro.6b00227; Bershtein S, 2012, P NATL ACAD SCI USA, V109, P4857, DOI 10.1073/pnas.1118157109; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Dunn ME, 2004, J AM CHEM SOC, V126, P2647, DOI 10.1021/ja038928p; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Fernandez A, 2003, BIOPHYS J, V85, P1914, DOI 10.1016/S0006-3495(03)74619-0; Fernandez A, 2003, P NATL ACAD SCI USA, V100, P113, DOI 10.1073/pnas.0136888100; Fernandez A, 2011, NATURE, V474, P502, DOI 10.1038/nature09992; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P19819, DOI 10.1073/pnas.0709915104; Grad LI, 2015, NEUROBIOL DIS, V77, P257, DOI 10.1016/j.nbd.2015.02.009; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Hart PJ, 1998, PROTEIN SCI, V7, P545; Healy EE, 2016, BIOCHEM BIOPH RES CO, V478, P1634, DOI 10.1016/j.bbrc.2016.08.172; Healy EF, 2016, EUR BIOPHYS J BIOPHY, V45, P853, DOI 10.1007/s00249-016-1163-9; Healy EF, 2015, BIOCHEM BIOPH RES CO, V465, P523, DOI 10.1016/j.bbrc.2015.08.052; Healy EF, 2011, COMPUT THEOR CHEM, V964, P91, DOI 10.1016/j.comptc.2010.12.003; Healy EF, 2009, FEBS LETT, V583, P2899, DOI 10.1016/j.febslet.2009.07.051; Hegler JA, 2008, HFSP J, V2, P307, DOI 10.2976/1.3003931; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Khare SD, 2006, P NATL ACAD SCI USA, V103, P3147, DOI 10.1073/pnas.0511266103; Levy Y, 2004, P NATL ACAD SCI USA, V101, P511, DOI 10.1073/pnas.2534828100; Maddipati S, 2006, BIOMOL ENG, V23, P307, DOI 10.1016/j.bioeng.2006.09.004; Marsh JA, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001870; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; Tsao D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011936	32	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177284	10.1371/journal.pone.0177284	http://dx.doi.org/10.1371/journal.pone.0177284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472188	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500156
J	Lin, BL; Wang, JX; Wang, HS; Wang, ZK; Li, J; Lin, RX; Xiao, J; Wu, JP				Lin, Boliang; Wang, Jiaxi; Wang, Huasheng; Wang, Zhongkai; Li, Jian; Lin, Ruixi; Xiao, Jie; Wu, Jianping			Inventory-transportation integrated optimization for maintenance spare parts of high-speed trains	PLOS ONE			English	Article							MANAGEMENT; POLICY; CLASSIFICATION; PRODUCTS; SYSTEM; CHAIN; MODEL	This paper presents a 0-1 programming model aimed at obtaining the optimal inventory policy and transportation mode for maintenance spare parts of high-speed trains. To obtain the model parameters for occasionally-replaced spare parts, a demand estimation method based on the maintenance strategies of China's high-speed railway system is proposed. In addition, we analyse the shortage time using PERT, and then calculate the unit time shortage cost from the viewpoint of train operation revenue. Finally, a real-world case study from Shanghai Depot is conducted to demonstrate our method. Computational results offer an effective and efficient decision support for inventory managers.	[Lin, Boliang; Wang, Jiaxi; Li, Jian; Xiao, Jie; Wu, Jianping] Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China; [Wang, Huasheng] China Acad Railway Sci, Locomot & Car Res Inst, Beijing, Peoples R China; [Wang, Zhongkai] China Acad Railway Sci, Inst Comp Technol, Beijing, Peoples R China; [Lin, Ruixi] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	Beijing Jiaotong University; Stanford University	Lin, BL (corresponding author), Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China.	bllin@bjtu.edu.cn			National Natural Science Foundation of China [51378056]; science and technology department of China Railway Corporation [2015J006-B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); science and technology department of China Railway Corporation	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under grant number 51378056; and the science and technology department of China Railway Corporation (http://www.china-railway.com.cn/) under grant number 2015J006-B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini Alireza, 2016, International Journal of Services and Operations Management, V25, P347; Burgin AT, 1975, J OPERATIONAL RES SO, V26, P507; Cardos M, 2006, INT J PROD ECON, V104, P525, DOI 10.1016/j.ijpe.2004.12.022; Dollevoet T, 2015, OMEGA, V57, P217; Guajardo M, 2015, J OPER RES SOC, V66, P331, DOI 10.1057/jors.2014.8; Hadi-Vencheh A, 2010, EUR J OPER RES, V201, P962, DOI 10.1016/j.ejor.2009.04.013; Hatefi SM, 2013, INTERNATIONAL JOURNA, V52, P776; Jha JK, 2014, J MANUF SYST, V33, P462, DOI 10.1016/j.jmsy.2014.04.002; Kamath KR, 2002, COMPUT OPER RES, V29, P403, DOI 10.1016/S0305-0548(00)00075-7; Kasilingam RG, 1998, LOGISTICS AND TRANSP; Kennedy WJ, 2002, INT J PROD ECON, V76, P201, DOI 10.1016/S0925-5273(01)00174-8; Kocaga YL, 2007, IIE TRANS, V39, P879, DOI 10.1080/07408170601013646; Kutanoglu E, 2008, TRANSPORT RES E-LOG, V44, P665, DOI 10.1016/j.tre.2007.02.001; Lee YCE, 2016, TRANSPORT RES E-LOG, V91, P68, DOI 10.1016/j.tre.2016.03.017; Marcello B, 2004, J QUALITY MAINTENANC, V10, P55; Molenaers A, 2012, INT J PROD ECON, V140, P570, DOI 10.1016/j.ijpe.2011.08.013; National Development and Reform Commission of the People's Republic of China, 2016, MID AND LONG TERM RA; National Railway Administration of the People's Republic of China, 2016, 2015 RAILW STAT B; Qu WW, 1999, EUR J OPER RES, V115, P254, DOI 10.1016/S0377-2217(98)00301-4; Ramanathan R, 2006, COMPUT OPER RES, V33, P695, DOI 10.1016/j.cor.2004.07.014; Romeijnders W, 2012, EUR J OPER RES, V220, P386, DOI 10.1016/j.ejor.2012.01.019; Selcuk B, 2013, INT J PROD ECON, V143, P304, DOI 10.1016/j.ijpe.2012.01.011; Sharif KI, 2016, INT J SUPPLY CHAIN M, V5, P96; Syntetos AA, 2012, INT J PROD RES, V50, P2101, DOI 10.1080/00207543.2011.562561; The Xinhua news agency, 2016, XINHUA NEWS AGE 0815; Topan E, 2017, EUR J OPER RES, V256, P126, DOI 10.1016/j.ejor.2016.06.012; WANG MC, 1992, EUR J OPER RES, V56, P332, DOI 10.1016/0377-2217(92)90316-2; Wang WB, 2012, EUR J OPER RES, V216, P127, DOI 10.1016/j.ejor.2011.07.031; Wang WB, 2011, TRANSPORT RES E-LOG, V47, P1194, DOI 10.1016/j.tre.2011.04.008; Watson BR, 1987, J OPERATIONAL RES SO, V38, P75; Wu GD, 2011, RAILWAY LOCOMOTIVE C, V31, P38; Zhao QH, 2010, TRANSPORT RES E-LOG, V46, P913, DOI 10.1016/j.tre.2010.03.001	33	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176961	10.1371/journal.pone.0176961	http://dx.doi.org/10.1371/journal.pone.0176961			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472097	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500104
J	Vallejo, V; Wyss, P; Rampa, L; Mitache, AV; Muri, RM; Mosimann, UP; Nef, T				Vallejo, Vanessa; Wyss, Patric; Rampa, Luca; Mitache, Andrei V.; Mueri, Rene M.; Mosimann, Urs P.; Nef, Tobias			Evaluation of a novel Serious Game based assessment tool for patients with Alzheimer's disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; INSTRUMENTAL ACTIVITIES; FUNCTIONAL IMPAIRMENT; EXECUTIVE FUNCTION; DEMENTIA; POPULATION; REHABILITATION; INFORMATION; ATTENTION; REALITY	Despite growing interest in developing ecological assessment of difficulties in patients with Alzheimer's disease new methods assessing the cognitive difficulties related to functional activities are missing. To complete current evaluation, the use of Serious Games can be a promising approach as it offers the possibility to recreate a virtual environment with daily living activities and a precise and complete cognitive evaluation. The aim of the present study was to evaluate the usability and the screening potential of a new ecological tool for assessment of cognitive functions in patients with Alzheimer's disease. Eighteen patients with Alzheimer's disease and twenty healthy controls participated to the study. They were asked to complete six daily living virtual tasks assessing several cognitive functions: three navigation tasks, one shopping task, one cooking task and one table preparation task following a oneday scenario. Usability of the game was evaluated through a questionnaire and through the analysis of the computer interactions for the two groups. Furthermore, the performances in terms of time to achieve the task and percentage of completion on the several tasks were recorded. Results indicate that both groups subjectively found the game user friendly and they were objectively able to play the game without computer interactions difficulties. Comparison of the performances between the two groups indicated a significant difference in terms of percentage of achievement of the several tasks and in terms of time they needed to achieve the several tasks. This study suggests that this new Serious Game based assessment tool is a user-friendly and ecological method to evaluate the cognitive abilities related to the difficulties patients can encounter in daily living activities and can be used as a screening tool as it allowed to distinguish Alzheimer's patient's performance from healthy controls.	[Vallejo, Vanessa; Wyss, Patric; Mitache, Andrei V.; Mueri, Rene M.; Mosimann, Urs P.; Nef, Tobias] Univ Bern, Gerontechnol & Rehabil Grp, Bern, Switzerland; [Rampa, Luca; Mosimann, Urs P.] Univ Bern, Univ Hosp Old Age Psychiat & Psychotherapy, Bern, Switzerland; [Mueri, Rene M.] Univ Bern, Univ Hosp Inselspital, Dept Neurol & Clin Res, Percept & Eye Movement Lab, Bern, Switzerland; [Mosimann, Urs P.] Private Hosp Wyss, Munchenbuchsee, Switzerland; [Nef, Tobias] Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Nef, T (corresponding author), Univ Bern, Gerontechnol & Rehabil Grp, Bern, Switzerland.; Nef, T (corresponding author), Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland.	tobias.nef@artorg.unibe.ch	; Muri, Rene/E-9320-2012	Nef, Tobias/0000-0002-8069-9450; Rampa, Luca/0000-0002-2907-667X; Wyss, Patric/0000-0002-8820-2963; Muri, Rene/0000-0001-6990-4188				[Anonymous], [No title captured]; Barberger-Gateau P, 1999, J AM GERIATR SOC, V47, P456, DOI 10.1111/j.1532-5415.1999.tb07239.x; Bouchard Bruno, 2012, Serious Games Development and Applications. Proceedings Third International Conference, SGDA 2012, P243, DOI 10.1007/978-3-642-33687-4_21; Boyle PA, 2003, AM J GERIAT PSYCHIAT, V11, P214, DOI 10.1176/appi.ajgp.11.2.214; Bucks RS, 1996, AGE AGEING, V25, P113, DOI 10.1093/ageing/25.2.113; Clark Christopher M, PERFORMANCE DEMENTIA; Cushman LA, 2008, NEUROLOGY, V71, P888, DOI 10.1212/01.wnl.0000326262.67613.fe; Fillenbaum GG, 1999, AGE AGEING, V28, P161, DOI 10.1093/ageing/28.2.161; Fissler P, 2013, PROG BRAIN RES, V207, P403, DOI 10.1016/B978-0-444-63327-9.00017-5; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Flaherty G, 2006, DEMENTIA WANDERING B; Flores E., 2008, P 2008 INT C ADV COM, P381, DOI [10.1145/1501750.1501839, DOI 10.1145/1501750.1501839]; Fua KC, 2013, DESIGNING SERIOUS GA, P291; HENDERSON VW, 1989, ARCH NEUROL-CHICAGO, V46, P391, DOI 10.1001/archneur.1989.00520400045018; Hollan J., 2000, ACM Transactions on Computer-Human Interaction, V7, P174, DOI 10.1145/353485.353487; Imbeault F., 2011, 2011 IEEE 1 INT C SE, P1, DOI DOI 10.1109/SEGAH.201; Jefferson AL, 2006, ARCH CLIN NEUROPSYCH, V21, P311, DOI 10.1016/j.acn.2006.03.007; Johnson N., ACTIVITIES DAILY LIV; Kluger A, 1997, Int Psychogeriatr, V9 Suppl 1, P307, DOI 10.1017/S1041610297005048; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Logan B, 2007, LECT NOTES COMPUT SC, V4717, P483; Manera V, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00024; Marshall GA, 2011, ALZHEIMERS DEMENT, V7, P300, DOI 10.1016/j.jalz.2010.04.005; Martyr A, 2012, DEMENT GERIATR COGN, V33, P189, DOI 10.1159/000338233; MORRIS JC, 1988, PSYCHOPHARMACOL BULL, V24, P641; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ng TP, 2006, J GERONTOL A-BIOL, V61, P726, DOI 10.1093/gerona/61.7.726; Nygard L, 2004, AM J OCCUP THER, V58, P435, DOI 10.5014/ajot.58.4.435; Parmelee PA, 1989, PSYCHOL ASSESSMENT J, V1, P331, DOI DOI 10.1037/1040-3590.1.4.331; Parsey CM, 2013, CLIN NEUROPSYCHOL, V27, P1328, DOI 10.1080/13854046.2013.834971; Patton M. Q., 2005, ENCY STAT BEHAV SCI, DOI 10.1002/0470013192.bsa514; Peres K, 2008, J AM GERIATR SOC, V56, P37, DOI 10.1111/j.1532-5415.2007.01499.x; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Pudaric S, 2003, SOC SCI MED, V56, P2493, DOI 10.1016/S0277-9536(02)00284-8; Rego P, 2010, 5 IB C INF SYST TECH, P1; Rizzo AA, 2000, CYBERPSYCHOL BEHAV, V3, P483, DOI 10.1089/10949310050078940; Robert PH, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00054; Schmitter-Edgecombe M, 2012, NEUROPSYCHOLOGY, V26, P631, DOI 10.1037/a0029352; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sikkes SAM, 2009, J NEUROL NEUROSUR PS, V80, P7, DOI 10.1136/jnnp.2008.155838; Spiers HJ, 2006, NEUROIMAGE, V31, P1826, DOI 10.1016/j.neuroimage.2006.01.037; STEELE C, 1990, AM J PSYCHIAT, V147, P1049; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V54, pE230, DOI 10.1016/j.archger.2011.06.015; Tarnanas I, 2013, JMIR SERIOUS GAMES, V1, P16, DOI 10.2196/games.2778; Tarnanas I, 2014, ALZHEIMERS DEMENT, V10, P790, DOI 10.1016/j.jalz.2014.01.002; Tekin S, 2001, AM J GERIAT PSYCHIAT, V9, P81, DOI 10.1176/appi.ajgp.9.1.81; Tong T., 2014, INT S HUM FACTORS ER, V3, P28; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Vallejo V., 2015, J PAIN MANAG, V9, P333; Vallejo V, 2015, IEEE ENG MED BIO, P1327, DOI 10.1109/EMBC.2015.7318613; Wiemeyer J, 2012, EUR REV AGING PHYS A, V9, P41, DOI 10.1007/s11556-011-0093-x; Wlodarczyk JH, 2004, ARCH GERONTOL GERIAT, V39, P25, DOI 10.1016/j.archger.2003.12.004; Zucchella C, 2014, FUNCT NEUROL, V29, P153, DOI 10.11138/FNeur/2014.29.3.153	53	35	35	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175999	10.1371/journal.pone.0175999	http://dx.doi.org/10.1371/journal.pone.0175999			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472049	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500020
J	Fair, PA; Schaefer, AM; Houser, DS; Bossart, GD; Romano, TA; Champagne, CD; Stott, JL; Rice, CD; White, N; Reif, JS				Fair, Patricia A.; Schaefer, Adam M.; Houser, Dorian S.; Bossart, Gregory D.; Romano, Tracy A.; Champagne, Cory D.; Stott, Jeffrey L.; Rice, Charles D.; White, Natasha; Reif, John S.			The environment as a driver of immune and endocrine responses in dolphins (Tursiops truncatus)	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; POLYCHLORINATED BIPHENYL EXPOSURE; TRACE-ELEMENT CONCENTRATIONS; INDIAN RIVER LAGOON; PERFLUOROALKYL COMPOUNDS; DELPHINAPTERUS-LEUCAS; THYROID-HORMONES; ESTUARINE AREAS; SOUTH-CAROLINA; LAND-USE	Immune and endocrine responses play a critical role in allowing animals to adjust to environmental perturbations. We measured immune and endocrine related markers in multiple samples from individuals from two managed-care care dolphin groups (n = 82 samples from 17 dolphins and single samples collected from two wild dolphin populations: Indian River Lagoon, (IRL) FL (n = 26); and Charleston, (CHS) SC (n = 19). The immune systems of wild dolphins were more upregulated than those of managed-care-dolphins as shown by higher concentrations of IgG and increases in lysozyme, NK cell function, pathogen antibody titers and leukocyte cytokine transcript levels. Collectively, managed-care care dolphins had significantly lower levels of transcripts encoding pro-inflammatory cytokine TNF, anti-viral MX1 and INFa and regulatory IL-10. IL-2Ra and CD69, markers of lymphocyte activation, were both lower in managed-care care dolphins. IL-4, a cytokine associated with T(H)2 activity, was lower in managed-care care dolphins compared to the free-ranging dolphins. Differences in immune parameters appear to reflect the environmental conditions under which these four dolphin populations live which vary widely in temperature, nutrition, veterinary care, pathogen/contaminant exposures, etc. Many of the differences found were consistent with reduced pathogenic antigenic stimulation in managed-care care dolphins compared to wild dolphins. Managed-care care dolphins had relatively low T(H)2 lymphocyte activity and fewer circulating eosinophils compared to wild dolphins. Both of these immunologic parameters are associated with exposure to helminth parasites which is uncommon in managed-care care dolphins. Less consistent trends were observed in a suite of hormones but significant differences were found for cortisol, ACTH, total T-4, free T-3, and epinephrine. While the underlying mechanisms are likely multiple and complex, the marked differences observed in the immune and endocrine systems of wild and managed-care care dolphins appear to be shaped by their environment.	[Fair, Patricia A.; White, Natasha] Natl Ocean Serv, NOAA, Ctr Coastal Environm Hlth & Biomol Res, Charleston, SC 29412 USA; [Fair, Patricia A.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Schaefer, Adam M.] Florida Atlantic Univ, Harbor Branch, Oceanog Inst, Ft Pierce, FL USA; [Houser, Dorian S.; Champagne, Cory D.] Marine Mammal Fdn, San Diego, CA USA; [Bossart, Gregory D.] Georgia Aquarium, Atlanta, GA USA; [Bossart, Gregory D.] Univ Miami, Miller Sch Med, Div Comparat Pathol, Miami, FL 33136 USA; [Romano, Tracy A.] Mystic Aquarium, Mystic, CT USA; [Stott, Jeffrey L.] Univ Calif Davis, Davis, CA 95616 USA; [Rice, Charles D.] Clemson Univ, Dept Biol Sci, Grad Program Environm Toxicol, Clemson, SC 29634 USA; [Reif, John S.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; Medical University of South Carolina; Harbor Branch Oceanographic Institute Foundation; State University System of Florida; Florida Atlantic University; University of Miami; University of California System; University of California Davis; Clemson University; Colorado State University	Fair, PA (corresponding author), Natl Ocean Serv, NOAA, Ctr Coastal Environm Hlth & Biomol Res, Charleston, SC 29412 USA.; Fair, PA (corresponding author), Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA.	pat.fair@noaa.gov	Houser, Dorian/AAG-6359-2020	Schaefer, Adam M/0000-0001-9604-3432	Office of Naval Research [N00014-11-1-0436]	Office of Naval Research(Office of Naval Research)	We include the funding source Office of Naval Research grant number N00014-11-1-0436 (DSH). We also include commercial affiliations, Georgia Aquarium and Mystic Aquarium, and a statement on the role of the funders as follows: The funding organizations, Georgia Aquarium and Mystic Aquarium, provided support in the form of salaries for authors [GDB, TAR] and did not play an additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abolins SR, 2011, MOL ECOL, V20, P881, DOI 10.1111/j.1365-294X.2010.04910.x; Adams J, 2008, MAR ENVIRON RES, V66, P430, DOI 10.1016/j.marenvres.2008.07.004; Adams J, 2014, ENVIRON RES, V135, P346, DOI 10.1016/j.envres.2014.08.037; [Anonymous], 2002, CELL MOL BIOL MARINE; Asper E.D., 1990, P479; Atkinson S, 2015, J COMP PHYSIOL B, V185, P463, DOI 10.1007/s00360-015-0901-0; Beck BM, 2003, MAR ENVIRON RES, V55, P161, DOI 10.1016/S0141-1136(02)00274-X; Beineke A, 2010, VET IMMUNOL IMMUNOP, V133, P81, DOI 10.1016/j.vetimm.2009.06.019; Bossart, 2006, OCEANOGRAPHY, V19, P134, DOI [10.1177/0300985810388525, DOI 10.5670/OCEANOG.2006.77]; Bossart G, 2011, DIS AQUAT ORG; BOSSART GD, 2001, MARINE MAMMAL MED; Bossart GD, 2010, VET PATHOL, P676; Bossart GD, 2015, DIS AQUAT ORGAN, V115, P175, DOI 10.3354/dao02895; Bossart GD, 2014, DIS AQUAT ORGAN, V108, P71, DOI 10.3354/dao02704; Bossart GD, 2010, VET MICROBIOL, V143, P160, DOI 10.1016/j.vetmic.2009.11.024; Bossart Gregory D., 2008, Aquatic Mammals, V34, P166, DOI 10.1578/AM.34.2.2008.166; Buehler DM, 2008, J AVIAN BIOL, V39, P560, DOI 10.1111/j.0908-8857.2008.04408.x; Champagne C.D., 2016, MAR MAMM SCI; Cray C, 2013, J VET DIAGN INVEST, V25, P107, DOI 10.1177/1040638712467986; Davis SL, 1998, DOMEST ANIM ENDOCRIN, V15, P283, DOI 10.1016/S0739-7240(98)00034-4; Descotes J., 2004, IMMUNOTOXICITY DRUGS, V1; Dorshkind K, 2001, BIOESSAYS, V23, P288, DOI 10.1002/1521-1878(200103)23:3<288::AID-BIES1039>3.0.CO;2-P; Fair Patricia A., 2006, Aquatic Mammals, V32, P182, DOI 10.1578/AM.32.2.2006.182; Fair PA, 2007, ARCH ENVIRON CON TOX, V53, P483, DOI 10.1007/s00244-006-0244-7; Fair PA, 2014, GEN COMP ENDOCR, V206, P203, DOI 10.1016/j.ygcen.2014.07.002; Fair PA, 2013, ENVIRON TOXICOL CHEM, V32, P736, DOI 10.1002/etc.2122; Fair PA, 2011, GEN COMP ENDOCR, V174, P184, DOI 10.1016/j.ygcen.2011.08.021; Fair Patricia A., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P335, DOI 10.1023/A:1009968113079; Fair PA, 2010, SCI TOTAL ENVIRON, V408, P1577, DOI 10.1016/j.scitotenv.2009.12.021; Flies AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137679; Goldstein JD, 2006, J WILDLIFE DIS, V42, P447, DOI 10.7589/0090-3558-42.2.447; Hall AJ, 2006, ENVIRON HEALTH PERSP, V114, P704, DOI 10.1289/ehp.8222; HOHN AA, 1989, MAR MAMMAL SCI, V5, P315, DOI 10.1111/j.1748-7692.1989.tb00346.x; Houde M, 2005, ENVIRON SCI TECHNOL, V39, P6591, DOI 10.1021/es0506556; Houser DS, 2011, J ZOO WILDLIFE MED, V42, P565, DOI 10.1638/2010-0121.1; Kane KL, 1996, CLIN DIAGN LAB IMMUN, V3, P295, DOI 10.1128/CDLI.3.3.295-300.1996; LAHVIS GP, 1995, ENVIRON HEALTH PERSP, V103, P67, DOI 10.2307/3432414; Larsen PR, 1992, THE THYROID GLAND; Lee C-S, 2010, IMMUNOLOGIC MARKERS; Long E, 1998, 12 NOAA NOS ORCA; McDonald TA, 2002, CHEMOSPHERE, V46, P745, DOI 10.1016/S0045-6535(01)00239-9; Myers MJ, 2006, COMP BIOCHEM PHYS A, V145, P90, DOI 10.1016/j.cbpa.2006.05.004; Ortiz RM, 2000, COMP BIOCHEM PHYS A, V125, P317, DOI 10.1016/S1095-6433(00)00158-6; Ortiz RM, 2010, MAR MAMMAL SCI, V26, P409, DOI 10.1111/j.1748-7692.2009.00309.x; Reddy M, 1989, MAR POLL B, V36, P892; Rehtanz M, 2006, J GEN VIROL, V87, P3559, DOI 10.1099/vir.0.82388-0; Rehtanz M, 2012, VET MICROBIOL, V160, P297, DOI 10.1016/j.vetmic.2012.05.042; Reif J. S., 2008, J CLIN MICRO INFEC I, V47, P125, DOI DOI 10.1080/13693780802178493 .; Reif JS, 2008, JAVMA-J AM VET MED A, V233, P299, DOI 10.2460/javma.233.2.299; Romano TA, 2004, CAN J FISH AQUAT SCI, V61, P1124, DOI [10.1139/f04-055, 10.1139/F04-055]; ROMANO TA, 1994, J MORPHOL, V221, P243, DOI 10.1002/jmor.1052210302; Schwacke LH, 2012, P ROY SOC B-BIOL SCI, V279, P48, DOI 10.1098/rspb.2011.0665; Sitt T, 2008, DEV COMP IMMUNOL, V32, P1253, DOI 10.1016/j.dci.2008.05.001; Sitt T, 2010, VET IMMUNOL IMMUNOP, V137, P181, DOI 10.1016/j.vetimm.2010.05.003; SMITH NP, 1993, ESTUARIES, V16, P739, DOI 10.2307/1352432; Soloff AC, 2017, APPL TOXICO IN PRESS; Spoon TR, 2012, BRAIN BEHAV IMMUN, V26, P122, DOI 10.1016/j.bbi.2011.08.003; St Aubin D, 1990, ADV RES BELUGA WHALE, P149; StAubin DJ, 1996, MAR MAMMAL SCI, V12, P1, DOI 10.1111/j.1748-7692.1996.tb00301.x; Stavros HCW, 2008, MAR POLLUT BULL, V56, P371, DOI 10.1016/j.marpolbul.2007.10.030; Stavros HCW, 2007, SCI TOTAL ENVIRON, V388, P300, DOI 10.1016/j.scitotenv.2007.07.030; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Taub DD, 2008, CELL IMMUNOL, V252, P1, DOI 10.1016/j.cellimm.2008.05.006; White ND, 2015, SCI TOTAL ENVIRON, V521, P79, DOI 10.1016/j.scitotenv.2015.03.078; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446; [No title captured], DOI DOI 10.1111/J.1748-7692.TB00301.X.	67	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176202	10.1371/journal.pone.0176202	http://dx.doi.org/10.1371/journal.pone.0176202			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467830	gold, Green Published, Green Submitted			2022-12-27	WOS:000400647000044
J	Luo, L; Kim, SW; Lee, HK; Kim, ID; Lee, H; Lee, JK				Luo, Lidan; Kim, Seung-Woo; Lee, Hye-Kyung; Kim, Il-Doo; Lee, Hahnbie; Lee, Ja-Kyeong			Anti-oxidative effects of 4-hydroxybenzyl alcohol in astrocytes confer protective effects in autocrine and paracrine manners	PLOS ONE			English	Article							HEME OXYGENASE-1; GENE-EXPRESSION; REGULATORY MECHANISMS; NRF2; NEURONS; OVEREXPRESSION; STABILIZATION; HIF-1-ALPHA; ACTIVATION; TARGET	4-Hydroxybenzyl alcohol (4-HBA) is an important phenolic constituent of Gastrodia elata Blume (GEB), a traditional herbal medicine used in East Asia. Many activities have been reported to underlie the beneficial effects of 4-HBA in the brain, and in particular, its anti-inflammatory, anti-oxidative, and anti-zinc-toxic effects have been implicated in the postischemic brain. Here, the authors investigated the anti-oxidative effect of 4-HBA on astrocytes and sought to identify the underlying molecular mechanisms involved. 4-HBA dose-dependently suppressed H2O2-induced astrocyte cell death. More specifically, pre-incubation of C6 cells (an astrocyte cell line) with 100 mu M 4-HBA for 6 hrs increased survival when cells were treated with H2O2 (100 mu M, 1 hr) from 54.2 +/- 0.7% to 85.9 +/- 1.5%. In addition, 4-HBA was found to up-regulate and activate Nrf2, and subsequently, to induce the expressions of several anti-oxidative genes, such as, HO-1, NQO1, and GCLM. Notably, HO-1 was induced by 3.4-fold in 4-HBA-treated C6 cells, and siRNA-mediated HO-1 knockdown demonstrated that Nrf2 activation and HO-1 induction were responsible for the observed cytoprotective effect of 4-HBA. ERK and Akt signaling pathways were activated by 4-HBA in C6 cells, suggesting their involvements in protective effect of 4-HBA. In addition, 4-HBA-conditioned astrocyte culture medium was found to have neuroprotective effects on primary neuronal cultures or fresh C6 cells exposed to oxidative stress, and these effects seemed to be mediated by glial cell line-derived neurotrophic factor (GDNF) and vascular endothelial growth factor (VEGF), which both accumulated in 4-HBA-treated astrocyte culture media. Thus, the 4-HBA-mediated activation of Nrf2 and induction of HO-1 in astrocytes were found to act via autocrine and paracrine mechanisms to confer protective effects. Furthermore, given the pleiotropic effects of 4-HBA with respect to its targeting of various brain cell types and functions, it would appear that 4-HBA has therapeutic potential for the prevention and amelioration of various brain diseases.	[Luo, Lidan; Lee, Hye-Kyung; Kim, Il-Doo; Lee, Hahnbie; Lee, Ja-Kyeong] Inha Univ, Dept Anat, Sch Med, Inchon, South Korea; [Luo, Lidan; Kim, Seung-Woo; Lee, Hye-Kyung; Kim, Il-Doo; Lee, Hahnbie; Lee, Ja-Kyeong] Inha Univ, Sch Med, Med Res Ctr, Inchon, South Korea; [Kim, Seung-Woo] Inha Univ, Sch Med, Dept Biomed Sci, Inchon, South Korea	Inha University; Inha University; Inha University	Lee, JK (corresponding author), Inha Univ, Dept Anat, Sch Med, Inchon, South Korea.; Lee, JK (corresponding author), Inha Univ, Sch Med, Med Res Ctr, Inchon, South Korea.	jklee@inha.ac.kr	ja-kyeong, lee/GZL-0409-2022		Mid-career Research Grant from the Korean National Research Foundation [2015R1A2A2A01003395]; Medical Research Center Grant from the Korean National Research Foundation [2014R1A5A2009392]	Mid-career Research Grant from the Korean National Research Foundation; Medical Research Center Grant from the Korean National Research Foundation(National Research Foundation of Korea)	This work was supported by a Mid-career Research Grant (#2015R1A2A2A01003395) from the Korean National Research Foundation (to J.-K.L.) and by a Medical Research Center Grant (#2014R1A5A2009392) from the Korean National Research Foundation (to J.-K.L.).	[Anonymous], ACTA BOT YUNNAN; Chio IIC, 2016, CELL, V166, P963, DOI 10.1016/j.cell.2016.06.056; Cho BR, 2015, BIOMATERIALS, V53, P679, DOI 10.1016/j.biomaterials.2015.02.107; Choi YK, 2010, J BIOL CHEM, V285, P32116, DOI 10.1074/jbc.M110.131284; Cuadrado A, 2008, CURR PHARM DESIGN, V14, P429, DOI 10.2174/138161208783597407; Descamps E, 2009, NEUROSCI RES, V64, P137, DOI 10.1016/j.neures.2009.02.005; Dhiman SB, 2009, CHEM-BIOL INTERACT, V182, P119, DOI 10.1016/j.cbi.2009.07.025; Hung SY, 2008, MOL PHARMACOL, V74, P1564, DOI 10.1124/mol.108.048611; Hus HY, 1986, ORIENTAL MAT MED CON, P662; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Jeyapaul J, 2000, BIOCHEM PHARMACOL, V59, P1433, DOI 10.1016/S0006-2952(00)00256-2; Kam KY, 2011, MOL CELLS, V31, P209, DOI 10.1007/s10059-011-0028-4; Kim HJ, 2007, BRAIN RES, V1181, P130, DOI 10.1016/j.brainres.2007.08.066; Kim SW, 2011, MOL PHARMACOL, V79, P220, DOI 10.1124/mol.110.067520; Kim SW, 2013, IEEE ICCE, P65, DOI 10.1109/ICCE.2013.6486797; Lakkisto P, 2010, EUR J PHARMACOL, V635, P156, DOI 10.1016/j.ejphar.2010.02.050; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Lee H, 2016, ANIM CELLS SYST, V20, P246, DOI 10.1080/19768354.2016.1223169; Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10393, DOI 10.1073/pnas.93.19.10393; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li WG, 2006, J BIOL CHEM, V281, P27251, DOI 10.1074/jbc.M602746200; Lim EJ, 2007, J PHARM PHARMACOL, V59, P1235, DOI 10.1211/jpp.59.9.0007; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120; Sandhu JK, 2009, NEUROBIOL DIS, V33, P405, DOI 10.1016/j.nbd.2008.11.016; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Shin JH, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/919650; Wan YQ, 2007, J NEUROSCI RES, V85, P73, DOI 10.1002/jnr.21091; Wang H., 2012, WAP C SERIES ED SOCI, V2012, P1, DOI DOI 10.1093/IJICT/CTS043; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Wu KW, 2015, NEUROSCIENCE, V298, P94, DOI 10.1016/j.neuroscience.2015.04.015; Yang CH, 2009, BRAIN RES, V1282, P133, DOI 10.1016/j.brainres.2009.05.009; Yu SS, 2011, NEUROCHEM RES, V36, P339, DOI 10.1007/s11064-010-0335-8; Yu SS, 2010, BRAIN RES, V1308, P167, DOI 10.1016/j.brainres.2009.10.037; Yu SS, 2013, NEUROCHEM RES, V38, P1501, DOI 10.1007/s11064-013-1052-x; Yu SJ, 2005, BIOL PHARM BULL, V28, P1016, DOI 10.1248/bpb.28.1016; Yue P, 2017, NEUROCHEM RES; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	42	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177322	10.1371/journal.pone.0177322	http://dx.doi.org/10.1371/journal.pone.0177322			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489907	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314100061
J	Eppinga, H; Thio, HB; Schreurs, MWJ; Blakaj, B; Tahitu, RI; Konstantinov, SR; Peppelenbosch, MP; Fuhler, GM				Eppinga, Hester; Thio, H. Bing; Schreurs, Marco W. J.; Blakaj, Blerdi; Tahitu, Ruena I.; Konstantinov, Sergey R.; Peppelenbosch, Maikel P.; Fuhler, Gwenny M.			Depletion of Saccharomyces cerevisiae in psoriasis patients, restored by Dimethylfumarate therapy (DMF)	PLOS ONE			English	Article							CONTACT-DERMATITIS; DISEASE; PATHWAYS; SURGERY; RISK	Background Psoriasis and inflammatory bowel disease (IBD) are chronic inflammatory diseases sharing similar pathogenic pathways. Intestinal microbial changes such as a decrease of bakers' yeast Saccharomyces cerevisiae have been reported in IBD, suggesting the presence of a gut-skin axis. Objective To investigate whether the S. cerevisiae abundance was altered in psoriasis patients versus healthy controls, and whether dimethylfumarate (DMF) interacted with this yeast. Methods Using qPCR, faecal samples were compared between psoriasis patients without DMF (n = 30), psoriasis patients with DMF (n = 28), and healthy controls (n = 32). Results Faecal S. cerevisiae abundance was decreased in psoriasis compared to healthy controls (p<0.001). Interestingly, DMF use raised S. cerevisiae levels (p<0.001). Gastrointestinal adverse-effects of DMF were correlated with a higher S. cerevisiae abundance (p = 0.010). In vitro, a direct effect of DMF on S. cerevisiae growth was observed. In addition, anti-Saccharomyces cerevisiae antibodies were not elevated in psoriasis. Conclusion The abundance of baker's yeast S. cerevisiae is decreased in psoriasis patients, but appears to be restored upon DMF use. S. cerevisiae is generally classified as a yeast with beneficial immunomodulatory properties, but may also be involved in the occurrence of DMF's gastrointestinal adverse-effects. Potentially, DMF might be a new therapy for IBD.	[Eppinga, Hester; Thio, H. Bing; Tahitu, Ruena I.] Erasmus MC Univ Med Ctr, Dept Dermatol, Rotterdam, Netherlands; [Eppinga, Hester; Blakaj, Blerdi; Konstantinov, Sergey R.; Peppelenbosch, Maikel P.; Fuhler, Gwenny M.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Schreurs, Marco W. J.] Erasmus MC Univ Med Ctr, Dept Immunol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Fuhler, GM (corresponding author), Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	g.fuhler@erasmusmc.nl	Fuhler, Gwenny/AAC-7122-2019; Peppelenbosch, Maikel P./U-5304-2019	Fuhler, Gwenny/0000-0001-9221-4855; Peppelenbosch, Maikel/0000-0001-9112-6028				Aterido A, 2016, J INVEST DERMATOL, V136, P593, DOI 10.1016/j.jid.2015.11.026; Atwan A, 2016, BR J DERMATOL; Casili G, 2016, J CROHNS COLITIS, V10, P472, DOI 10.1093/ecco-jcc/jjv231; D'Erme AM, 2012, INT J DERMATOL, V51, P42, DOI 10.1111/j.1365-4632.2011.04916.x; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Ellinghaus D, 2012, AM J HUM GENET, V90, P636, DOI 10.1016/j.ajhg.2012.02.020; Eppinga H, 2016, J CROHNS COLITIS; Forcione DG, 2004, GUT, V53, P1117, DOI 10.1136/gut.2003.030734; Gaspar LR, 2008, FOOD CHEM TOXICOL, V46, P3493, DOI 10.1016/j.fct.2008.08.028; Gimenez-Arnau A, 2009, CONTACT DERMATITIS, V61, P249, DOI 10.1111/j.1600-0536.2009.01628.x; Jawhara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040648; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Maillet J, 2016, ANTISACCHAROMYCES CE; Mrowietz U, 2005, TRENDS MOL MED, V11, P43, DOI 10.1016/j.molmed.2004.11.003; Palma ML, 2015, APPL MICROBIOL BIOT, V99, P6563, DOI 10.1007/s00253-015-6776-x; Perez-Torrado R, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01522; Skroza N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/983902; Sokol H, 2016, FUNGAL MIROBIOTA DYS; Takada Y, 2014, FEMS YEAST RES, V14, P261, DOI 10.1111/1567-1364.12098; Xu Z, 2015, COCHRANE DB SYST REV, V4; Zhang ZX, 2012, DIGEST DIS SCI, V57, P2944, DOI 10.1007/s10620-012-2244-y	23	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176955	10.1371/journal.pone.0176955	http://dx.doi.org/10.1371/journal.pone.0176955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486503	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000030
J	Horvath, D; Tamas, I; Sipos, A; Darula, Z; Becsi, B; Nagy, D; Ivan, J; Erdodi, F; Lontay, B				Horvath, Daniel; Tamas, Istvan; Sipos, Adrienn; Darula, Zsuzsanna; Becsi, Balint; Nagy, Denes; Ivan, Judit; Erdodi, Ferenc; Lontay, Beata			Myosin phosphatase and RhoA-activated kinase modulate neurotransmitter release by regulating SNAP-25 of SNARE complex	PLOS ONE			English	Article							SYNAPTOSOME-ASSOCIATED PROTEIN; DEPENDENT PHOSPHORYLATION; DIFFERENTIAL PHOSPHORYLATION; MEDIATED REGULATION; LEUKEMIC-CELLS; RAT-BRAIN; VESICLE; EXOCYTOSIS; SYNTAXIN; LOCALIZATION	Reversible phosphorylation of neuronal proteins plays an important role in the regulation of neurotransmitter release. Myosin phosphatase holoenzyme (MP) consists of a protein phosphatase-1 (PP1) catalytic subunit (PP1c) and a regulatory subunit, termed myosin phosphatase targeting subunit (MYPT1). The primary function of MP is to regulate the phosphorylation level of contractile proteins; however, recent studies have shown that MP is localized to neurons, and is also involved in the mediation of neuronal processes. Our goal was to investigate the effect of RhoA-activated kinase (ROK) and MP on the phosphorylation of one potential neuronal substrate, the synaptosomal-associated protein of 25 kDa (SNAP-25). SNAP-25 is a member of the SNARE (soluble N-ethylmaleimide sensitive factor attachment protein receptor) complex, along with synaptobrevin and syntaxin, and the primary role of SNAP25 is to mediate vesicle fusion. We showed that MYPT1 interacts with SNAP-25, as revealed by immunoprecipitation and surface plasmon resonance based binding studies. Mass spectrometry analysis and in vitro phosphorylation/dephosphorylation assays demonstrated that ROK phosphorylates, while MP dephosphorylates, SNAP-25 at Thr138. Silencing MYPT1 in B50 neuroblastoma cells increased phosphorylation of SNAP25 at Thr138. Inhibition of PP1 with tautomycetin increased, whereas inhibition of ROK by H1152, decreased the phosphorylation of SNAP-25 at Thr138 in B50 cells, in cortical synaptosomes, and in brain slices. In response to the transduction of the MP inhibitor, kinaseenhanced PP1 inhibitor (KEPI), into synaptosomes, an increase in phosphorylation of SNAP-25 and a decrease in the extent of neurotransmitter release were detected. The interaction between SNAP-25 and syntaxin increased with decreasing phosphorylation of SNAP-25 at Thr138, upon inhibition of ROK. Our data suggest that ROK/MP play a crucial role in vesicle trafficking, fusion, and neurotransmitter release by oppositely regulating the phosphorylation of SNAP-25 at Thr138.	[Horvath, Daniel; Tamas, Istvan; Sipos, Adrienn; Becsi, Balint; Nagy, Denes; Ivan, Judit; Erdodi, Ferenc; Lontay, Beata] Univ Debrecen, Dept Med Chem, Fac Med, Debrecen, Hungary; [Darula, Zsuzsanna] Hungarian Acad Sci, Prote Res Grp, Biol Res Ctr, Szeged, Hungary; [Becsi, Balint; Ivan, Judit; Erdodi, Ferenc] Univ Debrecen, MTA DE Cell Biol & Signaling Res Grp, Fac Med, Debrecen, Hungary	University of Debrecen; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Debrecen	Lontay, B (corresponding author), Univ Debrecen, Dept Med Chem, Fac Med, Debrecen, Hungary.	lontay@med.unideb.hu						Baker PR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008078; Baldwin ML, 2003, J NEUROCHEM, V85, P1190, DOI 10.1046/j.1471-4159.2003.01779.x; BIEMANN K, 1990, METHOD ENZYMOL, V193, P886, DOI 10.1016/0076-6879(90)93460-3; Chen YA, 2001, NEURON, V30, P161, DOI 10.1016/S0896-6273(01)00270-7; Cousin MA, 2000, J NEUROCHEM, V75, P1645, DOI 10.1046/j.1471-4159.2000.0751645.x; Cousin MA, 1999, J NEUROCHEM, V73, P2227, DOI 10.1046/j.1471-4159.1999.0732227.x; Dedinszki D, 2015, CELL SIGNAL, V27, P363, DOI 10.1016/j.cellsig.2014.11.021; Dedinszki D, 2015, BBA-MOL BASIS DIS, V1852, P22, DOI 10.1016/j.bbadis.2014.11.005; Erdodi F, 2003, BIOCHEM BIOPH RES CO, V306, P382, DOI 10.1016/S0006-291X(03)00976-8; Eto M, 2013, BIOCHEM BIOPH RES CO, V434, P137, DOI 10.1016/j.bbrc.2013.03.055; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Fu J, 2005, J BIOL CHEM, V280, P3178, DOI 10.1074/jbc.M410044200; Gao J, 2016, CELL SIGNAL, V28, P425, DOI 10.1016/j.cellsig.2015.12.014; Gao J, 2012, J BIOL CHEM, V287, P10565, DOI 10.1074/jbc.M111.294645; Genoud S, 1999, J NEUROCHEM, V72, P1699, DOI 10.1046/j.1471-4159.1999.721699.x; Gerst JE, 2003, BBA-MOL CELL RES, V1641, P99, DOI 10.1016/S0167-4889(03)00096-X; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Guan SH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010728; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hepp R, 2002, FEBS LETT, V532, P52, DOI 10.1016/S0014-5793(02)03629-3; Kiss A, 2008, CELL SIGNAL, V20, P2059, DOI 10.1016/j.cellsig.2008.07.018; Klenchin VA, 2000, BIOCHIMIE, V82, P399, DOI 10.1016/S0300-9084(00)00208-X; Koszeghy A, 2012, PFLUG ARCH EUR J PHY, V463, P829, DOI 10.1007/s00424-012-1103-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003; Lontay B, 2004, J COMP NEUROL, V478, P72, DOI 10.1002/cne.20273; Lontay B, 2012, J NEUROCHEM, V123, P84, DOI 10.1111/j.1471-4159.2012.07882.x; Mansuy IM, 2006, TRENDS NEUROSCI, V29, P679, DOI 10.1016/j.tins.2006.10.004; Mathe C, 2009, AQUAT TOXICOL, V92, P122, DOI 10.1016/j.aquatox.2009.02.005; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Nagy G, 2004, NEURON, V41, P417, DOI 10.1016/S0896-6273(04)00038-8; Nakata Y, 2012, J NEUROSCI, V32, P17186, DOI 10.1523/JNEUROSCI.2220-12.2012; NICHOLS RA, 1989, J NEUROCHEM, V52, P521, DOI 10.1111/j.1471-4159.1989.tb09151.x; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Richards DA, 2003, NEURON, V39, P529, DOI 10.1016/S0896-6273(03)00405-7; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Shu YL, 2008, J NEUROSCI, V28, P21, DOI 10.1523/JNEUROSCI.2352-07.2008; Sim ATR, 2003, BIOCHEM J, V373, P641, DOI 10.1042/BJ20030484; Snyder DA, 2006, CELL BIOCHEM BIOPHYS, V45, P111, DOI 10.1385/CBB:45:1:111; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tian JH, 2003, J BIOL CHEM, V278, P26265, DOI 10.1074/jbc.M300492200; Tolar LA, 1998, J NEUROSCI, V18, P10250; Turner KM, 1999, TRENDS NEUROSCI, V22, P459, DOI 10.1016/S0166-2236(99)01436-8; Yang Y, 2007, J GEN PHYSIOL, V129, P233, DOI 10.1085/jgp.200609685	51	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177046	10.1371/journal.pone.0177046	http://dx.doi.org/10.1371/journal.pone.0177046			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486561	gold, Green Published			2022-12-27	WOS:000401314000038
J	Some, EN; Engebretsen, IMS; Nagot, N; Meda, NY; Vallo, R; Kankasa, C; Tumwine, JK; Singata, M; Hofmeyr, JG; Van de Perre, P; Tylleskar, T				Some, Eric Nagaonle; Engebretsen, Ingunn M. S.; Nagot, Nicolas; Meda, Nicolas Y.; Vallo, Roselyne; Kankasa, Chipepo; Tumwine, James K.; Singata, Mandisa; Hofmeyr, Justus G.; Van de Perre, Philippe; Tylleskar, Thorkild		ANRs 12174 Trial Grp	Changes in body mass index and hemoglobin concentration in breastfeeding women living with HIV with a CD4 count over 350: Results from 4 African countries (The ANRS 12174 trial)	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; DISEASE PROGRESSION; RANDOMIZED-TRIAL; INFECTED MOTHERS; PREGNANT-WOMEN; WEIGHT CHANGES; MORTALITY; POSTPARTUM; MODALITY; PROPHYLAXIS	Introduction Breastfeeding is recommended for infants born to HIV-infected women in low-income settings. Both breastfeeding and HIV-infection are energy demanding. Our objective was to explore how exclusive and predominant breastfeeding changes body mass index (BMI) among breastfeeding HIV1-positive women participating in the ANRS12174 trial (clinical trial no NCT0064026). Methods HIV-positive women (n = 1 267) with CD4 count >350, intending to breastfeed HIV-negative infants were enrolled from Burkina Faso, South Africa, Uganda and Zambia and counselled on breastfeeding. N = 1 216 were included in the analysis. The trial compared Lamivudine and Lopinavir/Ritonavir as a peri-exposure prophylaxis. We ran a linear mixed-effect model with BMI as the dependent variable and exclusive or predominant breastfeeding duration as the key explanatory variable. Results Any breastfeeding or exclusive/predominant) breastfeeding was initiated by 99.6% and 98.6% of the mothers respectively in the first week after birth. The median (interquartile range: IQR) duration of the group that did any breastfeeding or the group that did exclusive /predominant breastfeeding were 9.5 (7.5; 10.6) and 5.8 (5.6; 5.9)) months, respectively. The median (IQR) age, BMI, CD4 count, and HIV viral load at baseline (day 7) were 27 (23.3; 31) years, 23.7 (21.3; 27.0) kg/m(2), 530 (432.5; 668.5) cells/mu l and 0.1 (0.8; 13.7) 1000 copies/mL, respectively. No major change in mean BMI was seen in this cohort over a 50-week period during lactation. The mean change between 26 and 50 weeks after birth was 0.7 kg/m(2). Baseline mean BMI (measured on day 7 postpartum) and CD4 count were positively associated with maternal BMI change, with a mean increase of 1.0 kg/m(2) (0.9; 1.0) per each additional baseline-BMI kilogram and 0.3 kg/m(2) (0.2; 0.5) for each additional CD4 cell/mu l, respectively. Conclusion Breastfeeding was not negatively correlated with the BMI of HIV-1 infected Sub-Saharan African mothers. However, a higher baseline BMI and a CD4 count >500 cells/mu l were associated with maternal BMI during the exclusive/predominant breastfeeding period. Considering the benefits of breast milk for the infants and the recurrent results from different studies that breastfeeding is not harmful to the HIV-1-infected mothers, this study also supports the WHO 2016 guidelines on infant feeding that mothers living with HIV should breastfeed where formula is not safe for at least 12 months and up to 24 months, given that the right treatment or prophylaxis for the infection is administered. These findings and conclusions cannot be extrapolated to women who are immune-compromised or have AIDS.	[Some, Eric Nagaonle; Engebretsen, Ingunn M. S.; Tylleskar, Thorkild] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Some, Eric Nagaonle] Natl Hlth Res Inst, Ctr Natl Rech Sci & Technol, Ouagadougou, Burkina Faso; [Nagot, Nicolas; Vallo, Roselyne; Van de Perre, Philippe] INSERM, UMR 1058, Pathogenesis & Control Chron Infect, Montpellier, France; [Nagot, Nicolas; Vallo, Roselyne; Van de Perre, Philippe] Univ Montpellier, Montpellier, France; [Nagot, Nicolas; Van de Perre, Philippe] Ctr Hosp Univ, Montpellier, France; [Meda, Nicolas Y.] Univ Ouagadougou, Fac Hlth Sci, CRIS, Ouagadougou, Burkina Faso; [Kankasa, Chipepo] Univ Zambia, Univ Teaching Hosp, Sch Med, Dept Paediat & Child Hlth, Lusaka, Zambia; [Tumwine, James K.] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Paediat & Child Hlth, Kampala, Uganda; [Singata, Mandisa; Hofmeyr, Justus G.] Univ Ft Hare, Effect Care Res Unit, Eastern Cape, South Africa	University of Bergen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Zambia; Makerere University; University of Fort Hare	Some, EN (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.; Some, EN (corresponding author), Natl Hlth Res Inst, Ctr Natl Rech Sci & Technol, Ouagadougou, Burkina Faso.	eric.nsome@gmail.com	Engebretsen, Ingunn Marie S/N-5692-2017; Tylleskär, Thorkild/S-5529-2017; Van de Perre, Philippe/B-9692-2008	Engebretsen, Ingunn Marie S/0000-0001-5852-3611; Tylleskär, Thorkild/0000-0003-4801-4324; Van de Perre, Philippe/0000-0002-3912-0427; Vallo, Roselyne/0000-0002-2447-6754; Nagot, Nicolas/0000-0002-3493-2821; Jackson, Debra/0000-0003-3307-632X	French National Institute of Health and Medical Research-National Agency for Research on AIDS and Viral Hepatitis (lnserm ANRS) [ANRS 12174]; European Developing Countries Clinical Trials Partnership (EDCTP) [CT.2006.33020.004]; Research Council of Norway (GlobVac) [183600]; Total Foundation; Norwegian Quota Scheme	French National Institute of Health and Medical Research-National Agency for Research on AIDS and Viral Hepatitis (lnserm ANRS); European Developing Countries Clinical Trials Partnership (EDCTP); Research Council of Norway (GlobVac)(Research Council of Norway); Total Foundation(Total SA); Norwegian Quota Scheme	This study used data collected in the context of the ANRS 12174 clinical trial funded by the French National Institute of Health and Medical Research-National Agency for Research on AIDS and Viral Hepatitis (lnserm ANRS), the European Developing Countries Clinical Trials Partnership (EDCTP; grant number CT.2006.33020.004), the Research Council of Norway (GlobVac grant number 183600) and the Total Foundation. NES benefited from a PhD grant from the Norwegian Quota Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WORLD MAL REP, P10; [Anonymous], 2016, CONS GUID HIV PREV D; ANRS, 2008, ANRS SCAL GRAD SEV A; Calvert C, 2013, AIDS, V27, P1631, DOI 10.1097/QAD.0b013e32835fd940; Cames C, 2014, AIDS, V28, P85, DOI 10.1097/01.aids.0000433243.24481.c3; Chetty T, 2014, TROP MED INT HEALTH, V19, P852, DOI 10.1111/tmi.12320; Cournil A, 2013, AIDS, V27, P1621, DOI 10.1097/QAD.0b013e32835d5226; Dewey K, 2001, J NUTR, V131, P6; Dioulasso B, 2011, CONTEMP CLIN TRIALS, V32, P74, DOI 10.1016/j.cct.2010.09.008; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gorman SE, 2013, INT J WOMENS HEALTH, V5, P271, DOI 10.2147/IJWH.S46872; Hartmann P, 1998, J NUTR, V128, P6; Kayira D, 2012, AM J CLIN NUTR, V95, P759, DOI 10.3945/ajcn.111.018812; Kieffer M, 2014, J ACQ IMMUN DEF SYND, V67, P7; Kosmiski L, 2011, AM J CLIN NUTR, V94, p1677S, DOI 10.3945/ajcn.111.012625; Kuhn L, 2005, AIDS, V19, P1677, DOI 10.1097/01.aids.0000186817.38112.da; Kuhn L, 2004, PAEDIATR PERINAT EP, V18, P10, DOI 10.1111/j.1365-3016.2003.00528.x; Kuhn L, 2007, J INFECT DIS, V195, P1728, DOI 10.1086/517530; Laar Amos K, 2013, BMC Res Notes, V6, P350, DOI 10.1186/1756-0500-6-350; Ladner J, 1998, INT J EPIDEMIOL, V27, P1072, DOI 10.1093/ije/27.6.1072; Ministry of Health, 2006, FOOD NUTR GUID HLTH, P212; Moran NF, 2012, INT J GYNECOL OBSTET, V119, pS26, DOI 10.1016/j.ijgo.2012.03.011; Murnane PM, 2010, INT J EPIDEMIOL, V39, P1299, DOI 10.1093/ije/dyq065; Nagot N, 2015, LANCET, V14, P8; Nagot N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-246; Nduati R, 2001, LANCET, V357, P1651, DOI 10.1016/S0140-6736(00)04820-0; Odhiambo C, 2016, TROP MED INT HEALTH, V21, P373, DOI 10.1111/tmi.12662; Organization PAH, 1989, EPIDEMIOLOGICAL B, V10, P4; Orish VN, 2013, INT J GYNECOL OBSTET, V120, P236, DOI 10.1016/j.ijgo.2012.09.021; Otieno PA, 2007, J INFECT DIS, V195, P220, DOI 10.1086/510245; Papathakis P, 2006, J ACQ IMMUN DEF SYND, V43, P8; Parkes-Ratanshi Rosalind, 2015, J Int Assoc Provid AIDS Care, V14, P455, DOI 10.1177/2325957414557264; Ross A, 2004, AIDS, V18, P799, DOI 10.1097/00002030-200403260-00012; Sedgh G, 2004, AIDS, V18, P1043, DOI 10.1097/00002030-200404300-00013; Stuebe AM, 2009, AM J PERINAT, V26, P81, DOI 10.1055/s-0028-1103034; van den Akker T, 2011, OBSTET GYNECOL, V118, P266, DOI 10.1097/AOG.0b013e3182254d03; Van der Paal L, 2007, TROP MED INT HEALTH, V12, P9; WHO, 1994, WKLY EPIDEM REC, V69, P3; WHO, 1985, WORKSH AIDS CENTR AF, V85, P16; WHO, 1986, WKLY EPIDEM REC, V61, P5; WHO UNICEF UNFPA Bank aTW, 2010, TRENDS MAT MORT 1990, P52; Winkvist A, 2003, EUR J CLIN NUTR, V57, P114, DOI 10.1038/sj.ejcn.1601502; World Health Organization, 2007, WHO CAS DEF HIV SURV, V2007, P52; World Health Organization, 1995, WHO TECHN REP SER, V854, P452; World Health Organization, 2016, GUID UPD HIV INF FEE; Ziske J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055633	46	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177259	10.1371/journal.pone.0177259	http://dx.doi.org/10.1371/journal.pone.0177259			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486519	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000401314000064
J	Wong, CKM; Kung, K; Au-Doung, PLW; Ip, M; Lee, N; Fung, A; Wong, SYS				Wong, Carmen Ka Man; Kung, Kenny; Au-Doung, Philip Lung Wai; Ip, Margaret; Lee, Nelson; Fung, Alice; Wong, Samuel Yeung Shan			Antibiotic resistance rates and physician antibiotic prescription patterns of uncomplicated urinary tract infections in southern Chinese primary care	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; EPIDEMIOLOGY; WOMEN	Uncomplicated urinary tract infections (UTI) are common in primary care. Whilst primary care physicians are called to be antimicrobial stewards, there is limited primary care antibiotic resistance surveillance and physician antibiotic prescription data available in southern Chinese primary care. The study aimed to investigate the antibiotic resistance rate and antibiotic prescription patterns in female patients with uncomplicated UTI. Factors associated with antibiotic resistance and prescription was explored. A prospective cohort study was conducted in 12 primary care group clinics in Hong Kong of patients presenting with symptoms of uncomplicated UTI from January 2012 to December 2013. Patients' characteristics such as age, comorbidity, presenting symptoms and prior antibiotic use were recorded by physicians, as well as any empirical antibiotic prescription given at presentation. Urine samples were collected to test for antibiotic resistance of uropathogens. Univariate analysis was conducted to identify factors associated with antibiotic resistance and prescription. A total of 298 patients were included in the study. E. coli was detected in 107 (76%) out of the 141 positive urine samples. Antibiotic resistance rates of E. coli isolates for ampicillin, co-trimoxazole, ciprofloxacin, amoxicillin and nitrofurantoin were 59.8%, 31.8%, 23.4%, 1.9% and 0.9% respectively. E. coli isolates were sensitive to nitrofurantoin (98.1%) followed by amoxicillin (78.5%). The overall physician antibiotic prescription rate was 82.2%. Amoxicillin (39.6%) and nitrofurantoin (28.6%) were the most common prescribed antibiotics. Meanwhile, whilst physicians in public primary care prescribed more amoxicillin (OR: 2.84, 95% CI: 1.67 to 4.85, P<0.001) and nitrofurantoin (OR: 2.01, 95% CI: 1.14 to 3.55, P = 0.015), physicians in private clinics prescribed more cefuroxime and ciprofloxacin (P<0.05). Matching of antibiotic prescription and antibiotic sensitivity of E. coli isolates occurred in public than private primary care prescriptions (OR: 6.72, 95% CI: 2.07 to 21.80 P = 0.001) and for other uropathogens (OR: 6.19, 95% CI: 1.04 to 36.78 P = 0.034). Mismatching differences of antibiotic prescription and resistance were not evident. In conclusion, nitrofurantoin and amoxicillin should be used as first line antibiotic treatment for uncomplicated UTI. There were significant differences in antibiotic prescription patterns between public and private primary care. Public primary care practitioners were more likely to prescribe first line antibiotic treatment which match antibiotic sensitivity of E. coli isolates and other uropathogens. Further exploration of physician prescribing behaviour and educational interventions, particularly in private primary care may helpful. Meanwhile, development and dissemination of guidelines for primary care management of uncomplicated UTI as well as continued surveillance of antibiotic resistance and physician antibiotic prescription is recommended.	[Wong, Carmen Ka Man; Kung, Kenny; Au-Doung, Philip Lung Wai; Fung, Alice; Wong, Samuel Yeung Shan] Chinese Univ Hong Kong, Fac Med, JC Sch Publ Hlth & Primary Care, Div Family Med & Primary Hlth Care, Hong Kong, Hong Kong, Peoples R China; [Ip, Margaret] Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Lee, Nelson] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Wong, CKM (corresponding author), Chinese Univ Hong Kong, Fac Med, JC Sch Publ Hlth & Primary Care, Div Family Med & Primary Hlth Care, Hong Kong, Hong Kong, Peoples R China.	carmenwong@cuhk.edu.hk	Ip, Margaret/K-1096-2013; WONG, Samuel Yeung Shan/D-7311-2013; Lee, Nelson/B-6418-2008	Ip, Margaret/0000-0003-1291-6537; WONG, Samuel Yeung Shan/0000-0003-0934-6385; Lee, Nelson/0000-0002-0783-6607	Research Fund for the Control of Infectious Disease [CU-10-01-03]	Research Fund for the Control of Infectious Disease	The study was funded by Research Fund for the Control of Infectious Disease (Reference no: CU-10-01-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alos JI, 2005, CLIN MICROBIOL INFEC, V11, P199, DOI 10.1111/j.1469-0691.2004.01057.x; Butler CC, 2006, BRIT J GEN PRACT, V56, P686; Centre of Health Protection. Department of Health, RED BACT RES IMPACT; Centre of Health Protection Hong Kong, BACT PATH IS PERC AN; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Grude N, 2005, SCAND J PRIM HEALTH, V23, P115, DOI 10.1080/02813430510015287; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Ho PL, 2007, DIAGN MICR INFEC DIS, V59, P439, DOI 10.1016/j.diagmicrobio.2007.06.012; Ho PL, 2010, DIAGN MICR INFEC DIS, V66, P87, DOI 10.1016/j.diagmicrobio.2009.03.027; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V51, P69, DOI 10.1093/jac/dkg028; Karlowsky JA, 2002, ANTIMICROB AGENTS CH, V46, P2540, DOI 10.1128/AAC.46.8.2540-2545.2002; Li Y, 2005, HONG KONG J EMERG ME, V12, P77; Little P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5633; Manka W, 2000, DRUG SAFETY, V22, P83, DOI 10.2165/00002018-200022010-00007; Ong DSY, 2008, J ANTIMICROB CHEMOTH, V62, P587, DOI 10.1093/jac/dkn230; Oplinger M, 2013, ANN PHARMACOTHER, V47, P106, DOI 10.1345/aph.1R352; Public Health England, MAN COMM INF GUID PR; RAZ R, 1988, J ANTIMICROB CHEMOTH, V22, P945, DOI 10.1093/jac/22.6.945; Ronald A, 2003, DM-DIS MON, V49, P71, DOI 10.1067/mda.2003.8; Schito GC, 2009, INT J ANTIMICROB AG, V34, P407, DOI 10.1016/j.ijantimicag.2009.04.012; Sotto A, 2001, J CLIN MICROBIOL, V39, P438, DOI 10.1128/JCM.39.2.438-444.2001; Wei XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121269; Zhanel GG, 2005, INT J ANTIMICROB AG, V26, P380, DOI 10.1016/j.ijantimicag.2005.08.003	25	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177266	10.1371/journal.pone.0177266	http://dx.doi.org/10.1371/journal.pone.0177266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486532	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314000067
J	Kang, M; Cha, SY; Jang, HK				Kang, Min; Cha, Se-Yeoun; Jang, Hyung-Kwan			Tropism and infectivity of duck-derived egg drop syndrome virus in chickens	PLOS ONE			English	Article							DNA-REPLICATION; BINDING DOMAIN; EARLY REGION-4; ADENOVIRUS; PROTEIN; EXPRESSION; INHIBITION; ANTIBODIES; SEQUENCE; FIBER	Egg drop syndrome virus (EDSV) can markedly decrease egg production in laying hens. Duck is the natural host of EDSV. EDSV derived from ducks abrogate egg drop in laying hens. We have previously confirmed that duck-derived EDSVs have a variety of replication activities in chick embryo liver (CEL) cells. However, it is currently unclear whether duck-derived EDSV could display tropism and adaptation in laying hens. This study assessed whether duck-derived EDSV can adapt to laying hens, and estimated the inducing factors. Complete genome sequences of duck-derived EDSVs (D11-JW-012, D11-JW-017, and D11-JW-032 isolates) with various replication efficiency in CEL cells and C10-GY-001 isolate causing disease in laying hens were analyzed to find their differences. Phylogenetic analysis of complete genome sequence revealed that C10-GY-001, D11-JW-032, and strain 127 virus as vaccine were clustered into the same group, with D11-JW-012 and D11-JW-017 clustered in another group. Comparison between D11-JW-012 isolate that poorly replicated and D11-JW-017 isolate that replicated well in CEL cells in same cluster revealed six amino acid differences on IVa2, DNA polymerase, endopeptidase, and DNA-binding protein. These amino acids might be key candidates enhancing cellular tropism in chicken. When the pathogenicities of these isolates in laying hens were compared, D11-JW-032 showed severe signs similar to 127 virus, D11-JW-017 showed intermediate signs, while D11-JW-012 showed almost no sign. Eleven amino acids differed between D11-JW-032 and D11-JW-017, and 17 amino acids were different between D11-JW-032 and D11-JW-012. These results suggest that EDSVs derived from ducks have various pathogenicities in laying hens. Key amino acid candidates might have altered their affinity to tropism of laying hens, causing difference pathogenicities.	[Jang, Hyung-Kwan] Chonbuk Natl Univ, Dept Vet Infect Dis & Avian Dis, Coll Vet Med, Iksan, South Korea; Chonbuk Natl Univ, Ctr Poultry Dis Control, Iksan, South Korea	Jeonbuk National University; Jeonbuk National University	Jang, HK (corresponding author), Chonbuk Natl Univ, Dept Vet Infect Dis & Avian Dis, Coll Vet Med, Iksan, South Korea.	hkjang@jbnu.ac.kr			Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries [314023-3, 316039-3, 314004-3, 716002-7]; Research of Animal and Plant Quarantine Agency, South Korea	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries; Research of Animal and Plant Quarantine Agency, South Korea	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (314023-3, 316039-3, 314004-3, 716002-7) and Research of Animal and Plant Quarantine Agency, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair B, 2008, GROUP 1 ADENOVIRUS I, V12, P251; BARTHA A, 1985, ACTA VET HUNG, V33, P125; BRUGH M, 1984, AVIAN DIS, V28, P168, DOI 10.2307/1590139; CALNEK BW, 1978, AVIAN DIS, V22, P798, DOI 10.2307/1589660; Cha SY, 2013, POULTRY SCI, V92, P1783, DOI 10.3382/ps.2013-03067; Christensen JB, 2012, VIROLOGY, V433, P124, DOI 10.1016/j.virol.2012.07.013; Cuesta R, 2004, J VIROL, V78, P7707, DOI 10.1128/JVI.78.14.7707-7716.2004; CUILLEL M, 1987, GENE, V55, P295, DOI 10.1016/0378-1119(87)90289-7; Fu G, 2013, GENOME ANNOUNC; GREEN NM, 1983, EMBO J, V2, P1357, DOI 10.1002/j.1460-2075.1983.tb01592.x; Hess M, 1997, VIROLOGY, V238, P145, DOI 10.1006/viro.1997.8815; Hong SS, 2005, J MOL BIOL, V352, P125, DOI 10.1016/j.jmb.2005.06.070; HUANG MM, 1989, J VIROL, V63, P2605, DOI 10.1128/JVI.63.6.2605-2615.1989; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; Liu H, 2003, CURR TOP MICROBIOL, V272, P131; LOUIS N, 1994, J VIROL, V68, P4104, DOI 10.1128/JVI.68.6.4104-4106.1994; MALKINSON M, 1980, AVIAN PATHOL, V9, P421, DOI 10.1080/03079458008418425; MCFERRAN JB, 1978, AVIAN PATHOL, V7, P35, DOI 10.1080/03079457808418258; Raj GD, 2001, AVIAN PATHOL, V30, P21, DOI 10.1080/03079450020023159; Raue R, 1998, J VIROL METHODS, V73, P211, DOI 10.1016/S0166-0934(98)00065-2; Reddy PS, 2006, VIRUS RES, V116, P119, DOI 10.1016/j.virusres.2005.09.005; RICHARDSON WD, 1981, CELL, V27, P133, DOI 10.1016/0092-8674(81)90367-6; SCHLOER GM, 1980, AVIAN DIS, V24, P91, DOI 10.2307/1589769; Thomas NJ, 2008, INFECT DIS WILD BIRD, P182; VANDERVLIET PC, 1973, NATURE-NEW BIOL, V246, P170, DOI 10.1038/newbio246170a0; VILLEGAS P, 1979, AVIAN DIS, V23, P507, DOI 10.2307/1589581; Weber J M, 1995, Curr Top Microbiol Immunol, V199 ( Pt 1), P227; WEINBERG DH, 1986, J VIROL, V57, P833, DOI 10.1128/JVI.57.3.833-838.1986	28	2	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177236	10.1371/journal.pone.0177236	http://dx.doi.org/10.1371/journal.pone.0177236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481913	gold, Green Published, Green Submitted			2022-12-27	WOS:000401313700042
J	Tascone, LD; Payne, ME; MacFall, J; Azevedo, D; de Castro, CC; Steffens, DC; Busatto, GF; Bottino, CMC				Tascone, Lyssandra dos Santos; Payne, Martha E.; MacFall, James; Azevedo, Dionisio; de Castro, Claudio Campi; Steffens, David C.; Busatto, Geraldo F.; Bottino, Cassio M. C.			Cortical brain volume abnormalities associated with few or multiple neuropsychiatric symptoms in Alzheimer's disease	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; SUPERIOR TEMPORAL GYRUS; COGNITIVE IMPAIRMENT; TALAIRACH ATLAS; CACHE COUNTY; GRAY-MATTER; DEMENTIA; PREVALENCE; INVENTORY; SCHIZOPHRENIA	New research on assessing neuropsychiatric manifestations of Alzheimer's Disease (AD) involves grouping neuropsychiatric symptoms into syndromes. Yet this approach is limited by high inter-subject variability in neuropsychiatric symptoms and a relatively low degree of concordance across studies attempting to cluster neuropsychiatric symptoms into syndromes. An alternative strategy that involves dichotomizing AD subjects into those with few versus multiple neuropsychiatric symptoms is both consonant with real-world clinical practice and can contribute to understanding neurobiological underpinnings of neuropsychiatric symptoms in AD patients. The aim of this study was to address whether the number of neuropsychiatric symptoms (i.e., presence of few [<= 2] versus multiple [<= 3] symptoms) in AD would be associated with degree of significant gray matter (GM) volume loss. Of particular interest was volume loss in brain regions involved in memory, emotional processing and salience brain networks, including the prefrontal, lateral temporal and parietal cortices, anterior cingulate gyrus, temporo-limbic structures and insula. We recruited 19 AD patients and 13 healthy controls, which underwent an MRI and neuropsychiatric assessment. Regional brain volumes were determined using voxel-based morphometry and other advanced imaging processing methods. Our results indicated the presence of different patterns of GM atrophy in the two AD subgroups relative to healthy controls. AD patients with multiple neuropsychiatric manifestations showed more evident GM atrophy in the left superior temporal gyrus and insula as compared with healthy controls. In contrast, AD subjects with few neuropsychiatric symptoms displayed more GM atrophy in prefrontal regions, as well as in the dorsal anterior cingulate ad post-central gyri, as compared with healthy controls. Our findings suggest that the presence of multiple neuropsychiatric symptoms is more related to the degree of atrophy in specific brain networks rather than dependent on the global severity of widespread neurodegenerative brain changes.	[Tascone, Lyssandra dos Santos; Azevedo, Dionisio; Bottino, Cassio M. C.] Univ Sao Paulo, Old Age Res Grp PROTER, Inst Psychiat, Sao Paulo, Brazil; [Tascone, Lyssandra dos Santos; Azevedo, Dionisio; Bottino, Cassio M. C.] Univ Sao Paulo, Old Age Res Grp PROTER, Dept Psychiat, Sao Paulo, Brazil; [Tascone, Lyssandra dos Santos] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Payne, Martha E.] Duke Univ, Sch Med, Off Res Dev, Durham, NC USA; [MacFall, James] Duke Univ, Dept Radiol, Sch Med, Durham, NC 27710 USA; [de Castro, Claudio Campi] Univ Sao Paulo, Hosp Clin, Dept Diagnost Imaging, Heart Inst nCor, Sao Paulo, Brazil; [Steffens, David C.] Univ Connecticut, Ctr Hlth, Dept Psychiat, Psychiat, Farmington, CT 06032 USA; [Busatto, Geraldo F.] Univ Sao Paulo, Fac Med, Dept Psychiat, Lab Psychiat Neuroimaging, Sao Paulo, Brazil; [Busatto, Geraldo F.] Univ Sao Paulo, Fac Med, Inst Psychiat, Lab Psychiat Neuroimaging, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Duke University; Duke University; Universidade de Sao Paulo; University of Connecticut; Universidade de Sao Paulo; Universidade de Sao Paulo	Tascone, LD (corresponding author), Univ Sao Paulo, Old Age Res Grp PROTER, Inst Psychiat, Sao Paulo, Brazil.; Tascone, LD (corresponding author), Univ Sao Paulo, Old Age Res Grp PROTER, Dept Psychiat, Sao Paulo, Brazil.; Tascone, LD (corresponding author), Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil.	lyss.tascone@gmail.com	Busatto, Geraldo F/D-4431-2009	Busatto, Geraldo F/0000-0003-4749-4602	FAPESP [2012/50329-6]; CNPQ-Brazil	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The first author was grantee of Brazilian Federal Agency for Support and Evaluation of Graduate Education CAPES, Brasilia, DF, Brazil. GFB was supported by FAPESP (2012/50329-6) and CNPQ-Brazil during the development of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalten P, 2005, INT J GERIATR PSYCH, V20, P531, DOI 10.1002/gps.1317; Aalten P, 2003, DEMENT GERIATR COGN, V15, P99, DOI 10.1159/000067972; Aalten P, 2007, DEMENT GERIATR COGN, V24, P457, DOI 10.1159/000110738; Aalten P, 2008, DEMENT GERIATR COGN, V25, P1, DOI 10.1159/000111082; American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Benoit M, 2005, J NUTR HEALTH AGING, V9, P95; Blanc F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114774; Bottino C. M. C., 1999, ENTREVISTA ESTRUTURA; Bottino CMC, 2008, DEMENT GERIATR COGN, V26, P291, DOI 10.1159/000161053; Bottino CMC, 2001, ARQ NEURO-PSIQUIAT, V59, pS20; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Bruen PD, 2008, BRAIN, V131, P2455, DOI 10.1093/brain/awn151; Camozzato AL, 2008, INT PSYCHOGERIATR, V20, P383, DOI 10.1017/S1041610207006254; Canevelli M, 2013, INT J GERIATR PSYCH, V28, P795, DOI 10.1002/gps.3904; Canu E, 2010, J ALZHEIMERS DIS, V19, P963, DOI 10.3233/JAD-2010-1295; Ceunen E, 2016, FRONT PSYCHOL, P7; Chaves MLF, 2007, ALZ DIS ASSOC DIS, V21, P210; Craig A. D., 2008, HDB EMOTIONS, P272; Craig D, 2005, AM J GERIAT PSYCHIAT, V13, P460, DOI 10.1176/appi.ajgp.13.6.460; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; EBLY EM, 1995, ARCH NEUROL-CHICAGO, V52, P612, DOI 10.1001/archneur.1995.00540300086018; Farber NB, 2000, ARCH GEN PSYCHIAT, V57, P1165, DOI 10.1001/archpsyc.57.12.1165; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geda YE, 2013, ALZHEIMERS DEMENT, V9, P602, DOI 10.1016/j.jalz.2012.12.001; Grupe DW, 2013, NAT REV NEUROSCI, V14, P488, DOI 10.1038/nrn3524; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Hu XC, 2015, CURR ALZHEIMER RES, V12, P266, DOI 10.2174/1567205012666150302154914; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Koppel J, 2014, NEUROPSYCH DIS TREAT, V10, P2253, DOI 10.2147/NDT.S60837; Koppel J, 2014, NEUROBIOL AGING, V35, P2021, DOI 10.1016/j.neurobiolaging.2014.03.003; Kragel PA, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0090-15.2016; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lehmann M, 2013, BRAIN, V136, P844, DOI 10.1093/brain/aws327; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Lyketsos CG, 2001, INT J GERIATR PSYCH, V16, P1037, DOI 10.1002/gps.440; Lyketsos CG, 2001, INT J GERIATR PSYCH, V16, P1043, DOI 10.1002/gps.448; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Mamah D, 2013, J AFFECT DISORDERS, V150, P601, DOI 10.1016/j.jad.2013.01.051; Manoliu A., 2013, SCHIZOPHR B; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McLaren DG, 2010, METHODS, V50, P157, DOI 10.1016/j.ymeth.2009.10.003; Mega MS, 2000, J NEUROL NEUROSUR PS, V69, P167, DOI 10.1136/jnnp.69.2.167; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mirakhur A, 2004, INT J GERIATR PSYCH, V19, P1035, DOI 10.1002/gps.1203; Moroney J T, 1997, Ann N Y Acad Sci, V826, P490, DOI 10.1111/j.1749-6632.1997.tb48510.x; Nakaaki S, 2013, NEUROPSYCH DIS TREAT, V9, P1, DOI 10.2147/NDT.S38939; Okura T, 2011, J AM GERIATR SOC, V59, P473, DOI 10.1111/j.1532-5415.2011.03314.x; Paulus MP, 2010, BRAIN STRUCT FUNCT, V214, P451, DOI 10.1007/s00429-010-0258-9; Peters KR, 2006, NEUROLOGY, V66, P523, DOI 10.1212/01.wnl.0000198255.84842.06; Ridgway G, 2011, ALZHEIMERS DEMENT, V7, pS62, DOI [10.1016/j.jalz.2011.05.099, DOI 10.1016/J.JALZ.2011.05.099]; Ridgway GR, 2009, NEUROIMAGE, V44, P99, DOI 10.1016/j.neuroimage.2008.08.045; Robert PH, 2005, EUR PSYCHIAT, V20, P490, DOI 10.1016/j.eurpsy.2004.09.031; Rosen HJ, 2005, BRAIN, V128, P2612, DOI 10.1093/brain/awh628; Rosenberg PB, 2015, MOL ASPECTS MED, V43-44, P25, DOI 10.1016/j.mam.2015.05.005; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Serra L, 2010, J ALZHEIMERS DIS, V21, P627, DOI 10.3233/JAD-2010-100048; Shin IS, 2005, AM J GERIAT PSYCHIAT, V13, P469, DOI 10.1176/appi.ajgp.13.6.469; Spalletta G, 2004, J NEUROL, V251, P688, DOI 10.1007/s00415-004-0403-6; Steinberg M, 2008, INT J GERIATR PSYCH, V23, P170, DOI 10.1002/gps.1858; Summerlin JL., 1997, NEUROIMAGE, V5, pS633, DOI DOI 10.1002/(SICI)1097-0193(1997)5:4<238:AID-HBM6>3.0.C0;2-4; Takahashi T, 2009, ARCH GEN PSYCHIAT, V66, P366, DOI 10.1001/archgenpsychiatry.2009.12; Tatsch MF, 2006, AM J GERIAT PSYCHIAT, V14, P438, DOI 10.1097/01.JGP.0000218218.47279.db; Tekin S, 2001, ANN NEUROL, V49, P355, DOI 10.1002/ana.72; Ting WKC, 2015, CURR ALZHEIMER RES, V12, P165, DOI 10.2174/1567205012666150204130456; Trzepacz Paula T, 2013, Alzheimers Dement, V9, pS95, DOI 10.1016/j.jalz.2012.10.005; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; van der Linde RM, 2014, INT J GERIATR PSYCH, V29, P562, DOI 10.1002/gps.4037; van Tol MJ, 2014, NEUROIMAGE-CLIN, V4, P249, DOI 10.1016/j.nicl.2013.12.008; Vermeiren Y, 2014, NEUROBIOL AGING, V35, P2691, DOI 10.1016/j.neurobiolaging.2014.05.031; Vita A, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.116; Wang HD, 2008, NEUROPSYCHOPHARMACOL, V33, P1276, DOI 10.1038/sj.npp.1301521; Warren JD, 2013, TRENDS NEUROSCI, V36, P561, DOI 10.1016/j.tins.2013.06.007; Woodward ND, 2009, NEUROIMAGE, V46, P31, DOI 10.1016/j.neuroimage.2009.01.049	81	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177169	10.1371/journal.pone.0177169	http://dx.doi.org/10.1371/journal.pone.0177169			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481904	gold, Green Submitted, Green Published			2022-12-27	WOS:000401313700038
J	Choi, YJ; Lee, DH; Han, KD; Yoon, H; Shin, CM; Park, YS; Kim, N				Choi, Yoon Jin; Lee, Dong Ho; Han, Kyung-Do; Yoon, Hyuk; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung			Elevated serum gamma-glutamyltransferase is associated with an increased risk of oesophageal carcinoma in a cohort of 8,388,256 Korean subjects	PLOS ONE			English	Article							BODY-MASS INDEX; CANCER INCIDENCE; LIVER-ENZYMES; GLUTAMYLTRANSFERASE; TRANSPEPTIDASE; POPULATION; RESISTANCE; PROGRESS; ALCOHOL; WEIGHT	Gamma-glutamyltransferase (GGT) is a marker for hepatic injury and alcohol consumption. However, the association of GGT with the risk of oesophageal carcinoma (OC) has not been fully recognized to date. Therefore, this study aimed to determine the association between elevated GGT and OC, by also considering the body mass index (BMI) of the subjects. Clinical data from 8,388,256 Korean individuals, who were aged 40 years and over and who received healthcare check-ups arranged by the national insurance program in 2007 and 2008, were analysed. Newly diagnosed OC was identified using claims data during a median follow-up duration of 8.72 years. During the study period, 6,863 individuals (0.08%) developed OC. We found that there was an increased risk of OC in subjects with serum GGT values >18 IU/L. Furthermore, a BMI <18.5 kg/m(2) (underweight) was associated with increased OC risk, while a BMI >= 23.0 kg/m(2) was associated with a reduced OC risk. Individuals who were both underweight and in the highest GGT quartile (>= 40 IU/L) had a far greater risk of OC compared to other individuals (hazard ratio: 3.65, 95% confidence interval: 3.10-4.30). In conclusion, increased serum GGT was associated with an increased risk of developing OC in the general Korean population, regardless of age, sex, smoker status, or alcohol consumption.	[Choi, Yoon Jin; Lee, Dong Ho; Yoon, Hyuk; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung] Dept Internal Med, Seongnam, Gyeonggi Do, South Korea; [Choi, Yoon Jin; Lee, Dong Ho; Yoon, Hyuk; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung] Seoul Natl Univ, Bundang Hosp, Seongnam, Gyeonggi Do, South Korea; [Lee, Dong Ho; Park, Young Soo; Kim, Nayoung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Dong Ho; Park, Young Soo; Kim, Nayoung] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Han, Kyung-Do] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Catholic University of Korea	Lee, DH (corresponding author), Dept Internal Med, Seongnam, Gyeonggi Do, South Korea.; Lee, DH (corresponding author), Seoul Natl Univ, Bundang Hosp, Seongnam, Gyeonggi Do, South Korea.; Lee, DH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Lee, DH (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	dhljohn@yahoo.com	Yoon, Hyuk/AAT-4978-2020	Yoon, Hyuk/0000-0002-2657-0349; Choi, Yoon Jin/0000-0002-1922-9388; Shin, Cheol Min/0000-0003-2265-9845; Kim, Nayoung/0000-0002-9397-0406	Ministry of Science, ICT and Future Planning [2011-0030001]	Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the Ministry of Science, ICT and Future Planning (http://english.msip.go.kr/english/main/main.do) No. 2011-0030001 to DHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0097-7; AlSarraf M, 1997, J CLIN ONCOL, V15, P277, DOI 10.1200/JCO.1997.15.1.277; Bollschweiler E, 2001, CANCER, V92, P549, DOI 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L; Borud O, 2000, INT J CANCER, V88, P464, DOI 10.1002/1097-0215(20001101)88:3<464::AID-IJC20>3.0.CO;2-F; Breitling LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013116; Conigrave KM, 2002, ALCOHOL CLIN EXP RES, V26, P332, DOI 10.1097/00000374-200203000-00005; Corti A, 2009, MUTAT RES-FUND MOL M, V669, P112, DOI 10.1016/j.mrfmmm.2009.05.010; DAWSON J, 1979, CLIN CHIM ACTA, V96, P37, DOI 10.1016/0009-8981(79)90049-4; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Fahey PP, 2015, CANCER CAUSE CONTROL, V26, P1365, DOI 10.1007/s10552-015-0635-z; Hanigan MH, 1999, HUM PATHOL, V30, P300, DOI 10.1016/S0046-8177(99)90009-6; Johnson IT, 2015, EXPERT REV GASTROENT, V9, P1347, DOI 10.1586/17474124.2015.1088383; Kim DJ, 2005, DIABETIC MED, V22, P1134, DOI 10.1111/j.1464-5491.2005.01581.x; Kunutsor SK, 2015, INT J CANCER, V136, P1162, DOI 10.1002/ijc.29084; Kunutsor SK, 2014, INT J EPIDEMIOL, V43, P187, DOI 10.1093/ije/dyt192; Lahmann PH, 2012, CANCER-AM CANCER SOC, V118, P1901, DOI 10.1002/cncr.26455; Lee DH, 2004, FREE RADICAL RES, V38, P535, DOI 10.1080/10715760410001694026; Lee DH, 2003, DIABETOLOGIA, V46, P359, DOI 10.1007/s00125-003-1036-5; Lee J., 2016, INT J EPIDEMIOL; Lee MY, 2008, DIABETIC MED, V25, P469, DOI 10.1111/j.1464-5491.2008.02415.x; Lelijveld N, 2016, LANCET GLOB HEALTH, V4, pE654, DOI 10.1016/S2214-109X(16)30133-4; Lim JS, 2004, FREE RADICAL BIO MED, V37, P1018, DOI 10.1016/j.freeradbiomed.2004.06.032; Liu RM, 1996, AM J RESP CELL MOL, V14, P192, DOI 10.1165/ajrcmb.14.2.8630270; Mok Y, 2016, INT J CANCER, V138, P311, DOI 10.1002/ijc.29659; Oh SW, 2005, J CLIN ONCOL, V23, P4742, DOI 10.1200/JCO.2005.11.726; Shiwaku K, 2004, LANCET, V363, P1077, DOI 10.1016/S0140-6736(04)15856-X; Smith M, 2008, INT J CANCER, V122, P1604, DOI 10.1002/ijc.23198; Son Ju Ik, 2001, Korean Journal of Internal Medicine, V16, P250; Stoner GD, 2001, CARCINOGENESIS, V22, P1737, DOI 10.1093/carcin/22.11.1737; Strasak AM, 2008, INT J CANCER, V123, P1902, DOI 10.1002/ijc.23714; SZASZ G, 1976, CLIN CHEM, V22, P2051; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Tsuboya T, 2012, J EPIDEMIOL, V22, P144, DOI 10.2188/jea.JE20110071; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Van Hemelrijck M, 2011, EUR J CANCER, V47, P2033, DOI 10.1016/j.ejca.2011.03.010; Venesky MD, 2012, OECOLOGIA, V169, P23, DOI 10.1007/s00442-011-2171-1; Wannamethee SG, 2010, ANN CLIN BIOCHEM, V47, P321, DOI 10.1258/acb.2010.009303; Zhang HQ, 2009, AM J RESP CELL MOL, V41, P509, DOI 10.1165/rcmb.2009-0169TR	38	11	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177053	10.1371/journal.pone.0177053	http://dx.doi.org/10.1371/journal.pone.0177053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475598	Green Published, gold, Green Submitted			2022-12-27	WOS:000400649500037
J	Ren, Y; Lai, YH; Laverde, EE; Lei, RP; Rein, HL; Liu, Y				Ren, Yaou; Lai, Yanhao; Laverde, Eduardo E.; Lei, Ruipeng; Rein, Hayley L.; Liu, Yuan			Modulation of trinucleotide repeat instability by DNA polymerase beta polymorphic variant R137Q	PLOS ONE			English	Article							BASE-EXCISION-REPAIR; SINGLE-NUCLEOTIDE POLYMORPHISMS; ANDROGEN RECEPTOR; MICROSATELLITE INSTABILITY; MONOUBIQUITINATED PCNA; MOLECULAR-BASIS; BLADDER-CANCER; CAG REPEAT; CTG REPEAT; EXPANSION	Trinucleotide repeat (TNR) instability is associated with human neurodegenerative diseases and cancer. Recent studies have pointed out that DNA base excision repair (BER) mediated by DNA polymerase beta (pol beta) plays a crucial role in governing somatic TNR instability in a damage-location dependent manner. It has been shown that the activities and function of BER enzymes and cofactors can be modulated by their polymorphic variations. This could alter the function of BER in regulating TNR instability. However, the roles of BER polymorphism in modulating TNR instability remain to be elucidated. A previous study has shown that a pol beta polymorphic variant, pol beta R137Q is associated with cancer due to its impaired polymerase activity and its deficiency in interacting with a BER cofactor, proliferating cell nuclear antigen (PCNA). In this study, we have studied the effect of the pol beta R137Q variant on TNR instability. We showed that pol beta R137Q exhibited weak DNA synthesis activity to cause TNR deletion during BER. We demonstrated that similar to wild-type pol beta, the weak DNA synthesis activity of pol beta R137Q allowed it to skip over a small loop formed on the template strand, thereby facilitating TNR deletion during BER. Our results further suggest that carriers with pol beta R137Q polymorphic variant may not exhibit an elevated risk of developing human diseases that are associated with TNR instability.	[Ren, Yaou; Laverde, Eduardo E.; Lei, Ruipeng; Liu, Yuan] Florida Int Univ, Biochem PhD Program, Miami, FL 33199 USA; [Lai, Yanhao; Rein, Hayley L.; Liu, Yuan] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Liu, Yuan] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA; [Rein, Hayley L.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University; State University System of Florida; Florida International University; State University System of Florida; University of South Florida	Liu, Y (corresponding author), Florida Int Univ, Biochem PhD Program, Miami, FL 33199 USA.; Liu, Y (corresponding author), Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA.; Liu, Y (corresponding author), Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA.	yualiu@fiu.edu	Lai, Yanhao/AAD-3392-2019	Lei, Ruipeng/0000-0002-4652-3400; Rein, Hayley/0000-0001-8939-3442	National Institutes of Health [ES023569]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants ES023569 (to Y. Liu).	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Ali MF, 2008, ONCOL REP, V19, P1033; Beard WA, 2014, BIOCHEMISTRY-US, V53, P2768, DOI 10.1021/bi500139h; Berger F, 2013, MUTAT RES-GEN TOX EN, V755, P115, DOI 10.1016/j.mrgentox.2013.04.020; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; BROOKS BP, 1995, TRENDS NEUROSCI, V18, P459, DOI 10.1016/0166-2236(95)94497-S; Brouwer JR, 2009, BIOESSAYS, V31, P71, DOI 10.1002/bies.080122; Chan NLS, 2013, J BIOL CHEM, V288, P15015, DOI 10.1074/jbc.M113.464370; Chang-Claude J, 2005, CLIN CANCER RES, V11, P4802, DOI 10.1158/1078-0432.CCR-04-2657; Coppede F, 2010, TOXICOLOGY, V278, P199, DOI 10.1016/j.tox.2009.10.019; Desai NA, 2003, FEMS MICROBIOL REV, V26, P457, DOI 10.1016/S0168-6445(02)00129-8; Dianova II, 2004, NUCLEIC ACIDS RES, V32, P2550, DOI 10.1093/nar/gkh567; Dion V, 2014, TRENDS GENET, V30, P220, DOI 10.1016/j.tig.2014.04.005; Dogru-Abbasoglu S, 2007, NEUROL SCI, V28, P31, DOI 10.1007/s10072-007-0744-x; Dogru-Abbasoglu S, 2009, CELL BIOCHEM FUNCT, V27, P462, DOI 10.1002/cbf.1595; El-Andaloussi N, 2007, FASEB J, V21, P26, DOI 10.1096/fj.06-6194com; Entezam A, 2010, HUM MUTAT, V31, P611, DOI 10.1002/humu.21237; Freudenthal BD, 2010, NAT STRUCT MOL BIOL, V17, P479, DOI 10.1038/nsmb.1776; Gary R, 1999, J BIOL CHEM, V274, P4354, DOI 10.1074/jbc.274.7.4354; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Guo ZG, 2009, NUCLEIC ACIDS RES, V37, P3431, DOI 10.1093/nar/gkp201; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hill JW, 2006, NUCLEIC ACIDS RES, V34, P1620, DOI 10.1093/nar/gkl060; Jakupciak JP, 2000, IUBMB LIFE, V50, P355, DOI 10.1080/152165400300089358; Jiang X, 2012, CHINESE J CANCER RES, V24, P181, DOI 10.1007/s11670-012-0181-0; Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kanvah S, 2010, ACCOUNTS CHEM RES, V43, P280, DOI 10.1021/ar900175a; KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Lai YH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12465; Lai YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093464; Lai YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056960; Lin GC, 2009, DNA REPAIR, V8, P182, DOI 10.1016/j.dnarep.2008.10.006; Lin YF, 2009, MOL CARCINOGEN, V48, P350, DOI 10.1002/mc.20488; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Liu Y, 2012, TRENDS BIOCHEM SCI, V37, P162, DOI 10.1016/j.tibs.2011.12.002; Liu Y, 2009, J BIOL CHEM, V284, P28352, DOI 10.1074/jbc.M109.050286; LOEB LA, 1994, CANCER RES, V54, P5059; Lonergan PE, 2011, J CARCINOG, P10; Martins S, 2014, HUM GENET, V133, P1311, DOI 10.1007/s00439-014-1467-8; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Miao HK, 2015, INT J CLIN EXP PATHO, V8, P11060; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mohrenweiser HW, 2002, CANCER EPIDEM BIOMAR, V11, P1054; Montermini L, 1997, HUM MOL GENET, V6, P1261, DOI 10.1093/hmg/6.8.1261; Morales F, 2016, DNA REPAIR, V40, P57, DOI 10.1016/j.dnarep.2016.01.001; Nazarkina ZK, 2007, DNA REPAIR, V6, P254, DOI 10.1016/j.dnarep.2006.10.002; Nolin SL, 2003, AM J HUM GENET, V72, P454, DOI 10.1086/367713; Oussatcheva EA, 2001, J BIOL CHEM, V276, P30878, DOI 10.1074/jbc.M104697200; Pan FY, 2016, SCI REP-UK, V6, DOI 10.1038/srep28614; Parildar-Karpuzoglu H, 2008, NEUROSCI LETT, V442, P287, DOI 10.1016/j.neulet.2008.07.047; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Rossner P, 2006, CANCER EPIDEM BIOMAR, V15, P811, DOI 10.1158/1055-9965.EPI-05-0659; Sak SC, 2006, CANCER EPIDEM BIOMAR, V15, P2537, DOI 10.1158/1055-9965.EPI-06-0288; Schaefer MH, 2012, NUCLEIC ACIDS RES, V40, P4273, DOI 10.1093/nar/gks011; Sobol RW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003086; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Terry PD, 2006, INT J CANCER, V118, P3170, DOI 10.1002/ijc.21768; Tirabassi G, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/298107; Tom S, 2001, J BIOL CHEM, V276, P24817, DOI 10.1074/jbc.M101673200; Tome S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003280; Turner C, 2010, J NEUROL NEUROSUR PS, V81, P358, DOI 10.1136/jnnp.2008.158261; Van Roon-Mom WMC, 2005, NEUROSCIENCE, V133, P863, DOI 10.1016/j.neuroscience.2005.03.024; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875; Xu M, 2014, NUCLEIC ACIDS RES, V42, P13749, DOI 10.1093/nar/gku1239; Xu M, 2014, NUCLEIC ACIDS RES, V42, P3675, DOI 10.1093/nar/gkt1372; Xu Meng, 2013, Nucleic Acids Res, V41, P1684, DOI 10.1093/nar/gks1306; Xu XL, 2015, GENET MOL RES, V14, P3525, DOI 10.4238/2015.April.15.16; Yamtich J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003052; Yamtich J, 2009, DNA REPAIR, V8, P579, DOI 10.1016/j.dnarep.2008.12.005; Zhang Jihong, 2012, Curr Mol Pharmacol, V5, P102; Zhang YW, 2006, CANCER EPIDEM BIOMAR, V15, P353, DOI 10.1158/1055-9965.EPI-05-0653	81	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177299	10.1371/journal.pone.0177299	http://dx.doi.org/10.1371/journal.pone.0177299			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475635	gold, Green Submitted, Green Published			2022-12-27	WOS:000400649500060
J	Valenchon, M; Levy, F; Moussu, C; Lansade, L				Valenchon, Mathilde; Levy, Frederic; Moussu, Chantal; Lansade, Lea			Stress affects instrumental learning based on positive or negative reinforcement in interaction with personality in domestic horses	PLOS ONE			English	Article							TEMPERAMENT TRAIT; TIME; FOOD; PERFORMANCE; FEARFULNESS; REACTIVITY; RESPONSES; ECOLOGY; HUMANS	The present study investigated how stress affects instrumental learning performance in horses (Equus caballus) depending on the type of reinforcement. Horses were assigned to four groups (N = 15 per group); each group received training with negative or positive reinforcement in the presence or absence of stressors unrelated to the learning task. The instrumental learning task consisted of the horse entering one of two compartments at the appearance of a visual signal given by the experimenter. In the absence of stressors unrelated to the task, learning performance did not differ between negative and positive reinforcements. The presence of stressors unrelated to the task (exposure to novel and sudden stimuli) impaired learning performance. Interestingly, this learning deficit was smaller when the negative reinforcement was used. The negative reinforcement, considered as a stressor related to the task, could have counterbalanced the impact of the extrinsic stressor by focusing attention toward the learning task. In addition, learning performance appears to differ between certain dimensions of personality depending on the presence of stressors and the type of reinforcement. These results suggest that when negative reinforcement is used (i.e. stressor related to the task), the most fearful horses may be the best performers in the absence of stressors but the worst performers when stressors are present. On the contrary, when positive reinforcement is used, the most fearful horses appear to be consistently the worst performers, with and without exposure to stressors unrelated to the learning task. This study is the first to demonstrate in ungulates that stress affects learning performance differentially according to the type of reinforcement and in interaction with personality. It provides fundamental and applied perspectives in the understanding of the relationships between personality and training abilities.	[Valenchon, Mathilde; Levy, Frederic; Moussu, Chantal; Lansade, Lea] INRA, Ctr Val Loire, UMR85, Physiol Reprod & Comportements, Nouzilly, France; [Valenchon, Mathilde; Levy, Frederic; Moussu, Chantal; Lansade, Lea] CNRS, UMR6175, Physiol Reprod & Comportements, Nouzilly, France; [Valenchon, Mathilde; Levy, Frederic; Moussu, Chantal; Lansade, Lea] Univ Tours, Tours, France; [Valenchon, Mathilde; Levy, Frederic; Moussu, Chantal; Lansade, Lea] IFCE, Nouzilly, France	INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Universite de Tours	Valenchon, M; Lansade, L (corresponding author), INRA, Ctr Val Loire, UMR85, Physiol Reprod & Comportements, Nouzilly, France.; Valenchon, M; Lansade, L (corresponding author), CNRS, UMR6175, Physiol Reprod & Comportements, Nouzilly, France.; Valenchon, M; Lansade, L (corresponding author), Univ Tours, Tours, France.; Valenchon, M; Lansade, L (corresponding author), IFCE, Nouzilly, France.	mathilde.valenchon@yahoo.fr; lea.lansade@tours.inra.fr		Valenchon, Mathilde/0000-0003-0226-8433	Region Centre; French Horses and Riding Institute (IFCE)	Region Centre(Region Centre-Val de Loire); French Horses and Riding Institute (IFCE)	The Ph.D. grant of MV was funded by the 'Region Centre' (50%) and the French Horses and Riding Institute (IFCE) (50%). The French Horses and Riding Institut (IFCE) also funded this experiment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The first author was supported by a Ph.D. grant from the 'Region Centre' and from the French Horse and Riding Institute (IFCE). This institute also funded this experiment. We thank Guy Duchamp and Fabrice Reigner and their staff (INRA, Nouzilly, France) for allowing the use of the animals and facilities. We also thank Jean-Marie Yvon and Rejane Monteville for their assistance in data collection and Ludovic Calandreau for his help throughout this project. We are also very grateful to three anonymous reviewers for providing valuable comments on an earlier version of the manuscript.	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Akirav I, 2001, EUR J NEUROSCI, V14, P719, DOI 10.1046/j.0953-816x.2001.01687.x; Arnsten AFT, 1998, SCIENCE, V280, P1711, DOI 10.1126/science.280.5370.1711; Budaev SV, 1998, J COMP PSYCHOL, V112, P92, DOI 10.1037/0735-7036.112.1.92; Carere C, 2011, CURR ZOOL, V57, P491, DOI 10.1093/czoolo/57.4.491; Christensen JW, 2012, APPL ANIM BEHAV SCI, V140, P44, DOI 10.1016/j.applanim.2012.05.003; Cockrem JF, 2007, J ORNITHOL, V148, pS169, DOI 10.1007/s10336-007-0175-8; Cockrem JF, 2013, GEN COMP ENDOCR, V181, P45, DOI 10.1016/j.ygcen.2012.11.025; Folkedal O, 2012, PHYSIOL BEHAV, V105, P283, DOI 10.1016/j.physbeh.2011.07.015; Hausberger M, 2008, APPL ANIM BEHAV SCI, V109, P1, DOI 10.1016/j.applanim.2007.04.015; Hendriksen P, 2011, J VET BEHAV, V6, P261, DOI 10.1016/j.jveb.2011.02.007; Innes L, 2008, APPL ANIM BEHAV SCI, V112, P357, DOI 10.1016/j.applanim.2007.08.011; Jiao XL, 2011, BEHAV BRAIN RES, V221, P98, DOI 10.1016/j.bbr.2011.02.029; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; Joels M, 2009, NATURE REV NEUROSCIE, V10, P459; Kalat JW, 2016, INTRO PSYCHOL CENGAG; Lansade L, 2007, DEV PSYCHOBIOL, V49, P501, DOI 10.1002/dev.20233; Lansade L, 2005, ETUDE THEORIQUE APPL; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P534, DOI 10.1016/j.applanim.2008.02.012; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P492, DOI 10.1016/j.applanim.2008.04.012; Lansade L, 2008, APPL ANIM BEHAV SCI, V109, P355, DOI 10.1016/j.applanim.2007.03.003; Lansade L, 2010, APPL ANIM BEHAV SCI, V125, P30, DOI 10.1016/j.applanim.2010.02.010; Lansade L, 2008, APPL ANIM BEHAV SCI, V115, P182, DOI 10.1016/j.applanim.2008.06.011; Laraway S, 2003, J APPL BEHAV ANAL, V36, P407, DOI 10.1901/jaba.2003.36-407; LeScolan N, 1997, BEHAV PROCESS, V41, P257, DOI 10.1016/S0376-6357(97)00052-1; Lesimple C, 2011, APPL ANIM BEHAV SCI, V129, P92, DOI 10.1016/j.applanim.2010.11.005; McDonnell S.M, 2003, EQUID ETHOGRAM PRACT; McDonnell SM, 2002, APPL ANIM BEHAV SCI, V78, P263, DOI 10.1016/S0168-1591(02)00112-0; Mendl M, 1999, APPL ANIM BEHAV SCI, V65, P221, DOI 10.1016/S0168-1591(99)00088-X; Minero M, 2009, ITAL J ANIM SCI, V8, P219, DOI 10.4081/ijas.2009.s1.219; Murphy J, 2007, BEHAV PROCESS, V76, P1, DOI 10.1016/j.beproc.2006.06.009; Nicol CJ, 2002, APPL ANIM BEHAV SCI, V78, P193, DOI 10.1016/S0168-1591(02)00093-X; Pritchett LC, 2003, APPL ANIM BEHAV SCI, V80, P31, DOI 10.1016/S0168-1591(02)00205-8; Range F, 2006, BEHAV PROCESS, V73, P100, DOI 10.1016/j.beproc.2006.04.002; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Sandi Carmen, 2007, Neural Plasticity, V2007, DOI 10.1055/2007/78970; Sankey C, 2010, ANIM COGN, V13, P753, DOI 10.1007/s10071-010-0326-9; Sankey C, 2010, ANIM BEHAV, V79, P869, DOI 10.1016/j.anbehav.2009.12.037; Scheid C, 2010, ANIM COGN, V13, P545, DOI 10.1007/s10071-009-0305-1; Schwabe L, 2010, NEUROSCI BIOBEHAV R, V34, P584, DOI 10.1016/j.neubiorev.2009.11.015; Sih A, 2012, PHILOS T R SOC B, V367, P2762, DOI 10.1098/rstb.2012.0216; SORG BA, 1992, J RES PERS, V26, P235, DOI 10.1016/0092-6566(92)90041-2; Upton KR, 2013, DOMEST ANIM ENDOCRIN, V44, P157, DOI 10.1016/j.domaniend.2012.10.001; Valenchon M, 2013, ANIMAL COGNITION, P1; Valenchon M, 2013, ANIM BEHAV, V86, P1233, DOI 10.1016/j.anbehav.2013.09.026; Valenchon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062324; von Borstel UU, 2009, APPL ANIM BEHAV SCI, V116, P228, DOI 10.1016/j.applanim.2008.10.001; Warren-Smith AK, 2007, ANIM WELFARE, V16, P481	48	22	23	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0170783	10.1371/journal.pone.0170783	http://dx.doi.org/10.1371/journal.pone.0170783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475581	Green Published, Green Submitted, gold			2022-12-27	WOS:000400649500001
J	Fakhraei, L; Gautam, SH; Shew, WL				Fakhraei, Leila; Gautam, Shree Hari; Shew, Woodrow L.			State-dependent intrinsic predictability of cortical network dynamics	PLOS ONE			English	Article							NEURONAL AVALANCHES; ACTIVITY PATTERNS; NEURAL ACTIVITY; SIMPLE-MODEL; VARIABILITY; CORTEX; EXCITATION/INHIBITION; CONSCIOUSNESS	The information encoded in cortical circuit dynamics is fleeting, changing from moment to moment as new input arrives and ongoing intracortical interactions progress. A combination of deterministic and stochastic biophysical mechanisms governs how cortical dynamics at one moment evolve from cortical dynamics in recently preceding moments. Such temporal continuity of cortical dynamics is fundamental to many aspects of cortex function but is not well understood. Here we study temporal continuity by attempting to predict cortical population dynamics (multisite local field potential) based on its own recent history in somatosensory cortex of anesthetized rats and in a computational network-level model. We found that the intrinsic predictability of cortical dynamics was dependent on multiple factors including cortical state, synaptic inhibition, and how far into the future the prediction extends. By pharmacologically tuning synaptic inhibition, we obtained a continuum of cortical states with asynchronous population activity at one extreme and stronger, spatially extended synchrony at the other extreme. Intermediate between these extremes we observed evidence for a special regime of population dynamics called criticality. Predictability of the near future (10-100 ms) increased as the cortical state was tuned from asynchronous to synchronous. Predictability of the more distant future (> 1 s) was generally poor, but, surprisingly, was higher for asynchronous states compared to synchronous states. These experimental results were confirmed in a computational network model of spiking excitatory and inhibitory neurons. Our findings demonstrate that determinism and predictability of network dynamics depend on cortical state and the time-scale of the dynamics.	[Fakhraei, Leila; Gautam, Shree Hari; Shew, Woodrow L.] Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Shew, WL (corresponding author), Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA.	shew@uark.edu		Shew, Woodrow/0000-0003-0679-1766	Arkansas Biosciences Institute [0055, 0070]; University of Arkansas	Arkansas Biosciences Institute; University of Arkansas	WLS and SHG were funded by the Arkansas Biosciences Institute (Grants 0055 and 0070; http://arbiosciences.org/). WLS and LF were funded by University of Arkansas. There was no additional funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Beggs JM, 2003, J NEUROSCI, V23, P11167; Bellay T, 2015, ELIFE, V4, DOI 10.7554/eLife.07224; Ching SN, 2014, CURR OPIN NEUROBIOL, V25, P116, DOI 10.1016/j.conb.2013.12.011; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Contreras EJB, 2013, NEURON, V79, P555, DOI 10.1016/j.neuron.2013.06.013; Curto C, 2009, J NEUROSCI, V29, P10600, DOI 10.1523/JNEUROSCI.2053-09.2009; Dehghani N, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00302; Fagerholm ED, 2015, J NEUROSCI, V35, P4626, DOI 10.1523/JNEUROSCI.3694-14.2015; Favero M, 2012, J NEUROPHYSIOL, V108, P1010, DOI 10.1152/jn.00256.2012; Gautam H, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004576; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Haimovici A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.178101; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Harris T. E., 1963, THEORY BRANCHING PRO; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Larremore DB, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.138103; Larremore DB, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066131; Meisel C, 2013, J NEUROSCI, V33, P17363, DOI 10.1523/JNEUROSCI.1516-13.2013; Munoz MA, 1999, PHYS REV E, V59, P6175, DOI 10.1103/PhysRevE.59.6175; Neumaier A, 2001, ACM T MATH SOFTWARE, V27, P27, DOI 10.1145/382043.382304; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Poil SS, 2012, J NEUROSCI, V32, P9817, DOI 10.1523/JNEUROSCI.5990-11.2012; Populin LC, 2005, J NEUROSCI, V25, P5903, DOI 10.1523/JNEUROSCI.1147-05.2005; Renart A, 2014, CURR OPIN NEUROBIOL, V25, P211, DOI 10.1016/j.conb.2014.02.013; Ribeiro TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014129; Scott G, 2014, J NEUROSCI, V34, P16611, DOI 10.1523/JNEUROSCI.3474-14.2014; Shew WL, 2015, NAT PHYS, V11, P659, DOI 10.1038/NPHYS3370; Shew WL, 2011, J NEUROSCI, V31, P55, DOI 10.1523/JNEUROSCI.4637-10.2011; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Solovey G, 2015, J NEUROSCI, V35, P10866, DOI 10.1523/JNEUROSCI.4895-14.2015; Solovey G, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00044; Steriade M., 2003, NEURONAL SUBSTRATES; Truccolo W, 2010, NAT NEUROSCI, V13, P105, DOI 10.1038/nn.2455; Vinck M, 2015, NEURON, V86, P740, DOI 10.1016/j.neuron.2015.03.028	37	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0173658	10.1371/journal.pone.0173658	http://dx.doi.org/10.1371/journal.pone.0173658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472037	Green Published, gold			2022-12-27	WOS:000400648500002
J	Hartung, N; Huynh, CTK; Gaudy-Marqueste, C; Flavian, A; Malissen, N; Richard-Lallemand, MA; Hubert, F; Grob, JJ				Hartung, Niklas; Huynh, Cecilia T. -K.; Gaudy-Marqueste, Caroline; Flavian, Antonin; Malissen, Nausicaa; Richard-Lallemand, Marie-Aleth; Hubert, Florence; Grob, Jean-Jacques			Study of metastatic kinetics in metastatic melanoma treated with B-RAF inhibitors: Introducing mathematical modelling of kinetics into the therapeutic decision	PLOS ONE			English	Article							COMPETING RISKS; RESISTANCE; VEMURAFENIB; SURVIVAL; BRAF(V600E); REVEALS; PATHWAY	Background Evolution of metastatic melanoma (MM) under B-RAF inhibitors (BRAFi) is unpredictable, but anticipation is crucial for therapeutic decision. Kinetics changes in metastatic growth are driven by molecular and immune events, and thus we hypothesized that they convey relevant information for decision making. Patients and methods We used a retrospective cohort of 37 MM patients treated by BRAFi only with at least 2 close CT-scans available before BRAFi, as a model to study kinetics of metastatic growth before, under and after BRAFi. All metastases (mets) were individually measured at each CT-scan. From these measurements, different measures of growth kinetics of each met and total tumor volume were computed at different time points. A historical cohort permitted to build a reference model for the expected spontaneous disease kinetics without BRAFi. All variables were included in Cox and multistate regression models for survival, to select best candidates for predicting overall survival. Results Before starting BRAFi, fast kinetics and moreover a wide range of kinetics (fast and slow growing mets in a same patient) were pejorative markers. At the first assessment after BRAFi introduction, high heterogeneity of kinetics predicted short survival, and added independent information over RECIST progression in multivariate analysis. Metastatic growth rates after BRAFi discontinuation was usually not faster than before BRAFi introduction, but they were often more heterogeneous than before. Conclusions Monitoring kinetics of different mets before and under BRAFi by repeated CT-scan provides information for predictive mathematical modelling. Disease kinetics deserves more interest	[Hartung, Niklas] Free Univ Berlin, Inst Pharm, Dept Clin Pharm & Biochem, Berlin, Germany; [Huynh, Cecilia T. -K.; Gaudy-Marqueste, Caroline; Malissen, Nausicaa; Richard-Lallemand, Marie-Aleth; Grob, Jean-Jacques] Aix Marseille Univ, AP HM, Dermatol & Skin Cancers Dept, Marseille, France; [Gaudy-Marqueste, Caroline; Richard-Lallemand, Marie-Aleth; Grob, Jean-Jacques] Aix Marseille Univ, CRO2, UMR S 911, Marseille, France; [Flavian, Antonin] Hop La Timone, AP HM, Radiol Dept, Marseille, France; [Hubert, Florence] Aix Marseille Univ, CNRS, I2M, UMR 7373,Cent Marseille, Marseille, France; [Hartung, Niklas] Univ Potsdam, Inst Math, Potsdam, Germany	Free University of Berlin; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Aix-Marseille Universite; University of Potsdam	Gaudy-Marqueste, C (corresponding author), Aix Marseille Univ, AP HM, Dermatol & Skin Cancers Dept, Marseille, France.; Gaudy-Marqueste, C (corresponding author), Aix Marseille Univ, CRO2, UMR S 911, Marseille, France.	caroline.gaudy@ap-hm.fr	Gaudy-Marqueste, caroline/AAN-1402-2021	Gaudy-Marqueste, caroline/0000-0001-6955-5117; Hartung, Niklas/0000-0002-4000-6525; Sempe, Christine/0000-0001-6903-1575	F. Hoffmann-La Roche Pharmaceutical	F. Hoffmann-La Roche Pharmaceutical(Hoffmann-La Roche)	This work was funded by a grant from F. Hoffmann-La Roche Pharmaceutical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PK, 2002, STAT METHODS MED RES, V11, P91, DOI 10.1191/0962280202SM276ra; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bucheit AD, 2014, BIOCHEM PHARMACOL, V87, P381, DOI 10.1016/j.bcp.2013.11.013; de Wreede LC, 2011, J STAT SOFTW, V38, P1; de Wreede LC, 2010, COMPUT METH PROG BIO, V99, P261, DOI 10.1016/j.cmpb.2010.01.001; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fallahi-Sichani M, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145877; Gaudy-Marqueste C, 2014, EUR J CANCER, V50, P1120, DOI 10.1016/j.ejca.2013.12.015; Girotti M. R., 2015, CANC DISCOVERY; Grob JJ, 2015, LANCET ONCOL, V16, pE522, DOI 10.1016/S1470-2045(15)00003-0; Hoogstraat Marlous, 2015, Pigment Cell Melanoma Res, V28, P318, DOI 10.1111/pcmr.12347; Kemper K, 2015, EMBO MOL MED, V7, P1104, DOI 10.15252/emmm.201404914; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Larkin J, 2014, LANCET ONCOL, V15, P436, DOI 10.1016/S1470-2045(14)70051-8; LEBLANC M, 1992, BIOMETRICS, V48, P411, DOI 10.2307/2532300; Long GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6694; Ma XH, 2011, CLIN CANCER RES, V17, P3478, DOI 10.1158/1078-0432.CCR-10-2372; McArthur GA, 2014, LANCET ONCOL, V15, P323, DOI 10.1016/S1470-2045(14)70012-9; Menzies AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085004; Monsma DJ, 2015, AM J CANCER RES, V5, P1507; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Qendro V, 2014, J PROTEOME RES, V13, P5031, DOI 10.1021/pr5006789; R Core Team, 2013, R LANG ENV STAT COMP; Rizos H, 2014, CLIN CANCER RES, V20, P1965, DOI 10.1158/1078-0432.CCR-13-3122; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Smith MP, 2014, CANCER DISCOV, V4, P1214, DOI 10.1158/2159-8290.CD-13-1007; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Therneau T, 2015, RPART RECURSIVE PART; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Therneau T. M., 1990, BIOMETRIKA; Therneau T.M., 2000, MODELING SURVIVAL DA	31	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176080	10.1371/journal.pone.0176080	http://dx.doi.org/10.1371/journal.pone.0176080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472075	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500024
J	Jesus, DA; Majewska, M; Krzyzanowska-Berkowska, P; Iskander, DR				Jesus, Danilo A.; Majewska, Malgorzata; Krzyzanowska-Berkowska, Patrycja; Iskander, D. Robert			Influence of eye biometrics and corneal micro-structure on noncontact tonometry	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; INTRAOCULAR-PRESSURE; BIOMECHANICAL PROPERTIES; DIABETES-MELLITUS; IN-VIVO; THICKNESS; GLAUCOMA; SPECKLE; PARAMETERS; HYSTERESIS	Purpose Tonometry is widely used as the main screening tool supporting glaucoma diagnosis. Still, its accuracy could be improved if full knowledge about the variation of the corneal biomechanical properties was available. In this study, Optical Coherence Tomography (OCT) speckle statistics are used to infer the organisation of the corneal micro-structure and hence, to analyse its influence on intraocular pressure (IOP) measurements. Methods Fifty-six subjects were recruited for this prospective study. Macro and micro-structural corneal parameters as well as subject age were considered. Macro-structural analysis included the parameters that are associated with the ocular anatomy, such as central corneal thickness (CCT), corneal radius, axial length, anterior chamber depth and white-to-white corneal diameter. Micro-structural parameters which included OCT speckle statistics were related to the internal organisation of the corneal tissue and its physiological changes during lifetime. The corneal speckle obtained from OCT was modelled with the Generalised Gamma (GG) distribution that is characterised with a scale parameter and two shape parameters. Results In macro-structure analysis, only CCT showed a statistically significant correlation with IOP (R-2 = 0.25, p<0.001). The scale parameter and the ratio of the shape parameters of GG distribution showed statistically significant correlation with IOP (R-2 = 0.19, p<0.001 and R-2 = 0.17, p<0.001, respectively). For the studied group, a weak, although significant correlation was found between age and IOP (R-2 = 0.053, p = 0.04). Forward stepwise regression showed that CCT and the scale parameter of the Generalised Gamma distribution can be combined in a regression model (R-2 = 0.39, p<0.001) to study the role of the corneal structure on IOP. Conclusions We show, for the first time, that corneal micro-structure influences the IOP measurements obtained from noncontact tonometry. OCT speckle statistics can be employed to learn about the corneal micro-structure and hence, to further calibrate the IOP measurements.	[Jesus, Danilo A.; Majewska, Malgorzata; Iskander, D. Robert] Wroclaw Univ Sci & Technol, Dept Biomed Engn, Wroclaw, Poland; [Krzyzanowska-Berkowska, Patrycja] Wroclaw Med Univ, Dept Ophthalmol, Wroclaw, Poland	Wroclaw University of Science & Technology; Wroclaw Medical University	Jesus, DA (corresponding author), Wroclaw Univ Sci & Technol, Dept Biomed Engn, Wroclaw, Poland.	danilo.jesus@pwr.edu.pl	Iskander, D Robert/E-3576-2017; De Jesus, Danilo Andrade/R-3790-2019	Iskander, D Robert/0000-0002-5962-6206; De Jesus, Danilo Andrade/0000-0001-5799-4163; Krzyzanowska-Berkowska, Patrycja/0000-0001-8034-2534	National Science Centre, Poland [2014/15/B/ST7/05220]; Marie Curie Innovative Training Networks, Ageing Eye, AGEYE [608049]	National Science Centre, Poland(National Science Centre, Poland); Marie Curie Innovative Training Networks, Ageing Eye, AGEYE	This work was supported by the Marie Curie Innovative Training Networks, Ageing Eye, AGEYE, 608049 and partially funded by National Science Centre, Poland, Grant No: 2014/15/B/ST7/05220.	Abramowitz M., 1967, HDB MATH FUNCTIONS; Akman A, 2015, BR J OPHTHALMOL; Amini Z, 2016, IEEE T MED IMAGING, V35, P1544, DOI 10.1109/TMI.2016.2519439; Asejczyk-Widlicka M, 2008, BRIT J OPHTHALMOL, V92, P1415, DOI 10.1136/bjo.2008.140178; Baneros-Rojas P, 2014, Arch Soc Esp Oftalmol, V89, P260, DOI 10.1016/j.oftal.2014.02.001; Bao FJ, 2016, J GLAUCOMA, V25, P510, DOI 10.1097/IJG.0000000000000359; Caixinha M, 2014, IEEE T BIO-MED ENG, V61, P2921, DOI 10.1109/TBME.2014.2335739; Cavallotti CAP., 2008, AGE RELATED CHANGES, DOI 10.1007/978-1-59745-507-7; Elsheikh A, 2008, CURR EYE RES, V33, P205, DOI 10.1080/02713680701882519; Elsheikh A, 2013, J GLAUCOMA, V22, P156, DOI 10.1097/IJG.0b013e3182312010; Elsheikh A, 2010, J R SOC INTERFACE, V7, P1475, DOI 10.1098/rsif.2010.0108; Farage M. A., 2008, International Journal of Cosmetic Science, V30, P87, DOI 10.1111/j.1468-2494.2007.00415.x; Farhat G, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3544543; Galgauskas S, 2014, CLIN INTERV AGING, V9, DOI 10.2147/CIA.S61790; Glass DH, 2008, INVEST OPHTH VIS SCI, V49, P3919, DOI 10.1167/iovs.07-1321; Goldich Y, 2009, J CATARACT REFR SURG, V35, P715, DOI 10.1016/j.jcrs.2008.12.013; Good TJ, 2011, BRIT J OPHTHALMOL, V95, P1111, DOI 10.1136/bjo.2010.180729; Gronniger E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000971; Grzywacz NM, 2010, IEEE T MED IMAGING, V29, P1224, DOI 10.1109/TMI.2009.2038375; Gunvant P, 2004, BRIT J OPHTHALMOL, V88, P518, DOI 10.1136/bjo.2003.019331; Hoffmann EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066158; Hong JX, 2013, INVEST OPHTH VIS SCI, V54, P659, DOI 10.1167/iovs.12-10984; Jesus DA, 2017, BIOMED OPT EXPRESS, V8, P162, DOI 10.1364/BOE.8.000162; Jesus DA, 2015, IEEE ENG MED BIO, P5659, DOI 10.1109/EMBC.2015.7319676; Joda AA, 2016, COMPUT METHOD BIOMEC, V19, P943, DOI 10.1080/10255842.2015.1077515; Kirillin MY, 2014, OPT LETT, V39, P3472, DOI 10.1364/OL.39.003472; Kohlhaas M, 2006, ARCH OPHTHALMOL-CHIC, V124, P471, DOI 10.1001/archopht.124.4.471; Kotecha A, 2007, SURV OPHTHALMOL, V52, pS109, DOI 10.1016/j.survophthal.2007.08.004; LACHIN JM, 1981, CONTROL CLIN TRIALS, V2, P93, DOI 10.1016/0197-2456(81)90001-5; Lindenmaier AA, 2013, OPT LETT, V38, P1280, DOI 10.1364/OL.38.001280; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; Patel SV, 2001, INVEST OPHTH VIS SCI, V42, P333; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Scheler A, 2012, ACTA OPHTHALMOL, V90, pe447, DOI 10.1111/j.1755-3768.2012.02437.x; Schmitt JM, 1999, J BIOMED OPT, V4, P95, DOI 10.1117/1.429925; Scholz F. W., 2006, ENCY STAT SCI; Shah S, 2007, INVEST OPHTH VIS SCI, V48, P3026, DOI 10.1167/iovs.04-0694; Shankar PM, 2001, IEEE T ULTRASON FERR, V48, P1716, DOI 10.1109/58.971725; Shimmyo M, 2003, AM J OPHTHALMOL, V136, P603, DOI 10.1016/S0002-9394(03)00424-0; Spoerl E, 2012, J GLAUCOMA, V1; STACY EW, 1965, TECHNOMETRICS, V7, P349, DOI 10.2307/1266594; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tunis AS, 2005, ULTRASOUND MED BIOL, V31, P1041, DOI 10.1016/j.ultrasmedbio.2005.04.020; Urcola JH, 2006, EXP EYE RES, V83, P429, DOI 10.1016/j.exer.2006.01.025; Vinciguerra R, 2016, J REFRACT SURG, V32, P550, DOI 10.3928/1081597X-20160524-01; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192	46	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177180	10.1371/journal.pone.0177180	http://dx.doi.org/10.1371/journal.pone.0177180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472178	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500150
J	Li, Q; Ye, HJ; Ding, YG; Chen, G; Liu, ZC; Xu, JA; Chen, RX; Yang, HS				Li, Qian; Ye, Huijing; Ding, Yungang; Chen, Guo; Liu, Zhichang; Xu, Jianan; Chen, Rongxin; Yang, Huasheng			Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases	PLOS ONE			English	Article								Thyroid associated ophthalmopathy (TAO) is an autoimmune inflammatory disorder which disfigures appearance, threatens vision, and results in a pronounced loss of quality of life. The diversity and ethnic difference of the disease manifestations have made it difficult to tailor therapies for each patient. Few studies have analyzed its characteristics in Chinese populations. We therefore enrolled 354 patients with moderate-to-severe TAO from February 2015 to July 2016. A single ophthalmologist consistently performed detailed ophthalmic examinations. Orbital computed tomography or magnetic resonance imaging scans were performed to verify enlarged extraocular muscles. Multiple linear regression was used to analyze the association between sex, age, smoking, family history of thyroid diseases, degree of proptosis and disease severity. The mean age of males (46.56 +/- 11.08 years) was significantly higher than that of females (41.39 +/- years), with a female-to-male ratio of 1.09. The females and males between 31 similar to 40 and 41 similar to 50 years, respectively, had the highest incidence of TAO. 81.48% of the patients suffered hyperthyroidism. TAO was diagnosed either after (47.17%) or simultaneously with thyroid dysfunction (27.68%). Proptosis (91.24%), eyelid retraction (83.33%), together with eyelid swelling (79.38%) and extraocular muscle enlargement (75.42%), were the most common clinical sign. 19.77% of patients manifested lower eyelid retraction. The mean values of exophthalmos and asymmetry on proptosis were 19.94 +/- 3.45mm and 2.1 +/- 2.06mm, respectively in males, 18.58 +/- 3.31mm and 1.61 +/- 1.53mm, respectively in females. The severity of disease was significantly associated with male, older age, smoking, family history of thyroid diseases and degree of proptosis. We found several differences in Chinese compared with White. The female-to-male ratio and mean value of exophthalmos were significantly lower than the data of White. Inferior and superior rectus became the most common extraocular muscles. Lower eyelid retraction should be included in diagnostic criteria in Asian patients. Understanding these differences, may allow better identification and treatment for TAO in China.	[Li, Qian; Ye, Huijing; Ding, Yungang; Chen, Guo; Liu, Zhichang; Xu, Jianan; Chen, Rongxin; Yang, Huasheng] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Ding, Yungang] Qingdao Ludong Eye Hosp, Qingdao, Shandong, Peoples R China	Sun Yat Sen University	Yang, HS (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	yanghs64@126.com		Yang, Huasheng/0000-0003-2767-8623	National Natural Science Foundation of China [81470664, 81670887]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Publication of this article was supported by the National Natural Science Foundation of China (81470664 and 81670887). The funding organizations had no role in the design or conduct of this research.; All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. All authors have no potential conflicts of interest. Publication of this article was supported by the National Natural Science Foundation of China (81470664). The funding organizations had no role in the design or conduct of this research. Qian Li and Huasheng Yang had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.	Abraham-Nordling M, 2011, EUR J ENDOCRINOL, V165, P899, DOI 10.1530/EJE-11-0548; Andersen S, 2012, J CLIN ENDOCR METAB, V97, P8; [Anonymous], 2015, HORM METAB RES, V447, P6; [Anonymous], 1992, THYROID, V2, P2; [Anonymous], 2002, EUR J ENDOCRINOL, V146, P9; Bahn RS, 2010, NEW ENGL J MED, V362, P726, DOI 10.1056/NEJMra0905750; Balazs C S V, 1990, LANCET, V336, P1; Bartalena L M C, 1998, ANN INTERN MED, V129, P4; Bartalena L P A, ENDOCR REV ENDOCR RE, V21, P31; Bartley GB, 1996, AM J OPHTHALMOL, V121, P200, DOI 10.1016/S0002-9394(14)70585-9; BARTLEY GB, 1995, AM J OPHTHALMOL, V119, P96, DOI 10.1016/S0002-9394(14)73821-8; BERGHOUT A, 1988, J ENDOCRINOL INVEST, V11, P15, DOI 10.1007/BF03350087; Blake CR L W, 2003, INT OPHTHALMOL CLIN, V43, P17; Chng CL, 2012, BEST PRACT RES CLIN, V26, P10; Cmelo J C M, 2006, CESK SLOV OFTALMOL, V62, P8; Douglas RS G S, 2011, CURR OPIN OPHTHALMOL, V22, P6; Eckstein AK P M, 2006, J CLIN ENDOCR METAB, V91, P7; Enzmann DR, 1979, J COMPUT ASSIST TOMO, V3, P5; Estcourt S H J, 2009, EUR J ENDOCRINOL, V161, P5; Ewa Fidor-Mikita WK, 2008, J PRECLINICAL CLIN R, V2, P5; FRUEH BR, 1986, OPHTHALMIC SURG LAS, V17, P37; GB B, 1994, T AM OPHTHALMOL SOC, P111; Hegedius L B T, 2004, J ENDOCRINOL INVEST, V27, P7; JH L, 2012, BEST PRACT RES CLIN, V26, P7; Kahaly G B H, 1990, J ENDOCRINOL INVEST, V13, P6; Kendler DL L J, 1993, ARCH OPHTHALMOL-CHIC, V111, P5; Kozaki A I R, 2010, OPTOMETRY VISION SCI, V87, P5; Kumari Sodhi P G V, 2001, ORBIT, V20, P9; Lee JH L S, 2010, KOREAN J OPHTHALMOL, V24, P8; Lim NC S G, 2015, BR J OPHTHALMOL, V99, P7; Lim SL L A, 2008, THYROID, V18, P5; Manji N J C-S, 2006, J CLIN ENDOCR METAB, V91, P8; Migliori ME G G., 1984, AM J OPHTHALMOL, V98, P5; Mourits MP, 1997, CLIN ENDOCRINOL, V47, P9, DOI 10.1046/j.1365-2265.1997.2331047.x; Murchison AP, 2009, ARCH FACIAL PLAST S, V11, P303, DOI 10.1001/archfacial.2009.9; Naik VM N M, 2010, SURV OPHTHALMOL, V55, P12; Perros P C A, 1993, CLIN ENDOCRINOL OXF, V38, P6; Perros P Z M, 2015, BR J OPHTHALMOL, V99, P5; Ponto KA H G, 2011, AM J OPHTHALMOL, V152, P8; Ponto KA K M, 2011, OPHTHALMOLOGY, V118, P7; Prummel MFWW, 1993, JAMA-J AM MED ASSOC, V269, P4; Rapoport B M S, 2007, THYROID, V17, P12; Scott IU, 1999, SEMIN OPHTHALMOL, V14, P10; Sheikh M A S, 2007, AUSTRALAS RADIOL, V51, P4; Smith TJ, 2015, NAT REV ENDOCRINOL, V11, P171, DOI 10.1038/nrendo.2014.226; Tsai CC K H, 2006, EYE LOND, V20, P5; Wang Y, 2014, INVEST OPHTH VIS SCI, V55, P1735, DOI 10.1167/iovs.14-14002; WIERSINGA WM, 1989, OPHTHALMIC RES, V21, P73, DOI 10.1159/000266782; WiersingaWilmar MK G J, 2010, GRAVES ORBITOPATHY M, P11; WMW, 2013, CLIN ENDOCRINOL OXF, V79, P7; WMW, 2012, INDIAN J ENDOCRIN S2, V16, P3; Wu D L X, 2015, SCI REP, V23	52	23	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176064	10.1371/journal.pone.0176064	http://dx.doi.org/10.1371/journal.pone.0176064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472149	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500022
J	Timsina, LR; Willetts, JL; Brennan, MJ; Marucci-Wellman, H; Lombardi, DA; Courtney, TK; Verma, SK				Timsina, Lava R.; Willetts, Joanna L.; Brennan, Melanye J.; Marucci-Wellman, Helen; Lombardi, David A.; Courtney, Theodore K.; Verma, Santosh K.			Circumstances of fall-related injuries by age and gender among community-dwelling adults in the United States	PLOS ONE			English	Article							OLDER-ADULTS; OUTDOOR FALLS; ENVIRONMENTAL-FACTORS; EMERGENCY-DEPARTMENTS; ELDERLY-PEOPLE; RISK-FACTORS; HOME; WALKING; HEALTH; YOUNG	Introduction Falls are the leading cause of injury in almost all age-strata in the U.S. However, fall-related injuries (FI) and their circumstances are under-studied at the population level, particularly among young and middle-aged adults. This study examined the circumstances of FI among community-dwelling U.S. adults, by age and gender. Methods Narrative texts of FI from the National Health Interview Survey (1997-2010) were coded using a customized taxonomy to assess place, activity, initiating event, hazards, contributing factors, fall height, and work-relatedness of FI. Weighted proportions and incidence rates of FI were calculated across six age-gender groups (18-44, 45-64, 65+ years; women, men). Results The proportion of FI occurring indoors increased with age in both genders (22%, 30%, and 48% among men, and 40%, 49% and 62% among women for 18-44, 45-64, 65+ age-groups, respectively). In each age group the proportion of indoor FI was higher among women as compared to men. Among women, using the stairs was the second leading activity (after walking) at the time of FI (19%, 14% and 10% for women in 18-44, 45-64, 65+ age groups, respectively). FI associated with tripping increased with age among both genders, and women were more likely to trip than men in every age group. Of all age-gender groups, the rate of FI while using ladders was the highest among middle-aged men (3.3 per 1000 person-year, 95% Cl 2.0, 4.5). Large objects, stairs and steps, and surface contamination were the three most common hazards noted for 15%, 14% and 13% of fall-related injuries, respectively. Conclusions The rate and the circumstances of FI differ by age and gender. Understanding these differences and obtaining information about circumstances could be vital for developing effective interventions to prevent falls and FI.	[Timsina, Lava R.; Willetts, Joanna L.; Brennan, Melanye J.; Marucci-Wellman, Helen; Lombardi, David A.; Courtney, Theodore K.; Verma, Santosh K.] Liberty Mutual Res Inst Safety, Ctr Injury Epidemiol, Hopkinton, MA USA; [Timsina, Lava R.] Univ Kentucky, Coll Publ Hlth, Lexington, KY USA; [Lombardi, David A.; Courtney, Theodore K.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Environm & Occupat Med & Epidemiol Program, Boston, MA USA; [Verma, Santosh K.] Univ Massachusetts, Med Sch, Dept Family Med & Community Hlth, Worcester, MA 01605 USA	Liberty Mutual Research Institute for Safety; University of Kentucky; Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Worcester	Verma, SK (corresponding author), Liberty Mutual Res Inst Safety, Ctr Injury Epidemiol, Hopkinton, MA USA.; Verma, SK (corresponding author), Univ Massachusetts, Med Sch, Dept Family Med & Community Hlth, Worcester, MA 01605 USA.	Santosh.Verma@LibertyMutual.com	Timsina, Lava/AFR-2241-2022; Courtney, Theodore K./P-4829-2019; Courtney, Theodore/J-8902-2013	Courtney, Theodore K./0000-0001-8139-1565; Courtney, Theodore/0000-0001-8139-1565; Holloway, Courtney Jean/0000-0003-3661-1957; Timsina, Lava/0000-0001-7493-5843; Lombardi, David/0000-0001-6151-2024	Liberty Mutual Research Institute for Safety of the Liberty Mutual Insurance Company; The Ministry of Science and Technology, Taiwan (NSC) [8WFD2100412, 99-2314-B-037-040-MY3, 101-2325-B-037-003]; Kaohsiung Medical University Hospital [KMUH-102-2R05]	Liberty Mutual Research Institute for Safety of the Liberty Mutual Insurance Company; The Ministry of Science and Technology, Taiwan (NSC); Kaohsiung Medical University Hospital	This research study was funded by the Liberty Mutual Research Institute for Safety which is a wholly owned subsidiary of the Liberty Mutual Insurance Company. The funder provided support in the form of salaries for authors [LRT, JLW, MJB, HMW, DAL, TKC, SKV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported partly by grants from The Ministry of Science and Technology, Taiwan (NSC 98WFD2100412, 99-2314-B-037-040-MY3, 101-2325-B-037-003) and Kaohsiung Medical University Hospital (KMUH-102-2R05). The authors thank serum processing help from Taiwan Liver Research Foundation (TLRF). The foundation did not influence how the study was conducted or the approval of the manuscript.	Adams Patricia E, 2011, Vital Health Stat 10, P1; Adams PE, 2010, VITAL HLTH STAT, V10, P1; Adams PF, 2013, VITAL HLTH STAT SERI, V10; [Anonymous], 2013, SAS STAT R 13 1 US G; Archea J., 1979, GUIDELINES STAIR SAF; Bath PA, 1999, EUR J EPIDEMIOL, V15, P65, DOI 10.1023/A:1007531101765; Begg R, 2007, GAIT POSTURE, V25, P191, DOI 10.1016/j.gaitpost.2006.03.008; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; Berggard G, 2010, ACCIDENT ANAL PREV, V42, P1199, DOI 10.1016/j.aap.2010.01.011; Bergland A, 1998, Physiother Res Int, V3, P164, DOI 10.1002/pri.138; Berrigan David, 2012, Morbidity and Mortality Weekly Report, V61, P595; Bjornstig U, 1997, ACCIDENT ANAL PREV, V29, P211, DOI 10.1016/S0001-4575(96)00074-7; BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Caban-Martinez AJ, 2015, AM J PREV MED, V49, P888, DOI 10.1016/j.amepre.2015.05.022; Centers for Disease Control and Prevention (CDC), 2013, STEADI STOPP ELD ACC; Chen LH, 2009, VITAL HLTH STAT, V10, P241; Cho SH, 2004, CLIN BIOMECH, V19, P145, DOI 10.1016/j.clinbiomech.2003.10.003; Cigolle CT, 2015, JAMA INTERN MED, V175, P443, DOI 10.1001/jamainternmed.2014.7533; Courtney TK, 2010, INJURY PREV, V16, P36, DOI 10.1136/ip.2009.022749; Courtney TK, 2001, ERGONOMICS, V44, P1118, DOI 10.1080/00140130110085538; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P57, DOI 10.4103/2229-5151.79283; D'Souza AL, 2007, AM J PREV MED, V32, P413, DOI 10.1016/j.amepre.2007.01.012; Duckham RL, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-133; Faulkner KA, 2005, J AM GERIATR SOC, V53, P1774, DOI 10.1111/j.1532-5415.2005.53514.x; Ferber R, 2003, CLIN BIOMECH, V18, P350, DOI 10.1016/S0268-0033(03)00025-1; FOTHERGILL J, 1995, ERGONOMICS, V38, P220, DOI 10.1080/00140139508925099; Gao CS, 2004, ERGONOMICS, V47, P573, DOI 10.1080/00140130410081658718; Garman CR, 2015, J BIOMECH, V48, P1229, DOI 10.1016/j.jbiomech.2015.01.031; Gorina Y, 2005, TRENDS CAUSES DEATH; Heijnen MJH, 2016, HUM MOVEMENT SCI, V46, P86, DOI 10.1016/j.humov.2015.12.007; HEMENWAY D, 1994, ACCIDENT ANAL PREV, V26, P675, DOI 10.1016/0001-4575(94)90029-9; Hsue BJ, 2014, ARCH PHYS MED REHAB, V95, P1860, DOI 10.1016/j.apmr.2014.05.001; Hu GQ, 2009, AM J PREV MED, V37, P188, DOI 10.1016/j.amepre.2009.04.023; Hu GQ, 2012, PUBLIC HEALTH REP, V127, P275, DOI 10.1177/003335491212700307; Jacobs JV, 2016, GAIT POSTURE; Keall MD, 2015, LANCET, V385, P231, DOI 10.1016/S0140-6736(14)61006-0; Kelsey JL, 2010, FOOTWEAR SCI, V2, P123, DOI 10.1080/19424280.2010.491074; Kelsey JL, 2012, AM J PUBLIC HEALTH, V102, P2149, DOI 10.2105/AJPH.2012.300677; Kelsey JL, 2010, J AM GERIATR SOC, V58, P2135, DOI 10.1111/j.1532-5415.2010.03062.x; Kerrigan DC, 1998, AM J PHYS MED REHAB, V77, P2, DOI 10.1097/00002060-199801000-00002; Lee CM, 2001, INT J IND ERGONOM, V28, P321, DOI 10.1016/S0169-8141(01)00038-5; Li WJ, 2006, AM J PUBLIC HEALTH, V96, P1192, DOI 10.2105/AJPH.2005.083055; Lincoln AE, 2004, INJURY PREV, V10, P249, DOI 10.1136/ip.2004.005181; Lombardi DA, 2011, SCAND J WORK ENV HEA, V37, P525, DOI 10.5271/sjweh.3174; Lombardi DA, 2010, CHRONOBIOL INT, V27, P1013, DOI 10.3109/07420528.2010.489466; Lombardi DA, 2009, J OCCUP ENVIRON HYG, V6, P612, DOI 10.1080/15459620903133683; Marucci-Wellman HR, 2014, AM J PUBLIC HEALTH, V104, P134, DOI 10.2105/AJPH.2013.301431; McKiernan FE, 2005, J AM GERIATR SOC, V53, P943, DOI 10.1111/j.1532-5415.2005.53302.x; Miller JA, 1959, NATURE CAUSES STAIRW; NAGATA H, 1991, SAFETY SCI, V14, P199, DOI 10.1016/0925-7535(91)90021-D; Nemire K, 2016, APPL ERGON, V52, P309, DOI 10.1016/j.apergo.2015.07.021; NORTHRIDGE ME, 1995, AM J PUBLIC HEALTH, V85, P509, DOI 10.2105/AJPH.85.4.509; O'Sullivan J, 2004, INJURY, V35, P429, DOI 10.1016/S0020-1383(03)00265-1; Orces CH, 2014, INJURY PREV, V20, P421, DOI 10.1136/injuryprev-2014-041268; Orces Carlos H, 2008, Tex Med, V104, P55; Pynoos J, 2010, CLIN GERIATR MED, V26, P633, DOI 10.1016/j.cger.2010.07.001; Singhal K, 2015, HUM MOVEMENT SCI, V41, P230, DOI 10.1016/j.humov.2015.03.004; Sise RG, 2014, J TRAUMA ACUTE CARE, V76, P913, DOI 10.1097/TA.0000000000000169; Smith GS, 2006, INJURY PREV, V12, P236, DOI 10.1136/ip.2006.011676; Smith GS, 2005, AM J PUBLIC HEALTH, V95, P1213, DOI 10.2105/AJPH.2004.049338; Smith GS, 2003, INJURY PREV, V9, P3, DOI 10.1136/ip.9.1.3; Talbot LA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-86; Templer J., 1995, STAIRCASE STUDIES HA; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1207, DOI 10.1111/j.1532-5415.1995.tb07395.x; Verma SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150939; Verma SK, 2011, OCCUP ENVIRON MED, V68, P575, DOI 10.1136/oem.2010.056226; Verma SK, 2011, OCCUP ENVIRON MED, V68, P279, DOI 10.1136/oem.2010.056218; Verma S, 2008, ERGONOMICS, V51, P1960, DOI 10.1080/00140130802558987; Voukelatos A, 2015, AGE AGEING, V44, P377, DOI 10.1093/ageing/afu186; Warner M, 2000, Vital Health Stat 10, P1; WEINBERG LE, 1995, ARCH PHYS MED REHAB, V76, P955, DOI 10.1016/S0003-9993(95)80074-3; Wright M, 2008, CONTEMPORARY ERGONOMICS 2008, P632; Yasumura S, 1996, ARCH GERONTOL GERIAT, V23, P95, DOI 10.1016/0167-4943(96)00711-X	74	65	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176561	10.1371/journal.pone.0176561	http://dx.doi.org/10.1371/journal.pone.0176561			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472065	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500052
J	Qiong, L; Zhang, WJ; Wang, H; Zeng, LY; Birks, HJB; Zhong, Y				Qiong, La; Zhang, Wenju; Wang, Hao; Zeng, Liyan; Birks, H. John B.; Zhong, Yang			Testing the effect of the Himalayan mountains as a physical barrier to gene flow in Hippophae tibetana Schlect. (Elaeagnaceae)	PLOS ONE			English	Article							MATING-SYSTEM; POPULATION; DIVERSITY; DIFFERENTIATION; SOFTWARE; PATTERNS; L.; MARKERS; CHINA; SHRUB	Hippophae tibetana is a small, dioecious wind-pollinated shrub endemic to the Tibetan-Qinghai Plateau. It is one of the shrubs that occur at very high elevations (5250 m a.s.l.). The Himalayan mountains provides a significant geographical barrier to the Qinghai-Tibetan Plateau, dividing the Himalayan area into two regions with Nepal to the south and Tibet to the north. There is no information on how the Himalayan mountains influence gene flow and population differentiation of alpine plants. In this study, we analyzed eight nuclear microsatellite markers and cpDNA trnT-trnF regions to test the role of the Himalayan mountains as a barrier to gene flow between populations of H. tibetana. We also examined the fine-scale genetic structure within a population of H. tibetana on the north slope of Mount (Mt.) Everest. For microsatellite analyses, a total of 241 individuals were sampled from seven populations in our study area (4 from Nepal, 3 from Tibet), including 121 individuals that were spatially mapped within a 100 m x 100 m plot. To test for seed flow, the cpDNA trnT-trnF regions of 100 individuals from 6 populations (4 from Nepal, 2 from Tibet) were also sequenced. Significant genetic differentiation was detected between the two regions by both microsatellite and cpDNA data analyses. These two datasets agree about southern and northern population differentiation, indicating that the Himalayan mountains represent a barrier to H. tibetana limiting gene flow between these two areas. At a fine scale, spatial autocorrelation analysis suggests significant genetic structure within a distance of less than 45 m, which may be attributed mainly to vegetative reproduction and habitat fragmentation, as well as limited gene flow.	[Qiong, La; Zhang, Wenju; Wang, Hao; Zeng, Liyan; Zhong, Yang] Fudan Univ, Inst Biodivers Sci, Sch Life Sci, Shanghai, Peoples R China; [Qiong, La; Zhong, Yang] Tibet Univ, Dept Biol, Lhasa, Peoples R China; [Birks, H. John B.] Univ Bergen, Dept Biol, Bergen, Norway; [Birks, H. John B.] UCL, Environm Change Res Ctr, London, England	Fudan University; Tibet University; University of Bergen; University of London; University College London	Zhong, Y (corresponding author), Fudan Univ, Inst Biodivers Sci, Sch Life Sci, Shanghai, Peoples R China.; Zhong, Y (corresponding author), Tibet Univ, Dept Biol, Lhasa, Peoples R China.	yangzhong@fudan.edu.cn			National Natural Science Foundation of China [41061007, 91131901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant Number 41061007 and Grant Number 91131901).; We thank Ning Zhao and Wei-dong Zhu for their help in sample collection, and Miao An and Ting Xu for their help in the data analysis. H. John B. Birks is grateful to Cathy Jenks for invaluable editorial help. This study was supported by the National Natural Science Foundation of China (Grant Number 41061007 and Grant Number 91131901).	Alberto F, MOL ECOLOGY, V14, P2669; ALLARD RW, 1975, GENETICS, V79, P115; Avise John C., 2004, P1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bartish IV, 1999, MOL ECOL, V8, P791, DOI 10.1046/j.1365-294X.1999.00631.x; Bartish IV, 2000, PLANT SYST EVOL, V225, P85, DOI 10.1007/BF00985460; Bauert MR, 1998, MOL ECOL, V7, P1519, DOI 10.1046/j.1365-294x.1998.00470.x; Berge G, 1998, OIKOS, V81, P17, DOI 10.2307/3546463; Chen SY, 2008, BOT J LINN SOC, V157, P125, DOI 10.1111/j.1095-8339.2008.00785.x; Chen SF, 2014, BIOCHEM SYST ECOL, V55, P66, DOI 10.1016/j.bse.2014.02.029; [陈学林 Chen Xuelin], 2003, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V23, P451; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; Cortes AJ, 2014, HEREDITY, V113, P233, DOI 10.1038/hdy.2014.19; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; ERIKSSON O, 1989, OIKOS, V55, P231, DOI 10.2307/3565427; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisher PJ, 1996, NUCLEIC ACIDS RES, V24, P4369, DOI 10.1093/nar/24.21.4369; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gayden T, 2007, AM J HUM GENET, V80, P884, DOI 10.1086/516757; Gehring JL, 1999, HEREDITY, V82, P628, DOI 10.1046/j.1365-2540.1999.00524.x; Geng YP, 2009, GENETICA, V135, P419, DOI 10.1007/s10709-008-9290-6; Hamilton MB, 1999, NATURE, V401, P129, DOI 10.1038/43597; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hawkes LA, 2011, P NATL ACAD SCI USA, V108, P9516, DOI 10.1073/pnas.1017295108; Hoffmann Robert S., 2001, Acta Zoologica Sinica, V47, P121; Hutsemekers V, 2013, AQUAT BOT, V108, P1, DOI 10.1016/j.aquabot.2013.02.001; Ikeda H, 2006, MOL ECOL, V15, P3731, DOI 10.1111/j.1365-294X.2006.03054.x; Jacquemyn H, 2005, MOL ECOL, V14, P4479, DOI 10.1111/j.1365-294X.2005.02741.x; Kang SC, 2001, EPISODES, V24, P176; Kittel TGF, 2000, GLOBAL CHANGE BIOL, V6, P1, DOI 10.1046/j.1365-2486.2000.06011.x; Lesica P, 2004, J VEG SCI, V15, P679, DOI 10.1111/j.1654-1103.2004.tb02310.x; Lian YS., 1998, SEABUCKTHORN RES, V1, P13; Lian YS, 2001, BIOL CHEM GENUS HIPP, P151; LIU Z, 1993, THEOR APPL GENET, V87, P97, DOI 10.1007/BF00223752; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; MANTEL N, 1967, CANCER RES, V27, P209; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M., 1987, MOL EVOLUTIONARY GEN; Nesbo CL, 1998, HEREDITAS, V129, P241, DOI 10.1111/j.1601-5223.1998.00241.x; Ness RW, 2010, GENETICS, V184, P381, DOI 10.1534/genetics.109.110130; Nie Y, 2010, J GEOGR SCI, V20, P667, DOI 10.1007/s11442-010-0803-8; Ohsawa T, 2008, GLOBAL ECOL BIOGEOGR, V17, P152, DOI 10.1111/j.1466-8238.2007.00357.x; Owen LA, 2009, QUATERNARY SCI REV, V28, P1412, DOI 10.1016/j.quascirev.2009.02.010; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pluess AR, 2004, AM J BOT, V91, P2013, DOI 10.3732/ajb.91.12.2013; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Pulido F, 2004, ADV ECOL RES, V35, P151, DOI 10.1016/S0065-2504(04)35008-7; RITLAND K, 1989, CAN J BOT, V67, P2017, DOI 10.1139/b89-255; Rousset F, 1997, GENETICS, V145, P1219; ROUSSET F, 1995, GENETICS, V140, P1413; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sebbenn AM, 2011, HEREDITY, V106, P134, DOI 10.1038/hdy.2010.33; Sharma SS, 2000, COLD REG SCI TECHNOL, V31, P95, DOI 10.1016/S0165-232X(99)00034-8; Sheng HM, 2006, PLANT SYST EVOL, V260, P25, DOI 10.1007/s00606-006-0413-1; Smith JM, 1999, EVOLUTIONARY GENETIC; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; SOKAL RR, 1983, GENETICS, V105, P219; Streiff R, 1998, MOL ECOL, V7, P317, DOI 10.1046/j.1365-294X.1998.00360.x; Su H, 2003, HEREDITY, V90, P212, DOI 10.1038/sj.hdy.6800237; Sun K, 2002, PLANT SYST EVOL, V235, P121, DOI 10.1007/s00606-002-0206-0; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Teixeira H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088996; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian CJ, 2004, BIOCHEM GENET, V42, P259, DOI 10.1023/B:BIGI.0000034430.93055.ff; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Von Oheimb PV, 2013, BIOL J LINN SOC, V109, P526, DOI 10.1111/bij.12068; Vornam B, 2004, CONSERV GENET, V5, P561, DOI 10.1023/B:COGE.0000041025.82917.ac; Wang H, 2010, MOL ECOL, V19, P2964, DOI 10.1111/j.1365-294X.2010.04729.x; Wang YH, 2011, PLANT SYST EVOL, V295, P97, DOI 10.1007/s00606-011-0466-7; Wolff K, 1997, MOL ECOL, V6, P365, DOI 10.1046/j.1365-294X.1997.00201.x; Yokozeki Y, 1997, THEOR APPL GENET, V94, P61, DOI 10.1007/s001220050382; YOUNG AG, 1993, HEREDITY, V71, P277, DOI 10.1038/hdy.1993.136; Yuan JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034955; Zeng LY, 2012, AM J BOT, V99, pE326, DOI 10.3732/ajb.1200019	81	12	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0172948	10.1371/journal.pone.0172948	http://dx.doi.org/10.1371/journal.pone.0172948			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489850	Green Published, gold			2022-12-27	WOS:000401314100002
J	van Aalst, S; Ludwig, IS; van der Zee, R; van Eden, W; Broere, F				van Aalst, Susan; Ludwig, Irene S.; van der Zee, Ruurd; van Eden, Willem; Broere, Femke			Bystander activation of irrelevant CD4(+) T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant	PLOS ONE			English	Article							IN-VIVO; AUTOIMMUNITY; PROLIFERATION; INFECTION; ARTHRITIS; VACCINES; VIRUS; STIMULATION; RECRUITMENT; PHENOTYPE	Autoimmune and other chronic inflammatory diseases (AID) are prevalent diseases which can severely impact the quality of life of those that suffer from the disease. In most cases, the etiology of these conditions have remained unclear. Immune responses that take place e.g. during natural infection or after vaccination are often linked with the development or exacerbation of AID. It is highly debated if vaccines induce or aggravate AID and in particular adjuvants are mentioned as potential cause. Since vaccines are given on a large scale to healthy individuals but also to elderly and immunocompromised individuals, more research is warranted. Non-specific induction of naive or memory autoreactive T cells via bystander activation is one of the proposed mechanisms of how vaccination might be involved in AID. During bystander activation, T cells unrelated to the antigen presented can be activated without (strong) T cell receptor (TCR) ligation, but via signals derived from the ongoing response directed against the vaccine-antigen or adjuvant at hand. In this study we have set up a TCR transgenic T cell transfer mouse model by which we were able to measure local bystander activation of transferred and labeled CD4(+) T cells. Intramuscular injection with the highly immunogenic Complete Freund's Adjuvant (CFA) led to local in vivo proliferation and activation of intravenously transferred CD4(+) T cells in the iliac lymph node. This local bystander activation was also observed after CFA prime and Incomplete Freund's Adjuvant (IFA) boost injection. Furthermore, we showed that an antigen specific response is sufficient for the induction of a bystander activation response and the general, immune stimulating effect of CFA or IFA does not appear to increase this effect. In other words, no evidence was obtained that adjuvation of antigen specific responses is essential for bystander activation.	[van Aalst, Susan; Ludwig, Irene S.; van der Zee, Ruurd; van Eden, Willem; Broere, Femke] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands	Utrecht University	Broere, F (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	f.broere@uu.nl		Broere, Femke/0000-0001-9343-0111; van Eden, Willem/0000-0003-1272-704X	Innovative Medicines Initiative Joint Undertaking [115308]; European Union's Seventh Framework Programme (FP7); EFPIA	Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme (FP7); EFPIA	This work was part of the BioVacSafe project. The BioVacSafe project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no 115308, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution.	Ahmed S.S., 2014, AUTOIMMUN DIS, V5th ed., P275, DOI [10.1016/B978-0-12-384929-8.00020-4, DOI 10.1016/B978-0-12-384929-8.00020-4]; AHMED SS, 2015, SCI TRANSL MED, V7; Bangs SC, 2006, TRENDS IMMUNOL, V27, P518, DOI 10.1016/j.it.2006.09.006; Barker CIS, 2014, LANCET INFECT DIS, V14, P227, DOI 10.1016/S1473-3099(13)70238-X; Batista-Duharte A, 2014, INT IMMUNOPHARMACOL, V20, P170, DOI 10.1016/j.intimp.2014.02.033; Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Berlo SE, 2005, J AUTOIMMUN, V25, P172, DOI 10.1016/j.jaut.2005.09.017; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; Boyman O, 2010, EUR J IMMUNOL, V40, P936, DOI 10.1002/eji.201040466; Broere F, 2008, J IMMUNOL, V181, P899, DOI 10.4049/jimmunol.181.2.899; Chapman TJ, 2005, VIROLOGY, V340, P296, DOI 10.1016/j.virol.2005.06.023; Chen RT, 2001, J AUTOIMMUN, V16, P309, DOI 10.1006/jaut.2000.0491; Chillingworth NL, 2003, J NEUROSCI METH, V128, P45, DOI 10.1016/S0165-0270(03)00147-X; Darabi K, 2004, J IMMUNOL, V173, P92, DOI 10.4049/jimmunol.173.1.92; Di Genova G, 2006, BLOOD, V107, P2806, DOI 10.1182/blood-2005-08-3255; Di Genova G, 2010, EUR J IMMUNOL, V40, P976, DOI 10.1002/eji.200940017; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; Eberl G, 2000, J IMMUNOL, V165, P4305, DOI 10.4049/jimmunol.165.8.4305; Ehl S, 1997, J EXP MED, V185, P1241, DOI 10.1084/jem.185.7.1241; Floreani A., 2015, CLIN REV ALLERGY IMM; Getts DR, 2013, IMMUNOL REV, V255, P197, DOI 10.1111/imr.12091; Goodridge HS, 2016, NAT REV IMMUNOL, V16, P392, DOI 10.1038/nri.2016.43; Hawkes D, 2015, J AUTOIMMUN, V59, P77, DOI 10.1016/j.jaut.2015.02.005; Holmdahl R, 2001, IMMUNOL REV, V184, P184, DOI 10.1034/j.1600-065x.2001.1840117.x; Jansen MAA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00090; Kamath AT, 2005, J IMMUNOL, V174, P767, DOI 10.4049/jimmunol.174.2.767; Lambert P., 2002, STATUS NONCLINICAL M, VI, P237; Letourneau S, 2009, J ALLERGY CLIN IMMUN, V123, P758, DOI 10.1016/j.jaci.2009.02.011; Li Causi E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136717; McLachlan JB, 2009, IMMUNITY, V30, P277, DOI 10.1016/j.immuni.2008.11.013; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; O'Donnell H, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00621; Pellegrino P, 2015, AUTOIMMUN REV, V14, P880, DOI 10.1016/j.autrev.2015.05.014; Polley R, 2005, EUR J IMMUNOL, V35, P498, DOI 10.1002/eji.200425436; Regner M, 2001, NAT IMMUNOL, V2, P185, DOI 10.1038/85228; Root-Bernstein R, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0407-3; Salemi S, 2010, INT REV IMMUNOL, V29, P247, DOI 10.3109/08830181003746304; Sandalova E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001051; Sckisel GD, 2014, CLIN EXP IMMUNOL, V175, P79, DOI 10.1111/cei.12186; Sfriso P, 2010, J LEUKOCYTE BIOL, V87, P385, DOI 10.1189/jlb.0709517; Sharma S, 2014, J LEUKOCYTE BIOL, V95, P405, DOI 10.1189/jlb.0713386; Shoenfeld Y, 2011, J AUTOIMMUN, V36, P4, DOI 10.1016/j.jaut.2010.07.003; Soriano A, 2015, PHARMACOL RES, V92, P18, DOI 10.1016/j.phrs.2014.08.002; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Tough DF, 1998, VET IMMUNOL IMMUNOP, V63, P123, DOI 10.1016/S0165-2427(98)00088-9; van Aalst S, 2017, VACCINE, V35, P1622, DOI 10.1016/j.vaccine.2017.02.005; van der Laan JW, 2015, VACCINE, V33, P1507, DOI 10.1016/j.vaccine.2015.01.073; van Eden W, 2001, ANONYMOUS CURRENT PR; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701; Wraith DC, 2003, LANCET, V362, P1659, DOI 10.1016/S0140-6736(03)14802-7	51	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177365	10.1371/journal.pone.0177365	http://dx.doi.org/10.1371/journal.pone.0177365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489886	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314100067
J	Anderson, BA				Anderson, Brian A.			On the feature specificity of value-driven attention	PLOS ONE			English	Article							OCULOMOTOR CAPTURE; VISUAL-CORTEX; REWARD; PRIORITY; SIGNALS; CONTINGENCIES; SALIENCE; COLOR	When an otherwise inconspicuous stimulus is learned to predict a reward, this stimulus will automatically capture visual attention. This learned attentional bias is not specific to the precise object previously associated with reward, but can be observed for different stimuli that share a defining feature with the reward cue. Under certain circumstances, value-driven attentional biases can even transfer to new contexts in which the reward cues were not previously experienced, and can also be evident for different exemplars of a stimulus category, suggesting some degree of tolerance in the scope of the underlying bias. Whether a match to a reward-predictive feature is necessary to support value-driven attention, or whether similar-looking features also receive some degree of elevated priority following associative reward learning, remains an open question. Here, I examine the impact of learned associations between reward and red-and green-colored stimuli on the processing of other colors. The findings show that even though other colors experienced during training were non-predictive with respect to reward, the speed with which targets possessing these colors were identified in a subsequent test phase was affected by their similarity to the high-value color. Thus, value-driven attentional biases for stimulus features are imprecise, as would be predicted by a sensory gain model of value-driven attention.	[Anderson, Brian A.] Texas A&M Univ, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Anderson, BA (corresponding author), Texas A&M Univ, College Stn, TX 77843 USA.	brian.anderson@tamu.edu			University Libraries; Office of the Vice President for Research	University Libraries; Office of the Vice President for Research	The open access publishing fees for this article have been covered by the Texas A&M University Open Access to Knowledge Fund (OAKFund), supported by the University Libraries and the Office of the Vice President for Research.	Anderson BA, ATTN PERCEP IN PRESS; Anderson BA, 2017, SOC COGN AFFECT NEUR, V12, P461, DOI 10.1093/scan/nsw141; Anderson BA, 2016, ANN NY ACAD SCI, V1369, P24, DOI 10.1111/nyas.12957; Anderson BA, 2016, CURR BIOL, V26, P550, DOI 10.1016/j.cub.2015.12.062; Anderson BA, 2015, PSYCHON B REV, V22, P750, DOI 10.3758/s13423-014-0724-0; Anderson BA, 2015, VIS COGN, V23, P67, DOI 10.1080/13506285.2014.956851; Anderson BA, 2014, BRAIN RES, V1587, P88, DOI 10.1016/j.brainres.2014.08.062; Anderson BA, 2014, COGN AFFECT BEHAV NE, V14, P1221, DOI 10.3758/s13415-014-0301-z; Anderson BA, 2014, J EXP PSYCHOL HUMAN, V40, P1755, DOI 10.1037/a0037685; Anderson BA, 2013, J VISION, V13, DOI 10.1167/13.3.7; Anderson BA, 2012, ATTEN PERCEPT PSYCHO, V74, P1183, DOI 10.3758/s13414-012-0325-9; Anderson BA, 2012, VIS COGN, V20, P647, DOI 10.1080/13506285.2012.679711; Anderson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027926; Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Anderson BA, 2010, ATTEN PERCEPT PSYCHO, V72, P342, DOI 10.3758/APP.72.2.342; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; Ansorge U, 2003, J EXP PSYCHOL HUMAN, V29, P937, DOI 10.1037/0096-1523.29.5.937; Arsenault JT, 2013, NEURON, V77, P1174, DOI 10.1016/j.neuron.2013.01.008; Della Libera C, 2009, PSYCHOL SCI, V20, P778, DOI 10.1111/j.1467-9280.2009.02360.x; Donohue SE, 2016, J COGNITIVE NEUROSCI, V28, P529, DOI 10.1162/jocn_a_00917; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; Engelmann JB, 2007, EMOTION, V7, P668, DOI 10.1037/1528-3542.7.3.668; Failing MF, 2014, J VISION, V14, DOI 10.1167/14.5.6; Failing MF, 2015, VIS COGN, V23, P82, DOI 10.1080/13506285.2014.990546; Folk CL, 1998, J EXP PSYCHOL HUMAN, V24, P847, DOI 10.1037/0096-1523.24.3.847; Hickey C, 2015, NEURON, V85, P512, DOI 10.1016/j.neuron.2014.12.049; Hickey C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103372; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Itthipuripat S, 2015, J NEUROPHYSIOL, V114, P560, DOI 10.1152/jn.00343.2015; Johnson EN, 2008, J NEUROSCI, V28, P8096, DOI 10.1523/JNEUROSCI.1404-08.2008; Kiss M, 2009, PSYCHOL SCI, V20, P245, DOI 10.1111/j.1467-9280.2009.02281.x; Krebs RM, 2012, CEREB CORTEX, V22, P607, DOI 10.1093/cercor/bhr134; Kristjansson A, 2010, ATTEN PERCEPT PSYCHO, V72, P1229, DOI 10.3758/APP.72.5.1229; Le Pelley ME, 2015, J EXP PSYCHOL GEN, V144, P158, DOI 10.1037/xge0000037; MacLean MH, 2015, BRAIN RES, V1606, P86, DOI 10.1016/j.brainres.2015.02.016; Navalpakkam V, 2010, P NATL ACAD SCI USA, V107, P5232, DOI 10.1073/pnas.0911972107; Navalpakkam V, 2009, J VISION, V9, DOI 10.1167/9.1.31; Pessoa L, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00017; Pool E, 2014, COGNITION, V130, P348, DOI 10.1016/j.cognition.2013.12.002; Qi SQ, 2013, BRAIN RES, V1532, P32, DOI 10.1016/j.brainres.2013.07.044; Roelfsema PR, 2005, NEURAL COMPUT, V17, P2176, DOI 10.1162/0899766054615699; Rombouts JO, 2015, VIS COGN, V23, P179, DOI 10.1080/13506285.2015.1010462; Serences JT, 2010, J NEUROPHYSIOL, V104, P76, DOI 10.1152/jn.01090.2009; Serences JT, 2008, NEURON, V60, P1169, DOI 10.1016/j.neuron.2008.10.051; Sharma G, 2005, COLOR RES APPL, V30, P21, DOI 10.1002/col.20070; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Stormer VS, 2014, CURR BIOL, V24, P1985, DOI 10.1016/j.cub.2014.07.030; Theeuwes J, 2012, VISION RES, V74, P80, DOI 10.1016/j.visres.2012.07.024; TREISMAN A, 1983, PERCEPT PSYCHOPHYS, V33, P527, DOI 10.3758/BF03202934; van Koningsbruggen MG, 2016, SOC COGN AFFECT NEUR, V11, P1481, DOI 10.1093/scan/nsw056; Yamamoto S, 2013, J NEUROSCI, V33, P11227, DOI 10.1523/JNEUROSCI.0318-13.2013	52	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177491	10.1371/journal.pone.0177491	http://dx.doi.org/10.1371/journal.pone.0177491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UM	28486526	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000082
J	Chen, L; Liu, X; Gao, LG; Wang, R; Gao, DW; Bai, DY				Chen, Lei; Liu, Xi; Gao, Linggen; Wang, Rong; Gao, Dewei; Bai, Dongyu			The clinicopathological features and prognosis of signet ring cell carcinoma of the esophagus: A 10-year retrospective study in China	PLOS ONE			English	Article							PREOPERATIVE CHEMORADIATION; ADENOCARCINOMA; CANCER; EPITHELIUM; HISTOLOGY; SURVIVAL	Objectives The aim of this study was to analyze the clinicopathological features and prognosis of esophageal signet ring cell (SRC) carcinoma in China. Methods Patients with poorly differentiated adenocarcinoma were identified in two hospitals from January 2006 to June 2016. The patients were divided into three groups according to component of SRCs: SRC >= 50% group, SRC < 50% group and non-SRC poorly differentiated adenocarcinoma group. Results Fifty-seven patients had carcinoma (SRC >= 50%), and 79 patients had tumors containing < 50% SRCs, and 535 patients was in non-SRC poorly differentiated adenocarcinoma group. There were no significant differences among the three groups in clinicopathological characteristics. Patients in SRC >= 50% group had a lower overall survival rate (at 3-year 37.6% versus71.1%; at 5-year 0% versus 43.3%; p<0.001) compared with the control group. Even survival outcome of patients in SRC < 50% was inferior to that of in control group (at 3-year 53.0% versus71.1%; at 5-year 25.9% versus 43.3%; p<0.001). Female sex, large tumor size and increasing TNM stage were independent prognostic factors for SRC >= 50% esophageal carcinoma patients. Conclusions The incidence of esophageal SRC carcinoma is relatively rare and the worst outcome is observed in the SRC >= 50% group. It is necessary to explore new therapeutic modalities to achieve further improvements in the clinical outcome of these patients.	[Chen, Lei; Liu, Xi] Chinese Peoples Liberat Army, Gen Hosp, Dept Thorac Surg, Beijing, Peoples R China; [Gao, Linggen; Wang, Rong; Gao, Dewei] Chinese Peoples Liberat Army, Gen Hosp, Dept Comprehens Surg, Beijing, Peoples R China; [Bai, Dongyu] Xiamen Univ, Affiliated Hosp 1, Dept Pathol, Xiamen, Province Fujian, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Xiamen University	Gao, DW (corresponding author), Chinese Peoples Liberat Army, Gen Hosp, Dept Comprehens Surg, Beijing, Peoples R China.; Bai, DY (corresponding author), Xiamen Univ, Affiliated Hosp 1, Dept Pathol, Xiamen, Province Fujian, Peoples R China.	gaodeweigdw@163.com; baidongyu@163.com			China Postdoctoral Science Foundation [2012T50865]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by a general financial grant from the China Postdoctoral Science Foundation (2012T50865, to L. Gao.).	Cen P, 2012, ANN SURG ONCOL, V19, P1685, DOI 10.1245/s10434-011-2141-1; Chirieac LR, 2005, CLIN CANCER RES, V11, P2229, DOI 10.1158/1078-0432.CCR-04-1840; Chon HJ, 2017, ANN SURG, V265, P946, DOI 10.1097/SLA.0000000000001793; Enlow JM, 2013, ANN THORAC SURG, V96, P1927, DOI 10.1016/j.athoracsur.2013.06.047; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; FROST AR, 1995, ARCH PATHOL LAB MED, V119, P64; Hornick JL, 2006, AM J SURG PATHOL, V30, P28, DOI 10.1097/01.pas.0000174011.29816.fa; KITAMURA H, 1985, ACTA PATHOL JAPON, V35, P675; Kwon KJ, 2014, GASTRIC CANCER, V17, P43, DOI 10.1007/s10120-013-0234-1; Kwon WA, 2013, CUAJ-CAN UROL ASSOC, V7, pE768, DOI 10.5489/cuaj.630; Liu XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144420; Maezato K, 2007, SURG TODAY, V37, P1096, DOI 10.1007/s00595-007-3533-5; Merchant SH, 2001, AM J SURG PATHOL, V25, P1515, DOI 10.1097/00000478-200112000-00007; Nafteux PR, 2014, ANN SURG, V260, P1023, DOI 10.1097/SLA.0000000000000689; Patel VR, 2014, ANN THORAC SURG, V98, P1064, DOI 10.1016/j.athoracsur.2014.04.099; Piessen G, 2014, EJSO-EUR J SURG ONC, V40, P1746, DOI 10.1016/j.ejso.2014.04.019; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Taghavi S, 2012, J CLIN ONCOL, V30, P3493, DOI 10.1200/JCO.2012.42.6635; TAKUBO K, 1987, ACTA PATHOL JAPON, V37, P989; Tan YN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121944; Wei Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156659; YAMASHINA M, 1986, CANCER, V58, P1333, DOI 10.1002/1097-0142(19860915)58:6<1333::AID-CNCR2820580625>3.0.CO;2-B; Yendamuri S, 2013, CANCER-AM CANCER SOC, V119, P3156, DOI 10.1002/cncr.28099	23	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176637	10.1371/journal.pone.0176637	http://dx.doi.org/10.1371/journal.pone.0176637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486494	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000020
J	Kenney, A; Cusick, A; Payne, J; Gaughenbaugh, A; Renshaw, A; Wright, J; Seeber, R; Barnes, R; Florjanczyk, A; Horzempa, J				Kenney, Adam; Cusick, Austin; Payne, Jessica; Gaughenbaugh, Anna; Renshaw, Andrea; Wright, Jenna; Seeber, Roger; Barnes, Rebecca; Florjanczyk, Aleksandr; Horzempa, Joseph			The potential for flower nectar to allow mosquito to mosquito transmission of Francisella tularensis	PLOS ONE			English	Article							DERMACENTOR-RETICULATUS TICKS; DIPTERA-CULICIDAE; TULAREMIA; SWEDEN; TEMPERATURE; TURKEY; OUTBREAK; GROWTH; FOCUS; PILIN	Francisella tularensis is disseminated in nature by biting arthropods such as mosquitoes. The relationship between mosquitoes and F. tularensis in nature is highly ambiguous, due in part to the fact that mosquitoes have caused significant tularemia outbreaks despite being classified as a mechanical vector of F. tularensis. One possible explanation for mosquitoes being a prominent, yet mechanical vector is that these insects feed on flower nectar between blood meals, allowing for transmission of F. tularensis between mosquitoes. Here, we aimed to assess whether F. tularensis could survive in flower nectar. Moreover, we examined if mosquitoes could interact with or ingest and transmit F. tularensis from one source of nectar to another. F. tularensis exhibited robust survivability in flower nectar with concentrations of viable bacteria remaining consistent with the rich growth medium. Furthermore, F. tularensis was able to survive (albeit to a lesser extent) in 30% sucrose (a nectar surrogate) over a period of time consistent with that of a typical flower bloom. Although we observed diminished bacterial survival in the nectar surrogate, mosquitoes that fed on this material became colonized with F. tularensis. Finally, colonized mosquitoes were capable of transferring F. tularensis to a sterile nectar surrogate. These data suggest that flower nectar may be capable of serving as a temporary source of F. tularensis that could contribute to the amplification of outbreaks. Mosquitoes that feed on an infected mammalian host and subsequently feed on flower nectar could deposit some F. tularensis bacteria into the nectar in the process. Mosquitoes subsequently feeding on this nectar source could potentially become colonized by F. tularensis. Thus, the possibility exists that flower nectar may allow for vector-vector transmission of F. tularensis.	[Kenney, Adam; Cusick, Austin; Payne, Jessica; Gaughenbaugh, Anna; Renshaw, Andrea; Wright, Jenna; Seeber, Roger; Barnes, Rebecca; Florjanczyk, Aleksandr; Horzempa, Joseph] West Liberty Univ, Dept Nat Sci & Math, West Liberty, WV USA		Horzempa, J (corresponding author), West Liberty Univ, Dept Nat Sci & Math, West Liberty, WV USA.	joseph.horzempa@westliberty.edu			NASA WV Space Grant Consortium [NNX10AK62H]; National Institute of General Medical Sciences of the National Institutes of Health [P20GM103434]; National Institutes of Health, National Institute of Allergy and Infectious Diseases [5K22AI087703]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI087703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103434] Funding Source: NIH RePORTER	NASA WV Space Grant Consortium; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant through the NASA WV Space Grant Consortium (NNX10AK62H), an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (P20GM103434), and a grant from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (5K22AI087703).; The authors thank Deanna Schmitt and Tricia Gilson for technical contributions and helpful insight. This work was funded by a grant through the NASA WV Space Grant Consortium (NNX10AK62H), an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (P20GM103434), and a grant from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (5K22AI087703).	Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003; Akimana C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00034; Andrews FM, 1929, PLANT PHYSIOL, V4, P281, DOI 10.1104/pp.4.2.281; Asare R, 2010, ENVIRON MICROBIOL, V12, P2587, DOI 10.1111/j.1462-2920.2010.02230.x; Baron GS, 1998, MOL MICROBIOL, V29, P247, DOI 10.1046/j.1365-2958.1998.00926.x; CASTRIC PA, 1989, MOL GEN GENET, V216, P75, DOI 10.1007/BF00332233; Chadee DD, 2014, ACTA TROP, V132, pS86, DOI 10.1016/j.actatropica.2013.09.019; Chalcoff VR, 2006, ANN BOT-LONDON, V97, P413, DOI 10.1093/aob/mcj043; CHRISTENSON B, 1984, SCAND J INFECT DIS, V16, P285, DOI 10.3109/00365548409070402; Clemons A, 2010, COLD SPRING HARB PRO, V2010; Desvars A, 2015, EMERG INFECT DIS, V21, P32, DOI 10.3201/eid2101.140916; Duzlu O, 2016, VECTOR-BORNE ZOONOT, V16, P26, DOI 10.1089/vbz.2015.1818; Eliasson H, 2002, EMERG INFECT DIS, V8, P956, DOI 10.3201/eid0809.020051; Eliasson H, 2007, SCAND J INFECT DIS, V39, P880, DOI 10.1080/00365540701402970; GUERRANT RL, 1976, ARCH INTERN MED, V136, P811, DOI 10.1001/archinte.136.7.811; Hanke CA, 2009, EUR J PEDIATR, V168, P937, DOI 10.1007/s00431-008-0862-3; Horzempa J, 2006, J BIOL CHEM, V281, P1128, DOI 10.1074/jbc.M510975200; Horzempa J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-172; Hubalek Z, 1998, WIEN KLIN WOCHENSCHR, V110, P909; Hubalek Z, 1997, J MED ENTOMOL, V34, P660, DOI 10.1093/jmedent/34.6.660; Hubalek Z, 1996, MED VET ENTOMOL, V10, P241, DOI 10.1111/j.1365-2915.1996.tb00737.x; Karolyi F, 2014, ARTHROPOD STRUCT DEV, V43, P403, DOI 10.1016/j.asd.2014.07.003; Kilic S, 2015, EMERG INFECT DIS, V21, P2213, DOI 10.3201/eid2112.150634; Lindh JM, 2006, ACTA TROP, V99, P173, DOI 10.1016/j.actatropica.2006.07.008; Lundstrom JO, 2011, EMERG INFECT DIS, V17, P794, DOI 10.3201/eid1705.100426; Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004; Mostowy WM, 2004, J VECTOR ECOL, V29, P84; Olin Gunnar, 1942, ACTA PATH ET MICROBIOL SCAND, V19, P220; Payne L, 2005, EMERG INFECT DIS, V11, P1440, DOI 10.3201/eid1109.041189; Petersen JM, 2009, VET RES, V40, DOI 10.1051/vetres:2008045; Ryden P, 2012, J INFECT DIS, V205, P297, DOI 10.1093/infdis/jir732; Santic M, 2009, ENVIRON MICROBIOL, V11, P1473, DOI 10.1111/j.1462-2920.2009.01875.x; SASLAW S, 1961, AM J MED SCI, V241, P689, DOI 10.1097/00000441-196106000-00001; SMITH SM, 1994, MED VET ENTOMOL, V8, P201, DOI 10.1111/j.1365-2915.1994.tb00499.x; Svensson K, 2009, EMERG INFECT DIS, V15, P1937, DOI 10.3201/eid1512.090487; Tarnvik A, 1996, FEMS IMMUNOL MED MIC, V13, P201, DOI 10.1016/0928-8244(95)00104-2; Thelaus J, 2014, MICROB ECOL, V67, P96, DOI 10.1007/s00248-013-0285-1; Triebenbach AN, 2010, J MED ENTOMOL, V47, P639, DOI 10.1603/ME09192; Yanik K, 2015, MIKROBIYOL BUL, V49, P139, DOI 10.5578/mb.8632	39	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0175157	10.1371/journal.pone.0175157	http://dx.doi.org/10.1371/journal.pone.0175157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486521	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000003
J	Nguyen-McCarty, M; Klein, PS				Nguyen-McCarty, Michelle; Klein, Peter S.			Autophagy is a signature of a signaling network that maintains hematopoietic stem cells	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; MITOCHONDRIAL BIOGENESIS; MAMMALIAN TARGET; BONE-MARROW; MTOR; DIFFERENTIATION; INHIBITION; RENEWAL; GSK3; PHOSPHORYLATION	Hematopoietic stem cells (HSCs) are able to self-renew and to differentiate into all blood cells. HSCs reside in a low-perfusion niche and depend on local signals to survive and to maintain the capacity for self-renewal. HSCs removed from the niche are unable to survive without addition of hematopoietic cytokines and rapidly lose their ability to self-renew. We reported previously that inhibition of both GSK-3 and mTORC1 is essential to maintain long-term HSCs ex vivo. Although Wnt/beta-catenin signaling downstream of GSK-3 is required for this response, the downstream effectors of mTORC1 remain undefined. We now report that HSCs express a pro-autophagic gene signature and accumulate LC3 puncta only when both mTORC1 and GSK-3 are inhibited, identifying autophagy as a signature for a signaling network that maintains HSCs ex vivo. In addition, these conditions sustain HSC repopulating function despite an increased rate of global translation. Together, these findings provide new insight into the relative contributions of various mTORC1 outputs toward the maintenance of HSC function and build upon the growing body of literature implicating autophagy and tightly controlled protein synthesis as important modulators of diverse stem cell populations.	[Nguyen-McCarty, Michelle; Klein, Peter S.] Univ Penn, Perelman Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; [Klein, Peter S.] Univ Penn, Perelman Sch Med, Dept Med Hematol Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Klein, PS (corresponding author), Univ Penn, Perelman Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA.	pklein@mail.med.upenn.edu			Hematopoiesis Training Grant at the University of Pennsylvania [T32-DK07780]; Penn-CHOP Blood Center for Patient Care and Discovery; United States National Institutes of Health [1R21HL107968, 1R01HL110806, 1R01GM115517]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110806, R21HL107968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK103001, T32DK007780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115517] Funding Source: NIH RePORTER	Hematopoiesis Training Grant at the University of Pennsylvania; Penn-CHOP Blood Center for Patient Care and Discovery; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MN was supported by the Hematopoiesis Training Grant at the University of Pennsylvania (T32-DK07780). This study was supported by grants to PSK from The Penn-CHOP Blood Center for Patient Care and Discovery and the United States National Institutes of Health (1R21HL107968, 1R01HL110806, and 1R01GM115517).; We thank Zhixun Dou, Caiyue Xu, and Jian Huang for technical advice and insightful discussion. We also thank all members of the Klein laboratory for support and discussions. We are grateful to Hank Pletcher, Richard Schretzenmair, and the University of Pennsylvania Flow Cytometry and Cell Sorting Facility. M.N. was supported by the Hematopoiesis Training Grant at the University of Pennsylvania (T32-DK07780). This study was supported by grants to P.S.K. from The Penn-CHOP Blood Center for Patient Care and Discovery and the United States National Institutes of Health (1R21HL107968, 1R01HL110806, and 1R01GM115517).	Azoulay-Alfaguter I, 2015, ONCOGENE, V34, P4613, DOI 10.1038/onc.2014.390; Blattler SM, 2012, MOL CELL BIOL, V32, P3333, DOI 10.1128/MCB.00337-12; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cook M, 2007, CURR OPIN BIOTECH, V18, P341, DOI 10.1016/j.copbio.2007.07.006; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Garcia-Prat L, 2016, AUTOPHAGY, V12, P612, DOI 10.1080/15548627.2016.1143211; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132; Guezguez B, 2016, CANCER CELL, V29, P61, DOI 10.1016/j.ccell.2015.11.012; Ho TT, 2017, NATURE; Huang J, 2012, NAT MED, V18, P1778, DOI 10.1038/nm.2984; Huang J, 2009, J CLIN INVEST, V119, P3519, DOI 10.1172/JCI40572; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kalaitzidis D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003776; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Lloyd AC, 2013, CELL, V154, P1194, DOI 10.1016/j.cell.2013.08.053; Lymperi S, 2010, ANN NY ACAD SCI, V1192, P12, DOI 10.1111/j.1749-6632.2009.05223.x; Mantel C, 2010, CELL CYCLE, V9, P2008, DOI 10.4161/cc.9.10.11733; Marchand B, 2015, J BIOL CHEM, V290, P5592, DOI 10.1074/jbc.M114.616714; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Parr C, 2012, MOL CELL BIOL, V32, P4410, DOI 10.1128/MCB.00930-12; Phadwal K, 2013, CELL MOL LIFE SCI, V70, P89, DOI 10.1007/s00018-012-1032-3; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Salemi S, 2012, CELL RES, V22, P432, DOI 10.1038/cr.2011.200; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schultz MB, 2016, DEVELOPMENT, V143, P3, DOI 10.1242/dev.130633; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Signer RAJ, 2016, GENE DEV, V30, P1698, DOI 10.1101/gad.282756.116; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; Tang AH, 2014, EMBO J, V33, P2782, DOI 10.15252/embj.201488278; Vazquez P, 2012, AUTOPHAGY, V8, P187, DOI 10.4161/auto.8.2.18535; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Watson AS, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.8; Wu XT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10533; Xiao LJ, 2009, CURR GENOMICS, V10, P198, DOI 10.2174/138920209788185261; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	49	16	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177054	10.1371/journal.pone.0177054	http://dx.doi.org/10.1371/journal.pone.0177054			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486555	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314000040
J	Etienne-Grimaldi, MC; Boyer, JC; Beroud, C; Mbatchi, L; van Kuilenburg, A; Bobin-Dubigeon, C; Thomas, F; Chatelut, E; Merlin, JL; Pinguet, F; Ferrand, C; Meijer, J; Evrard, A; Llorca, L; Romieu, G; Follana, P; Bachelot, T; Chaigneau, L; Pivot, X; Dieras, V; Largillier, R; Mousseau, M; Goncalves, A; Roche, H; Bonneterre, J; Servent, V; Dohollou, N; Chateau, Y; Chamorey, E; Desvignes, JP; Salgado, D; Ferrero, JM; Milano, G				Etienne-Grimaldi, Marie-Christine; Boyer, Jean-Christophe; Beroud, Christophe; Mbatchi, Litaty; van Kuilenburg, Andre; Bobin-Dubigeon, Christine; Thomas, Fabienne; Chatelut, Etienne; Merlin, Jean-Louis; Pinguet, Frederic; Ferrand, Christophe; Meijer, Judith; Evrard, Alexandre; Llorca, Laurence; Romieu, Gilles; Follana, Philippe; Bachelot, Thomas; Chaigneau, Loic; Pivot, Xavier; Dieras, Veronique; Largillier, Remy; Mousseau, Mireille; Goncalves, Anthony; Roche, Henri; Bonneterre, Jacques; Servent, Veronique; Dohollou, Nadine; Chateau, Yann; Chamorey, Emmanuel; Desvignes, Jean-Pierre; Salgado, David; Ferrero, Jean-Marc; Milano, Gerard			New advances in DPYD genotype and risk of severe toxicity under capecitabine	PLOS ONE			English	Article							DIHYDROPYRIMIDINE DEHYDROGENASE GENE; FLUOROPYRIMIDINE-ASSOCIATED TOXICITY; III COLON-CANCER; 5-FLUOROURACIL TOXICITY; CLINICAL-RELEVANCE; COLORECTAL-CANCER; PLUS OXALIPLATIN; VARIANTS; PHARMACOGENETICS; FLUOROURACIL	Background Deficiency in dihydropyrimidine dehydrogenase (DPD) enzyme is the main cause of severe and lethal fluoropyrimidine-related toxicity. Various approaches have been developed for DPD-deficiency screening, including DPYD genotyping and phenotyping. The goal of this prospective observational study was to perform exhaustive exome DPYD sequencing and to examine relationships between DPYD variants and toxicity in advanced breast cancer patients receiving capecitabine. Methods Two-hundred forty-three patients were analysed (88.5% capecitabine monotherapy). Grade 3 and grade 4 capecitabine-related digestive and/or neurologic and/or hemato-toxicities were observed in 10.3% and 2.1% of patients, respectively. DPYD exome, along with flanking intronic regions 3'UTR and 5'UTR, were sequenced on MiSeq Illumina. DPD phenotype was assessed by pre-treatment plasma uracil (U) and dihydrouracil (UH2) measurement. Results Among the 48 SNPs identified, 19 were located in coding regions, including 3 novel variations, each observed in a single patient (among which, F100L and A26T, both pathogenic in silico). Combined analysis of deleterious variants *2A, I560S (*13) and D949V showed significant association with grade 3-4 toxicity (sensitivity 16.7%, positive predictive value (PPV) 71.4%, relative risk (RR) 6.7, p<0.001) but not with grade 4 toxicity. Considering additional deleterious coding variants D342G, S492L, R592W and F100L increased the sensitivity to 26.7% for grade 3-4 toxicity (PPV 72.7%, RR 7.6, p<0.001), and was significantly associated with grade 4 toxicity (sensitivity 60%, PPV 27.3%, RR 31.4, p = 0.001), suggesting the clinical relevance of extended targeted DPYD genotyping. As compared to extended genotype, combining genotyping (7 variants) and phenotyping (U>16 ng/ml) did not substantially increase the sensitivity, while impairing PPV and RR. Conclusions Exploring an extended set of deleterious DPYD variants improves the performance of DPYD genotyping for predicting both grade 3-4 and grade 4 toxicities (digestive and/or neurologic and/or hematotoxicities) related to capecitabine, as compared to conventional genotyping restricted to consensual variants *2A, *13 and D949V.	[Etienne-Grimaldi, Marie-Christine; Llorca, Laurence; Follana, Philippe; Chateau, Yann; Chamorey, Emmanuel; Ferrero, Jean-Marc; Milano, Gerard] Ctr Antoine Lacassagne, Nice, France; [Boyer, Jean-Christophe] CHU Nimes, Nimes, France; [Beroud, Christophe; Desvignes, Jean-Pierre; Salgado, David] Aix Marseille Univ, INSERM UMR S910, GMGF, Marseille, France; [Beroud, Christophe] Hop La Timone, AP HM, Lab Genet Mol, Marseille, France; [Mbatchi, Litaty; Evrard, Alexandre] Fac Pharm Montpellier, Montpellier, France; [van Kuilenburg, Andre; Meijer, Judith] Acad Med Ctr, Lab Genet Metab Dis, Amsterdam, Netherlands; [Bobin-Dubigeon, Christine] Univ Nantes, MMS EA 2160, Inst Cancerol Ouest, Nantes, France; [Thomas, Fabienne; Chatelut, Etienne; Roche, Henri] Univ Toulouse, Inst Claudius Regaud, CRCT, UPS,INSERM, Toulouse, France; [Merlin, Jean-Louis] Univ Lorraine, UMR CNRS CRAN 7039, Inst Cancerol Lorraine, Nancy, France; [Romieu, Gilles] Ctr Paul Lamarque, Montpellier, France; [Ferrand, Christophe; Chaigneau, Loic; Pivot, Xavier] CHU Besancon, Besancon, France; [Bachelot, Thomas] Ctr Leon Berard, Lyon, France; [Servent, Veronique] Inst Curie, Paris, France; [Largillier, Remy] Ctr Azureen Cancerol, Mougins, France; [Mousseau, Mireille] CHU Grenoble, Grenoble, France; [Goncalves, Anthony] Inst Paoli Calmettes, Marseille, France; [Bonneterre, Jacques; Servent, Veronique] Ctr Oscar Lambret, Lille, France; [Dohollou, Nadine] Polyclin Nord Aquitaine, Bordeaux, France	UNICANCER; Centre Antoine Lacassagne; Universite de Montpellier; CHU de Nimes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montpellier; University of Amsterdam; Academic Medical Center Amsterdam; Nantes Universite; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Claudius Regaud; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Lorraine; Universite de Montpellier; Universite de Franche-Comte; CHU Besancon; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Centre Oscar Lambret	Milano, G (corresponding author), Ctr Antoine Lacassagne, Nice, France.	gerard.milano@nice.unicancer.fr	Mousseau, Mireille/M-5942-2014; BEROUD, Christophe/A-8381-2008; SALGADO, David/A-1417-2014; , Chatelut/I-7916-2014; THOMAS, Fabienne/B-8993-2013; Chamorey, Emmanuel/AGO-9982-2022; Desvignes, Jean-Pierre/I-2858-2016	BEROUD, Christophe/0000-0003-2986-8738; , Chatelut/0000-0002-7740-9096; THOMAS, Fabienne/0000-0001-9886-412X; Desvignes, Jean-Pierre/0000-0003-3142-1994; Salgado, David/0000-0002-5905-3591; Milano, Gerard/0000-0003-2478-0040; van Kuilenburg, Andre/0000-0002-7989-4910	French National Cancer Institute (INCa, Programme Hospitalier de Recherche Clinique)	French National Cancer Institute (INCa, Programme Hospitalier de Recherche Clinique)	This work was supported by the French National Cancer Institute (INCa, Programme Hospitalier de Recherche Clinique). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstutz U, 2015, CLIN CANCER RES, V21, P2038, DOI 10.1158/1078-0432.CCR-14-2817; Amstutz U, 2009, PHARMACOGENOMICS, V10, P931, DOI [10.2217/pgs.09.28, 10.2217/PGS.09.28]; BECK A, 1994, EUR J CANCER, V30A, P1517, DOI 10.1016/0959-8049(94)00216-R; Boisdron-Celle M, 2007, CANCER LETT, V249, P271, DOI 10.1016/j.canlet.2006.09.006; Caudle KE, 2013, CLIN PHARMACOL THER, V94, P640, DOI 10.1038/clpt.2013.172; Ciccolini J, 2006, CANCER CHEMOTH PHARM, V58, P272, DOI 10.1007/s00280-005-0139-8; Deenen MJ, 2016, J CLIN ONCOL, V34, P227, DOI 10.1200/JCO.2015.63.1325; Deenen MJ, 2011, CLIN CANCER RES, V17, P3455, DOI 10.1158/1078-0432.CCR-10-2209; Deporte R, 2006, J CHROMATOGR B, V834, P170, DOI 10.1016/j.jchromb.2006.02.046; Desmet FO, NUCL ACIDS RES, V37, pe67; ETIENNE MC, 1994, J CLIN ONCOL, V12, P2248, DOI 10.1200/JCO.1994.12.11.2248; Ezzeldin HH, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/4/047002; FLEMING RA, 1992, CANCER RES, V52, P2899; Froehlich TK, 2015, INT J CANCER, V136, P730, DOI 10.1002/ijc.29025; Gross E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004003; Lam SW, 2016, CANCER TREAT REV, V50, P9, DOI 10.1016/j.ctrv.2016.08.001; Largillier R, 2006, CLIN CANCER RES, V12, P5496, DOI 10.1158/1078-0432.CCR-06-0320; Lee AM, 2016, PHARMACOGENET GENOM, V26, P133, DOI 10.1097/FPC.0000000000000197; Lee AM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju298; Loganayagam A, 2013, BRIT J CANCER, V108, P2505, DOI 10.1038/bjc.2013.262; Lunenburg CATC, 2016, EUR J CANCER, V54, P40, DOI 10.1016/j.ejca.2015.11.008; Magne N, 2007, BRIT J CLIN PHARMACO, V64, P237, DOI 10.1111/j.1365-2125.2007.02869.x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meulendijks D, 2016, EUR J CANCER, V54, P120, DOI 10.1016/j.ejca.2015.10.013; Meulendijks D, 2015, LANCET ONCOL, V16, P1639, DOI 10.1016/S1470-2045(15)00286-7; Milano G, 2013, SAN ANT BREAST CANC; Nishimura M, 2006, DRUG METAB PHARMACOK, V21, P357, DOI 10.2133/dmpk.21.357; Offer SM, 2014, CANCER RES, V74, P2545, DOI 10.1158/0008-5472.CAN-13-2482; Offer SM, 2014, MOL CANCER THER, V13, P742, DOI 10.1158/1535-7163.MCT-13-0878; Rosmarin D, 2015, GUT, V64, P111, DOI 10.1136/gutjnl-2013-306571; Salgado D, 2016, HUM MUTAT, V37, P439, DOI 10.1002/humu.22965; Schmoll HJ, 2007, J CLIN ONCOL, V25, P102, DOI 10.1200/JCO.2006.08.1075; STEIN BN, 1995, CANCER-AM CANCER SOC, V75, P11, DOI 10.1002/1097-0142(19950101)75:1<11::AID-CNCR2820750104>3.0.CO;2-N; Terrazzino S, 2013, PHARMACOGENOMICS, V14, P1255, DOI 10.2217/pgs.13.116; Thomas F, 2016, CLIN PHARMACOL THER, V99, P235, DOI 10.1002/cpt.210; TUCHMAN M, 1985, NEW ENGL J MED, V313, P245, DOI 10.1056/NEJM198507253130407; van Kuilenburg ABP, 2004, EUR J CANCER, V40, P939, DOI 10.1016/j.ejca.2003.12.004; van Kuilenburg ABP, 2016, BBA-MOL BASIS DIS, V1862, P754, DOI 10.1016/j.bbadis.2016.01.009; van Kuilenburg ABP, 2010, HUM GENET, V128, P529, DOI 10.1007/s00439-010-0879-3; van Staveren MC, 2013, PHARMACOGENOMICS J, V13, P389, DOI 10.1038/tpj.2013.25; van Staveren MC, 2016, BRIT J CLIN PHARMACO, V81, P553, DOI 10.1111/bcp.12821; Wei XX, 1998, GENOMICS, V51, P391, DOI 10.1006/geno.1998.5379	42	59	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0175998	10.1371/journal.pone.0175998	http://dx.doi.org/10.1371/journal.pone.0175998			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481884	Green Published, gold, Green Submitted			2022-12-27	WOS:000401313700006
J	Chang, KK; Wang, S; Zhang, H; Guo, QQ; Hu, XR; Lin, ZL; Sun, HF; Jiang, M; Hu, JD				Chang, Keke; Wang, Shun; Zhang, Hao; Guo, Qingqian; Hu, Xinran; Lin, Zhili; Sun, Haifeng; Jiang, Min; Hu, Jiandong			Colorimetric detection of melamine in milk by using gold nanoparticles-based LSPR via optical fibers	PLOS ONE			English	Article							PLASMON RESONANCE SPECTROSCOPY; LINKED-IMMUNOSORBENT-ASSAY; DAIRY-PRODUCTS; SPECTROMETRY	A biosensing system with optical fibers is proposed for the colorimetric detection of melamine in liquid milk samples by using the localized surface plasmon resonance (LSPR) of unmodified gold nanoparticles (AuNPs). The biosensing system consists of a broadband light source that covers the spectral range from 200 nm to 1700 nm, an optical attenuator, three types of 600 mu m premium optical fibers with SMA905 connectors and a miniature spectrometer with a linear charge coupled device (CCD) array. The biosensing system with optical fibers is low-cost, simple and is well-proven for the detection of melamine. Its working principle is based on the color changes of AuNPs solution from wine-red to blue due to the inter-particle coupling effect that causes the shifts of wavelength and absorbance in LSPR band after the to-be-measured melamine samples were added. Under the optimized conditions, the detection response of the LSPR biosensing system was found to be linear in melamine detection in the concentration range from 0 mu M to 0.9 mu M with a correlation coefficient (R-2) 0.99 and a detection limit 33 nM. The experimental results obtained from the established LSPR biosensing system in the actual detection of melamine concentration in liquid milk samples show that this technique is highly specific and sensitive and would have a huge application prospects.	[Chang, Keke; Wang, Shun; Zhang, Hao; Guo, Qingqian; Sun, Haifeng; Hu, Jiandong] Henan Agr Univ, Coll Mech & Elect Engn, Zhengzhou, Peoples R China; [Chang, Keke; Wang, Shun; Guo, Qingqian; Sun, Haifeng; Hu, Jiandong] State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Peoples R China; [Hu, Xinran] McGill Univ, Sch Human Nutr & Dietet, Macdonald Campus, Ste Anne De Bellevue, PQ, Canada; [Lin, Zhili] Huaqiao Univ, Coll Informat Sci & Engn, Xiamen, Peoples R China; [Jiang, Min] Henan Agr Univ, Coll Iife Sci, Zhengzhou, Peoples R China	Henan Agricultural University; McGill University; Huaqiao University; Henan Agricultural University	Hu, JD (corresponding author), Henan Agr Univ, Coll Mech & Elect Engn, Zhengzhou, Peoples R China.; Hu, JD (corresponding author), State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Peoples R China.	jiandonghu@163.com	Lin, Zhili/D-6735-2013		National Natural Science Foundation of China [31671581]; Natural Science Foundation of Henan Province [162300410143]; Henan Province Collaborative Innovation Center of Biomass Energy; State Key Laboratory of Wheat and Maize Crop Science Funding [SKL2014ZH-06, 39990026]; Project 948 of the Ministry of Agriculture of China [2015-Z45]; Fujian Province Science Fund for Distinguished Young Scholars [2015J06015]; Zhengzhou Science and Technology Program [141PPTGG405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Henan Province; Henan Province Collaborative Innovation Center of Biomass Energy; State Key Laboratory of Wheat and Maize Crop Science Funding; Project 948 of the Ministry of Agriculture of China; Fujian Province Science Fund for Distinguished Young Scholars; Zhengzhou Science and Technology Program	The financial support was provided by the National Natural Science Foundation of China (31671581), Natural Science Foundation of Henan Province (162300410143), Henan Province Collaborative Innovation Center of Biomass Energy, State Key Laboratory of Wheat and Maize Crop Science Funding (SKL2014ZH-06, 39990026), Project 948 of the Ministry of Agriculture of China (2015-Z45), Fujian Province Science Fund for Distinguished Young Scholars (2015J06015), and the Zhengzhou Science and Technology Program (141PPTGG405).; We are grateful for the financial support provided by the National Natural Science Foundation of China (31671581), Natural Science Foundation of Henan Province (162300410143), Henan Province Collaborative Innovation Center of Biomass Energy, State Key Laboratory of Wheat and Maize Crop Science Funding (SKL2014ZH-06, 39990026), Project 948 of the Ministry of Agriculture of China (2015-Z45), Fujian Province Science Fund for Distinguished Young Scholars (2015J06015), and the Zhengzhou Science and Technology Program (141PPTGG405).	Aernouts B, 2015, J DAIRY SCI, V98, P6727, DOI 10.3168/jds.2015-9630; Chi H, 2010, ANALYST, V135, P1070, DOI 10.1039/c000285b; Chu CY, 2013, J ENVIRON SCI HEAL C, V31, P342, DOI 10.1080/10590501.2013.844758; Cretu V, 2016, J MATER CHEM A, V4, P6527, DOI 10.1039/c6ta01355d; Dalal RP, 2011, NAT REV NEPHROL, V7, P267, DOI 10.1038/nrneph.2011.24; Filazi A, 2012, J DAIRY SCI, V95, P602, DOI 10.3168/jds.2011-4926; Filigenzi MS, 2008, J AGR FOOD CHEM, V56, P7593, DOI 10.1021/jf801008s; Garber EAE, 2008, J FOOD PROTECT, V71, P590, DOI 10.4315/0362-028X-71.3.590; Haes AJ, 2002, J AM CHEM SOC, V124, P10596, DOI 10.1021/ja020393x; Hwang WS, 2012, ANAL BIOCHEM, V421, P213, DOI 10.1016/j.ab.2011.11.001; Jin X, 2014, PLOS ONE, V9; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Kumar N, 2014, ANAL BIOCHEM, V456, P43, DOI 10.1016/j.ab.2014.04.002; Lei HT, 2011, MOLECULES, V16, P5591, DOI 10.3390/molecules16075591; Li Y, 2015, RSC ADV, V5, P1125, DOI 10.1039/c4ra13080d; Li ZJ, 2015, BIOSENS BIOELECTRON, V68, P668, DOI 10.1016/j.bios.2015.01.062; Najim M, 2015, PHYS CHEM CHEM PHYS, V17, P22923, DOI 10.1039/c5cp03488d; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Ping H, 2012, FOOD CONTROL, V23, P191, DOI 10.1016/j.foodcont.2011.07.009; Polavarapu L, 2015, CRYSTENGCOMM, V17, P3727, DOI 10.1039/c5ce00112a; Polavarapu L, 2014, J MATER CHEM C, V2, P7460, DOI 10.1039/c4tc01142b; Sepulveda B, 2009, NANO TODAY, V4, P244, DOI 10.1016/j.nantod.2009.04.001; Shiohara A, 2014, NANOSCALE, V6, P9817, DOI 10.1039/c4nr02648a; Song J, 2015, FOOD CONTROL, V50, P356, DOI 10.1016/j.foodcont.2014.08.049; Sun JF, 2011, BIOSENS BIOELECTRON, V28, P152, DOI 10.1016/j.bios.2011.07.012; Vail TM, 2007, J ANAL TOXICOL, V31, P304, DOI 10.1093/jat/31.6.304; Wang CL, 2014, CHEM SOC REV, V43, P7188, DOI 10.1039/c4cs00145a; Wei F, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3373325; Wei H, 2007, CHEM COMMUN, P3735, DOI 10.1039/b707642h; Wen YY, 2010, J SCI FOOD AGR, V90, P2178, DOI 10.1002/jsfa.4066; Willets KA, 2007, ANNU REV PHYS CHEM, V58, P267, DOI 10.1146/annurev.physchem.58.032806.104607; Xin JY, 2015, FOOD CHEM, V174, P473, DOI 10.1016/j.foodchem.2014.11.098; Xu XM, 2009, ANAL CHIM ACTA, V650, P39, DOI 10.1016/j.aca.2009.04.026; Zhang XF, 2010, J RAMAN SPECTROSC, V41, P1655, DOI 10.1002/jrs.2629; Zhu L, 2009, CHEM COMMUN, P559, DOI 10.1039/b818541g; Zhu YY, 2015, BIOSENS BIOELECTRON, V69, P174, DOI 10.1016/j.bios.2015.02.018	36	26	27	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177131	10.1371/journal.pone.0177131	http://dx.doi.org/10.1371/journal.pone.0177131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475597	Green Published, gold, Green Submitted			2022-12-27	WOS:000400649500049
J	Nikolaev, MV; Dorofeeva, NA; Komarova, MS; Korolkova, YV; Andreev, YA; Mosharova, IV; Grishin, EV; Tikhonov, DB; Kozlov, SA				Nikolaev, Maxim V.; Dorofeeva, Natalia A.; Komarova, Margarita S.; Korolkova, Yuliya V.; Andreev, Yaroslav A.; Mosharova, Irina V.; Grishin, Eugene V.; Tikhonov, Denis B.; Kozlov, Sergey A.			TRPV1 activation power can switch an action mode for its polypeptide ligands	PLOS ONE			English	Article							ANEMONE HETERACTIS-CRISPA; VANILLOID RECEPTOR TRPV1; CAPSAICIN RECEPTOR; SEA-ANEMONE; ION-CHANNEL; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-BASIS; NUCLEIC-ACIDS; PORE DOMAIN; FORCE-FIELD	TRPV1 (vanilloid) receptors are activated by different types of stimuli including capsaicin, acidification and heat. Various ligands demonstrate stimulus-dependent action on TRPV1. In the present work we studied the action of polypeptides isolated from sea anemone Heteractis crispa (APHC1, APHC2 and APHC3) on rat TRPV1 receptors stably expressed in CHO cells using electrophysiological recordings, fluorescent Ca2+ measurements and molecular modeling. The APHCs potentiated TRPV1 responses to low (3-300 nM) concentrations of capsaicin but inhibited responses to high (> 3.0 mu M) concentrations. The activity-dependent action was also found for TRPV1 responses to 2APB and acidification. Thus the action mode of APHCs is bimodal and depended on the activation stimuli strength-potentiation of low-amplitude responses and no effect/inhibition of high-amplitude responses. The double-gate model of TRPV1 activation suggests that APHC-polypeptides may stabilize an intermediate state during the receptor activation. Molecular modeling revealed putative binding site at the outer loops of TRPV1. Binding to this site can directly affect activation by protons and can be allosterically coupled with capsaicin site. The results are important for further investigations of both TRPV1 and its ligands for potential therapeutic use.	[Nikolaev, Maxim V.; Dorofeeva, Natalia A.; Komarova, Margarita S.; Tikhonov, Denis B.] RAS, IM Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia; [Korolkova, Yuliya V.; Andreev, Yaroslav A.; Mosharova, Irina V.; Grishin, Eugene V.; Kozlov, Sergey A.] RAS, Shemyakin Ovchinnikov Inst Bioorgan, Moscow, Russia; [Andreev, Yaroslav A.] Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow, Russia	Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Sechenov First Moscow State Medical University	Kozlov, SA (corresponding author), RAS, Shemyakin Ovchinnikov Inst Bioorgan, Moscow, Russia.	serg@ibch.ru	Komarova, Margarita/AAN-2166-2020; Nikolaev, Maxim/AAM-9380-2020; Kozlov, Sergey A/D-1548-2012; Tikhonov, Denis/AAK-9148-2020; Andreev, Yaroslav A/C-6627-2012	Komarova, Margarita/0000-0001-5035-6900; Nikolaev, Maxim/0000-0001-6501-7143; Kozlov, Sergey A/0000-0002-0242-4240; Andreev, Yaroslav/0000-0002-7628-0980; Tikhonov, Denis/0000-0001-8523-4305	program of Presidium of RAS "Molecular and Cell Biology"; RF science program [01201351571]; Russian Foundation for Basic Research [15-04-04666A]; President of RF [SSh-7676.2016.4]; RSF [16-15-00167]; Russian Science Foundation [16-15-00167] Funding Source: Russian Science Foundation	program of Presidium of RAS "Molecular and Cell Biology"; RF science program; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); President of RF; RSF(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This research work was supported by the program of Presidium of RAS "Molecular and Cell Biology", RF science program 01201351571, the Russian Foundation for Basic Research (grant 15-04-04666A) and by the grant SSh-7676.2016.4 from the President of RF. YK and YA responsible for fluorescent based intracellular calcium assay are grateful to RSF (grant No 16-15-00167) for support.	Andreev YA, 2009, DOKL BIOCHEM BIOPHYS, V424, P46, DOI 10.1134/S160767290901013X; Andreev YA, 2008, J BIOL CHEM, V283, P23914, DOI 10.1074/jbc.M800776200; Andreev YA, 2013, MAR DRUGS, V11, P5100, DOI 10.3390/md11125100; Andreev YA, 2012, RECENT PATENTS INFLA, V6, P35, DOI 10.2174/187221312798889266; Andreev YA, 2010, ANAL BIOCHEM, V407, P144, DOI 10.1016/j.ab.2010.07.023; Aneiros E, 2011, EMBO J, V30, P994, DOI 10.1038/emboj.2011.19; Blumberg PM, 2011, CURR TOP MED CHEM, V11, P2151; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cuypers E, 2011, ACTA CHIM SLOV, V58, P735; Garden DP, 2010, J COMPUT AID MOL DES, V24, P91, DOI 10.1007/s10822-009-9317-9; Gavva NR, 2008, PAIN, V136, P202, DOI 10.1016/j.pain.2008.01.024; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; Jakab B, 2005, EUR J PHARMACOL, V517, P35, DOI 10.1016/j.ejphar.2005.05.002; Johnson DM, 2006, MOL PHARMACOL, V70, P1005, DOI 10.1124/mol.106.023945; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kozlov SA, 2009, RUSS J BIOORG CHEM+, V35, P711, DOI 10.1134/S1068162009060065; Lazar J, 2009, EXPERT OPIN DRUG DIS, V4, P159, DOI 10.1517/17460440802681300; Lehto SG, 2008, J PHARMACOL EXP THER, V326, P218, DOI 10.1124/jpet.107.132233; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Makarieva TN, 2013, NAT PROD COMMUN, V8, P1229; MALMBERG AB, 2005, TURNING HEAT PAIN TR; Philyppov IB, 2012, LIFE SCI, V91, P912, DOI 10.1016/j.lfs.2012.09.001; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Romanovsky AA, 2009, PHARMACOL REV, V61, P228, DOI 10.1124/pr.109.001263; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Savidge J, 2002, NEUROPHARMACOLOGY, V43, P450, DOI 10.1016/S0028-3908(02)00122-3; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Sutton KG, 2005, BRIT J PHARMACOL, V146, P702, DOI 10.1038/sj.bjp.0706356; Tamayo N, 2008, J MED CHEM, V51, P2744, DOI 10.1021/jm7014638; Wang S, 2010, J BIOL CHEM, V285, P11547, DOI 10.1074/jbc.M109.058727; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Yang SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9297; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	40	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177077	10.1371/journal.pone.0177077	http://dx.doi.org/10.1371/journal.pone.0177077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475608	Green Published, Green Submitted, gold			2022-12-27	WOS:000400649500043
J	Mora, AR; Meniri, M; Gning, O; Glauser, G; Vallat, A; Helfenstein, F				Mora, Alfonso Rojas; Meniri, Magali; Gning, Ophelie; Glauser, Gaetan; Vallat, Armelle; Helfenstein, Fabrice			Antioxidant allocation modulates sperm quality across changing social environments	PLOS ONE			English	Article							HISTORY TRADE-OFFS; OXIDATIVE STRESS; HOUSE SPARROW; PASSER-DOMESTICUS; METABOLIC-RATE; EJACULATE QUALITY; SEXUAL SELECTION; BETA-CAROTENE; COMPETITION; EVOLUTION	In promiscuous species, male reproductive success depends on their ability to mate with fertile females and on the fertilizing ability of their sperm. In such species, theory predicts that, owing to a trade-off between pre-and post-copulatory reproductive traits, males with lesser access to females should increase resource investment into those sperm traits that enhance fertilization success-usually referred to as ejaculate quality. This prediction has been validated in several taxa, yet studies on the physiological mechanisms modulating ejaculate quality are lacking. Sperm cells are highly vulnerable to oxidative stress, which impairs male fertility. Therefore, males that better protect their sperm from oxidative stress are expected to achieve higher ejaculate quality. Based on theoretical expectations, and since social dominance is a major determinant of mating opportunity, we predicted that subordinate males should invest more into the antioxidant protection of their sperm in order to achieve higher ejaculate quality. We maintained 60 male and 60 female wild-caught house sparrows Passer domesticus in outdoor aviaries, where we experimentally manipulated male social status to test our predictions. We measured cellular oxidative stress and enzymatic antioxidant activity in blood and sperm both before and after manipulating social ranks. Before manipulating the social status, we found that ejaculate viability correlated with oxidative stress level in sperm, with dominant males producing more oxidized and less viable ejaculates. Further, males at the lower end of the hierarchy produced ejaculates of similar quality to those of dominant males, suggesting that restricted access to resources might limit male reproductive strategies. After experimentally manipulating the social status, males matched their ejaculate quality to their new rank, while increases in antioxidant investment into ejaculates paralleled increases in ejaculate viability. Oxidative stress has been proposed as a general constraint to the evolution of life histories. Our results highlight oxidative stress and strategic antioxidant allocation as important proximate physiological mechanisms underlying male reproductive strategies.	[Mora, Alfonso Rojas; Meniri, Magali; Gning, Ophelie; Helfenstein, Fabrice] Univ Neuchatel, Fac Sci, Inst Biol, Lab Evolutionary Ecophysiol, Neuchatel, Switzerland; [Glauser, Gaetan; Vallat, Armelle] Univ Neuchatel, Fac Sci, Inst Chem, Neuchatel Platform Analyt Chem, Neuchatel, Switzerland	University of Neuchatel; University of Neuchatel	Helfenstein, F (corresponding author), Univ Neuchatel, Fac Sci, Inst Biol, Lab Evolutionary Ecophysiol, Neuchatel, Switzerland.	fabrice.helfenstein@free.fr	Glauser, Gaetan/K-7574-2017; Helfenstein, Fabrice/I-5634-2013	Glauser, Gaetan/0000-0002-0983-8614; Helfenstein, Fabrice/0000-0001-8412-0461; Rojas Mora, Alfonso/0000-0002-1815-0424	Swiss National Science Foundation [PP00P3_139011]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We are very grateful to the Laboratory of Behavioural Ecology at the university of Bern for granting us access to their aviaries. We thank Sabrina Ciprietti for her help in conducting the experiment and Leif Engqvist for commenting an earlier version of the manuscript. We are also grateful to the farmers who allowed us to catch birds in their properties. This study was supported by a grant from the Swiss National Science Foundation no PP00P3_139011 to FH; This work was supported by the Swiss National Science Foundation (grant no PP00P3_139011 to FH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 1999, J REPROD FERTIL, V115, P1; Aitken RJ, 2004, REPROD FERT DEVELOP, V16, P581, DOI 10.1071/RD03089; Almbro M, 2011, ECOL LETT, V14, P891, DOI 10.1111/j.1461-0248.2011.01653.x; Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Anderson TR., 2006, BIOL UBIQUITOUS HOUS; Atessahin A, 2006, REPROD TOXICOL, V21, P42, DOI 10.1016/j.reprotox.2005.05.003; BHAT G, 1988, ZOOL ANZ, V221, P430; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; BIRKHEAD TR, 1993, BIOL J LINN SOC, V50, P295, DOI 10.1111/j.1095-8312.1993.tb00933.x; Buchanan KL, 2010, J AVIAN BIOL, V41, P445, DOI 10.1111/j.1600-048X.2010.04929.x; Catoni C, 2008, ANIM BEHAV, V76, P1107, DOI 10.1016/j.anbehav.2008.05.027; Chitra KC, 2003, TOXICOLOGY, V185, P119, DOI 10.1016/S0300-483X(02)00597-8; CIERESZKO A, 1995, BIOL REPROD, V52, P982, DOI 10.1095/biolreprod52.5.982; Cohen AA, 2009, OECOLOGIA, V161, P673, DOI 10.1007/s00442-009-1423-9; Cohen AA, 2009, FUNCT ECOL, V23, P310, DOI 10.1111/j.1365-2435.2009.01540.x; Cornwallis CK, 2007, AM NAT, V170, P758, DOI 10.1086/521955; Cornwallis CK, 2009, P ROY SOC B-BIOL SCI, V276, P3467, DOI 10.1098/rspb.2009.0807; Costantini D, 2011, J COMP PHYSIOL B, V181, P447, DOI 10.1007/s00360-011-0566-2; delBarco-Trillo J, 2014, J EVOLUTION BIOL, V27, P55, DOI 10.1111/jeb.12275; Duru NK, 2000, FERTIL STERIL, V74, P1200; El-Demerdash FM, 2004, J ENVIRON SCI HEAL B, V39, P443, DOI 10.1081/PFC-120035929; Engqvist L, 2011, BEHAV ECOL, V22, P345, DOI 10.1093/beheco/arq211; Evans JP, 2010, P ROY SOC B-BIOL SCI, V277, P3195, DOI 10.1098/rspb.2010.0826; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Firman RC, 2015, J EVOLUTION BIOL, V28, P1373, DOI 10.1111/jeb.12661; Fitzpatrick JL, 2014, MOL HUM REPROD, V20, P1180, DOI 10.1093/molehr/gau067; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Froman DP, 1999, BIOL REPROD, V61, P400, DOI 10.1095/biolreprod61.2.400; Froman DP, 2000, BIOL REPROD, V62, P303, DOI 10.1095/biolreprod62.2.303; Gammell MP, 2003, ANIM BEHAV, V66, P601, DOI 10.1006/anbe.2003.2226; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Gonzalez G, 2002, ETHOLOGY, V108, P289, DOI 10.1046/j.1439-0310.2002.00779.x; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; HAUSSMANN MF, 2010, ECOLOGY EVOLUTION, V56, P714; Helfenstein F, 2010, ECOL LETT, V13, P213, DOI 10.1111/j.1461-0248.2009.01419.x; Horak P, 2010, FUNCT ECOL, V24, P960, DOI 10.1111/j.1365-2435.2010.01755.x; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; Immler S, 2010, EVOLUTION, V64, P1634, DOI 10.1111/j.1558-5646.2009.00924.x; JONES R, 1978, PROC R SOC SER B-BIO, V201, P413, DOI 10.1098/rspb.1978.0053; Jones R.C., 1993, Oxford Reviews of Reproductive Biology, V15, P233; Krishnan N, 2006, ARCH INSECT BIOCHEM, V63, P1, DOI 10.1002/arch.20135; Lemaitre JF, 2012, J EVOLUTION BIOL, V25, P1216, DOI 10.1111/j.1420-9101.2012.02511.x; Lindstrom KM, 2005, HORM BEHAV, V48, P311, DOI 10.1016/j.yhbeh.2005.04.002; Locatello L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2891; Losdat S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022221; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; MOLLER AP, 1994, EVOLUTION, V48, P1089, DOI 10.1111/j.1558-5646.1994.tb05296.x; MOLLER AP, 1990, BEHAV ECOL SOCIOBIOL, V27, P23; MOLLER AP, 1987, ANIM BEHAV, V35, P203, DOI 10.1016/S0003-3472(87)80225-7; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Mora AR, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00067; Nakagawa S, 2007, BEHAV ECOL, V18, P831, DOI 10.1093/beheco/arm050; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; Parker GA, 1996, P ROY SOC B-BIOL SCI, V263, P1291, DOI 10.1098/rspb.1996.0189; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Parker GA, 2013, EVOLUTION, V67, P95, DOI 10.1111/j.1558-5646.2012.01741.x; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Perry JC, 2013, TRENDS ECOL EVOL, V28, P414, DOI 10.1016/j.tree.2013.03.005; Pizzari T, 2008, TRENDS ECOL EVOL, V23, P131, DOI 10.1016/j.tree.2007.12.003; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; Pizzari T, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-332; Preston BT, 2001, NATURE, V409, P681, DOI 10.1038/35055617; Ribou AC, 2012, P ROY SOC B-BIOL SCI, V279, P2196, DOI 10.1098/rspb.2011.2422; Rudolfsen G, 2006, P ROY SOC B-BIOL SCI, V273, P325, DOI 10.1098/rspb.2005.3305; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simmons LW, 2012, REPRODUCTION, V144, P519, DOI 10.1530/REP-12-0285; Siva-Jothy MT, 2000, ECOL LETT, V3, P172; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Tazzyman SJ, 2009, AM NAT, V174, pE71, DOI 10.1086/603612; Thomas ML, 2009, BEHAV ECOL, V20, P1118, DOI 10.1093/beheco/arp105; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Wang Y, 2001, EXP GERONTOL, V36, P1349, DOI 10.1016/S0531-5565(01)00095-X; Wesseling C, 2016, J EXP BIOL, V219, P1363, DOI 10.1242/jeb.133843; WETTON JH, 1995, P ROY SOC B-BIOL SCI, V260, P91, DOI 10.1098/rspb.1995.0064; WETTON JH, 1991, P ROY SOC B-BIOL SCI, V245, P227, DOI 10.1098/rspb.1991.0114; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wilson-Leedy JG, 2007, THERIOGENOLOGY, V67, P661, DOI 10.1016/j.theriogenology.2006.10.003; Wolfson A., 1952, Bird-Banding, V23, P159	79	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176385	10.1371/journal.pone.0176385	http://dx.doi.org/10.1371/journal.pone.0176385			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472052	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500043
J	Yang, Y; Wang, FJ; Zheng, KY; Deng, LM; Yang, L; Zhang, N; Xu, CY; Ran, HT; Wang, ZX; Wang, ZG; Zheng, YY				Yang, Yang; Wang, Fengjuan; Zheng, Kaiyuan; Deng, Liming; Yang, Lu; Zhang, Nan; Xu, Chunyan; Ran, Haitao; Wang, Zhaoxia; Wang, Zhigang; Zheng, Yuanyi			Injectable PLGA/Fe3O4 implants carrying cisplatin for synergistic magnetic hyperthermal ablation of rabbit VX2 tumor	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; DRUG-RELEASE; IN-VIVO; FLUID HYPERTHERMIA; LIVER-TUMORS; CANCER; CHEMOTHERAPY; MODEL; CHAPERONE; DELIVERY	Magnetic hyperthermia ablation has attracted wide attention in tumor therapy for its minimal invasion. Although the chemo-hyperthermal synergism has been proven to be effective in subcutaneously xenografted tumors of nude mice in our previous experiment, the occurrence of residual tumors due to incomplete ablation is more common in relatively larger and deeper-seated tumors in anti-tumor therapy. Thus, a larger tumor and larger animal model are needed for further study of the therapeutic efficacy. In this study, we tested the efficiency of this newly developed technique using a rabbit tumor model. Furthermore, we chose cisplatin (DDP), which has been confirmed with high efficiency in enhancing hyperthermia therapy as the chemotherapeutic drug for the synergistic magnetic hyperthermal ablation therapy of tumors. In vitro studies demonstrated that developed DDP-loaded magnetic implants (DDP/PLGA-Fe3O4) have great heating efficacy and the drug release can be significantly boosted by an external alternating magnetic field (AMF). In vivo studies showed that the phase-transitional DDP/PLGA-Fe3O4 materials that are ultrasound (US) and computerized tomography (CT) visible can be well confined in the tumor tissues after injection. When exposed to AMF, efficient hyperthermia was induced, which led to the cancer cells' coagulative necrosis and accelerating release of the drug to kill residual tumors. Furthermore, an activated anti-tumor immune system can promote apoptosis of tumor cells. In conclusion, the DDP/PLGA-Fe3O4 implants can be used efficiently for the combined chemotherapy and magnetic-hyperthermia ablation of rabbit tumors.	[Yang, Yang; Wang, Fengjuan; Deng, Liming; Yang, Lu; Zhang, Nan; Xu, Chunyan; Ran, Haitao; Wang, Zhigang] Chongqing Med Univ, Affiliated Hosp 2, Chongqing Key Lab Ultrasound Mol Imaging, Chongqing, Peoples R China; [Zheng, Kaiyuan] Chongqing Peoples Hosp, Dept Nephrol, Chongqing, Peoples R China; [Wang, Zhaoxia] Chongqing Med Univ, Childrens Hosp, Dept Ultrasound, Chongqing, Peoples R China; [Zheng, Yuanyi] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Shanghai Inst Ultrasound Med, Shanghai, Peoples R China	Chongqing Medical University; Chongqing Medical University; Shanghai Jiao Tong University	Zheng, YY (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Shanghai Inst Ultrasound Med, Shanghai, Peoples R China.	zhengyuanyi@163.com			National Science Fund for Distinguished Young Scholars [81425014]; Chongqing Nature Science Fund [cstc2016jcyjA0823]; National Nature Science Fund of China [81227801, 81501482]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Chongqing Nature Science Fund; National Nature Science Fund of China(National Natural Science Foundation of China (NSFC))	This work is supported by the funds as follows: 1. National Science Fund for Distinguished Young Scholars (Grant No. 81425014), Y.Y. Zheng received the funding. The URLs is http://npd.nsfc.gov.cn/fundingProjectSearchAction!search.action. 2. Chongqing Nature Science Fund (Grant No. cstc2016jcyjA0823),Y. Yang received the funding. The URLs is http://wvw.cstc.gov.cn/Class.aspx?clsld=226. 3. The National Nature Science Fund of China (Grant No. 81227801), Z.G. Wang received the funding. The URLs is http://npd.nsfc.gov.cn/fundingProjectSearchAction!search.action. 4. The National Nature Science Fund of China (Grant No. 81501482), M. Ao received the funding. he URLs is http://npd.nsfc.gov.cn/fundingProjectSearchAction!search.action.	Ahmed M, 2013, BIOMED RES INT, V2013, P499; Al-Jamal WT, 2012, BIOMATERIALS, V33, P4608, DOI 10.1016/j.biomaterials.2012.03.018; Alvarez-Berrios MP, 2013, INT J NANOMED, V8, P1003, DOI 10.2147/IJN.S38842; Anayama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067355; Beckham JT, 2010, LASER SURG MED, V42, P752, DOI 10.1002/lsm.20983; Chen JH, 2004, LAB ANIM-UK, V38, P79, DOI 10.1258/00236770460734434; Chen X, 2008, IEEE T BIO-MED ENG, V55, P1004, DOI 10.1109/TBME.2008.915694; Chen Y, 2014, ADV MATER, V26, P7468, DOI 10.1002/adma.201402509; Dutz S, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/45/452001; Facy O, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-4; Gao W, 2016, ACTA BIOMATER, V29, P298, DOI 10.1016/j.actbio.2015.09.037; Huang L, 2001, MOL CELL BIOL, V21, P8575, DOI 10.1128/MCB.21.24.8575-8591.2001; Issels RD, 2008, EUR J CANCER, V44, P2546, DOI 10.1016/j.ejca.2008.07.038; Ito A, 2004, CANCER IMMUNOL IMMUN, V53, P26; Itoh Y, 2010, EXP THER MED, V1, P319, DOI 10.3892/etm_00000049; Kang JA, 2010, J ULTRAS MED, V29, P61, DOI 10.7863/jum.2010.29.1.61; Khandhar AP, 2012, J BIOMED MATER RES A, V100A, P728, DOI 10.1002/jbm.a.34011; Ko YH, 2001, CANCER LETT, V173, P83, DOI 10.1016/S0304-3835(01)00667-X; Kong SD, 2013, ACTA BIOMATER, V9, P5447, DOI 10.1016/j.actbio.2012.11.006; Kranz H, 2008, PHARM RES, V25, P1347, DOI 10.1007/s11095-007-9478-y; Krishnan S, 2010, INT J HYPERTHER, V26, P775, DOI 10.3109/02656736.2010.485593; Kruse AM, 2014, ACTA BIOMATER, V10, P2622, DOI 10.1016/j.actbio.2014.01.025; Kumar CSSR, 2011, ADV DRUG DELIVER REV, V63, P789, DOI 10.1016/j.addr.2011.03.008; Latorre M, 2009, P R HEALTH SCI J, V28, P227; Laurent S, 2011, ADV COLLOID INTERFAC, V166, P8, DOI 10.1016/j.cis.2011.04.003; Lee N, 2015, CHEM REV, V115, P10637, DOI 10.1021/acs.chemrev.5b00112; Luis S, 2012, THERANOSTICS, V2, P1064; Mahmoudi M, 2011, ADV DRUG DELIVER REV, V63, P24, DOI 10.1016/j.addr.2010.05.006; Matsumoto H, 1996, CANCER LETT, V110, P253, DOI 10.1016/S0304-3835(96)04508-9; Mohamed M, 2012, J DRUG DELIV SCI TEC, V22, P393, DOI 10.1016/S1773-2247(12)50066-3; Moroz P, 2001, J SURG ONCOL, V78, P22, DOI 10.1002/jso.1118; Patel RB, 2010, J CONTROL RELEASE, V147, P350, DOI 10.1016/j.jconrel.2010.08.020; Petryk AA, 2013, INT J HYPERTHER, V29, P845, DOI 10.3109/02656736.2013.825014; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Raman C, 2005, J CONTROL RELEASE, V102, P145, DOI 10.1016/j.jconrel.2004.09.022; Ren YY, 2012, INT J NANOMED, V7, P2261, DOI 10.2147/IJN.S29357; Skitzki JJ, 2009, CURR OPIN INVEST DR, V10, P550; Takahashi I, 2002, SURGERY, V131, pS78, DOI 10.1067/msy.2002.119308; Torres-Lugo M, 2016, NANOMEDICINE, V8, P1689; Wang H, 2012, EUR J RADIOL, V81, P104, DOI 10.1016/j.ejrad.2010.03.022; Westermann AM, 2001, EUR J CANCER, V37, P1111, DOI 10.1016/S0959-8049(01)00074-0; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; Zolnik BS, 2006, J CONTROL RELEASE, V112, P293, DOI 10.1016/j.jconrel.2006.02.015	43	14	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177049	10.1371/journal.pone.0177049	http://dx.doi.org/10.1371/journal.pone.0177049			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472102	gold, Green Submitted, Green Published			2022-12-27	WOS:000400648500130
J	Jing, XR; Lin, JR; Wang, HW; Tian, LY; Tian, RH; Zhang, YY; Chen, X; Zhang, JY				Jing, Xuran; Lin, Jieru; Wang, Hongwei; Tian, Liyuan; Tian, Runhua; Zhang, Yunyuan; Chen, Xian; Zhang, Jinyu			Prognostic value of lncRNA SOX2OT for Chinese cancer patients: A meta-analysis	PLOS ONE			English	Article							LONG NONCODING RNA; GASTRIC-CANCER; HETEROGENEITY; INVOLVEMENT; PROGRESSION; STATISTICS; EXPRESSION; CARCINOMA	SOX2OT has been demonstrated to be aberrantly expressed in several types of cancer and maybe serve as a prognostic marker for cancer patients. However, most individual studies have been limited by small sample sizes and controversial results. Therefore, the present meta-analysis was conducted to analyze available data to reveal the potential clinical application of SOX2OT on cancer prognosis, tumor progression, distance metastasis and lymph node metastasis. Up to February 20, 2017, literature collections were conducted by comprehensive searching electronic databases, including Cochrane Library, PubMed, Embase, BioMed Central, Springer, ScienceDirect, ISI Web of Knowledge, together with three Chinese databases: China National Knowledge Internet (CNKI), Weipu and Wanfang. The hazard ratios (HR) with 95% confidence interval (95% CI) were calculated to assess the strength of the association. Five studies with a total of 481 cancer patients were included in the present meta-analysis. The results indicated that elevated SOX2OT significantly predicted unfavorable overall survival (OS) (HR = 2.44, 95% CI: 1.75-3.39, P<0.0001) and tumor progression (III/IV vs. I/II: HR 1.62, 95% CI: 1.30-2.02, P<0.0001), but failed to predict distant metastasis (HR: 3.30, 95% CI: 0.74-14.61, P = 0.12) and lymph node metastasis (HR: 1.29, 95% CI: 0.87-1.91, P = 0.21). The results revealed that SOX2OT expression level was an independent prognostic biomarker for OS and tumor progression in Chinese cancer patients.	[Jing, Xuran; Tian, Liyuan] Qingdao Univ, Med Coll, Qingdao, Shandong, Peoples R China; [Lin, Jieru] Guizhou Prov Peoples Hosp, Dept Resp & Crit Care Med, Guiyang, Guizhou, Peoples R China; [Wang, Hongwei; Tian, Runhua; Zhang, Yunyuan; Chen, Xian] Qingdao Univ, Affiliated Hosp, Dept Clin Lab, Qingdao, Shandong, Peoples R China; [Tian, Runhua; Zhang, Jinyu] Qingdao Univ, Coll Med, Dept Biochem & Mol Biol, Qingdao, Shandong, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Chen, X (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Clin Lab, Qingdao, Shandong, Peoples R China.; Zhang, JY (corresponding author), Qingdao Univ, Coll Med, Dept Biochem & Mol Biol, Qingdao, Shandong, Peoples R China.	cxkakicoco2014@163.com; zhangjinyu6768@163.com	chen, xian/AAF-5997-2020	chen, xian/0000-0002-5141-7979	National Natural Science Foundation of China [81601821, 81501872]; China Postdoctoral Science Foundation [2016M590621, 2016M592144]; Distinguished Middle-Aged and Young Scientist Encourage and Reward Foundation of Shandong Province [BS2014YY034]; Postdoctoral innovation project of Shandong Province [201603069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Distinguished Middle-Aged and Young Scientist Encourage and Reward Foundation of Shandong Province; Postdoctoral innovation project of Shandong Province	This study is fully supported by the National Natural Science Foundation of China (No. 81601821 and No. 81501872), China Postdoctoral Science Foundation (No. 2016M590621 and No. 2016M592144), Distinguished Middle-Aged and Young Scientist Encourage and Reward Foundation of Shandong Province (No. BS2014YY034), Postdoctoral innovation project of Shandong Province (No. 201603069).	Askarian-Amiri ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102140; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bowden J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-41; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hou ZB, 2014, INT J BIOCHEM CELL B, V53, P380, DOI 10.1016/j.biocel.2014.06.004; Iranpour M, 2016, TUMOR BIOL, V37, P2933, DOI 10.1007/s13277-015-4135-2; Johnsson P, 2014, BBA-GEN SUBJECTS, V1840, P1063, DOI 10.1016/j.bbagen.2013.10.035; Maruyama R, 2012, BMB REP, V45, P604, DOI 10.5483/BMBRep.2012.45.11.227; Moran VA, 2012, NUCLEIC ACIDS RES, V40, P6391, DOI 10.1093/nar/gks296; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Shahryari A, 2014, STEM CELLS, V32, P126, DOI 10.1002/stem.1542; Shi XM, 2015, INT J CLIN EXP PATHO, V8, P4008; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Wu YS, 2014, TUMOR BIOL, V35, P9531, DOI 10.1007/s13277-014-2523-7; Zhang H, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-37; Zhang YY, 2016, AM J TRANSL RES, V8, P5035; Zhang YY, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0328-z; Zou JH, 2016, EUR REV MED PHARMACO, V20, P4482	26	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176889	10.1371/journal.pone.0176889	http://dx.doi.org/10.1371/journal.pone.0176889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489861	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100034
J	Krambeck, FJ; Bennun, SV; Andersen, MR; Betenbaugh, MJ				Krambeck, Frederick J.; Bennun, Sandra V.; Andersen, Mikael R.; Betenbaugh, Michael J.			Model-based analysis of N-glycosylation in Chinese hamster ovary cells	PLOS ONE			English	Article							MATHEMATICAL-MODEL; MOLECULAR-CLONING; MUTANTS; OLIGOSACCHARIDES; GLYCOPROTEINS; NOMENCLATURE; EXPRESSION; MUTATIONS; GLYCOFORM; LECTINS	The Chinese hamster ovary (CHO) cell is the gold standard for manufacturing of glycosylated recombinant proteins for production of biotherapeutics. The similarity of its glycosylation patterns to the human versions enable the products of this cell line favorable pharmacokinetic properties and lower likelihood of causing immunogenic responses. Because glycan structures are the product of the concerted action of intracellular enzymes, it is difficult to predict a priori how the effects of genetic manipulations alter glycan structures of cells and therapeutic properties. For that reason, quantitative models able to predict glycosylation have emerged as promising tools to deal with the complexity of glycosylation processing. For example, an earlier version of the same model used in this study was used by others to successfully predict changes in enzyme activities that could produce a desired change in glycan structure. In this study we utilize an updated version of this model to provide a comprehensive analysis of N-glycosylation in ten Chinese hamster ovary (CHO) cell lines that include a wild type parent and nine mutants of CHO, through interpretation of previously published mass spectrometry data. The updated N-glycosylation mathematical model contains up to 50,605 glycan structures. Adjusting the enzyme activities in this model to match N-glycan mass spectra produces detailed predictions of the glycosylation process, enzyme activity profiles and complete glycosylation profiles of each of the cell lines. These profiles are consistent with biochemical and genetic data reported previously. The modelbased results also predict glycosylation features of the cell lines not previously published, indicating more complex changes in glycosylation enzyme activities than just those resulting directly from gene mutations. The model predicts that the CHO cell lines possess regulatory mechanisms that allow them to adjust glycosylation enzyme activities to mitigate side effects of the primary loss or gain of glycosylation function known to exist in these mutant cell lines. Quantitative models of CHO cell glycosylation have the potential for predicting how glycoengineering manipulations might affect glycoform distributions to improve the therapeutic performance of glycoprotein products.	[Krambeck, Frederick J.; Bennun, Sandra V.; Betenbaugh, Michael J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Krambeck, Frederick J.; Bennun, Sandra V.] ReacTech Inc, Alexandria, VA USA; [Andersen, Mikael R.] Tech Univ Denmark, Dept Syst Biol, Lyngby, Denmark; [Bennun, Sandra V.] Regeneron Pharmaceut Inc, Tarrytown, NY USA	Johns Hopkins University; Technical University of Denmark; Regeneron	Krambeck, FJ (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA.	fjkrambeck@reactech.net	Andersen, Mikael Rørdam/P-6743-2019; Andersen, Mikael R/F-9377-2013	Andersen, Mikael Rørdam/0000-0003-4794-6808; Andersen, Mikael R/0000-0003-4794-6808	National Cancer Institute [5R41CA127885-02]; Consortium for Functional Glycomics; Bridging Grant [U54-GM062116-10]; Regeneron	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Consortium for Functional Glycomics; Bridging Grant; Regeneron(Regeneron)	This work was supported by the National Cancer Institute Award 5R41CA127885-02 (administered by ReacTech Inc.), and the Consortium for Functional Glycomics (http://www.functionalglycomics.org), Bridging Grant Number U54-GM062116-10 (administered by Johns Hopkins University). Sandra V. Bennun is currently employed by Regeneron Inc. The work reported in this manuscript is unrelated to Dr. Bennun's duties at Regeneron, and Regeneron has provided no funding of any kind for this effort and had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. She was previously employed by Johns Hopkins University and ReacTech Inc. where her compensation for the work described was fully funded by the awards stated above. ReacTech Inc. is a pass-through entity for management of consulting and other business income of Frederick J. Krambeck and provided no separate financial support or any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Baker KN, 2001, BIOTECHNOL BIOENG, V73, P188, DOI 10.1002/bit.1051; Banin E, 2002, TRENDS GLYCOSCI GLYC, V14, P127, DOI 10.4052/tigg.14.127; Bennun SV, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002813; Bennun SV, 2008, CELL ENG; Bork K, 2009, J PHARM SCI-US, V98, P3499, DOI 10.1002/jps.21684; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Cummings R.D., 2009, ESSENTIALS GLYCOBIOL; CUMMINGS RD, 1994, METHOD ENZYMOL, V230, P66; DEBRAY H, 1981, EUR J BIOCHEM, V117, P41; del Val IJ, 2011, BIOTECHNOL PROGR, V27, P1730, DOI 10.1002/btpr.688; Eckhardt M, 1998, J BIOL CHEM, V273, P20189, DOI 10.1074/jbc.273.32.20189; Esko JD, 2009, GLYCOSYLATION MUTANT; GOOCHEE CF, 1991, BIO-TECHNOL, V9, P1347, DOI 10.1038/nbt1291-1347; Hong YJ, 2003, J BIOL CHEM, V278, P53045, DOI 10.1074/jbc.M309967200; Hossler P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000713; Hou W, 2016, BIOINFORMATICS S7, V17, P465; Inoue N, 1999, GLYCOCONJUGATE J, V16, P707, DOI 10.1023/A:1007159409961; Ismail MN, 2011, GLYCOBIOLOGY, V21, P82, DOI 10.1093/glycob/cwq134; Jedrzejewski PM, 2014, INT J MOL SCI, V15, P4492, DOI 10.3390/ijms15034492; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Krambeck FJ, 2005, BIOTECHNOL BIOENG, V92, P711, DOI 10.1002/bit.20645; Krambeck FJ, 2009, GLYCOBIOLOGY, V19, P1163, DOI 10.1093/glycob/cwp081; LEE EU, 1989, J BIOL CHEM, V264, P13848; Liu G, 2008, BIOINFORMATICS, V24, P1109, DOI 10.1093/bioinformatics/btn061; Liu G, 2008, BIOINFORMATICS, V24, P2740, DOI 10.1093/bioinformatics/btn515; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; McDonald AG, 2014, J CELL SCI, V127, P5014, DOI 10.1242/jcs.151878; McNaught AD, 1996, PURE APPL CHEM, V68, P1919, DOI 10.1351/pac199668101919; Mkhikian H, 2016, ELIFE, V5, DOI 10.7554/eLife.14814; NARASIMHAN S, 1977, J BIOL CHEM, V252, P3926; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Ohyama C, 1998, J BIOL CHEM, V273, P14582, DOI 10.1074/jbc.273.23.14582; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Patnaik SK, 2000, ARCH BIOCHEM BIOPHYS, V375, P322, DOI 10.1006/abbi.1999.1693; Spahn PN, 2016, METAB ENG, V33, P52, DOI 10.1016/j.ymben.2015.10.007; SPELLMAN MW, 1989, J BIOL CHEM, V264, P14100; St Amand MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087973; STANLEY P, 1992, GLYCOBIOLOGY, V2, P99, DOI 10.1093/glycob/2.2.99; Stanley P, 2005, GLYCOBIOLOGY, V15, P43, DOI 10.1093/glycob/cwh136; Stanley P, 1996, GLYCOBIOLOGY, V6, P695, DOI 10.1093/glycob/6.7.695; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Stone EL, 2009, MOL CELL BIOL, V29, P3770, DOI 10.1128/MCB.00204-09; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Umana P, 1997, BIOTECHNOL BIOENG, V55, P890, DOI 10.1002/(SICI)1097-0290(19970920)55:6<890::AID-BIT7>3.0.CO;2-B; Varki A., 2009, ESSENTIALS GLYCOBIOL; Varki A., 2009, ESSENTIALS GLYCOBIOL; Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040; Wang Y, 2001, GLYCOBIOLOGY, V11, P1051, DOI 10.1093/glycob/11.12.1051; Weinstein J, 1996, J BIOL CHEM, V271, P27462, DOI 10.1074/jbc.271.44.27462; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Zhang AM, 1999, J BIOL CHEM, V274, P10439, DOI 10.1074/jbc.274.15.10439	52	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0175376	10.1371/journal.pone.0175376	http://dx.doi.org/10.1371/journal.pone.0175376			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486471	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000004
J	Ohno, Y; Koizumi, M; Nakayama, H; Watanabe, T; Hirooka, M; Tokumoto, Y; Kuroda, T; Abe, M; Fukuda, S; Higashiyama, S; Kumagi, T; Hiasa, Y				Ohno, Yoshinori; Koizumi, Mitsuhito; Nakayama, Hironao; Watanabe, Takao; Hirooka, Masashi; Tokumoto, Yoshio; Kuroda, Taira; Abe, Masanori; Fukuda, Shinji; Higashiyama, Shigeki; Kumagi, Teru; Hiasa, Yoichi			Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma	PLOS ONE			English	Article							HEPATOPOIETIN CN; SET COMPLEX; FAMILY; PROTEINS; BAD; SORAFENIB; INHIBITOR; GROWTH; CANCER; MEMBER	The acidic (leucine-rich) nuclear phosphoprotein 32 family member B (ANP32B), a highly conserved member of the acidic nuclear phosphoprotein 32 (ANP32) family, is critical for the development of normal tissue. However, its role in the development of hepatocellular carcinoma (HCC) is controversial. In this study, we elucidated the role of ANP32B in HCC cell lines and tissues. ANP32B expression in HCC cell lines was modulated using siRNA and ANP32B expression plasmids and lentiviruses. The levels of apoptosis-related proteins were analyzed by real-time RT-PCR and Western blotting. The expression of ANP32B in tissues from patients with HCC was investigated using real-time RT-PCR and immunohistochemistry. ANP32B knockdown by siRNA altered the expression of apoptosis-related proteins in HCC cell lines and reduced the expression of cleaved forms of caspase 3 and caspase 9, but not that of caspase 8, in HCC cells cultured with the pro-apoptotic agent staurosporine. Phosphorylated Bad was upregulated, whereas Bak was downregulated. Moreover, ABT-737, which binds to and inhibits anti-apoptotic proteins of the Bcl-2 family, rendered HCC cells resistant to apoptosis induced by ANP32B silencing. Conversely, ANP32B overexpression decreased Bad phosphorylation and upregulated Bak, but did not induce apoptosis because Bax expression was downregulated. In tissues from patients with HCC, a low tumor/non-tumor ratio of ANP32B mRNA expression was related to advanced UICC stage (p = 0.032). TUNEL-positive cells were observed in parallel with ANP32B expression in HCC tissues. ANP32B modulates Bad phosphorylation as well as Bak and Bax expression, resulting in regulation of apoptosis in HCC. These findings indicate the potential value of ANP32B as a therapeutic target for HCC.	[Ohno, Yoshinori; Koizumi, Mitsuhito; Watanabe, Takao; Hirooka, Masashi; Tokumoto, Yoshio; Kuroda, Taira; Abe, Masanori; Kumagi, Teru; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan; [Nakayama, Hironao; Fukuda, Shinji; Higashiyama, Shigeki] Ehime Univ, Dept Biochem & Mol Genet, Grad Sch Med, Toon, Ehime, Japan; [Nakayama, Hironao; Fukuda, Shinji; Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Div Cell Growth & Tumor Regulat, Proteosci Ctr PROS, Toon, Ehime, Japan	Ehime University; Ehime University; Ehime University	Hiasa, Y (corresponding author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan.	hiasa@m.ehime-u.ac.jp	Hiasa, Yoichi/ABD-2759-2021; Kumagi, Teru/AAS-7427-2021	Hiasa, Yoichi/0000-0003-4117-339X; Kumagi, Teru/0000-0002-2292-7750	Japan Society for the Promotion of Science, KAKENHI [15K19334, 26461034, 15K09006]; Program for Enhancing Systematic Education in Graduate School from the Japanese Ministry of Education, Culture, Sports, Science and Technology; Japanese Ministry of Health, Labor, and Welfare	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program for Enhancing Systematic Education in Graduate School from the Japanese Ministry of Education, Culture, Sports, Science and Technology; Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Scientific Research (Japan Society for the Promotion of Science, KAKENHI 15K19334 to MK, 26461034 to T. Kumagi, and 15K09006 to YH), by the Program for Enhancing Systematic Education in Graduate School from the Japanese Ministry of Education, Culture, Sports, Science and Technology (to YO), and by a Grant-in-Aid for Scientific Research and Development from the Japanese Ministry of Health, Labor, and Welfare (to YH).	Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Chang J, 2010, WORLD J GASTROENTERO, V16, P193, DOI 10.3748/wjg.v16.i2.193; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Cui CP, 2008, HEPATOLOGY, V47, P986, DOI 10.1002/hep.22126; Cui CP, 2009, HEPATOL RES, V39, P200, DOI 10.1111/j.1872-034X.2008.00447.x; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Galmiche A, 2010, MOL CANCER RES, V8, P1116, DOI 10.1158/1541-7786.MCR-10-0029; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hikita H, 2012, J HEPATOL, V57, P92, DOI 10.1016/j.jhep.2012.01.027; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kadkol SS, 1998, PROSTATE, V34, P231, DOI 10.1002/(SICI)1097-0045(19980215)34:3<231::AID-PROS11>3.0.CO;2-F; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Li CX, 2015, MOL MED REP, V11, P2813, DOI 10.3892/mmr.2014.3035; Li C, 2012, J PROTEOME RES, V11, P871, DOI 10.1021/pr2006999; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu Y, 2013, J PATHOL, V230, P365, DOI 10.1002/path.4194; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Matilla A, 2005, CEREBELLUM, V4, P7, DOI 10.1080/14734220410019020; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ouellet V, 2006, INT J CANCER, V119, P2119, DOI 10.1002/ijc.22054; Reilly PT, 2014, BIOESSAYS, V36, P1062, DOI 10.1002/bies.201400058; Reilly PT, 2011, P NATL ACAD SCI USA, V108, P10243, DOI 10.1073/pnas.1106211108; Saraswat VA, 2014, J CLIN EXP HEPATOL, V4, pS80, DOI 10.1016/j.jceh.2014.05.004; Shen SM, 2010, CARCINOGENESIS, V31, P419, DOI 10.1093/carcin/bgp320; Shi HJ, 2011, J PROTEOMICS, V75, P339, DOI 10.1016/j.jprot.2011.07.025; Siegel AB, 2010, HEPATOLOGY, V52, P360, DOI 10.1002/hep.23633; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113; Weber A, 2010, HEPATOLOGY, V51, P1226, DOI 10.1002/hep.23479; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yang S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.8; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu Y, 2012, BIOCHEM BIOPH RES CO, V423, P721, DOI 10.1016/j.bbrc.2012.06.025; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhu BD, 2010, CLIN EXP METASTAS, V27, P571, DOI 10.1007/s10585-010-9346-8	39	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177343	10.1371/journal.pone.0177343	http://dx.doi.org/10.1371/journal.pone.0177343			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486557	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314000072
J	Entin-Meer, M; Cohen, L; Hertzberg-Bigelman, E; Levy, R; Ben-Shoshan, J; Keren, G				Entin-Meer, Michal; Cohen, Lena; Hertzberg-Bigelman, Einat; Levy, Ran; Ben-Shoshan, Jeremy; Keren, Gad			TRPV2 knockout mice demonstrate an improved cardiac performance following myocardial infarction due to attenuated activity of peri-infarct macrophages	PLOS ONE			English	Article							POTENTIAL VANILLOID 2; CHANNEL; TRANSLOCATION; PHAGOCYTOSIS; INNATE	Background We have recently shown that the expression of the transient receptor potential vanilloid 2 channel, TRPV2, is upregulated in the peri-infarct zone 3-5 days following an acute myocardial infarction (AMI). Further analysis has demonstrated that invading monocytes maturing to macrophages merely harbor the documented elevated expression of this channel. Purpose Assess cardiac function in TRPV2-KO mice compared to TRPV2-WT following AMI and analyze the potential involvement of TRPV2-expressing macrophages in the recovery process. Methods TRPV2-KO or WT mice were induced with AMI by ligation of the left anterior descending artery (LAD). In another set of experiments, TRPV2-KO mice induced with AMI, were intravenously (IV) injected with WT or TRPV2-KO peritoneal macrophages in order to directly assess the potential contribution of TRPV2-expressing macrophages to cardiac healing. Cardiac parameters were obtained by echocardiography 1 day and 30 days post infarction. The relative changes in the ejection fraction (EF) and additional cardiac parameters between baseline (day 1) and day 30 were calculated and statistical significance was determined (SPSS). Results The in vivo study showed that while EF was significantly decreased in the WT animals between baseline and day 30, EF was only slightly and insignificantly reduced in the KO animals. Likewise LVESD and LVESA were significantly modified exclusively in the WT animals. Moreover, intravenous administration of peritoneal WT macrophages, but not KO macrophages, significantly reduced survival of post-MI TRPV2-KO mice. Conclusion The data suggest that knockout of the TRPV2 channel may attenuate macrophage-dependent pro-inflammatory processes and result in better cardiac recovery. TRPV2 may thus represent a novel therapeutic target for treatment of patients undergoing an acute MI.	[Entin-Meer, Michal; Cohen, Lena; Hertzberg-Bigelman, Einat; Levy, Ran; Ben-Shoshan, Jeremy; Keren, Gad] Tel Aviv Sourasky Med Ctr, Dept Cardiol, Lab Cardiovasc Res, Tel Aviv, Israel; [Entin-Meer, Michal; Cohen, Lena; Hertzberg-Bigelman, Einat; Ben-Shoshan, Jeremy; Keren, Gad] Tel Aviv Sourasky Med Ctr, Dept Cardiol, Sackler Fac Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Entin-Meer, M (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Cardiol, Lab Cardiovasc Res, Tel Aviv, Israel.; Entin-Meer, M (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Cardiol, Sackler Fac Med, Tel Aviv, Israel.	michale@tlvmc.gov.il			Israel Science Foundation [400/15]; Tel-Aviv University Research [0601243392]	Israel Science Foundation(Israel Science Foundation); Tel-Aviv University Research	This work was supported by the Israel Science Foundation NO. 400/15 and Tel-Aviv University Research grant No. 0601243392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Entin-Meer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105055; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frantz S, 2013, FASEB J, V27, P871, DOI 10.1096/fj.12-214049; Gao Shumin, 2011, Curr Protoc Mouse Biol, V1, P71; Hassan S, 2014, BRIT J PHARMACOL, V171, P2426, DOI 10.1111/bph.12615; Huynh KW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11130; Issa CM, 2014, SCAND J IMMUNOL, V80, P307, DOI 10.1111/sji.12206; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Katanosaka Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4932; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Nagasawa M, 2007, J CELL PHYSIOL, V210, P692, DOI 10.1002/jcp.20883; Nagasawa M, 2012, CELL CALCIUM, V51, P186, DOI 10.1016/j.ceca.2011.12.012; Nahrendorf M, 2016, EUR HEART J, V37, P868, DOI 10.1093/eurheartj/ehv453; Naticchioni M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136901; Park U, 2011, J NEUROSCI, V31, P11425, DOI 10.1523/JNEUROSCI.1384-09.2011; Penna A, 2006, CELL CALCIUM, V39, P495, DOI 10.1016/j.ceca.2006.01.009; Peralvarez-Marin A, 2013, FEBS J, V280, P5471, DOI 10.1111/febs.12302; Roberts E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h910; Rubinstein J, 2014, AM J PHYSIOL-HEART C, V306, pH574, DOI 10.1152/ajpheart.00854.2013; Santoni G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00034; Schwarz E. C., 2007, V179, P445; Sharir R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113653; Sopel M, 2010, J INVEST SURG, V23, P79, DOI 10.3109/08941930903469425; Tang MS, 2012, GROWTH HORM IGF RES, V22, P206, DOI 10.1016/j.ghir.2012.09.002; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; van der Laan AM, 2014, EUR HEART J, V35, P376, DOI 10.1093/eurheartj/eht331; Weinberger T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00107; Yamashiro K, 2010, BIOCHEM BIOPH RES CO, V398, P284, DOI 10.1016/j.bbrc.2010.06.082	30	26	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177132	10.1371/journal.pone.0177132	http://dx.doi.org/10.1371/journal.pone.0177132			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481959	Green Published, Green Submitted, gold			2022-12-27	WOS:000401313700036
J	Sidney, J; Becart, S; Zhou, M; Duffy, K; Lindvall, M; Moore, EC; Moore, EL; Rao, T; Rao, N; Nielsen, M; Peters, B; Sette, A				Sidney, John; Becart, Stephane; Zhou, Mimi; Duffy, Karen; Lindvall, Mikaela; Moore, Erin C.; Moore, Eugene L.; Rao, Tadimeti; Rao, Navin; Nielsen, Morten; Peters, Bjoern; Sette, Alessandro			Citrullination only infrequently impacts peptide binding to HLA class II MHC	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; SHARED EPITOPE; HLA-DRB1 ALLELES; AUTOANTIBODIES; AFFINITY; SUSCEPTIBILITY; ASSOCIATION; ANTIBODIES; MOLECULES; SEVERITY	It has been hypothesized that HLA class II alleles associated with rheumatoid arthritis (RA) preferentially present self-antigens altered by post-translational modification, such as citrullination. To understand the role of citrullination we tested four RA-associated citrullinated epitopes and their corresponding wild-type version for binding to 28 common HLA class II. Binding patterns were variable, and no consistent impact of citrullination was identified. Indeed, in one case citrullination significantly increased binding compared to the WT peptide, in another citrullination was associated with a reduction in promiscuity by 40%. For a more comprehensive analysis, we tested over 200 citrullinated peptides derived from vimentin and collagen II for their capacity to bind the RA-associated shared epitope alleles DRB1*01:01 and DRB1*04:01. The overall effect of citrullination on binding was found to be relatively minor, and only rarely associated with 3-fold increases or decreases in affinity. Previous studies have suggested that citrullination of MHC anchor residues, in particular P4, is associated with generation of novel RA-associated epitopes. However, analysis of the predicted MHC-binding cores of all peptides tested found that in modified peptides with increased binding affinity the citrullinated residue was predicted to occupy an anchor position in only a minority of cases. Finally, we also show that identification of citrullinated peptide binders could be facilitated by using the NetMHCIIpan 3.1 algorithm, representing citrullination as a wildcard. Our studies identify a total of 117 citrullinated peptides that bound RA-associated alleles with an affinity of 1000 nM or better.	[Sidney, John; Lindvall, Mikaela; Moore, Erin C.; Moore, Eugene L.; Peters, Bjoern; Sette, Alessandro] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Becart, Stephane; Zhou, Mimi; Duffy, Karen; Rao, Tadimeti; Rao, Navin] Janssen Res & Dev, San Diego, CA USA; [Nielsen, Morten] Tech Univ Denmark, Dept Bio & Hlth Informat, Ctr Biol Sequence Anal, Lyngby, Denmark; [Nielsen, Morten] Univ Nacl San Martin, Inst Invest Biotecnol, Buenos Aires, DF, Argentina	La Jolla Institute for Immunology; Technical University of Denmark	Sidney, J (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA USA.	jsidney@lji.org	Sette, Alessandro/AFO-8916-2022; Nielsen, Morten/AAL-8700-2020	Nielsen, Morten/0000-0001-7885-4311; Lindvall, Mikaela/0000-0002-0042-1353; Rao, Tadimeti/0000-0001-5332-7304	Janssen Research and Development; NIH-NIAID Immune Epitope Database and Analysis Project [HHSN272201200010C]	Janssen Research and Development; NIH-NIAID Immune Epitope Database and Analysis Project	These collaborative studies have been supported by funding from Janssen Research and Development. Janssen Research and Development provided financial support in the form of authors' salaries (SB, KD, NR, TR, MZ), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.Additional support has been provided from the NIH-NIAID Immune Epitope Database and Analysis Project [contract HHSN272201200010C] (AS).	ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Andreatta M, 2015, IMMUNOGENETICS, V67, P641, DOI 10.1007/s00251-015-0873-y; Arkema EV, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4342; Avouac J, 2006, ANN RHEUM DIS, V65, P845, DOI 10.1136/ard.2006.051391; Balandraud N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064108; Benham H, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9301; Calvo-Calle JM, 2007, PLOS PATHOG, V3, P1511, DOI 10.1371/journal.ppat.0030144; Chemin K, 2016, ARTHRITIS RHEUMATOL, V68, P1124, DOI 10.1002/art.39553; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; DEIGHTON CM, 1989, CLIN GENET, V36, P178; Ding B, 2009, ARTHRITIS RHEUM, V60, P30, DOI 10.1002/art.24135; Fries JF, 2002, ARTHRITIS RHEUM, V46, P2320, DOI 10.1002/art.10485; Gerstner C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00494; Gonzalez-Gay MA, 2002, SEMIN ARTHRITIS RHEU, V31, P355, DOI 10.1053/sarh.2002.32552; Gourraud PA, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2131; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Griffiths B, 2000, RHEUMATOLOGY, V39, P857, DOI 10.1093/rheumatology/39.8.857; Gulukota K, 1997, J MOL BIOL, V267, P1258, DOI 10.1006/jmbi.1997.0937; Harre U, 2012, J CLIN INVEST, V122, P1791, DOI 10.1172/JCI60975; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Hill JA, 2008, J EXP MED, V205, P967, DOI 10.1084/jem.20072051; James EA, 2014, ARTHRITIS RHEUMATOL, V66, P1712, DOI 10.1002/art.38637; James EA, 2010, ARTHRITIS RHEUM-US, V62, P2909, DOI 10.1002/art.27594; Kampstra ASB, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1153-4; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kotturi Maya F, 2010, Immunome Res, V6, P4, DOI 10.1186/1745-7580-6-4; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Law SC, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3848; Lundstrom E, 2009, ARTHRITIS RHEUM-US, V60, P924, DOI 10.1002/art.24410; Meyer D, 2007, P 13 INT HIST WORKSH, V1, P653; Meyer O, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1896; Moreno I, 1996, J RHEUMATOL, V23, P6; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Reviron D, 2001, ARTHRITIS RHEUM, V44, P535, DOI 10.1002/1529-0131(200103)44:3<535::AID-ANR101>3.0.CO;2-Z; Roark CL, 2016, J AUTOIMMUN, V72, P25, DOI 10.1016/j.jaut.2016.04.006; ROCHE PA, 1990, J IMMUNOL, V144, P1849; Sakkas LI, 2014, AUTOIMMUN REV, V13, P1114, DOI 10.1016/j.autrev.2014.08.012; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Scholz E, 2016, ARTHRITIS RHEUMATOL, V68, P2412, DOI 10.1002/art.39736; Sidney J, 1996, HUM IMMUNOL, V45, P79, DOI 10.1016/0198-8859(95)00173-5; Sidney J., 2013, CURR PROTOC IMMUNOL, V100, p18.3.1, DOI [DOI 10.1002/0471142735.IM1803S100, 10.1002/0471142735.im1803s100]; Sidney J, 2010, J IMMUNOL, V185, P4189, DOI 10.4049/jimmunol.1001006; Sidney J, 2010, J IMMUNOL, V184, P2492, DOI 10.4049/jimmunol.0903655; SMILEK DE, 1991, P NATL ACAD SCI USA, V88, P9633, DOI 10.1073/pnas.88.21.9633; Snir O, 2011, ARTHRITIS RHEUM-US, V63, P2873, DOI 10.1002/art.30445; Southwood S, 1998, J IMMUNOL, V160, P3363; Turesson C, 2005, ARTHRITIS RES THER, V7, pR1386, DOI 10.1186/ar1837; Valesini G, 2015, AUTOIMMUN REV, V14, P490, DOI 10.1016/j.autrev.2015.01.013; van der Helm-van Mil AHM, 2005, ARTHRITIS RES THER, V7, pR949, DOI 10.1186/ar1767; van der Woude D, 2009, ARTHRITIS RHEUM-US, V60, P916, DOI 10.1002/art.24385; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P2113, DOI 10.1002/art.20316; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P709, DOI 10.1002/art.20044; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; von Delwig A, 2010, ARTHRITIS RHEUM-US, V62, P143, DOI 10.1002/art.25064; WORDSWORTH BP, 1991, BRIT J RHEUMATOL, V30, P178; Zou J, 2005, ANN RHEUM DIS, V64, P722, DOI 10.1136/ard.2004.024455; Zou J, 2003, RHEUMATOLOGY, V42, P846, DOI 10.1093/rheumatology/keg230	62	31	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177140	10.1371/journal.pone.0177140	http://dx.doi.org/10.1371/journal.pone.0177140			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481943	Green Published, Green Submitted, gold			2022-12-27	WOS:000401313700037
J	Papp, Z; Clark, RG; Parmley, EJ; Leighton, FA; Waldner, C; Soos, C				Papp, Zsuzsanna; Clark, Robert G.; Parmley, E. Jane; Leighton, Frederick A.; Waldner, Cheryl; Soos, Catherine			The ecology of avian influenza viruses in wild dabbling ducks (Anas spp.) in Canada	PLOS ONE			English	Article							A VIRUSES; MIGRATORY BIRDS; NORTH-AMERICA; A(H7N9) VIRUS; INFECTION; WATERFOWL; HOST; PREVALENCE; PATTERNS; CHINA	Avian influenza virus (AIV) occurrence and transmission remain important wildlife and human health issues in much of the world, including in North America. Through Canada's Inter-Agency Wild Bird Influenza Survey, close to 20,000 apparently healthy, wild dabbling ducks (of seven species) were tested for AIV between 2005 and 2011. We used these data to identify and evaluate ecological and demographic correlates of infection with low pathogenic AIVs in wild dabbling ducks (Anas spp.) across Canada. Generalized linear mixed effects model analyses revealed that risk of AIV infection was higher in hatch-year birds compared to adults, and was positively associated with a high proportion of hatch-year birds in the population. Males were more likely to be infected than females in British Columbia and in Eastern Provinces of Canada, but more complex relationships among age and sex cohorts were found in the Prairie Provinces. A species effect was apparent in Eastern Canada and British Columbia, where teal (A. discors and/or A. carolinensis) were less likely to be infected than mallards (A. platyrhynchos). Risk of AIV infection increased with the density of the breeding population, in both Eastern Canada and the Prairie Provinces, and lower temperatures preceding sampling were associated with a higher probability of AIV infection in Eastern Canada. Our results provide new insights into the ecological and demographic factors associated with AIV infection in waterfowl.	[Papp, Zsuzsanna; Clark, Robert G.; Soos, Catherine] Environm & Climate Change Canada, Sci & Technol Branch, Saskatoon, SK, Canada; [Parmley, E. Jane] Univ Guelph, Canadian Wildlife Hlth Cooperat, Guelph, ON, Canada; [Leighton, Frederick A.; Soos, Catherine] Univ Saskatchewan, Dept Vet Pathol, Saskatoon, SK, Canada; [Leighton, Frederick A.] Univ Saskatchewan, Canadian Wildlife Hlth Cooperat, Saskatoon, SK, Canada; [Waldner, Cheryl] Univ Saskatchewan, Dept Large Anim Sci, Saskatoon, SK, Canada	Environment & Climate Change Canada; University of Guelph; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Soos, C (corresponding author), Environm & Climate Change Canada, Sci & Technol Branch, Saskatoon, SK, Canada.; Soos, C (corresponding author), Univ Saskatchewan, Dept Vet Pathol, Saskatoon, SK, Canada.	catherine.soos@canada.ca	Soos, Catherine/Q-4983-2019	Soos, Catherine/0000-0003-4610-3614; Waldner, Cheryl/0000-0002-7152-4261	Environment and Climate Change Canada (ECCC); ECCC; Canadian Food Inspection Agency; Public Health Agency of Canada; Provincial/Territorial departments responsible for agriculture (animal health), wildlife, and public health; Centre for Coastal Health; Ducks Unlimited Canada (Institute for Wetland and Waterfowl Research); Alberta Conservation Association; University of Saskatchewan	Environment and Climate Change Canada (ECCC); ECCC; Canadian Food Inspection Agency; Public Health Agency of Canada; Provincial/Territorial departments responsible for agriculture (animal health), wildlife, and public health; Centre for Coastal Health; Ducks Unlimited Canada (Institute for Wetland and Waterfowl Research); Alberta Conservation Association; University of Saskatchewan	Financial support for analysis of surveillance data was provided by Environment and Climate Change Canada (ECCC). Financial, field, and laboratory support for Canadas Inter-Agency Wild Bird Influenza Survey was provided by ECCC, the Canadian Food Inspection Agency, Public Health Agency of Canada, Provincial/Territorial departments responsible for agriculture (animal health), wildlife, and public health, the Centre for Coastal Health, Ducks Unlimited Canada (Institute for Wetland and Waterfowl Research), Alberta Conservation Association, and University of Saskatchewan.	[Anonymous], 2017, WILD BIRD HIGHLY PAT; [Anonymous], 2016, NAT WILDL HLTH CTR W; [Anonymous], 2017, CUM NUMB CONF HUM CA; [Anonymous], 2017, HUMAN INFECT AVIAN I; Avril A, 2016, J APPL ECOL, V53, P1289, DOI 10.1111/1365-2664.12699; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Buhnerkempe MG, 2016, ECOL APPL, V26, P740, DOI 10.1890/15-0934; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Costa TP, 2011, AVIAN PATHOL, V40, P119, DOI 10.1080/03079457.2010.540002; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; DEIBEL R, 1985, AVIAN DIS, V29, P970, DOI 10.2307/1590450; Farnsworth ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032729; Ferro PJ, 2010, EMERG INFECT DIS, V16, P1224, DOI 10.3201/eid1608.091864; Gaidet N, 2012, P ROY SOC B-BIOL SCI, V279, P1131, DOI 10.1098/rspb.2011.1417; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Groepper SR, 2014, AVIAN DIS, V58, P531, DOI 10.1637/10849-042214-Reg.1; Hill NJ, 2016, ECOL LETT, V19, P915, DOI 10.1111/ele.12629; Hill NJ, 2012, VECTOR-BORNE ZOONOT, V12, P243, DOI 10.1089/vbz.2010.0246; Hill NJ, 2010, AVIAN DIS, V54, P426, DOI 10.1637/8912-043009-Reg.1; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001; Howerter DW, 2014, WILDLIFE MONOGR, V188, P1, DOI 10.1002/wmon.1012; Hoye BJ, 2016, INTEGR COMP BIOL, V56, P317, DOI 10.1093/icb/icw038; Hoye BJ, 2012, P ROY SOC B-BIOL SCI, V279, P529, DOI 10.1098/rspb.2011.0958; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; Ip HS, 2015, EMERG INFECT DIS, V21, P886, DOI 10.3201/eid2105.142020; Ip HS, 2016, AVIAN DIS; Jennelle CS, 2016, EMERG INFECT DIS, V22, P1278, DOI 10.3201/eid2207.152032; JOHNSON DH, 1988, WILDLIFE MONOGR, P1; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Latorre-Margalef N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003443; Lebarbenchon C, 2010, EMERG INFECT DIS, V16, P1057, DOI 10.3201/eid1607.090389; Lee DH, 2015, J VIROL, V89, P6521, DOI 10.1128/JVI.00728-15; Liu CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000191; Munster VJ, 2009, VACCINE, V27, P6340, DOI 10.1016/j.vaccine.2009.02.082; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Murray K, 2009, ECOLOGY, V90, P348, DOI 10.1890/07-1929.1; Murti M, 2015, CCDR; Nallar R, 2016, J WILDLIFE DIS, V52, P33, DOI 10.7589/2013-07-191; Nallar R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130662; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Parmley EJ, 2008, EMERG INFECT DIS, V14, P84, DOI 10.3201/eid1401.061562; Parmley J, 2009, INTEGR ZOOL, V4, P409, DOI 10.1111/j.1749-4877.2009.00177.x; Pasick J, 2010, AVIAN DIS, V54, P440, DOI 10.1637/8800-040109-Reg.1; Pasick J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09484; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reperant LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000854; Runstadler JA, 2007, ARCH VIROL, V152, P1901, DOI 10.1007/s00705-007-0994-1; Segovia KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170335; SHARP GB, 1993, EPIDEMIOL INFECT, V110, P161, DOI 10.1017/S0950268800050780; Soos C, 2012, J WILDLIFE DIS, V48, P444, DOI 10.7589/0090-3558-48.2.444; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stallknecht DE, 2010, AVIAN DIS, V54, P461, DOI 10.1637/8760-033109-Reg.1; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; Takekawa JY, 2010, AVIAN BIOL RES, V3, P51, DOI 10.3184/175815510X12737339356701; van Dijk JGB, 2014, J ANIM ECOL, V83, P266, DOI 10.1111/1365-2656.12131; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Verhagen JH, 2015, SCIENCE, V347, P616, DOI 10.1126/science.aaa6724; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010; Xiang NJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2049-2; Xu CL, 2013, EMERG INFECT DIS, V19, P1289, DOI 10.3201/eid1908.130662	67	16	16	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e017629	10.1371/journal.pone.0176297	http://dx.doi.org/10.1371/journal.pone.0176297			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475626	gold, Green Published, Green Submitted			2022-12-27	WOS:000400649500007
J	Yang, JK; Xiong, W; Chen, FY; Xu, L; Han, ZG				Yang, Jiang-Ke; Xiong, Wei; Chen, Fang-Yuan; Xu, Li; Han, Zheng-Gang			Aromatic amino acids in the cellulose binding domain of Penicillium crustosum endoglucanase EGL1 differentially contribute to the cellulose affinity of the enzyme	PLOS ONE			English	Article							MODULE; CELLULASES; FIMI	The cellulose binding domain (CBD) of cellulase binding to cellulosic materials is the initiation of a synergistic action on the enzymatic hydrolysis of the most abundant renewable biomass resources in nature. The binding of the CBD domain to cellulosic substrates generally relies on the interaction between the aromatic amino acids structurally located on the flat face of the CBD domain and the glucose rings of cellulose. In this study, we found the CBD domain of a newly cloned Penicillium crustosum endoglucanase EGL1, which was phylogenetically related to Aspergillus, Fusarium and Rhizopus, and divergent from the well-characterized Trichoderma reeseis cellulase CBD domain, contain two conserved aromatic amino acid-rich regions, Y-451-Y-452 and Y-477-Y-478-Y-479, among which three amino acids Y-451, Y-477, and Y-478 structurally sited on a flat face of this domain. Cellulose binding assays with green fluorescence protein as the marker, adsorption isotherm assays and an isothermal titration calorimetry assays revealed that although these three amino acids participated in this process, the Y-451-Y-452 appears to contribute more to the cellulose binding than Y-477-Y-478-Y-479. Further glycine scanning mutagenesis and structural modelling revealed that the binding between CBD domain and cellulosic materials might be multi-amino-acids that participated in this process. The flexible poly-glucose molecule could contact Y-451, Y-477, and Y-478 which form the contacting flat face of CBD domain as the typical model, some other amino acids in or outside the flat face might also participate in the interaction. Thus, it is possible that the conserved Y-451-Y-452 of CBD might have a higher chance of contacting the cellulosic substrates, contributing more to the affinity of CBD than the other amino acids.	[Yang, Jiang-Ke; Xiong, Wei; Chen, Fang-Yuan; Xu, Li; Han, Zheng-Gang] Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Peoples R China	Wuhan Polytechnic University	Yang, JK (corresponding author), Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Peoples R China.	jiangke.yang@gmail.com	XU, LIWU/GYR-0963-2022	Yang, Jiangke/0000-0001-6234-451X	Wuhan Science and Technology Project, China [2016020101010084]	Wuhan Science and Technology Project, China	There has been no significant financial support for this work that could have influenced its outcome. This work was granted by Wuhan Science and Technology Project (No. 2016020101010084), China.	Arai T, 2003, J BACTERIOL, V185, P504, DOI 10.1128/JB.185.2.504-512.2003; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Ciolacu D, 2010, CARBOHYD RES, V345, P621, DOI 10.1016/j.carres.2009.12.023; Happs RM, 2015, FEBS J, V282, P4341, DOI 10.1111/febs.13500; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kormos J, 2000, BIOCHEMISTRY-US, V39, P8844, DOI 10.1021/bi000607s; LYND LR, 1991, SCIENCE, V251, P1318, DOI 10.1126/science.251.4999.1318; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mattinen ML, 1997, PROTEIN SCI, V6, P294; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; Ohmiya K, 1997, BIOTECHNOL GENET ENG, V14, P365, DOI 10.1080/02648725.1997.10647949; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; Sharma A, 2016, APPL BIOCHEM BIOTECH, V179, P1346, DOI 10.1007/s12010-016-2070-3; Takashima S, 2007, FEBS LETT, V581, P5891, DOI 10.1016/j.febslet.2007.11.068; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; VANTILBEURGH H, 1986, FEBS LETT, V204, P223, DOI 10.1016/0014-5793(86)80816-X	20	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176444	10.1371/journal.pone.0176444	http://dx.doi.org/10.1371/journal.pone.0176444			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475645	Green Published, gold, Green Submitted			2022-12-27	WOS:000400649500009
J	Csutak, A; Steiber, Z; Tozser, J; Jakab, A; Berta, A; Silver, DM				Csutak, Adrienne; Steiber, Zita; Tozser, Jozsef; Jakab, Attila; Berta, Andras; Silver, David M.			Plasminogen activator activity in tears of pregnant women	PLOS ONE			English	Article							LASER PHOTOREFRACTIVE KERATECTOMY; SEVERE PREECLAMPSIA; PERIODONTAL HEALTH; PROTEIN-LEVELS; PLASMA-LEVELS; RABBIT TEARS; INHIBITORS; MYOPIA; FLUID; FIBRINOLYSIS	Purpose Plasminogen activator activity (PAA) in tears of pregnant women was investigated at various gestation times to assess the availability of plasminogen activator for aiding potential corneal wound healing processes during pregnancy. Methods PAA was measured by a spectrophotometric method. The analysis used 91 tear samples from pregnant and non-pregnant women, supplemented with 10 additional tear PAA measurements from non-pregnant women obtained in a previous study. Results Tear levels of PAA in pregnant women formed a bimodal distribution. Either the tear PAA level was zero or non-zero during pregnancy. When non-zero, the tear PAA level was dissociated from gestation time and not different than non-pregnant and post-pregnant levels. The frequency of occurrence of zero level tear PAA increased with gestation: 16%, 17% and 46% had zero tear PAA in samples taken from women in the first, second and third trimester, respectively. Conclusions Overall, of the tear samples taken from women during pregnancy, a total of 26% were at zero tear PAA. The remaining tear samples had non-zero tear PAA values throughout gestation equivalent to non-pregnant tear PAA values, suggesting local control of the source of PAA in tears. Given the importance of the plasminogen activator system in tears to wound healing in the cornea, and the high occurrence of zero tear PAA in our sample of pregnant women, elective corneal surgery would be contraindicated. If corneal surgery is nevertheless necessary, the tear PAA level would be worth checking and patients with low level should be closely observed during the postoperative period.	[Csutak, Adrienne; Steiber, Zita; Berta, Andras] Univ Debrecen, Fac Med, Dept Ophthalmol, Debrecen, Hungary; [Tozser, Jozsef] Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Debrecen, Hungary; [Jakab, Attila] Univ Debrecen, Fac Med, Dept Obstet & Gynecol, Debrecen, Hungary; [Silver, David M.] Johns Hopkins Univ, Bethesda, MD USA	University of Debrecen; University of Debrecen; University of Debrecen; Johns Hopkins University	Csutak, A (corresponding author), Univ Debrecen, Fac Med, Dept Ophthalmol, Debrecen, Hungary.	acsutak@med.unideb.hu	Tozser, Jozsef/A-7840-2008; Jakab, Attila/ABZ-9541-2022; Silver, David M/I-7734-2014	Tozser, Jozsef/0000-0003-0274-0056; Silver, David M/0000-0002-1631-1466; Csutak, Adrienne/0000-0002-7821-2412	Janos Bolyai Postdoctoral Fellowship; Lajos Szodoray Postdoctoral Fellowship	Janos Bolyai Postdoctoral Fellowship(Hungarian Academy of Sciences); Lajos Szodoray Postdoctoral Fellowship	Support was provided by Janos Bolyai and Lajos Szodoray Postdoctoral Fellowships to AC.	ASTEDT B, 1985, THROMB HAEMOSTASIS, V53, P122; Barbazetto Irene A, 2007, Compr Ophthalmol Update, V8, P155; Becerik S, 2010, J PERIODONTOL, V81, P673, DOI 10.1902/jop.2010.090590; BERTA A, 1983, AM J OPHTHALMOL, V96, P115, DOI 10.1016/0002-9394(83)90473-7; Bland M., 1995, INTRO MED STAT, P101; Bower KS, 2014, CURR OPIN OPHTHALMOL, V25, P251, DOI 10.1097/ICU.0000000000000055; Brenner B, 2004, THROMB RES, V114, P409, DOI 10.1016/j.thromres.2004.08.004; Buduneli N, 2010, AUST DENT J, V55, P292, DOI 10.1111/j.1834-7819.2010.01237.x; Carpintero A, 1996, CLIN CHIM ACTA, V255, P153, DOI 10.1016/0009-8981(96)06403-0; Coolman M, 2006, EUR J OBSTET GYN R B, V128, P22, DOI 10.1016/j.ejogrb.2006.02.004; Csutak A, 2000, INVEST OPHTH VIS SCI, V41, P3743; Csutak A, 2004, INVEST OPHTH VIS SCI, V45, P1329, DOI 10.1167/iovs.03-0881; Csutak A, 2003, EXP EYE RES, V77, P675, DOI 10.1016/j.exer.2003.08.012; Csutak A, 2008, J CATARACT REFR SURG, V34, P897, DOI 10.1016/j.jcrs.2008.02.024; ESTELLES A, 1989, BLOOD, V74, P1332; FULLARD RJ, 1991, INVEST OPHTH VIS SCI, V32, P2290; FULLARD RJ, 1990, INVEST OPHTH VIS SCI, V31, P1119; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hellgren M, 2003, SEMIN THROMB HEMOST, V29, P125, DOI 10.1055/s-2003-38897; Kinnby B, 2002, BIOL CHEM, V383, P85, DOI 10.1515/BC.2002.008; Kleinbaum DG, 1998, APPL REGRESSION ANAL, P423; KOH CLS, 1992, INT J GYNECOL OBSTET, V38, P9, DOI 10.1016/0020-7292(92)90723-V; Koh SCL, 2002, THROMB HAEMOSTASIS, V87, P175; KRUITHOF EKO, 1987, BLOOD, V69, P460; Leonardi A, 2005, INVEST OPHTH VIS SCI, V46, P1364, DOI 10.1167/iovs.04-1196; Lindberg P, 2001, HISTOCHEM CELL BIOL, V116, P447, DOI 10.1007/s00418-001-0341-7; LOHMANN CP, 1993, REFRACT CORNEAL SURG, V9, P300; López-Prats M.J., 2012, Arch Soc Esp Oftalmol, V87, P173, DOI 10.1016/j.oftal.2011.09.021; Margetic S, 2012, BIOCHEM MEDICA, V22, P49; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Nakashima A, 1996, GYNECOL OBSTET INVES, V42, P95, DOI 10.1159/000291899; OBRART DPS, 1994, OPHTHALMOLOGY, V101, P1565; Olofsson A, 2002, J PERIODONTAL RES, V37, P60, DOI 10.1034/j.1600-0765.2002.00325.x; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pizzarello LD, 2003, GRAEF ARCH CLIN EXP, V241, P484, DOI 10.1007/s00417-003-0674-0; Saleh Y., 2004, INTERNET J GYNECOL O, V5, P1; Saw SM, 1996, EPIDEMIOL REV, V18, P175, DOI 10.1093/oxfordjournals.epirev.a017924; Sharif K, 1997, J REFRACT SURG, V13, pS445; SHIMADA H, 1981, THROMB HAEMOSTASIS, V46, P507; SHIMADA H, 1989, THROMB RES, V54, P91, DOI 10.1016/0049-3848(89)90039-X; Shimizu N, 2003, JPN J OPHTHALMOL, V47, P6, DOI 10.1016/S0021-5155(02)00620-2; Steiber Z, 2015, INT J OPHTHALMOL EYE, V3, P121; Sulniute R, 2016, THROMB HAEMOSTASIS, V115, P1001, DOI 10.1160/TH15-08-0653; TOZSER J, 1990, EXP EYE RES, V51, P33, DOI 10.1016/0014-4835(90)90167-S; TOZSER J, 1989, CLIN CHIM ACTA, V183, P323, DOI 10.1016/0009-8981(89)90367-7; Uszynski M, 2004, EUR J OBSTET GYN R B, V114, P54, DOI 10.1016/j.ejogrb.2003.12.006; Uszynski M, 2001, GYNECOL OBSTET INVES, V52, P189, DOI 10.1159/000052971; VANWERSCH JWJ, 1991, EUR J CLIN CHEM CLIN, V29, P45; Watanabe M, 2003, INVEST OPHTH VIS SCI, V44, P3332, DOI 10.1167/iovs.02-1280; Williams DL, 1999, INVEST OPHTH VIS SCI, V40, P1669; Xiao Y, 2000, J CLIN PERIODONTOL, V27, P149	51	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177003	10.1371/journal.pone.0177003	http://dx.doi.org/10.1371/journal.pone.0177003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472076	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500113
J	Ermagun, A; Chatterjee, S; Levinson, D				Ermagun, Alireza; Chatterjee, Snigdhansu; Levinson, David			Using temporal detrending to observe the spatial correlation of traffic	PLOS ONE			English	Article							FLOW; PREDICTION; MULTIVARIATE; NETWORK; VOLUME	This empirical study sheds light on the spatial correlation of traffic links under different traffic regimes. We mimic the behavior of real traffic by pinpointing the spatial correlation between 140 freeway traffic links in a major sub-network of the Minneapolis-St. Paul freeway system with a grid-like network topology. This topology enables us to juxtapose the positive and negative correlation between links, which has been overlooked in short-term traffic forecasting models. To accurately and reliably measure the correlation between traffic links, we develop an algorithm that eliminates temporal trends in three dimensions: (1) hourly dimension, (2) weekly dimension, and (3) system dimension for each link. The spatial correlation of traffic links exhibits a stronger negative correlation in rush hours, when congestion affects route choice. Although this correlation occurs mostly in parallel links, it is also observed upstream, where travelers receive information and are able to switch to substitute paths. Irrespective of the time-of-day and day-of-week, a strong positive correlation is witnessed between upstream and downstream links. This correlation is stronger in uncongested regimes, as traffic flow passes through consecutive links more quickly and there is no congestion effect to shift or stall traffic. The extracted spatial correlation structure can augment the accuracy of short-term traffic forecasting models.	[Ermagun, Alireza] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA; [Chatterjee, Snigdhansu] Univ Minnesota, Sch Stat, Minneapolis, MN 55455 USA; [Levinson, David] Univ Sydney, Sch Civil Engn, Sydney, NSW, Australia	Northwestern University; University of Minnesota System; University of Minnesota Twin Cities; University of Sydney	Ermagun, A (corresponding author), Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA.	alireza.ermagun@northwestern.edu	Levinson, David/A-8554-2012	Levinson, David/0000-0002-4563-2963; Chatterjee, Snigdhansu/0000-0002-7986-0470				Cai PL, 2016, TRANSPORT RES C-EMER, V62, P21, DOI 10.1016/j.trc.2015.11.002; Chandra SR, 2008, TRANSPORT RES REC, P64, DOI 10.3141/2061-08; Chandra SR, 2009, J INTELL TRANSPORT S, V13, P53, DOI 10.1080/15472450902858368; Cheng T, 2012, J GEOGR SYST, V14, P389, DOI 10.1007/s10109-011-0149-5; Djuric N, 2011, TRANSPORT RES REC, P131, DOI 10.3141/2263-15; Ermagun A., 2016, SPATIOTEMPORAL TRAFF; Ermagun A, 2016, INTRO NETWO IN PRESS; Ermagun A, 2016, DEV APPL NETWORK WEI; Haixiang Zou, 2010, 2010 13th International IEEE Conference on Intelligent Transportation Systems (ITSC 2010), P557, DOI 10.1109/ITSC.2010.5625226; Jiang H, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/9236156; Li L, 2013, TRANSPORT RES C-EMER, V34, P108, DOI 10.1016/j.trc.2013.05.008; Liu HX, 2004, TRANSPORT RES A-POL, V38, P435, DOI 10.1016/j.tra.2004.03.003; Ma D, 2010, TRAFF TRANSP STUD 20, P477; Ma XL, 2015, TRANSPORT RES C-EMER, V54, P187, DOI 10.1016/j.trc.2015.03.014; Ma XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119044; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; OKUTANI I, 1984, TRANSPORT RES B-METH, V18, P1, DOI 10.1016/0191-2615(84)90002-X; Peng CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034487; Shang Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161259; Stathopoulos A, 2003, TRANSPORT RES C-EMER, V11, P121, DOI 10.1016/S0968-090X(03)00004-4; Stathopoulos A, 2008, COMPUT-AIDED CIV INF, V23, P521, DOI 10.1111/j.1467-8667.2008.00558.x; Sun SL, 2005, LECT NOTES COMPUT SC, V3697, P273; van Lint JWC, 2006, J TRANSP ENG, V132, P921, DOI 10.1061/(ASCE)0733-947X(2006)132:12(921); Vlahogianni EI, 2005, TRANSPORT RES C-EMER, V13, P211, DOI 10.1016/j.trc.2005.04.007; Vlahogianni EI, 2004, TRANSPORT REV, V24, P533, DOI 10.1080/0144164042000195072; Vlahogianni EI, 2007, COMPUT-AIDED CIV INF, V22, P317, DOI 10.1111/j.1467-8667.2007.00488.x; Vlahogianni EI, 2014, TRANSPORT RES C-EMER, V43, P3, DOI 10.1016/j.trc.2014.01.005; Xinyu Min, 2010, 2010 13th International IEEE Conference on Intelligent Transportation Systems (ITSC 2010), P1535, DOI 10.1109/ITSC.2010.5625123; Yang S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141223; Yang W, 2009, INTERNATIONAL CONFER, P699; Yue Y, 2008, ENVIRON PLANN B, V35, P762, DOI 10.1068/b33090; Zockaie A, 2013, TRANSPORT RES REC, P1, DOI 10.3141/2334-01; Zou YJ, 2014, TRANSPORT RES C-EMER, V43, P33, DOI 10.1016/j.trc.2013.10.007	34	18	19	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176853	10.1371/journal.pone.0176853	http://dx.doi.org/10.1371/journal.pone.0176853			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472093	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500087
J	Olesen, SW; Duvallet, C; Alm, EJ				Olesen, Scott W.; Duvallet, Claire; Alm, Eric J.			dbOTU3: A new implementation of distribution-based OTU calling	PLOS ONE			English	Article								Distribution-based operational taxonomic unit-calling (dbOTU) improves on other approaches by incorporating information about the input sequences' distribution across samples. Previous implementations of dbOTU presented challenges for users. Here we introduce and evaluate a new implementation of dbOTU that is faster and more user-friendly. We show that this new implementation has theoretical and practical improvements over previous implementations of dbOTU, making the algorithm more accessible to microbial ecology and biomedical researchers.	[Olesen, Scott W.; Duvallet, Claire; Alm, Eric J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Alm, Eric J.] Inst Med Engn & Sci, Ctr Microbiome Informat & Therapeut, Cambridge, MA USA	Massachusetts Institute of Technology (MIT)	Olesen, SW (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	swo@alum.mit.edu		Olesen, Scott/0000-0001-5400-4945	Center for Microbiome Informatics and Therapeutics at MIT; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Center for Microbiome Informatics and Therapeutics at MIT; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This material is based on work supported by the Center for Microbiome Informatics and Therapeutics at MIT (microbiome.mit.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Preheim SP, 2013, APPL ENVIRON MICROB, V79, P6593, DOI 10.1128/AEM.00342-13; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107	9	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176335	10.1371/journal.pone.0176335	http://dx.doi.org/10.1371/journal.pone.0176335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472072	Green Submitted, gold, Green Published			2022-12-27	WOS:000400648500038
J	Ross, A; Shamburek, R; Wehrlen, L; Klagholz, SD; Yang, L; Stoops, E; Flynn, SL; Remaley, AT; Pacak, K; Shelburne, N; Bevans, MF				Ross, Alyson; Shamburek, Robert; Wehrlen, Leslie; Klagholz, Stephen D.; Yang, Li; Stoops, Elyssa; Flynn, Sharon L.; Remaley, Alan T.; Pacak, Karel; Shelburne, Nonniekaye; Bevans, Margaret F.			Cardiometabolic risk factors and health behaviors in family caregivers	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; TERM-FOLLOW-UP; METABOLIC SYNDROME; CHRONIC STRESS; ASSOCIATION; FRAMINGHAM; MORTALITY; PATIENT	The purpose of this study was to compare components of cardiometabolic risk and health behaviors of 20 family caregivers of allogeneic hematopoietic stem cell transplant patients to those of age, gender, and race/ethnicity-matched controls. A prospective, repeated measures design was used to compare cardiometabolic risk and health behaviors in caregivers and controls at three time-points: pre-transplantation, discharge, and six weeks post-discharge. Measures included components of metabolic syndrome, Reynolds Risk Score, NMR serum lipoprotein particle analyses, and the Health-Promoting Lifestyle Profile II (HPLP-II). Mixed-model repeated measure analyses were used. There were no between or within group differences in LDL cholesterol, HDL cholesterol, and triglycerides. There was a significant interaction effect between time and role in large VLDL concentration (VLDL-P) (F (2, 76) = 4.36, p = .016), with the trajectory of large VLDL-P increasing over time in caregivers while remaining stable in controls. Within care-givers, VLDL particle size (VLDL-Z) was significantly larger at time-point three compared to time-points one (p = .015) and two (p = .048), and VLDL-Z was significantly larger in caregivers than in controls at time point three (p = .012). HPLP-II scores were lower in caregivers than controls at all time-points (p < .01). These findings suggest that caregiving may have a bigger impact on triglycerides than on other lipids, and it is through this pathway that caregivers may be at increased cardiometabolic risk. More sensitive measurement methods, such as NMR lipoprotein particle analyses, may be able to detect early changes in cardiometabolic risk.	[Ross, Alyson; Wehrlen, Leslie; Klagholz, Stephen D.; Yang, Li; Stoops, Elyssa; Flynn, Sharon L.; Bevans, Margaret F.] NIH, Ctr Clin, Dept Nursing, Bethesda, MD 20892 USA; [Shamburek, Robert] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Remaley, Alan T.] NIH, Ctr Clin, Dept Lab Med, Bethesda, MD 20892 USA; [Pacak, Karel] NICHHD, NIH, Bethesda, MD 20892 USA; [Shelburne, Nonniekaye] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ross, A (corresponding author), NIH, Ctr Clin, Dept Nursing, Bethesda, MD 20892 USA.	alyson.ross@nih.gov	Klagholz, Stephen/M-4119-2019		Intramural Research Program at the National Institutes of Health [11-CC-0265]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL001154] Funding Source: NIH RePORTER	Intramural Research Program at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); CLINICAL CENTER	This research was funded by the Intramural Research Program at the National Institutes of Health, Clinical Center 11-CC-0265 "A pilot study to examine physiological and clinical markers of chronic stress in caregivers of allogeneic hematopoietic stem cell transplant (HSCT) recipients".	Arnaout K, 2014, CANCER INVEST, V32, P349, DOI 10.3109/07357907.2014.919301; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Beattie S, 2011, PSYCHO-ONCOLOGY, V20, P1137, DOI 10.1002/pon.1962; Bevans M, 2012, JAMA-J AM MED ASSOC, V307, P398, DOI 10.1001/jama.2012.29; Bevans MF, 2016, STRESS, V19, P175, DOI 10.3109/10253890.2016.1146670; Bishop MM, 2011, PSYCHO-ONCOLOGY, V20, P926, DOI 10.1002/pon.1812; Bishop MM, 2009, BIOL BLOOD MARROW TR, V15, P29, DOI 10.1016/j.bbmt.2008.10.001; Brown SL, 2009, PSYCHOL SCI, V20, P488, DOI 10.1111/j.1467-9280.2009.02323.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DeFilippis AP, 2011, J AM COLL CARDIOL, V58, P2076, DOI 10.1016/j.jacc.2011.08.022; Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024; Foster LW, 2013, BONE MARROW TRANSPL, V48, P671, DOI 10.1038/bmt.2012.208; Frazier-Wood AC, 2012, METAB SYNDR RELAT D, V10, P244, DOI 10.1089/met.2011.0148; Gibbons SW, 2014, RES NURS HEALTH, V37, P423, DOI 10.1002/nur.21622; Golbidi S, 2015, AM J PHYSIOL-HEART C, V308, pH1476, DOI 10.1152/ajpheart.00859.2014; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Hashmi S, 2015, BIOL BLOOD MARROW TR, V21, P225, DOI 10.1016/j.bbmt.2014.06.035; Hering D, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0594-5; Laudenslager ML, 2014, BRAIN BEHAV IMMUN, V36, P1, DOI 10.1016/j.bbi.2013.08.012; Lee S, 2003, AM J PREV MED, V24, P113, DOI 10.1016/S0749-3797(02)00582-2; Mackey RH, 2015, DIABETES CARE, V38, P628, DOI 10.2337/dc14-0645; Mausbach BT, 2007, PSYCHOSOM MED, V69, P816, DOI 10.1097/PSY.0b013e318157d461; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; Mora S, 2010, DIABETES, V59, P1153, DOI 10.2337/db09-1114; Otvos JD, 2011, J CLIN LIPIDOL, V5, P105, DOI 10.1016/j.jacl.2011.02.001; Pavletic SZ, 2012, HEMATOL-AM SOC HEMAT, P251, DOI 10.1182/asheducation-2012.1.251; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; Phillips CM, 2015, ATHEROSCLEROSIS, V242, P399, DOI 10.1016/j.atherosclerosis.2015.07.040; Plaisance EP, 2009, PHYSICIAN SPORTSMED, V37, P11, DOI 10.3810/psm.2009.04.1678; Rasouli M, 2006, CLIN BIOCHEM, V39, P971, DOI 10.1016/j.clinbiochem.2006.07.003; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Roepke SK, 2012, STRESS, V15, P121, DOI 10.3109/10253890.2011.596866; Ross A, 2013, CANCER NURS, V36, P474, DOI 10.1097/NCC.0b013e3182747b75; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Sinha R, 2013, BIOL PSYCHIAT, V73, P827, DOI 10.1016/j.biopsych.2013.01.032; Stenberg U, 2010, PSYCHO-ONCOLOGY, V19, P1013, DOI 10.1002/pon.1670; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; von Kanel R, 2008, GERONTOLOGY, V54, P131, DOI 10.1159/000113649; WALKER SN, 1987, NURS RES, V36, P76; Wallenfeldt K, 2004, STROKE, V35, P2248, DOI 10.1161/01.STR.0000140629.65145.3c; Williams LA, 2007, ONCOL NURS FORUM, V34, P379, DOI 10.1188/07.ONF.379-387; Wulff-Burchfield EM, 2013, BONE MARROW TRANSPL, V48, P469, DOI 10.1038/bmt.2012.123	43	8	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176408	10.1371/journal.pone.0176408	http://dx.doi.org/10.1371/journal.pone.0176408			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472106	Green Submitted, gold, Green Published			2022-12-27	WOS:000400648500045
J	Sanchez-Diaz, PC; Chang, JC; Moses, ES; Dao, T; Chen, YD; Hung, JY				Sanchez-Diaz, Patricia C.; Chang, Judy C.; Moses, Emily S.; Dao, Tu; Chen, Yidong; Hung, Jaclyn Y.			Ubiquitin carboxyl-terminal esterase L1 (UCHL1) is associated with stem-like cancer cell functions in pediatric high-grade glioma	PLOS ONE			English	Article							HYDROLASE L1; UCH-L1; DIFFERENTIATION; EXPRESSION; ONCOGENE; INVASION; PATHWAY; SYSTEM; ROLES; AKT	Pediatric high-grade gliomas represent 8 - 12% of all primary tumors of the nervous system in children. Five-year survival for these pediatric aggressive tumors is poor (15 - 35%) indicating the need to develop better treatments for pediatric high-grade gliomas. In this work we used SF188 and SJ-GBM2 cell lines to study the function of the ubiquitin carboxyl-terminal esterase L1 (UCHL1), a deubiquitinase de-regulated in several cancers, in pediatric high-grade gliomas. UCHL1 depletion in SF188 and SJ-GBM2 glioma cells was associated with decreased cell proliferation and invasion, along with a reduced ability to grow in soft agar and to form spheres (i.e. self-renewal measure). A 70% reduction in Wnt signaling was also observed in the SF188 and SJ-GBM2 UCHL1 knockdowns (KDs) using a TCF-dependent TOPflash reporter assay. Transcriptome comparisons of UCHL1 KDs versus vector control identified a list of 306 differentially expressed genes (at least 2-fold change; p < 0.05) which included genes known to be involved in cancer like ACTA2, POSTN, LIF, FBXL7, FBXW11, GDF15, HEY2, but also potential novel genes such us IGLL5, ABCA4, AQP3, AQP4, CALB1, and ALK. Bioinformatics gene ontology (GO) analysis of these 306 genes revealed significant enrichment in "signal peptides", "extracellular matrix" and "secreted proteins "GO Terms. "Angiogenesis and blood vessel development", "neuron differentiation/development ",cell adhesion", and "cell migration" also showed significant enrichment in our GO analysis. Top canonical pathways identified by Ingenuity Pathway Analysis (IPA) included "Clathrin-mediated Endocytosis Signaling" (p = 5.14x10 (-4)), "Virus Entry via Endocytic Pathways" (p = 6.15x 10(-4)), and "High Mobility Group-Box 1 (HMGB1) Signaling" (p = 6.15x10(-4)). While FGF2, IL1B, TNF and PDGFB were predicted as top upstream regulators (p < 2x10(-16)) of the UCHL1 KD-associated transcriptome. Aberrant expression of UCHL1 in pediatric high-grade gliomas may promote cell invasion, transformation, and self-renewal properties, at least in part, by modulating Wnt/Beta catenin activity. UCHL1 might act as an oncogene in glioma within the gene network that imparts stem-like characteristics to these cancer cells.	[Sanchez-Diaz, Patricia C.; Chang, Judy C.; Moses, Emily S.; Chen, Yidong; Hung, Jaclyn Y.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Sanchez-Diaz, Patricia C.; Dao, Tu] Univ Incarnate Word, Rosenberg Sch Optometry, San Antonio, TX USA; [Moses, Emily S.] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Epidemiol & Biostat, San Antonio, TX 78229 USA; [Hung, Jaclyn Y.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, Div Hematol & Oncol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Virginia; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Hung, JY (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA.; Hung, JY (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, Div Hematol & Oncol, San Antonio, TX 78229 USA.	hungj@uthscsa.edu			Shelby Rae Tengg Foundation; Greehey Cancer Research Institute Permanent Health Fund Permanent Endowments Higher Education (Children's Cancer Research) at the University of Texas Health Science Center at San Antonio; Greehey Graduate Fellowship in Children's Health (Greehey Family); Faculty Development Funds (University of the Incarnate Word); Summer Fellowship Training Program (University of the Incarnate Word); Beez Foundation	Shelby Rae Tengg Foundation; Greehey Cancer Research Institute Permanent Health Fund Permanent Endowments Higher Education (Children's Cancer Research) at the University of Texas Health Science Center at San Antonio; Greehey Graduate Fellowship in Children's Health (Greehey Family); Faculty Development Funds (University of the Incarnate Word); Summer Fellowship Training Program (University of the Incarnate Word); Beez Foundation	Funding for this work was provided in part by the Shelby Rae Tengg Foundation for Dr. Jaclyn Y Hung, the Greehey Cancer Research Institute Permanent Health Fund Permanent Endowments Higher Education (Children's Cancer Research) at the University of Texas Health Science Center at San Antonio for Dr. Jaclyn Y Hung, the Greehey Graduate Fellowship in Children's Health (Greehey Family) for Judy C Chang, the Faculty Development Funds and the Summer Fellowship Training Program (University of the Incarnate Word) for Dr. Patricia C Sanchez-Diaz, and The Beez Foundation for Dr. Jaclyn Y Hung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersson FI, 2011, J MOL BIOL, V407, P261, DOI 10.1016/j.jmb.2010.12.029; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Bheda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005955; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; DORAN JF, 1983, J NEUROCHEM, V40, P1542, DOI 10.1111/j.1471-4159.1983.tb08124.x; Esteve-Rudd J, 2010, BRAIN RES, V1352, P70, DOI 10.1016/j.brainres.2010.07.019; Frisan T, 2012, FASEB J, V26, P5060, DOI 10.1096/fj.12-211946; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Goto Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7153; Gu YY, 2015, TUMOR BIOL, V36, P8379, DOI 10.1007/s13277-015-3566-0; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang XD, 2016, CELL RES, V26, P484, DOI 10.1038/cr.2016.31; Hurst-Kennedy J, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/123706; Hussain S, 2010, LEUKEMIA, V24, P1641, DOI 10.1038/leu.2010.138; Hussain S, 2013, MOL CELL BIOL, V33, P1188, DOI 10.1128/MCB.01389-12; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Isokpehi RD, 2015, CANCER INFORM, V14, P95, DOI 10.4137/CIN.S22058; Jang MJ, 2011, CANCER LETT, V302, P128, DOI 10.1016/j.canlet.2011.01.006; Kim HJ, 2009, ONCOGENE, V28, P117, DOI 10.1038/onc.2008.364; Kim HJ, 2015, ONCOTARGET, V6, P16287, DOI 10.18632/oncotarget.3843; Landre V, 2016, ONCOTARGET, V7, P11785, DOI 10.18632/oncotarget.7600; Luo JP, 2009, J CELL PHYSIOL, V220, P460, DOI 10.1002/jcp.21789; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Nager Mireia, 2012, Chemother Res Pract, V2012, P192362, DOI 10.1155/2012/192362; Naujokat C, 2007, STEM CELLS, V25, P2408, DOI 10.1634/stemcells.2007-0255; Park SY, 2016, MOL CANCER THER, V15, P2187, DOI 10.1158/1535-7163.MCT-15-0427; Pollock NL, 2011, FEBS J, V278, P3204, DOI 10.1111/j.1742-4658.2011.08169.x; Pulvirenti T, 2011, CANCER RES, V71, P7280, DOI 10.1158/0008-5472.CAN-11-1531; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Shi DD, 2010, CANCER BIOL THER, V10, P737, DOI 10.4161/cbt.10.8.13417; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Wobst H, 2012, FEBS J, V279, P4398, DOI 10.1111/febs.12029; Xiang TX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029783; Yang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067755; Zhang MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep07298; Zheng HW, 2010, CANCER CELL, V17, P497, DOI 10.1016/j.ccr.2010.03.020; Zhong JL, 2012, INT J MOL MED, V30, P430, DOI 10.3892/ijmm.2012.1012; Zhou WC, 2015, NAT CELL BIOL, V17, P170, DOI 10.1038/ncb3090	48	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176879	10.1371/journal.pone.0176879	http://dx.doi.org/10.1371/journal.pone.0176879			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472177	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500092
J	Trochta, J; Krucek, M; Vrska, T; Kral, K				Trochta, Jan; Krucek, Martin; Vrska, Tomas; Kral, Kamil			3D Forest: An application for descriptions of three-dimensional forest structures using terrestrial LiDAR	PLOS ONE			English	Article							LASER SCANNER DATA; TREE MODELS; BIOMASS; COMPETITION; GROWTH	Terrestrial laser scanning is a powerful technology for capturing the three-dimensional structure of forests with a high level of detail and accuracy. Over the last decade, many algorithms have been developed to extract various tree parameters from terrestrial laser scanning data. Here we present 3D Forest, an open-source non-platform-specific software application with an easy-to-use graphical user interface with the compilation of algorithms focused on the forest environment and extraction of tree parameters. The current version (0.42) extracts important parameters of forest structure from the terrestrial laser scanning data, such as stem positions (X, Y, Z), tree heights, diameters at breast height (DBH), as well as more advanced parameters such as tree planar projections, stem profiles or detailed crown parameters including convex and concave crown surface and volume. Moreover, 3D Forest provides quantitative measures of between-crown interactions and their real arrangement in 3D space. 3D Forest also includes an original algorithm of automatic tree segmentation and crown segmentation. Comparison with field data measurements showed no significant difference in measuring DBH or tree height using 3D Forest, although for DBH only the Randomized Hough Transform algorithm proved to be sufficiently resistant to noise and provided results comparable to traditional field measurements.	[Trochta, Jan; Krucek, Martin; Vrska, Tomas; Kral, Kamil] Silva Tarouca Res Inst, Dept Forest Ecol, Brno, Czech Republic; [Krucek, Martin] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Geoinformat Technol, Brno, Czech Republic	Mendel University in Brno	Trochta, J (corresponding author), Silva Tarouca Res Inst, Dept Forest Ecol, Brno, Czech Republic.	j.trochta@gmail.com	Kral, Kamil/E-4415-2014; Trochta, Jan/B-9383-2015; Krůček, Martin/B-9394-2015	Trochta, Jan/0000-0002-1004-7465; Krůček, Martin/0000-0002-3137-2259	Czech Science Foundation (GACR) [P504/15-23242S];  [VUKOZ-IP-00027073]	Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); 	This research was supported by the Czech Science Foundation (GACR), project No. P504/15-23242S and by Institutional subsidy VUKOZ-IP-00027073. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Teixeira KJ, 2015, GLOBAL CHANGE BIOL, V21, P528, DOI 10.1111/gcb.12712; Bienert A., 2006, INT ARCH PHOTOGRAMME, V36; Brolly G., 2009, ACTA SILV LIGNARIA H, V5, P119; Calders K, 2015, METHODS ECOL EVOL, V6, P198, DOI 10.1111/2041-210X.12301; Campbell J.B., 2011, INTRO REMOTE SENSING; Chernov N, 2005, J MATH IMAGING VIS, V23, P239, DOI 10.1007/s10851-005-0482-8; Condit R, 1998, TROPICAL FOREST CENS; Coomes DA, 2012, J ECOL, V100, P42, DOI 10.1111/j.1365-2745.2011.01920.x; Cote JF, 2012, AGR FOREST METEOROL, V166, P72, DOI 10.1016/j.agrformet.2012.06.007; Hackenberg J, 2015, FORESTS, V6, P4245, DOI 10.3390/f6114245; Hackenberg J, 2014, FORESTS, V5, P1069, DOI 10.3390/f5051069; Hanwell Marcus D., 2015, SoftwareX, V1-2, P9, DOI 10.1016/j.softx.2015.04.001; Isenburg M., 2014, LASTOOLS SOFTWARE RA, V1, P17071; Maas HG, 2008, INT J REMOTE SENS, V29, P1579, DOI 10.1080/01431160701736406; Metz J, 2013, FOREST ECOL MANAG, V310, P275, DOI 10.1016/j.foreco.2013.08.014; Piboule A, 2015, COMPUTREE COLLABORAT; PREPARATA FP, 1977, COMMUN ACM, V20, P87, DOI 10.1145/359423.359430; Raumonen P, 2013, REMOTE SENS-BASEL, V5, P491, DOI 10.3390/rs5020491; Rusu R. B., 2011, 3D IS HERE POINT CLO, P8; Seidel D, 2015, FOREST ECOL MANAG, V336, P119, DOI 10.1016/j.foreco.2014.10.020; Seidel D, 2011, AGR FOREST METEOROL, V151, P1305, DOI 10.1016/j.agrformet.2011.05.013; Seidel D, 2011, FOREST ECOL MANAG, V261, P2123, DOI 10.1016/j.foreco.2011.03.008; Tao SL, 2015, ISPRS J PHOTOGRAMM, V110, P66, DOI 10.1016/j.isprsjprs.2015.10.007; Trochta J, 2013, CAN J FOREST RES, V43, P355, DOI 10.1139/cjfr-2012-0347; van Leeuwen M, 2010, EUR J FOREST RES, V129, P749, DOI 10.1007/s10342-010-0381-4; XU L, 1993, CVGIP-IMAG UNDERSTAN, V57, P131, DOI 10.1006/ciun.1993.1009	26	104	106	12	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176871	10.1371/journal.pone.0176871	http://dx.doi.org/10.1371/journal.pone.0176871			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472167	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500090
J	Furrow, E; McCue, ME; Lulich, JP				Furrow, Eva; McCue, Molly E.; Lulich, Jody P.			Urinary metals in a spontaneous canine model of calcium oxalate urolithiasis	PLOS ONE			English	Article							IDIOPATHIC HYPERCALCIURIA; STONE FORMATION; CADMIUM; DOGS; METABOLISM; ABSORPTION; CREATININE; EXCRETION; ZINC; LITHOGENESIS	Calcium oxalate urolithiasis is a common and painful condition in people. The pathogenesis of this disease is complex and poorly understood. Laboratory animal and in vitro studies have demonstrated an effect of multiple trace metals in the crystallization process, and studies in humans have reported relationships between urinary metal concentrations and stone risk. Dogs are a spontaneous model of calcium oxalate urolithiasis, and the metal content of canine calcium oxalate stones mirrors that of human stones. The aim of this study was to test for a relationship between urinary metals and calcium oxalate urolithiasis in dogs. We hypothesized that urinary metals would differ between dogs with and without calcium oxalate urolithiasis. Urine from 122 dogs (71 cases and 51 stone-free controls) was analyzed for calcium and 12 other metals. The cases had higher urinary calcium, copper, iron, and vanadium and lower urinary cobalt. Higher urinary vanadium in the cases was associated with being fed a therapeutic stone-prevention diet. Urinary calcium had a strong positive correlation with strontium and moderate positive correlations with chromium, nickel, and zinc. The results of this study complement the findings of similar human studies and suggest a potential role of trace metals in calcium oxalate urolithiasis. Further investigation into how trace metals may affect stone formation is warranted.	[Furrow, Eva; Lulich, Jody P.] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [McCue, Molly E.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Furrow, E (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA.	furro004@umn.edu	Furrow, Eva/W-9963-2018	Lulich, Jody/0000-0002-2338-1569; Furrow, Eva/0000-0002-7339-2354; McCue, Molly/0000-0002-6807-0318	Nestle Purina Veterinary Resident Research Grant [771371]; Morris Animal Foundation grant [D12CA-031]; Office of the Director, National Institutes of Health (NIH) [K010D019912]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019912] Funding Source: NIH RePORTER	Nestle Purina Veterinary Resident Research Grant(Nestle SA); Morris Animal Foundation grant; Office of the Director, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a Nestle Purina Veterinary Resident Research Grant (771371) and a Morris Animal Foundation grant (D12CA-031). Partial funding for E.F. was provided by the Office of the Director, National Institutes of Health (NIH) under award number K010D019912.	Allen HS, 2015, JAVMA-J AM VET MED A, V246, P1098, DOI 10.2460/javma.246.10.1098; Atakan IH, 2007, INT UROL NEPHROL, V39, P351, DOI 10.1007/s11255-006-9050-4; Barbier O, 2004, AM J PHYSIOL-RENAL, V287, pF1067, DOI 10.1152/ajprenal.00120.2004; Bazin D, 2007, UROL RES, V35, P179, DOI 10.1007/s00240-007-0099-z; Blaschko SD, 2013, J UROLOGY, V189, P735, DOI 10.1016/j.juro.2012.08.199; BULUSU L, 1970, CLIN SCI, V38, P601, DOI 10.1042/cs0380601; BYRNE AR, 1978, SCI TOTAL ENVIRON, V10, P17, DOI 10.1016/0048-9697(78)90046-3; Carpentier X, 2011, J TRACE ELEM MED BIO, V25, P160, DOI 10.1016/j.jtemb.2011.05.004; Cheungpasitporn W, 2016, J NEPHROL, V29, P211, DOI 10.1007/s40620-015-0210-4; Datta P, 2009, J CLIN LAB ANAL, V23, P399, DOI 10.1002/jcla.20353; Devuyst O, 2007, KIDNEY INT, V72, P1065, DOI 10.1038/sj.ki.5002441; Dijcker JC, 2012, VET REC, V171, P646, DOI 10.1136/vr.101130; Ferraro PM, 2011, J ENDOUROL, V25, P875, DOI 10.1089/end.2010.0572; Ferraro PM, 2016, J NEPHROL; Furrow E, 2015, J VET INTERN MED, V29, P113, DOI 10.1111/jvim.12527; Gallagher CM, 2008, ENVIRON HEALTH PERSP, V116, P1338, DOI 10.1289/ehp.11452; Hong YH, 2010, UROLOGY, V75, P1294, DOI 10.1016/j.urology.2009.08.061; HUNGERFORD LL, 1995, VET HUM TOXICOL, V37, P158; Isomura H, 2004, TOXICOLOGY, V197, P93, DOI 10.1016/j.tox.2003.12.006; JOHNSON CM, 1979, KIDNEY INT, V16, P624, DOI 10.1038/ki.1979.173; Kazantzis G, 2004, BIOMETALS, V17, P493, DOI 10.1023/B:BIOM.0000045727.76054.f3; Killilea DW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128374; KOMLEH K, 1990, International Urology and Nephrology, V22, P113, DOI 10.1007/BF02549826; Lieske JC, 1979, KIDNEY INT, V16, P624; Lulich JP, 2013, VET REC, V172, P363, DOI 10.1136/vr.101056; LULICH JP, 1991, AM J VET RES, V52, P1583; MATSUNO K, 1991, BIOL TRACE ELEM RES, V28, P99, DOI 10.1007/BF02863076; MATSUNO K, 1991, BIOL TRACE ELEM RES, V29, P111, DOI 10.1007/BF03032688; Munoz JA, 2005, UROL RES, V33, P267, DOI 10.1007/s00240-005-0468-4; NIELSEN FH, 1974, FOOD TECHNOL-CHICAGO, V28, P38; NUTTALL KL, 1995, ANN CLIN LAB SCI, V25, P264; Ogawa Y, 2003, FRONT BIOSCI, V8, pal67; Ozgurtas T, 2004, UROL INT, V72, P233, DOI 10.1159/000077122; Romero Victoriano, 2010, Rev Urol, V12, pe86; Singh P, 2015, MAYO CLIN PROC, V90, P1356, DOI 10.1016/j.mayocp.2015.07.016; Slojewski M, 2011, CENT EUR J UROL, V64, P58, DOI 10.5173/ceju.2011.02.art1; Slojewski M, 2010, BIOL TRACE ELEM RES, V137, P301, DOI 10.1007/s12011-009-8584-6; Stevenson AE, 2003, J SMALL ANIM PRACT, V44, P491, DOI 10.1111/j.1748-5827.2003.tb00109.x; Strohmaier WL, 1997, EUR UROL, V32, P294, DOI 10.1159/000480828; Swarup D, 2000, VET HUM TOXICOL, V42, P232; Vezzoli G, 2003, AM J KIDNEY DIS, V42, P1177, DOI 10.1053/j.ajkd.2003.08.018; Vezzoli G, 1999, CLIN CHEM, V45, P257; Vezzoli G, 1998, CLIN CHEM, V44, P586; Villena VP, 2010, J ANAL TOXICOL, V34, P39, DOI 10.1093/jat/34.1.39; Wong P, 2013, OSTEOPOROSIS INT, V24, P1965, DOI 10.1007/s00198-012-2260-y; Worcester EM, 2008, SEMIN NEPHROL, V28, P120, DOI 10.1016/j.semnephrol.2008.01.005; YAZAKI T, 1991, UROLOGY, V38, P290, DOI 10.1016/S0090-4295(91)80364-D	47	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176595	10.1371/journal.pone.0176595	http://dx.doi.org/10.1371/journal.pone.0176595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467511	Green Published, gold, Green Submitted			2022-12-27	WOS:000400647000060
J	Carreras-Planella, L; Soler-Majoral, J; Rubio-Esteve, C; Lozano-Ramos, SI; Franquesa, M; Bonet, J; Troya-Saborido, MI; Borras, FE				Carreras-Planella, Laura; Soler-Majoral, Jordi; Rubio-Esteve, Cristina; Ines Lozano-Ramos, Sara; Franquesa, Marcella; Bonet, Josep; Isabel Troya-Saborido, Maria; Enric Borras, Francesc			Characterization and proteomic profile of extracellular vesicles from peritoneal dialysis efflux	PLOS ONE			English	Article							HEMODIALYSIS; BIOMARKERS; FLUID; MODEL	Peritoneal Dialysis (PD) is considered the best option for a cost-effective mid-term dialysis in patients with Chronic Renal Failure. However, functional failure of the peritoneal membrane (PM) force many patients to stop PD treatment and start haemodialysis. Currently, PM functionality is monitored by the peritoneal equilibration test, a tedious technique that often show changes when the membrane damage is advanced. As in other pathologies, the identification and characterization of extracellular vesicles (EVs) in the peritoneal dialysis efflux (PDE) may represent a non-invasive alternative to identify biomarkers of membrane failure. Using size-exclusion chromatography, we isolated EVs from PDE in a group of patients. Vesicles were characterized by the presence of tetraspanin markers, nanoparticle tracking analysis profile, cryo-electron microscopy and mass spectrometry. Here, we report the isolation and characterization of PDE-EVs. Based on mass spectrometry, we have found a set of well-conserved proteins among patients. Interestingly, the peptide profile also revealed remarkable changes between newly enrolled and longer-treated PD patients. These results are the first step to the identification of PDE-EVs based new markers of PM damage, which could support clinicians in their decision-making in a non-invasive manner.	[Carreras-Planella, Laura; Soler-Majoral, Jordi; Rubio-Esteve, Cristina; Ines Lozano-Ramos, Sara; Franquesa, Marcella; Bonet, Josep; Isabel Troya-Saborido, Maria; Enric Borras, Francesc] Germans Trias & Pujol Hlth Sci Res Inst, REMAR IVECAT Grp, Can Ruti Campus, Badalona, Spain; [Carreras-Planella, Laura; Ines Lozano-Ramos, Sara; Enric Borras, Francesc] Autonomous Univ Barcelona, Dept Cell Biol Physiol & Immunol, Barcelona, Spain; [Soler-Majoral, Jordi; Rubio-Esteve, Cristina; Franquesa, Marcella; Bonet, Josep; Isabel Troya-Saborido, Maria; Enric Borras, Francesc] Germans Trias & Pujol Univ Hosp, Nephrol Dept, Can Ruti Campus, Badalona, Spain; [Soler-Majoral, Jordi] Autonomous Univ Barcelona, Dept Med, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Troya-Saborido, MI; Borras, FE (corresponding author), Germans Trias & Pujol Hlth Sci Res Inst, REMAR IVECAT Grp, Can Ruti Campus, Badalona, Spain.; Borras, FE (corresponding author), Autonomous Univ Barcelona, Dept Cell Biol Physiol & Immunol, Barcelona, Spain.; Troya-Saborido, MI; Borras, FE (corresponding author), Germans Trias & Pujol Univ Hosp, Nephrol Dept, Can Ruti Campus, Badalona, Spain.	mitroya.germanstrias@gencat.cat; feborras@igtp.cat	Franquesa, Marcella/A-7231-2017; Borràs, Francesc E/P-2287-2017	Franquesa, Marcella/0000-0002-1287-8908; Borràs, Francesc E/0000-0003-4038-1912; Carreras-Planella, Laura/0000-0003-3512-0849; Soler, Jordi/0000-0001-6693-4859; Franquesa/0000-0001-6251-8575	National R+D+I [PI16/00072]; ISCIII; European Regional Development Fund [2014SGR804]; Instituto de Salud Carlos III-Red de Investigacion Renal (REDinREN) [RD16/0009]; Fundacio Cellex; Beatriu de Pinos-B contract from Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)-Generalitat de Catalunya [2014BPB00118]; Spanish "Sistema Nacionalde Salud" (SNS-ISCIII); "Direccio d'Estrategia i Coordinacio" Catalan Health Department [CES07/015]	National R+D+I; ISCIII(Instituto de Salud Carlos III); European Regional Development Fund(European Commission); Instituto de Salud Carlos III-Red de Investigacion Renal (REDinREN)(Instituto de Salud Carlos III); Fundacio Cellex(Foundation CELLEX); Beatriu de Pinos-B contract from Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)-Generalitat de Catalunya; Spanish "Sistema Nacionalde Salud" (SNS-ISCIII); "Direccio d'Estrategia i Coordinacio" Catalan Health Department	This work was supported by the PI16/00072 project, integrated in the National R+D+I and funded by the ISCIII and the European Regional Development Fund http://www.isciii.es), "Suport Grups de Recerca" programme of Generalitat de Catalunya (2014SGR804, Group REMAR, http://agaur.gencat.cat), Instituto de Salud Carlos III-Red de Investigacion Renal (REDinREN) (RD16/0009 Feder Funds, http://www.isciii.es, http://redinren.org), and Fundacio Cellex. MF is sponsored by the Beatriu de Pinos-B contract (2014BPB00118, http://agaur.gencat.cat) from Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)-Generalitat de Catalunya. FEB is sponsored by the "Researchers Stabilization Program" from the Spanish "Sistema Nacionalde Salud" (SNS-ISCIII, http://www.isciii.es) and "Direccio d'Estrategia i Coordinacio" Catalan Health Department (CES07/015, http://salutweb.gencat.cat). The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera Abelardo, 2005, Curr Opin Investig Drugs, V6, P262; Aroeira L, 2008, PERIT DIAL, V28, P29; Atapour A, 2015, SAUDI J KIDNEY DIS T, V26, P962, DOI 10.4103/1319-2442.164578; Barreto DL, 2013, AM J KIDNEY DIS, V62, P823, DOI 10.1053/j.ajkd.2013.01.031; Boukouris S, 2015, PROTEOM CLIN APPL, V9, P358, DOI 10.1002/prca.201400114; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Erdbrugger U, 2015, J AM SOC NEPHROL, P1; Fais S, 2016, ACS NANO, V10, P3886, DOI 10.1021/acsnano.5b08015; Gamez-Valero A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33641; Gamez-Valero A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00006; Heaf JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090119; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Kim DK, 2015, BIOINFORMATICS, V31, P933, DOI 10.1093/bioinformatics/btu741; Lechner M, 2010, J PROTEOME RES, V9, P2472, DOI 10.1021/pr9011574; Lener T, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.30087; Lin F, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0039-z; Lozano-Ramos I, 2015, J EXTRACELL VESICLES, P1; Lozano-Ramos I, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27369; Lukowsky LR, 2013, CLIN J AM SOC NEPHRO, V8, P619, DOI 10.2215/CJN.04810512; LYNOE N, 1991, BRIT MED J, V303, P610, DOI 10.1136/bmj.303.6803.610; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Mujais S, 2000, PERITON DIALYSIS INT, V20, pS5; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Sritippayawain S, 2007, J PROTEOME RES, V6, P4356, DOI 10.1021/pr0702969; Treharne C, 2014, APPL HEALTH ECON HEA, V12, P409, DOI 10.1007/s40258-014-0108-7; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Wang HY, 2010, NEPHROL DIAL TRANSPL, V25, P1955, DOI 10.1093/ndt/gfp696; WANIEWSKI J, 1991, BLOOD PURIFICAT, V9, P129, DOI 10.1159/000170009; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066	31	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176987	10.1371/journal.pone.0176987	http://dx.doi.org/10.1371/journal.pone.0176987			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489901	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100041
J	Fegraeus, KJ; Lawrence, C; Petajisto, K; Johansson, MK; Wiklund, M; Olsson, C; Andersson, L; Andersson, LS; Roed, KH; Ihler, CF; Strand, E; Lindgren, G; Velie, BD				Fegraeus, Kim Jaderkvist; Lawrence, Chameli; Petajisto, Katrine; Johansson, Maria K.; Wiklund, Maja; Olsson, Christina; Andersson, Leif; Andersson, Lisa S.; Roed, Knut H.; Ihler, Carl-Fredrik; Strand, Eric; Lindgren, Gabriella; Velie, Brandon D.			Lack of significant associations with early career performance suggest no link between the DMRT3 "Gait Keeper" mutation and precocity in Coldblooded trotters	PLOS ONE			English	Article							STANDARD-BRED TROTTERS; HORSES; ABILITY; GENE	The Swedish-Norwegian Coldblooded trotter (CBT) is a local breed in Sweden and Norway mainly used for harness racing. Previous studies have shown that a mutation from cytosine (C) to adenine (A) in the doublesex and mab-3 related transcription factor 3 (DMRT3) gene has a major impact on harness racing performance of different breeds. An association of the DMRT3 mutation with early career performance has also been suggested. The aim of the current study was to investigate this proposed association in a randomly selected group of CBTs. 769 CBTs (485 raced, 284 unraced) were genotyped for the DMRT3 mutation. The association with racing performance was investigated for 13 performance traits and three different age intervals: 3 years, 3 to 6 years, and 7 to 10 years of age, using the statistical software R. Each performance trait was analyzed for association with DMRT3 using linear models. The results suggest no association of the DMRT3 mutation with precocity (i.e. performance at 3 years of age). Only two traits (race time and number of disqualifications) were significantly different between the genotypes, with AA horses having the fastest times and CC horses having the highest number of disqualifications at 3 years of age. The frequency of the AA genotype was significantly lower in the raced CBT sample compared with the unraced sample and less than 50% of the AA horses participated in a race. For the age intervals 3 to 6 and 7 to 10 years the AA horses also failed to demonstrate significantly better performance than the other genotypes. Although suggested as the most favorable genotype for racing performance in Standardbreds and Finnhorses across all ages, the AA genotype does not appear to be associated with superior performance, early or late, in the racing career of CBTs.	[Fegraeus, Kim Jaderkvist; Lawrence, Chameli; Petajisto, Katrine; Johansson, Maria K.; Andersson, Leif; Lindgren, Gabriella; Velie, Brandon D.] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Wiklund, Maja] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Olsson, Christina] Swedish Trotting Assoc, Bromma, Sweden; [Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Andersson, Leif] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA; [Andersson, Lisa S.] Capilet Genet AB, Vasteras, Sweden; [Roed, Knut H.] Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Fac Vet Med, Oslo, Norway; [Ihler, Carl-Fredrik; Strand, Eric] Norwegian Univ Life Sci, Dept Compan Anim Clin Sci, Fac Vet Med, Oslo, Norway	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Uppsala University; Texas A&M University System; Texas A&M University College Station; Norwegian University of Life Sciences; Norwegian University of Life Sciences	Fegraeus, KJ (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden.	kim.jaderkvist@slu.se	Strand, Eric/J-4452-2019	Wiklund, Maja/0000-0002-4196-2498; Lindgren, Gabriella/0000-0001-6046-9669; Rosengren, Maria/0000-0003-0144-7034	Swedish Norwegian Foundation for Equine Research [H-15-47-075]; Swedish Research Council [621-2012-4666]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [221-2013-1661]; Capilet Genetics AB; Swedish Trotting Association	Swedish Norwegian Foundation for Equine Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Capilet Genetics AB; Swedish Trotting Association	This work was supported by: Swedish Norwegian Foundation for Equine Research, H-15-47-075, http://hastforskning.se (GL, ES); The Swedish Research Council (VR), 621-2012-4666, www.ur.se (GL); The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), 221-2013-1661, www.formas.se (GL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Capilet Genetics AB and The Swedish Trotting Association provided support in the form of salaries for authors LSA and CO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these authors is articulated in the 'author contributions' section.	Abdi H., 2010, ENCY RES DESIGN; Andersson LS, 2012, NATURE, V488, P642, DOI 10.1038/nature11399; Arnason T., 1994, Genetics and breeding of dairy and beef cattle, swine and horses, Volume 17. Proceedings of the 5th World Congress on Genetics applied to Livestock Production, University of Guelph, Guelph, Ontario, Canada, 7-12 August, 1994., P462; Arnason T, 1999, J ANIM BREED GENET, V116, P387, DOI 10.1046/j.1439-0388.1999.00202.x; Fegraeus KJ, 2015, J HERED, V106, P734, DOI 10.1093/jhered/esv062; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Hill EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008645; Jaderkvist K, 2014, J ANIM SCI, V92, P4279, DOI [10.2527/jas2014-7803, 10.2527/jas.2014-7803]; Kristjansson T, 2016, LIVEST SCI, V189, P91, DOI 10.1016/j.livsci.2016.05.010; Promerova M, 2014, ANIM GENET, V45, P274, DOI 10.1111/age.12120; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ricard A, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0095-7; Thiruvenkadan AK, 2009, LIVEST SCI, V124, P163, DOI 10.1016/j.livsci.2009.01.010	13	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							0177351	10.1371/journal.pone.0177351	http://dx.doi.org/10.1371/journal.pone.0177351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489879	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314100066
J	Fernandez-Dominguez, JC; de Pedro-Gomez, JE; Morales-Asencio, JM; Bennasar-Veny, M; Sastre-Fullana, P; Sese-Abad, A				Carlos Fernandez-Dominguez, Juan; Ernest de Pedro-Gomez, Joan; Miguel Morales-Asencio, Jose; Bennasar-Veny, Miquel; Sastre-Fullana, Pedro; Sese-Abad, Albert			Health Sciences-Evidence Based Practice questionnaire (HS-EBP) for measuring transprofessional evidence-based practice: Creation, development and psychometric validation	PLOS ONE			English	Article							INSTRUMENTS; KNOWLEDGE; ATTITUDES; BEHAVIOR; BARRIERS; SKILLS; RELIABILITY; VALIDITY; THERAPY	Introduction Most of the EBP measuring instruments available to date present limitations both in the operationalisation of the construct and also in the rigour of their psychometric development, as revealed in the literature review performed. The aim of this paper is to provide rigorous and adequate reliability and validity evidence of the scores of a new transdisciplinary psychometric tool, the Health Sciences Evidence-Based Practice (HS-EBP), for measuring the construct EBP in Health Sciences professionals. Methods A pilot study and a subsequent two-stage validation test sample were conducted to progressively refine the instrument until a reduced 60-item version with a five-factor latent structure. Reliability was analysed through both Cronbach's alpha coefficient and intraclass correlations (ICC). Latent structure was contrasted using confirmatory factor analysis (CFA) following a model comparison aproach. Evidence of criterion validity of the scores obtained was achieved by considering attitudinal resistance to change, burnout, and quality of professional life as criterion variables; while convergent validity was assessed using the Spanish version of the Evidence-Based Practice Questionnaire (EBPQ-19). Results Adequate evidence of both reliability and ICC was obtained for the five dimensions of the questionnaire. According to the CFA model comparison, the best fit corresponded to the five-factor model (RMSEA = 0.049; CI 90% RMSEA = [0.047; 0.050]; CFI = 0.99). Adequate criterion and convergent validity evidence was also provided. Finally, the HS-EBP showed the capability to find differences between EBP training levels as an important evidence of decision validity. Conclusions Reliability and validity evidence obtained regarding the HS-EBP confirm the adequate operationalisation of the EBP construct as a process put into practice to respond to every clinical situation arising in the daily practice of professionals in health sciences (transprofessional). The tool could be useful for EBP individual assessment and for evaluating the impact of specific interventions to improve EBP.	[Carlos Fernandez-Dominguez, Juan; Ernest de Pedro-Gomez, Joan; Sastre-Fullana, Pedro] Univ Balearic Isl, Dept Nursing & Physiotherapy, Palma De Mallorca, Balearic Island, Spain; [Miguel Morales-Asencio, Jose] Univ Malaga, Dept Nursing, Fac Hlth Sci, Andalucia, Spain; [Bennasar-Veny, Miquel] Univ Illes Balears, Res Grp Evidence Lifestyles & Hlth, Res Inst Hlth Sci IUNICS, Palma De Mallorca, Baleares, Spain; [Sastre-Fullana, Pedro] Son Llatzer Hosp, Balearic Isl Hlth Serv, Palma De Mallorca, Spain; [Sese-Abad, Albert] Univ Balearic Isl, Dept Psychol, Palma De Mallorca, Balearic Island, Spain	Universitat de les Illes Balears; Universidad de Malaga; Universitat de les Illes Balears; Hospital Universitari Son Llatzer; Universitat de les Illes Balears	de Pedro-Gomez, JE (corresponding author), Univ Balearic Isl, Dept Nursing & Physiotherapy, Palma De Mallorca, Balearic Island, Spain.	depedro@uib.es	Sesé, Albert/D-3124-2011; Bennasar-Veny, Miquel/C-5881-2008; MORALES-ASENCIO, JOSE MIGUEL/B-4996-2008	Sesé, Albert/0000-0003-3771-1749; Bennasar-Veny, Miquel/0000-0003-1668-2141; MORALES-ASENCIO, JOSE MIGUEL/0000-0001-7911-7487	Health Research Fund of the Institute de Salud Carlos III [PI12/02456]	Health Research Fund of the Institute de Salud Carlos III	This article forms part of a project entitled 'Health Sciences-Evidence Based Practice Questionnaire (HS-EBP) for Measuring Transprofessional Evidence-Based Practice',financed by the Health Research Fund of the Institute de Salud Carlos III (award number: PI12/02456) following a rigorous peer-reviewed funding process. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Educational Research Association American Psychological Association Na- tional Council on Measurement in Education, 2014, STAND ED PSYCH TEST; [Anonymous], 2014, EVIDENCE BASED NURSI; Arciniega LM, 2009, PERS INDIV DIFFER, V46, P178, DOI 10.1016/j.paid.2008.09.024; Benner P., 2001, NOVICE EXPERT EXCELL; Bernal G, 2010, P R HEALTH SCI J, V29, P385; Buchanan H, 2016, OCCUP THER INT, V23, P59, DOI 10.1002/oti.1398; Cabezas C, 2000, FORMACION MED CONTIN, V7, P53; Fernandez-Dominguez JC, 2016, INT J QUAL HEALTH C, V28, P764, DOI 10.1093/intqhc/mzw106; Fernandez-Dominguez JC, 2014, J EVAL CLIN PRACT, V20, P767, DOI 10.1111/jep.12180; Dawes Martin, 2005, BMC Med Educ, V5, P1; Gomez JD, 2009, REV ESP SALUD PUBLIC, V83, P577, DOI 10.1590/S1135-57272009000400009; Fritsche L, 2002, BMJ-BRIT MED J, V325, P1338, DOI 10.1136/bmj.325.7376.1338; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; International Test Commission, 2013, ITC GUID QUAL CONTR; J?reskog, 2006, LISREL 8 80 WINDOWS; Kaper NM, 2015, J CLIN EPIDEMIOL, V68, P1261, DOI 10.1016/j.jclinepi.2015.06.002; KRAUS SJ, 1995, PERS SOC PSYCHOL B, V21, P58, DOI 10.1177/0146167295211007; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leung K, 2014, J ADV NURS, V70, P2181, DOI 10.1111/jan.12454; Martín Jesús, 2004, Gac Sanit, V18, P129, DOI 10.1157/13059283; McEvoy MP, 2010, MED TEACH, V32, pE373, DOI 10.3109/0142159X.2010.494741; Melnyk BM, 2014, WORLDV EVID-BASED NU, V11, P79, DOI 10.1111/wvn.12032; Metcalfe C., 2001, PHYSIOTHERAPY, V87, P433, DOI [DOI 10.1016/S0031-9406(05)65462-4, 10.1016/S0031-9406(05)65462-4]; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-22; Palfreyman Simon, 2003, Br J Nurs, V12, P246; Pallant J., 2005, SPSS SURVIVAL MANUAL, V2; Pollock AS, 2000, CLIN REHABIL, V14, P611, DOI 10.1191/0269215500cr369oa; Ramos KD, 2003, BRIT MED J, V326, P319, DOI 10.1136/bmj.326.7384.319; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Scurlock-Evans L, 2014, PHYSIOTHERAPY, V100, P208, DOI 10.1016/j.physio.2014.03.001; Seisdedos N., 1997, MBI INVENTARIO BURNO; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; The American Educational Research Association The American Psychological Association & The National Council on Measurement in Education, 1999, STAND ED PSYCH TEST; Tilson JK, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-38; Williams Brett, 2015, Nurse Educ Today, V35, pe34, DOI 10.1016/j.nedt.2014.11.012	36	11	11	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177172	10.1371/journal.pone.0177172	http://dx.doi.org/10.1371/journal.pone.0177172			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UM	28486533	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000052
J	Kim, JS; Cho, MS; Nam, JH; Kim, HJ; Choi, KW; Ryu, JS				Kim, Jung Soo; Cho, Min Seong; Nam, Jong Hyeon; Kim, Hyun-Jung; Choi, Kyeng-Won; Ryu, Jeong-Seon			Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; T790M MUTATION; NEVER SMOKERS; ASSOCIATION; TUMORS; RISK; GENE	Background A family history can be a valuable tool in the era of precision medicine. Although a few studies have described an association of family history of lung cancer with EGFR activating mutation, their impact on survival of lung cancer patients is unclear. Methods The study included consecutive 829 non-small-cell lung cancer patients who received analysis of EGFR mutation in a prospective lung cancer cohort. Family history of lung cancer was obtained by face-to-face interviews at the time of diagnosis. An association of EGFR activating mutation with a family history of lung cancer in first-degree relatives was evaluated with multivariate logistic regression analysis, and its association with survival was estimated with Cox's proportional hazards model. Results Seventy five (9.0%) patients had family history of lung cancer. The EGFR mutation was commonly observed in patients with positive family history compared to those with no family history (46.7% v 31.3%, x(2) p = 0.007). The family history was significantly associated with the EGFR mutation (aOR and 95% CI: 2.01 and 1.18-3.60, p = 0.011). Patients with the positive family history survived longer compared to those without (MST, 17.9 v 13.0 months, log-rank p = 0.037). The presence of the EGFR mutation was associated with better survival in patients without the family history (aHR and 95% CI: 0.72 and 0.57-0.90, p = 0.005). However, this prognostic impact was not observed in patients with the positive family history (aHR and 95% CI: 1.01 and 0.50-2.36, p = 0.832). Conclusions In comparison to patients without the family history, EGFR activating mutation was common, and it did not affect prognosis in patients with positive family history.	[Kim, Jung Soo; Cho, Min Seong; Nam, Jong Hyeon; Kim, Hyun-Jung; Choi, Kyeng-Won; Ryu, Jeong-Seon] Inha Univ Hosp, Dept Internal Med, 27 Inhang Ro, Incheon, South Korea	Inha University; Inha University Hospital	Ryu, JS (corresponding author), Inha Univ Hosp, Dept Internal Med, 27 Inhang Ro, Incheon, South Korea.	jsryu@inha.ac.kr		Kim, Jung Soo/0000-0001-6603-6768	Korea government (MSIP) (Medical Research Center (MRC) [2014009392]	Korea government (MSIP) (Medical Research Center (MRC)	This work was supported by the Korea government (MSIP) (Medical Research Center (MRC) No. 2014009392). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostou VK, 2015, CLIN CANCER RES, V21, P976, DOI 10.1158/1078-0432.CCR-14-1187; Bell DW, 2005, NAT GENET, V37, P1315, DOI 10.1038/ng1671; Cassidy A, 2009, EUR J CANCER, V45, P3047, DOI 10.1016/j.ejca.2009.05.006; Cheng PC, 2015, J THORAC DIS, V7, P281, DOI 10.3978/j.issn.2072-1439.2015.02.03; Ganti AK, 2009, LUNG CANCER, V63, P136, DOI 10.1016/j.lungcan.2008.04.008; Gaughan EM, 2013, LUNG CANCER, V79, P193, DOI 10.1016/j.lungcan.2012.12.002; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Haraguchi S, 2012, INT J MED SCI, V9, P68, DOI 10.7150/ijms.9.68; He YY, 2013, LUNG CANCER, V81, P162, DOI 10.1016/j.lungcan.2013.05.004; Inukai M, 2006, CANCER RES, V66, P7854, DOI 10.1158/0008-5472.CAN-06-1951; Jonsson S, 2004, JAMA-J AM MED ASSOC, V292, P2977, DOI 10.1001/jama.292.24.2977; Li N, 2011, FAM CANCER, V10, P331, DOI 10.1007/s10689-010-9403-0; Liu PY, 2008, JNCI-J NATL CANCER I, V100, P1326, DOI 10.1093/jnci/djn268; Matakidou A, 2005, BRIT J CANCER, V93, P825, DOI 10.1038/sj.bjc.6602769; Ohtsuka K, 2011, J CLIN ONCOL, V29, pE191, DOI 10.1200/JCO.2010.31.4492; Oxnard GR, 2012, J THORAC ONCOL, V7, P1049, DOI 10.1097/JTO.0b013e318250ed9d; Rachtan J, 2009, LUNG CANCER, V65, P138, DOI 10.1016/j.lungcan.2008.10.029; Ryu JS, 2014, J CLIN ONCOL, V32, P960, DOI 10.1200/JCO.2013.50.5453; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Wu JY, 2011, CLIN CANCER RES, V17, P3812, DOI 10.1158/1078-0432.CCR-10-3408; Yu HA, 2014, ANN ONCOL, V25, P423, DOI 10.1093/annonc/mdt573; Yu HA, 2014, J THORAC ONCOL, V9, P554, DOI 10.1097/JTO.0000000000000052	24	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177015	10.1371/journal.pone.0177015	http://dx.doi.org/10.1371/journal.pone.0177015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486527	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000035
J	Li, K; Yu, N; Li, PF; Song, SM; Wu, YL; Li, Y; Liu, M				Li, Ke; Yu, Nan; Li, Pengfei; Song, Shimin; Wu, Yalei; Li, Yang; Liu, Meng			Multi-label spacecraft electrical signal classification method based on DBN and random forest	PLOS ONE			English	Article								In spacecraft electrical signal characteristic data, there exists a large amount of data with high-dimensional features, a high computational complexity degree, and a low rate of identification problems, which causes great difficulty in fault diagnosis of spacecraft electronic load systems. This paper proposes a feature extraction method that is based on deep belief networks (DBN) and a classification method that is based on the random forest (RF) algorithm; The proposed algorithm mainly employs a multi-layer neural network to reduce the dimension of the original data, and then, classification is applied. Firstly, we use the method of wavelet denoising, which was used to pre-process the data. Secondly, the deep belief network is used to reduce the feature dimension and improve the rate of classification for the electrical characteristics data. Finally, we used the random forest algorithm to classify the data and comparing it with other algorithms. The experimental results show that compared with other algorithms, the proposed method shows excellent performance in terms of accuracy, computational efficiency, and stability in addressing spacecraft electrical signal data.	[Li, Ke; Yu, Nan; Li, Pengfei; Wu, Yalei; Liu, Meng] Beihang Univ, Ergon & Environm Control Lab, Beijing, Peoples R China; [Song, Shimin] China Acad Space Technol, Beijing, Peoples R China; [Li, Yang] Beihang Univ, Sch Automat Sci & Elect Engn, Beijing, Peoples R China	Beihang University; Beihang University	Liu, M (corresponding author), Beihang Univ, Ergon & Environm Control Lab, Beijing, Peoples R China.	like@buaa.edu.cn			Aeronautical Science Foundation of China [2012ZD51043]; Fanzhou Youth Scientific Funds [20100504]; Chinese Government Fundamental Research Funds for the Central Universities [YWF-14-HKXY-017, YWF-13-HKXY-033]; National Natural Science Foundation of China [61403016]	Aeronautical Science Foundation of China; Fanzhou Youth Scientific Funds; Chinese Government Fundamental Research Funds for the Central Universities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are supported by the Aeronautical Science Foundation of China (No. 2012ZD51043), Fanzhou Youth Scientific Funds (No. 20100504), Chinese Government Fundamental Research Funds for the Central Universities (No. YWF-14-HKXY-017, YWF-13-HKXY-033), and the National Natural Science Foundation of China (61403016).	Batzel TD, 2009, IEEE T AERO ELEC SYS, V45, P473, DOI 10.1109/TAES.2009.5089535; Deng HT, 2013, PATTERN RECOGN, V46, P3483, DOI 10.1016/j.patcog.2013.05.018; Goadrich M., 2010, P 23 INT C MACH LEAR, P233; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hu Qing, 2010, High Voltage Engineering, V36, P1725; Khaing H K.T., 2013, INT J ADV RES COMPUT, V2; Kulkarni V. Y., 2015, J I ENG, V23, P1; Li K., 2015, PLOS ONE, V10; Li K, 2014, CHINESE J AERONAUT, V27, P1390, DOI 10.1016/j.cja.2014.10.005; Li K, 2013, CHINESE J AERONAUT, V26, P1360, DOI 10.1016/j.cja.2013.07.006; Liu Yang, 2014, ScientificWorldJournal, V2014, P476219, DOI 10.1155/2014/476219; Liu Y, 2014, INT CONF SIGN PROCES, P1413, DOI 10.1109/ICOSP.2014.7015232; Luo R., 2013, ANAL PHM TECHNOLOGY; Pal M, 2005, INT J REMOTE SENS, V26, P217, DOI 10.1080/01431160412331269698; Quiroga RQ, 2003, CLIN NEUROPHYSIOL, V114, P376, DOI 10.1016/S1388-2457(02)00365-6; Shaw S R., 2005, SYSTEM IDENTIFICATIO; Toth N, 2008, INT J INTELL COMPUT, V1, P169, DOI 10.1108/17563780810874708; Vidakovic B, 1998, IEEE T SIGNAL PROCES, V46, P2549, DOI 10.1109/78.709544; Xi Chen, 2011, 2011 International Conference on Intelligent Computation Technology and Automation (ICICTA), P132, DOI 10.1109/ICICTA.2011.40; Xiang Gao, 2013, Advanced Materials Research, V760-762, P1062, DOI 10.4028/www.scientific.net/AMR.760-762.1062; Yan WZ, 2006, 2006 IMACS: MULTICONFERENCE ON COMPUTATIONAL ENGINEERING IN SYSTEMS APPLICATIONS, VOLS 1 AND 2, P468; Yi WG, 2011, INT J MACH LEARN CYB, V2, P67, DOI 10.1007/s13042-011-0015-2; Zhao L, 2016, NEUROCOMPUTING, V171, P230, DOI 10.1016/j.neucom.2015.06.063; Zhuang Jin-fa, 2009, Computer Integrated Manufacturing Systems, V15, P777	25	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176614	10.1371/journal.pone.0176614	http://dx.doi.org/10.1371/journal.pone.0176614			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486479	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000018
J	Linhart, P; Salek, M				Linhart, Pavel; Salek, Martin			The assessment of biases in the acoustic discrimination of individuals	PLOS ONE			English	Article							OWL ATHENE-NOCTUA; POPULATION DECLINE; RECOGNITION; CALLS; CLASSIFICATION; ANIMALS; SIGNALS; SONG; DISTINCTIVENESS; IDENTIFICATION	Animal vocalizations contain information about individual identity that could potentially be used for the monitoring of individuals. However, the performance of individual discrimination is subjected to many biases depending on factors such as the amount of identity information, or methods used. These factors need to be taken into account when comparing results of different studies or selecting the most cost-effective solution for a particular species. In this study, we evaluate several biases associated with the discrimination of individuals. On a large sample of little owl male individuals, we assess how discrimination performance changes with methods of call description, an increasing number of individuals, and number of calls per male. Also, we test whether the discrimination performance within the whole population can be reliably estimated from a subsample of individuals in a pre-screening study. Assessment of discrimination performance at the level of the individual and at the level of call led to different conclusions. Hence, studies interested in individual discrimination should optimize methods at the level of individuals. The description of calls by their frequency modulation leads to the best discrimination performance. In agreement with our expectations, discrimination performance decreased with population size. Increasing the number of calls per individual linearly increased the discrimination of individuals (but not the discrimination of calls), likely because it allows distinction between individuals with very similar calls. The available pre-screening index does not allow precise estimation of the population size that could be reliably monitored. Overall, projects applying acoustic monitoring at the individual level in population need to consider limitations regarding the population size that can be reliably monitored and fine-tune their methods according to their needs and limitations.	[Linhart, Pavel] Inst Anim Sci, Ethol Dept, Prague, Czech Republic; [Linhart, Pavel] Adam Mickiewicz Univ, Dept Behav Ecol, Fac Biol, Poznan, Poland; [Salek, Martin] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic; [Salek, Martin] Czech Univ Life Sci Prague, Fac Environm Sci, Prague, Czech Republic	Czech Research Institute of Animal Science; Adam Mickiewicz University; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Czech University of Life Sciences Prague	Linhart, P (corresponding author), Inst Anim Sci, Ethol Dept, Prague, Czech Republic.; Linhart, P (corresponding author), Adam Mickiewicz Univ, Dept Behav Ecol, Fac Biol, Poznan, Poland.	pavel.linhart83@gmail.com	Salek, Martin/H-6253-2011; Salek, Martin/AAE-9233-2019; Linhart, Pavel/AAZ-7474-2021	Linhart, Pavel/0000-0002-6097-5892; Salek, Martin/0000-0003-2639-9745	Czech Science Foundation [GA14-279255]; Ministry of Agriculture of Czech Republic [MZER00716]; National Science Centre, Poland [2015/19/P/NZ8/02507]; Academy of Sciences of the Czech Republic [RV068081766]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Agriculture of Czech Republic(Ministry of Agriculture, Czech Republic); National Science Centre, Poland(National Science Centre, Poland); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	PL was supported by the Czech Science Foundation (GA14-279255), Ministry of Agriculture of Czech Republic (MZER00716), and National Science Centre, Poland (2015/19/P/NZ8/02507); MS was funded by the Academy of Sciences of the Czech Republic (RV068081766). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adi K, 2010, J ACOUST SOC AM, V127, P874, DOI 10.1121/1.3273887; Amorim MCP, 2011, BEHAV ECOL SOCIOBIOL, V65, P707, DOI 10.1007/s00265-010-1072-3; Antunes R, 2011, ANIM BEHAV, V81, P723, DOI 10.1016/j.anbehav.2010.12.019; Arriaga JG, 2014, LECT NOTES COMPUT SC, V8495, P291, DOI 10.1007/978-3-319-07491-7_30; BEECHER MD, 1982, AM ZOOL, V22, P477; BEECHER MD, 1989, ANIM BEHAV, V38, P248, DOI 10.1016/S0003-3472(89)80087-9; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Budka M, 2015, J ORNITHOL, V156, P481, DOI 10.1007/s10336-014-1149-2; Budka M, 2013, ETHOLOGY, V119, P960, DOI 10.1111/eth.12141; Cheng JK, 2010, PATTERN RECOGN, V43, P3846, DOI 10.1016/j.patcog.2010.04.026; Cinkova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098475; Delport W, 2002, IBIS, V144, P30, DOI 10.1046/j.0019-1019.2001.00019.x; Exo K. M., 1989, VOGELWARTE, V35, P99; Exo K. M., 1989, ECOLOGY BIRDS, V11, P149; Feng AS, 2009, ETHOLOGY, V115, P1015, DOI 10.1111/j.1439-0310.2009.01692.x; Feng JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096317; Fernandez-Juricic E, 2009, AUK, V126, P89, DOI 10.1525/auk.2009.07090; Fox EJS, 2008, ANIM BEHAV, V75, P1187, DOI 10.1016/j.anbehav.2007.11.003; Grava T, 2008, IBIS, V150, P279, DOI 10.1111/j.1474-919X.2007.00776.x; Hardouin LA, 2006, ANIM BEHAV, V72, P105, DOI 10.1016/j.anbehav.2005.09.020; Jacobsen LB, 2013, ORNIS FENNICA, V90, P41; Janik VM, 2013, J COMP PHYSIOL A, V199, P479, DOI 10.1007/s00359-013-0817-7; Janik VM, 1999, ANIM BEHAV, V57, P133, DOI 10.1006/anbe.1998.0923; Kennedy RAW, 2009, J AVIAN BIOL, V40, P481, DOI 10.1111/j.1600-048X.2008.04682.x; Kirschel ANG, 2009, BIOACOUSTICS, V19, P1; Klenova AV, 2009, J ETHOL, V27, P401, DOI 10.1007/s10164-008-0133-9; Laiolo P, 2007, J AVIAN BIOL, V38, P672, DOI 10.1111/j.2007.0908-8857.04006.x; Lein MR, 2008, WILSON J ORNITHOL, V120, P256, DOI 10.1676/07-067.1; Lengagne T, 2001, BEHAVIOUR, V138, P1407, DOI 10.1163/156853901317367663; Lengagne T, 1997, CR ACAD SCI III-VIE, V320, P885, DOI 10.1016/S0764-4469(97)80873-6; MEDVIN MB, 1993, ANIM BEHAV, V45, P841, DOI 10.1006/anbe.1993.1105; Merchant ND, 2015, METHODS ECOL EVOL, V6, P257, DOI 10.1111/2041-210X.12330; Milligan JL, 2003, J FIELD ORNITHOL, V74, P111, DOI 10.1648/0273-8570-74.2.111; Nieuwenhuyse DV, 2008, LITTLE OWL CONSERVAT; Odom KJ, 2013, J RAPTOR RES, V47, P21, DOI 10.3356/JRR-12-11.1; Peake TM, 1998, IBIS, V140, P120, DOI 10.1111/j.1474-919X.1998.tb04548.x; Petruskova T, 2016, METHODS ECOL EVOL, V7, P274, DOI 10.1111/2041-210X.12496; Pollard KA, 2010, J APPL ECOL, V47, P1103, DOI 10.1111/j.1365-2664.2010.01851.x; Ptacek L, 2016, BIOACOUSTICS, V25, P55, DOI 10.1080/09524622.2015.1089524; Robertson BC, 1996, ANIM BEHAV, V51, P303, DOI 10.1006/anbe.1996.0030; Rognan CB, 2009, J WILDLIFE MANAGE, V73, P755, DOI 10.2193/2008-124; Salek M, 2008, POL J ECOL, V56, P527; Salek M, 2016, AGR ECOSYST ENVIRON, V224, P56, DOI 10.1016/j.agee.2016.03.031; Salek Martin, 2014, Sylvia, V50, P2; Salek M, 2013, POL J ECOL, V61, P165; Salmi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101940; Schneiderova I, 2010, BIOACOUSTICS, V20, P29; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Terry AMR, 2002, ANIM CONSERV, V5, P103, DOI 10.1017/S1367943002002147; Terry AMR, 2005, FRONT ZOOL, V2, P10, DOI DOI 10.1186/1742-9994-2-10; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; WEARY DM, 1990, AUK, V107, P623; Wiley RH, 2013, BIOL REV, V88, P179, DOI 10.1111/j.1469-185X.2012.00246.x; Wilson DR, 2014, BIOACOUSTICS, V23, P99, DOI 10.1080/09524622.2013.827588; Xia CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042528; Xia Canwei, 2011, Chinese Birds, V2, P132; Zmihorski M, 2006, POL J ECOL, V54, P321	57	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177206	10.1371/journal.pone.0177206	http://dx.doi.org/10.1371/journal.pone.0177206			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486488	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000057
J	Thiault, L; Collin, A; Chlous, F; Gelcich, S; Claudet, J				Thiault, Lauric; Collin, Antoine; Chlous, Frederique; Gelcich, Stefan; Claudet, Joachim			Combining participatory and socioeconomic approaches to map fishing effort in small-scale fisheries	PLOS ONE			English	Article							MARINE PROTECTED AREAS; POLYNESIAN CORAL-REEFS; ECOSYSTEM SERVICES; COMMUNITIES; MANAGEMENT; KNOWLEDGE; COASTAL; GIS; CHALLENGES; POLITICS	Mapping the spatial allocation of fishing effort while including key stakeholders in the decision making process is essential for effective fisheries management but is difficult to implement in complex small-scale fisheries that are diffuse, informal and multifaceted. Here we present a standardized but flexible approach that combines participatory mapping approaches (fishers' spatial preference for fishing grounds, or fishing suitability) with socioeconomic approaches (spatial extrapolation of social surrogates, or fishing capacity) to generate a comprehensive map of predicted fishing effort. Using a real world case study, in Moorea, French Polynesia, we showed that high predicted fishing effort is not simply located in front of, or close to, main fishing villages with high dependence on marine resources; it also occurs where resource dependency is moderate and generally in near-shore areas and reef passages. The integrated approach we developed can contribute to addressing the recurrent lack of fishing effort spatial data through key stakeholders' (i.e., resource users) participation. It can be tailored to a wide range of social, ecological and data availability contexts, and should help improve place-based management of natural resources.	[Thiault, Lauric; Claudet, Joachim] PSL Res Univ, USR CNRS EPHE UPVD 3278, Natl Ctr Sci Res, CRIOBE, Perpignan, France; [Thiault, Lauric; Collin, Antoine; Claudet, Joachim] CORAIL, Lab Excellence, Corsica, France; [Thiault, Lauric; Chlous, Frederique] Museum Natl Hist Nat, PALOC, UMR MNHN IRD 208, Paris, France; [Thiault, Lauric; Gelcich, Stefan] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Ctr Appl Ecol & Sustainabil, Santiago, Chile; [Collin, Antoine] PSL Univ EPHE, CNRS Prodig, Dinard, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Museum National d'Histoire Naturelle (MNHN); Pontificia Universidad Catolica de Chile; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Thiault, L (corresponding author), PSL Res Univ, USR CNRS EPHE UPVD 3278, Natl Ctr Sci Res, CRIOBE, Perpignan, France.; Thiault, L (corresponding author), CORAIL, Lab Excellence, Corsica, France.; Thiault, L (corresponding author), Museum Natl Hist Nat, PALOC, UMR MNHN IRD 208, Paris, France.; Thiault, L (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Ctr Appl Ecol & Sustainabil, Santiago, Chile.	lauric.thiault@gmail.com	Collin, Antoine/AAL-4560-2021; Thiault, Lauric/J-2060-2019; BITOUN, RACHEL Elisabeth/AAC-9538-2021; Claudet, Joachim/C-6335-2008	Collin, Antoine/0000-0001-9559-7572; Thiault, Lauric/0000-0002-5572-7632; BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Claudet, Joachim/0000-0001-6295-1061	Agence Nationale de la Recherche ANR [ANR-14-CE03-0001-01]; Fondation de France (INTHENSE project); EU DG-MARE (SafeNet project) [MARE 2014/41]; Universite Pierre et Marie Curie-Institut de Recherche et de Developpement: Programme Doctoral International: Modelisation des Systemes Complexes (PDI MSC); Fondation de France (INTHENSE); ANR [ANR-14-CE03-0001-01]; EU DG MARE (SafeNet project) [MARE 2014/41]; Pierre and Marie Curie University (PDI-MSC); Conicyt Basal [0002]	Agence Nationale de la Recherche ANR(French National Research Agency (ANR)); Fondation de France (INTHENSE project); EU DG-MARE (SafeNet project); Universite Pierre et Marie Curie-Institut de Recherche et de Developpement: Programme Doctoral International: Modelisation des Systemes Complexes (PDI MSC); Fondation de France (INTHENSE); ANR(French National Research Agency (ANR)); EU DG MARE (SafeNet project); Pierre and Marie Curie University (PDI-MSC); Conicyt Basal	This work was supported by the Agence Nationale de la Recherche ANR (ANR-14-CE03-0001-01): http://www.agence-nationale-recherche.fr; the Fondation de France (INTHENSE project): http://www.fondationdefrance.org; the EU DG-MARE (SafeNet project, MARE 2014/41): http://ec.europa.eu/dgs/maritimeaffairs_fisheries/index_en.htm; the Universite Pierre et Marie Curie-Institut de Recherche et de Developpement: Programme Doctoral International: Modelisation des Systemes Complexes (PDI MSC): http//www.pdmsc.upmc.fr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by Fondation de France (INTHENSE), ANR (ANR-14-CE03-0001-01) and EU DG MARE (SafeNet project, MARE 2014/41). LT fellowship was funded by Pierre and Marie Curie University (PDI-MSC). SG thanks the support of Conicyt Basal 0002. We are grateful to Julien Vucher-Visin and Sebastien Merceron from ISPF for providing population census data and kindly helping us with data interpretation and analysis. Service d'Observation CORAIL from CRIOBE kindly provided the ecological monitoring data. We thank Sebastian Ferse, Annette Breckwoldt and an anonymous reviewer for constructive comments that helped improve an earlier version of this manuscript.	Agrawal A, 2002, INT SOC SCI J, V54, P287, DOI 10.1111/1468-2451.00382; Albert S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130800; Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; [Anonymous], 2014, R LANG ENV STAT COMP; Aswani S, 2006, HUM ORGAN, V65, P81, DOI 10.17730/humo.65.1.4y2q0vhe4l30n0uj; B en e, 2006, 1008 FAO, V1008, P57; Ban NC, 2009, MAR POLICY, V33, P794, DOI 10.1016/j.marpol.2009.02.011; Bana E, 1994, INT T OPER RES, V1, P489, DOI [DOI 10.1016/0969-6016(94)90010-8, 10.1111/j.1475-3995.1994.00325.x]; Basurto X, 2013, GLOBAL ENVIRON CHANG, V23, P1366, DOI 10.1016/j.gloenvcha.2013.08.001; Bell ML, 2001, J MULTICRITERIA DECI, V10, P229, DOI DOI 10.1002/MCDA.305; Bene C., 2007, FAO Fisheries Technical Paper; Bennett E, 2001, MAR POLICY, V25, P365, DOI 10.1016/S0308-597X(01)00022-7; Berkes F., 2003, NAVIGATING SOCIAL EC, V1, P30; Berkes F., 2001, MANAGING SMALL SCALE; Bivand R, 2016, RGDAL BINDINGS GEOS; Bremer A, 2013, NATURES SCI SOC, V21, P293; Brown G, 2012, SOC NATUR RESOUR, V25, P633, DOI 10.1080/08941920.2011.621511; Campaner A, 2010, ESSAI AIDE GESTION I; Carvalho N, 2011, FISH RES, V109, P360, DOI 10.1016/j.fishres.2011.03.006; Cinner JE, 2006, ENVIRON CONSERV, V33, P73, DOI 10.1017/S0376892906002748; Cinner JE, 2012, GLOBAL ENVIRON CHANG, V22, P12, DOI 10.1016/j.gloenvcha.2011.09.018; Cinner JE, 2011, GLOBAL ENVIRON CHANG, V21, P835, DOI 10.1016/j.gloenvcha.2011.04.012; Cinner JE, 2009, ENVIRON CONSERV, V36, P321, DOI 10.1017/S0376892910000123; Collin A, 2015, CMN24 ICES, V24; Daw T, 2011, ENVIRON CONSERV, V38, P370, DOI 10.1017/S0376892911000506; Daw TM, 2008, FISH RES, V90, P17, DOI 10.1016/j.fishres.2007.09.027; Daw TM, 2011, SPATIAL BEHAV ARTISA, P1; Di Maida G, 2011, ICES J MAR SCI, V68, P12, DOI 10.1093/icesjms/fsq130; DuBois C, 2012, MAR POLICY, V36, P1211, DOI 10.1016/j.marpol.2012.03.007; FAOTEDTER, 2007, SMALL SCAL FISH; Feral F, EAU PACIFIQUE ENTRE; Figueira J, 2005, INT SER OPER RES MAN, V78, P1, DOI 10.1007/b100605; GALZIN R, 1987, MAR ECOL PROG SER, V41, P137, DOI 10.3354/meps041137; GALZIN R, 1987, MAR ECOL PROG SER, V41, P129, DOI 10.3354/meps041129; Gaspar C., 2008, J SOC OCEANISTES, V127, P231, DOI [10.4000/jso.2462, DOI 10.4000/JSO.2462]; Grantham HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011430; Insee-ISPF, 2012, REC POP; Insee-ISPF, 2007, REC POP; Jacquet J, 2008, CONSERV BIOL, V22, P832, DOI 10.1111/j.1523-1739.2008.00978.x; Jones JPG, 2008, J APPL ECOL, V45, P1205, DOI 10.1111/j.1365-2664.2008.01487.x; Kavadas S, 2015, MULTICRITERIA DECISI, P294; Kenny AJ, 2003, ICES J MAR SCI, V60, P411, DOI 10.1016/S1054-3139(03)00006-7; Kittinger JN, 2013, CURR OPIN ENV SUST, V5, P352, DOI 10.1016/j.cosust.2013.06.008; Kittinger JN, 2013, PAC SCI, V67, P315, DOI 10.2984/67.3.1; Knudby A, 2007, PROG PHYS GEOG, V31, P421, DOI 10.1177/0309133307081292; Leenhardt P, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00070; Leenhardt P, 2015, OCEAN COAST MANAGE, V115, P49, DOI 10.1016/j.ocecoaman.2015.04.018; Leopold M, 2014, ICES J MAR SCI, V71, P1781, DOI 10.1093/icesjms/fst204; Levine AS, 2015, APPL GEOGR, V59, P60, DOI 10.1016/j.apgeog.2014.12.004; Lynham J, 2017, MAR POLICY, V76, P122, DOI 10.1016/j.marpol.2016.11.011; Maurstad A, 2002, MAR POLICY, V26, P159, DOI 10.1016/S0308-597X(01)00045-8; Mazor T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104489; McCluskey SM, 2008, FISH FISH, V9, P188, DOI 10.1111/j.1467-2979.2008.00283.x; McConney P., 2008, HDB MARINE FISHERIES; Metcalfe K, 2016, CONSERV LETT, P1; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Pollnac RB, 2008, HUM ECOL REV, V15, P194; Pomeroy R, 2008, MAR POLICY, V32, P816, DOI 10.1016/j.marpol.2008.03.017; Pomeroy RS, 2012, MAR POLICY, V36, P520, DOI 10.1016/j.marpol.2011.10.002; Pressey RL, 2001, CONSERV BIOL, V15, P275, DOI 10.1046/j.1523-1739.2001.99541.x; Ramirez-Gomez SOI, 2016, J NAT CONSERV, V29, P69, DOI 10.1016/j.jnc.2015.11.004; Saaty TL., 2008, INT J SERV SCI, V1, P2008, DOI [DOI 10.1504/IJSSCI.2008.017590, 10.1504/IJSSCI.2008.017590]; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Scholz AJ, 2011, CONSERV BIOL, V25, P485, DOI 10.1111/j.1523-1739.2010.01626.x; Shester GG, 2011, BIOL CONSERV, V144, P1673, DOI 10.1016/j.biocon.2011.02.023; Site P.D., 2009, EUR TRANSP RES REV, V1, P199, DOI [10.1007/s12544-009-0018-1, DOI 10.1007/S12544-009-0018-1]; Stelzenmuller V, 2008, MAR POLLUT BULL, V56, P2018, DOI 10.1016/j.marpolbul.2008.08.006; Stewart KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014451; Stobutzki IC, 2006, FISH RES, V78, P109, DOI 10.1016/j.fishres.2006.02.002; Thiault L., 2014, EVALUATION ECOLOGIQU; Tunstall J, 1969, FISHERMEN SOCIOLOGY; Urquhart J, 2014, SOC NATUR RESOUR, V27, P3, DOI 10.1080/08941920.2013.820811; van Ginkel R., 2001, INSHORE FISHERIES MA, P177, DOI [10.1007/978-94-017-1892-9_10, DOI 10.1007/978-94-017-1892-9_10]; von Winterfeldt D., 1986, DECISION ANAL BEHAV; Walker BLE, 2009, GENDER PLACE CULT, V16, P467, DOI 10.1080/09663690903003983; Walker BLE, 2001, IN PAC REG M INT ASS, P1; Weeks R, 2014, F1000RESEARCH, V3; Weeks R, 2010, BIOL CONSERV, V143, P1236, DOI 10.1016/j.biocon.2010.02.031; Wynne SP, 2007, J APPL ECOL, V44, P488, DOI 10.1111/j.1365-2664.2007.01312.x; Yates KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068424; Zeller D., 2006, MAR RES EC, V21, P355, DOI [DOI 10.1086/MRE.21.4.42629521, 10.1086/mre.21.4.42629521]	82	36	37	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176862	10.1371/journal.pone.0176862	http://dx.doi.org/10.1371/journal.pone.0176862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UM	28486509	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314000027
J	Pal, P; Balaban, AE; Diamond, MS; Sinnis, P; Klein, RS; Goldberg, DE				Pal, Priya; Balaban, Amanda E.; Diamond, Michael S.; Sinnis, Photini; Klein, Robyn S.; Goldberg, Daniel E.			Plasmodium falciparum histidine-rich protein II causes vascular leakage and exacerbates experimental cerebral malaria in mice	PLOS ONE			English	Article							CHILDREN; MODELS	A devastating complication of Plasmodium falciparum infection is cerebral malaria, in which vascular leakage and cerebral swelling lead to coma and often death. P. falciparum produces a protein called histidine-rich protein II (HRPII) that accumulates to high levels in the bloodstream of patients and serves as a diagnostic and prognostic marker for falciparum malaria. Using a human cerebral microvascular endothelial barrier model, we previously found that HRPII activates the endothelial cell inflammasome, resulting in decreased integrity of tight junctions and increased endothelial barrier permeability. Here, we report that intravenous administration of HRPII induced blood-brain barrier leakage in uninfected mice. Furthermore, HRPII infusion in P. berghei-infected mice increased early mortality from experimental cerebral malaria. These data support the hypothesis that HRPII is a virulence factor that contributes to cerebral malaria by compromising the integrity of the blood-brain barrier.	[Pal, Priya; Diamond, Michael S.; Klein, Robyn S.; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; [Pal, Priya; Diamond, Michael S.; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Balaban, Amanda E.; Sinnis, Photini] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Balaban, Amanda E.; Sinnis, Photini] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Malaria Res Inst, Baltimore, MD USA; [Diamond, Michael S.; Klein, Robyn S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Washington University (WUSTL); Washington University (WUSTL)	Goldberg, DE (corresponding author), Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA.; Goldberg, DE (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	dgoldberg@wustl.edu	Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165	National Institute of Allergy and Infectious Diseases [R01 AI26909, R01 AI056840]; National Institute of Heart, Lung and Blood [F30 HL119031]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056840, T32AI007172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052632] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Heart, Lung and Blood(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Allergy and Infectious Diseases (DEG) R01 AI26909; National Institute of Allergy and Infectious Diseases (PS) R01 AI056840; and National Institute of Heart, Lung and Blood (PP) F30 HL119031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas S, 2005, ANN TROP MED PARASIT, V99, P553, DOI 10.1179/136485905X51463; Craig AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002401; Cruz-Orengo L, 2014, J CLIN INVEST, V124, P2571, DOI 10.1172/JCI73408; de Oca Marcela Montes, 2013, Methods Mol Biol, V1031, P203, DOI 10.1007/978-1-62703-481-4_23; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; de Souza JB, 2002, MICROBES INFECT, V4, P291, DOI 10.1016/S1286-4579(02)01541-1; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Gething PW, 2016, NEW ENGL J MED, V375, P2435, DOI 10.1056/NEJMoa1606701; Howland SW, 2013, EMBO MOL MED, V5, P984, DOI 10.1002/emmm.201202273; Medana IM, 2001, IMMUNOL CELL BIOL, V79, P101, DOI 10.1046/j.1440-1711.2001.00995.x; Moxon CA, 2014, J INFECT DIS, V209, P610, DOI 10.1093/infdis/jit419; Ndonwi M, 2011, BLOOD, V117, P6347, DOI 10.1182/blood-2010-12-326876; Pal P, 2016, MBIO, V7, DOI 10.1128/mBio.00617-16; PARRA ME, 1991, J CLIN MICROBIOL, V29, P1629, DOI 10.1128/JCM.29.8.1629-1634.1991; Riley EM, 2010, TRENDS PARASITOL, V26, P277, DOI 10.1016/j.pt.2010.03.002; Seydel KB, 2015, NEW ENGL J MED, V372, P1126, DOI 10.1056/NEJMoa1400116; Swarthout TD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-58; White NJ, 2010, TRENDS PARASITOL, V26, P11, DOI 10.1016/j.pt.2009.10.007	18	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177142	10.1371/journal.pone.0177142	http://dx.doi.org/10.1371/journal.pone.0177142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475625	gold, Green Published, Green Submitted			2022-12-27	WOS:000400649500051
J	Huth, S; Reverey, JF; Leippe, M; Selhuber-Unkel, C				Huth, Steven; Reverey, Julia F.; Leippe, Matthias; Selhuber-Unkel, Christine			Adhesion forces and mechanics in mannose-mediated acanthamoeba interactions	PLOS ONE			English	Article							BINDING PROTEIN; CELL-ADHESION; IN-VITRO; PATHOGENIC ACANTHAMOEBA; CONTACT-LENSES; KERATITIS; CASTELLANII; DISEASE; AMEBAS; SOFT	The human pathogenic amoeba Acanthamoeba castellanii (A. castellanii) causes severe diseases, including acanthamoeba keratitis and encephalitis. Pathogenicity arises from the killing of target-cells by an extracellular killing mechanism, where the crucial first step is the formation of a close contact between A. castellanii and the target-cell. This process is mediated by the glycocalix of the target-cell and mannose has been identified as key mediator. The aim of the present study was to carry out a detailed biophysical investigation of mannose-mediated adhesion of A. castellanii using force spectroscopy on single trophozoites. In detail, we studied the interaction of a mannose-coated cantilever with an A. castellanii trophozoite, as mannose is the decisive part of the cellular glycocalix in mediating pathogenicity. We observed a clear increase of the force to initiate cantilever detachment from the trophozoite with increasing contact time. This increase is also associated with an increase in the work of detachment. Furthermore, we also analyzed single rupture events during the detachment process and found that single rupture processes are associated with membrane tether formation, suggesting that the cytoskeleton is not involved in mannose binding events during the first few seconds of contact. Our study provides an experimental and conceptual basis for measuring interactions between pathogens and target-cells at different levels of complexity and as a function of interaction time, thus leading to new insights into the biophysical mechanisms of parasite pathogenicity.	[Huth, Steven; Reverey, Julia F.; Selhuber-Unkel, Christine] Christian Albrecht Univ Kiel, Inst Mat Sci Biocompatible Nanomat, Kaiserstr 2, D-24143 Kiel, Germany; [Leippe, Matthias] Christian Albrecht Univ Kiel, Zool Inst, Comparat Immunobiol, Botanischen Garten 1-9, D-24118 Kiel, Germany	University of Kiel; University of Kiel	Selhuber-Unkel, C (corresponding author), Christian Albrecht Univ Kiel, Inst Mat Sci Biocompatible Nanomat, Kaiserstr 2, D-24143 Kiel, Germany.	cse@tf.uni-kiel.de	Leippe, Matthias/AAP-1677-2020; Selhuber-Unkel, Christine/D-9715-2016	Selhuber-Unkel, Christine/0000-0002-5051-4822	DFG [SE-1801/2-1]; ERC [336104]	DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	C. S., J. F. R. and S. H. acknowledge support from the DFG through the Emmy Noether program (grant SE-1801/2-1), as well as from the ERC (Starting grant no. 336104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C. S., J. F. R. and S. H. acknowledge support from the DFG through the Emmy Noether program (grant SE-1801/2-1), as well as from the ERG (Starting grant no. 336104). We further acknowledge Constanze Lamprecht for her support with the AFM and Manuela Lieb for support in the lab.	Benoit M, 2011, METHODS MOL BIOL, V736, P355, DOI 10.1007/978-1-61779-105-5_21; Cao ZY, 1998, J BIOL CHEM, V273, P15838, DOI 10.1074/jbc.273.25.15838; Caumo K, 2011, ACANTHAMOEBA T3 T4 T; DART JKG, 1991, LANCET, V338, P650, DOI DOI 10.1016/0140-6736(91)91231-I; Dufour AC, 2015, SEMIN CELL DEV BIOL, V46, P128, DOI 10.1016/j.semcdb.2015.10.010; Friedrichs J, 2013, METHODS, V60, P169, DOI 10.1016/j.ymeth.2013.01.006; Garate M, 2006, INVEST OPHTH VIS SCI, V47, P1056, DOI 10.1167/iovs.05-0477; Garate M, 2004, J BIOL CHEM, V279, P29849, DOI 10.1074/jbc.M402334200; GORDON VR, 1993, INVEST OPHTH VIS SCI, V34, P658; Gutekunst SB, 2014, BEILSTEIN J NANOTECH, V5, P1393, DOI 10.3762/bjnano.5.152; Ithoi I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024327; Kadem LF, 2016, ADV MATER, V28, P1799, DOI 10.1002/adma.201504394; Khan, 2009, ACANTHAMOEBA BIOL PA; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; Kim JH, 2012, EXP PARASITOL, V132, P287, DOI 10.1016/j.exppara.2012.08.007; Klink F, 1993, INVEST OPHTH VIS SCI, V34, P1937; LARKIN DFP, 1990, BRIT J OPHTHALMOL, V74, P133, DOI 10.1136/bjo.74.3.133; Leher H, 1998, INFECT IMMUN, V66, P5, DOI 10.1128/IAI.66.1.5-10.1998; Li Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep30452; Lorenzo-Morales J, 2013, TRENDS PARASITOL, V29, P181, DOI 10.1016/j.pt.2013.01.006; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Martinez AJ, 1997, BRAIN PATHOL, V7, P583, DOI 10.1111/j.1750-3639.1997.tb01076.x; Michalek M, 2013, NAT CHEM BIOL, V9, P37, DOI [10.1038/NCHEMBIO.1116, 10.1038/nchembio.1116]; Michel R, 2004, ACTA PROTOZOOL, V43, P37; MOORE MB, 1987, OPHTHALMOLOGY, V94, P1654, DOI 10.1016/S0161-6420(87)33238-5; Niederkorn JY, 1999, MICROBES INFECT, V1, P437, DOI 10.1016/S1286-4579(99)80047-1; Panjwani N, 2010, OCUL SURF, V8, P70, DOI 10.1016/S1542-0124(12)70071-X; Ralston KS, 2014, NATURE, V508, P526, DOI 10.1038/nature13242; Reverey JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11690; Reverey JF, 2014, CONTACT LENS ANTERIO, V37, P262, DOI 10.1016/j.clae.2013.11.010; Sariisik E, 2015, BIOPHYS J, V109, P1330, DOI 10.1016/j.bpj.2015.07.048; Selhuber-Unkel C, 2008, BIOPHYS J, V95, P5424, DOI 10.1529/biophysj.108.139584; Sharma S, 2000, BRIT J OPHTHALMOL, V84, P1103, DOI 10.1136/bjo.84.10.1103; Yang Z, 1997, INVEST OPHTHALMOL, V38, P439	34	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176207	10.1371/journal.pone.0176207	http://dx.doi.org/10.1371/journal.pone.0176207			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472161	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500028
J	Kachaamy, T; Gupta, D; Edwin, P; Vashi, P				Kachaamy, Toufic; Gupta, Digant; Edwin, Persis; Vashi, Pankaj			Safety of endoscopy in cancer patients on antiangiogenic agents: A retrospective multicenter outcomes study	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; WOUND-HEALING COMPLICATIONS; CELL LUNG-CANCER; PHASE-3 TRIAL; DOUBLE-BLIND; BEVACIZUMAB; PERFORATION; RECOMMENDATIONS; CHEMOTHERAPY; METAANALYSIS	Background/Aims The use of antiangiogenic agents (AAs) in cancer treatment has increased because they offer survival benefit in combination with cytotoxic chemotherapy. Given their potential to cause gastrointestinal (GI) perforation and bleeding, it is currently recommended that AAs be held for 28 days before and after surgery. However, there are no specific guidelines which address their use around endoscopic procedures because data regarding the safety of endoscopy in cancer patients while on AAs is scarce despite the fact that these patients often require endoscopy. This study investigated the safety of endoscopy in cancer patients receiving AAs. Methods This is a retrospective multicenter study of a consecutive case series of 445 cancer patients undergoing endoscopy within 31 days of administration of AAs at 5 specialized cancer centers between April 2008 and August 2014. Endoscopies were classified into two different categories based on the risk of GI bleeding and perforation: low and high. The primary outcome measures were procedure-related adverse events (AEs) and death within 30 days of endoscopy. The severity of AEs was classified according to the common terminology criteria for adverse events (CTCAE) version 4.0. The incidence of AEs and mortality was calculated using the total number of patients as the denominator. Results 445 cancer patients with a mean age of 54 years underwent a total of 545 endoscopies. Median time duration from AAs to endoscopy was 11 days. Of 545 endoscopic procedures, 398 (73%) were low-risk and 147 (27%) were high-risk. There were 3 procedure-related AEs: esophageal perforation (grade 3) two days after an EGD, pancreatitis (grade 5) a day after failed ERCP, and bleeding from the gastrostomy site (grade 1) two days after an EGD. Of 445 patients, 29 (6.5%) died within 30 days of the procedure with no deaths deemed procedure-related. The most common causes of death were terminal cancer (n = 10), hepatic decompensation (n = 5) and sepsis (n = 4). Conclusion In this retrospective study, the rate of endoscopy-related AEs in patients on AAs appears to be low when performed in specialized cancer centers. However, future prospective studies are needed to confirm this finding.	[Kachaamy, Toufic; Gupta, Digant; Edwin, Persis; Vashi, Pankaj] Canc Treatment Ctr Amer, 5900 Broken Sound Pkwy, Boca Raton, FL 33487 USA		Gupta, D (corresponding author), Canc Treatment Ctr Amer, 5900 Broken Sound Pkwy, Boca Raton, FL 33487 USA.	digant.gupta@ctca-hope.com	GUPTA, DIGANT/ABA-9729-2020	GUPTA, DIGANT/0000-0002-1963-8886	Cancer Treatment Centers of America	Cancer Treatment Centers of America	This work was supported by Cancer Treatment Centers of America.	Acosta RD, 2016, GASTROINTEST ENDOSC, V83, P3, DOI 10.1016/j.gie.2015.09.035; Bear HD, 2012, NEW ENGL J MED, V366, P310, DOI 10.1056/NEJMoa1111097; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Cao D, 2015, TUMORI J, V101, P46, DOI 10.5301/tj.5000211; Cohen R, 2009, FUTURE ONCOL, V5, P915, DOI 10.2217/FON.09.63; Cordon CR, 2009, ANN PLAS SURG, V62, P707, DOI 10.1097/SAP.0b013e3181828141; D'Angelica M, 2007, ANN SURG ONCOL, V14, P759, DOI 10.1245/s10434-006-9074-0; Elice F, 2012, THROMB RES, V129, pS50, DOI 10.1016/S0049-3848(12)70016-6; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Gounant V, 2009, REV MAL RESPIR, V26, P221, DOI 10.1016/S0761-8425(09)71598-0; Hang XF, 2011, EUR J CLIN PHARMACOL, V67, P613, DOI 10.1007/s00228-010-0988-x; Herbst RS, 2007, J CLIN ONCOL, V25, P4743, DOI 10.1200/JCO.2007.12.3026; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Hong SD, 2015, J CANCER RES CLIN, V141, P909, DOI 10.1007/s00432-014-1862-5; Huang HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089960; Imbulgoda A, 2015, CAN J SURG, V58, P167, DOI 10.1503/cjs.013014; Kesmodel SB, 2008, J CLIN ONCOL, V26, P5254, DOI 10.1200/JCO.2008.17.7857; Manes G, 2011, ARCH SURG-CHICAGO, V146, P1157, DOI 10.1001/archsurg.2011.233; Saif MW, 2007, ANN SURG ONCOL, V14, P1860, DOI 10.1245/s10434-006-9337-9; Scappaticci FA, 2005, J SURG ONCOL, V91, P173, DOI 10.1002/jso.20301; Sharma K, 2013, ANN PLAS SURG, V71, P434, DOI 10.1097/SAP.0b013e31824e5e57; Tol J, 2008, INVEST NEW DRUG, V26, P393, DOI 10.1007/s10637-008-9125-4; van Halsema EE, 2014, GASTROINTEST ENDOSC, V79, P970, DOI 10.1016/j.gie.2013.11.038; Walraven M, 2011, ANGIOGENESIS, V14, P135, DOI 10.1007/s10456-010-9197-6	24	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176899	10.1371/journal.pone.0176899	http://dx.doi.org/10.1371/journal.pone.0176899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472195	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500094
J	Kiss, T; Szabo, A; Oszlanczi, G; Lukacs, A; Timar, Z; Tiszlavicz, L; Csupor, D				Kiss, Tivadar; Szabo, Andrea; Oszlanczi, Gabor; Lukacs, Anita; Timar, Zoltan; Tiszlavicz, Laszlo; Csupor, Dezso			Repeated-dose toxicity of common ragweed on rats	PLOS ONE			English	Article							AMBROSIA-ARTEMISIIFOLIA L.; SPECIES-MEDIATED APOPTOSIS; SESQUITERPENE LACTONES; INULA-HELENIUM; IN-VITRO; NRF2-MEDIATED INDUCTION; CHEMICAL-COMPOSITION; DETOXIFYING ENZYMES; TRYPANOSOMA-CRUZI; PSILOSTACHYIN-C	Ambrosia artemisiifolia L. is an invasive species with highly allergenic pollens. Ragweed originates from North America, but it also occurs and is spreading in Europe, causing seasonal allergic rhinitis for millions of people. Recently, the herb of A. artemisiifolia has gained popularity as medicinal plant and food. The effects of its long-term intake are unknown; there are no toxicological data to support the safe use of this plant. The aim of our study was to assess the repeated dose toxicity of A. artemisiifolia on animals. Ragweed puree was administered in low dose (500 mg/kg b. w.) and high dose (1000 mg/kg b. w.) to male Wistar rats according to 407 OECD Guidelines for the Testing of Chemicals. Clinical symptoms, various blood chemical parameters, body weight and organ weights of the rats were measured. Reduced liver function enzymes (AST, ALT), reduced triglyceride level in the low dose and increased carbamide level in the high dose group were observed. The weight of the liver relative to body weight was significantly reduced in both groups, while the brain weight relative to body weight was significantly elevated in both groups. According to our results, the repeated use of ragweed resulted in toxic effects in rats and these results question the safety of long-term human consumption of common ragweed.	[Kiss, Tivadar; Csupor, Dezso] Univ Szeged, Fac Pharm, Dept Pharmacognosy, Szeged, Hungary; [Kiss, Tivadar; Szabo, Andrea; Lukacs, Anita; Csupor, Dezso] Univ Szeged, Interdisciplinary Ctr Nat Prod, Szeged, Hungary; [Szabo, Andrea; Oszlanczi, Gabor; Lukacs, Anita] Univ Szeged, Fac Med, Dept Publ Hlth, Szeged, Hungary; [Timar, Zoltan] SOLVO Biotechnol, Szeged, Hungary; [Tiszlavicz, Laszlo] Univ Szeged, Fac Med, Dept Pathol, Szeged, Hungary	Szeged University; Szeged University; Szeged University; Szeged University	Csupor, D (corresponding author), Univ Szeged, Fac Pharm, Dept Pharmacognosy, Szeged, Hungary.; Csupor, D (corresponding author), Univ Szeged, Interdisciplinary Ctr Nat Prod, Szeged, Hungary.	csupor.dezso@pharm.u-szeged.hu	Csupor, Dezso/B-2952-2009; Kiss, Tivadar/L-3233-2013; Csupor, Dezső/ABE-1830-2021	Csupor, Dezso/0000-0002-4088-3333; Kiss, Tivadar/0000-0003-3538-377X; Csupor, Dezső/0000-0002-4088-3333; Lukacs, Anita/0000-0002-0746-8920; Timar, Zoltan/0000-0003-0316-9947	European Union and the State of Hungary; European Social Fund [TAMOP 4.2.4A/2-11-1-2012-0001]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; National Research, Development and Innovation Office [115796]; SOLVO Biotechnology;  [GINOP-2.3.2-15-2016-00012]	European Union and the State of Hungary; European Social Fund(European Social Fund (ESF)); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); SOLVO Biotechnology; 	This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4A/2-11-1-2012-0001 'National Excellence Program'. This paper was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, the National Research, Development and Innovation Office (115796) and the project GINOP-2.3.2-15-2016-00012 (New ways in the natural product-based drug discovery system metabolomic approaches to discover biologically active terpenoids of herbal and microbial origin). The funder SOLVO Biotechnology provided support in the form of salaries for author ZT. The specific roles of the author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11-1-2012-0001 'National Excellence Program'. This paper was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, the National Research, Development and Innovation Office (115796) and the project GINOP-2.3.2-15-2016-00012 (New ways in the natural product-based drug discovery-system metabolomic approaches to discover biologically active terpenoids of herbal and microbial origin). The funder SOLVO Biotechnology provided support in the form of salaries for author ZT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz M, 1991, ALEX J PHARM SCI, V5, P98; Abdelgaleil SAM, 2011, AFR J MICROBIOL RES, V5, P3385; AbouZid S, 2007, NAT PROD COMMUN, V2, P177; Amorim MHR, 2013, CRIT REV TOXICOL, V43, P559, DOI 10.3109/10408444.2013.813905; Aponte JC, 2010, PLANTA MED, V76, P705, DOI 10.1055/s-0029-1240681; ARNASON JT, 1985, J NAT PROD, V48, P581, DOI 10.1021/np50040a010; Bashir MEH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053337; BIANCHI E, 1968, AUST J CHEM, V21, P1109, DOI 10.1071/CH9681109; Blanco JG, 1997, FEBS LETT, V409, P396, DOI 10.1016/S0014-5793(97)00560-7; BLOSZYK E, 1992, COLLECT CZECH CHEM C, V57, P1092, DOI 10.1135/cccc19921092; Cai H, 2014, PHYTOTHER RES, V28, P1679, DOI 10.1002/ptr.5182; Cantrell CL, 1999, PLANTA MED, V65, P351, DOI 10.1055/s-1999-14001; [陈进军 Chen Jinjun], 2010, [癌变·畸变·突变, Carcinogenesis, Teratogenesis and Mutagenesis], V22, P440; Corbett A, 2012, LAB ANIM-UK, V46, P318, DOI 10.1258/la.2012.012018; Cotugno R, 2012, CELL PROLIFERAT, V45, P53, DOI 10.1111/j.1365-2184.2011.00796.x; Csubak M., 2012, PARAMEDICA, V8; Csupor-Loffler B, 2009, PHYTOTHER RES, V23, P672, DOI 10.1002/ptr.2697; da Silva CF, 2013, ANTIMICROB AGENTS CH, V57, P5307, DOI 10.1128/AAC.00595-13; David JP, 1999, PHARM BIOL, V37, P165, DOI 10.1076/phbi.37.2.165.6077; de Oliveira RB, 2011, J ETHNOPHARMACOL, V133, P434, DOI 10.1016/j.jep.2010.10.019; Ding WB, 2015, MOLECULES, V20, P4450, DOI 10.3390/molecules20034450; Dirsch VM, 2001, PLANTA MED, V67, P557, DOI 10.1055/s-2001-16478; Duan HuiPing, 2000, Acta Agriculturae Shanghai, V16, P73; El Kelish A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-176; Elufioye TO, 2009, J ETHNOPHARMACOL, V122, P410, DOI 10.1016/j.jep.2008.12.007; Ene-ojo AS, 2013, INT J BIOCH REREV, V3, P119; Essl F, 2015, J ECOL, V103, P1069, DOI 10.1111/1365-2745.12424; Foster S., 2000, FIELD GUIDE MED PLAN, V2nd ed.; Gattone VH, 2004, ANAT REC PART A, V277A, P384, DOI 10.1002/ar.a.20022; Gerber E, 2011, WEED RES, V51, P559, DOI 10.1111/j.1365-3180.2011.00879.x; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Gilmore MR., 1913, COLLECTIONS NEBRASKA, V17, P358; Gowda S, 2009, PAN AFR MED J, V3, P1; Green D., RAGWEED; Hamel P.B., 1975, CHEROKEE PLANTS THEI; He Q, 2014, J CHEM-NY, V2014, DOI 10.1155/2014/738796; Herrick JW, 1977, IROQUOIS MED NOTANY; HERZ W, 1961, J ORG CHEM, V26, P5011, DOI 10.1021/jo01070a056; Heyl FW, 1917, J AM CHEM SOC, V39, P1470, DOI 10.1021/ja02252a022; ISSG, 2010, AMBR ART HERB; KELSEY RG, 1973, PHYTOCHEMISTRY, V12, P1345, DOI 10.1016/0031-9422(73)80562-X; Khan M, 2012, INT J BIOL SCI, V8, P533, DOI 10.7150/ijbs.3753; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KING TP, 1964, BIOCHEMISTRY-US, V3, P458, DOI 10.1021/bi00891a026; Kiss T, 2012, GYOGYSZERESZET, V56, P560; Konishi T, 2002, BIOL PHARM BULL, V25, P1370, DOI 10.1248/bpb.25.1370; Kumar A, 2016, PHYTOCHEM LETT, V18, P117, DOI 10.1016/j.phytol.2016.09.004; Lake IR, 2016, ENV HLTH PERSPECT; Lastra AL, 2004, J ETHNOPHARMACOL, V95, P221, DOI 10.1016/j.jep.2004.07.020; Lawrence NJ, 2001, BIOORG MED CHEM LETT, V11, P429, DOI 10.1016/S0960-894X(00)00686-7; Leach MC, 2010, LAB ANIM-UK, V44, P54, DOI 10.1258/la.2009.009029; Leiblein M.C., 2013, ISRN ECOL, V2013, DOI [10.1155/2013/610126, DOI 10.1155/2013/610126]; Li M, 2013, HEBEI YIKE DAXUE XUE, V34, P869; Li M, 2013, TIANRAN CHANWU YANJI, V25, P529; [李明 Li Ming], 2013, [天然产物研究与开发, Natural Product R & D], V25, P555; Li Y, 2006, J NAT PROD, V69, P616, DOI 10.1021/np050480d; Li Y, 2010, ZHONG CAO YAO, V41, P1336; Li Y, 2012, Z NATURFORSCH C, V67, P375; Li Yong, 2010, Zhongguo Yaolixue Tongbao, V26, P112; Li ZL, 2016, ARCH PHARM RES, V39, P1441, DOI 10.1007/s12272-016-0815-8; Liu CH, 2001, CHINESE SCI BULL, V46, P498, DOI 10.1007/BF03187267; Mahesh A, 2010, ACTA BIOL HUNG, V61, P175, DOI 10.1556/ABiol.61.2010.2.6; Martino R, 2015, TOXICOL IN VITRO, V29, P1529, DOI 10.1016/j.tiv.2015.06.011; Milosavljevic S, 1999, J SERB CHEM SOC, V64, P397; Moller H, 2002, CONTACT DERMATITIS, V47, P157, DOI 10.1034/j.1600-0536.2002.470306.x; NARASIMHAN TR, 1985, PLANTA MED, V51, P194, DOI 10.1055/s-2007-969454; Nirogi R, 2014, INT J PHARM SCI RES, V5, P1525, DOI 10.13040/IJPSR.0975-8232.5(4).1525-32; Noori A, 2014, AVICENNA J PHYTOMEDI, V4, P371; OECD, 2008, TEST NO 407 REP DOS; Ognjenovic J, 2013, VET IMMUNOL IMMUNOP, V155, P38, DOI 10.1016/j.vetimm.2013.06.005; Parkhomenko A.Y., 2006, PHARM CHEM J, V40, P627, DOI DOI 10.1007/S11094-006-0208-2; Parkhomenko A.Yu., 2005, PHARM CHEM J+, V39, P149, DOI [10.1007/s11094-005-0106-z, DOI 10.1007/S11094-005-0106-Z]; PAYNE WW, 1966, BRITTONIA, V18, P28, DOI 10.2307/2805107; Piao Y, 2013, J TOXICOL PATHOL, V26, P29, DOI 10.1293/tox.26.29; PICMAN AK, 1982, CONTACT DERMATITIS, V8, P294, DOI 10.1111/j.1600-0536.1982.tb04234.x; PORTER TH, 1969, PHYTOCHEMISTRY, V8, P793, DOI 10.1016/S0031-9422(00)85858-6; Ramesh C, 2004, ARKIVOC, V2003, P126; Rasul A, 2013, ARCH PHARM RES, V36, P1262, DOI 10.1007/s12272-013-0217-0; RASZEJA W, 1977, PLANTA MED, V32, P319, DOI 10.1055/s-0028-1097606; RODRIGUEZ E, 1976, EXPERIENTIA, V32, P236, DOI 10.1007/BF01937785; Romero JB., 1954, BOT LORE CALIFORNIA, P13; Rugutt JK, 1997, J AGR FOOD CHEM, V45, P4845, DOI 10.1021/jf970420g; Schomburg C, 2013, EUR J MED CHEM, V63, P313, DOI 10.1016/j.ejmech.2013.02.018; Seo JY, 2009, J MED FOOD, V12, P1038, DOI 10.1089/jmf.2009.0072; Seo JY, 2008, PHYTOTHER RES, V22, P1500, DOI 10.1002/ptr.2521; Solujic S, 2008, J SERB CHEM SOC, V73, P1039, DOI 10.2298/JSC0811039S; Speck F.G., 1941, PRIMITIVE MAN, V14, P49; STEFANOVIC M, 1987, PHYTOCHEMISTRY, V26, P850, DOI 10.1016/S0031-9422(00)84804-9; Stefanovic M, 1972, GLAS HEM DRUG BEOGRA, V37, P463; Stojanovic-Radic Z, 2012, EUR J CLIN MICROBIOL, V31, P1015, DOI 10.1007/s10096-011-1400-1; Sturgeon CM, 2005, PLANTA MED, V71, P938, DOI 10.1055/s-2005-873109; Sulsen VP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002494; Sulsen VP, 2011, LAT AM J PHARM, V30, P202; Sulsen VP, 2011, INT J ANTIMICROB AG, V37, P536, DOI 10.1016/j.ijantimicag.2011.02.003; Sulsen V., 2011, EVID BASED COMPLEMEN, P1; Sulsen V, 2010, MOLECULES, V15, P545, DOI 10.3390/molecules15010545; Sulsen VP, 2008, ANTIMICROB AGENTS CH, V52, P2415, DOI 10.1128/AAC.01630-07; Sulsen VP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150526; Szigetvari C, 2004, ZONNOVENYEK BIOL INV, P337; Taglialatela-Scafati O, 2012, EUR J ORG CHEM, V2012, P5162, DOI 10.1002/ejoc.201200650; Tantaquidgeon G., 1972, PENN HIST COMM ANTH, V3, P28; Tantaquidgeon G., 1942, STUDY DELAWARE INDIA; TORRANCE SJ, 1975, J PHARM SCI, V64, P887, DOI 10.1002/jps.2600640542; Venables L, 2016, S AFR J BOT, V103, P216, DOI 10.1016/j.sajb.2015.08.016; Villagomez R., 2014, J BIOMEDICAL SCI ENG, DOI DOI 10.4236/JBISE.2014.710083; Villagomez R, 2013, ANTICANCER RES, V33, P3799; Wan F., 1995, P 8 INT S BIOLOGICAL, P193; Wayne P, 2002, ANN ALLERG ASTHMA IM, V88, P279, DOI 10.1016/S1081-1206(10)62009-1; Wopfner N, 2009, MOL IMMUNOL, V46, P2090, DOI 10.1016/j.molimm.2009.02.005; Wu MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076000; Zhao F, 2016, PLANT CELL ENVIRON, V39, P147, DOI 10.1111/pce.12601	113	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176818	10.1371/journal.pone.0176818	http://dx.doi.org/10.1371/journal.pone.0176818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472131	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000400648500077
J	Bollum, LK; Huse, K; Oksvold, MP; Bai, BY; Hilden, VI; Forfang, L; Yoon, SO; Walchli, S; Smeland, EB; Myklebust, JH				Bollum, Lise K.; Huse, Kanutte; Oksvold, Morten P.; Bai, Baoyan; Hilden, Vera I.; Forfang, Lise; Yoon, Sun Ok; Walchli, Sebastien; Smeland, Erlend B.; Myklebust, June H.			BMP-7 induces apoptosis in human germinal center B cells and is influenced by TGF-beta receptor type I ALK5	PLOS ONE			English	Article							UP-REGULATION; HEMATOPOIETIC STEM; SMAD; DIFFERENTIATION; ACTIVATION; GROWTH; IL-21; PROLIFERATION; INHIBITION; INDUCTION	Selection and maturation of B cells into plasma cells producing high-affinity antibodies occur in germinal centers (GC). GCs form transiently in secondary lymphoid organs upon antigen challenge, and the GC reaction is a highly regulated process. TGF-beta is a potent negative regulator, but the influence of other family members including bone morphogenetic proteins (BMPs) is less known. Studies of human peripheral blood B lymphocytes showed that BMP-6 suppressed plasmablast differentiation, whereas BMP-7 induced apoptosis. Here, we show that human naive and GC B cells had a strikingly different receptor expression pattern. GC B cells expressed high levels of BMP type I receptor but low levels of type II receptors, whereas naive B cells had the opposite pattern. Furthermore, GC B cells had elevated levels of downstream signaling components SMAD1 and SMAD5, but reduced levels of the inhibitory SMAD7. Functional assays of GC B cells revealed that BMP-7 suppressed the viability-promoting effect of CD40L and IL-21, but had no effect on CD40L- and IL-21-induced differentiation into plasmablasts. BMP-7-induced apoptosis was counteracted by a selective TGF-beta type I receptor (ALK4/5/7) inhibitor, but not by a selective BMP receptor type I inhibitor. Furthermore, overexpression of truncated ALK5 in a B-cell line counteracted BMP-7-induced apoptosis, whereas overexpression of truncated ALK4 had no effect. BMP-7 mRNA and protein was readily detected in tonsillar B cells, indicating a physiological relevance of the study. Altogether, we identified BMP-7 as a negative regulator of GC B-cell survival. The effect was counteracted by truncated ALK5, suggesting greater complexity in regulating BMP-7 signaling than previously believed.	[Bollum, Lise K.; Huse, Kanutte; Oksvold, Morten P.; Bai, Baoyan; Hilden, Vera I.; Forfang, Lise; Walchli, Sebastien; Smeland, Erlend B.; Myklebust, June H.] Norwegian Radium Hosp, Inst Canc Res, Dept Canc Immunol, Oslo, Norway; [Bollum, Lise K.; Huse, Kanutte; Oksvold, Morten P.; Bai, Baoyan; Hilden, Vera I.; Forfang, Lise; Walchli, Sebastien; Smeland, Erlend B.; Myklebust, June H.] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Bollum, Lise K.] Univ Oslo, Fac Med, Oslo, Norway; [Yoon, Sun Ok] Ochsner Clin Fdn, Lab Cellular Immunol, New Orleans, LA USA; [Yoon, Sun Ok] Seoul Natl Univ, Transplantat Res Inst, Coll Med, Seoul, South Korea; [Walchli, Sebastien] Norwegian Radium Hosp, Dept Cellular Therapy, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Ochsner Health System; Seoul National University (SNU); University of Oslo	Myklebust, JH (corresponding author), Norwegian Radium Hosp, Inst Canc Res, Dept Canc Immunol, Oslo, Norway.; Myklebust, JH (corresponding author), Univ Oslo, Ctr Canc Biomed, Oslo, Norway.	junehm@rr-research.no	Myklebust, June Helen/ABH-6494-2020; Smeland, Erlend/AAO-3214-2020	Myklebust, June Helen/0000-0003-0394-9986; Huse, Kanutte/0000-0001-9128-670X; Walchli, Sebastien/0000-0001-5869-1746				Bakkebo M, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-57; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Borggrete I, 2016, BIOCHIM BIOPHYS ACTA, V1863, P303; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Camara-Clayette V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073993; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chen WJ, 2016, NAT REV IMMUNOL, V16, P723, DOI 10.1038/nri.2016.112; Ding BB, 2013, J IMMUNOL, V190, P1827, DOI 10.4049/jimmunol.1201678; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Fuchs O, 2002, BLOOD CELL MOL DIS, V28, P221, DOI 10.1006/bcmd.2002.0487; Ginkel FWv, 1999, J IMMUNOL, V163, P1951; Goldman DC, 2009, BLOOD, V114, P4393, DOI 10.1182/blood-2009-02-206433; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; Hildebrand L, 2017, CELL SIGNAL, V29, P23, DOI 10.1016/j.cellsig.2016.10.001; Holien T, 2012, LEUKEMIA, V26, P1073, DOI 10.1038/leu.2011.263; Holtzhausen A, 2014, FASEB J, V28, P1248, DOI 10.1096/fj.13-239178; Huse K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046117; Huse K, 2011, EUR J IMMUNOL, V41, P3135, DOI 10.1002/eji.201141558; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Kersten C, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-9; Kersten C, 2006, EXP HEMATOL, V34, P72, DOI 10.1016/j.exphem.2005.09.010; Khurana S, 2013, BLOOD, V121, P781, DOI 10.1182/blood-2012-07-446443; KIM HS, 1995, J IMMUNOL, V155, P1101; KIM HS, 1994, J IMMUNOL, V153, P2951; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Lagna G, 2006, AM J PHYSIOL-LUNG C, V291, pL1059, DOI 10.1152/ajplung.00180.2006; Lu Q, 2009, AM J PHYSIOL-LUNG C, V296, pL825, DOI 10.1152/ajplung.90307.2008; MartinezValdez H, 1996, J EXP MED, V183, P971, DOI 10.1084/jem.183.3.971; Miyazono K., 2002, SCI SIGNAL TRANSDUCT, V2002, pE40, DOI DOI 10.1126/3114E.2002.151.0E40; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Pene J, 2004, J IMMUNOL, V172, P5154, DOI 10.4049/jimmunol.172.9.5154; Pi WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035283; Piek E, 1999, J CELL SCI, V112, P4557; Recher M, 2011, BLOOD, V118, P6824, DOI 10.1182/blood-2011-06-362533; Ro TB, 2004, ONCOGENE, V23, P3024, DOI 10.1038/sj.onc.1207386; Seckinger A, 2009, ONCOGENE, V28, P3866, DOI 10.1038/onc.2009.257; Shimizu T, 2012, BIOCHEM BIOPH RES CO, V417, P869, DOI 10.1016/j.bbrc.2011.12.064; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; SMELAND EB, 1987, EXP CELL RES, V171, P213, DOI 10.1016/0014-4827(87)90264-3; Spender LC, 2009, CELL DEATH DIFFER, V16, P593, DOI 10.1038/cdd.2008.183; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Walchli S, 2011, PLOS ONE, V6; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Yang SX, 2006, CANCER RES, V66, P4285, DOI 10.1158/0008-5472.CAN-05-4456; Yang Y, 2009, MIDWEST SYMP CIRCUIT, P5, DOI 10.1109/MWSCAS.2009.5236167; Yoon SO, 2009, J IMMUNOL, V183, P352, DOI 10.4049/jimmunol.0803183; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002	55	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177188	10.1371/journal.pone.0177188	http://dx.doi.org/10.1371/journal.pone.0177188			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489883	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314100054
J	McDonald, AT; Gates, TA; Zanno, LE; Makovicky, PJ				McDonald, Andrew T.; Gates, Terry A.; Zanno, Lindsay E.; Makovicky, Peter J.			Anatomy, taphonomy, and phylogenetic implications of a new specimen of Eolambia caroljonesa (Dinosauria: Ornithopoda) from the Cedar Mountain Formation, Utah, USA	PLOS ONE			English	Article							CRETACEOUS KITADANI FORMATION; HADROSAUROID DINOSAUR; ORNITHISCHIA ORNITHOPODA; GROWTH DYNAMICS; DELAPPARENTIA-TUROLENSIS; JINZHOUSAURUS-YANGI; YIXIAN FORMATION; NORTH-AMERICA; CHINA; SPAIN	Background Eolambia caroljonesa is the most abundant dinosaur in the lower Cenomanian Mussentuchit Member of the Cedar Mountain Formation of Utah, and one of the most completely known non-hadrosaurid iguanodontians from North America. In addition to the large holotype and paratype partial skulls, copious remains of skeletally immature individuals, including three bonebeds, have been referred to E. caroljonesa. Nevertheless, aspects of the postcranial anatomy of this taxon, particularly the pelvic girdle, have remained ambiguous due to the lack of associated postcranial material of larger, more mature individuals. Methodology/Principal findings Here we describe a recently discovered associated partial postcranial skeleton of a large Eolambia caroljonesa. This specimen, FMNH PR 3847, provides new anatomical data regarding the vertebral column and pelvic girdle, supplementing previous diagnoses and descriptions of E. caroljonesa. A new phylogenetic analysis incorporating information from FMNH PR 3847 places E. caroljonesa as a basal hadrosauromorph closely related to Protohadros byrdi from the Cenomanian Woodbine Formation of Texas. Histological analysis of FMNH PR 3847 reveals that it represents a subadult individual eight to nine years of age. Taphonomic analysis indicates that FMNH PR 3847 was preserved in a crevasse splay deposit, along with an unusual abundance of small crocodylomorph material. Conclusions/Significance FMNH PR 3847 provides a wealth of new morphological data, adding to the anatomical and systematic characterization of Eolambia caroljonesa, and histological data, revealing new information on growth history in a basal hadrosauromorph. Taphonomic characterization of FMNH PR 3847 and associated vertebrate material will allow comparison with other vertebrate localities in the Mussentuchit Member of the Cedar Mountain Formation.	[McDonald, Andrew T.] St Louis Sci Ctr, St Louis, MO 63110 USA; [Gates, Terry A.; Zanno, Lindsay E.] North Carolina State Univ, Dept Biol Sci, Raleigh, NC USA; [Gates, Terry A.; Zanno, Lindsay E.] North Carolina Museum Nat Sci, Raleigh, NC USA; [Makovicky, Peter J.] Field Museum Nat Hist, Sect Earth Sci, Chicago, IL 60605 USA	Saint Louis University; University of North Carolina; North Carolina State University; Field Museum of Natural History (Chicago)	McDonald, AT (corresponding author), St Louis Sci Ctr, St Louis, MO 63110 USA.	andrew.mcdonald@slsc.org		Zanno, Lindsay/0000-0002-1654-1990	Jurassic Foundation; Evolving Earth Foundation; Utah Friends of Paleontology; University of Pennsylvania Paleobiology Summer Stipend; John Caldwell Meeker postdoctoral fellowship at The Field Museum [FMNH PR 3847]	Jurassic Foundation; Evolving Earth Foundation; Utah Friends of Paleontology; University of Pennsylvania Paleobiology Summer Stipend; John Caldwell Meeker postdoctoral fellowship at The Field Museum	TNT is provided free by the Willi Hennig Society. We thank Jim Kirkland and Martha Hayden of the Utah Geological Survey and Randall Irmis and Janaki Krishna of the Natural History Museum of Utah for assistance with permits. We are grateful to Akiko Shinya, Bill Simpson, Connie van Beek, Lisa Herzog, James Holstein, Debbie Wagner, Josh Ostergaard, Erin Fitzgerald, Christian Kammerer, Michael Eklund, Will Adams, Allie Weil, and Odin for excavation and fieldwork. Akiko Shinya, Kurt Zahnle, Tim Nelson, Lis Meeker, Eric Ahlgren, Steve Clawson, Debbie Wagner, Jim Holstein, Joanne Kluger, Bill Zandrew, Magdalena Garczynska, and Janice Kelly ably prepared the material described herein. ATM thanks the following people for access to specimens under their care: Carl Mehling (AMNH); Ted Daeschler (ANSP); Jeff Bartlett and John Bird (CEUM); Amy Henrici and Matt Lamanna (CM); Ken Carpenter (DMNS); Annelise Folie and Hugo du Potter (IRSNB); Steve Hutt (MIWG); Ronan Allain (MNHN); Robert McCord (MSM); Paul Barrett, Sandra Chapman, and Lorna Steel (NHMUK); Sally Shelton (SDSM); Louis Jacobs (SMU); Don DeBlieux, Jim Kirkland, and Scott Madsen (Utah Geological Survey); Michael Brett-Surman and Matt Carrano (USNM); Douglas Wolfe (White Mountain Dinosaur Exploration Center); and Dan Brinkman (YPM). ATM is grateful to Paul Barrett, Ken Carpenter, Matt Lamanna, Chloe Marquart, David Norman, and Christopher Noto for discussions and correspondence on iguanodontian taxonomy. ATM also thanks Hailu You for providing additional images of Xuwulong and Luis Alcala for providing additional images of Proa. ATMs research on iguanodontians was supported by grants from the Jurassic Foundation, Evolving Earth Foundation, Utah Friends of Paleontology, and University of Pennsylvania Paleobiology Summer Stipend. PJM thanks The Field Museum Women's Board for their generous support to acquire equipment used in the excavation of FMNH PR 3847. LEZ was supported by the John Caldwell Meeker postdoctoral fellowship at The Field Museum over the span of the fieldwork that resulted in collection of FMNH PR 3847. Finally, we thank Mark Spigelman, the Academic Editor, and Glenn Storrs for reviewing the manuscript.	Ramirez-Velasco AA, 2012, CAN J EARTH SCI, V49, P379, DOI 10.1139/E11-062; Allain R, 2012, NATURWISSENSCHAFTEN, V99, P369, DOI 10.1007/s00114-012-0911-7; Apesteguia S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157793; Barrett PM, 2011, SPEC PAP PALAEONTOL, P131, DOI 10.1111/j.1475-4983.2011.01076.x; Barrett PM, 2009, ACTA PALAEONTOL POL, V54, P35, DOI 10.4202/app.2009.0105; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; Boyd CA, 2015, PEERJ, V3, DOI 10.7717/peerj.1263; BRILL K, 2006, HORNS BEAKS CERATOPS, P49; Brinkman Donald B., 2013, P195; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brusatte SL, 2012, ACTA PALAEONTOL POL, V57, P65, DOI 10.4202/app.2010.0125; Brusatte SL, 2009, NATURWISSENSCHAFTEN, V96, P1051, DOI 10.1007/s00114-009-0565-2; Buffetaut E, 2011, ANN PALEONTOL, V97, P51, DOI 10.1016/j.annpal.2011.08.001; Campione Nicolas E., 2014, P208; CARPENTER K, 1995, J VERTEBR PALEONTOL, V15, P275, DOI 10.1080/02724634.1995.10011230; Carpenter K, 2008, ANN CARNEGIE MUS, V76, P227, DOI 10.2992/0097-4463(2008)76[227:ANSOCO]2.0.CO;2; Cifelli R.I., 1999, VERTEBRATE PALEONTOL, V99, P219; Cifelli RL, 1997, P NATL ACAD SCI USA, V94, P11163, DOI 10.1073/pnas.94.21.11163; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; Cooper LN, 2008, P ROY SOC B-BIOL SCI, V275, P2609, DOI 10.1098/rspb.2008.0912; Cope E.D., 1869, T AM PHIL SOC, V14, P1; Dalla Vecchia FM, 2009, J VERTEBR PALEONTOL, V29, P1100, DOI 10.1671/039.029.0428; DiCroce Tony, 2001, P183; DOLLO L, 1888, CR HEBD ACAD SCI, V106, P775; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Escaso F, 2014, J VERTEBR PALEONTOL, V34, P1102, DOI 10.1080/02724634.2014.849715; Garrison JR, 2007, CRETACEOUS RES, V28, P461, DOI 10.1016/j.cretres.2006.07.007; Gasca JM, 2015, J IBER GEOL, V41, P57, DOI 10.5209/rev_JIGE.2015.v41.n1.48655; Gilmore C. W., 1909, P US NATIONAL MUSEUM, V36, P197, DOI DOI 10.5479/SI.00963801.36-1666.197; Gilpen D., 2006, HORNS BEAKS CERATOPS, P79; Godefroit P, 2005, CR PALEVOL, V4, P697, DOI 10.1016/j.crpv.2005.07.004; Godefroit P., 1998, B I ROYAL SCI NAT S, V68, P3; Godefroit Pascal, 2012, P334; Goloboff P, 2008, CLADISTICS, V24, P91; Grande L, 2010, COPEIA, P1; Head JJ, 1998, J VERTEBR PALEONTOL, V18, P718, DOI 10.1080/02724634.1998.10011101; Head JJ, 2001, J VERTEBR PALEONTOL, V21, P392, DOI 10.1671/0272-4634(2001)021[0392:AROTPP]2.0.CO;2; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; Hunt G.J., 2011, SEVIER THRUST BELT N, VVolume 40, P193; Irmis Randall B., 2013, P424; Jiang BY, 2006, J ASIAN EARTH SCI, V28, P205, DOI 10.1016/j.jseaes.2005.07.006; Kirkland J. I., 1999, VERTEBRATE PALEONTOL, V99, P243; Kirkland J.I., 1999, UTAH GEOLOGICAL SURV, V99-1, P201; Kirkland James I., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P283; Kirkland James I., 1997, Brigham Young University Geology Studies, V42, P69; Kobayashi Y, 2003, J VERTEBR PALEONTOL, V23, P166, DOI 10.1671/0272-4634(2003)23[166:ANIDOF]2.0.CO;2; Lu Junchang, 1997, P27; Main Derek J., 2014, P77; Makovicky PJ, 2014, MIDMESOZOIC AGE DINO, P70; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; McDonald Andrew T., 2014, P44; Mcdonald AT, 2011, ZOOTAXA, P52, DOI 10.11646/zootaxa.2783.1.4; Mcdonald AT, 2010, ZOOTAXA, P1; Mcdonald AT, 2012, ZOOTAXA, P61; McDonald AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045712; McDonald AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036745; McDonald AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014075; Mcdonald AT, 2010, J VERTEBR PALEONTOL, V30, P799, DOI 10.1080/02724631003763516; Gasulla JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144167; Mo JY, 2007, ACTA GEOL SIN-ENGL, V81, P550; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P413; Norman DB, 2015, ZOOL J LINN SOC-LOND, V173, P92, DOI 10.1111/zoj.12193; Norman David B., 2012, P174; Norman DB, 2011, SPEC PAP PALAEONTOL, P165, DOI 10.1111/j.1475-4983.2011.01082.x; Norman DB, 2002, ZOOL J LINN SOC-LOND, V136, P113, DOI 10.1046/j.1096-3642.2002.00027.x; Norman DB, 1998, ZOOL J LINN SOC-LOND, V122, P291; Norman DB., 1980, MEMOIRES I ROYAL SCI, V178, P1; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Prieto-Marquez A, 2010, AM MUS NOVIT, P1, DOI 10.1206/3694.2; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Ruiz-Omenaca JI, 2011, ESTUD GEOL-MADRID, V67, P83, DOI 10.3989/egeol.40276.124; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno P. C, 2005, STEM ARCHOSAURIA VER; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Shibata M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145904; Shibata M, 2015, ZOOTAXA, V3914, P421, DOI 10.11646/zootaxa.3914.4.3; Sues HD, 2009, P R SOC B, V276, P2549, DOI 10.1098/rspb.2009.0229; Taquet P., 1976, GEOLOGIE PALEONTOLOG, P57; Taquet Philippe, 2012, P282; Taquet Philippe, 1999, Annales de Paleontologie, V85, P85, DOI 10.1016/S0753-3969(99)80009-3; Tsogtbaatar Khishigjav, 2014, P108; Verdu FJ, 2017, HIST BIOL; Verdu FJ, 2015, CRETACEOUS RES, V56, P250, DOI 10.1016/j.cretres.2015.05.010; Wang Deyou, 2013, Dizhi Xuebao, V87, P1049; Wang RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077058; Wang XL, 2010, EARTH ENV SCI T R SO, V101, P135, DOI 10.1017/S1755691010009266; Waskow K, 2014, J VERTEBR PALEONTOL, V34, P852, DOI 10.1080/02724634.2014.840645; WEISHAMPEL DB, 1993, PALAEONTOLOGY, V36, P361; Wiman C., 1929, Palaeontologia Sinica C vi, V1, P1; Woodward HN, 2015, PALEOBIOLOGY, V41, P503, DOI 10.1017/pab.2015.19; Wu Wenhao, 2012, P292; Xing H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098821; Xu Xing, 2000, Vertebrata Palasiatica, V38, P176; You Hai-lu, 2014, P73; [You Hailu 尤海鲁], 2005, [地质通报, Geological Bulletin of China], V24, P785; You H, 2011, ACTA GEOL SIN-ENGL, V85, P51, DOI 10.1111/j.1755-6724.2011.00377.x; You HL, 2003, CRETACEOUS RES, V24, P347, DOI 10.1016/S0195-6671(03)00048-X; You HL, 2003, ACTA GEOL SIN-ENGL, V77, P148; Zanno L.E., 2016, SOC VERT PAL 76 ANN, V2016, P256; Zanno LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3827; Zheng WJ, 2014, HIST BIOL, V26, P236, DOI 10.1080/08912963.2013.809347	108	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176896	10.1371/journal.pone.0176896	http://dx.doi.org/10.1371/journal.pone.0176896			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489871	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100035
J	Sosa-Calvo, J; Jesovnik, A; Vasconcelos, HL; Bacci, M; Schultz, TR				Sosa-Calvo, Jeffrey; Jesovnik, Ana; Vasconcelos, Heraldo L.; Bacci, Mauricio, Jr.; Schultz, Ted R.			Rediscovery of the enigmatic fungus-farming ant "Mycetosoritis" asper Mayr (Hymenoptera: Formicidae): Implications for taxonomy, phylogeny, and the evolution of agriculture in ants	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GROWING ANTS; MYRMICINAE ATTINI; SPECIES COMPLEX; SOCIAL PARASITE; INSECT ORDER; TRIBE ATTINI; COSTA-RICA; MANTOPHASMATODEA; MITOCHONDRIAL	We report the rediscovery of the exceedingly rarely collected and enigmatic fungus-farming ant species Mycetosoritis asper. Since the description of the type specimen in 1887, only four additional specimens are known to have been added to the world's insect collections. Its biology is entirely unknown and its phylogenetic position within the fungus-farming ants has remained puzzling due to its aberrant morphology. In 2014 we excavated and collected twenty-one colonies of M. asper in the Floresta Nacional de Chapeco A in Santa Catarina, Brazil. We describe here for the first time the male and larva of the species and complement the previous descriptions of both the queen and the worker. We describe, also for the first time, M. asper biology, nest architecture, and colony demographics, and identify its fungal cultivar. Molecular phylogenetic analyses indicate that both M. asper and M. clorindae are members of the genus Cyphomyrmex, which we show to be paraphyletic as currently defined. More precisely, M. asper is a member of the Cyphomyrmex strigatus group, which we also show to be paraphyletic with respect to the genus Mycetophylax. Based on these results, and in the interest of taxonomic stability, we transfer the species M. asper, M. clorindae, and all members of the C. strigatus group to the genus Mycetophylax, the oldest available name for this clade. Based on ITS sequence data, Mycetophylax asper practices lower agriculture, cultivating a fungal species that belongs to lower-attine fungal Clade 2, subclade F.	[Sosa-Calvo, Jeffrey] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Sosa-Calvo, Jeffrey; Jesovnik, Ana; Schultz, Ted R.] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA; [Sosa-Calvo, Jeffrey; Jesovnik, Ana] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Vasconcelos, Heraldo L.] Univ Fed Uberlandia, Inst Biol, Uberlandia, MG, Brazil; [Bacci, Mauricio, Jr.] Univ Estadual Paulista, Ctr Estudos Insetos Sociais, Rio Claro, SP, Brazil	University of Rochester; Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Maryland; University of Maryland College Park; Universidade Federal de Uberlandia; Universidade Estadual Paulista	Sosa-Calvo, J (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.; Sosa-Calvo, J; Schultz, TR (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA.; Sosa-Calvo, J (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	jsosacalvo@gmail.com; schultzt@si.edu	Vasconcelos, Heraldo L/C-3353-2013; Bacci, Mauricio/C-4960-2013	Vasconcelos, Heraldo L/0000-0001-6969-7131; Bacci, Mauricio/0000-0002-5619-1411	National Science Foundation (NSF) [DEB-1456964, DEB-0949689]; National Museum of Natural History (NMNH) Small Grants program; Smithsonian Institution Scholarly Studies Program; NMNH Peter Buck Predoctoral Fellowships; Max and Vera Britton Environmental Science Awards (Cosmos Club Foundation); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP [2011/50226-0]; CNPq [311562/2012-4, 487639/2012-0]; Brazilian Council of Research and Scientific Development (CNPq) [302588/2015-9]	National Science Foundation (NSF)(National Science Foundation (NSF)); National Museum of Natural History (NMNH) Small Grants program; Smithsonian Institution Scholarly Studies Program; NMNH Peter Buck Predoctoral Fellowships; Max and Vera Britton Environmental Science Awards (Cosmos Club Foundation); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Council of Research and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	T.R.S., and J.S.-C, were partially supported by National Science Foundation (NSF) grants DEB-1456964 and DEB-0949689 and the National Museum of Natural History (NMNH) Small Grants program; T.R.S. by the Smithsonian Institution Scholarly Studies Program; J.S.-C. and A.J. by NMNH Peter Buck Predoctoral Fellowships and Max and Vera Britton Environmental Science Awards (Cosmos Club Foundation); M.B. by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; 2011/50226-0) and CNPq (311562/2012-4 and 487639/2012-0), and H.L.V. by the Brazilian Council of Research and Scientific Development (CNPq grant 302588/2015-9).; We are exceedingly grateful to Maria Tavano (MSNG) for facilitating access to the worker described by Emery (1906), for further investigating F. Silvestri's travels in South America, and especially for suggesting that the Chubut locality in Emery (1906) may have been erroneous. We are equally grateful to Rogerio da Silva for invaluable locality information and for directing us onto the right path for locating colonies of Mycetophylax asper. We are additionally indebted to Bonnie Blaimer (USNM) for help with translation of Mayr's publication; to ICMbio for granting us permission to collect at Floresta Nacional de Chapeco; to Eugenia Okonski (NMNH) for collections and research support; to Eugenia Okonski and Nick Silverson (NMNH) for help maintaining the live colonies and for helping with the census; and to Scott Whittaker (NMNH) for help with the preparation of the larvae. J.S.-C. is exceedingly grateful to Christian Rabeling for support. T.R.S., and J.S.-C, were partially supported by National Science Foundation (NSF) grants DEB-1456964 and DEB-0949689 and the National Museum of Natural History (NMNH) Small Grants program; T.R.S. by the Smithsonian Institution Scholarly Studies Program; J.S.-C. and A.J. by NMNH Peter Buck Predoctoral Fellowships and Max and Vera Britton Environmental Science Awards (Cosmos Club Foundation); M.B. by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; 2011/50226-0) and CNPq (311562/2012-4 and 487639/2012-0); and H.L.V. by the Brazilian Council of Research and Scientific Development (CNPq grant 302588/2015-9). Fabio S. Nascimento, Rodrigo M. Feitosa, and Lars Vilhelmsen provided many helpful comments that greatly improved the manuscript.	[Anonymous], 2012, OXFORD LATIN DICT; Boudinot BE, 2015, EUR J TAXON, V120, P1, DOI 10.5852/ejt.2015.120; Branstetter MG, 2017, P ROYAL SOC B, V284; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; Cameron SL, 2006, MOL PHYLOGENET EVOL, V38, P274, DOI 10.1016/j.ympev.2005.09.020; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; CREIGHTON W. S., 1950, BULL MUS COMP ZOOL HARVARD UNIV, V104, P1; Currie CR, 2006, SCIENCE, V311, P81, DOI 10.1126/science.1119744; Emery C., 1894, Bollettino della Societa Entomologica Italiana, Vxxvi, P137; Emery C., 1922, Genera Insectorum Fasc Bruxelles, V174, P207; Emery C., 1888, BOLLETTINO SOCIET EN, V19, P352; Emery C, 1913, ANN SOC ENTOMOLOGIQU, V57, P250; Emery C, 1906, B SOC ENTOMOLOGICA I, V37, P107; Forel A., 1893, Annales de la Societe Entomologique de Belgique, Vxxxvii, P586; FOREL A, 1911, DTSCH ENTOMOLOGISCHE, P285; Frandsen PB, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0283-7; Gallardo A., 1916, Anales del Museo Nacional Buenos Aires, V28; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; ICMBio, 2013, SUMR EX PLAN AO NAC; ICZN [International Commission of Zoological Nomenclature], 1999, INT COD ZOOL NOM AD; Jesovnik A, 2013, INSECT SOC, V60, P531, DOI 10.1007/s00040-013-0320-8; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kempf W. W., 1962, Studia Entomologica Petropolis (NS), V5, P1; Kempf W. W., 1964, Studia Entomologica Petropolis (NS), V7, P1; Kempf W.W., 1968, STUDIA ENTOMOLOGICA, V11, P369; Klass KD, 2002, SCIENCE, V296, P1456, DOI 10.1126/science.1069397; Klass Klaus-Dieter, 2003, Entomologische Abhandlungen (Dresden), V61, P3; Klingenberg C, 2009, ZOOTAXA, P1; Kusnezov N., 1957, Revista de la Sociedad Uruguaya de Entomologia, V2, P7; KUSNEZOV NICOLAS, 1949, ACTA ZOOL LILLOANA, V8, P427; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Little AEF, 2003, NATURWISSENSCHAFTEN, V90, P558, DOI 10.1007/s00114-003-0480-x; Lucas Elaine Maria, 2008, Biota Neotrop., V8, P0, DOI 10.1590/S1676-06032008000300004; Lutinski JA, 2008, CIENC RURAL, V38, P1810, DOI 10.1590/S0103-84782008000700002; Mackay WP, 2010, J HYMENOPT RES, V19, P44; Mackay WP, 1998, REV BIOL TROP, V46, P421; Maddison WP, 2015, MESQUITE 3 0 MOD SYS; Marshall DC, 2006, SYST BIOL, V55, P993, DOI 10.1080/10635150601087641; Marshall DC, 2010, SYST BIOL, V59, P108, DOI 10.1093/sysbio/syp080; Mayr G., 1884, T RUSSKAGO ENTOMOLOG, V18, P31; MAYR G, 1887, VERHANDLUNGEN KAISER, V37, P511; Mehdiabadi NJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1844; Mehdiabadi NJ, 2010, MYRMECOL NEWS, V13, P37; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Oxford University Press, 1996, GREEK ENGLISH LEXICO; Picker MD, 2002, SCIENCE, V297, P1475; Rabeling C, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.4001; Rabeling C, 2015, INSECT SOC, V62, P335, DOI 10.1007/s00040-015-0406-6; Rabeling C, 2008, P NATL ACAD SCI USA, V105, P14913, DOI 10.1073/pnas.0806187105; Rabeling C, 2007, ZOOTAXA, P1; Rabeling C, 2016, ZOOKEYS, P79, DOI 10.3897/zookeys.618.9692; Rabeling C, 2011, P NATL ACAD SCI USA, V108, P12366, DOI 10.1073/pnas.1105467108; Rabeling C, 2010, SYST ENTOMOL, V35, P379, DOI 10.1111/j.1365-3113.2010.00533.x; Rambaut A, TRACER 1 5 0 U EDINB; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SANTSCHI F., 1933, ANALES SOC CIENT ARGENTINA, V116, P105; Santschi F, 1917, ANALES SOC CIENTIFIC, V84, P277; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Schultz TR, 2015, AM NAT, V185, P693, DOI 10.1086/680501; Schultz TR, 1998, INSECT SOC, V45, P457, DOI 10.1007/s000400050101; Schultz TR, 1995, SYST ENTOMOL, V20, P337, DOI 10.1111/j.1365-3113.1995.tb00100.x; Schultz TR, 1993, NOTES UNDERGROUND, V8, P7; SILVESTRI F., 1959, RICORDI ITINERARI SC; Soares AER, 2012, BIOINFORM BIOL INSIG, V6, P129, DOI 10.4137/BBI.S9677; Solomon SE, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0112; Sosa-Calvo J, 2015, SOCIOBIOLOGY, V62, P300; Sosa-Calvo J, 2010, ANN ENTOMOL SOC AM, V103, P181, DOI 10.1603/AN09108; Sosa-Calvo J., 2015, THESIS; Sosa-Calvo J, 2017, INSECTES SOCIAUX; Sosa-Calvo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080498; Sosa-Calvo J, 2009, J HYMENOPT RES, V18, P113; Spinks PQ, 2009, SYST BIOL, V58, P1, DOI 10.1093/sysbio/syp005; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Ward PS, 2015, SYST ENTOMOL, V40, P61, DOI 10.1111/syen.12090; Ward PS, 2010, SYST BIOL, V59, P342, DOI 10.1093/sysbio/syq012; WHEELER GC, 1974, P ENTOMOL SOC WASH, V76, P76; WHEELER GC, 1948, AM MIDL NAT, V40, P664, DOI 10.2307/2421490; Wheeler GC., 1956, MYRMECOLOGICAL ORTHO; Wheeler WM, 1907, B AM MUS NAT HIST, V23, P669; Wheeler WM, 1922, B AM MUSEUM NATURAL, V1139; Wheeler WM., 1925, ARK ZOOL, V17A, P1; Yoshimura M, 2007, ZOOTAXA, P21, DOI 10.11646/zootaxa.1654.1.2; Zompro Oliver, 2001, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V85, P229	88	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176498	10.1371/journal.pone.0176498	http://dx.doi.org/10.1371/journal.pone.0176498			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489860	gold, Green Published			2022-12-27	WOS:000401314100024
J	Byberg, KK; Oymar, K; Eide, GE; Forman, MR; Juliusson, PB				Byberg, Kristine Kjer; Oymar, Knut; Eide, Geir Egil; Forman, Michele R.; Juliusson, Petur Benedikt			Exposure to preeclampsia in utero affects growth from birth to late childhood dependent on child's sex and severity of exposure: Follow-up of a nested case-control study	PLOS ONE			English	Article							NORWEGIAN CHILDREN; POSTNATAL-GROWTH; PRETERM INFANTS; BLOOD-PRESSURE; WEIGHT; AGE; PREGNANCY; FETAL; REFERENCES; CYTOKINES	Background and objective An adverse intrauterine environment may affect offspring growth and development. Our aim was to explore whether preeclampsia (PE) exposure in utero influences growth from birth to 13 years. Methods In a nested case-control study, 229 children were exposed to PE (mild/moderate: n = 164, severe: n = 54) and 385 were unexposed. Length/height and weight were abstracted from records at birth, 3 and 6 months, 1 and 4 years, and measured along with waist circumference and skinfolds at follow-up at 11/12 (girls/boys) and 13 years (both sexes). Associations between PE and z-scores for growth were analyzed by multiple linear and fractional polynomial regression with adjustment for potential confounders. Results In boys, exposure to mild/moderate PE was positively associated with linear growth after 0.5 years, but severe PE was negatively associated with linear growth in all ages. In girls, both exposure to mild/moderate and severe PE were negatively associated with linear growth. Exposure to PE was negatively associated with weight and body mass index (BMI) during infancy, but positively associated with weight and BMI thereafter, except that boys exposed to severe PE consistently had a lower weight and BMI compared to the unexposed. Exposure to severe PE only was positively associated with waist-to-height ratio at 11/12 (girls/boys) and 13 years (both sexes). Conclusions From birth to adolescence, linear growth, weight and BMI trajectories differed between the sexes by severity of exposure to PE. In general, PE exposure was negatively associated with linear growth, while in girls; positive associations with weight and BMI were observed. This underlines fetal life as a particularly sensitive period affecting subsequent growth and this may have implications for targeted approaches for healthy growth and development.	[Byberg, Kristine Kjer; Oymar, Knut] Stavanger Univ Hosp, Dept Pediat, Stavanger, Norway; [Oymar, Knut; Juliusson, Petur Benedikt] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Eide, Geir Egil] Haukeland Hosp, Ctr Clin Res, Bergen, Norway; [Eide, Geir Egil] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Forman, Michele R.] Univ Texas Austin, Sch Human Ecol, Dept Nutr Sci, Austin, TX 78712 USA; [Juliusson, Petur Benedikt] Haukeland Hosp, Dept Pediat, Bergen, Norway; [Forman, Michele R.] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA	Stavanger University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Texas System; University of Texas Austin; University of Bergen; Haukeland University Hospital; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Byberg, KK (corresponding author), Stavanger Univ Hosp, Dept Pediat, Stavanger, Norway.	kristine.kjer.byberg@sus.no			National Cancer Institute, National Institute of Health, R03 [1R03CA137754]; MD Anderson Global Programme; Western Norway Regional Health Authority [911835]	National Cancer Institute, National Institute of Health, R03; MD Anderson Global Programme; Western Norway Regional Health Authority	"The Stavanger Study was funded by an internal grant from the National Cancer Institute, National Institute of Health, R03 (grant number: 1R03CA137754) and is a part of the MD Anderson Global Programme. The present study was funded by a PhD grant for the first author, from the Western Norway Regional Health Authority, grant number: 911835. URL: http://www.helse-vest.no/ en/FagOgSamarbeid/forsking/retringslinjer-skiema/Sider/dektorgrad.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aibar L, 2012, J PERINAT MED, V40, P271, DOI 10.1515/jpm-2011-0137; Alsnes IV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167714; Alsnes IV, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.026; Beardsall K, 2014, J PEDIATR-US, V164, P1038, DOI 10.1016/j.jpeds.2013.12.046; BEROYZ G, 1994, LANCET, V343, P619; Brannsether B, 2013, EUR J CLIN NUTR, V67, P928, DOI 10.1038/ejcn.2013.91; Brannsether B, 2011, ACTA PAEDIATR, V100, P1576, DOI 10.1111/j.1651-2227.2011.02370.x; Byberg KK, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-101; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; De Boo HA, 2006, AUST NZ J OBSTET GYN, V46, P4, DOI 10.1111/j.1479-828X.2006.00506.x; Druet C, 2008, BEST PRACT RES CL EN, V22, P489, DOI 10.1016/j.beem.2008.02.002; Dubova EA, 2014, B EXP BIOL MED+, V157, P103, DOI 10.1007/s10517-014-2502-4; Gillman MW, 2008, AM J CLIN NUTR, V87, P1587, DOI 10.1093/ajcn/87.6.1587; Guasti L, 2014, J CLIN ENDOCR METAB, V99, pE2198, DOI 10.1210/jc.2014-1566; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hellstrom A, 2016, ACTA PAEDIATR, V105, P576, DOI 10.1111/apa.13350; Herberth G, 2011, ALLERGY, V66, P1065, DOI 10.1111/j.1398-9995.2011.02587.x; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Jain V, 2012, REV ENDOCR METAB DIS, V13, P141, DOI 10.1007/s11154-012-9216-6; Jensen RB, 2015, J CLIN ENDOCR METAB, V100, pE503, DOI 10.1210/jc.2014-3469; Jim B, 2010, CARDIOL REV, V18, P178, DOI 10.1097/CRD.0b013e3181c60ca6; Juliusson PB, 2011, ARCH DIS CHILD, V96, P916, DOI 10.1136/adc.2009.166157; Juliusson PB, 2013, ANN HUM BIOL, V40, P220, DOI 10.3109/03014460.2012.759276; LANES R, 1989, BIOL NEONATE, V56, P252; Mansson J, 2015, ACTA PAEDIATR, V104, P514, DOI 10.1111/apa.12937; Odegard RA, 2000, OBSTET GYNECOL, V96, P950, DOI 10.1016/S0029-7844(00)01040-1; Ogland B, 2009, ARCH DIS CHILD, V94, P855, DOI 10.1136/adc.2008.150870; Ogland B, 2011, ARCH DIS CHILD, V96, P740, DOI 10.1136/adc.2009.178434; Ong KK, 2015, ACTA PAEDIATR, V104, P974, DOI 10.1111/apa.13128; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Orak U, 2016, J MATERN-FETAL NEO M, V29, P270, DOI 10.3109/14767058.2014.998191; Pizzi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090291; Royston P., 2008, MULTIVARIABLE MODEL, V1st ed., P115, DOI DOI 10.1002/9780470770771.CH6; Sederquist B, 2014, J MOL ENDOCRINOL, V53, pT35, DOI 10.1530/JME-14-0006; SEIDMAN DS, 1991, BRIT J OBSTET GYNAEC, V98, P1009, DOI 10.1111/j.1471-0528.1991.tb15339.x; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Simchen MJ, 2014, J MATERN-FETAL NEO M, V27, P839, DOI 10.3109/14767058.2013.845658; Szarka A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-59; Taveras EM, 2009, PEDIATRICS, V123, P1177, DOI 10.1542/peds.2008-1149; Turner JA, 2010, INT J WOMENS HEALTH, V2, P327, DOI 10.2147/IJWH.S8550; Valensise H, 2008, HYPERTENSION, V52, P873, DOI 10.1161/HYPERTENSIONAHA.108.117358; van der Steen M, 2016, ENDOCRIN METAB CLIN, V45, P283, DOI 10.1016/j.ecl.2016.01.008; Vatten LJ, 2003, OBSTET GYNECOL, V101, P529, DOI 10.1016/S0029-7844(02)02718-7; Vatten LJ, 2002, OBSTET GYNECOL, V99, P85, DOI 10.1016/S0029-7844(01)01651-9; Westerberg AC, 2010, ACTA PAEDIATR, V99, P556, DOI 10.1111/j.1651-2227.2009.01667.x; Yadav S, 2015, INDIAN PEDIATR, V52, P135, DOI 10.1007/s13312-015-0588-z	46	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176627	10.1371/journal.pone.0176627	http://dx.doi.org/10.1371/journal.pone.0176627			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486480	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000401314000019
J	Li, QF; Deng, C; Xia, Y; Kong, LS; Zhang, HG; Zhang, SG; Wang, JH				Li, Qingfen; Deng, Cheng; Xia, Yan; Kong, Lisheng; Zhang, Hanguo; Zhang, Shougong; Wang, Junhui			Identification of novel miRNAs and miRNA expression profiling in embryogenic tissues of Picea balfouriana treated by 6-benzylaminopurine	PLOS ONE			English	Article							SUITABLE REFERENCE GENES; WHEAT TRITICUM-AESTIVUM; PROGRAMMED CELL-DEATH; QUANTITATIVE RT-PCR; SOMATIC EMBRYOGENESIS; CONSERVED MICRORNAS; TARGET GENES; SMALL RNAS; CALCIUM; NORMALIZATION	Here, we compared miRNA expression profiles in embryonic cell cultures of the conifer Picea balfouriana following application of the synthetic cytokinin 6-benzylaminopurine (6-BAP). We used next-generation sequencing to analyze three libraries of small RNAs from the treated embryogenic cell cultures and generated 24,000,000 raw reads from each of the libraries. Over 70 differentially regulated micro RNA (miRNA) families (>= 2 fold change in expression) were identified between pairs of treatments. A quantitative analysis showed that miR3633 and miR1026 were upregulated in tissues with the highest embryogenic ability. These two miRNAs were predicted to target genes encoding receptor-like protein kinase and GAMYB transcription factors, respectively. In one library, miR1160, miR5638, miR1315, and miR5225 were downregulated. These four miRNAs were predicted to target genes encoding APETALA2, calmodulin-binding protein, and calciumdependent protein kinase transcription factors. The expression patterns of the miRNAs and their targets were negatively correlated. Approximately 181 potentially novel P. balfouriana miRNAs were predicted from the three libraries, and seven were validated during the quantitative analysis. This study is the first report of differential miRNA regulation in tissues treated with 6-BAP during somatic embryogenesis. The differentially expressed miRNAs will be of value for investigating the mechanisms of embryogenic processes that are responsive to 6-BAP in P. balfouriana.	[Li, Qingfen; Deng, Cheng] South China Agr Univ, Coll Forestry & Landscape Architecture, Guangdong Key Lab Innovat Dev & Utilizat Forest P, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Li, Qingfen; Xia, Yan; Zhang, Shougong; Wang, Junhui] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat,State Forestry A, Beijing, Peoples R China; [Kong, Lisheng] Univ Victoria, Dept Biol, Ctr Forest Biol, Victoria, BC, Canada; [Zhang, Hanguo] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China	South China Agricultural University; Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; University of Victoria; Northeast Forestry University - China	Wang, JH (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat,State Forestry A, Beijing, Peoples R China.	wangjh@caf.ac.cn			Fundamental Research Funds for the Central Non-profit Research Institution of CAF, China [TGB2013011]	Fundamental Research Funds for the Central Non-profit Research Institution of CAF, China	Financial support for this study was provided by the Fundamental Research Funds for the Central Non-profit Research Institution of CAF, China (TGB2013011).	Alonso-Peral MM, 2010, PLANT PHYSIOL, V154, P757, DOI 10.1104/pp.110.160630; Anil VS, 2000, PLANT PHYSIOL, V122, P1035, DOI 10.1104/pp.122.4.1035; Anil VS, 2000, PLANT PHYSIOL, V123, P1301, DOI 10.1104/pp.123.4.1301; Barakat Abdelali, 2007, BMC Genomics, V8, P481, DOI 10.1186/1471-2164-8-481; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Che P, 2006, PLANT MOL BIOL, V62, P1, DOI 10.1007/s11103-006-9013-2; Dai XB, 2011, BRIEF BIOINFORM, V12, P115, DOI 10.1093/bib/bbq065; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Duan CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-30; El Ouakfaoui S, 2010, PLANT MOL BIOL, V74, P313, DOI 10.1007/s11103-010-9674-8; Ge XX, 2012, PLANTA, V236, P1107, DOI 10.1007/s00425-012-1661-7; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gimenez MJ, 2011, PLANTA, V233, P163, DOI 10.1007/s00425-010-1290-y; Guo WJ, 2008, PLANT PHYSIOL, V147, P1710, DOI 10.1104/pp.108.120238; He Z., 1993, LAB GUIDE CHEM CONTR; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; JANSEN MAK, 1990, PLANT CELL REP, V9, P221, DOI 10.1007/BF00232184; Jeyaraj A, 2014, PLANT CELL REP, V33, P1053, DOI 10.1007/s00299-014-1589-4; Jia BX, 2012, J NANOMATER, V2012, DOI 10.1155/2012/796815; Jime Anez VM, 2000, VITIS, V39, P151; Jimenez V. M, 2001, PLANT CELL TISS ORG, V67, P37; Jimenez VM, 2001, PHYSIOL PLANTARUM, V111, P389, DOI 10.1034/j.1399-3054.2001.1110317.x; Jimenez VM, 2001, PLANT SCI, V160, P247, DOI 10.1016/S0168-9452(00)00382-4; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Kou SJ, 2012, PLANT CELL REP, V31, P2151, DOI 10.1007/s00299-012-1325-x; Lau S, 2012, ANNU REV PLANT BIOL, V63, P483, DOI 10.1146/annurev-arplant-042811-105507; Li QF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141841; Li QF, 2015, PHYSIOL PLANTARUM, V154, P95, DOI 10.1111/ppl.12276; Li QF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-553; Li TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043451; Li WF, 2013, PLANT CELL TISS ORG, V113, P131, DOI [10.1007/s11240-012-0233-7, 10.1007/s11240-012-0221-y]; Li ZX, 2016, PLANT CELL TISS ORG, V127, P461, DOI 10.1007/s11240-016-1071-9; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Lin YC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054466, 10.1371/journal.pone.0069722]; LITVAY JD, 1981, I PAPER CHEM TECH PA, V115, P1; Luo YC, 2006, FEBS LETT, V580, P5111, DOI 10.1016/j.febslet.2006.08.046; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Morcillo F, 2007, PLANTA, V226, P1353, DOI 10.1007/s00425-007-0574-3; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Nolan KE, 2009, J EXP BOT, V60, P1759, DOI 10.1093/jxb/erp046; NOMA M, 1982, PLANTA, V155, P369, DOI 10.1007/BF00394464; Oh TJ, 2008, NEW PHYTOL, V179, P67, DOI 10.1111/j.1469-8137.2008.02448.x; OVERVOORDE PJ, 1994, PLANT CELL PHYSIOL, V35, P135; Piyatrakul P, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-244; Prabu G. R., 2010, Genomics Proteomics & Bioinformatics, V8, P113, DOI 10.1016/S1672-0229(10)60012-5; Qiu DY, 2009, GENE, V436, P37, DOI 10.1016/j.gene.2009.01.006; Sharma SK, 2008, PLANT MOL BIOL, V68, P185, DOI 10.1007/s11103-008-9360-2; Singla B, 2007, PLANT MOL BIOL, V65, P677, DOI 10.1007/s11103-007-9234-z; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Stasolla C, 2003, PLANT PHYSIOL, V131, P49, DOI 10.1104/pp.015214; Su YH, 2016, PLANT CELL TISS ORG, V124, P405, DOI 10.1007/s11240-015-0903-3; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Thibaud-Nissen FO, 2003, PLANT PHYSIOL, V132, P118, DOI 10.1104/pp.103.019968; Tsuji H, 2006, PLANT J, V47, P427, DOI 10.1111/j.1365-313X.2006.02795.x; Tsuwamoto R, 2010, PLANT MOL BIOL, V73, P481, DOI 10.1007/s11103-010-9634-3; van Zyl L, 2003, GENE EXPR PATTERNS, V3, P83, DOI 10.1016/S1567-133X(02)00068-6; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vernoux T, 2005, CURR OPIN GENET DEV, V15, P388, DOI 10.1016/j.gde.2005.06.008; WEILER EW, 1981, PLANTA, V153, P561, DOI 10.1007/BF00385542; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Woodger FJ, 2003, J PLANT GROWTH REGUL, V22, P176, DOI 10.1007/s00344-003-0025-8; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Wu XM, 2015, PLANT BIOTECHNOL J, V13, P383, DOI 10.1111/pbi.12317; Wu XM, 2011, PLANTA, V233, P495, DOI 10.1007/s00425-010-1312-9; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Yang XY, 2010, CRIT REV PLANT SCI, V29, P36, DOI 10.1080/07352680903436291; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zeng FC, 2006, PLANT MOL BIOL, V60, P167, DOI 10.1007/s11103-005-3381-x; Zhang JH, 2012, PLANTA, V236, P647, DOI 10.1007/s00425-012-1643-9; Zhang SG, 2010, BIOCHEM BIOPH RES CO, V398, P355, DOI 10.1016/j.bbrc.2010.06.056; Zhang SZ, 2011, PLANT CELL TISS ORG, V105, P29, DOI 10.1007/s11240-010-9834-1; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3	73	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176112	10.1371/journal.pone.0176112	http://dx.doi.org/10.1371/journal.pone.0176112			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486552	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000008
J	Moonen, AJH; Weiss, PH; Wiesing, M; Weidner, R; Fink, GR; Reijnders, JSAM; Weber, WM; Leentjens, AFG				Moonen, Anja J. H.; Weiss, Peter H.; Wiesing, Michael; Weidner, Ralph; Fink, Gereon R.; Reijnders, Jennifer S. A. M.; Weber, Wim M.; Leentjens, Albert F. G.			An fMRI study into emotional processing in Parkinson's disease: Does increased medial prefrontal activation compensate for striatal dysfunction?	PLOS ONE			English	Article							QUALITY-OF-LIFE; DIAGNOSTIC-CRITERIA; LIMBIC SYSTEM; RATING-SCALE; DEPRESSION; AMYGDALA; RECOGNITION; AROUSAL; CORTEX; APATHY	Background Apart from a progressive decline of motor functions, Parkinson's disease (PD) is also characterized by non-motor symptoms, including disturbed processing of emotions. This study aims at assessing emotional processing and its neurobiological correlates in PD with the focus on how medicated Parkinson patients may achieve normal emotional responsiveness despite basal ganglia dysfunction. Methods Nineteen medicated patients with mild to moderate PD (without dementia or depression) and 19 matched healthy controls passively viewed positive, negative, and neutral pictures in an event-related blood oxygen level-dependent functional magnetic resonance imaging study (BOLD-fMRI). Individual subjective ratings of valence and arousal levels for these pictures were obtained right after the scanning. Results Parkinson patients showed similar valence and arousal ratings as controls, denoting intact emotional processing at the behavioral level. Yet, Parkinson patients showed decreased bilateral putaminal activation and increased activation in the right dorsomedial prefrontal cortex (PFC), compared to controls, both most pronounced for highly arousing emotional stimuli. Conclusions Our findings revealed for the first time a possible compensatory neural mechanism in Parkinson patients during emotional processing. The increased medial PFC activity may have modulated emotional responsiveness in patients via top-down cognitive control, therewith restoring emotional processing at the behavioral level, despite striatal dysfunction. These results may impact upon current treatment strategies of affective disorders in PD as patients may benefit from this intact or even compensatory influence of prefrontal areas when therapeutic strategies are applied that rely on cognitive control to modulate disturbed processing of emotions.	[Moonen, Anja J. H.; Leentjens, Albert F. G.] Maastricht Univ, Med Ctr, Dept Psychiat, Maastricht, Netherlands; [Moonen, Anja J. H.; Weiss, Peter H.; Wiesing, Michael; Weidner, Ralph; Fink, Gereon R.] Res Ctr Julich, Inst Neurosci & Med INM3, Julich, Germany; [Weiss, Peter H.; Fink, Gereon R.] Univ Hosp Cologne, Dept Neurol, Cologne, Germany; [Reijnders, Jennifer S. A. M.] Open Univ, Dept Lifespan Psychol, Heerlen, Netherlands; [Weber, Wim M.] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands	Maastricht University; Helmholtz Association; Research Center Julich; University of Cologne; Open University Netherlands; Maastricht University	Moonen, AJH (corresponding author), Maastricht Univ, Med Ctr, Dept Psychiat, Maastricht, Netherlands.; Moonen, AJH (corresponding author), Res Ctr Julich, Inst Neurosci & Med INM3, Julich, Germany.	anja.moonen@maastrichtuniversity.nl	Fink, Gereon R./AFW-9377-2022; Weidner, Ralph/H-3796-2013; Fink, Gereon R./E-1616-2012; Weiss, Peter H./H-8983-2013	Fink, Gereon R./0000-0002-8230-1856; Weidner, Ralph/0000-0002-4502-0166; Fink, Gereon R./0000-0002-8230-1856; Weiss, Peter H./0000-0002-5230-9080; Wiesing, Michael/0000-0001-8287-127X	Stichting ParkinsonFonds, Hoofddorp, the Netherlands	Stichting ParkinsonFonds, Hoofddorp, the Netherlands	This study was funded by the Stichting ParkinsonFonds, Hoofddorp, the Netherlands. The research grant was awarded to A.F.G. Leentjens and does not have a grant number.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Association AP, 1994, DIAGN STAT MAN MENT, P143; Baggio HC, 2012, NEUROPSYCHOLOGIA, V50, P2121, DOI 10.1016/j.neuropsychologia.2012.05.020; Barbas H, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-25; Barbas H., 2006, ORBITOFRONTAL CORTEX, P57, DOI [DOI 10.1093/ACPROF:OSO/9780198565741.003.0004, 10.1093/acprof:oso/9780198565741.003.0004]; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brucke C, 2007, EUR J NEUROSCI, V26, P767, DOI 10.1111/j.1460-9568.2007.05683.x; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Delaveau P, 2010, EUR NEUROPSYCHOPHARM, V20, P784, DOI 10.1016/j.euroneuro.2010.07.001; Delaveau P, 2009, J CLIN PSYCHOPHARM, V29, P548, DOI 10.1097/JCP.0b013e3181bf1c5f; deRijk MC, 1997, NEUROLOGY, V48, P1277, DOI 10.1212/WNL.48.5.1277; Dietz J, 2013, NEUROPSYCHOLOGIA, V51, P960, DOI 10.1016/j.neuropsychologia.2013.01.001; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Folstein MF, 1975, MINIMENTAL STATE PRA; Garrido-Vasquez P, 2012, SOC COGN AFFECT NEUR; Geng DY, 2006, NEUROSURGERY, V58, P256, DOI 10.1227/01.NEU.0000194845.19462.7B; Gross J.J., 2008, HDB EMOTIONS, P497; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Hacker C, 2012, BRAIN AWS, V281; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Ibarretxe-Bilbao N, 2009, EUR J NEUROSCI, V30, P1162, DOI 10.1111/j.1460-9568.2009.06892.x; Kehoe EG, 2012, SOC COGN AFFECT NEUR, V7, P858, DOI 10.1093/scan/nsr059; Lang PJ, 2008, INT AFFECTIVE PICTUR; Leentjens AFG, 2014, MOVEMENT DISORD, V29, P1035, DOI 10.1002/mds.25919; Lisanby SH, 1992, J NEURAL TRANSM-SUPP, V40, P13; Lotze M, 2009, J COGNITIVE NEUROSCI, V21, P1321, DOI 10.1162/jocn.2009.21087; Mansson KNT, 2013, PSYCHIAT RES-NEUROIM, V214, P229, DOI 10.1016/j.pscychresns.2013.08.012; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Miller KM, 2009, NEUROPSYCHOLOGIA, V47, P1917, DOI 10.1016/j.neuropsychologia.2009.03.002; O'Callaghan C, 2014, J NEUROL NEUROSUR PS, V85, P371, DOI 10.1136/jnnp-2012-304558; Paquette V, 2003, NEUROIMAGE, V18, P401, DOI 10.1016/S1053-8119(02)00030-7; Phan KL, 2003, BIOL PSYCHIAT, V53, P211, DOI 10.1016/S0006-3223(02)01485-3; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Price J. L., 2006, ORBITOFRONTAL CORTEX, P39; Ray RD, 2012, NEUROSCI BIOBEHAV R, V36, P479, DOI 10.1016/j.neubiorev.2011.08.005; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Rottenberg J, 2003, CLIN PSYCHOL-SCI PR, V10, P227, DOI 10.1093/clipsy/bpg012; Schrag A, 2006, J NEUROL SCI, V248, P151, DOI 10.1016/j.jns.2006.05.030; Schroder C, 2006, MOVEMENT DISORD, V21, P1774, DOI 10.1002/mds.21038; Slawek J, 2005, PARKINSONISM RELAT D, V11, P465, DOI 10.1016/j.parkreldis.2005.04.006; Sockeel P, 2006, J NEUROL NEUROSUR PS, V77, P579, DOI 10.1136/jnnp.2005.075929; Taylor SF, 2003, NEUROIMAGE, V18, P650, DOI 10.1016/S1053-8119(02)00051-4; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Wieser MJ, 2012, CORTEX, V48, P1207, DOI 10.1016/j.cortex.2011.06.006; Wieser MJ, 2006, CLIN NEUROPHYSIOL, V117, P94, DOI 10.1016/j.clinph.2005.09.009; Yoshimura N, 2005, NEUROSCIENCE, V131, P523, DOI 10.1016/j.neuroscience.2004.09.054; Yuvaraj R, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-12	54	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177085	10.1371/journal.pone.0177085	http://dx.doi.org/10.1371/journal.pone.0177085			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486506	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314000042
J	Belteky, J; Agnvall, B; Jensen, P				Belteky, Johan; Agnvall, Beatrix; Jensen, Per			Gene expression of behaviorally relevant genes in the cerebral hemisphere changes after selection for tameness in Red Junglefowl	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DOMESTICATION; PROTEIN; EVOLUTION; MAMMALS; WILD; FEAR	The process of domestication in animals has led to alterations in behavior, physiology and phenotypic traits, changes that may be driven by correlations with reduced fear of humans. We used Red Junglefowl, ancestors of all domesticated chickens selected for either high or low fear of humans for five generations to study the effects of selection on gene transcription in the cerebral hemisphere, which is heavily involved in behaviour control. A total of 24 individuals from the parental generation as well as from the fifth selected generation were used. Twenty-two genes were significantly differentially expressed at p < 0.05 after false discovery rate (FDR) correction. Those genes that were upregulated in the low fearful animals were found to be involved in neural functions. Gene ontology and pathway analysis revealed enrichment for terms associated with behavioural processes. We conclude that five generations of divergent selection for high or low tameness has significantly changed gene expression patterns in the cerebral hemisphere in the Red Junglefowl population used here, which could underlie a range of changes in the domestic phenotype.	[Belteky, Johan; Agnvall, Beatrix; Jensen, Per] Linkoping Univ, IFM Biol, AVIAN Behav Physiol & Genom Grp, Linkoping, Sweden	Linkoping University	Jensen, P (corresponding author), Linkoping Univ, IFM Biol, AVIAN Behav Physiol & Genom Grp, Linkoping, Sweden.	perje@ifm.liu.se			research council Formas [221-2010-35]; Swedish Research Council VR [621-2011-4731]; European Research Council, ERC [322206 GENEWELL]; ERC [322206 GENEWELL]	research council Formas(Swedish Research Council Formas); Swedish Research Council VR(Swedish Research Council); European Research Council, ERC(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission)	The project was supported by grants from the research council Formas (Grant no: 221-2010-35) (http://www.formas.se/), the Swedish Research Council VR (Grant no: 621-2011-4731) (http://www.vr.se/) and the European Research Council, ERC (Grant no: 322206 GENEWELL) (https://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project was supported by grants from the research council Formas, and ERC (grant no. 322206 GENEWELL). We thank Lejla Bektic for technical assistance and for supervising the animals, Markus Jongren for help in developing the breeding programme, and also Petros Batakis for sample preparations.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Agnvall B, 2014, ANIMAL, V8, P1498, DOI 10.1017/S1751731114001426; Agnvall B, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0509; Agnvall B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035162; Albert FW, 2008, HORM BEHAV, V53, P413, DOI 10.1016/j.yhbeh.2007.11.010; Albert FW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002962; Albert FW, 2009, GENETICS, V182, P541, DOI 10.1534/genetics.109.102186; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Belteky J, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160033; BELYAEV DK, 1979, J HERED, V70, P301, DOI 10.1093/oxfordjournals.jhered.a109263; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burdette AJ, 2010, CELL STRESS CHAPERON, V15, P605, DOI 10.1007/s12192-010-0173-2; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; EBINGER P, 1995, J BRAIN RES, V36, P219; Fu J, 2015, BBA-MOL CELL RES, V1853, P1, DOI 10.1016/j.bbamcr.2014.09.022; Heyne HO, 2014, GENETICS, V198, P1277, DOI 10.1534/genetics.114.168948; Jensen P, 2006, APPL ANIM BEHAV SCI, V97, P3, DOI 10.1016/j.applanim.2005.11.015; Kruska DCT, 2005, BRAIN BEHAV EVOLUT, V65, P73, DOI 10.1159/000082979; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Natt D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-59; NAUMENKO EV, 1989, PHARMACOL BIOCHEM BE, V33, P85, DOI 10.1016/0091-3057(89)90434-6; Patterson Marc C, 2005, Semin Pediatr Neurol, V12, P144, DOI 10.1016/j.spen.2005.10.002; Price E.O., 2002, ANIMAL DOMESTICATION; Rehkamper G, 2008, BRAIN BEHAV EVOLUT, V71, P115, DOI 10.1159/000111458; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez AR, 2014, J COMP NEUROL, V522, P1411, DOI 10.1002/cne.23521; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sanchez-Villagra MR, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160107; Shao XP, 1999, DEV BIOL, V211, P109, DOI 10.1006/dbio.1999.9297; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Tixier-Boichard M, 2011, CR BIOL, V334, P197, DOI 10.1016/j.crvi.2010.12.012; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070; Vigne JD, 2011, CR BIOL, V334, P171, DOI 10.1016/j.crvi.2010.12.009; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; WEST B, 1988, J ARCHAEOL SCI, V15, P515, DOI 10.1016/0305-4403(88)90080-5; Wilkins AS, 2014, GENETICS, V197, P795, DOI 10.1534/genetics.114.165423; Yassine S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118698; Zeder MA, 2012, BIODIVERSITY IN AGRICULTURE: DOMESTICATION, EVOLUTION, AND SUSTAINABILITY, P227; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018	42	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177004	10.1371/journal.pone.0177004	http://dx.doi.org/10.1371/journal.pone.0177004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481924	Green Submitted, Green Published, gold			2022-12-27	WOS:000401313700027
J	Pluess, M; Boniwell, I; Hefferon, K; Tunariu, A				Pluess, Michael; Boniwell, Ilona; Hefferon, Kate; Tunariu, Aneta			Preliminary evaluation of a school-based resilience-promoting intervention in a high-risk population: Application of an exploratory two-cohort treatment/control design	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; PREVENTION PROGRAMS; CHILDREN; ADOLESCENTS; YOUTH; METAANALYSIS; HEALTH; TRENDS; DISORDER; SCALES	Applying innovative methodology, we explored the efficacy of SPARK Resilience Programme-a new universal school-based resilience-promoting programme-regarding effects on depression symptoms and resilience in a high risk population in England. Quantitative and qualitative methods were combined in an exploratory two cohort treatment/control design with one cohort serving as the control group (single assessment) and a subsequent cohort as the treatment group (assessed before and immediately after treatment as well as 6 and 12 months after treatment ended), involving a total of 438 11-13 year old girls, According to analyses, depression symptoms were significantly lower directly after treatment and at 6 months but no longer at 12 months. Resilience scores, on the other hand, were significantly higher in the treatment cohort compared to the year-ahead control cohort at post-treatment and both follow-up assessments. Qualitative results demonstrated beneficial teacher experience overall. The current study provides first evidence for the efficacy of SPARK Resilience Programme. Furthermore, the applied two cohort treatment/control mixed methods design proved helpful for the preliminary testing of a school-based universal intervention programme efficacy in an authentic setting.	[Pluess, Michael] Queen Mary Univ London, London, England; [Boniwell, Ilona] Anglia Ruskin Univ, Cambridge, England; [Hefferon, Kate; Tunariu, Aneta] Univ East London, London, England	University of London; Queen Mary University London; Anglia Ruskin University; University of East London	Pluess, M (corresponding author), Queen Mary Univ London, London, England.	m.pluess@qmul.ac.uk	Pluess, Michael/D-6526-2011	Pluess, Michael/0000-0001-5071-2047	Swiss National Science Foundation [PBBSP1-130909]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work received support from a Fellowship grant by Swiss National Science Foundation awarded to Michael Pluess (PBBSP1-130909) during the period the study was conducted.	Ahern NR, 2006, COMPR CHILD ADOLES N, V29, P103, DOI 10.1080/01460860600677643; Ashworth P., 2008, QUALITATIVE PSYCHOL; Boniwell I., 2009, SPARK RESILIENCE TEA; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brunwasser SM, 2009, J CONSULT CLIN PSYCH, V77, P1042, DOI 10.1037/a0017671; Collishaw S, 2004, J CHILD PSYCHOL PSYC, V45, P1350, DOI 10.1111/j.1469-7610.2004.00335.x; Collishaw S, 2010, J CHILD PSYCHOL PSYC, V51, P885, DOI 10.1111/j.1469-7610.2010.02252.x; Covey LS, 1998, J ADDICT DIS, V17, P35, DOI 10.1300/J069v17n01_04; Department for Communities and Local Government, 2011, ENGLISH INDICES DEPR; Durlak JA, 2011, CHILD DEV, V82, P405, DOI 10.1111/j.1467-8624.2010.01564.x; Fergusson DM, 2000, PSYCHOL MED, V30, P23, DOI 10.1017/S003329179900135X; Fichter MM, 2004, EUR ARCH PSY CLIN N, V254, P27, DOI 10.1007/s00406-004-0450-0; Green H., 2005, J RES SPEC EDUC NEED; Greenberg MT, 2003, AM PSYCHOL, V58, P466, DOI 10.1037/0003-066X.58.6-7.466; Horowitz JL, 2006, J CONSULT CLIN PSYCH, V74, P401, DOI 10.1037/0022-006X.74.3.401; Hyde JS, 2008, PSYCHOL REV, V115, P291, DOI 10.1037/0033-295X.115.2.291; Lenhard W., 2015, CALCULATION EFFECT S; Masten A.S., 2009, OXFORD HDB POSITIVE, P117; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROBERTS RE, 1991, J AM ACAD CHILD PSY, V30, P58, DOI 10.1097/00004583-199101000-00009; Rushton JL, 2002, J AM ACAD CHILD PSY, V41, P199, DOI 10.1097/00004583-200202000-00014; RUTTER M, 1985, BRIT J PSYCHIAT, V147, P598, DOI 10.1192/bjp.147.6.598; Stallard Paul, 2013, Br J Psychiatry Suppl, V54, ps18, DOI 10.1192/bjp.bp.112.119172; Stice E, 2009, J CONSULT CLIN PSYCH, V77, P486, DOI 10.1037/a0015168; Stockings E, 2015, J AFFECT DISORDERS, V174, P447, DOI 10.1016/j.jad.2014.11.061; Sutton JM, 2007, CLIN PSYCHOL REV, V27, P552, DOI 10.1016/j.cpr.2007.01.014; Tick NT, 2007, ACTA PSYCHIAT SCAND, V116, P473, DOI 10.1111/j.1600-0447.2007.01068.x; Tomba E, 2010, J ANXIETY DISORD, V24, P326, DOI 10.1016/j.janxdis.2010.01.005; Wagnild G M, 1993, J Nurs Meas, V1, P165; Weissman MM, 1999, JAMA-J AM MED ASSOC, V281, P1707, DOI 10.1001/jama.281.18.1707; Werner-Seidler A, 2017, CLIN PSYCHOL REV, V51, P30, DOI 10.1016/j.cpr.2016.10.005; Yoshikawa H, 2008, DEV PSYCHOL, V44, P344, DOI 10.1037/0012-1649.44.2.344; Yoshikawa H, 2012, AM PSYCHOL, V67, P272, DOI 10.1037/a0028015; Zolkoski SM, 2012, CHILD YOUTH SERV REV, V34, P2295, DOI 10.1016/j.childyouth.2012.08.009	34	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177191	10.1371/journal.pone.0177191	http://dx.doi.org/10.1371/journal.pone.0177191			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481905	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000401313700039
J	Katevatis, C; Fan, A; Klapperich, CM				Katevatis, Constantinos; Fan, Andy; Klapperich, Catherine M.			Low concentration DNA extraction and recovery using a silica solid phase	PLOS ONE			English	Article							NUCLEIC-ACIDS; MICROFLUIDIC DEVICE; WATER INTERFACE; PURIFICATION; DIAGNOSTICS; ADSORPTION; POINT; SURFACES; CHIP	DNA extraction from clinical samples is commonly achieved with a silica solid phase extraction column in the presence of a chaotrope. Versions of these protocols have been adapted for point of care (POC) diagnostic devices in miniaturized platforms, but commercial kits require a high amount of input DNA. Thus, when the input clinical sample contains less than 1 mu g of total DNA, the target-specific DNA recovery from most of these protocols is low without supplementing the sample with exogenous carrier DNA. In fact, many clinical samples used in the development of POC diagnostics often exhibit target DNA concentrations as low as 3 ng/mL. With the broader goal of improving the yield and efficiency of nucleic acid-based POC devices for dilute samples, we investigated both DNA adsorption and recovery from silica particles by using 1 pg- 1 mu g of DNA with a set of adsorption and elution buffers ranging in pH and chaotropic presence. In terms of adsorption, we found that low pH and the presence of chaotropic guanidinium thiocyanate (GuSCN) enhanced DNA-silica adsorption. When eluting with a standard low-salt, high-pH buffer, > 70% of DNA was unrecoverable, except when DNA was initially adsorbed with 5 M GuSCN at pH 5.2. Unrecovered DNA was either not initially adsorbed or irreversibly bound on the silica surface. Recovery was improved when eluting with 95 degrees C formamide and 1 M NaOH, which suggested that DNA-silica- chaotrope interactions are dominated by hydrophobic interactions and hydrogen bonding. While heated formamide and NaOH are non-ideal elution buffers for practical POC devices, the salient results are important for engineering a set of optimized reagents that could maximize nucleic acid recovery from a microfluidic DNA-silica-chaotrope system.	[Katevatis, Constantinos; Klapperich, Catherine M.] Boston Univ, Div Mat Sci & Engn, Boston, MA 02215 USA; [Fan, Andy; Klapperich, Catherine M.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; Boston University	Klapperich, CM (corresponding author), Boston Univ, Div Mat Sci & Engn, Boston, MA 02215 USA.; Klapperich, CM (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	catherin@bu.edu			National Institute of Health: National Institute of Biomedical Imaging and Bioengineering [5U54EB015403]; National Institute of Health: National of Allergy and Infectious Disease [1R56AI113927]; National Institutes of Health NIBIB [5U54EB015403]; NIAID grant [1R56AI113927]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI113927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB015403] Funding Source: NIH RePORTER	National Institute of Health: National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Health: National of Allergy and Infectious Disease; National Institutes of Health NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIAID grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a) National Institute of Health: National Institute of Biomedical Imaging and Bioengineering Grant #5U54EB015403, Recipient: CMK, https://www.nibib.nih.gov; and b) National Institute of Health: National of Allergy and Infectious Disease Grant #1R56AI113927, Recipient: CMK, https://www. niaid.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the National Institutes of Health NIBIB grant 5U54EB015403 and NIAID grant 1R56AI113927.	Bhattacharyya A, 2006, ANAL CHEM, V78, P788, DOI 10.1021/ac051449j; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Byrnes S, 2013, ANAL METHODS-UK, V5, P3177, DOI 10.1039/c3ay40162f; Cady NC, 2003, BIOSENS BIOELECTRON, V19, P59, DOI 10.1016/S0956-5663(03)00123-4; Chatterjee A, 2010, ANAL CHEM, V82, P4344, DOI 10.1021/ac100063f; Chen X, 2007, ANAL CHIM ACTA, V584, P237, DOI 10.1016/j.aca.2006.11.057; Collins KD, 2012, BIOPHYS CHEM, V167, P43, DOI 10.1016/j.bpc.2012.04.002; CRAMERS CA, 1981, CHROMATOGRAPHIA, V14, P439, DOI 10.1007/BF02262882; Gillers S, 2009, J MICROBIOL METH, V78, P203, DOI 10.1016/j.mimet.2009.05.020; Gubala V, 2012, ANAL CHEM, V84, P487, DOI 10.1021/ac2030199; Harris DC., 1996, QUANTITATIVE CHEM AN; HAYNES CA, 1994, J COLLOID INTERF SCI, V164, P394, DOI 10.1006/jcis.1994.1182; Horsman KM, 2007, J FORENSIC SCI, V52, P784, DOI 10.1111/j.1556-4029.2007.00468.x; Kashkary L, 2012, ANAL CHIM ACTA, V750, P127, DOI 10.1016/j.aca.2012.05.019; Kunz W, 2004, CURR OPIN COLLOID IN, V9, P1, DOI 10.1016/j.cocis.2004.05.004; Li X, 2012, LANGMUIR, V28, P2827, DOI 10.1021/la204443j; Melzak KA, 1996, J COLLOID INTERF SCI, V181, P635, DOI 10.1006/jcis.1996.0421; ONG SW, 1992, CHEM PHYS LETT, V191, P327, DOI 10.1016/0009-2614(92)85309-X; Ostroverkhov V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.046102; Pan WY, 2015, CLIN CHEM, V61, P514, DOI 10.1373/clinchem.2014.235457; Park S, 2011, BIOTECHNOL ADV, V29, P830, DOI 10.1016/j.biotechadv.2011.06.017; Pegram LM, 2010, P NATL ACAD SCI USA, V107, P7716, DOI 10.1073/pnas.0913376107; Poeckh T, 2008, ANAL BIOCHEM, V373, P253, DOI 10.1016/j.ab.2007.10.026; Qiagen Qiagen, 2012, RNEASY MINI HDB; Qiagen Qiagen, 2006, DNEASY BLOOD TISSUE, P1; Qiagen Qiagen, 2007, QIAPREP MINIPREP HDB, P1; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Rimola A, 2013, CHEM REV, V113, P4216, DOI 10.1021/cr3003054; Salis A, 2014, CHEM SOC REV, V43, P7358, DOI 10.1039/c4cs00144c; Sambrook J., 2001, MOL CLONING LAB MANU, P1, DOI DOI 10.1002/HUMU.1186.ABS; Su YH, 2004, J MOL DIAGN, V6, P101, DOI 10.1016/S1525-1578(10)60497-7; Tan SC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/574398; Tian HJ, 2000, ANAL BIOCHEM, V283, P175, DOI 10.1006/abio.2000.4577; Toner M, 2005, ANNU REV BIOMED ENG, V7, P77, DOI 10.1146/annurev.bioeng.7.011205.135108; Vandeventer PE, 2013, J PHYS CHEM B, V117, P10742, DOI 10.1021/jp405753m; Vandeventer PE, 2012, J PHYS CHEM B, V116, P5661, DOI 10.1021/jp3017776; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020	37	52	55	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176848	10.1371/journal.pone.0176848	http://dx.doi.org/10.1371/journal.pone.0176848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475611	Green Submitted, gold, Green Published			2022-12-27	WOS:000400649500019
J	Liu, CL; Zhang, Y; Jiang, H; Wu, H				Liu, Chunli; Zhang, Yi; Jiang, Hong; Wu, Hui			Association between social support and post-traumatic stress disorder symptoms among Chinese patients with ovarian cancer: A multiple mediation model	PLOS ONE			English	Article							BREAST-CANCER; PTSD SYMPTOMS; PSYCHOMETRIC PROPERTIES; PSYCHOLOGICAL DISTRESS; DEPRESSIVE SYMPTOMS; COST-EFFECTIVENESS; RESILIENCE; WOMEN; PREVALENCE; HOPE		[Liu, Chunli] Lib China Med Univ, Shenyang, Liaoning, Peoples R China; [Liu, Chunli; Wu, Hui] China Med Univ, Coll Publ Hlth, Dept Social Med, Shenyang, Liaoning, Peoples R China; [Zhang, Yi] China Med Univ, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China; [Jiang, Hong] China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Wu, H (corresponding author), China Med Univ, Coll Publ Hlth, Dept Social Med, Shenyang, Liaoning, Peoples R China.	hwu@cmu.edu.cn	Liu, Chunli/K-4147-2019; 刘, 春丽/Y-6158-2018	刘, 春丽/0000-0002-3671-6487				Andrykowski MA, 1998, J TRAUMA STRESS, V11, P189, DOI 10.1023/A:1024490718043; [Anonymous], IOSR J HUMANITIES SO; Ardino V, 2013, EUR J PSYCHOTRAUMATO, V4; Auxemery Y, 2012, ENCEPHALE, V38, P373, DOI 10.1016/j.encep.2011.12.003; Bastani F, 2012, JOUNAL CLIN NURSING, V1, P23; Besser A, 2014, J CLIN PSYCHOL, V70, P1227, DOI 10.1002/jclp.22083; Bjorge T, 1998, INT J CANCER, V75, P663, DOI 10.1002/(SICI)1097-0215(19980302)75:5<663::AID-IJC1>3.0.CO;2-X; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; Brancu M, 2014, PSYCHIAT RES, V217, P86, DOI 10.1016/j.psychres.2014.02.025; BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cohen J, 2003, J ROY STAT SOC, V52, P227; Solano JPC, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0139-y; Dahl AA, 2016, J CANCER SURVIV, V10, P842, DOI 10.1007/s11764-016-0529-4; Dai WJ, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2871-x; Dinenberg RE, 2014, AM J HEALTH PROMOT, V28, P294, DOI 10.4278/ajhp.121023-QUAN-511; DUNKELSCHETTER C, 1984, J SOC ISSUES, V40, P77, DOI 10.1111/j.1540-4560.1984.tb01108.x; Eskander RN, 2014, GYNECOL ONCOL, V132, P496, DOI 10.1016/j.ygyno.2013.11.029; Evren C, 2016, PSYCHIAT RES, V239, P320, DOI 10.1016/j.psychres.2016.03.049; Fava GA, 2009, J PERS, V77, P1903, DOI 10.1111/j.1467-6494.2009.00604.x; Goncalves V, 2011, J PSYCHOSOM RES, V70, P422, DOI 10.1016/j.jpsychores.2010.09.017; Hamilton AB, 1999, CANCER INVEST, V17, P335, DOI 10.3109/07357909909032875; Hao JH, 2015, INT J ENV RES PUB HE, V12, P6682, DOI 10.3390/ijerph120606682; Herth K, 1991, Sch Inq Nurs Pract, V5, P39; HERTH K, 1992, J ADV NURS, V17, P1251, DOI 10.1111/j.1365-2648.1992.tb01843.x; Holland KD, 2003, PSYCHOL HEALTH, V18, P15, DOI 10.1080/0887044031000080656; Howard S, 2012, ANXIETY STRESS COPIN, V25, P411, DOI 10.1080/10615806.2011.640933; Jacobsen PB, 2002, J CONSULT CLIN PSYCH, V70, P235, DOI 10.1037//0022-006X.70.1.235; Jeantieu M, 2014, J THORAC ONCOL, V9, P362, DOI 10.1097/JTO.0000000000000084; Joscelyne A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145188; Kangas M, 2002, CLIN PSYCHOL REV, V22, P499, DOI 10.1016/S0272-7358(01)00118-0; Kathleen T, 2004, HOLIST NURS PRACT, V10, P45; Kwakkenbos L, 2014, J PSYCHOSOM RES, V76, P485, DOI 10.1016/j.jpsychores.2014.03.103; Li MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154729; Li RH, 2016, PSYCHOPHYSIOLOGY, V53, P705, DOI 10.1111/psyp.12603; Li YX, 2008, J HENAN U SOCIAL SCI, V48, P13; Litz B.T, 1993, PTSD CHECKL PCL REL; Liu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145103; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Mackay HJ, 2010, INT J GYNECOL CANCER, V20, P945, DOI 10.1111/IGC.0b013e3181dd0110; Maley JH, 2016, ANN AM THORAC SOC, V13, P1351, DOI 10.1513/AnnalsATS.201511-782OC; Mattioli JL, 2008, ONCOL NURS FORUM, V35, P822, DOI 10.1188/08.ONF.822-829; McCanlies EC, 2014, STRESS HEALTH, V30, P405, DOI 10.1002/smi.2615; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Mealer M, 2016, J NURS MEAS, V24, P28, DOI 10.1891/1061-3749.24.1.28; Mehnert A, 2007, PSYCHO-ONCOLOGY, V16, P181, DOI 10.1002/pon.1057; Mehnert A, 2009, PSYCHO-ONCOLOGY, V18, P1273, DOI 10.1002/pon.1481; Miller JF, 2007, NURS FORUM, V42, P12, DOI 10.1111/j.1744-6198.2007.00061.x; Miller K, 2006, CANCER J, V12, P388, DOI 10.1097/00130404-200609000-00008; Mo PKH, 2014, AIDS CARE, V26, P1526, DOI 10.1080/09540121.2014.923810; Muramatsu N, 2010, SOC SCI MED, V70, P1050, DOI 10.1016/j.socscimed.2009.12.005; National Cancer Institute, 2016, SEER STAT FACT SHEET; Norton TR, 2004, J CLIN ONCOL, V22, P919, DOI 10.1200/JCO.2004.07.028; O'Connor M, 2011, BRIT J CANCER, V104, P419, DOI 10.1038/sj.bjc.6606073; Office for National Statistics. Cancer Registration Statistics, 2015, ENGL STAT B; Palesh O, 2013, NAT REV CLIN ONCOL, V10, P252, DOI 10.1038/nrclinonc.2013.49; Palgi Y, 2011, EUR J ONCOL NURS, V15, P454, DOI 10.1016/j.ejon.2010.11.011; Phillips-Salimi CR, 2007, J NURS MEAS, V15, P3, DOI 10.1891/106137407780851769; Pinar G, 2012, CANCER NURS, V35, P229, DOI 10.1097/NCC.0b013e31822c47bd; Plamadeala V, 2015, GYNECOL ONCOL, V136, P94, DOI 10.1016/j.ygyno.2014.11.019; Poonawalla IB, 2015, VALUE HEALTH, V18, P387, DOI 10.1016/j.jval.2015.01.005; Posluszny DM, 2015, HEAD NECK-J SCI SPEC, V37, P1282, DOI 10.1002/hed.23760; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Ruiz-Robledillo N, 2014, RES DEV DISABIL, V35, P686, DOI 10.1016/j.ridd.2013.12.007; Shand LK, 2015, PSYCHO-ONCOLOGY, V24, P190, DOI 10.1002/pon.3627; Short NA, 2015, J ANXIETY DISORD, V35, P68, DOI 10.1016/j.janxdis.2015.09.004; Sippel LM, 2015, ECOL SOC, V20, DOI 10.5751/ES-07832-200410; Snyder C.R., 2000, HDB HOPE THEORY MEAS; Sripada RK, 2015, PSYCHIAT SERV, V66, P65, DOI 10.1176/appi.ps.201400029; Suryawanshi S, 2013, CLIN CANCER RES, V19, P1213, DOI 10.1158/1078-0432.CCR-12-2726; Tanimukai H, 2013, AM J HOSP PALLIAT ME, V30, P359, DOI 10.1177/1049909112452334; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; Thomas KS, 2012, PSYCHONEUROENDOCRINO, V37, P1181, DOI 10.1016/j.psyneuen.2011.12.008; Vin-Raviv N, 2013, JNCI-J NATL CANCER I, V105, P563, DOI 10.1093/jnci/djt024; Wang Y., 2010, CHINESE NURSING RES, V24, P20, DOI [DOI 10.3969/J.ISSN.1009-6493.2010.01.008, 10.3969/j.issn.1009-6493.2010.01.008]; Wang Y, 2015, PSYCHO-ONCOLOGY, V24, P1701, DOI 10.1002/pon.3838; Wenzel LB, 2002, PSYCHO-ONCOLOGY, V11, P142, DOI 10.1002/pon.567; Wilks SE, 2008, AGING MENT HEALTH, V12, P357, DOI 10.1080/13607860801933323; Wright AM, 2016, J IMMIGR MINOR HLTH; Wu KK., 2008, HONG KONG J PSYCHIAT, V18, P144; [吴明 Wu Ming], 2015, [中国公共卫生, China Journal of Public Health], V31, P101; Yang YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155607	83	16	16	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177055	10.1371/journal.pone.0177055	http://dx.doi.org/10.1371/journal.pone.0177055			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475593	gold, Green Published, Green Submitted			2022-12-27	WOS:000400649500038
J	Qin, M; Li, L; Liu, X; Liu, T; Shi, SB				Qin, Mu; Li, Li; Liu, Xu; Liu, Tao; Shi, Shao Bo			Neural substrate of posterior left atrium: A novel modulation for inducibility and remodeling of atrial fibrillation in canine	PLOS ONE			English	Article							GANGLIONATED PLEXI ABLATION; PULMONARY VEINS; PARASYMPATHETIC BLOCKADE; HEART-FAILURE; STIMULATION; ACTIVATION	Background The neural mechanism of posterior left atrium (PLA) for genesis of atrial fibrillation has not been completely elucidated. We sought to assess the contribution of PLA denervation on atrial fibrillation (AF) inducibility and atrial remodeling. Methods and results After left thoracotomy in anesthetized dogs (n = 32), electrode catheters were attached to the PLA, left atrial roof, left pulmonary vein and left atrial appendage. Experiment 1 (n = 16): Vagal stimulation (VS group, n = 8) led to more pronounced ERP shortening in PLA than in other sites (CTL: 71 +/- 7 ms vs VS: 52 +/- 6 ms, P<0.05;). Compared with control group (CTL group, n = 8), atropine alone or with propranolol applied to PLA greatly inhibited VS-induced ERP shortening, ERP dispersion increase, and AF inducibility in the left atrium (P<0.05); but ERP was not significantly different between atropine alone and DB conditions (Atro: 85 +/- 8 ms vs DB: 90 +/- 9ms, P>0.05). In addition, domain frequency (DF) of VS-induced AF waveform was not affected by atropine alone, while selective double autonomic blockade at PLA significantly decreased DF at all sites (P<0.05). Experiment 2 (n = 16): In group 1 (n = 8), ERP was markedly shortened in the first 2 hours (11 +/- 19% decrease) and then stabilized; however, WOV was progressively widened throughout the 6 hours rapid atrial pacing (BS: 51 +/- 9ms vs 6th hour: 161 +/- 30ms, P<0.05). After drug application, ERP was increased in all sites of atria, the ERP dispersion was significantly decreased (Atro: 2.36 +/- 0.02 vs 6th hour: 5.09 +/- 0.07, P<0.05) and AF could be induced in only 1 of 8 dogs. In group 2 (n = 8), 6 hours rapid atrial pacing failed to shorten the ERP and increased ERP dispersion, and only 2 episodes of AF could be induced (WOV = 0). Conclusion Local denervation of PLA, as predominant atrial autonomic profile, greatly inhibits AF inducibility and atrial remodeling.	[Qin, Mu; Liu, Xu] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cardiol, Shanghai, Peoples R China; [Li, Li] China Three Gorges Univ, Coll Clin Med Sci 1, Dept Cardiol, Yichang, Peoples R China; [Liu, Tao; Shi, Shao Bo] Wuhan Univ, Cardiovasc Res Inst, Wuhan, Peoples R China	Shanghai Jiao Tong University; China Three Gorges University; Wuhan University	Qin, M (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cardiol, Shanghai, Peoples R China.	qinmu-1001@live.cn			National Natural Science Foundation of China [81400246]; China Postdoctoral Science Foundation [2015M571570]; National Natural Science Foundation of China [81400246]; China Postdoctoral Science Foundation [2015M571570]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was supported by National Natural Science Foundation of China Grants (Grant No: 81400246) and China Postdoctoral Science Foundation Grant (Grant No: 2015M571570).	Armour JA, 2008, EXP PHYSIOL, V93, P165, DOI 10.1113/expphysiol.2007.041178; Arora R, 2008, AM J PHYSIOL-HEART C, V294, pH134, DOI 10.1152/ajpheart.00732.2007; Arora R, 2007, J AM COLL CARDIOL, V49, P1340, DOI 10.1016/j.jacc.2006.10.075; Atienza F, 2006, CIRCULATION, V114, P2434, DOI 10.1161/CIRCULATIONAHA.106.633735; Choi EK, 2010, CIRCULATION, V121, P2615, DOI 10.1161/CIRCULATIONAHA.109.919829; Driessen AHG, 2016, J AM COLL CARDIOL, V68, P1155, DOI 10.1016/j.jacc.2016.06.036; Gao CH, 2011, AUTON NEUROSCI-BASIC, V162, P42, DOI 10.1016/j.autneu.2011.03.004; Habel N, 2011, PACE, V34, P1460, DOI 10.1111/j.1540-8159.2011.03212.x; Hou YL, 2007, J AM COLL CARDIOL, V50, P61, DOI 10.1016/j.jacc.2007.02.066; Hou YL, 2007, HEART RHYTHM, V4, P56, DOI 10.1016/j.hrthm.2006.09.020; Ng J, 2011, CIRC-ARRHYTHMIA ELEC, V4, P388, DOI 10.1161/CIRCEP.110.959650; Jones DL, 2008, J INTERV CARD ELECTR, V21, P187, DOI 10.1007/s10840-008-9205-6; Katritsis DG, 2013, J AM COLL CARDIOL, V62, P2318, DOI 10.1016/j.jacc.2013.06.053; Lee KW, 2006, CIRCULATION, V114, P1703, DOI 10.1161/CIRCULATIONAHA.106.624320; Mikhaylov E, 2011, EUROPACE, V13, P362, DOI 10.1093/europace/euq416; Oliveira M, 2012, REV PORT CARDIOL, V31, P215, DOI 10.1016/j.repc.2012.01.007; Patterson E, 2005, HEART RHYTHM, V2, P624, DOI 10.1016/j.hrthm.2005.02.012; Pokushalov E, 2009, HEART RHYTHM, V6, P1257, DOI 10.1016/j.hrthm.2009.05.018; Suenari K, 2011, BASIC RES CARDIOL, V106, P65, DOI 10.1007/s00395-010-0132-1; Tamborero D, 2009, CIRC-ARRHYTHMIA ELEC, V2, P35, DOI 10.1161/CIRCEP.108.797944; Yamazaki M, 2012, PROG BIOPHYS MOL BIO, V110, P269, DOI 10.1016/j.pbiomolbio.2012.08.004; Zhao QY, 2008, INT J CARDIOL, V126, P352, DOI 10.1016/j.ijcard.2007.04.050	22	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176626	10.1371/journal.pone.0176626	http://dx.doi.org/10.1371/journal.pone.0176626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475580	Green Published, Green Submitted, gold			2022-12-27	WOS:000400649500011
J	Wang, YH; Ding, FR; Wang, T; Liu, WJ; Lindquist, S; Hernell, O; Wang, JW; Li, J; Li, L; Zhao, YF; Dai, YP; Li, N				Wang, Yuhang; Ding, Fangrong; Wang, Tao; Liu, Wenjie; Lindquist, Susanne; Hernell, Olle; Wang, Jianwu; Li, Jing; Li, Ling; Zhao, Yaofeng; Dai, Yunping; Li, Ning			Purification and characterization of recombinant human bile salt-stimulated lipase expressed in milk of transgenic cloned cows	PLOS ONE			English	Article							CARBOXYL ESTER HYDROLASE; PROLINE-RICH REPEATS; BINDS DC-SIGN; ACTIVATED LIPASE; PRETERM INFANTS; PANCREATIC-JUICE; PICHIA-PASTORIS; LIPID DIGESTION; GLYCOSYLATION; ABSORPTION	Bile salt-stimulated lipase (BSSL) is a lipolytic digestive enzyme with broad substrate specificity secreted from exocrine pancreas into the intestinal lumen in all species and from the lactating mammary gland into the milk of some species, notably humans but not cows. BSSL in breast milk facilitates digestion and absorption of milk fat and promotes growth of small for gestational age preterm infants. Thus, purified recombinant human BSSL (rhBSSL) can be used for treatment of patients with fat malabsorption and expressing rhBSSL in the milk of transgenic cloned cows would therefore be a mean to meet a medical need. In the present study, a vector pBAC-hLF-hBSSL was constructed, which efficiently expressed active rhBSSL in milk of transgenic cloned cows to a concentration of 9.8 mg/ml. The rhBSSL purified from cow milk had the same enzymatic activity, N-terminal amino acid sequence, amino acid composition and isoelectric point and similar physicochemical characteristics as human native BSSL. Our study supports the use of transgenic cattle for the cost-competitive, large-scale production of therapeutic rhBSSL.	[Wang, Yuhang; Ding, Fangrong; Wang, Tao; Liu, Wenjie; Wang, Jianwu; Li, Jing; Li, Ling; Zhao, Yaofeng; Dai, Yunping; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Lindquist, Susanne; Hernell, Olle] Umea Univ, Pediat, Dept Clin Sci, Umea, Sweden	China Agricultural University; Umea University	Dai, YP; Li, N (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China.	daiyunping@sina.com; ninglcau@cau.edu.cn			China transgenic project [2016ZX08010005, 2014ZX08007001]	China transgenic project	This work was supported by China transgenic project. Project number 2016ZX08010005, 2014ZX08007001.; This study was supported by China transgenic project, 2016ZX08010005 to YZ and 2014ZX08007001 to YD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2009, J PEDIATR GASTR NUTR, V49, P112, DOI 10.1097/MPG.0b013e31819f1e05; Andersson EL, 2011, J LIPID RES, V52, P1949, DOI 10.1194/jlr.M015685; Andersson Y, 2007, ACTA PAEDIATR, V96, P1445, DOI 10.1111/j.1651-2227.2007.00450.x; BLACKBERG L, 1995, EUR J BIOCHEM, V228, P817, DOI 10.1111/j.1432-1033.1995.tb20327.x; BLACKBERG L, 1983, FEBS LETT, V157, P337, DOI 10.1016/0014-5793(83)80571-7; BLACKBERG L, 1981, EUR J BIOCHEM, V116, P221, DOI 10.1111/j.1432-1033.1981.tb05322.x; BLACKBERG L, 1985, J PEDIATR GASTR NUTR, V4, P441, DOI 10.1097/00005176-198506000-00020; Blackberg L, 1997, METHOD ENZYMOL, V284, P185; BLACKBERG L, 1981, FEBS LETT, V136, P284, DOI 10.1016/0014-5793(81)80636-9; Casper C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156071; Casper C, 2014, J PEDIATR GASTR NUTR, V59, P61, DOI 10.1097/MPG.0000000000000365; Fontbonne H, 2011, J BIOCHEM, V149, P145, DOI 10.1093/jb/mvq132; FREDRIKZON B, 1978, PEDIATR RES, V12, P1048, DOI 10.1203/00006450-197811000-00004; Garcia C, 2013, Cell Mol Biol (Noisy-le-grand), V59, P108; HANSSON L, 1993, J BIOL CHEM, V268, P26692; HERNELL O, 1982, PEDIATR RES, V16, P882, DOI 10.1203/00006450-198210000-00016; HERNELL O, 1974, BIOCHIM BIOPHYS ACTA, V369, P234, DOI 10.1016/0005-2760(74)90254-9; HERNELL O, 1975, EUR J CLIN INVEST, V5, P267, DOI 10.1111/j.1365-2362.1975.tb02294.x; HERNELL O, 1991, ENCY HUMAN BIOL, V3, P47; Hernell O, 2011, NESTLE NUTR WORKS SE, V67, P17, DOI 10.1159/000325572; Howles PN, 1999, AM J PHYSIOL-GASTR L, V277, pG653, DOI 10.1152/ajpgi.1999.277.3.G653; HUI DY, 1990, FEBS LETT, V276, P131, DOI 10.1016/0014-5793(90)80525-N; LEBENTHAL E, 1980, PEDIATRICS, V66, P556; Li X, 2007, PEDIATR RES, V62, P537, DOI 10.1203/PDR.0b013e3181559e75; Lindquist S, 2010, CURR OPIN CLIN NUTR, V13, P314, DOI 10.1097/MCO.0b013e328337bbf0; Liu B, 2013, BREASTFEED MED, V8, P354, DOI 10.1089/bfm.2013.0016; LOMBARDO D, 1980, BIOCHIM BIOPHYS ACTA, V611, P147, DOI 10.1016/0005-2744(80)90050-9; Lu D, 2016, SCI REP-UK, V6, DOI 10.1038/srep22947; Murasugi A, 2001, PROTEIN EXPRES PURIF, V23, P282, DOI 10.1006/prep.2001.1509; Naarding MA, 2005, J CLIN INVEST, V115, P3256, DOI 10.1172/JCI25105; Naarding MA, 2006, ANTIMICROB AGENTS CH, V50, P3367, DOI 10.1128/AAC.00593-06; Niemi LD, 2009, CARIES RES, V43, P171, DOI 10.1159/000213888; NILSSON J, 1990, EUR J BIOCHEM, V192, P543, DOI 10.1111/j.1432-1033.1990.tb19259.x; Nyberg L, 1998, J PEDIATR GASTR NUTR, V27, P560, DOI 10.1097/00005176-199811000-00013; Poorkhalkali N, 1998, HISTOCHEM CELL BIOL, V110, P367, DOI 10.1007/s004180050297; Ruvoen-Clouet N, 2006, BIOCHEM J, V393, P627, DOI 10.1042/BJ20050898; Sahasrabudhe AV, 1998, PROTEIN EXPRES PURIF, V14, P425, DOI 10.1006/prep.1998.0974; Stromqvist M, 1996, TRANSGENIC RES, V5, P475, DOI 10.1007/BF01980213; Stromqvist M, 1995, J CHROMATOGR A, V718, P53, DOI 10.1016/0021-9673(95)00632-X; Uauy R, 2003, J PEDIATR-US, V143, pS17, DOI 10.1067/S0022-3476(03)00398-6; WANG CS, 1989, AM J CLIN NUTR, V49, P457, DOI 10.1093/ajcn/49.3.457; WANG CS, 1980, ANAL BIOCHEM, V105, P398, DOI 10.1016/0003-2697(80)90476-5; WANG CS, 1983, ANAL BIOCHEM, V133, P457, DOI 10.1016/0003-2697(83)90108-2; Wang J, 2008, J DAIRY SCI, V91, P4466, DOI 10.3168/jds.2008-1189; Wang YY, 2015, MOL BIOTECHNOL, V57, P287, DOI 10.1007/s12033-014-9822-5; WARDELL JM, 1984, PEDIATR RES, V18, P382, DOI 10.1203/00006450-198404000-00017; WILLIAMSON S, 1978, ARCH DIS CHILD, V53, P555, DOI 10.1136/adc.53.7.555; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017593; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Zbacnik TJ, 2017, J PHARM SCI-US, V106, P713, DOI 10.1016/j.xphs.2016.11.014	50	9	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176864	10.1371/journal.pone.0176864	http://dx.doi.org/10.1371/journal.pone.0176864			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475629	Green Submitted, Green Published, gold			2022-12-27	WOS:000400649500022
J	Xu, WH; Hole, K; Goolia, M; Pickering, B; Salo, T; Lung, O; Nfon, C				Xu, Wanhong; Hole, Kate; Goolia, Melissa; Pickering, Bradley; Salo, Tim; Lung, Oliver; Nfon, Charles			Genome wide analysis of the evolution of Senecavirus A from swine clinical material and assembly yard environmental samples	PLOS ONE			English	Article							IDIOPATHIC VESICULAR DISEASE; PHYLOGENETIC ANALYSIS; ONCOLYTIC PICORNAVIRUS; VALLEY-VIRUS; TRANSMISSION; PIGS; INFECTION; OUTBREAK; GENUS	Senecavirus A (SVA), previously known as Seneca Valley virus, was first isolated in the United States in 2002. SVA was associated with porcine idiopathic vesicular disease in Canada and the USA in 2007 and 2012, respectively. Recent increase in SVA outbreaks resulting in neonatal mortality of piglets and/or vesicular lesions in sows in Brazil, the USA and Canada point to the necessity to study the pathogenicity and molecular epidemiology of the virus. Here, we report the analysis of the complete coding sequences of SVA from 2 clinical cases and 9 assembly yard environmental samples collected in 2015 in Canada, along with 22 previously released complete genomes in the GenBank. With this combined data set, the evolution of the SVA over a 12-month period in 2015/2016 was evaluated. These SVA isolates were characterized by a rapid accumulation of genetic variations driven mainly by a high nucleotide substitution rate and purifying selection. The SVA sequences clustered in clearly defined geographical areas with reported cases of SVA infection. No transmission links were identified between assembly yards, suggesting that point source introductions may have occurred. In addition, 25 fixed non-synonymous mutations were identified across all analyzed strains when compared to the prototype SVA strain (SVV-001). This study highlights the importance of monitoring SVA mutations for their role in increased virulence and impact on SVA diagnostics.	[Xu, Wanhong; Hole, Kate; Goolia, Melissa; Pickering, Bradley; Salo, Tim; Lung, Oliver; Nfon, Charles] Canadian Food Inspect Agcy, NCFAD, Winnipeg, MB, Canada	Canadian Food Inspection Agency	Nfon, C (corresponding author), Canadian Food Inspect Agcy, NCFAD, Winnipeg, MB, Canada.	Charles.nfon@inspection.gc.ca			CFIA; Canadian Food Inspection Agency	CFIA; Canadian Food Inspection Agency	We thank the Manitoba Agriculture and Rural Initiatives and Ontario CFIA staff veterinarians for sample collection, and the CFIA for funding this study. We also thank Drs. Alfonso Clavijo and John Copps for review of the manuscript.; This work was supported by the Canadian Food Inspection Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Cattoli G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004842; Cottam EM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000050; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2002, GENETICS, V161, P1307; Fukai K, 2015, J VET DIAGN INVEST, V27, P516, DOI 10.1177/1040638715584156; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Hales LM, 2008, J GEN VIROL, V89, P1265, DOI 10.1099/vir.0.83570-0; Hicks AL, 2011, J VIROL, V85, P7942, DOI 10.1128/JVI.02535-10; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Joshi LR, 2016, J GEN VIROL, V97, P3267, DOI 10.1099/jgv.0.000631; Kitching R.P., 1987, REV SCI TECH OIE, V6, P263, DOI DOI 10.20506/RST.6.1.291; Kittelberger R, 2015, TRANSBOUND EMERG DIS; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Lam TTY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000130; LaRocco M, 2015, J CLIN MICROBIOL, V53, P755, DOI 10.1128/JCM.03220-14; Leme RA, 2015, TRANSBOUND EMERG DIS, V62, P603, DOI 10.1111/tbed.12430; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; MARTINEZ HM, 1983, NUCLEIC ACIDS RES, V11, P4629, DOI 10.1093/nar/11.13.4629; Montiel N, 2016, EMERG INFECT DIS, V22, P1246, DOI 10.3201/eid2207.151863; Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007; Pasma T, 2008, CAN VET J, V49, P84; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Rambaut A, FIGTREE V 1 4 2; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Singh K., 2012, J VET SCI TECHNOL, V3, P1; TAMURA K., 2015, MEGA7 MOL EVOLUTIONA; Vannucci FA, 2015, TRANSBOUND EMERG DIS, V62, P589, DOI 10.1111/tbed.12410; Venkataraman S, 2008, STRUCTURE, V16, P1555, DOI 10.1016/j.str.2008.07.013; VOSLOO W, 1992, EPIDEMIOL INFECT, V109, P547, DOI 10.1017/S0950268800050536; Wu Q., 2016, GENOME ANNOUNC, V4; Xu WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30858; Yang M, 2012, J VET DIAGN INVEST, V24, P42, DOI 10.1177/1040638711426323	35	36	43	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176964	10.1371/journal.pone.0176964	http://dx.doi.org/10.1371/journal.pone.0176964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475630	gold, Green Published, Green Submitted			2022-12-27	WOS:000400649500031
J	Bwalya, EC; Kim, S; Fang, J; Wijekoon, HMS; Hosoya, K; Okumura, M				Bwalya, Eugene C.; Kim, Sangho; Fang, Jing; Wijekoon, H. M. Suranji; Hosoya, Kenji; Okumura, Masahiro			Pentosan polysulfate inhibits IL-1 beta-induced iNOS, c-Jun and HIF-1 alpha upregulation in canine articular chondrocytes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; EXPERIMENTAL OSTEOARTHRITIS; NUCLEAR TRANSLOCATION; SELECTIVE-INHIBITION; HYPOXIA PROMOTES; CPG SITES; EXPRESSION; CARTILAGE; INTERLEUKIN-1	Osteoarthritic (OA) chondrocytes are shown to express inducible nitric oxide synthase (iNOS) which produces high concentrations of nitric oxide (NO), particularly when stimulated with proinflammatory cytokines. NO is involved in OA cartilage degradation. On the other hand, c-Jun N-terminal Kinase (JNK) pathway mediates the activation and transcription of c-Jun, which is required for interleukin-1 (IL-1)-induction of matrix metalloproteinases-13 (MMP-13) in OA pathogenesis. Therefore, the selective inhibition of iNOS and c-Jun is a promising target for treatment and prevention of OA. The purpose of the study was to investigate the inhibitory effects of pentosan polysulfate (PPS) on IL-1 beta-induced iNOS, c-Jun and HIF-alpha isoforms upregulation in canine articular chondrocytes (CACs). Primary (P0) chondrocytes were isolated and cultured from femoral head cartilages of three (3) dogs. First passage (P1) chondrocytes were preincubated with 0, 1, 5, 15 and 40 mu g/mL of PPS for 4 hr before treatment with 10 ng/mL rhIL-1 beta for a further 8 hr. In addition, we evaluated the effects of single and multiple cytokine with or without LPS on iNOS protein induction. PPS significantly inhibited (P < 0.05) IL-1 beta-induced iNOS, c-Jun and HIF-1 alpha mRNA upregulation in a dose-dependent pattern. iNOS mRNA was significantly inhibited at 15 and 40 mu g/mL whereas c-Jun and HIF-1 alpha were significantly downregulated at 5, 15 and 40 mu g/mL of PPS compared to chondrocytes treated with only rhIL-1 beta. Intriguingly, CACs were recalcitrant to single IL-1 beta, TNF-alpha or LPS-induction of iNOS protein including to a combination of IL-1 beta+TNF-alpha, IL-1 beta+LPS except to TNF-alpha+LPS and IL-1 beta+TNF-alpha+LPS suggestive of a protective mechanism from iNOS detrimental effects on perpetuating OA. IL-1 beta+TNF-alpha+LPS-induced iNOS protein expression was significantly abrogated by PPS. We demonstrate for the first time that PPS is a novel inhibitor of IL-1 beta-induced iNOS, c-Jun, and HIF-1 alpha mRNA upregulation and iNOS protein induction which may be beneficial for prevention and treatment OA.	[Bwalya, Eugene C.; Kim, Sangho; Fang, Jing; Wijekoon, H. M. Suranji; Hosoya, Kenji; Okumura, Masahiro] Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Vet Surg, Sapporo, Hokkaido, Japan	Hokkaido University	Bwalya, EC (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Vet Surg, Sapporo, Hokkaido, Japan.	eugenelb2000@yahoo.com	Bwalya, Eugene/AAD-8172-2021; Okumura, Masahiro/AAO-4766-2021	Bwalya, Eugene/0000-0002-2887-3116; 	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the government of Japan [MEXT 133003]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the government of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors also state that the first author, Eugene C Bwalya has a scholarship (Scholarship ID: MEXT 133003) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the government of Japan. All the authors declare that the provider of the scholarship for the first author had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaganur V, 2014, J PHARM PHARMACOL, V66, P1021, DOI 10.1111/jphp.12228; Bohensky J, 2009, ARTHRITIS RHEUM-US, V60, P1406, DOI 10.1002/art.24444; Boileau C, 2002, ARTHRITIS RHEUM, V46, P2637, DOI 10.1002/art.10518; Budsberg SC, 2007, VET SURG, V36, P234, DOI 10.1111/j.1532-950X.2007.00256.x; Campo GM, 2009, J CELL BIOCHEM, V106, P83, DOI 10.1002/jcb.21981; Cheung KSC, 2009, RHEUMATOL INT, V29, P525, DOI 10.1007/s00296-008-0744-z; Coimbra IB, 2004, OSTEOARTHR CARTILAGE, V12, P336, DOI 10.1016/j.joca.2003.12.005; de Andres MC, 2013, ARTHRITIS RHEUM-US, V65, P732, DOI 10.1002/art.37806; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; FORSTERMANN U, 1995, N-S ARCH PHARMACOL, V352, P351; Freshney I.R, 2010, CULTURE ANIMAL CELLS; Ghosh P, 1999, SEMIN ARTHRITIS RHEU, V28, P211, DOI 10.1016/S0049-0172(99)80021-3; Ghosh P, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2935; Giatromanolaki A, 2003, ARTHRITIS RES THER, V5, pR193, DOI 10.1186/ar756; Imagawa K, 2011, BIOCHEM BIOPH RES CO, V405, P362, DOI 10.1016/j.bbrc.2011.01.007; Innes JF, 2000, VET REC, V146, P433, DOI 10.1136/vr.146.15.433; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JARVINEN TAH, 1995, MEDIAT INFLAMM, V4, P107, DOI 10.1155/S0962935195000184; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Krasnokutsky S, 2008, OSTEOARTHR CARTILAGE, V16, pS1, DOI 10.1016/j.joca.2008.06.025; Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200; Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878; Le Graverand-Gastineau MPH, 2009, OSTEOARTHR CARTILAGE, V17, P1393, DOI 10.1016/j.joca.2009.04.009; Loeser RF, 2009, OSTEOARTHR CARTILAGE, V17, P513, DOI 10.1016/j.joca.2008.08.003; MacPhail CM, 2000, WALTHAM FOCUS, V10, P25; MCCARTNEYFRANCIS N, 1993, J EXP MED, V178, P749, DOI 10.1084/jem.178.2.749; Mendes AF, 2002, NITRIC OXIDE-BIOL CH, V6, P35, DOI 10.1006/niox.2001.0378; Mendes AF, 2002, INFLAMM RES, V51, P369, DOI 10.1007/PL00000317; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Murphy CL, 2010, CELL RES, V20, P977, DOI 10.1038/cr.2010.99; MURRELL GAC, 1995, BIOCHEM BIOPH RES CO, V206, P15, DOI 10.1006/bbrc.1995.1003; Otero M, 2005, ARTHRITIS RES THER, V7, pR581, DOI 10.1186/ar1708; PALMER RMJ, 1993, BIOCHEM BIOPH RES CO, V193, P398, DOI 10.1006/bbrc.1993.1637; Pelletier JP, 1999, J RHEUMATOL, V26, P2002; Pelletier JP, 1998, ARTHRITIS RHEUM-US, V41, P1275, DOI 10.1002/1529-0131(199807)41:7<1275::AID-ART19>3.0.CO;2-T; Richard F, 2005, REV ARTIC, V21, P104; Roach HI, 2005, ARTHRITIS RHEUM-US, V52, P3110, DOI 10.1002/art.21300; Sadhukhan PC, 2002, J UROLOGY, V168, P289, DOI 10.1016/S0022-5347(05)64909-9; Saito T, 2010, OSTEOARTHR CARTILAGE, V18, P1552, DOI 10.1016/j.joca.2010.10.006; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; SAKURAI H, 1995, J CLIN INVEST, V96, P2357, DOI 10.1172/JCI118292; Stichtenoth DO, 1998, BRIT J RHEUMATOL, V37, P246; Sunaga T, 2012, J VET MED SCI, V74, P707, DOI 10.1292/jvms.11-0511; TASKIRAN D, 1994, BIOCHEM BIOPH RES CO, V200, P142, DOI 10.1006/bbrc.1994.1426; Thoms BL, 2013, ARTHRITIS RHEUM-US, V65, P1302, DOI 10.1002/art.37867; Thoms BL, 2010, J BIOL CHEM, V285, P20472, DOI 10.1074/jbc.M110.115238; Tung JT, 2002, OSTEOARTHR CARTILAGE, V10, P5, DOI 10.1053/joca.2001.0476; VaughanScott T, 1997, J S AFR VET ASSOC, V68, P21; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Yudoh K, 2005, ARTHRITIS RES THER, V7, pR904, DOI 10.1186/ar1765; ZAFARULLAH M, 1992, FEBS LETT, V306, P169, DOI 10.1016/0014-5793(92)80992-P; Zhong HM, 2013, INT IMMUNOPHARMACOL, V17, P329, DOI 10.1016/j.intimp.2013.06.027	54	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177144	10.1371/journal.pone.0177144	http://dx.doi.org/10.1371/journal.pone.0177144			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472120	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500144
J	Dumont, F; Lucas, E; Reale, D				Dumont, Francois; Lucas, Eric; Reale, Denis			Coexistence of zoophytophagous and phytozoophagous strategies linked to genotypic diet specialization in plant bug	PLOS ONE			English	Article							TUTA ABSOLUTA LEPIDOPTERA; BIOLOGICAL-CONTROL; PREDATORY MIRIDS; PRACTICAL GUIDE; APPLE ORCHARD; POTENTIAL USE; MULLEIN BUG; HEMIPTERA; POPULATIONS; HETEROPTERA	Zoophytophagous predators can substitute zoophagy for phytophagy to complete their development and reproduction. In such predators, variation in feeding behaviour is observed both across and within populations. This may be caused by genetic variation in diet specialization, some genotypes specializing on plant resources, whereas others rely mostly on prey to meet their energy and nutriment requirements. We tested the hypothesis that genotypes specialize either on prey or plant resources in the zoophytophagous mullein bug Campylomma verbasci. In the laboratory, we reared 11 isogroup lines of the mullein bug and recorded feeding behaviour on two diets. The first diet was composed of two-spotted spider mites and leaves, and in the second we added pollen, a high-quality vegetal resource. Overall differences in zoophagy among isogroup lines remained consistent regardless of the presence or absence of pollen. While some lines were insensitive to changes in trophic resource composition others switched from prey to pollen feeding when the pollen was available, revealing a negative genetic correlation between the probabilities of feeding on both resources. A significant line by diet interaction in the proportion of time spent feeding on prey in presence or absence of pollen indicated a genetic basis for diet preference. In absence of the preferred resource, nymphs act as generalists, but exhibited individual diet specialisation when facing the choice between high-quality animal and vegetal resources. Results suggest that zoophytophagous predators can exhibit genetic variation in diet preference, which can generate important ecological and economic differences in natural or agricultural systems.	[Dumont, Francois; Lucas, Eric; Reale, Denis] Univ Quebec Montreal, Dept Sci Biol, CP,Succ Ctr Ville, Montreal, PQ, Canada	University of Quebec; University of Quebec Montreal	Dumont, F (corresponding author), Univ Quebec Montreal, Dept Sci Biol, CP,Succ Ctr Ville, Montreal, PQ, Canada.	dumont.francois.3@courrier.uqam.ca	REALE, Denis/AAG-1571-2020	REALE, Denis/0000-0002-0419-7125; Dumont, Francois/0000-0001-7587-072X	NSERC; NSERC Natural Sciences and Engineering Research Council fellowship; NSERC discovery grants program	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Natural Sciences and Engineering Research Council fellowship; NSERC discovery grants program	Thanks to Pascale Ayotte, Andreanne Lavallee, Laurent Fraser, Sheena-Emilie Boucher and Mailys Allirand for their help in maintenance the isogroup lines and tests. We are grateful to Olivier Aubry for help during rearing setting and discussion on this work. F.D. was supported by a NSERC fellowship. The project expenses were financed by NSERC discovery grants program to E.L and D.R.; FD was supported by a NSERC Natural Sciences and Engineering Research Council (http.//www.nserc-crsng.gc.ca) fellowship. The project expenses were financed by NSERC discovery grants program to EL and DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Arno J, 2010, B ENTOMOL RES, V100, P105, DOI 10.1017/S0007485309006841; Arno J, 2011, J PEST SCI, V84, P513, DOI 10.1007/s10340-011-0384-z; ARNOLDI D, 1992, ENTOMOPHAGA, V37, P283, DOI 10.1007/BF02372429; Aubry O, 2010, FAUN ENTOMOL, V63, P91; Biondi A, 2016, BIOCONTROL, V61, P79, DOI 10.1007/s10526-015-9700-5; BOIVIN G, 1982, CAN ENTOMOL, V114, P1037, DOI 10.4039/Ent1141037-11; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bolnick DI, 2007, P NATL ACAD SCI USA, V104, P10075, DOI 10.1073/pnas.0703743104; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Calvo J, 2009, BIOCONTROL, V54, P237, DOI 10.1007/s10526-008-9164-y; Castane C, 2011, BIOL CONTROL, V59, P22, DOI 10.1016/j.biocontrol.2011.03.007; Coll M, 2002, ANNU REV ENTOMOL, V47, P267, DOI 10.1146/annurev.ento.47.091201.145209; Dall SRX, 2012, ECOL LETT, V15, P1189, DOI 10.1111/j.1461-0248.2012.01846.x; David JR, 2005, HEREDITY, V94, P3, DOI 10.1038/sj.hdy.6800562; Dumont F, 2016, BIOCONTROL, V61, P425, DOI 10.1007/s10526-016-9721-8; Frechette B, 2008, EUR J ENTOMOL, V105, P521, DOI 10.14411/eje.2008.069; HOFFMANN AA, 1988, GENET SEL EVOL, V20, P87, DOI 10.1186/1297-9686-20-1-87; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Kinkorova J, 2000, J APPL ENTOMOL, V124, P381, DOI 10.1046/j.1439-0418.2000.00488.x; Luna MG, 2007, ENVIRON ENTOMOL, V36, P887, DOI 10.1603/0046-225X(2007)36[887:POTALG]2.0.CO;2; Mcgregor RR, 1999, BIOL CONTROL, V16, P104, DOI 10.1006/bcon.1999.0743; MCMULLEN R D, 1970, Canadian Entomologist, V102, P1390; MORETEAU B, 1995, GENETICA, V96, P207, DOI 10.1007/BF01439574; Moser SE, 2009, BIOL CONTROL, V51, P487, DOI 10.1016/j.biocontrol.2009.09.001; Nachappa P, 2011, FUNCT ECOL, V25, P1309, DOI 10.1111/j.1365-2435.2011.01892.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nannini M., 2012, Bulletin OEPP, V42, P255, DOI 10.1111/epp.2563; R Core Team, 2021, R LANGUAGE ENV STAT; Reding ME, 2001, J ECON ENTOMOL, V94, P33, DOI 10.1603/0022-0493-94.1.33; Roitberg BD, 2005, NATURWISSENSCHAFTEN, V92, P431, DOI 10.1007/s00114-005-0013-x; SANFORD KH, 1964, J ECON ENTOMOL, V57, P921, DOI 10.1093/jee/57.6.921; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Svanback R, 2005, EVOL ECOL RES, V7, P993; THISTLEWOOD HMA, 1990, CAN ENTOMOL, V122, P1045, DOI 10.4039/Ent1221045-11; Torres JB, 2010, ARTHROPOD-PLANT INTE, V4, P219, DOI 10.1007/s11829-010-9095-2; Torres X, 1999, INTEGRATED PLANT PRO, V6, P139; WESTOBY M, 1978, AM NAT, V112, P627, DOI 10.1086/283303; Wheeler AG, 2001, BIOL PLANT BUGS; Zappala L, 2013, J PEST SCI, V86, P635, DOI 10.1007/s10340-013-0531-9; Zuur Alain F., 2009, P1	43	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176369	10.1371/journal.pone.0176369	http://dx.doi.org/10.1371/journal.pone.0176369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472105	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500041
J	Hallman, DM; Jorgensen, MB; Holtermann, A				Hallman, David M.; Jorgensen, Marie Birk; Holtermann, Andreas			On the health paradox of occupational and leisure-time physical activity using objective measurements: Effects on autonomic imbalance	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; INFLAMMATORY MARKERS; RISK; EXERCISE; HYPERTENSION; ASSOCIATION; VALIDITY; FITNESS	Objective Leisure-time physical activity (LTPA) has considerable benefits for cardiovascular health and longevity, while occupational physical activity (OPA) is associated with an elevated cardiovascular risk. This "health paradox" may be explained by different effects on the autonomic nervous system from OPA and LTPA. Thus, we aimed to investigate whether objectively measured OPA and LTPA are differentially associated with autonomic regulation among workers. Methods The study comprised 514 blue-collar workers from the Danish cohort DPHACTO. Physical activity (i.e. walking, climbing stairs, running and cycling) was assessed objectively using accelerometers worn on the thigh, hip and trunk over multiple working days. During this period, a heart rate monitor was used to sample heart period intervals from the ECG signal. Heart rate and heart rate variability (HRV) indices were analyzed during nocturnal sleep as markers of autonomic regulation. Multiple regression analysis was used to determine the main effects of OPA and LTPA and their interaction on heart rate and HRV, adjusting for multiple confounders. Results Statistically significant interaction was found between OPA and LTPA on heart rate (adjusted p<0.0001) and HRV indices in time (rMSSD, adjusted p = 0.004) and frequencydomains (HF, adjusted p = 0.022; LF, adjusted p = 0.033). The beneficial effect of LTPA on nocturnal heart rate and HRV clearly diminished with higher levels of OPA, and high levels of both OPA and LTPA had a detrimental effect. Conclusion We found contrasting associations for objectively measured OPA and LTPA with heart rate and HRV during sleep. Differential effects of OPA and LTPA on autonomic regulation may contribute to the physical activity health paradox.	[Hallman, David M.] Univ Gavle, Ctr Musculoskeletal Res, Dept Occupat & Publ Hlth Sci, Gavle, Sweden; [Jorgensen, Marie Birk; Holtermann, Andreas] Natl Res Ctr Working Environm, Copenhagen, Denmark	University of Gavle; National Research Centre for the Working Environment	Hallman, DM (corresponding author), Univ Gavle, Ctr Musculoskeletal Res, Dept Occupat & Publ Hlth Sci, Gavle, Sweden.	david.hallman@hig.se		Jorgensen, Marie Birk/0000-0002-1479-2622; Hallman, David/0000-0002-2741-1868				Ahdesmaki M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-233; Allen K, 2018, EDUC PSYCHOL REV, V30, P1, DOI 10.1007/s10648-016-9389-8; Allesoe K, 2015, EUR J PREV CARDIOL, V22, P1601, DOI 10.1177/2047487314554866; [Anonymous], 2011, JOINT BONE SPINE, DOI DOI 10.1016/j.jbspin.2011.01.014; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Blair SN, 2009, ANN EPIDEMIOL, V19, P253, DOI 10.1016/j.annepidem.2009.01.019; Boyett MR, 2013, J APPL PHYSIOL, V114, P1351, DOI 10.1152/japplphysiol.01126.2012; Camm AJ, 1996, CIRCULATION, V93, P1043; Clays E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1002; Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239; Gerritsen J, 2001, DIABETES CARE, V24, P1793, DOI 10.2337/diacare.24.10.1793; Gupta N, 2016, SCAND J WORK ENV HEA, V42, P237, DOI 10.5271/sjweh.3561; Habib GB, 1999, EUR HEART J SUPPL, V1, pH2; Hallman DM, 2017, PHYSIOL BEHAV, V169, P90, DOI 10.1016/j.physbeh.2016.11.031; Hallman DM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012689; Hallman DM, 2016, INT ARCH OCC ENV HEA, V89, P823, DOI 10.1007/s00420-016-1123-9; Hallman DM, 2015, INT J ENV RES PUB HE, V12, P14811, DOI 10.3390/ijerph121114811; Hallman DM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2339-4; Harari G, 2015, OCCUP ENVIRON MED, V72, P617, DOI 10.1136/oemed-2014-102613; Holtermann A, 2012, BRIT J SPORT MED, V46, P291, DOI 10.1136/bjsm.2010.079582; Holtermann A, 2016, SCAND J WORK ENV HEA, V42, P291, DOI 10.5271/sjweh.3563; Holtermann A, 2015, OCCUP ENVIRON MED, V72, P615, DOI 10.1136/oemed-2015-102933; Holtermann A, 2010, SCAND J WORK ENV HEA, V36, P357, DOI 10.5271/sjweh.2913; Ingebrigtsen J., 2013, J ERGON, V03, P2, DOI DOI 10.4172/2165-7556.1000119; Jensen MT, 2012, EUR J PREV CARDIOL, V19, P102, DOI 10.1177/1741826710394274; Johansen CD, 2013, EUR HEART J, V34, P1732, DOI 10.1093/eurheartj/ehs449; Jorgensen MB, 2013, BMC MUSCULOSKEL DIS, V14, DOI [10.1186/1471-2474-14-213, 10.1186/1471-2474-14-86]; Joyner MJ, 2009, J PHYSIOL-LONDON, V587, P5551, DOI 10.1113/jphysiol.2009.179432; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Korshoj M, 2014, ERGONOMICS, V57, P247, DOI 10.1080/00140139.2013.869358; Krause N, 2015, SCAND J WORK ENV HEA, V41, P124, DOI 10.5271/sjweh.3476; Kristiansen J, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-27; Lahti J, 2014, PLOS ONE, V9; Li J, 2013, CURR OPIN CARDIOL, V28, P575, DOI 10.1097/HCO.0b013e328364289c; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Liao DP, 2002, DIABETES, V51, P3524, DOI 10.2337/diabetes.51.12.3524; Liao DP, 1996, AM J HYPERTENS, V9, P1147, DOI 10.1016/S0895-7061(96)00249-X; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; Myllymaki T, 2011, J SLEEP RES, V20, P146, DOI 10.1111/j.1365-2869.2010.00874.x; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; Pejtersen JH, 2010, SCAND J PUBLIC HEALT, V38, P8, DOI 10.1177/1403494809349858; Reiner M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-813; Rennie KL, 2003, AM J EPIDEMIOL, V158, P135, DOI 10.1093/aje/kwg120; Sandercock GRH, 2005, MED SCI SPORT EXER, V37, P433, DOI 10.1249/01.MSS.0000155388.39002.9D; Schuster AK, 2016, INT J CARDIOL, V203, P728, DOI 10.1016/j.ijcard.2015.11.027; Skotte J, 2014, J PHYS ACT HEALTH, V11, P76, DOI 10.1123/jpah.2011-0347; Skotte JH, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-138; Sloan RP, 2007, MOL MED, V13, P178, DOI 10.2119/2006-00112.Sloan; Soares-Miranda L, 2014, CIRCULATION, V129, P2100, DOI 10.1161/CIRCULATIONAHA.113.005361; Stemland I, 2015, ERGONOMICS, V58, P953, DOI 10.1080/00140139.2014.998724; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39	54	46	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177042	10.1371/journal.pone.0177042	http://dx.doi.org/10.1371/journal.pone.0177042			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472190	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500127
J	Lemyre, B; Fusch, C; Schmolzer, GM; Bouali, NR; Reddy, D; Barrowman, N; Huneault-Purney, N; Lacaze-Masmonteil, T				Lemyre, Brigitte; Fusch, Christoph; Schmoelzer, Georg M.; Bouali, Nicole Rouvinez; Reddy, Deepti; Barrowman, Nicholas; Huneault-Purney, Nicole; Lacaze-Masmonteil, Thierry			Poractant alfa versus bovine lipid extract surfactant for infants 24+0 to 31+6 weeks gestational age: A randomized controlled trial	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; TREATMENT REGIMENS; PREMATURE-INFANTS; PRETERM INFANTS; CLINICAL-TRIAL; INSTILLATION; MULTICENTER; SURVANTA; EFFICACY	Objectives To compare the efficacy and safety of poractant alfa and bovine lipid extract surfactant in preterm infants. Study design Randomized, partially-blinded, multicenter trial. Infants <32 weeks needing surfactant before 48 hours were randomly assigned to receive poractant alfa or bovine lipid extract surfactant. The primary outcome was being alive and extubated at 48 hours post-randomization. Secondary outcomes included need for re-dosing, duration of respiratory support and oxygen, bronchopulmonary dysplasia, mortality and complications during administration. Results Three centers recruited 87 infants (mean 26.7 weeks and 906 grams) at a mean age of 5.9 hours, between March 2013 and December 2015. 21/42 (50%) were alive and extubated at 48 hours in the poractant alfa group vs 26/45 (57.8%) in the bovine lipid extract surfactant group; adjusted OR 0.76 (95% CI 0.30-1.93) (p = 0.56). No differences were observed in the need to re-dose. Duration of oxygen support (41.5 vs 62 days; adjusted OR 1.69 95% CI 1.02-2.80; p = 0.04) was reduced in infants who received poractant alfa. We observed a trend in bronchopulmonary dysplasia among survivors (51.5% vs 72.1%; adjusted OR 0.35 95% CI 0.12-1.04; p = 0.06) favoring poractant alfa. Twelve infants died before discharge, 9 in the poractant alfa group and 3 in the bovine lung extract group. Severe airway obstruction following administration was observed in 0 (poractant alfa) and 5 (bovine lipid extract surfactant) infants (adjusted OR 0.09 95%CI < 0.01-1.27; p = 0.07). Conclusion No statistically significant difference was observed in the proportion of infants alive and extubated within 48h between the two study groups. Poractant alfa may be more beneficial and associated with fewer complications than bovine lipid extract surfactant. However, we observed a trend towards higher mortality in the poractant alfa group. Larger studies are needed to determine whether observed possible benefits translate in shorter hospital admissions, or other long term benefits and determine whether there is a difference in mortality.	[Lemyre, Brigitte; Bouali, Nicole Rouvinez; Lacaze-Masmonteil, Thierry] Ottawa Hosp, Dept Obstet Gynecol & Newborn Care, Ottawa, ON, Canada; [Lemyre, Brigitte; Bouali, Nicole Rouvinez; Lacaze-Masmonteil, Thierry] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Lemyre, Brigitte; Bouali, Nicole Rouvinez; Lacaze-Masmonteil, Thierry] Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON, Canada; [Lemyre, Brigitte; Bouali, Nicole Rouvinez; Reddy, Deepti; Barrowman, Nicholas; Lacaze-Masmonteil, Thierry] CHEO Res Inst, Ottawa, ON, Canada; [Fusch, Christoph] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Schmoelzer, Georg M.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Schmoelzer, Georg M.] Royal Alexandra Hosp, Ctr Studies Asphyxia & Resuscitat, Neonatal Res Unit, Edmonton, AB, Canada; [Huneault-Purney, Nicole] Ottawa Hosp, Dept Resp Therapy, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; McMaster University; University of Alberta; Royal Alexandra Hospital; University of Ottawa; Ottawa Hospital Research Institute	Lemyre, B (corresponding author), Ottawa Hosp, Dept Obstet Gynecol & Newborn Care, Ottawa, ON, Canada.; Lemyre, B (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.; Lemyre, B (corresponding author), Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON, Canada.; Lemyre, B (corresponding author), CHEO Res Inst, Ottawa, ON, Canada.	blemyre@toh.on.ca	Lemyre, Brigitte/I-2571-2019; Rouvinez Bouali, Nicole/AGE-6603-2022; Schmölzer, Georg M/E-7883-2010; Barrowman, Nick/AAL-3166-2020	Lemyre, Brigitte/0000-0003-2743-0417; Schmölzer, Georg M/0000-0001-9798-2415; Barrowman, Nick/0000-0002-4704-9595; Reddy, Deepti/0000-0002-0457-1885	AHSCAFP Innovation Fund, Ministry of Health and Long Term Care of Ontario [CHA-12-003]	AHSCAFP Innovation Fund, Ministry of Health and Long Term Care of Ontario	This study was supported by the AHSCAFP Innovation Fund, Ministry of Health and Long Term Care of Ontario (grant # CHA-12-003). The poractant alfa for study patients was provided in kind by Chiesi Farmaceutici. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth SB, 2000, LANCET, V355, P1387, DOI 10.1016/S0140-6736(00)02136-X; Baroutis G, 2003, EUR J PEDIATR, V162, P476, DOI 10.1007/s00431-002-1144-0; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; DOWNES JJ, 1970, CLIN PEDIATR, V9, P325, DOI 10.1177/000992287000900607; DUNN MS, 1991, PEDIATRICS, V87, P377; ENHORNING G, 1985, PEDIATRICS, V76, P145; Fujii AM, 2010, J PERINATOL, V30, P665, DOI 10.1038/jp.2010.20; Halliday HL, 2008, J PERINATOL, V28, pS47, DOI 10.1038/jp.2008.50; Hentschel R, 2002, INTENS CARE MED, V28, P622, DOI 10.1007/s00134-002-1277-7; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Lam BCC, 2005, PEDIATR PULM, V39, P64, DOI 10.1002/ppul.20125; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Peliowski A., 1998, PEDIAT RES, V43; Ramanathan R, 2004, AM J PERINAT, V21, P109, DOI 10.1055/s-2004-823779; Ramanathan R, 2009, J PERINATOL, V29, pS38, DOI 10.1038/jp.2009.31; Seger N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007836; SEGERER H, 1993, PEDIATR RES, V34, P490, DOI 10.1203/00006450-199310000-00021; Singh N, 2011, PEDIATRICS, V128, pE1588, DOI 10.1542/peds.2011-1395; Sinha SK, 2005, PEDIATRICS, V115, P1030, DOI 10.1542/peds.2004-2231; Soll RF., 2000, COCHRANE DB SYST REV, V1997, DOI DOI 10.1002/14651858.CD000511; Soll R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001079.pub2; SPEER CP, 1995, ARCH DIS CHILD-FETAL, V72, pF8, DOI 10.1136/fn.72.1.F8; Tarawneh A, 2011, J PERINATOL; Rojas-Reyes MX, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000510.pub2	24	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175922	10.1371/journal.pone.0175922	http://dx.doi.org/10.1371/journal.pone.0175922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472058	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500019
J	Lin, YC; Chang, SC; Juang, RH				Lin, Yi-Chen; Chang, Shih-Chung; Juang, Rong-Huay			Plastidial alpha-glucan phosphorylase 1 complexes with disproportionating enzyme 1 in Ipomoea batatas storage roots for elevating malto-oligosaccharide metabolism	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SWEET-POTATO ROOTS; STARCH BIOSYNTHETIC-ENZYMES; CHLAMYDOMONAS-REINHARDTII; GRANULE BIOSYNTHESIS; RICE ENDOSPERM; AMYLOPECTIN; PURIFICATION; ARABIDOPSIS; AMYLOPLASTS	It has been proposed that malto-oligosaccharides (MOSs) are possibly recycled back into amylopectin biosynthesis via the sequential reactions catalyzed by plastidial a-glucan phosphorylase 1 (Pho1) and disproportionating enzyme 1 (Dpe1). In the present study, the reciprocal co-immunoprecipitation experiments using specific antibodies against Pho1 and Dpe1 demonstrated that these two enzymes can form a complex (the PD complex) in Ipomoea batatas storage roots. The immunohistochemistry analyses also revealed the co-localization of Pho1 and Dpe1 in the amyloplasts, and the protein levels of Pho1 and Dpe1 increased gradually throughout sweet potato storage root development. A high molecular weight PD complex was co-purified from sweet potato storage root lysates by size exclusion chromatography. Enzyme kinetic analyses showed that the PD complex can catalyze maltotriose and maltotetraose to generate glucose-1-phosphate in the presence of inorganic phosphate, and it also performs greater Dpe1 activity toward MOSs than does free form Dpe1. These data suggest that Pho1 and Dpe1 may form a metabolon complex, which provides elevated metabolic fluxes for MOS metabolism via a direct transfer of sugar intermediates, resulting in recycling of glucosyl units back into amylopectin biosynthesis more efficiently.	[Lin, Yi-Chen; Chang, Shih-Chung; Juang, Rong-Huay] Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, Taipei, Taiwan	National Taiwan University	Chang, SC; Juang, RH (corresponding author), Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, Taipei, Taiwan.	shihchung@ntu.edu.tw; juang@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013	CHANG, SHIH-CHUNG/0000-0002-5015-8178	Ministry of Science and Technology, Taiwan [105-2119-M-001-014, 103-2313-B-002-030-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Ministry of Science and Technology, Taiwan (105-2119-M-001-014 awarded to SCC; 103-2313-B-002-030-MY3 awarded to RHJ), https://www.most.gov.tw/.. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2015, PLANT SCI, V233, P95, DOI 10.1016/j.plantsci.2014.12.016; Ball S, 1996, CELL, V86, P349, DOI 10.1016/S0092-8674(00)80107-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bresolin NS, 2006, PLANTA, V224, P20, DOI 10.1007/s00425-005-0187-7; BRISSON N, 1989, PLANT CELL, V1, P559, DOI 10.1105/tpc.1.5.559; Chang SC, 2000, BOT BULL ACAD SINICA, V41, P105; CHANG TC, 1987, AGR BIOL CHEM TOKYO, V51, P187, DOI 10.1080/00021369.1987.10867980; Chen HM, 2002, PHYSIOL PLANTARUM, V114, P506, DOI 10.1034/j.1399-3054.2002.1140402.x; Colleoni C, 1999, PLANT PHYSIOL, V120, P993, DOI 10.1104/pp.120.4.993; Colleoni C, 1999, PLANT PHYSIOL, V120, P1005, DOI 10.1104/pp.120.4.1005; Critchley JH, 2001, PLANT J, V26, P89, DOI 10.1046/j.1365-313x.2001.01012.x; Crofts N, 2015, J EXP BOT, V66, P4469, DOI 10.1093/jxb/erv212; da Mota RV, 2002, PLANTA, V216, P325, DOI 10.1007/s00425-002-0858-6; Dauvillee D, 2006, PLANT J, V48, P274, DOI 10.1111/j.1365-313X.2006.02870.x; Dong XB, 2015, PLANT PHYSIOL, V169, P2496, DOI 10.1104/pp.15.01411; Fettke J, 2006, PLANT J, V46, P668, DOI 10.1111/j.1365-313X.2006.02732.x; Hwang SK, 2010, ARCH BIOCHEM BIOPHYS, V495, P82, DOI 10.1016/j.abb.2009.12.023; Hwang SK, 2016, J BIOL CHEM; KAKEFUDA G, 1989, PLANT PHYSIOL, V91, P136, DOI 10.1104/pp.91.1.136; Ko YT, 2005, J AGR FOOD CHEM, V53, P5708, DOI 10.1021/jf050193f; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035336; Liu FS, 2009, J EXP BOT, V60, P4423, DOI 10.1093/jxb/erp297; Lutken H, 2010, PLANTA, V232, P1127, DOI 10.1007/s00425-010-1245-3; Mu HH, 2001, ARCH BIOCHEM BIOPHYS, V388, P155, DOI 10.1006/abbi.2000.2267; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Nakamura Y, 2012, PLANT CELL PHYSIOL, V53, P869, DOI 10.1093/pcp/pcs030; Orawetz T, 2016, PLANT PHYSIOL BIOCH, V100, P141, DOI 10.1016/j.plaphy.2016.01.013; Satoh H, 2008, PLANT CELL, V20, P1833, DOI 10.1105/tpc.107.054007; Steup M., 1988, BIOCH PLANTS COMPREH, P255; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Subasinghe RM, 2014, PLANT PHYSIOL BIOCH, V83, P168, DOI 10.1016/j.plaphy.2014.07.016; Sweetlove LJ, 2013, ANNU REV PLANT BIOL, V64, P723, DOI 10.1146/annurev-arplant-050312-120233; Tagami T, 2013, BIOSCI BIOTECH BIOCH, V77, P312, DOI 10.1271/bbb.120732; TAKAHA T, 1993, J BIOL CHEM, V268, P1391; Takaha T, 1998, PLANTA, V205, P445, DOI 10.1007/s004250050342; Tetlow IJ, 2004, PLANT CELL, V16, P694, DOI 10.1105/tpc.017400; Tickle P, 2009, J PLANT PHYSIOL, V166, P1465, DOI 10.1016/j.jplph.2009.05.004; Tiessen A, 2002, PLANT CELL, V14, P2191, DOI 10.1105/tpc.003640; Wattebled F, 2003, PLANT PHYSIOL, V132, P137, DOI 10.1104/pp.102.016527; Young GH, 2006, PLANTA, V223, P468, DOI 10.1007/s00425-005-0103-1; Yu Y, 2001, PLANT PHYSIOL, V125, P351, DOI 10.1104/pp.125.1.351; Zeeman SC, 2004, PLANT PHYSIOL, V135, P849, DOI 10.1104/pp.103.032631	43	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177115	10.1371/journal.pone.0177115	http://dx.doi.org/10.1371/journal.pone.0177115			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472155	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500137
J	Rosenberger, DW; Venette, RC; Maddox, MP; Aukema, BH				Rosenberger, Derek W.; Venette, Robert C.; Maddox, Mitchell P.; Aukema, Brian H.			Colonization behaviors of mountain pine beetle on novel hosts: Implications for range expansion into northeastern North America	PLOS ONE			English	Article							DENDROCTONUS-PONDEROSAE COLEOPTERA; BARK BEETLES; LODGEPOLE PINE; BRITISH-COLUMBIA; MONOTERPENE COMPOSITION; PHEROMONE PRODUCTION; CHEMICAL DEFENSES; PHLOEM THICKNESS; UNITED-STATES; EXOTIC BARK	As climates change, thermal limits may no longer constrain some native herbivores within their historical ranges. The mountain pine beetle, Dendroctonus ponderosae Hopkins, is a tree-killing bark beetle native to western North America that is currently expanding its range. Continued eastward expansion through the newly invaded and novel jack pine (Pinus bank-siana Lamb.) trees of the Canadian boreal forest could result in exposure of several species of novel potential host pines common in northeastern North America to this oligophagous herbivore. Due to the tightly co-evolved relationship between mountain pine beetle and western pine hosts, in which the insect utilizes the defensive chemistry of the host to stimulate mass attacks, we hypothesized that lack of co-evolutionary association would affect the host attraction and acceptance behaviors of this insect among novel hosts, particularly those with little known historical association with an aggressive stem-infesting insect. We studied how beetle behavior differed among the various stages of colonization on newly cut logs of four novel potential pine host species; jack, red (P. resinosa Ait.), eastern white (P. strobus L.) and Scots (P. sylvestris L.) pines, as well as two historical hosts, ponderosa (P. ponderosa Dougl. ex. Laws. var. scopulorum Engelm.) and lodgepole (P. contorta Dougl. var. latifolia Engelm.) pines. Overall, we found that beetle colonization behaviors at each stage in the colonization process differ between pine hosts, likely due to differing chemical and physical bark traits. Pines without co-evolved constitutive defenses against mountain pine beetle exhibited reduced amounts of defensive monoterpenoid chemicals; however, such patterns also reduced beetle attraction and colonization. Neither chemical nor physical defenses fully defended trees against the various stages of host procurement that can result in tree colonization and death.	[Rosenberger, Derek W.; Aukema, Brian H.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; [Rosenberger, Derek W.] Olivet Nazarene Univ, Dept Biol Sci, Bourbonnais, IL 60914 USA; [Venette, Robert C.] USDA, US Forest Serv, Northern Res Stn, St Paul, MN USA; [Maddox, Mitchell P.] Bethel Univ, Dept Chem, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); United States Forest Service	Rosenberger, DW (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.; Rosenberger, DW (corresponding author), Olivet Nazarene Univ, Dept Biol Sci, Bourbonnais, IL 60914 USA.	dwrosenberger@olivet.edu			Minnesota Environment and Natural Resources Trust Fund; University of Minnesota Graduate Fellowship	Minnesota Environment and Natural Resources Trust Fund; University of Minnesota Graduate Fellowship(University of Minnesota System)	This research was funded by the Minnesota Environment and Natural Resources Trust Fund (Appropriation: M.L.2014 Chpt. 226, Sec. 2 subd.4e.) and a University of Minnesota Graduate Fellowship to DWR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2006, OIKOS, V114, P556, DOI 10.1111/j.2006.0030-1299.15025.x; Amman G.D., 1969, USDA FOREST SERVICE; Amman G.D, 1986, USDA FOREST SERVICE; AMMAN GD, 1972, J ECON ENTOMOL, V65, P138, DOI 10.1093/jee/65.1.138; Anderson RF, 1993, 66 N CAR FOR SERV; [Anonymous], 1971, ATLAS US TREES; Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; Bentz BJ, 2017, NEW PHYTOL, V213, P611, DOI 10.1111/nph.14191; Bentz BJ, 2015, AGR FOREST ENTOMOL, V17, P421, DOI 10.1111/afe.12124; BERRYMAN AA, 1976, ENVIRON ENTOMOL, V5, P1225, DOI 10.1093/ee/5.6.1225; Bertheau C, 2010, ECOL LETT, V13, P506, DOI 10.1111/j.1461-0248.2010.01445.x; BILLINGS RF, 1976, ENVIRON ENTOMOL, V5, P171, DOI 10.1093/ee/5.1.171; Boone CK, 2011, CAN J FOREST RES, V41, P1174, DOI [10.1139/X11-041, 10.1139/x11-041]; Borden JH, 2008, J ECON ENTOMOL, V101, P1266, DOI 10.1603/0022-0493(2008)101[1266:SBOMFA]2.0.CO;2; Boyd IL, 2013, SCIENCE, V342, P823, DOI 10.1126/science.1235773; Brockerhoff EG, 2006, CAN J FOREST RES, V36, P289, DOI [10.1139/x05-250, 10.1139/X05-250]; Burke JL, 2016, FOREST ECOL MANAG, V359, P59, DOI 10.1016/j.foreco.2015.09.044; Cale JA, 2015, CAN J FOREST RES, V45, P1873, DOI 10.1139/cjfr-2015-0277; CARMER SG, 1973, J AM STAT ASSOC, V68, P66, DOI 10.2307/2284140; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Carrillo-Gavilan A, 2012, FUNCT ECOL, V26, P283, DOI 10.1111/j.1365-2435.2011.01931.x; Clark EL, 2012, ENVIRON ENTOMOL, V41, P392, DOI 10.1603/EN11295; Clark EL, 2014, PEERJ, V2, DOI 10.7717/peerj.240; Clark EL, 2010, CAN ENTOMOL, V142, P557, DOI 10.4039/n10-022; CONN JE, 1983, CAN J FOREST RES, V13, P320, DOI 10.1139/x83-045; Cullingham CI, 2011, MOL ECOL, V20, P2157, DOI 10.1111/j.1365-294X.2011.05086.x; Davis TS, 2014, FOREST SCI, V60, P270, DOI 10.5849/forsci.12-155; de la Giroday HMC, 2012, J BIOGEOGR, V39, P1112, DOI 10.1111/j.1365-2699.2011.02673.x; Dodds KJ, 2010, ANN ENTOMOL SOC AM, V103, P39, DOI 10.1603/008.103.0106; Elkin CM, 2004, ENVIRON ENTOMOL, V33, P1070, DOI 10.1603/0046-225X-33.4.1070; Emerick JJ, 2008, ENVIRON ENTOMOL, V37, P871, DOI 10.1603/0046-225X(2008)37[871:MPBAAW]2.0.CO;2; Erbilgin N, 2001, J ECON ENTOMOL, V94, P1113, DOI 10.1603/0022-0493-94.5.1113; Erbilgin N, 2014, NEW PHYTOL, V201, P940, DOI 10.1111/nph.12573; EVANS HF, 1994, FOREST ECOL MANAG, V65, P17, DOI 10.1016/0378-1127(94)90254-2; Ferrenberg S, 2014, FUNCT ECOL, V28, P837, DOI 10.1111/1365-2435.12228; Ferrenberg S, 2014, OECOLOGIA, V174, P1283, DOI 10.1007/s00442-013-2841-2; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; FURNISS MM, 1969, J ECON ENTOMOL, V62, P518, DOI 10.1093/jee/62.2.518; Goodsman DW, 2016, ECOL APPL IN PRESS; Gray CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135752; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; Haack RA, 2006, CAN J FOREST RES, V36, P269, DOI 10.1139/x05-249; Hain Fred P., 2011, U S Forest Service General Technical Report SRS, V140, P13; Harvey BJ, 2014, ECOL APPL, V24, P1608, DOI 10.1890/13-1851.1; Hassett M, 2015, MCDONNELL S NEW YORK; HAYES JL, 1994, J ECON ENTOMOL, V87, P1586, DOI 10.1093/jee/87.6.1586; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hubbard RM, 2013, FOREST ECOL MANAG, V289, P312, DOI 10.1016/j.foreco.2012.09.028; HYNUM BG, 1980, CAN ENTOMOL, V112, P185, DOI 10.4039/Ent112185-2; Kane JM, 2010, OECOLOGIA, V164, P601, DOI 10.1007/s00442-010-1683-4; Karst J, 2015, NEW PHYTOL, V208, P904, DOI 10.1111/nph.13492; Keefover-Ring K, 2016, J CHEM ECOL, V42, P1, DOI 10.1007/s10886-015-0659-6; Kim JJ, 2005, CAN J FOREST RES, V35, P274, DOI 10.1139/x04-178; Klepzig KD, 1996, J CHEM ECOL, V22, P1367, DOI 10.1007/BF02027719; KLEPZIG KD, 1995, J CHEM ECOL, V21, P601, DOI 10.1007/BF02033704; Kovacs KF, 2010, ECOL ECON, V69, P569, DOI 10.1016/j.ecolecon.2009.09.004; Krokene P., 2015, BARK BEETLES BIOL EC, P177, DOI [10.1016/B978-0-12-417156-5.00005-8, DOI 10.1016/B978-0-12-417156-5.00005-8]; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Kyto M, 1998, FOREST ECOL MANAG, V102, P121, DOI 10.1016/S0378-1127(97)00150-3; Latty TM, 2010, BEHAV ECOL SOCIOBIOL, V64, P639, DOI 10.1007/s00265-009-0881-8; LIEUTIER F, 1989, ENVIRON ENTOMOL, V18, P228, DOI 10.1093/ee/18.2.228; Lindgren BS, 2013, CAN ENTOMOL, V145, P471, DOI 10.4039/tce.2013.27; LINDGREN BS, 1983, CAN ENTOMOL, V115, P299, DOI 10.4039/Ent115299-3; Logan JA, 1999, ENVIRON ENTOMOL, V28, P924, DOI 10.1093/ee/28.6.924; Logan JA, 2010, ECOL APPL, V20, P895, DOI 10.1890/09-0655.1; Lovett GM, 2016, ECOL APPL, V26, P1437, DOI 10.1890/15-1176; Maness H., 2012, NAT GEOSCI, V5, P1; Manninen AM, 2002, J CHEM ECOL, V28, P211, DOI 10.1023/A:1013579222600; McKee FR, 2015, CAN ENTOMOL, V7, P1; McKee FR, 2013, AGR FOREST ENTOMOL, V15, P310, DOI 10.1111/afe.12019; Meddens AJH, 2012, ECOL APPL, V22, P1876, DOI 10.1890/11-1785.1; Miller Daniel R., 2000, Journal of the Entomological Society of British Columbia, V97, P41; Miller DR, 2000, CAN ENTOMOL, V132, P183, DOI 10.4039/Ent132183-2; MOECK HA, 1991, CAN ENTOMOL, V123, P299, DOI 10.4039/Ent123299-2; Moore DJP, 2013, ECOL LETT, V16, P731, DOI 10.1111/ele.12097; Nealis VG, 2014, RISK ASSESSMENT THRE; PITMAN GB, 1968, NATURE, V218, P168, DOI 10.1038/218168a0; Pureswaran DS, 2000, CHEMOECOLOGY, V10, P153, DOI 10.1007/PL00001818; Raffa K.F., 1991, P245; Raffa K.F., 1993, STRATEGIES MECH HOST, P103; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Raffa KF, 2014, J CHEM ECOL, V40, P1, DOI 10.1007/s10886-013-0368-y; Raffa KF, 2013, P NATL ACAD SCI USA, V110, P2193, DOI 10.1073/pnas.1216666110; RAFFA KF, 1982, CAN ENTOMOL, V114, P97, DOI 10.4039/Ent11497-2; RAFFA KF, 1983, ECOL MONOGR, V53, P27, DOI 10.2307/1942586; RAFFA KF, 1988, CAN J FOREST RES, V18, P581, DOI 10.1139/x88-084; RAFFA KF, 1995, OECOLOGIA, V102, P285, DOI 10.1007/BF00329795; Reed DE, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/105004; RICHMOND HECTOR A., 1933, FOREST CHRON, V9, P60; Robertson C, 2009, J BIOGEOGR, V36, P1446, DOI 10.1111/j.1365-2699.2009.02100.x; Rosenberger D.W., 2016, THESIS; Rosenberger DW, 2016, ENTOMOL EXP APPL, V160, P195, DOI 10.1111/eea.12463; Safranyik L., 2006, The mountain pine beetle: a synthesis of biology, management and impacts on lodgepole pine; SAFRANYIK L, 1971, CAN ENTOMOL, V103, P1607, DOI 10.4039/Ent1031607-11; Safranyik L, 2010, CAN ENTOMOL, V142, P415, DOI 10.4039/n08-CPA01; Safranyik L., 1975, MANAGEMENT LODGEPOLE, P406; Schaupp W. C, 1993, RM522 USDA FOR SERV; Seybold Steven J., 2006, Phytochemistry Reviews, V5, P143, DOI 10.1007/s11101-006-9002-8; SHRIMPTON DM, 1985, CAN J FOREST RES, V15, P1004, DOI 10.1139/x85-161; Six DL, 1998, ENVIRON ENTOMOL, V27, P1393, DOI 10.1093/ee/27.6.1393; Six DL, 2003, CAN J FOREST RES, V33, P1331, DOI [10.1139/x03-047, 10.1139/X03-047]; Smith R.H., 1981, PSW354 USDA FOR SERV; SMITH RH, 1963, J ECON ENTOMOL, V56, P827, DOI 10.1093/jee/56.6.827; Solheim H, 1998, CAN J BOT, V76, P561, DOI 10.1139/cjb-76-4-561; Strom BL, 1999, ECOL APPL, V9, P1028, DOI 10.1890/1051-0761(1999)009[1028:VASDOH]2.0.CO;2; Sun JH, 2013, ANNU REV ENTOMOL, V58, P293, DOI 10.1146/annurev-ento-120811-153624; Taft S, 2015, J CHEM ECOL, V41, P540, DOI 10.1007/s10886-015-0590-x; Taft S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00342; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; Wallin KF, 2000, ENVIRON ENTOMOL, V29, P442, DOI 10.1603/0046-225X-29.3.442; Weed AS, 2013, ECOL MONOGR, V83, P441, DOI 10.1890/13-0160.1; Werner RA., 1995, ENVIRON ENTOMOL, V24, P151; West DR, 2016, ENVIRON ENTOMOL, V45, P127, DOI 10.1093/ee/nvv167; West DR., 2013, THESIS; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; Wood SL, 1982, PROVO UTAH GREAT BAS, V6	116	33	33	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176269	10.1371/journal.pone.0176269	http://dx.doi.org/10.1371/journal.pone.0176269			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472047	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500034
J	Ackermann, M; Hatt, JM; Schetle, N; Steinmetz, H				Ackermann, Mathias; Hatt, Jean-Michel; Schetle, Nelli; Steinmetz, Hanspeter			Identification of shedders of elephant endotheliotropic herpesviruses among Asian elephants (Elephas maximus) in Switzerland	PLOS ONE			English	Article							INFECTION	Elephants, particularly Asian (Elephas maximus), are threatened by lethal elephant hemorrhagic disease (EHD) due to elephant endotheliotropic herpesviruses (EEHV). At least five of seven known EEHV types have been associated to EHD, with types 1, 4, and 5 predominantly affecting Asian elephants. In Switzerland, at least three Asian elephants have been lost due to EHD but nothing is known about the present EEHV1 circulation. Moreover, the prevalence of other EEHV types has never been assessed. Intermittent shedding of EEHV can be monitored through collecting trunk secretions and analyzing them by PCR methods that discriminate the different EEHV types. To identify EEHV shedders, seven of eight Asian elephants in a Swiss zoo were trained to provide trunk wash samples. These were collected at intervals over a period of four months and tested by PCR for presence of EEHV1 through 6. Moreover, the quality of each sample was assessed by testing for the elephant TNFalpha gene. Overall, 57% of the samples were valid with five of seven participating elephants identified as EEHV shedders. Two of those shed virus only once, whereas the other three, all closely related among each other, shed virus on multiple occasions. One of the frequent shedders had been in very close contact to all of the three EHD victims. Therefore, we speculate that this particular animal may represent the virus source in all three cases. However, when subtyping was conducted, the presently circulating virus was identified as EEHV1B, while the virus subtype causing EHD had been 1A in all three cases. In addition to four animals excreting EEHV1, a recently introduced animal was observed to shed EEHV3/4. We suggest that the policy of trunk washing to identify and characterize EEHV-shedders is to be endorsed in zoos with ongoing or planned elephant breeding programs.	[Ackermann, Mathias; Schetle, Nelli] Univ Zurich, Vetsuisse Fac, Inst Virol, Zurich, Switzerland; [Hatt, Jean-Michel] Univ Zurich, Clin Zoo Anim Exot Pets & Wildlife, Vetsuisse Fac, Zurich, Switzerland; [Steinmetz, Hanspeter] Walter Zoo, Gossau, Switzerland	University of Zurich; University of Zurich	Ackermann, M (corresponding author), Univ Zurich, Vetsuisse Fac, Inst Virol, Zurich, Switzerland.	mathias.ackermann@uzh.ch	Hatt, Jean-Michel/C-3850-2015	Steinmetz, Hanspeter W./0000-0002-5879-0207; Hatt, Jean-Michel/0000-0002-7043-7430	University of Zurich [F-52601-10-01]	University of Zurich	This work was supported by a private donation of the late Prof. Dr. Robert Wyler to MA (F-52601-10-01) as well as by general funds allocated to MA by the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Fickel J, 2001, VET MICROBIOL, V82, P103, DOI 10.1016/S0378-1135(01)00363-7; Garner MM, 2009, VET PATHOL, V46, P97, DOI 10.1354/vp.46-1-97; Guttman-Yassky E, 2004, J INFECT DIS, V189, P2023, DOI 10.1086/386308; Hayward GS, 2012, VET REC, V170, P202, DOI 10.1136/vr.e1212; Latimer E, 2011, VET MICROBIOL, V147, P28, DOI 10.1016/j.vetmic.2010.05.042; Ling PD, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00106-13; Long SY, 2015, ILAR J, V56, P283, DOI 10.1093/ilar/ilv041; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; OSSENT P, 1990, VET PATHOL, V27, P131, DOI 10.1177/030098589002700212; Pellett PE, 2014, J VIROL, V88, P13520, DOI 10.1128/JVI.02359-14; Plancoulaine S, 2003, J INFECT DIS, V187, P1944, DOI 10.1086/375345; Richman LK, 1999, SCIENCE, V283, P1171, DOI 10.1126/science.283.5405.1171; Richman LK, 2014, J VIROL; Schmitt DL, 2000, J ZOO WILDLIFE MED, V31, P518, DOI 10.1638/1042-7260(2000)031[0518:UOFFTT]2.0.CO;2; Stanton JJ, 2013, J ZOO WILDLIFE MED, V44, P42, DOI 10.1638/1042-7260-44.1.42; Stanton JJ, 2012, J VIROL METHODS, V186, P73, DOI 10.1016/j.jviromet.2012.07.024; Stanton JJ, 2010, AM J VET RES, V71, P925, DOI 10.2460/ajvr.71.8.925; Wilkie GS, 2013, J VIROL, V87, P6700, DOI 10.1128/JVI.00655-13; Work TM, 2015, VET PATHOL, V52, P1195, DOI 10.1177/0300985814560236; Zong JC, 2014, J VIROL	20	12	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176891	10.1371/journal.pone.0176891	http://dx.doi.org/10.1371/journal.pone.0176891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467495	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000400647000083
J	Koc, I; Caetano-Anolles, G				Koc, Ibrahim; Caetano-Anolles, Gustavo			The natural history of molecular functions inferred from an extensive phylogenomic analysis of gene ontology data	PLOS ONE			English	Article							PROTEIN DOMAINS; EVOLUTIONARY HISTORY; AEROBIC METABOLISM; COMMON ANCESTOR; UNIVERSAL TREE; GENOMIC CENSUS; ORIGIN; PROTEOMES; FOLD; ANCIENT	The origin and natural history of molecular functions hold the key to the emergence of cellular organization and modern biochemistry. Here we use a genomic census of Gene Ontology (GO) terms to reconstruct phylogenies at the three highest (1, 2 and 3) and the lowest (terminal) levels of the hierarchy of molecular functions, which reflect the broadest and the most specific GO definitions, respectively. These phylogenies define evolutionary timelines of functional innovation. We analyzed 249 free-living organisms comprising the three super-kingdoms of life, Archaea, Bacteria, and Eukarya. Phylogenies indicate catalytic, binding and transport functions were the oldest, suggesting a `metabolism-first' origin scenario for biochemistry. Metabolism made use of increasingly complicated organic chemistry. Primordial features of ancient molecular functions and functional recruitments were further distilled by studying the oldest child terms of the oldest level 1 GO definitions. Network analyses showed the existence of an hourglass pattern of enzyme recruitment in the molecular functions of the directed acyclic graph of molecular functions. Older high-level molecular functions were thoroughly recruited at younger lower levels, while very young high-level functions were used throughout the timeline. This pattern repeated in every one of the three mappings, which gave a criss-cross pattern. The timelines and their mappings were remarkable. They revealed the progressive evolutionary development of functional toolkits, starting with the early rise of metabolic activities, followed chronologically by the rise of macromolecular biosynthesis, the establishment of controlled interactions with the environment and self, adaptation to oxygen, and enzyme coordinated regulation, and ending with the rise of structural and cellular complexity. This historical account holds important clues for dissection of the emergence of biomcomplexity and life.	[Koc, Ibrahim] Gebze Tech Univ, Mol Biol & Genet, Kocaeli, Turkey; [Caetano-Anolles, Gustavo] Univ Illinois, Evolutionary Bioinformat Lab, Dept Crop Sci, Urbana, IL 61801 USA	Gebze Technical University; University of Illinois System; University of Illinois Urbana-Champaign	Caetano-Anolles, G (corresponding author), Univ Illinois, Evolutionary Bioinformat Lab, Dept Crop Sci, Urbana, IL 61801 USA.	gca@illinois.edu			National Science Foundation [OISE-1132791]; United States Department of Agriculture [ILLU-802-909, ILLU-483-625]; Blue Waters computer grid allocation of the National Center for Supercomputer Applications (NCSA); Scientific and Technological Research Council of Turkey (TUBITAK) [1059B141400573]; TUBITAK	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); Blue Waters computer grid allocation of the National Center for Supercomputer Applications (NCSA); Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	Computational biology in the Evolutionary Bioinformatics Laboratory (EBL) is supported by grants from the National Science Foundation (OISE-1132791) and the United States Department of Agriculture (ILLU-802-909 and ILLU-483-625) and by a Blue Waters computer grid allocation of the National Center for Supercomputer Applications (NCSA) to GCA. The visit of IK to EBL was supported by a grant from Scientific and Technological Research Council of Turkey (TUBITAK, No. no. 1059B141400573). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Arshan Nasir for his help and sugestions. IK spent a year working in the Evolutionary Bioinformatics Laboratory thanks to the support of TUBITAK.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balakrishnan R, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat054; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Caetano-Anolles G, 2005, J MOL EVOL, V60, P484, DOI 10.1007/s00239-004-0221-6; Caetano-Anolles G, 2003, GENOME RES, V13, P1563, DOI 10.1101/gr.1161903; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Caetano-Anolles G, 2012, J MOL EVOL, V74, P1, DOI 10.1007/s00239-011-9480-1; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; Caetano-Anolles G, 2009, INT J BIOCHEM CELL B, V41, P285, DOI 10.1016/j.biocel.2008.08.022; Campbell IH, 2008, NAT GEOSCI, V1, P554, DOI 10.1038/ngeo259; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Carrigan MA, 2015, P NATL ACAD SCI USA, V112, P458, DOI 10.1073/pnas.1404167111; CASTRESANA J, 1994, EMBO J, V13, P2516, DOI 10.1002/j.1460-2075.1994.tb06541.x; Chang CW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S27; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Devasagayam T P A, 2004, J Assoc Physicians India, V52, P794; Doolittle RF, 2005, CURR OPIN STRUC BIOL, V15, P248, DOI 10.1016/j.sbi.2005.04.001; Dupont CL, 2006, P NATL ACAD SCI USA, V103, P17822, DOI 10.1073/pnas.0605798103; Ebach MC, 1999, CLADISTICS, V15, P387, DOI 10.1111/j.1096-0031.1999.tb00275.x; FARRIS JS, 1989, SYST ZOOL, V38, P406, DOI 10.2307/2992406; Forterre P, 1999, BIOESSAYS, V21, P871, DOI 10.1002/(SICI)1521-1878(199910)21:10<871::AID-BIES10>3.0.CO;2-Q; Garcia-Vallve S, 2003, NUCLEIC ACIDS RES, V31, P187, DOI 10.1093/nar/gkg004; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Gerstein M, 1998, PROTEINS, V33, P518, DOI 10.1002/(SICI)1097-0134(19981201)33:4<518::AID-PROT5>3.0.CO;2-J; Glansdorff N, 2000, MOL MICROBIOL, V38, P177, DOI 10.1046/j.1365-2958.2000.02126.x; Glansdorff N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-29; GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; Gribaldo S, 2002, THEOR POPUL BIOL, V61, P391, DOI 10.1006/tpbi.2002.1593; Hakansson K, 2000, P NATL ACAD SCI USA, V97, P14097, DOI 10.1073/pnas.260376797; Harish A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032776; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hawkins JA, 1997, CLADISTICS, V13, P275, DOI 10.1111/j.1096-0031.1997.tb00320.x; Hlinkova V, 2008, ACTA CRYSTALLOGR D, V64, P941, DOI 10.1107/S0907444908021665; Huntley RP, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-4; Illergard K, 2009, PROTEINS, V77, P499, DOI 10.1002/prot.22458; IWABE N, 1989, P NATL ACAD SCI USA, V86, P9355, DOI 10.1073/pnas.86.23.9355; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; KACSER H, 1984, J MOL EVOL, V20, P38, DOI 10.1007/BF02101984; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; Kazmierczak RA, 2002, NUCLEIC ACIDS RES, V30, P5193, DOI 10.1093/nar/gkf652; Kim KM, 2014, J MOL EVOL, V79, P240, DOI 10.1007/s00239-014-9637-9; Kim KM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-13; Kim KM, 2012, STRUCTURE, V20, P67, DOI 10.1016/j.str.2011.11.003; Kim KM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-140; Kim KM, 2010, MOL BIOL EVOL, V27, P1710, DOI 10.1093/molbev/msq106; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Kondrashov FA, 2004, TRENDS GENET, V20, P287, DOI 10.1016/j.tig.2004.05.001; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Korza HJ, 2005, J BIOL CHEM, V280, P40802, DOI 10.1074/jbc.M506328200; Kump LR, 2014, NATURE GEOSCI, V7, P248; Kurland CG, 2006, SCIENCE, V312, P1011, DOI 10.1126/science.1121674; Kurland CG, 2005, BIOESSAYS, V27, P741, DOI 10.1002/bies.20258; LUNDBERG JG, 1972, SYST ZOOL, V21, P398, DOI 10.2307/2412433; Ma BG, 2008, BIOCHEM BIOPH RES CO, V366, P607, DOI 10.1016/j.bbrc.2007.12.014; Marcet-Houben M, 2007, BIOINFORMATION, V2, P135, DOI 10.6026/97320630002135; Martins BMC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003175; Mittenthal Jay, 2012, Frontiers in Genetics, V3, P147, DOI [10.3389/fgene.2012.00147, 10.3389/fgene.2012.00172]; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nasir A, 2014, ARCHAEA, V2014, P425; Nasir A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003452; Nasir A, 2013, ARCHAEA, V2013, DOI 10.1155/2013/648746; Nasir A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-156; Nasir A, 2011, GENES-BASEL, V2, P869, DOI 10.3390/genes2040869; Nath N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003642; Newton MS, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0036; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Penny D, 1999, CURR OPIN GENET DEV, V9, P672, DOI 10.1016/S0959-437X(99)00020-9; Pfeiffer T, 2005, PLOS BIOL, V3, P1269, DOI 10.1371/journal.pbio.0030228; Philippe H, 1999, J MOL EVOL, V49, P509, DOI 10.1007/PL00006573; Poole AM, 1998, J MOL EVOL, V46, P1, DOI 10.1007/PL00006275; Popa O, 2011, CURR OPIN MICROBIOL, V14, P615, DOI 10.1016/j.mib.2011.07.027; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Risso VA, 2013, J AM CHEM SOC, V135, P2899, DOI 10.1021/ja311630a; Sessions AL, 2009, CURR BIOL, V19, pR567, DOI 10.1016/j.cub.2009.05.054; Shegogue D, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-113; Skunca N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002533; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Swoford DL, 2002, PAUP PHYLOGENETIC AN; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Trefil J, 2009, AM SCI, V97, P206, DOI 10.1511/2009.78.206; Turan S, 2011, FASEB J, V25, P4088, DOI 10.1096/fj.11-186940; Volkov AN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002807; Voordeckers K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001446; WACHTERSHAUSER G, 1992, PROG BIOPHYS MOL BIO, V58, P85, DOI 10.1016/0079-6107(92)90022-X; Wang M, 2007, GENOME RES, V17, P1572, DOI 10.1101/gr.6454307; Wang ML, 2006, MOL BIOL EVOL, V23, P2444, DOI 10.1093/molbev/msl117; Wang ML, 2006, COMPLEXITY, V12, P27, DOI 10.1002/cplx.20141; Wang ML, 2011, MOL BIOL EVOL, V28, P567, DOI 10.1093/molbev/msq232; Wang ML, 2009, STRUCTURE, V17, P66, DOI 10.1016/j.str.2008.11.008; Williams GJ, 2006, ACTA CRYSTALLOGR F, V62, P944, DOI 10.1107/S1744309106034075; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Xu Y, 2002, COMP BIOCHEM PHYS A, V133, P677, DOI 10.1016/S1095-6433(02)00197-6; Yang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008378; YCAS M, 1974, J THEOR BIOL, V44, P145, DOI 10.1016/S0022-5193(74)80035-4; Ye JQ, 2004, BBA-BIOENERGETICS, V1659, P1, DOI 10.1016/j.bbabio.2004.06.003; Zhuang ZH, 2010, BBA-PROTEINS PROTEOM, V1804, P1081, DOI 10.1016/j.bbapap.2009.06.018; Zou TS, 2015, MOL BIOL EVOL, V32, P132, DOI 10.1093/molbev/msu281	101	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176129	10.1371/journal.pone.0176129	http://dx.doi.org/10.1371/journal.pone.0176129			56	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467492	gold, Green Submitted, Green Published			2022-12-27	WOS:000400647000038
J	Mihai-Alexandru, S; Noemi, G; Ioana, LR				Mihai-Alexandru, Suciu; Noemi, Gasko; Ioana, Lung Rodica			Approximation of Nash equilibria and the network community structure detection problem	PLOS ONE			English	Article							COMPLEX NETWORKS	Game theory based methods designed to solve the problem of community structure detection in complex networks have emerged in recent years as an alternative to classical and optimization based approaches. The Mixed Nash Extremal Optimization uses a generative relation for the characterization of Nash equilibria to identify the community structure of a network by converting the problem into a non-cooperative game. This paper proposes a method to enhance this algorithm by reducing the number of payoff function evaluations. Numerical experiments performed on synthetic and real-world networks show that this approach is efficient, with results better or just as good as other state-of the-art methods.	[Mihai-Alexandru, Suciu; Noemi, Gasko; Ioana, Lung Rodica] Babes Bolyai Univ, Ctr Study Complex, Cluj Napoca, Romania	Babes Bolyai University from Cluj	Ioana, LR (corresponding author), Babes Bolyai Univ, Ctr Study Complex, Cluj Napoca, Romania.	rodica.lung@econ.ubbcluj.ro	Suciu, Mihai/B-4564-2014	Suciu, Mihai/0000-0003-0659-4594; Lung, Rodica Ioana/0000-0002-5572-8141	Romanian National Authority for Scientific Research and Innovation, CNCS UEFISCDI [PN-II-RU-TE-2014-4-2332]	Romanian National Authority for Scientific Research and Innovation, CNCS UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was supported by a grant of the Romanian National Authority for Scientific Research and Innovation, CNCS UEFISCDI (www.uefiscdtgov.ro), project number PN-II-RU-TE-2014-4-2332.	Alvari H, 2014, 2014 PROCEEDINGS OF THE IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2014), P101, DOI 10.1109/ASONAM.2014.6921567; [Anonymous], IIE ANN C EXP 2013 I; [Anonymous], NATURE; [Anonymous], LNCS; Basu S, 2015, SOC NETW ANAL MIN, V5, DOI 10.1007/s13278-015-0299-4; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Chen W, 2010, DATA MIN KNOWL DISC, V21, P224, DOI 10.1007/s10618-010-0186-6; Chira C, 2011, IEEE C EVOL COMPUTAT, P2200; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gao Z, 2013, 2013 INTERNATIONAL CONFERENCE ON SOCIAL INTELLIGENCE AND TECHNOLOGY (SOCIETY), P28, DOI 10.1109/SOCIETY.2013.10; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gleiser PM, 2003, ADV COMPLEX SYST, V6, P565, DOI 10.1142/S0219525903001067; Hu Y., 2008, PHYS REV E, V78, P1; Knuth D.E., 2008, ART COMPUTER PROGRAM, V4a; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Li CB, 2014, INTELL DECIS TECHNOL, V8, P207, DOI 10.3233/IDT-140189; Li JW, 2016, IEEE T EVOLUT COMPUT, V20, P460, DOI 10.1109/TEVC.2015.2490076; Li ZP, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036109; Lung RI, 2008, INT J COMPUT COMMUN, V3, P364; Lung RI, 2010, IEEE C EVOL COMPUTAT; Lung RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086891; Lung RI, 2011, STUD COMPUT INTELL, V387, P121; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Mandala S, 2014, INFORMS J COMPUT, V26, P629, DOI 10.1287/ijoc.2013.0588; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McSweeney PJ, 2012, 2012 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P227, DOI 10.1109/ASONAM.2012.47; MOKKEN RJ, 1979, QUAL QUANT, V13, P161, DOI 10.1007/BF00139635; Narayanam R, 2012, INT C PATT RECOG, P1072; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Palchykov V, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0090-4; Pavlidis NG, 2005, J COMPUT APPL MATH, V175, P113, DOI 10.1016/j.cam.2004.06.005; Pizzuti C, 2008, LECT NOTES COMPUT SC, V5199, P1081, DOI 10.1007/978-3-540-87700-4_107; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Steinhaeuser K, 2010, PATTERN RECOGN LETT, V31, P413, DOI 10.1016/j.patrec.2009.11.001; Suciu M, 2015, LECT NOTES COMPUT SC, V9026, P126, DOI 10.1007/978-3-319-16468-7_11; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhou LH, 2016, EXPERT SYST, V33, P176, DOI 10.1111/exsy.12141	46	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0174963	10.1371/journal.pone.0174963	http://dx.doi.org/10.1371/journal.pone.0174963			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467496	gold, Green Published, Green Submitted			2022-12-27	WOS:000400647000010
J	Hung, PS; Chen, CY; Chen, WT; Kuo, CY; Fang, WL; Huang, KH; Chiu, PC; Lo, SS				Hung, Pei-Shih; Chen, Chin-Yau; Chen, Wei-Ting; Kuo, Chen-Yu; Fang, Wen-Liang; Huang, Kuo-Hung; Chiu, Peng-Chih; Lo, Su-Shun			miR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinoma	PLOS ONE			English	Article							CIRCULATING MICRORNAS; ENDOGENOUS CONTROL; CANCER; DNA; EXPRESSION; ARID1A; IDENTIFICATION; PROLIFERATION; PATHOGENESIS; BIOMARKERS	Gastric carcinoma is highly prevalent throughout the world. Understanding the pathogenesis of this disease will benefit diagnosis and resolution. Studies show that miRNAs are involved in the tumorigenesis of gastric carcinoma. An initial screening followed by subsequent validation identified that miR-376c is up-regulated in gastric carcinoma tissue and the plasma of patients with the disease. In addition, the urinary level of miR-376c is also significantly increased in gastric carcinoma patients. The plasma miR-376c level was validated as a biomarker for gastric carcinoma, including early stage tumors. The induction of miR-376c was found to enrich the proliferation, migration and anchorage-independent growth of carcinoma cells and, furthermore, the repression of the expression of endogenous miR-376c was able to reduce such oncogenic phenotypes. ARID4A gene is a direct target of miR-376c. Knockdown of endogenous ARID4A increased the oncogenicity of carcinoma cells, while ARID4A was found to be drastically down-regulated in tumor tissue. Thus, expression levels of miR-376c and ARID4A mRNA tended to be opposing in tumor tissue. Our results demonstrate that miR-376c functions by suppressing ARID4A expression, which in turn enhances the oncogenicity of gastric carcinoma cells. It seems likely that the level of miR-376c in plasma and urine could act as invaluable markers for the detection of gastric carcinoma.	[Hung, Pei-Shih] Natl Yang Ming Univ Hosp, Dept Educ & Med Res, Yilan, Taiwan; [Chen, Chin-Yau; Chen, Wei-Ting; Lo, Su-Shun] Natl Yang Ming Univ Hosp, Dept Surg, Yilan, Taiwan; [Kuo, Chen-Yu] Natl Yang Ming Univ Hosp, Dept Med, Yilan, Taiwan; [Fang, Wen-Liang; Huang, Kuo-Hung] Vet Gen Hosp Taipei, Div Gen Surg, Taipei, Taiwan; [Fang, Wen-Liang; Huang, Kuo-Hung; Chiu, Peng-Chih] Natl Yang Ming Univ Hosp, Dept Dent, Yilan, Taiwan; [Lo, Su-Shun] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan	National Yang Ming Chiao Tung University	Lo, SS (corresponding author), Natl Yang Ming Univ Hosp, Dept Surg, Yilan, Taiwan.; Lo, SS (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	sslo@ymuh.ym.edu.tw			Ministry of Science and Technology [MOST-102-2314-B-010-043-MY3]; National Yang-Ming University Hospital [RD2014001, RD2015-001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Yang-Ming University Hospital	This study was supported by grant MOST-102-2314-B-010-043-MY3 from Ministry of Science and Technology, and National Yang-Ming University Hospital grants RD2014001 and RD2015-001.; We acknowledge the technical services provided by Clinical Medicine Research Laboratory of National Yang-Ming University Hospital. This study was supported by grant MOST-102-2314-B-010-043-MY3 from Ministry of Science and Technology, and National Yang-Ming University Hospital grants RD2014-001 and RD2015-001.	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Cajuso T, 2014, INT J CANCER, V135, P611, DOI 10.1002/ijc.28705; Calcagno DQ, 2013, WORLD J GASTROENTERO, V19, P1182, DOI 10.3748/wjg.v19.i8.1182; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Chin LT, 1987, J SURG ASS ROC, V19, P27; CHITTENDEN T, 1991, CELL, V65, P1073, DOI 10.1016/0092-8674(91)90559-H; Conteduca V, 2013, INT J ONCOL, V42, P5, DOI 10.3892/ijo.2012.1701; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Cuk K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076729; Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Figueiredo C, 2013, HELICOBACTER, V18, P28, DOI 10.1111/hel.12083; Formosa A, 2014, ONCOGENE, V33, P5173, DOI 10.1038/onc.2013.451; Gao X, 2016, ONCOTARGET, DOI 10.18632/oncotarget.11198; Gonzalez CA, 2012, INT J CANCER, V130, P745, DOI 10.1002/ijc.26430; Gonzalez-Perez A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r106; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Hu J, 2014, INT J CANCER, V135, P1187, DOI 10.1002/ijc.28757; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim SH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003563; Kuroda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022313; Lo SS, 2012, ONCOGENE, V31, P226, DOI 10.1038/onc.2011.226; Lo SS, 2007, ANN SURG ONCOL, V14, P340, DOI 10.1245/s10434-006-9077-x; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Pang ALY, 2014, ONCOL LETT, V7, P1819, DOI 10.3892/ol.2014.2034; Qiu X, 2016, J GASTROENTEROL HEPA; Rodrigues-Lisoni FC, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-14; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Sheng JP, 2013, CANCER BIOTHER RADIO, V28, P523, DOI 10.1089/cbr.2012.1446; Singchat W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160901; Song MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033608; Stuopelyte K, 2016, BR J CANC; Tsai MM, 2016, EUR J CANCER, V64, P137, DOI 10.1016/j.ejca.2016.05.007; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; Wu CW, 2006, LANCET ONCOL, V7, P309, DOI 10.1016/S1470-2045(06)70623-4; Wu MY, 2008, JNCI-J NATL CANCER I, V100, P1247, DOI 10.1093/jnci/djn253; Wu Q, 2010, BIOCHEM BIOPH RES CO, V392, P340, DOI 10.1016/j.bbrc.2009.12.182; Xiao B, 2012, ONCOL REP, V27, P559, DOI 10.3892/or.2011.1514; Yabushita S, 2012, PANCREAS, V41, P1013, DOI 10.1097/MPA.0b013e31824ac3a5; Yang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep28919; Ye G, 2011, J CELL SCI, V124, P359, DOI 10.1242/jcs.072223; Zehavi L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-44; Zeng ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073278; Zhang Y, 2013, NEOPLASMA, V60, P247, DOI 10.4149/neo_2013_033; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zhou J, 2015, ONCOL REP, V33, P2915, DOI 10.3892/or.2015.3937	51	28	28	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177346	10.1371/journal.pone.0177346	http://dx.doi.org/10.1371/journal.pone.0177346			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486502	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000073
J	Thomazelli, LM; de Araujo, J; Fabrizio, T; Walker, D; Reischak, D; Ometto, T; Barbosa, CM; Petry, MV; Webby, RJ; Durigon, EL				Thomazelli, Luciano Matsumiya; de Araujo, Jansen; Fabrizio, Thomas; Walker, David; Reischak, Dilmara; Ometto, Tatiana; Barbosa, Carla Meneguin; Petry, Maria Virginia; Webby, Richard J.; Durigon, Edison Luiz			Novel avian paramyxovirus (APMV-15) isolated from a migratory bird in South America	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; PENGUINS; SEROTYPE; VIRUS	A novel avian paramyxovirus (APMV) isolated from a migratory bird cloacal swab obtained during active surveillance in April 2012 in the Lagoa do Peixe National Park, Rio Grande do Sul state, South of Brazil was biologically and genetically characterized. The nucleotide sequence of the full viral genome was completed using a next-generation sequencing approach. The genome was 14,952 nucleotides (nt) long, with six genes (3'-NP-P-M-F-HNL-5') encoding 7 different proteins, typical of APMV. The fusion (F) protein gene of isolate RS-1177 contained 1,707 nucleotides in a single open reading frame encoding a protein of 569 amino acids. The F protein cleavage site contained two basic amino acids (VPKER down arrow L), typical of avirulent strains. Phylogenetic analysis of the whole genome indicated that the virus is related to APMV-10, -2 and -8, with 60.1% nucleotide sequence identity to the closest APMV-10 virus, 58.7% and 58.5% identity to the closest APMV-8 and APMV-2 genome, respectively, and less than 52% identity to representatives of the other APMVs groups. Such distances are comparable to the distances observed among other previously identified APMVs serotypes. These results suggest that unclassified/calidris_fuscicollis/Brazil/RS1177/2012 is the prototype strain of a new APMV serotype, APMV-15.	[Thomazelli, Luciano Matsumiya; de Araujo, Jansen; Ometto, Tatiana; Barbosa, Carla Meneguin; Durigon, Edison Luiz] Univ Sao Paulo, Lab Virol Clin & Mol, Inst Ciencias Biomed, Sao Paulo, Brazil; [Fabrizio, Thomas; Walker, David; Webby, Richard J.] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Reischak, Dilmara] Lab Nacl Agropecuario, Campinas, SP, Brazil; [Petry, Maria Virginia] Univ Vale Rio dos Sinos, Sao Leopoldo, Rio Grande Do S, Brazil	Universidade de Sao Paulo; St Jude Children's Research Hospital; Universidade do Vale do Rio dos Sinos (Unisinos)	Thomazelli, LM (corresponding author), Univ Sao Paulo, Lab Virol Clin & Mol, Inst Ciencias Biomed, Sao Paulo, Brazil.	lucmt@usp.br	Petry, Maria Virginia/AAG-5333-2021; Webby, Richard J/N-5657-2018; Thomazelli, Luciano/Q-6119-2017; Fabrizio, Thomas/J-9935-2013; Barbosa, Carla Meneguin/AAA-8413-2019; Petry, Maria Virginia/K-8410-2013	Thomazelli, Luciano/0000-0002-9157-6122; Fabrizio, Thomas/0000-0002-8960-0728; Barbosa, Carla Meneguin/0000-0002-7329-202X; Petry, Maria Virginia/0000-0002-7870-7394; Araujo, Jansen/0000-0002-7250-3024	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/05485-2]; Conselho Nacional de Desenvolvimento a Pesquisa (CNPq); National Institute of Allergy and Infectious Diseases of the National Institutes of Health [HHSN266200700005C]; ALSAC; The British Council [172710323] Funding Source: researchfish	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento a Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); The British Council	This work has been funded in part by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2013/05485-2), Conselho Nacional de Desenvolvimento a Pesquisa (CNPq) and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, under contract number HHSN266200700005C and ALSAC. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; Field logistic support by Centro Nacional de Pesquisa e Conservacao das Ayes Silvestres (CEMAVE-ICMBio), Universidade Vale do Rio do Sinos (UNISINOS), field team of University of Sao Paulo and Secretaria de Estado da Agricultura, Pecuaria e Abastecimento SEAPA-RS, MAPA. We thank Dr. Andre de Oliveira Mendonca and Dra. Maria Angela Orsi from LANAGRO for the institutional support and Monique Guardieiro, Rodrigo Labello and Soraya C. A. Camillo for the technical support.	Briand FX, 2012, J VIROL, V86, P7710, DOI 10.1128/JVI.00946-12; Costa Erli Schneider, 2011, Oecologia Australis, V15, P59; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Fornells LAMG, 2012, VET MICROBIOL, V156, P429, DOI 10.1016/j.vetmic.2011.11.026; Goraichuk I, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00729-16; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hayman P, 1986, SHOREBIRDS IDENTIFIC; Karamendin K, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00167-16; Kolakofsky D, 2005, J GEN VIROL, V86, P1869, DOI 10.1099/vir.0.80986-0; Maximino C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103943; Miller PJ, 2010, J VIROL, V84, P11496, DOI 10.1128/JVI.00822-10; OIE (Office International des Epizooties) Newcastle disease, 2004, OIE MAN STAND DIAGN; Rosseel T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-463; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terregino C, 2013, ARCH VIROL, V158, P2233, DOI 10.1007/s00705-013-1735-2; Thampaisarn R, 2017, VIRUS RES, V228, P46, DOI 10.1016/j.virusres.2016.11.018; Thomazelli LM, 2012, BRAZ J POULTRY SCI, V14, P1, DOI 10.1590/S1516-635X2012000100001; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; White DJ, 2016, VIRUS GENES, V52, P727, DOI 10.1007/s11262-016-1342-x; Yamamo E, 2015, J VET MED SCI, V77, P1079, DOI 10.1292/jvms.14-0529	21	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177214	10.1371/journal.pone.0177214	http://dx.doi.org/10.1371/journal.pone.0177214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486490	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000058
J	Wang, SY; Yang, YF; Zhi, H				Wang, Shiyu; Yang, Yunfei; Zhi, Heng			Water-soluble carbohydrates of root components and activity rhythms at vegetative growth stage of Artemisia scoparia in northeastern grassland of China	PLOS ONE			English	Article							DACTYLIS-GLOMERATA L.; NONSTRUCTURAL CARBOHYDRATE; LEYMUS-CHINENSIS; STORAGE ORGANS; SONGNEN PLAINS; PERENNIAL HERB; LOESS PLATEAU; GRASSES; POPULATIONS; RESERVES	The root system of perennials is composed of the roots of different growth years. The nutrient storage capacities and activities of roots are an important basis for judging root components and plant senescence. In this research, changes in the contents of water-soluble carbohydrate (WSC) were used as indicators of the nutrient storage and activity of roots of different life years. From the early resprouting stage to the rapid growth stage, Artemisia scoparia L. plants of 1-3 age classes were sampled and measured once every 18 days. The nutrient storage capacities and activity rhythms of plant root components of the three age classes were analysed quantitatively. Among the A. scoparia population in northeast China, the nutrient storage capacities of 1a/2a plant root collars and 2-year old roots were generally large, whereas those of 3a plant root collars and 3-year old roots were significantly reduced. As for changes in the WSC content in the root system at the 18 day resprouting stage, the decline rates in the root collars of the 1a and 2a plants were 102 and 109 times those of the 3a plants, respectively. The decline rate in the 2-year old roots of the 1a plants was 1.8 times that of the 2a plants and 29.6 times that of the 3a plants. When nutrients were most active, all root components of the 1a plants entered into the resprouting stage, but the 2/3-year old roots of the 2a plants lagged behind. All the root components of the 3a plants generally lagged. At the vegetative growth stage, the WSC contents in all root components of the 1a plants declined logarithmically. For the 3a plants, the content in the root collars decreased linearly with that in the 3-year old roots. The older root components (3-year old roots) of the 2a plants and all root components of the 3a plants exhibited signs of aging.	[Wang, Shiyu; Yang, Yunfei; Zhi, Heng] Northeast Normal Univ, Inst Grassland Sci, Key Lab Vegetat Ecol, Minist Educ, Changchun, Jilin Province, Peoples R China	Northeast Normal University - China	Yang, YF (corresponding author), Northeast Normal Univ, Inst Grassland Sci, Key Lab Vegetat Ecol, Minist Educ, Changchun, Jilin Province, Peoples R China.	yunfeiyangcncn@sina.com			National Natural Science Foundation of China [31672471, 31170504, 31670427]; National Key Research and Development Program of China [2016YFC0500602]; Natural Science and Technology Commission of Jilin Province, China [20170101150JC]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Natural Science and Technology Commission of Jilin Province, China	This work was funded by the National Natural Science Foundation of China (Grant numbers: 31672471, 31170504, 31670427), the National Key Research and Development Program of China (2016YFC0500602), and the Natural Science and Technology Commission of Jilin Province, China (20170101150JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YF, 1995, GRASSLAND CHINA, V1, P7; Bai ZJ, 2015, J VEG SCI, V26, P686, DOI 10.1111/jvs.12282; Ding XM, 2007, J INTEGR PLANT BIOL, V49, P576, DOI 10.1111/j.1744-7909.2007.00487.x; Du Feng, 2006, Zhiwu Shengtai Xuebao, V30, P601; Fulkerson WJ, 2001, AUST J EXP AGR, V41, P261, DOI 10.1071/EA00062; Gao Y, 2014, PLANT BIOLOGY, V16, P774, DOI 10.1111/plb.12122; Hedhly A, 2016, PLANT PHYSIOL, V172, P2388, DOI 10.1104/pp.16.00916; Huang Gang, 2007, Zhiwu Shengtai Xuebao, V31, P1161; Johnson MP, 2016, ESSAYS BIOCHEM, V60, P255, DOI 10.1042/EBC20160016; Kabeya D, 2003, ANN BOT-LONDON, V92, P537, DOI 10.1093/aob/mcg165; Li XH, 2012, J ARID LAND, V4, P36, DOI 10.3724/SP.J.1227.2012.00036; Lin R, 1991, FLORA CHINA, V76; Liu LX, 2008, NEW ZEAL J BOT, V46, P119, DOI 10.1080/00288250809509759; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; McGrath S, 2014, PLANT GENET RESOUR-C, V12, P236, DOI 10.1017/S1479262113000567; Newell EA, 2002, OECOLOGIA, V131, P333, DOI 10.1007/s00442-002-0888-6; [潘庆民 Pan Qingmin], 2002, [植物学通报, Chinese Bulletin of Botany], V19, P30; Phillips N, 2015, HORTTECHNOLOGY, V25, P536, DOI 10.21273/HORTTECH.25.4.536; Ranjbar M, 2015, IND CROP PROD, V76, P836, DOI 10.1016/j.indcrop.2015.07.077; Ranwala AP, 2008, NEW PHYTOL, V180, P421, DOI 10.1111/j.1469-8137.2008.02585.x; Roberto GG, 2015, BRAGANTIA, V74, P379, DOI 10.1590/1678-4499.0062; Robins JG, 2015, EUPHYTICA, V204, P503, DOI 10.1007/s10681-014-1326-7; Sanada Y, 2007, EUPHYTICA, V153, P267, DOI 10.1007/s10681-006-9262-9; Sharma I, 2014, NATL ACAD SCI LETT, V37, P285, DOI 10.1007/s40009-014-0233-8; Shi LX, 2006, PHOTOSYNTHETICA, V44, P542, DOI 10.1007/s11099-006-0068-8; Singh HP, 2009, J CHEM ECOL, V35, P154, DOI 10.1007/s10886-009-9595-7; Su Yuan, 2014, Chinese Journal of Plant Ecology, V38, P694, DOI 10.3724/SP.J.1258.2014.00065; Suzuki Jun-ichirou, 1999, Plant Species Biology, V14, P11, DOI 10.1046/j.1442-1984.1999.00002.x; Tamura Y, 2001, PLANT PROD SCI, V4, P56, DOI 10.1626/pps.4.56; Volaire F, 1997, AUST J AGR RES, V48, P933, DOI 10.1071/A97004; Wang J, 2002, ACTA ECOLOGICA SINIC, V23, P908; [王勇 Wang Yong], 2014, [生态学报, Acta Ecologica Sinica], V34, P4535; Wang Zheng-Wen, 2007, Zhiwu Shengtai Xuebao, V31, P673; WHITE LM, 1973, J RANGE MANAGE, V26, P13, DOI 10.2307/3896873; Wulfes R, 1999, AGR SYST, V61, P1, DOI 10.1016/S0308-521X(99)00028-1; Wyka T, 1999, OECOLOGIA, V120, P198, DOI 10.1007/s004420050849; Xu ZX, 1994, ACTA PRATACULTURAL S, V4, P27; Yan Q, 2003, ACTA ECOLOGICA SINIC, V24, P2422; [杨超 YANG Chao], 2008, [生态学报, Acta Ecologica Sinica], V28, P4732; Yang YF, 2003, ACTA BOT SIN, V45, P158; Yang YunFei, 2003, Acta Prataculturae Sinica, V12, P8; Ye XiaoQi, 2013, Acta Hydrobiologica Sinica, V37, P450; Zhang BaoTian, 2002, Grassland of China, V24, P13; Zhang ZL, 2003, GUIDE PLANT PHYSL EX, P127; [周天 ZHOU Tian], 2008, [草业科学, Pratacultural Science], V25, P41; Zhou Yong-Bin, 2009, Zhiwu Shengtai Xuebao, V33, P118, DOI 10.3773/j.issn.1005-264x.2009.01.013	46	1	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176667	10.1371/journal.pone.0176667	http://dx.doi.org/10.1371/journal.pone.0176667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486507	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000022
J	Benz, C; Stribrna, E; Hashimi, H; Lukes, J				Benz, Corinna; Stribrna, Eva; Hashimi, Hassan; Lukes, Julius			Dynamin-like proteins in Trypanosoma brucei: A division of labour between two paralogs?	PLOS ONE			English	Article							BLOOD-STREAM FORMS; MITOCHONDRIAL FISSION; SEQUENCE ALIGNMENT; GTPASE ACTIVITY; SINGLE DYNAMIN; LIFE-CYCLE; ENDOCYTOSIS; FIS1; EXPRESSION; SURFACE	Dynamins and dynamin-like proteins (DLPs) belong to a family of large GTPases involved in membrane remodelling events. These include both fusion and fission processes with different dynamin proteins often having a specialised function within the same organism. Trypanosoma brucei is thought to have only one multifunctional DLP (TbDLP). While this was initially reported to function in mitochondrial division only, an additional role in endocytosis and cytokinesis was later also proposed. Since there are two copies of TbDLP present in the trypanosome genome, we investigated potential functional differences between these two paralogs by re-expressing either protein in a TbDLP RNAi background. These paralogs, called TbDLP1 and TbDLP2, are almost identical bar a few amino acid substitutions. Our results, based on cell lines carrying tagged and RNAi-resistant versions of each protein, show that overexpression of TbDLP1 alone is able to rescue the observed endocytosis and growth defects in the mammalian bloodstream form (BSF) of the parasite. While TbDLP2 shows no rescue in our experiments in BSF, this might also be due to lower expression levels of the protein in this life stage. In contrast, both TbDLP proteins apparently play more complementary roles in the insect procyclic form (PCF) since neither TbDLP1 nor TbDLP2 alone can fully restore wildtype growth and morphology in TbDLP-depleted parasites.	[Benz, Corinna; Hashimi, Hassan; Lukes, Julius] Univ South Bohemia, Fac Sci, Ceske Budejovice, Budweis, Czech Republic; [Stribrna, Eva; Hashimi, Hassan; Lukes, Julius] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Budweis, Czech Republic; [Lukes, Julius] Canadian Inst Adv Res, Toronto, ON, Canada; [Benz, Corinna] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Canadian Institute for Advanced Research (CIFAR); Lancaster University	Lukes, J (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Budweis, Czech Republic.; Lukes, J (corresponding author), Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Budweis, Czech Republic.; Lukes, J (corresponding author), Canadian Inst Adv Res, Toronto, ON, Canada.	jula@paru.cas.cz	Lukes, Julius/H-6760-2012; Benz, Corinna/AAD-8702-2021; Hashimi, Hassan/H-6740-2012	Lukes, Julius/0000-0002-0578-6618; Benz, Corinna/0000-0003-4367-2758; Hashimi, Hassan/0000-0002-6678-1618	Grant Agency of the Czech Republic [15-21974S, 17-24036S]; Bioglobe [CZ.1.07/2.3.00/30.0006]; European Research Council [CZ LL1601]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Bioglobe; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Grant Agency of the Czech Republic (grant number: 15-21974S; https.//gacr.cz/en/) to JL and (grant number: 17-24036S; https://gacr.cz/en/) to HH, Bioglobe grant CZ.1.07/2.3.00/30.0006 (http://alfa. bc.cas.czlen/Postdok-BIOGLOBE/) to JL and CB and the European Research Council (grant number: CZ LL1601; https.//erc.europa.eu/) to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Benz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030367; BIENEN EJ, 1991, MOL BIOCHEM PARASIT, V45, P185, DOI 10.1016/0166-6851(91)90085-K; Bramkamp M, 2012, BIOL CHEM, V393, P1203, DOI 10.1515/hsz-2012-0185; BRUN R, 1979, ACTA TROP, V36, P289; Burmann F, 2011, MOL MICROBIOL, V79, P1294, DOI 10.1111/j.1365-2958.2011.07523.x; Bui HT, 2013, CURR BIOL, V23, pR891, DOI 10.1016/j.cub.2013.08.040; Butter F, 2013, MOL CELL PROTEOMICS, V12, P172, DOI 10.1074/mcp.M112.019224; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Chanez AL, 2006, J CELL SCI, V119, P2968, DOI 10.1242/jcs.03023; Changmai P, 2013, MOL MICROBIOL, V89, P135, DOI 10.1111/mmi.12264; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Cross GAM, 2014, MOL BIOCHEM PARASIT, V195, P59, DOI 10.1016/j.molbiopara.2014.06.004; Dejung M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005439; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Field MC, 2009, NAT REV MICROBIOL, V7, P775, DOI 10.1038/nrmicro2221; Figueroa-Romero C, 2009, FASEB J, V23, P3917, DOI 10.1096/fj.09-136630; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gunasekera K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-556; Guo Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053523; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Kumar S, 2007, EUKARYOT CELL, V6, P2029, DOI 10.1128/EC.00213-07; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Macdonald PJ, 2016, J BIOL CHEM, V291, P493, DOI 10.1074/jbc.M115.680181; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Morgan GW, 2004, J BIOL CHEM, V279, P10692, DOI 10.1074/jbc.M312178200; Morrison LJ, 2014, MICROBIOLOGY SPECTRU, P409; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Osellame L. D., 2016, J CELL SCI; Purkanti R, 2015, P NATL ACAD SCI USA, V112, P2800, DOI 10.1073/pnas.1407163112; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Surve S, 2012, EUKARYOT CELL, V11, P183, DOI 10.1128/EC.05282-11; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tielens AGM, 1998, PARASITOL TODAY, V14, P265, DOI 10.1016/S0169-4758(98)01263-0; Tielens AGM, 2009, TRENDS PARASITOL, V25, P482, DOI 10.1016/j.pt.2009.07.007; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; Vanwalleghem G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9078; Verner Z, 2015, INT REV CEL MOL BIO, V315, P73, DOI 10.1016/bs.ircmb.2014.11.001; Wang B, 2011, EMBO J, V30, P451, DOI 10.1038/emboj.2010.352; Wang JY, 2012, MOL MICROBIOL, V83, P471, DOI 10.1111/j.1365-2958.2011.07938.x; Wickstead B, MOL BIOCH PARASITOL, V125, P211; Williams M, 2014, EUR J CELL BIOL, V93, P267, DOI 10.1016/j.ejcb.2014.05.002; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhang ZZ, 2016, FASEB J, V30, P466, DOI 10.1096/fj.15-274258	55	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177200	10.1371/journal.pone.0177200	http://dx.doi.org/10.1371/journal.pone.0177200			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481934	gold, Green Published, Green Submitted			2022-12-27	WOS:000401313700040
J	Wong, VCL; Ko, JMY; Lam, CT; Lung, ML				Wong, Victor Chun-Lam; Ko, Josephine Mun-Yee; Lam, Chi-Tat; Lung, Maria Li			Succinct workflows for circulating tumor cells after enrichment: From systematic counting to mutational profiling	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; HEPATOCELLULAR-CARCINOMA; BREAST-CANCER; ANALYSIS SOFTWARE; CELLPROFILER; ASSOCIATION; PHENOTYPES	Purpose This study aims to establish a highly adaptable workflow downstream of microfluidic enrichment for facilitating systematic CTC enumeration and genetic discovery. Methods To facilitate CTC enumeration, we established a CK/EPCAM-combined immunostaining strategy and an automated CTC analytical pipeline using an open-source image analyzer. By virtue of this workflow, we conducted a pilot study of 56 cancer patients and 21 healthy individuals using a high-throughput spiral microfluidic chip system. To facilitate genetic discovery of somatic mutations in CTCs, we integrated the CTC enumeration into next-generation sequencing and established a straightforward amplicon library comprising diversifier random sequences to sequence CTC samples. Results The CTC staining and enumeration workflow achieved 80.4% sensitivity and 85.7% specificity (AUC = 0.87, p = 0.004, power = 0.985), as evaluated by ROC analysis. Univariate and multivariate analysis verified that the CTC (CK/EpCAM(+)CD45(-)), but not other cell populations, is a significant and independent biomarker for cancer patients (p < 0.01). Serial CTC monitoring of the patients revealed reduction in CTC numbers after treatments, suggesting its clinical utility in pharmacodynamic studies. Deep sequencing of CTC samples revealed somatic mutations in TP53 and ESR1. Conclusions The significance of this report is to demonstrate a systematic and adaptable workflow to bridge the gap between the microfluidic enrichment and CTC analyses, which fosters broader applications of CTCs in both clinical settings and academic studies.	[Wong, Victor Chun-Lam; Lam, Chi-Tat] OncoSeek Ltd, Hong Kong Sci & Technol Pk, Hong Kong, Hong Kong, Peoples R China; [Ko, Josephine Mun-Yee; Lung, Maria Li] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Wong, VCL (corresponding author), OncoSeek Ltd, Hong Kong Sci & Technol Pk, Hong Kong, Hong Kong, Peoples R China.; Lung, ML (corresponding author), Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China.	victor@oncoseek-hk.com; mlilung@hku.hk	Ko, Josephine/U-2972-2019; Lung, Maria Li/C-4495-2009	Ko, Josephine/0000-0002-7997-331X; Lung, Maria Li/0000-0003-2559-3626	Innovation and Technology Commission of the Hong Kong Government [TSSSU/HKU/14/01/1, TSSSU/HKU/14/01/2]; OncoSeek Ltd	Innovation and Technology Commission of the Hong Kong Government; OncoSeek Ltd	This work was partially funded by the Innovation and Technology Commission of the Hong Kong Government, which aimed to assist the setup of university spin-off technology start-ups through the Technology Start-up Support Scheme for Universities (TSSSU/HKU/14/01/1 & TSSSU/HKU/14/01/2 to ML). With this funding, OncoSeek Ltd was established. We do not have any benefits haring relationship with the funder. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The study was funded in part by OncoSeek Ltd. VW and CL received salaries from OncoSeek Ltd for this study. There is no additional external funding for this study. In collaboration with JK and ML, OncoSeek Ltd (VW and CL) designed the study, collected and analyzed the data, prepared the manuscript, and made the decision to submit for publication.	Afgan E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140829; Alix-Panabieres C, 2014, NAT REV CANCER, V14, P623, DOI 10.1038/nrc3820; Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Bidard FC, 2016, MOL ONCOL, V10, P418, DOI 10.1016/j.molonc.2016.01.001; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chiu CH, 2015, J THORAC ONCOL, V10, P793, DOI 10.1097/JTO.0000000000000504; Ding L, 2014, NAT REV GENET, V15, P556, DOI 10.1038/nrg3767; Hishida M, 2013, INT J ONCOL, V43, P88, DOI 10.3892/ijo.2013.1951; Hou HW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01259; Hu Y, 2014, CANCER INFORM, V13, P13, DOI 10.4137/CIN.S13495; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Khoo BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099409; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krebs MG, 2014, NAT REV CLIN ONCOL, V11, P129, DOI 10.1038/nrclinonc.2013.253; Krebs Matthew G, 2010, Ther Adv Med Oncol, V2, P351, DOI 10.1177/1758834010378414; Lee VHF, 2013, J THORAC ONCOL, V8, P1148, DOI 10.1097/JTO.0b013e31829f684a; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lorente David, 2014, Am Soc Clin Oncol Educ Book, pe197, DOI 10.14694/EdBook_AM.2014.34.e197; Lustberg MB, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3622; Millner LM, 2013, ANN CLIN LAB SCI, V43, P295; Pierga JY, 2008, CLIN CANCER RES, V14, P7004, DOI 10.1158/1078-0432.CCR-08-0030; Sun HL, 2015, J BUON, V20, P296; Sun YF, 2013, HEPATOLOGY, V57, P1458, DOI 10.1002/hep.26151; Weiss L, 2000, CANCER METAST REV, V19, P193, DOI 10.1023/A:1010646304844; Wong VCL, 2012, INT J CANCER, V130, P83, DOI 10.1002/ijc.25970; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Yu VZ, 2015, GASTROENTEROLOGY, V149, P1825, DOI 10.1053/j.gastro.2015.08.025	30	9	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177276	10.1371/journal.pone.0177276	http://dx.doi.org/10.1371/journal.pone.0177276			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481895	Green Published, Green Submitted, gold			2022-12-27	WOS:000401313700046
J	Angwin, AJ; Dissanayaka, NNW; McMahon, KL; Silburn, PA; Copland, DA				Angwin, Anthony J.; Dissanayaka, Nadeeka N. W.; McMahon, Katie L.; Silburn, Peter A.; Copland, David A.			Lexical ambiguity resolution during sentence processing in Parkinson's disease: An event-related potential study	PLOS ONE			English	Article							NONTHALAMIC SUBCORTICAL LESIONS; BASAL GANGLIA; SEMANTIC ACTIVATION; MEANING FREQUENCY; CORTICAL-LESIONS; TIME-COURSE; WORDS; COMPREHENSION; SELECTION; INDIVIDUALS	Event-related potentials (ERPs) were recorded to investigate lexical ambiguity resolution during sentence processing in 16 people with Parkinson's disease (PD) and 16 healthy controls. Sentences were presented word-by-word on computer screen, and participants were required to decide if a subsequent target word was related to the meaning of the sentence. The task consisted of related, unrelated and ambiguous trials. For the ambiguous trials, the sentence ended with an ambiguous word and the target was related to one of the meanings of that word, but not the one captured by the sentence context (e.g., 'He dug with the spade', Target 'ACE'). Both groups demonstrated slower reaction times and lower accuracy for the ambiguous condition relative to the unrelated condition, however accuracy was impacted by the ambiguous condition to a larger extent in the PD group. These results suggested that PD patients experience increased difficulties with contextual ambiguity resolution. The ERP results did not reflect increased ambiguity resolution difficulties in PD, as a similar N400 effect was evident for the unrelated and ambiguous condition in both groups. However, the magnitude of the N400 for these conditions was correlated with a measure of inhibition in the PD group, but not the control group. The ERP results suggest that semantic processing may be more compromised in PD patients with increased response inhibition deficits.	[Angwin, Anthony J.; Copland, David A.] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Dissanayaka, Nadeeka N. W.; Copland, David A.] Univ Queensland, Ctr Clin Res, Brisbane, Qld, Australia; [Dissanayaka, Nadeeka N. W.] Royal Brisbane & Womens Hosp, Neurol Res Ctr, Brisbane, Qld, Australia; [Dissanayaka, Nadeeka N. W.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [McMahon, Katie L.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Silburn, Peter A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; University of Queensland; University of Queensland	Angwin, AJ (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.	a.angwin@uq.edu.au	Angwin, Anthony J/F-7888-2010; Copland, David/AAE-5334-2020; Dissanayaka, Nadeeka N/B-6658-2011; Angwin, Anthony/AAC-8524-2019; McMahon, Katie L/C-6440-2009; Copland, David A/F-1409-2010	Angwin, Anthony J/0000-0003-4547-9433; Copland, David/0000-0002-2257-4270; Dissanayaka, Nadeeka N/0000-0002-0164-3337; Angwin, Anthony/0000-0003-4547-9433; McMahon, Katie L/0000-0002-6357-615X; Copland, David A/0000-0002-2257-4270	Parkinson's Queensland Inc; Australian Research Council [DP120104420]; Lions Medical Research Fellowship	Parkinson's Queensland Inc; Australian Research Council(Australian Research Council); Lions Medical Research Fellowship	This research was supported by a Parkinson's Queensland Inc seeding grant (http://parkinsons-qld.org.au/) awarded to AJA, DAC, KLM and NNWD, and an Australian Research Council grant DP120104420 (http://www.arc.gov.au/) awarded to DAC, KLM, PAS and AJA. Nadeeka Dissanayaka is supported by the Lions Medical Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angwin AJ, 2006, J NEUROLINGUIST, V19, P239, DOI 10.1016/j.jneuroling.2005.11.004; Angwin AJ, 2005, COGNITIVE BRAIN RES, V25, P78, DOI 10.1016/j.cogbrainres.2005.04.008; Angwin AJ, 2007, J CLIN EXP NEUROPSYC, V29, P73, DOI 10.1080/13803390500507188; Angwin AJ, 2006, NEUROPSYCHOLOGY, V20, P299, DOI 10.1037/0894-4105.20.3.299; Angwin AJ, 2017, J INT NEUROPSYCH SOC, V23, P78, DOI 10.1017/S1355617716000953; Angwin AJ, 2009, CORTEX, V45, P950, DOI 10.1016/j.cortex.2009.02.012; Arnott WL, 2010, INT J SPEECH-LANG PA, V12, P437, DOI 10.3109/17549507.2010.492875; Arnott WL, 2001, J CLIN EXP NEUROPSYC, V23, P502, DOI 10.1076/jcen.23.4.502.1224; Bocanegra Y, 2015, CORTEX, V69, P237, DOI 10.1016/j.cortex.2015.05.022; Brandt J, 2001, HOPKINS VERBAL LEARN; Colman KSF, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/213983; Colman KSF, 2009, CORTEX, V45, P930, DOI 10.1016/j.cortex.2008.12.010; Copland D, 2003, J INT NEUROPSYCH SOC, V9, P1041, DOI 10.1017/S1355617703970081; Copland DA, 2000, BRAIN LANG, V74, P360; Copland DA, 2000, CORTEX, V36, P601, DOI 10.1016/S0010-9452(08)70541-0; Copland DA, 2001, J CLIN EXP NEUROPSYC, V23, P538, DOI 10.1076/jcen.23.4.538.1233; Copland DA, 2009, CORTEX, V45, P943, DOI 10.1016/j.cortex.2009.02.023; Cramer P, 1970, NORMS WORD ASS, P361; De Letter M, 2012, J NEUROLINGUIST, V25, P95, DOI 10.1016/j.jneuroling.2011.09.001; Debruille JB, 2008, BRAIN RES, V1187, P167, DOI 10.1016/j.brainres.2007.10.021; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Faust ME, 1997, BRAIN LANG, V57, P225, DOI 10.1006/brln.1997.1747; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Friederici AD, 2003, NEUROPSYCHOLOGY, V17, P133, DOI 10.1037/0894-4105.17.1.133; GERNSBACHER MA, 1990, J EXP PSYCHOL LEARN, V16, P430, DOI 10.1037/0278-7393.16.3.430; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Grossman M, 2002, NEUROPSYCHOLOGY, V16, P174, DOI 10.1037//0894-4105.16.2.174; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; KAUSLER DH, 1970, J VERB LEARN VERB BE, V9, P444, DOI 10.1016/S0022-5371(70)80086-X; Kehagia AA, 2010, LANCET NEUROL, V9, P1200, DOI 10.1016/S1474-4422(10)70212-X; Ketteler D, 2008, NEUROIMAGE, V39, P2002, DOI 10.1016/j.neuroimage.2007.10.023; Ketteler S, 2014, BRAIN RES, V1581, P51, DOI 10.1016/j.brainres.2014.06.030; Klepousniotou E, 2012, BRAIN LANG, V123, P11, DOI 10.1016/j.bandl.2012.06.007; Kotchoubey B, 2014, BRAIN COGNITION, V92, P48, DOI 10.1016/j.bandc.2014.10.007; Kutas M, 2014, COGNITIVE ELECTROPHYSIOLOGY OF ATTENTION: SIGNALS OF THE MIND, P254, DOI 10.1016/B978-0-12-398451-7.00020-8; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lee CL, 2012, NEUROPSYCHOLOGIA, V50, P869, DOI 10.1016/j.neuropsychologia.2012.01.027; Lee CL, 2011, PSYCHOPHYSIOLOGY, V48, P960, DOI 10.1111/j.1469-8986.2010.01158.x; Longworth CE, 2005, BRAIN, V128, P584, DOI 10.1093/brain/awh387; Mari-Beffa P, 2005, NEUROPSYCHOLOGIA, V43, P638, DOI 10.1016/j.neuropsychologia.2004.07.006; Meyer AM, 2007, BRAIN RES, V1183, P91, DOI 10.1016/j.brainres.2007.09.007; Meyer AM, 2010, PSYCHOPHYSIOLOGY, V47, P673, DOI 10.1111/j.1469-8986.2010.00983.x; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; NELSON DL, 1980, BEHAV RES METH INSTR, V12, P16, DOI 10.3758/BF03208320; Pagonabarraga J, 2008, MOVEMENT DISORD, V23, P998, DOI 10.1002/mds.22007; Raling R, 2015, NEUROPSYCHOLOGIA, V75, P186, DOI 10.1016/j.neuropsychologia.2015.05.031; Shang M, 2013, NEUROPSYCHOLOGIA, V51, P1989, DOI 10.1016/j.neuropsychologia.2013.06.006; SIMPSON GB, 1985, J EXP PSYCHOL HUMAN, V11, P28, DOI 10.1037/0096-1523.11.1.28; Swaab T, 2003, BRAIN LANG, V86, P326, DOI 10.1016/S0093-934X(02)00547-3; Swaab TY, 1998, NEUROPSYCHOLOGIA, V36, P737, DOI 10.1016/S0028-3932(97)00174-7; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; TWILLEY LC, 1994, MEM COGNITION, V22, P111, DOI 10.3758/BF03202766; VANPETTEN C, 1987, J MEM LANG, V26, P188, DOI 10.1016/0749-596X(87)90123-9	53	2	2	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176281	10.1371/journal.pone.0176281	http://dx.doi.org/10.1371/journal.pone.0176281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475582	Green Submitted, Green Published, gold			2022-12-27	WOS:000400649500006
J	Esposti, MD; Romero, EM				Degli Esposti, Mauro; Martinez Romero, Esperanza			The functional microbiome of arthropods	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIAL COMMUNITY; GEN. NOV.; DIVERSITY; EVOLUTION; TREE; IDENTIFICATION; GENOMES; MEMBER; LIFE	Many studies on the microbiome of animals have been reported but a comprehensive analysis is lacking. Here we present a meta-analysis on the microbiomes of arthropods and their terrestrial habitat, focusing on the functional profile of bacterial communities derived from metabolic traits that are essential for microbial life. We report a detailed analysis of probably the largest set of biochemically defined functional traits ever examined in microbiome studies. This work deals with the phylum proteobacteria, which is usually dominant in marine and terrestrial environments and covers all functions associated with microbiomes. The considerable variation in the distribution and abundance of proteobacteria in microbiomes has remained fundamentally unexplained. This analysis reveals discrete functional groups characteristic for adaptation to anaerobic conditions, which appear to be defined by environmental filtering of taxonomically related taxa. The biochemical diversification of the functional groups suggests an evolutionary trajectory in the structure of arthropods' microbiome, from metabolically versatile to specialized proteobacterial organisms that are adapted to complex environments such as the gut of social insects. Bacterial distribution in arthropods' microbiomes also shows taxonomic clusters that do not correspond to functional groups and may derive from other factors, including common contaminants of soil and reagents.	[Degli Esposti, Mauro] Italian Inst Technol, Genoa, Italy; [Degli Esposti, Mauro; Martinez Romero, Esperanza] UNAM Campus Cuernavaca, Ctr Genom Sci, Cuernavaca, Morelos, Mexico	Istituto Italiano di Tecnologia - IIT	Esposti, MD (corresponding author), Italian Inst Technol, Genoa, Italy.; Esposti, MD (corresponding author), UNAM Campus Cuernavaca, Ctr Genom Sci, Cuernavaca, Morelos, Mexico.	mauro.degliesposti@iit.it			Consejo National de Ciencia y Tecnologia, Mexico [263876, 253116]; CONACyT [263876, 253116]	Consejo National de Ciencia y Tecnologia, Mexico; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Consejo National de Ciencia y Tecnologia, Mexico (http://www.conacyt.gob.mx/#) Grants No. 263876 and 253116. Grant No. 263876 was awarded to finance the sabbatical period of MDE at CCG UNAM during 2016. Grant No. 253116 was awarded to EMR to continue here research program of environmental microbiology and genomics of gram negative bacteria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Julio Martinez Romero (CCG UNAM) for his help in data analysis. This work was sponsored by CONACyT grants No. 263876 and 253116.	Adams RI, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0108-3; Almagro G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115516; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Aujoulat F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083376; Aylward FO, 2012, ISME J, V6, P1688, DOI 10.1038/ismej.2012.10; Baldani JI, 2015, BERGEYS MANUAL SYSTE, P1, DOI [10. 1002/9781118960608. gbm00963, DOI 10.1002/9781118960608.GBM00891]; Berg M, 2016, ISME J, V10, P1998, DOI 10.1038/ismej.2015.253; Berlanga M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152400; Bhatt AS, 2013, NEW ENGL J MED, V369, P517, DOI 10.1056/NEJMoa1211115; Bolanos LM, 2016, ENVIRON MICROBIOL, V18, P1364, DOI 10.1111/1462-2920.12939; Boon E, 2014, FEMS MICROBIOL REV, V38, P90, DOI 10.1111/1574-6976.12035; Bouchon D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01472; Brune A, 2015, ANNU REV MICROBIOL, V69, P145, DOI 10.1146/annurev-micro-092412-155715; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Cardona T, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00257; Castro-Nallar E, 2015, PEERJ, V3, DOI 10.7717/peerj.1140; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Chan AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28061; Chang YT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00893; Chen MJ, 2013, J BACTERIOL, V195, P2768, DOI 10.1128/JB.00141-13; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; Chou JH, 2007, INT J SYST EVOL MICR, V57, P887, DOI 10.1099/ijs.0.64551-0; Chouaia B, 2014, GENOME BIOL EVOL, V6, P912, DOI 10.1093/gbe/evu062; Colston TJ, 2016, MOL ECOL, V25, P3776, DOI 10.1111/mec.13730; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Esposti MD, 2016, GENOME BIOL EVOL, V8, P2031, DOI 10.1093/gbe/evw130; Esposti MD, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0136-3; Degli Esposti M, 2015, GENOME BIOL EVOL, V7, P801, DOI 10.1093/gbe/evv032; Esposti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096566; Dirksen P, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0258-1; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Esposti MD, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw084; Esposti MD, 2016, GENOME BIOL EVOL, V8, P126, DOI 10.1093/gbe/evv239; Fan L, 2012, P NATL ACAD SCI USA, V109, pE1878, DOI 10.1073/pnas.1203287109; Gebhardt MJ, 2015, MBIO, V6, DOI 10.1128/mBio.01660-15; Glassing A, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0103-7; Greening C, 2016, ISME J, V10, P761, DOI 10.1038/ismej.2015.153; Hata H, 2016, MICROBIOL IMMUNOL, V60, P303, DOI 10.1111/1348-0421.12374; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Ikeda-Ohtsubo W, 2016, ENVIRON MICROBIOL, V18, P2548, DOI 10.1111/1462-2920.13234; Kaplan MM, 2004, AM J GASTROENTEROL, V99, P2147, DOI 10.1111/j.1572-0241.2004.41121.x; Kawamura Y, 2012, MICROBIOL IMMUNOL, V56, P21, DOI 10.1111/j.1348-0421.2011.00401.x; Kellner K, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv073; Ku C, 2015, NATURE, V524, P427, DOI 10.1038/nature14963; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lawrence AL, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv134; Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110; Liotenberg S, 2008, ENVIRON MICROBIOL, V10, P2267, DOI 10.1111/j.1462-2920.2008.01649.x; Liu JN, 2016, NEOTROP ENTOMOL, V45, P397, DOI 10.1007/s13744-016-0388-8; Louca S, 2016, SCIENCE, V353, P1272, DOI 10.1126/science.aaf4507; Lozano-Fernandez J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0133; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; Mikaelyan A, 2016, APPL ENVIRON MICROB, V82, P1256, DOI 10.1128/AEM.03700-15; Montagna M, 2015, INSECT SCI, V22, P340, DOI 10.1111/1744-7917.12143; Montagna M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117439; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Nagai F, 2009, INT J SYST EVOL MICR, V59, P1793, DOI 10.1099/ijs.0.002519-0; Nakao R, 2013, ISME J, V7, P1003, DOI 10.1038/ismej.2012.171; Nayfach S, 2016, CELL, V166, P1103, DOI 10.1016/j.cell.2016.08.007; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Pan MM, 2015, J BASIC MICROB, V55, P1336, DOI 10.1002/jobm.201500124; Pascual J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146558; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Romano-Bertrand S, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.05.024; Rossmassler K, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0118-1; Roy P, 2014, J CLIN DIAGN RES, V8, pDD1, DOI 10.7860/JCDR/2014/7940.4329; Rungrassamee W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091853; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schauer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085861; Simon J, 2013, BBA-BIOENERGETICS, V1827, P114, DOI 10.1016/j.bbabio.2012.07.005; Smith RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129004; Thomas T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11870; Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006; Tzeng TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132860; van der Lelie D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036740; Vanthournout B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117297; Viklund J, 2012, MOL BIOL EVOL, V29, P599, DOI 10.1093/molbev/msr203; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Wong ACN, 2015, APPL ENVIRON MICROB, V81, P6232, DOI 10.1128/AEM.01442-15; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028995; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035181; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330	83	58	60	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176573	10.1371/journal.pone.0176573	http://dx.doi.org/10.1371/journal.pone.0176573			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475624	gold, Green Submitted, Green Published			2022-12-27	WOS:000400649500010
J	Starr, M; Lair, S; Michaud, S; Scarratt, M; Quilliam, M; Lefaivre, D; Robert, M; Wotherspoon, A; Michaud, R; Menard, N; Sauve, G; Lessard, S; Beland, P; Measures, L				Starr, Michel; Lair, Stephane; Michaud, Sonia; Scarratt, Michael; Quilliam, Michael; Lefaivre, Denis; Robert, Michel; Wotherspoon, Andrew; Michaud, Robert; Menard, Nadia; Sauve, Gilbert; Lessard, Sylvie; Beland, Pierre; Measures, Lena			Multispecies mass mortality of marine fauna linked to a toxic dinoflagellate bloom	PLOS ONE			English	Article							PORPOISE PHOCOENA-PHOCOENA; PARALYTIC SHELLFISH TOXINS; ATLANTIC RIGHT WHALES; POISONING PSP TOXINS; HARMFUL ALGAL BLOOMS; ST-LAWRENCE; ALEXANDRIUM-TAMARENSE; EUBALAENA-GLACIALIS; ESTUARY; GULF	Following heavy precipitation, we observed an intense algal bloom in the St. Lawrence Estuary (SLE) that coincided with an unusually high mortality of several species of marine fish, birds and mammals, including species designated at risk. The algal species was identified as Alexandrium tamarense and was determined to contain a potent mixture of paralytic shellfish toxins (PST). Significant levels of PST were found in the liver and/or gastrointestinal contents of several carcasses tested as well as in live planktivorous fish, molluscs and plankton samples collected during the bloom. This provided strong evidence for the trophic transfer of PST resulting in mortalities of multiple wildlife species. This conclusion was strengthened by the sequence of mortalities, which followed the drift of the bloom along the coast of the St. Lawrence Estuary. No other cause of mortality was identified in the majority of animals examined at necropsy. Reports of marine fauna presenting signs of neurological dysfunction were also supportive of exposure to these neurotoxins. The event reported here represents the first well-documented case of multispecies mass mortality of marine fish, birds and mammals linked to a PST-producing algal bloom.	[Starr, Michel; Michaud, Sonia; Scarratt, Michael; Lefaivre, Denis; Lessard, Sylvie; Measures, Lena] Maurice Lamontagne Inst, Fisheries & Oceans Canada, DFO, Mont Joli, PQ, Canada; [Lair, Stephane] Univ Montreal, Fac Med Vet, Canadian Cooperat Wildlife Hlth Ctr, St Hyacinthe, PQ, Canada; [Quilliam, Michael; Wotherspoon, Andrew] Natl Res Council Canada, Biotoxin Metrol, Halifax, NS, Canada; [Robert, Michel] Canadian Wildlife Serv, Environm & Climate Change Canada, Quebec City, PQ, Canada; [Michaud, Robert] GREMM, Tadoussac, PQ, Canada; [Menard, Nadia] Parks Canada, Saguenay St Lawrence Marine Pk, Tadoussac, PQ, Canada; [Sauve, Gilbert] Canadian Food Inspect Agcy, Quebec City, PQ, Canada	Fisheries & Oceans Canada; Universite de Montreal; International Business Machines (IBM); National Research Council Canada; Environment & Climate Change Canada; Canadian Wildlife Service; Parks Canada; Canadian Food Inspection Agency	Starr, M (corresponding author), Maurice Lamontagne Inst, Fisheries & Oceans Canada, DFO, Mont Joli, PQ, Canada.	Michel.Starr@dfo-mpo.gc.ca		Quilliam, Michael/0000-0002-2670-4220; Michaud, Sonia/0000-0001-9267-0404				ANDERSON DM, 1994, MAR BIOL, V120, P467, DOI 10.1007/BF00680222; [Anonymous], 2003, MANUAL HARMFUL MARIN, P347; Beck CA, 2005, CAN J ZOOL, V83, P377, DOI 10.1139/Z05-021; Benoit D, 1990, CAN B FISH AQUAT SCI, V222, P227; Berard-Therriault L, 1999, PUBLICATION SPECIALE; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Bricelj V. Monica, 1998, Reviews in Fisheries Science, V6, P315, DOI 10.1080/10641269891314294; Cembella AD, 2002, HARMFUL ALGAE, V1, P313, DOI 10.1016/S1568-9883(02)00048-3; Costa PR, 2011, MAR BIOL, V158, P2805, DOI 10.1007/s00227-011-1779-3; Dam HG, 2011, HARMFUL ALGAE, V10, P245, DOI 10.1016/j.hal.2010.10.004; Deeds JR, 2008, MAR DRUGS, V6, P308, DOI [10.3390/md6020308, 10.3390/md20080015]; Dell'Aversano C, 2005, J CHROMATOGR A, V1081, P190, DOI 10.1016/j.chroma.2005.05.056; Doucette G, 2006, ECOL STU AN, V189, P283, DOI 10.1007/978-3-540-32210-8_22; Doucette GJ, 2006, MAR ECOL PROG SER, V306, P303, DOI 10.3354/meps306303; Durbin E, 2002, HARMFUL ALGAE, V1, P243, DOI 10.1016/S1568-9883(02)00046-X; Fire SE, 2012, MAR ECOL PROG SER, V460, P145, DOI 10.3354/meps09768; FONTAINE PM, 1994, CAN J FISH AQUAT SCI, V51, P172, DOI 10.1139/f94-019; FRANKS PJS, 1992, MAR ECOL PROG SER, V82, P1, DOI 10.3354/meps082001; GERACI JR, 1989, CAN J FISH AQUAT SCI, V46, P1895, DOI 10.1139/f89-238; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; Gracia S, 2013, ESTUAR COAST SHELF S, V121, P20, DOI 10.1016/j.ecss.2013.01.019; Gulland FMD, 2007, ECOHEALTH, V4, P135, DOI 10.1007/s10393-007-0097-1; HALL S, 1990, ACS SYM SER, V418, P29; Hollingworth T, 1990, OFFICIAL METHODS ANA, V15th, P881; Kotaki Y, 1985, TOXIC DINOFLAGELLATE, P287; Lair S, 2015, DOCUMENTATION EVOLUT, V3143; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; LAROCQUE R, 1990, TOXIC MARINE PHYTOPLANKTON, P368; Lesage V, 2001, MAR ECOL PROG SER, V210, P203, DOI 10.3354/meps210203; Levasseur Maurice, 1995, P463; LUND J. W. G., 1958, HYDROBIOLOGIA, V11, P143, DOI 10.1007/BF00007865; MacIntyre JG, 1997, MAR ECOL PROG SER, V148, P201, DOI 10.3354/meps148201; OSHIMA Y, 1995, J AOAC INT, V78, P528; Oshima Yasukatsu, 1995, P475; Parkhill JP, 1999, J PLANKTON RES, V21, P939, DOI 10.1093/plankt/21.5.939; Rail Jean-Francois, 2009, Naturaliste Canadien (Quebec), V133, P33; Rail JF, 1998, CAN J ZOOL, V76, P635, DOI 10.1139/cjz-76-4-635; Reyero M, 1999, NAT TOXINS, V7, P311, DOI 10.1002/1522-7189(199911/12)7:6<311::AID-NT75>3.0.CO;2-I; Rourke WA, 2008, J AOAC INT, V91, P589; Saucier F.J., 2009, REV SCI EAU, V22, P159, DOI 10.7202/037480ar; Saucier FJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000686; Saucier FJ, 2000, ATMOS OCEAN, V38, P505, DOI 10.1080/07055900.2000.9649658; Selander E, 2006, P ROY SOC B-BIOL SCI, V273, P1673, DOI 10.1098/rspb.2006.3502; Senft-Batoh CD, 2015, HARMFUL ALGAE, V44, P20, DOI 10.1016/j.hal.2015.02.008; Senft-Batoh CD, 2015, LIMNOL OCEANOGR, V60, P318, DOI 10.1002/lno.10027; Shimizu Y., 1986, NATURAL TOXINS ANIMA, P115; SHUMWAY S E, 1990, Journal of the World Aquaculture Society, V21, P65, DOI 10.1111/j.1749-7345.1990.tb00529.x; Shumway SE, 2003, HARMFUL ALGAE, V2, P1, DOI 10.1016/S1568-9883(03)00002-7; SMITH RJ, 1992, CAN J ZOOL, V70, P1629, DOI 10.1139/z92-225; Stoskopf MK, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P703; Tan KS, 2015, REV ENVIRON CONTAM T, V235, P1, DOI 10.1007/978-3-319-10861-2_1; Therriault J.C., 1985, P141; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Weise AM, 2002, CAN J FISH AQUAT SCI, V59, P464, DOI 10.1139/F02-024	54	37	44	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176299	10.1371/journal.pone.0176299	http://dx.doi.org/10.1371/journal.pone.0176299			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472048	Green Submitted, gold, Green Published			2022-12-27	WOS:000400648500036
J	Sui, M; Li, MY; Kunwar, S; Pandey, P; Zhang, Q; Lee, J				Sui, Mao; Li, Ming-Yu; Kunwar, Sundar; Pandey, Puran; Zhang, Quanzhen; Lee, Jihoon			Effects of annealing temperature and duration on the morphological and optical evolution of self-assembled Pt nanostructures on c-plane sapphire	PLOS ONE			English	Article							PLATINUM NANOPARTICLES; THIN-FILMS; RAYLEIGH INSTABILITY; SYSTEMATIC CONTROL; AG NANOSTRUCTURES; HYDROGEN STORAGE; CATALYSTS; SIZE; DEPOSITION; SCATTERING	Metallic nanostructures (NSs) have been widely adapted in various applications and their physical, chemical, optical and catalytic properties are strongly dependent on their surface morphologies. In this work, the morphological and optical evolution of self-assembled Pt nanostructures on c-plane sapphire (0001) is demonstrated by the control of annealing temperature and dwelling duration with the distinct thickness of Pt films. The formation of Pt NSs is led by the surface diffusion, agglomeration and surface and interface energy minimization of Pt thin films, which relies on the growth parameters such as system temperature, film thickness and annealing duration. The Pt layer of 10 nm shows the formation of overlaying NPs below 650 degrees C and isolated Pt nanoparticles above 700 degrees C based on the enhanced surface diffusion and Volmer-Weber growth model whereas larger wiggly nanostructures are formed with 20 nm thick Pt layers based on the coalescence growth model. The morphologies of Pt nanostructures demonstrate a sharp distinction depending on the growth parameters applied. By the control of dwelling duration, the gradual transition from dense Pt nanoparticles to networks-like and large clusters is observed as correlated to the Rayleigh instability and Ostwald ripening. The various Pt NSs show a significant distinction in the reflectance spectra depending on the morphology evolution: i.e. the enhancement in UV-visible and NIR regions and the related optical properties are discussed in conjunction with the Pt NSs morphology and the surface coverage.	[Sui, Mao; Li, Ming-Yu; Kunwar, Sundar; Pandey, Puran; Zhang, Quanzhen; Lee, Jihoon] Kwangwoon Univ, Coll Elect & Informat, Seoul, South Korea; [Lee, Jihoon] Univ Arkansas, Inst Nanoscale Sci & Engn, Fayetteville, AR 72701 USA	Kwangwoon University; University of Arkansas System; University of Arkansas Fayetteville	Lee, J (corresponding author), Kwangwoon Univ, Coll Elect & Informat, Seoul, South Korea.; Lee, J (corresponding author), Univ Arkansas, Inst Nanoscale Sci & Engn, Fayetteville, AR 72701 USA.	jihoonleenano@gmail.com	Pandey, Puran/AFR-7802-2022; Li, Ming-Yu/AAH-6879-2020; /B-7688-2019; KUNWAR, SUNDAR/AAD-1483-2020	Pandey, Puran/0000-0002-4993-2066; Li, Ming-Yu/0000-0003-4812-8604; /0000-0002-8768-8586; Kunwar, Sundar/0000-0001-6289-6613; SUI, MAO/0000-0002-3772-6986; Lee, Jihoon/0000-0002-0508-486X	National Research Foundation of Korea [2011-0030079, 2016R1A1A1A05005009]; Kwangwoon University	National Research Foundation of Korea(National Research Foundation of Korea); Kwangwoon University	Financial support from the National Research Foundation of Korea (no. 2011-0030079 and 2016R1A1A1A05005009), and in part by the research grant of Kwangwoon University in 2017 is gratefully acknowledged.	Baldizzone C, 2014, ANGEW CHEM INT EDIT, V53, P14250, DOI 10.1002/anie.201406812; Cai WB, 1998, SURF SCI, V406, P9, DOI 10.1016/S0039-6028(97)01030-3; Callegari G, 2002, LANGMUIR, V18, P4795, DOI 10.1021/la011862w; Eason R., 2007, PULSED LASER DEPOSIT, P628, DOI [10.1002/0470052120, DOI 10.1002/9780470052129]; Garbarino S, 2010, J PHYS CHEM C, V114, P2980, DOI 10.1021/jp908724k; Hong SH, 2013, OPT EXPRESS, V21, P3138, DOI 10.1364/OE.21.003138; Kaplan WD, 2013, J MATER SCI, V48, P5681, DOI 10.1007/s10853-013-7462-y; Kar JP, 2010, APPL SURF SCI, V256, P4995, DOI 10.1016/j.apsusc.2010.03.040; Kong L, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165422; Kunwar S, 2016, CRYST GROWTH DES, V16, P6974, DOI 10.1021/acs.cgd.6b01185; Lando A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.133402; Langhammer C, 2006, NANO LETT, V6, P833, DOI 10.1021/nl060219x; Langhammer C, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2734550; Li Y, 2007, IND ENG CHEM RES, V46, P8277, DOI 10.1021/ie0712075; Li YW, 2007, J PHYS CHEM C, V111, P11086, DOI 10.1021/jp072867q; Liu CY, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3291041; Marshall MSJ, 2014, CHEM SOC REV, V43, P2226, DOI 10.1039/c3cs60458f; Mayrhofer KJJ, 2005, J PHYS CHEM B, V109, P14433, DOI 10.1021/jp051735z; Nakashima S, 2016, AIP ADV, V6, DOI 10.1063/1.4939985; Ovari L, 2010, LANGMUIR, V26, P2167, DOI 10.1021/la902674u; Pandey P, 2016, APPL SURF SCI, V368, P198, DOI 10.1016/j.apsusc.2016.02.001; Pandey P, 2015, RSC ADV, V5, P66212, DOI 10.1039/c5ra07631e; Park J, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2206580; Ruffino F, 2010, J APPL PHYS, V107, DOI 10.1063/1.3428467; Sau TK, 2010, ADV MATER, V22, P1781, DOI 10.1002/adma.200901271; SHEN ZY, 1992, IEEE T MICROW THEORY, V40, P2424, DOI 10.1109/22.179912; Shiraishi Y, 2013, ACS NANO, V7, P9287, DOI 10.1021/nn403954p; Shiraishi Y, 2012, ACS CATAL, V2, P1984, DOI 10.1021/cs300407e; Simonsen SB, 2010, J AM CHEM SOC, V132, P7968, DOI 10.1021/ja910094r; Simonsen SB, 2011, J CATAL, V281, P147, DOI 10.1016/j.jcat.2011.04.011; Stuchebnikov VM, 2005, J COMMUN TECHNOL EL+, V50, P622; Sui M, 2016, SUPERLATTICE MICROST, V100, P1128, DOI 10.1016/j.spmi.2016.10.083; Sui M, 2017, J MATER SCI, V52, P391, DOI 10.1007/s10853-016-0339-0; Sui M, 2014, J APPL CRYSTALLOGR, V47, P505, DOI 10.1107/S1600576713034316; Tan ST, 2006, J APPL PHYS, V100, DOI 10.1063/1.2218468; Tang ZY, 2013, NANO ENERGY, V2, P622, DOI 10.1016/j.nanoen.2013.07.014; Thouti E, 2013, J OPTICS-UK, V15, DOI 10.1088/2040-8978/15/3/035005; Tripathy S, 1999, J APPL PHYS, V85, P8386, DOI 10.1063/1.370686; VENABLES JA, 1984, REP PROG PHYS, V47, P399, DOI 10.1088/0034-4885/47/4/002; VOORHEES PW, 1985, J STAT PHYS, V38, P231, DOI 10.1007/BF01017860; WEAVER JH, 1975, PHYS REV B, V11, P1416, DOI 10.1103/PhysRevB.11.1416; Wiley BJ, 2006, J PHYS CHEM B, V110, P15666, DOI 10.1021/jp0608628; YAO JH, 1993, PHYS REV B, V47, P14110, DOI 10.1103/PhysRevB.47.14110; YUAN C, 1995, J ELECTROCHEM SOC, V142, pL163, DOI 10.1149/1.2048735; Zhang JM, 2004, APPL SURF SCI, V229, P34, DOI 10.1016/j.apsusc.2003.09.050; Zhang N, 2016, NAT PHOTONICS, V10, P473, DOI [10.1038/NPHOTON.2016.76, 10.1038/nphoton.2016.76]; Zhao YD, 2014, NANOSCALE, V6, P1311, DOI 10.1039/c3nr05303b; Zoric I, 2011, ACS NANO, V5, P2535, DOI 10.1021/nn102166t	48	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177048	10.1371/journal.pone.0177048	http://dx.doi.org/10.1371/journal.pone.0177048			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472142	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500129
J	Yamane, A; Kohno, H; Ikeda, T; Kaneko, K; Ugajin, A; Fujita, T; Kunieda, T; Kubo, T				Yamane, Atsuhiro; Kohno, Hiroki; Ikeda, Tsubomi; Kaneko, Kumi; Ugajin, Atsushi; Fujita, Toshiyuki; Kunieda, Takekazu; Kubo, Takeo			Gene expression and immunohistochemical analyses of mKast suggest its late pupal and adult-specific functions in the honeybee brain	PLOS ONE			English	Article							1ST OPTIC GANGLION; SHORT-TERM-MEMORY; MUSHROOM BODIES; APIS-MELLIFERA; SUBESOPHAGEAL GANGLION; EUROPEAN HONEYBEE; E3 LIGASE; BEE; ORGANIZATION; RECEPTOR	In insect brains, the mushroom bodies (MBs, a higher center) comprise intrinsic neurons, termed Kenyon cells (KCs). We previously showed that the honeybee (Apis mellifera L.) MBs comprise four types of KCs, in addition to the previously known three types of KCs: class I large-type KCs (lKCs), class I small-type KCs (sKCs) and class II KCs, novel class I 'middle-type' KCs (mKCs), which are characterized by the preferential expression of a gene, termed mKast. Although mKast was originally discovered during the search for genes whose expression is enriched in the optic lobes (OLs) in the worker brain, subsequent analysis revealed that the gene is expressed in an mKC-preferential manner in the MBs. To gain more insights into the function of mKast in the honeybee brain, we here performed expression analysis of mKast and immunohistochemistry of the mKast protein. Prominent mKast expression was first detected in the brain after the P7 pupal stage. In addition, mKast was expressed almost selectively in the brain, suggesting its late pupal and adult specific functions in the brain. Immunohistochemistry revealed that mKast-like immunoreactivity is detected in several regions in the worker brain: inside and around the MB calyces, at the outer edges of the OL lobula, at the outer surface of and posterior to the antennal lobes (ALs), along the dorsal midline of the anterior brain and at the outer surface of the subesophageal ganglions (SOG). mKast-like immunoreactivities in the MBs, OLs, ALs and SOG were due to the corresponding neurons, while mKast-like immunoreactivities beneath/between the MB calyces were assumed to most likely correspond to the lateral/medial neurosecretory cells.	[Yamane, Atsuhiro; Kohno, Hiroki; Ikeda, Tsubomi; Kaneko, Kumi; Ugajin, Atsushi; Fujita, Toshiyuki; Kunieda, Takekazu; Kubo, Takeo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Kubo, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan.	stkubo@bs.s.u-tokyo.ac.jp	Kunieda, Takekazu/G-4946-2014; KUBO, TAKEO/G-4951-2014	Kunieda, Takekazu/0000-0002-6256-1335; Ugajin, Atsushi/0000-0003-1834-3565; Kubo, Takeo/0000-0002-5914-5269	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [26291068]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (grant number: 26291068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Hideaki Takeuchi (Okayama University), for his critical reading of this manuscript. We would also like to express our sincere gratitude to Dr. Wulfia Gronenberg (The University of Arizona) for his valuable comments in writing this manuscript. This work was supported by the Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	EICHMULLER S, 1991, J COMP NEUROL, V312, P164, DOI 10.1002/cne.903120112; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; Fahrbach SE, 2006, ANNU REV ENTOMOL, V51, P209, DOI 10.1146/annurev.ento.51.110104.150954; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Farris SM, 2001, P BIOL SCI, V278, P940; Ganeshina O, 2000, J COMP NEUROL, V417, P349, DOI 10.1002/(SICI)1096-9861(20000214)417:3&lt;349::AID-CNE8&gt;3.0.CO;2-E; Gronenberg W, 2001, J COMP NEUROL, V435, P474, DOI 10.1002/cne.1045; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Han SO, 2013, EMBO REP, V14, P164, DOI 10.1038/embor.2012.187; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; HERTEL H, 1987, J EXP BIOL, V133, P283; HERTEL H, 1987, J EXP BIOL, V133, P301; HERTEL H, 1980, J COMP PHYSIOL, V137, P215, DOI 10.1007/BF00657117; Kamikouchi A, 1998, BIOCHEM BIOPH RES CO, V242, P181, DOI 10.1006/bbrc.1997.7870; Kaneko K, 2016, ZOOL LETT, V2, DOI 10.1186/s40851-016-0051-6; Kaneko K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071732; Kaneko K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009213; Kiya T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000371; Kohno H, 2016, ZOOL SCI, V33, P505, DOI 10.2108/zs160043; KREISSL S, 1994, J COMP NEUROL, V348, P583, DOI 10.1002/cne.903480408; Kubo T, 1996, J BIOCHEM-TOKYO, V119, P291, DOI 10.1093/oxfordjournals.jbchem.a021237; Kubo T, 2012, HONEYBEE NEUROBIOLOG, P341; Kucharski R, 1998, NATURWISSENSCHAFTEN, V85, P343, DOI 10.1007/s001140050512; Locatelli F, 2005, J NEUROSCI, V25, P11614, DOI 10.1523/JNEUROSCI.3180-05.2005; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Mobbs P.G., 1985, P299; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Nishinaka Y, 2004, J BIOL CHEM, V279, P37559, DOI 10.1074/jbc.M405473200; Orihara-Ono M, 2011, DEV BIOL, V351, P163, DOI 10.1016/j.ydbio.2010.12.044; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Puca L, 2014, J CELL SCI, V127, P1359, DOI 10.1242/jcs.142539; Puca L, 2013, J CELL SCI, V126, P4457, DOI 10.1242/jcs.130500; REHDER V, 1988, PROC R SOC SER B-BIO, V235, P179, DOI 10.1098/rspb.1988.0071; RIBI WA, 1976, CELL TISSUE RES, V171, P359, DOI 10.1007/BF00224660; RIBI WA, 1981, CELL TISSUE RES, V221, P17, DOI 10.1007/BF00216567; RIBI WA, 1981, CELL TISSUE RES, V215, P443, DOI 10.1007/BF00233522; Rybak J, 1998, LEARN MEMORY, V5, P133; Rybak J, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00030; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Seeley T., 1995, WISDOM HIVE SOCIAL P; Shea FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050557; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Suenami S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157841; VONFRISCH K, 1967, SCIENCE, V158, P1072; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Winston M. L, 1986, BIOL HONEYBEE; WITHERS GS, 1995, J NEUROBIOL, V26, P130, DOI 10.1002/neu.480260111; YAMAKI K, 1990, J BIOL CHEM, V265, P20757; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	52	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176809	10.1371/journal.pone.0176809	http://dx.doi.org/10.1371/journal.pone.0176809			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472083	Green Published, gold			2022-12-27	WOS:000400648500074
J	Yap, YC; King, AE; Guijt, RM; Jiang, TC; Blizzard, CA; Breadmore, MC; Dickson, TC				Yap, Yiing C.; King, Anna E.; Guijt, Rosanne M.; Jiang, Tongcui; Blizzard, Catherine A.; Breadmore, Michael C.; Dickson, Tracey C.			Mild and repetitive very mild axonal stretch injury triggers cystoskeletal mislocalization and growth cone collapse	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; TRANSGENIC MOUSE MODEL; COGNITIVE IMPAIRMENT; MICROTUBULES; DEGENERATION; TRANSPORT; NEUROFILAMENTS; VULNERABILITY; CYTOSKELETAL; REGENERATION	Diffuse axonal injury is a hallmark pathological consequence of non-penetrative traumatic brain injury (TBI) and yet the axonal responses to stretch injury are not fully understood at the cellular level. Here, we investigated the effects of mild (5%), very mild (0.5%) and repetitive very mild (2x0.5%) axonal stretch injury on primary cortical neurons using a recently developed compartmentalized in vitro model. We found that very mild and mild levels of stretch injury resulted in the formation of smaller growth cones at the tips of axons and a significantly higher number of collapsed structures compared to those present in uninjured cultures, when measured at both 24 h and 72 h post injury. Immunocytochemistry studies revealed that at 72 h following mild injury the axonal growth cones had a significantly higher colocalization of ss III tubulin and F-actin and higher percentage of collapsed morphology than those present following a very mild injury. Interestingly, cultures that received a second very mild stretch injury, 24 h after the first insult, had a further increased proportion of growth cone collapse and increased ss III tubulin and F-actin colocalization, compared with a single very mild injury at 72 h PI. In addition, our results demonstrated that microtubule stabilization of axons using brain penetrant Epothilone D (EpoD) (100 nM) resulted in a significant reduction in the number of fragmented axons following mild injury. Collectively, these results suggest that mild and very mild stretch injury to a very localized region of the cortical axon is able to trigger a degenerative response characterized by growth cone collapse and significant abnormal cytoskeletal rearrangement. Furthermore, repetitive very mild stretch injury significantly exacerbated this response. Results suggest that axonal degeneration following stretch injury involves destabilization of the microtubule cytoskeleton and hence treatment with EpoD reduced fragmentation. Together, these results contribute a better understanding of the pathogenesis of mild and repetitive TBI and highlight the therapeutic effect of microtubule targeted drugs on distal part of neurons using a compartmentalized culturing model.	[Yap, Yiing C.; Jiang, Tongcui; Blizzard, Catherine A.; Dickson, Tracey C.] Univ Tasmania, Menzies Inst Med Res, Hobart, Australia; [Yap, Yiing C.; King, Anna E.] Univ Tasmania, Wicking Dementia Res & Educ Ctr, Hobart, Australia; [Yap, Yiing C.; Guijt, Rosanne M.] Univ Tasmania, Pharm Sch Med, Australian Ctr Res Separat Sci ACROSS, Hobart, Australia; [Yap, Yiing C.; Breadmore, Michael C.] Univ Tasmania, Sch Phys Sci, ACROSS, Hobart, Australia	University of Tasmania; Menzies Institute for Medical Research; University of Tasmania; University of Tasmania; University of Tasmania	Dickson, TC (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Australia.	Tracey.Dickson@utas.edu.au	Breadmore, Michael/J-7628-2014; Guijt, Rosanne Marieke/R-2428-2017; King, Anna/J-7927-2014	Breadmore, Michael/0000-0001-5591-4326; Guijt, Rosanne Marieke/0000-0003-0011-5708; King, Anna/0000-0003-1792-0965; Blizzard, Catherine/0000-0002-8683-2937; Dickson, Tracey/0000-0002-9196-1661	Select Foundation; Wicking Dementia Research and Education Centre; Australian Research Council; ARC Discovery Project [DP150100998]; UTAS Pro Vice Chancellor for Research; UTAS Cross Theme Grant; NHMRC project grant [APP1042556]; NHMRC project grant	Select Foundation; Wicking Dementia Research and Education Centre; Australian Research Council(Australian Research Council); ARC Discovery Project(Australian Research Council); UTAS Pro Vice Chancellor for Research; UTAS Cross Theme Grant; NHMRC project grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC project grant(National Health and Medical Research Council (NHMRC) of Australia)	This research is supported by Select Foundation (Fellowship to TD), the Wicking Dementia Research and Education Centre (Fellowship to AK), Australian Research Council (Future Fellowship to MCB), ARC Discovery Project Grant (DP150100998), UTAS Pro Vice Chancellor for Research and UTAS Cross Theme Grant and NHMRC project grant (APP1042556) to TD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Mr Graeme McCormark, Miss Clara Lee, Mr Justin Dittman and Mr John Davis for their technical assistance in completing this work. This research is supported by Select Foundation (Fellowship to TD), the Wicking Dementia Research and Education Centre (Fellowship to AK), Australian Research Council (Future Fellowship to MCB), ARC Discovery Project Grant (DP150100998), UTAS Pro Vice Chancellor for Research and UTAS Cross Theme Grant and NHMRC project grant to TD.	Adlard PA, 2000, ACTA NEUROPATHOL, V100, P183, DOI 10.1007/s004019900160; Andrieux A, 2006, BIOL PSYCHIAT, V60, P1224, DOI 10.1016/j.biopsych.2006.03.048; Blizzard CA, 2007, EUR J NEUROSCI, V26, P1100, DOI 10.1111/j.1460-9568.2007.05750.x; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Brizuela M, 2015, MOL CELL NEUROSCI, V66, P129, DOI 10.1016/j.mcn.2015.02.006; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; Childs WR, 2005, LANGMUIR, V21, P10096, DOI 10.1021/la050011b; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Farkas O, 2007, PROGR BRAIN RES, V161, P43; Finn JT, 2000, J NEUROSCI, V20, P1333; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Hill CE, 2001, EXP NEUROL, V171, P153, DOI 10.1006/exnr.2001.7734; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Jang EH, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5056418; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; King CE, 2000, CLIN EXP PHARMACOL P, V27, P548, DOI 10.1046/j.1440-1681.2000.03292.x; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller CCJ, 2002, CELL MOL LIFE SCI, V59, P323, DOI 10.1007/s00018-002-8425-7; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; Mueller BK, 2009, BRIT J PHARMACOL, V157, P675, DOI 10.1111/j.1476-5381.2009.00220.x; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Peyrin JM, 2011, LAB CHIP, V11, P3663, DOI 10.1039/c1lc20014c; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Richter M, 2007, J NEUROSCI, V27, P14205, DOI 10.1523/JNEUROSCI.2746-07.2007; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vickers JC, 2009, BRAIN RES BULL, V80, P217, DOI 10.1016/j.brainresbull.2009.08.004; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Yap YC, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4891098; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161	54	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176997	10.1371/journal.pone.0176997	http://dx.doi.org/10.1371/journal.pone.0176997			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472086	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000400648500112
J	Sepanlou, SG; Barahimi, H; Najafi, I; Kamangar, F; Poustchi, H; Shakeri, R; Hakemi, MS; Pourshams, A; Khoshnia, M; Gharravi, A; Broumand, B; Nobakht-Haghighi, A; Kalantar-Zadeh, K; Malekzadeh, R				Sepanlou, Sadaf G.; Barahimi, Hamid; Najafi, Iraj; Kamangar, Farin; Poustchi, Hossein; Shakeri, Ramin; Hakemi, Monir Sadat; Pourshams, Akram; Khoshnia, Masoud; Gharravi, Abdolsamad; Broumand, Behrooz; Nobakht-Haghighi, Ali; Kalantar-Zadeh, Kamyar; Malekzadeh, Reza			Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; RISK-FACTORS; SYSTEMATIC ANALYSIS; SERUM CREATININE; GLOBAL BURDEN; ALBUMINURIA; KNOWLEDGE; MORTALITY; EQUATION; OBESITY	Background The burden of chronic kidney disease (CKD) is increasing globally in particular in fast emerging economies such as Iran. Population-based studies on prevalence of CKD in Iran are scarce. The objective of the current study was to explore the prevalence and determinants of CKD in the setting of Golestan Cohort Study (GCS), the largest prospective cohort in the Middle East. Methods In this observational study, 11,409 participants enrolled in the second phase of GCS were included. Sex, age, literacy, residence, anthropometric measurements, smoking, opium use, self-reported history of cardiovascular diseases (heart disease and/or stroke), hypertension, diabetes, and lipid profile were the predictors of interest. The outcomes of interest were eGFR and CKD defined as eGFR< 60 ml/min/1.73m(2). Results Mean (SD) of GFR was 70.0 +/- 14.7 ml/min/1.73m(2) among all participants, 68.2 +/- 14.2 among women, and 72.0 +/- 15.0 among men. Prevalence of CKD was 23.7% (26.6% in women, 20.6% in men). The prevalence of CKD stages 3a, 3b, 4, and 5 were 20.0%, 3.3%, 0.4% and 0.1%, respectively. Female sex, older age, urban residence, history of CVD, hypertension or diabetes, larger body mass and surrogates of body fat and opium use were all associated with CKD. Opium had a significant positive association with CKD in adjusted model. All anthropometric measurements had positive linear association with CKD. Being literate had inverse association. Sex had significant interaction with anthropometric indices, with higher odds ratios among men compared with women. A significantly high association was observed between the rate of change in waist circumference and systolic blood pressure with risk of CKD. Conclusion One in four people in this cohort had low eGFR. Obesity and overweight, diabetes, hypertension, and dyslipidemia are major risk factors for CKD. Halting the increase in waist circumference and blood pressure may be as important as reducing the current levels.	[Sepanlou, Sadaf G.; Barahimi, Hamid; Poustchi, Hossein; Shakeri, Ramin; Pourshams, Akram; Gharravi, Abdolsamad; Malekzadeh, Reza] Univ Tehran Med Sci, Digest Dis Res Inst, Digest Dis Res Ctr, Tehran, Iran; [Sepanlou, Sadaf G.; Malekzadeh, Reza] Shiraz Univ Med Sci, Noncommunicable Dis Res Ctr, Shiraz, Fars, Iran; [Barahimi, Hamid; Najafi, Iraj; Hakemi, Monir Sadat] Univ Tehran Med Sci, Shariati Hosp, Dept Nephrol, Tehran, Iran; [Kamangar, Farin] Morgan State Univ, Sch Community Hlth & Policy, Dept Publ Hlth Anal, Baltimore, MD 21239 USA; [Khoshnia, Masoud] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, Gorgan, Iran; [Broumand, Behrooz; Nobakht-Haghighi, Ali] Acad Med Sci, Tehran, Iran; [Kalantar-Zadeh, Kamyar] Univ Calif Irvine, Sch Med, Div Nephrol & Hypertens, Irvine, CA 92717 USA; [Kalantar-Zadeh, Kamyar] Vet Affairs VA Long Beach Healthcare Syst, Long Beach, CA USA; [Kalantar-Zadeh, Kamyar] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA	Tehran University of Medical Sciences; Shiraz University of Medical Science; Tehran University of Medical Sciences; Morgan State University; Golestan University of Medical Sciences; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Los Angeles	Malekzadeh, R (corresponding author), Univ Tehran Med Sci, Digest Dis Res Inst, Digest Dis Res Ctr, Tehran, Iran.; Malekzadeh, R (corresponding author), Shiraz Univ Med Sci, Noncommunicable Dis Res Ctr, Shiraz, Fars, Iran.	malek@tums.ac.ir	Sepanlou, Sadaf G/H-9343-2016; Kalantar-Zadeh, Kamyar/Q-4734-2018; Malekzadeh, Reza/U-1382-2017	Sepanlou, Sadaf G/0000-0002-3669-5129; Kalantar-Zadeh, Kamyar/0000-0002-8666-0725; Malekzadeh, Reza/0000-0002-9820-6335; Pourshams, Akram/0000-0002-7950-3983	Social Security Organization of Iran, Golestan Branch; Tehran University of Medical Sciences [82-603]; Social Security Organization of Iran, Golestan Branch; Tehran University of Medical Sciences [82-603]	Social Security Organization of Iran, Golestan Branch; Tehran University of Medical Sciences(Tehran University of Medical Sciences); Social Security Organization of Iran, Golestan Branch; Tehran University of Medical Sciences(Tehran University of Medical Sciences)	Many individuals have contributed to this study. We wish to thank the study participants for their cooperation over many years and the Behvarz' working in the study areas for their help. We thank the directors of the public health districts of Gonbad and Kalaleh for their collaboration. We express our special thanks to general physicians, nurses, and nutritionists in the enrolment teams for their collaboration and assistance. We received special support from the Social Security Organization of Iran, Golestan Branch. We have enjoyed the close collaboration of the Golestan health deputies and the Chief of the Gonbad health district.r Tehran University of Medical Sciences was the funder of this study, grant number 82-603, at www.tums.ac.ir. RM received the fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi J, 2002, AM J NEPHROL, V22, P11, DOI 10.1159/000046668; Barahimi H, 2011, IRAN J KIDNEY DIS, V5, P374; Choukem Simeon-Pierre, 2016, BMC Res Notes, V9, P29, DOI 10.1186/s13104-016-1845-5; Coresh J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5553; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Hallan S, 2006, AM J KIDNEY DIS, V47, P396, DOI 10.1053/j.ajkd.2005.11.027; Huang MX, 2015, AM J KIDNEY DIS, V65, P58, DOI 10.1053/j.ajkd.2014.06.025; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Khademi H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2502; Khademi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011183; Kovesdy CP, 2012, LANCET, V379, P783, DOI 10.1016/S0140-6736(12)60115-9; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2015, CLIN CHEM, V61, P1226, DOI 10.1373/clinchem.2015.245282; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2014, ANN INTERN MED, V161, P81, DOI 10.7326/L14-5013-2; Nafar Mohsen, 2008, Iran J Kidney Dis, V2, P183; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Naghibi M, 2015, IRAN J KIDNEY DIS, V9, P449; Najafi I, 2012, ARCH IRAN MED, V15, pVI, DOI 012152/AIM.003; Najafi I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014216; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Rhee CM, 2016, CURR OPIN NEPHROL HY, V25, P208, DOI 10.1097/MNH.0000000000000212; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Roomizadeh P, 2014, INT J HEALTH POLICY, V2, P161, DOI 10.15171/ijhpm.2014.37; Ryu S, 2008, J AM SOC NEPHROL, V19, P1798, DOI 10.1681/ASN.2007121286; Safarinejad MR, 2009, J NEPHROL, V22, P99; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4	29	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176540	10.1371/journal.pone.0176540	http://dx.doi.org/10.1371/journal.pone.0176540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467510	Green Published, gold			2022-12-27	WOS:000400647000058
J	Horn, S; de la Vega, C; Asmus, R; Schwemmer, P; Enners, L; Garthe, S; Binder, K; Asmus, H				Horn, Sabine; de la Vega, Camille; Asmus, Ragnhild; Schwemmer, Philipp; Enners, Leonie; Garthe, Stefan; Binder, Kirsten; Asmus, Harald			Interaction between birds and macrofauna within food webs of six intertidal habitats of the Wadden Sea	PLOS ONE			English	Article							SYLT-ROMO BIGHT; ECOLOGICAL NETWORK ANALYSIS; ESTUARINE NITROGEN-CYCLE; ECOSYSTEM STRUCTURE; MARINE ECOSYSTEMS; TROPHIC STRUCTURE; BROUAGE MUDFLAT; AIGUILLON COVE; FEEDING BIRDS; NORTH-SEA	The determination of food web structures using Ecological Network Analysis (ENA) is a helpful tool to get insight into complex ecosystem processes. The intertidal area of the Wadden Sea is structured into diverse habitat types which differ in their ecological functioning. In the present study, six different intertidal habitats (i.e. cockle field, razor clam field, mud flat, mussel bank, sand flat and seagrass meadow) were analyzed using ENA to determine similarities and characteristic differences in the food web structure of the systems. All six systems were well balanced between their degree of organization and their robustness. However, they differed in their detailed features. The cockle field and the mussel bank exhibited a strong dependency on external imports. The razor clam field appeared to be a rather small system with low energy transfer. In the mud flat microphytobenthos was used as a main food source and the system appeared to be sensitive to perturbations. Bird predation was the most pronounced in the sand flat and the seagrass meadow and led to an increase in energy transfer and parallel trophic cycles in these habitats. Habitat diversity appears to be an important trait for the Wadden Sea as each subsystem seems to have a specific role in the overall functioning of the entire ecosystem.	[Horn, Sabine; de la Vega, Camille; Asmus, Ragnhild; Asmus, Harald] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, WaddenSea Stn Sylt, List Auf Sylt, Germany; [Schwemmer, Philipp; Enners, Leonie; Garthe, Stefan] Univ Kiel, Res & Technol Ctr FTZ, Busum, Germany; [Binder, Kirsten] State Agcy Agr Environm & Rural Areas Schleswig H, Flintbek, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Kiel	Horn, S (corresponding author), Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, WaddenSea Stn Sylt, List Auf Sylt, Germany.	sabine.horn@awi.de	Asmus, Ragnhild/O-2397-2017; Asmus, Harald/O-2417-2017; Horn, Sabine/L-2689-2017	Asmus, Ragnhild/0000-0003-3300-6065; Asmus, Harald/0000-0002-7772-1303; Horn, Sabine/0000-0003-1637-1191	Federal Ministry of Education and Research [FKZ 03F672B]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Federal Ministry of Education and Research (DE) FKZ 03F672B.	Abarca-Arenas LG, 2002, ECOL MODEL, V149, P285, DOI 10.1016/S0304-3800(01)00474-4; [Anonymous], WADDEN SEA ECOSYSTEM; ASMUS H, 1987, MAR ECOL PROG SER, V39, P251, DOI 10.3354/meps039251; Asmus H, 2000, HELGOLAND MAR RES, V54, P137, DOI 10.1007/s101520050012; Asmus R., 1998, BEDEUTUNG ORGANISMEN, P257; BAIRD D, 1985, OCEANOGR MAR BIOL, V23, P573; BAIRD D, 1993, MAR ECOL PROG SER, V99, P221, DOI 10.3354/meps099221; Baird D, 2004, MAR ECOL PROG SER, V279, P45, DOI 10.3354/meps279045; BAIRD D, 1989, ECOL MONOGR, V59, P329, DOI 10.2307/1943071; BAIRD D, 1991, PHILOS T R SOC B, V333, P15, DOI 10.1098/rstb.1991.0058; Baird D, 2011, COASTAL SHELF SCI, V91, P51; Baird D, 2008, ESTUAR COAST SHELF S, V80, P339, DOI 10.1016/j.ecss.2008.08.012; Baird D, 2007, MAR ECOL PROG SER, V351, P25, DOI 10.3354/meps07137; Baird D, 2012, MAR ECOL PROG SER, V462, P143, DOI 10.3354/meps09837; Baird D, 2009, ECOL MODEL, V220, P3465, DOI 10.1016/j.ecolmodel.2009.09.008; BALDWIN JR, 1994, MAR BIOL, V120, P627, DOI 10.1007/BF00350084; Beukema JJ, 2015, MAR ECOL PROG SER, V538, P157, DOI 10.3354/meps11485; Bezzel E., 1985, KOMPENDIUM VOGEL MIT; Blew J., 2015, TRENDS MIGRATORY WIN; Borrett SR, 2014, METHODS ECOL EVOL, V5, P1206, DOI 10.1111/2041-210X.12282; Buttger H, 2008, HELGOLAND MAR RES, V62, P23, DOI 10.1007/s10152-007-0099-y; BUXTON NE, 1981, BIRD STUDY, V28, P41, DOI 10.1080/00063658109476697; CHRISTENSEN V, 1995, ECOL MODEL, V77, P3, DOI 10.1016/0304-3800(93)E0073-C; COSTANZA R, 1992, ENVIRON MANAGE, V16, P121, DOI 10.1007/BF02393914; Costanza R., 1992, ECOLOGICAL EC SCI MA; Dannheim J, 2012, HELGOLAND MAR RES, V66, P307, DOI 10.1007/s10152-011-0271-2; Degre D, 2006, ESTUAR COAST SHELF S, V69, P107, DOI 10.1016/j.ecss.2006.04.001; Dolch T, 2013, J SEA RES; Edler L., 1979, PHYTOPLANKTON CHLORO; Fath BD, 2007, ECOL MODEL, V208, P49, DOI 10.1016/j.ecolmodel.2007.04.029; Fath BD, 2015, OCEAN COAST MANAGE, V108, P13, DOI 10.1016/j.ocecoaman.2014.06.020; Fath BD, 2013, ECOL MODEL, V252, P214, DOI 10.1016/j.ecolmodel.2012.06.010; FINN JT, 1980, ECOLOGY, V61, P562, DOI 10.2307/1937422; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; Goerner SJ, 2009, ECOL ECON, V69, P76, DOI 10.1016/j.ecolecon.2009.07.018; Gollasch Stephan, 2015, ICES Cooperative Research Report, V323, P1; Goss-Custard J, 1977, J ANIM ECOL, P1; HARRIS PR, 1979, BIRD STUDY, V26, P258; Heymans JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095845; Hines DE, 2016, ECOL ENG, V89, P70, DOI 10.1016/j.ecoleng.2016.01.009; Hines DE, 2015, MAR ECOL PROG SER, V524, P137, DOI 10.3354/meps11187; Hines DE, 2012, ESTUAR COAST SHELF S, V106, P45, DOI 10.1016/j.ecss.2012.04.018; Horn S, 2016, J EXP MAR BIOL ECOL, V481, P41, DOI 10.1016/j.jembe.2016.04.010; Jeffrey S. W., 1975, BIOCH PHYSL PFLANZ B; Kabat P, 2012, OCEAN COAST MANAGE, V68, P4, DOI 10.1016/j.ocecoaman.2012.05.022; Kaufman AG, 2010, ECOL MODEL, V221, P1230, DOI 10.1016/j.ecolmodel.2009.12.018; Kay J. J., 1989, NETWORK ANAL MARINE, P15, DOI DOI 10.1007/978-3-642-75017-5_2; Kones JK, 2009, ECOL MODEL, V220, P370, DOI 10.1016/j.ecolmodel.2008.10.012; Kubetzki U, 2003, MAR BIOL, V143, P199, DOI 10.1007/s00227-003-1036-5; Lau M. K., 2015, ECOSYSTEM NETWORK AN; Leguerrier D, 2003, MAR ECOL PROG SER, V246, P17, DOI 10.3354/meps246017; Leguerrier D, 2007, ESTUAR COAST SHELF S, V74, P403, DOI 10.1016/j.ecss.2007.04.014; Mann KH, 1989, NETWORK ANAL MARINE; Mathers R.G., 1998, OCEANOGRAPHIC LIT RE, V1, P126; MELTOFTE H, 1994, IWRB PUBLICATION, V34; Mendel B., 2008, PROFILES SEABIRDS WA; Merkel C., 2015, THESIS; Monaco ME, 1986, MARINE ECOLOGY PROGR, V1, P9; NEHLS G, 1989, HELGOLANDER MEERESUN, V43, P385, DOI 10.1007/BF02365898; NEHLS G, 1993, NETH J SEA RES, V31, P375, DOI 10.1016/0077-7579(93)90054-V; Nienhuis P, 1986, MARINE ECOLOGY PROGR, V29, P1; Nithart M, 1999, J MAR BIOL ASSOC UK, V79, P1029, DOI 10.1017/S0025315499001265; Odum E.P., 1969, SUSTAINABILITY SUSTA, V164, P58; Parsons T. R., 1973, BIOL OCEANOGRAPHIC P; Pienkowski KW., 1980, ASPECTS ECOLOGY BEHA; PIERSMA T, 1993, NETH J SEA RES, V31, P331, DOI 10.1016/0077-7579(93)90052-T; Pockberger M., 2014, EMPFEHLUNGEN ANWENDU; Reise K., 2010, WADDEN SEA UNIVERSAL, V29, P7; Reise K, 2008, HELGOLAND MAR RES, V62, P77, DOI 10.1007/s10152-007-0088-1; RIEMANN B, 1989, J PLANKTON RES, V11, P1037, DOI 10.1093/plankt/11.5.1037; Saint-Beat B, 2015, ECOL INDIC, V52, P458, DOI 10.1016/j.ecolind.2014.12.017; Saint-Beat B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076739; Scharler UM, 2005, J MARINE SYST, V56, P283, DOI 10.1016/j.jmarsys.2004.12.003; Scheiffarth G, 2001, ARDEA, V89, P481; Schuckel U, 2015, MAR ECOL PROG SER, V536, P25, DOI 10.3354/meps11391; Schwemmer P, 2016, J AVIAN BIOL; Schwemmer P, 2016, ECOL MODEL, V320, P322, DOI 10.1016/j.ecolmodel.2015.10.023; Schwemmer Philipp, 2012, Vogelwarte, V50, P141; Schwemmer P, 2011, MAR BIOL, V158, P541, DOI 10.1007/s00227-010-1579-1; Soetaert K., 2009, LIM LINEAR INVERSE M; Soetaert K, 2013, PACKAGE LIMSOLVE; SWENNEN C, 1985, HELGOLANDER MEERESUN, V39, P255, DOI 10.1007/BF01992773; Tiedemann R, 1997, J ORNITHOL, V138, P183, DOI 10.1007/BF01651622; Tulp I, 2010, ESTUAR COAST SHELF S, V90, P116, DOI 10.1016/j.ecss.2010.07.008; ULANOWICZ RE, 1980, J THEOR BIOL, V85, P223, DOI 10.1016/0022-5193(80)90019-3; Ulanowicz RE, 2004, COMPUT BIOL CHEM, V28, P321, DOI 10.1016/j.compbiolchem.2004.09.001; Ulanowicz RE, 2014, ECOL LETT, V17, P127, DOI 10.1111/ele.12216; Ulanowicz RE, 2009, ECOL COMPLEX, V6, P27, DOI 10.1016/j.ecocom.2008.10.005; Van den Meersche K., 2009, J STAT SOFTW, V30, P1, DOI [DOI 10.18637/JSS.V030.C01, 10.1002/wics.10., DOI 10.18637/jss.v030.c01]; van Roomen M, 2012, OCEAN COAST MANAGE, V68, P79, DOI 10.1016/j.ocecoaman.2012.04.004; Vasconcellos M, 1997, ECOL MODEL, V100, P125, DOI 10.1016/S0304-3800(97)00150-6; Wulff F., 1989, NETWORK ANAL MARINE; [No title captured]	93	12	13	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176381	10.1371/journal.pone.0176381	http://dx.doi.org/10.1371/journal.pone.0176381			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489869	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100021
J	Dong, XL; Lytle, DA; Olden, JD; Schriever, TA; Muneepeerakul, R				Dong, Xiaoli; Lytle, David A.; Olden, Julian D.; Schriever, Tiffany A.; Muneepeerakul, Rachata			Importance of neutral processes varies in time and space: Evidence from dryland stream ecosystems	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PATTERNS; DISTURBANCE; DISPERSAL; DIVERSITY; SIMILARITY; ABUNDANCE; NICHES	Many ecosystems experience strong temporal variability in environmental conditions; yet, a clear picture of how niche and neutral processes operate to determine community assembly in temporally variable systems remains elusive. In this study, we constructed neutral metacommunity models to assess the relative importance of neutral processes in a spatially and temporally variable ecosystem. We analyzed macroinvertebrate community data spanning multiple seasons and years from 20 sites in a Sonoran Desert river network in Arizona. The model goodness-of-fit was used to infer the importance of neutral processes. Averaging over eight stream flow conditions across three years, we found that neutral processes were more important in perennial streams than in non-perennial streams (intermittent and ephemeral streams). Averaging across perennial and non-perennial streams, we found that neutral processes were more important during very high flow and in low flow periods; whereas, at very low flows, the relative importance of neutral processes varied greatly. These findings were robust to the choice of model parameter values. Our study suggested that the net effect of disturbance on the relative importance of niche and neutral processes in community assembly varies non-monotonically with the severity of disturbance. In contrast to the prevailing view that disturbance promotes niche processes, we found that neutral processes could become more important when the severity of disturbance is beyond a certain threshold such that all organisms are adversely affected regardless of their biological traits and strategies.	[Dong, Xiaoli] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Dong, Xiaoli] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Lytle, David A.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Olden, Julian D.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Schriever, Tiffany A.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; [Schriever, Tiffany A.] Western Michigan Univ, Inst Environm & Sustainabil, Kalamazoo, MI 49008 USA; [Muneepeerakul, Rachata] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL USA	Arizona State University; Arizona State University-Tempe; Duke University; Oregon State University; University of Washington; University of Washington Seattle; Western Michigan University; Western Michigan University; State University System of Florida; University of Florida	Dong, XL (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.; Dong, XL (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	xiaoli.dong@duke.edu	Olden, Julian D/A-8535-2010	Olden, Julian/0000-0003-2143-1187	U.S. Department of Defense Strategic Environmental Research and Development Program [RC-2203]	U.S. Department of Defense Strategic Environmental Research and Development Program(United States Department of Defense)	Funding support by the U.S. Department of Defense Strategic Environmental Research and Development Program (RC-2203). URL (https://www.serdp-estcp.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge funding support by the U.S. Department of Defense Strategic Environmental Research and Development Program (RC-2203). We thank Michael Bogan, Kate Boersma, Miguel Canedo-Arguelles, and Richard Van Driesche for help with sample collection and identification, and Kristin Jaeger and Meryl Mims for assisting with the electrical resistance sensors. The manuscript benefited from comments by Nancy B. Grimm, Stuart G. Fisher and 4 anonymous reviewers.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Bogan MT, 2013, FRESHWATER BIOL, V58, P1016, DOI 10.1111/fwb.12105; Bogan MT, 2011, FRESHWATER BIOL, V56, P2070, DOI 10.1111/j.1365-2427.2011.02638.x; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; BOULTON AJ, 1992, FRESHWATER BIOL, V27, P123, DOI 10.1111/j.1365-2427.1992.tb00528.x; Canedo-Arguelles M, 2015, ECOGRAPHY, V42, P778; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Datry T, 2016, OIKOS, V125, P149, DOI 10.1111/oik.02922; Dong X, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00497.1; Ferrenberg S, 2016, PEERJ, V4, DOI 10.7717/peerj.2545; Ferrenberg S, 2013, ISME J, V7, P1102, DOI 10.1038/ismej.2013.11; Fritz KM, 2004, HYDROBIOLOGIA, V527, P99, DOI 10.1023/B:HYDR.0000043188.53497.9b; Gause G. F., 1934, STRUGGLE EXISTENCE; Gouhier TC, 2010, AM NAT, V175, pE16, DOI 10.1086/649579; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Harpole WS, 2006, ECOL LETT, V9, P15, DOI 10.1111/j.1461-0248.2005.00836.x; Hubbell Stephen P., 2001, V32, pi; INOUYE RS, 1995, ECOLOGY, V76, P1872, DOI 10.2307/1940720; Jaeger KL, 2012, RIVER RES APPL, V28, P1843, DOI 10.1002/rra.1554; Jaeger KL, 2014, P NATL ACAD SCI USA, V111, P13894, DOI 10.1073/pnas.1320890111; Jiang L, 2008, ECOLOGY, V89, P1931, DOI 10.1890/07-1263.1; Leigh C, 2016, ECOGRAPHY, V39, P1; Lepori F, 2009, OIKOS, V118, P471, DOI 10.1111/j.1600-0706.2008.16989.x; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Muneepeerakul R, 2008, NATURE, V453, P220, DOI 10.1038/nature06813; Muneepeerakul R, 2011, J THEOR BIOL, V269, P256, DOI 10.1016/j.jtbi.2010.11.003; POFF NL, 1989, CAN J FISH AQUAT SCI, V46, P1805, DOI 10.1139/f89-228; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Schriever TA, 2015, FRESHW SCI, V34, P399, DOI 10.1086/680518; Stokes CJ, 2010, ECOLOGY, V91, P1152, DOI 10.1890/08-1105.1; Trexler JC, 2005, OECOLOGIA, V145, P140, DOI 10.1007/s00442-005-0094-4; Tucker CM, 2016, OIKOS, V125, P778, DOI 10.1111/oik.02803; Urban MC, 2004, ECOLOGY, V85, P2971, DOI 10.1890/03-0631; Vergnon R, 2009, ECOL LETT, V12, P1079, DOI 10.1111/j.1461-0248.2009.01364.x; Vinson MR, 2003, ECOGRAPHY, V26, P751, DOI 10.1111/j.0906-7590.2003.03397.x	42	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176949	10.1371/journal.pone.0176949	http://dx.doi.org/10.1371/journal.pone.0176949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486499	Green Published, gold			2022-12-27	WOS:000401314000028
J	Ma, JN; Du, C; Zhou, C; Sheng, YM; Fan, ZX; Yue, BS; Zhang, XY				Ma, Jinnan; Du, Chao; Zhou, Chuang; Sheng, Yongmei; Fan, Zhenxin; Yue, Bisong; Zhang, Xiuyue			Complete mitochondrial genomes of two blattid cockroaches, Periplaneta australasiae and Neostylopyga rhombifolia, and phylogenetic relationships within the Blattaria	PLOS ONE			English	Article							CONTROL REGION; STRUCTURAL CONSERVATION; MOLECULAR PHYLOGENY; MAXIMUM-LIKELIHOOD; GENE-SEQUENCES; WEB SERVER; EVOLUTION; DNA; DICTYOPTERA; TERMITES	Complete mitochondrial genomes (mitogenomes) of two cockroach species, Periplaneta australasiae and Neostylopyga rhombifolia, 15,605 bp and 15,711 bp in length, respectively, were determined. As reported for other cockroach mitogenomes, the two mitogenomes possessed typical ancestral insect mitogenome gene composition and arrangement. Only several small intergenic spacers were found: one, which was common in all sequenced cockroach mitogenomes except for the genus Cryptocercus, was between tRNA-Ser (UCN) and ND1 and contained a 7bp highly conserved motif (WACTTAA). Three different types of short tandem repeats in the N. rhombifolia control region (CR) were observed. The homologous alignments of these tandem repeats with other six cockroach mitogenome CRs revealed a low similarity. Three conserved sequence blocks (CSB) were detected in both cockroach mitochondrial CRs. CSB1 was specific for blattinine mitogenomes and was highly conserved with 95% similarity, speculating that this block was a possible molecular synapomorphy for this subfamily. CSB3 located nearby downstream of CSB1 and has more variations within blattinine mitogenomes compared with CSB1. The CSB3 was capable of forming stable stem-loop structure with a small T-stretch in the loop portion. We assessed the influence of four datasets and two inference methods on topology within Orthopteroidea. All genes excluding the third codon positions of PCGs could generate more stable topology, and higher posterior probabilities than bootstrap values were presented at some branch nodes. The phylogenetic analysis with different datasets and analytical methods supported the monophyly of Dictyoptera and supported strongly the proposal that Isoptera should be classified as a family (Termitidae) of the Blattaria. Specifically, Shelfordella lateralis was inserted in the clade Periplaneta. Considering the K2P genetic distance, morphological characters, and the phylogenetic trees, we suggested that S. lateralis should be placed in the genus Periplaneta.	[Ma, Jinnan; Du, Chao; Fan, Zhenxin; Yue, Bisong; Zhang, Xiuyue] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ, Coll Life Sci, Chengdu, Peoples R China; [Zhou, Chuang; Fan, Zhenxin; Yue, Bisong; Zhang, Xiuyue] Sichuan Univ, Sichuan Key Lab Conservat Biol Endangered Wildlif, Coll Life Sci, Chengdu, Peoples R China; [Sheng, Yongmei] Sichuan Key Lab Med Amer Cockroach, Chengdu, Peoples R China	Sichuan University; Sichuan University	Zhang, XY (corresponding author), Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ, Coll Life Sci, Chengdu, Peoples R China.; Zhang, XY (corresponding author), Sichuan Univ, Sichuan Key Lab Conservat Biol Endangered Wildlif, Coll Life Sci, Chengdu, Peoples R China.	zhangxy317@126.com			Science and Technology Project of Sichuan Province [2015SZ0036]	Science and Technology Project of Sichuan Province	The research was funded by the Science and Technology Project of Sichuan Province, 2015SZ0036 (Department of Science and Technology of Sichuan Province http://www.scst.gov.cn/). Prof. Xiuyue Zhang received the funding.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely appreciate Shilin He and Wujiao Li at Sichuan University for the sample collection. We also thank professor Timothy Moermond (University of Wisconsin-Madison) and Alexa C Privratsky (University of North Dakota) for editing the manuscript and thank the anonymous reviewers for insightful comments. The research was funded by the Science and Technology Project of Sichuan Province, 2015SZ0036.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anisyutkin LN, 2010, ENTOMOLOGICAL REV, V90, P871, DOI DOI 10.1134/S0013873810070055; Appel AG, 2002, ANNU REV ENTOMOL, V47, P33, DOI 10.1146/annurev.ento.47.091201.145106; Avise John C., 1994, pi; Ballard JWO, 2005, ANNU REV ECOL EVOL S, V36, P621, DOI 10.1146/annurev.ecolsys.36.091704.175513; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Cameron SL, 2007, GENOME, V50, P188, DOI 10.1139/G06-148; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Cameron SL, 2012, MOL PHYLOGENET EVOL, V65, P163, DOI 10.1016/j.ympev.2012.05.034; Chandra SBC, 2006, AFR J BIOTECHNOL, V5, P1308; Cheng XF, 2016, GENE, V586, P115, DOI 10.1016/j.gene.2016.03.057; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Djernaes M, 2015, MOL PHYLOGENET EVOL, V84, P284, DOI 10.1016/j.ympev.2014.08.019; Djernaes M, 2012, SYST ENTOMOL, V37, P65, DOI 10.1111/j.1365-3113.2011.00598.x; Dotson EM, 2001, INSECT MOL BIOL, V10, P205, DOI 10.1046/j.1365-2583.2001.00258.x; Du C, 2016, GENE, V578, P274, DOI 10.1016/j.gene.2015.12.036; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Grandcolas P, 1996, CAN J ZOOL, V74, P508, DOI 10.1139/z96-059; Grandcolas P, 2001, CLADISTICS, V17, P48, DOI 10.1111/j.1096-0031.2001.tb00110.x; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guthrie D., 1968, BIOL COCKROACH; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; Jeon MG, 2015, ANIM CELLS SYST, V19, P432, DOI 10.1080/19768354.2015.1105866; Kambhampati S, 1996, SYST ENTOMOL, V21, P89; KAMBHAMPATI S, 1995, P NATL ACAD SCI USA, V92, P2017, DOI 10.1073/pnas.92.6.2017; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klass Klaus-Dieter, 2006, Entomologische Abhandlungen (Dresden), V63, P3; Kuzmenko A, 2014, BIOCHIMIE, V100, P132, DOI 10.1016/j.biochi.2013.07.024; Legendre F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130127; Lo N, 2003, MOL BIOL EVOL, V20, P907, DOI 10.1093/molbev/msg097; Lo N, 2000, CURR BIOL, V10, P801, DOI 10.1016/S0960-9822(00)00561-3; Lo N, 2007, BIOL LETTERS, V3, P327, DOI 10.1098/rsbl.2006.0614; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maekawa K, 1999, ZOOL SCI, V16, P175, DOI 10.2108/zsj.16.175; Maekawa K, 2000, SYST ENTOMOL, V25, P511, DOI 10.1046/j.1365-3113.2000.00128.x; Mancini E, 2008, GENOME, V51, P196, DOI 10.1139/G07-116; Mao M, 2015, MOL PHYLOGENET EVOL, V84, P34, DOI 10.1016/j.ympev.2014.12.009; Nelson LA, 2012, GENE, V511, P131, DOI 10.1016/j.gene.2012.09.103; Pellens R, 2007, MOL PHYLOGENET EVOL, V43, P616, DOI 10.1016/j.ympev.2006.12.017; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 2009, FIGTREE; Robinson William H., 2005, P147; Roth LM, 2003, ORIENT INSECTS, V37, P1, DOI 10.1080/00305316.2003.10417344; Roth S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-50; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Schultheis AS, 2002, INSECT MOL BIOL, V11, P605, DOI 10.1046/j.1365-2583.2002.00371.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAYLOR MFJ, 1993, MOL BIOL EVOL, V10, P1259; Tian X, 2015, MITOCHONDR DNA, V28, P1; Timmermans MJTN, 2016, GENOME BIOL EVOL, V8, P161, DOI 10.1093/gbe/evv241; Tokuda G, 2012, INSECT SOC, V59, P17, DOI 10.1007/s00040-011-0182-x; Walker FLS, 1868, CATALOGUE SPECIMENS; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xiao B, 2012, CURR GENET, V58, P65, DOI 10.1007/s00294-012-0365-7; Yamauchi MM, 2004, INSECT MOL BIOL, V13, P435, DOI 10.1111/j.0962-1075.2004.00505.x; Ye F, 2016, SCI REP-UK, V6, DOI 10.1038/srep25634; Yin H, 2012, GENE, V494, P214, DOI 10.1016/j.gene.2011.12.020; Yue H, 2015, BIOCHEM SYST ECOL, V60, P123, DOI 10.1016/j.bse.2015.04.013; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; ZHANG DX, 1995, J MOL EVOL, V40, P382, DOI 10.1007/BF00164024; Zhang YY, 2010, MOL BIOL REP, V37, P3509, DOI 10.1007/s11033-009-9944-1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	69	6	7	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177162	10.1371/journal.pone.0177162	http://dx.doi.org/10.1371/journal.pone.0177162			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486518	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314000050
J	Rico, JE; Samii, SS; Mathews, AT; Lovett, J; Haughey, NJ; McFadden, JW				Rico, J. Eduardo; Samii, Sina Saed; Mathews, Alice T.; Lovett, Jacqueline; Haughey, Norman J.; McFadden, Joseph W.			Temporal changes in sphingolipids and systemic insulin sensitivity during the transition from gestation to lactation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INTRAMYOCELLULAR CERAMIDE ACCUMULATION; BODY CONDITION SCORE; DAIRY-COWS; FATTY LIVER; SKELETAL-MUSCLE; LATE PREGNANCY; GLUCOSE-TOLERANCE; PLASMA CERAMIDES; MILK-PRODUCTION	Reduced insulin action develops naturally during the peripartum to ensure maternal nutrient delivery to the fetus and neonate. However, increased insulin resistance can facilitate excessive lipolysis which in turn promotes metabolic disease in overweight dairy cattle. Increased fatty acid availability favors the accumulation of the sphingolipid ceramide and is implicated in the pathogenesis of insulin resistance, however, the relationship between sphingolipid metabolism and insulin resistance during the peripartum remains largely unknown. Our objectives were to characterize temporal responses in plasma and tissue sphingolipids in lean and overweight peripartal cows and to establish the relationships between sphingolipid supply and lipolysis, hepatic lipid deposition, and systemic insulin action. Twenty-one multiparous lean and overweight Holstein cows were enrolled in a longitudinal study spanning the transition from gestation to lactation (d -21 to 21, relative to parturition). Plasma, liver, and skeletal muscle samples were obtained, and sphingolipids were profiled using LC/MS/MS. Insulin sensitivity was assessed utilizing intravenous insulin and glucose challenges. Our results demonstrated the following: first, insulin resistance develops postpartum concurrently with increased lipolysis and hepatic lipid accumulation; second, ceramides and glycosylated ceramides accumulate during the transition from gestation to lactation and are further elevated in overweight cows; third, ceramide accrual is associated with lipolysis and liver lipid accumulation, and C16: 0- and C24: 0-ceramide are inversely associated with systemic insulin sensitivity postpartum; fourth, plasma sphingomyelin, a potential source of ceramides reaches a nadir at parturition and is closely associated with feed intake; fifth, select sphingomyelins are lower in the plasma of overweight cows during the peripartal period. Our results demonstrate that dynamic changes occur in peripartal sphingolipids that are influenced by adiposity, and are associated with the onset of peripartal insulin resistance. These observations are in agreement with a putative potential role for sphingolipids in facilitating the physiological adaptations of peripartum.	[Rico, J. Eduardo; Samii, Sina Saed; Mathews, Alice T.; McFadden, Joseph W.] West Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV 26506 USA; [Lovett, Jacqueline; Haughey, Norman J.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	West Virginia University; Johns Hopkins University	McFadden, JW (corresponding author), West Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV 26506 USA.	JWMcFadden@mail.wvu.edu	Samii, Sina Saed/AAO-3223-2020; Rico, Eduardo/M-6779-2019	Samii, Sina Saed/0000-0002-4218-3146; Rico, Eduardo/0000-0003-0286-1747	United States Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative [2014-67016-21611]	United States Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative(United States Department of Agriculture (USDA))	This work was supported by the United States Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative 2014-67016-21611, http://portal.nifa.usda.gov/web/crisprojectpages/1001895-mechanisms-mediating-insulin-resistance-in-overconditioned-dairy-cows-transitioning-from-gestation-to-lactation.html (JWM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; AOAC, 2000, AOAC INT OFF METH AN, V17; AOAC International, 2012, AOAC OFFICIAL METHOD; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; BELL AW, 1995, J DAIRY SCI, V78, P1954, DOI 10.3168/jds.S0022-0302(95)76821-7; BELL AW, 1995, J ANIM SCI, V73, P2804, DOI 10.2527/1995.7392804x; Blouin CM, 2010, DIABETES, V59, P600, DOI 10.2337/db09-0897; Bobe G, 2004, J DAIRY SCI, V87, P3105, DOI 10.3168/jds.S0022-0302(04)73446-3; Boon J, 2013, DIABETES, V62, P401, DOI 10.2337/db12-0686; Canals D, 2011, BRIT J PHARMACOL, V163, P694, DOI 10.1111/j.1476-5381.2011.01279.x; Chapinal N, 2012, J DAIRY SCI, V95, P5676, DOI 10.3168/jds.2011-5132; Chavez JA, 2014, J BIOL CHEM, V289, P723, DOI 10.1074/jbc.M113.522847; Contreras GA, 2015, J DAIRY SCI, V98, P6176, DOI 10.3168/jds.2015-9370; Cooke RF, 2007, J DAIRY SCI, V90, P2413, DOI 10.3168/jds.2006-028; Drackley JK, 2005, ITAL J ANIM SCI, V4, P323, DOI 10.4081/ijas.2005.323; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; ELEY RM, 1978, J DAIRY SCI, V61, P467, DOI 10.3168/jds.S0022-0302(78)83622-4; Ghafourifar P, 1999, J BIOL CHEM, V274, P6080, DOI 10.1074/jbc.274.10.6080; Hall MB, 2009, J AOAC INT, V92, P42; Hanamatsu H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.38; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Haughey NJ, 2004, ANN NEUROL, V55, P257, DOI 10.1002/ana.10828; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Hla T, 2014, CELL METAB, V20, P703, DOI 10.1016/j.cmet.2014.10.017; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; HUGHES JP, 1962, AM J VET RES, V23, P1111; Kabayama K, 2005, GLYCOBIOLOGY, V15, P21, DOI 10.1093/glycob/cwh135; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kasumov T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126910; Kerestes M, 2009, DOMEST ANIM ENDOCRIN, V37, P250, DOI 10.1016/j.domaniend.2009.07.003; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Mann S, 2016, J DAIRY SCI, V99, P701, DOI 10.3168/jds.2015-9908; Mathews AT, 2016, J DAIRY SCI, V99, P8802, DOI 10.3168/jds.2016-11295; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; MORROW DA, 1976, J DAIRY SCI, V59, P1625, DOI 10.3168/jds.S0022-0302(76)84415-3; NRC (National Research Council), 2001, NUTRIENT REQUIREMENT; O'Boyle N, 2006, VET IMMUNOL IMMUNOP, V113, P297, DOI 10.1016/j.vetimm.2006.05.013; Ohtsuka H, 2001, J VET MED SCI, V63, P1021, DOI 10.1292/jvms.63.1021; Oikawa S, 2006, J DAIRY SCI, V89, P2999, DOI 10.3168/jds.S0022-0302(06)72572-3; Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005; Park M, 2016, J BIOL CHEM, V291, P23978, DOI 10.1074/jbc.M116.737684; Peraldi P, 1996, J BIOL CHEM, V271, P13018, DOI 10.1074/jbc.271.22.13018; Petersen MC, 2016, J PHYSIOL-LONDON, V594, P3171, DOI 10.1113/JP271677; Pires JAA, 2007, J DAIRY SCI, V90, P2735, DOI 10.3168/jds.2006-759; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Rico JE, 2016, J DAIRY SCI, V99, P8817, DOI 10.3168/jds.2016-11296; Rico JE, 2015, J DAIRY SCI, V98, P7757, DOI 10.3168/jds.2015-9519; Roche JR, 2009, J DAIRY SCI, V92, P5769, DOI 10.3168/jds.2009-2431; Sordillo LM, 2013, VET CLIN N AM-FOOD A, V29, P267, DOI 10.1016/j.cvfa.2013.03.002; Starke A, 2010, J ANIM SCI, V88, P2741, DOI 10.2527/jas.2009-2599; Straczkowski M, 2007, DIABETOLOGIA, V50, P2366, DOI 10.1007/s00125-007-0781-2; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Summers SA, 2016, J PHYSIOL-LONDON, V594, P3167, DOI 10.1113/JP271676; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Watt MJ, 2012, DIABETOLOGIA, V55, P2741, DOI 10.1007/s00125-012-2649-3; WILDMAN EE, 1982, J DAIRY SCI, V65, P495, DOI 10.3168/jds.S0022-0302(82)82223-6; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JY, 2015, CELL METAB, V22, P266, DOI 10.1016/j.cmet.2015.06.007; Zachut M, 2013, J DAIRY SCI, V96, P5656, DOI 10.3168/jds.2012-6142	66	27	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176787	10.1371/journal.pone.0176787	http://dx.doi.org/10.1371/journal.pone.0176787			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486481	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314000025
J	Wang, C; Dang, YL; Waxman, S; Xia, XB; Weinreb, RN; Loewen, NA				Wang, Chao; Dang, Yalong; Waxman, Susannah; Xia, Xiaobo; Weinreb, Robert N.; Loewen, Nils A.			Angle stability and outflow in dual blade ab interno trabeculectomy with active versus passive chamber management	PLOS ONE			English	Article							DIFFERENTIAL CANALOGRAMS; ANTERIOR-SEGMENT; GLAUCOMA; GONIOTOMY; OUTCOMES	Purpose To compare intraoperative angle stability and postoperative outflow of two ab interno trabeculectomy devices that excise the trabecular meshwork with or without active aspiration and irrigation. We hypothesized that anterior segment optical coherence tomography (AS-OCT) allows for a quantitative comparison of intraoperative angle stability in a microincisional glaucoma surgery (MIGS) pig eye training model. Methods Twelve freshly enucleated porcine eyes were measured with AS-OCT at baseline, at the beginning of the procedure and at its conclusion to determine the anterior chamber depth (ACD) and the nasal angle a in degrees. The right and left eye of pairs were randomly assigned to an active dual blade goniectome (aDBG) and a passive dual blade goniectome (pDBG) group, respectively. The aDBG had irrigation and aspiration ports while the pDBG required surgery under viscoelastic. We performed the procedures using our MIGS training system with a standard, motorized ophthalmic operating microscope. We estimated outflow by obtaining canalograms with fluorescent spheres. Results In aDBG, the nasal angle remained wide open during the procedure at above 90 degrees and did not change towards the end (100 +/- 10%, p = 0.9). In contrast, in pDBG, ACD decreased by 51 +/- 19% to 21% below baseline (p<0.01) while the angle progressively narrowed by 40 +/- 12% (p< 0.001). Canalograms showed a similar extent of access to the outflow tract with the aDBG and the pDBG (p = 0.513). The average increase for the aDBG in the superonasal and inferonasal quadrants was between 27 to 31% and for the pDBG between 15 to 18%. Conclusion AS-OCT demonstrated that active irrigation and aspiration improved anterior chamber maintenance and ease of handling with the aDBG in this MIGS training model. The immediate postoperative outflow was equally good with both devices.	[Wang, Chao; Dang, Yalong; Waxman, Susannah; Loewen, Nils A.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Wang, Chao; Xia, Xiaobo] Cent S Univ, Xiangya Hosp, Dept Ophthalmol, Changsha, Hunan, Peoples R China; [Weinreb, Robert N.] Univ Calif San Diego, Shiley Eye Inst, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA; [Weinreb, Robert N.] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; University of California System; University of California San Diego; University of California System; University of California San Diego	Loewen, NA (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.	loewen.nils@gmail.com	Loewen, Nils/E-9946-2014; Waxman, Susannah/AAM-4636-2020; Dang, Yalong/Q-4156-2017	Loewen, Nils/0000-0001-7167-1213; Dang, Yalong/0000-0003-2194-6375; Xia, Xiaobo/0000-0002-2785-3391; Waxman, Susannah/0000-0001-6708-3187	The Initiative to Cure Glaucoma; Eye and Ear Foundation of Pittsburgh [R44 - EY 015037-02]; SBIR; Wiegand Fellowship; Eye and Ear Foundation of Pittsburgh; Third Xiangya Hospital of Central South University for studying in University of Pittsburgh School of Medicine; NATIONAL EYE INSTITUTE [K08EY022737, P30EY008098] Funding Source: NIH RePORTER	The Initiative to Cure Glaucoma; Eye and Ear Foundation of Pittsburgh; SBIR; Wiegand Fellowship; Eye and Ear Foundation of Pittsburgh; Third Xiangya Hospital of Central South University for studying in University of Pittsburgh School of Medicine; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by The Initiative to Cure Glaucoma by the Eye and Ear Foundation of Pittsburgh, R44 - EY 015037-02, SBIR grant, the Wiegand Fellowship, Eye and Ear Foundation of Pittsburgh, and an unrestricted grant from the Third Xiangya Hospital of Central South University for studying in University of Pittsburgh School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DR, 1983, OPHTHALMOLOGY, V90, P805; Arshinoff SA, 2005, J CATARACT REFR SURG, V31, P2167, DOI 10.1016/j.jcrs.2005.08.056; Baerveldt G, 2005, US Patent, Patent No. [6979328, 6979328 B2]; Bussel II, 2015, BRIT J OPHTHALMOL, V99, P914, DOI 10.1136/bjophthalmol-2014-305577; Carreon T., 2016, PROG RETIN EYE RES; Dang Y, 2017, SCI REPORTS IN PRESS; Dang Y, 2017, PEER J PREPRINTS; DRAEGER J, 1982, KLIN MONATSBL AUGENH, V180, P264, DOI 10.1055/s-2008-1055063; Duker JS, 2013, OPHTHALMOLOGY EXPERT, P1133; Fallano K, 2017, TRAINING STRATEGIES; Kaplowitz K, 2016, EXPERT REV OPHTHALMO, P1; Kaplowitz K, 2016, BRIT J OPHTHALMOL, V100, P594, DOI 10.1136/bjophthalmol-2015-307131; Kaplowitz K, 2014, BRIT J OPHTHALMOL, V98, P579, DOI 10.1136/bjophthalmol-2013-304256; Lewis RA, 2014, J CATARACT REFR SURG, V40, P1301, DOI 10.1016/j.jcrs.2014.01.032; LISTER A, 1965, BRIT J OPHTHALMOL, V49, P594, DOI 10.1136/bjo.49.11.594; Loewen RT, 2016, INVEST OPHTH VIS SCI, V57, P2831, DOI 10.1167/iovs.16-19541; Loewen RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151754; LUNTZ MH, 1977, AM J OPHTHALMOL, V83, P174, DOI 10.1016/0002-9394(77)90612-2; Narayanaswamy A, 2010, ARCH OPHTHALMOL-CHIC, V128, P1321, DOI 10.1001/archophthalmol.2010.231; Neiweem AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153585; Oatts JT, 2013, INVEST OPHTH VIS SCI, V54, P5416, DOI 10.1167/iovs.13-11853; Parikh HA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34705; Parikh HA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149384; Pfeiffer N, 2015, OPHTHALMOLOGY, V122, P1283, DOI 10.1016/j.ophtha.2015.03.031; Quintana M, 1985, 2 EUR GLAUC S HELS M, P265; Radhakrishnan S, 2001, ARCH OPHTHALMOL-CHIC, V119, P1179, DOI 10.1001/archopht.119.8.1179; Samuelson TW, 2011, OPHTHALMOLOGY, V118, P459, DOI 10.1016/j.ophtha.2010.07.007; SooHoo JR, 2015, MIDDLE EAST AFR J OP, V22, P25, DOI 10.4103/0974-9233.148345; Sorensen JT, 2015, US Patent, Patent No. [20150297400A1, 20150297400]; Vold S, 2016, OPHTHALMOLOGY; Yeung HH, 2016, PEARLS GLAUCOMA MANA, P487	31	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177238	10.1371/journal.pone.0177238	http://dx.doi.org/10.1371/journal.pone.0177238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486513	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314000062
J	Assenova, VA; Regele, M				Assenova, Valentina A.; Regele, Matthew			Revisiting the effect of colonial institutions on comparative economic development	PLOS ONE			English	Article							GEOGRAPHY; ORIGINS	European settler mortality has been proposed as an instrument to predict the causal effect of colonial institutions on differences in economic development. We examine the relationship between mortality, temperature, and economic development in former European colonies in Asia, Africa, and the Americas. We find that (i) European settler mortality rates increased with regional temperatures and (ii) economic output decreased with regional temperatures. Conditioning on the continent of settlement and accounting for colonies that were not independent as of 1900 undermines the causal effect of colonial institutions on comparative economic development. Our findings run counter to the institutions hypothesis of economic development, showing instead that geography affected both historic mortality rates and present-day economic output.	[Assenova, Valentina A.; Regele, Matthew] Yale Univ, Dept Management, New Haven, CT 06520 USA	Yale University	Assenova, VA (corresponding author), Yale Univ, Dept Management, New Haven, CT 06520 USA.	valentina.assenova@yale.edu		/0000-0002-5637-8139				Acemoglu D, 2002, Q J ECON, V117, P1231, DOI 10.1162/003355302320935025; Acemoglu D, 2001, AM ECON REV, V91, P1369, DOI 10.1257/aer.91.5.1369; Acemoglu D, 2003, J MONETARY ECON, V50, P49, DOI 10.1016/S0304-3932(02)00208-8; Acemoglu D, 2005, HANDB ECON, V22, P385; Acemoglu D, 2012, WHY NATIONS FAIL ORI, P556; Acemoglu D, 2014, ANNU REV ECON, V6, P875, DOI 10.1146/annurev-economics-080213-041119; Acemoglu D, 2012, AM ECON REV, V102, P3077, DOI 10.1257/aer.102.6.3077; Auer RA, 2013, J ECON GROWTH, V18, P179, DOI 10.1007/s10887-013-9087-z; Bates R.H., 1983, ESSAYS POLITICAL EC; Bleaney M, 2010, J AFR ECON, V19, P635, DOI 10.1093/jae/ejq014; Bloom DE, 1998, BROOKINGS PAP ECO AC, P207, DOI 10.2307/2534695; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Easterly W, 2016, J ECON GROWTH, V21, P225, DOI 10.1007/s10887-016-9130-y; Engerman S., 1997, LATIN AM FELL ESSAYS, P260; Gallup JL, 1999, INT REGIONAL SCI REV, V22, P179, DOI 10.1177/016001799761012334; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Glaeser EL, 2004, J ECON GROWTH, V9, P271, DOI 10.1023/B:JOEG.0000038933.16398.ed; Henige David P., 1970, COLONIAL GOVERNORS 1; Herrera JL, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004928; McArthur JW, 2000, NATL BUREAU EC RES W, V2001; McCord GC, 2013, 19152 NBER, V19512, P1; Murray DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062275; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Rodrik D, 2004, J ECON GROWTH, V9, P131, DOI 10.1023/B:JOEG.0000031425.72248.85; Sachs JD, 2003, NBER WORKING PAPER S, V9305, P1689; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Wooldridge J., 2002, ECONOMETRIC ANAL CRO	27	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177100	10.1371/journal.pone.0177100	http://dx.doi.org/10.1371/journal.pone.0177100			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481920	gold, Green Published, Green Submitted			2022-12-27	WOS:000401313700034
J	Chang, CC; Hsu, HJ; Yen, JH; Lo, SY; Liou, JW				Chang, Chun-Chun; Hsu, Hao-Jen; Yen, Jui-Hung; Lo, Shih-Yen; Liou, Je-Wen			A Sequence in the loop domain of hepatitis C virus E2 protein identified in silico as crucial for the selective binding to human CD81	PLOS ONE			English	Article							LARGE EXTRACELLULAR LOOP; ENVELOPE GLYCOPROTEIN; VIRAL ENTRY; NEUTRALIZING ANTIBODIES; STRUCTURE PREDICTION; ANTIVIRAL THERAPY; INFECTION; RECEPTOR; ESCAPE; HCV	Hepatitis C virus (HCV) is a species-specific pathogenic virus that infects only humans and chimpanzees. Previous studies have indicated that interactions between the HCV E2 protein and CD81 on host cells are required for HCV infection. To determine the crucial factors for species-specific interactions at the molecular level, this study employed in silico molecular docking involving molecular dynamic simulations of the binding of HCV E2 onto human and rat CD81s. In vitro experiments including surface plasmon resonance measurements and cellular binding assays were applied for simple validations of the in silico results. The in silico studies identified two binding regions on the HCV E2 loop domain, namely E2-site1 and E2-site2, as being crucial for the interactions with CD81s, with the E2-site2 as the determinant factor for human-specific binding. Free energy calculations indicated that the E2/CD81 binding process might follow a two-step model involving (i) the electrostatic interaction-driven initial binding of human-specific E2-site2, followed by (ii) changes in the E2 orientation to facilitate the hydrophobic and van der Waals interaction-driven binding of E2-site1. The sequence of the human-specific, stronger-binding E2-site2 could serve as a candidate template for the future development of HCV-inhibiting peptide drugs.	[Chang, Chun-Chun; Liou, Je-Wen] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Chang, Chun-Chun] Dept Lab Med, Tzu Chi Med Ctr, Hualien, Taiwan; [Hsu, Hao-Jen] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Yen, Jui-Hung] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Lo, Shih-Yen] Tzu Chi Univ, Dept Lab Med & Biotechnol, Hualien, Taiwan; [Liou, Je-Wen] Tzu Chi Univ, Dept Biochem, Sch Med, Hualien, Taiwan	Tzu Chi University; Buddhist Tzu Chi General Hospital; Tzu Chi University; Tzu Chi University; Tzu Chi University; Tzu Chi University	Liou, JW (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.; Liou, JW (corresponding author), Tzu Chi Univ, Dept Biochem, Sch Med, Hualien, Taiwan.	jwliou@mail.tcu.edu.tw	Hsu, Hao-Jen/ABE-3718-2020; Liou, Je-Wen/ABB-2157-2020	Liou, Je-Wen/0000-0002-6181-7263	Tzu Chi University [TCIRP 103002-01]; Tzu Chi Medical Center, Hualien, Taiwan [TCRD 105-34]	Tzu Chi University; Tzu Chi Medical Center, Hualien, Taiwan	This work is supported by Tzu Chi University (TCIRP 103002-01, http://www.tcu.edu.tw/) and Tzu Chi Medical Center, Hualien, Taiwan (TCRD 105-34, http://hlm.tzuchi.com.tw/).	Al Olaby RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111333; Alhammad YMO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126397; Au JS, 2014, CLIN PHARMACOL THER, V95, P78, DOI 10.1038/clpt.2013.206; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Bertaux C, 2006, J VIROL, V80, P4940, DOI 10.1128/JVI.80.10.4940-4948.2006; Bitzegeio J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000978; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Colpitts CC, 2016, HEPATOL INT, V10, P741, DOI 10.1007/s12072-016-9724-7; Dorner M, 2013, NATURE, V501, P237, DOI 10.1038/nature12427; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Drummer HE, 2002, J VIROL, V76, P11143, DOI 10.1128/JVI.76.21.11143-11147.2002; Drummer HE, 2006, J VIROL, V80, P7844, DOI 10.1128/JVI.00029-06; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Fauvelle C, 2013, MICROB PATHOGENESIS, V58, P66, DOI 10.1016/j.micpath.2013.02.005; Feneant L, 2014, VIRUSES-BASEL, V6, P535, DOI 10.3390/v6020535; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Forns X, 2000, VIROLOGY, V274, P75, DOI 10.1006/viro.2000.0419; Ginalski K, 2006, CURR OPIN STRUC BIOL, V16, P172, DOI 10.1016/j.sbi.2006.02.003; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; Houldsworth A, 2014, J MED VIROL, V86, P162, DOI 10.1002/jmv.23726; Jiang SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18638; Keck ZY, 2008, J VIROL, V82, P6067, DOI 10.1128/JVI.00252-08; Keck ZY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004297; Keck ZY, 2011, J VIROL, V85, P10451, DOI 10.1128/JVI.05259-11; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khan AG, 2014, NATURE, V509, P381, DOI 10.1038/nature13117; Kitadokoro K, 2002, BIOL CHEM, V383, P1447, DOI 10.1515/BC.2002.164; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; Krey T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003364; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098; Liou JC, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-1; Meyer K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09012; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Pawlotsky JM, 2014, ANTIVIR RES, V105, P22, DOI 10.1016/j.antiviral.2014.02.008; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Rothwang KB, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-46; Rupp D, 2014, SEMIN LIVER DIS, V34, P9, DOI 10.1055/s-0034-1371006; Schneider MD, 2014, ANTIVIR RES, V105, P64, DOI 10.1016/j.antiviral.2014.02.011; von Hahn T, 2008, J BIOL CHEM, V283, P3689, DOI 10.1074/jbc.R700024200; Wasitthankasem R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149362; Wunschmann S, 2000, J VIROL, V74, P10055, DOI 10.1128/JVI.74.21.10055-10062.2000; Xiao F, 2015, GUT, V64, P483, DOI 10.1136/gutjnl-2013-306155; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zhao Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084346; Zhu YZ, 2014, WORLD J GASTROENTERO, V20, P3457, DOI 10.3748/wjg.v20.i13.3457; Zona L, 2014, VIRUSES-BASEL, V6, P875, DOI 10.3390/v6020875	54	9	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177383	10.1371/journal.pone.0177383	http://dx.doi.org/10.1371/journal.pone.0177383			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481946	gold, Green Published, Green Submitted			2022-12-27	WOS:000401313700057
J	Jaffe, A; Giveon, S; Wulffhart, L; Oberman, B; Baidousi, M; Ziv, A; Kalter-Leibovici, O				Jaffe, Anat; Giveon, Shmuel; Wulffhart, Liat; Oberman, Bernice; Baidousi, Maslama; Ziv, Arnona; Kalter-Leibovici, Ofra			Adult Arabs have higher risk for diabetes mellitus than Jews in Israel	PLOS ONE			English	Article							POPULATION; PREVALENCE	Objective Diabetes mellitus is an emerging epidemic in the Arab world. Although high diabetes prevalence is documented in Israeli Arabs, information from cohort studies is scant. Methods This is a population study, based on information derived between 2007-2011, from the electronic database of the largest health fund in Israel, among Arabs and Jews. Prevalence, 4-year- incidence and diabetes hazard ratios [HRs], adjusted for sex and the metabolic-syndrome [MetS]-components, were determined in 3 age groups (<50 years, 50-59 years, and >= 60 years). Results The study cohort included 17,044 Arabs (males: 49%, age: 39.4 +/- 17.3) and 16,012 Jews (males: 50%, age: 40.5 +/- 17.6). The overall age and sex-adjusted diabetes prevalence rates were much higher among Arabs 18.4% (95% CI: 17.6-19.1); and 10.3% (95% CI: 9.7-10.9) among Jews. Arab females had higher prevalence rates 20.0% (95% CI: 19-21) than Arab males 16.7% (95% CI: 15.7-17.8). Annual incidence rates were also significantly higher among Arabs 2.9% (95% CI: 2.7-3.1) than among Jews 1.7% (95% CI: 1.6-1.8). This held true across all age and sex subgroups. Adjustment for body mass index [BMI] attenuated HR estimates associated with Arab ethnicity across all age subgroups, mainly in the <50yrs age group from HR 2.04 (95% CI: 1.74-2.40) to 1.64 (95% CI: 1.40-1.92). BMI at incident diabetes among females was higher in Arabs than Jews. Males, however, did not differ by ethnicity. Conclusion Arabs, mainly female, have high incidence and prevalence of diabetes. This excess risk is only partially explained by the high prevalence of obesity. Effective culturally-congruent diabetes prevention and treatment and an effective engagement partnership with the Arab community are of paramount need.	[Jaffe, Anat; Baidousi, Maslama] Hillel Yaffe Med Ctr, Endocrinol & Diabet Unit, Hadera, Israel; [Giveon, Shmuel] Clalit Hlth Serv, Tel Aviv, Israel; [Giveon, Shmuel] Tel Aviv Univ, Dept Family Med, Tel Aviv, Israel; [Wulffhart, Liat; Oberman, Bernice] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Unit Biostat, Ramat Gan, Israel; [Ziv, Arnona] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Informat & Comp Unit, Ramat Gan, Israel; [Kalter-Leibovici, Ofra] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Unit Cardiovasc Epidemiol, Ramat Gan, Israel; [Kalter-Leibovici, Ofra] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Clalit Health Services; Tel Aviv University; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Jaffe, A (corresponding author), Hillel Yaffe Med Ctr, Endocrinol & Diabet Unit, Hadera, Israel.	anatjaffe@gmail.com		Jaffe, Anat/0000-0003-3976-0923				Abu-Rmeileh NME, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001061; Abu-Saad K, 2012, J NUTR, V142, P2175, DOI 10.3945/jn.112.166611; Ajlouni K, 2008, J DIABETES COMPLICAT, V22, P317, DOI 10.1016/j.jdiacomp.2007.01.004; Al-Mahroos F, 1998, DIABETES CARE, V21, P936, DOI 10.2337/diacare.21.6.936; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Badran M, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/902873; Baron-Epel O, 2009, SOC SCI MED, V69, P1460, DOI 10.1016/j.socscimed.2009.08.028; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Daoud N, 2008, WOMEN HEALTH, V48, P145, DOI 10.1080/03630240802313530; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Israel Central Bureau of Statistics, 65 IND DAY; Israeli Center of Disease Control, 2003, MABAT 1 ISR NAT HLTH; Jaber LA, 2003, DIABETES CARE, V26, P2010, DOI 10.2337/diacare.26.7.2010; Kalter-Leibovici O, 2012, DIABETIC MED, V29, P748, DOI 10.1111/j.1464-5491.2011.03516.x; Kalter-Leibovici O, 2007, ISR MED ASSOC J, V9, P525; Lysy Z, 2013, DIABETES RES CLIN PR, V99, P372, DOI 10.1016/j.diabres.2012.12.005; Ma YS, 2012, DIABETES CARE, V35, P2226, DOI 10.2337/dc12-0412; Malik M, 2005, DIABETES RES CLIN PR, V69, P188, DOI 10.1016/j.diabres.2004.12.005; Motlagh B, 2009, EUR J CARDIOV PREV R, V16, P268, DOI 10.1097/HJR.0b013e328322ca1b; Pinelli NR, 2011, ETHNIC DIS, V21, P480; Saabneh AM, 2016, EUR J PUBLIC HEALTH, V26, P433, DOI 10.1093/eurpub/ckv211; Shalaby S, 2015, WORLD J DIABETES, V6, P304, DOI 10.4239/wjd.v6.i2.304; Yitzhaki S., 2010, ISRAEL FIGURES 2010	23	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176661	10.1371/journal.pone.0176661	http://dx.doi.org/10.1371/journal.pone.0176661			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481942	Green Submitted, Green Published, gold			2022-12-27	WOS:000401313700013
J	Pantin-Jackwood, MJ; Stephens, CB; Bertran, K; Swayne, DE; Spackman, E				Pantin-Jackwood, Mary J.; Stephens, Christopher B.; Bertran, Kateri; Swayne, David E.; Spackman, Erica			The pathogenesis of H7N8 low and highly pathogenic avian influenza viruses from the United States 2016 outbreak in chickens, turkeys and mallards	PLOS ONE			English	Article							DUCKS; INFECTIONS; ADAPTATION; SUBTYPE; POULTRY; US	In January 2016, a combined outbreak of highly pathogenic (HP) avian influenza virus (AIV) and low pathogenicity (LP) AIV occurred in commercial turkeys in the state of Indiana, United States. Genetically, the viruses were highly similar, belonged to the North American wild bird lineage, and had not been previously detected in poultry. In order to understand the pathobiology of the H7N8 LPAIV and HPAIV, infectivity, transmission and pathogenicity studies were conducted in chickens, turkeys, and mallards. Among the three species the lowest mean infectious dose for both the LP and HP phenotype was for turkeys, and also disease from the LPAIV was only observed with turkeys. Furthermore, although the HPAIV was lethal for both chickens and turkeys, clinical signs caused by the HPAIV isolate differed between the two species; neurological signs were only observed in turkeys. Mallards could be infected with and transmit both viruses to contacts, but neither caused clinical disease. Interestingly, with all three species, the mean infectious dose of the HP isolate was at least ten times lower than that of the LP isolate. This study corroborates the high susceptibility of turkeys to AIV as well as a pathobiology that is different from chickens. Further, this study demonstrates that mallards can be asymptomatically infected with HP and LP AIV from gallinaceous poultry and may not just be involved in transmitting AIV to them.	[Pantin-Jackwood, Mary J.; Stephens, Christopher B.; Bertran, Kateri; Swayne, David E.; Spackman, Erica] ARS, Exot & Emerging Avian Viral Dis Unit, Southeast Poultry Res Lab, US Natl Poultry Res Ctr,USDA, Athens, GA 30602 USA	United States Department of Agriculture (USDA)	Spackman, E (corresponding author), ARS, Exot & Emerging Avian Viral Dis Unit, Southeast Poultry Res Lab, US Natl Poultry Res Ctr,USDA, Athens, GA 30602 USA.	Erica.Spackman@ARS.USDA.gov	Bertran, Kateri/H-3458-2019; Swayne, David/AAP-7166-2020	Bertran, Kateri/0000-0002-6920-4154; Spackman, Erica/0000-0002-4935-2360; Swayne, David/0000-0001-7472-1992; Pantin-Jackwood, Mary J./0000-0003-0414-213X				ALEXANDER DJ, 1986, AVIAN PATHOL, V15, P647, DOI 10.1080/03079458608436328; Bardakcioglu D., 2013, DIS POULTRY, V13, P181, DOI DOI 10.1002/9781119421481; Bertran K, 2016, VIROLOGY, V494, P190, DOI 10.1016/j.virol.2016.04.019; Bonfanti L, 2014, VET REC, V174, DOI 10.1136/vr.102202corr1; Bowes VA, 2004, AVIAN DIS, V48, P928, DOI 10.1637/7218-060304R; Dargatz D, 2016, AVIAN DIS, V60, P467, DOI 10.1637/11350-121715-Reg; Das A, 2009, J VET DIAGN INVEST, V21, P771, DOI 10.1177/104063870902100603; DeJesus E, 2016, VIROLOGY, V499, P52, DOI 10.1016/j.virol.2016.08.036; Donatelli I, 2001, J GEN VIROL, V82, P623, DOI 10.1099/0022-1317-82-3-623; HOMME PJ, 1970, AVIAN DIS, V14, P240, DOI 10.2307/1588468; KARUNAKARAN D, 1988, AVIAN DIS, V32, P319, DOI 10.2307/1590820; Killian ML, 2016, GENOME ANNOUNC, V4; KLEVEN S H, 1970, Avian Diseases, V14, P153, DOI 10.2307/1588566; Morales Jr AC, AVIAN DIS; OIE, 2016, MAN DIAGN TESTS VACC; Pantin-Jackwood MJ, 2007, AVIAN DIS, V51, P250, DOI 10.1637/7710-090606R.1; Pantin-Jackwood MJ, 2016, J VIROL, V90, P9967, DOI 10.1128/JVI.01165-16; Pantin-Jackwood MJ, 2014, METHODS MOL BIOL, V1161, P51, DOI 10.1007/978-1-4939-0758-8_5; Pantin-Jackwood MJ, 2016, J VIROL; Pedersen JC, 2014, METHODS MOL BIOL, V1161, P11, DOI 10.1007/978-1-4939-0758-8_2; Pillai SPS, 2010, ARCH VIROL, V155, P1439, DOI 10.1007/s00705-010-0727-8; RANCK F M JR, 1970, Avian Diseases, V14, P54, DOI 10.2307/1588556; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reid SM, 2016, AVIAN DIS, V60, P126, DOI 10.1637/11356-122315-Case.1; Spackman E, 2016, BMC VET RES, P12; Spackman E, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0890-6; Spackman E, 2015, VIROLOGY, V477, P72, DOI 10.1016/j.virol.2015.01.013; Spackman E, 2014, METHODS MOL BIOL, V1161, P125, DOI 10.1007/978-1-4939-0758-8_12; Spackman E, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-331; Swayne DE, 2008, AVIAN DIS, V52, P455, DOI 10.1637/8229-012508-Reg.1; Swayne DE, 2008, AVIAN DIS; Swayne DE., 2008, AVIAN INFLUENZA, V1, P87, DOI 10.1002/9780813818634.ch5; USDA APHIS, 2015, EP OTH AN HPAI AFF P; Van der Goot JA, 2003, EPIDEMIOL INFECT, V131, P1003, DOI 10.1017/S0950268803001067; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu Y, 2017, J VIROL, V91, DOI [10.1128/JVI.02208-16, 10.1128/jvi.02208-16]; Zanella A, 2001, AVIAN DIS, V45, P257, DOI 10.2307/1593038; Ziegler AF, 1999, AVIAN DIS, V43, P142, DOI 10.2307/1592774	38	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177265	10.1371/journal.pone.0177265	http://dx.doi.org/10.1371/journal.pone.0177265			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481948	Green Published, Green Submitted, gold			2022-12-27	WOS:000401313700045
J	Ramke, J; Palagyi, A; Jordan, V; Petkovic, J; Gilbert, CE				Ramke, Jacqueline; Palagyi, Anna; Jordan, Vanessa; Petkovic, Jennifer; Gilbert, Clare E.			Using the STROBE statement to assess reporting in blindness prevalence surveys in low and middle income countries	PLOS ONE			English	Article							COMPLETENESS; EPIDEMIOLOGY; GUIDELINES; JOURNALS; QUALITY; TRIALS	Objective Cross-sectional blindness prevalence surveys are essential to plan and monitor eye care services. Incomplete or inaccurate reporting can prevent effective translation of research findings. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement is a 32 item checklist developed to improve reporting of observational studies. The aim of this study was to assess the completeness of reporting in blindness prevalence surveys in low and middle income countries (LMICs) using STROBE. Methods MEDLINE, EMBASE and Web of Science databases were searched on April 8 2016 to identify cross-sectional blindness prevalence surveys undertaken in LMICs and published after STROBE was published in December 2007. The STROBE tool was applied to all included studies, and each STROBE item was categorized as 'yes' (met criteria), 'no' (did not meet criteria) or 'not applicable'. The 'Completeness of reporting (COR) score' for each manuscript was calculated: COR score = yes / [yes + no]. In journals with included studies the instructions to authors and reviewers were checked for reference to STROBE. Results The 89 included studies were undertaken in 32 countries and published in 37 journals. The mean COR score was 60.9% (95% confidence interval [CI] 58.1-63.7%; range 30.8-88.9%). The mean COR score did not differ between surveys published in journals with author instructions referring to STROBE (10/37 journals; 61.1%, 95% CI 56.4-65.8%) or in journals where STROBE was not mentioned (60.9%, 95% CI 57.4-64.3%; p = 0.93). Conclusion While reporting in blindness prevalence surveys is strong in some areas, others need improvement. We recommend that more journals adopt the STROBE checklist and ensure it is used by authors and reviewers.	[Ramke, Jacqueline] Univ Auckland, Sch Populat Hlth, Fac Med & Hlth Sci, Auckland, New Zealand; [Palagyi, Anna] Univ Sydney, George Inst Global Hlth, Sydney Med Sch, Sydney, NSW, Australia; [Jordan, Vanessa] Univ Auckland, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, Auckland, New Zealand; [Petkovic, Jennifer] Univ Ottawa, Bruyere Res Inst, Ottawa, ON, Canada; [Gilbert, Clare E.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Int Ctr Eye Hlth, Clin Res Unit, London, England	University of Auckland; George Institute for Global Health; University of Sydney; University of Auckland; University of Ottawa; University of London; London School of Hygiene & Tropical Medicine	Ramke, J (corresponding author), Univ Auckland, Sch Populat Hlth, Fac Med & Hlth Sci, Auckland, New Zealand.	jramke@gmail.com	Ramke, Jacqueline/I-8844-2019; Palagyi, Anna/AAB-5634-2022	Ramke, Jacqueline/0000-0002-5764-1306; Palagyi, Anna/0000-0002-8127-9351				Bastuji-Garin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064733; Bourne R, 2013, OPHTHAL EPIDEMIOL, V20, P33, DOI 10.3109/09286586.2012.741279; Cobo E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6783; da Costa BR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000048; Ebrahim S, 2007, INT J EPIDEMIOL, V36, P946, DOI 10.1093/ije/dym185; Furtado JM, 2012, SURV OPHTHALMOL, V57, P149, DOI 10.1016/j.survophthal.2011.07.002; Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014; Institute of Social and Preventive Medicine, 2009, TRANSL STROBE STAT 2; International Centre for Eye Health, RAP ASS AV BLINDN 20; Kuper Hannah, 2006, Community Eye Health, V19, P68; Morissette K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000025.pub2; Murthy GV, 2012, EPIDEMIOLOGY EYE DIS; Parsons NR, 2011, J BONE JOINT SURG BR, V93B, P1154, DOI 10.1302/0301-620X.93B9.27193; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Sorensen AA, 2013, J HAND SURG-AM, V38A, P1584, DOI 10.1016/j.jhsa.2013.05.008; Stevens A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3804; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI 10.1016/j.ophtha.2013.05.025; The PLOS Medicine Editors, 2014, PLOS MED, V11; Turner L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-60; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; World Bank, 2014, COUNTR EC 2014; World Health Organization, 2012, WHO STRAT RES HLTH; World Health Organization, 2013, UN EYE HLTH GLOB ACT	23	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176178	10.1371/journal.pone.0176178	http://dx.doi.org/10.1371/journal.pone.0176178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481888	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000401313700007
J	Schutte, I; Slagter, HA; Collins, AGE; Frank, MJ; Kenemans, JL				Schutte, Iris; Slagter, Heleen A.; Collins, Anne G. E.; Frank, Michael J.; Kenemans, J. Leon			Stimulus discriminability may bias value-based probabilistic learning	PLOS ONE			English	Article							DECISION-MAKING; PARKINSONS-DISEASE; DOPAMINE; REWARD; NEUROBIOLOGY; SIGNALS; DISSOCIATION; DYSFUNCTION; MEDICATION; DISORDERS	Reinforcement learning tasks are often used to assess participants' tendency to learn more from the positive or more from the negative consequences of one's action. However, this assessment often requires comparison in learning performance across different task conditions, which may differ in the relative salience or discriminability of the stimuli associated with more and less rewarding outcomes, respectively. To address this issue, in a first set of studies, participants were subjected to two versions of a common probabilistic learning task. The two versions differed with respect to the stimulus (Hiragana) characters associated with reward probability. The assignment of character to reward probability was fixed within version but reversed between versions. We found that performance was highly influenced by task version, which could be explained by the relative perceptual discriminability of characters assigned to high or low reward probabilities, as assessed by a separate discrimination experiment. Participants were more reliable in selecting rewarding characters that were more discriminable, leading to differences in learning curves and their sensitivity to reward probability. This difference in experienced reinforcement history was accompanied by performance biases in a test phase assessing ability to learn from positive vs. negative outcomes. In a subsequent large-scale web-based experiment, this impact of task version on learning and test measures was replicated and extended. Collectively, these findings imply a key role for perceptual factors in guiding reward learning and underscore the need to control stimulus discriminability when making inferences about individual differences in reinforcement learning.	[Schutte, Iris; Kenemans, J. Leon] Univ Utrecht, Helmholtz Inst, Dept Expt Psychol & Psychopharmacol, Utrecht, Netherlands; [Slagter, Heleen A.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Slagter, Heleen A.] Univ Amsterdam, ABC, Amsterdam, Netherlands; [Collins, Anne G. E.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Psychol, Berkeley, CA 94720 USA; [Frank, Michael J.] Brown Univ, Brown Inst Brain Sci, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA	Utrecht University; University of Amsterdam; University of Amsterdam; University of California System; University of California Berkeley; Brown University	Schutte, I (corresponding author), Univ Utrecht, Helmholtz Inst, Dept Expt Psychol & Psychopharmacol, Utrecht, Netherlands.	i.schutte@uu.nl	Slagter, Heleen/ABF-1338-2020; Schutte, Iris/AAN-8455-2020	Slagter, Heleen/0000-0002-4180-1483; 	Netherlands Organization for Scientific Research [404-10-318]; National Science Foundation (NSF) [1460604]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); National Science Foundation (NSF)(National Science Foundation (NSF))	Experiment 1 and 2 were supported by a grant from the Netherlands Organization for Scientific Research awarded to LK (grant nr: 404-10-318). Experiment 3 was supported by a grant from the National Science Foundation awarded to MF (NSF grant, nr 1460604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bodi N, 2009, BRAIN, V132, P2385, DOI 10.1093/brain/awp094; Cavanagh JF, 2014, J EXP PSYCHOL GEN, V143, P1476, DOI 10.1037/a0035813; Cavanagh JF, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00331; Cockburn J, 2014, NEURON, V83, P551, DOI 10.1016/j.neuron.2014.06.035; Cools R, 2006, NEUROPSYCHOLOGIA, V44, P1663, DOI 10.1016/j.neuropsychologia.2006.03.030; Cools R, 2009, J NEUROSCI, V29, P1538, DOI 10.1523/JNEUROSCI.4467-08.2009; Cox SML, 2015, NEUROIMAGE, V109, P95, DOI 10.1016/j.neuroimage.2014.12.070; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Doll BB, 2011, J NEUROSCI, V31, P6188, DOI 10.1523/JNEUROSCI.6486-10.2011; Ernst M, 2006, PSYCHOL MED, V36, P299, DOI 10.1017/S0033291705005891; FABIANI M, 1986, PSYCHOPHYSIOLOGY, V23, P298, DOI 10.1111/j.1469-8986.1986.tb00636.x; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; Gillan CM, 2016, NEURON, V91, P19, DOI 10.1016/j.neuron.2016.06.002; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Grillon C, 2002, BIOL PSYCHIAT, V52, P958, DOI 10.1016/S0006-3223(02)01665-7; Grundler TOJ, 2009, NEUROPSYCHOLOGIA, V47, P1978, DOI 10.1016/j.neuropsychologia.2009.03.010; HUNT RR, 1995, PSYCHON B REV, V2, P105, DOI 10.3758/BF03214414; IMAI S, 1965, J EXP PSYCHOL, V69, P596, DOI 10.1037/h0021980; Jocham G, 2011, J NEUROSCI, V31, P1606, DOI 10.1523/JNEUROSCI.3904-10.2011; Kiss M, 2007, J COGNITIVE NEUROSCI, V19, P1316, DOI 10.1162/jocn.2007.19.8.1316; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Lou B, 2015, J NEUROSCI, V35, P13064, DOI 10.1523/JNEUROSCI.1601-15.2015; LUBOW RE, 1973, PSYCHOL BULL, V79, P398, DOI 10.1037/h0034425; Maltzman I., 1979, ORIENTING REFLEX HUM, P323; Manil S, 2013, NEUROPSYCHOLOGIA, V51, P818, DOI 10.1016/j.neuropsychologia.2013.02.003; Navalpakkam V, 2010, P NATL ACAD SCI USA, V107, P5232, DOI 10.1073/pnas.0911972107; Palminteri S, 2009, P NATL ACAD SCI USA, V106, P19179, DOI 10.1073/pnas.0904035106; Piray P, 2014, J NEUROSCI, V34, P7814, DOI 10.1523/JNEUROSCI.4063-13.2014; Polania R, 2014, NEURON, V82, P709, DOI 10.1016/j.neuron.2014.03.014; SCHMAJUK NA, 1992, PSYCHOL REV, V99, P268, DOI 10.1037/0033-295X.99.2.268; Schonberg T, 2007, J NEUROSCI, V27, P12860, DOI 10.1523/JNEUROSCI.2496-07.2007; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Thorndike EL, 1927, AM J PSYCHOL, V39, P212, DOI 10.2307/1415413; Waltz JA, 2007, BIOL PSYCHIAT, V62, P756, DOI 10.1016/j.biopsych.2006.09.042	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176205	10.1371/journal.pone.0176205	http://dx.doi.org/10.1371/journal.pone.0176205			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481915	gold, Green Published, Green Submitted			2022-12-27	WOS:000401313700008
J	Honda, H; Michihata, T; Shishido, K; Takahashi, K; Takahashi, G; Hosaka, N; Ikeda, M; Sanada, D; Shibata, T				Honda, Hirokazu; Michihata, Tetsuo; Shishido, Kanji; Takahashi, Keiko; Takahashi, Go; Hosaka, Nozomu; Ikeda, Misa; Sanada, Daisuke; Shibata, Takanori			High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients	PLOS ONE			English	Article							DOMINANT HYPOPHOSPHATEMIC RICKETS; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR EVENTS; DEFICIENCY ANEMIA; DIALYSIS-THERAPY; JAPANESE-SOCIETY; DOUBLE-BLIND; FGF23; PHOSPHATE; METABOLISM	A recent study demonstrated the association between inflammation, iron metabolism and fibroblast growth factor (FGF) 23. The present clinical study aimed to assess associations between anemia, iron metabolism and FGF23 in hemodialysis (HD) patients. This prospective observational study examined a cohort of prevalent HD patients (n = 282). Blood samples were obtained before dialysis sessions to measure baseline levels of hemoglobin (Hb), transferrin saturation (TSAT), ferritin, albumin-adjusted calcium (Ca), phosphate (P), intact (i)-PTH, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, intact (i)-FGF23, high sensitive (hs)-CRP, and interleukin-6. After the baseline measurement, study patients were followed-up for 6 months. Biochemical measurements were subsequently performed at 1 (Hb), 2 (TSAT and ferritin) or 3 (Ca, P and hs-CRP) month intervals. Doses of ESAs and intravenous iron supplementation during the study period were recorded. i-FGF23 was positively correlated with Ca, P, i-PTH and inversely correlated with TSAT and ferritin. However, levels of Hb and hs-CRP and doses of ESAs during the study period did not differ among the i-FGF23 tertiles, with levels of ferritin and TSAT in the higher i-FGF23 tertile being consistently lower than in the middle to lower i-FGF23 tertiles. Multivariate repeated measures analysis indicated that the higher i-FGF23 tertile was independently associated with repeated measurements of ferritin, but not of TSAT. Doses of intravenous iron supplementation were significantly increased in the higher i-FGF23 tertile in multivariate models. In conclusion, high i-FGF23 levels may be associated with prolongation of low levels of ferritin, resulting in increased usages of iron supplementation in HD patients.	[Honda, Hirokazu; Hosaka, Nozomu] Showa Univ, Koto Toyosu Hosp, Dept Med, Div Nephrol, Tokyo, Japan; [Honda, Hirokazu; Hosaka, Nozomu; Ikeda, Misa; Sanada, Daisuke] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo, Japan; [Michihata, Tetsuo] Ebara Clin, Dept Dialysis, Tokyo, Japan; [Shishido, Kanji] Kawasaki Clin, Dept Dialysis, Kawasaki, Kanagawa, Japan; [Takahashi, Keiko] Kitami Higashiyama Clin, Div Dialysis, Tokyo, Japan; [Takahashi, Go; Shibata, Takanori] Showa Univ Northern Yokohama Hosp, Dept Internal Med, Yokohama, Kanagawa, Japan	Showa University; Showa University	Honda, H (corresponding author), Showa Univ, Koto Toyosu Hosp, Dept Med, Div Nephrol, Tokyo, Japan.; Honda, H (corresponding author), Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo, Japan.	hondah@med.showa-u.ac.jp		Honda, Hirokazu/0000-0002-5634-6145				Block GA, 2015, AM J KIDNEY DIS, V65, P728, DOI 10.1053/j.ajkd.2014.10.014; Block GA, 2012, J AM SOC NEPHROL, V23, P1407, DOI 10.1681/ASN.2012030223; Bozentowicz-Wikarek M, 2015, CLIN BIOCHEM, V48, P431, DOI 10.1016/j.clinbiochem.2014.12.027; Braithwaite V, 2012, BONE, V50, P1351, DOI 10.1016/j.bone.2012.03.010; Chang YM, 2017, CLIN EXP NE IN PRESS; Chonchol M, 2016, J AM SOC NEPHROL, V27, P227, DOI 10.1681/ASN.2014101009; Coe LM, 2014, J BIOL CHEM, V289, P9795, DOI 10.1074/jbc.M113.527150; David V, 2016, KIDNEY INT, V89, P135, DOI 10.1038/ki.2015.290; di Giuseppe R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133580; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Gaweda AE, 2010, CLIN J AM SOC NEPHRO, V5, P576, DOI 10.2215/CJN.04710709; Gejyo F, 2004, THER APHER DIAL, V8, P443, DOI 10.1111/j.1774-9987.2004.00199.x; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hanks LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122885; Hanudel MR, 2016, AM J PHYSIOL-RENAL, V311, pF1369, DOI 10.1152/ajprenal.00281.2016; Honda H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151601; Honda H, 2012, ATHEROSCLEROSIS, V220, P493, DOI 10.1016/j.atherosclerosis.2011.10.038; Imel EA, 2011, J CLIN ENDOCR METAB, V96, P3541, DOI 10.1210/jc.2011-1239; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Kazama JJ, 2007, THER APHER DIAL, V11, pS44, DOI 10.1111/j.1744-9987.2007.00516.x; Mendoza FA, 2012, CLIN J AM SOC NEPHRO, V7, P1155, DOI 10.2215/CJN.13281211; Mendoza JM, 2017, KIDNEY INT, V91, P711, DOI 10.1016/j.kint.2016.10.021; Nowak KL, 2017, J AM SOC NEPHROL, V28, P1239, DOI 10.1681/ASN.2016040401; Roberts MA, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0391-7; Scialla JJ, 2014, J AM SOC NEPHROL, V25, P349, DOI 10.1681/ASN.2013050465; Singh S, 2016, KIDNEY INT, V90, P985, DOI 10.1016/j.kint.2016.05.019; Takeda Y, 2011, AM J NEPHROL, V33, P421, DOI 10.1159/000327019; Urena-Torres P, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-71; Vaziri ND, 2016, SEMIN NEPHROL, V36, P112, DOI 10.1016/j.semnephrol.2016.02.005; Wolf M, 2013, J BONE MINER RES, V28, P1793, DOI 10.1002/jbmr.1923; Wolf M, 2010, J AM SOC NEPHROL, V21, P1427, DOI 10.1681/ASN.2009121293; Yokoyama K, 2014, CLIN J AM SOC NEPHRO, V9, P543, DOI 10.2215/CJN.05170513	33	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176984	10.1371/journal.pone.0176984	http://dx.doi.org/10.1371/journal.pone.0176984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475601	Green Published, Green Submitted, gold			2022-12-27	WOS:000400649500034
J	Hultgren, EM; Patrick, ME; Evans, RL; Stoos, CT; Egland, KA				Hultgren, Elizabeth M.; Patrick, Mitch E.; Evans, Rick L.; Stoos, Catherine T.; Egland, Kristi A.			SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer	PLOS ONE			English	Article							GROWTH-FACTOR; ANGIOGENESIS; CELLS; PROGRESSION; MICROENVIRONMENT; EXPRESSION; CCL2	Tumor-associated macrophages (TAMs) play a role in tumor angiogenesis and are recruited into the tumor microenvironment (TME) by secreted chemokines, including Monocyte Chemoattractant Protein-1 (MCP-1/CCL2). Angiogenesis is required to sustain proliferation and enable metastasis of breast cancer (BCa) cells. Understanding the underlying mechanisms of TAM recruitment would allow for the identification of desperately needed novel drug targets. Sushi Domain Containing 2 (SUSD2), a transmembrane protein on BCa cells, was previously shown to promote tumor angiogenesis in a murine model. To identify the role of SUSD2 in angiogenesis, 175 human breast tumors were surveyed by immunohistochemical analysis for the presence of SUSD2 and macrophages. Tumors with high levels of SUSD2 staining contained 2-fold more TAMs, mainly of the M2 pro-angiogenic phenotype. An in vitro co-culture model system was developed by differentiating SC monocytes into SC MO macrophages. A 2-fold increase in polarized M2 macrophages was observed when MO macrophages were incubated with SUSD2-expressing BCa cells compared to cancer cells that do not contain SUSD2. Since MCP-1 is known to recruit macrophages, levels of MCP-1 were compared between SUSD2-expressing MDA-MB-231 and MBA-MB-231-vector control cell lines. MCP-1 RNA, intracellular protein and secreted MCP-1 were all significantly increased compared to the vector control. Knockdown of SUSD2 in SKBR3 resulted in significantly decreased levels of secreted MCP-1. Consistently, increased levels of MCP-1 were observed in Susd2-expressing tumors generated from an in vivo isogeneic mouse model compared to the vector control tumors. Because SUSD2 recruits macrophages into the TME and promotes M2 polarization, inhibiting the function of SUSD2 may be an effective therapy for breast cancer patients.	[Hultgren, Elizabeth M.; Patrick, Mitch E.; Evans, Rick L.; Egland, Kristi A.] Univ South Dakota, Sanford Sch Med, Sanford Res, Canc Biol Res Ctr, Sioux Falls, SD USA; [Stoos, Catherine T.] Phys Lab, Sioux Falls, SD USA	Sanford Health; University of South Dakota	Egland, KA (corresponding author), Univ South Dakota, Sanford Sch Med, Sanford Res, Canc Biol Res Ctr, Sioux Falls, SD USA.	kristi.egland@sanfordhealth.org			National Institutes of Health, National Institute of General Medical Science (NIGMS), Center of Biomedical Research Excellence (COBRE) grant [P20GM103548]; NIH; NIH, NIGMS, COBRE grants [P20GM103548, P20GM103620]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103548, P20GM103620] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Science (NIGMS), Center of Biomedical Research Excellence (COBRE) grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIGMS, COBRE grants; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	CS is an employee of Physicians Laboratory, Sioux Falls, South Dakota, United States of America. This research was supported by a National Institutes of Health, National Institute of General Medical Science (NIGMS), Center of Biomedical Research Excellence (COBRE) grant, number P20GM103548, to Keith Miskimins, PhD. Kristi A Egland, PhD is a Project Leader on this grant. The Molecular Pathology Core is supported by two NIH, NIGMS, COBRE grants, numbers P20GM103548 & P20GM103620. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Barrionuevo P, 2007, J IMMUNOL, V178, P436, DOI 10.4049/jimmunol.178.1.436; Ben-Baruch A, 2003, BREAST CANCER RES, V5, P31, DOI 10.1186/bcr554; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Egland KA, 2003, P NATL ACAD SCI USA, V100, P1099, DOI 10.1073/pnas.0337425100; Evans RL, 2014, CANCER PREV RES, V7, P545, DOI 10.1158/1940-6207.CAPR-13-0416; Guo CQ, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-20; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Kau P, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-120; Kawano K, 2012, EXP THER MED, V4, P61, DOI 10.3892/etm.2012.564; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Kwon KY, 2007, ARCH PATHOL LAB MED, V131, P593; Leek RD, 1996, CANCER RES, V56, P4625; Low-Marchelli JM, 2013, CANCER RES, V73, P662, DOI 10.1158/0008-5472.CAN-12-0653; Mantovani A, 2009, HUM IMMUNOL, V70, P325, DOI 10.1016/j.humimm.2009.02.008; Matsunaga T, 2011, YONAGO ACTA MED, V54, P1; Mittal K, 2014, SEMIN ONCOL, V41, P235, DOI 10.1053/j.seminoncol.2014.02.007; Motz GT, 2011, NAT REV IMMUNOL, V11, P702, DOI 10.1038/nri3064; Owen JL, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00159; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Preusser M, 2008, HISTOPATHOLOGY, V53, P39, DOI 10.1111/j.1365-2559.2008.03065.x; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Starossom Sarah C, IMMUNITY, V37, P249; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Wang J, 2015, INT J CLIN EXP MED, V8, P15684; Wang JB, 2012, PEPTIDES, V38, P457, DOI 10.1016/j.peptides.2012.09.007; Watson AP, 2013, MOL CANCER RES, V11, P74, DOI 10.1158/1541-7786.MCR-12-0501-T; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wu H, 2012, J SURG ONCOL, V106, P462, DOI 10.1002/jso.23110; Yamamoto A, 2007, AATEX, V14, P647	36	19	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177089	10.1371/journal.pone.0177089	http://dx.doi.org/10.1371/journal.pone.0177089			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475599	Green Submitted, gold, Green Published			2022-12-27	WOS:000400649500045
J	Rivero-Segura, NA; Flores-Soto, E; de la Cadena, G; Coronado-Mares, I; Gomez-Verjan, JC; Ferreira, DG; Cabrera-Reyes, EA; Lopes, LV; Massieu, L; Cerbon, M				Rivero-Segura, Nadia A.; Flores-Soto, Edgar; Garcia de la Cadena, Selene; Coronado-Mares, Isabel; Gomez-Verjan, Juan C.; Ferreira, Diana G.; Alejandra Cabrera-Reyes, Erika; Lopes, Luisa V.; Massieu, Lourdes; Cerbon, Marco			Prolactin-induced neuroprotection against glutamate excitotoxicity is mediated by the reduction of [Ca2+]i overload and NF-kappa B activation	PLOS ONE			English	Article							INTRACELLULAR CALCIUM; CELL-PROLIFERATION; DORSAL HIPPOCAMPUS; BRAIN PROLACTIN; RECEPTOR; NEURONS; PROTEIN; EXPRESSION; APOPTOSIS; STIMULATION	Prolactin (PRL) is a peptidic hormone that displays pleiotropic functions in the organism including different actions in the brain. PRL exerts a neuroprotective effect against excitotoxicity produced by glutamate (Glu) or kainic acid in both in vitro and in vivo models. It is well known that Glu excitotoxicity causes cell death through apoptotic or necrotic pathways due to intracellular calcium ([Ca2+]i) overload. Therefore, the aim of the present study was to assess the molecular mechanisms by which PRL maintains cellular viability of primary cultures of rat hippocampal neurons exposed to Glu excitotoxicity. We determined cell viability by monitoring mitochondrial activity and using fluorescent markers for viable and dead cells. The intracellular calcium level was determined by a fluorometric assay and proteins involved in the apoptotic pathway were determined by immunoblot. Our results demonstrated that PRL afforded neuroprotection against Glu excitotoxicity, as evidenced by a decrease in propidium iodide staining and by the decrease of the LDH activity. In addition, the MTT assay shows that PRL maintains normal mitochondrial activity even in neurons exposed to Glu. Furthermore, the Glu-induced intracellular [Ca2+]i overload was attenuated by PRL. These data correlate with the reduction found in the level of active caspase-3 and the pro-apoptotic ratio (Bax/Bcl-2). Concomitantly, PRL elicited the nuclear translocation of the transcriptional factor NF-kappa B, which was detected by immunofluorescence and confocal microscopy. To our knowledge, this is the first report demonstrating that PRL prevents Glu excitotoxicity by a mechanism involving the restoration of the intracellular calcium homeostasis and mitochondrial activity, as well as an antiapoptotic action possibly mediated by the activity of NF-kappa B. Overall, the current results suggest that PRL could be of potential therapeutic advantage in the treatment of neurodegenerative diseases.	[Rivero-Segura, Nadia A.; Coronado-Mares, Isabel; Alejandra Cabrera-Reyes, Erika; Cerbon, Marco] Univ Nacl Autonoma Mexico, Fac Quim, Inst Nacl Perinatol, Unidad Invest Reprod & Humana, Ciudad De Mexico, Mexico; [Flores-Soto, Edgar] Univ Nacl Autonoma Mexico, Dept Farmacol, Fac Med, Ciudad De Mexico, Mexico; [Garcia de la Cadena, Selene; Massieu, Lourdes] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Ciudad De Mexico, Mexico; [Gomez-Verjan, Juan C.] Inst Nacl Geriatria, Dept Invest Basica, Ciudad De Mexico, Mexico; [Ferreira, Diana G.; Lopes, Luisa V.] Univ Lisbon, Fac Med Lisboa, Inst Med Mol, Lisbon, Portugal	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidade de Lisboa	Cerbon, M (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Inst Nacl Perinatol, Unidad Invest Reprod & Humana, Ciudad De Mexico, Mexico.	mcerbon85@yahoo.com.mx	Rivero, Nadia/ABE-5424-2020; Massieu, Lourdes/GNW-3740-2022; Reyes, Erika Alejandra Cabrera/AAS-2336-2021; Flores Soto, Edgar/GZG-4426-2022	Rivero, Nadia/0000-0002-2659-6864; Reyes, Erika Alejandra Cabrera/0000-0003-4110-1660; Flores Soto, Edgar/0000-0003-2649-8751; Lopes, Luisa/0000-0001-8367-3005	CONACYT [290096, CB239607]; PAPIIT-UNAM [IN220315, IN205416, IN201216]; PAIP-UNAM [S000-9108]; Fundagao para a Ciencia e Tecnologia; Nadia Alejandra Rivero Segura is a doctoral student from Programa de Doctorado en Ciencias Biomedicas; Universidad Nacional Autonoma de Mexico (UNAM)	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); PAIP-UNAM; Fundagao para a Ciencia e Tecnologia; Nadia Alejandra Rivero Segura is a doctoral student from Programa de Doctorado en Ciencias Biomedicas; Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico)	Nadia Alejandra Rivero Segura is a doctoral student from Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM) and received fellowship 290096 from CONACYT. This work was submitted in fulfillment of the requirements to obtain a PhD degree at the Programa de Doctorado en Ciencias Biomedicas in the Universidad Nacional Auto A noma de Mexico (UNAM). The authors give thanks to Ana Margarida Santos do Nascimento (AMSN) and Antonio Temudo (AT) from the Bioimaging Unit of the Instituto de Medicina Molecular (iMM-Lisboa) and to Teresa Montiel (TM) from the Instituto de Fisiologia Celular-Division de Neurociencias (UNAM) for technical assistance.r This worked was supported by PAPIIT-UNAM (IN220315, MC; IN205416, LM; IN201216, EFS), PAIP-UNAM (S000-9108, MC), CONACyT (CB239607, LM), Fundagao para a Ciencia e Tecnologia (LVL) and Nadia Alejandra Rivero Segura is a doctoral student from Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM) and received fellowship 290096 from CONACYT. This work was submitted in fulfillment of the requirements to obtain a PhD degree at the Programa de Doctorado en Ciencias Biomedicas in the Universidad Nacional Autonoma de Mexico (UNAM). The authors give thanks to Ana Margarida Santos do Nascimento (AMSN) and Antonio Temudo (AT) from the Bioimaging Unit of the Institute de Medicina Molecular (iMM-Lisboa) and to Teresa Montiel (TM) from the Institute de Fisiologia Celular-Division de Neurociencias (UNAM) for technical assistance.	Adan N, 2013, J CLIN INVEST, V123, P3902, DOI 10.1172/JCI69485; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; Bordin S, 2004, MOL CELL ENDOCRINOL, V220, P41, DOI 10.1016/j.mce.2004.04.001; Brown RSE, 2010, J COMP NEUROL, V518, P92, DOI 10.1002/cne.22208; Brunton PJ, 2010, BRAIN RES, V1364, P198, DOI 10.1016/j.brainres.2010.09.062; Cabrera V, 2009, NEUROSCI LETT, V461, P136, DOI 10.1016/j.neulet.2009.06.017; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; DEVITO WJ, 1992, ENDOCRINOLOGY, V130, P2549, DOI 10.1210/en.130.5.2549; DEVITO WJ, 1995, MOL CELL ENDOCRINOL, V108, P125, DOI 10.1016/0303-7207(94)03465-6; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Ducret T, 2002, GLIA, V38, P200, DOI 10.1002/glia.10056; Ferreira DG, 2017, CEREB CORTEX, V27, P718, DOI 10.1093/cercor/bhv268; Flores-Soto E, 2013, EUR J PHARMACOL, V721, P21, DOI 10.1016/j.ejphar.2013.09.060; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Gallardo-Perez JC, 2009, J CELL BIOCHEM, V108, P169, DOI 10.1002/jcb.22237; de la Cadena SC, 2014, APOPTOSIS, V19, P414, DOI 10.1007/s10495-013-0930-7; Gonzalez-Sanchez I, 2011, EUR J MED CHEM, V46, P2102, DOI 10.1016/j.ejmech.2011.02.063; Gorbacheva L, 2013, NEUROCHEM INT, V63, P101, DOI 10.1016/j.neuint.2013.05.008; Gregg C, 2009, J NEUROL SCI, V285, P22, DOI 10.1016/j.jns.2009.06.040; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; KAJITA J, 1993, AM J PHYSIOL, V264, pL496, DOI 10.1152/ajplung.1993.264.5.L496; Kochendoerfer SK, 2003, PROLACTIN REGULATION, P265; Konig HG, 2005, J CELL BIOL, V168, P1077, DOI 10.1083/jcb.200407027; Krumenacker JS, 1998, ENDOCRINE, V9, P163, DOI 10.1385/ENDO:9:2:163; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macotela Y, 2002, J ENDOCRINOL, V175, pR13, DOI 10.1677/joe.0.175R013; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Nylander E, 2016, NEUROSCIENCE, V339, P538, DOI 10.1016/j.neuroscience.2016.10.019; Paramo B, 2010, NEUROSCIENCE, V167, P1057, DOI 10.1016/j.neuroscience.2010.02.074; Pedros I, 2015, J NUTR HEALTH AGING, V19, P403, DOI 10.1007/s12603-014-0574-5; Prehn JHM, 1996, MOL PHARMACOL, V49, P319; PREHN JHM, 1994, P NATL ACAD SCI USA, V91, P12599, DOI 10.1073/pnas.91.26.12599; Pujianto DA, 2010, ENDOCRINOLOGY, V151, P1269, DOI 10.1210/en.2009-0964; Sapsford TJ, 2012, J COMP NEUROL, V520, P1062, DOI 10.1002/cne.22775; Tejadilla D, 2010, NEUROSCIENCE, V169, P1178, DOI 10.1016/j.neuroscience.2010.05.074; Tessier C, 2001, ENDOCRINOLOGY, V142, P4086, DOI 10.1210/en.142.9.4086; Torner L, 2001, J NEUROSCI, V21, P3207, DOI 10.1523/JNEUROSCI.21-09-03207.2001; Torner L, 2002, STRESS, V5, P249, DOI 10.1080/1025389021000048638; VACHER P, 1994, ENDOCRINOLOGY, V134, P1213, DOI 10.1210/en.134.3.1213; Valadas JS, 2012, J NEUROCHEM, V123, P1030, DOI 10.1111/jnc.12050; Vanoye-Carlo A, 2008, HORM BEHAV, V53, P112, DOI 10.1016/j.yhbeh.2007.09.004; Vergara-Castaneda E, 2016, BRAIN RES, V1636, P193, DOI 10.1016/j.brainres.2016.02.011; Walker TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044371; Weimann E, 1999, LEUKEMIA RES, V23, P751, DOI 10.1016/S0145-2126(99)00050-8; Yap YW, 2016, NEUROCHEM RES, V41, P554, DOI 10.1007/s11064-015-1666-2; Zermeno C, 2006, J ENDOCRINOL, V189, pR1, DOI 10.1677/joe.1.06766; Zhang F, 2007, STROKE, V38, P2329, DOI 10.1161/STROKEAHA.107.482786; Zhu Y, 2001, NEUROCHEM INT, V38, P227, DOI 10.1016/S0197-0186(00)00084-X; Zhu Y, 2004, NEUROSCIENCE, V123, P897, DOI 10.1016/j.neuroscience.2003.10.037	53	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176910	10.1371/journal.pone.0176910	http://dx.doi.org/10.1371/journal.pone.0176910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475602	Green Published, Green Submitted, gold			2022-12-27	WOS:000400649500026
J	Bakhchane, A; Charif, M; Bousfiha, A; Boulouiz, R; Nahili, H; Rouba, H; Charoute, H; Lenaers, G; Barakat, A				Bakhchane, Amina; Charif, Majida; Bousfiha, Amale; Boulouiz, Redouane; Nahili, Halima; Rouba, Hassan; Charoute, Hicham; Lenaers, Guy; Barakat, Abdelhamid			Novel compound heterozygous MYO7A mutations in Moroccan families with autosomal recessive non-syndromic hearing loss	PLOS ONE			English	Article							MYOSIN-VIIA GENE; SYNDROME TYPE 1B; USHER-SYNDROME; MISSENSE MUTATIONS; PROTEIN STABILITY; DEAFNESS; DFNB2; PHENOTYPE; SERVER; SPECTRUM	The MYO7A gene encodes a protein belonging to the unconventional myosin super family. Mutations within MYO7A can lead to either non syndromic hearing loss or to the Usher syndrome type 1B (USH1B). Here, we report the results of genetic analyses performed on Moroccan families with autosomal recessive non syndromic hearing loss that identified two families with compound heterozygous MYO7A mutations. Five mutations (c.6025delG, c.6229T>A, c.3500T>A, c.5617C>T and c.4487C>A) were identified in these families, the latter presenting two differently affected branches. Multiple bioinformatics programs and molecular modelling predicted the pathogenic effect of these mutations. In conclusion, the absence of vestibular and retinal symptom in the affected patients suggests that these families have the isolated non-syndromic hearing loss DFNB2 (nonsyndromic autosomal recessive hearing loss) presentation, instead of USH1B.	[Bakhchane, Amina; Charif, Majida; Bousfiha, Amale; Boulouiz, Redouane; Nahili, Halima; Rouba, Hassan; Charoute, Hicham; Barakat, Abdelhamid] Inst Pasteur Maroc, Human Mol Genet Lab, Casablanca, Morocco; [Charif, Majida; Lenaers, Guy] Univ Angers, CHU Angers, INSERM, Inst MitoVasc,Equipe MitoLab,U1083, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Barakat, A (corresponding author), Inst Pasteur Maroc, Human Mol Genet Lab, Casablanca, Morocco.	hamid.barakat@pasteur.ma	Lenaers, guy/X-4727-2019; lenaers, guy/K-2421-2015	BOULOUIZ, Redouane/0000-0003-4430-3612; lenaers, guy/0000-0003-2736-3349; Charoute, Hicham/0000-0002-9338-6744	Pasteur Institute of Morocco (IPM); French National Institute of Health and Medical Research (INSERM); Moroccan National Centre for Scientific and Technical Research (CNRST)	Pasteur Institute of Morocco (IPM); French National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Moroccan National Centre for Scientific and Technical Research (CNRST)	This work was supported by Pasteur Institute of Morocco (IPM) and a collaborative project between the French National Institute of Health and Medical Research (INSERM) and the Moroccan National Centre for Scientific and Technical Research (CNRST).; The authors would like to thank all patients and their families for their collaboration. Pasteur Institute of Morocco (IPM) and a collaborative project between the French National Institute of Health and Medical Research (INSERM) supported this work and the Moroccan National Centre supported this work for Scientific and Technical Research (CNRST).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bakhchane A, 2016, EUR J MED GENET, V59, P325, DOI 10.1016/j.ejmg.2016.05.002; Bakhchane A, 2015, GENE, V574, P28, DOI 10.1016/j.gene.2015.07.075; Bakhchane A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138072; Ben-Salem S, 2014, MOL BIOL REP, V41, P193, DOI 10.1007/s11033-013-2851-5; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Boulouiz R, 2007, MOL VIS, V13, P1862; Charif M, 2012, MOL BIOL REP, V39, P11011, DOI 10.1007/s11033-012-2003-3; Finsterer J, 2005, INT J PEDIATR OTORHI, V69, P621, DOI 10.1016/j.ijporl.2004.12.002; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hildebrand MS, 2010, CLIN GENET, V77, P563, DOI 10.1111/j.1399-0004.2009.01344.x; Inoue A, 2003, J BIOL CHEM, V278, P5478, DOI 10.1074/jbc.M210489200; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Laimer J, 2016, BIOINFORMATICS, V32, P1414, DOI 10.1093/bioinformatics/btv769; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Liu YQ, 2014, FEBS LETT, V588, P2859, DOI 10.1016/j.febslet.2014.06.049; Millan JM, 2011, J OPHTHALMOL, V2011; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Petit C, 2001, ANNU REV GENOM HUM G, V2, P271, DOI 10.1146/annurev.genom.2.1.271; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Riazuddin S, 2008, HUM MUTAT, V29, P502, DOI 10.1002/humu.20677; Rong WN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097808; Sakai T, 2015, J BIOL CHEM, V290, P17587, DOI 10.1074/jbc.M114.599365; Sambrook J., 2001, MOL CLONING LAB MANU; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Tamagawa Y, 2002, LARYNGOSCOPE, V112, P292, DOI 10.1097/00005537-200202000-00017; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Wu L, 2011, SCIENCE, V331, P757, DOI 10.1126/science.1198848; Yoshimura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090688; Zhai W, 2015, INT J OPHTHALMOL-CHI, V8, P670, DOI 10.3980/j.issn.2222-3959.2015.04.05	37	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176516	10.1371/journal.pone.0176516	http://dx.doi.org/10.1371/journal.pone.0176516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472130	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500050
J	Caudle, RM; Caudle, SL; Jenkins, AC; Ahn, AH; Neubert, JK				Caudle, Robert M.; Caudle, Stephanie L.; Jenkins, Alan C.; Ahn, Andrew H.; Neubert, John K.			Sex differences in mouse Transient Receptor Potential Cation Channel, Subfamily M, Member 8 expressing trigeminal ganglion neurons	PLOS ONE			English	Article							TRPM8 ION CHANNELS; PAIN SENSITIVITY; OROFACIAL PAIN; I-H; COLD HYPERSENSITIVITY; ACTIVATED CURRENTS; THERMAL PREFERENCE; HCN CHANNELS; SUBSTANCE-P; ASSAY	The detection of cool temperatures is thought to be mediated by primary afferent neurons that express the cool temperature sensing protein Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8). Using mice, this study tested the hypothesis that sex differences in sensitivity to cool temperatures were mediated by differences in neurons that express TRPM8. Ion currents from TRPM8 expressing trigeminal ganglion (TRG) neurons in females demonstrated larger hyperpolarization-activated cyclic nucleotide-gated currents (I-h) than male neurons at both 30 degrees and 18 degrees C. Additionally, female neurons' voltage gated potassium currents (I-k) were suppressed by cooling, whereas male Ik was not significantly affected. At the holding potential tested (-60mV) TRPM8 currents were not visibly activated in either sex by cooling. Modeling the effect of Ih and Ik on membrane potentials demonstrated that at 30 E the membrane potential in both sexes is unstable. At 18 E, female TRPM8 TRG neurons develop a large oscillating pattern in their membrane potential, whereas male neurons become highly stable. These findings suggest that the differences in Ih and Ik in the TRPM8 TRG neurons of male and female mice likely leads to greater sensitivity of female mice to the cool temperature. This hypothesis was confirmed in an operant reward/conflict assay. Female mice contacted an 18 degrees C surface for approximately half the time that males contacted the cool surface. At 33 degrees and 10 degrees C male and female mice contacted the stimulus for similar amounts of time. These data suggest that sex differences in the functioning of Ih and Ik in TRPM8 expressing primary afferent neurons leads to differences in cool temperature sensitivity.	[Caudle, Robert M.; Caudle, Stephanie L.] Univ Florida, Coll Dent, Dept Oral & Maxillofacial Surg, Gainesville, FL 32611 USA; [Caudle, Robert M.; Neubert, John K.] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32611 USA; [Jenkins, Alan C.; Neubert, John K.] Univ Florida, Coll Dent, Dept Orthodont, Gainesville, FL USA; [Ahn, Andrew H.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Ahn, Andrew H.] Eli Lilly & Co, Indianapolis, IN 46285 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Eli Lilly	Caudle, RM (corresponding author), Univ Florida, Coll Dent, Dept Oral & Maxillofacial Surg, Gainesville, FL 32611 USA.; Caudle, RM (corresponding author), Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32611 USA.	caudle@ufl.edu		Caudle, Robert/0000-0002-2394-4114	Pain Research and Intervention Center of Excellence at the University of Florida	Pain Research and Intervention Center of Excellence at the University of Florida	This research was funded by the Pain Research and Intervention Center of Excellence at the University of Florida (RMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Pain Research and Intervention Center of Excellence at the University of Florida.	Anderson EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089137; Anderson EM, 2013, JOVE-J VIS EXP, DOI 10.3791/50336; Babes A, 2011, CURR PHARM BIOTECHNO, V12, P78, DOI 10.2174/138920111793937835; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Caudle RM, 2003, NEUROTOXICOLOGY, V24, P895, DOI 10.1016/S0161-813X(03)00146-3; Caudle RM, 2010, J PAIN, V11, P838, DOI 10.1016/j.jpain.2010.05.007; Daniels RL, 2009, J BIOL CHEM, V284, P1570, DOI 10.1074/jbc.M807270200; Descoeur J, 2011, EMBO MOL MED, V3, P266, DOI 10.1002/emmm.201100134; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Fernandez JA, 2011, J GEN PHYSIOL, V137, P173, DOI 10.1085/jgp.201010498; He C, 2014, PROG NEUROBIOL, V112, P1, DOI 10.1016/j.pneurobio.2013.10.001; Karjalainen S, 2012, INDOOR AIR, V22, P96, DOI 10.1111/j.1600-0668.2011.00747.x; Kim H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036079; Knowlton WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025894; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Luthi A, 1998, J NEUROPHYSIOL, V79, P3284, DOI 10.1152/jn.1998.79.6.3284; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; Madrid R, 2009, J NEUROSCI, V29, P3120, DOI 10.1523/JNEUROSCI.4778-08.2009; Mahieu F, 2010, J PHYSIOL-LONDON, V588, P315, DOI 10.1113/jphysiol.2009.183582; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Mustafa G, 2013, PAIN, V154, P2547, DOI 10.1016/j.pain.2013.07.041; Nealen ML, 2003, J NEUROPHYSIOL, V90, P515, DOI 10.1152/jn.00843.2002; Neubert JK, 2006, BEHAV BRAIN RES, V170, P308, DOI 10.1016/j.bbr.2006.03.008; Neubert JK, 2005, PAIN, V116, P386, DOI 10.1016/j.pain.2005.05.011; Neubert JK, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-49; Neubert JK, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-43; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nolan TA, 2012, PAIN, V153, P2009, DOI 10.1016/j.pain.2012.04.026; Nolan TA, 2011, BEHAV BRAIN RES, V217, P477, DOI 10.1016/j.bbr.2010.10.022; Nolan TA, 2011, BEHAV BRAIN RES, V216, P723, DOI 10.1016/j.bbr.2010.08.023; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Orio P, 2012, J NEUROPHYSIOL, V108, P3009, DOI 10.1152/jn.01033.2011; Orio P, 2009, J PHYSIOL-LONDON, V587, P1961, DOI 10.1113/jphysiol.2008.165738; Patel R, 2014, J PHARMACOL EXP THER, V349, P47, DOI 10.1124/jpet.113.211243; Pertusa M, 2014, J BIOL CHEM, V289, P21828, DOI 10.1074/jbc.M114.565994; Pertusa M, 2012, J BIOL CHEM, V287, P18218, DOI 10.1074/jbc.M111.312645; Petruska JC, 2000, J NEUROPHYSIOL, V84, P2365, DOI 10.1152/jn.2000.84.5.2365; Ramirez HE, 2012, J AM ASSOC LAB ANIM, V51, P638; Rau KK, 2007, J NEUROPHYSIOL, V97, P2651, DOI 10.1152/jn.00840.2006; Rau KK, 2005, J CHEM NEUROANAT, V29, P255, DOI 10.1016/j.jchemneu.2005.02.002; Rossi HL, 2012, NEUROSCIENCE, V224, P294, DOI 10.1016/j.neuroscience.2012.08.015; Rossi HL, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-37; Rossi HL, 2008, BEHAV BRAIN RES, V187, P478, DOI 10.1016/j.bbr.2007.09.021; Rossi HL, 2009, BEHAV BRAIN RES, V203, P240, DOI 10.1016/j.bbr.2009.05.009; Rusznak Z, 2013, EUR J NEUROSCI, V37, P876, DOI 10.1111/ejn.12116; Sartiani L, 2015, CURR DRUG TARGETS, V16, P868, DOI 10.2174/1389450116666150531152047; Teichert RW, 2014, P NATL ACAD SCI USA, V111, P2319, DOI 10.1073/pnas.1324019111; Vierck CJ, 2008, J PAIN, V9, P739, DOI 10.1016/j.jpain.2008.03.008; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Williams AD, 2015, J PHYSIOL-LONDON, V593, P2779, DOI 10.1113/JP270453; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404; Zha QQ, 2008, J NEUROCHEM, V105, P68, DOI 10.1111/j.1471-4159.2007.05110.x	56	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176753	10.1371/journal.pone.0176753	http://dx.doi.org/10.1371/journal.pone.0176753			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472061	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500068
J	Crane, NL; Nelson, P; Abelson, A; Precoda, K; Rulmal, J; Bernardi, G; Paddack, M				Crane, Nicole L.; Nelson, Peter; Abelson, Avigdor; Precoda, Kristin; Rulmal, John, Jr.; Bernardi, Giacomo; Paddack, Michelle			Atoll-scale patterns in coral reef community structure: Human signatures on Ulithi Atoll, Micronesia	PLOS ONE			English	Article							MARINE RESERVES; FISH; HABITAT; BIODIVERSITY; DEGRADATION; RESILIENCE; MANAGEMENT; SPILLOVER; RICHNESS; IMPACTS	The dynamic relationship between reefs and the people who utilize them at a subsistence level is poorly understood. This paper characterizes atoll-scale patterns in shallow coral reef habitat and fish community structure, and correlates these with environmental characteristics and anthropogenic factors, critical to conservation efforts for the reefs and the people who depend on them. Hierarchical clustering analyses by site for benthic composition and fish community resulted in the same 3 major clusters: cluster 1-oceanic (close proximity to deep water) and uninhabited (low human impact); cluster 2-oceanic and inhabited (high human impact); and cluster 3-lagoonal (facing the inside of the lagoon) and inhabited (highest human impact). Distance from village, reef exposure to deep water and human population size had the greatest effect in predicting the fish and benthic community structure. Our study demonstrates a strong association between benthic and fish community structure and human use across the Ulithi Atoll (Yap State, Federated States of Micronesia) and confirms a pattern observed by local people that an 'opportunistic' scleractinian coral (Montipora sp.) is associated with more highly impacted reefs. Our findings suggest that small human populations (subsistence fishing) can nevertheless have considerable ecological impacts on reefs due, in part, to changes in fishing practices rather than overfishing per se, as well as larger global trends. Findings from this work can assist in building local capacity to manage reef resources across an atoll-wide scale, and illustrates the importance of anthropogenic impact even in small communities.	[Crane, Nicole L.] Cabrillo Coll, Dept Biol, Aptos, CA 95003 USA; [Crane, Nicole L.] Ocean Soc, Ross, CA 94957 USA; [Crane, Nicole L.; Nelson, Peter; Abelson, Avigdor; Precoda, Kristin; Rulmal, John, Jr.; Bernardi, Giacomo; Paddack, Michelle] One People One Reef, Santa Cruz, CA 95062 USA; [Nelson, Peter] HT Harvey & Associates, Bldg D, Los Gatos, CA USA; [Abelson, Avigdor] Tel Aviv Univ, Dept Zool, Ramat Aviv, Israel; [Precoda, Kristin] Univ Sydney, Marine Studies Inst, Sydney, NSW, Australia; [Rulmal, John, Jr.] Ulithi Falalop Community Act Program, Yap, Micronesia; [Bernardi, Giacomo] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Paddack, Michelle] Santa Barbara City Coll, Santa Barbara, CA USA	Tel Aviv University; University of Sydney; University of California System; University of California Santa Cruz	Crane, NL (corresponding author), Cabrillo Coll, Dept Biol, Aptos, CA 95003 USA.; Crane, NL (corresponding author), Ocean Soc, Ross, CA 94957 USA.; Crane, NL (corresponding author), One People One Reef, Santa Cruz, CA 95062 USA.	nicrane@cabrillo.edu	Bernardi, Giacomo/F-6346-2011	Bernardi, Giacomo/0000-0002-8249-4678	University of California Santa Cruz Pacific Rim award; David and Lucile Packard Foundation; The Nature Conservancy; Department of the Interior/Office of Insular Affairs [CRI-Ulithi1-2]; NOAA [NA15NMF4270336]; National Science Foundation [OCE 1546374]	University of California Santa Cruz Pacific Rim award; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); The Nature Conservancy; Department of the Interior/Office of Insular Affairs; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation(National Science Foundation (NSF))	This work was funded by a University of California Santa Cruz Pacific Rim award, the David and Lucile Packard Foundation, The Nature Conservancy, Department of the Interior/Office of Insular Affairs (CRI-Ulithi1-2), NOAA (Award # NA15NMF4270336), the National Science Foundation (OCE 1546374) and the many contributors to our Indiegogo crowd-funding campaign.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Adam TC, 2015, MAR ECOL PROG SER, V520, P1, DOI 10.3354/meps11170; Adam TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023717; ALCALA AC, 1988, AMBIO, V17, P194; Allen GR, 2007, CONSERV INT REP, P1; Alvarez-Filip L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126004; Beldade R, 2015, PEERJ, V3, DOI 10.7717/peerj.745; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bruno JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep29778; Burgi M, 2013, FOREST ECOL MANAG, V289, P115, DOI 10.1016/j.foreco.2012.10.012; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Crane Nicole L., 2016, Journal of the Ocean Science Foundation, V21, P10; Cudney-Bueno R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004140; D'Angelo C, 2014, CURR OPIN ENV SUST, V7, P82, DOI 10.1016/j.cosust.2013.11.029; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Dulvy NK, 2015, NATURE, V520, P304, DOI 10.1038/nature14384; Dulvy NK, 2004, CAN J FISH AQUAT SCI, V61, P466, DOI 10.1139/F03-169; Espinoza-Tenorio A, 2013, ECOL SOC, V18, DOI 10.5751/ES-05369-180206; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Food and Agriculture Organization (FAO), 2009, CLIM CHANG FOOD SEC; FROESE R, 2000, FISHBASE 2000 CONCEP; Fujita R, 2013, MAR POLICY, V38, P538, DOI 10.1016/j.marpol.2012.05.025; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Holbrook SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124054; Houk P, 2007, CONSERV INT REP, V43; Houk P, 2008, QUANTITATIVE ASSESSM; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johnson AE, 2013, FISH FISH, V14, P281, DOI 10.1111/j.1467-2979.2012.00468.x; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Jouffray JB, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0268; Kittinger JN, 2013, CURR OPIN ENV SUST, V5, P352, DOI 10.1016/j.cosust.2013.06.008; Kittinger JN, 2012, ECOL SOC, V17, DOI 10.5751/ES-05115-170417; Kulbicki M, 2005, CYBIUM, V29, P235; Lessa William A, 1966, ULITHI MICRONESIAN D; Levis C, 2017, SCIENCE, V355, P925, DOI 10.1126/science.aal0157; Lilley I., 2010, EARLY HUMAN EXPANSIO; McClanahan TR, 2014, CURR OPIN ENV SUST, V7, P59, DOI 10.1016/j.cosust.2013.11.028; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; McCune B., 2002, ANAL ECOLOGICAL COMM, P1; Messmer V, 2011, ECOLOGY, V92, P2285, DOI 10.1890/11-0037.1; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Oksanen J, 2016, COMMUNITY ECOLOGY PA; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Plass-Johnson JG, 2015, LIMNOL OCEANOGR, V60, P1382, DOI 10.1002/lno.10105; Poepoe KK., 2003, PUTTING FISHERSKNOWL, V11, P328; Quimbayo JP, 2017, ENVIRON BIOL FISH, V100, P149, DOI 10.1007/s10641-016-0557-y; Randall CJ, 2009, BIOL BULL-US, V217, P269, DOI 10.1086/BBLv217n3p269; ROBERTS CM, 1995, CONSERV BIOL, V9, P988, DOI 10.1046/j.1523-1739.1995.9051332.x-i1; ROY P, 1991, J COASTAL RES, V7, P1057; Russ GR, 2015, CORAL REEFS, V34, P773, DOI 10.1007/s00338-015-1296-9; Russ GR, 2015, MAR ECOL PROG SER, V529, P233, DOI 10.3354/meps11246; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sheppard CRC, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198566359.001.0001; Smith JE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.1985; Spalding MD, 2015, SCIENCE, V350, P769, DOI 10.1126/science.aad0349; Team RDC, 2016, R LANG ENV STAT COMP; Vroom PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009733; Ward-Paige C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011722, 10.1371/journal.pone.0011968]; Williams GJ, 2013, PEERJ, V1, DOI 10.7717/peerj.81; Williams ID, 2006, MAR ECOL PROG SER, V310, P139, DOI 10.3354/meps310139; Williams ID, PLOS ONE, V10; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x	74	7	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177083	10.1371/journal.pone.0177083	http://dx.doi.org/10.1371/journal.pone.0177083			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489903	gold, Green Published			2022-12-27	WOS:000401314100048
J	Dong, YT; Liu, H; Zhang, Y; Hu, JH; Feng, JY; Li, C; Li, C; Chen, JH; Zhu, SJ				Dong, Yating; Liu, Hui; Zhang, Yi; Hu, Jiahui; Feng, Jiyu; Li, Cong; Li, Cheng; Chen, Jinhong; Zhu, Shuijin			Comparative genomic study of ALDH gene superfamily in Gossypium: A focus on Gossypium hirsutum under salt stress	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE GENE; SUBCELLULAR-LOCALIZATION; ARABIDOPSIS; EVOLUTIONARY; DUPLICATION; SEQUENCE; PLANTS; POLYPLOIDY; EXPRESSION; TOLERANCE	Aldehyde dehydrogenases (ALDHs) are a superfamily of enzymes which play important role in the scavenging of active aldehydes molecules. In present work, a comprehensive whole-genomic study of ALDH gene superfamily was carried out for an allotetraploid cultivated cotton species, G. hirsutum, as well as in parallel relative to their diploid progenitors, G. arboreum and G. raimondii. Totally, 30 and 58 ALDH gene sequences belong to 10 families were identified from diploid and allotetraploid cotton species, respectively. The gene structures among the members from same families were highly conserved. Whole-genome duplication and segmental duplication might be the major driver for the expansion of ALDH gene superfamily in G. hirsutum. In addition, the expression patterns of GhALDH genes were diverse across tissues. Most GhALDH genes were induced or repressed by salt stress in upland cotton. Our observation shed lights on the molecular evolutionary properties of ALDH genes in diploid cottons and their alloallotetraploid derivatives. It may be useful to mine key genes for improvement of cotton response to salt stress.	[Dong, Yating; Liu, Hui; Zhang, Yi; Hu, Jiahui; Feng, Jiyu; Li, Cong; Li, Cheng; Chen, Jinhong; Zhu, Shuijin] Zhejiang Univ, Dept Agron, Zhejiang Key Lab Crop Germplasm, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Chen, JH; Zhu, SJ (corresponding author), Zhejiang Univ, Dept Agron, Zhejiang Key Lab Crop Germplasm, Hangzhou, Zhejiang, Peoples R China.	jinhongchen@zju.edu.cn; shjzhu@zju.edu.cn	Dong, Yating/AAR-2051-2021	Dong, Yating/0000-0002-0268-2995; Li, Cheng/0000-0003-4366-6139	National High Technology Research and Development Program of China [2013AA102601]; China Agriculture Research System [CARS-18-25]; Jiangsu Collaborative Innovation Center for Modern Crop Production; Zhejiang Provincial Top Key Discipline of Biology Open Foundation [2016D06]; National Natural Science Foundation of China [31371667]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); China Agriculture Research System; Jiangsu Collaborative Innovation Center for Modern Crop Production; Zhejiang Provincial Top Key Discipline of Biology Open Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was funded by the National High Technology Research and Development Program of China (2013AA102601), China Agriculture Research System (CARS-18-25), Jiangsu Collaborative Innovation Center for Modern Crop Production, Zhejiang Provincial Top Key Discipline of Biology Open Foundation (2016D06), and National Natural Science Foundation of China (31371667).	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Brocker C, 2010, J BIOL CHEM, V285, P18452, DOI 10.1074/jbc.M109.077925; Chen JM, 2015, PLANTA, V242, P137, DOI 10.1007/s00425-015-2290-8; Cong J, 2015, SCI REP-UK, V5, DOI [10.1038/srep10007, 10.1038/srep14139]; Dong YT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00139; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Force A, 1999, GENETICS, V151, P1531; Gao CX, 2009, GENE, V431, P86, DOI 10.1016/j.gene.2008.11.010; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; He DH, 2014, GENE, V549, P123, DOI 10.1016/j.gene.2014.07.054; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jimenez-Lopez JC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-43; Kirch HH, 2005, PLANT MOL BIOL, V57, P315, DOI 10.1007/s11103-004-7796-6; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Kotchoni SO, 2012, GENE, V495, P128, DOI 10.1016/j.gene.2011.12.035; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lan T, 2009, PLANT CELL, V21, P3749, DOI 10.1105/tpc.109.070219; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; LINDAHL R, 1992, CRIT REV BIOCHEM MOL, V27, P283, DOI 10.3109/10409239209082565; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Missihoun TD, 2011, PLANTA, V233, P369, DOI 10.1007/s00425-010-1297-4; opdenCamp RGL, 1997, PLANT MOL BIOL, V35, P355, DOI 10.1023/A:1005889129491; Ouyang YD, 2009, PLANT MOL BIOL, V70, P341, DOI 10.1007/s11103-009-9477-y; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Rodrigues SM, 2006, J EXP BOT, V57, P1909, DOI 10.1093/jxb/erj132; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Skibbe David S., 2002, Plant Molecular Biology, V48, P751, DOI 10.1023/A:1014870429630; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; Stiti N, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00065; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka KM, GENET RES CAMB; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tian FX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124669; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wei YL, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-7; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Wood AJ, 2009, BRYOLOGIST, V112, P1, DOI 10.1639/0007-2745-112.1.1; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang YA, 2012, J NANOMATER, V2012, DOI 10.1155/2012/375496	56	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176733	10.1371/journal.pone.0176733	http://dx.doi.org/10.1371/journal.pone.0176733			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489898	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314100029
J	Githaiga, MN; Kairo, JG; Gilpin, L; Huxham, M				Githaiga, Michael N.; Kairo, James G.; Gilpin, Linda; Huxham, Mark			Carbon storage in the seagrass meadows of Gazi Bay, Kenya	PLOS ONE			English	Article							THALASSODENDRON-CILIATUM; POSIDONIA-OCEANICA; MANGROVE FOREST; LEAF PRODUCTION; BLUE CARBON; IMPACT; SEQUESTRATION	Vegetated marine habitats are globally important carbon sinks, making a significant contribution towards mitigating climate change, and they provide a wide range of other ecosystem services. However, large gaps in knowledge remain, particularly for seagrass meadows in Africa. The present study estimated biomass and sediment organic carbon (C-org) stocks of four dominant seagrass species in Gazi Bay, Kenya. It compared sediment Corg between seagrass areas in vegetated and un-vegetated 'controls', using the naturally patchy occurence of seagrass at this site to test the impacts of seagrass growth on sediment C-org. It also explored relationships between the sediment and above-ground C-org, as well as between the total biomass and above-ground parameters. Sediment Corg was significantly different between species, range: 160.7-233.8 Mg C ha(-1) (compared to the global range of 115.3 to 829.2 Mg C ha(-1)). Vegetated areas in all species had significantly higher sediment C-org compared with un-vegetated controls; the presence of seagrass increased C-org by 4-6 times. Biomass carbon differed significantly between species with means ranging between 4.8-7.1 Mg C ha(-1) compared to the global range of 2.5-7.3 Mg C ha(-1). To our knowledge, these are among the first results on seagrass sediment Corg to be reported from African seagrass beds; and contribute towards our understanding of the role of seagrass in global carbon dynamics.	[Githaiga, Michael N.; Kairo, James G.] Kenya Marine & Fisheries Res Inst, Mombasa, Kenya; [Githaiga, Michael N.; Gilpin, Linda; Huxham, Mark] Edinburgh Napier Univ, Sch Appl Sci, Edinburgh, Midlothian, Scotland	Edinburgh Napier University	Githaiga, MN (corresponding author), Kenya Marine & Fisheries Res Inst, Mombasa, Kenya.; Githaiga, MN (corresponding author), Edinburgh Napier Univ, Sch Appl Sci, Edinburgh, Midlothian, Scotland.	njoroge.michael04@gmail.com	Githaiga, Michael/AAB-4442-2021; Huxham, Mark/D-4427-2015	James, Kairo/0000-0001-8325-2550; Huxham, Mark/0000-0001-7877-6675	Coastal Ecosystem Services in East Africa (CESEA) [NE/L001535/1]; Ecosystem Services for Poverty Alleviation (ESPA) programme; Department for International Development (DFID); Economic and Social Research Council (ESRC); Natural Environment Research Council (NERC); Edinburgh Napier University; Kenya Marine and Fisheries Research Institute (KMFRI); Natural Environment Research Council [NE/L001535/1] Funding Source: researchfish; NERC [NE/L001535/1] Funding Source: UKRI	Coastal Ecosystem Services in East Africa (CESEA); Ecosystem Services for Poverty Alleviation (ESPA) programme; Department for International Development (DFID); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Edinburgh Napier University; Kenya Marine and Fisheries Research Institute (KMFRI); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This article is based on research undertaken for Coastal Ecosystem Services in East Africa (CESEA) NE/L001535/1 research project and was funded with support from the Ecosystem Services for Poverty Alleviation (ESPA) programme. The ESPA programme is funded by the Department for International Development (DFID), the Economic and Social Research Council (ESRC) and the Natural Environment Research Council (NERC). Additional support was made through Edinburgh Napier University and Kenya Marine and Fisheries Research Institute (KMFRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandeira SO, 2002, AQUAT BOT, V72, P13, DOI 10.1016/S0304-3770(01)00192-9; Bouillon S, 2004, BIOGEOSCIENCES, V1, P71, DOI 10.5194/bg-1-71-2004; Bouillon S, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000325; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; COPPEJANS E, 1992, HYDROBIOLOGIA, V247, P59, DOI 10.1007/BF00008205; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dahdouh E, 1999, HYDROBIOLOGIA, V400, P63; Dahl M, 2016, J ECOL, V104, P654, DOI 10.1111/1365-2745.12564; de la Torre-Castro M, 2004, OCEAN COAST MANAGE, V47, P361, DOI 10.1016/j.ocecoaman.2004.07.005; Duarte C.M., 2005, BIOGEOSCIENCES, V2, P2005; Duarte CM, 2013, NAT CLIM CHANGE, V3, P961, DOI [10.1038/nclimate1970, 10.1038/NCLIMATE1970]; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Duarte CM, 1999, AQUAT BOT, V65, P159, DOI 10.1016/S0304-3770(99)00038-8; Duarte CM, 1996, AQUAT BOT, V55, P1, DOI 10.1016/0304-3770(96)01066-2; Erftemeier P., 1993, THESIS; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Gacia E, 2001, ESTUAR COAST SHELF S, V52, P505, DOI 10.1006/ecss.2000.0753; Githaiga MN, 2016, BOT MAR, V59, P173, DOI 10.1515/bot-2015-0075; Greiner JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072469; HAAS LW, 1977, ESTUAR COAST MAR SCI, V5, P485, DOI 10.1016/0302-3524(77)90096-2; HEMMINGA MA, 1995, AQUAT BOT, V50, P159, DOI 10.1016/0304-3770(95)00450-E; HEMMINGA MA, 1994, MAR ECOL PROG SER, V106, P291, DOI 10.3354/meps106291; Howard J., 2014, COASTAL BLUE CARBON, P99; IPCC, 2014, 2013 SUPPL 2006 IPCC, V2; Irving AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018311; ISAAC W E, 1968, Journal of the East Africa Natural History Society and National Museum, V27, P7; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Kitheka JU, 1996, LIMNOL OCEANOGR, V41, P169, DOI 10.4319/lo.1996.41.1.0169; Lavery PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073748; Macreadie PI, 2014, MAR BIOL, V161, P2939, DOI 10.1007/s00227-014-2558-8; Marba N, 2002, MAR ECOL PROG SER, V226, P287, DOI 10.3354/meps226287; Marba N, 2015, J ECOL, V103, P296, DOI 10.1111/1365-2745.12370; McGlathery KJ, 2007, MAR ECOL PROG SER, V348, P1, DOI 10.3354/meps07132; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; MPRUT-KWS, 2016, PROP MAR TRANSB CONS; Nellemann C., 2009, BLUE CARBON RAPID RE; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Prrezllorrns JL, 1993, SEASONAL DYNAMICS BI, P46; Richmond Matthew, 1997, GUIDE SEASHORES E AF; ROMERO J, 1994, AQUAT BOT, V47, P13, DOI 10.1016/0304-3770(94)90044-2; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Serrano O, 2016, SCI REP-UK, V6, DOI 10.1038/srep23193; Serrano O, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00042; WATSON RA, 1993, AUST J MAR FRESH RES, V44, P211; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106	46	32	33	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177001	10.1371/journal.pone.0177001	http://dx.doi.org/10.1371/journal.pone.0177001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489880	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314100044
J	Vedachalam, S; MacDonald, LH; Shiferaw, S; Seme, A; Schwab, KJ				Vedachalam, Sridhar; MacDonald, Luke H.; Shiferaw, Solomon; Seme, Assefa; Schwab, Kellogg J.		PMA2020 Investigators	Underreporting of high-risk water and sanitation practices undermines progress on global targets	PLOS ONE			English	Article							ACCESS	Water and sanitation indicators under the Millennium Development Goals failed to capture high-risk practices undertaken on a regular basis. In conjunction with local partners, fourteen rounds of household surveys using mobile phones with a customized open-source application were conducted across nine study geographies in Asia and Africa. In addition to the main water and sanitation facilities, interviewees (n = 245,054) identified all water and sanitation options regularly used for at least one season of the year. Unimproved water consumption and open defecation were targeted as high-risk practices. We defined underreporting as the difference between the regular and main use of high-risk practices. Our estimates of high-risk practices as the main option matched the widely accepted Demographic and Health Surveys (DHS) estimates within the 95% confidence interval. However, estimates of these practices as a regular option was far higher than the DHS estimates. Across the nine geographies, median underreporting of unimproved water use was 5.5%, with a range of 0.5% to 13.9%. Median underreporting of open defecation was much higher at 9.9%, with a range of 2.7% to 11.5%. This resulted in an underreported population of 25 million regularly consuming unimproved water and 50 million regularly practicing open defecation. Further examination of data from Ethiopia suggested that location and socio-economic factors were significant drivers of underreporting. Current global monitoring relies on a framework that considers the availability and use of a single option to meet drinking water and sanitation needs. Our analysis demonstrates the use of multiple options and widespread underreporting of high-risk practices. Policies based on current monitoring data, therefore, fail to consider the range of challenges and solutions to meeting water and sanitation needs, and result in an inflated sense of progress. Mobile surveys offer a cost-effective and innovative platform to rapidly and repeatedly monitor critical development metrics.	[Vedachalam, Sridhar; MacDonald, Luke H.; Schwab, Kellogg J.] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Water Inst, Baltimore, MD 21205 USA; [Shiferaw, Solomon; Seme, Assefa] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Addis Ababa University	Vedachalam, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Water Inst, Baltimore, MD 21205 USA.	svedach1@jhu.edu	-, Sanjoyo/AAP-2920-2021	-, Sanjoyo/0000-0002-5494-0140; Wilopo, Siswanto Agus/0000-0003-1284-7228; Ansariadi, Ansariadi/0000-0002-9692-6136	Bill and Melinda Gates Foundation; Johns Hopkins Water Institute; The Osprey Foundation of Maryland	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Johns Hopkins Water Institute; The Osprey Foundation of Maryland	This work was supported by the Bill and Melinda Gates Foundation, Johns Hopkins Water Institute and The Osprey Foundation of Maryland.	Bain RES, 2012, B WORLD HEALTH ORGAN, V90, P228, DOI 10.2471/BLT.11.094284; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Baum R, 2013, ENVIRON SCI TECHNOL, V47, P1994, DOI 10.1021/es304284f; Clasen TF, 2012, TROP MED INT HEALTH, V17, P1178, DOI 10.1111/j.1365-3156.2012.03052.x; Coffey D., 2014, ECON POLIT WEEKLY, P43; Cumming O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114699; Deen T., 2015, OPEN DEFECATION END; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gates B., 2013, ANN LETT 2013; Hunter PR, 2009, SCI TOTAL ENVIRON, V407, P2621, DOI 10.1016/j.scitotenv.2009.01.018; Institut National De La Statistique, 2015, REC GEN POP HAB 2012; Kazadi Joy; Kleemeier Elizabeth, 2011, MOBILE PHONES WATER; Knipe Duleeka W, 2014, BMC Res Notes, V7, P452, DOI 10.1186/1756-0500-7-452; Lane Shannon J, 2006, BMC Med Inform Decis Mak, V6, P23, DOI 10.1186/1472-6947-6-23; Lucas PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021098; Nakagiri A, 2015, HABITAT INT, V49, P529, DOI 10.1016/j.habitatint.2015.07.005; Ntozini R, 2015, CLIN INFECT DIS, V61, pS716, DOI 10.1093/cid/civ847; Office S.I.N.S, 2009, REPORT 2009 POPULATI; Patil SR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001709; Rutstein S. O., 2004, DHS COMP REPORTS; Salaam-Blyther T., 2012, R42717 C RES SERV; SATTERTHWAITE D., 2003, ENVIRON URBAN, V15, P179, DOI DOI 10.1177/095624780301500208; Spears D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073784; StataCorp, 2015, STAT STAT SOFTW REL; The World Bank, 2015, HLTH NUTR POP STAT P; TIEBOUT CM, 1956, J POLIT ECON, V64, P416, DOI 10.1086/257839; Tomlinson M, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-51; UN-HABITAT, 2012, STAT WORLDS CIT REP; [UNICEF WHO], 2015, SAN DRINK WAT LADD; USAID, 2012, USAID WAT DEV STRAT; Vedachalam S, 2015, ENVIRON URBAN, V27, P117, DOI 10.1177/0956247814560978; Vesel L., 2015, African Population Studies, V29, P1683; Walker K, 2009, FORMATIVE ASSESSMENT; WHO/UNICEF, 2015, PROGR DRINKING WATER; Zhang SY, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2183; Zimmerman L., 2015, AFRICAN POPULATION S, V29	36	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176272	10.1371/journal.pone.0176272	http://dx.doi.org/10.1371/journal.pone.0176272			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UN	28489904	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100019
J	Kim, TN				Kim, Tania N.			How plant neighborhood composition influences herbivory: Testing four mechanisms of associational resistance and susceptibility	PLOS ONE			English	Article							INSECT HERBIVORES; INTERSPECIFIC COMPETITION; SOLIDAGO-ALTISSIMA; BRASSICA-NAPUS; SOIL-MOISTURE; DAMAGE; COMMUNITY; DENSITY; DEFENSE; GROWTH	Neighboring plants can decrease or increase each other's likelihood of damage from herbivores through associational resistance or susceptibility, respectively. Associational effects (AE) can transpire through changes in herbivore or plant traits that affect herbivore movement, densities, and feeding behaviors to ultimately affect plant damage. While much work has focused on understanding the mechanisms that underlie associational effects, we know little about how these mechanisms are influenced by neighborhood composition, i.e., plant density or relative frequency which is necessary to make predictions about when AE should occur in nature. Using a series of field and greenhouse experiments, I examined how plant density and relative frequency affected plant damage to Solanum carolinense and four mechanisms that underlie AE; (i) accumulation of insect herbivores and arthropod predators, (ii) microclimate conditions, (iii) plant resistance, and (iv) specialist herbivore preference. I found a positive relationship between S. carolinense damage and the relative frequency of a non-focal neighbor (Solidago altissima) and all four AE mechanisms were influenced by one or multiple neighborhood components. Frequency-dependence in S. carolinense damage is most likely due to greater generalist herbivore load on S. carolinense (through spillover from S. altissima) with microclimate variables, herbivore preference, predation pressures, and plant resistance having relatively weaker effects. Associational effects may have long-term consequences for these two plant species during plant succession and understanding context-dependent herbivory has insect pest management implication for other plant species in agriculture and forestry.	[Kim, Tania N.] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Kim, Tania N.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA	State University System of Florida; Florida State University; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Kim, TN (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.; Kim, TN (corresponding author), Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA.	tania.kim@wisc.edu			National Science Foundation Division of Environmental Biology [1110460]	National Science Foundation Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation Division of Environmental Biology #1110460. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2004, ECOLOGY, V85, P2118, DOI 10.1890/03-4084; Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; BACH CE, 1984, ECOLOGY, V65, P175; BACH CE, 1993, AM MIDL NAT, V130, P193, DOI 10.2307/2426287; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; BOSIO CF, 1990, ENVIRON ENTOMOL, V19, P465, DOI 10.1093/ee/19.3.465; Castagneyrol B, 2013, J ECOL, V101, P418, DOI 10.1111/1365-2745.12055; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Cipollini DF, 2002, PLANT ECOL, V162, P227, DOI 10.1023/A:1020377627529; Cipollini DF, 2001, J CHEM ECOL, V27, P593, DOI 10.1023/A:1010384805014; EDWARDS RL, 1965, CAN ENTOMOL, V97, P401, DOI 10.4039/Ent97401-4; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; Gelman A., 2007, DATA ANAL USING REGR; Hahn PG, 2016, ECOLOGY, V97, P2103, DOI 10.1002/ecy.1430; Hamback PA, 2005, ECOL LETT, V8, P1057, DOI 10.1111/j.1461-0248.2005.00811.x; Hamback PA, 2000, ECOLOGY, V81, P1784, DOI 10.1890/0012-9658(2000)081[1784:ARIDTP]2.0.CO;2; Hamback PA, 2014, ECOLOGY, V95, P1370, DOI 10.1890/13-0793.1; Himanen SJ, 2010, NEW PHYTOL, V186, P722, DOI 10.1111/j.1469-8137.2010.03220.x; HOLM S, 1979, SCAND J STAT, V6, P65; Hughes AR, 2012, ECOLOGY, V93, P1411, DOI 10.1890/11-1555.1; Inouye BD, 2001, ECOLOGY, V82, P2696, DOI 10.2307/2679954; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Karban R, 2001, BIOCHEM SYST ECOL, V29, P995, DOI 10.1016/S0305-1978(01)00046-1; Kim TN, 2015, ECOLOGY, V96, P1431, DOI 10.1890/14-1097.1; Kim TN, 2014, OIKOS, V123, P886, DOI 10.1111/j.1600-0706.2013.00946.x; Kim TN, 2013, ECOLOGY, V94, P1753, DOI 10.1890/12-1261.1; Kos M, 2015, ECOLOGY, V96, P164, DOI 10.1890/14-0563.1; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; Lapointe SL, 1999, FLA ENTOMOL, V82, P291, DOI 10.2307/3496582; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; LETOURNEAU DK, 1995, ECOL APPL, V5, P823, DOI 10.2307/1941990; Marquis RJ, 2002, OIKOS, V99, P531, DOI 10.1034/j.1600-0706.2002.11897.x; McNutt DW, 2012, OECOLOGIA, V170, P1033, DOI 10.1007/s00442-012-2377-x; Morrison S, 2004, CAN J ZOOL, V82, P533, DOI 10.1139/Z04-024; Orians CM, 2009, J TROP ECOL, V25, P551, DOI 10.1017/S0266467409990071; Orrock JL, 2010, ECOL LETT, V13, P11, DOI 10.1111/j.1461-0248.2009.01412.x; Plath M, 2012, OECOLOGIA, V169, P477, DOI 10.1007/s00442-011-2215-6; R Development Core Team, 2014, R LANG ENV STAT COMP; Rand TA, 1999, OECOLOGIA, V121, P39, DOI 10.1007/s004420050905; Root RB, 1996, ECOLOGY, V77, P1074, DOI 10.2307/2265577; Sato Y, 2016, EVOL ECOL, V30, P137, DOI 10.1007/s10682-015-9809-0; Schroeder R, 2008, BIOSCIENCE, V58, P308, DOI 10.1641/B580406; Shiojiri K, 2006, OECOLOGIA, V149, P214, DOI 10.1007/s00442-006-0441-0; SILANDER JA, 1985, OECOLOGIA, V66, P256, DOI 10.1007/BF00379863; Stastny M, 2014, ECOLOGY, V95, P2904, DOI 10.1890/13-1115.1; Strong D., 1984, INSECTS PLANTS COMMU; TAHVANAINEN JO, 1972, OECOLOGIA, V10, P321, DOI 10.1007/BF00345736; Turchin P, 2003, ECOLOGY, V84, P1207, DOI 10.1890/0012-9658(2003)084[1207:DEOPQA]2.0.CO;2; Underwood N, 2014, Q REV BIOL, V89, P1, DOI 10.1086/674991; Verschut TA, 2016, FUNCT ECOL, V30, P1826, DOI 10.1111/1365-2435.12670; WERNER PA, 1980, CAN J PLANT SCI, V60, P1393, DOI 10.4141/cjps80-194; Wise MJ, 2008, EVOL ECOL, V22, P19, DOI 10.1007/s10682-007-9156-x; Wise MJ, 2010, AM J BOT, V97, P525, DOI 10.3732/ajb.0900227; Wise MJ, 1996, OECOLOGIA, V108, P328, DOI 10.1007/BF00334658; Yamawo A, 2012, J PLANT RES, V125, P71, DOI 10.1007/s10265-011-0407-0	55	20	21	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176499	10.1371/journal.pone.0176499	http://dx.doi.org/10.1371/journal.pone.0176499			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486538	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000013
J	Lee, JY; Kim, TW; Kim, HT; Lee, MY; Min, HW; Won, YS; Kwon, HS; Park, KH; Kim, JM				Lee, Jae Yeun; Kim, Tae-Woo; Kim, Hyun Tae; Lee, Mi Yeon; Min, Hye Won; Won, Yu Sam; Kwon, Hyun Seok; Park, Ki Ho; Kim, Joon Mo		Korean Ophthalmological Soc	Relationship between anthropometric parameters and open angle glaucoma: The Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							BODY-MASS INDEX; CEREBROSPINAL-FLUID PRESSURE; NORMAL-TENSION GLAUCOMA; HUMAN TRABECULAR MESHWORK; RISK-FACTORS; INTRAOCULAR-PRESSURE; OCULAR HYPERTENSION; METABOLIC SYNDROME; ALZHEIMER-DISEASE; PHYSICAL-ACTIVITY	Aims To evaluate the relationships between open-angle glaucoma (OAG) and various anthropometric measurements. Design Korea National Health and Nutrition Examination Survey (KNHANES), a population-based cross-sectional study using a complex, stratified, multistage, probability-cluster survey. Methods A total of 5,255 participants including 247 glaucoma patients, aged >= 19 years were included from the KNHANES V database. Glaucoma diagnosis was based on International Society of Geographical and Epidemiological Ophthalmology criteria. Various anthropometric data regarding obesity were analyzed including body mass index (BMI), total body fat mass, total body muscle mass (lean body mass, non-bone lean body mass, and appendicular skeletal muscle (ASM) mass), and waist circumference (WC). The differences in OAG prevalence with respect to anthropometric parameter quartiles were examined. Results In males, the multivariate general linear model adjusted for age, alcohol, smoking, exercise, systemic hypertension, diabetes, and intraocular pressure (IOP) showed the quartiles for the anthropometric parameters BMI, fat mass/weight ratio and fat mass/muscle mass ratio were negatively associated with OAG. However, muscle mass parameter/BMI ratio was significantly positively associated with OAG (P for trend< 0.05). In females, height and fat mass/ BMI showed a significant relationship with the risk of OAG. (P value< 0.05) Conclusions In the present study, high fat mass was associated with low OAG risk. Body composition seemed to affect the prevalence of OAG, but further evaluation is needed.	[Lee, Jae Yeun; Kim, Hyun Tae; Kim, Joon Mo] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Ophthalmol, Sch Med, Seoul, South Korea; [Kim, Tae-Woo] Seoul Natl Univ, Dept Ophthalmol, Bundang Hosp, Coll Med, Gyeonggi Do, South Korea; [Lee, Mi Yeon] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept R&D Management,Div Biostat, Seoul, South Korea; [Min, Hye Won] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Div Med Informat,Dept Phys Educ & Training, Seoul, South Korea; [Won, Yu Sam] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Neurosurg, Seoul, South Korea; [Kwon, Hyun Seok] SU Yonsei Eye Clin, Seoul, South Korea; [Park, Ki Ho] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Ophthalmol, Coll Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital	Kim, JM (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Ophthalmol, Sch Med, Seoul, South Korea.	kjoonmo1@gmail.com		Kim, Tae-Woo/0000-0002-5180-0978				Anderson DR, 2003, AM J OPHTHALMOL, V136, P820, DOI 10.1016/S0002-9394(03)00478-1; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bouloumie A, 1999, FASEB J, V13, P1231, DOI 10.1096/fasebj.13.10.1231; Caballero M, 2003, BIOCHEM BIOPH RES CO, V308, P346, DOI 10.1016/S0006-291X(03)01385-8; Cepeda-Valery B, 2011, NAT REV CARDIOL, V8, P233, DOI 10.1038/nrcardio.2010.209; Chon B, 2013, INVEST OPHTH VIS SCI, V54, P6570, DOI 10.1167/iovs.13-12173; Climie RED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142589; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Fleischman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052664; Fleischman D, 2011, OPHTHALMOLOGY, V118, P1225, DOI 10.1016/j.ophtha.2011.01.025; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gasser P, 1999, J GLAUCOMA, V8, P8; Gustafson DR, 2009, NEUROLOGY, V73, P1559, DOI 10.1212/WNL.0b013e3181c0d4b6; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214; Howard KP, 2014, INVEST OPHTH VIS SCI, V55, P2592, DOI 10.1167/iovs.13-13763; Izzotti A, 2003, AM J MED, V114, P638, DOI 10.1016/S0002-9343(03)00114-1; Kim HT, 2017, AM J OPHTHALMOL, V173, P23, DOI 10.1016/j.ajo.2016.09.031; Kim M, 2014, ACTA OPHTHALMOL, V92, pe637, DOI 10.1111/aos.12434; Kim MJ, 2014, CLIN EXP OPHTHALMOL, V42, P825, DOI 10.1111/ceo.12347; Kim S.H., 2015, EUR HEART J; Kim Yang Jae, 2015, Korean J Ophthalmol, V29, P336, DOI 10.3341/kjo.2015.29.5.336; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kolovou GD, 2007, AM J MED SCI, V333, P362, DOI 10.1097/MAJ.0b013e318065c3a1; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; Lin SC, 2014, JAMA OPHTHALMOL, V132, P1414, DOI 10.1001/jamaophthalmol.2014.2876; Man REK, 2016, JAMA OPHTHALMOL, V134, P251, DOI 10.1001/jamaophthalmol.2015.5103; McMonnies CW, 2016, J OPTOM; Newman-Casey PA, 2011, OPHTHALMOLOGY, V118, P1318, DOI 10.1016/j.ophtha.2010.11.022; Pasquale LR, 2010, OPHTHALMOLOGY, V117, P1521, DOI 10.1016/j.ophtha.2009.12.017; Prior BM, 1997, J APPL PHYSIOL, V83, P623, DOI 10.1152/jappl.1997.83.2.623; Ren RJ, 2012, GRAEF ARCH CLIN EXP, V250, P445, DOI 10.1007/s00417-011-1746-1; Ren RJ, 2011, ACTA OPHTHALMOL, V89, pE142, DOI 10.1111/j.1755-3768.2010.02015.x; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Sacca SC, 2005, ARCH OPHTHALMOL-CHIC, V123, P458, DOI 10.1001/archopht.123.4.458; Shah P, 2001, EYE, V15, P616, DOI 10.1038/eye.2001.196; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Vohra R, 2013, SURV OPHTHALMOL, V58, P311, DOI 10.1016/j.survophthal.2012.08.010; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047; Williams PT, 2009, MED SCI SPORT EXER, V41, P1566, DOI 10.1249/MSS.0b013e31819e420f; Wong SL, 2004, J CLIN ENDOCR METAB, V89, P2672, DOI 10.1210/jc.2003-031931; World Health Organization, 2015, CONTR GLOB OB EP; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421; ZANG EA, 1994, NUTR CANCER, V21, P247, DOI 10.1080/01635589409514323; Zhao D, 2015, OPHTHALMOLOGY, V122, P72, DOI 10.1016/j.ophtha.2014.07.051	50	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176894	10.1371/journal.pone.0176894	http://dx.doi.org/10.1371/journal.pone.0176894			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481907	Green Published, gold, Green Submitted			2022-12-27	WOS:000401313700022
J	Scholten, L; Maurer, M; Lienert, J				Scholten, Lisa; Maurer, Max; Lienert, Judit			Comparing multi-criteria decision analysis and integrated assessment to support long-term water supply planning	PLOS ONE			English	Article							MULTIPLE CRITERIA ANALYSIS; URBAN WATER; SUSTAINABILITY ASSESSMENT; STAKEHOLDER PREFERENCE; INFRASTRUCTURE; MANAGEMENT; REHABILITATION; AGGREGATION; UNCERTAINTY; CLIMATE	We compare the use of multi-criteria decision analysis (MCDA)-or more precisely, models used in multi-attribute value theory (MAVT)-to integrated assessment (IA) models for supporting long-term water supply planning in a small town case study in Switzerland. They are used to evaluate thirteen system scale water supply alternatives in four future scenarios regarding forty-four objectives, covering technical, social, environmental, and economic aspects. The alternatives encompass both conventional and unconventional solutions and differ regarding technical, spatial and organizational characteristics. This paper focuses on the impact assessment and final evaluation step of the structured MCDA decision support process. We analyze the performance of the alternatives for ten stakeholders. We demonstrate the implications of model assumptions by comparing two IA and three MAVT evaluation model layouts of different complexity. For this comparison, we focus on the validity (ranking stability), desirability (value), and distinguishability (value range) of the alternatives given the five model layouts. These layouts exclude or include stakeholder preferences and uncertainties. Even though all five led us to identify the same best alternatives, they did not produce identical rankings. We found that the MAVT-type models provide higher distinguishability and a more robust basis for discussion than the IA-type models. The needed complexity of the model, however, should be determined based on the intended use of the model within the decision support process. The best-performing alternatives had consistently strong performance for all stakeholders and future scenarios, whereas the current water supply system was outperformed in all evaluation layouts. The best-performing alternatives comprise proactive pipe rehabilitation, adapted firefighting provisions, and decentralized water storage and/or treatment. We present recommendations for possible ways of improving water supply planning in the case study and beyond.	[Scholten, Lisa] Delft Univ Technol, Fac Civil Engn & Geosci, Delft, Netherlands; [Maurer, Max; Lienert, Judit] Eawag Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland; [Maurer, Max] ETH, Inst Environm Engn, Zurich, Switzerland	Delft University of Technology; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	Scholten, L (corresponding author), Delft Univ Technol, Fac Civil Engn & Geosci, Delft, Netherlands.	l.scholten@tudelft.nl	Lienert, Judit/B-1138-2013; Maurer, Max/B-5579-2009	Lienert, Judit/0000-0003-1925-3895; Maurer, Max/0000-0002-5326-6035; Scholten, Lisa/0000-0002-4487-758X	National Research Program 61 on Sustainable Water Management by the Swiss National Science Foundation (SNF) [406140_125901/1]	National Research Program 61 on Sustainable Water Management by the Swiss National Science Foundation (SNF)	This research was funded within the National Research Program 61 on Sustainable Water Management by the Swiss National Science Foundation (SNF), project no. 406140_125901/1, URL http://www.nfp61.ch/en/projects/project-swip. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afify A, 2010, DESALINATION, V250, P928, DOI 10.1016/j.desal.2009.03.005; Alegre H, 2013, UTILITY TAILORED MET, P1444; Ana E, 2009, J MULTI-CRITERIA DEC, V16, P111, DOI 10.1002/mcda.443; Ananda J, 2009, ECOL ECON, V68, P2535, DOI 10.1016/j.ecolecon.2009.05.010; [Anonymous], 2012, COMMUNICATION; [Anonymous], 2011, RICHTLINIEN AUSFUHRU; Ashley R, 2008, J ENVIRON ENG-ASCE, V134, P200, DOI 10.1061/(ASCE)0733-9372(2008)134:3(200); Balkema, 2002, URBAN WATER, V4, P153, DOI [DOI 10.1016/S1462-0758(02)00014-6, 10.1016/S1462-0758(02)00014-6]; Belton V., 2002, MULTIPLE CRITERIA DE, DOI DOI 10.1007/978-1-4615-1495-4; Belton V, 2010, INT SER OPER RES MAN, V142, P209, DOI 10.1007/978-1-4419-5904-1_8; Biber E, 2012, U CHICAGO LAW REV, V79, P471; Bohringer C, 2007, ECOL ECON, V63, P1, DOI 10.1016/j.ecolecon.2007.03.008; Booysen F, 2002, SOC INDIC RES, V59, P115, DOI 10.1023/A:1016275505152; Borsuk ME, 2008, ENVIRON SCI TECHNOL, V42, P1855, DOI 10.1021/es702184p; Bradfield R, 2005, FUTURES, V37, P795, DOI 10.1016/j.futures.2005.01.003; Brown RR, 2009, WATER SCI TECHNOL, V59, P847, DOI 10.2166/wst.2009.029; Brown RR, 2009, WATER SCI TECHNOL, V59, P839, DOI 10.2166/wst.2009.028; Calizaya A, 2010, WATER RESOUR MANAG, V24, P2267, DOI 10.1007/s11269-009-9551-x; Carrico N, 2012, WATER SCI TECHNOL, V66, P1007, DOI 10.2166/wst.2012.274; Cashman A, 2008, FORESIGHT, V10, P9, DOI 10.1108/14636680810883099; Christodoulou S., 2008, Water Science and Technology: Water Supply, V8, P231, DOI 10.2166/ws.2008.066; Clemen RT, 2001, INTERFACES, V31, P74, DOI 10.1287/inte.31.6.74.9655; Cobb C.W., 1928, AM ECON REV, V18, P139, DOI DOI 10.2307/1811556; Convertino M, 2013, ECOL INDIC, V26, P76, DOI 10.1016/j.ecolind.2012.10.005; Cox J., 2012, ECON THEOR, P1; Dehe B, 2015, EXPERT SYST APPL, V42, P6717, DOI 10.1016/j.eswa.2015.04.059; Dominguez D, 2009, CALIF MANAGE REV, V51, P30, DOI 10.2307/41166479; Dowle M., 2014, DATA TABLE EXTENSION; DUCKSTEIN L, 1994, J WATER RES PLAN MAN, V120, P546, DOI 10.1061/(ASCE)0733-9496(1994)120:4(546); Durbach IN, 2012, EUR J OPER RES, V223, P1, DOI 10.1016/j.ejor.2012.04.038; DYER JS, 1979, OPER RES, V27, P810, DOI 10.1287/opre.27.4.810; Eawag, PAP PROD SWIP 2016; Eawag, 2009, WASS 2025 VORPR WISS; Ebert U, 2004, J ENVIRON ECON MANAG, V47, P270, DOI 10.1016/j.jeem.2003.09.001; Economides JA, 2012, J AM WATER WORKS ASS, V104, P74; Eden, 2010, HDB GROUP DECISION N; Egger C, 2015, WATER RES, V73, P78, DOI 10.1016/j.watres.2014.12.050; Eisenfuhr F, 2010, RATIONAL DECISION MAKING, P1, DOI 10.1007/978-3-642-02851-9; Ferguson BC, 2013, LANDSCAPE URBAN PLAN, V117, P32, DOI 10.1016/j.landurbplan.2013.04.016; Franco LA, 2011, ENCY OPERATIONS RES, P1; Freeman R. E., 1984, STRATEGIC MANAGEMENT; FRENCH S, 1995, J OPER RES SOC, V46, P70; French S., 2003, TOP, V11, P229, DOI DOI 10.1007/8F02579043; Giuliani M, 2014, WATER RESOUR RES, V50, P3355, DOI 10.1002/2013WR014700; Goodwin P, 2001, J MANAGE STUD, V38, P1, DOI 10.1111/1467-6486.00225; Greco S., 2016, MULTIPLE CRITERIA DE, V37; Gregory R., 2012, STRUCTURED DECISION, DOI [DOI 10.1002/9781444398557, 10.1002/9781444398557]; Gregory R, 2012, J ENVIRON MANAGE, V105, P30, DOI 10.1016/j.jenvman.2012.03.001; HADAR J, 1969, AM ECON REV, V59, P25; Hajkowicz S, 2008, EUR J OPER RES, V184, P255, DOI 10.1016/j.ejor.2006.10.045; Hajkowicz S, 2007, WATER RESOUR MANAG, V21, P1553, DOI 10.1007/s11269-006-9112-5; Hajkowicz S, 2007, ENVIRON SCI POLICY, V10, P177, DOI 10.1016/j.envsci.2006.09.003; HANOCH G, 1969, REV ECON STUD, V36, P335, DOI 10.2307/2296431; Heather AIJ, 2007, WATER ENVIRON J, V21, P127, DOI 10.1111/j.1747-6593.2006.00057.x; Howick S, 2011, EUR J OPER RES, V215, P503, DOI 10.1016/j.ejor.2011.03.013; Huang IB, 2011, SCI TOTAL ENVIRON, V409, P3578, DOI 10.1016/j.scitotenv.2011.06.022; Huang L, 2015, LANDSCAPE ECOL, V30, P1175, DOI 10.1007/s10980-015-0208-2; Innes JE, 2011, J AM PLANN ASSOC, V77, P55, DOI 10.1080/01944363.2011.533640; Jackson CH, 2011, J STAT SOFTW, V38, P1; Janssen R, 2001, J MULTICRITERIA DECI, V10, P101, DOI [DOI 10.1002/MCDA.293, 10.1002/MCDA.293]; Joubert A., 2003, J MULTICRITERIA DECI, V12, P17, DOI [10.1002/mcda.342, DOI 10.1002/MCDA.342, DOI 10.1002/mcda.342]; Keeney R.L., 2004, INT J TECHNOL POLICY, V4, P95, DOI [10.1504/IJTPM.2004.004815, DOI 10.1504/IJTPM.2004.004815]; Keeney RL, 1996, WATER RESOUR BULL, V32, P293; KEENEY RL, 1982, OPER RES, V30, P803, DOI 10.1287/opre.30.5.803; Keeney RL, 1993, DECISIONS MULTIPLE O, DOI DOI 10.1017/CBO9781139174084; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; Kiparsky M, 2013, ENVIRON ENG SCI, V30, P395, DOI 10.1089/ees.2012.0427; Kodikara PN, 2010, EUR J OPER RES, V206, P209, DOI 10.1016/j.ejor.2010.02.016; Kugler T, 2012, WIRES COGN SCI, V3, P471, DOI 10.1002/wcs.1184; Lai E, 2008, URBAN WATER J, V5, P315, DOI 10.1080/15730620802041038; Langhans SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150695; Langhans SD, 2014, ECOL INDIC, V45, P494, DOI 10.1016/j.ecolind.2014.05.014; Larsen TA, 2016, SCIENCE, V352, P928, DOI 10.1126/science.aad8641; Lieberherr E, 2012, PUBLIC MANAG REV, V14, P923, DOI 10.1080/14719037.2011.650056; Lienert J, 2016, EUR J OPER RES, V253, P746, DOI 10.1016/j.ejor.2016.03.010; Lienert J, 2015, EURO J DECIS PROCESS, V3, P107, DOI 10.1007/s40070-014-0030-0; Lienert J, 2013, J ENVIRON MANAGE, V125, P134, DOI 10.1016/j.jenvman.2013.03.052; Lienert J, 2011, ENVIRON SCI TECHNOL, V45, P3848, DOI 10.1021/es1031294; Makropoulos CK, 2010, WATER RESOUR MANAG, V24, P2795, DOI 10.1007/s11269-010-9580-5; Marlow DR, 2010, WATER SCI TECHNOL, V61, P1245, DOI 10.2166/wst.2010.043; Marlow DR, 2013, WATER RES, V47, P7150, DOI 10.1016/j.watres.2013.07.046; Marttunen M, 2008, ENVIRON MANAGE, V42, P1026, DOI 10.1007/s00267-008-9200-9; Means E, 2005, J AM WATER WORKS ASS, V97, P68; Mendoza GA, 2006, FOREST ECOL MANAG, V230, P1, DOI 10.1016/j.foreco.2006.03.023; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Mitchell G., 1996, Sustainable Development (Bradford), V4, P1, DOI 10.1002/(SICI)1099-1719(199603)4:1&lt;1::AID-SD24&gt;3.0.CO;2-N; Montibeller G, 2006, J MULTI-CRITERIA DEC, V14, P5, DOI 10.1002/mcda.403; Mysiak J, 2006, ENVIRON PLANN C, V24, P257, DOI 10.1068/c04103s; Nutt PC, 2004, ACAD MANAGE EXEC, V18, P13, DOI 10.5465/AME.2004.15268668; OECD, 2011, WAT GOV OECD COUNTR; ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT (OECD), 2006, NEW RUR PAR; Pollesch N, 2015, ECOL ECON, V114, P117, DOI 10.1016/j.ecolecon.2015.03.011; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reichert P, 2007, ENVIRON MODELL SOFTW, V22, P188, DOI 10.1016/j.envsoft.2005.07.017; Reichert P, 2015, J ENVIRON MANAGE, V154, P316, DOI 10.1016/j.jenvman.2015.01.053; Reichert P, 2013, ENVIRON MODELL SOFTW, V46, P283, DOI 10.1016/j.envsoft.2013.01.017; Ringland G, 2002, SCENARIO PLANNING MA; ROTHSCHILD M, 1970, J ECON THEORY, V2, P225, DOI 10.1016/0022-0531(70)90038-4; Ruth M, 2007, WATER RESOUR MANAG, V21, P1031, DOI 10.1007/s11269-006-9071-x; Schmidt U, 2008, J RISK UNCERTAINTY, V36, P203, DOI 10.1007/s11166-008-9040-2; SCHNAARS SP, 1987, LONG RANGE PLANN, V20, P105, DOI 10.1016/0024-6301(87)90038-0; SCHOEMAKER PJH, 1995, SLOAN MANAGE REV, V36, P25; SCHOEMAKER PJH, 1991, J FORECASTING, V10, P549, DOI 10.1002/for.3980100602; Scholten L, 2012, COMMUNICATION; Scholten L, 2015, EUR J OPER RES, V242, P243, DOI 10.1016/j.ejor.2014.09.044; Scholten L, 2014, WATER RES, V49, P124, DOI 10.1016/j.watres.2013.11.017; Schulz M, 2012, INTEGR ENVIRON ASSES, V8, P183, DOI 10.1002/ieam.247; Schuwirth N, 2012, EUR J OPER RES, V220, P472, DOI 10.1016/j.ejor.2012.01.055; Selvakumar A, 2012, J INFRASTRUCT SYST, V18, P202, DOI 10.1061/(ASCE)IS.1943-555X.0000091; Sharma AK, 2010, WATER SCI TECHNOL, V62, P570, DOI 10.2166/wst.2010.205; Singh RK, 2012, ECOL INDIC, V15, P281, DOI 10.1016/j.ecolind.2011.01.007; Smidts A, 1997, MANAGE SCI, V43, P357, DOI 10.1287/mnsc.43.3.357; Snyder J. K., 2003, IMPACTS FIRE FLOW DI; Starkl M, 2013, WATER RES, V47, P7175, DOI 10.1016/j.watres.2013.10.037; Stewart TJ, 2013, OMEGA-INT J MANAGE S, V41, P679, DOI 10.1016/j.omega.2012.09.003; Stormer E, 2009, TECHNOL FORECAST SOC, V76, P1150, DOI 10.1016/j.techfore.2009.07.008; SVGW, 2009, STAT ERH WASS SCHW B; Torrance GW, 1996, MED CARE, V34, P702, DOI 10.1097/00005650-199607000-00004; Tourki Yousra, 2013, Environment Systems & Decisions, V33, P3, DOI 10.1007/s10669-013-9437-6; UN (United Nations), 1990, HUMAN DEV REPORT; van Leeuwen CJ, 2013, WATER RESOUR MANAG, V27, P5191, DOI 10.1007/s11269-013-0462-5; Vreeburg J. H. G., 2009, Water Science and Technology: Water Supply, V9, P635, DOI 10.2166/ws.2009.689; Wallenius J, 2008, MANAGE SCI, V54, P1336, DOI 10.1287/mnsc.1070.0838; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; Wong THF, 2009, WATER SCI TECHNOL, V60, P673, DOI 10.2166/wst.2009.436; Yatsalo BI, 2007, INTEGR ENVIRON ASSES, V3, P223, DOI 10.1897/IEAM_2006-036.1; Zheng J, 2016, J ENVIRON MANAGE, V183, P895, DOI 10.1016/j.jenvman.2016.09.027; Zhou P, 2009, SOC INDIC RES, V94, P83, DOI 10.1007/s11205-008-9338-0	130	14	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176663	10.1371/journal.pone.0176663	http://dx.doi.org/10.1371/journal.pone.0176663			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481881	Green Published, gold			2022-12-27	WOS:000401313700014
J	Yang, L; Ruan, X; Jiang, DA; Zhang, JH; Pan, CD; Wang, Q				Yang, Li; Ruan, Xiao; Jiang, Dean; Zhang, Jianhong; Pan, Cunde; Wang, Qiang			Physiological effects of autotoxicity due to DHAP stress on Picea schrenkiana regeneration	PLOS ONE			English	Article							INDUCED CELL-DEATH; ANTIOXIDANT ENZYMES; LYCOPERSICON-ESCULENTUM; SUPEROXIDE DISMUTASES; GLUTATHIONE-REDUCTASE; HYDROGEN-PEROXIDE; SEED-GERMINATION; PROPIDIUM IODIDE; GIBBERELLIC-ACID; HIGHER-PLANTS	Picea Schrenkiana as one of the most important zonal vegetation was an endemic species in Middle Asia. Natural regeneration of P. Schrenkiana is a long existing problem troubling scientists. The autotoxicity of 3,4-dihydroxy-acetophenone (DHAP) was found to be a causative factor causing the failure of P. Schrenkiana natural regeneration. The effects of concentrations of DHAP treatment on the viability of root cell, activities of antioxidant enzymes and levels of P. Schrenkiana phytohormones were performed to disclose the physiological mechanism of DHAP autotoxicity. It was observed that high concentration of DHAP could inhibit the seed germination and seedling growth, but had a hormesis at low concentrations. Analyses showed that the root cells significantly lost their viability treated with high DHAP. The enzymes activities of seedlings were significantly stimulated by the treatment of 0.5 mM DHAP to give a transient increase and then decrease as DHAP concentration increased to 1.0 mM except for GR (glutathione reductase) in which DHAP treatment had little effect on its activity. Comparing with the control, an increase in the levels of phytohormones ZT (zeatin), GA3 (gibberellic acid) and IAA (indole acetic acid) was induced by the treatment of DHAP at low concentrations (0.1-0.25 mM), but the significant deficiency was found treated by high concentrations (0.5-1.0 mM). In addition, the ABA (abscisic acid) level increased in all experimental observations. These results suggested that DHAP significantly affected indices of growth and physiology, and provided some new information about different effect in P. Schrenkiana treated with DHAP.	[Yang, Li; Ruan, Xiao; Wang, Qiang] Zhejiang Univ, Ningbo Inst Technol, Ningbo, Zhejiang, Peoples R China; [Yang, Li; Jiang, Dean] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Zhang, Jianhong] Ningbo Acad Agr Sci, Ningbo, Zhejiang, Peoples R China; [Pan, Cunde] Xinjiang Agr Univ, Coll Forestry & Hort, Urumqi, Peoples R China	Zhejiang University; Zhejiang University; Xinjiang Agricultural University	Wang, Q (corresponding author), Zhejiang Univ, Ningbo Inst Technol, Ningbo, Zhejiang, Peoples R China.	wangqiangsky@263.net			Natural Science Foundation of China (NSFC) [31670631]; Preferential Foundation for Postdoctoral Research Project of Zhejiang [20300586201]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Preferential Foundation for Postdoctoral Research Project of Zhejiang	This work was supported by Natural Science Foundation of China (NSFC, 31670631) and Preferential Foundation for Postdoctoral Research Project of Zhejiang (20300586201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2004, BIOL PLANTARUM, V48, P555, DOI 10.1023/B:BIOP.0000047152.07878.e7; Alrababah MA, 2009, NEW FOREST, V38, P261, DOI 10.1007/s11056-009-9145-8; Batish DR, 2008, J PLANT PHYSIOL, V165, P297, DOI 10.1016/j.jplph.2007.05.003; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Broncano MJ, 1998, PLANT ECOL, V138, P17, DOI 10.1023/A:1009784215900; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Devi SR, 1996, BIOL PLANTARUM, V38, P387, DOI 10.1007/BF02896668; Duke SO, 2010, ALLELOPATHY J, V25, P17; Falik O, 2003, J ECOL, V91, P525, DOI 10.1046/j.1365-2745.2003.00795.x; Fernandez C, 2008, FOREST ECOL MANAG, V255, P2928, DOI 10.1016/j.foreco.2008.01.072; Fernandez C, 2009, J CHEM ECOL, V35, P970, DOI 10.1007/s10886-009-9667-8; GALLET C, 1994, J CHEM ECOL, V20, P1009, DOI 10.1007/BF02059738; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309; Gossett DR, 1996, PLANT PHYSIOL, V112, P803, DOI 10.1104/pp.112.2.803; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; HALLIWELL B, 1978, PLANTA, V139, P9, DOI 10.1007/BF00390803; Hao ZP, 2007, SCI HORTIC-AMSTERDAM, V112, P315, DOI 10.1016/j.scienta.2006.12.030; Harrison Marcia A, 2012, PHYTOHORMONES ABIOTI, P49, DOI [10.1007/978-981-10-7479-0_12, DOI 10.1007/978-981-10-7479-0_12]; Inderjit, 2006, TRENDS PLANT SCI, V11, P574, DOI 10.1016/j.tplants.2006.10.004; JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146; Kamal J, 2008, AFR J BIOTECHNOL, V7; Kato-Noguchi H, 2010, J PLANT PHYSIOL, V167, P468, DOI 10.1016/j.jplph.2009.10.018; Kaya Y, 2015, TOXICOL IND HEALTH, V31, P247, DOI 10.1177/0748233712471702; Kazan K, 2013, ANN BOT-LONDON, V112, P1655, DOI 10.1093/aob/mct229; KEFU Z, 1991, AUST J PLANT PHYSIOL, V18, P17, DOI 10.1071/PP9910017; KOCHBA J, 1977, PLANT CELL PHYSIOL, V18, P463, DOI 10.1093/oxfordjournals.pcp.a075455; Lara-Nunez A, 2006, PLANT CELL ENVIRON, V29, P2009, DOI 10.1111/j.1365-3040.2006.01575.x; Lara-Nunez A, 2009, PHYSIOL PLANTARUM, V136, P180, DOI 10.1111/j.1399-3054.2009.01228.x; Lee DH, 2001, J PLANT PHYSIOL, V158, P737, DOI 10.1078/0176-1617-00174; Li ZH, 2009, CHINESE J ANAL CHEM, V37, P888; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Maffei M, 1999, PLANT SCI, V141, P139, DOI 10.1016/S0168-9452(98)00235-0; Mallik AU, 2003, CRIT REV PLANT SCI, V22, P341, DOI 10.1080/713610860; MALLIK AU, 1988, FOREST ECOL MANAG, V23, P273, DOI 10.1016/0378-1127(88)90058-8; Matsukura C, 1998, PLANTA, V205, P145, DOI 10.1007/s004250050306; Mazhoudi S, 1997, PLANT SCI, V127, P129, DOI 10.1016/S0168-9452(97)00116-7; Mushtaq MN, 2013, PLANT PHYSIOL BIOCH, V70, P374, DOI 10.1016/j.plaphy.2013.06.003; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nathan R, 2004, PLANT ECOL, V171, P123, DOI 10.1023/B:VEGE.0000029379.32705.0f; O'Brien MJ, 2007, FOREST ECOL MANAG, V240, P178, DOI 10.1016/j.foreco.2006.12.025; Pan JW, 2001, ENVIRON EXP BOT, V46, P71, DOI 10.1016/S0098-8472(01)00083-1; Qin F, 2011, PLANT PHYSIOL, V157, P1900, DOI 10.1104/pp.111.187302; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Romero-Romero T, 2002, J CHEM ECOL, V28, P617, DOI 10.1023/A:1014504531418; Ruan X, 2011, MOLECULES, V16, P8874, DOI 10.3390/molecules16108874; SCANDALIOS JG, 1993, PLANT PHYSIOL, V101, P7, DOI 10.1104/pp.101.1.7; Schenk HJ, 1999, ADV ECOL RES, V28, P145, DOI 10.1016/S0065-2504(08)60032-X; Sunohara Y, 2008, PHYTOCHEMISTRY, V69, P2312, DOI 10.1016/j.phytochem.2008.06.012; Tamas L, 2004, ENVIRON EXP BOT, V51, P281, DOI 10.1016/j.envexpbot.2003.11.007; THIBAULT JR, 1982, AM J BOT, V69, P676, DOI 10.2307/2442957; Turker M, 2008, ALLELOPATHY J, V21, P273; Ullah N, 2015, TOXICOL IND HEALTH, V31, P931, DOI 10.1177/0748233713483205; Umebayashi Y, 2003, J BIOCHEM, V134, P219, DOI 10.1093/jb/mvg132; Utsugi E, 2006, FOREST ECOL MANAG, V237, P15, DOI 10.1016/j.foreco.2006.09.011; Wang Q, 2006, FOREST CHRON, V82, P31, DOI 10.5558/tfc82031-1; WEIDENHAMER JD, 1989, J APPL ECOL, V26, P613, DOI 10.2307/2404086; Weir TL, 2004, CURR OPIN PLANT BIOL, V7, P472, DOI 10.1016/j.pbi.2004.05.007; Wu T, 2008, SCI HORTIC-AMSTERDAM, V116, P27, DOI 10.1016/j.scienta.2007.11.003; Yang GQ, 2006, ALLELOPATHY J, V18, P237; Yang L, 2016, MOLECULES, V21, DOI 10.3390/molecules21040528; Ye SF, 2006, ENVIRON EXP BOT, V56, P255, DOI 10.1016/j.envexpbot.2005.02.010; Yokoyama H, 1997, J FISH DIS, V20, P281, DOI 10.1046/j.1365-2761.1997.00293.x; Yu JQ, 2003, BIOCHEM SYST ECOL, V31, P129, DOI 10.1016/S0305-1978(02)00150-3; Yu JQ, 2000, PLANT SOIL, V223, P149, DOI 10.1023/A:1004829512147; Zeevaart JAD, 2003, ANNU REV PLANT BIOL, V39, P439; Zhang AH, 2011, J MED PLANTS RES, V5, P3217; Zhang J, 1990, ACTA AGR BOREALI S S, V5, P19; ZHANG QS, 1993, PLANT SOIL, V151, P205, DOI 10.1007/BF00016285	69	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177047	10.1371/journal.pone.0177047	http://dx.doi.org/10.1371/journal.pone.0177047			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481896	Green Published, Green Submitted, gold			2022-12-27	WOS:000401313700029
J	Gorodzeisky, A; Semyonov, M				Gorodzeisky, Anastasia; Semyonov, Moshe			Labor force participation, unemployment and occupational attainment among immigrants in West European countries	PLOS ONE			English	Article							SEGMENTED ASSIMILATION; 2ND-GENERATION; MARKET; GERMANY; DISCRIMINATION; DISADVANTAGE; ORIGIN; NETHERLANDS; EMPLOYMENT; EARNINGS	The present paper examines modes of immigrants' labor market incorporation into European societies with specific emphasis on the role played by immigrant status (i.e. first-generation immigrants, immigrant descendants and native born without migrant background), region of origin, and gender. The data were obtained from the European Union Labour Forces Survey 2008 Ad-Hoc Module for France, Belgium, UK and Sweden. In order to supplement the results from the country-specific analysis, we replicated the analysis using pooled data from the five rounds of the European Social Survey conducted between 2002 and 2010, for nine 'old immigration' Western European countries together. The analysis centered on two aspects of incorporation: labor force status and occupation. Multinominal, binary logistic as well as linear probability regression models were estimated. The findings suggest that in all countries non-European origin is associated with greater disadvantage in finding employment not only among first-generation immigrants, but also among sons and daughters of immigrants (i.e. second-generation). Moreover, the relative employment disadvantage among immigrant men of non-European origin is especially pronounced in the second-generation. The likelihood of attaining a high-status job is influenced mostly by immigrant status, regardless of region of origin and gender. The results of the study reveal that patterns of labor force incorporation vary considerably across origin groups and across generations. The patterns do not vary as much across countries, despite cross-country differences in welfare state regimes, migration integration policy and composition of migration flows.	[Gorodzeisky, Anastasia; Semyonov, Moshe] Tel Aviv Univ, Dept Sociol & Anthropol, Tel Aviv, Israel; [Semyonov, Moshe] Univ Illinois, Dept Sociol, Chicago, IL 60680 USA	Tel Aviv University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gorodzeisky, A (corresponding author), Tel Aviv Univ, Dept Sociol & Anthropol, Tel Aviv, Israel.	anastasiag@post.tau.ac.il	Gorodzeisky, Anastasia/F-7896-2012; Gorodzeisky, Anastasia/AAS-5286-2020	Gorodzeisky, Anastasia/0000-0002-9244-8501; Gorodzeisky, Anastasia/0000-0002-9244-8501; Semyonov, Moshe/0000-0001-8794-6322	People Programme (Marie Curie Actions) of the European Union (EU) Seventh Framework Programme under REA grant [PCIG11-GA-2012-321730]	People Programme (Marie Curie Actions) of the European Union (EU) Seventh Framework Programme under REA grant	The work was supported by the People Programme (Marie Curie Actions) of the European Union (EU) Seventh Framework Programme (FP/2007-2013) under REA grant agreement PCIG11-GA-2012-321730. Anastasia Gorodzeisky received the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsera A, 2007, J POPUL ECON, V20, P495, DOI 10.1007/s00148-006-0082-y; Alba R, 1997, INT MIGR REV, V31, P826, DOI 10.2307/2547416; Algan Y, 2010, ECON J, V120, pF4, DOI 10.1111/j.1468-0297.2009.02338.x; [Anonymous], ESS ROUND 1 5 EUR SO; Bevelander P, 1999, J ETHN MIGR STUD, V25, P445, DOI DOI 10.1080/1369183X.1999.9976695; Blommaert L, 2014, SOC FORCES, V92, P957, DOI 10.1093/sf/sot124; BORJAS GJ, 1994, J ECON LIT, V32, P1667; BOYD M, 1984, INT MIGR REV, V18, P1091, DOI 10.2307/2546074; Carlsson M, 2010, LABOUR-ENGL, V24, P263, DOI 10.1111/j.1467-9914.2010.00482.x; CASTLES S, 1986, INT MIGR REV, V20, P761, DOI 10.2307/2545735; Chiswick B R, 1988, Res Popul Econ, V6, P183; CHISWICK BR, 1978, J POLIT ECON, V86, P897, DOI 10.1086/260717; Crul M, 2003, INT MIGR REV, V37, P1039, DOI 10.1111/j.1747-7379.2003.tb00169.x; Crul M, 2003, INT MIGR REV, V37, P965, DOI 10.1111/j.1747-7379.2003.tb00166.x; Demireva N, 2011, INT J COMP SOCIOL, V52, P306, DOI 10.1177/0020715211412116; Emilsson H, 2014, EUROPEAN IMMIGRATION, P351; Esping-Andersen G., 1990, INT J SOCIOLOGY, V20, P92, DOI DOI 10.1080/15579336.1990.11770001; Eurostat, 2010, REP QUAL LFS AD HOC; Eurostat, 2010, LAB FORC SURV EU CAN; EVANS MDR, 1991, AM J SOCIOL, V97, P721, DOI 10.1086/229818; Fleischmann F, 2010, WORK EMPLOY SOC, V24, P337, DOI 10.1177/0950017010362153; Glikman A, 2012, CITY COMMUNITY, V11, P198, DOI 10.1111/j.1540-6040.2012.01398.x; Gropas R., 2014, EUROPEAN IMMIGRATION, P363; Heath AF, 2007, P BR ACAD, V137; Heath AF, 2008, ANNU REV SOCIOL, V34, P211, DOI 10.1146/annurev.soc.34.040507.134728; Hooghe M, 2008, INT MIGR REV, V42, P476, DOI 10.1111/j.1747-7379.2008.00132.x; Jacobs D., 2014, EUROPEAN IMMIGRATION, P29; Kaas L, 2012, GER ECON REV, V13, P1, DOI 10.1111/j.1468-0475.2011.00538.x; Kesler C, 2006, SOC FORCES, V85, P743, DOI 10.1353/sof.2007.0013; King R., 2002, INT J POPULATION GEO, V8, P89, DOI DOI 10.1002/IJPG.246; Kogan I, 2006, SOC FORCES, V85, P697, DOI 10.1353/sof.2007.0014; Kogan I, 2011, INT J COMP SOCIOL, V52, P264, DOI 10.1177/0020715211412113; Koopmans R, 2010, J ETHN MIGR STUD, V36, P1, DOI 10.1080/13691830903250881; Lesthaeghe R., 2000, COMMUNITIES GENERATI, P243; Massey D. S., 1998, WORLDS MOTION UNDERS, DOI DOI 10.1111/j.1468-2435.2010.00678.x; Mood C, 2010, EUR SOCIOL REV, V26, P67, DOI 10.1093/esr/jcp006; Niessen J, 2007, MIPEX MIGRANT INTEG; OECD, 2014, FOR BORN POP IND; Park RE., 1921, INTRO SCI SOCIOLOGY; Peach C, 2005, DESEGREGATING CITY G, P31; Portes A, 2005, ETHNIC RACIAL STUD, V28, P1000, DOI 10.1080/01419870500224117; Portes A, 2005, ETHNIC RACIAL STUD, V28, P983, DOI 10.1080/01419870500224109; PORTES A, 1993, ANN AM ACAD POLIT SS, V530, P74, DOI 10.1177/0002716293530001006; Raijman R, 1997, GENDER SOC, V11, P108, DOI 10.1177/089124397011001007; Reitz JG, 2007, J INT MIGR INTEGR, V8, P11, DOI 10.1007/s12134-007-0001-4; Reitz JG., 2001, J INT MIGR INTEGR, V2, P347, DOI [DOI 10.1007/S12134-001-1004-1, 10.1007/s12134-001-1004-1]; Riach PA, 2002, ECON J, V112, pF480, DOI 10.1111/1468-0297.00080; Rumbaut R.G., 2001, LEGACIES STORY IMMIG; Semyonov M, 2016, ETHNIC RACIAL STUD, V39, P994, DOI 10.1080/01419870.2015.1081968; Simon P, 2003, INT MIGR REV, V37, P1091, DOI 10.1111/j.1747-7379.2003.tb00171.x; Stalker P., 1994, WORK STRANGERS SURVE; Thomson M, 2007, J ETHN MIGR STUD, V33, P1025, DOI 10.1080/13691830701541556; Triandafylliodi A, 2014, EUROPEAN IMMIGRATION; van Tubergen F, 2005, SOC FORCES, V84, P709, DOI 10.1353/sof.2006.0039; van Tubergen F, 2004, AM SOCIOL REV, V69, P704, DOI 10.1177/000312240406900505; Warner WL., 1945, SOCIAL SYSTEMS AM ET; Wihtol de Wenden C, 2014, EUROPEAN IMMIGRATION, P135; Worbs S, 2003, INT MIGR REV, V37, P1011, DOI 10.1111/j.1747-7379.2003.tb00168.x; Zeng Z, 2004, AM J SOCIOL, V109, P1075, DOI 10.1086/381914; Zhou M, 1997, INT MIGR REV, V31, P975, DOI 10.2307/2547421	60	32	32	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176856	10.1371/journal.pone.0176856	http://dx.doi.org/10.1371/journal.pone.0176856			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475632	Green Submitted, Green Published, gold			2022-12-27	WOS:000400649500020
J	Kaisers, W; Boukamp, P; Stark, HJ; Schwender, H; Tigges, J; Krutmann, J; Schaal, H				Kaisers, Wolfgang; Boukamp, Petra; Stark, Hans-Juergen; Schwender, Holger; Tigges, Julia; Krutmann, Jean; Schaal, Heiner			Age, gender and UV-exposition related effects on gene expression in in vivo aged short term cultivated human dermal fibroblasts	PLOS ONE			English	Article							HUMAN SKIN FIBROBLASTS; HUMAN PERIPHERAL-BLOOD; TISSUE GROWTH-FACTOR; RNA-SEQ; CELLULAR SENESCENCE; MATRIX METALLOPROTEINASE-1; ULTRAVIOLET-IRRADIATION; TUMOR SUPPRESSION; AGING RESEARCH; II RECEPTOR	Ageing, the progressive functional decline of virtually all tissues, affects numerous living organisms. Main phenotypic alterations of human skin during the ageing process include reduced skin thickness and elasticity which are related to extracellular matrix proteins. Dermal fibroblasts, the main source of extracellular fibrillar proteins, exhibit complex alterations during in vivo ageing and any of these are likely to be accompanied or caused by changes in gene expression. We investigated gene expression of short term cultivated in vivo aged human dermal fibroblasts using RNA-seq. Therefore, fibroblast samples derived from unaffected skin were obtained from 30 human donors. The donors were grouped by gender and age 9Young: 19 to 25 years, Middle: 36 to 45 years, Old: 60 to 66 years). Two samples were taken from each donor, one from a sun-exposed and one from a sun-unexposed site. In our data, no consistently changed gene expression associated with donor age can be asserted. Instead, highly correlated expression of a small number of genes associated with transforming growth factor beta signalling was observed. Also, known gene expression alterations of in vivo aged dermal fibroblasts seem to be non-detectable in cultured fibroblasts.	[Kaisers, Wolfgang; Schwender, Holger] Heinrich Heine Univ Dusseldorf, BMFZ, Ctr Bioinformat & Biostat, Dusseldorf, Germany; [Schwender, Holger] Heinrich Heine Univ Dusseldorf, Math Inst, Dusseldorf, Germany; [Schaal, Heiner] Heinrich Heine Univ Dusseldorf, Inst Virol, Dusseldorf, Germany; [Boukamp, Petra; Tigges, Julia; Krutmann, Jean] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Boukamp, Petra; Stark, Hans-Juergen] German Canc Res Ctr, Heidelberg, Germany; [Krutmann, Jean] Heinrich Heine Univ Dusseldorf, Med Fac, Dusseldorf, Germany; [Kaisers, Wolfgang] Heinrich Heine Univ Dusseldorf, Dept Anaesthesiol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Helmholtz Association; German Cancer Research Center (DKFZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Kaisers, W (corresponding author), Heinrich Heine Univ Dusseldorf, BMFZ, Ctr Bioinformat & Biostat, Dusseldorf, Germany.; Kaisers, W (corresponding author), Heinrich Heine Univ Dusseldorf, Dept Anaesthesiol, Dusseldorf, Germany.	kaisers@med.uni-duesseldorf.de	Schaal, Heiner/A-5115-2008		Deutsche Forschungsgemeinschaft [SCHW 1508/3-1]; Ministerium fur Wissenschaft, Forschung und Kultur (DE) [Network Gerontosys, Stromal Aging WP3, PartC, Stromal Aging]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministerium fur Wissenschaft, Forschung und Kultur (DE)	This work was supported by Deutsche Forschungsgemeinschaft, Award Number: SCHW 1508/3-1, Grant Recipient: Holger Schwender; Ministerium fur Wissenschaft, Forschung und Kultur (DE), Award Number: Network Gerontosys, Stromal Aging WP3, PartC, Grant Recipient: Heiner Schaal; Ministerium fur Wissenschaft, Forschung und Kultur (DE), Award Number: Network Gerontosys, Stromal Aging, Grant Recipient: Jean Krutmann; and Ministerium fur Wissenschaft, Forschung und Kultur (DE), Award Number: Network Gerontosys, Stromal Aging, Grant Recipient: Petra Boukamp.	Barzilai N, 2012, NAT REV GENET, V13, P589, DOI 10.1038/nrg3290; Battie C, 2014, EXP DERMATOL, V23, P7, DOI 10.1111/exd.12388; Brun C, 2016, EXP DERMATOL, V25, P113, DOI 10.1111/exd.12874; Campisi J, 2005, MECH AGEING DEV, V126, P51, DOI 10.1016/j.mad.2004.09.024; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Deelen J, 2013, BIOESSAYS, V35, P386, DOI 10.1002/bies.201200148; Dekker P, 2012, MECH AGEING DEV, V133, P498, DOI 10.1016/j.mad.2012.06.002; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DUMAS M, 1994, MECH AGEING DEV, V73, P179, DOI 10.1016/0047-6374(94)90050-7; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eckes B, 2006, J INVEST DERM SYMP P, V11, P66, DOI 10.1038/sj.jidsymp.5650003; Edfors F, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20167144; Fisher GJ, 2016, AGING CELL, V15, P67, DOI 10.1111/acel.12410; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Fligiel SEG, 2003, J INVEST DERMATOL, V120, P842, DOI 10.1046/j.1523-1747.2003.12148.x; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Glass D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r75; Guberman JM, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar041; Han ES, 2001, MECH AGEING DEV, V122, P999, DOI 10.1016/S0047-6374(01)00215-9; He TY, 2014, AGE, V36, P1079, DOI 10.1007/s11357-014-9623-6; Holick MF, 2016, ANTICANCER RES, V36, P1345; Hornsby PJ, 2010, PFLUG ARCH EUR J PHY, V459, P291, DOI 10.1007/s00424-009-0723-6; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Jansen R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-33; Kaisers W, 2016, REFGENOME GENE SPLIC; Kaisers W., 2012, SPLICESITES BIOCONDU; Kaisers W, 2016, RBAMTOOLS READ WRITE; Kaisers W, ARXIV14050114; Kaisers W, 2015, BIOINFORMATICS, V31, P1663, DOI 10.1093/bioinformatics/btu846; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kirkwood TBL, 2011, CURR BIOL, V21, pR701, DOI 10.1016/j.cub.2011.07.020; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Mine S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004066; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Passtoors WM, 2008, J INTERN MED, V263, P153, DOI 10.1111/j.1365-2796.2007.01904.x; Peters MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9570; Pittayapruek P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060868; Purohit T, 2016, J DERMATOL SCI, V83, P80, DOI 10.1016/j.jdermsci.2016.04.004; Quan TH, 2010, J INVEST DERMATOL, V130, P415, DOI 10.1038/jid.2009.224; Quan TH, 2005, J BIOL CHEM, V280, P8079, DOI 10.1074/jbc.M409647200; Quan TH, 2002, J INVEST DERMATOL, V118, P402, DOI 10.1046/j.0022-202x.2001.01678.x; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schurch NJ, 2016, RNA, V22, P839, DOI 10.1261/rna.053959.115; Tigges J, 2013, J INVEST DERMATOL, V133, P87, DOI 10.1038/jid.2012.259; Tobin D.J., 2016, J TISSUE VIABILITY; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valdes AM, 2013, NAT REV GENET, V14, P601, DOI 10.1038/nrg3553; Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302; Yang JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15145; Zeng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21243; Zhang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023506	65	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0175657	10.1371/journal.pone.0175657	http://dx.doi.org/10.1371/journal.pone.0175657			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475575	Green Published, gold			2022-12-27	WOS:000400649500004
J	Liu, J; Silapong, S; Jeanwattanalert, P; Lertsehtakarn, P; Bodhidatta, L; Swierczewski, B; Mason, C; McVeigh, AL; Savarino, SJ; Nshama, R; Mduma, E; Maro, A; Zhang, JX; Gratz, J; Houpt, ER				Liu, Jie; Silapong, Sasikorn; Jeanwattanalert, Pimmada; Lertsehtakarn, Paphavee; Bodhidatta, Ladaporn; Swierczewski, Brett; Mason, Carl; McVeigh, Annette L.; Savarino, Stephen J.; Nshama, Rosemary; Mduma, Esto; Maro, Athanasia; Zhang, Jixian; Gratz, Jean; Houpt, Eric R.			Multiplex real time PCR panels to identify fourteen colonization factors of enterotoxigenic Escherichia coli (ETEC)	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; DIARRHEAL DISEASE; VACCINE; CHILDREN; EPIDEMIOLOGY; ETIOLOGY; INFANTS; COHORT; GEMS	Enterotoxigenic Escherichia coli (ETEC) is a leading cause of childhood diarrhea in low income countries and in travelers to those areas. Inactivated enterotoxins and colonization factors (CFs) are leading vaccine candidates, therefore it is important to determine the prevailing CF types in different geographic locations and populations. Here we developed real time PCR (qPCR) assays for 14 colonization factors, including the common vaccine targets. These assays, along with three enterotoxin targets (STh, STp, and LT) were formulated into three 5-plex qPCR panels, and validated on 120 ETEC isolates and 74 E. coli colony pools. The overall sensitivity and specificity was 99% (199/202) and 99% (2497/2514), respectively, compared to the CF results obtained with conventional PCR. Amplicon sequencing of discrepant samples revealed that the qPCR was 100% accurate. qPCR panels were also performed on nucleic acid extracted from stool and compared to the results of the ETEC isolates or E. coli colony pools cultured from them. 95% (105/110) of the CF detections in the cultures were confirmed in the stool. Additionally, direct testing of stool yielded 30 more CF detections. Among 74 randomly selected E. coli colony pools with paired stool, at least one CF was detected in 63% (32/51) of the colony pools while at least one CF was detected in 78% (47/60) of the stool samples (P = NS). We conclude that these ETEC CF assays can be used on both cultures and stool samples to facilitate better understanding of CF distribution for ETEC epidemiology and vaccine development.	[Liu, Jie; Zhang, Jixian; Gratz, Jean; Houpt, Eric R.] Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA USA; [Silapong, Sasikorn; Jeanwattanalert, Pimmada; Lertsehtakarn, Paphavee; Bodhidatta, Ladaporn; Swierczewski, Brett; Mason, Carl] Armed Forces Res Inst Med Sci, Bangkok, Thailand; [McVeigh, Annette L.; Savarino, Stephen J.] Naval Med Res Ctr, Infect Dis Clin Res Program, Enter Dis Dept, Infect Dis Directorate, Silver Spring, MD USA; [Nshama, Rosemary; Mduma, Esto] Haydom Global Hlth Ctr, Haydom, Tanzania; [Maro, Athanasia] Kilimanjaro Clin Res Inst, Moshi, Tanzania; [Savarino, Stephen J.] Sanofi Pasteur, Translat Sci & Biomarkers Dept, Swiftwater, PA USA	University of Virginia; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Naval Medical Research Center (NMRC); Sanofi-Aventis	Liu, J (corresponding author), Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA USA.	jl5yj@virginia.edu	Mason, Carl/ABH-3298-2021	Mason, Carl/0000-0002-3676-2811	Henry M. Jackson Foundation [SA2885/PO832803]; Bill & Melinda Gates Foundation; Foundation for the NIH; National Institutes of Health; Fogarty International Center	Henry M. Jackson Foundation; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Foundation for the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Etiology, Risk Factors and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development Project (MAL-ED) is carried out as a collaborative project supported by the Bill & Melinda Gates Foundation, the Foundation for the NIH, and the National Institutes of Health, Fogarty International Center. The authors thank the staff and participants of the MAL-ED Network Project for their important contributions. We also thank Tahaniyat Lalani and Michele Tisdale for procuring ETEC isolates.; Support was provided by Henry M. Jackson Foundation (http://www.hjf.org/, SA2885/PO832803 to JL) and Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/, to ERH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban E, 2015, VIRULENCE, V6, P735, DOI 10.1080/21505594.2015.1094606; Darsley MJ, 2012, CLIN VACCINE IMMUNOL, V19, P1921, DOI 10.1128/CVI.00364-12; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Houpt E, 2014, CLIN INFECT DIS, V59, pS225, DOI 10.1093/cid/ciu413; Isidean SD, 2011, VACCINE, V29, P6167, DOI 10.1016/j.vaccine.2011.06.084; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; LEVINE MM, 1983, INFECT IMMUN, V39, P889, DOI 10.1128/IAI.39.2.889-897.1983; Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X; Liu J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158199; Liu J, 2013, J CLIN MICROBIOL, V51, P472, DOI 10.1128/JCM.02658-12; Lundgren A, 2014, VACCINE, V32, P7077, DOI 10.1016/j.vaccine.2014.10.069; Nada RA, 2010, DIAGN MICR INFEC DIS, V67, P134, DOI 10.1016/j.diagmicrobio.2010.01.011; Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5; Porter CK, 2011, VACCINE, V29, P5869, DOI 10.1016/j.vaccine.2011.05.021; Rodas C, 2009, J CLIN MICROBIOL, V47, P1218, DOI 10.1128/JCM.00316-09; Sabui S, 2012, J CLIN MICROBIOL, V50, P1308, DOI 10.1128/JCM.05424-11; Sahl JW, 2011, INFECT IMMUN, V79, P950, DOI 10.1128/IAI.00932-10; Steffen R, 1999, JAMA-J AM MED ASSOC, V281, P811, DOI 10.1001/jama.281.9.811; Svennerholm AM, 2012, EXPERT REV VACCINES, V11, P495, DOI [10.1586/erv.12.12, 10.1586/ERV.12.12]; Tobias J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152899; Turner SM, 2006, J CLIN MICROBIOL, V44, P4528, DOI 10.1128/JCM.01474-06; von Mentzer A, 2014, NAT GENET, V46, P1321, DOI 10.1038/ng.3145; Walker RI, 2015, VACCINE, V33, P954, DOI 10.1016/j.vaccine.2014.11.049	23	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176882	10.1371/journal.pone.0176882	http://dx.doi.org/10.1371/journal.pone.0176882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475640	Green Published, gold, Green Submitted			2022-12-27	WOS:000400649500023
J	Cavalleri, T; Angelici, L; Favero, C; Dioni, L; Mensi, C; Bareggi, C; Palleschi, A; Rimessi, A; Consonni, D; Bordini, L; Todaro, A; Bollati, V; Pesatori, AC				Cavalleri, Tommaso; Angelici, Laura; Favero, Chiara; Dioni, Laura; Mensi, Carolina; Bareggi, Claudia; Palleschi, Alessandro; Rimessi, Arianna; Consonni, Dario; Bordini, Lorenzo; Todaro, Aldo; Bollati, Valentina; Pesatori, Angela Cecilia			Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease	PLOS ONE			English	Article							TARGETS; EXPRESSION; EPIDEMIC; CELLS	Background Malignant Pleural Mesothelioma (MPM) is an aggressive cancer mainly caused by asbestos exposure and refractory to current therapies. Specific diagnostic markers for early MPM diagnosis are needed. Changes in miRNA expression have been implicated in several diseases and cancers, including MPM. We examined if a specific miRNA signature in plasmatic extracellular vesicles (EV) may help to discriminate between malignant pleural mesothelioma patients (MPM) and subjects with Past Asbestos Exposure (PAE). Methodology/Principal findings We investigated 23 MPM patients and 19 cancer-free subjects with past asbestos exposure (PAE). We screened 754 miRNAs in plasmatic EVs by OpenArray and found 55 differential miRNAs using logistic regression models adjusted for age, sex, BMI, and smoking. Among the top-20 differential miRNAs chosen for validation by Real time PCR, 16 were confirmed. Using receiver operating characteristic (ROC) curve analysis, the most discriminating miRNA combination was given by miR-103a-3p + miR-30e-3p, which generated an AUC of 0.942 (95% CI 0.87-1.00), with a sensitivity of 95.5% and a specificity of 80.0%. Using multi-variate Cox regression analysis including gender, age, BMI and smoking we found a Hazard Ratio for miR-103a-3p above the median of 0.37 (95% CI 0.13-1.13) and of 0.51 (95% CI 0.17-1.52) for miR-30e-3p. Conclusions This study suggests EV-associated miR-103a-3p and miR-30e-3p are able to discriminate MPM from PAE subjects. Larger and prospective studies are needed to confirm these two-miRNA signature alone or in combination with other biomarkers as diagnostic tools for MPM.	[Cavalleri, Tommaso] Humanitas Clin & Res Ctr, Dept Gastroenterol, Via Manzoni 56, Rozzano, Milan, Italy; [Angelici, Laura; Favero, Chiara; Dioni, Laura; Bollati, Valentina; Pesatori, Angela Cecilia] Univ Milan, Dept Clin Sci & Community Hlth, EPIGET, Epidemiol Epigenet & Toxicol Lab, Via San Barnaba 8, Milan, Italy; Ca Granda Osped Maggiore Policlin, Milan, Italy	IRCCS Humanitas Research Hospital; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	Pesatori, AC (corresponding author), Univ Milan, Dept Clin Sci & Community Hlth, EPIGET, Epidemiol Epigenet & Toxicol Lab, Via San Barnaba 8, Milan, Italy.	angela.pesatori@unimi.it	Palleschi, Alessandro/J-6416-2015; Angelici, Laura/AAC-2633-2019; rimessi, alessandro/O-3335-2019; Consonni, Dario/AAM-2947-2020; Mensi, Carolina/J-9774-2014; Rimessi, Alessandro/K-5420-2016	Palleschi, Alessandro/0000-0003-4510-5167; rimessi, alessandro/0000-0001-7091-5765; Consonni, Dario/0000-0002-8935-3843; Mensi, Carolina/0000-0002-9075-3684; Rimessi, Alessandro/0000-0001-7091-5765; Cavalleri, Tommaso/0000-0002-8606-7382; Angelici, Laura/0000-0003-3731-1606	Associazione Italiana per la Ricerca sul Cancro (AIRC) [17692]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This study was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC: http://www.airc.it/) Investigator Grant 2015, number 17692.	Babar IA, 2008, FUTURE ONCOL, V4, P289, DOI 10.2217/14796694.4.2.289; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Busacca S, 2010, AM J RESP CELL MOL, V42, P312, DOI 10.1165/rcmb.2009-0060OC; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Kim Young-Kook, 2015, Chonnam Med J, V51, P51, DOI 10.4068/cmj.2015.51.2.51; Kirschner MB, 2012, J THORAC ONCOL, V7, P1184, DOI 10.1097/JTO.0b013e3182572e83; Lamberti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135331; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marinaccio A, 2012, INT J CANCER, V130, P2146, DOI 10.1002/ijc.26229; MCDONALD JC, 1985, ENVIRON HEALTH PERSP, V62, P319, DOI 10.2307/3430132; Mensi C, 2016, OCCUPATIONAL ENV MED; Micolucci L, 2016, ONCOTARGET; Pass Harvey I, 2004, Curr Probl Cancer, V28, P93, DOI 10.1016/j.currproblcancer.2004.04.001; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Reid G, 2015, J THORAC DIS, V7, P1031, DOI 10.3978/j.issn.2072-1439.2015.04.56; Santarelli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018232; Tomasetti M, 2012, CLIN BIOCHEM, V45, P575, DOI 10.1016/j.clinbiochem.2012.02.009; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Truini A, 2014, CELL MOL LIFE SCI, V71, P2865, DOI 10.1007/s00018-014-1584-5; Vigneri P, 2015, FUTURE ONCOL, V11, P29, DOI 10.2217/fon.15.317; Weber DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114483; Weber DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030221; Wu FT, 2009, CLIN CANCER RES, V15, P1550, DOI 10.1158/1078-0432.CCR-08-0820; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yang Q, 2016, J CLIN EPIGENETICS, V2; Zhou HL, 2014, RNA, V20, P1431, DOI 10.1261/rna.045757.114	28	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176680	10.1371/journal.pone.0176680	http://dx.doi.org/10.1371/journal.pone.0176680			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472171	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500062
J	Michelotto, MD; de Godoy, IJ; Pirotta, MZ; dos Santos, JF; Finoto, EL; Favero, AP				Michelotto, Marcos Doniseti; de Godoy, Ignacio Jose; Pirotta, Melina Zacarelli; dos Santos, Joao Francisco; Finoto, Everton Luiz; Favero, Alessandra Pereira			Resistance to thrips (Enneothrips flavens) in wild and amphidiploid Arachis species	PLOS ONE			English	Article							LATE LEAF-SPOT; CULTIVATED PEANUT; GROWING HABIT; MOULTON	Thrips (Enneothrips flavens) is a pest that causes severe damage and yield losses to peanut crop if not properly controlled. The main control method currently used by farmers is biweekly application of insecticides during crop development, which, in addition to its toxicity, is very costly. Thus, new sources of resistance must be identified in order to reduce the use of insecticides and effectively manage the pest. This study aimed to evaluate the occurrence and symptoms of E. flavens infestations in 12 accessions of 10 wild species of Arachis and nine amphidiploids, as well as to compare their morphoagronomic characteristics to those of commercial cultivars. To this end, we conducted experiments during two summer seasons, using a randomized block design with four replications. We conducted evaluations of the severity of infestation, noting visual symptoms of E. flavens and morphological and reproductive characteristics of the Arachis plants. Results indicated that wild accessions V 7635 (A. vallsii), V 13250 (A. kempff-mercadoi), K 9484 (A. batizocoi), Wi 1118 (A. williamsii), V 14167 (A. duranensis) and V 13751 (A. magna) are the most promising for obtaining useful new amphidiploids. Among the amphidiploids, An 12 (A. batizocoi x A. kempff-mercadoi)(4x), An 9 (A. gregoryi x A. stenosperma)(4x), and An 8 (A. magna x A. cardenasii)(4x) showed high level of resistance to E. flavens. The identified thrips resistant wild and amphidiploid Arachis species may be used in future breeding program to produce thrips resistant peanut cultivars.	[Michelotto, Marcos Doniseti; Finoto, Everton Luiz] Sao Paulo Agcy Agribusiness Technol APTA, Polo Ctr Norte, Sao Paulo, Brazil; [de Godoy, Ignacio Jose; dos Santos, Joao Francisco] Agron Inst IAC, Sao Paulo, Brazil; [Pirotta, Melina Zacarelli] Univ Estadual Paulista Julio Mesquite Filho FCAV, Fac Ciencias Agr & Vet, Sao Paulo, Brazil; [Favero, Alessandra Pereira] Embrapa Pecuaria Sudeste, Sao Carlos, SP, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Favero, AP (corresponding author), Embrapa Pecuaria Sudeste, Sao Carlos, SP, Brazil.	alessandra.favero@embrapa.br	Michelotto, Marcos Doniseti/AAY-6542-2020; Fávero, Alessandra P/I-3557-2012	Michelotto, Marcos Doniseti/0000-0002-2381-2090; Favero, Alessandra/0000-0001-9461-1539	Embrapa [0211080060000]; National Council for Scientific and Technological Development (CNPq) [480921/2013-0, 471657/2011-5]; Sao Paulo Agency for Agribusiness Technology (APTA); Fundacao de Apoio a Pesquisa Agricola (Fundag); Brazilian Agricultural Research Corporation (Embrapa)	Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Agency for Agribusiness Technology (APTA); Fundacao de Apoio a Pesquisa Agricola (Fundag); Brazilian Agricultural Research Corporation (Embrapa)(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA))	This study was funded by Embrapa (grant number 0211080060000), National Council for Scientific and Technological Development (CNPq) (grant numbers 480921/2013-0 and 471657/2011-5) Sao Paulo Agency for Agribusiness Technology (APTA) and Fundacao de Apoio a Pesquisa Agricola (Fundag).; The authors thank Sao Paulo Agency for Agribusiness Technology (APTA), National Council for Scientific and Technological Development (CNPq), Fundacao de Apoio a Pesquisa Agricola (Fundag) and Brazilian Agricultural Research Corporation (Embrapa) for their financial support.	Boiça Junior A.L., 2012, Arq. Inst. Biol., V79, P33; Chagas Filho N.R., 2008, Arq. Inst. Biol., V75, P149, DOI 10.1590/1808-1657v75p1492008; COMPANY M, 1982, EUPHYTICA, V31, P885, DOI 10.1007/BF00039228; de Moraes ARA, 2005, SCI AGR, V62, P469, DOI 10.1590/S0103-90162005000500010; Favero AP, 2006, CROP SCI, V46, P1546, DOI 10.2135/cropsci2005.09-0331; Favero AP, 2009, SCI AGR, V66, P110, DOI 10.1590/S0103-90162009000100015; Gabriel Dalva, 1996, Bragantia, V55, P253, DOI 10.1590/S0006-87051996000200007; Gallo D, 2002, ENTOMOLOGIA AGR COLA; Holbrook CC, 2014, CSSA SPEC PUBL, V33, P173, DOI 10.2135/cssaspecpub33.c7; Janini Julio Cesar, 2010, Bragantia, V69, P891, DOI 10.1590/S0006-87052010000400015; Lourenção André Luiz, 2007, Bragantia, V66, P623, DOI 10.1590/S0006-87052007000400013; Mallikarjuna N, 2012, EUR J PLANT PATHOL, V132, P17, DOI 10.1007/s10658-011-9859-2; Michelotto MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128811; Michelotto MD, 2013, BIOSCI J, V29, P115; Michereff Filho M, 2012, 108 MIN RIO AGR PEC; Moraes ARA, 2005, THESIS; Pereira JCVNA, 1999, PESQUISA AGROPECUARI, V34, P1183; Santos J.F., 2013, BIOSCI J, V29, P280, DOI DOI 10.1590/S0006-87052011005000001; SAS Institute Inc. Cary NC USA, 2002, SOFTW 9 3; Sharma HC, 2003, J ECON ENTOMOL, V96, P1886, DOI 10.1603/0022-0493-96.6.1886; Simpson C. E., 1991, Peanut Science, V18, P22, DOI 10.3146/i0095-3679-18-1-8; STALKER HT, 1987, ADV AGRON, V41, P1, DOI 10.1016/S0065-2113(08)60801-9	22	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176811	10.1371/journal.pone.0176811	http://dx.doi.org/10.1371/journal.pone.0176811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472187	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500076
J	Typiak, M; Rebala, K; Haras, A; Skotarczak, M; Slominski, JM; Dubaniewicz, A				Typiak, Marlene; Rebala, Krzysztof; Haras, Agnieszka; Skotarczak, Monika; Slominski, Jan Marek; Dubaniewicz, Anna			Copy number variation of FCGR genes in etiopathogenesis of sarcoidosis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ASSOCIATION; GAMMA; SUSCEPTIBILITY; POLYMORPHISM; AUTOIMMUNITY; PREDISPOSES; RECEPTORS; DISEASE	We have previously revealed that, in contrast to polymorphism of FCGR2B and FCGR3B, polymorphism of FCGR2A, FCGR2C and FCGR3A genes, encoding receptors for Fc fragment of immunoglobulin G (Fc gamma receptors), play a role in increased level of circulating immune complexes with occurrence of Mycobacterium tuberculosis heat shock proteins in patients with sarcoidosis. However, this immunocomplexemia might also be caused by decreased clearance by immune cells due to a changed copy number of FCGR genes. Thus, the next step of our study was to evaluate copy number variation of FCGR2A, FCGR2B, FCGR2C, FCGR3A and FCGR3B in this disease. The analysis was carried out by real-time quantitative PCR on 104 patients and 110 healthy volunteers. Despite previously detected variation in allele/genotype frequencies of FCGR in sarcoidosis and its particular stages, there was no copy number variation of the tested genes between sarcoidosis or its stages and healthy control, as well as between stages themselves. A relevant increase in copy number of FCGR2C and FCGR3B in Stage IV of sarcoidosis vs. other stages and controls was detected, but this observation was based on a limited number of Stage IV patients. Hence, polymorphism of FCGR genes seems to be more important than their copy number variation in etiopathogenesis of sarcoidosis in patients from the Polish population.	[Typiak, Marlene; Slominski, Jan Marek; Dubaniewicz, Anna] Med Univ Gdansk, Dept Pulmonol, Gdansk, Poland; [Rebala, Krzysztof; Haras, Agnieszka] Med Univ Gdansk, Dept Forens Med, Gdansk, Poland; [Skotarczak, Monika] Med Univ Gdansk, Dept Radiol 2, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Dubaniewicz, A (corresponding author), Med Univ Gdansk, Dept Pulmonol, Gdansk, Poland.	aduban@gumed.edu.pl	Typiak, Marlena/ABG-9726-2020; Rębała, Krzysztof/U-9856-2018; Dubaniewicz, Anna/Q-9523-2018; Haraś, Agnieszka/R-4357-2018; Słomiński, Jan Marek/U-5035-2018	Rębała, Krzysztof/0000-0003-2236-7455; Dubaniewicz, Anna/0000-0002-0557-2345; Haraś, Agnieszka/0000-0003-1012-339X; Słomiński, Jan Marek/0000-0003-2284-0740; Typiak, Marlena/0000-0002-9687-1016	Ministry of Science and Higher Education; National Science Centre in Poland; Medical University of Gdansk [5160/B/P01/2010/39, ST-02-0127/07/232]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre in Poland(National Science Centre, Poland); Medical University of Gdansk(Medical University Gdansk)	The study was funded by the Ministry of Science and Higher Education and the National Science Centre in Poland, and Medical University of Gdansk (grants number 5160/B/P01/2010/39 and ST-02-0127/07/232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Asano K, 2013, INFLAMM BOWEL DIS, V19, P2061, DOI 10.1097/MIB.0b013e318298118e; Baughman RP, 2011, AM J RESP CRIT CARE, V183, P573, DOI 10.1164/rccm.201006-0865CI; Bournazos S, 2009, CLIN EXP IMMUNOL, V157, P244, DOI 10.1111/j.1365-2249.2009.03980.x; Breunis WB, 2009, HUM MUTAT, V30, pE640, DOI 10.1002/humu.20997; Breunis WB, 2008, BLOOD, V111, P1029, DOI 10.1182/blood-2007-03-079913; Chen JY, 2014, ARTHRITIS RHEUMATOL, V66, P3113, DOI 10.1002/art.38813; Chen K, 2012, BLOOD, V120, P4421, DOI 10.1182/blood-2011-12-401133; Dubaniewicz A, 2006, TUBERCULOSIS, V86, P60, DOI 10.1016/j.tube.2005.09.004; Dubaniewicz A, 2013, HUM IMMUNOL, V74, P1550, DOI 10.1016/j.humimm.2013.08.275; Dubaniewicz A, 2013, HUM IMMUNOL, V74, P45, DOI 10.1016/j.humimm.2012.10.007; Dubaniewicz A, 2012, HUM IMMUNOL, V73, P788, DOI 10.1016/j.humimm.2012.05.005; Dubaniewicz A, 2010, AUTOIMMUN REV, V9, P419, DOI 10.1016/j.autrev.2009.11.015; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Haldorsen K, 2013, GENES IMMUN, V14, P234, DOI 10.1038/gene.2013.12; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Kivity S, 2009, TRENDS IMMUNOL, V30, P409, DOI 10.1016/j.it.2009.05.005; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Li X, 2009, GENES IMMUN, V10, P380, DOI 10.1038/gene.2009.35; Li XR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007097; Makowsky R, 2013, PHARMACOGENET GENOM, V23, P455, DOI 10.1097/FPC.0b013e328363686e; Mamtani M, 2010, GENES IMMUN, V11, P155, DOI 10.1038/gene.2009.71; McKinney C, 2012, HUM MOL GENET, V21, P2370, DOI 10.1093/hmg/dds039; Nagelkerke SQ, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00674; Niederer HA, 2010, HUM MOL GENET, V19, P3282, DOI 10.1093/hmg/ddq216; Olsson LM, 2012, EUR J IMMUNOL, V42, P1969, DOI 10.1002/eji.201242601; Robinson JI, 2012, HUM MUTAT, V33, P741, DOI 10.1002/humu.22031; SCADDING JG, 1961, BRIT MED J, V2, P1165, DOI 10.1136/bmj.2.5261.1165; Schaschl H, 2009, CLIN EXP IMMUNOL, V156, P12, DOI 10.1111/j.1365-2249.2008.03865.x; Typiak M, 2016, ADV EXP MED BIOL, V905, P57, DOI 10.1007/5584_2015_193; Typiak MJ, 2014, HUM IMMUNOL, V75, P283, DOI 10.1016/j.humimm.2014.02.011; Willcocks LC, 2008, J EXP MED, V205, P1573, DOI 10.1084/jem.20072413; Wu YM, 2014, DERMATOLOGY, V229, P70, DOI 10.1159/000360160; Zhou XJ, 2010, INT IMMUNOL, V22, P45, DOI 10.1093/intimm/dxp113	34	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177194	10.1371/journal.pone.0177194	http://dx.doi.org/10.1371/journal.pone.0177194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472129	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500151
J	Saarenpaa, T; Kogan, K; Sidorova, Y; Mahato, AK; Tascon, I; Kaljunen, H; Yu, LY; Kaiiijarvi, J; Jurvansuu, J; Saarma, M; Goldman, A				Saarenpaa, Tuulia; Kogan, Konstantin; Sidorova, Yulia; Mahato, Arun Kumar; Tascon, Igor; Kaljunen, Heidi; Yu, Liying; Kaiiijarvi, Jukka; Jurvansuu, Jaana; Saarma, Mart; Goldman, Adrian			Zebrafish GDNF and its co-receptor GFR alpha 1 activate the human RET receptor and promote the survival of dopaminergic neurons in vitro	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; TYROSINE KINASE; TRANSFORMING GENE; BINDING; DOMAIN; EXPRESSION; MECHANISM; COMPLEX; RECOGNITION; ONCOGENE	Glial cell line-derived neurotrophic factor ( GDNF) is a ligand that activates, through coreceptor GDNF family receptor alpha-1 (GFR alpha 1) and receptor tyrosine kinase "RET ", several signaling pathways crucial in the development and sustainment of multiple neuronal populations. We decided to study whether non-mammalian orthologs of these three proteins have conserved their function: can they activate the human counterparts? Using the baculovirus expression system, we expressed and purified Danio rerio RET, and its binding partners GFRa1 and GDNF, and Drosophila melanogaster RET and two isoforms of coreceptor GDNF receptor-like. Our results report high-level insect cell expression of posttranslationally modified and dimerized zebrafish RET and its binding partners. We also found that zebrafish GFRa1 and GDNF are comparably active as mammalian cell- produced ones. We also report the first measurements of the affinity of the complex to RET in solution: at least for zebrafish, the Kd for GFR alpha 1-GDNF binding RET is 5.9 mu M. Surprisingly, we also found that zebrafish GDNF as well as zebrafish GFRa1 robustly activated human RET signaling and promoted the survival of cultured mouse dopaminergic neurons with comparable efficiency to mammalian GDNF, unlike E. coli-produced human proteins. These results contradict previous studies suggesting that mammalian GFRa1 and GDNF cannot bind and activate non-mammalian RET and vice versa.	[Saarenpaa, Tuulia; Kogan, Konstantin; Tascon, Igor; Kaljunen, Heidi; Goldman, Adrian] Univ Helsinki, Dept Biochem, Fac Biol & Environm Sci, Helsinki, Finland; [Sidorova, Yulia; Mahato, Arun Kumar; Yu, Liying; Kaiiijarvi, Jukka; Jurvansuu, Jaana; Saarma, Mart] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Goldman, Adrian] Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Tascon, Igor] Goethe Univ Frankfurt, Inst Biochem, Frankfurt, Germany; [Kaiiijarvi, Jukka] Univ Helsinki, Folkhalsan Res Ctr, Biomedicum, Helsinki, Finland; [Jurvansuu, Jaana] Univ Oulu, Dept Biol, Oulu, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Leeds; Goethe University Frankfurt; Folkhalsan Research Center; University of Helsinki; University of Oulu	Goldman, A (corresponding author), Univ Helsinki, Dept Biochem, Fac Biol & Environm Sci, Helsinki, Finland.; Goldman, A (corresponding author), Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England.	a.goldman@leeds.ac.uk	Sidorova, Yulia/L-5340-2019; Tascón, Igor/AAA-9466-2019; Jurvansuu, Jaana/AAZ-8835-2020; Kallijarvi, Jukka/AAV-5091-2021	Tascón, Igor/0000-0003-2526-6238; Kallijarvi, Jukka/0000-0003-3773-7025; Kaljunen, Heidi/0000-0002-5962-9503; Kogan, Konstantin/0000-0003-3270-9391; Goldman, Adrian/0000-0001-8032-9700; Jurvansuu, Jaana/0000-0002-7801-3237; Sidorova, Yulia/0000-0001-8230-0530	Academy of Finland [1286429]; Biotechnology and Biological Sciences Research Council [BB/M021610/1]; Sigrid Juselius Foundation; European Union Seventh Framework Programme (FP7) [602919, 612275]; Parkinsons UK Innovation [K-1408]; Finnish Graduate School of Neuroscience/Brain Mind; BBSRC [BB/M021610/1] Funding Source: UKRI; Parkinson&quot;s UK [K-1408] Funding Source: researchfish	Academy of Finland(Academy of Finland); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Union Seventh Framework Programme (FP7); Parkinsons UK Innovation; Finnish Graduate School of Neuroscience/Brain Mind; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Parkinson&quot;s UK(Parkinson&apos;s UK)	This study was funded by the Academy of Finland (grant no. 1286429), Biotechnology and Biological Sciences Research Council (grant no. BB/M021610/1) (AG), the Sigrid Juselius Foundation (AG and MS), the European Union Seventh Framework Programme (FP7/20072013) under grant agreements No 602919, 612275, Parkinsons UK Innovation grant K-1408 (MS) and Finnish Graduate School of Neuroscience/Brain & Mind (TS).	Abrescia C, 2005, FEBS LETT, V579, P3789, DOI 10.1016/j.febslet.2005.05.075; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; Bisgrove BW, 1997, J NEUROBIOL, V33, P749; Eigenbrot C, 1997, NAT STRUCT BIOL, V4, P435, DOI 10.1038/nsb0697-435; Eketjall S, 1999, EMBO J, V18, P5901, DOI 10.1093/emboj/18.21.5901; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Glerup S, 2013, CELL REP, V3, P186, DOI 10.1016/j.celrep.2012.12.011; Goodman KM, 2014, CELL REP, V8, P1894, DOI 10.1016/j.celrep.2014.08.040; GRIECO D, 1995, ONCOGENE, V11, P113; Haavik J, 1997, J NEUROCHEM, V68, P328; Hahn M, 2001, P NATL ACAD SCI USA, V98, P1053, DOI 10.1073/pnas.021558598; Hayashi Y, 2001, BIOCHEM BIOPH RES CO, V281, P682, DOI 10.1006/bbrc.2001.4338; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; Iwashita T, 1996, HUM MOL GENET, V5, P1577, DOI 10.1093/hmg/5.10.1577; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Kallijarvi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051997; Kaslin J, 2004, J NEUROSCI, V24, P2678, DOI 10.1523/JNEUROSCI.4908-03.2004; Kato M, 2000, ANTIOXID REDOX SIGN, V2, P841, DOI 10.1089/ars.2000.2.4-841; Keinanen K, 1998, BIOCHEM J, V330, P1461, DOI 10.1042/bj3301461; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kjaer S, 2003, J BIOL CHEM, V278, P47898, DOI 10.1074/jbc.M309772200; Kjaer S, 2010, NAT STRUCT MOL BIOL, V17, P726, DOI 10.1038/nsmb.1808; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Parkash V, 2008, J BIOL CHEM, V283, P35164, DOI 10.1074/jbc.M802543200; Piccinini E, 2013, ANN MED, V45, P66, DOI 10.3109/07853890.2012.663927; Planken A, 2010, J NEUROSCI METH, V194, P122, DOI 10.1016/j.jneumeth.2010.10.005; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Schlee S, 2006, NAT CHEM BIOL, V2, P636, DOI 10.1038/nchembio823; Sidorova YA, 2010, MOL CELL NEUROSCI, V44, P223, DOI 10.1016/j.mcn.2010.03.009; Soba P, 2015, ELIFE, V4, DOI 10.7554/eLife.05491; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; TAKAHASHI M, 1988, ONCOGENE, V3, P571; Wang XQ, 2006, STRUCTURE, V14, P1083, DOI 10.1016/j.str.2006.05.010	41	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176166	10.1371/journal.pone.0176166	http://dx.doi.org/10.1371/journal.pone.0176166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467503	Green Published, gold			2022-12-27	WOS:000400647000042
J	Zhang, YY; Kumada, T				Zhang, Yuyu; Kumada, Takatsune			Relationship between workload and mind-wandering in simulated driving	PLOS ONE			English	Article							ATTENTION; FATIGUE; REVEALS	Mental workload and mind-wandering are highly related to driving safety. This study investigated the relationship between mental workload and mind-wandering while driving. Participants (N = 40) were asked to perform a car following task in driving simulator, and report whether they had experienced mind-wandering upon hearing a tone. After driving, participants reported their workload using the NASA-Task Load Index (TLX). Results revealed an interaction between workload and mind-wandering in two different perspectives. First, there was a negative correlation between workload and mind-wandering (r = -0.459, p < 0.01) for different individuals. Second, from temporal perspective workload and mind-wandering frequency increased significantly over task time and were positively correlated. Together, these findings contribute to understanding the roles of workload and mind-wandering in driving.	[Zhang, Yuyu; Kumada, Takatsune] Kyoto Univ, Grad Sch Informat, Dept Intelligence Sci & Technol, Kyoto, Japan	Kyoto University	Zhang, YY (corresponding author), Kyoto Univ, Grad Sch Informat, Dept Intelligence Sci & Technol, Kyoto, Japan.	zhangyy985@gmail.com						Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; [Anonymous], NONPARAMETRIC MONOTO; Borghini G, 2014, NEUROSCI BIOBEHAV R, V44, P58, DOI 10.1016/j.neubiorev.2012.10.003; Braboszcz C, 2011, NEUROIMAGE, V54, P3040, DOI 10.1016/j.neuroimage.2010.10.008; David MM., 2015, APPL TIM SER AN LESS; DeWaard D, 1996, MEASUREMENT DRIVERS; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dixon ML, 2014, NEUROPSYCHOLOGIA, V62, P321, DOI 10.1016/j.neuropsychologia.2014.05.024; Edwards, 2012, P 4 INT C AUT US INT, P261, DOI DOI 10.1145/2390256.2390299; Forster S, 2009, COGNITION, V111, P345, DOI 10.1016/j.cognition.2009.02.006; Gruberger M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00056; Hancock PA, 1997, ACCIDENT ANAL PREV, V29, P495, DOI 10.1016/S0001-4575(97)00029-8; HART S G, 1988, P139; Hart S.G., 2006, P HUM FACT ERG SOC A, DOI [10.1177/154193120605000909, DOI 10.1177/154193120605000909]; He JB, 2011, HUM FACTORS, V53, P13, DOI 10.1177/0018720810391530; Helsel DR, 2002, STAT METHODS WATER R, DOI [10.2307/1269385, DOI 10.2307/1269385, DOI 10.3133/TWRI04A3522]; Ho C., 2012, MULTISENSORY DRIVER; Kane MJ, 2012, CURR DIR PSYCHOL SCI, V21, P348, DOI 10.1177/0963721412454875; Kantowitz BH, 2000, P HUMAN FACTORS ERGO, DOI [10.1177/154193120004402121, DOI 10.1177/154193120004402121]; Kawakita E., 2010, 2010 13th International IEEE Conference on Intelligent Transportation Systems (ITSC 2010), P765, DOI 10.1109/ITSC.2010.5625079; Lavie N, 2010, CURR DIR PSYCHOL SCI, V19, P143, DOI 10.1177/0963721410370295; Lyznicki JM, 1998, JAMA-J AM MED ASSOC, V279, P1908, DOI 10.1001/jama.279.23.1908; MathWorks, 2015, CONF INT SAMPL AUT; Mcvay JC, 2010, PSYCHOL BULL, V136, P188, DOI 10.1037/a0018298; McVay JC, 2009, PSYCHON B REV, V16, P857, DOI 10.3758/PBR.16.5.857; Oken BS, 2006, CLIN NEUROPHYSIOL, V117, P1885, DOI 10.1016/j.clinph.2006.01.017; Paxion J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01344; Penaranda B. N., 2012, P HUM FACT ERG SOC A, V56, P188, DOI [10.1177/1071181312561016, DOI 10.1177/1071181312561016]; Persson J, 2013, J COGNITIVE NEUROSCI, V25, P338, DOI 10.1162/jocn_a_00321; Risko EF, 2012, APPL COGNITIVE PSYCH, V26, P234, DOI 10.1002/acp.1814; Robert N., 2016, TESTING ASSUMPTIONS; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2015, ANNU REV PSYCHOL, V66, P487, DOI 10.1146/annurev-psych-010814-015331; Thomson DR, 2014, CONSCIOUS COGN, V27, P14, DOI 10.1016/j.concog.2014.04.001; van der Linden D, 2003, ACTA PSYCHOL, V113, P45, DOI 10.1016/S0001-6918(02)00150-6; Warm J. S., 1996, VIGILANCE WORKLOAD A; Yanko MR, 2013, HUMAN FACTORS J HUMA; Yue S, 2004, WATER RESOUR MANAG, V18, P201, DOI 10.1023/B:WARM.0000043140.61082.60; Zhang YL, 2004, ITSC 2004: 7TH INTERNATIONAL IEEE CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS, PROCEEDINGS, P642, DOI 10.1109/ITSC.2004.1398976	40	10	10	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176962	10.1371/journal.pone.0176962	http://dx.doi.org/10.1371/journal.pone.0176962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SB	28467513	Green Published, gold, Green Submitted			2022-12-27	WOS:000400647000092
J	Amarasekera, AT; Assadi-Khansari, B; Liu, SF; Black, M; Dymmott, G; Rogers, NM; Sverdlov, AL; Horowitz, JD; Ngo, DTM				Amarasekera, Anjalee T.; Assadi-Khansari, Bahador; Liu, Saifei; Black, Marilyn; Dymmott, Greer; Rogers, Natasha M.; Sverdlov, Aaron L.; Horowitz, John D.; Ngo, Doan T. M.			Vitamin D supplementation lowers thrombospondin-1 levels and blood pressure in healthy adults	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; NITRIC-OXIDE; D DEFICIENCY; ACTIVIN-A; SERUM 25-HYDROXYVITAMIN-D; RISK; RESPONSES; IMPACT	Introduction Vitamin D insufficiency, defined as 25-hydroxyvitamin D (25(OH)D) levels < 75nmol/L is associated with cardio-metabolic dysfunction. Vitamin D insufficiency is associated with inflammation and fibrosis, but it remains uncertain whether these anomalies are readily reversible. Therefore, we aimed to determine the effects of vitamin D supplementation on markers of: 1) nitric oxide (NO) signaling, 2) inflammation, and 3) fibrosis, in healthy volunteers with mild hypovitaminosis. Methods Healthy volunteers (n = 35) (mean age: 45 +/- 11 years) with 25(OH)D levels <75nmol/L, received vitamin D supplementation (Ostelin (R) capsules 2000IU) for 12 weeks. Resting systolic and diastolic blood pressures (BP) were assessed. Routine biochemistry was examined. Plasma concentrations of asymmetric dimethylarginine (ADMA), thrombospondin-1 (TSP-1), plasminogen activator inhibitor-1 (PAI-1), hs-CRP, activin-A, and follistatin-like 3 (FSTL3) were quantitated. Results Vitamin D administration for 12 weeks significantly increased 25-(OH)D levels (48.8 +/- 16 nmol/L to 100.8 +/- 23.7 nmol/L, p<0.001). There was significant lowering of systolic and diastolic BP, while there was no significant change in lipid profiles, or fasting insulin. Plasma concentrations of ADMA, hs-CRP, PAI-1, activin A, and FSTL-3 did not change with vitamin D supplementation. However, there was a marked reduction of TSP-1 (522.7 +/- 379.8 ng/mL vs 206.7 +/- 204.5 ng/mL, p<0.001). Conclusions Vitamin D supplementation in vitamin D insufficient, but otherwise healthy individuals markedly decreased TSP-1 levels and blood pressure. Since TSP-1 suppresses signaling of NO, it is possible that the fall in BP is engendered by restoration of NO effect.	[Amarasekera, Anjalee T.; Assadi-Khansari, Bahador; Liu, Saifei; Black, Marilyn; Dymmott, Greer; Sverdlov, Aaron L.; Horowitz, John D.; Ngo, Doan T. M.] Univ Adelaide, Queen Elizabeth Hosp, Dept Med, Cardiol Unit,Basil Hetzel Inst, Adelaide, SA, Australia; [Amarasekera, Anjalee T.; Ngo, Doan T. M.] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia; [Rogers, Natasha M.] Westmead Inst Med Res, Ctr Transplant & Renal Res, Sydney, NSW, Australia	University of Adelaide; University of South Australia; University of Sydney; Westmead Institute for Medical Research	Ngo, DTM (corresponding author), Univ Adelaide, Queen Elizabeth Hosp, Dept Med, Cardiol Unit,Basil Hetzel Inst, Adelaide, SA, Australia.; Ngo, DTM (corresponding author), Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia.	doan.ngo@adelaide.edu.au	Liu, Saifei/AAH-9701-2020; Rogers, Natasha/ABC-2546-2020; Amarasekera, Anjalee Thanuja/N-7258-2017; Sverdlov, Aaron/G-1384-2010	Liu, Saifei/0000-0003-4200-431X; Amarasekera, Anjalee Thanuja/0000-0003-3922-2914; Horowitz, John/0000-0001-6883-0703; Sverdlov, Aaron/0000-0003-2539-8038	Rebecca L. Cooper Medical Research Foundation; Tom Simpson Trust Fund Award; Hospital Research Foundation; Lyn Huddleston Award, University of Adelaide	Rebecca L. Cooper Medical Research Foundation; Tom Simpson Trust Fund Award; Hospital Research Foundation; Lyn Huddleston Award, University of Adelaide	This work was supported by the Rebecca L. Cooper Medical Research Foundation (AU) (Dr Doan TM Ngo); Tom Simpson Trust Fund Award (Dr Doan TM Ngo); Hospital Research Foundation (Dr Doan TM Ngo); and Lyn Huddleston Award, University of Adelaide (Dr Aaron L Sverdlov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K, 2004, J BIOL CHEM, V279, P35798, DOI 10.1074/jbc.M404865200; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Assalin HB, 2013, CIRC-HEART FAIL, V6, P809, DOI 10.1161/CIRCHEARTFAILURE.112.000298; Bauer EM, 2010, CARDIOVASC RES, V88, P471, DOI 10.1093/cvr/cvq218; Beveridge LA, 2015, JAMA INTERN MED, V175, P745, DOI 10.1001/jamainternmed.2015.0237; Blondon M, 2016, J CLIN ENDOCR METAB, V101, P2348, DOI 10.1210/jc.2016-1368; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Calton EK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141770; Carvalho LSF, 2015, ATHEROSCLEROSIS, V241, P729, DOI 10.1016/j.atherosclerosis.2015.06.034; Choi KY, 2012, KOREAN CIRC J, V42, P100, DOI 10.4070/kcj.2012.42.2.100; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Forman JP, 2010, HYPERTENSION, V55, P1283, DOI 10.1161/HYPERTENSIONAHA.109.148619; Fraser A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013882; Gao JB, 2015, CLIN CHIM ACTA, V450, P176, DOI 10.1016/j.cca.2015.08.014; Harris RA, 2011, AM J HYPERTENS, V24, P557, DOI 10.1038/ajh.2011.12; Hobson SR, 2016, PREGNANCY HYPERTENS, V6, P130, DOI 10.1016/j.preghy.2016.03.001; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Isenberg JS, 2006, CARDIOVASC RES, V71, P785, DOI 10.1016/j.cardiores.2006.05.024; Kaur S, 2010, J BIOL CHEM, V285, P38923, DOI 10.1074/jbc.M110.172304; Krishna SM, 2013, INT J CARDIOL, V168, P692, DOI 10.1016/j.ijcard.2013.04.139; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Li Y, 2005, IEEE COMMUN LETT, V9, P1, DOI 10.1109/LCOMM.200501010; Looker AC, 2002, BONE, V30, P771, DOI 10.1016/S8756-3282(02)00692-0; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; Ngo DTM, 2011, NITRIC OXIDE-BIOL CH, V25, P326, DOI 10.1016/j.niox.2011.06.005; Ngo DT, 2010, AM J MED, V123, P335, DOI 10.1016/j.amjmed.2009.09.024; OKABEKADO J, 1991, ANTICANCER RES, V11, P181; Roberts DD, 2012, MATRIX BIOL, V31, P162, DOI 10.1016/j.matbio.2012.01.005; Rochette L, 2013, PHARMACOL THERAPEUT, V140, P239, DOI 10.1016/j.pharmthera.2013.07.004; Rogers NM, 2014, MATRIX BIOL, V37, P92, DOI 10.1016/j.matbio.2014.01.002; Scragg R, 2007, AM J HYPERTENS, V20, P713, DOI 10.1016/j.amjhyper.2007.01.017; Smadja DM, 2011, ARTERIOSCL THROM VAS, V31, P551, DOI 10.1161/ATVBAHA.110.220624; Sugden JA, 2008, DIABETIC MED, V25, P320, DOI 10.1111/j.1464-5491.2007.02360.x; Sverdlov AL, 2012, EUR HEART J, V33, P2419, DOI 10.1093/eurheartj/ehs171; Szeto FL, 2012, MOL ENDOCRINOL, V26, P1091, DOI 10.1210/me.2011-1329; Talmor Y, 2008, AM J PHYSIOL-RENAL, V294, pF1059, DOI 10.1152/ajprenal.00051.2008; Temmerman JC, 2011, J AM COLL NUTR, V30, P167, DOI 10.1080/07315724.2011.10719956; Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang TT, 2005, MOL ENDOCRINOL, V19, P2685, DOI 10.1210/me.2005-0106; Woeckel VJ, 2013, J CELL PHYSIOL, V228, P2167, DOI 10.1002/jcp.24388; Wong MSK, 2010, AM J PHYSIOL-HEART C, V299, pH1226, DOI 10.1152/ajpheart.00288.2010; Wu-Wong JR, 2007, J VASC RES, V44, P11, DOI 10.1159/000097812; Wu-Wong JR, 2006, ATHEROSCLEROSIS, V186, P20, DOI 10.1016/j.atherosclerosis.2005.06.046; Yndestad A, 2009, J APPL PHYSIOL, V106, P1356, DOI 10.1152/japplphysiol.90719.2008; Zittermann A, 2008, CURR OPIN CLIN NUTR, V11, P752, DOI 10.1097/MCO.0b013e328312c33f	46	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0174435	10.1371/journal.pone.0174435	http://dx.doi.org/10.1371/journal.pone.0174435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489857	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000401314100003
J	Anjum, M; Budgen, D				Anjum, Maria; Budgen, David			An investigation of modelling and design for software service applications	PLOS ONE			English	Article							FRAMEWORK	Software services offer the opportunity to use a component-based approach for the design of applications. However, this needs a deeper understanding of how to develop service-based applications in a systematic manner, and of the set of properties that need to be included in the `design model'. We have used a realistic application to explore systematically how service-based designs can be created and described. We first identified the key properties of an SOA (service oriented architecture) and then undertook a single-case case study to explore its use in the development of a design for a large-scale application in energy engineering, modelling this with existing notations wherever possible. We evaluated the resulting design model using two walkthroughs with both domain and application experts. We were able to successfully develop a design model around the ten properties identified, and to describe it by adapting existing design notations. A component-based approach to designing such systems does appear to be feasible. However, it needs the assistance of a more integrated set of notations for describing the resulting design model.	[Anjum, Maria] Lahore Coll Women Univ, Dept Comp Sci, Lahore, Pakistan; [Anjum, Maria; Budgen, David] Univ Durham, Sci Labs, Sch Engn & Comp Sci, South Rd, Durham DH1 3LE, England	Durham University	Anjum, M (corresponding author), Lahore Coll Women Univ, Dept Comp Sci, Lahore, Pakistan.; Anjum, M (corresponding author), Univ Durham, Sci Labs, Sch Engn & Comp Sci, South Rd, Durham DH1 3LE, England.	maria.anjum@gmail.com		Budgen, David/0000-0001-7143-0241				Ali N, 2010, P 2 INT WORKSH PRINC, P8; Amir R, 2004, 19 ANN ACM SIGPLAN C, P192; Anjum M., 2012, Proceedings of the 2012 IEEE 36th IEEE Annual Computer Software and Applications Conference Workshops (COMPSACW), P538, DOI 10.1109/COMPSACW.2012.100; Anjum M., 2012, P 16 INT C EV ASS SO, P57; [Anonymous], 2008, IEEESTD159712008, pc1, DOI [10.1109/IEEESTD.2008.4601584, DOI 10.1109/IEEESTD.2008.4601584]; [Anonymous], 2005, RES INFORM SYSTEMS C; Ardissono L, 2006, LECT NOTES COMPUT SC, V4344, P2; Baresi L., 2004, ICSOC 04, P193, DOI DOI 10.1145/1035167.1035195; Bianculli D, 2007, IW SOSWE 07, P15; Booth A, 2016, SYSTEMATIC APPROACHE; Bratthall L., 2002, EMPIR SOFTW ENG, V7, P9, DOI [DOI 10.1023/A:1014866909191, 10.1023/A:1014866909191]; Brereton P, 1999, COMMUN ACM, V42, P78, DOI 10.1145/322796.322813; Budgen D., 2004, Proceedings of the 28th Annual International Computer Software and Applications Conference. COMPSAC 2004, P16, DOI 10.1109/CMPSAC.2004.1342800; Budgen D., 2003, SOFTWARE DESIGN; Cheng Y, 2008, IEEE COMMUN MAG, V46, P138, DOI 10.1109/MCOM.2008.4511662; Cipcigan L., 2009, INT J RENEW ENERGY T, V1, P173, DOI [DOI 10.1504/IJRET.2009.027989, 10.1504/ijret.2009.027989]; DeMarco T, 1979, STRUCTURED ANAL SYST, DOI [10.1007/978-3-642-48354-7_9, DOI 10.1007/978]; Detienne F, 2002, SPRINGER PRACTITIONE; Dijkstra E.W., 1976, DISCIPLINE PROGRAMMI, V1; Erradi A, 2006, P IEEE I C SERV COMP, P151, DOI 10.1109/SCC.2006.97; Espinha T, 2012, EUR CON SFTWR MTNCE, P391, DOI 10.1109/CSMR.2012.49; Garousi V, 2010, IEEE T EDUC, V53, P182, DOI 10.1109/TE.2008.2010994; Gu Q, 2007, 2 INT WORKSH SERV OR, P1, DOI DOI 10.1145/1294928.1294930; GUINDON R, 1990, INT J MAN MACH STUD, V33, P279, DOI 10.1016/S0020-7373(05)80120-8; Karhunen H, 2005, 2005 International Conference on Services Systems and Services Management, Vols 1 and 2, Proceedings, P1199; Kitchenham BA, 2011, INFORM SOFTWARE TECH, V53, P638, DOI 10.1016/j.infsof.2010.12.011; Laliwala Zakir, 2008, 2008 International Conference on Service Systems and Service Management (ICSSSM 2008), P1, DOI 10.1109/ICSSSM.2008.4598452; Laplante Phillip A., 2008, IT Professional, V10, P46, DOI 10.1109/MITP.2008.60; Lopez-Sanza M, 2008, ELECTRON NOTES THEOR, V194, P23, DOI 10.1016/j.entcs.2008.03.097; Mahdavi-Hezavehi S, 2012, INFORM SOFTWARE TECH; Moody DL, 2009, IEEE T SOFTWARE ENG, V35, P756, DOI 10.1109/TSE.2009.67; Muller B., 2012, ENERGY EVERYWHERE PI, P68; Offermann P, 2009, P 17 EUR C INF SYST; Papazoglou M. P., 2006, International Journal of Web Engineering and Technology, V2, P412, DOI 10.1504/IJWET.2006.010423; Petre M, 2013, PROCEEDINGS OF THE 35TH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING (ICSE 2013), P722, DOI 10.1109/ICSE.2013.6606618; Runeson P., 2012, GUIDELINES EXAMPLES, DOI DOI 10.1002/9781118181034; Seaman CB, 1999, IEEE T SOFTWARE ENG, V25, P557, DOI 10.1109/32.799955; SIMPSON HR, 1979, COMPUT J, V22, P332, DOI 10.1093/comjnl/22.4.332; Smith GA, 2000, IEE P-ELECT POW APPL, V147, P1, DOI 10.1049/ip-epa:20000004; Stojanovic Z, 2004, IEEE SYS MAN CYBERN, P4147; Turner M, 2003, COMPUTER, V36, P38, DOI 10.1109/MC.2003.1236470; Venables Mark, 2012, Engineering & Technology, V7, P20, DOI 10.1049/et.2012.1100; Visser J.-M., 1990, PSYCHOL PROGRAMMING, P235; Wada H, 2006, P IEEE I C SERV COMP, P222, DOI 10.1109/SCC.2006.74; WEINBERG GM, 1984, IEEE T SOFTWARE ENG, V10, P68, DOI 10.1109/TSE.1984.5010200; Wieringa R, 2006, REQUIR ENG, V11, P102, DOI 10.1007/s00766-005-0021-6; Wieringa R, 1998, ACM COMPUT SURV, V30, P459, DOI 10.1145/299917.299919; Yin R.K., 2009, CASE STUDY RES DESIG, V4th ed., DOI [10.33524/cjar.v14i1.73, DOI 10.33524/CJAR.V14I1.73]; Yourdon E, 1989, STRUCTURED WALKTHROU; Zhang T, 2006, INT CONF QUAL SOFTW, P219	50	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176936	10.1371/journal.pone.0176936	http://dx.doi.org/10.1371/journal.pone.0176936			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489905	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000401314100037
J	Brouwer, MJ; Kersbergen, KJ; van Kooij, BJM; Benders, MJNL; van Haastert, IC; Koopman-Esseboom, C; Neil, JJ; de Vries, LS; Kidokoro, H; Inder, TE; Groenendaal, F				Brouwer, Margaretha J.; Kersbergen, Karina J.; van Kooij, Britt J. M.; Benders, Manon J. N. L.; van Haastert, Ingrid C.; Koopman-Esseboom, Corine; Neil, Jeffrey J.; de Vries, Linda S.; Kidokoro, Hiroyuki; Inder, Terrie E.; Groenendaal, Floris			Preterm brain injury on term-equivalent age MRI in relation to perinatal factors and neurodevelopmental outcome at two years	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; MAGNETIC-RESONANCE; WHITE-MATTER; PREMATURE-INFANTS; CEREBRAL-PALSY; MOTOR FUNCTION; GROWTH; BORN; ABNORMALITIES; CEREBELLUM	Objectives First, to apply a recently extended scoring system for preterm brain injury at term-equivalent age (TEA-)MRI in a regional extremely preterm cohort; second, to identify independent perinatal factors associated with this score; and third, to assess the prognostic value of this TEA-MRI score with respect to early neurodevelopmental outcome. Study design 239 extremely preterm infants (median gestational age [range] in weeks: 26.6 [24.3-27.9]), admitted to the Wilhelmina Children's Hospital between 2006 and 2012 were included. Brain abnormalities in white matter, cortical and deep grey matter and cerebellum and brain growth were scored on T1-and T2-weighted TEA-MRI using the Kidokoro scoring system. Neurodevelopmental outcome was assessed at two years corrected age using the Bayley Scales of Infant and Toddler Development, third edition. The association between TEA-MRI and perinatal factors as well as neurodevelopmental outcome was evaluated using multivariable regression analysis. Results The distribution of brain abnormalities and brain metrics in the Utrecht cohort differed from the original St. Louis cohort (p < .05). Mechanical ventilation > 7 days ( [95% confidence interval, CI]: 1.3 [. 5; 2.0]) and parenteral nutrition > 21 days (2.2 [1.2; 3.2]) were independently associated with higher global brain abnormality scores (p < .001). Global brain abnormality scores were inversely associated with cognitive (a in composite scores [95% CI]: -.7 [-1.2; -.2], p = .004), fine motor (a in scaled scores [95% CI]: -.1 [-.3; -.0], p = .007) and gross motor outcome (beta in scaled scores [ 95% CI]: -.2 [-.3; -.1], p < .001) at two years corrected age, although the explained variances were low (R-2 <=.219). Conclusion Patterns of brain injury differed between cohorts. Prolonged mechanical ventilation and parenteral nutrition were identified as independent perinatal risk factors. The prognostic value of the TEA-MRI score was rather limited in this well-performing cohort.	[Brouwer, Margaretha J.; Kersbergen, Karina J.; van Kooij, Britt J. M.; Benders, Manon J. N. L.; van Haastert, Ingrid C.; Koopman-Esseboom, Corine; de Vries, Linda S.; Groenendaal, Floris] Wilhelmina Childrens Hosp, Dept Perinatol, Utrecht, Netherlands; [Brouwer, Margaretha J.; Kersbergen, Karina J.; van Kooij, Britt J. M.; Benders, Manon J. N. L.; van Haastert, Ingrid C.; Koopman-Esseboom, Corine; de Vries, Linda S.; Groenendaal, Floris] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Neil, Jeffrey J.] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Kidokoro, Hiroyuki] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi, Japan; [Kidokoro, Hiroyuki] Nagoya Univ, Brain & Mind Res Ctr, Nagoya, Aichi, Japan; [Inder, Terrie E.] Brigham & Womens Hosp, Dept Pediat Newborn Med, Boston, MA 02115 USA	Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Harvard University; Boston Children's Hospital; Nagoya University; Nagoya University; Harvard University; Brigham & Women's Hospital	Groenendaal, F (corresponding author), Wilhelmina Childrens Hosp, Dept Perinatol, Utrecht, Netherlands.	f.groenendaal@umcutrecht.nl	Kidokoro, Hiroyuki/AGN-1205-2022; de Vries, Linda S/AAB-6454-2021; Groenendaal, Floris/P-6872-2019	Kidokoro, Hiroyuki/0000-0002-7991-8580; Groenendaal, Floris/0000-0002-9284-1637	ZonMW [LSHM-CT-2006-036534]; The Netherlands Organization for Health Research and Development [94527022]; Wilhelmina Research Fund [10-427]; Alexander Suerman MD/ PhD Stipendium of the University Medical Center Utrecht	ZonMW(Netherlands Organization for Health Research and Development); The Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Wilhelmina Research Fund; Alexander Suerman MD/ PhD Stipendium of the University Medical Center Utrecht	This study includes infants participating in the Neobrain study (LSHM-CT-2006-036534) as well as infants participating in two studies funded by, respectively, the ZonMW, The Netherlands Organization for Health Research and Development, project 94527022, and Wilhelmina Research Fund (10-427). Margaretha J. Brouwer received a grant from the Alexander Suerman MD/ PhD Stipendium of the University Medical Center Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alders M, 2001, CLASSIFICATION POPUL; Allin M, 2001, BRAIN, V124, P60, DOI 10.1093/brain/124.1.60; Aylward GP, 2002, MENT RETARD DEV D R, V8, P234, DOI 10.1002/mrdd.10043; Ball G, 2010, NEUROIMAGE, V53, P94, DOI 10.1016/j.neuroimage.2010.05.055; Bayley N., 2019, BAYLEY SCALES INFANT; Boardman JP, 2010, NEUROIMAGE, V52, P409, DOI 10.1016/j.neuroimage.2010.04.261; Boardman JP, 2007, ANN NEUROL, V62, P185, DOI 10.1002/ana.21171; Brouwer AJ, 2012, NEONATOLOGY, V101, P210, DOI 10.1159/000331797; Brouwer A, 2008, J PEDIATR-US, V152, P648, DOI 10.1016/j.jpeds.2007.10.005; Brouwer MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109556; Childs AM, 2001, CLIN RADIOL, V56, P647, DOI 10.1053/crad.2001.0754; de Bruine FT, 2011, RADIOLOGY, V261, P899, DOI 10.1148/radiol.11110797; de Vries LS, 2011, SEMIN FETAL NEONAT M, V16, P279, DOI 10.1016/j.siny.2011.04.004; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Ehrenkranz RA, 1999, PEDIATRICS, V104, P280, DOI 10.1542/peds.104.2.280; Hay Jr WW, 2013, CURR PEDIAT REP, V1; Inder TE, 2003, J PEDIATR-US, V143, P171, DOI 10.1067/S0022-3476(03)00357-3; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kaukola T, 2009, ACTA PAEDIATR, V98, P990, DOI 10.1111/j.1651-2227.2009.01268.x; Keunen K, 2015, PEDIATR RES, V77, P148, DOI 10.1038/pr.2014.171; Kidokoro H, 2013, AM J NEURORADIOL, V34, P2208, DOI 10.3174/ajnr.A3521; Latal B, 2009, PEDIATR NEUROL, V40, P413, DOI 10.1016/j.pediatrneurol.2009.01.008; LEVENE MI, 1981, ARCH DIS CHILD, V56, P900, DOI 10.1136/adc.56.12.900; Limperopoulos C, 2007, PEDIATRICS, V120, P584, DOI 10.1542/peds.2007-1041; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Omizzolo C, 2014, MEMORY, V22, P605, DOI 10.1080/09658211.2013.809765; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Parikh NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062804; Rosenbaum PL, 2008, DEV MED CHILD NEUROL, V50, P249, DOI 10.1111/j.1469-8749.2008.02045.x; Short EJ, 2003, PEDIATRICS, V112, pE359, DOI 10.1542/peds.112.5.e359; Spittle AJ, 2011, DEV MED CHILD NEUROL, V53, P1000, DOI 10.1111/j.1469-8749.2011.04095.x; Thompson DK, 2007, BRAIN, V130, P667, DOI 10.1093/brain/awl277; van Haastert IC, 2011, J PEDIATR-US, V159, P86, DOI 10.1016/j.jpeds.2010.12.053; Van Kooij BJM, 2012, DEV MED CHILD NEUROL, V54, P260, DOI 10.1111/j.1469-8749.2011.04168.x; van't Hooft J, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0058-7; Vinall J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004666; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Volpe JJ, 2009, J CHILD NEUROL, V24, P1085, DOI 10.1177/0883073809338067; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792	39	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177128	10.1371/journal.pone.0177128	http://dx.doi.org/10.1371/journal.pone.0177128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486543	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314000047
J	Brusco, M; Stolze, HJ; Hoffman, M; Steinley, D				Brusco, Michael; Stolze, Hannah J.; Hoffman, Michaela; Steinley, Douglas			A simulated annealing heuristic for maximum correlation core/periphery partitioning of binary networks	PLOS ONE			English	Article							MODELS; OPTIMIZATION	A popular objective criterion for partitioning a set of actors into core and periphery subsets is the maximization of the correlation between an ideal and observed structure associated with intra-core and intra-periphery ties. The resulting optimization problem has commonly been tackled using heuristic procedures such as relocation algorithms, genetic algorithms, and simulated annealing. In this paper, we present a computationally efficient simulated annealing algorithm for maximum correlation core/periphery partitioning of binary networks. The algorithm is evaluated using simulated networks consisting of up to 2000 actors and spanning a variety of densities for the intra-core, intra-periphery, and inter-core-periphery components of the network. Core/periphery analyses of problem solving, trust, and information sharing networks for the frontline employees and managers of a consumer packaged goods manufacturer are provided to illustrate the use of the model.	[Brusco, Michael] Florida State Univ, Dept Mkt, Tallahassee, FL 32306 USA; [Stolze, Hannah J.] Wheaton Coll, Dept Econ & Business, Wheaton, IL 60187 USA; [Hoffman, Michaela; Steinley, Douglas] Univ Missouri, Dept Psychol Sci, Columbia, MO USA	State University System of Florida; Florida State University; Wheaton College; University of Missouri System; University of Missouri Columbia	Brusco, M (corresponding author), Florida State Univ, Dept Mkt, Tallahassee, FL 32306 USA.	steinleyd@missouri.edu			NIH [R21AA022074]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The only funding to support this work was the NIH grant mentioned - R21AA022074, awarded to Douglas Steinley. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E., 2005, SEARCH METHODOLOGIES, P187, DOI 10.1007/0-387-28356-0_7; [Anonymous], [No title captured]; [Anonymous], 1981, MANAGING MULTIORGANI; [Anonymous], 2005, MODELS METHODS SOCIA, DOI [10.1017/cbo9780511811395.004, DOI 10.1017/CBO9780511811395.004]; Baker D. R., 1992, J SOCIAL SERVICE RES, V15, P153, DOI [DOI 10.1300/J079V15N03_09, DOI 10.1300/J079V15N03_]; BATAGELJ V, 1992, SOC NETWORKS, V14, P63, DOI 10.1016/0378-8733(92)90014-X; Borgatti S. P., 2002, UCINET WINDOWS VERSI; Borgatti SP, 1999, SOC NETWORKS, V21, P375; Boyd JP, 2010, SOC NETWORKS, V32, P125, DOI 10.1016/j.socnet.2009.09.003; Boyd JP, 2006, SOC NETWORKS, V28, P165, DOI 10.1016/j.socnet.2005.06.003; Brewer DD, 2000, SOC NETWORKS, V22, P29, DOI 10.1016/S0378-8733(99)00017-9; Brusco M, 2011, SOC NETWORKS, V33, P201, DOI 10.1016/j.socnet.2011.05.001; Brusco M, 2011, SOC NETWORKS, V33, P12, DOI 10.1016/j.socnet.2010.08.002; Brusco MJ, 2014, COMPUT STAT DATA AN, V77, P38, DOI 10.1016/j.csda.2014.03.001; CERNY V, 1985, J OPTIMIZ THEORY APP, V45, P41, DOI 10.1007/BF00940812; Csermely P, 2013, J COMPLEX NETW, V1, P93, DOI 10.1093/comnet/cnt016; Everett MG, 1999, SOC NETWORKS, V21, P397; Glover F., 1993, MODERN HEURISTIC TEC, P70; Goldberg D.E., 1989, GENETIC ALGORITHMS; Groenen PJF, 1996, PSYCHOMETRIKA, V61, P529, DOI 10.1007/BF02294553; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; KERNIGHAN BW, 1970, BELL SYST TECH J, V49, P221; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lee JS, 2012, HDB OPTIMIZATION CLA, P395; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mladenovic N, 1997, COMPUT OPER RES, V24, P1097, DOI 10.1016/S0305-0548(97)00031-2; Muniz ASG, 2006, SOC NETWORKS, V28, P442, DOI 10.1016/j.socnet.2005.11.001; Nourani Y, 1998, J PHYS A-MATH GEN, V31, P8373, DOI 10.1088/0305-4470/31/41/011; van der Ark LA, 2008, PSYCHOMETRIKA, V73, P183, DOI 10.1007/s11336-007-9034-z; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0170448	10.1371/journal.pone.0170448	http://dx.doi.org/10.1371/journal.pone.0170448			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486475	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000001
J	Goodwin, JM; Rana, H; Ndungu, J; Chakrabarti, G; Moomaw, EW				Goodwin, John M.; Rana, Hassan; Ndungu, Joan; Chakrabarti, Gaurab; Moomaw, Ellen W.			Hydrogen peroxide inhibition of bicupin oxalate oxidase	PLOS ONE			English	Article							SEED STORAGE PROTEINS; BACILLUS-SUBTILIS; MICROBIAL RELATIVES; SPECIFICITY SWITCH; PANCREATIC-CANCER; CUPIN SUPERFAMILY; MEMBRANE INLET; NITRIC-OXIDE; DECARBOXYLASE; OXIDATION	Oxalate oxidase is a manganese containing enzyme that catalyzes the oxidation of oxalate to carbon dioxide in a reaction that is coupled with the reduction of oxygen to hydrogen peroxide. Oxalate oxidase from Ceriporiopsis subvermispora (CsOxOx) is the first fungal and bicupin enzyme identified that catalyzes this reaction. Potential applications of oxalate oxidase for use in pancreatic cancer treatment, to prevent scaling in paper pulping, and in bio-fuel cells have highlighted the need to understand the extent of the hydrogen peroxide inhibition of the CsOxOx catalyzed oxidation of oxalate. We apply a membrane inlet mass spectrometry (MIMS) assay to directly measure initial rates of carbon dioxide formation and oxygen consumption in the presence and absence of hydrogen peroxide. This work demonstrates that hydrogen peroxide is both a reversible noncompetitive inhibitor of the CsOxOx catalyzed oxidation of oxalate and an irreversible inactivator. The build-up of the turnover-generated hydrogen peroxide product leads to the inactivation of the enzyme. The introduction of catalase to reaction mixtures protects the enzyme from inactivation allowing reactions to proceed to completion. Circular dichroism spectra indicate that no changes in global protein structure take place in the presence of hydrogen peroxide. Additionally, we show that the CsOxOx catalyzed reaction with the three carbon substrate mesoxalate consumes oxygen which is in contrast to previous proposals that it catalyzed a non-oxidative decarboxylation with this substrate.	[Goodwin, John M.; Rana, Hassan; Ndungu, Joan; Moomaw, Ellen W.] Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA; [Chakrabarti, Gaurab] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol Oncol & Radiat Oncol, Dallas, TX 75390 USA; [Chakrabarti, Gaurab] Univ Texas Southwestern Med Ctr Dallas, Lab Mol Stress Responses, Dallas, TX 75390 USA; [Chakrabarti, Gaurab] Univ Texas Southwestern Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	University System of Georgia; Kennesaw State University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Moomaw, EW (corresponding author), Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA.	emoomaw@kennesaw.edu			National Science Foundation [MRI- 1337781, MCB1041912]; Kennesaw State University Office of the Vice President of Research; Kennesaw State University College of Science and Mathematics	National Science Foundation(National Science Foundation (NSF)); Kennesaw State University Office of the Vice President of Research; Kennesaw State University College of Science and Mathematics	This work was supported by National Science Foundation (MRI- 1337781 and MCB1041912), the Kennesaw State University Office of the Vice President of Research, and the Kennesaw State University College of Science and Mathematics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge helpful discussions with Kennesaw State University colleagues Chris Dockery, John Haseltine, Chris Alexander, Daniela Tapu, and Marina Koether. We gratefully acknowledge the support provided by the National Science Foundation (MRI-1337781 and MCB-1041912), the Kennesaw State University Office of the Vice President of Research, and the Kennesaw State University College of Science and Mathematics. We are also grateful for the support and collaboration that we have received from Hiden Analytical.	Baid R, 2013, J BIOL CHEM, V288, P17372, DOI 10.1074/jbc.M112.441618; Burrell MR, 2007, BIOCHEMISTRY-US, V46, P12327, DOI 10.1021/bi700947s; Carrillo MC, 2008, PHYTOPATHOLOGY, V98, pS31; Chakrabarti G, 2015, THESIS; Chakrabarti G, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0137-1; CHIRIBOGA J, 1963, BIOCHEM BIOPH RES CO, V11, P277, DOI 10.1016/0006-291X(63)90557-6; CHIRIBOGA J, 1966, ARCH BIOCHEM BIOPHYS, V116, P516, DOI 10.1016/0003-9861(66)90057-9; Ciriminna R, 2003, ADV SYNTH CATAL, V345, P383, DOI 10.1002/adsc.200390043; Cleland W. W., 1979, METHOD ENZYMOL, V62, P151; Cook P. F., 2007, ENZYME KINETICS MECH; Du JA, 2010, CLIN CANCER RES, V16, P509, DOI 10.1158/1078-0432.CCR-09-1713; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Dunwell JM, 1998, BIOTECHNOL GENET ENG, V15, P1; Dunwell JM, 1998, J MOL EVOL, V46, P147, DOI 10.1007/PL00006289; Escutia MR, 2005, APPL ENVIRON MICROB, V71, P3608, DOI 10.1128/AEM.71.7.3608-3616.2005; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hickey DP, 2014, J AM CHEM SOC, V136, P15917, DOI 10.1021/ja5098379; Imaram W, 2011, FREE RADICAL BIO MED, V50, P1009, DOI 10.1016/j.freeradbiomed.2011.01.023; Kotsira VP, 1997, ARCH BIOCHEM BIOPHYS, V340, P239, DOI 10.1006/abbi.1997.9896; Lane BG, 2000, BIOCHEM J, V349, P309, DOI 10.1042/0264-6021:3490309; Lardinois OM, 1996, BBA-PROTEIN STRUCT M, V1295, P222, DOI 10.1016/0167-4838(96)00043-X; Larsson S, 2003, ACS SYM SER, V855, P81, DOI 10.1021/bk-2003-0855.ch005; LEEK AE, 1972, BIOCHEM J, V128, pP87; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moomaw EW, 2014, BIOCHEM BIOPH RES CO, V450, P750, DOI 10.1016/j.bbrc.2014.06.040; Moomaw EW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057933; Moral MEG, 2011, CHEM COMMUN, V47, P3111, DOI 10.1039/c0cc04946h; Moussatche P, 2011, ARCH BIOCHEM BIOPHYS, V509, P100, DOI 10.1016/j.abb.2011.02.022; Nilvebrant NO, 2002, ABSTR PAP AM CHEM S, V223, pU125; PUNDIR CS, 1993, INDIAN J BIOCHEM BIO, V30, P54; Rana Hassan, 2016, Biochem Biophys Rep, V5, P396, DOI 10.1016/j.bbrep.2016.01.016; Requena L, 1999, BIOCHEM J, V343, P185, DOI 10.1042/0264-6021:3430185; SATYAPAL, 1993, BIOCHIM BIOPHYS ACTA, V1161, P1, DOI 10.1016/0167-4838(93)90188-W; SCHIMERLIK MI, 1973, J BIOL CHEM, V248, P8418; Segel IH, 1975, ENZYME KINETICS BEHA; SELWYN MJ, 1965, BIOCHIM BIOPHYS ACTA, V105, P193, DOI 10.1016/S0926-6593(65)80190-4; SHIMAZONO H, 1955, J BIOCHEM-TOKYO, V42, P321, DOI 10.1093/oxfordjournals.jbchem.a126533; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Svedruzic D, 2005, ARCH BIOCHEM BIOPHYS, V433, P176, DOI 10.1016/j.abb.2004.08.032; Svedruzic D, 2007, ARCH BIOCHEM BIOPHYS, V464, P36, DOI 10.1016/j.abb.2007.03.016; Tu C, 2007, FREE RADICAL BIO MED, V43, P1453, DOI 10.1016/j.freeradbiomed.2007.07.026; Twahir UT, 2015, FREE RADICAL BIO MED, V80, P59, DOI 10.1016/j.freeradbiomed.2014.12.012; Twahir UT, 2016, BIOCHEMISTRY; Urbansky ET, 2000, J CHROMATOGR A, V867, P143, DOI 10.1016/S0021-9673(99)01158-9; VAISEY EB, 1961, ARCH BIOCHEM BIOPHYS, V95, P66, DOI 10.1016/0003-9861(61)90109-6; VARALAKSHMI P, 1992, BIOCHEM INT, V26, P153; Whittaker MM, 2007, J BIOL CHEM, V282, P7011, DOI 10.1074/jbc.M609374200; Whittaker MM, 2002, J BIOL INORG CHEM, V7, P136, DOI 10.1007/s007750100281; Xu S, 2012, ACS CATAL, V2, P91, DOI 10.1021/cs200523s; Zhu W, 2016, BIOCHEMISTRY-US, V55, P2163, DOI 10.1021/acs.biochem.6b00043; Zhu W, 2016, BIOCHEMISTRY-US, V55, P429, DOI 10.1021/acs.biochem.5b01340	53	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177164	10.1371/journal.pone.0177164	http://dx.doi.org/10.1371/journal.pone.0177164			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486485	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314000051
J	Lumber, R; Richardson, M; Sheffield, D				Lumber, Ryan; Richardson, Miles; Sheffield, David			Beyond knowing nature: Contact, emotion, compassion, meaning, and beauty are pathways to nature connection	PLOS ONE			English	Article							ENVIRONMENTAL CONCERN; CONNECTEDNESS; BIOPHILIA; PEOPLE; SCALE	Feeling connected to nature has been shown to be beneficial to wellbeing and pro-environmental behaviour. General nature contact and knowledge based activities are often used in an attempt to engage people with nature. However the specific routes to nature connectedness have not been examined systematically. Two online surveys (total n = 321) of engagement with, and value of, nature activities structured around the nine values of the Biophila Hypothesis were conducted. Contact, emotion, meaning, and compassion, with the latter mediated by engagement with natural beauty, were predictors of connection with nature, yet knowledge based activities were not. In a third study (n = 72), a walking intervention with activities operationalising the identified predictors, was found to significantly increase connection to nature when compared to walking in nature alone or walking in and engaging with the built environment. The findings indicate that contact, emotion, meaning, compassion, and beauty are pathways for improving nature connectedness. The pathways also provide alternative values and frames to the traditional knowledge and identification routes often used by organisations when engaging the public with nature.	[Lumber, Ryan] De Montfort Univ, Sch Appl Social Sci, Leicester, Leics, England; [Richardson, Miles; Sheffield, David] Univ Derby, Dept Life Sci, Coll Life & Nat Sci, Derby, England	De Montfort University; University of Derby	Lumber, R (corresponding author), De Montfort Univ, Sch Appl Social Sci, Leicester, Leics, England.	ryan.lumber@dmu.ac.uk		Richardson, Miles/0000-0002-7223-7053; Sheffield, David/0000-0001-9121-1783; Lumber, Ryan/0000-0002-6308-2221				[Anonymous], DIVERSITY LIFE; Beery TH, 2014, J ENVIRON PSYCHOL, V40, P198, DOI 10.1016/j.jenvp.2014.06.006; Beery TH, 2013, ENVIRON EDUC RES, V19, P94, DOI 10.1080/13504622.2012.688799; Blackmore E., 2013, COMMON CAUSE NATURE; Bruni C. M., 2015, ENVIRON EDUC RES, P1, DOI [10.1080/13504622.2015.1074659, DOI 10.1080/13504622.2015.1074659]; Capaldi CA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00976; Charlton Noel G., 2008, UNDERSTANDING GREGOR; Clayton S.D., 2012, OXFORD HDB ENV CONSE, P45, DOI [DOI 10.1093/OXFORDHB/9780199733026.013.0029, 10.1093/oxfordhb/9780199733026.013.0010, DOI 10.1093/OXFORDHB/9780199733026.013.0010]; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Cox DTC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141505; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cristancho Sergio, 2004, HUM ECOL REV, V11, P36; Davis JL, 2011, J ENVIRON PSYCHOL, V31, P257, DOI 10.1016/j.jenvp.2011.01.004; Ernst J, 2011, ENVIRON EDUC RES, V17, P577, DOI 10.1080/13504622.2011.565119; Feral C. H., 1998, HUMANISTIC PSYCHOL, V26, P243, DOI DOI 10.1080/08873267.1998.9976975; Gullone E., 2000, J HAPPINESS STUD, V1, P293; Hartig T, 2011, FORESTS, TREES AND HUMAN HEALTH, P127, DOI 10.1007/978-90-481-9806-1_5; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hinds J, 2008, J ENVIRON PSYCHOL, V28, P109, DOI 10.1016/j.jenvp.2007.11.001; Kahn P., 1999, HUMAN RELATIONSHIP N; Kahn P.H., 2011, TECHNOLOGICAL NATURE; Kahn PH, 1997, DEV REV, V17, P1, DOI 10.1006/drev.1996.0430; KAPLAN S, 1987, ENVIRON BEHAV, V19, P3, DOI 10.1177/0013916587191001; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Kellert S.R., 1993, BIOPHILIA HYPOTHESIS, P42; Lewis M, 2014, ECOHEALTH; Lieflander AK, 2013, ENVIRON EDUC RES, V19, P370, DOI 10.1080/13504622.2012.697545; Lumber R., 2017, THESIS; Maller C., 2009, G WRIGHT FORUM, V26, P51; Martin P., 2004, AUSTR J OUTDOOR ED, V8, P20, DOI [10.1007/BF03400792, DOI 10.1007/BF03400792]; Mayer FS, 2009, ENVIRON BEHAV, V41, P607, DOI 10.1177/0013916508319745; Mayer FS, 2004, J ENVIRON PSYCHOL, V24, P503, DOI 10.1016/j.jenvp.2004.10.001; McMahan EA, 2015, J POSIT PSYCHOL, V9760, P1, DOI DOI 10.1080/17439760.2014.994224; Merchant C, 2006, ISIS, V97, P513, DOI 10.1086/508090; Muller Markus M., 2009, J DEV PROCESSES, V4, P59; Newman L, 2013, ENVIRON VALUE, V22, P401, DOI 10.3197/096327113X13648087563827; Nisbet EK, 2009, ENVIRON BEHAV, V41, P715, DOI 10.1177/0013916508318748; Pedhazur EJ., 1997, MULTIPLE REGRESSION, V3rd ed; Perkins HE, 2010, J ENVIRON PSYCHOL, V30, P455, DOI 10.1016/j.jenvp.2010.05.004; Pyle RM, 2003, ORYX, V37, P206, DOI 10.1017/S0030605303000383; Richard RM, 2009, J PERS, V65, P529; Richardson M., 2015, ECOPSYCHOLOGY, V7, P166; Richardson M., 2016, EVOL PSYCHOL SCI, V2, P308; Richardson M, 2016, PSYECOLOGY, V8, P1; Richardson M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149777; Richardson M, 2015, ENVIRON VALUE, V24, P603, DOI 10.3197/096327115X14384223590131; Samson SD., 2012, ECOPSYCHOLOGY SCI TO; Sandifer PA, 2015, ECOSYST SERV, V12, P1, DOI 10.1016/j.ecoser.2014.12.007; Schmitt N, 1996, PSYCHOL ASSESSMENT, V8, P350, DOI 10.1037/1040-3590.8.4.350; Schultz PW, 2004, J ENVIRON PSYCHOL, V24, P31, DOI 10.1016/S0272-4944(03)00022-7; Schultz PW, 2001, J ENVIRON PSYCHOL, V21, P327; Simaika JP, 2010, CONSERV BIOL, V24, P903, DOI 10.1111/j.1523-1739.2010.01485.x; Tam KP, 2013, J ENVIRON PSYCHOL, V34, P64, DOI 10.1016/j.jenvp.2013.01.004; Tam KP, 2013, J EXP SOC PSYCHOL, V49, P514, DOI 10.1016/j.jesp.2013.02.001; Vining J., 2003, HUM ECOL REV, V10, P87, DOI DOI 10.2307/3802153; Vining J, 2008, HUM ECOL REV, V15, P1; White P.R., 2012, ECOPSYCHOLOGY, V4, P345, DOI [10.1089/eco.2012.0054, DOI 10.1089/ECO.2012.0054]; Windhager S, 2011, LANDSCAPE URBAN PLAN, V99, P23, DOI 10.1016/j.landurbplan.2010.08.008; Zelenski JM, 2012, ENV BEHAV; Zhang JW, 2014, J ENVIRON PSYCHOL, V38, P55, DOI 10.1016/j.jenvp.2013.12.013; Zylstra MJ, 2014, SPRINGER SCI REV; [No title captured]	62	172	176	14	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177186	10.1371/journal.pone.0177186	http://dx.doi.org/10.1371/journal.pone.0177186			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UM	28486515	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314000054
J	Valera, MC; Noirrit-Esclassan, E; Dupuis, M; Buscato, M; Vinel, A; Guillaume, M; Briaux, A; Garcia, C; Benoit, T; Lairez, O; Fontaine, C; Payrastre, B; Arnal, JF				Valera, Marie-Cecile; Noirrit-Esclassan, Emmanuelle; Dupuis, Marion; Buscato, Melissa; Vinel, Alexia; Guillaume, Maeva; Briaux, Anne; Garcia, Cedric; Benoit, Thibaut; Lairez, Olivier; Fontaine, Coralie; Payrastre, Bernard; Arnal, Jean-Francois			Effect of chronic estradiol plus progesterone treatment on experimental arterial and venous thrombosis in mouse	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; POSTMENOPAUSAL HORMONE-THERAPY; MEDROXYPROGESTERONE ACETATE; REPLACEMENT THERAPY; THROMBOEMBOLISM; RISKS; WOMEN; HRT	Postmenopausal hormone replacement therapy (HRT) with estrogen plus progestogens is the first line therapy to treat menopausal symptoms. The progestogen is added to estrogen to reduce or eliminate the excess risk of endometrial cancer due to the unopposed effect of estrogen. Whereas progestin clearly opposes the proliferative and deleterious long-term actions of estrogen on the endometrium, the interference of progestin on the other estrogen action remains unclear. We previously reported that chronic subcutaneous 17 alpha-estradiol (E2) in mice decreases platelet responsiveness, prolongs the tail-bleeding time and protects against acute thromboembolism. Here, we report the tissue-specific interference of progesterone (P4) on the action of E2 in ovariectomized mice. We first confirm that, in our experimental conditions, P4 attenuates the proliferative action of E2 on the uterus and the effects of E2 on vagina weight and lubrication. We then studied the effect of E2 combined with P4 on hemostasis and thrombosis in vivo in mice and found that P4 did not interfere with the main actions of E2 on platelets, bleeding time and arterial and venous thrombosis. Thus, whereas activation of progesterone receptor interferes with the action of E2 on its classic sex targets, P4 appears to have minimal effect on the hemostasis and thrombosis actions of E2, supporting the prominent role of estrogens and the accessory role of natural progestin on the extra-reproductive cells and tissues involved in thrombosis.	[Valera, Marie-Cecile; Noirrit-Esclassan, Emmanuelle; Dupuis, Marion; Buscato, Melissa; Vinel, Alexia; Guillaume, Maeva; Briaux, Anne; Benoit, Thibaut; Lairez, Olivier; Fontaine, Coralie; Payrastre, Bernard; Arnal, Jean-Francois] INSERM, U1048, Toulouse, France; [Valera, Marie-Cecile; Noirrit-Esclassan, Emmanuelle; Dupuis, Marion; Buscato, Melissa; Vinel, Alexia; Guillaume, Maeva; Briaux, Anne; Benoit, Thibaut; Lairez, Olivier; Fontaine, Coralie; Payrastre, Bernard; Arnal, Jean-Francois] Univ Toulouse III, I2MC, Toulouse, France; [Valera, Marie-Cecile; Noirrit-Esclassan, Emmanuelle; Vinel, Alexia] Univ Toulouse III, Fac Chirurg Dent, Toulouse, France; [Garcia, Cedric; Payrastre, Bernard] CHU Toulouse, Lab Hematol, Toulouse, France; [Benoit, Thibaut] CHU Toulouse, Serv Urol, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse	Valera, MC (corresponding author), INSERM, U1048, Toulouse, France.	marie.valera@inserm.fr	Fontaine, Coralie/N-3814-2017; Noirrit, Emmanuelle/ADK-4568-2022; Cédric, GARCIA/AAG-8785-2020; O, Lairez/B-7152-2016	Noirrit, Emmanuelle/0000-0002-7039-6405; Cédric, GARCIA/0000-0003-1566-3846; O, Lairez/0000-0001-8141-6582; ARNAL, Jean Francois/0000-0003-2229-6300; Fontaine, Coralie/0000-0002-7253-922X; , Bernard/0000-0002-8693-0190; Guillaume, Maeva/0000-0002-2782-7556; briaux, anne/0000-0001-8278-4256				Abot A, 2013, ENDOCRINOLOGY, V154, P2222, DOI 10.1210/en.2012-2059; Adlanmerini M, 2014, P NATL ACAD SCI USA, V111, pE283, DOI 10.1073/pnas.1322057111; Canonico M, 2007, CIRCULATION, V115, P840, DOI 10.1161/CIRCULATIONAHA.106.642280; Canonico M, 2015, MATURITAS, V82, P304, DOI 10.1016/j.maturitas.2015.06.040; Canonico M, 2010, ARTERIOSCL THROM VAS, V30, P340, DOI 10.1161/ATVBAHA.109.196022; Cooke PS, 1997, P NATL ACAD SCI USA, V94, P6535, DOI 10.1073/pnas.94.12.6535; DONALDSO.LE, 1970, J ENDOCRINOL, V48, P599, DOI 10.1677/joe.0.0480599; Douin-Echinard V, 2008, J IMMUNOL, V180, P3661, DOI 10.4049/jimmunol.180.6.3661; Freudenberger T, 2014, BRIT J PHARMACOL, V171, P5032, DOI 10.1111/bph.12814; Freudenberger T, 2009, BRIT J PHARMACOL, V158, P1951, DOI 10.1111/j.1476-5381.2009.00470.x; Furness S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000402.pub4; Game X, 2013, J SEX MED, V10, P1452, DOI 10.1111/jsm.12127; Geddings J, 2014, J THROMB HAEMOST, V12, P571, DOI 10.1111/jth.12510; Hoibraaten E, 2001, BRIT J HAEMATOL, V115, P415, DOI 10.1046/j.1365-2141.2001.03111.x; Karas RH, 2001, J CLIN INVEST, V108, P611; L'Hermite M, 2013, CLIMACTERIC, V16, P44, DOI 10.3109/13697137.2013.808563; L'Hermite M, 2008, MATURITAS, V60, P185, DOI 10.1016/j.maturitas.2008.07.007; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Miyagawa K, 1997, NAT MED, V3, P324, DOI 10.1038/nm0397-324; Modena MG, 2005, MATURITAS, V52, P1, DOI 10.1016/j.maturitas.2005.05.003; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Salerni S, 2015, EUR J CLIN INVEST, V45, P634, DOI 10.1111/eci.12447; Scarabin PY, 2014, CLIMACTERIC, V17, P34, DOI 10.3109/13697137.2014.956717; Scarabin PY, 2014, FRONT HORM RES, V43, P21, DOI 10.1159/000360554; Scarabin PY, 2003, LANCET, V362, P428, DOI 10.1016/S0140-6736(03)14066-4; Schnoes KK, 2008, MOL ENDOCRINOL, V22, P2544, DOI 10.1210/me.2008-0044; Shultz JM, 2004, FERTIL STERIL, V82, P1133, DOI 10.1016/j.fertnstert.2004.05.069; Stanczyk FZ, 2013, ENDOCR REV, V34, P171, DOI 10.1210/er.2012-1008; Subramaniam Saravanan, 2014, Curr Protoc Mouse Biol, V4, P151, DOI 10.1002/9780470942390.mo140140; Valera MC, 2012, BLOOD, V120, P1703, DOI 10.1182/blood-2012-01-405498; Wrobleski SK, 2011, JOVE-J VIS EXP, DOI 10.3791/2738; Zaragoza C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/497841	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177043	10.1371/journal.pone.0177043	http://dx.doi.org/10.1371/journal.pone.0177043			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486478	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000037
J	Blanco, M; Ospina-Alvarez, A; Gonzalez, C; Fernandez, M				Blanco, Marta; Ospina-Alvarez, Andres; Gonzalez, Catherine; Fernandez, Miriam			Egg production patterns of two invertebrate species in rocky subtidal areas under different fishing regimes along the coast of central Chile	PLOS ONE			English	Article							MARINE PROTECTED AREAS; SNAPPER PAGRUS-AURATUS; BENTHIC INVERTEBRATES; RESERVES; FISHERIES; CONSERVATION; COMMUNITIES; ECOSYSTEMS; MANAGEMENT; POPULATIONS	Fishing is a major source of human impact, reducing density and size of a wide range of exploited species in comparison to areas exhibiting strong regulations (no-take and partially protected areas, including Territorial Use Rights for Fisheries, TURFs). Since size and density might have important consequences on reproduction, and therefore natural re-seeding, we monitored adult size, density and potential fecundity of the keyhole limpet (Fissurella latimarginata) and the red sea urchin (Loxechinus albus) in areas under two fishing regimes (TURFs and Open Access Areas, OAAs). Analyzing the distribution of suitable habitats, we predict spatial patterns of potential egg production, to identify reproductive hotspots along the central coast of Chile. The current system of TURFs in central Chile showed higher potential egg production of F. latimarginata and of L. albus than expected under a complete OAAs scenario (67 and 52% respectively). Potential egg production showed more than a twofold reduction when the complete TURFs scenario was compared against complete OAAs condition in both species. Individual size and density explained between 60% and 100% of the variability in potential egg production, suggesting the importance of the enhancement of both biological variables in TURFs in Chile. Potential egg production for both species in the northern part of the studied domain was higher due to the combined effect of (a) suitable habitat and (b) concentration of TURFs. Our results suggest that partially protected areas, such as TURFs can significantly enhance the production of propagules that could seed exploited areas.	[Blanco, Marta; Ospina-Alvarez, Andres; Gonzalez, Catherine; Fernandez, Miriam] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Nucleo Milenio,CCM,ECIM, Santiago, Chile; [Fernandez, Miriam] Pontificia Univ Catolica Chile, Dept Ecol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Blanco, M (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Nucleo Milenio,CCM,ECIM, Santiago, Chile.	marblasa@gmail.com	Ospina-Alvarez, Andres/M-2556-2014	Ospina-Alvarez, Andres/0000-0003-2454-7169; Blanco, Marta/0000-0002-8172-7628	Fundacion Mutua Madrilena; Fondecyt [3150425, 1130976]; Iniciativa Cientifica Milenio from the Ministerio de Economia, Fomento y Turismo de Chile [CCM RC 1300004]	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifica Milenio from the Ministerio de Economia, Fomento y Turismo de Chile	We thank Fundacion Mutua Madrilena (MB), Fondecyt 3150425 (AO), Fondecyt 1130976 (MF) and the Iniciativa Cientifica Milenio CCM RC 1300004 from the Ministerio de Economia, Fomento y Turismo de Chile.	Aburto-Oropeza O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023601; Afflerbach JC, 2014, GLOB ECOL CONSERV; Anger K, 1998, J CRUSTACEAN BIOL, V18, P823, DOI 10.2307/1549156; Brown G. DI, 1997, INFORM FINAL PROYECT, P196; CASTILLA JC, 1985, OIKOS, V45, P391, DOI 10.2307/3565575; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Castilla JC, 1998, ECOL APPL, V8, pS124, DOI 10.1890/1051-0761(1998)8[S124:SBFICO]2.0.CO;2; Castilla JC, 2000, J EXP MAR BIOL ECOL, V250, P3, DOI 10.1016/S0022-0981(00)00177-5; Costello C, 2013, SCIENCE, P517; de Juan S, 2015, SCI TOTAL ENVIRON, V533, P122, DOI 10.1016/j.scitotenv.2015.06.094; Denny CM, 2004, MAR ECOL PROG SER, V272, P183, DOI 10.3354/meps272183; Edgar GJ, 1999, J EXP MAR BIOL ECOL, V242, P107, DOI 10.1016/S0022-0981(99)00098-2; FAO, 2014, COUNTR REC VIT ROL S; Fernandez M, 2005, CONSERV BIOL, V19, P1752, DOI 10.1111/j.1523-1739.2005.00277.x; Fogarty MJ, 2007, OCEANOGRAPHY, V20, P112, DOI 10.5670/oceanog.2007.34; Freire J, 2000, MAR POLICY, V24, P375, DOI 10.1016/S0308-597X(00)00013-0; Gelcich S, 2012, CONSERV BIOL, V26, P1005, DOI 10.1111/j.1523-1739.2012.01928.x; Gelcich S, 2010, P NATL ACAD SCI USA, V107, P16794, DOI 10.1073/pnas.1012021107; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gonza A, 1782, J SHELLFISH RES, V6, P109; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Jennings S, 1996, BIOL CONSERV, V75, P201, DOI 10.1016/0006-3207(95)00081-X; Kaiser MJ, 2009, EVIDENCE GREATER REP; Kelly S, 2000, BIOL CONSERV, V92, P359, DOI 10.1016/S0006-3207(99)00109-3; Lester SE, 2008, MAR ECOL PROG SER, V367, P49, DOI 10.3354/meps07599; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; LEVITAN DR, 1991, BIOL BULL-US, V181, P261, DOI 10.2307/1542097; LOWERREBARBIERI SK, 1993, FISH B-NOAA, V91, P165; Manriquez PH, 2001, MAR ECOL PROG SER, V215, P201, DOI 10.3354/meps215201; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Murray SN, 1999, FISHERIES, V24, P11, DOI 10.1577/1548-8446(1999)024&lt;0011:NRN&gt;2.0.CO;2; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pelc RA, 2009, MAR ECOL PROG SER, V394, P65, DOI 10.3354/meps08326; Prado P, 2009, ESTUAR COAST SHELF S, V85, P472, DOI 10.1016/j.ecss.2009.09.012; R DCT, 2013, R LANG ENV STAT COMP; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Rogers-Bennett L, 2002, CONSERV BIOL, V16, P1308, DOI 10.1046/j.1523-1739.2002.01002.x; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Shears NT, 2006, BIOL CONSERV, V132, P222, DOI 10.1016/j.biocon.2006.04.001; Tognelli MF, 2009, BIOL CONSERV, V142, P3147, DOI 10.1016/j.biocon.2009.08.016; Walters CJ, 2007, CAN J FISH AQUAT SCI, V64, P1009, DOI 10.1139/F07-072; Willis TJ, 2003, J APPL ECOL, V40, P214, DOI 10.1046/j.1365-2664.2003.00775.x; Wood CL, 2013, J ANIM ECOL, V82, P1276, DOI 10.1111/1365-2656.12104; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	49	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176758	10.1371/journal.pone.0176758	http://dx.doi.org/10.1371/journal.pone.0176758			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481886	Green Submitted, Green Published, gold			2022-12-27	WOS:000401313700015
J	Monasterio, L				Monasterio, Leonardo			Surnames and ancestry in Brazil	PLOS ONE			English	Article								This paper presents a method for classifying the ancestry of Brazilian surnames based on historical sources. The information obtained forms the basis for applying fuzzy matching and machine learning classification algorithms to more than 46 million workers in 5 categories: Iberian, Italian, Japanese, German and East European. The vast majority (96.7%) of the single surnames were identified using a fuzzy matching and the rest using a method proposed by Cavnar and Trenkle (1994). A comparison of the results of the procedures with data on foreigners in the 1920 Census and with the geographic distribution of non-Iberian surnames underscores the accuracy of the procedure. The study shows that surname ancestry is associated with significant differences in wages and schooling.	[Monasterio, Leonardo] Inst Appl Econ Res, Dept Reg Urban & Environm Studies, Brasilia, DF, Brazil; [Monasterio, Leonardo] Univ Catolica Brasilia, Grad Sch Econ, Brasilia, DF, Brazil	Universidade Catolica de Brasilia	Monasterio, L (corresponding author), Inst Appl Econ Res, Dept Reg Urban & Environm Studies, Brasilia, DF, Brazil.; Monasterio, L (corresponding author), Univ Catolica Brasilia, Grad Sch Econ, Brasilia, DF, Brazil.	leonardo.monasterio@ipea.gov.br	Monasterio, Leonardo/GQY-6847-2022	Monasterio, Leonardo/0000-0001-6692-3236	CAPES/BEX [2549/15-8]	CAPES/BEX(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CAPES/BEX Grant 2549/15-8, https://www.capes.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I wish to thank William Summerhill, Pedro Herculano Souza, Rafael Osorio, Claudio Shikida, Daniel Franken, the participants in the UCLAs Economic History Seminar, the editor and two anonymous reviewers for their comments and suggestions. I am grateful to Chung-hong Chan, the creator of ngramrr, for agreeing to my request to alter the package. Any mistakes are mine. This work was supported by CAPES/BEX Grant 2549/15-8.	Alvarez L, 2010, HUM ECOL, V38, P831, DOI 10.1007/s10745-010-9363-x; ALVES V. E., 2005, AGRARIA, P40; [Anonymous], 2013, SURNAME FREQUENCY LI; Carneiro PedroManuel., 2015, PLEASE CALL ME JOHN; Cavnar W.B., 1994, P SDAIR 94 3 ANN S D, VVolume 161175, DOI DOI 10.1.1.53.9367; Chan Ch, 2016, NGRAMRR SIMPLE GEN P; Clark G, 2015, EXPLOR ECON HIST, V55, P3, DOI 10.1016/j.eeh.2014.12.002; Clark Gregory., 2015, SON ALSO RISES SURNA; Dancygier RM, 2014, WORLD POLIT, V66, P229, DOI 10.1017/S0043887114000021; de Carvalho I, 2012, REG SCI URBAN ECON, V42, P794, DOI 10.1016/j.regsciurbeco.2011.08.002; Eyheramendy S, 2003, 9 INT WORKSH ART INT, P332; Florou E, 2011, P 18 NORD C COMP LIN; Fragoso JLR, 2002, FINAL REPORT DATABAS; Green F, 2001, WORLD DEV, V29, P1923, DOI 10.1016/S0305-750X(01)00071-7; Guell M, 2014, REV ECON STUD; Homma AKO, 2009, REV ESTUDOS AMAZONIC, V9, P113; Hornik K, 2016, TEXTCAT N GRAM BASED; Instituto Nacional de Estadistica, 2015, FREC AP; Jurka T. P., 2014, RTEXTTOOLS AUTOMATIC; Keiji Jooka, 2016, SOBRENOMES JAPONESES; Komahan K, 2014, AM J EPIDEMIOL; LACd Lago, 2014, ESCRAVIDAO AO TRABAL; Lakha F, 2011, PUBLIC HEALTH, V125, P688, DOI 10.1016/j.puhe.2011.05.003; Levy M., 1974, REV SAUDE PUBL, V8, P49, DOI DOI 10.1590/S0034-89101974000500003; Lima-Costa MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144456; Manfredini M, 2003, HUM BIOL, V75, P255, DOI 10.1353/hub.2003.0034; Mateos P., 2007, P SOC STAT ETHN DIV; Meyer D., 2015, E1071 MISC FUNCTIONS; mic Ancestry, 2015, PLOS ONE, V10, DOI DOI 10.1371/J0URNAL.P0NE.0144456; North Atlantic Population Project, 2016, N ATL POP PROJ; Oliveira Md, 2009, ESTUD HIST-BRAZIL, V22, P218; Osorio RG, LEANDO RACA SERIO AC; Petersen J, 2011, HEALTH PLACE, V17, P1162, DOI 10.1016/j.healthplace.2010.09.010; Piza E, 1999, REV USP, V40, P122, DOI [10.11606/issn.2316-9036, DOI 10.11606/ISSN.2316-9036, 10.11606/issn.2316-9036.v0i40p122-137, DOI 10.11606/ISSN.2316-9036.V0I40P122-137]; R-Core-Team, 2015, LANG ENV STAT COMP; REIS EJ, 1988, DADOS-REV CIENC SOC, V31, P309; Reis EJ, ELITES AGRARIAS ABOL; Rodriguez-Diaz R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121472; Rossi P, 2013, PHYS LIFE REV, V10, P395, DOI 10.1016/j.plrev.2013.06.005; Santana Cidadania, 2015, BANC SOBR IM IT PROC; Santos RV, 2009, CURR ANTHROPOL, V50, P787, DOI 10.1086/644532; Susewind R, 2015, FIELD METHOD, V27, P319, DOI 10.1177/1525822X14564275; Travassos Claudia, 2004, Cad. Saúde Pública, V20, P660, DOI 10.1590/S0102-311X2004000300003; Trento A., 1989, OUTRO LADO ATLANTICO; Weston S., 2016, CARET CLASSIFICATION	45	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176890	10.1371/journal.pone.0176890	http://dx.doi.org/10.1371/journal.pone.0176890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481940	Green Published, gold, Green Submitted			2022-12-27	WOS:000401313700020
J	Valent, D; Arroyo, L; Pena, R; Yu, K; Carreras, R; Mainau, E; Velarde, A; Bassols, A				Valent, Daniel; Arroyo, Laura; Pena, Raquel; Yu, Kuai; Carreras, Ricard; Mainau, Eva; Velarde, Antonio; Bassols, Anna			Effects on pig immunophysiology, PBMC proteome and brain neurotransmitters caused by group mixing stress and human-animal relationship	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; LIPID-PEROXIDATION; TRANSPORT STRESS; OXIDATIVE STRESS; CYCLOPHILIN; CORTISOL; WELFARE; GLUCOCORTICOIDS; IDENTIFICATION; HAPTOGLOBIN	Peripheral blood mononuclear cells (PBMC) are an interesting sample for searching for biomarkers with proteomic techniques because they are easy to obtain and do not contain highly abundant, potentially masking proteins. Two groups of pigs (n = 56) were subjected to mixing under farm conditions and afterwards subjected to different management treatments: negative handling (NH) and positive handling (PH). Serum and PBMC samples were collected at the beginning of the experiment one week after mixing (t0) and after two months of different handling (t2). Brain areas were collected after slaughter and neurotransmitters quantified by HPLC. Hair cortisol and serum acute phase proteins decreased and serum glutathione peroxidase increased at t2, indicating a lower degree of stress at t2 after adaptation to the farm. Differential gel electrophoresis (DIGE) was applied to study the effects of time and treatment on the PBMC proteome. A total of 54 differentially expressed proteins were identified, which were involved in immune system modulation, cell adhesion and motility, gene expression, splicing and translation, protein degradation and folding, oxidative stress and metabolism. Thirty-seven protein spots were up-regulated at t2 versus t0 whereas 27 were down-regulated. Many of the identified proteins share the characteristic of being potentially up or down-regulated by cortisol, indicating that changes in protein abundance between t0 and t2 are, at least in part, consequence of lower stress upon adaptation to the farm conditions after group mixing. Only slight changes in brain neurotransmitters and PBMC oxidative stress markers were observed. In conclusion, the variation in hair cortisol and serum APPs as well as the careful analysis of the identified proteins indicate that changes in protein composition in PBMC throughout time is mainly due to a decrease in the stress status of the individuals, following accommodation to the farm and the new group.	[Valent, Daniel; Arroyo, Laura; Pena, Raquel; Yu, Kuai; Bassols, Anna] Univ Autonoma Barcelona, Fac Vet, Dept Bioquim & Biol Mol, Cerdanyola Del Valles, Spain; [Pena, Raquel; Bassols, Anna] Univ Autonoma Barcelona, Fac Vet, Serv Bioquim Clin Vet, Cerdanyola Del Valles, Spain; [Carreras, Ricard; Velarde, Antonio] IRTA, Subprograma Benestar Anim, Monells, Spain; [Mainau, Eva] Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Fac Vet, Cerdanyola Del Valles, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona	Bassols, A (corresponding author), Univ Autonoma Barcelona, Fac Vet, Dept Bioquim & Biol Mol, Cerdanyola Del Valles, Spain.; Bassols, A (corresponding author), Univ Autonoma Barcelona, Fac Vet, Serv Bioquim Clin Vet, Cerdanyola Del Valles, Spain.	anna.bassols@uab.cat	Bassols, Anna/K-7961-2014; Mainau, Eva/L-7497-2014; Velarde, Antonio/L-4466-2014	Bassols, Anna/0000-0003-4213-2274; Mainau, Eva/0000-0003-4331-415X; Velarde, Antonio/0000-0002-2634-3138; Carreras, Ricard/0000-0003-1610-7630; Valent, Daniel/0000-0001-6927-3099; Yu, Kuai/0000-0002-6516-7616; Pena, Raquel/0000-0002-7193-9141	Spanish Ministerio de Economia y Competitividad [AGL2011-30598-C03-01, AG L2011-30598-C03-02]; Generalitat de Catalunya [2014SGR4]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	AGL2011-30598-C03-01 (to AV) and grant AG L2011-30598-C03-02 (to AB) from the Spanish Ministerio de Economia y Competitividad, and 2014SGR4 from the Generalitat de Catalunya (to AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEOLA O, 1993, J ANIM SCI, V71, P968, DOI 10.2527/1993.714968x; Albert PR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00199; Almeida AM, 2015, ANIMAL, V9, P1, DOI 10.1017/S1751731114002602; Ammari M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S9; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; AREY DS, 1995, APPL ANIM BEHAV SCI, V45, P23, DOI 10.1016/0168-1591(95)00600-W; Arias MP, 2001, BIOCHEMISTRY-US, V40, P12974, DOI 10.1021/bi010098+; Asan E, 2013, HISTOCHEM CELL BIOL, V139, P785, DOI 10.1007/s00418-013-1081-1; Auboeuf D, 2007, TRENDS ENDOCRIN MET, V18, P122, DOI 10.1016/j.tem.2007.02.003; Bassols A, 2014, CURR PROTEIN PEPT SC, V15, P156, DOI 10.2174/1389203715666140221125958; Belujon P, 2011, ANN NY ACAD SCI, V1216, P114, DOI 10.1111/j.1749-6632.2010.05896.x; Bendixen E, 2011, J PROTEOMICS, V74, P282, DOI 10.1016/j.jprot.2010.11.005; Billing AM, 2007, J MASS SPECTROM, V42, P1433, DOI 10.1002/jms.1270; Braun TP, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00012; Brenes JC, 2008, PHARMACOL BIOCHEM BE, V89, P85, DOI 10.1016/j.pbb.2007.11.004; Brenner BG, 2001, EXPERT OPIN BIOL TH, V1, P67, DOI 10.1517/14712598.1.1.67; Burke NC, 2009, VET IMMUNOL IMMUNOP, V127, P365, DOI 10.1016/j.vetimm.2008.11.017; Bush BM, 1991, INTERPRETATION LAB R, P132; Cao S, 2008, J IMMUNOL, V181, P476, DOI 10.4049/jimmunol.181.1.476; Cappiello M, 2004, BIOCHEM J, V378, P35, DOI 10.1042/BJ20031336; Casal N, 2017, J VET BEHAV, V19, P1, DOI 10.1016/j.jveb.2017.01.002; Ceciliani F, 2014, PROTEOM CLIN APPL, V8, P677, DOI 10.1002/prca.201300080; Chae JI, 2012, ANIM REPROD SCI, V134, P164, DOI 10.1016/j.anireprosci.2012.07.008; Chirase NK, 2004, AM J VET RES, V65, P860, DOI 10.2460/ajvr.2004.65.860; Coutts AS, 2003, J CELL SCI, V116, P897, DOI 10.1242/jcs.00278; Cruzen SM, 2015, J PROTEOMICS, V128, P141, DOI 10.1016/j.jprot.2015.07.032; de Wilde AH, 2013, J VIROL, V87, P1454, DOI 10.1128/JVI.02078-12; Gonzalez-de-la-Vara MD, 2011, CAN J VET RES, V75, P216; Di Girolamo F, 2014, INT J MOL SCI, V15, P15396, DOI 10.3390/ijms150915396; Dupre L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00586; Flint MS, 2011, BRAIN BEHAV IMMUN, V25, P1187, DOI 10.1016/j.bbi.2011.03.009; Forster F, 2014, J IMMUNOL, V192, P771, DOI 10.4049/jimmunol.1300377; Frank MG, 2015, BRAIN BEHAV IMMUN, V48, P1, DOI 10.1016/j.bbi.2015.03.010; Frank MG, 2013, BRAIN BEHAV IMMUN, V33, P1, DOI 10.1016/j.bbi.2013.02.004; GAILANI D, 1990, BRIT J HAEMATOL, V74, P192, DOI 10.1111/j.1365-2141.1990.tb02565.x; Gow R, 2010, FORENSIC SCI INT, V196, P32, DOI 10.1016/j.forsciint.2009.12.040; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; Hemsworth PH, 2003, APPL ANIM BEHAV SCI, V81, P185, DOI 10.1016/S0168-1591(02)00280-0; HEMSWORTH PH, 1986, APPL ANIM BEHAV SCI, V15, P303, DOI 10.1016/0168-1591(86)90123-1; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Kaur H, 2009, J BIOL CHEM, V284, P14493, DOI 10.1074/jbc.M808952200; KIRBY LG, 1995, BRAIN RES, V682, P189, DOI 10.1016/0006-8993(95)00349-U; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Kumar Balvinder, 2012, Front Biosci (Elite Ed), V4, P1759; Li YZ, 2006, J ANIM SCI, V84, P212, DOI 10.2527/jas.2006-144; Lissner MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132061; Liu XL, 2013, VIRUSES-BASEL, V5, P182, DOI 10.3390/v5010182; Marco-Ramell A, 2016, MOL BIOSYST, V12, P2024, DOI 10.1039/c5mb00788g; Marco-Ramell A, 2011, Vet J, V190, pe66, DOI 10.1016/j.tvjl.2011.01.003; Marco-Ramell A, 2012, J PROTEOMICS, V75, P4399, DOI 10.1016/j.jprot.2012.04.002; Martelli G, 2014, ANIMAL, V8, P810, DOI 10.1017/S1751731114000433; Masis-Calvo M, 2013, PHYSIOL BEHAV, V118, P212, DOI 10.1016/j.physbeh.2013.05.033; Mora F, 2012, BRAIN RES, V1476, P71, DOI 10.1016/j.brainres.2011.12.049; Olivan M., 2016, BR BIOTECHNOL J, V11, P1, DOI [DOI 10.9734/BBJ/2016/22402, 10.9734/BBJ/2016/22402]; Oliveira RAS, 2012, INT IMMUNOPHARMACOL, V14, P54, DOI 10.1016/j.intimp.2012.05.022; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; PAQUEREAU L, 1992, EUR J BIOCHEM, V209, P1053, DOI 10.1111/j.1432-1033.1992.tb17381.x; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Pineiro C, 2007, ANIMAL, V1, P133, DOI 10.1017/S1751731107283909; Pineiro M, 2007, VET J, V173, P669, DOI 10.1016/j.tvjl.2006.02.006; Poletto R, 2011, BRAIN RES, V1381, P11, DOI 10.1016/j.brainres.2010.11.035; Poletto R, 2010, APPL ANIM BEHAV SCI, V122, P98, DOI 10.1016/j.applanim.2009.11.015; Ramirez-Boo M, 2006, PROTEOMICS, V6, pS215, DOI 10.1002/pmic.200500386; Ramirez-Boo M, 2011, PROTEOMICS, V11, P3452, DOI 10.1002/pmic.201000610; Robinson CE, 1999, ANAL BIOCHEM, V266, P48, DOI 10.1006/abio.1998.2932; Rubio-Gonzalez A, 2015, ANIMAL, V9, P1188, DOI 10.1017/S1751731115000518; Rueter LE, 1996, BRAIN RES, V739, P57, DOI 10.1016/S0006-8993(96)00809-8; Rushen J, 1999, APPL ANIM BEHAV SCI, V65, P285, DOI 10.1016/S0168-1591(99)00089-1; Saco Y, 2003, ANIM WELFARE, V12, P403; Saco Y, 2010, ANIMAL, V4, P1561, DOI 10.1017/S1751731109991418; Saco Y, 2010, RES VET SCI, V89, P159, DOI 10.1016/j.rvsc.2010.02.006; Salamano G, 2008, VET J, V177, P110, DOI 10.1016/j.tvjl.2007.03.015; Sarr O, 2010, J ANIM SCI, V88, P1626, DOI 10.2527/jas.2009-2542; Sejersen H, 2013, J ANIM SCI, V91, P147, DOI 10.2527/jas.2012-5303; Shen YF, 2005, PROTEOMICS, V5, P4034, DOI 10.1002/pmic.200401246; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; STOLBA A, 1984, ANN RECH VET, V15, P287; Terlouw EMC, 2008, ANIMAL, V2, P1501, DOI 10.1017/S1751731108002723; Tonomura N, 2003, J IMMUNOL, V170, P2469, DOI 10.4049/jimmunol.170.5.2469; Truckenmiller ME, 2006, BRAIN BEHAV IMMUN, V20, P210, DOI 10.1016/j.bbi.2006.01.002; van Staaveren N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122841; Voegtli WC, 2003, J BIOL CHEM, V278, P34373, DOI 10.1074/jbc.M302773200; von Hahn T, 2015, CURR OPIN VIROL, V14, P47, DOI 10.1016/j.coviro.2015.07.012; Waiblinger S, 2006, APPL ANIM BEHAV SCI, V101, P185, DOI 10.1016/j.applanim.2006.02.001; Wu KC, 2008, CELL BIOCHEM BIOPHYS, V52, P139, DOI 10.1007/s12013-008-9031-6; Zelnickova P, 2008, VET IMMUNOL IMMUNOP, V124, P367, DOI 10.1016/j.vetimm.2008.04.016; Zhou DH, 2011, PARASITOL RES, V109, P1637, DOI 10.1007/s00436-011-2435-z; Zhou DJ, 2012, BIOCHEM BIOPH RES CO, V424, P647, DOI 10.1016/j.bbrc.2012.07.024	89	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176928	10.1371/journal.pone.0176928	http://dx.doi.org/10.1371/journal.pone.0176928			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475627	Green Published, Green Submitted, gold			2022-12-27	WOS:000400649500028
J	Li, YM; Zhang, TX; Zhou, JT; Yang, S; Fan, MY; Sun, XN; Zhang, MS; Xu, SH; Cha, MH; Hu, XL; Qi, L; Lin, SB; Liu, SQ; Hu, DF				Li, Yimeng; Zhang, Tianxiang; Zhou, Juntong; Yang, Shuang; Fan, Mengyuan; Sun, Xiaoning; Zhang, Meishan; Xu, Shanghua; Cha, Muha; Hu, Xiaolong; Qi, Lei; Lin, Shaobi; Liu, Shuqiang; Hu, Defu			Transcriptome analysis of muskrat scented glands degeneration mechanism	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; APOPTOSIS; DATABASE; CALCIUM; SMAD7; CELLS; MAPK; TOOL	The scented gland, a musk-secreting organ of male muskrats, shows clear seasonal changes. When entering the secreting season in March, scented glands gradually increase in size and active secretion starts. In September, scented glands become gradually smaller and secretion decreases. By November, scented glands are gradually replaced by adipose tissue. In this study, six healthy adult male muskrats were analysed: three from the secreting season (March) and three from the non-secreting season (November). Using RNA-Seq analysis, gene expression profiles of scented glands from both seasons were determined. Using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database, we found that genes involved in calcium and TGF-beta signalling pathways were significantly more expressed in the non-secreting than in the secreting season. These changes in gene expression correlated with alterations in scented gland size. Both calcium and TGF-beta signalling pathways are important regulators of cell apoptosis, which may thus be involved in muskrat scented gland degeneration.	[Li, Yimeng; Zhang, Tianxiang; Zhou, Juntong; Yang, Shuang; Fan, Mengyuan; Sun, Xiaoning; Zhang, Meishan; Xu, Shanghua; Cha, Muha; Hu, Xiaolong; Qi, Lei; Liu, Shuqiang; Hu, Defu] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Lin, Shaobi; Liu, Shuqiang] Zhangzhou Pien Tze Huang Pharmaceut Co Ltd, Res Dept, Zhangzhou City, Fujian Province, Peoples R China	Beijing Forestry University	Liu, SQ; Hu, DF (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.; Liu, SQ (corresponding author), Zhangzhou Pien Tze Huang Pharmaceut Co Ltd, Res Dept, Zhangzhou City, Fujian Province, Peoples R China.	liushuqiang@bjfu.edu.cn; hudf@bjfu.edu.cn	Hu, Xiaolong/GRR-4875-2022	Hu, Xiaolong/0000-0001-9071-0177	China Postdoctoral Science Foundation [168033, 2016M591094]; Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd [2015HXFWBHQ-LSQ-001]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd	This work was supported by the China Postdoctoral Science Foundation (Postdoctor No. 168033, Grant No. 2016M591094) and Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd (grant no. 2015HXFWBHQ-LSQ-001). The Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd, an institution also have their own independent research department, mainly engaged in scientific research. This institution in addition to providing us with funding support, it also contributes to experimental design and manuscript content revise. The experimental facilities were provided by the College of Nature Conservation's Innovation Laboratory, Beijing Forestry University.	Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apati A, 2003, ANN NY ACAD SCI, V1010, P70, DOI 10.1196/annals.1299.010; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bilezikjian LM, 2001, ENDOCRINOLOGY, V142, P1065, DOI 10.1210/en.142.3.1065; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Brown TL, 1998, CELL GROWTH DIFFER, V9, P869; Caron PL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-80; [陈心智 Chen Xinzhi], 2005, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V31, P414; Chen Yushan, 1996, Acta Theriologica Sinica, V16, P43; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; [邓泱泱 DENG Yangyang], 2006, [计算机工程, Computer Engineering], V32, P71; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hentges S, 2000, ENDOCRINOLOGY, V141, P1528, DOI 10.1210/en.141.4.1528; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Jie H, 2015, SPECIAL WILD EC ANIM, V3, P65; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Li BT, 1994, CHINESE PHARM J BEIJ, V29, P396; Li JH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014252.37680.E4; Li YB, 2001, FOR SCI TECHNOL, V26, P33; Liao JH, 2001, CELL RES, V11, P89, DOI 10.1038/sj.cr.7290072; Liu Na, 2007, Zhongguo Yaolixue Tongbao, V23, P298; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Marinova-Mutafchieva L, 2006, CLIN EXP IMMUNOL, V146, P287, DOI 10.1111/j.1365-2249.2006.03204.x; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Memon MA, 2008, MOL CELL ENDOCRINOL, V294, P70, DOI 10.1016/j.mce.2008.08.017; Niu J, 1999, INSPECTION QUARANTIN, V9, P41; Shereshkov VI, 2006, J EVOL BIOCHEM PHYS+, V42, P461, DOI 10.1134/S0022093006040120; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Ugarte G, 2006, J BIOL CHEM, V281, P18473, DOI 10.1074/jbc.M600918200; VANDORP DA, 1973, RECL TRAV CHIM PAY B, V92, P915; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wyatt L, 2007, J CELL BIOL, V178, P1223, DOI 10.1083/jcb.200705035; Yuan L, 2010, J NINGXIA MED U, V32, P1, DOI [10.16050/j.cnki.issn1674-6309.2010.01.019, DOI 10.16050/J.CNKI.ISSN1674-6309.2010.01.019]; Zhao WG, 2009, SPECIAL WILD EC ANIM, V4, P50, DOI DOI 10.16720/J.CNKI.TCYJ.2009.04.023	41	5	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176935	10.1371/journal.pone.0176935	http://dx.doi.org/10.1371/journal.pone.0176935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472080	gold, Green Submitted, Green Published			2022-12-27	WOS:000400648500100
J	Megale, RZ; Pollack, A; Britt, H; Latimer, J; Naganathan, V; McLachlan, AJ; Ferreira, ML				Megale, Rodrigo Z.; Pollack, Allan; Britt, Helena; Latimer, Jane; Naganathan, Vasi; McLachlan, Andrew J.; Ferreira, Manuela L.			Management of vertebral compression fracture in general practice: BEACH program	PLOS ONE			English	Article							QUALITY-OF-LIFE; CONSERVATIVE TREATMENT; OLDER-PEOPLE; ACUTE PAIN; BACK-PAIN; OUTCOMES; EPIDEMIOLOGY; IMPACT; VERTEBROPLASTY; EFFICACY	Importance The pain associated with vertebral compression fractures can cause significant loss of function and quality of life for older adults. Despite this, there is little consensus on how best to manage this condition. Objective To describe usual care provided by general practitioners (GPs) in Australia for the management of vertebral compression fractures. Design, setting and participants Data from the Bettering the Evaluation And Care of Health (BEACH) program collected between April 2005 and March 2015 was used for this study. Each year, a random sample of approximately 1,000 GPs each recorded information on 100 consecutive encounters. We selected those encounters at which vertebral compression fracture was managed. Analyses of management options were limited to encounters with patients aged 50 years or over. Main outcome(s) and measure(s) i) patient demographics; ii) diagnoses/problems managed; iii) the management provided for vertebral compression fracture during the encounter. Robust 95% confidence intervals, adjusted for the cluster survey design, were used to assess significant differences between group means. Results Vertebral compression fractures were managed in 211 (0.022%; 95% CI: 0.018-0.025) of the 977,300 BEACH encounters recorded April 2005-March 2015. That provides a national annual estimate of 26,000 (95% CI: 22,000-29,000) encounters at which vertebral fractures were managed. At encounters with patients aged 50 years or over (those at higher risk of primary osteoporosis), prescription of analgesics was the most common management action, particularly opioids analgesics (47.1 per 100 vertebral fractures; 95% CI: 38.4-55.7). Prescriptions of paracetamol (8.2; 95% CI: 4-12.4) or non-steroidal anti-inflammatory drugs (4.1; 95% CI: 1.1-7.1) were less frequent. Non-pharmacological treatment was provided at a rate of 22.4 per 100 vertebral fractures (95% CI: 14.6-30.1). At least one referral (to hospital, specialist, allied health care or other) was given for 12.3 per 100 vertebral fractures (95% CI: 7.8-16.8). Conclusions and relevance The prescription of oral opioid analgesics remains the common general practice approach for vertebral compression fractures management, despite the lack of evidence to support this. Clinical trials addressing management of these fractures are urgently needed to improve the quality of care patients receive.	[Megale, Rodrigo Z.; Ferreira, Manuela L.] Univ Sydney, Sydney Med Sch, Kolling Inst, Inst Bone & Joint Res, Sydney, NSW, Australia; [Pollack, Allan] Univ Sydney, Family Med Res Ctr, Sch Publ Hlth, Sydney, NSW, Australia; [Britt, Helena] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Latimer, Jane] Univ Sydney, Sydney Med Sch, George Inst Global Hlth, Stdney, Australia; [Naganathan, Vasi; McLachlan, Andrew J.] Univ Sydney, Ctr Educ & Res Ageing, Concord Clin Sch, Sydney, NSW, Australia; [McLachlan, Andrew J.] Univ Sydney, Fac Pharm, Sydney, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; University of Sydney; University of Sydney; George Institute for Global Health; University of Sydney; University of Sydney; University of Sydney	Megale, RZ (corresponding author), Univ Sydney, Sydney Med Sch, Kolling Inst, Inst Bone & Joint Res, Sydney, NSW, Australia.	rzun6620@uni.sydney.edu.au	Ferreira, Manuela/AAQ-5446-2020	Ferreira, Manuela/0000-0002-3479-0683; Naganathan, Vasikaran/0000-0001-7243-0796	Australian Government Department of Health; Novartis Pharmaceuticals Australia Pty Ltd; Merck; Sharp and Dohme (Australia) Pty Ltd; Pfizer Australia; National Prescribing Service Ltd; GlaxoSmithKline Australia Pty Ltd; Sanofi-Aventis Australia Pty Ltd; Bayer Australia Ltd; Roche Products Pty Ltd; Janssen-Cilag PtyLtd; Abbott Australasia Pty Ltd; Wyeth Australia Pty Ltd; AbbVie Pty Ltd; Australian Government Department of Veterans' Affairs; Sydney Medical Foundation Fellowship/Sydney Medical School; AstraZeneca Pty Ltd (Australia); bioCSL (Australia) Pty Ltd	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); Novartis Pharmaceuticals Australia Pty Ltd; Merck(Merck & Company); Sharp and Dohme (Australia) Pty Ltd; Pfizer Australia(PfizerPfizer Australia); National Prescribing Service Ltd; GlaxoSmithKline Australia Pty Ltd; Sanofi-Aventis Australia Pty Ltd(Sanofi-Aventis); Bayer Australia Ltd; Roche Products Pty Ltd; Janssen-Cilag PtyLtd(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Abbott Australasia Pty Ltd(Abbott Laboratories); Wyeth Australia Pty Ltd; AbbVie Pty Ltd(AbbVie); Australian Government Department of Veterans' Affairs(US Department of Veterans Affairs); Sydney Medical Foundation Fellowship/Sydney Medical School; AstraZeneca Pty Ltd (Australia)(AstraZeneca); bioCSL (Australia) Pty Ltd	The authors received no specific funding for this work; however, during the data collection period of this study, the BEACH program was funded by: the Australian Government Department of Health,AstraZeneca Pty Ltd (Australia), Novartis Pharmaceuticals Australia Pty Ltd,bioCSL (Australia) Pty Ltd, Merck, Sharp and Dohme (Australia) Pty Ltd, Pfizer Australia, National Prescribing Service Ltd, GlaxoSmithKline Australia Pty Ltd, Sanofi-Aventis Australia Pty Ltd, Bayer Australia Ltd, Roche Products Pty Ltd, Janssen-Cilag PtyLtd, Abbott Australasia Pty Ltd, Wyeth Australia Pty Ltd, AbbVie Pty Ltd, and the Australian Government Department of Veterans' Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RM thanks Fundacao Hospitalar do Estado de Minas Gerais (FHEMIG) for supporting his PhD. MLF holds a Sydney Medical Foundation Fellowship/Sydney Medical School.	American Geriatrics Society, 2009, J AM GERIATR SOC, V57, P1331, DOI [10.1111/j.1532-5415.2009.02376.x, DOI 10.1111/J.1532-5415.2009.02376.X]; [Anonymous], 2015, GUID ATC CLASS DDD A; Barr JD, 2014, J VASC INTERV RADIOL, V25, P171, DOI 10.1016/j.jvir.2013.10.001; Bennell KL, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-36; Borgstrom F, 2013, OSTEOPOROSIS INT, V24, P811, DOI 10.1007/s00198-012-2240-2; Brenneman SK, 2006, J BONE MINER RES, V21, P809, DOI 10.1359/JBMR.060301; Britt H.M.G., 2015, DECADE AUSTR GEN PRA; Britt H, 2007, AUST FAM PHYSICIAN, V36, P36; Britt H, 2015, AUST FAM PHYSICIAN, V44, P411; Chang V, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.4.FOCUS1477; Classification Commitee of the World Organization of Family Doctors W, 1997, ICPC 2 INT CLASS PRI; Comstock BA, 2013, RADIOLOGY, V269, P224, DOI 10.1148/radiol.13120821; COOPER C, 1993, BONE, V14, pS89; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; English KL, 2010, CURR OPIN CLIN NUTR, V13, P34, DOI 10.1097/MCO.0b013e328333aa66; Esses Stephen I, 2011, J Bone Joint Surg Am, V93, P1934, DOI 10.2106/JBJS.9320ebo; Francis RM, 2008, OSTEOPOROSIS INT, V19, P895, DOI 10.1007/s00198-007-0530-x; Gehlbach SH, 2000, OSTEOPOROSIS INT, V11, P577, DOI 10.1007/s001980070078; Giangregorio LM, 2013, COCHRANE DB SYST REV, V1; Hagino H, 2009, OSTEOPOROSIS INT, V20, P695, DOI 10.1007/s00198-008-0761-5; Hallberg I, 2004, OSTEOPOROSIS INT, V15, P834, DOI 10.1007/s00198-004-1622-5; Hegeman J, 2009, DRUG SAFETY, V32, P489, DOI 10.2165/00002018-200932060-00005; Henschke N, 2008, J CLIN EPIDEMIOL, V61, P110, DOI 10.1016/j.jclinepi.2007.04.013; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Karanges EA, 2016, BR J CLIN PHARM; Kim David H, 2006, Spine J, V6, P479, DOI 10.1016/j.spinee.2006.04.013; Kim HJ, 2014, J BONE JOINT SURG AM, V96A, P1959, DOI 10.2106/JBJS.N.00187; Klazen CAH, 2010, LANCET, V376, P1085, DOI 10.1016/S0140-6736(10)60954-3; Klazen CAH, 2010, J VASC INTERV RADIOL, V21, P1405, DOI 10.1016/j.jvir.2010.05.018; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Kortebein P, 2007, JAMA-J AM MED ASSOC, V297, P1772, DOI 10.1001/jama.297.16.1772-b; Lee HM, 2012, SPINE J, V12, P998, DOI 10.1016/j.spinee.2012.08.024; Longo UG, 2012, J BONE JOINT SURG BR, V94B, P152, DOI 10.1302/0301-620X.94B2.26894; Majumdar SR, 2005, ARCH INTERN MED, V165, P905, DOI 10.1001/archinte.165.8.905; Makris UE, 2014, JAMA-J AM MED ASSOC, V312, P825, DOI 10.1001/jama.2014.9405; McLachlan AJ, 2011, BRIT J CLIN PHARMACO, V71, P351, DOI 10.1111/j.1365-2125.2010.03847.x; MELTON LJ, 1989, AM J EPIDEMIOL, V129, P1000, DOI 10.1093/oxfordjournals.aje.a115204; Papaioannou A, 2009, OSTEOPOROSIS INT, V20, P703, DOI 10.1007/s00198-008-0743-7; Papaioannou A, 2002, AM J MED, V113, P220, DOI 10.1016/S0002-9343(02)01190-7; Research Committee of the Faculty of Pain Medicine, 2014, OP CONV TABL; Rogers KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080095; Rzewuska M, 2015, EUR SPINE J, V24, P702, DOI 10.1007/s00586-015-3821-5; Schousboe JT, 2015, J CLIN DENSITOM; Suzuki N, 2008, EUR SPINE J, V17, P1380, DOI 10.1007/s00586-008-0753-3; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Venmans A, 2012, AM J NEURORADIOL, V33, P519, DOI 10.3174/ajnr.A2817; Vitry AI, 2008, MED J AUSTRALIA, V189, P360, DOI 10.5694/j.1326-5377.2008.tb02079.x; Vorsanger GJ, 2013, PAIN MANAG, V3, P109, DOI [10.2217/pmt.13.5, 10.2217/PMT.13.5]; Wallace E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h176; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; World Health Organization, 1996, CANC PAIN REL GUID O; Zambito A, 2007, OSTEOPOROSIS INT, V18, P1541, DOI 10.1007/s00198-007-0391-3; [张天浩 Zhang Tianhao], 2013, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V17, P6364	54	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176351	10.1371/journal.pone.0176351	http://dx.doi.org/10.1371/journal.pone.0176351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472151	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500039
J	Tiedge, K; Lohaus, G				Tiedge, Kira; Lohaus, Gertrud			Nectar sugars and amino acids in day- and night-flowering Nicotiana species are more strongly shaped by pollinators' preferences than organic acids and inorganic ions	PLOS ONE			English	Article							SECONDARY METABOLITES; FLORAL NECTAR; TREE TOBACCO; PLANT; TEMPERATURE; SECRETION; CHEMISTRY; RESPONSES; DEFENSE; COMPLEX	Floral nectar contains mainly sugars but also amino acids, organic acids, inorganic ions and secondary compounds to attract pollinators. The genus Nicotiana exhibits great diversity among species in floral morphology, flowering time, nectar compositions, and predominant pollinators. We studied nectar samples of 20 Nicotiana species, composed equally of day-and night-flowering plants and attracting different groups of pollinators (e.g. hummingbirds, moths or bats) to investigate whether sugars, amino acids, organic acids and inorganic ions are influenced by pollinator preferences. Glucose, fructose and sucrose were the only sugars found in the nectar of all examined species. Sugar concentration of the nectar of day-flowering species was 20% higher and amino acid concentration was 2-3-fold higher compared to the nectar of night-flowering species. The sucrose-to-hexose ratio was significantly higher in night-flowering species and the relative share of sucrose based on the total sugar correlated with the flower tube length in the nocturnal species. Flowers of different tobacco species contained varying volumes of nectar which led to about 150-fold higher amounts of total sugar per flower in bat-or sunbird-pollinated species than in bee-pollinated or autogamous species. This difference was even higher for total amino acids per flower (up to 1000-fold). As a consequence, some Nicotiana species invest large amounts of organic nitrogen for certain pollinators. Higher concentrations of inorganic ions, predominantly anions, were found in nectar of night-flowering species. Therefore, higher anion concentrations were also associated with pollinator types active at night. Malate, the main organic acid, was present in all nectar samples but the concentration was not correlated with pollinator type. In conclusion, statistical analyses revealed that pollinator types have a stronger effect on nectar composition than phylogenetic relations. In this context, nectar sugars and amino acids are more strongly correlated with the preferences of predominant pollinators than organic acids and inorganic ions.	[Tiedge, Kira; Lohaus, Gertrud] Univ Wuppertal, Mol Plant Sci Plant Biochem, Wuppertal, Germany	University of Wuppertal	Lohaus, G (corresponding author), Univ Wuppertal, Mol Plant Sci Plant Biochem, Wuppertal, Germany.	lohaus@uni-wuppertal.de		Tiedge, Kira/0000-0002-7239-6767	Deutsche Forschungsgemeinschaft [LO 734/10-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (LO 734/10-1). The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Adler LS, 2012, ECOL LETT, V15, P1140, DOI 10.1111/j.1461-0248.2012.01838.x; Aigner PA, 2002, SOUTHWEST NAT, V47, P1, DOI 10.2307/3672796; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Baker H. G., 1975, Coevolution of animals and plants. Symposium 5 of the 1st International Congress of Systematic and Evolutionary Biology, Boulder, Colorado, USA. (Editors L. E. Gilbert and P. H. Raven)., P100; Baker H.G., 1983, P117; BAKER HG, 1973, NATURE, V241, P543, DOI 10.1038/241543b0; BAKER HG, 1977, BOT GAZ, V138, P183, DOI 10.1086/336914; Baker HG., 1982, BIOCH ASPECTS EVOLUT, P131; Bertazzini M, 2010, AMINO ACIDS, V39, P315, DOI 10.1007/s00726-010-0474-x; CALDER WA, 1979, J THEOR BIOL, V78, P185, DOI 10.1016/0022-5193(79)90263-7; CALDER WA, 1983, PHYSIOL ZOOL, V56, P325, DOI 10.1086/physzool.56.3.30152597; Carter C, 2004, TRENDS PLANT SCI, V9, P320, DOI 10.1016/j.tplants.2004.05.008; Carter C, 2007, PLANT PHYSIOL, V143, P389, DOI 10.1104/pp.106.089326; Chase MW, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-45; Clarkson JJ, 2004, MOL PHYLOGENET EVOL, V33, P75, DOI 10.1016/j.ympev.2004.05.002; DELRIO CM, 1990, PHYSIOL ZOOL, V63, P987, DOI 10.1086/physzool.63.5.30152625; GALETTO L, 1993, CAN J BOT, V71, P1394, DOI 10.1139/b93-167; Gardener MC, 2002, OIKOS, V98, P552, DOI 10.1034/j.1600-0706.2002.980322.x; Gardener MC, 2001, J CHEM ECOL, V27, P2545, DOI 10.1023/A:1013687701120; Gonzalez-Teuber M, 2014, PSB, V4, P809; Goodspeed TH, 1954, ORIGINS RELATIONSHIP; Goulson Dave, 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P185, DOI 10.1078/1433-8319-00070; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; Herrera CM, 2009, ANN BOT-LONDON, V103, P1415, DOI 10.1093/aob/mcp026; HIEBERT SM, 1983, ECOLOGY, V64, P399, DOI 10.2307/1937086; HOCKING PJ, 1980, ANN BOT-LONDON, V45, P633, DOI 10.1093/oxfordjournals.aob.a085871; INOUYE DW, 1984, ECOLOGY, V65, P618, DOI 10.2307/1941424; Ippolito A, 2004, EVOLUTION, V58, P2634, DOI 10.1111/j.0014-3820.2004.tb01617.x; Jurgens A, 2004, S AFR J BOT, V70, P191, DOI 10.1016/S0254-6299(15)30235-0; Kaczorowski RL, 2005, AM J BOT, V92, P1270, DOI 10.3732/ajb.92.8.1270; Kelly LJ, 2013, EVOLUTION, V67, P80, DOI 10.1111/j.1558-5646.2012.01748.x; Kessler D, 2007, PLANT J, V49, P840, DOI 10.1111/j.1365-313X.2006.02995.x; Kessler D, 2012, PLANT J, V71, P529, DOI 10.1111/j.1365-313X.2012.05008.x; Kim W, 2011, P NATL ACAD SCI USA, V108, P16618, DOI 10.1073/pnas.1108642108; Knapp S, 2004, TAXON, V53, P73, DOI 10.2307/4135490; Kromer T, 2008, PLANT BIOLOGY, V10, P502, DOI 10.1111/j.1438-8677.2008.00058.x; KRUGER K, 1982, COMP BIOCHEM PHYS A, V73, P679, DOI 10.1016/0300-9629(82)90275-4; Lohaus G, 2000, J EXP BOT, V51, P1721, DOI 10.1093/jexbot/51.351.1721; Lohaus G, 2001, PHYSIOL PLANTARUM, V111, P457, DOI 10.1034/j.1399-3054.2001.1110405.x; Lohaus G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087689; Lotz CN, 2006, BIOTROPICA, V38, P3, DOI 10.1111/j.1744-7429.2005.00104.x; Marlin D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102661; Merxmuller H, 1975, MITTEILUNGEN BOT STA, P91; Nabhan G.P., 2004, CONSERVING MIGRATORY; Nadwodnik J, 2008, PLANTA, V227, P1079, DOI 10.1007/s00425-007-0682-0; Napier KR, 2013, PHYSIOL BIOCHEM ZOOL, V86, P499, DOI 10.1086/672013; Nattero J, 2003, PLANT SYST EVOL, V241, P47, DOI 10.1007/s00606-003-0027-9; Nattero J, 2007, BIOL J LINN SOC, V90, P657, DOI 10.1111/j.1095-8312.2007.00756.x; Nicolson SW, 2003, PLANT SYST EVOL, V238, P139, DOI 10.1007/s00606-003-0276-7; Noutsos C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124501; Oksanen J., 2007, COMMUNITY ECOLOGY PA, V10, P719; Ollerton J, 2009, ANN BOT-LONDON, V103, P1471, DOI 10.1093/aob/mcp031; Pacini Ettore, 2007, P167, DOI 10.1007/978-1-4020-5937-7_4; Pender RJ, 2014, AM J BOT, V101, P201, DOI 10.3732/ajb.1300338; PERCIVAL MARY S., 1961, NEW PHYTOL, V60, P235, DOI 10.1111/j.1469-8137.1961.tb06255.x; Petanidou T, 2000, PLANT SYST EVOL, V225, P103, DOI 10.1007/BF00985461; Petanidou T, 2006, OIKOS, V115, P155, DOI 10.1111/j.2006.0030-1299.14487.x; Peter CI, 2014, ANN BOT-LONDON, V113, P277, DOI 10.1093/aob/mct216; PRINZINGER R, 1989, COMP BIOCHEM PHYS A, V92, P393, DOI 10.1016/0300-9629(89)90581-1; Proctor M., 1996, The natural history of pollination.; PYKE GH, 1981, BIOTROPICA, V13, P260, DOI 10.2307/2387804; Raguso RA, 2003, PHYTOCHEMISTRY, V63, P265, DOI 10.1016/S0031-9422(03)00113-4; RIENS B, 1994, PLANTA, V192, P497, DOI 10.1007/BF00203587; RIENS B, 1991, PLANT PHYSIOL, V97, P227, DOI 10.1104/pp.97.1.227; Rodriguez-Riano T, 2014, PLANT BIOLOGY, V16, P1075, DOI 10.1111/plb.12159; Ruhlmann JM, 2010, J EXP BOT, V61, P395, DOI 10.1093/jxb/erp309; Schmidt-Lebuhn AN, 2007, FLORA, V202, P62, DOI 10.1016/j.flora.2006.02.005; Schueller SK, 2004, AM J BOT, V91, P672, DOI 10.3732/ajb.91.5.672; Soltis DE., 2005, ANGIOSPERM PHYLOGENY; SOUTHWICK EE, 1981, AM J BOT, V68, P994, DOI 10.2307/2443231; Stevenson PC, 2017, FUNCT ECOL, V31, P65, DOI 10.1111/1365-2435.12761; Stuurman J, 2004, GENETICS, V168, P1585, DOI 10.1534/genetics.104.031138; Torres C, 2002, PLANT BIOLOGY, V4, P360, DOI 10.1055/s-2002-32326; Torres CC., 2014, INT J PLANT REPROD B, V6, P174; WALLER GD, 1972, ANN ENTOMOL SOC AM, V65, P857, DOI 10.1093/aesa/65.4.857; Witt T, 2013, J EVOLUTION BIOL, V26, P2244, DOI 10.1111/jeb.12224	78	30	30	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176865	10.1371/journal.pone.0176865	http://dx.doi.org/10.1371/journal.pone.0176865			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467507	Green Published, Green Submitted, gold			2022-12-27	WOS:000400647000080
J	Araujo, EB; Araujo, NAM; Moreira, AA; Herrmann, HJ; Andrade, JAS				Araujo, Eduardo B.; Araujo, Nuno A. M.; Moreira, Andre A.; Herrmann, Hans J.; Andrade, Jose A. S., Jr.			Gender differences in scientific collaborations: Women are more egalitarian than men	PLOS ONE			English	Article							SCIENCE; PRODUCTIVITY; STRATEGIES	By analyzing a unique dataset of more than 270,000 scientists, we discovered substantial gender differences in scientific collaborations. While men are more likely to collaborate with other men, women are more egalitarian. This is consistently observed over all fields and regardless of the number of collaborators a scientist has. The only exception is observed in the field of engineering, where this gender bias disappears with increasing number of collaborators. We also found that the distribution of the number of collaborators follows a truncated power law with a cut-off that is gender dependent and related to the gender differences in the number of published papers. Considering interdisciplinary research, our analysis shows that men and women behave similarly across fields, except in the case of natural sciences, where women with many collaborators are more likely to have collaborators from other fields.	[Araujo, Eduardo B.; Moreira, Andre A.; Herrmann, Hans J.; Andrade, Jose A. S., Jr.] Univ Fed Ceara, Dept Fis, Campus Pici, BR-60451970 Fortaleza, Ceara, Brazil; [Araujo, Eduardo B.] Inst Fed Educ Ciencia & Tecnol Ceara, Campus Acarau, BR-62580000 Acarau, Ceara, Brazil; [Araujo, Nuno A. M.] Univ Lisbon, Fac Ciencias, Ctr Fis Teor & Computac, P-1749016 Lisbon, Portugal; [Araujo, Nuno A. M.] Univ Lisbon, Fac Ciencias, Dept Fis, P-1749016 Lisbon, Portugal; [Herrmann, Hans J.] ETH, IfB, Computat Phys Engn Mat, Wolfgang Pauli Str 27, CH-8093 Zurich, Switzerland	Universidade Federal do Ceara; Instituto Federal do Ceara (IFCE); Universidade de Lisboa; Universidade de Lisboa; Swiss Federal Institutes of Technology Domain; ETH Zurich	Herrmann, HJ (corresponding author), Univ Fed Ceara, Dept Fis, Campus Pici, BR-60451970 Fortaleza, Ceara, Brazil.; Herrmann, HJ (corresponding author), ETH, IfB, Computat Phys Engn Mat, Wolfgang Pauli Str 27, CH-8093 Zurich, Switzerland.	hans@ifb.baug.ethz.ch	Araujo, Nuno/AAA-2996-2020; Araújo, Eduardo B/P-4044-2014; Andrade, José S/C-5451-2013; Araujo, Nuno A M/B-6313-2008; Moreira, Andre Auto A/C-5290-2013	Araújo, Eduardo B/0000-0003-0807-3178; Andrade, José S/0000-0002-5571-7610; Araujo, Nuno A M/0000-0002-1677-6060; Moreira, Andre Auto A/0000-0003-1046-5218	ETH Risk Center; Brazilian institute INCT-SC; FlowCCS of the European Researcher Council [319968]; Portuguese Foundation for Sciences and Technology (FCT) [UID/FIS/00618/2013, IF/00255/2013]	ETH Risk Center; Brazilian institute INCT-SC; FlowCCS of the European Researcher Council; Portuguese Foundation for Sciences and Technology (FCT)(Portuguese Foundation for Science and Technology)	This work received financial support from ETH Risk Center, the Brazilian institute INCT-SC, and grant number 319968-FlowCCS of the European Researcher Council. NA acknowledges financial support from the Portuguese Foundation for Sciences and Technology (FCT) under Contracts nos. UID/FIS/00618/2013 and IF/00255/2013.; We acknowledge financial support from the ETH Risk Center, the Brazilian institute INCTSC, and grant number 319968-FlowCCS of the European Researcher Council. NA acknowledges financial support from the Portuguese Foundation for Sciences and Technology (FCT) under Contracts nos. UID/FIS/00618/2013 and IF/00255/2013.	Abramo G, 2013, J INFORMETR, V7, P811, DOI 10.1016/j.joi.2013.07.002; Araujo EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090537; Bottcher L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149514; Boyle P, 2015, NATURE, V525, P181, DOI 10.1038/525181a; Bozeman B, 2004, RES POLICY, V33, P599, DOI 10.1016/j.respol.2004.01.008; Bozeman B, 2011, RES POLICY, V40, P1393, DOI 10.1016/j.respol.2011.07.002; Cole JR., 1984, ADV MOTIVATION ACHIE; Cole S, 1992, MAKING SCI NATURE SO; Duch J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051332; Fox MF, 2001, GENDER SOC, V15, P654, DOI 10.1177/089124301015005002; Handelsman J, 2005, SCIENCE, V309, P1190, DOI 10.1126/science.1113252; Kyvik S, 1996, SCI TECHNOL HUM VAL, V21, P54, DOI 10.1177/016224399602100103; Lee S, 2005, SOC STUD SCI, V35, P673, DOI 10.1177/0306312705052359; Leslie LL, 1996, J HIGH EDUC, V69, P239; LOWRANCE R, 1975, J ACM, V22, P177, DOI 10.1145/321879.321880; Mena-Chalco JP, 2014, J ASSOC INF SCI TECH, V65, P1424, DOI 10.1002/asi.23010; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Newman MEJ, 2002, PHYS REV E, V64; ONEILL ET, 1993, LIBR RESOUR TECH SER, V37, P59; Rhoten D, 2007, RES POLICY, V36, P56, DOI 10.1016/j.respol.2006.08.001; Schiebinger L., 2007, HARVARD J LAW GENDER, V30, P350; Sugimoto GR, 2015, PLOS ONE, V10; Szell M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01214; West J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074795; Zeng XHT, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002573	25	47	48	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176791	10.1371/journal.pone.0176791	http://dx.doi.org/10.1371/journal.pone.0176791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UN	28489872	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314100031
J	Chen, LJ; Fei, CY; Zhu, L; Xu, ZP; Zou, WS; Yang, T; Lin, HH; Xi, DH				Chen, Lijuan; Fei, Chunyan; Zhu, Lin; Xu, Zhenpeng; Zou, Wenshan; Yang, Ting; Lin, Honghui; Xi, Dehui			RNA-seq approach to analysis of gene expression profiles in dark green islands and light green tissues of Cucumber mosaic virus-infected Nicotiana tabacum	PLOS ONE			English	Article							TOBACCO-LEAVES; REFERENCE GENOME; CELL-DEATH; PLANTS; QUANTIFICATION; RESISTANCE; INTERFERENCE; ANNOTATION; MELATONIN; MOVEMENT	Dark green islands (DGIs) surrounded by light green tissues (LGTs) are common leaf symptoms of plants that are systemically infected by various viruses that induce leaf mosaic in infected plants. The inoculation of Cucumber mosaic virus (CMV) in Nicotiana tabacum produced a commonly occurring sequence of classic patterns of DGIs and LGTs. Previous studies confirmed that there are significant differences between DGIs and LGTs in terms of physiology, biochemistry and molecular biology, but the mechanisms by which DGIs form remain unclear. To investigate the global gene expression changes that occur in these special tissues, individual differential gene expression tag libraries were constructed from three total RNA samples isolated from DGIs, LGTs and control plants (CK) and were sequenced using an Illumina HiSeq(TM) 2000. An analysis of differentially expressed genes (DEGs) and Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed. These analyses revealed the differences between DGIs, LGTs and CK. GO enrichment and KEGG pathway analyses suggested that several pathways related to photosynthesis and chlorophyll metabolism were enriched in DGIs compared to LGTs and CK. Several pathways related to apoptosis were significantly up-regulated in LGTs compared to DGIs. Additionally, we identified sets of DEGs that may be related to the formation or development of DGIs and LGTs. Our systematic analyses provide comprehensive transcriptomic information regarding DGIs and LGTs in CMV-infected N. tabacum. These data will help characterize the detailed mechanisms of DGI and LGT formation.	[Chen, Lijuan; Fei, Chunyan; Zhu, Lin; Xu, Zhenpeng; Zou, Wenshan; Yang, Ting; Lin, Honghui; Xi, Dehui] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresource & Ecoenvironm, Chengdu, Peoples R China	Sichuan University	Xi, DH (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresource & Ecoenvironm, Chengdu, Peoples R China.	xidh@scu.edu.cn	Chen, lijuan/GYA-3236-2022		National Nature Science Foundation of China [31270290, 31171835, 91417305]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (31270290, 31171835, 91417305).	Allard H. A, 1914, B TORREY BOT CLUB, V41, P435; Allard HA, 1912, SCIENCE, P875; ATKINSON PH, 1970, VIROLOGY, V40, P344, DOI 10.1016/0042-6822(70)90411-3; Berry J. A., 1982, Photosynthesis. Volume II. Development, carbon metabolism, and productivity, P263; Burundukova OL, 2009, BIOL PLANTARUM, V53, P294, DOI 10.1007/s10535-009-0053-8; Caldwell J, 1934, ANN APPL BIOL, V21, P191, DOI 10.1111/j.1744-7348.1934.tb06899.x; Chen LJ, 2015, J GEN PLANT PATHOL, V81, P399, DOI 10.1007/s10327-015-0602-2; Chen LJ, 2015, PLANT CELL REP, V34, P1225, DOI 10.1007/s00299-015-1781-1; Chen Q, 2009, J PLANT PHYSIOL, V166, P324, DOI 10.1016/j.jplph.2008.06.002; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; DOUGHERTY WG, 1994, MOL PLANT MICROBE IN, V7, P544, DOI 10.1094/MPMI-7-0554; FULTON RW, 1951, PHYTOPATHOLOGY, V41, P579; GALON A, 1994, VIROLOGY, V205, P280, DOI 10.1006/viro.1994.1644; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; GOLDSTEIN BESSIE, 1926, BULL TORREY BOT CLUB, V53, P499, DOI 10.2307/2480367; Grabherr M. G., 2011, NATURE BIOTECHNOLOGY, V29; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hanssen IM, 2011, PLANT PHYSIOL, V156, P301, DOI 10.1104/pp.111.173906; HONDA Y, 1974, PHYTOPATHOLOGY, V64, P534, DOI 10.1094/Phyto-64-534; Huang LK, 2015, MOL ECOL RESOUR, V15, P1497, DOI 10.1111/1755-0998.12418; Ji H, 2014, J EXPT BOT; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kichtenthaler H.K., 1983, BIOCHEM SOC T, V603, P591; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu ZG, 2005, CELL RES, V15, P24, DOI 10.1038/sj.cr.7290259; LOEBENSTEIN G, 1977, VIROLOGY, V81, P117, DOI 10.1016/0042-6822(77)90063-0; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; Moore CJ, 2006, NATURAL RESISTANCE MECHANISMS OF PLANTS TO VIRUSES, P187, DOI 10.1007/1-4020-3780-5_9; Moore CJ, 2001, MOL PLANT MICROBE IN, V14, P939, DOI 10.1094/MPMI.2001.14.8.939; PALUKAITIS P, 1992, ADV VIRUS RES, V41, P281, DOI 10.1016/B978-0-12-394314-9.00013-0; Pang SZ, 2000, MOL BREEDING, V6, P87, DOI 10.1023/A:1009619230918; Pei MS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2470-3; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; Reape TJ, 2008, NEW PHYTOL, V180, P13, DOI 10.1111/j.1469-8137.2008.02549.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROTHE J, 1992, IMMUNOL RES, V11, P81, DOI 10.1007/BF02918612; Shang J, 2009, PHYSIOL MOL PLANT P, V74, P184, DOI 10.1016/j.pmpp.2009.11.005; Shang J, 2010, Z NATURFORSCH C, V65, P73; Sindelarova M, 2004, BIOL PLANTARUM, V48, P419, DOI 10.1023/B:BIOP.0000041096.21583.61; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Tran L. S. P., 2014, PHYTOHORMONES WINDOW; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tyerman SD, 2002, PLANT CELL ENVIRON, V25, P173, DOI 10.1046/j.0016-8025.2001.00791.x; VOGELMANN TC, 1993, PLANT CELL ENVIRON, V16, P65, DOI 10.1111/j.1365-3040.1993.tb00845.x; Wang H, 1996, PLANT CELL, V8, P375, DOI 10.1105/tpc.8.3.375; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Xi DH, 2010, J PHYTOPATHOL, V158, P263, DOI 10.1111/j.1439-0434.2009.01607.x; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang L, 2012, PLANT PHYSIOL, V160, P1453, DOI 10.1104/pp.112.200865; Zhang N, 2014, J PINEAL RES, V56, P39, DOI 10.1111/jpi.12095; Zhang Y., 2016, SCI REPORTS, V6; Zhou L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098578; Zitter T, CUCUMBER MOSAIC	58	8	8	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0175391	10.1371/journal.pone.0175391	http://dx.doi.org/10.1371/journal.pone.0175391			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489891	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314100006
J	Jud, NA; Gandolfo, MA; Iglesias, A; Wilf, P				Jud, Nathan A.; Gandolfo, Maria A.; Iglesias, Ari; Wilf, Peter			Flowering after disaster: Early Danian buckthorn (Rhamnaceae) flowers and leaves from Patagonia	PLOS ONE			English	Article							SP-NOV RHAMNACEAE; LAGUNA DEL HUNCO; SAN JORGE BASIN; EARLY PALEOCENE; SOUTH-AMERICA; SALAMANCA FORMATION; MIDTERTIARY AMBER; PLANT DIVERSITY; FOSSIL FRUITS; RAIN-FOREST	Southern-Hemisphere terrestrial communities from the early Paleocene are poorly known, but recent work on Danian plant fossils from the Salamanca Formation in Chubut Province, Argentina are providing critical data on earliest Paleocene floras. The fossils described here come from a site in the Salamanca Formation dating to ca. 1 million years or less after the end-Cretaceous extinction event; they are the first fossil flowers reported from the Danian of South America, and possible the entire Southern Hemisphere. They are compressions and impressions in flat-laminated light gray shale, and they belong to the family Rhamnaceae (buckthorns). Flowers of Notiantha grandensis gen. et sp. nov. are pentamerous, with distinctly keeled calyx lobes projecting from the hypanthium, clawed and cucullate emarginate petals, antepetalous stamens, and a pentagonal floral disk that fills the hypanthium. Their phylogenetic position was evaluated using a molecular scaffold approach combined with morphological data. Results indicate that the flowers are most like those of extant ziziphoid Rhamnaceae. The associated leaves, assigned to Suessenia grandensis gen. et sp. nov. are simple and ovate, with serrate margins and three acrodromous basal veins. They conform to the distinctive leaves of some extant Rhamnaceae in the ziziphoid and ampelozizyphoid clades. These fossils provide the first unequivocal megafossil evidence of Rhamnaceae in the Southern Hemisphere, demonstrating that Rhamnaceae expanded beyond the tropics by the earliest Paleocene. Given previous reports of rhamnaceous pollen in the late Paleogene and Neogene of Antarctica and southern Australia, this new occurrence increases the possibility of high-latitude dispersal of this family between South America and Australia via Antarctica during the Cenozoic.	[Jud, Nathan A.; Gandolfo, Maria A.] Cornell Univ, Plant Biol Sect, LH Bailey Hortorium, Sch Integrat Plant Sci, Ithaca, NY 14853 USA; [Iglesias, Ari] Univ Nacl Comahue, Inst Invest Biodiversidad & Ambiente INIBIO, CONICET, San Carlos De Bariloche, Rio Negro, Argentina; [Wilf, Peter] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Cornell University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Jud, NA (corresponding author), Cornell Univ, Plant Biol Sect, LH Bailey Hortorium, Sch Integrat Plant Sci, Ithaca, NY 14853 USA.	nathan.jud@cornell.edu	Jud, Nathan/AAI-2384-2020	Jud, Nathan/0000-0001-6100-9779; Iglesias, Ari/0000-0002-9098-8758	National Science Foundation [DEB-1556136, DEB-0918932, DEB-1556666, DEB-0919071, DEB-0345750]; David and Lucile Packard Foundation; Fulbright Foundation; Direct For Biological Sciences [1556136] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Fulbright Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funded by National Science Foundation DEB-1556136 to MAG www.nsf.gov, National Science Foundation DEB-0918932 to MAG www.nsf.gov, National Science Foundation DEB-1556666 to NRC and PW www.nsf.gov, National Science Foundation DEB-0919071 to NRC and PW www.nsf.gov, National Science Foundation DEB-0345750 to NRC, PW and MAG www.nsf.gov, David and Lucile Packard Foundation to PW, Fulbright Foundation to MAG.; The authors thank M. Caffa, L. Canessa, K. Johnson, P. Puerta, A. Reznicek, J. Svitko, and many others for assistance in the field and laboratory work. We also thank the Secretaria de Cultura de la Provincia de Chubut, and E. Thomas for facilitating land access. Funding supporting this work came from the National Science Foundation (grants DEB -1556136, DEB-0918932, DEB-1556666, DEB-0919071, and DEB-0345750) and the Fulbright Foundation (MAG).	Aagesen L, 1999, BOT J LINN SOC, V131, P1; Akkiraz MS, 2008, TURK J EARTH SCI, V17, P317; Andreis R.R., 1977, OBRA CENTENARIO MUSE, V4, P77; Andreis RR, 1975, REV ASOCIACION GEOL, V30, P85; [Anonymous], 1992, B MUSEO NACL HIST NA; [Anonymous], 1971, ROZPRAVY USTREDNIHO; [Anonymous], 1925, J HOPKINS U STUD GEO; ARCHANGELSKY S, 1973, Ameghiniana, V10, P339; Archangelsky S., 1986, AMEGHINIANA, V23, P35; AVERDIECK F-R, 1971, Meyniana, V21, P1; Axelrod D.I., 1995, U CALIFORNIA PUBLICA, V139; Axelrod DI, 1985, U CALIFORNIA PUBLICA, V129; Barreda VD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052455; BASINGER JF, 1984, SCIENCE, V224, P511, DOI 10.1126/science.224.4648.511; Bentham G, 1862, GENERA PLANTARUM AD; Berry E.W., 1931, GEOL SURV PROF PAPER, P31; BERRY EDWARD W., 1929, JOHNS HOPKINS UNIV STUD GEOL, V10, P79; Berry EW, 1928, AM J SCI, V16, P39; Berry EW, 1930, REVISION LOWER EOCEN; Berry EW, 1937, J HOPKINS U STUDIES, V12, P33; Berry EW, 1916, LOWER EOCENE FLORAS; Bertels A., 1975, Revista Esp Micropaleont, V7, P429; Blackburn DT, 1994, HIST AUSTR VEGETATIO, P328; Bona P, 2005, J VERTEBR PALEONTOL, V25, P569, DOI 10.1671/0272-4634(2005)025[0569:PAPIOY]2.0.CO;2; Bona P., 2012, AMEGHINIANA, V44, P435; Bonaparte J. F., 1997, Estudios Geologicos (Madrid), V53, P263; Bonaparte JF, 1993, EVOLUTIONARY MONOGRA, V14, P161; BRABENEC B, 1904, ROZPRAVY CESKE AKAD, V2, P1; Brea M, 2005, AMEGHINIANA, V42, P407; Brea M, 2008, ALCHERINGA, V32, P427, DOI 10.1080/03115510802417695; BROWN R, 1814, GEN REMARKS GEOGRAPH; Brown R. W., 1939, J PALEONTOL, V13, P485; BROWN RW, 1962, PALEOCENE FLORA ROCK; Burge DO, 2008, INT J PLANT SCI, V169, P1066, DOI 10.1086/590453; Burge DO, 2011, INT J PLANT SCI, V172, P1137, DOI 10.1086/662028; Buzek C., 1992, J MINERALOGY GEOLOGY, V37, P117; Callmander MW, 2008, ADANSONIA, V30, P151; Calvillo-Canadell L., 2000, THESIS; Calvillo-Canadell L, 2007, AM J BOT, V94, P1658, DOI 10.3732/ajb.94.10.1658; Camacho H., 1967, REV ASOC GEOL ARGENT, V22, P253; CAMACHO H. H., 1954, CONTR CUSHMAN FOUND FORAMINIFERAL RES, V5, P31; Campbell JD, 2002, J ROY SOC NEW ZEAL, V32, P149, DOI 10.1080/03014223.2002.9517687; Carvalho MR, 2013, AM J BOT, V100, P1831, DOI 10.3732/ajb.1200637; Chambers Kenton L., 2015, Journal of the Botanical Research Institute of Texas, V9, P361; Chambers Kenton L., 2014, Journal of the Botanical Research Institute of Texas, V8, P551; Chebli G., 1974, REV ASOC GEOL ARGENT, V29, P311; Chesters K.I.M., 1957, PALAEONTOGR ABT B, V101, P30; CHITALEY S D, 1972, Botanique (Nagpur), V3, P41; Clyde WC, 2014, GEOL SOC AM BULL, V126, P289, DOI 10.1130/B30915.1; Collinson Margaret E., 2012, Abhandlungen der Senckenberg Gesellschaft fur Naturforschung, V570, P1; Collinson ME, 2009, J HUM EVOL, V57, P149, DOI 10.1016/j.jhevol.2009.02.010; Comer EE, 2015, PALAIOS, V30, P553, DOI 10.2110/palo.2014.064; Correa E, 2010, AM J BOT, V97, P71, DOI 10.3732/ajb.0900093; Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; Cronquist A., 1981, INTEGRATED SYSTEM CL; Cuneo NR, 2013, INT J PLANT SCI, V174, P340, DOI 10.1086/668811; CUNNINGHAM WD, 1995, J GEOPHYS RES-SOL EA, V100, P8257, DOI 10.1029/95JB00033; Dong JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140653; Donovan MP, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0012; Dorofeev P.I., 1963, TERTIARY FLORAS W SI; Ettingshausen C., 1869, DENKSCHR K AKAD W MN, V29, P1; Feldmann RM, 1997, J PALEONTOL, V71, P125, DOI 10.1017/S0022336000039019; FERUGLIO E, 1949, YACIMIENTOS PETROLIF, V2, P1; Forasiepi AM, 2003, AMEGHINIANA, V40, P625; Frenguelli J., 1936, BANCO VERDE PASO NIE; Futey MK, 2012, BOT REV, V78, P205, DOI 10.1007/s12229-012-9100-9; Gandolfo MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021084; Gelfo JN, 2007, EARTH ENV SCI T R SO, V98, P127, DOI 10.1017/SI755691007006081; Gelfo JN, 2008, J PALEONTOL, V82, P329, DOI 10.1666/06-099.1; Gelfo JN, 2007, J VERTEBR PALEONTOL, V27, P651, DOI 10.1671/0272-4634(2007)27[651:TCRPMD]2.0.CO;2; Gelfo Javier N., 2001, Geodiversitas, V23, P369; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Goloboff PA, 1998, CLADISTICS, V14, P229, DOI 10.1111/j.1096-0031.1998.tb00336.x; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Gregor H. -J., 1978, PALAEONTOGRAPHICA B, V167, P8; Grote PJ, 2007, STUDIES FLORA PLEIST; GULERIA J.S., 1992, PALEOBOTANIST, V39, P303; Gurovich Y, 2008, PALAEONTOLOGY, V51, P1069, DOI 10.1111/j.1475-4983.2008.00805.x; Han M, 2016, SCI CHINA EARTH SCI, V59, P824, DOI 10.1007/s11430-015-5245-9; Hauenschild F, 2016, TAXON, V65, P65, DOI 10.12705/651.5; Hauenschild F, 2016, TAXON, V65, P47, DOI 10.12705/651.4; Henrickson J., 2003, LONDELLIA, V6, P138; Hermsen EJ, 2016, SYST BOT, V41, P316, DOI 10.1600/036364416X691830; Herrera F, 2011, AM J BOT, V98, P2004, DOI 10.3732/ajb.1000461; Hinojosa LF, 2011, GLOBAL ECOL BIOGEOGR, V20, P380, DOI 10.1111/j.1466-8238.2010.00595.x; Iglesias A, 2007, GEOLOGY, V35, P947, DOI 10.1130/G23889A.1; Iglesias A, 2011, BIOL J LINN SOC, V103, P409, DOI 10.1111/j.1095-8312.2011.01657.x; Islam MB, 2006, SYST BOT, V31, P826, DOI 10.1600/036364406779695997; JACCARD A, 1858, B SOC NEUCHATEL SCI, V4, P55; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; JOHNSTON MC, 1974, B TORREY BOT CLUB, V101, P64, DOI 10.2307/2484536; JONES JH, 1980, AM J BOT, V67, P959, DOI 10.2307/2442438; KERSHAW AP, 1976, NEW PHYTOL, V77, P469, DOI 10.1111/j.1469-8137.1976.tb01534.x; Knobloch E, 1976, MIOZANE BLATTERFLORE; Kooyman RM, 2014, AM J BOT, V101, P2121, DOI 10.3732/ajb.1400340; Kovar-Eder J, 2004, EVOLUTION W EURASIAN, P399; KRYSHTOFOVICH A, 1918, J GEOL SOC TOKYO, V25, P25; Kvacek Zlatko, 2000, Sbornik Narodniho Muzea v Praze Rada B Prirodni Vedy, V56, P1; LACROIX C, 1988, AM J BOT, V75, P906, DOI 10.2307/2444011; LANGERON M, 2002, B TRIMEST SOC HIST N, V15, P35; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; Le Houerou HN, 1997, J ARID ENVIRON, V37, P619, DOI 10.1006/jare.1997.0315; Legarreta Leonardo, 1994, Ameghiniana, V31, P257; Leon Rolando J. C., 1998, Ecologia Austral, V8, P125; Li XC, 2014, ACTA GEOL SIN-ENGL, V88, P1364, DOI 10.1111/1755-6724.12304; Liu KN, 2015, J SYST EVOL, V53, P252, DOI 10.1111/jse.12136; MacGinitie HD, 1953, CARNEGIE I WASHINGTO, V599; Mai DH, 2000, FUNDSTELLEN EOZANER; Mai Dieter Hans, 2001, Palaeontographica Abteilung B Palaeophytologie, V257, P35; Manchester S. R., 2001, PROC DENVER MUS NAT, V4, P137; Manchester SR, 1999, ANN MO BOT GARD, V86, P472, DOI 10.2307/2666183; Manchester Steven R., 2014, Sbornik Narodniho Muzea v Praze Rada B Prirodni Vedy, V70, P153, DOI 10.14446/AMNP.2014.153; Masiuk V., 1967, REV MUSEO PLATA NUEV, V5, P197; Mason HL, 1942, DISTRIBUTIONAL HIST; Matheos S.D., 2001, REV ASOCIACION ARGEN, V8, P93; Matheos SD, 2005, ACT 16 C GEOL ARG LA, P83; Medan D, 2004, FA GE VAS P, V6, P320; Meier W, 2008, BRITTONIA, V60, P131, DOI 10.1007/s12228-008-9011-6; Mendez I. A., 1966, Revista Soc geol argent, V21, P127; Menke, 1976, GEOLOGISCHES JB, V32; MEYER H., 1997, U CALIFORNIA PUBLICA, V141; Miki S., 1933, YAMASHIRO JPN KYOTO, V14, P1; MIKI SHIGERU, 1937, JAP JOUR BOT, V8, P303; Millan M, 2014, BOT REV, V80, P73, DOI 10.1007/s12229-014-9134-2; Mohr B.A.R., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V113, P595, DOI 10.2973/odp.proc.sr.113.140.1990; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Nobs M. A., 1963, CARNEGIE I WASHINGTO, P623; Nowicke JW, 1971, NNALS MO BOT GARD, V58, P267; Onstein RE, 2016, J ECOL, V104, P665, DOI 10.1111/1365-2745.12538; Onstein RE, 2015, EVOLUTION, V69, P756, DOI 10.1111/evo.12605; OZAKI K, 1991, B KANAGAWA PREFECTUR; Palazzesi L, 2007, FLORA, V202, P328, DOI 10.1016/j.flora.2006.07.006; Parma SG, 2005, J PALEONTOL, V79, P1072; Pascual R, 2002, ACTA PALAEONTOL POL, V47, P487; PASCUAL R, 1992, NATURE, V356, P704, DOI 10.1038/356704a0; Pascual Rosendo, 2007, Journal of Mammalian Evolution, V14, P75, DOI 10.1007/s10914-007-9039-5; Pennington RT, 2004, PHILOS T R SOC B, V359, P1611, DOI 10.1098/rstb.2004.1532; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; PETRIELLA B.T.P., 1975, ACT 1 C ARG PAL BIOE, V2, P257; Prakash U., 1974, ASPECTS APPRAISAL IN, P306; Pusalkar PK, 2010, NORD J BOT, V28, P49, DOI 10.1111/j.1756-1051.2009.00520.x; Raigemborn María Sol, 2010, Rev. Asoc. Geol. Argent., V67, P239; Ramrez-Arriaga E, PALAEONTOL ELECT, V18, P1; Raniecka-Bobrowska J., 1959, I GEOL BIUL, V130, P159; RAVEN PH, 1974, ANN MO BOT GARD, V61, P539, DOI 10.2307/2395021; RETALLACK GJ, 1992, PALEOBIOLOGY, V18, P383, DOI 10.1017/S0094837300010964; Richardson J. E., 2000, Kew Bulletin, V55, P311, DOI 10.2307/4115645; Richardson JE, 2004, PHILOS T R SOC B, V359, P1495, DOI 10.1098/rstb.2004.1537; Richardson JE, 2000, AM J BOT, V87, P1309, DOI 10.2307/2656724; Servicio Meteorologico Nacional, ATL CLIM, P658; Singh H, 2010, CURR SCI, V001, P98; Smiley C., 1985, LATE CENOZOIC HIST P, V95, P112; SMILEY CHARLES J., 1963, UNIV CALIFORNIA PUBL GEOL SCI, V35, P159; SMITH N, 2004, FLOWERING PLANTS NEO; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Sterli J, 2013, J SYST PALAEONTOL, V11, P835, DOI 10.1080/14772019.2012.708674; STUCHLIK L, 1981, Studia Geologica Polonica, V72, P109; Suessenguth K, 1953, NATURLICHEN PFLANZEN, V20d; SUZUKI M, 1982, BOT MAG TOKYO, V95, P281, DOI 10.1007/BF02488539; TIFFNEY BH, 1994, REV PALAEOBOT PALYNO, V82, P299, DOI 10.1016/0034-6667(94)90081-7; Tortosa Roberto D., 1992, Darwiniana (San Isidro), V31, P223; Traverse A, 1955, REPORT INVESTIGATION; Trivedi BS, 1982, J INDIAN BOT SOC, V61, P212; Tsukagoshi M., 1990, JAPAN B MISUNAMI FOS, V17, P71; Udhoji S. G, 1990, CRETACEOUS EVENT STR, P99; Udhoji SG, 1989, REC GEOL SURV INDIA, V122, P214; Watari S1952Dicotyledonous, J FAC SCI U TOKYO SE, V6, P97; *WGCPC, 1978, CHIN MES PLANTS CLAS; Wheeler EA, 2012, IAWA J, V33, P309, DOI 10.1163/22941932-90000096; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wilf P, 2005, AM NAT, V165, P634, DOI 10.1086/430055; Wilf P, 2003, SCIENCE, V300, P122, DOI 10.1126/science.1080475; Wilf P, 2013, ANNU REV EARTH PL SC, V41, P561, DOI 10.1146/annurev-earth-050212-124217; Wilford G.E., 1994, HIST AUSTR VEGETATIO, P5; ZHILIN SG, 1989, BOT REV, V55, P205, DOI 10.1007/BF02858522; Zuccarini J.G, 1832, ABH MATH PHYS KGL, V1, P287; Zucol AF, 2008, FITOLITOS ESTADO ACT, P149; Zuloaga Fernando O., 2015, Rodriguésia, V66, P989, DOI 10.1590/2175-7860201566405; Zuloaga FO., 1999, MONOGRAPHS SYSTEMATI, V74	180	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176164	10.1371/journal.pone.0176164	http://dx.doi.org/10.1371/journal.pone.0176164			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489895	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100016
J	Iqbal, M; Rehan, M; Hong, KS				Iqbal, Muhammad; Rehan, Muhammad; Hong, Keum-Shik			Modeling of inter-neuronal coupling medium and its impact on neuronal synchronization	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; FITZHUGH-NAGUMO NEURONS; EXTERNAL ELECTRICAL-STIMULATION; PID CONTROLLER; GAP-JUNCTIONS; SYSTEMS; BRAIN; NETWORK; INPUT; COMMUNICATION	In this paper, modeling of the coupling medium between two neurons, the effects of the model parameters on the synchronization of those neurons, and compensation of coupling strength deficiency in synchronization are studied. Our study exploits the inter-neuronal coupling medium and investigates its intrinsic properties in order to get insight into neuronal-information transmittance and, there from, brain-information processing. A novel electrical model of the coupling medium that represents a well-known RLC circuit attributable to the coupling medium's intrinsic resistive, inductive, and capacitive properties is derived. Surprisingly, the integration of such properties reveals the existence of a natural three-term control strategy, referred to in the literature as the proportional integral derivative (PID) controller, which can be responsible for synchronization between two neurons. Consequently, brain-information processing can rely on a large number of PID controllers based on the coupling medium properties responsible for the coherent behavior of neurons in a neural network. Herein, the effects of the coupling model (or natural PID controller) parameters are studied and, further, a supervisory mechanism is proposed that follows a learning and adaptation policy based on the particle swarm optimization algorithm for compensation of the coupling strength deficiency.	[Iqbal, Muhammad] Pakistan Inst Engn & Appl Sci, Dept Comp & Informat Sci, Islamabad, Pakistan; [Rehan, Muhammad] Pakistan Inst Engn & Appl Sci, Dept Elect Engn, Islamabad, Pakistan; [Hong, Keum-Shik] Pusan Natl Univ, Dept Cognomechatron Engn, Busan, South Korea; [Hong, Keum-Shik] Pusan Natl Univ, Sch Mech Engn, Busan, South Korea	Pakistan Institute of Engineering & Applied Science; Pakistan Institute of Engineering & Applied Science; Pusan National University; Pusan National University	Rehan, M (corresponding author), Pakistan Inst Engn & Appl Sci, Dept Elect Engn, Islamabad, Pakistan.	rehanqau@gmail.com	Hong, Keum-Shik/B-9911-2013; Rehan, Muhammad/ABG-5590-2020	Hong, Keum-Shik/0000-0002-8528-4457; Rehan, Muhammad/0000-0002-9908-3971	Higher Education Commission (HEC) of Pakistan; National Research Foundation of Korea under Ministry of Science, ICT and Future Planning, Korea [NRF-2014-R1A2A1A10049727]	Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan); National Research Foundation of Korea under Ministry of Science, ICT and Future Planning, Korea	This work was supported by Higher Education Commission (HEC) of Pakistan (to MR) and the National Research Foundation of Korea under the auspices of the Ministry of Science, ICT and Future Planning, Korea (grant no. NRF-2014-R1A2A1A10049727 to KSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel H. D. I., 1996, Physics-Uspekhi, V39, P337, DOI 10.1070/PU1996v039n04ABEH000141; Aqil M, 2012, NEUROIMAGE, V63, P553, DOI 10.1016/j.neuroimage.2012.07.006; Aqil M, 2012, COMMUN NONLINEAR SCI, V17, P1615, DOI 10.1016/j.cnsns.2011.09.028; Bedard C, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022709; Chang WD, 2010, COMMUN NONLINEAR SCI, V15, P3632, DOI 10.1016/j.cnsns.2010.01.005; Chang WD, 2009, CHAOS SOLITON FRACT, V39, P910, DOI 10.1016/j.chaos.2007.01.064; Deak GO, 2007, NEUROCOMPUTING, V70, P2139, DOI 10.1016/j.neucom.2006.06.008; Dehghani N, 2010, J COMPUT NEUROSCI, V29, P405, DOI 10.1007/s10827-010-0263-2; Di Garbo A, 2007, BIOSYSTEMS, V88, P216, DOI 10.1016/j.biosystems.2006.08.011; Dunin-Barkowski WL, 2002, NEUROCOMPUTING, V44, P381, DOI 10.1016/S0925-2312(02)00385-5; Eberhart RC, 2004, IEEE T EVOLUT COMPUT, V8, P201, DOI 10.1109/tevc.2004.830335; Gaing ZL, 2004, IEEE T ENERGY CONVER, V19, P384, DOI 10.1109/TEC.2003.821821; Gharghory SM, 2012, INT J COMPUT COMMUN, V7, P101, DOI 10.15837/ijccc.2012.1.1426; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Iqbal M, 2015, CHAOS SOLITON FRACT, V77, P158, DOI 10.1016/j.chaos.2015.05.021; Iqbal M, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/367173; Jobst B, 2010, EPILEPSY RES, V89, P154, DOI 10.1016/j.eplepsyres.2009.08.017; Kassimali A., 2011, STRUCTURAL ANAL, V4th; Knoblauch A, 2005, BIOSYSTEMS, V79, P83, DOI 10.1016/j.biosystems.2004.09.007; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Nguyen LH, 2013, APPL MATH MODEL, V37, P2460, DOI 10.1016/j.apm.2012.06.003; Nguyen LH, 2011, MATH COMPUT SIMULAT, V82, P590, DOI 10.1016/j.matcom.2011.10.005; Limousin P, 2008, NEUROTHERAPEUTICS, V5, P309, DOI 10.1016/j.nurt.2008.01.006; Lv M, 2016, NONLINEAR DYNAM, V85, P1479, DOI 10.1007/s11071-016-2773-6; Lv M, 2016, NEUROCOMPUTING, V205, P375, DOI 10.1016/j.neucom.2016.05.004; Marrazzi AS, 1944, J NEUROPHYSIOL, V7, P83, DOI 10.1152/jn.1944.7.2.83; Mejias JF, 2007, NEUROCOMPUTING, V70, P2026, DOI 10.1016/j.neucom.2006.10.097; Nowotny T, 2008, CHAOS, V18, DOI 10.1063/1.2949925; Pikovsky A., 2003, SYNCHRONIZATION UNIV, V12; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Raffone A, 2003, CHAOS, V13, P1090, DOI 10.1063/1.1602211; Rehan M, 2016, CHAOS SOLITON FRACT, V87, P197, DOI 10.1016/j.chaos.2016.04.001; Rehan M, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/230980; Rehan M, 2011, NEUROCOMPUTING, V74, P3296, DOI 10.1016/j.neucom.2011.05.015; Rehan M, 2011, PHYS LETT A, V375, P1666, DOI 10.1016/j.physleta.2011.03.012; Sadiku MN., 2007, ELEMENTS ELECTROMAGN; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Shin JH, 2010, IEEE T NEURAL NETWOR, V21, P1697, DOI 10.1109/TNN.2010.2050600; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107; Suykens JAK, 2008, CHAOS, V18, DOI 10.1063/1.2985139; Thompson CJ, 1999, CHAOS SOLITON FRACT, V10, P1825, DOI 10.1016/S0960-0779(98)00131-3; Tsumoto K, 2003, INT J BIFURCAT CHAOS, V13, P653, DOI 10.1142/S0218127403006832; Wang J, 2007, CHAOS SOLITON FRACT, V31, P30, DOI 10.1016/j.chaos.2005.09.006; Wang QY, 2006, PHYS LETT A, V356, P17, DOI 10.1016/j.physleta.2006.03.017; Wang QY, 2008, PHYSICA A, V387, P4404, DOI 10.1016/j.physa.2008.02.067; Wang Y, 2010, NEUROCOMPUTING, V73, P2532, DOI 10.1016/j.neucom.2010.06.006; Xu Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep43452; Zhang T, 2007, CHAOS SOLITON FRACT, V33, P194, DOI 10.1016/j.chaos.2006.01.037	50	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176986	10.1371/journal.pone.0176986	http://dx.doi.org/10.1371/journal.pone.0176986			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486505	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314000032
J	Kumar, S; Jung, JK; Kim, Y				Kumar, Sunil; Jung, Jin-Kyo; Kim, Yonggyun			Characterization of joining sites of a viral histone H4 on host insect chromosomes	PLOS ONE			English	Article							COTESIA-PLUTELLAE BRACOVIRUS; DIAMONDBACK MOTH; TRANSCRIPTOME ANALYSIS; TRANSIENT EXPRESSION; GENE-EXPRESSION; WASP; POLYDNAVIRUS; PARASITISM; SUPPRESSES; PROTEIN	A viral histone H4 (CpBV-H4) is encoded in a polydnavirus, Cotesia plutellae bracovirus (CpBV). It plays a crucial role in parasitism of an endoparasitoid wasp, C. plutellae, against diamondback moth, Plutella xylostella, by altering host gene expression in an epigenetic mode by its N-terminal tail after joining host nucleosomes. Comparative transcriptomic analysis between parasitized and nonparasitized P. xylostella by RNA-Seq indicated that 1,858 genes were altered at more than two folds in expression levels at late parasitic stage, including 877 up-regulated genes and 981 down-regulated genes. Among parasitic factors altering host gene expression, CpBV-H4 alone explained 16.3% of these expressional changes. To characterize the joining sites of CpBV-H4 on host chromosomes, ChIP-Seq (chromatin immunoprecipitation followed by deep sequencing) was applied to chromatins extracted from parasitized larvae. It identified specific 538 ChIP targets. Joining sites were rich (60.2%) in AT sequence. Almost 40% of ChIP targets included short nucleotide repeat sequences presumably recognizable by transcriptional factors and chromatin remodeling factors. To further validate these CpBV-H4 targets, CpBV-H4 was transiently expressed in nonparasitized host at late larval stage and subjected to ChIP-Seq.Two kinds of ChIP-Seqs shared 51 core joining sites. Common targets were close (within 1 kb) to genes regulated at expression levels by CpBV-H4. However, other host genes not close to CpBV-H4 joining sites were also regulated by CpBV-H4. These results indicate that CpBV-H4 joins specific chromatin regions of P. xylostella and controls about one sixth of the total host genes that were regulated by C. plutellae parasitism in an epigenetic mode.	[Kumar, Sunil; Kim, Yonggyun] Andong Natl Univ, Dept Plant Med, Andong, South Korea; [Jung, Jin-Kyo] Rural Dev Adm, Natl Inst Crop Sci, Dept Cent Area Crop Sci, Div Crop Cultivat & Environm Res, Suwon, South Korea	Andong National University; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science	Kim, Y (corresponding author), Andong Natl Univ, Dept Plant Med, Andong, South Korea.	hosanna@anu.ac.kr		Jung, Jin Kyo/0000-0003-3809-1836; Kim, Yonggyun/0000-0002-6840-2167	Agenda Research Grant - Rural Administration Development, Republic of Korea [PJ01182003]	Agenda Research Grant - Rural Administration Development, Republic of Korea	This study was supported by an Agenda Research Grant (Project number: PJ01182003) funded by Rural Administration Development, Republic of Korea.	Ali MR, 2013, COMP BIOCHEM PHYS A, V166, P251, DOI 10.1016/j.cbpa.2013.06.028; Andrew N, 2006, PHYSIOL ENTOMOL, V31, P341, DOI 10.1111/j.1365-3032.2006.00524.x; Armstrong JA, 2002, EMBO J, V21, P5245, DOI 10.1093/emboj/cdf517; Asgari S, 2006, ARCH INSECT BIOCHEM, V61, P146, DOI 10.1002/arch.20109; Bae S, 2004, COMP BIOCHEM PHYS A, V138, P39, DOI 10.1016/j.cbpb.2004.02.018; Bae S, 2009, J INVERTEBR PATHOL, V102, P79, DOI 10.1016/j.jip.2009.06.007; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Bezier A, 2009, J INVERTEBR PATHOL, V101, P194, DOI 10.1016/j.jip.2009.04.006; Black JC, 2010, MOL CELL, V40, P736, DOI 10.1016/j.molcel.2010.11.008; Burke GR, 2014, MOL ECOL, V23, P890, DOI 10.1111/mec.12648; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Gad W, 2009, INSECT MOL BIOL, V18, P111, DOI 10.1111/j.1365-2583.2009.00860.x; Gad W, 2008, J GEN VIROL, V89, P931, DOI 10.1099/vir.0.83585-0; Hepat R, 2013, J VIROL, V87, P11223, DOI 10.1128/JVI.01759-13; Hepat R, 2013, J INVERTEBR PATHOL, V114, P34, DOI 10.1016/j.jip.2013.05.004; Hepat R, 2012, J INVERTEBR PATHOL, V111, P152, DOI 10.1016/j.jip.2012.07.025; Hepat R, 2011, BIOCHEM BIOPH RES CO, V415, P279, DOI 10.1016/j.bbrc.2011.10.040; Ibrahim AMA, 2006, J INSECT PHYSIOL, V52, P943, DOI 10.1016/j.jinsphys.2006.06.001; Kim E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161661; Kim GS, 2010, J INSECT PHYSIOL, V56, P559, DOI 10.1016/j.jinsphys.2009.11.022; Kim J, 2013, COMP BIOCHEM PHYS A, V166, P60, DOI 10.1016/j.cbpa.2013.04.025; Kim Y, INSECT SCI UNPUB; Kim Yonggyun, 2007, Journal of Asia-Pacific Entomology, V10, P181, DOI 10.1016/S1226-8615(08)60351-9; Kumar S, 2016, J GEN VIROL, V97, P2780, DOI 10.1099/jgv.0.000560; Kwon B, 2010, J INSECT PHYSIOL, V56, P650, DOI 10.1016/j.jinsphys.2010.01.013; Luckhart S, 1996, DEV COMP IMMUNOL, V20, P1, DOI 10.1016/0145-305X(95)00040-Z; Provost B, 2011, INSECT BIOCHEM MOLEC, V41, P582, DOI 10.1016/j.ibmb.2011.03.010; Qi YX, 2015, ARCH INSECT BIOCHEM, V88, P203, DOI 10.1002/arch.21214; Shi M, 2016, INSECT MOL BIOL, V25, P679, DOI 10.1111/imb.12252; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Strand MR, 2015, VIROLOGY, V479, P393, DOI 10.1016/j.virol.2015.01.018; Strand MR, 2013, CURR OPIN VIROL, V3, P587, DOI 10.1016/j.coviro.2013.06.004; Surakasi VP, 2011, INSECT MOL BIOL, V20, P609, DOI 10.1111/j.1365-2583.2011.01091.x; Webb B.A., 2000, VIRUS TAXONOMY, P253; Webb BA, 1996, ARCH INSECT BIOCH PH, V26, P147	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177066	10.1371/journal.pone.0177066	http://dx.doi.org/10.1371/journal.pone.0177066			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486493	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000041
J	Beauchaine, TP; Ben-David, I; Sela, A				Beauchaine, Theodore P.; Ben-David, Itzhak; Sela, Aner			Attention-deficit/ hyperactivity disorder, delay discounting, and risky financial behaviors: A preliminary analysis of self-report data	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; DRUG-USE; ADHD; REWARD; CHILDREN; DISTINCT	Delay discounting-often referred to as hyperbolic discounting in the financial literature-is defined by a consistent preference for smaller, immediate rewards over larger, delayed rewards, and by failure of future consequences to curtail current consummatory behaviors. Previous research demonstrates (1) excessive delay discounting among individuals with attention-deficit/ hyperactivity disorder (ADHD), (2) common neural substrates of delay discounting and hyperactive-impulsive symptoms of ADHD, and (3) associations between delay discounting and both debt burden and high interest rate borrowing. This study extends prior research by examining associations between ADHD symptoms, delay discounting, and an array of previously unevaluated financial outcomes among 544 individuals (mean age 35 years). Controlling for age, income, sex, education, and substance use, ADHD symptoms were associated with delay discounting, late credit card payments, credit card balances, use of pawn services, personal debt, and employment histories (less time spent at more jobs). Consistent with neural models of reward processing and associative learning, more of these relations were attributable to hyperactive-impulsive symptoms than inattentive symptoms. Implications for financial decision-making and directions for future research are discussed.	[Beauchaine, Theodore P.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Ben-David, Itzhak] Ohio State Univ, Dept Finance, Columbus, OH 43210 USA; [Sela, Aner] Univ Florida, Dept Mkt, Warrington Coll Business, Gainesville, FL USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; State University System of Florida; University of Florida	Beauchaine, TP (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA.	beauchaine.1@osu.edu; bendavid@fisher.osu.edu	Beauchaine, Theodore P/CAF-4478-2022	Ben-David, Itzhak/0000-0001-9743-7441				Achtziger A, 2015, J ECON PSYCHOL, V49, P141, DOI 10.1016/j.joep.2015.04.003; Adams ZW, 2008, DEV DISABIL RES REV, V14, P268, DOI 10.1002/ddrr.37; Ahmad SI, 2016, OXFORD HDB EXTERNALI, P19; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Barkley RA, 2006, J AM ACAD CHILD PSY, V45, P192, DOI 10.1097/01.chi.0000189134.97436.e2; Beauchaine TP, 2017, ANN REV CLI IN PRESS, V13; Ben-David I, 2016, WORKING PAPER; Bertrand M, 2011, J FINANC, V66, P1865, DOI 10.1111/j.1540-6261.2011.01698.x; Brook JS, 2013, PEDIATRICS, V131, P5, DOI 10.1542/peds.2012-1725; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Diamond A, 2005, DEV PSYCHOPATHOL, V17, P807, DOI 10.1017/S0954579405050388; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; Gadow K.D., 2004, ADULT SELF REPORT IN; Gatzke-Kopp L.M., 2007, HUMAN BEHAV LEARNING, P239; Gatzke-Kopp LM, 2009, J ABNORM PSYCHOL, V118, P203, DOI 10.1037/a0014378; Goodman JK, 2013, J BEHAV DECIS MAKING, V26, P213, DOI 10.1002/bdm.1753; Graziano PA, 2015, J ATTEN DISORD, V19, P179, DOI 10.1177/1087054714527792; Hinshaw Stephen P, 2015, Wiley Interdiscip Rev Cogn Sci, V6, P39; Hinshaw SP, 2012, J CONSULT CLIN PSYCH, V80, P1041, DOI 10.1037/a0029451; Hurst RM, 2011, J ATTEN DISORD, V15, P412, DOI 10.1177/1087054710365993; Jackson Jacob N S, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P316; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Knutson B, 2001, PLOS ONE, V6; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Lebowitz MS, 2016, J ATTEN DISORD, V20, P199, DOI 10.1177/1087054712475211; Lee S, 2016, PSYCHOL ASSESSMENT, V28, P917, DOI 10.1037/pas0000232; Loe IM, 2007, J PEDIATR PSYCHOL, V32, P643, DOI 10.1093/jpepsy/jsl054; MacKillop J, 2011, PSYCHOPHARMACOLOGY, V216, P305, DOI 10.1007/s00213-011-2229-0; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Milich R, 2001, CLIN PSYCHOL-SCI PR, V8, P463, DOI 10.1093/clipsy/8.4.463; Patros CHG, 2016, CLIN PSYCHOL REV, V43, P162, DOI 10.1016/j.cpr.2015.11.001; Pedhazur E. J., 1982, MULTIPLE REGRESSION; Peper JS, 2013, CEREB CORTEX, V23, P1695, DOI 10.1093/cercor/bhs163; Plichta MM, 2014, NEUROSCI BIOBEHAV R, V38, P125, DOI 10.1016/j.neubiorev.2013.07.012; Reynolds B, 2006, BEHAV PHARMACOL, V17, P651, DOI 10.1097/FBP.0b013e3280115f99; Sagvolden T, 2005, BEHAV BRAIN SCI, V28, P397, DOI 10.1017/S0140525X05000075; Shenhav A, 2016, NAT NEUROSCI, V19, P1286, DOI 10.1038/nn.4384; Skiba PM, 2008, 0833 VAND LAW EC RES, P08; Smith PC, 2010, ARCH INTERN MED, V170, P1155, DOI 10.1001/archinternmed.2010.140; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Wehmeier PM, 2010, J ADOLESCENT HEALTH, V46, P209, DOI 10.1016/j.jadohealth.2009.09.009; Wilson VB, 2011, J CHILD PSYCHOL PSYC, V52, P256, DOI 10.1111/j.1469-7610.2010.02347.x; Zisner A, 2016, DEV PSYCHOPATHOL, V28, P1177, DOI 10.1017/S0954579416000754	44	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176933	10.1371/journal.pone.0176933	http://dx.doi.org/10.1371/journal.pone.0176933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481903	gold, Green Published			2022-12-27	WOS:000401313700023
J	Santra, T; Roche, S; Conlon, N; O'Donovan, N; Crown, J; O'Connor, R; Kolch, W				Santra, Tapesh; Roche, Sandra; Conlon, Neil; O'Donovan, Norma; Crown, John; O'Connor, Robert; Kolch, Walter			Identification of potential new treatment response markers and therapeutic targets using a Gaussian process-based method in lapatinib insensitive breast cancer models	PLOS ONE			English	Article							CELL-LINES; VITAMIN-D; DIFFERENTIAL EXPRESSION; NETWORK RECONSTRUCTION; KINASE INHIBITOR; TIME-SERIES; IN-VITRO; RESISTANCE; CALCITRIOL; RECEPTOR	Molecularly targeted therapeutics hold promise of revolutionizing treatments of advanced malignancies. However, a large number of patients do not respond to these treatments. Here, we take a systems biology approach to understand the molecular mechanisms that prevent breast cancer (BC) cells from responding to lapatinib, a dual kinase inhibitor that targets human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR). To this end, we analysed temporal gene expression profiles of four BC cell lines, two of which respond and the remaining two do not respond to lapatinib. For this analysis, we developed a Gaussian process based algorithm which can accurately find differentially expressed genes by analysing time course gene expression profiles at a fraction of the computational cost of other state-of-the-art algorithms. Our analysis identified 519 potential genes which are characteristic of lapatinib non-responsiveness in the tested cell lines. Data from the Genomics of Drug Sensitivity in Cancer (GDSC) database suggested that the basal expressions 120 of the above genes correlate with the response of BC cells to HER2 and/or EGFR targeted therapies. We selected 27 genes from the larger panel of 519 genes for experimental verification and 16 of these were successfully validated. Further bioinformatics analysis identified vitamin D receptor (VDR) as a potential target of interest for lapatinib non-responsive BC cells. Experimentally, calcitriol, a commonly used reagent for VDR targeted therapy, in combination with lapatinib additively inhibited proliferation in two HER2 positive cell lines, lapatinib insensitive MDA-MB-453 and lapatinib resistant HCC 1954-L cells.	[Santra, Tapesh; Kolch, Walter] Univ Coll Dublin, Syst Biol Ireland, Dublin, Ireland; [Roche, Sandra; Conlon, Neil; O'Donovan, Norma; Crown, John; O'Connor, Robert] Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin, Ireland; [Crown, John] St Vincents Univ Hosp, Dept Med Oncol, Dublin, Elm Park, Ireland; [Kolch, Walter] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin, Ireland; [Kolch, Walter] Univ Coll Dublin, Sch Med, Dublin, Ireland	University College Dublin; Dublin City University; University College Dublin; Saint Vincent's University Hospital; University College Dublin; University College Dublin	Santra, T (corresponding author), Univ Coll Dublin, Syst Biol Ireland, Dublin, Ireland.	tapesh.santra@ucd.ie	Kolch, Walter/ABF-2102-2021; Admin, SBI/HGB-2738-2022; Roche, Sandra/AAM-9800-2021; Crown, John/AAL-3367-2020	Roche, Sandra/0000-0002-4363-4607; Conlon, Neil/0000-0001-5921-7114; Santra, Tapesh/0000-0003-2242-3189; Crown, John/0000-0002-3125-7613	Science Foundation Ireland [06/CE/B1129]; Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT [CCRC13GAL]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT	This work was supported by the Science Foundation Ireland under Grant No. 06/CE/B1129 (CSET) and the Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT (CCRC13GAL).	Batut P, 2013, GENOME RES, V23, P169, DOI 10.1101/gr.139618.112; Beer TM, 2004, CANCER EPIDEM BIOMAR, V13, P2225; Beer TM, 2004, MOL CANCER THER, V3, P373; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Bovolenta LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-405; Brawer Michael K, 2007, Rev Urol, V9, P1; Bryan EJ, 2002, INT J CANCER, V102, P137, DOI 10.1002/ijc.10682; Burris HA, 2005, J CLIN ONCOL, V23, P5305, DOI 10.1200/JCO.2005.16.584; Charlebois DA, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.022713; Creighton CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071158; D'Amato V, 2015, CANCER TREAT REV, V41, P877, DOI 10.1016/j.ctrv.2015.08.001; Docquier F, 2005, CANCER RES, V65, P5112, DOI 10.1158/0008-5472.CAN-03-3498; Donders ART, J CLIN EPIDEMIOLOGY, V59, P1087; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691; Fiorito E, 2013, CHROMOSOMA, V122, P1, DOI 10.1007/s00412-012-0392-7; Pons DG, 2015, FREE RADICAL BIO MED, V86, P67, DOI 10.1016/j.freeradbiomed.2015.04.032; Gajria D, 2011, EXPERT REV ANTICANC, V11, P263, DOI 10.1586/ERA.10.226; Ganesh SK, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-20; Gee JMW, 2009, J PATHOL, V217, P32, DOI 10.1002/path.2430; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gomez HL, 2008, J CLIN ONCOL, V26, P2999, DOI 10.1200/JCO.2007.14.0590; Grigorov MG, 2011, METHODS MOL BIOL, V719, P153, DOI 10.1007/978-1-61779-027-0_7; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Halasz M, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aae0535; Hannesdottir L, 2013, EUR J IMMUNOL, V43, P2718, DOI 10.1002/eji.201242505; Hegde PS, 2007, MOL CANCER THER, V6, P1629, DOI 10.1158/1535-7163.MCT-05-0399; Hejblum BP, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004310; Henjes F, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.16; Hensman J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-252; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094226; Iglesias-Martinez LF, 2016, SCI REP-UK, V6, DOI 10.1038/srep37140; Kalaitzis AA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-180; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kayano M, 2015, BIOSTATISTICS; Kim J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-310; Kim S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-299; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Kurozumi S, 2016, J HUM GENET; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Lee YY, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.115; Liang YL, 2005, BIOINFORMATICS, V21, P3009, DOI 10.1093/bioinformatics/bti465; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MARTIN A, 1991, IN VITRO CELL DEV B, V27, P183; Mayer IA, 2010, CLIN CANCER RES, V16, P1355, DOI 10.1158/1078-0432.CCR-09-3223; McDermott M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00040; McDermott MSJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-157; Mckay JD, 2009, CANCER EPIDEM BIOMAR, V18, P297, DOI 10.1158/1055-9965.EPI-08-0539; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Muindi JR, 2002, CLIN PHARMACOL THER, V72, P648, DOI 10.1067/mcp.2002.129305; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Brien NA, 2010, MOL CANCER THER, V9, P1489, DOI 10.1158/1535-7163.MCT-09-1171; O'Neill F, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-41; Okolicsanyi RK, 2015, TUMOR BIOL, V36, P1731, DOI 10.1007/s13277-014-2774-3; Park SH, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0594-z; PATEL SR, 1994, KIDNEY INT, V45, P1020, DOI 10.1038/ki.1994.138; Petralia F, 2015, BIOINFORMATICS, V31, P197, DOI 10.1093/bioinformatics/btv268; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Rohlfs RV, 2014, MOL BIOL EVOL, V31, P201, DOI 10.1093/molbev/mst190; Rosenfeldt MT, 2014, ONCOGENE, V33, P4164, DOI 10.1038/onc.2013.470; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Santos-Martinez N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-230; Santra T., 2014, FRONTIERS BIOENGINEE, P2; Santra T, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-57; Santra T, 2012, ADV EXP MED BIOL, V736, P59, DOI 10.1007/978-1-4419-7210-1_3; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Segovia-Mendoza M, 2015, J STEROID BIOCHEM, V148, P122, DOI 10.1016/j.jsbmb.2014.12.006; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Singh JC, 2014, BRIT J CANCER, V111, P1888, DOI 10.1038/bjc.2014.388; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stewart B, 2014, WORLD CANC REPORT 20; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Szasz A.M., 2016, CROSS VALIDATION SUR; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thill M, 2012, ANTICANCER RES, V32, P359; Topa H, 2015, BIOINFORMATICS, V31, P1762, DOI 10.1093/bioinformatics/btv014; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; van der Watt PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027723; Wang YXR, 2014, J THEOR BIOL, V362, P53, DOI 10.1016/j.jtbi.2014.03.040; Yan LH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-904; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhao P, 2012, J BIOL CHEM, V287, P25230, DOI 10.1074/jbc.M112.339465; Zur Hausen H., 2008, INT J CANCER, V122, P15004, DOI [10. 1002/ijc. 23348, DOI 10.1002/IJC.23348, 10.1002/ijc.23348]	89	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177058	10.1371/journal.pone.0177058	http://dx.doi.org/10.1371/journal.pone.0177058			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481952	Green Published, gold, Green Submitted			2022-12-27	WOS:000401313700030
J	Beasley, JT; Bonneau, JP; Johnson, AAT				Beasley, Jesse T.; Bonneau, Julien P.; Johnson, Alexander A. T.			Characterisation of the nicotianamine aminotransferase and deoxymugineic acid synthase genes essential to Strategy II iron uptake in bread wheat (Triticum aestivum L.)	PLOS ONE			English	Article							ORYZA-SATIVA L.; PHYTOSIDEROPHORE RELEASE; REGULATORY ELEMENTS; GRAMINEOUS PLANTS; DEFICIENT BARLEY; RICE PLANTS; EXPRESSION; IDENTIFICATION; PROMOTER; ZINC	Iron (Fe) uptake in graminaceous plant species occurs via the release and uptake of Fe-chelating compounds known as mugineic acid family phytosiderophores (MAs). In the MAs biosynthetic pathway, nicotianamine aminotransferase (NAAT) and deoxymugineic acid synthase (DMAS) enzymes catalyse the formation of 2'-deoxymugineic acid (DMA) from nicotianamine (NA). Here we describe the identification and characterisation of six TaNAAT and three TaDMAS1 genes in bread wheat (Triticum aestivum L.). The coding sequences of all six TaNAAT homeologs consist of seven exons with >= 88.0% nucleotide sequence identity and most sequence variation present in the first exon. The coding sequences of the three TaDMAS1 homeologs consist of three exons with >= 97.8% nucleotide sequence identity. Phylogenetic analysis revealed that the TaNAAT and TaDMAS1 proteins are most closely related to the HvNAAT and HvDMAS1 proteins of barley and that there are two distinct groups of TaNAAT proteins-TaNAAT1 and TaNAAT2 -that correspond to the HvNAATA and HvNAATB proteins, respectively. Quantitative reverse transcription-PCR analysis revealed that the TaNAAT2 genes are expressed at highest levels in anther tissues whilst the TaNAAT1 and TaDMAS1 genes are expressed at highest levels in root tissues of bread wheat. Furthermore, the TaNAAT1, TaNAAT2 and TaDMAS1 genes were differentially regulated by plant Fe status and their expression was significantly upregulated in root tissues from day five onwards during a seven-day Fe deficiency treatment. The identification and characterization of the TaNAAT1, TaNAAT2 and TaDMAS1 genes provides a valuable genetic resource for improving bread wheat growth on Fe deficient soils and enhancing grain Fe nutrition.	[Beasley, Jesse T.; Bonneau, Julien P.; Johnson, Alexander A. T.] Univ Melbourne, Sch Biosci, Melbourne, Vic, Australia	University of Melbourne	Johnson, AAT (corresponding author), Univ Melbourne, Sch Biosci, Melbourne, Vic, Australia.	johnsa@unimelb.edu.au			Australian Research Council [LP130100785]; HarvestPlus Challenge Program	Australian Research Council(Australian Research Council); HarvestPlus Challenge Program	This research was supported by grants from the Australian Research Council (http://www.arc.gov.au/grants; LP130100785) and the HarvestPlus Challenge Program (http://www.harvestplus.org) to AATJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2013, PLANT PHYSIOL, V161, P252, DOI 10.1104/pp.112.205161; Aoyama T, 2009, PLANT MOL BIOL, V70, P681, DOI 10.1007/s11103-009-9500-3; Bartos J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-155; Bashir K, 2006, J BIOL CHEM, V281, P32395, DOI 10.1074/jbc.M604133200; Bate N, 1998, PLANT MOL BIOL, V37, P859, DOI 10.1023/A:1006095023050; Bonneau J, 2016, PLANT BIOTECHNOL J; Cheng LJ, 2007, PLANT PHYSIOL, V145, P1647, DOI 10.1104/pp.107.107912; Close TJ, 2004, PLANT PHYSIOL, V134, P960, DOI 10.1104/pp.103.034462; Daneshbakhsh B, 2013, J PLANT PHYSIOL, V170, P41, DOI 10.1016/j.jplph.2012.08.016; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; Druka Arnis, 2006, Functional & Integrative Genomics, V6, P202, DOI 10.1007/s10142-006-0025-4; Eagling T, 2014, J AGR FOOD CHEM, V62, P10320, DOI 10.1021/jf5026295; Eagling T, 2014, J AGR FOOD CHEM, V62, P708, DOI 10.1021/jf403331p; GUERINOT ML, 1994, PLANT PHYSIOL, V104, P815, DOI 10.1104/pp.104.3.815; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hansen NC, 1996, CROP SCI, V36, P1473, DOI 10.2135/cropsci1996.0011183X003600060009x; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Inoue H, 2008, PLANT MOL BIOL, V66, P193, DOI 10.1007/s11103-007-9262-8; KANAZAWA K, 1995, J EXP BOT, V46, P1241, DOI 10.1093/jxb/46.9.1241; Kobayashi T, 2005, J EXP BOT, V56, P1305, DOI 10.1093/jxb/eri131; Kobayashi T, 2003, PLANT J, V36, P780, DOI 10.1046/j.1365-313X.2003.01920.x; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Leach LJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-276; LIU CJ, 1992, THEOR APPL GENET, V83, P305, DOI 10.1007/BF00224276; Liu XH, 2013, PLANTA, V238, P845, DOI 10.1007/s00425-013-1934-9; Liu ZS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0511-8; MA JF, 1995, J BIOL CHEM, V270, P16549, DOI 10.1074/jbc.270.28.16549; Ma JF, 1999, J EXP BOT, V50, P723, DOI 10.1093/jexbot/50.334.723; Manimaran P, 2015, PLANT REPROD, V28, P133, DOI 10.1007/s00497-015-0264-4; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; MORTVEDT JJ, 1991, PLANT SOIL, V130, P273, DOI 10.1007/BF00011883; Nagasaka S, 2009, PLANT MOL BIOL, V69, P621, DOI 10.1007/s11103-008-9443-0; Nishiyama R, 2012, PLANT CELL PHYSIOL, V53, P381, DOI 10.1093/pcp/pcr188; Nozoye T, 2007, PLANT MOL BIOL, V64, P35, DOI 10.1007/s11103-007-9132-4; Nussbaumer T, 2015, G3-GENES GENOM GENET, V5, P2579, DOI 10.1534/g3.115.021550; Park JI, 2006, PLANT CELL REP, V25, P466, DOI 10.1007/s00299-005-0077-2; Pearce S, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0368-2; Riewe D, 2012, PLANT J, V71, P850, DOI 10.1111/j.1365-313X.2012.05035.x; ROMHELD V, 1990, PLANT SOIL, V123, P147, DOI 10.1007/BF00011260; Roschzttardtz H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00350; Schreiber AW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-285; Sears E.R, 1954, ANEUPLOIDS COMMON WH; Sengupta D, 2015, J PLANT PHYSIOL, V179, P40, DOI 10.1016/j.jplph.2015.03.004; Shi RL, 2012, NEW PHYTOL, V195, P372, DOI 10.1111/j.1469-8137.2012.04165.x; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Suzuki M, 2008, PLANT MOL BIOL, V66, P609, DOI 10.1007/s11103-008-9292-x; Suzuki M, 2006, PLANT J, V48, P85, DOI 10.1111/j.1365-313X.2006.02853.x; Swapna L, 2011, MOL BIOTECHNOL, V48, P49, DOI 10.1007/s12033-010-9347-5; TAKAGI S, 1984, J PLANT NUTR, V7, P469, DOI 10.1080/01904168409363213; Takahashi M, 1999, PLANT PHYSIOL, V121, P947, DOI 10.1104/pp.121.3.947; Takahashi M, 2003, PLANT CELL, V15, P1263, DOI 10.1105/tpc.010256; Takahashi M, 2001, NAT BIOTECHNOL, V19, P466, DOI 10.1038/88143; Tauris B, 2009, J EXP BOT, V60, P1333, DOI 10.1093/jxb/erp023; TWELL D, 1991, GENE DEV, V5, P496, DOI 10.1101/gad.5.3.496; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Widodo, 2010, NEW PHYTOL, V186, P400, DOI 10.1111/j.1469-8137.2009.03177.x	57	33	38	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177061	10.1371/journal.pone.0177061	http://dx.doi.org/10.1371/journal.pone.0177061			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475636	Green Published, gold			2022-12-27	WOS:000400649500039
J	Beghe, D; Dall'Asta, L; Garavelli, C; Pastorelli, AA; Muscarella, M; Saccani, G; Aiello, M; Crisafulli, E; Corradi, M; Stacchini, P; Chetta, A; Bertorelli, G				Beghe, Deborah; Dall'Asta, Luca; Garavelli, Claudia; Pastorelli, Augusto Alberto; Muscarella, Marilena; Saccani, Gloria; Aiello, Marina; Crisafulli, Ernesto; Corradi, Massimo; Stacchini, Paolo; Chetta, Alfredo; Bertorelli, Giuseppina			Sarcoidosis in an Italian province. Prevalence and environmental risk factors	PLOS ONE			English	Article							TRADE-CENTER DISASTER; GRANULOMATOUS PULMONARY-DISEASE; AIR-POLLUTION; PO VALLEY; EPIDEMIOLOGY; LICHENS; FIREFIGHTERS; MESOTHELIOMA; OPHIOLITES; MORTALITY	Background and aim Sarcoidosis is a systemic granulomatous inflammatory disease whose causes are still unknown and for which epidemiological data are often discordant. The aim of our study is to investigate prevalence and spatial distribution of cases, and identify environmental exposures associated with sarcoidosis in an Italian province. Methods After georeferentiation of cases, the area under study was subdivided with respect to Municipality and Health Districts and to the altitude in order to identify zonal differences in prevalence. The bioaccumulation levels of 12 metals in lichen tissues were analyzed, in order to determine sources of air pollution. Finally, the analysis of the correlation between metals and between pickup stations was performed. Results 223 patients were identified (58.3% female and 41.7% male of total) and the mean age was 50.6 +/- 15.4 years (53.5 +/- 15.5 years for the females and 46.5 +/- 14.4 for the males). The mean prevalence was 49 per 100.000 individuals. However, we observed very heterogeneous prevalence in the area under study. The correlations among metals revealed different deposition patterns in lowland area respect to hilly and mountain areas. Conclusions The study highlights a high prevalence of sarcoidosis cases, characterized by a very inhomogeneous and patchy distribution with phenomena of local aggregation. Moreover, the bioaccumulation analysis was an effective method to identify the mineral particles that mostly contribute to air pollution in the different areas, but it was not sufficient to establish a clear correlation between the onset of sarcoidosis and environmental risk factors.	[Beghe, Deborah] Univ Parma, Dept Food & Drug, Parma, Italy; [Dall'Asta, Luca] Polytech Univ Turin, Dept Appl Sci & Technol, Turin, Italy; [Dall'Asta, Luca] Coll Carlo Alberto, Turin, Italy; [Garavelli, Claudia; Corradi, Massimo] Univ Parma, Occupat Med Unit, Dept Med & Surg, Parma, Italy; [Pastorelli, Augusto Alberto; Stacchini, Paolo] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Natl Reference Lab Heavy Met Food, Rome, Italy; [Muscarella, Marilena] Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy; [Saccani, Gloria] Univ Parma, Dept Med & Surg, Parma, Italy; [Aiello, Marina; Crisafulli, Ernesto; Chetta, Alfredo; Bertorelli, Giuseppina] Univ Parma, Dept Med & Surg, Resp Dis & Lung Funct Unit, Parma, Italy	University of Parma; Polytechnic University of Turin; Collegio Carlo Alberto; University of Parma; Istituto Superiore di Sanita (ISS); IZS Puglia e Basilicata; University of Parma; University of Parma	Crisafulli, E (corresponding author), Univ Parma, Dept Med & Surg, Resp Dis & Lung Funct Unit, Parma, Italy.	ernesto.crisafulli@unipr.it	Crisafulli, Ernesto/AAB-9595-2019; Beghè, Deborah/AAS-2940-2020; Aiello, Marina/ABD-1516-2021	Crisafulli, Ernesto/0000-0001-7298-7084; Chetta, Alfredo/0000-0002-0416-5334; Beghe, Deborah/0000-0002-0945-5365	Fondazione Cariparma-Parma, Italy	Fondazione Cariparma-Parma, Italy	This work was supported by a grant from the Fondazione Cariparma-Parma, Italy, to Prof. Giuseppina Bertorelli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate E, 1980, APENNINE OPHIOLITES, P59; Agostini C, 2001, Monaldi Arch Chest Dis, V56, P364; Agrawal R, 2016, TUBERCULOSIS, V98, P21, DOI 10.1016/j.tube.2016.01.003; [Anonymous], 2005, 17025 UNI CEI EN ISO; Barnard J, 2005, J OCCUP ENVIRON MED, V47, P226, DOI 10.1097/01.jom.0000155711.88781.91; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885, DOI 10.1164/ajrccm.164.10.2104046; Bayram M, 2013, CHEST, V143, P164, DOI 10.1378/chest.11-2727; Bernardini P, 2003, G Ital Med Lav Ergon, V25, P408; Bigi A, 2014, ATMOS CHEM PHYS, V14, P4895, DOI 10.5194/acp-14-4895-2014; Bigi A, 2012, J ENVIRON MONITOR, V14, P552, DOI 10.1039/c1em10728c; Brunialti G, 2007, SCI TOTAL ENVIRON, V387, P289, DOI 10.1016/j.scitotenv.2007.06.033; Comba P, 2003, ARCH ENVIRON HEALTH, V58, P229, DOI 10.3200/AEOH.58.4.229-232; Corradi M, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/4/046003; Crowley LE, 2011, AM J IND MED, V54, P175, DOI 10.1002/ajim.20924; Deubelbeiss U, 2010, EUR RESPIR J, V35, P1088, DOI 10.1183/09031936.00197808; Dongel I, 2013, RESP MED, V107, P870, DOI 10.1016/j.rmed.2013.03.006; Dubrey S, 2014, POSTGRAD MED J, V90, P582, DOI 10.1136/postgradmedj-2014-132584; Erdal BS, 2012, RESP MED, V106, P893, DOI 10.1016/j.rmed.2012.02.007; Fabrellas EF, 2007, ARCH BRONCONEUMOL, V43, P92, DOI 10.1016/S1579-2129(07)60030-5; GENTRY JT, 1955, J CLIN INVEST, V34, P1839, DOI 10.1172/JCI103240; Goldberg M, 2009, EUR J CANCER PREV, V18, P489, DOI 10.1097/CEJ.0b013e32832f9bee; Gorham ED, 2004, CHEST, V126, P1431, DOI 10.1378/chest.126.5.1431; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Guevara SR, 1995, J RADIOAN NUCL CH AR, V198, P437, DOI 10.1007/BF02036560; Harmens H., 2008, SPATIAL TEMPORAL TRE; HUNNINGHAKE GW, 1981, NEW ENGL J MED, V305, P429, DOI 10.1056/NEJM198108203050804; ISTAT, 2013, HLTH ALL IT; Izbicki G, 2007, CHEST, V131, P1414, DOI 10.1378/chest.06-2114; Jordan HT, 2011, J OCCUP ENVIRON MED, V53, P966, DOI 10.1097/JOM.0b013e31822a3596; KERN DG, 1993, AM REV RESPIR DIS, V148, P974, DOI 10.1164/ajrccm/148.4_Pt_1.974; Lodenius M., 2014, WIT T ECOLOGY ENV, V183, P75, DOI [10.2495/AIR140071, DOI 10.2495/AIR140071]; Loppi S, 2003, ENVIRON POLLUT, V121, P327, DOI 10.1016/S0269-7491(02)00269-5; Maslow CB, 2012, AM J PUBLIC HEALTH, V102, P1186, DOI 10.2105/AJPH.2011.300561; Musellim B, 2009, RESP MED, V103, P907, DOI 10.1016/j.rmed.2008.12.011; Newman KL, 2012, CURR OPIN ALLERGY CL, V12, P145, DOI 10.1097/ACI.0b013e3283515173; Newman LS, 2004, AM J RESP CRIT CARE, V170, P1324, DOI 10.1164/rccm.200402-249OC; Nicholson TT, 2010, SARCOIDOSIS VASC DIF, V27, P111; Nimis PL, 2000, SCI TOTAL ENVIRON, V255, P97, DOI 10.1016/S0048-9697(00)00454-X; Nimis PL, 1999, P WORKSH BIOM QUAL A, V1999, P279; Perez-Simon MR, 2003, ANALES MED INTERNA, V20, P21; Prezant DJ, 1999, CHEST, V116, P1183, DOI 10.1378/chest.116.5.1183; Putaud JP, 2010, ATMOS ENVIRON, V44, P1308, DOI 10.1016/j.atmosenv.2009.12.011; R Development Core Team, 2005, R LANG ENV STAT COMP; Regione Emilia Romagna in collaborazione con: Arpa Amianto Stop Servizio Sanitario Regionale Emilia-Romagna Provincia di Piacenza Provincia di Parma Provincia di Reggio Emilia Provincia di Modena, 2004, PROG REG PIETR VERD; Saiki M, 2014, J RADIOANAL NUCL CH, V299, P773, DOI 10.1007/s10967-013-2698-1; SARTWELL PE, 1974, AM J EPIDEMIOL, V99, P250, DOI 10.1093/oxfordjournals.aje.a121609; Tinelli C, 2005, SARCOIDOSIS VASC DIF, V22, pS4; TYLER G, 1990, BOT J LINN SOC, V104, P231, DOI 10.1111/j.1095-8339.1990.tb02220.x; Valeyre D, 2014, CURR OPIN PULM MED, V20, P488, DOI 10.1097/MCP.0000000000000075; Wahlstrom J, 1999, THORAX, V54, P339, DOI 10.1136/thx.54.4.339; [No title captured]	51	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176859	10.1371/journal.pone.0176859	http://dx.doi.org/10.1371/journal.pone.0176859			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475583	Green Submitted, Green Published, gold			2022-12-27	WOS:000400649500021
J	Fabi, F; Grenier, K; Parent, S; Adam, P; Tardif, L; Leblanc, V; Asselin, E				Fabi, Francois; Grenier, Kathy; Parent, Sophie; Adam, Pascal; Tardif, Laurence; Leblanc, Valerie; Asselin, Eric			Regulation of the PI3K/Akt pathway during decidualization of endometrial stromal cells	PLOS ONE			English	Article							NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; IN-VITRO DECIDUALIZATION; AKT ISOFORMS; PROLIFERATIVE ENDOMETRIUM; PROLACTIN EXPRESSION; CROSS-TALK; ACTIVATION; SURVIVAL; GROWTH	Infertility is constantly increasing in Canada, where 16% of Canadian couples are experiencing difficulty conceiving. It is thought that infertility can emanate from the dysregulated communication between the embryo and the maternal endometrium. In order to allow for this window of implantation to be open at the right moment, endometrial stromal cells proliferate and differentiate by a mechanism called decidualization. Intracellular and molecular mechanisms involved in the regulation of apoptosis and cell proliferation during decidualization of the endometrium are yet to be fully understood. It has been well demonstrated previously that Akt is importantly involved in cell survival and glycogen synthesis. Akt1, Akt2 and Akt3 isoforms have distinct physiological roles; this could also be the case during decidualization and pregnancy. The aim of this study is to investigate the regulation of PI3K/Akt pathway during the decidualization process of endometrial stromal cells. Expression of Akt isoforms, Akt activity (phospho-Akt), pI kappa B and substrates of Akt during decidualization were measured. To our knowledge, these results are the first to suggest a decrease in levels of Akt isoforms as well as a downregulation of Akt activity in the process of decidualization of human endometrial stromal cells. We also uncovered that decidualization induced nuclear localization of p65 through the phosphorylation of I.B, its inhibitory subunit; however, Par-4, a recently uncovered regulator of cell differentiation, was displaced from the nucleus upon decidualization. Our results also suggest that HIESC cells exhibit decreased motility during decidualization and that PI3K pathway inhibition could be involved in this process. Finally, we demonstrate that specific Akt isoforms present unique effects on the successful induction of decidualization. Further analyses will involve investigations to understand the precise signaling mechanisms by which this pathway is regulated.	[Fabi, Francois; Grenier, Kathy; Parent, Sophie; Adam, Pascal; Tardif, Laurence; Leblanc, Valerie; Asselin, Eric] Univ Quebec Trois Rivieres, Dept Med Biol, CP 500, Trois Rivieres, PQ, Canada	University of Quebec; University of Quebec Trois Rivieres	Asselin, E (corresponding author), Univ Quebec Trois Rivieres, Dept Med Biol, CP 500, Trois Rivieres, PQ, Canada.	eric.asselin@uqtr.ca		Fabi, Francois/0000-0003-3923-2880	Natural Sciences and Engineering Research Council of Canada (NSERC) [238501-01]; Reseau Quebecois en Reproduction (RQR); FRQ-S PhD Scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Reseau Quebecois en Reproduction (RQR); FRQ-S PhD Scholarship	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) (238501-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Francois Fabi was holder of a FRQ-S PhD Scholarship and Kathy Grenier was holder of master scholarship from Reseau Quebecois en Reproduction (RQR). We are grateful to Michel A. Fortier for the HIESC cells.	Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Brar AK, 1997, ENDOCRINE, V6, P301, DOI 10.1007/BF02820507; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Brosens JJ, 1996, ENDOCRINOLOGY, V137, P2225, DOI 10.1210/en.137.6.2225; Bushnik T, 2012, HUM REPROD, V27, P738, DOI 10.1093/humrep/der465; Chaudhry P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.7; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; DALY DC, 1983, AM J OBSTET GYNECOL, V145, P672, DOI 10.1016/0002-9378(83)90572-0; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dery Marie-Claude, 2003, Reprod Biol Endocrinol, V1, P47; Dunn Carolyn L, 2003, Reprod Biomed Online, V7, P151; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Fabi F, 2014, REPRODUCTION, V148, pR85, DOI 10.1530/REP-14-0270; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Girouard J, 2013, GYNECOL ONCOL, V128, P335, DOI 10.1016/j.ygyno.2012.11.016; Grille SJ, 2003, CANCER RES, V63, P2172; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Haslinger P, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104778; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kong DH, 1997, NAT GENET, V17, P143, DOI 10.1038/ng1097-143; Logan PC, 2012, REPROD SCI, V19, P883, DOI 10.1177/1933719112438447; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Park BK, 2001, CANCER RES, V61, P7647; Patterson AL, 2013, STEM CELLS DEV, V22, P964, DOI 10.1089/scd.2012.0435; Risinger JI, 1998, CLIN CANCER RES, V4, P3005; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sekulic A, 2000, CANCER RES, V60, P3504; TANG BQ, 1994, ANN NY ACAD SCI, V734, P19, DOI 10.1111/j.1749-6632.1994.tb21731.x; TANG BQ, 1993, ENDOCRINOLOGY, V133, P2197, DOI 10.1210/en.133.5.2197; Telgmann R, 1998, HUM REPROD UPDATE, V4, P472, DOI 10.1093/humupd/4.5.472; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Veillette A, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107136; Yin XQ, 2012, J CLIN ENDOCR METAB, V97, pE35, DOI 10.1210/jc.2011-1527; Yu J, 2016, ENDOCRINOLOGY, V157, P2432, DOI 10.1210/en.2015-1942; Zhang XH, 2013, REPROD SCI, V20, P354, DOI 10.1177/1933719112472738; Zhao L, 2008, BIOCHEM PHARMACOL, V75, P1515, DOI 10.1016/j.bcp.2007.12.014	47	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177387	10.1371/journal.pone.0177387	http://dx.doi.org/10.1371/journal.pone.0177387			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475617	gold, Green Published, Green Submitted			2022-12-27	WOS:000400649500066
J	Nakamura, M; Kanda, T; Jiang, X; Haga, Y; Takahashi, K; Wu, S; Yasui, S; Nakamoto, S; Yokosuka, O				Nakamura, Masato; Kanda, Tatsuo; Jiang, Xia; Haga, Yuki; Takahashi, Koji; Wu, Shuang; Yasui, Shin; Nakamoto, Shingo; Yokosuka, Osamu			Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis	PLOS ONE			English	Article							C VIRUS; HEPATOCELLULAR-CARCINOMA; TRANSIENT ELASTOGRAPHY; EXPRESSION; INFECTION; MIR-122; GENES; RISK	Background Noninvasive methods to accurately and conveniently evaluate liver fibrosis are desirable. MicroRNA (miR) is one of the candidates. MiRs are small RNAs consisting of 19-25 nucleotides that negatively regulate many target genes at transcriptional levels. Recently, many researchers have focused on circulating miRs in the blood stream as biomarkers. Hepatic miR-122 has been reported to have an association with viral replication and hepatic fibrosis in chronic hepatitis B virus (HBV) and hepatic C virus (HCV) infection. Methods We measured serum miR-122 levels in HBV- and HCV-infected patients confirmed with liver biopsy. We also investigated a novel liver fibrosis marker Wisteria floribunda agglutinin-positive Mac-2 binding protein [WFA(+)-M2BP]. We evaluated the diagnostic usefulness of these markers in hepatic fibrosis and inflammation of patients with chronic viral infection. Results The serum miR-122 levels of HBV-infected patients were higher than those of the control subjects. In HBV-infected patients, the serum miR-122 levels of patients with advanced liver fibrosis were significantly lower. Serum WFA(+)-M2BP was significantly higher dependent on both the staging of fibrosis and the grading of inflammatory activity in patients with both HBV and HCV infection. We also observed that higher serum WFA(+)-M2BP levels augmented the prediction of advanced liver fibrosis among HBV-infected patients with lower serum miR-122 levels. Conclusions A lower serum miR-122 level is a useful predictor of advanced liver fibrosis in HBV-infected patients. Serum WFA(+)-M2BP could predict liver fibrosis in both HBV and HCV infection. The combination of these markers may result in the more accurate evaluation of liver fibrosis in HBV infection.	[Nakamura, Masato; Kanda, Tatsuo; Jiang, Xia; Haga, Yuki; Takahashi, Koji; Wu, Shuang; Yasui, Shin; Nakamoto, Shingo; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan; [Nakamoto, Shingo] Chiba Univ, Grad Sch Med, Dept Mol Virol, Chiba, Japan; [Yokosuka, Osamu] Japan Community Hlth Care Org, Dept Internal Med, Funabashi Chuo Hosp, Funabashi, Chiba, Japan	Chiba University; Chiba University	Kanda, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.	kandat-cib@umin.ac.jp		Kanda, Tatsuo/0000-0002-1654-5385	MSD; Chugai Pharmaceutical [AC-1-2 0160603004715-334801]; Abbvie [201606_CASE, 58]; Sysmex; Japan Agency for Medical Research and Development, AMED	MSD; Chugai Pharmaceutical; Abbvie(AbbVie); Sysmex; Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported by are search grants from MSD, Chugai Pharmaceutical (AC-1-2 0160603004715-334801), Abbvie (201606_CASE No.58) and Sysmex. This research was (partially) supported by the Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekki Y, 2016, J GASTROENTEROL HEPA; Cheng HR, 2015, HEPATOL INT, V9, P35, DOI 10.1007/s12072-014-9591-z; Devhare PB, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.12.75; Fan CG, 2011, ONCOL REP, V26, P1281, DOI 10.3892/or.2011.1375; Haga Yuki, 2016, Diseases, V4, DOI 10.3390/diseases4040038; Hayes CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047490; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Ichikawa Y, 2016, HEPATOL RES; Inohara H, 1996, CANCER RES, V56, P4530; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jiang X, 2014, WORLD J GASTROENTERO, V20, P7197, DOI 10.3748/wjg.v20.i23.7197; Kamezaki H, 2011, SCAND J GASTROENTERO, V46, P1111, DOI 10.3109/00365521.2011.584898; Kim SU, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003434; Kumar S, 2017, EXP BIOL MED, V242, P436, DOI 10.1177/1535370216681548; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Masuzaki R, 2009, HEPATOLOGY, V49, P1954, DOI 10.1002/hep.22870; Nakamura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144295; Nakamura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081312; Nishikawa H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004679; Parikh P, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.01.28; Qiao DD, 2017, EUR REV MED PHARMACO, V21, P742; Qiu LP, 2010, BIOCHEM BIOPH RES CO, V398, P771, DOI 10.1016/j.bbrc.2010.07.021; Raitoharju E, 2016, SCI REP-UK, V6, DOI 10.1038/srep38262; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Sarkar N, 2015, J VIRAL HEPATITIS, V22, P817, DOI 10.1111/jvh.12390; Schwarzenbach H, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3446; TANAKA T, 1994, HEPATOLOGY, V19, P1347, DOI 10.1016/0270-9139(94)90226-7; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341; Wojcik K, 2016, ACTA BIOCHIM POL, V63, P527, DOI [10.18388/abp.2015_1216, 10.18388/abp.2016_1216]; Yamasaki K, 2014, HEPATOLOGY, V60, P1563, DOI 10.1002/hep.27305; Yarushkin AA, 2017, EUR J PHARMACOL, V797, P39, DOI 10.1016/j.ejphar.2017.01.016; Yoshimoto K, 2003, LEUKEMIA LYMPHOMA, V44, P229, DOI 10.1080/1042819021000029704	34	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177302	10.1371/journal.pone.0177302	http://dx.doi.org/10.1371/journal.pone.0177302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475652	Green Published, Green Submitted, gold			2022-12-27	WOS:000400649500063
J	Andersen, CM; Pedersen, AF; Carlsen, AH; Olesen, F; Vedsted, P				Andersen, Christina Maar; Pedersen, Anette Fischer; Carlsen, Anders Helles; Olesen, Frede; Vedsted, Peter			Data quality and factor analysis of the Danish version of the Relationship Scale Questionnaire	PLOS ONE			English	Article							ADULT ATTACHMENT; NEURAL RESPONSE; STYLES; MODELS; SELF; PERSONALITY; AVOIDANCE; ANXIETY	Background The Relationship Scale Questionnaire (RSQ) is a widely-used measure of adult attachment, but whether the results obtained by the RSQ fit the attachment construct has only been examined to a limited extent. Objective The objectives of this study were to investigate the psychometric properties of the Danish translation of the RSQ and to test whether the results are consistent with the hypothesized model of attachment. Methods The study included two samples: 602 general practitioners and 611 cancer patients. The two samples were analyzed separately. Data quality was assessed by mean, median and missing values for each item, floor and ceiling effects, average inter-item correlations and Cronbach's a for each subscale. Test-retest was assessed by intra-class correlations among 76 general practitioners. A confirmatory factor analysis was conducted to establish evidence of the four proposed subscales. Due to an inadequate fit of the model, data was randomly split into two equally sized subsamples and an exploratory factor analysis was conducted for all 30 items in the first subsample comprised of 286 cancer patients and 285 general practitioners. The EFA yielded a three-factor structure which was validated through a confirmatory factor analyses in a second subsample comprised of 278 cancer patients and 289 general practitioners. Results The data quality of the RSQ was generally good, except low internal consistency and low to moderate test-retest reliability. The four subscales of the RSQ were not confirmed by the confirmatory factor analysis. An exploratory factor analysis suggested a three-factor solution for both general practitioners and patients, which accounted for 61.1% of the variance among general practitioners and 62.5% among patients. The new three-factor solution was verified in a confirmatory factor analyses. Conclusion The proposed four-factor model of the RSQ could not be confirmed in this study. Similar challenges have been found by other studies validating the RSQ. An alternative three-factor structure was found for the RSQ.	[Andersen, Christina Maar] Univ Southern Denmark, Dept Psychol, Odense, Denmark; [Andersen, Christina Maar; Pedersen, Anette Fischer; Carlsen, Anders Helles; Olesen, Frede; Vedsted, Peter] Aarhus Univ, Res Ctr Canc Diag Primary Care CaP, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark	University of Southern Denmark; Aarhus University	Andersen, CM (corresponding author), Univ Southern Denmark, Dept Psychol, Odense, Denmark.; Andersen, CM (corresponding author), Aarhus Univ, Res Ctr Canc Diag Primary Care CaP, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark.	cma@feap.dk	Vedsted, Peter/C-2583-2008; Pedersen, Anette F/T-7737-2017	Vedsted, Peter/0000-0003-2113-5599; Pedersen, Anette Fischer/0000-0003-0253-3671	Efteruddannelsesudvalget Region Midt [1-30-72-207-12]; Novo Nordisk; Multipraksisudvalget [585-04/2072]	Efteruddannelsesudvalget Region Midt; Novo Nordisk(Novo Nordisk); Multipraksisudvalget	The study was funded by the following: Kvalitets- og Efteruddannelsesudvalget Region Midt, Grant number: 1-30-72-207-12, URL: https://www.rm.dkipalitkudvalg/samarbeidsudvalg-forprimar-sektoretAvalitetsogefferuddarelsesudvalgeti; Kretens bekarnpelse, URL: https://www.cancer.dkiorimosithe-danishcancer-societyt, Novo Nordisk, URL: http://www.novonordiskfonden.dk/en/content/fondations-grants; Multipraksisudvalget, Grant number: 585-04/2072, URL: http://www.dsam.dk/flx/forskning/multipraksisudvalget/. PV was the recipient of all the grants listed above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TE, 2011, EUR J PSYCHOTRAUMATO, V2, DOI 10.3402/ejpt.v2i0.5633; [Anonymous], 2012, PROC TRANSL AD INSTR; Bartholomew DJ, 2008, ANAL MULTIVARIATE SO; BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037/0022-3514.61.2.226; BARTHOLOMEW K, 1990, J SOC PERS RELAT, V7, P147, DOI 10.1177/0265407590072001; Bowlby, 1973, ATTACHMENT LOSS, V2; Bowlby J., 1988, SECURE BASE; Bowlby J., 1969, ATTACHMENT LOSS; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; Cicero V, 2009, PSYCHO-ONCOLOGY, V18, P1045, DOI 10.1002/pon.1390; Ciechanowski P, 2010, DIABETES CARE, V33, P539, DOI 10.2337/dc09-1298; Ciechanowski PS, 2001, AM J PSYCHIAT, V158, P29, DOI 10.1176/appi.ajp.158.1.29; Ciechanowski PS, 2002, PSYCHOSOM MED, V64, P660, DOI 10.1097/01.PSY.0000021948.90613.76; COLLINS NL, 1990, J PERS SOC PSYCHOL, V58, P644, DOI 10.1037/0022-3514.58.4.644; Creasey G, 2005, PERS SOC PSYCHOL B, V31, P1026, DOI 10.1177/0146167204274096; Davies KA, 2009, PAIN, V143, P200, DOI 10.1016/j.pain.2009.02.013; De Rick A, 2009, SUBST USE MISUSE, V44, P99, DOI 10.1080/10826080802525744; de Vet H.C.W., 2011, MEASUREMENT MED PRAC; Donges US, 2012, NEUROSCIENCE, V220, P149, DOI 10.1016/j.neuroscience.2012.06.036; Feeney JA, 2001, ATTACHMENT SPOUSAL C; Fontanil Y, 2013, PSICOTHEMA, V25, P275, DOI 10.7334/psicothema2012.125; GRIFFIN D, 1994, J PERS SOC PSYCHOL, V67, P430, DOI 10.1037/0022-3514.67.3.430; Griffin DW, 1994, ATTACHMENT PROCESSES, P17, DOI DOI 10.1037//0022-3514.67.3.430; Hansen AL, 2011, SCAND J PSYCHOL, V52, P268, DOI 10.1111/j.1467-9450.2010.00864.x; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; Kelley ML, 2004, ADDICT BEHAV, V29, P1633, DOI 10.1016/j.addbeh.2004.02.064; Kurdek LA, 2002, J SOC PERS RELAT, V19, P811, DOI 10.1177/0265407502196005; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Maunder RG, 2001, PSYCHOSOM MED, V63, P556, DOI 10.1097/00006842-200107000-00006; Maunder RG, 2006, SOC SCI MED, V63, P552, DOI 10.1016/j.socscimed.2006.01.001; Meredith P, 2008, CLIN PSYCHOL REV, V28, P407, DOI 10.1016/j.cpr.2007.07.009; Meredith Pamela Joy, 2008, Aust Occup Ther J, V55, P297, DOI 10.1111/j.1440-1630.2007.00720.x; Morriss RK, 2009, PSYCHOL PSYCHOTHER-T, V82, P267, DOI 10.1348/147608309X415309; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pedersen Anette Fischer, 2013, Int J Family Med, V2013, P603713, DOI 10.1155/2013/603713; Ravitz P, 2010, J PSYCHOSOM RES, V69, P419, DOI 10.1016/j.jpsychores.2009.08.006; Salmon P, 2008, GEN HOSP PSYCHIAT, V30, P104, DOI 10.1016/j.genhosppsych.2007.12.002; Schmidt S, 2002, J PSYCHOSOM RES, V53, P763, DOI 10.1016/S0022-3999(02)00335-5; Segal DL, 2009, INT J AGING HUM DEV, V69, P119, DOI 10.2190/AG.69.2.c; SIEGERT RJ, 1995, NEW ZEAL J PSYCHOL, V24, P13; Sonnby-Borgstrom M, 2003, SCAND J PSYCHOL, V44, P141, DOI 10.1111/1467-9450.00332; StataCorp, 2013, PANCREATOLOGY; Streiner DL., 2001, HLTH MEASUREMENT SCA, V2nd; Suslow T, 2009, HUM BRAIN MAPP, V30, P3553, DOI 10.1002/hbm.20778; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Wamper KE, 2010, ACTA ORTHOP, V81, P703, DOI 10.3109/17453674.2010.537808; Wedekind D, 2013, SUBST ABUSE TREAT PR, V8, DOI 10.1186/1747-597X-8-1	48	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176810	10.1371/journal.pone.0176810	http://dx.doi.org/10.1371/journal.pone.0176810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472074	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500075
J	Aung, WPP; Htoon, TT; Tina, HH; Thinn, KK; Sanpool, O; Jongthawin, J; Sadaow, L; Phosuk, I; Rodpai, R; Intapan, PM; Maleewong, W				Aung, Win Pa Pa; Htoon, Thi Thi; Tina, Htay Htay; Thinn, Kyi Kyi; Sanpool, Oranuch; Jongthawin, Jurairat; Sadaow, Lakkhana; Phosuk, Issarapong; Rodpai, Rutchanee; Intapan, Pewpan M.; Maleewong, Wanchai			First report and molecular identification of Opisthorchis viverrini infection in human communities from Lower Myanmar	PLOS ONE			English	Article							RISK-FACTORS; TREMATODA OPISTHORCHIIDAE; LIVER FLUKES; CHOLANGIOCARCINOMA; FISH; HELMINTHIASIS; PREVALENCE; PROVINCE; AREA; PCR	Opisthorchis viverrini is endemic in the South East Asian region, especially in Cambodia, Lao People's Democratic Republic, Vietnam and Thailand, but there have been no previous records from Myanmar. During stool surveys of rural populations in three regions of Lower Myanmar, Opisthorchis-like eggs were found in 34 out of 364 (9.3%) participants by stool microscopy after using the modified formalin-ether concentration technique. DNA was extracted from these positive stool samples and a portion of the mitochondrial cytochrome c oxidase subunit I (cox1) gene was amplified using the polymerase chain reaction and then sequenced. DNA sequences, successfully obtained from 18 of 34 positive samples (Bago Region, n = 13; Mon State, n = 3; Yangon Region, n = 2), confirmed that the eggs were of O. viverrini. Sequences showed 99.7% identity with O. viverrini mitochondrial cox1 (GenBank accession no. JF739555) but 95%, 88.7%, 82.6% and 81.4% identities with those of Opisthorchis lobatus from Lao People's Democratic Republic (GenBank accession nos. HQ328539-HQ328541), Metorchis orientalis from China (KT239342), Clonorchis sinensis from China (JF729303) and Opisthorchis felineus from Russia (EU921260), respectively. When alignement with other Opisthorchiidae trematodes, 81% similarity with Metorchis bilis from Czech Republic (GenBank accession nos. KT740966, KT740969, KT740970) and Slovakia (GenBank accession nos. KT740971-KT740973), 84.6% similarity with Metorchis xanthosomus from Czech Republic (GenBank accession no. KT740974), 78.6% similarity with M. xanthosomus from Poland (GenBank accession no. KT740968) and 82.2% similarity with Euamphimerus pancreaticus from Czech Republic (GenBank accession no. KT740975) were revealed. This study demonstrated, for the first time, O. viverrini from rural people in Myanmar using molecular methods and is an urgent call for surveillance and control activities against opisthorchiasis in Myanmar.	[Aung, Win Pa Pa; Sanpool, Oranuch; Jongthawin, Jurairat; Sadaow, Lakkhana; Phosuk, Issarapong; Rodpai, Rutchanee; Intapan, Pewpan M.; Maleewong, Wanchai] Khon Kaen Univ, Fac Med, Dept Parasitol, Khon Kaen, Thailand; [Aung, Win Pa Pa; Sanpool, Oranuch; Jongthawin, Jurairat; Sadaow, Lakkhana; Phosuk, Issarapong; Rodpai, Rutchanee; Intapan, Pewpan M.; Maleewong, Wanchai] Khon Kaen Univ, Res & Diagnost Ctr Emerging Infect Dis, Mekong Hlth Sci Res Inst, Khon Kaen, Thailand; [Aung, Win Pa Pa] Univ Med 2, Dept Microbiol, Minist Hlth & Sport, Yangon, Myanmar; [Htoon, Thi Thi; Tina, Htay Htay] Natl Hlth Lab, Dept Parasitol, Yangon, Myanmar; [Thinn, Kyi Kyi] Univ Med 1, Int Relat Div, Minist Hlth & Sport, Yangon, Myanmar; [Jongthawin, Jurairat] Mahasarakham Univ, Fac Med, Maha Sarakham, Thailand	Khon Kaen University; Khon Kaen University; Mahasarakham University	Maleewong, W (corresponding author), Khon Kaen Univ, Fac Med, Dept Parasitol, Khon Kaen, Thailand.; Maleewong, W (corresponding author), Khon Kaen Univ, Res & Diagnost Ctr Emerging Infect Dis, Mekong Hlth Sci Res Inst, Khon Kaen, Thailand.	wanch_ma@kku.ac.th		Maleewong, Wanchai/0000-0002-6726-3759	TRF Senior Research Scholar Grant; Thailand Research Fund [RTA5880001]; Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission, Thailand; Faculty of Medicine, Khon Kaen University [TR57201, IN59211]; Research and Diagnostic Center for Emerging Infectious Disease, Mekong Health Science lnstitue, Khon Kaen University; Research Affairs and Graduate School, Khon Kaen University [58101]	TRF Senior Research Scholar Grant; Thailand Research Fund(Thailand Research Fund (TRF)); Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission, Thailand; Faculty of Medicine, Khon Kaen University; Research and Diagnostic Center for Emerging Infectious Disease, Mekong Health Science lnstitue, Khon Kaen University; Research Affairs and Graduate School, Khon Kaen University	This study was supported by a TRF Senior Research Scholar Grant, Thailand Research Fund grant number RTA5880001; the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, Thailand, through the Health Cluster (SHeP-GMS); the Faculty of Medicine, Khon Kaen University (TR57201); Research and Diagnostic Center for Emerging Infectious Disease, Mekong Health Science lnstitue, Khon Kaen University through Wanchai Maleewong and Pewpan M. lntapan. Win Pa Pa Aung was partial supported by the Faculty of Medicine, Khon Kaen University (IN59211). Oranuch Sanpool was supported by the Post Doctoral Training Program from Research Affairs and Graduate School, Khon Kaen University (grant no. 58101). We also certified that all the funders and sources of support received during this specific study (whether external or internal to our organizations) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anamnart W, 2010, J CLIN MICROBIOL, V48, P97, DOI 10.1128/JCM.01613-09; [Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P121; Buathong S, 2015, PARASITOL RES, V114, P3547, DOI 10.1007/s00436-015-4640-7; Chai JY, 2014, KOREAN J PARASITOL, V52, P35, DOI 10.3347/kjp.2014.52.1.35; Forrer A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001481; Honjo S, 2005, INT J CANCER, V117, P854, DOI 10.1002/ijc.21146; Jongsuksuntigul P, 2003, ACTA TROP, V88, P229, DOI 10.1016/j.actatropica.2003.01.002; Le TH, 2006, EXP PARASITOL, V112, P109, DOI 10.1016/j.exppara.2005.09.012; Miyamoto K, 2014, PARASITOL INT, V63, P366, DOI 10.1016/j.parint.2013.12.003; Na L, 2016, INFECT GENET EVOL, V39, P45, DOI 10.1016/j.meegid.2016.01.010; Hung NM, 2013, ACTA PARASITOL, V58, P231, DOI 10.2478/s11686-013-0155-5; Sahu R, 2016, J HELMINTHOL, V90, P607, DOI 10.1017/S0022149X15000851; Sanpool O, 2012, PARASITOL RES, V111, P89, DOI 10.1007/s00436-011-2804-7; Sayasone S, 2009, T ROY SOC TROP MED H, V103, P247, DOI 10.1016/j.trstmh.2008.10.011; Sithithaworn P, 2012, PARASITOL INT, V61, P10, DOI 10.1016/j.parint.2011.08.014; Sitko J, 2016, PARASITOL INT, V65, P258, DOI 10.1016/j.parint.2016.01.011; Sohn WM, 2012, ACTA TROP, V124, P215, DOI 10.1016/j.actatropica.2012.08.011; Sripa B, 2008, CURR OPIN GASTROEN, V24, P349, DOI 10.1097/MOG.0b013e3282fbf9b3; Sripa B, 2011, ACTA TROP, V120, pS158, DOI 10.1016/j.actatropica.2010.07.006; Sripa B, 2010, ADV PARASIT, V72, P305, DOI 10.1016/S0065-308X(10)72011-X; Thaenkham U, 2007, ACTA TROP, V103, P26, DOI 10.1016/j.actatropica.2007.05.006; Thaenkham U, 2011, J PARASITOL, V97, P1152, DOI 10.1645/GE-2764.1; Dao TTH, 2016, ACTA TROP, V157, P151, DOI 10.1016/j.actatropica.2016.01.029; Tun A, 2013, TROP MED INT HEALTH, V18, P1017, DOI 10.1111/tmi.12130; Dung VT, 2014, EMERG INFECT DIS, V20, P152, DOI 10.3201/eid2001.130168; Yong TS, 2014, KOREAN J PARASITOL, V52, P661, DOI 10.3347/kjp.2014.52.6.661; Yoon HJ, 2014, AM J TROP MED HYG, V91, P384, DOI 10.4269/ajtmh.13-0596; Zheng SH, 2017, PARASITOL RES, V116, P11, DOI 10.1007/s00436-016-5276-y	28	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177130	10.1371/journal.pone.0177130	http://dx.doi.org/10.1371/journal.pone.0177130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472153	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500142
J	Nordahl, H; Wells, A				Nordahl, Henrik; Wells, Adrian			Testing the metacognitive model against the benchmark CBT model of social anxiety disorder: Is it time to move beyond cognition?	PLOS ONE			English	Article							ANXIOUS INDIVIDUALS; THERAPY; BELIEFS; PHOBIA; SELF	The recommended treatment for Social Phobia is individual Cognitive-Behavioural Therapy (CBT). CBT-treatments emphasize social self-beliefs (schemas) as the core underlying factor for maladaptive self-processing and social anxiety symptoms. However, the need for such beliefs in models of psychopathology has recently been questioned. Specifically, the metacognitive model of psychological disorders asserts that particular beliefs about thinking (metacognitive beliefs) are involved in most disorders, including social anxiety, and are a more important factor underlying pathology. Comparing the relative importance of these disparate underlying belief systems has the potential to advance conceptualization and treatment for SAD. In the cognitive model, unhelpful self-regulatory processes (self-attention and safety behaviours) arise from (e.g. correlate with) cognitive beliefs (schemas) whilst the metacognitive model proposes that such processes arise from metacognitive beliefs. In the present study we therefore set out to evaluate the absolute and relative fit of the cognitive and metacognitive models in a longitudinal data-set, using structural equation modelling. Five-hundred and five (505) participants completed a battery of self-report questionnaires at two time points approximately 8 weeks apart. We found that both models fitted the data, but that the metacognitive model was a better fit to the data than the cognitive model. Further, a specified metacognitive model, emphasising negative metacognitive beliefs about the uncontrollability and danger of thoughts and cognitive confidence improved the model fit further and was significantly better than the cognitive model. It would seem that advances in understanding and treating social anxiety could benefit from moving to a full metacognitive theory that includes negative metacognitive beliefs about the uncontrollability and danger of thoughts, and judgements of cognitive confidence. These findings challenge a core assumption of the cognitive model and treatment of social phobia and offer further support to the metacognitive model.	[Nordahl, Henrik] Norwegian Univ Sci & Technol, Dept Psychol, Trondheim, Norway; [Nordahl, Henrik] St Olays Hosp, Div Psychiat, Trondheim, Norway; [Wells, Adrian] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Hlth Sci,Div Psychol & Mental Hlth, Manchester, Lancs, England; [Wells, Adrian] Greater Manchester Mental Hlth NHS Fdn Trust, Prestwich, England	Norwegian University of Science & Technology (NTNU); University of Manchester	Nordahl, H (corresponding author), Norwegian Univ Sci & Technol, Dept Psychol, Trondheim, Norway.; Nordahl, H (corresponding author), St Olays Hosp, Div Psychiat, Trondheim, Norway.	henrik.nordahl@ntnu.no		Wells, Adrian/0000-0001-7713-1592	Norwegian University of Science and Technology publication fund	Norwegian University of Science and Technology publication fund	The publication was funded by the Norwegian University of Science and Technology publication fund.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Beck A.T., 1979, COGNITIVE THERAPY EM; Beck AT, 1985, ANXIETY DISORDERS PH; Bentler P.M., 2005, EQS STRUCTURAL EQUAT; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Dannahy L, 2007, BEHAV RES THER, V45, P1207, DOI 10.1016/j.brat.2006.08.017; Fisak B, 2013, BEHAV CHANGE, V30, P36, DOI 10.1017/bec.2013.4; Gkika S, 2016, J EXP PSYCHOPATHOL, V7, P588, DOI 10.5127/jep.054916; Gregory B, 2017, CLIN PSYCHOL REV, V52, P1, DOI 10.1016/j.cpr.2016.11.008; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kline P., 1994, EASY GUIDE FACTOR AN; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Mayo-Wilson E, 2014, LANCET PSYCHIAT, V1, P368, DOI 10.1016/S2215-0366(14)70329-3; National Institute for Health and Care Excellence, 2013, CLIN GUID, V159; Ng AS, 2014, CLIN PSYCHOL REV, V34, P620, DOI 10.1016/j.cpr.2014.09.003; Nordahl H, 2017, CLIN PSYCHOL PSYCHOT, P1; Nordahl HM, 2016, J EXP PSYCHOPATHOL, V7, P601, DOI 10.5127/jep.055616; Nordahl HM, 2016, PSYCHOTHER PSYCHOSOM, V85, P346, DOI 10.1159/000447013; Normann N, 2014, DEPRESS ANXIETY, V31, P402, DOI 10.1002/da.22273; Piccirillo ML, 2016, BEHAV THER, V47, P675, DOI 10.1016/j.beth.2015.11.005; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Vassilopoulos SP, 2015, BEHAV CHANGE, V32, P114, DOI 10.1017/bec.2015.4; Vogel PA, 2016, J EXP PSYCHOPATHOL, V7, P608, DOI 10.5127/jep.054716; WATSON D, 1969, J CONSULT CLIN PSYCH, V33, P448, DOI 10.1037/h0027806; Wells A, 2004, BEHAV RES THER, V42, P385, DOI 10.1016/S0005-7967(03)00147-5; Wells A, 2001, BEHAV RES THER, V39, P713, DOI 10.1016/S0005-7967(00)00036-X; Wells A, 1996, BEHAV RES THER, V34, P881, DOI 10.1016/S0005-7967(96)00050-2; Wells A., 2000, EMOTIONAL DISORDERS, DOI DOI 10.1017/S0033291702225702; Wells A., 1994, ATTENTION EMOTION CL; Wells A., 2009, METACOGNITIVE THERAP; Wells A., 1997, COGNITIVE THERAPY AN; Wong QJJ, 2010, BEHAV CHANGE, V27, P69, DOI 10.1375/bech.27.2.69	33	17	17	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177109	10.1371/journal.pone.0177109	http://dx.doi.org/10.1371/journal.pone.0177109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472176	Green Submitted, gold, Green Published			2022-12-27	WOS:000400648500135
J	Rychli, K; Wagner, EM; Ciolacu, L; Zaiser, A; Tasara, T; Wagner, M; Schmitz-Esser, S				Rychli, Kathrin; Wagner, Eva M.; Ciolacu, Luminita; Zaiser, Andreas; Tasara, Taurai; Wagner, Martin; Schmitz-Esser, Stephan			Comparative genomics of human and non-human Listeria monocytogenes sequence type 121 strains	PLOS ONE			English	Article							BENZALKONIUM CHLORIDE RESISTANCE; PLASMID-BORNE CADMIUM; MOBILE GENETIC ELEMENTS; PREMATURE STOP CODONS; PROCESSING PLANTS; LOW-VIRULENCE; IN-VIVO; MUTATIONS; FOODS; ACTA	The food-borne pathogen Listeria (L.) monocytogenes is able to survive for months and even years in food production environments. Strains belonging to sequence type (ST) 121 are particularly found to be abundant and to persist in food and food production environments. To elucidate genetic determinants characteristic for L. monocytogenes ST121, we sequenced the genomes of 14 ST121 strains and compared them with currently available L. monocytogenes ST121 genomes. In total, we analyzed 70 ST121 genomes deriving from 16 different countries, different years of isolation, and different origins-including food, animal and human ST121 isolates. All ST121 genomes show a high degree of conservation sharing at least 99.7% average nucleotide identity. The main differences between the strains were found in prophage content and prophage conservation. We also detected distinct highly conserved subtypes of prophages inserted at the same genomic locus. While some of the prophages showed more than 99.9% similarity between strains from different sources and years, other prophages showed a higher level of diversity. 81.4% of the strains harbored virtually identical plasmids. 97.1% of the ST121 strains contain a truncated internalin A (inlA) gene. Only one of the seven human ST121 isolates encodes a full-length inlA gene, illustrating the need of better understanding their survival and virulence mechanisms.	[Rychli, Kathrin; Wagner, Eva M.; Ciolacu, Luminita; Zaiser, Andreas; Wagner, Martin; Schmitz-Esser, Stephan] Univ Vet Med Vienna, Inst Milk Hyg, Vienna, Austria; [Tasara, Taurai] Univ Zurich, Vetsuisse Fac, Inst Food Safety & Hyg, Zurich, Switzerland; [Schmitz-Esser, Stephan] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA	University of Veterinary Medicine Vienna; University of Zurich; Iowa State University	Schmitz-Esser, S (corresponding author), Univ Vet Med Vienna, Inst Milk Hyg, Vienna, Austria.; Schmitz-Esser, S (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	sse@iastate.edu	Tasara, Taurai/B-3467-2018; Schmitz-Esser, Stephan/AAA-7287-2019	Tasara, Taurai/0000-0003-3377-8858; Schmitz-Esser, Stephan/0000-0002-1907-0709; Ciolacu, Luminita/0000-0003-4123-7859; Kober-Rychli, Kathrin/0000-0001-6147-577X; Voglauer, Eva/0000-0003-1552-4459	Austrian Science Fund (EWE) [P27920-B22]; USDA National Institute of Food and Agriculture [1011114]	Austrian Science Fund (EWE)(Austrian Science Fund (FWF)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was funded by the Austrian Science Fund (EWE) to KR: project number P27920-B22, and by the USDA National Institute of Food and Agriculture (Hatch project 1011114) to Dr. Stephan Schmitz-Esser. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Althaus D, 2014, FOODBORNE PATHOG DIS, V11, P753, DOI 10.1089/fpd.2014.1747; Ates LS, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0011-2015; Begley M, 2005, INFECT IMMUN, V73, P894, DOI 10.1128/IAI.73.2.894-904.2005; Begley M, 2010, APPL ENVIRON MICROB, V76, P6541, DOI 10.1128/AEM.00203-10; Bossi L, 2003, J BACTERIOL, V185, P6467, DOI 10.1128/JB.185.21.6467-6471.2003; Brown SP, 2006, CURR BIOL, V16, P2048, DOI 10.1016/j.cub.2006.08.089; Burns N, 2015, EVOL APPL, V8, P346, DOI 10.1111/eva.12243; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cao Zhenping, 2016, Nat Microbiol, V2, P16183, DOI 10.1038/nmicrobiol.2016.183; Casey A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00068; Chenal-Francisque V, 2011, EMERG INFECT DIS, V17, P1110, DOI [10.3201/eid/1706.101778, 10.3201/eid1706.101778]; Ciolacu L, 2015, INT J FOOD MICROBIOL, V209, P44, DOI 10.1016/j.ijfoodmicro.2014.08.035; Cruz CD, 2014, APPL ENVIRON MICROB, V80, P1489, DOI 10.1128/AEM.03305-13; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Demsar J, 2013, J MACH LEARN RES, V14, P2349; den Bakker HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-688; Diniz JA, 2015, J BACTERIOL, V197, P2350, DOI 10.1128/JB.00199-15; Dutta V, 2013, APPL ENVIRON MICROB, V79, P6067, DOI 10.1128/AEM.01751-13; Ebner R, 2015, FOOD CONTROL, V57, P321, DOI 10.1016/j.foodcont.2015.04.030; EDLIN G, 1977, J VIROL, V21, P560, DOI 10.1128/JVI.21.2.560-564.1977; Elhanafi D, 2010, APPL ENVIRON MICROB, V76, P8231, DOI 10.1128/AEM.02056-10; Fagerlund A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151117; Fortier LC, 2013, VIRULENCE, V4, P354, DOI 10.4161/viru.24498; Fox EM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02057; Garcia-del Portillo F, 2011, J BIOL CHEM, V286, P34675, DOI 10.1074/jbc.M111.230441; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Haase JK, 2014, ENVIRON MICROBIOL, V16, P405, DOI 10.1111/1462-2920.12342; Hein I, 2011, APPL ENVIRON MICROB, V77, P2169, DOI 10.1128/AEM.02159-10; Henri C, 2016, APPL ENV MICROBIOL; Holch A, 2013, J MED MICROBIOL, V62, P1799, DOI 10.1099/jmm.0.057505-0; Holch A, 2013, APPL ENVIRON MICROB, V79, P2944, DOI 10.1128/AEM.03715-12; Ivy RA, 2012, APPL ENVIRON MICROB, V78, P3824, DOI 10.1128/AEM.00051-12; Jacquet C, 2004, J INFECT DIS, V189, P2094, DOI 10.1086/420853; Jensen AK, 2016, EMERG INFECT DIS, V22, P625, DOI 10.3201/eid2204.150998; Jordan SJ, 2008, APPL ENVIRON MICROB, V74, P5451, DOI 10.1128/AEM.02419-07; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; Kovacevic J, 2016, APPL ENVIRON MICROB, V82, P939, DOI 10.1128/AEM.03741-15; Kuenne C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47; Kuenne C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012511; Kwong JC, 2016, J CLIN MICROBIOL, V54, P333, DOI 10.1128/JCM.02344-15; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; LEBRUN M, 1994, J BACTERIOL, V176, P3040, DOI 10.1128/JB.176.10.3040-3048.1994; LEBRUN M, 1994, J BACTERIOL, V176, P3049, DOI 10.1128/JB.176.10.3049-3061.1994; Leong D, 2015, J FOOD PROTECT, V78, P2184, DOI 10.4315/0362-028X.JFP-15-233; Linden SK, 2008, ARCH MICROBIOL, V190, P101, DOI 10.1007/s00203-008-0358-6; Martin B, 2014, FOOD MICROBIOL, V44, P119, DOI 10.1016/j.fm.2014.05.014; Maury MM, 2016, NAT GENET, V48, P308, DOI 10.1038/ng.3501; Morganti M, 2016, APPL ENVIRON MICROB, V82, P822, DOI 10.1128/AEM.03103-15; Moura A, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.185; Muller A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076835; Mullapudi S, 2008, APPL ENVIRON MICROB, V74, P1464, DOI 10.1128/AEM.02426-07; Muller A, 2014, FEMS MICROBIOL LETT; Nightingale KK, 2008, APPL ENVIRON MICROB, V74, P6570, DOI 10.1128/AEM.00997-08; Nightingale KK, 2005, APPL ENVIRON MICROB, V71, P8764, DOI 10.1128/AEM.71.12.8764-8772.2005; Ortiz S, 2016, APPL ENVIRON MICROB, V82, P308, DOI 10.1128/AEM.02824-15; OSULLIVAN DJ, 1995, J BACTERIOL, V177, P134, DOI 10.1128/jb.177.1.134-143.1995; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Parisi A, 2010, FOOD MICROBIOL, V27, P101, DOI 10.1016/j.fm.2009.09.001; Pinheiro J, 2016, VIRULENCE, P1, DOI DOI 10.1080/21505594.2016; Quereda JJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004765; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Richter M, 2016, BIOINFORMATICS, V32, P929, DOI 10.1093/bioinformatics/btv681; Roberts AJ, 2006, FEMS MICROBIOL LETT, V254, P300, DOI 10.1111/j.1574-6968.2005.00041.x; Roche SM, 2005, APPL ENVIRON MICROB, V71, P6039, DOI 10.1128/AEM.71.10.6039-6048.2005; Ryan S, 2010, J APPL MICROBIOL, V109, P984, DOI 10.1111/j.1365-2672.2010.04726.x; Sabet C, 2005, INFECT IMMUN, V73, P6912, DOI 10.1128/IAI.73.10.6912-6922.2005; Sabet C, 2008, INFECT IMMUN, V76, P1368, DOI 10.1128/IAI.01519-07; Schmitz-Esser S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00380; Schultze T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01199; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Temoin S, 2008, MICROBIOL-SGM, V154, P939, DOI 10.1099/mic.0.2007/011106-0; Travier L, 2014, CURR OPIN MICROBIOL, V17, P53, DOI 10.1016/j.mib.2013.11.007; Van Stelten A, 2010, APPL ENVIRON MICROB, V76, P2783, DOI 10.1128/AEM.02651-09; Verghese B, 2011, APPL ENVIRON MICROB, V77, P3279, DOI 10.1128/AEM.00546-11; Wang QN, 2015, J CLIN MICROBIOL, V53, P3492, DOI 10.1128/JCM.00202-15; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Wiedmann M, 1997, INFECT IMMUN, V65, P2707, DOI 10.1128/IAI.65.7.2707-2716.1997; Zhang H, 2015, MICROBIOL RES, V172, P1, DOI 10.1016/j.micres.2015.01.008	81	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176857	10.1371/journal.pone.0176857	http://dx.doi.org/10.1371/journal.pone.0176857			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472116	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000400648500088
J	Garrison, P; Yue, SN; Hanson, J; Baron, J; Lui, JLC				Garrison, Presley; Yue, Shanna; Hanson, Jeffrey; Baron, Jeffrey; Lui, Julian C.			Spatial regulation of bone morphogenetic proteins (BMPs) in postnatal articular and growth plate cartilage	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; SKELETAL DEVELOPMENT; IN-VIVO; CHONDROGENESIS; CELLS; ZONE; IDENTIFICATION; CHONDROCYTES; INITIATION; ADIPOSE	Articular and growth plate cartilage both arise from condensations of mesenchymal cells, but ultimately develop important histological and functional differences. Each is composed of three layers-the superficial, mid and deep zones of articular cartilage and the resting, proliferative and hypertrophic zones of growth plate cartilage. The bone morphogenetic protein (BMP) system plays an important role in cartilage development. A gradient in expression of BMP-related genes has been observed across growth plate cartilage, likely playing a role in zonal differentiation. To investigate the presence of a similar expression gradient in articular cartilage, we used laser capture microdissection (LCM) to separate murine growth plate and articular cartilage from the proximal tibia into their six constituent zones, and used a solution hybridization assay with color-coded probes (nCounter) to quantify mRNAs for 30 different BMP-related genes in each zone. In situ hybridization and immunohistochemistry were then used to confirm spatial expression patterns. Expression gradients for Bmp2 and 6 were observed across growth plate cartilage with highest expression in hypertrophic zone. However, intracellular BMP signaling, assessed by phospho-Smad1/5/8 immunohistochemical staining, appeared to be higher in the proliferative zone and prehypertrophic area than in hypertrophic zone, possibly due to high expression of Smad7, an inhibitory Smad, in the hypertrophic zone. We also found BMP expression gradients across the articular cartilage with BMP agonists primarily expressed in the superficial zone and BMP functional antagonists primarily expressed in the deep zone. Phospho-Smad1/5/8 immunohistochemical staining showed a similar gradient. In combination with previous evidence that BMPs regulate chondrocyte proliferation and differentiation, the current findings suggest that BMP signaling gradients exist across both growth plate and articular cartilage and that these gradients may contribute to the spatial differentiation of chondrocytes in the postnatal endochondral skeleton.	[Garrison, Presley; Yue, Shanna; Baron, Jeffrey; Lui, Julian C.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Dev, NIH, Bethesda, MD 20892 USA; [Hanson, Jeffrey] NCI, Laser Capture Microdissect Core Facil, Pathol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lui, JLC (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Dev, NIH, Bethesda, MD 20892 USA.	luichunk@mail.nih.gov	Lui, Julian/E-2253-2012	Lui, Julian/0000-0002-0611-4901	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000640] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH.; This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH. We thank the Center for Center Research (CCR) Genomics Core of National Center Institute (NCI) and NanoString Technologies Inc. for providing technical support for our experiments.	Abad V, 2002, ENDOCRINOLOGY, V143, P1851, DOI 10.1210/en.143.5.1851; Bandyopadhyay A, 2008, DEV BIOL, V321, P162, DOI 10.1016/j.ydbio.2008.06.012; Bentley-Hewitt KL, 2016, NEW BIOTECHNOL, V33, P380, DOI 10.1016/j.nbt.2016.01.002; Chau M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103061; COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3; De Luca F, 2001, ENDOCRINOLOGY, V142, P430, DOI 10.1210/en.142.1.430; Erickson HS, 2009, NAT PROTOC, V4, P902, DOI 10.1038/nprot.2009.61; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Estrada KD, 2013, DEV BIOL, V382, P375, DOI 10.1016/j.ydbio.2013.08.021; GARDNER E, 1968, J ANAT, V102, P289; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Jing JJ, 2013, INT J BIOL SCI, V9, P895, DOI 10.7150/ijbs.7508; Khalafi A, 2007, J ORTHOP RES, V25, P293, DOI 10.1002/jor.20329; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; Kozhemyakina E, 2015, ARTHRITIS RHEUMATOL, V67, P1261, DOI 10.1002/art.39030; Lui JLC, 2015, PEDIATR RES, V77, P406, DOI 10.1038/pr.2014.208; Lui JCK, 2010, BONE, V46, P1380, DOI 10.1016/j.bone.2010.01.373; Malkov Vladislav A, 2009, BMC Res Notes, V2, P80, DOI 10.1186/1756-0500-2-80; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nilsson O, 2007, J ENDOCRINOL, V193, P75, DOI 10.1677/joe.1.07099; Ono N, 2014, NAT CELL BIOL, V16, P1157, DOI 10.1038/ncb3067; Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050; Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; Shi JJ, 2013, ARTHROSCOPY, V29, P2001, DOI 10.1016/j.arthro.2013.09.076; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Veldman-Jones MH, 2015, CANCER RES, V75, P2587, DOI 10.1158/0008-5472.CAN-15-0262; Yasuhara R, 2011, LAB INVEST, V91, P1739, DOI 10.1038/labinvest.2011.144; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680	31	21	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176752	10.1371/journal.pone.0176752	http://dx.doi.org/10.1371/journal.pone.0176752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467498	gold, Green Published, Green Submitted			2022-12-27	WOS:000400647000071
J	O'Hara, CC; Afflerbach, JC; Scarborough, C; Kaschner, K; Halpern, BS				O'Hara, Casey C.; Afflerbach, Jamie C.; Scarborough, Courtney; Kaschner, Kristin; Halpern, Benjamin S.			Aligning marine species range data to better serve science and conservation	PLOS ONE			English	Article								Species distribution data provide the foundation for a wide range of ecological research studies and conservation management decisions. Two major efforts to provide marine species distributions at a global scale are the International Union for Conservation of Nature (IUCN), which provides expert-generated range maps that outline the complete extent of a species' distribution; and AquaMaps, which provides model-generated species distribution maps that predict areas occupied by the species. Together these databases represent 24,586 species (93.1% within AquaMaps, 16.4% within IUCN), with only 2,330 shared species. Differences in intent and methodology can result in very different predictions of species distributions, which bear important implications for scientists and decision makers who rely upon these datasets when conducting research or informing conservation policy and management actions. Comparing distributions for the small subset of species with maps in both datasets, we found that AquaMaps and IUCN range maps show strong agreement for many well-studied species, but our analysis highlights several key examples in which introduced errors drive differences in predicted species ranges. In particular, we find that IUCN maps greatly overpredict coral presence into unsuitably deep waters, and we show that some AquaMaps computer-generated default maps (only 5.7% of which have been reviewed by experts) can produce odd discontinuities at the extremes of a species' predicted range. We illustrate the scientific and management implications of these tradeoffs by repeating a global analysis of gaps in coverage of marine protected areas, and find significantly different results depending on how the two datasets are used. By highlighting tradeoffs between the two datasets, we hope to encourage increased collaboration between taxa experts and large scale species distribution modeling efforts to further improve these foundational datasets, helping to better inform science and policy recommendations around understanding, managing, and protecting marine biodiversity.	[O'Hara, Casey C.; Afflerbach, Jamie C.; Scarborough, Courtney; Halpern, Benjamin S.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Kaschner, Kristin] Albert Ludwigs Univ, Dept Biometry & Environm Syst Anal, Tennenbacher Str 4, Freiburg, Germany; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Halpern, Benjamin S.] Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of Freiburg; University of California System; University of California Santa Barbara; Imperial College London	O'Hara, CC (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.	ohara@nceas.ucsb.edu	O'Hara, Casey/AGF-2964-2022; Kaschner, Kristin/GQQ-6475-2022	O'Hara, Casey/0000-0003-2968-7005; Scarborough, Courtney/0000-0001-7270-9228; Kaschner, Kristin/0000-0002-4061-626X	Gordon and Betty Moore Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This study was supported by funding from the Gordon and Betty Moore Foundation (https://www.moore.org/) received by BSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; BirdLife International  & NatureServe, 2015, BIRD SPEC DISTR MAPS; [CBI Fl LBAL BioDIvERsiTY INFoRmATIoN FAcitsri, 2010, GLOB BIOD INF FAC GB; Chamberlain S, 2017, WORLD REGISTER MARIN; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; FAO Fisheries and Aquaculture Department, 2015, CWP HDB FISH STAT ST; Froese R., 2016, WORLD WIDE WEB ELECT; Garcia Molinos J., 2015, NATURE CLIMATE CHANG, DOI [10.1038/nclimate2769, DOI 10.1111/GCB]; Gaston KJ, 2009, J APPL ECOL, V46, P1, DOI 10.1111/j.1365-2664.2008.01596.x; Halpern BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117863; Halpern BS, 2012, NATURE; IUCN, 2015, RED LIST MAPP STAND; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; IUCN & UNEP-WCMC, 2014, WORLD DAT PROT AR WD; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; Kaschner K., 2015, AQUAMAPS PREDICTED R; Kaschner K., 2013, AQUAMAPS PREDICTED R; Kaschner K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019653; Klein CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17539; Martin C, 2014, MANUAL MARINE COASTA; OBIS, 2016, DAT OC BIOG INF SYST; Palomares M, 2017, WORLD WIDE WEB ELECT; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Ramirez F, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601198; Ready J, 2010, ECOL MODEL, V221, P467, DOI 10.1016/j.ecolmodel.2009.10.025; Selig ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060284; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707	27	23	23	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175739	10.1371/journal.pone.0175739	http://dx.doi.org/10.1371/journal.pone.0175739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467508	Green Published, gold, Green Submitted			2022-12-27	WOS:000400647000025
J	Wang, Z; Zhou, XP; Lin, QX; Fang, WZ; Chen, XL				Wang, Zeng; Zhou, Xiaoping; Lin, Qingxian; Fang, Wenzhen; Chen, Xiaolin			Diversity and selection of MHC class I genes in the vulnerable Chinese egret (Egretta eulophotes)	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEOTIDE SUBSTITUTION; EVOLUTION; POLYMORPHISM; LOCI; DNA; SOFTWARE; GENETICS; REVEALS; ALLELES	The genes of major histocompatibility complex (MHC) are important to vertebrate immune system. In this study, two new MHC class I genes, designated as Egeu-UAA and Egeu-UBA, were discovered in the vulnerable Chinese egret (Egretta eulophotes). Using a full length DNA and cDNA produced by PCR and RACE methods, these two MHC class I loci were characterized in the genome of the Chinese egret and were also found to be expressed in liver and blood. Both new genes showed the expected eight exons and were similar to two copies of the minimal essential MHC complex of chicken. In genetic diversity, 14 alleles (8 for UAA and 6 for UBA) in the MHC class I gene exon 3 were found in 60 individuals using locus-specific primers and showed little polymorphism. Only three potential amino acid residues were detected under positive selection in potential peptide-binding regions (PBRs) by Bayesian analysis. These new results provide the fundamental basis for further studies to elucidate the molecular mechanisms and significance of MHC molecular adaptation in vulnerable Chinese egret and other ardeids, finding that have not been previously reported.	[Wang, Zeng; Zhou, Xiaoping; Lin, Qingxian; Fang, Wenzhen; Chen, Xiaolin] Xiamen Univ, Coll Environm & Ecol, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Xiamen, Fujian, Peoples R China	Xiamen University	Fang, WZ; Chen, XL (corresponding author), Xiamen Univ, Coll Environm & Ecol, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Xiamen, Fujian, Peoples R China.	wzfang@xmu.edu.cn; xlchen@xmu.edu.cn		Chen, Xiaolin/0000-0001-8486-9747	National Natural Science Foundation of China [41476113, 41676123]; Fujian Natural Science Foundation of China [2010Y2007]; Ministry of Science and Technology of China [2016YFC0602900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Natural Science Foundation of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This research was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn) (Grant #41476113 to XC, and 41676123 to WF), the Fujian Natural Science Foundation of China (http://xmgl.fikit.gov.cn/) (Grant #2010Y2007 to XC), and the Ministry of Science and Technology of China (http://service.most.gov.cn/) (Grant #2016YFC0602900 to XC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2007, J MOL EVOL, V65, P541, DOI 10.1007/s00239-007-9033-9; Alcaide M, 2014, ECOL EVOL, V4, P688, DOI 10.1002/ece3.974; Alcaide M, 2009, CONSERV GENET, V10, P1349, DOI 10.1007/s10592-008-9653-7; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Bollmer JL, 2007, IMMUNOGENETICS, V59, P593, DOI 10.1007/s00251-007-0221-y; Bradley RD, 1997, MOL BIOL EVOL, V14, P592, DOI 10.1093/oxfordjournals.molbev.a025797; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chappell P, 2015, ELIFE, V4, DOI 10.7554/eLife.05345; Chen LC, 2015, SCI REP-UK, V5, DOI 10.1038/srep07963; Cloutier A, 2011, IMMUNOGENETICS, V63, P377, DOI 10.1007/s00251-011-0516-x; Eizaguirre C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1632; Fain MA, 2001, TISSUE ANTIGENS, V57, P332, DOI 10.1034/j.1399-0039.2001.057004332.x; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gangoso L, 2012, J EVOLUTION BIOL, V25, P1438, DOI 10.1111/j.1420-9101.2012.02529.x; Garrigan D, 2001, IMMUNOGENETICS, V53, P483, DOI 10.1007/s002510100352; Goyos A, 2011, J IMMUNOL, V186, P372, DOI 10.4049/jimmunol.1001467; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedrick PW, 1998, EVOLUTION, V52, P194, DOI 10.1111/j.1558-5646.1998.tb05152.x; Hess CM, 2002, BIOSCIENCE, V52, P423, DOI 10.1641/0006-3568(2002)052[0423:TEOTMH]2.0.CO;2; Huang XH, 2010, CONSERV GENET, V11, P1211, DOI 10.1007/s10592-009-9921-1; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Kaufman J, 1994, Semin Immunol, V6, P411, DOI 10.1006/smim.1994.1050; Kaufman J, 1999, IMMUNOL REV, V167, P101, DOI 10.1111/j.1600-065X.1999.tb01385.x; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; Koch M, 2007, IMMUNITY, V27, P885, DOI 10.1016/j.immuni.2007.11.007; Krebs KC, 2005, J IMMUNOL, V175, P5230, DOI 10.4049/jimmunol.175.8.5230; Lei W, 2016, CONSERV GENET, V17, P1459, DOI 10.1007/s10592-016-0876-8; Li L, 2011, J MOL EVOL, V72, P474, DOI 10.1007/s00239-011-9446-3; Marshall D. R., 1975, Crop genetic resources for today and tomorrow. Genetic variation in plant populations., P53; Mesa CM, 2004, IMMUNOGENETICS, V56, P192, DOI 10.1007/s00251-004-0672-3; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Miller HC, 2007, J HERED, V98, P666, DOI 10.1093/jhered/esm095; Minias P, 2016, EVOLUTION; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; NEI M, 1986, MOL BIOL EVOL, V3, P418; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Reichard M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040780; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; Shum BP, 1999, IMMUNOGENETICS, V49, P479, DOI 10.1007/s002510050524; SJOGREN P, 1994, CONSERV BIOL, V8, P267, DOI 10.1046/j.1523-1739.1994.08010267.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ujvari B, 2011, INT J MOL SCI, V12, P5168, DOI 10.3390/ijms12085168; Wan QH, 2006, MOL ECOL, V15, P2441, DOI 10.1111/j.1365-294X.2006.02966.x; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074185; Winternitz JC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1605; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Zhou XP, 2008, MOL ECOL RESOUR, V8, P412, DOI 10.1111/j.1471-8286.2007.01975.x	52	0	0	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176671	10.1371/journal.pone.0176671	http://dx.doi.org/10.1371/journal.pone.0176671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467494	Green Published, Green Submitted, gold			2022-12-27	WOS:000400647000067
J	Karimipanah, Y; Ma, ZY; Miller, JEK; Yuste, R; Wessel, R				Karimipanah, Yahya; Ma, Zhengyu; Miller, Jae-eun Kang; Yuste, Rafael; Wessel, Ralf			Neocortical activity is stimulus- and scale-invariant	PLOS ONE			English	Article							SPONTANEOUS CORTICAL ACTIVITY; NEURONAL AVALANCHES; HUMAN BRAIN; DYNAMICS; AWAKE; CONNECTIVITY; OSCILLATIONS; NETWORK; CORTEX	Mounting evidence supports the hypothesis that the cortex operates near a critical state, defined as the transition point between order (large-scale activity) and disorder (small-scale activity). This criticality is manifested by power law distribution of the size and duration of spontaneous cascades of activity, which are referred as neuronal avalanches. The existence of such neuronal avalanches has been confirmed by several studies both in vitro and in vivo, among different species and across multiple spatial scales. However, despite the prevalence of scale free activity, still very little is known concerning whether and how the scale-free nature of cortical activity is altered during external stimulation. To address this question, we performed in vivo two-photon population calcium imaging of layer 2/3 neurons in primary visual cortex of behaving mice during visual stimulation and conducted statistical analyses on the inferred spike trains. Our investigation for each mouse and condition revealed power law distributed neuronal avalanches, and irregular spiking individual neurons. Importantly, both the avalanche and the spike train properties remained largely unchanged for different stimuli, while the cross-correlation structure varied with stimuli. Our results establish that microcircuits in the visual cortex operate near the critical regime, while rearranging functional connectivity in response to varying sensory inputs.	[Karimipanah, Yahya; Ma, Zhengyu; Wessel, Ralf] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [Miller, Jae-eun Kang; Yuste, Rafael] Columbia Univ, Neurotechnol Ctr, New York, NY USA; [Miller, Jae-eun Kang; Yuste, Rafael] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Washington University (WUSTL); Columbia University; Columbia University	Ma, ZY (corresponding author), Washington Univ, Dept Phys, St Louis, MO 63130 USA.	zhengyuma@wustl.edu			Whitehall Foundation [20121221]; National Science Foundation (Collaborative Research in Computational Neuroscience) [1308159]; National Eye Institute [DP1EY024503, RO1EY011787, F32EY022579, K99EY024653]; NATIONAL EYE INSTITUTE [K99EY024653] Funding Source: NIH RePORTER	Whitehall Foundation; National Science Foundation (Collaborative Research in Computational Neuroscience)(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by Whitehall Foundation grant #20121221 (RW) http://www.whitehall.org/; National Science Foundation (Collaborative Research in Computational Neuroscience) grant #1308159 (RW) https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5147; National Eye Institute (DP1EY024503 and RO1EY011787 to RY, and F32EY022579 and K99EY024653 to JKM) https://nei.nih.gov/.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Arviv O, 2015, J NEUROSCI, V35, P13927, DOI 10.1523/JNEUROSCI.0477-15.2015; Bak P., 1996, NATURE WORKS SCI SEL; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beggs JM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00163; Bellay T, 2015, ELIFE, V4, DOI 10.7554/eLife.07224; Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Downing KL, 2015, INTELLIGENCE EMERGING: ADAPTIVITY AND SEARCH IN EVOLVING NEURAL SYSTEMS, P1; Eurich CW, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.066137; Evangelidis GD, 2008, IEEE T PATTERN ANAL, V30, P1858, DOI 10.1109/TPAMI.2008.113; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fraiman D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00307; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Gautam SH, 2015, PLOS COMPUT BIOL, V11, P1; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hahn G, 2010, J NEUROPHYSIOL, V104, P3312, DOI 10.1152/jn.00953.2009; Haldeman C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058101; Hamel EJO, 2015, NEURON, V86, P140, DOI 10.1016/j.neuron.2015.03.055; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Jensen H.J., 1998, SELF ORG CRITICALITY; Kaifosh P, 2013, NAT NEUROSCI, V16, P1182, DOI 10.1038/nn.3482; Karimipanah Y, 2016, NEW HALLMARKS CRITIC, P1; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; Meisel C, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061917; Miller JEK, 2014, P NATL ACAD SCI USA, V111, pE4053, DOI 10.1073/pnas.1406077111; Mohajerani MH, 2013, NAT NEUROSCI, V16, P1426, DOI 10.1038/nn.3499; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Plenz D, 2014, CRITICALITY IN NEURAL SYSTEMS, P1; Poil SS, 2008, HUM BRAIN MAPP, V29, P770, DOI 10.1002/hbm.20590; Poil SS, 2012, J NEUROSCI, V32, P9817, DOI 10.1523/JNEUROSCI.5990-11.2012; Priesemann V, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002985; Ribeiro TL, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00016; Ringach DL, 2009, CURR OPIN NEUROBIOL, V19, P439, DOI 10.1016/j.conb.2009.07.005; Scott G, 2014, J NEUROSCI, V34, P16611, DOI 10.1523/JNEUROSCI.3474-14.2014; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shew WL, 2015, NAT PHYS, V11, P659, DOI 10.1038/NPHYS3370; Shriki O, 2013, J NEUROSCI, V33, P7079, DOI 10.1523/JNEUROSCI.4286-12.2013; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009	58	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177396	10.1371/journal.pone.0177396	http://dx.doi.org/10.1371/journal.pone.0177396			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489906	gold, Green Submitted, Green Published			2022-12-27	WOS:000401314100070
J	Munk, MR; Giannakaki-Zimmermann, H; Berger, L; Huf, W; Ebneter, A; Wolf, S; Zinkernagel, MS				Munk, Marion R.; Giannakaki-Zimmermann, Helena; Berger, Lieselotte; Huf, Wolfgang; Ebneter, Andreas; Wolf, Sebastian; Zinkernagel, Martin S.			OCT-angiography: A qualitative and quantitative comparison of 4 OCT-A devices	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; TECHNICAL ASPECTS; IMAGE ARTIFACTS; NORMAL EYES; RETINA	Purpose To compare the quality of four OCT-angiography(OCT-A) modules. Method The retina of nineteen healthy volunteers were scanned with four OCT-devices (Topcon DRI-OCT Triton Swept-source OCT, Optovue RTVue-XR, a prototype Spectralis OCT2, Heidelberg-Engineering and Zeiss Cirrus 5000-HD-OCT). The device-software generated en-face OCT-A images of the superficial (SCP) and deep capillary plexuses (DCP) were evaluated and scored by 3 independent retinal imaging experts. The SCP vessel density was assessed using Angiotool-software. After the inter-grader reliability assessment, a consensus grading was performed and the modules were ranked based on their scoring. Results There was no significant difference in the vessel density among the modules (Zeiss 48.7 +/- 4%, Optovue 47.9 +/- 3%, Topcon 48.3 +/- 2%, Heidelberg 46.5 +/- 4%, p = 0.2). The numbers of discernible vessel-bifurcations differed significantly on each module (Zeiss 2 +/- 0.9 bifurcations, Optovue 2.5 +/- 1.2, Topcon 1.3 +/- 0.7 and Heidelberg 0.5 +/- 0.6, p <= 0.001). The ranking of each module differed depending on the evaluated parameter. In the overall ranking, the Zeiss module was superior and in 90% better than the median (Bonferroni corrected p-value = 0.04). Optovue was better than the median in 60%, Topcon in 40% and Heidelberg module in 10%, however these differences were not statistically significant. Conclusion Each of the four evaluated OCT-A modules had particular strengths, which differentiated it from their competitors.	[Munk, Marion R.; Giannakaki-Zimmermann, Helena; Berger, Lieselotte; Ebneter, Andreas; Wolf, Sebastian; Zinkernagel, Martin S.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Ophthalmol, Bern, Switzerland; [Munk, Marion R.; Giannakaki-Zimmermann, Helena; Wolf, Sebastian; Zinkernagel, Martin S.] Univ Bern, Bern Photog Reading Ctr, Bern, Switzerland; [Berger, Lieselotte; Ebneter, Andreas; Wolf, Sebastian; Zinkernagel, Martin S.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Clin Res, Bern, Switzerland; [Huf, Wolfgang] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; Medical University of Vienna	Munk, MR (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Ophthalmol, Bern, Switzerland.; Munk, MR (corresponding author), Univ Bern, Bern Photog Reading Ctr, Bern, Switzerland.	marion_munk@hotmail.com	Ebneter, Andreas/C-5226-2017; Wolf, Sebastian/B-8782-2008	Ebneter, Andreas/0000-0001-6666-2558; Wolf, Sebastian/0000-0002-7467-7028; Zinkernagel, Martin S./0000-0003-3447-2359				Alshareef RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155319; Campbell JP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42201; Coscas F, 2016, INVEST OPHTH VIS SCI, V57, pOCT211, DOI 10.1167/iovs.15-18793; Coscas G, 2016, DEV OPHTHALMOL, V56, P1, DOI 10.1159/000442768; Coscas G, 2011, EUR J OPHTHALMOL, V21, P631, DOI 10.5301/EJO.2011.7428; De Vitis LA, 2016, OPHTHALMIC RES; Ferrara D, 2016, CLIN EXP OPHTHALMOL, V44, P367, DOI 10.1111/ceo.12781; Gao SS, 2016, INVEST OPHTH VIS SCI, V57, pOCT27, DOI 10.1167/iovs.15-19043; Ghasemi Falavarjani K, 2016, BR J OPHTHALMOL; Huang D, 2016, DEV OPHTHALMOL, V56, P6, DOI 10.1159/000442770; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Kafieh Raheleh, 2013, J Med Signals Sens, V3, P45; LIPSON BK, 1989, INT OPHTHALMOL CLIN, V29, P200, DOI 10.1097/00004397-198902930-00011; Lumbroso B, 2016, DEV OPHTHALMOL, V56, P77, DOI 10.1159/000442782; Lupidi M, 2016, AM J OPHTHALMOL, V169, P9, DOI 10.1016/j.ajo.2016.06.008; Palma CV, 2016, RETINA-J RET VIT DIS, V36, P1888, DOI 10.1097/IAE.0000000000001060; Park JJ, 2016, RETINA; Rosenfeld PJ, 2016, DEV OPHTHALMOL, V56, P18, DOI 10.1159/000442773; Ruminski D, 2015, BIOMED OPT EXPRESS, V6, P2738, DOI 10.1364/BOE.6.002738; Say EA, 2016, RETINA; Spaide RF, 2017, JAMA OPHTHALMOL, V135, P259, DOI 10.1001/jamaophthalmol.2016.5327; Spaide RF, 2015, RETINA-J RET VIT DIS, V35, P2163, DOI 10.1097/IAE.0000000000000765; Stanga PE, 2016, DEV OPHTHALMOL, V56, P13, DOI 10.1159/000442771; Zhang AQ, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.10.100901; Zhang Q, 2016, PROJECTION ARTIFACT; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	26	135	140	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177059	10.1371/journal.pone.0177059	http://dx.doi.org/10.1371/journal.pone.0177059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489918	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100045
J	Yamazaki, H; Lai, YC; Tateno, M; Setoguchi, A; Goto-Koshino, Y; Endo, Y; Nakaichi, M; Tsujimoto, H; Miura, N				Yamazaki, Hiroki; Lai, Yu-Chang; Tateno, Morihiro; Setoguchi, Asuka; Goto-Koshino, Yuko; Endo, Yasuyuki; Nakaichi, Munekazu; Tsujimoto, Hajime; Miura, Naoki			Hypoxia-activated prodrug TH-302 decreased survival rate of canine lymphoma cells under hypoxic condition	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SOFT-TISSUE SARCOMA; INDUCIBLE FACTOR-1-ALPHA; PHASE-I; MULTIDRUG-RESISTANCE; MALIGNANT-LYMPHOMA; EXPRESSION; CANCER; LINE; LEUKEMIA	We tested the hypotheses that hypoxic stimulation enhances growth potentials of canine lymphoma cells by activating hypoxia-inducible factor 1 alpha (HIF-1 alpha), and that the hypoxia-activated prodrug (TH-302) inhibits growth potentials in the cells. We investigated how hypoxic culture affects the growth rate, chemoresistance, and invasiveness of canine lymphoma cells and doxorubicin (DOX)-resistant lymphoma cells, and influences of TH-302 on survival rate of the cells under hypoxic conditions. Our results demonstrated that hypoxic culture upregulated the expression of HIF-1a and its target genes, including ATP-binding cassette transporter B1 (ABCB1), ATP-binding cassette transporter G2 (ABCG2), platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and survivin, and enhanced the growth rate, DOX resistance, and invasiveness of the cells. Additionally, TH-302 decreased the survival rate of the cells under hypoxic condition. Our studies suggest that hypoxic stimulation may advance the tumorigenicity of canine lymphoma cells, favoring malignant transformation. Therefore, the data presented may contribute to the development of TH-302-based hypoxia-targeting therapies for canine lymphoma.	[Yamazaki, Hiroki; Lai, Yu-Chang; Miura, Naoki] Kagoshima Univ, Vet Teaching Hosp, Joint Fac Vet Med, Korimoto, Kagoshima, Japan; [Tateno, Morihiro; Endo, Yasuyuki] Kagoshima Univ, Joint Fac Vet Med, Lab Vet Internal Med, Korimoto, Kagoshima, Japan; [Setoguchi, Asuka] Bayside Anim Clin, Yokohama, Kanagawa, Japan; [Goto-Koshino, Yuko; Tsujimoto, Hajime] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Internal Med, Bunkyo Ku, Tokyo, Japan; [Nakaichi, Munekazu] Yamaguchi Univ, Joint Fac Vet Med, Dept Vet Med, Lab Vet Radiol, Yoshida, Yamaguchi, Japan; [Yamazaki, Hiroki] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Vet Med Ctr, Izumisano, Osaka, Japan	Kagoshima University; Kagoshima University; University of Tokyo; Yamaguchi University; Osaka Metropolitan University	Miura, N (corresponding author), Kagoshima Univ, Vet Teaching Hosp, Joint Fac Vet Med, Korimoto, Kagoshima, Japan.	k9236024@kadai.jp	Miura, Naoki/A-5734-2010; Miura, Naoki/O-6997-2016	Miura, Naoki/0000-0002-4625-5231; Miura, Naoki/0000-0002-4625-5231; Goto-Koshino, Yuko/0000-0002-5228-7125; Tsujimoto, Hajime/0000-0002-3771-6235	Japan Society for the Promotion of Science (JSPS) KAKENHI [25292180, 15K14872, 17H03926]; Grants-in-Aid for Scientific Research [16H05845, 17H03926] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant numbers 25292180, 15K14872, and 17H03926). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appiah-Kubi K, 2016, TUMOUR BIOL; Arico A, 2014, J COMP PATHOL, V151, P322, DOI 10.1016/j.jcpa.2014.07.001; Badar T, 2016, AM J HEMATOL, V91, P800, DOI 10.1002/ajh.24415; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Chawla SP, 2014, J CLIN ONCOL, V32, P3299, DOI 10.1200/JCO.2013.54.3660; Chen YQ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-29; Comerford KM, 2002, CANCER RES, V62, P3387; Evens AM, 2010, J CLIN ONCOL, V28, P1017, DOI 10.1200/JCO.2009.24.1893; Ganjoo KN, 2011, ONCOLOGY-BASEL, V80, P50, DOI 10.1159/000327739; Garrido-Laguna I, 2015, NAT REV CLIN ONCOL, V12, P319, DOI 10.1038/nrclinonc.2015.53; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Hendifar AE, 2015, ANN CANC RES, V2, P5; Hernandez-Luna MA, 2013, LEUKEMIA LYMPHOMA, V54, P1048, DOI 10.3109/10428194.2012.733874; Hu JS, 2010, BLOOD, V116, P1524, DOI 10.1182/blood-2010-02-269126; Ito D, 2014, VET IMMUNOL IMMUNOP, V159, P192, DOI 10.1016/j.vetimm.2014.02.016; Izaki S, 2007, INT J HEMATOL, V86, P253, DOI 10.1007/BF03006930; Kambayashi S, 2015, J VET MED SCI, V77, P1405, DOI 10.1292/jvms.15-0258; Marconato L, 2009, VET COMP ONCOL, V7, P236, DOI 10.1111/j.1476-5829.2009.00196.x; Momoi Y, 1997, VET IMMUNOL IMMUNOP, V59, P11, DOI 10.1016/S0165-2427(97)00053-6; Nakaichi M, 1996, J VET MED SCI, V58, P469, DOI 10.1292/jvms.58.469; Pang YY, 2015, LEUKEMIA LYMPHOMA, V56, P1821, DOI 10.3109/10428194.2014.963575; Perry AM, 2016, HAEMATOLOGICA, V101, P1244, DOI 10.3324/haematol.2016.148809; Phillips RM, 2016, CANCER CHEMOTH PHARM, V77, P441, DOI 10.1007/s00280-015-2920-7; Powell JR, 2013, LEUKEMIA LYMPHOMA, V54, P959, DOI 10.3109/10428194.2012.733875; Sharif H, 2012, VET J, V194, P40, DOI 10.1016/j.tvjl.2012.03.006; Shoeneman JK, 2016, VET COMP ONCOL, V14, pE45, DOI 10.1111/vco.12104; Sia D, 2014, CURR PHARM DESIGN, V20, P2834, DOI 10.2174/13816128113199990590; Takahashi M, 2014, J VET MED SCI, V76, P895, DOI 10.1292/jvms.13-0345; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tuomela J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-596; Weiss GJ, 2011, CLIN CANCER RES, V17, P2997, DOI 10.1158/1078-0432.CCR-10-3425; Wolfesberger B, 2007, J COMP PATHOL, V137, P30, DOI 10.1016/j.jcpa.2007.03.003; Xia Y, 2012, EUR J MED CHEM, V49, P24, DOI 10.1016/j.ejmech.2012.01.033; Zandvliet M, 2016, VET QUART, V36, P76, DOI 10.1080/01652176.2016.1152633; Zandvliet M, 2015, VET J, V205, P263, DOI 10.1016/j.tvjl.2014.11.002; Zandvliet M, 2014, TOXICOL IN VITRO, V28, P1498, DOI 10.1016/j.tiv.2014.06.004	36	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177305	10.1371/journal.pone.0177305	http://dx.doi.org/10.1371/journal.pone.0177305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489881	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100058
J	Pandolfi, R; de Almeida, DR; Pinto, MA; Kreutz, LC; Frandoloso, R				Pandolfi, Rafael; de Almeida, Denise Ramos; Pinto, Marcelo Alves; Kreutz, Luiz Carlos; Frandoloso, Rafael			In house ELISA based on recombinant ORF2 protein underline high prevalence of IgG anti-hepatitis E virus amongst blood donors in south Brazil	PLOS ONE			English	Article							ORGAN-TRANSPLANT RECIPIENTS; INFECTIOUS-DISEASE; HEV IGM; SWINE; PIGS; STANDARDIZATION; IMMUNOASSAY; ANTIBODIES; GERMANY; FRANCE	Hepatitis E Virus (HEV) is a zoonotic pathogen responsible for causing acute hepatitis in human, especially in developing countries. Diagnosis of HEV usually relies on the detection of antibodies mostly by enzyme-linked immunosorbent assay (ELISA). In the present study, we designed a new indirect ELISA (iELISA) based on a short recombinant peptide derived from the capsid protein (ORF2p) and demonstrated its potential for detecting human IgG against HEV genotype 3. The best polystyrene plate (Maxisorp (R)), optimal ORF2p coating antigen concentration (0,67 mu g/well) and primary antibody dilution (1: 100) were determined. This iELISA showed a sensitivity of 91.4% and specificity of 95.9%. The comparison of our in house iELISA with a commercial assay (RecomWell, Mikrogen (R)) showed 94.25% of agreement and a kappa index of 0.88. The ORF2 recombinant ELISA was used to screen 780 blood donors for anti-HEV IgG and we found that 314 (40,25%) of these donors were IgG positive. This high prevalence of antibodies suggests, for the first time, that the Southern Brazil region might be endemic to Hepatitis E Virus genotype 3.	[Pandolfi, Rafael; de Almeida, Denise Ramos; Kreutz, Luiz Carlos; Frandoloso, Rafael] Univ Passo Fundo, Fac Agron & Med Vet, Lab Microbiol & Imunol Avancada, Passo Fundo, RS, Brazil; [Pinto, Marcelo Alves] Fundacao Oswaldo Cruz, Lab Desenvolvimento Tecnol Virol IOC, Rio De Janeiro, RJ, Brazil	Universidade de Passo Fundo; Fundacao Oswaldo Cruz	Frandoloso, R (corresponding author), Univ Passo Fundo, Fac Agron & Med Vet, Lab Microbiol & Imunol Avancada, Passo Fundo, RS, Brazil.	rfran@upf.br	Pinto, Marcelo Alves/ABA-3312-2020; Pinto, Marcelo/G-7503-2012; Kreutz, Luiz Carlos/A-3729-2015; Frandoloso, Rafael/D-3774-2013	Pinto, Marcelo/0000-0003-3462-7277; Kreutz, Luiz Carlos/0000-0002-7685-7401; Frandoloso, Rafael/0000-0002-3361-2420	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [485807/2013]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The author RF received financial support from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant no 485807/2013).	Aggarwal R, 2013, J CLIN EXP HEPATOL, V3, P125, DOI 10.1016/j.jceh.2013.05.010; Aggarwal R, 2013, NAT REV GASTRO HEPAT, V10, P24, DOI 10.1038/nrgastro.2012.187; Aggarwal R, 2011, VIRUS RES, V161, P15, DOI 10.1016/j.virusres.2011.03.017; Arankalle VA, 2007, J VIRAL HEPATITIS, V14, P435, DOI 10.1111/j.1365-2893.2006.00801.x; Behrendt P, 2016, J INFECT DIS, V214, P361, DOI 10.1093/infdis/jiw161; Lana MVD, 2014, TROP ANIM HEALTH PRO, V46, P399, DOI 10.1007/s11250-013-0503-3; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; de Deus N, 2008, VET MICROBIOL, V129, P163, DOI 10.1016/j.vetmic.2007.11.002; Echevarria JM, 2013, J MED VIROL, V85, P1037, DOI 10.1002/jmv.23526; Emerson S.U., 2005, VIRUS TAXONOMY, P853; Engle RE, 2002, J CLIN MICROBIOL, V40, P4576, DOI 10.1128/JCM.40.12.4576-4580.2002; Erez-Granat O, 2016, WORLD J GASTROENTERO, V22, P5568, DOI 10.3748/wjg.v22.i24.5568; Fischer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119576; IBGE, 2016, EF REB BRAS ANO 2015; de Oya NJ, 2009, J CLIN MICROBIOL, V47, P3276, DOI 10.1128/JCM.00750-09; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Khuroo MS, 2004, J GASTROEN HEPATOL, V19, P778, DOI 10.1111/j.1440-1746.2004.03437.x; Krumbholz A, 2014, MED MICROBIOL IMMUN, V203, P273, DOI 10.1007/s00430-014-0336-3; Legrand-Abravanel F, 2010, J INFECT DIS, V202, P835, DOI 10.1086/655899; dos Santos DRL, 2010, J CLIN VIROL, V47, P276, DOI 10.1016/j.jcv.2009.12.021; dos Santos DRL, 2009, VET J, V182, P474, DOI 10.1016/j.tvjl.2008.08.001; Ma HX, 2011, J MED VIROL, V83, P827, DOI 10.1002/jmv.22032; Ma HX, 2009, J MED VIROL, V81, P1052, DOI 10.1002/jmv.21484; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; Meng XJ, 2010, VET MICROBIOL, V140, P256, DOI 10.1016/j.vetmic.2009.03.017; Meng XJ, 2011, VIRUS RES, V161, P23, DOI 10.1016/j.virusres.2011.01.016; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; Navaneethan U, 2008, LIVER INT, V28, P1190, DOI 10.1111/j.1478-3231.2008.01840.x; Nouhin J, 2016, TRANSFUSION; Pas SD, 2013, J CLIN VIROL, V58, P629, DOI 10.1016/j.jcv.2013.10.010; Pas SD, 2012, EMERG INFECT DIS, V18, P869, DOI 10.3201/eid1805.111712; Passos-Castilho AM, 2016, J MED VIROL, V88, P361, DOI 10.1002/jmv.24336; Pezzoni G, 2014, J VIROL METHODS, V207, P95, DOI 10.1016/j.jviromet.2014.06.025; Pischke S, 2014, DTSCH ARZTEBL INT, V111, P577, DOI 10.3238/arztebl.2014.0577; Pischke S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085330; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Ramos DD, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw021; Schlauder GG, 2001, J MED VIROL, V65, P282, DOI 10.1002/jmv.2031; Seminati C, 2008, VET J, V175, P130, DOI 10.1016/j.tvjl.2006.11.018; Perez-Gracia MT, 2016, FUTURE MICROBIOL, V11, P789, DOI 10.2217/fmb-2016-0012; TROTTIER YL, 1992, J CLIN MICROBIOL, V30, P46, DOI 10.1128/JCM.30.1.46-53.1992; Vitral CL, 2005, MEM I OSWALDO CRUZ, V100, P117, DOI 10.1590/S0074-02762005000200003; Wenzel JJ, 2013, J INFECT DIS, V207, P497, DOI 10.1093/infdis/jis688; WHO, 2015, HEPATITIS E; Wright P F, 1993, Rev Sci Tech, V12, P435; Yugo DM, 2013, INT J ENV RES PUB HE, V10, P4507, DOI 10.3390/ijerph10104507	46	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176409	10.1371/journal.pone.0176409	http://dx.doi.org/10.1371/journal.pone.0176409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486512	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314000011
J	Nadorf, J; Kinkel, S; Gantz, S; Jakubowitz, E; Kretzer, JP				Nadorf, Jan; Kinkel, Stefan; Gantz, Simone; Jakubowitz, Eike; Kretzer, J. Philippe			Tibial revision knee arthroplasty with metaphyseal sleeves: The effect of stems on implant fixation and bone flexibility	PLOS ONE			English	Article							TOTAL JOINT ARTHROPLASTY; RADIOGRAPHIC EVALUATION; COMPONENT STABILITY; PROXIMAL TIBIA; REPLACEMENT; DESIGN; CEMENTLESS; MICROMOTION; PROSTHESIS; REGISTRIES	Introduction Revision total knee arthoplasty often requires modular implants to treat bone defects of varying severity. In some cases, it may not be clear which module size and implant combination (e.g. sleeve and stem) should be chosen for a specific defect. When balancing implant stability and osseointegration against stress-shielding, it is important to choose an appropriate implant combination in order to match the given level of bone loss. Therefore, the necessity of stems in less extensive tibial defects and the advantage of different stems (lengths and stiffnesses) in combination with large metaphyseal sleeves on implant fixation and bone flexibility using a modular tibial revision knee system, were analyzed. Materials and methods Four different stem combinations for a tibial revision implant (Sigma TC3, DePuy) were compared to an intact bone. Standardized implantation with n = 4 synthetic tibial bones was performed after generating an Anderson Orthopaedic Research Institute (AORI) Type T1 bone defect. Axial torques around the longitudinal stem axis and varus-valgus torques were separately applied to the implant. Micromotions of bone and implant were tracked using a digital image correlation system to calculate relative micromotions at the implant-bone-interface and bone deformation. Results Overall, using stems reduced the proximal micromotions of tray and sleeve compared to no stem, while reducing bone deformation proximally at the same time, indicating some potential for proximal stress-shielding compared to no stem. The potential for increased proximal stress-shield due to reduced proximal deformation appeared to be greater when using the longer stems. The location of lowest relative micromotions was also more distal when using long stems as opposed to short stems. A short stem (especially a smaller diameter short stem which still achieves diaphyseal fixation) displayed less potential for stress-shielding, but greater bone deformation distal to the tip of the stem than in the natural model. Discussion In the case of tibial revision implants with metaphyseal sleeves in a simple fully contained Type I defect, the absence of a stem provides for more natural bone deformation. However, adding a stem reduces overall relative micromotions, while introducing some risk of proximal stress-shielding due to increased diaphyseal fixation. Increasing stem length intensifies this effect. Short stems offered a balance between reduced micromotions and more proximal bone deformation that reduced the potential for stress-shielding when compared to long stems. A short stem with slightly smaller diameter (simulating a less stiff stem which still has diaphyseal fixation) increased the proximal bone deformation, but also tended to increase the bone deformation even further at the distal stem's tip. Conclusion In conclusion, further investigation should be conducted on fully contained Type I defects and the addition of a stem to offer better initial stability, taking into account stem length (i.e. shorter or more flexible stems) to support metaphyseal fixation and allowing bending found in intact bone. In addition, further study into more extensive tibial defects is required to determine if the stability/micromotion trends observed in this study with stems and sleeves in Type I defects still apply in cases of extensive proximal bone loss.	[Nadorf, Jan; Kinkel, Stefan; Kretzer, J. Philippe] Univ Hosp Heidelberg, Ctr Orthoped & Traumatol, Lab Biomech & Implant Res, Heidelberg, Germany; [Gantz, Simone] Univ Hosp Heidelberg, Ctr Orthoped & Traumatol, Biometr Consulting & Project Management, Heidelberg, Germany; [Jakubowitz, Eike] Hannover Med Sch, Lab Biomech & Biomat, Dept Orthopaed Surg, Hannover, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Hannover Medical School	Nadorf, J (corresponding author), Univ Hosp Heidelberg, Ctr Orthoped & Traumatol, Lab Biomech & Implant Res, Heidelberg, Germany.	JNadorf@yahoo.de			DePuy Synthes; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing	DePuy Synthes; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing	The authors acknowledge financial support by DePuy Synthes (http://www.depuysynthes.com/). In addition, DePuy Synthes provided the tested implants. We acknowledge financial support by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552; Bensmann G, 1999, BIOMED ENG, V35, P44, DOI DOI 10.1515/BMTE.1990.35.S3.44; Bergmann G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086035; Bertin KC, 2007, J ARTHROPLASTY, V22, P670, DOI 10.1016/j.arth.2006.07.004; Bieger R, 2013, J ORTHOP RES, V31, P1180, DOI 10.1002/jor.22349; Bottlang M, 2006, CLIN ORTHOP RELAT R, P105, DOI 10.1097/01.blo.0000203463.27937.97; Clarius M, 2010, KNEE, V17, P398, DOI 10.1016/j.knee.2009.11.006; Clatworthey M., 2003, ADULT KNEE, P1455; Completo A, 2008, KNEE, V15, P227, DOI 10.1016/j.knee.2008.01.008; Completo A, 2008, J BIOMECH, V41, P560, DOI 10.1016/j.jbiomech.2007.10.006; Conlisk N, 2012, BONE JOINT RES, V1, P281, DOI 10.1302/2046-3758.111.2000107; Cristofolini L, 1996, J BIOMECH, V29, P525, DOI 10.1016/0021-9290(95)00084-4; Dalury DF, 2008, J BONE JOINT SURG BR, V90B, P1594, DOI 10.1302/0301-620X.90B12.21064; DORR LD, 1989, ORTHOP CLIN N AM, V20, P179; ENGH CA, 1992, CLIN ORTHOP RELAT R, P13; ENGH CA, 1988, CLIN ORTHOP RELAT R, P7; Engh G A, 1997, Instr Course Lect, V46, P227; Engh GA, 1998, ORTHOP CLIN N AM, V29, P205, DOI 10.1016/S0030-5898(05)70319-9; Frost HM, 2004, ANGLE ORTHOD, V74, P3; Gortz W, 2002, J BIOMECH ENG-T ASME, V124, P706, DOI 10.1115/1.1517565; Graichen H, 2015, J ARTHROPLASTY, V30, P2256, DOI 10.1016/j.arth.2015.06.030; Holt G, 2007, CLIN ORTHOP RELAT R, P240, DOI 10.1097/BLO.0b013e31804b4147; Jakubowitz E, 2008, J BIOMECH, V41, P3078, DOI 10.1016/j.jbiomech.2008.06.002; Jasty M, 1997, J BONE JOINT SURG AM, V79A, P707, DOI 10.2106/00004623-199705000-00010; Jazrawi LM, 2001, J ARTHROPLASTY, V16, P759, DOI 10.1054/arth.2001.25507; Kinkel S, 2013, INT ORTHOP, V37, P1877, DOI 10.1007/s00264-013-2052-9; McLean A, 2006, ORTHOPAEDIC P B S3, V88-B, P397; Meneghini RM, 2015, J ARTHROPLASTY, V30, P2311, DOI 10.1016/j.arth.2015.05.049; Molt M, 2015, ACTA ORTHOP, V86, P594, DOI 10.3109/17453674.2015.1033303; Nadorf J, 2014, ARCH ORTHOP TRAUM SU, V134, P719, DOI 10.1007/s00402-014-1946-3; Nadorf J, 2016, INT J ARTIF ORGANS, V39, P534, DOI 10.5301/ijao.5000530; Niinimaki TT, 2015, KNEE, V22, P142, DOI 10.1016/j.knee.2014.12.007; Ong KL, 2010, CLIN ORTHOP RELAT R, V468, P3070, DOI 10.1007/s11999-010-1399-0; Pal B, 2010, J BIOMECH, V43, P1923, DOI 10.1016/j.jbiomech.2010.03.019; Papakostidou I, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-116; Parfitt AM, 2002, BONE, V30, P5, DOI 10.1016/S8756-3282(01)00642-1; Petersen KK, 2015, CLIN J PAIN, V31, P1, DOI 10.1097/AJP.0000000000000146; PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108; RAND JA, 1991, CLIN ORTHOP RELAT R, P63; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Sadoghi P, 2013, J ARTHROPLASTY, V28, P1329, DOI 10.1016/j.arth.2013.01.012; Scott CEH, 2012, J BONE JOINT SURG BR, V94B, P1009, DOI 10.1302/0301-620X.94B8.28289; Siqueira MBP, 2015, J KNEE SURG, V28, P127, DOI 10.1055/s-0034-1396014; Stern SH, 1997, CLIN ORTHOP RELAT R, P44; Thomsen M, 2010, ORTHOPADE, V39, P623, DOI 10.1007/s00132-010-1617-1; Wolff J, 1892, GESETZ TRANSFORMATIO	46	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177285	10.1371/journal.pone.0177285	http://dx.doi.org/10.1371/journal.pone.0177285			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481956	Green Submitted, gold, Green Published			2022-12-27	WOS:000401313700048
J	Bernardo, BS; Goodbourn, S; Baron, MD				Bernardo, Beatriz Sanz; Goodbourn, Stephen; Baron, Michael D.			Control of the induction of type I interferon by Peste des petits ruminants virus	PLOS ONE			English	Article							PARAMYXOVIRUS V-PROTEINS; NONSTRUCTURAL C PROTEIN; DOUBLE-STRANDED-RNA; DEFICIENT MEASLES-VIRUS; IFN-BETA PROMOTER; RIG-I; RINDERPEST VIRUS; MESSENGER-RNA; VIRAL-RNA; ANTIVIRAL RESPONSES	Peste des petits ruminants virus (PPRV) is a morbillivirus that produces clinical disease in goats and sheep. We have studied the induction of interferon-beta (IFN-beta) following infection of cultured cells with wild-type and vaccine strains of PPRV, and the effects of such infection with PPRV on the induction of IFN-beta through both MDA-5 and RIG-I mediated pathways. Using both reporter assays and direct measurement of IFN-beta mRNA, we have found that PPRV infection induces IFN-beta only weakly and transiently, and the virus can actively block the induction of IFN-beta. We have also generated mutant PPRV that lack expression of either of the viral accessory proteins (V&C) to characterize the role of these proteins in IFN-beta induction during virus infection. Both PPRV_Delta V and PPRV_Delta C were defective in growth in cell culture, although in different ways. While the PPRV V protein bound to MDA-5 and, to a lesser extent, RIG-I, and over-expression of the V protein inhibited both IFN-beta induction pathways, PPRV lacking V protein expression can still block IFN-beta induction. In contrast, PPRV C bound to neither MDA-5 nor RIG-I, but PPRV lacking C protein expression lost the ability to block both MDA-5 and RIG-I mediated activation of IFN-beta. These results shed new light on the inhibition of the induction of IFN-beta by PPRV.	[Bernardo, Beatriz Sanz; Baron, Michael D.] Pirbright Inst, Pirbright, Surrey, England; [Goodbourn, Stephen] St Georges Univ London, Inst Infect & Immun, London, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; St Georges University London	Baron, MD (corresponding author), Pirbright Inst, Pirbright, Surrey, England.	michael.baron@pirbright.ac.uk		Goodbourn, Stephen/0000-0002-4530-1179; Sanz Bernardo, Beatriz/0000-0001-6965-3497	Biotechnology and Biological Sciences Research Council; Institute Strategic Programme on Livestock Viral Diseases at The Pirbright Institute; Wellcome Trust [101792/Z/13/Z]; BBSRC [BBS/E/I/00001576, BBS/E/I/00001719] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001576, BBS/E/I/00001719] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute Strategic Programme on Livestock Viral Diseases at The Pirbright Institute; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) Institute Strategic Programme on Livestock Viral Diseases at The Pirbright Institute (BSB and MDB), and grant 101792/Z/13/Z from the Wellcome Trust (www.wellcome.ac.uk) (SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABREU SL, 1979, J BIOL CHEM, V254, P4114; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Bankamp B, 2005, VIROLOGY, V336, P120, DOI 10.1016/j.virol.2005.03.009; Baron J, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-22; Baron MD, 2016, ADV VIRUS RES, V95, P1, DOI 10.1016/bs.aivir.2016.02.001; Baron MD, 2000, J VIROL, V74, P2603, DOI 10.1128/JVI.74.6.2603-2611.2000; BELLINI WJ, 1985, J VIROL, V53, P908, DOI 10.1128/JVI.53.3.908-919.1985; Boxer EL, 2009, VIROLOGY, V385, P134, DOI 10.1016/j.virol.2008.11.022; BROWN CC, 1991, VET PATHOL, V28, P166, DOI 10.1177/030098589102800209; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; CATTANEO R, 1989, CELL, V56, P759, DOI 10.1016/0092-8674(89)90679-X; CAVALIERI RL, 1977, P NATL ACAD SCI USA, V74, P4415, DOI 10.1073/pnas.74.10.4415; Childs KS, 2009, J VIROL, V83, P1465, DOI 10.1128/JVI.01768-08; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Childs K, 2012, J VIROL, V86, P3411, DOI 10.1128/JVI.06405-11; Childs KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064202; Chinnakannan SK, 2014, J GEN VIROL, V95, P44, DOI 10.1099/vir.0.056739-0; Chinnakannan SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057063; Couacy-Hymann E, 2007, VET J, V173, P178, DOI 10.1016/j.tvjl.2005.08.020; Davis ME, 2014, CELL HOST MICROBE, V16, P19, DOI 10.1016/j.chom.2014.06.007; DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968; Devaux P, 2008, J VIROL, V82, P5359, DOI 10.1128/JVI.00169-08; Dhar P, 2002, VET MICROBIOL, V88, P153, DOI 10.1016/S0378-1135(02)00102-5; Diallo A, 1989, Rev Elev Med Vet Pays Trop, V42, P311; DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; DINTER H, 1987, EMBO J, V6, P599, DOI 10.1002/j.1460-2075.1987.tb04796.x; Escoffier C, 1999, J VIROL, V73, P1695, DOI 10.1128/JVI.73.2.1695-1698.1999; Finney D. J., 1964, STAT METHOD BIOL ASS, V2nd; Fontana JM, 2008, IMMUNOL REV, V225, P46, DOI 10.1111/j.1600-065X.2008.00669.x; GOODBOURN S, 1986, CELL, V45, P601, DOI 10.1016/0092-8674(86)90292-8; GOODBOURN S, 1985, CELL, V41, P509, DOI 10.1016/S0092-8674(85)80024-6; Goodbourn S, 2009, J INTERF CYTOK RES, V29, P539, DOI 10.1089/jir.2009.0071; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Hata N, 2001, BIOCHEM BIOPH RES CO, V285, P518, DOI 10.1006/bbrc.2001.5159; Hausmann S, 1999, J VIROL, V73, P5568, DOI 10.1128/JVI.73.7.5568-5576.1999; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Holzer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028594; Horikami SM, 1996, VIROLOGY, V222, P383, DOI 10.1006/viro.1996.0435; HU A, 1993, ARCH VIROL, V133, P201, DOI 10.1007/BF01309756; Hu QQ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-48; Ikegame S, 2010, J VIROL, V84, P372, DOI 10.1128/JVI.01690-09; Irie T, 2012, J VIROL, V86, P7136, DOI 10.1128/JVI.06705-11; Ito M, 2013, J VIROL, V87, P9633, DOI 10.1128/JVI.00714-13; Killip MJ, 2011, VIROLOGY, V415, P39, DOI 10.1016/j.virol.2011.03.027; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; KING P, 1992, NUCLEIC ACIDS RES, V20, P1039, DOI 10.1093/nar/20.5.1039; Komatsu T, 2004, VIROLOGY, V325, P137, DOI 10.1016/j.virol.2004.04.025; Kul O, 2007, VET PATHOL, V44, P479, DOI 10.1354/vp.44-4-479; Kumar P, 2004, J VET MED B, V51, P153, DOI 10.1111/j.1439-0450.2004.00747.x; Kwiatek O, 2011, EMERG INFECT DIS, V17, P1223, DOI 10.3201/eid1707.101216; Lasecka L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094656; MASSON N, 1992, MOL CELL BIOL, V12, P1096, DOI 10.1128/MCB.12.3.1096; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; MOSCA JD, 1986, MOL CELL BIOL, V6, P2279, DOI 10.1128/MCB.6.6.2279; Motz C, 2013, SCIENCE, V339, P690, DOI 10.1126/science.1230949; Nakatsu Y, 2008, J VIROL, V82, P8296, DOI 10.1128/JVI.00108-08; Nakatsu Y, 2006, J VIROL, V80, P11861, DOI 10.1128/JVI.00751-06; Nanda SK, 2006, J VIROL, V80, P7555, DOI 10.1128/JVI.02720-05; Nishie T, 2015, BIOCHEM BIOPH RES CO, V463, P1262, DOI 10.1016/j.bbrc.2015.06.099; Parisien JP, 2009, J VIROL, V83, P7252, DOI 10.1128/JVI.00153-09; Parks GD, 2013, J MOL BIOL, V425, P4872, DOI 10.1016/j.jmb.2013.09.015; Patterson JB, 2000, VIROLOGY, V267, P80, DOI 10.1006/viro.1999.0118; Pfaller CK, 2015, J VIROL, V89, P7735, DOI 10.1128/JVI.01017-15; Pfaller CK, 2014, J VIROL, V88, P456, DOI 10.1128/JVI.02572-13; Pfaller CK, 2008, J VIROL, V82, P12365, DOI 10.1128/JVI.01321-08; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Pope RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055830; Radecke F, 1996, VIROLOGY, V217, P418, DOI 10.1006/viro.1996.0134; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rodriguez KR, 2014, J VIROL, V88, P8180, DOI 10.1128/JVI.00737-14; Rodriguez KR, 2013, J VIROL, V87, P2974, DOI 10.1128/JVI.02843-12; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schneider H, 1997, VIROLOGY, V227, P314, DOI 10.1006/viro.1996.8339; Shaffer JA, 2003, VIROLOGY, V315, P389, DOI 10.1016/S0042-6822(03)00537-3; Shaila MS, 1996, VIRUS RES, V43, P149, DOI 10.1016/0168-1702(96)01312-3; Son KN, 2015, J VIROL, V89, P9383, DOI 10.1128/JVI.01299-15; Sparrer KMJ, 2012, J VIROL, V86, P796, DOI 10.1128/JVI.05899-11; SUGIYAMA M, 1989, J GEN VIROL, V70, P2605, DOI 10.1099/0022-1317-70-10-2605; Sweetman DA, 2001, VIROLOGY, V281, P193, DOI 10.1006/viro.2000.0805; Takeuchi K, 2005, J VIROL, V79, P7838, DOI 10.1128/JVI.79.12.7838-7844.2005; Takeuchi K, 2008, J VIROL, V82, P10102, DOI 10.1128/JVI.00599-08; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; Truong T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087145; Tober C, 1998, J VIROL, V72, P8124, DOI 10.1128/JVI.72.10.8124-8132.1998; Toth AM, 2009, J VIROL, V83, P961, DOI 10.1128/JVI.01669-08; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VIDAL S, 1990, EMBO J, V9, P2017, DOI 10.1002/j.1460-2075.1990.tb08330.x; Watanabe N, 1996, MED MICROBIOL IMMUN, V185, P89, DOI 10.1007/s004300050019; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Wemike K, 2014, VET MICROBIOL, V172, P140, DOI 10.1016/j.vetmic.2014.05.010; WHITTEMORE LA, 1990, P NATL ACAD SCI USA, V87, P7799, DOI 10.1073/pnas.87.20.7799; Yount JS, 2006, J IMMUNOL, V177, P4503, DOI 10.4049/jimmunol.177.7.4503; Zahur A, 2014, J BIOSCIENCES MED, V2, P8	96	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177300	10.1371/journal.pone.0177300	http://dx.doi.org/10.1371/journal.pone.0177300			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475628	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000400649500061
J	Chao, G; Tian, XN; Zhang, WT; Ou, XH; Cong, F; Song, T				Chao, Gao; Tian, Xiaoning; Zhang, Wentao; Ou, Xuehai; Cong, Fei; Song, Tao			Blocking Smad2 signalling with loganin attenuates SW10 cell cycle arrest induced by TNF-alpha	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; TRANSCRIPTION FACTORS; ACTIVATION; PROTEINS; DEATH; E2F; PROLIFERATION; EXPRESSION; PATHWAY	The activity of Schwann cells (SWCs) is very important in trauma-induced nerve repair, and tumour necrosis factor-alpha (TNF-alpha) produced during tissue injury inhibits the viability of SWCs, which delays the repair of peripheral nerves. Loganin is an iridoid glycoside that has been shown to alleviate a variety of cytotoxic effects. In the current study, we evaluated the potential efficacy and the mechanism of action of loganin in TNF-alpha induced cytotoxicity in SW10 cells. The experimental results indicated that loganin blocked TNF-alpha-mediated Smad2 activation, downregulated the expression of the G1 phase cell cycle inhibitor p15(IN4KB), and upregulated the expression of the G1 phase cell cycle activator cyclin D1CDK4/6, which upregulated E2F-1-dependent survivin expression and relieved TNF-ainduced apoptosis in SW10 cells. The protective effect of loganin on SWCs has potential medicinal value in the promotion of peripheral nerve repair and is significant for studies in the field of tissue regeneration.	[Chao, Gao; Tian, Xiaoning; Zhang, Wentao; Ou, Xuehai; Cong, Fei; Song, Tao] Xi An Jiao Tong Univ, Honghui Hosp, Coll Med, Dept Bone Microsurg, Xian, Peoples R China	Xi'an Jiaotong University	Song, T (corresponding author), Xi An Jiao Tong Univ, Honghui Hosp, Coll Med, Dept Bone Microsurg, Xian, Peoples R China.	st0325@163.com						Amrita Chatterjee, 2015, CANC LETT, V360, P134; Boyle K, 2005, NEUROBIOL DIS, V20, P412, DOI 10.1016/j.nbd.2005.03.022; Chen HS, 2015, INT J ONCOL, V46, P1730, DOI 10.3892/ijo.2015.2870; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Howard BA, 2000, J MAMMARY GLAND BIOL, V5, P119, DOI 10.1023/A:1026487120779; Hyeri Kim, 2015, Food & Function, V6, P1108, DOI 10.1039/C5FO00055F; Jessen KR, 2015, COLD SPRING HARBOR P, V7; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Kay S., 1973, PLASTIC RECONSTRUCTI, V105, P365; Kim MJ, 2015, EUR J PHARMACOL, V765, P541, DOI 10.1016/j.ejphar.2015.09.019; Kurimchak A, 2015, CELL CYCLE, V14, P18, DOI 10.4161/15384101.2014.985069; Li Y, 2016, INT IMMUNOPHARMACOL, V36, P173, DOI 10.1016/j.intimp.2016.04.026; Liu K, 2015, LIFE SCI, V123, P78, DOI 10.1016/j.lfs.2014.12.028; Llobet Navas D, 2014, MOL CELL BIOL, V34, P4216; Macias H, 1995, ADV DENT RES, P533; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mulleman D, 2006, JOINT BONE SPINE, V73, P270, DOI 10.1016/j.jbspin.2005.03.004; Park Kyung-Soon, 2011, Int J Stem Cells, V4, P18; Pollheimer J, 2005, PLACENTA, V26, pS21, DOI 10.1016/j.placenta.2004.11.013; Reed JC, 1999, NAT CELL BIOL, V1, pE199, DOI 10.1038/70227; Schafers M, 2002, J NEUROSCI, V22, P536, DOI 10.1523/JNEUROSCI.22-02-00536.2002; Takahashi Y, 2000, GENE DEV, V14, P804; Tseng YT, 2016, PHARMACOL RES, V111, P58, DOI 10.1016/j.phrs.2016.05.023; Wagner R, 1996, NEUROSCIENCE, V73, P625, DOI 10.1016/0306-4522(96)00127-3; Wajant H, TNFR1 INDUCED ACTIVA, V278, P862; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yao L, 2017, J CELL BIOCHEM, V118, P615, DOI 10.1002/jcb.25749; Zhao M, 2016, J CHROMATOGR B, V1009, P122, DOI 10.1016/j.jchromb.2015.12.020	31	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176965	10.1371/journal.pone.0176965	http://dx.doi.org/10.1371/journal.pone.0176965			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475649	gold, Green Published, Green Submitted			2022-12-27	WOS:000400649500032
J	Lee, SH; Yang, JH; Choi, SH; Park, TK; Jang, WJ; Song, YB; Hahn, JY; Choi, JH; Gwon, HC				Lee, Seung Hwa; Yang, Jeong Hoon; Choi, Seung-Hyuk; Park, Taek Kyu; Jang, Woo Jin; Song, Young Bin; Hahn, Joo-Yong; Choi, Jin-Ho; Gwon, Hyeon-Cheol			Duration of dual antiplatelet therapy in patients treated with percutaneous coronary intervention for coronary chronic total occlusion	PLOS ONE			English	Article							ELUTING STENT IMPLANTATION; ELDERLY-PATIENTS; OUTCOMES; REVASCULARIZATION; RECANALIZATION; METAANALYSIS; EFFICACY	Background The duration of dual antiplatelet therapy (DAPT) after drug-eluting stent implantation in coronary chronic total occlusion (CTO) remains unclear. Methods We retrospectively analyzed a total of 512 patients treated with percutaneous coronary intervention (PCI) in the Samsung Medical Center CTO registry. Patients were separated into <= 12-month (199, 38.9%) vs. > 12 month (313, 61.1%) based on DAPT duration with aspirin and clopidogrel. The primary outcome was major adverse cardiac and cerebrovascular event (MACCE) during follow-up. Results Median follow-up duration was 67 (interquartile range: 51-84) months. MACCE occurred in 43 patients (21.6%) in the <= 12-month and 55 patients (17.6%) in the > 12-month groups. In the propensity-matched population, the rate of MACCE did not differ significantly between the <= 12-month and > 12-month group (19.4% vs. 18.8%; hazard ratio [HR], 0.95; 95% confidential interval [CI], 0.52-1.76, p = 0.88). Moreover, moderate or severe bleeding according to BARC criteria (type 2, 3 or 5) was also similar between the <= 12-month and > 12month group (2.5% vs. 1.9%; HR, 1.00; 95% CI, 0.20-4.96, p = 0.99). Conclusion Among patients treated with PCI for CTO, DAPT with durations of <= 12-month showed similar long-term clinical outcomes compared to > 12-month DAPT.	[Lee, Seung Hwa; Yang, Jeong Hoon; Choi, Seung-Hyuk; Park, Taek Kyu; Song, Young Bin; Hahn, Joo-Yong; Choi, Jin-Ho; Gwon, Hyeon-Cheol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Stroke & Vasc Inst, Seoul, South Korea; [Jang, Woo Jin] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Cardiol,Dept Med, Chang Won, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Choi, SH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Stroke & Vasc Inst, Seoul, South Korea.	sh1214.choi@samsung.com	Hahn, Joo-Yong/AAU-7250-2020	Hahn, Joo-Yong/0000-0002-4412-377X; Lee, Seung Hwa/0000-0001-5508-7519				Abo-salem E, 2015, CARDIOVASC THER, V33, P253, DOI 10.1111/1755-5922.12137; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Costa F, 2015, EUR HEART J, V36, P1242, DOI 10.1093/eurheartj/ehv038; Fefer P, 2012, J AM COLL CARDIOL, V59, P991, DOI 10.1016/j.jacc.2011.12.007; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Galassi AR, 2011, J INTERV CARDIOL, V24, P426, DOI 10.1111/j.1540-8183.2011.00648.x; Gilard M, 2015, J AM COLL CARDIOL, V65, P2222, DOI 10.1016/j.jacc.2015.03.541; Giustino G, 2016, J AM COLL CARDIOL, V68, P1851, DOI 10.1016/j.jacc.2016.07.760; Giustino G, 2015, J AM COLL CARDIOL, V65, P1298, DOI 10.1016/j.jacc.2015.01.039; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Iannaccone M, 2016, EUR HEART J-CARD IMG, V17, P1128, DOI 10.1093/ehjci/jev283; Ikegami Y, 2015, CIRC J, V79, P2598, DOI 10.1253/circj.CJ-15-0484; Lee CW, 2014, CIRCULATION, V129, P304, DOI 10.1161/CIRCULATIONAHA.113.003303; Lee KH, 2011, J AM COLL CARDIOL, V58, P1664, DOI 10.1016/j.jacc.2011.05.057; Lee SH, 2015, CIRC J, V79, P1780, DOI 10.1253/circj.CJ-15-0041; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Patel MR, 2012, JACC-CARDIOVASC INTE, V5, P1054, DOI 10.1016/j.jcin.2012.05.017; Reifart N, 2010, EUROINTERVENTION, V6, P356, DOI 10.4244/EIJV6I3A59; Schulz-Schupke S, 2015, EUR HEART J, V36, P1252, DOI 10.1093/eurheartj/ehu523; Stone GW, 2005, CIRCULATION, V112, P2364, DOI 10.1161/CIRCULATIONAHA.104.481283; Tamburino C, 2013, AM HEART J, V165, P133, DOI 10.1016/j.ahj.2012.10.017; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]; Yeh RW, 2015, J AM COLL CARDIOL, V65, P2211, DOI 10.1016/j.jacc.2015.03.003	26	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176737	10.1371/journal.pone.0176737	http://dx.doi.org/10.1371/journal.pone.0176737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475584	Green Published, Green Submitted, gold			2022-12-27	WOS:000400649500013
J	Ma, LX; Saiyin, H				Ma, Lixiang; Saiyin, Hexige			LSL-Kras(G12D); LSL-Trp53(R172H/+); Ink4 (flox/+); Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer	PLOS ONE			English	Article							ENGINEERED MOUSE MODELS; ONCOGENIC K-RAS; DUCTAL ADENOCARCINOMA; MUTANT P53; MESENCHYMAL TRANSITION; CELLS; PROGRESSION; CHEMORESISTANCE; KRAS(G12D); COOPERATE	Pancreatic cancer (PC) accumulates multiple genetic mutations, including activating KRAS mutations and inactivating TP53, SMAD4 and CDKN2A mutations, during progression. The combination of mutant KRAS with a single inactivating TP53, SMAD4 or CDKN2A mutation in genetically engineered mouse models (GEMMs) showed that these mutations exert different synergistic effects in PC. However, the effect of the combination of TP53, CDKN2A and KRAS mutations on the trajectory of PC progression is unknown. Here, we report a GEMM that harbors KRAS (Kras(G12D)), TP53 (Trp53(R172H/+)), CDKN2A (Ink4(flox/+)) and Ptf1/ p48-Cre (KPIC) mutations. Histopathology showed that KPIC mice developed adenocarcinoma that strongly resembled the pathology of human PC, characterized by rich desmoplastic stroma and low microvascularity. The median survival of KPIC mice was longer than that of LSL-Kras(G12D); Ink4(flox/flox); Ptf1/p48-Cre mice (KIC) (89 vs 62 days) and shorter than that of KRAS (Kras(G12D)), TP53 (Trp53(R172H/+)) and Ptf1/p48-Cre (KPC) mice. Moreover, the neoplastic cells of KPIC mice were epithelial, highly proliferative tumor cells that exhibited ERK and MAPK pathway activation and high glucose uptake. Isolated neoplastic cells from spontaneous KPIC tumors showed all molecular profiles and cellular behaviors of spontaneous KPIC tumors, including epithelial-mesenchymal transition (EMT) under drug stress as well as tumorigenic, metastatic and invasive abilities in immunocompetent mice. Furthermore, orthotopic and metastatic tumors of KPIC cells almost recapitulated the pathology of spontaneous KPIC tumors. These data show that in addition to spontaneous KPIC tumors, KPIC cells are a valuable tool for preclinical studies of locally invasive and metastatic PC.	[Ma, Lixiang] Shanghai Med Coll, Dept Anat Histol & Embryol, Shanghai, Peoples R China; [Saiyin, Hexige] Fudan Univ, Sch Life Sci, Shanghai, Peoples R China	Fudan University	Saiyin, H (corresponding author), Fudan Univ, Sch Life Sci, Shanghai, Peoples R China.	saiyin@fudan.edu.cn		ma, lixiang/0000-0001-9399-155X; Saiyin, Hexige/0000-0003-2993-6817				Acin S, 2011, J PATHOL, V225, P479, DOI 10.1002/path.2971; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Alexandrova EM, 2015, NATURE, V523, P352, DOI 10.1038/nature14430; Bang S, 2006, J CLIN GASTROENTEROL, V40, P923, DOI 10.1097/01.mcg.0000225672.68852.05; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Cowan RW, 2014, CANCER J, V20, P80, DOI 10.1097/PPO.0000000000000011; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Fiorini C, 2015, BBA-MOL CELL RES, V1853, P89, DOI 10.1016/j.bbamcr.2014.10.003; Fitzgerald Timothy L., 2015, Advances in Biological Regulation, V59, P65, DOI 10.1016/j.jbior.2015.06.003; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Hwang CI, 2016, J PATHOL, V238, P197, DOI 10.1002/path.4651; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jacobetz MA, 2013, GUT, V62, P112, DOI 10.1136/gutjnl-2012-302529; Kajiyama H, 2007, INT J ONCOL, V31, P277; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kim JJ, 2013, J CELL BIOCHEM, V114, P1286, DOI 10.1002/jcb.24464; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Majumder K, 2015, J GASTROINTEST SURG; Majumder K, 2016, J GASTROINTEST SURG, V20, P53, DOI 10.1007/s11605-015-2985-y; Miura Fumihiko, 2006, HPB (Oxford), V8, P337, DOI 10.1080/13651820500540949; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Rozenblum E, 1997, CANCER RES, V57, P1731; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Saiyin H, 2015, J PATHOL, V236, P142, DOI 10.1002/path.4506; Sangwan V, 2015, PANCREAS, V44, P583, DOI 10.1097/MPA.0000000000000317; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sheikhbahaei S, 2016, NUCL MED COMMUN, V37, P231, DOI 10.1097/MNM.0000000000000436; Shetzer Y., 2016, COLD SPRING HARB PER; Shroff S, 2014, HUM PATHOL, V45, P456, DOI 10.1016/j.humpath.2013.10.008; Torres MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080580; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Westphalen CB, 2012, CANCER J, V18, P502, DOI 10.1097/PPO.0b013e31827ab4c4; Ying HQ, 2016, GENE DEV, V30, P355, DOI 10.1101/gad.275776.115; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	43	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176844	10.1371/journal.pone.0176844	http://dx.doi.org/10.1371/journal.pone.0176844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475592	Green Submitted, Green Published, gold			2022-12-27	WOS:000400649500017
J	Restivo, MR; McKinnon, MC; Frey, BN; Hall, GB; Syed, W; Taylor, VH				Restivo, Maria R.; McKinnon, Margaret C.; Frey, Benicio N.; Hall, Geoffrey B.; Syed, Wasimuddin; Taylor, Valerie H.			The impact of obesity on neuropsychological functioning in adults with and without major depressive disorder	PLOS ONE			English	Article							COGNITIVE FUNCTION; EXECUTIVE DYSFUNCTION; BIPOLAR DISORDER; ASSOCIATION; METAANALYSIS; QUESTIONNAIRE; HYPERTENSION; HEALTH; MEMORY; MANIA	Background Evidence suggests obesity exerts a negative impact on cognition. Major Depressive Disorder (MDD) is also linked to problems in cognitive functioning. Obesity is highly prevalent in individuals with MDD and is linked to a failure to return to a full level of functioning. The study's objective was to investigate the effect of obesity on cognitive impairment in participants with MDD. Methods This study compared cognitive performance in obese individuals with MDD and two control populations (obese individuals without a psychiatric illness and non-obese controls). A standardized battery of neuropsychological tests specifically designed to assess performance in declarative memory, executive functioning, processing speed and attention was administered. Mood ratings, physical measurements, nutritional and health questionnaires were also completed. Results We observed a consistent pattern across measures of memory, executive functioning, attention and processing speed. Whereas healthy controls performed better than both bariatric groups across the majority of measures administered, bariatric controls tended to outperform bariatric MDD patients. Limitations The overall sample size of our study was small and thus largely explorative in nature. However, it provides compelling results (while controlling for extraneous variables such as medication load, nutritional status and common metabolic comordidities) that strongly urges for further investigation and study replication with larger sample sizes. Conclusions We found obesity has a subtle impact on cognition in obese individuals, and when obesity is present in individuals with MDD, this impact may be significant. It is important to minimize all modifiable variables that can add to cognitive burden in this population.	[Restivo, Maria R.; Taylor, Valerie H.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [McKinnon, Margaret C.; Frey, Benicio N.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [McKinnon, Margaret C.; Frey, Benicio N.] St Josephs Healthcare Hamilton, Mood Disorders Program, Hamilton, ON, Canada; [McKinnon, Margaret C.; Frey, Benicio N.] St Josephs Healthcare Hamilton, Womens Hlth Concerns Clin, Hamilton, ON, Canada; [Hall, Geoffrey B.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada; [Syed, Wasimuddin] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada; [Taylor, Valerie H.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; University of Toronto	Restivo, MR (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada.	maria.restivo@wchospital.ca	McKinnon, Margaret/AAT-5821-2021; Frey, Benicio/AAJ-8212-2021	McKinnon, Margaret/0000-0002-8315-7657; /0000-0002-3398-6692; Taylor, Valerie/0000-0002-8948-638X; Frey, Benicio N./0000-0001-8267-943X	Bristol Myers Squibb; Canadian Institute of Health Research; Government of Ontario	Bristol Myers Squibb(Bristol-Myers Squibb); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Government of Ontario	Dr .Valerie Taylor received an unrestricted educational grant from Bristol Myers Squibb to help fund this study. They had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MR has been supported by fellowships from the Canadian Institute of Health Research and Government of Ontario.	Alonso-Alonso M, 2007, JAMA-J AM MED ASSOC, V297, P1819, DOI 10.1001/jama.297.16.1819; Alosco ML, 2014, AM J SURG, V207, P870, DOI 10.1016/j.amjsurg.2013.05.018; Altman EG, 1997, BIOL PSYCHIAT, V42, P948, DOI 10.1016/S0006-3223(96)00548-3; Anvari M SA, 2015, REGISTRY DATA PRODUC; Barrett-Connor E, 2013, CARDIOLOGY, V125, P94; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benito-Leon J, 2013, EUR J NEUROL, V20, P899, DOI 10.1111/ene.12083; Benton AL, 1983, MULTILINGUAL APHASIA; Berstein D.P, 1998, CHILDHOOD TRAUMA QUE; Birt Julie, 2003, Ann Clin Psychiatry, V15, P49, DOI 10.1023/A:1023280610379; Boeka AG, 2008, ARCH CLIN NEUROPSYCH, V23, P467, DOI 10.1016/j.acn.2008.03.003; Bora E, 2013, PSYCHOL MED, V43, P2017, DOI 10.1017/S0033291712002085; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Chung F, 2008, ANESTHESIOLOGY, V108, P822, DOI 10.1097/ALN.0b013e31816d91b5; Cook R, 2013, OBESITY FACTS, V6, P173; Costa E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/871656; Delis DC., 2000, CALIFORNIA VERBAL LE; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; First M. B, 2007, SCID I P; Golden J.C., 1978, STROOP COLOR WORD TE; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Harvey PO, 2004, J PSYCHIATR RES, V38, P567, DOI 10.1016/j.jpsychires.2004.03.003; Hassel S, 2008, BIPOLAR DISORD, V10, P916, DOI 10.1111/j.1399-5618.2008.00641.x; Hasselbalch BJ, 2011, J AFFECT DISORDERS, V134, P20, DOI 10.1016/j.jad.2010.11.011; Heaton EK, 1993, WISCONSIN CARD SORTI; Hedlund J.L., 1979, J OPER PSYCHIATR, V10, P149, DOI DOI 10.1192/BJP.BP.106.032532; Janssen I, 2013, CAN J DIABETES, V37, P90, DOI 10.1016/j.jcjd.2013.02.059; Jean MDK, 2014, DIABETES, V63, pA212; Lee RSC, 2012, J AFFECT DISORDERS, V140, P113, DOI 10.1016/j.jad.2011.10.023; Liang J, 2014, INT J OBESITY, V38, P494, DOI 10.1038/ijo.2013.142; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; McIntyre RS, 2011, J AFFECT DISORDERS, V128, pS29, DOI 10.1016/S0165-0327(11)70006-4; McIntyre RS, 2006, CAN J PSYCHIAT, V51, P274, DOI 10.1177/070674370605100502; McLennan SN, 2010, INT J GERIATR PSYCH, V25, P933, DOI 10.1002/gps.2431; Oliveira de Lima Queiroz L, 2013, 21 WORLD C NEUR VIEN, pe537; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Reitan RM, 1985, HALSTEAD REITAN NEUR; Restivo MR, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009347; Restivo MR, 2014, BIOL PSYCHIAT, V75, p55S; Rock PL, 2014, PSYCHOL MED, V44, P2029, DOI 10.1017/S0033291713002535; Sackeim Harold A., 2001, Journal of Clinical Psychiatry, V62, P10; Schoedel KA, 2012, J CLIN PSYCHOPHARM, V32, P492, DOI 10.1097/JCP.0b013e31825d380d; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Simon GE, 2008, GEN HOSP PSYCHIAT, V30, P32, DOI 10.1016/j.genhosppsych.2007.09.001; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Snyder HR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00328; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Spitznagel MB, 2013, SURG OBES RELAT DIS, V9, P765, DOI 10.1016/j.soard.2013.04.011; Talarowska M, 2010, ADV MED SCI-POLAND, V55, P317, DOI 10.2478/v10039-010-0053-0; Trivedi MH, J AFFECTIVE DISORDER, V152-154, P19; van den Berg E, 2009, BBA-MOL BASIS DIS, V1792, P470, DOI 10.1016/j.bbadis.2008.09.004; Wagner S, 2012, ACTA PSYCHIAT SCAND, V125, P281, DOI 10.1111/j.1600-0447.2011.01762.x; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Willett WC, 2002, AM J MED, V113, P47, DOI 10.1016/S0002-9343(01)00992-5; World Health Organization, 2008, WHO STEPWISE APPR SU; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	60	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176898	10.1371/journal.pone.0176898	http://dx.doi.org/10.1371/journal.pone.0176898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475603	Green Published, gold, Green Submitted			2022-12-27	WOS:000400649500025
J	Chang, PA; Heier, C; Qin, WZ; Han, LP; Huang, FF; Sun, Q				Chang, Ping'an; Heier, Christoph; Qin, Wenzhen; Han, Liping; Huang, Feifei; Sun, Quan			Molecular identification of transmembrane protein 68 as an endoplasmic reticulum-anchored and brain-specific protein	PLOS ONE			English	Article							ACYL-COA; TRIACYLGLYCEROL SYNTHESIS; ACYLTRANSFERASE; DOMAIN; ENZYMES; ACID; LOCALIZATION; DIVERSITY; MUTANT; SIGNAL	Acyltransferases catalyze essential reactions in the buildup and remodeling of glycerophospholipids and contribute to the maintenance and diversity of cellular membranes. Transmembrane protein 68 (TMEM68) is an evolutionarily conserved protein of unknown function, that forms a distinct subgroup within the glycerophospholipid acyltransferase family. In the current study we expressed murine TMEM68 for the first time in mammalian cells to characterize its subcellular localization, topology, and possible biological function(s). We show that TMEM68 is an integral membrane protein and orients both, the N- and C-terminus towards the cytosol. Live cell imaging demonstrated that TMEM68 is localized mainly at the endoplasmic reticulum (ER), but not at cellular lipid droplets (LDs). The positioning of TMEM68 at the ER was dependent on its first transmembrane domain (TMD), which by itself was sufficient to target cytosolic green fluorescence protein (GFP) to the ER. In contrast, a second TMD was dispensable for ER localization of TMEM68. Finally, we found that among multiple murine tissues the expression level of TMEM68 transcripts was highest in brain. We conclude that TMEM68 is an integral ER membrane protein and a putative acyltransferase involved in brain glycerolipid metabolism.	[Chang, Ping'an; Qin, Wenzhen; Han, Liping; Huang, Feifei; Sun, Quan] Chongqing Univ Posts & Telecommun, Sch Bioinformat, Key Lab Mol Biol, Chongqing, Peoples R China; [Heier, Christoph] Karl Franzens Univ Graz, Inst Mol Biosci, Heinrichstr 31-11, Graz, Austria	Chongqing University of Posts & Telecommunications; University of Graz	Chang, PA (corresponding author), Chongqing Univ Posts & Telecommun, Sch Bioinformat, Key Lab Mol Biol, Chongqing, Peoples R China.	changpa@cqupt.edu.cn		Heier, Christoph/0000-0001-6858-408X	Natural Science Foundation Project of CQ CSTC [2014jcyjA10033, cstc2016jcyjA0572]; Science and Technology Project from Chongqing Municipal Education Committee [KJ1400424]	Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Science and Technology Project from Chongqing Municipal Education Committee	This researching work is supported both by the Natural Science Foundation Project of CQ CSTC (2014jcyjA10033, cstc2016jcyjA0572) and by the Science and Technology Project from Chongqing Municipal Education Committee (KJ1400424). The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao JS, 2008, J BIOL CHEM, V283, P19049, DOI 10.1074/jbc.M800364200; Chang PA, 2013, MOL BIOL REP, V40, P5597, DOI 10.1007/s11033-013-2661-9; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Eto M, 2014, BIOCHEM BIOPH RES CO, V443, P718, DOI 10.1016/j.bbrc.2013.12.043; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gimeno RE, 2008, J LIPID RES, V49, P2079, DOI 10.1194/jlr.R800013-JLR200; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; Honsho M, 1998, J BIOL CHEM, V273, P20860, DOI 10.1074/jbc.273.33.20860; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Kory N, 2016, TRENDS CELL BIOL, V26, P535, DOI 10.1016/j.tcb.2016.02.007; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424; Shan DD, 2010, J LIPID RES, V51, P1971, DOI 10.1194/jlr.M006304; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2013, J BIOCHEM, V154, P21, DOI 10.1093/jb/mvt048; Shindou H, 2009, BIOCHEM BIOPH RES CO, V383, P320, DOI 10.1016/j.bbrc.2009.04.013; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Yamashita Atsushi, 2014, Biology (Basel), V3, P801, DOI 10.3390/biology3040801; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970	27	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176980	10.1371/journal.pone.0176980	http://dx.doi.org/10.1371/journal.pone.0176980			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472192	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500108
J	Edelman, EJ; So-Armah, K; Cheng, DM; Doyley, MF; Coleman, SM; Bridden, C; Gnatienko, N; Lioznov, DA; Blokhina, E; Freiberg, MS; Krupitsky, EM; Emu, B; Samet, JH				Edelman, E. Jennifer; So-Armah, Kaku; Cheng, Debbie M.; Doyley, Margaret F.; Coleman, Sharon M.; Bridden, Carly; Gnatienko, Natalia; Lioznov, Dmitry A.; Blokhina, Elena; Freiberg, Matthew S.; Krupitsky, Evgeny M.; Emu, Brinda; Samet, Jeffrey H.			Impact of illicit opioid use on T cell subsets among HIV-infected adults	PLOS ONE			English	Article							DRUG-USE; REPLICATIVE SENESCENCE; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; LENINGRAD REGION; FAGERSTROM TEST; HEROIN-ADDICTS; ST-PETERSBURG; IMMUNOSENESCENCE; WITHDRAWAL	Objectives Opioids have immunosuppressive properties, yet opioid effects on T cell abnormalities consistent with the immune risk phenotype among HIV-infected individuals are understudied. Methods To assess associations between illicit opioid use and T cell characteristics (CD4/CD8 ratio, memory profiles based on CD45RO and CD28 expression, and senescence based on CD57 expression), we conducted an exploratory cross-sectional analysis of Russia ARCH, a cohort of antiretroviral therapy (ART)-naive HIV-infected individuals recruited 11/2012 to 10/2014 in St. Petersburg, Russia. The main independent variable was past 30 day illicit opioid use (yes vs. no). Secondary analyses evaluated none (0 days), intermittent (1 to 7 days), and persistent (8 to 30 days) opioid use. Outcomes were determined with flow cytometry. Analyses were conducted using linear regression models. Results Among 186 participants, 38% reported any illicit opioid use (18% intermittent and 20% persistent). Any illicit opioid use was not significantly associated with T cell characteristics. Intermittent opioid use appeared to be associated with decreased memory CD8+ T cells proportion (CD45RO+ CD45RA-CD8+T cells: adjusted mean difference [AMD] [95% CI] = -6.15 [-11.50, -0.79], p = 0.02) and borderline significant increased senescent T cells (% CD57+ of total CD28-CD8+ T cells (AMD [95% CI] = 7.70 [-0.06, 15.46], p = 0.05). Conclusions Among ART-naive HIV-infected Russians, any illicit opioid use was not significantly associated with T cell abnormalities although intermittent illicit opioid use may be associated with CD8 T cell abnormalities. Longitudinal studies are warranted to confirm these findings given increased risk of infections and comorbidities seen among HIV-infected individuals with illicit opioid use.	[Edelman, E. Jennifer] Yale Univ, Sch Med, Dept Med, Gen Internal Med Sect, New Haven, CT 06520 USA; [Edelman, E. Jennifer] Yale Univ, Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA; [So-Armah, Kaku] Boston Med Ctr, Dept Med, Gen Internal Med Sect, Clin Addict Res & Educ Unit, Boston, MA USA; [Cheng, Debbie M.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Doyley, Margaret F.] Univ Vermont, Dept Pathol, Colchester, VT USA; [Doyley, Margaret F.] Univ Vermont, Lab Med, Colchester, VT USA; [Coleman, Sharon M.] Boston Univ, Data Coordinating Ctr, Sch Publ Hlth, Boston, MA 02215 USA; [Lioznov, Dmitry A.; Blokhina, Elena; Krupitsky, Evgeny M.] First Pavlov State Med Univ St Petersburg, St Petersburg, Russia; [Freiberg, Matthew S.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Freiberg, Matthew S.] Nashville Vet Affairs Med Ctr, Nashville, TN USA; [Krupitsky, Evgeny M.] St Petersburg Bekhterev Res Psychoneurol Inst, St Petersburg, Russia; [Emu, Brinda] Yale Univ, Dept Med, Sch Med, Sect Infect Dis, New Haven, CT 06520 USA; [Samet, Jeffrey H.] Boston Univ, Boston Med Ctr, Sch Med, Dept Med,Sect Gen Internal Med,Clin Addict Res &, Boston, MA 02215 USA; [Samet, Jeffrey H.] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA 02215 USA	Yale University; Yale University; Boston Medical Center; Boston University; University of Vermont; University of Vermont; Boston University; Pavlov First Saint Petersburg State Medical University; Vanderbilt University; V.M. Bekhterev National Research Medical Center Psychiatry & Neurology; Yale University; Boston Medical Center; Boston University; Boston University	Edelman, EJ (corresponding author), Yale Univ, Sch Med, Dept Med, Gen Internal Med Sect, New Haven, CT 06520 USA.; Edelman, EJ (corresponding author), Yale Univ, Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA.	ejennifer.edelman@yale.edu	Blokhina, Elena A/V-6040-2018; Lioznov, Dmitry/J-2539-2013; Krupitsky, Evgeny/M-5935-2016	Blokhina, Elena A/0000-0001-5811-9897; Lioznov, Dmitry/0000-0003-3643-7354; Krupitsky, Evgeny/0000-0002-0529-4525; Samet, Jeffrey/0000-0002-0897-3400; Doyle, Margaret/0000-0001-6769-5386; So-Armah, Kaku/0000-0003-1505-6384	National Institute on Alcohol Abuse and Alcoholism (NIAAA) [U01AA020780, U24AA020779, U24AA020778, U01AA020780-02S1, U01AA021989]; National Institute on Drug Abuse (NIDA) [R25DA013582]; Yale-Drug Abuse, Addiction and HIV Research Scholars Program (Yale-DAHRS) [NIDA K12DA033312]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA020779, U24AA020778, U01AA020780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K12DA033312] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Yale-Drug Abuse, Addiction and HIV Research Scholars Program (Yale-DAHRS); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported by grants from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (U01AA020780, U24AA020779, U24AA020778, U01AA020780-02S1, and U01AA021989) and National Institute on Drug Abuse (NIDA) (R25DA013582). EJ Edelman was supported during the conduct of this work by a career development award through the Yale-Drug Abuse, Addiction and HIV Research Scholars Program (Yale-DAHRS, NIDA K12DA033312). The funding source had no role in the study design, the data collection, analysis and interpretation of the data; in the writing of this manuscript or decision to submit this article for publication.	Barrett L, 2014, AIDS, V28, P2045, DOI 10.1097/QAD.0000000000000405; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Cherny NI, 2010, ANN ONCOL, V21, P615, DOI 10.1093/annonc/mdp581; Chisenga CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129928; Chishinga N, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-75; Cofrancesco J, 2008, AIDS, V22, P357, DOI 10.1097/QAD.0b013e3282f3cc21; Cornwell WD, 2013, J NEUROIMMUNOL, V265, P43, DOI 10.1016/j.jneuroim.2013.09.013; D'Abramo A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/192594; de Meneses-Gaya IC, 2009, J BRAS PNEUMOL, V35, P73, DOI 10.1590/S1806-37132009000100011; Dock JN, 2011, AGING DIS, V2, P382; Dowling-Guyer SJ M, 1994, ASSESSMENT, V1, P1383; Edelman EJ, 2014, AIDS BEHAV; Eisenstein TK, 2006, J NEUROIMMUNE PHARM, V1, P237, DOI 10.1007/s11481-006-9019-1; Emu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085613; Govitrapong P, 1998, J PHARMACOL EXP THER, V286, P883; Hao L, 2007, QUANTILE REGRESSION; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Henson SM, 2012, CURR OPIN IMMUNOL, V24, P476, DOI 10.1016/j.coi.2012.04.001; Kapadia F, 2005, CLIN INFECT DIS, V41, P1027, DOI 10.1086/433175; Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626; Khademi H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2502; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Krupitsky E, 2004, HIV MED, V5, P30, DOI 10.1111/j.1468-1293.2004.00182.x; Krupitsky EM, 2006, EUR ADDICT RES, V12, P12, DOI 10.1159/000088578; Lee SA, 2014, J INFECT DIS, V210, P374, DOI 10.1093/infdis/jiu109; Lee SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089444; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Li L, 2013, J INTERN MED, V273, P511, DOI 10.1111/joim.12035; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Lucas GM, 2006, AM J EPIDEMIOL, V163, P412, DOI 10.1093/aje/kwj059; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Moorman J, 2009, BBA-MOL CELL RES, V1793, P1366, DOI 10.1016/j.bbamcr.2009.05.007; Mudd JC, 2014, CURR OPIN HIV AIDS, V9, P500, DOI 10.1097/COH.0000000000000086; NEEDLE R, 1995, PSYCHOL ADDICT BEHAV, V9, P242, DOI 10.1037/0893-164X.9.4.242; NOVICK DM, 1989, J PHARMACOL EXP THER, V250, P606; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Riss GL, 2012, BRAIN BEHAV IMMUN, V26, P972, DOI 10.1016/j.bbi.2012.05.008; Roy S, 2011, J NEUROIMMUNE PHARM; Sacerdote P, 2008, BRAIN BEHAV IMMUN, V22, P606, DOI 10.1016/j.bbi.2007.12.013; Sacerdote Paola, 2008, Curr Opin Support Palliat Care, V2, P14, DOI 10.1097/SPC.0b013e3282f5272e; Samet JH, 2007, PANMINERVA MED, V49, P67; Serrano-Villar S, 2014, HIV MED, V15, P40, DOI 10.1111/hiv.12081; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Sobell L.C., 1996, ALCOHOL TIMELINE FOL; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391; Strioga M, 2011, IMMUNOLOGY, V134, P17, DOI 10.1111/j.1365-2567.2011.03470.x; Suzuki S, 2003, BIOCHEM BIOPH RES CO, V308, P802, DOI 10.1016/S0006-291X(03)01472-4; Tassiopoulos K, 2012, J INFECT DIS, V205, P1730, DOI 10.1093/infdis/jis260; Tsoukas C, 2014, CURR OPIN HIV AIDS, V9, P398, DOI 10.1097/COH.0000000000000077; Unemori P, 2013, AIDS, V27, P1735, DOI 10.1097/QAD.0b013e3283601144; WEATHERBY NL, 1994, EVAL PROGRAM PLANN, V17, P347, DOI 10.1016/0149-7189(94)90035-3; Weed MR, 2006, J NEUROIMMUNE PHARM, V1, P250, DOI 10.1007/s11481-006-9029-z; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Zhang EY, 2011, BRIT J PHARMACOL, V164, P1829, DOI 10.1111/j.1476-5381.2011.01475.x	54	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176617	10.1371/journal.pone.0176617	http://dx.doi.org/10.1371/journal.pone.0176617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472064	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500059
J	Gebremedhin, D; Zhang, DX; Weihrauch, D; Uche, NN; Harder, DR				Gebremedhin, Debebe; Zhang, David X.; Weihrauch, Dorothee; Uche, Nnamdi N.; Harder, David R.			Detection of TRPV4 channel current-like activity in Fawn Hooded hypertensive (FHH) rat cerebral arterial muscle cells	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; RECEPTOR POTENTIAL CHANNELS; SMOOTH-MUSCLE; MEMBRANE STRETCH; CA2+ CHANNELS; BLOOD-FLOW; ACTIVATION; VASOCONSTRICTION; CHANNELOPATHIES; AUTOREGULATION	The transient receptor potential vallinoid type 4 (TRPV4) is a calcium entry channel known to modulate vascular function by mediating endothelium-dependent vasodilation. The present study investigated if isolated cerebral arterial myocytes of the Fawn Hooded hypertensive (FHH) rat, known to display exaggerated K-Ca channel current activity and impaired myogenic tone, express TRPV4 channels at the transcript and protein level and exhibit TRPV4-like single-channel cationic current activity. Reverse transcription polymerase chain reaction (RT-PCR), Western blot, and immunostaining analysis detected the expression of mRNA transcript and translated protein of TRPV4 channel in FHH rat cerebral arterial myocytes. Patch clamp recording of single-channel current activity identified the presence of a single-channel cationic current with unitary conductance of similar to 85 pS and similar to 96 pS at hyper-polarizing and depolarizing potentials, respectively, that was inhibited by the TRPV4 channel antagonist RN 1734 or HC 067074 and activated by the potent TRPV4 channel agonist GSK1016790A. Application of negative pressure via the interior of the patch pipette increased the NPo of the TRPV4-like single-channel cationic current recorded in cell-attached patches at a patch potential of 60 mV that was inhibited by prior application of the TRPV4 channel antagonist RN 1734 or HC 067047. Treatment with the TRPV4 channel agonist GSK1016790A caused concentration-dependent increase in the NPo of KCa single-channel current recorded in cell-attached patches of cerebral arterial myocytes at a patch potential of 40 mV, which was not influenced by pretreatment with the voltage-gated L-type Ca2+ channel blocker nifedipine or the T-type Ca2+ channel blocker Ni2+. These findings demonstrate that FHH rat cerebral arterial myocytes express mRNA transcript and translated protein for TRPV4 channel and display TRPV4-like single-channel cationic current activity that was stretch-sensitive and activation of which increased the open state probability of KCa single-channel current in these arterial myocytes.	[Gebremedhin, Debebe; Uche, Nnamdi N.; Harder, David R.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Gebremedhin, Debebe; Zhang, David X.; Harder, David R.] Med Coll Wisconsin, Cardiovasc Res Ctr, Milwaukee, WI 53226 USA; [Zhang, David X.] Med Coll Wisconsin, Milwaukee, WI USA; [Zhang, David X.] Dept Med, Milwaukee, WI USA; [Weihrauch, Dorothee] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI USA; [Harder, David R.] Clement Zablocki VA Med Ctr, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Gebremedhin, D (corresponding author), Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA.; Gebremedhin, D (corresponding author), Med Coll Wisconsin, Cardiovasc Res Ctr, Milwaukee, WI 53226 USA.	dgebreme@mcw.edu			National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) [R01 HL033833, R01 HL092105, R01 HL105997]; VA Research Career Scientist Award from Clement Zablocki VA Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096647, R01HL033833] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); VA Research Career Scientist Award from Clement Zablocki VA Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) Grants R01 HL033833, R01 HL092105, R01 HL105997 and by the VA Research Career Scientist Award from the Clement Zablocki VA Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JZ, 2010, NEUROTOXICOLOGY, V31, P204, DOI 10.1016/j.neuro.2010.01.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brayden JE, 2008, CLIN EXP PHARMACOL P, V35, P1116, DOI 10.1111/j.1440-1681.2007.04855.x; Butenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039959; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Clapp LH, 2003, CIRC RES, V93, P893, DOI 10.1161/01.RES.0000103309.55054.3E; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Earley S, 2015, PHYSIOL REV, V95, P645, DOI 10.1152/physrev.00026.2014; Everaerts W, 2010, AM J PHYSIOL-RENAL, V298, pF692, DOI 10.1152/ajprenal.00599.2009; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Fan F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112878; Gao F, 2010, J HYPERTENS, V28, P102, DOI 10.1097/HJH.0b013e328332b865; Gasull X, 2003, INVEST OPHTH VIS SCI, V44, P706, DOI 10.1167/iovs.02-0384; Gebremedhin D, 2003, J NEUROSCI, V23, P1678; GEBREMEDHIN D, 1994, PFLUG ARCH EUR J PHY, V428, P621, DOI 10.1007/BF00374586; Gebremedhin D, 2008, AM J PHYSIOL-HEART C, V294, pH107, DOI 10.1152/ajpheart.01416.2006; Gebremedhin D, 2010, J CEREBR BLOOD F MET, V30, P1777, DOI 10.1038/jcbfm.2010.70; Goldenberg NM, 2015, ANESTHESIOLOGY, V122, P1338, DOI 10.1097/ALN.0000000000000647; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harraz OF, 2013, J CELL SCI, V126, P2944, DOI 10.1242/jcs.128363; Harraz OF, 2013, MICROCIRCULATION, V20, P299, DOI 10.1111/micc.12038; Isozumi K, 1996, HUM MOL GENET, V5, P1377, DOI 10.1093/hmg/5.9.1377; Jie P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.146; Jo AO, 2015, J NEUROSCI, V35, P13525, DOI 10.1523/JNEUROSCI.1987-15.2015; Kim KJ, 2015, J NEUROSCI, V35, P8245, DOI 10.1523/JNEUROSCI.4486-14.2015; KNAUS HG, 1994, BIOCHEMISTRY-US, V33, P5819, DOI 10.1021/bi00185a021; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liu YP, 1998, CIRC RES, V82, P729, DOI 10.1161/01.RES.82.6.729; Ma X, 2011, BBA-BIOMEMBRANES, V1808, P2789, DOI 10.1016/j.bbamem.2011.07.049; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Mercado J, 2014, J GEN PHYSIOL, V143, P559, DOI 10.1085/jgp.201311050; Mobasheri A, 2011, VET J, V187, P145, DOI 10.1016/j.tvjl.2010.02.003; Mobasheri A, 2010, J CELL PHYSIOL, V223, P511, DOI 10.1002/jcp.22075; Mufti RE, 2010, J PHYSIOL-LONDON, V588, P3983, DOI 10.1113/jphysiol.2010.193300; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B., 2004, NOVART FDN SYMP, V258, P149; Nilius B, 2004, NOVARTIS FDN S, V258, P263; Nilius Bernd, 2004, Novartis Found Symp, V258, P140; Nilius B, 2013, EMBO REP, V14, P152, DOI 10.1038/embor.2012.219; Nilius Bernd, 2005, Sci STKE, V2005, pre8, DOI 10.1126/stke.2952005re8; Nilius B, 2010, NAT GENET, V42, P98, DOI 10.1038/ng0210-98; Pabbidi MR, 2014, AM J PHYSIOL-HEART C, V306, pH989, DOI 10.1152/ajpheart.00636.2013; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Retailleau K, 2015, CELL REP, V13, P1161, DOI 10.1016/j.celrep.2015.09.072; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; van Dokkum RPE, 1999, AM J PHYSIOL-REG I, V276, pR189, DOI 10.1152/ajpregu.1999.276.1.R189; Vincent F, 2009, BIOCHEM BIOPH RES CO, V389, P490, DOI 10.1016/j.bbrc.2009.09.007; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Wu SN, 2003, J CARDIOVASC ELECTR, V14, P44, DOI 10.1046/j.1540-8167.2003.02040.x; Zhang LQ, 2013, BRIT J PHARMACOL, V170, P661, DOI 10.1111/bph.12315; Zheng XD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000080	53	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176796	10.1371/journal.pone.0176796	http://dx.doi.org/10.1371/journal.pone.0176796			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472069	gold, Green Published			2022-12-27	WOS:000400648500072
J	Tripp, EA; Tsai, YHE				Tripp, Erin A.; Tsai, Yi-Hsin Erica			Disentangling geographical, biotic, and abiotic drivers of plant diversity in neotropical Ruellia (Acanthaceae)	PLOS ONE			English	Article							LATITUDINAL GRADIENT; EXTINCTION RATES; DIVERSIFICATION; EVOLUTION; POLLINATION; SPECIATION; PATTERNS; SHIFTS; MODEL; SPECIALIZATION	has long been hypothesized that biotic interactions are important drivers of biodiversity evolution, yet such interactions have been relatively less studied than abiotic factors owing to the inherent complexity in and the number of types of such interactions. Amongst the most prominent of biotic interactions worldwide are those between plants and pollinators. In the Neotropics, the most biodiverse region on Earth, hummingbird and bee pollination have contributed substantially to plant fitness. Using comparative methods, we test the macroevolutionary consequences of bird and bee pollination within a species rich lineage of flowering plants: Ruellia. We additionally explore impacts of species occupancy of ever-wet rainforests vs. dry ecosystems including cerrado and seasonally dry tropical forests. We compared outcomes based on two different methods of model selection: a traditional approach that utilizes a series of transitive likelihood ratio tests as well as a weighted model averaging approach. Analyses yield evidence for increased net diversification rates among Neotropical Ruellia ( compared to Paleotropical lineages) as well as among hummingbirdadapted species. In contrast, we recovered no evidence of higher diversification rates among either bee-or non-bee-adapted lineages and no evidence for higher rates among wet or dry habitat lineages. Understanding fully the factors that have contributed to biases in biodiversity across the planet will ultimately depend upon incorporating knowledge of biotic interactions as well as connecting microevolutionary processes to macroevolutionary patterns.	[Tripp, Erin A.; Tsai, Yi-Hsin Erica] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Tripp, Erin A.; Tsai, Yi-Hsin Erica] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Tripp, EA (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.; Tripp, EA (corresponding author), Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA.	erin.tripp@colorado.edu		TRIPP, ERIN/0000-0001-9340-8723	US National Science Foundation [DEB-1354963, DEB-1355138]	US National Science Foundation(National Science Foundation (NSF))	Financial support for this research was provided by the US National Science Foundation Awards DEB-1354963 & DEB-1355138 to Erin A. Tripp and Lucinda McDade. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamczyk S, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0388-z; Antonelli A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00130; Antonelli A, 2011, TAXON, V60, P403, DOI 10.1002/tax.602010; Armbruster WS, 2009, P NATL ACAD SCI USA, V106, P18085, DOI 10.1073/pnas.0907051106; Banda-R K, 2016, SCIENCE, V353, P1383, DOI 10.1126/science.aaf5080; Bardon L, 2013, BOT J LINN SOC, V171, P19, DOI 10.1111/j.1095-8339.2012.01289.x; Bloom DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098430; Borg AJ, 2008, TAXON, V57, P811, DOI 10.1002/tax.573012; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; Burnham RJ, 2004, PHILOS T R SOC B, V359, P1595, DOI 10.1098/rstb.2004.1531; Cardinal S, 2013, P ROYAL SOC B, V30, P280; Daniel TF, 2008, SYST BOT, V33, P416, DOI 10.1600/036364408784571581; Darwin C., 1877, VARIOUS CONTRIVANCES; Davis MP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-38; Dobzhansky T., 1950, AM SCI, V38, P208, DOI DOI 10.2307/2989767; Fine PVA, 2006, AM NAT, V168, P796, DOI 10.1086/508635; FitzJohn RG, 2012, METHODS ECOL EVOL, V3, P1084, DOI 10.1111/j.2041-210X.2012.00234.x; FitzJohn RG, 2009, SYST BIOL, V58, P595, DOI 10.1093/sysbio/syp067; Forest F, 2014, ANN BOT-LONDON, V113, P357, DOI 10.1093/aob/mct248; Gamisch A, 2016, EVOL BIOINFORM, V12, P165, DOI 10.4137/EBO.S39732; GENTRY AH, 1982, EVOL BIOL, V15, P1; Givnish TJ, 2014, MOL PHYLOGENET EVOL, V71, P55, DOI 10.1016/j.ympev.2013.10.010; Graham A, 2011, AM J BOT, V98, P336, DOI 10.3732/ajb.1000353; GRANT V, 1949, EVOLUTION, V3, P82, DOI 10.2307/2405454; Grant V., 1965, FLOWER POLLINATION P; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Hernandez-Hernandez T, 2014, NEW PHYTOL, V202, P1382, DOI 10.1111/nph.12752; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Johnson SD, 2010, PHILOS T R SOC B, V365, P499, DOI 10.1098/rstb.2009.0243; Kay KM, 2006, EVOLUTION, V60, P538; Kay KM, 2003, BIOTROPICA, V35, P198, DOI 10.1111/j.1744-7429.2003.tb00279.x; Kiel CA, 2006, TAXON, V55, P683, DOI 10.2307/25065644; Kiel CK, 2015, THESIS; Kursar TA, 2009, P NATL ACAD SCI USA, V106, P18073, DOI 10.1073/pnas.0904786106; Lindberg AB, 2001, J TROP ECOL, V17, P323, DOI 10.1017/S0266467401001213; Malecot G., 1969, MATH HEREDITY; McCain C.M., 2010, ENCY LIFE SCI; McDade LA, 2005, SYST BOT, V30, P834, DOI 10.1600/036364405775097734; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; O'Meara BC, 2016, AM J BOT, V103, P792, DOI 10.3732/ajb.1600012; Odegaard F., 2015, BIOL J LINN SOC, V71, P583; Pennington RT, 2009, ANNU REV ECOL EVOL S, V40, P437, DOI 10.1146/annurev.ecolsys.110308.120327; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rabosky DL, 2015, SYST BIOL, V64, P340, DOI 10.1093/sysbio/syu131; Rabosky DL, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001381; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Roalson EH, 2016, SYST BIOL, V65, P662, DOI 10.1093/sysbio/syw012; Rousset F, 1997, GENETICS, V145, P1219; Schemske DM, 2009, BIOTIC INTERACTIONS, P228; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Schiestl FP, 2009, ANNU REV ENTOMOL, V54, P425, DOI 10.1146/annurev.ento.54.110807.090603; Schmidt-Lebuhn AN, 2007, TRENDS PLANT SCI, V12, P329, DOI 10.1016/j.tplants.2007.06.009; Schnitzler J, 2011, SYST BIOL, V60, P343, DOI 10.1093/sysbio/syr006; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; STEBBINS G. L., 1970, Annual review of ecology and systematics., V1, P307, DOI 10.1146/annurev.es.01.110170.001515; Stebbins GL, 1989, EVOLUTIONARY ECOLOGY, P39; Temeles EJ, 2003, SCIENCE, V300, P630, DOI 10.1126/science.1080003; Toon A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-43; Toussaint EFA, 2015, SYST BIOL, V64, P3, DOI 10.1093/sysbio/syu067; Tripp E, 2017, SYSTEMATIC IN PRESS; Tripp Erin, 2013, Aliso, V31, P89; Tripp EA, 2008, EVOLUTION, V62, P1712, DOI 10.1111/j.1558-5646.2008.00398.x; Tripp EA, 2007, SYST BOT, V32, P628, DOI 10.1600/036364407782250625; Valente LM, 2012, AM NAT, V180, P83, DOI 10.1086/666003; van der Niet T, 2012, TRENDS ECOL EVOL, V27, P353, DOI 10.1016/j.tree.2012.02.002; Vermeij Geerat J., 2005, Proceedings of the California Academy of Sciences, V56, P12; WILLIS EO, 1978, ANNU REV ECOL SYST, V9, P243, DOI 10.1146/annurev.es.09.110178.001331; WRIGHT S, 1946, GENETICS, V31, P39	68	14	15	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176021	10.1371/journal.pone.0176021	http://dx.doi.org/10.1371/journal.pone.0176021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472046	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500021
J	Wang, YX; Ren, BA; Zhou, XD; Liu, SY; Zhou, YJ; Li, BL; Jiang, YL; Li, MY; Feng, MY; Cheng, L				Wang, Yuxia; Ren, Biao; Zhou, Xuedong; Liu, Shiyu; Zhou, Yujie; Li, Bolei; Jiang, Yaling; Li, Mingyun; Feng, Mingye; Cheng, Lei			Growth and adherence of Staphylococcus aureus were enhanced through the PGE(2) produced by the activated COX-2/PGE(2) pathway of infected oral epithelial cells	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; PROSTAGLANDIN E-2 SYNTHESIS; CYCLOOXYGENASE-2 PATHWAY; ALVEOLAR MACROPHAGES; MYCOSIS-FUNGOIDES; CANDIDA-ALBICANS; SUPPRESSOR-CELLS; COX-2 EXPRESSION; FACTOR RECEPTOR; CYCLIC-AMP	Staphylococcus aureus is a major pathogen of varieties of oral mucous infection. Prostaglandin E2 (PGE(2)) is a pro-inflammatory factor and Cyclooxygenase 2 (COX-2) is a critical enzyme of PGE(2) biosynthesis. The purpose of this study is to investigate whether Staphylococcus aureus can increase PGE(2) production of oral epithelial cells and how PGE(2) functions in the growth and adherence of Staphylococcus aureus. mRNA levels of COX-2, fnbpA and fnbpB were estimated by quantitative PCR. PGE(2) production was measured by Enzyme Linked Immunosorbent Assay (ELISA). The binding biomass of Staphylococcus aureus to human fibronectin was investigated by crystal violet staining and confocal laser scanning microscopy and the adherent force was measured by atomic force microscope (AFM). The COX-2 mRNA level and PGE(2) production were increased by Staphylococcus aureus. PGE(2) promoted the growth and biofilm formation of Staphylococcus aureus, enhanced the attachment of Staphylococcus aureus to the human fibronectin as well as to the HOK cells. The transcription of fnbpB was up-regulated by PGE(2) in both early and middle exponential phase but not fnbpA. These results suggest that the activation of COX-2/PGE(2) pathway in oral epithelial cell by Staphylococcus aureus can in turn facilitate the growth and the ability to adhere of the pathogen. These findings uncover a new function of PGE(2) and may lead to the potential of COX-2/PGE(2) targeting in the therapy of inflammation and cancer in both which the COX-2/PGE(2) pathway were observed activated.	[Wang, Yuxia; Ren, Biao; Zhou, Xuedong; Liu, Shiyu; Zhou, Yujie; Li, Bolei; Jiang, Yaling; Li, Mingyun; Feng, Mingye; Cheng, Lei] Sichuan Univ, State Key Lab Oral Dis, Chengdu, Peoples R China; [Wang, Yuxia; Zhou, Xuedong; Liu, Shiyu; Zhou, Yujie; Li, Bolei; Jiang, Yaling; Feng, Mingye; Cheng, Lei] Sichuan Univ, West China Hosp Stomatol, Dept Operat Dent & Endodont, Chengdu, Peoples R China	Sichuan University; Sichuan University	Feng, MY; Cheng, L (corresponding author), Sichuan Univ, State Key Lab Oral Dis, Chengdu, Peoples R China.; Feng, MY; Cheng, L (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dept Operat Dent & Endodont, Chengdu, Peoples R China.	tengmingye@gmail.com; chenglei@scu.edu.cn	ZHOU, XUE/F-6129-2013; Zhou, Yu/HHN-3071-2022; Ren, Biao/P-1067-2015	Ren, Biao/0000-0003-4215-2873; Cheng, Lei/0000-0002-2762-4740; Zhou, Xuedong/0000-0002-9319-7302	National Key Research and Development Program of China [2016YFC1102700]; National Natural Science Foundation of China [81372889, 81600858, 81372890, 81430011]; Open Fund of State Key Laboratory of Oral Diseases [2040305193002]; Recruitment Program for Young Professionals	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Fund of State Key Laboratory of Oral Diseases; Recruitment Program for Young Professionals	This study was supported by the National Key Research and Development Program of China (http://www.nsfc.gov.cn/) 2016YFC1102700 to X.Z.; National Natural Science Foundation of China grant (http://www.nsfv.gov.cn/) 81372889 to L.C., 81600858 to B.R., 81372890 to M.F. and 81430011 to X.Z.; and Open Fund of State Key Laboratory of Oral Diseases (http://www.sklod.org/CN/index_cn.html) 2040305193002; Recruitment Program for Young Professionals to M.F.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agard M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00045; Agerer F, 2003, J BIOL CHEM, V278, P42524, DOI 10.1074/jbc.M302096200; Altrock E., 2015, Z GASTROENTEROL, V53, pA1; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Chan G, 1999, CANCER RES, V59, P991; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; Chen JH, 2015, NAT MED, V21, P327, DOI 10.1038/nm.3831; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Dziewanowska K, 2000, INFECT IMMUN, V68, P6321, DOI 10.1128/IAI.68.11.6321-6328.2000; Foster T., 2016, EUR J CLIN MICROBIOL, P1; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; Gallo O, 2002, HUM PATHOL, V33, P708, DOI 10.1053/hupa.2002.125376; Gallo O, 2001, NEOPLASIA, V3, P53, DOI 10.1038/sj.neo.7900127; GOTO T, 1983, J IMMUNOL, V130, P1350; Green AW, 2001, BRIT DENT J, V190, P529, DOI 10.1038/sj.bdj.4801024a; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Griffin EW, 2013, J NEUROSCI, V33, P15248, DOI 10.1523/JNEUROSCI.6361-11.2013; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hara S, 2010, BIOCHIMIE, V92, P651, DOI 10.1016/j.biochi.2010.02.007; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; HOOk M, 1989, FIBRONECTIN, V1, P295; Hussain M, 2008, INFECT IMMUN, V76, P5615, DOI 10.1128/IAI.00480-08; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; KALOKLEIN A, 1990, INFECT IMMUN, V58, P260, DOI 10.1128/IAI.58.1.260-262.1990; Kim J, 2016, MOL CARCINOG; Kintarak S, 2004, INFECT IMMUN, V72, P5668, DOI 10.1128/IAI.72.10.5668-5675.2004; Kopp KLM, 2010, LEUKEMIA, V24, P1179, DOI 10.1038/leu.2010.66; Krause J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135404; Kullander J, 2009, CANCER EPIDEM BIOMAR, V18, P472, DOI 10.1158/1055-9965.EPI-08-0905; Kyzas PA, 2005, MODERN PATHOL, V18, P153, DOI 10.1038/modpathol.3800244; LINNEMEYER PA, 1993, J IMMUNOL, V150, P3747; McCormack MG, 2015, AM J INFECT CONTROL, V43, P35, DOI 10.1016/j.ajic.2014.09.015; McCrae M., 1997, MOL ASPECTS HOST PAT, P50; Mei L, 2009, J DENT RES, V88, P841, DOI 10.1177/0022034509342523; Menter DG, 2010, CLIN CANCER RES, V16, P1384, DOI 10.1158/1078-0432.CCR-09-0788; Mirvish ED, 2011, J AM ACAD DERMATOL, V64, P423, DOI 10.1016/j.jaad.2009.11.692; Mongodin E, 2002, INFECT IMMUN, V70, P620; Moraitis D, 2005, CANCER RES, V65, P664; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V21; Nakayama T, 2006, J LEUKOCYTE BIOL, V79, P95, DOI 10.1189/jlb.0405226; Nguyen V, 2008, J AM ACAD DERMATOL, V59, P949, DOI 10.1016/j.jaad.2008.08.030; Noverr MC, 2001, INFECT IMMUN, V69, P2957, DOI 10.1128/IAI.69.5.2957-2963.2001; Obermajer N, 2012, IMMUNOL INVEST, V41, P635, DOI 10.3109/08820139.2012.695417; Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825; Ohara-Nemoto Y, 2008, J MED MICROBIOL, V57, P95, DOI 10.1099/jmm.0.47561-0; Ondrey FG, 1996, LARYNGOSCOPE, V106, P129, DOI 10.1097/00005537-199602000-00003; OUELLET M, 1995, BIOCHEM J, V306, P247, DOI 10.1042/bj3060247; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; Paupiere S, 2013, JOINT BONE SPINE, V80, P669, DOI 10.1016/j.jbspin.2013.03.016; Peacock SJ, 2000, J INFECTION, V41, P23, DOI 10.1053/jinf.2000.0657; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Perez-Novo CA, 2008, J INFECT DIS, V197, P1036, DOI 10.1086/528989; PHIPPS RP, 1991, IMMUNOL TODAY, V12, P349, DOI 10.1016/0167-5699(91)90064-Z; Pietra G, 2012, CANCER RES, V72, P1407, DOI 10.1158/0008-5472.CAN-11-2544; Ridley RA, 2012, J MED MICROBIOL, V61, P1654, DOI 10.1099/jmm.0.049650-0; Roelofs HMJ, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-1; Sakata D, 2010, J PHARMACOL SCI, V112, P1, DOI 10.1254/jphs.09R03CP; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; Sierra JC, 2013, AM J PHYSIOL-GASTR L, V305, pG196, DOI 10.1152/ajpgi.00495.2012; Somayaji SN, 2008, INFECT IMMUN, V76, P5120, DOI 10.1128/IAI.00228-08; Sreeramkumar V, 2012, MED HUMANIT, V90, P579; Takagi M, 2008, VET J, V177, P398, DOI 10.1016/j.tvjl.2007.05.017; Talpur R, 2008, BRIT J DERMATOL, V159, P105, DOI 10.1111/j.1365-2133.2008.08612.x; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199; VANDEWATER L, 1983, SCIENCE, V220, P201, DOI 10.1126/science.6338594; VERBRUGH HA, 1981, INFECT IMMUN, V33, P811, DOI 10.1128/IAI.33.3.811-819.1981; Walia IS, 2014, J MAXILLOFAC ORAL SU, V13, P16, DOI 10.1007/s12663-012-0455-6; Wang CY, 2015, SCANNING, V37, P313, DOI 10.1002/sca.21218; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Zaleckas Linas, 2010, Stomatologija, V12, P23; Zbinden C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087374; Zhu YM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-218	76	27	30	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177166	10.1371/journal.pone.0177166	http://dx.doi.org/10.1371/journal.pone.0177166			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472126	gold, Green Submitted, Green Published			2022-12-27	WOS:000400648500148
J	Watson, SC; Liu, Y; Lund, RB; Gettings, JR; Nordone, SK; McMahan, CS; Yabsley, MJ				Watson, Stella C.; Liu, Yan; Lund, Robert B.; Gettings, Jenna R.; Nordone, Shila K.; McMahan, Christopher S.; Yabsley, Michael J.			A Bayesian spatio-temporal model for forecasting the prevalence of antibodies to Borrelia burgdorferi, causative agent of Lyme disease, in domestic dogs within the contiguous United States	PLOS ONE			English	Article							IXODES-SCAPULARIS TICKS; DIROFILARIA-IMMITIS; ANAPLASMA-PHAGOCYTOPHILUM; BLACKLEGGED TICKS; ACARI IXODIDAE; SENSU-LATO; DIAGNOSIS; INFECTION; PREVENTION; ELISA	This paper models the prevalence of antibodies to Borrelia burgdorferi in domestic dogs in the United States using climate, geographic, and societal factors. We then use this model to forecast the prevalence of antibodies to B. burgdorferi in dogs for 2016. The data available for this study consists of 11,937,925 B. burgdorferi serologic test results collected at the county level within the 48 contiguous United States from 2011-2015. Using the serologic data, a baseline B. burgdorferi antibody prevalence map was constructed through the use of spatial smoothing techniques after temporal aggregation; i.e., head-banging and Kriging. In addition, several covariates purported to be associated with B. burgdorferi prevalence were collected on the same spatio-temporal granularity, and include forestation, elevation, water coverage, temperature, relative humidity, precipitation, population density, and median household income. A Bayesian spatio-temporal conditional autoregressive (CAR) model was used to analyze these data, for the purposes of identifying significant risk factors and for constructing disease forecasts. The fidelity of the forecasting technique was assessed using historical data, and a Lyme disease forecast for dogs in 2016 was constructed. The correlation between the county level model and baseline B. burgdorferi antibody prevalence estimates from 2011 to 2015 is 0.894, illustrating that the Bayesian spatio-temporal CAR model provides a good fit to these data. The fidelity of the forecasting technique was assessed in the usual fashion; i.e., the 2011-2014 data was used to forecast the 2015 county level prevalence, with comparisons between observed and predicted being made. The weighted (to acknowledge sample size) correlation between 2015 county level observed prevalence and 2015 forecasted prevalence is 0.978. A forecast for the prevalence of B. burgdorferi antibodies in domestic dogs in 2016 is also provided. The forecast presented from this model can be used to alert veterinarians in areas likely to see above average B. burgdorferi antibody prevalence in dogs in the upcoming year. In addition, because dogs and humans can be exposed to ticks in similar habitats, these data may ultimately prove useful in predicting areas where human Lyme disease risk may emerge.	[Watson, Stella C.; Liu, Yan; Lund, Robert B.; Gettings, Jenna R.; McMahan, Christopher S.] Clemson Univ, Dept Math Sci, Clemson, SC 29634 USA; [Nordone, Shila K.] North Carolina State Univ, Coll Vet Med, Comparat Med Inst, Dept Mol & Biomed Sci, Raleigh, NC 27695 USA; [Nordone, Shila K.; Yabsley, Michael J.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Yabsley, Michael J.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA	Clemson University; University of North Carolina; North Carolina State University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	McMahan, CS (corresponding author), Clemson Univ, Dept Math Sci, Clemson, SC 29634 USA.; Yabsley, MJ (corresponding author), Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA.; Yabsley, MJ (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	mcmaha2@clemson.edu; myabsley@uga.edu		mcmahan, christopher/0000-0001-5056-9615; Liu, Yan/0000-0002-3787-5906; Yabsley, Michael/0000-0003-2452-5015	Companion Animal Parasite Council; National Science Foundation Grant [DMS 1407480]; National Institutes of Health [R01 A1121351]; Boehringer Ingelheim Vetmedica-CAPC Infectious Disease Postdoctoral Fellowship	Companion Animal Parasite Council; National Science Foundation Grant(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Vetmedica-CAPC Infectious Disease Postdoctoral Fellowship(Boehringer Ingelheim)	IDEXX Laboratories, Inc. is thanked for their data contribution. The Companion Animal Parasite Council financially supported this work. YL and RBL also thank National Science Foundation Grant DMS 1407480. CSM was partially supported by Grant R01 A1121351 from the National Institutes of Health. JRG is supported by The Boehringer Ingelheim Vetmedica-CAPC Infectious Disease Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; IDEXX Laboratories, Inc. is thanked for their data contribution. The Companion Animal Parasite Council financially supported this work. YL and RBL also thank National Science Foundation Grant DMS 1407480. CSM was partially supported by Grant R01 AI121351 from the National Institutes of Health. JRG is supported by The Boehringer Ingelheim Vetmedica-CAPC Infectious Disease Postdoctoral Fellowship.	Adams Deborah A, 2014, MMWR Morb Mortal Wkly Rep, V61, P1; Adams Deborah A., 2012, Morbidity and Mortality Weekly Report, V59, P1; Adrion ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116767; [Anonymous], 2013, TEXTS STAT SCI SERIE; Arvikar SL, 2015, INFECT DIS CLIN N AM, V29, P269, DOI 10.1016/j.idc.2015.02.004; Bachur RG, 2015, J PEDIATR-US, V166, P407, DOI 10.1016/j.jpeds.2014.09.040; Bacon RM, 2003, J INFECT DIS, V187, P1187, DOI 10.1086/374395; Banerjee S., 2014, HIERARCHICAL MODELIN; Benito J, 2013, VET J, V196, P368, DOI 10.1016/j.tvjl.2012.12.015; BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; Besag J, 2013, BIOMETRICS, V69, P488, DOI 10.1111/biom.12009; Bowman D, 2009, VET PARASITOL, V160, P138, DOI 10.1016/j.vetpar.2008.10.093; Bowman DD, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1804-y; Branda JA, 2010, CLIN INFECT DIS, V50, P20, DOI 10.1086/648674; Brockwell PJ, 2006, INTRO TIME SERIES FO; Cohn KA, 2012, PEDIATRICS, V129, pE46, DOI 10.1542/peds.2011-1215; Conlon J A, 2000, Vet Ther, V1, P96; Costello JM, 2009, PEDIATRICS, V123, pE835, DOI 10.1542/peds.2008-3058; Cressie NAC, 2011, WILEY SERIES PROBABI; Daniels TJ, 1998, APPL ENVIRON MICROB, V64, P4663; Detmer SE, 2016, J VET DIAGN INVEST, V28, P144, DOI 10.1177/1040638715626486; Eisen RJ, 2008, J MED ENTOMOL, V45, P181, DOI 10.1603/0022-2585(2008)45[181:SMOHRO]2.0.CO;2; Eisen RJ, 2015, J MED ENTOMOL; Eisen RJ, 2016, J MED ENTOMOL; Embers ME, 2016, CLIN VACCINE IMMUNOL, V23, P294, DOI 10.1128/CVI.00685-15; Environmental Systems Research Institute I, 2016, DOCUMENTATION; Eschner AK, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0676-x; Gasmi S, 2016, TICKS TICK-BORNE DIS, V7, P1075, DOI 10.1016/j.ttbdis.2016.09.006; Hanzlicek GA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151924; Harrison Jeff, 1999, BAYESIAN FORECASTING; Hinckley AF, 2014, CLIN INFECT DIS, V59, P676, DOI 10.1093/cid/ciu397; Hosking FJ, 2008, GENET EPIDEMIOL, V32, P497, DOI 10.1002/gepi.20322; Hutchinson ML, 2015, J MED ENTOMOL, V52, P693, DOI 10.1093/jme/tjv037; Krupka I, 2010, VET CLIN N AM-SMALL, V40, P1103, DOI 10.1016/j.cvsm.2010.07.011; LaFleur RL, 2009, CLIN VACCINE IMMUNOL, V16, P253, DOI 10.1128/CVI.00373-08; Levi T, 2016, ECOL APPL, V26, P484, DOI 10.1890/15-0122; LEVY SA, 1993, J AM VET MED ASSOC, V202, P1834; Levy SA, 2008, CLIN VACCINE IMMUNOL, V15, P115, DOI 10.1128/CVI.00340-07; Levy Steven A, 2002, Vet Ther, V3, P420; Liang FT, 2000, J CLIN MICROBIOL, V38, P4160, DOI 10.1128/JCM.38.11.4160-4166.2000; Lipsett SC, 2015, PEDIATR INFECT DIS J, V34, P1260, DOI 10.1097/INF.0000000000000858; Little SE, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-257; Little SE, 2010, TRENDS PARASITOL, V26, P213, DOI 10.1016/j.pt.2010.01.006; Littman MP, 2006, J VET INTERN MED, V20, P422, DOI 10.1892/0891-6640(2006)20[422:ASACSO]2.0.CO;2; Liu Y, 2016, PARASIT VEC IN PRESS; Lopez-Quilez A, 2009, ZENODO; Madhav NK, 2004, J MED ENTOMOL, V41, P842, DOI 10.1603/0022-2585-41.5.842; Maggi RG, 2010, TICKS TICK-BORNE DIS, V1, P168, DOI 10.1016/j.ttbdis.2010.08.003; Martinez-Beneito MA, 2008, STAT MED, V27, P2874, DOI 10.1002/sim.3103; Mathews K, 2014, J SMALL ANIM PRACT, V55, pE10, DOI 10.1111/jsap.12200; McNabb SJ, 2007, MMWR-MORBID MORTAL W, V54, P1; Mead P, 2011, EMERG INFECT DIS, V17, P1710, DOI 10.3201/eid1709.110210; Mead PS, 2015, INFECT DIS CLIN N AM, V29, P187, DOI 10.1016/j.idc.2015.02.010; Millen K, 2013, VECTOR-BORNE ZOONOT, V13, P340, DOI 10.1089/vbz.2012.1025; Nelder MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105358; Nelson CA, 2015, EMERG INFECT DIS, V21, P1625, DOI 10.3201/eid2109.150417; Nieto NC, 2010, J VECTOR ECOL, V35, P43, DOI 10.1111/j.1948-7134.2010.00026.x; Nobre AA, 2005, ENVIRONMETRICS, V16, P291, DOI 10.1002/env.704; Nyman D, 2006, CLIN MICROBIOL INFEC, V12, P496, DOI 10.1111/j.1469-0691.2006.01374.x; Ogden NH, 2007, PARASITOLOGY, V134, P209, DOI 10.1017/S0031182006001417; Ogden NH, 2014, ENVIRON HEALTH PERSP, V122, P631, DOI 10.1289/ehp.1307799; Ogden NH, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00046; Parham PE, 2015, PHILOS T R SOC LON B, V370; Raghavan RK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150180; Raghavan RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100850; Rhodes DVL, 2013, VET J, V198, P412, DOI 10.1016/j.tvjl.2013.07.019; Scott JD, 2016, INT J MED SCI, V13, P881, DOI 10.7150/ijms.16922; Scott JD, 2016, TICKS TICK-BORNE DIS, V7, P327, DOI 10.1016/j.ttbdis.2015.12.001; Spencer JA, 2003, PARASITOL RES, V90, pS106, DOI 10.1007/s00436-003-0904-8; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Steere AC, 2003, AM J MED, V114, P58, DOI 10.1016/S0002-9343(02)01440-7; Stich RW, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-417; Stillman BA, 2014, JAVMA-J AM VET MED A, V245, P80, DOI 10.2460/javma.245.1.80; Stone BL, 2015, APPL ENVIRON MICROB, V81, P48, DOI 10.1128/AEM.02422-14; Thompson A, 2009, PEDIATRICS, V123, P959, DOI 10.1542/peds.2008-1511; Wagner B, 2012, CLIN VACCINE IMMUNOL, V19, P527, DOI 10.1128/CVI.05653-11; Wang DM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-264; Wengenmayer C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0525-3; Wiseman-Orr ML, 2004, AM J VET RES, V65, P1077, DOI 10.2460/ajvr.2004.65.1077; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Xia H, 1998, STAT MED, V17, P2025, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2025::AID-SIM865>3.0.CO;2-M; Zoetis, 2016, B865RUS12018 ZOET IN	83	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0174428	10.1371/journal.pone.0174428	http://dx.doi.org/10.1371/journal.pone.0174428			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472096	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500004
J	Fernandes-Matano, L; Monroy-Munoz, IE; Angeles-Martinez, J; Sarquiz-Martinez, B; Palomec-Nava, ID; Pardave-Alejandre, HD; Coy-Arechavaleta, AS; Santacruz-Tinoco, CE; Gonzalez-Ibarra, J; Gonzalez-Bonilla, CR; Munoz-Medina, JE				Fernandes-Matano, Larissa; Eloisa Monroy-Munoz, Irma; Angeles-Martinez, Javier; Sarquiz-Martinez, Brenda; Donaji Palomec-Nava, Iliana; Daniel Pardave-Alejandre, Hector; Santos Coy-Arechavaleta, Andrea; Esperanza Santacruz-Tinoco, Clara; Gonzalez-Ibarra, Joaquin; Raul Gonzalez-Bonilla, Cesar; Esteban Munoz-Medina, Jose			Prevalence of non-influenza respiratory viruses in acute respiratory infection cases in Mexico	PLOS ONE			English	Article							HUMAN METAPNEUMOVIRUS; HUMAN BOCAVIRUS; VIRAL ETIOLOGY; TRACT INFECTIONS; SYNCYTIAL VIRUS; HOSPITALIZED CHILDREN; SYMPTOMATIC CHILDREN; DISEASE SEVERITY; RHINOVIRUS; SEASONALITY	Background Acute respiratory infections are the leading cause of morbidity and mortality worldwide. Although a viral aetiological agent is estimated to be involved in up to 80% of cases, the majority of these agents have never been specifically identified. Since 2009, diagnostic and surveillance efforts for influenza virus have been applied worldwide. However, insufficient epidemiological information is available for the many other respiratory viruses that can cause Acute respiratory infections. Methods This study evaluated the presence of 14 non-influenza respiratory viruses in 872 pharyngeal exudate samples using RT-qPCR. All samples met the operational definition of a probable case of an influenza-like illness or severe acute respiratory infection and had a previous negative result for influenza by RT-qPCR. Results The presence of at least one non-influenza virus was observed in 312 samples (35.8%). The most frequent viruses were rhinovirus (RV; 33.0%), human respiratory syncytial virus (HRSV; 30.8%) and human metapneumovirus (HMPV; 10.6%). A total of 56 cases of coinfection (17.9%) caused by 2, 3, or 4 viruses were identified. Approximately 62.5% of all positive cases were in children under 9 years of age. Conclusion In this study, we identified 13 non-influenza respiratory viruses that could occur in any season of the year. This study provides evidence for the prevalence and seasonality of a wide range of respiratory viruses that circulate in Mexico and constitute a risk for the population. Additionally, our data suggest that including these tests more widely in the diagnostic algorithm for influenza may reduce the use of unnecessary antibiotics, reduce the hospitalisation time, and enrich national epidemiological data with respect to the infections caused by these viruses.	[Fernandes-Matano, Larissa] Univ Valle Mexico, Campus Chapultepec, Mexico City, DF, Mexico; [Eloisa Monroy-Munoz, Irma] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Lab Genom, Dept Genet & Genom Humana, Mexico City, DF, Mexico; [Angeles-Martinez, Javier] Inst Nacl Cardiol Ignacio Chavez, Lab Genom, Dept Biol Mol, Mexico City, DF, Mexico; [Sarquiz-Martinez, Brenda; Donaji Palomec-Nava, Iliana; Daniel Pardave-Alejandre, Hector; Santos Coy-Arechavaleta, Andrea; Esperanza Santacruz-Tinoco, Clara; Esteban Munoz-Medina, Jose] Inst Mexicano Seguro Social, Ctr Med Nacl La Raza, Lab Cent Epidemiol, Mexico City, DF, Mexico; [Gonzalez-Ibarra, Joaquin; Raul Gonzalez-Bonilla, Cesar] Inst Mexicano Seguro Social, Div Labs Vigilancia & Invest Epidemiol, Mexico City, DF, Mexico	National Institute of Cardiology - Mexico; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social	Munoz-Medina, JE (corresponding author), Inst Mexicano Seguro Social, Ctr Med Nacl La Raza, Lab Cent Epidemiol, Mexico City, DF, Mexico.	eban10@hotmail.com	Esteban, Muñoz Medina José/B-6186-2015	Esteban, Muñoz Medina José/0000-0002-1289-4457; Sarquiz, Brenda/0000-0003-1931-0781; Gonzalez Bonilla, Cesar/0000-0002-2225-5069; Angeles Martinez, Javier/0000-0001-5405-0482; Santos Coy-Arechavaleta, Andrea/0000-0001-7096-2545				Ahn JG, 2014, J MED VIROL, V86, P2011, DOI 10.1002/jmv.23880; Aldana RS, 2016, PRACTICA MED EFECTIV, V3, P1; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Arango M, 2002, MEADICA PANAMERICANA; Asner SA, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.08.024; Talavera GA, 2007, AM J TROP MED HYG, V76, P182, DOI 10.4269/ajtmh.2007.76.182; Bloom Barbara, 2009, Vital Health Stat 10, P1; Breiman RF, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0827-x; Broberg E, 2011, J CLIN VIROL, V51, P79, DOI 10.1016/j.jcv.2011.01.018; Cabello C, 2006, MEM I OSWALDO CRUZ, V101, P21, DOI 10.1590/S0074-02762006000100005; Canducci F, 2008, J MED VIROL, V80, P716, DOI 10.1002/jmv.21108; Centers for Disease Control and Prevention, 2012, REAL TIM RT PCR ASS; Costa LF, 2014, PEDIATRICS, V133, pE312, DOI 10.1542/peds.2013-2216; Cui BL, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0863-6; Diaz J, 2015, ITAL J PEDIATR, V41, DOI 10.1186/s13052-015-0133-7; Direccion General de Epidemiologia, 2015, AN MORB 1984 2014; Flores JC, 2011, REV CHIL INFECTOL, V28, P504, DOI /S0716-10182011000700001; Friedlander SL, 2005, J ALLERGY CLIN IMMUN, V116, P267, DOI 10.1016/j.jaci.2005.06.003; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Gern JE, 2010, J VIROL, V84, P7418, DOI 10.1128/JVI.02290-09; Haas LEM, 2013, VIRUSES-BASEL, V5, P87, DOI 10.3390/v5010087; Harada Y, 2013, PEDIATR INFECT DIS J, V32, P441, DOI 10.1097/INF.0b013e31828ba08c; Health Protection Agency, 2014, RESP PATH CIRC; Henrickson KJ, 2003, CLIN MICROBIOL REV, V16, P242, DOI 10.1128/CMR.16.2.242-264.2003; Huijskens EG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-276; Instituto de Diagnostico y Referencia Epidemiologicos, 2015, LIN VIG INF LAB; Jevsnik M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-365; Justo Iván, 2004, Rev Cubana Med Gen Integr, V20; Kaida A, 2014, JPN J INFECT DIS, V67, P469, DOI 10.7883/yoken.67.469; Kennedy JL, 2012, CURR OPIN VIROL, V2, P287, DOI 10.1016/j.coviro.2012.03.008; Landes MB, 2013, INFLUENZA OTHER RESP, V7, P1122, DOI 10.1111/irv.12145; Lekana-Douki SE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-373; Liu T, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0388-z; Liu WK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-28; Longtin J, 2008, EMERG INFECT DIS, V14, P217, DOI 10.3201/eid1402.070851; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; Manjarrez ME, 2003, J MED MICROBIOL, V52, P579, DOI 10.1099/jmm.0.05007-0; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; Martinez-Roig A, 2015, ARCH BRONCONEUMOL, V51, P5, DOI 10.1016/j.arbres.2014.01.018; Meerhoff TJ, 2010, EUR J CLIN MICROBIOL, V29, P365, DOI 10.1007/s10096-009-0865-7; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Mizuta K, 2012, MICROBIOL IMMUNOL, V56, P855, DOI 10.1111/j.1348-0421.2012.00507.x; Montejano-Elias L, 2009, PEDIATR INFECT DIS J, V28, P1024, DOI 10.1097/INF.0b013e3181aa6c3e; Moore ML, 2013, CURR OPIN IMMUNOL, V25, P761, DOI 10.1016/j.coi.2013.09.016; Moreno-Valencia Y, 2015, INFLUENZA OTHER RESP; Nascimento-Carvalho CM, 2010, SCAND J INFECT DIS, V42, P839, DOI 10.3109/00365548.2010.498020; Noyola DE, 2005, J MED MICROBIOL, V54, P969, DOI 10.1099/jmm.0.46052-0; Organizacion Mundial de la Salud, 2009, PREP RESP ANT PAND I; Pancer Katarzyna W, 2014, Przegl Epidemiol, V68, P627; Panda S, 2014, INT J INFECT DIS, V25, P45, DOI 10.1016/j.ijid.2014.03.1394; Pascalis H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044755; Peng D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-155; Public Health Agency of Canada, 2014, RESP VIR DET SURV; Rodriguez OI, 2015, REV ARCH MEADICO, V14; Ruohola A, 2009, EMERG INFECT DIS, V15, P344, DOI 10.3201/eid1502.081468; Schildgen O, 2013, PATHOGENS, V2, P1, DOI 10.3390/pathogens2010001; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Tanner H, 2012, EUR J CLIN MICROBIOL, V31, P3001, DOI 10.1007/s10096-012-1653-3; Teeratakulpisarn J, 2014, ASIAN PAC J ALLERGY, V32, P226, DOI [10.12932/ap0417.32.3.2014, 10.12932/AP0417.32.3.2014]; Viegas M, 2004, J INFECTION, V49, P222, DOI 10.1016/j.jinf.2003.10.006; Wansaula Z, 2016, INFLUENZA OTHER RESP, V10, P161, DOI 10.1111/irv.12360; Wong-Chew Rosa M, 2015, BMC Res Notes, V8, P261, DOI 10.1186/s13104-015-1239-0; Yu XF, 2015, J CLIN VIROL, V69, P1, DOI 10.1016/j.jcv.2015.05.015; Zimmerman RK, 2014, INFLUENZA OTHER RESP, V8, P397, DOI 10.1111/irv.12247	64	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176298	10.1371/journal.pone.0176298	http://dx.doi.org/10.1371/journal.pone.0176298			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467515	gold, Green Published, Green Submitted			2022-12-27	WOS:000400647000047
J	Gebrihet, TA; Mesgna, KH; Gebregiorgis, YS; Kahsay, AB; Weldehaweria, NB; Weldu, MG				Gebrihet, Teklay Aredehey; Mesgna, Kebede Haile; Gebregiorgis, Yosef Sibhatu; Kahsay, Alemayehu Bayray; Weldehaweria, Negassie Berhe; Weldu, Meresa Gebremedhin			Awareness, treatment, and control of hypertension is low among adults in Aksum town, northern Ethiopia: A sequential quantitative-qualitative study	PLOS ONE			English	Article							BLOOD-PRESSURE; VEGETABLE CONSUMPTION; RISK-FACTORS; PREVALENCE; KNOWLEDGE; FRUIT; POPULATION; EDUCATION; HOME	Introduction Hypertension is a major risk factor of cardiovascular diseases which are the leading causes of deaths from chronic non-communicable diseases in Ethiopia. However, little is documented in the issue. Therefore, this study aimed to assess the prevalence, associated factors, awareness, treatment and control of hypertension among adults 18 years old or above in Aksum town, Tigray region, North Ethiopia. Methods A sequential quantitative-qualitative study was conducted among adults aged 18 years and above in Aksum town. A multi stage sampling procedure was used to select the study participants for the quantitative study whilst convenience sampling technique was used for the qualitative part. A pre-tested and structured questionnaire was used to collect quantitative data, and an interview guide was used to collect the qualitative data. The logistic regression model was fitted to identify factors independently associated with hypertension using SPSS Version 20. P-values of < 0.05 were considered statistically significant. For the qualitative data, iterative hearing of the discussions verbatim interpretation was followed by categorizing similar ideas into themes and finally triangulated with the quantitative results. Results The overall prevalence of hypertension was 16.5% (95% CI: 13.4, 20.0). Awareness, treatment and control of hypertension were 43%, 2.1% and 18.2%, respectively. Being unable to read and write [AOR = 4.73, 95% CI: 1.11, 20.23], not consuming fruit [ AOR = 4.31, 95% CI: 1.74, 10.66], being physically inactive [AOR = 20.11, 95% CI: 8.75, 6.20], not knowing physical inactivity is a risk factor of hypertension [AOR = 3.57, 95% CI: 1.69, 7.69] and being overweight/obese [AOR = 9.2, 95% CI: 4.54, 18.67] were significantly associated with hypertension. Remarkably, all identified hypertensive cases were linked to the nearby hospital for confirmation of diagnosis, care and follow-up and all of them were found to be hypertensive. This suggests that implementing primary health care approach integrated with the urban health extension package may be effective in the prevention and control of hypertension in poor settings. Conclusion and recommendation Prevalence of hypertension among adults was very high, but awareness, treatment and control of hypertension was very low. Being unable to read and write, not consuming fruit, being physically inactive, overweight/obesity and not knowing physical inactivity is a risk factor for hypertension were independently associated with hypertension. Policy makers need to consider integrating prevention and control of hypertension with health extension package. Appropriate information, education and communication strategies should also be designed and implemented to avoid unhealthy lifestyles and promote healthy practices.	[Gebrihet, Teklay Aredehey] Dist Hlth Off, Aksum, Ethiopia; [Mesgna, Kebede Haile; Gebregiorgis, Yosef Sibhatu; Weldehaweria, Negassie Berhe; Weldu, Meresa Gebremedhin] Aksum Univ, Coll Hlth Sci, Aksum, Ethiopia; [Kahsay, Alemayehu Bayray] Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia	Mekelle University	Gebregiorgis, YS (corresponding author), Aksum Univ, Coll Hlth Sci, Aksum, Ethiopia.	yosefsibhatu@gmail.com	Weldu, Meresa Gebremedhin/ABA-5452-2020	Gebregiorgis, Yosef/0000-0003-1329-7782				Adeloye D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104300; Almas Aysha, 2012, BMC Res Notes, V5, P579, DOI 10.1186/1756-0500-5-579; Alonso A, 2004, BRIT J NUTR, V92, P311, DOI 10.1079/BJN20041196; Asefa B G HB Zikru, 2014, IJIPSR, V2, P653; Aung MN, 2012, INT J GEN MED, V5, P553, DOI 10.2147/IJGM.S29406; Awoke A, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-113; Bhadoria AS, 2014, J FAM COMMUNITY MED, V21, P29, DOI 10.4103/2230-8229.128775; [Blood Institute National Heart L], 2014, NIH PUBL; Bonsa F, 2014, ETHIOP J HEALTH SCI, V24, P21, DOI 10.4314/ejhs.v24i1.3; Bowman TS, 2007, J AM COLL CARDIOL, V50, P2085, DOI 10.1016/j.jacc.2007.08.017; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Diaz KM, 2013, CURR HYPERTENS REP, V15, P659, DOI 10.1007/s11906-013-0386-8; Federal Democratic Republic of Ethiopia CSA, 2007, POP CENS REP POP HOU; Giday Araya, 2011, Ethiop Med J, V49, P139; Giles TD, 2009, J CLIN HYPERTENS, V11, P611, DOI 10.1111/j.1751-7176.2009.00179.x; Gudina EK, 2013, INTEGR BLOOD PRESS C, V6, P111, DOI 10.2147/IBPC.S47298; Helelo TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112790; HYPERTENSION DETECTION FOLLOW-UP, 1977, AM J EPIDEMIOL, V106, P351; Joshi MD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1177; Kayima J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2146-y; Kibret KT, 2015, PUBLIC HEALTH REV, V36, DOI 10.1186/s40985-015-0014-z; Li X, 2013, INT J ENV RES PUB HE, V10, P1125, DOI 10.3390/ijerph10031125; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mendis S, 2014, GLOBAL STATUS REPORT; Mengistu MD, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-33; Midha T, 2009, E AFRICAN J PUBLIC H, V6; Moges B, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-155; Quasem I, 2001, B WORLD HEALTH ORGAN, V79, P490; Samal D, 2007, STROKE, V38, P1304, DOI 10.1161/01.STR.0000259733.43470.27; Seedat YK, 2000, J HUM HYPERTENS, V14, P739, DOI 10.1038/sj.jhh.1001059; Sesso HD, 2008, HYPERTENSION, V51, P1080, DOI 10.1161/HYPERTENSIONAHA.107.104968; Sisay B, 2014, WORLD J MED MED SCI, V2; Tadesse T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-937; Tedesco MA, 2001, J HUM HYPERTENS, V15, P727, DOI 10.1038/sj.jhh.1001249; Tesfaye F, 2007, J HUM HYPERTENS, V21, P28, DOI 10.1038/sj.jhh.1002104; Tesfaye F, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-39; Tsubota-Utsugi M, 2011, J HUM HYPERTENS, V25, P164, DOI 10.1038/jhh.2010.48; Utsugi MT, 2008, HYPERTENS RES, V31, P1435, DOI 10.1291/hypres.31.1435; Viera AJ, 2008, J AM BOARD FAM MED, V21, P300, DOI 10.3122/jabfm.2008.04.070254; Wamala JF, 2009, AFRICAN HLTH SCI, V9; Wang L, 2012, AM J HYPERTENS, V25, P180, DOI 10.1038/ajh.2011.186; Wang Y, 2006, J HUM HYPERTENS, V20, P898, DOI 10.1038/sj.jhh.1002086; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2002, RED RISKS PROM HLTH; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; World Health Organization, 2005, WHO STEPS SURV MAN W; World Health Organization, 2013, NONC DIS COUNTR PROF	48	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176904	10.1371/journal.pone.0176904	http://dx.doi.org/10.1371/journal.pone.0176904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489865	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100036
J	Gotink, RA; Younge, JO; Wery, MF; Utens, EMWJ; Michels, M; Rizopoulos, D; van Rossum, LFC; Roos-Hesselink, JW; Hunink, MMG				Gotink, Rinske A.; Younge, John O.; Wery, Machteld F.; Utens, Elisabeth M. W. J.; Michels, Michelle; Rizopoulos, Dimitris; van Rossum, Liesbeth F. C.; Roos-Hesselink, Jolien W.; Hunink, Myriam M. G.			Online mindfulness as a promising method to improve exercise capacity in heart disease: 12-month follow-up of a randomized controlled trial	PLOS ONE			English	Article							MULTIDIMENSIONAL SCALE; HEALTH-STATUS; STRESS; MEDITATION; ASSOCIATION; DEPRESSION; ANXIETY; INTERVENTION; METAANALYSIS; FEASIBILITY	There is increasing evidence that mindfulness can reduce stress, and thereby affect other psychological and physiological outcomes as well. Earlier, we reported the direct 3-month results of an online modified mindfulness-based stress reduction training in patients with heart disease, and now we evaluate the effect at 12-month follow-up. 324 patients (mean age 43.2 years, 53.7% male) were randomized in a 2: 1 ratio to additional 3-month online mindfulness training or to usual care alone. The primary outcome was exercise capacity measured with the 6 minute walk test (6MWT). Secondary outcomes were blood pressure, heart rate, respiratory rate, NT-proBNP, cortisol levels (scalp hair sample), mental and physical functioning (SF-36), anxiety and depression (HADS), perceived stress (PSS), and social support (PSSS12). Differences between groups on the repeated outcome measures were analyzed with linear mixed models. At 12-months follow-up, participants showed a trend significant improvement exercise capacity (6MWT: 17.9 meters, p = 0.055) compared to UC. Cohen's D showed significant but small improvement on exercise capacity (d = 0.22; 95% CI 0.05 to 0.39), systolic blood pressure (d = 0.19; 95% CI 0.03 to 0.36), mental functioning (d = 0.22; 95% CI 0.05 to 0.38) and depressive symptomatology (d = 0.18; 95% CI 0.02 to 0.35). All other outcome measures did not change statistically significantly. In the as-treated analysis, systolic blood pressure decreased significantly with 5.5 mmHg (p = 0.045; d = 0.23 (95% CI 0.05-0.41)). Online mindfulness training shows favorable albeit small long-term effects on exercise capacity, systolic blood pressure, mental functioning, and depressive symptomatology in patients with heart disease and might therefore be a beneficial addition to current clinical care.	[Gotink, Rinske A.; Younge, John O.; Wery, Machteld F.; Hunink, Myriam M. G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Gotink, Rinske A.] Erasmus MC, Sect Med Psychol & Psychotherapy, Dept Psychiat, Rotterdam, Netherlands; [Gotink, Rinske A.; Hunink, Myriam M. G.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Younge, John O.; Michels, Michelle; Roos-Hesselink, Jolien W.] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands; [Utens, Elisabeth M. W. J.] Erasmus MC, Dept Child & Adolescent Psychiat Psychol, Rotterdam, Netherlands; [Rizopoulos, Dimitris] Erasmus MC, Dept Biostat, Rotterdam, Netherlands; [van Rossum, Liesbeth F. C.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Hunink, Myriam M. G.] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health	Hunink, MMG (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.; Hunink, MMG (corresponding author), Erasmus MC, Dept Radiol, Rotterdam, Netherlands.; Hunink, MMG (corresponding author), Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA.	m.hunink@erasmusmc.nl	Michels, Michelle/C-1687-2014	Michels, Michelle/0000-0001-6432-0431; Gotink, Rinske/0000-0002-4760-3226	Erasmus Medical Center	Erasmus Medical Center	Gotink, Younge, Roos-Hesselink and Hunink were supported by an Internal Grant from the Erasmus Medical Center.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Abbott RA, 2014, J PSYCHOSOM RES, V76, P341, DOI 10.1016/j.jpsychores.2014.02.012; [Anonymous], 2012, SPSS STAT WIND VERS; Arslan S, 2007, TEX HEART I J, V34, P166; Baer RA, 2003, CLIN PSYCHOL-SCI PR, V10, P125, DOI 10.1093/clipsy/bpg015; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; BLAIR SN, 1984, JAMA-J AM MED ASSOC, V252, P487, DOI 10.1001/jama.252.4.487; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S., 1988, SOCIAL PSYCHOL HLTH; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Custodis F, 2011, STROKE, V42, P1742, DOI 10.1161/STROKEAHA.110.598607; DEMEERSMAN RE, 1993, AM HEART J, V125, P726, DOI 10.1016/0002-8703(93)90164-5; Diller GP, 2005, CIRCULATION, V112, P828, DOI 10.1161/CIRCULATIONAHA.104.529800; Gluck TM, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-175; Gotink RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124344; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Healthcare Do, 2013, KOST ZORG HART VAATZ; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Huffman JC, 2013, CARDIOVASC PSYCHIAT, V2013, P14, DOI [10.1155/2013/695925, DOI 10.1155/2013/695925]; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; KabatZinn J, 2009, FULL CATASTROPHE LIV; Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Krusche A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000803; Maex E., 2006, MINDFULNESS MAALSTRO; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Moons P, 2006, EUR J CARDIOV PREV R, V13, P407, DOI 10.1097/00149831-200606000-00017; Morledge TJ, 2013, ANN BEHAV MED, V46, P137, DOI 10.1007/s12160-013-9490-x; Olivo EL, 2009, PSYCHOL HEALTH MED, V14, P513, DOI 10.1080/13548500902890087; Ospina Maria B, 2007, Evid Rep Technol Assess (Full Rep), P1; Pedersen SS, 2009, PSYCHOSOMATICS, V50, P461, DOI 10.1176/appi.psy.50.5.461; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Richardson S, 2012, AM J CARDIOL, V110, P1711, DOI 10.1016/j.amjcard.2012.08.004; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Strath SJ, 2000, MED SCI SPORT EXER, V32, pS465, DOI 10.1097/00005768-200009001-00005; Younge JO, 2015, INT J CARDIOL, V184, P71, DOI 10.1016/j.ijcard.2015.02.005; Younge JO, 2014, EUR J PREV CARDIOL; Younge JO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143843; Zeidan F, 2010, J ALTERN COMPLEM MED, V16, P867, DOI 10.1089/acm.2009.0321; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	42	19	19	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0175923	10.1371/journal.pone.0175923	http://dx.doi.org/10.1371/journal.pone.0175923			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UM	28486559	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000006
J	Zarai, Y; Margaliot, M; Tuller, T				Zarai, Yoram; Margaliot, Michael; Tuller, Tamir			On the Ribosomal Density that Maximizes Protein Translation Rate(vol 11, e0166481, 2016)	PLOS ONE			English	Correction														Tuller, Tamir/0000-0003-4194-7068				Zarai Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166481	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177650	10.1371/journal.pone.0177650	http://dx.doi.org/10.1371/journal.pone.0177650			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486545	gold, Green Published			2022-12-27	WOS:000401314000085
J	Fusco, FB; Gomes, DJ; Bispo, KCS; Toledo, VP; Barbeiro, DF; Capelozzi, VL; Furukawa, LNS; Velosa, APP; Teodoro, WR; Heimann, JC; Quintao, ECR; Passarelli, M; Nakandakare, ER; Catanozi, S				Fusco, Fernanda B.; Gomes, Diego J.; Bispo, Kely C. S.; Toledo, Veronica P.; Barbeiro, Denise F.; Capelozzi, Vera L.; Furukawa, Luzia N. S.; Velosa, Ana P. P.; Teodoro, Walcy R.; Heimann, Joel C.; Quintao, Eder C. R.; Passarelli, Marisa; Nakandakare, Edna R.; Catanozi, Sergio			Low-sodium diet induces atherogenesis regardless of lowering blood pressure in hypertensive hyperlipidemic mice	PLOS ONE			English	Article							E-DEFICIENT MICE; PLASMA-LIPID CONCENTRATION; LOW-SALT DIET; OXIDATIVE STRESS; CHLORIDE RESTRICTION; INSULIN-RESISTANCE; KNOCKOUT MICE; WISTAR RATS; RECEPTOR; ATHEROSCLEROSIS	This study investigated the influence of sodium restriction and antihypertensive drugs on atherogenesis utilizing hypertensive (H) low-density lipoprotein-receptor knockout mice treated or not with losartan (Los) or hydralazine (Hyd) and fed low-sodium (LS) or normal-sodium (NS) chow. Despite reducing the blood pressure (BP) of H-LS mice, the LS diet caused arterial lipid infiltration due to increased plasma total cholesterol (TC) and triglycerides (TG). Los and Hyd reduced the BP of H-LS mice, and Los effectively prevented arterial injury, likely by reducing plasma TG and nonesterified fatty acids. Aortic lipid infiltration was lower in Los-treated H-LS mice (H-LS+Los) than in normotensive (N)-LS and H-LS mice. Aortic angiotensin II type 1 (AT1) receptor content was greater in H-NS than H-LS mice and in H-LS+Hyd than H-LS+Los mice. Carboxymethyl-lysine (CML) and receptor for advanced glycation end products (RAGE) immunostaining was greater in H-LS than H-NS mice. CML and RAGE levels were lower in LS animals treated with antihypertensive drugs, and Hyd enhanced the AT1 receptor level. Hyd also increased the gene expression of F4/80 but not tumor necrosis factor-a, interleukin (IL)-1 beta, IL-6, IL-10, intercellular adhesion molecule-1 or cluster of differentiation 66. The novelty of the current study is that in a murine model of simultaneous hypertension and hyperlipidemia, the pleiotropic effect of chronic, severe sodium restriction elicited aortic damage even with reduced BP. These negative effects on the arterial wall were reduced by AT1 receptor antagonism, demonstrating the influence of angiotensin II in atherogenesis induced by a severely LS diet.	[Fusco, Fernanda B.; Gomes, Diego J.; Quintao, Eder C. R.; Passarelli, Marisa; Nakandakare, Edna R.; Catanozi, Sergio] Univ Sao Paulo, Med Sch, Lipids Lab LIM 10, Endocrinol Div, Sao Paulo, SP, Brazil; [Bispo, Kely C. S.; Capelozzi, Vera L.] Univ Sao Paulo, Med Sch, Dept Pathol, Sao Paulo, SP, Brazil; [Toledo, Veronica P.; Velosa, Ana P. P.; Teodoro, Walcy R.] Univ Sao Paulo, Med Sch, Rheumatol Div LIM 17, Sao Paulo, SP, Brazil; [Barbeiro, Denise F.] Univ Sao Paulo, Med Sch, Emergency Med Dept LIM 51, Sao Paulo, SP, Brazil; [Furukawa, Luzia N. S.; Heimann, Joel C.] Univ Sao Paulo, Med Sch, Expt Hypertens Lab LIM 16, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Catanozi, S (corresponding author), Univ Sao Paulo, Med Sch, Lipids Lab LIM 10, Endocrinol Div, Sao Paulo, SP, Brazil.	catanozi@usp.br	Teodoro, Walcy/H-5133-2017; teodoro, walcy/J-7602-2018; , Capelozzi/N-1737-2019; Kjerulf, Diego Gomes/C-4037-2014; Furukawa, Luzia/A-1257-2013; Nakandakare, Edna R/D-6625-2012; Passarelli, Marisa/C-8129-2012	Teodoro, Walcy/0000-0001-7559-4542; teodoro, walcy/0000-0001-7559-4542; , Capelozzi/0000-0001-9732-5853; Kjerulf, Diego Gomes/0000-0002-4115-2428; Furukawa, Luzia/0000-0002-0457-6651; Pereira Velosa, Ana Paula/0000-0002-6465-0796; delmonte, samuel/0000-0002-3289-4577; Quintao, Eder/0000-0001-9810-3259	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2013/11084-0, 2012/19755-9, 2011/16164-7, 2011/04631-0]; Antonio dos Santos Filho for the animal care; Rheumatology Division for the availability of the animal housing unit (Centro de Manutencao e Experimentacao de Animais da Clinica Medica) [LIM-17]; Laboratorio de Investigacao Medica do Hospital das Clinicas (LIM); Fundacao Faculdade de Medicina	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Antonio dos Santos Filho for the animal care; Rheumatology Division for the availability of the animal housing unit (Centro de Manutencao e Experimentacao de Animais da Clinica Medica); Laboratorio de Investigacao Medica do Hospital das Clinicas (LIM); Fundacao Faculdade de Medicina	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP grants 2013/11084-0 to SC; 2012/19755-9 to MP; 2011/16164-7 to FBF and 2011/04631-0 to DJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (grants 2013/11084-0 to SC; 2012/19755-9 to MP; 2011/16164-7 to FBF and 2011/ 04631-0 to DJG).; The authors wish to acknowledge Jussara C. Rocha, Professors Jose L. Guerra and Marcia M. Jerico for providing invaluable suggestions and constructive discussion regarding the study, Antonio dos Santos Filho for the animal care, Karolline Santana for the expert assistance with the figures, the Rheumatology Division (LIM-17) for the availability of the animal housing unit (Centro de Manutencao e Experimentacao de Animais da Clinica Medica), and Laboratorio de Investigacao Medica do Hospital das Clinicas (LIM) and Fundacao Faculdade de Medicina for continuous and generous support.	Alderman MH, 2004, J AM SOC NEPHROL, V15, pS47, DOI 10.1097/01.ASN.0000093236.74397.F3; Alderman MH, 2010, JAMA-J AM MED ASSOC, V303, P448, DOI 10.1001/jama.2010.69; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bouguerne B, 2011, ANTIOXID REDOX SIGN, V14, P2093, DOI 10.1089/ars.2010.3321; BRENSILVER JM, 1985, KIDNEY INT, V27, P497, DOI 10.1038/ki.1985.38; Catanozi S, 2003, J LIPID RES, V44, P727, DOI 10.1194/jlr.M200330-JLR200; Catanozi S, 2001, ATHEROSCLEROSIS, V158, P81, DOI 10.1016/S0021-9150(01)00415-4; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; Curfs DMJ, 2004, AM J PATHOL, V164, P101, DOI 10.1016/S0002-9440(10)63101-X; Daugherty A, 2004, CIRCULATION, V110, P3849, DOI 10.1161/01.CIR.0000150540.54220.C4; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P281, DOI 10.1089/ars.2012.4918; Dikalov SI, 2013, ANTIOXID REDOX SIGN, V19, P1085, DOI 10.1089/ars.2012.4604; El Mouedden M, 2007, PHARMACOL BIOCHEM BE, V86, P458, DOI 10.1016/j.pbb.2007.01.003; Ferreira DN, 2010, J NUTR, V140, P1742, DOI 10.3945/jn.109.117473; Fu MX, 1996, J BIOL CHEM, V271, P9982, DOI 10.1074/jbc.271.17.9982; Galvani S, 2008, FREE RADICAL BIO MED, V45, P1457, DOI 10.1016/j.freeradbiomed.2008.08.026; Garg R, 2014, HYPERTENSION, V64, P1384, DOI 10.1161/HYPERTENSIONAHA.114.03880; Garg R, 2011, METABOLISM, V60, P965, DOI 10.1016/j.metabol.2010.09.005; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Goel Reema, 2008, Arterioscler Thromb Vasc Biol, V28, P1996, DOI 10.1161/ATVBAHA.108.172270; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; Graudal NA, 2012, AM J HYPERTENS, V25, P1, DOI 10.1038/ajh.2011.210; Humalda JK, 2014, CURR OPIN NEPHROL HY, V23, P533, DOI 10.1097/MNH.0000000000000073; Ivanovski O, 2005, ATHEROSCLEROSIS, V180, P271, DOI 10.1016/j.atherosclerosis.2004.12.020; Johns C, 1996, HYPERTENSION, V28, P1064, DOI 10.1161/01.HYP.28.6.1064; Kalea AZ, 2009, FASEB J, V23, P1766, DOI 10.1096/fj.08-117739; KATSUTANI N, 1992, INT J IMMUNOPHARMACO, V14, P673, DOI 10.1016/0192-0561(92)90130-D; Keidar S, 1999, ATHEROSCLEROSIS, V146, P249, DOI 10.1016/S0021-9150(99)00145-8; Keidar S, 1997, BIOCHEM BIOPH RES CO, V236, P622, DOI 10.1006/bbrc.1997.6844; Krikken JA, 2012, NUTR METAB CARDIOVAS, V22, P35, DOI 10.1016/j.numecd.2010.03.010; Lichtman AH, 1999, ARTERIOSCL THROM VAS, V19, P1938, DOI 10.1161/01.ATV.19.8.1938; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Diez R, 2013, GENOME BIOL EVOL, V5, P2420, DOI 10.1093/gbe/evt188; MITCHELL JA, 1990, DRUG SAFETY, V5, P168, DOI 10.2165/00002018-199005030-00002; Nakandakare ER, 2008, ATHEROSCLEROSIS, V200, P410, DOI 10.1016/j.atherosclerosis.2007.12.034; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute for Laboratory Animal Research (US) and National Academies Press (US), 2011, GUIDE CARE USE LAB A; Nickenig G, 2000, BRIT J PHARMACOL, V131, P795, DOI 10.1038/sj.bjp.0703623; Nickenig G, 1997, AM J PHYSIOL-HEART C, V272, pH2701, DOI 10.1152/ajpheart.1997.272.6.H2701; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Rugale C, 2007, J CARDIOVASC PHARM, V50, P293, DOI 10.1097/FJC.0b013e3180a72606; RUPPERT M, 1994, AM J MED SCI, V307, pS87; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Tikellis C, 2012, HYPERTENSION, V60, P98, DOI 10.1161/HYPERTENSIONAHA.112.191767; Van Assche T, 2011, J VASC RES, V48, P31, DOI 10.1159/000317398; Weiss D, 2001, CIRCULATION, V103, P448; Wiesel P, 1997, HYPERTENSION, V29, P1025, DOI 10.1161/01.HYP.29.4.1025; Zhang YH, 2014, J RENIN-ANGIO-ALDO S, V16, P292	47	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177086	10.1371/journal.pone.0177086	http://dx.doi.org/10.1371/journal.pone.0177086			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481921	Green Published, Green Submitted, gold			2022-12-27	WOS:000401313700032
J	Tasmin, R; Hasan, NA; Grim, CJ; Grant, A; Choi, SY; Alam, MS; Bell, R; Cavanaugh, C; Balan, KV; Babu, US; Parveen, S				Tasmin, Rizwana; Hasan, Nur A.; Grim, Christopher J.; Grant, Ar'Quette; Choi, Seon Young; Alam, M. Samiul; Bell, Rebecca; Cavanaugh, Christopher; Balan, Kannan V.; Babu, Uma S.; Parveen, Salina			Genotypic and phenotypic characterization of multidrug resistant Salmonella Typhimurium and Salmonella Kentucky strains recovered from chicken carcasses	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ANTIMICROBIAL RESISTANCE; SUBSYSTEMS TECHNOLOGY; ACTIN CYTOSKELETON; VIRULENCE PLASMIDS; MICROBIAL GENOMES; GRANULOSA-CELLS; UNITED-STATES; GENES; 1,2-PROPANEDIOL	Salmonella Typhimurium is the leading cause of human non-typhoidal gastroenteritis in the US. S. Kentucky is one the most commonly recovered serovars from commercially processed poultry carcasses. This study compared the genotypic and phenotypic properties of two Salmonella enterica strains Typhimurium (ST221_31B) and Kentucky (SK222_32B) recovered from commercially processed chicken carcasses using whole genome sequencing, phenotype characterizations and an intracellular killing assay. Illumina MiSeq platform was used for sequencing of two Salmonella genomes. Phylogenetic analysis employing homologous alignment of a 1,185 non-duplicated protein-coding gene in the Salmonella core genome demonstrated fully resolved bifurcating patterns with varying levels of diversity that separated ST221_31B and SK222_32B genomes into distinct monophyletic serovar clades. Single nucleotide polymorphism (SNP) analysis identified 2,432 (ST19) SNPs within 13 Typhimurium genomes including ST221_31B representing Sequence Type ST19 and 650 (ST152) SNPs were detected within 13 Kentucky genomes including SK222_32B representing Sequence Type ST152. In addition to serovar-specific conserved coding sequences, the genomes of ST221_31B and SK222_32B harbor several genomic regions with significant genetic differences. These included phage and phage-like elements, carbon utilization or transport operons, fimbriae operons, putative membrane associated protein-encoding genes, antibiotic resistance genes, siderophore operons, and numerous hypothetical protein-encoding genes. Phenotype microarray results demonstrated that ST221_31B is capable of utilizing certain carbon compounds more efficiently as compared to SK222_3B; namely, 1,2-propanediol, M-inositol, L-threonine, a-D-lactose, D-tagatose, adonitol, formic acid, acetoacetic acid, and L-tartaric acid. ST221_31B survived for 48 h in macrophages, while SK222_32B was mostly eliminated. Further, a 3-fold growth of ST221_31B was observed at 24 hours post-infection in chicken granulosa cells while SK222_32B was unable to replicate in these cells. These results suggest that Salmonella Typhimurium can survive host defenses better and could be more invasive than Salmonella Kentucky and provide some insights into the genomic determinants responsible for these differences.	[Tasmin, Rizwana; Grant, Ar'Quette; Parveen, Salina] Univ Maryland Eastern Shore, Agr Food & Resource Sci, Princess Anne, MD 21853 USA; [Hasan, Nur A.] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA; [Hasan, Nur A.; Choi, Seon Young] CosmosID Inc, Rockville, MD USA; [Grim, Christopher J.; Alam, M. Samiul; Cavanaugh, Christopher; Balan, Kannan V.; Babu, Uma S.] US FDA, Off Appl Res & Safety Assessment, Ctr Food Safety & Appl Nutr, Laurel, MD USA; [Bell, Rebecca] US FDA, Off Regulatory Sci, Ctr Food Safety & Appl Nutr, College Pk, MD USA	University System of Maryland; University of Maryland Eastern Shore; University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Parveen, S (corresponding author), Univ Maryland Eastern Shore, Agr Food & Resource Sci, Princess Anne, MD 21853 USA.	sparveen@umes.edu	Balan, Kannan/P-8892-2015; hasan, nur a/AAX-3881-2021	hasan, nur a/0000-0003-0175-8879	USDA Evans-Allen Grant; USFDA; FDA; Research Participation Program at the U.S. Food and Drug Administration; Cosmos ID Inc.	USDA Evans-Allen Grant; USFDA; FDA(United States Department of Health & Human Services); Research Participation Program at the U.S. Food and Drug Administration; Cosmos ID Inc.	This research was funded in part by USDA Evans-Allen Grant and USFDA. CJG was supported through an FDA funded research contract, administered by Goldbelt C6. CC and KVB were supported by the Research Participation Program at the U.S. Food and Drug Administration, administered by the Oak Ridge Institute for Science and Education. Cosmos ID Inc. provided support in the form of salaries for author NH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Alam MS, 2006, MICROB PATHOGENESIS, V40, P116, DOI 10.1016/j.micpath.2005.11.007; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; BOWE F, 1994, METHOD ENZYMOL, V236, P509; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; *CDC, 2008, SALM SURV ANN SUMM 2; Cheng SQ, 2011, J BACTERIOL, V193, P1385, DOI 10.1128/JB.01473-10; Chu CS, 2006, MICROBES INFECT, V8, P1931, DOI 10.1016/j.micinf.2005.12.026; Conner CP, 1998, P NATL ACAD SCI USA, V95, P4641, DOI 10.1073/pnas.95.8.4641; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; GILBERT AB, 1977, J REPROD FERTIL, V50, P179, DOI 10.1530/jrf.0.0500179; Haley BJ, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01289-16; Hoffmann M, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01068-13; Hoffmann S, 2015, EC INFORM B, V140, P53; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Le Hello S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00395; Le Hello S, 2011, J INFECT DIS, V204, P675, DOI 10.1093/infdis/jir409; Lindgren SW, 1996, P NATL ACAD SCI USA, V93, P4197, DOI 10.1073/pnas.93.9.4197; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mohamed T, 2014, FOOD MICROBIOL, V38, P6, DOI 10.1016/j.fm.2013.08.002; Montero I, 2013, PLASMID, V70, P104, DOI 10.1016/j.plasmid.2013.03.002; OBRADORS N, 1988, J BACTERIOL, V170, P2159, DOI 10.1128/jb.170.5.2159-2162.1988; Oscar TP, 2010, J FOOD PROTECT, V73, P1596, DOI 10.4315/0362-028X-73.9.1596; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Parveen S, 2007, J FOOD PROTECT, V70, P2466, DOI 10.4315/0362-028X-70.11.2466; Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001; Rabsch W, 2002, INFECT IMMUN, V70, P2249, DOI 10.1128/IAI.70.5.2249-2255.2002; Ramos-Morales F, 2012, ISRN CELL BIOL, P78934; Rotger R, 1999, Int Microbiol, V2, P177; Russell SM, 2012, Controlling Salmonella in Poultry Production and Processing, P1, DOI 10.1201/b11519; Rychlik I, 2006, VET MICROBIOL, V112, P1, DOI 10.1016/j.vetmic.2005.10.030; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Sheppard AE, 2016, ANTIMICROB AGENTS CH, V60, P3767, DOI 10.1128/AAC.00464-16; Sly LM, 2002, INFECT IMMUN, V70, P5312, DOI 10.1128/IAI.70.9.5312-5315.2002; Sneeringer S., 2015, RESTRICTIONS ANTIBIO; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thiagarajan D, 1996, INFECT IMMUN, V64, P5015, DOI 10.1128/IAI.64.12.5015-5021.1996; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; USDA, 2013, SER PROF SALM STRAIN; USDA, 2003, FSIS NOT; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Winter SE, 2011, GUT MICROBES, V2, P58, DOI 10.4161/gmic.2.1.14911; Zhao S, 2006, J FOOD PROTECT, V69, P500, DOI 10.4315/0362-028X-69.3.500; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	52	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e176938	10.1371/journal.pone.0176938	http://dx.doi.org/10.1371/journal.pone.0176938			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481935	gold, Green Published, Green Submitted			2022-12-27	WOS:000401313700025
J	Fisher, P; Aumann, C; Chia, K; O'Halloran, N; Chandra, S				Fisher, Peter; Aumann, Colin; Chia, Kohleth; O'Halloran, Nick; Chandra, Subhash			Adequacy of laser diffraction for soil particle size analysis	PLOS ONE			English	Article							SODIUM-HYPOCHLORITE; PLUMMET BALANCE; ORGANIC-MATTER; CLAY; DIFFRACTOMETRY; DISTRIBUTIONS; SENSITIVITY; INSTRUMENT; HYDROMETER; FRACTIONS	Sedimentation has been a standard methodology for particle size analysis since the early 1900s. In recent years laser diffraction is beginning to replace sedimentation as the prefered technique in some industries, such as marine sediment analysis. However, for the particle size analysis of soils, which have a diverse range of both particle size and shape, laser diffraction still requires evaluation of its reliability. In this study, the sedimentation based sieve plummet balance method and the laser diffraction method were used to measure the particle size distribution of 22 soil samples representing four contrasting Australian Soil Orders. Initially, a precise wet riffling methodology was developed capable of obtaining representative samples within the recommended obscuration range for laser diffraction. It was found that repeatable results were obtained even if measurements were made at the extreme ends of the manufacturer's recommended obscuration range. Results from statistical analysis suggested that the use of sample pretreatment to remove soil organic carbon ( and possible traces of calcium-carbonate content) made minor differences to the laser diffraction particle size distributions compared to no pretreatment. These differences were found to be marginally statistically significant in the Podosol topsoil and Vertosol subsoil. There are well known reasons why sedimentation methods may be considered to 'overestimate' plate-like clay particles, while laser diffraction will 'underestimate' the proportion of clay particles. In this study we used Lin's concordance correlation coefficient to determine the equivalence of laser diffraction and sieve plummet balance results. The results suggested that the laser diffraction equivalent thresholds corresponding to the sieve plummet balance cumulative particle sizes of < 2 mu m, < 20 mu m, and < 200 mu m, were < 9 mu m, < 26 mu m, < 275 mu m respectively. The many advantages of laser diffraction for soil particle size analysis, and the empirical results of this study, suggest that deployment of laser diffraction as a standard test procedure can provide reliable results, provided consistent sample preparation is used.	[Fisher, Peter; Aumann, Colin; Chia, Kohleth; O'Halloran, Nick; Chandra, Subhash] Dept Econ Dev Jobs Transport & Resources, Agr Res & Dev Div, Tatura, Vic, Australia		Fisher, P (corresponding author), Dept Econ Dev Jobs Transport & Resources, Agr Res & Dev Div, Tatura, Vic, Australia.	peter.fisher@ecodev.vic.gov.au	Fisher, Peter/T-4121-2019		Victorian Department of Economic Development, Jobs, Transport Resources	Victorian Department of Economic Development, Jobs, Transport Resources	The research was undertaken with funding from the Victorian Department of Economic Development, Jobs, Transport & Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Allen, 1997, POWDER SAMPLING PART; Altman D.G., 1990, PRACTICAL STAT MED R, DOI DOI 10.1201/9780429258589; [Anonymous], 2002, D11277 ISO; Arriaga FJ, 2006, SOIL SCI, V171, P663, DOI 10.1097/01.ss.0000228056.92839.88; Blott SJ, 2006, SEDIMENTOLOGY, V53, P671, DOI 10.1111/j.1365-3091.2006.00786.x; Buurman P, 2001, GEOL MIJNBOUW-N J G, V80, P49, DOI 10.1017/S0016774600022319; Buurman P, 1997, SOIL SCI, V162, P211, DOI 10.1097/00010694-199703000-00007; Cheshire MV, 2000, EUR J SOIL SCI, V51, P497, DOI 10.1111/j.1365-2389.2000.00325.x; Cochran W.G., 1967, STAT METHODS; Di Stefano C, 2010, BIOSYST ENG, V106, P205, DOI 10.1016/j.biosystemseng.2010.03.013; Emerson WW, 2000, AUST J SOIL RES, V38, P203, DOI 10.1071/SR97105; Ernst MD, 2004, PERMUTATION METHODS, P676; Eshel G, 2004, SOIL SCI SOC AM J, V68, P736, DOI 10.2136/sssaj2004.0736; Fedotov GN, 2007, EURASIAN SOIL SCI+, V40, P281, DOI 10.1134/S1064229307030064; Galwey N. W., 2014, INTRO MIXED MODELLIN; GEE GW, 1979, SOIL SCI SOC AM J, V43, P1004, DOI 10.2136/sssaj1979.03615995004300050038x; Goossens D, 2008, SEDIMENTOLOGY, V55, P65, DOI 10.1111/j.1365-3091.2007.00893.x; GUGGENHEIM S, 1995, CLAY CLAY MINER, V43, P255, DOI 10.1346/CCMN.1995.0430213; Hall AD, 1904, J CHEM SOC, V85, P950, DOI 10.1039/ct9048500950; Hutton JT, 1955, 11 CSIRO DIV SOILS; Isbell R.F., 2002, AUSTR SOIL CLASSIFIC; Kerry R, 2009, GEODERMA, V152, P324, DOI 10.1016/j.geoderma.2009.06.018; Konert M, 1997, SEDIMENTOLOGY, V44, P523, DOI 10.1046/j.1365-3091.1997.d01-38.x; Kowalenko CG, 2013, GEODERMA, V193, P22, DOI 10.1016/j.geoderma.2012.09.006; Lin L., 2000, BIOMETRICS, V56, P324, DOI [10.1111/j.0006-341X.2000.00324.x, DOI 10.1111/J.0006-341X.2000.00324.X]; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lu N, 2000, GEOTECH TEST J, V23, P487; Ma ZH, 2000, POWDER TECHNOL, V111, P66, DOI 10.1016/S0032-5910(00)00242-4; MARSHALL T. J., 1956, AUSTRALIAN JOUR APPL SCI, V7, P142; Mason C., 2011, NMBAQCS BEST PRACTIC; Matthews MD, 1991, PRINCIPLES METHODS A; Mcintyre D, 1974, METHODS ANAL IRRIGAT, V11; MIKHAIL EH, 1978, AUST J SOIL RES, V16, P241, DOI 10.1071/SR9780241; Mikutta R, 2005, SOIL SCI SOC AM J, V69, P120, DOI 10.2136/sssaj2005.0120; Miller BA, 2012, SOIL SCI SOC AM J, V76, P1719, DOI 10.2136/sssaj2011.0303; Miller W.P., 1988, J AGRONOMY ED, V17, P24; NELSON DW, 1973, AGRON J, V65, P109, DOI 10.2134/agronj1973.00021962006500010033x; OMUETI JAI, 1980, SOIL SCI SOC AM J, V44, P878, DOI 10.2136/sssaj1980.03615995004400040044x; Ozer M, 2010, ENVIRON ENG GEOSCI, V16, P163, DOI 10.2113/gseegeosci.16.2.163; Pabst W, 2000, J EUR CERAM SOC, V20, P1429, DOI 10.1016/S0955-2219(00)00016-9; Payne R, 2016, GENSTAT WINDOWS INTR; Pearson K., 1896, P ROY SOC LONDON, V60, P489, DOI DOI 10.1098/RSPL.1896.0076; Piper C.S, 1942, SOIL PLANT ANAL LAB; Rayment G.E., 1992, AUSTR SOIL LAND SURV; Roberson S, 2014, SEDIMENTOLOGY, V61, P1157, DOI 10.1111/sed.12093; Ryzak M, 2011, J PLANT NUTR SOIL SC, V174, P624, DOI 10.1002/jpln.201000255; Scealy JL, 2014, AUST NZ J STAT, V56, P145, DOI 10.1111/anzs.12073; Scott-Jackson JE, 2005, J ARCHAEOL SCI, V32, P969, DOI 10.1016/j.jas.2005.01.013; SHELDRICK BH, 1976, CAN J SOIL SCI, V56, P55, DOI 10.4141/cjss76-008; SLAGER S, 1964, SEDIMENTOLOGY, V3, P240, DOI 10.1111/j.1365-3091.1964.tb00463.x; Sochan A, 2015, SOIL SCI SOC AM J, V79, P37, DOI 10.2136/sssaj2013.07.0308n; Sperazza M, 2004, J SEDIMENT RES, V74, P736, DOI 10.1306/031104740736; Standards Australia, 2003, 1289332003 AS; Vdovic N, 2010, EUR J SOIL SCI, V61, P854, DOI 10.1111/j.1365-2389.2010.01298.x; Watson DF., 1989, MATH GEOL, V21, P233, DOI 10.1007/bf00893217; WEIPENG W, 2015, PLOS ONE, V0010; Zobeck TM, 2004, APPL ENG AGRIC, V20, P633	58	65	67	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176510	10.1371/journal.pone.0176510	http://dx.doi.org/10.1371/journal.pone.0176510			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472043	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500049
J	He, JB; Chen, YH; Lin, Y; Zhang, WY; Cai, YJ; Chen, F; Liao, QH; Yin, ZH; Wang, Y; Tao, SB; Lin, XL; Huang, PR; Cui, LL; Shao, YM				He, Junbing; Chen, Yuhua; Lin, Yao; Zhang, Wenying; Cai, Yujie; Chen, Feng; Liao, Qinghui; Yin, Zihan; Wang, Yan; Tao, Shoubao; Lin, Xiaoli; Huang, Pengru; Cui, Lili; Shao, Yiming			Association study of MCP-1 promoter polymorphisms with the susceptibility and progression of sepsis	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; SINGLE-NUCLEOTIDE POLYMORPHISMS; CHEMOTACTIC PROTEIN-1; SEPTIC SHOCK; GENETIC POLYMORPHISMS; MICE; RECRUITMENT; CHEMOKINES; CYTOKINES; SEVERITY	Previous studies have indicated that the monocyte chemo-attractant protein 1 (MCP-1), also referred to as C-C motif chemokine ligand 2 (CCL2), plays a significant role in the pathogenesis of sepsis, and this study investigated the clinical relevance of two MCP-1 gene polymorphisms on sepsis onset and progression. The Multiplex SNaPshot genotyping method was used to detect MCP-1 gene polymorphisms in the Chinese Han population (403 sepsis patients and 400 controls). MCP-1 mRNA expression levels were measured using real-time quantitative PCR, and enzyme-linked immunosorbent assays were used to analyze MCP-1, tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (IL-6) and interleukin-1 beta (IL-1 beta) plasma concentrations. The rs1024611 polymorphism analysis showed lower frequencies of minor homozygous genotype (AA) and allele (A) in sepsis patients compared to the healthy controls (19.4% vs. 31.5%, P = 0.0001 and 45.9% vs. 54.8%, P = 0.0004, respectively). And the frequencies of GG genotype and G allele were lower in sepsis patients compared to the controls (19.6% vs. 31.3%, P = 0.0002 and 46.0% vs. 54.5%, P = 0.0007, respectively). The rs1024611 AG/GG and rs2857656 GC/CC genotypes were both overrepresented in patients with severe sepsis (both P = 0.0005) and septic shock (P = 0.010 and P = 0.015, respectively) compared to the patients with mild sepsis. Moreover, among sepsis patients, the rs1024611 AG/GG and rs2857656 GC/CC carriers exhibited significant increases in expression levels of MCP-1 (P = 0.025), TNF-alpha (P = 0.034) and IL-6 (P = 0.043) compared with the rs1024611 AA or rs2857656 GG carriers. This study provides valuable clinical evidence that the MCP-1/CCL2 polymorphisms rs1024611 and rs2857656 are associated with sepsis susceptibility and development. We conclude that MCP-1/CCL2 plays a significant role in the pathogenesis of sepsis, which has potentially important therapeutic implications.	[He, Junbing; Zhang, Wenying; Chen, Feng; Yin, Zihan; Tao, Shoubao; Shao, Yiming] Guangdong Med Univ, Affiliated Hosp, Guangdong Key Lab Age Related Cardiac & Cerebral, Intens Care Unit, Zhanjiang, Guangdong, Peoples R China; [Chen, Yuhua; Liao, Qinghui] Longgang Dist Peoples Hosp Shenzhen, Dept Endocrinol & Metab, Shenzhen, Guangdong, Peoples R China; [Lin, Yao; Lin, Xiaoli] Sun Yat Sen Univ, Jieyang Affiliated Hosp, Dept Stomatol, Jieyang, Guangdong, Peoples R China; [Cai, Yujie; Wang, Yan; Huang, Pengru; Cui, Lili] Guangdong Med Univ, Affiliated Hosp, Guangdong Key Lab Age Related Cardiac & Cerebral, Inst Neurol, Zhanjiang, Guangdong, Peoples R China	Guangdong Medical University; Sun Yat Sen University; Guangdong Medical University	Shao, YM (corresponding author), Guangdong Med Univ, Affiliated Hosp, Guangdong Key Lab Age Related Cardiac & Cerebral, Intens Care Unit, Zhanjiang, Guangdong, Peoples R China.; Cui, LL (corresponding author), Guangdong Med Univ, Affiliated Hosp, Guangdong Key Lab Age Related Cardiac & Cerebral, Inst Neurol, Zhanjiang, Guangdong, Peoples R China.	cuilili@gdmu.edu.cn; yimingshao_gmc@126.com	, YoMo/AGX-5555-2022	, YoMo/0000-0003-0273-2531	National Nature Science Foundation of China [81471326, 81301038, 81401061]; special competitive assignment funds of Zhanjiang City [2016A01026]; Startup Fund of Affiliated Hospital of Guangdong Medical College [BJ201507]; Health Science and Technology Funds of Longgang District, Shenzhen City [20160612104602724]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); special competitive assignment funds of Zhanjiang City; Startup Fund of Affiliated Hospital of Guangdong Medical College; Health Science and Technology Funds of Longgang District, Shenzhen City	This work was supported by funding from the National Nature Science Foundation of China (81471326, 81301038 and 81401061), the special competitive assignment fiscal funds of Zhanjiang City (2016A01026), the PhD Startup Fund of Affiliated Hospital of Guangdong Medical College (BJ201507), and the Health Science and Technology Funds of Longgang District, Shenzhen City (20160612104602724).	Aguilar F, 2001, TISSUE ANTIGENS, V58, P335, DOI 10.1034/j.1399-0039.2001.580508.x; BOSSINK AWJ, 1995, BLOOD, V86, P3841, DOI 10.1182/blood.V86.10.3841.bloodjournal86103841; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Cui LL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0796-x; Da LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082855; Damas JK, 2001, BASIC RES CARDIOL, V96, P345, DOI 10.1007/s003950170042; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Guo CF, 2014, DIAGN MICR INFEC DIS, V78, P49, DOI 10.1016/j.diagmicrobio.2013.07.024; Han YL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035506, 10.1371/journal.pone.0048966]; Hanemann ALP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080421; Holtkamp GM, 1999, CLIN EXP IMMUNOL, V118, P35; Hotchkiss RS, 2015, SCIENCE, V347, P1201, DOI 10.1126/science.aaa8334; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kimura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091522; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Labbe K, 2010, CRIT CARE, V14, DOI 10.1186/cc9295; Li YW, 2015, J DIGEST DIS, V16, P177, DOI 10.1111/1751-2980.12232; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Matsukawa A, 2000, EXP MOL PATHOL, V68, P77, DOI 10.1006/exmp.1999.2296; Namath A, 2011, CRIT CARE NURS CLIN, V23, P181, DOI 10.1016/j.ccell.2010.12.011; Nyquist P, 2010, CEREBROVASC DIS, V29, P242, DOI 10.1159/000267849; Nyquist PA, 2009, CEREBROVASC DIS, V28, P124, DOI 10.1159/000223437; Ozyurek AR, 2007, CLIN RHEUMATOL, V26, P546, DOI 10.1007/s10067-006-0347-6; Palmieri O, 2010, AM J GASTROENTEROL, V105, P1586, DOI 10.1038/ajg.2010.4; Ping DS, 1996, IMMUNITY, V4, P455, DOI 10.1016/S1074-7613(00)80412-4; Ramnath RD, INT IMMUNOPHARMACOL; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Salama MK, 2014, WORLD J GASTROENTERO, V20, P11793, DOI 10.3748/wjg.v20.i33.11793; Shao Y, 2017, CLIN GENET, V91, P564, DOI 10.1111/cge.12800; Shao YM, 2016, CELL PHYSIOL BIOCHEM, V39, P1247, DOI 10.1159/000447830; Shimada T, 2011, CYTOKINE, V54, P79, DOI 10.1016/j.cyto.2010.12.001; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sipahi T, 2006, CLIN APPL THROMB-HEM, V12, P47, DOI 10.1177/107602960601200108; Slimani H, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0527-8; Speyer CL, 2004, AM J PATHOL, V165, P2187, DOI 10.1016/S0002-9440(10)63268-3; Suffredini AF, 2011, JAMA-J AM MED ASSOC, V306, P194, DOI 10.1001/jama.2011.909; Szakmany T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167230; Taub Dennis D., 1996, Cytokine and Growth Factor Reviews, V7, P355, DOI 10.1016/S1359-6101(97)89237-4; Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352; Tsuda Y, 2004, J LEUKOCYTE BIOL, V76, P368, DOI 10.1189/jlb.1203645; Turler A, 2002, AM J PHYSIOL-GASTR L, V282, pG145, DOI 10.1152/ajpgi.00263.2001; UEDA A, 1994, J IMMUNOL, V153, P2052; Valente AJ, 1998, J IMMUNOL, V161, P3719; Walczak Anna, 2012, Pol Przegl Chir, V84, P238, DOI 10.2478/v10035-012-0039-7; Zhang HL, 2007, AM J PHYSIOL-LUNG C, V292, pL960, DOI 10.1152/ajplung.00388.2006; Ziraldo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079804	51	21	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176781	10.1371/journal.pone.0176781	http://dx.doi.org/10.1371/journal.pone.0176781			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472164	Green Submitted, gold, Green Published			2022-12-27	WOS:000400648500071
J	Kroeger, T; Frieg, B; Zhang, T; Hansen, FK; Marmann, A; Proksch, P; Nagel-Steger, L; Groth, G; Smits, SHJ; Gohlke, H				Kroeger, Tobias; Frieg, Benedikt; Zhang, Tao; Hansen, Finn K.; Marmann, Andreas; Proksch, Peter; Nagel-Steger, Luitgard; Groth, Georg; Smits, Sander H. J.; Gohlke, Holger			EDTA aggregates induce SYPRO orange-based fluorescence in thermal shift assay	PLOS ONE			English	Article							DIFFERENTIAL SCANNING FLUOROMETRY; RANGE ELECTROSTATIC INTERACTIONS; MOLECULAR-DYNAMICS SIMULATIONS; X-RAY; TEMPERATURE-DEPENDENCE; PROTEIN; BINDING; SODIUM; WATER; FIBRINOGEN	Ethylenediaminetetraacetic acid (EDTA) is widely used in the life sciences as chelating ligand of metal ions. However, formation of supramolecular EDTA aggregates at pH > 8 has been reported, which may lead to artifactual assay results. When applied as a buffer component at pH approximate to 10 in differential scanning fluorimetry (TSA) using SYPRO Orange as fluorescent dye, we observed a sharp change in fluorescence intensity about 20 degrees C lower than expected for the investigated protein. We hypothesized that this change results from SYPRO Orange/EDTA interactions. TSA experiments in the presence of SYPRO Orange using solutions that contain EDTA-Na+ but no protein were performed. The TSA experiments provide evidence that suggests that at pH > 9, EDTA(4-) interacts with SYPRO Orange in a temperature-dependent manner, leading to a fluorescence signal yielding a "denaturation temperature" of similar to 68 degrees C. Titrating Ca2+ to SYPRO Orange and EDTA solutions quenched fluorescence. Ethylene glycol tetraacetic acid (EGTA) behaved similarly to EDTA. Analytical ultracentrifugation corroborated the formation of EDTA aggregates. Molecular dynamics simulations of free diffusion of EDTA-Na+ and SYPRO Orange of in total 27 mu s suggested the first structural model of EDTA aggregates in which U-shaped EDTA(4-) arrange in an inverse bilayer-like manner, exposing ethylene moieties to the solvent, with which SYPRO Orange interacts. We conclude that EDTA aggregates induce a SYPRO Orange-based fluorescence in TSA. These results make it relevant to ascertain that future TSA results are not influenced by interference between EDTA, or EDTA-related molecules, and the fluorescent dye.	[Kroeger, Tobias; Frieg, Benedikt; Hansen, Finn K.; Gohlke, Holger] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, Dusseldorf, Germany; [Zhang, Tao; Nagel-Steger, Luitgard] Heinrich Heine Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Zhang, Tao; Nagel-Steger, Luitgard] Forschungszentrum Julich, Inst Complex Syst Struct Biochem ICS 6, Julich, Germany; [Marmann, Andreas; Proksch, Peter] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut Biol & Biotechnol, Dusseldorf, Germany; [Groth, Georg] Heinrich Heine Univ Dusseldorf, Inst Biochem Plant Physiol, Dusseldorf, Germany; [Smits, Sander H. J.] Heinrich Heine Univ Dusseldorf, Inst Biochem, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Gohlke, H (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, Dusseldorf, Germany.	gohlke@uni-duesseldorf.de	Zhang, Tao/O-6541-2019; Nagel-Steger, Luitgard/H-6415-2013; Proksch, Peter/AAR-4593-2020	Zhang, Tao/0000-0003-2970-0468; Nagel-Steger, Luitgard/0000-0001-5232-2149; Hansen, Finn Kristian/0000-0001-9765-5975; Frieg, Benedikt/0000-0002-7877-0262	Deutsche Forschungsgemeinschaft (DFG) [INST 208/704-1 FUGG]; Deutsche Forschungsgemeinschaft (DFG) through the Graduate School ("Natural products and natural product analogs against therapy resistant tumors and microorganisms: new lead structures and modes of action", Dusseldorf) [GRK2158]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG) through the Graduate School ("Natural products and natural product analogs against therapy resistant tumors and microorganisms: new lead structures and modes of action", Dusseldorf)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) by funds (INST 208/704-1 FUGG) to purchase the hybrid computer cluster used in this study, and the Deutsche Forschungsgemeinschaft (DFG) through the Graduate School GRK2158 ("Natural products and natural product analogs against therapy resistant tumors and microorganisms: new lead structures and modes of action", Dusseldorf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassopoulou J, 2012, INFRARED SPECTROSCOPY - LIFE AND BIOMEDICAL SCIENCES, P259; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Aziz EF, 2008, J PHYS CHEM B, V112, P12567, DOI 10.1021/jp805177v; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Boonyarattanakalin K, 2015, SCI PHARM, V83, P387, DOI 10.3797/scipharm.1412-08; Bradbrook GM, 1998, J CHEM SOC FARADAY T, V94, P1603, DOI 10.1039/a800429c; Carballo-Pacheco M, 2016, J PHYS CHEM B, V120, P2991, DOI 10.1021/acs.jpcb.6b00059; Case DA, 2014, AMBER 14; Case DA, 2012, AMBER 12; Chen CY, 2015, J PHYS CHEM LETT, V6, P2733, DOI 10.1021/acs.jpclett.5b01134; Cheng SY, 2016, DATA BRIEF, V7, P658, DOI 10.1016/j.dib.2016.03.015; Cherif S, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-221; Ciglia E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096031; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; Collins KD, 1997, BIOPHYS J, V72, P65, DOI 10.1016/S0006-3495(97)78647-8; Corradini D, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4930542; DANG LX, 1992, J CHEM PHYS, V97, P1919, DOI 10.1063/1.463128; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darden T, 1998, J CHEM PHYS, V109, P10921, DOI 10.1063/1.477788; Diedrich D, 2016, CHEM D EUR J; Dorn T, 2006, NEW J CHEM, V30, P156, DOI 10.1039/b510617f; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Elber R, 2005, CURR OPIN STRUC BIOL, V15, P151, DOI 10.1016/j.sbi.2005.02.004; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; Fedorov MV, 2009, J AM CHEM SOC, V131, P10854, DOI 10.1021/ja9030374; Forneris F, 2009, FEBS J, V276, P2833, DOI 10.1111/j.1742-4658.2009.07006.x; Frieg B, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004693; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Han S., 2007, J CHEM-NY, V1, P1; HARRISON DG, 1968, J PHYSIOL-LONDON, V199, P367, DOI 10.1113/jphysiol.1968.sp008658; Haugland RP, 1996, World patent, Patent No. [WO96368821996, 96368821996]; Hess B, 2009, P NATL ACAD SCI USA, V106, P13296, DOI 10.1073/pnas.0902904106; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Jager CM, 2010, LANGMUIR, V26, P10460, DOI 10.1021/la9038123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joubert MK, 2011, J BIOL CHEM, V286, P25118, DOI 10.1074/jbc.M110.160457; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kang I, 1999, FEBS LETT, V462, P89, DOI 10.1016/S0014-5793(99)01509-4; Keshwani N, 2013, BIOPHYS J, V105, P1681, DOI 10.1016/j.bpj.2013.08.018; Kohagen M, 2014, J PHYS CHEM B, V118, P7902, DOI 10.1021/jp5005693; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; Maestro v Schrodinger LLC New York, 2013, MAESTR VERS 9 5; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Mobasheri M, 2016, MOLECULES, V21, DOI 10.3390/molecules21010006; Mountain RD, 2015, J SOLUTION CHEM, V44, P2179, DOI 10.1007/s10953-015-0401-6; MULLER M, 1994, FEBS LETT, V340, P17, DOI 10.1016/0014-5793(94)80164-9; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; NIEUWENHUIZEN W, 1981, THROMB RES, V22, P659, DOI 10.1016/0049-3848(81)90064-5; Panneerselvam S, 2015, MOLECULES, V20, P14915, DOI 10.3390/molecules200814915; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Paschek D, 2004, J CHEM PHYS, V120, P6674, DOI 10.1063/1.1652015; Patel TR, 2016, METHODS, V95, P55, DOI 10.1016/j.ymeth.2015.11.006; PERIZZOLO KE, 1985, ARCH BIOCHEM BIOPHYS, V237, P520, DOI 10.1016/0003-9861(85)90305-4; RAAFLAUB J, 1956, Methods Biochem Anal, V3, P301; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Rosenlehner K, 2010, CHEM-EUR J, V16, P9544, DOI 10.1002/chem.201001150; ROTI JLR, 1985, CYTOMETRY, V6, P101, DOI 10.1002/cyto.990060204; Saeki K, 2007, J BIOSCI BIOENG, V103, P501, DOI 10.1263/jbb.103.501; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; SANDO JJ, 1979, J BIOL CHEM, V254, P4779; Satoh M, 2015, FEBS OPEN BIO, V5, P557, DOI 10.1016/j.fob.2015.06.011; Schafmeister CEAF, 1995, U CALIFORNIA; Steinberg TH, 1996, ANAL BIOCHEM, V239, P223, DOI 10.1006/abio.1996.0319; Steinberg TH, 2009, METHOD ENZYMOL, V463, P541, DOI 10.1016/S0076-6879(09)63031-7; Vrbka L, 2006, P NATL ACAD SCI USA, V103, P15440, DOI 10.1073/pnas.0606959103; Wan KF, 2009, CELL CYCLE, V8, P3943, DOI 10.4161/cc.8.23.10114; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wichmann C, 2010, BLOOD, V116, P603, DOI 10.1182/blood-2009-10-248047; Wildman J, 2016, J CHEM THEORY COMPUT, V12, P3813, DOI 10.1021/acs.jctc.5b01195; Yeh AP, 2006, BIOL CRYSTALLOGRAP 4, V62, P451; YORK DM, 1993, J CHEM PHYS, V99, P8345, DOI 10.1063/1.465608	72	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177024	10.1371/journal.pone.0177024	http://dx.doi.org/10.1371/journal.pone.0177024			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472107	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500123
J	Li, XW; Xu, HX; Feng, L; Fu, X; Zhang, YL; Nansen, C				Li, Xiaowei; Xu, Hongxing; Feng, Ling; Fu, Xiao; Zhang, Yalin; Nansen, Christian			Using proximal remote sensing in non-invasive phenotyping of invertebrates	PLOS ONE			English	Article							IDENTIFICATION; PHENOMICS; EYES	Proximal imaging remote sensing technologies are used to phenotype and to characterize organisms based on specific external body reflectance features. These imaging technologies are gaining interest and becoming more widely used and applied in ecological, systematic, evolutionary, and physiological studies of plants and also of animals. However, important factors may impact the quality and consistency of body reflectance features and therefore the ability to use these technologies as part of non-invasive phenotyping and characterization of organisms. We acquired hyperspectral body reflectance profiles from three insect species, and we examined how preparation procedures and preservation time affected the ability to detect reflectance responses to gender, origin, and age. Different portions of the radiometric spectrum varied markedly in their sensitivity to preparation procedures and preservation time. Based on studies of three insect species, we successfully identified specific radiometric regions, in which phenotypic traits become significantly more pronounced based on either: 1) gentle cleaning of museum specimens with distilled water, or 2) killing and preserving insect specimens in 70% ethanol. Standardization of killing and preservation procedures will greatly increase the ability to use proximal imaging remote sensing technologies as part of phenotyping and also when used in ecological and evolutionary studies of invertebrates.	[Li, Xiaowei; Xu, Hongxing; Nansen, Christian] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China; [Feng, Ling; Fu, Xiao; Zhang, Yalin] Northwest A&F Univ, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Entomol Museum, Yangling, Shaanxi, Peoples R China; [Nansen, Christian] Univ Calif Davis, Dept Entomol & Nematol, Briggs Hall, Davis, CA 95616 USA	Zhejiang Academy of Agricultural Sciences; Northwest A&F University - China; University of California System; University of California Davis	Nansen, C (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China.; Nansen, C (corresponding author), Univ Calif Davis, Dept Entomol & Nematol, Briggs Hall, Davis, CA 95616 USA.	chrnansen@ucdavis.edu	nansen, christian/H-5003-2014	nansen, christian/0000-0003-1324-1949	National Natural Science Foundation of China [31570387]; National Key Research AMP; Development (RAMP;D) Plan of China; State Key Laboratory Breeding Base for Zhejiang Sustainable Pest and Disease Control [2010DS700124-ZM1601, 2010DS700124-ZZ1601, 2010DS700124-KF1603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research AMP; Development (RAMP;D) Plan of China; State Key Laboratory Breeding Base for Zhejiang Sustainable Pest and Disease Control	We would like to thank Dr. Mielewczik and an anonymous reviewer for their careful reviews of an early version of this study. This work was supported by the National Natural Science Foundation of China (grant number 31570387), the National Key Research & Development (R&D) Plan of China (Synergistic technologies for biological pesticides and mechanisms of ecological control of pests), and the State Key Laboratory Breeding Base for Zhejiang Sustainable Pest and Disease Control (grant number 2010DS700124-ZM1601, 2010DS700124-ZZ1601 and 2010DS700124-KF1603).r This work was supported by the National Natural Science Foundation of China (grant number 31570387), the National Key Research & Development (R&D) Plan of China (Synergistic technologies for biological pesticides and mechanisms of ecological control of pests), and the State Key Laboratory Breeding Base for Zhejiang Sustainable Pest and Disease Control (grant number 2010DS700124-ZM1601, 2010DS700124-ZZ1601 and 2010DS700124-KF1603).	Arbuckle T, 2002, INT S INF ENV PROT; Aw WC, 2012, G3-GENES GENOM GENET, V2, P1057, DOI 10.1534/g3.112.003103; Burleigh JG, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.085c713acafc8711b2ff7010a4b03733; Cao Y, 2015, PEST MANAG SCI, V71, P1113, DOI 10.1002/ps.3893; Chiao CC, 2011, P NATL ACAD SCI USA, V108, P9148, DOI 10.1073/pnas.1019090108; Chiao CC, 2009, J EXP BIOL, V212, P2269, DOI 10.1242/jeb.030734; Dowell FE, 1999, J ECON ENTOMOL, V92, P165, DOI 10.1093/jee/92.1.165; Faria FA, 2014, J VIS COMMUN IMAGE R, V25, P1516, DOI 10.1016/j.jvcir.2014.06.014; Fiorani F, 2013, ANNU REV PLANT BIOL, V64, P267, DOI 10.1146/annurev-arplant-050312-120137; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Jia FY, 2007, J ECON ENTOMOL, V100, P759, DOI 10.1603/0022-0493(2007)100[759:DTBACE]2.0.CO;2; Klarica J, 2011, J CHEM ECOL, V37, P549, DOI 10.1007/s10886-011-9956-x; Araus JL, 2014, TRENDS PLANT SCI, V19, P52, DOI 10.1016/j.tplants.2013.09.008; Luo CQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118554; Matzrafi M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00474; Mielewczik M., 2012, ENTOMOLOGIE BEUTE, V24, P183; Nansen C, 2016, J FOOD ENG, V190, P34, DOI 10.1016/j.jfoodeng.2016.06.010; Nansen C, 2016, ANNU REV ENTOMOL, V61, P139, DOI 10.1146/annurev-ento-010715-023834; Nansen C, 2016, PEST MANAG SCI, V72, P653, DOI 10.1002/ps.4209; Nansen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124866; Nansen C, 2015, J PHOTOCH PHOTOBIO B, V145, P19, DOI 10.1016/j.jphotobiol.2015.02.015; Nansen C, 2014, J EXP BIOL, V217, P1187, DOI 10.1242/jeb.095661; Nansen C, 2013, APPL SPECTROSC, V67, P1332, DOI 10.1366/12-06933; Nansen C, 2011, OPT EXPRESS, V19, P15173, DOI 10.1364/OE.19.015173; Nguyen CV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094346; Pinto F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073234; Singh CB, 2009, J STORED PROD RES, V45, P151, DOI 10.1016/j.jspr.2008.12.002; Singh CB, 2010, BIOSYST ENG, V105, P380, DOI 10.1016/j.biosystemseng.2009.12.009; Teixeira R, 2015, NEOTROP ENTOMOL, V44, P129, DOI 10.1007/s13744-015-0272-y; Voss SC, 2017, INT J LEGAL MED, V131, P263, DOI 10.1007/s00414-016-1458-5; Wang Y, 2016, ZOOLOGICAL J LINNEAN; Watson Anna T., 2003, Systematics and Biodiversity, V1, P287; White JW, 2012, FIELD CROP RES, V133, P101, DOI 10.1016/j.fcr.2012.04.003; Zhu L, 2014, J COMPUTATIONAL INFO, V10, P3031	34	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176392	10.1371/journal.pone.0176392	http://dx.doi.org/10.1371/journal.pone.0176392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472152	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500044
J	Appelbaum, T; Santana, E; Aguirre, GD				Appelbaum, Tatyana; Santana, Evelyn; Aguirre, Gustavo D.			Strong upregulation of inflammatory genes accompanies photoreceptor demise in canine models of retinal degeneration	PLOS ONE			English	Article							NLRP3 INFLAMMASOME; MICROGLIAL PHAGOCYTOSIS; DISEASE EXPRESSION; BETA-SUBUNIT; ACTIVATION; MACROPHAGES; MUTATION; PROTEIN; INTERLEUKIN-1; NECROPTOSIS	We have analyzed the complex pattern of the inflammatory response in early-onset canine models of human retinitis pigmentosa, rcd1, xlpra2 and erd, as well as late-onset xlpra1, in comparative manner. The time course of immune response genes and proteins expression was examined along the timeline of photoreceptors degeneration. Gene expression analysis of the early-onset models prior to and after the peak of photoreceptors death identified the involvement of multiple immune response genes including those encoding constituents of the NLRP3 inflammasome, its substrates, pro-IL1B, pro-IL18, and common components of IL1B, IL18 and TLR4 pathways. Out of two activated caspase-1 cleavage products, IL1B and IL18, only IL1B was detected in rcd1 and xlpra2 while precursor IL18 remained unprocessed in the same protein extract highlighting prominence of IL1B pathway. An overall immune response was most prominent in rcd1 followed by xlpra2 and least prominent in erd. Noticeably, in rcd1 and xlpra2, but not in erd, early induction of the immune response was accompanied by sustained intraretinal migration and activation of retinal microglia. Lastly, delayed activation of the anti-inflammatory factors in all early-onset models was insufficient to counterbalance rapidly progressing inflammation. In contrast to early-onset models, in late-onset xlpra1 retinas a subset of the pro-inflammatory genes was highly upregulated long before any disease-related structural changes occurred, but was counterbalanced by an adequate anti-inflammatory response. Results point out to upregulated immune response accompanying disease progression in animal models of retinal degeneration, and to potential benefits of early anti-inflammatory therapy.	[Appelbaum, Tatyana; Santana, Evelyn; Aguirre, Gustavo D.] Univ Penn, Sch Vet Med, Sect Ophthalmol, Philadelphia, PA 19104 USA	University of Pennsylvania	Appelbaum, T; Aguirre, GD (corresponding author), Univ Penn, Sch Vet Med, Sect Ophthalmol, Philadelphia, PA 19104 USA.	tatyanak@upenn.edu; gda@vet.upenn.edu		Aguirre, Gustavo/0000-0002-5228-256X	Foundation Fighting Blindness [GDA]; National Eye Institute [EY-06855, EY-17549]; Vision research [P30EY-001583]; The Alcon Research Foundation; Hope for Vision; Van Sloun Fund for Canine Genetic Research; NATIONAL EYE INSTITUTE [R01EY006855, R01EY017549] Funding Source: NIH RePORTER	Foundation Fighting Blindness [GDA]; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Vision research; The Alcon Research Foundation; Hope for Vision; Van Sloun Fund for Canine Genetic Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by Foundation Fighting Blindness [GDA]; National Eye Institute Grant EY-06855 [GDA]; National Eye Institute Grant EY-17549 [GDA]; Core grant for Vision research P30EY-001583 [GDA is Module co-PI); The Alcon Research Foundation [GDA]; Hope for Vision [GDA]; Van Sloun Fund for Canine Genetic Research [GDA]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACLAND GM, 1987, EXP EYE RES, V44, P491, DOI 10.1016/S0014-4835(87)80160-4; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Appelbaum T, 2016, MOL VIS, V22, P319; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Beltran WA, 2006, INVEST OPHTH VIS SCI, V47, P1669, DOI 10.1167/iovs.05-0845; Beltran WA, 2009, INVEST OPHTH VIS SCI, V50, P3985, DOI 10.1167/iovs.08-3364; Berta AI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024074; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cantley MD, 2013, INFLAMMOPHARMACOLOGY, V21, P301, DOI 10.1007/s10787-012-0166-0; Cherry JD, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00594; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eandi CM, 2016, ELIFE, V5, DOI 10.7554/eLife.16490; FARBER DB, 1992, NEURON, V9, P349, DOI 10.1016/0896-6273(92)90173-B; Filgueiras LR, 2016, J DIABETES COMPLICAT; Fontaine V, 1998, J NEUROSCI, V18, P9662; Gardiner KL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2477-9; Genini S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-172; Genini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085408; Gicquel T, 2014, CLIN EXP PHARMACOL P, V41, P279, DOI 10.1111/1440-1681.12214; Goldstein O, 2010, GENOMICS, V96, P362, DOI 10.1016/j.ygeno.2010.09.003; Gong DP, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-31; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Guyon R, 2007, MOL VIS, V13, P1094; Jablonski KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159724; Kataoka K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.73; Kikkawa S, 2001, BIOCHEM BIOPH RES CO, V281, P461, DOI 10.1006/bbrc.2001.4378; Lagali Pamela S, 2011, J Ocul Biol Dis Infor, V4, P111, DOI 10.1007/s12177-012-9080-3; Lamkanfi M, 2004, J BIOL CHEM, V279, P51729, DOI 10.1074/jbc.M407891200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Munoz M, 2015, IMMUNITY, V42, P321, DOI 10.1016/j.immuni.2015.01.011; Neves J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf3646; Nielsen H.M., 2013, BIOCHEM, V61, P455, DOI DOI 10.1007/978-94-007-4525-4_; Noailles A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0186-3; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Provis JM, 1996, PERSPECT DEV NEUROBI, V3, P213; Radwan M, 2010, J IMMUNOL, V185, P3544, DOI 10.4049/jimmunol.0904000; Rajan JV, 2010, FEBS LETT, V584, P4627, DOI 10.1016/j.febslet.2010.10.036; RAY K, 1994, INVEST OPHTH VIS SCI, V35, P4291; Rivera JC, 2013, ARTERIOSCL THROM VAS, V33, P1881, DOI 10.1161/ATVBAHA.113.301331; Robert S, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160107; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; Schott J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004368; Shanmugam Muthu K, 2013, Subcell Biochem, V61, P627, DOI 10.1007/978-94-007-4525-4_27; Sivakumar V, 2011, J PATHOL, V224, P245, DOI 10.1002/path.2858; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Traverso V, 2003, INVEST OPHTH VIS SCI, V44, P4550, DOI 10.1167/iovs.03-0460; Villagra A, 2010, ONCOGENE, V29, P157, DOI 10.1038/onc.2009.334; Walsh JG, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-35; Wang MH, 2014, ADV EXP MED BIOL, V801, P333, DOI 10.1007/978-1-4614-3209-8_42; Wang MH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-173; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Weinstock JV, 2003, J IMMUNOL, V170, P5003, DOI 10.4049/jimmunol.170.10.5003; WHITCUP SM, 2013, INT J INFLAMM, V2013, DOI DOI 10.1155/2013/724648; Wicki S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.311; Yabal M, 2014, CELL REP, V7, P1796, DOI 10.1016/j.celrep.2014.05.008; Yoshida N, 2013, OPHTHALMOLOGY, V120, P100, DOI 10.1016/j.ophtha.2012.07.006; Zabel MK, 2016, GLIA, V64, P1479, DOI 10.1002/glia.23016; Zeiss GJ, 1999, INVEST OPHTH VIS SCI, V40, P3292; Zhang B, 2015, EXP NEUROL, V273, P83, DOI 10.1016/j.expneurol.2015.08.001; Zhang F., 2016, ONCOTARGET; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993; Zhao L, 2015, EMBO MOL MED, V7, P1179, DOI 10.15252/emmm.201505298	70	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177224	10.1371/journal.pone.0177224	http://dx.doi.org/10.1371/journal.pone.0177224			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486508	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000060
J	Jemec, A; Skufca, D; Prevorcnik, S; Fiser, Z; Zidar, P				Jemec, Anita; Skufca, David; Prevorcnik, Simona; Fiser, Ziga; Zidar, Primoz			Comparative study of acetylcholinesterase and glutathione S-transferase activities of closely related cave and surface Asellus aquaticus (Isopoda: Crustacea)	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; GAMMARUS-FOSSARUM; HYPOGEAN POPULATIONS; EPIGEAN CRUSTACEANS; PORCELLIO-SCABER; OXIDATIVE STRESS; LIFE-HISTORY; BIOMARKERS; RESPONSES; AMPHIPODA	The freshwater isopod crustacean Asellus aquaticus has recently been developed as an emerging invertebrate cave model for studying evolutionary and developmental biology. Mostly morphological and genetic differences between cave and surface A. aquaticus populations have been described up to now, while scarce data are available on other aspects, including physiology. The purpose of this study was to advance our understanding of the physiological differences between cave A. aquaticus and its surface-dwelling counterparts. We sampled two surface populations from the surface section of the sinking Pivka River (central Slovenia, Europe), i.e. locality Pivka Polje, and locality Planina Polje, and one cave population from the subterranean section of the sinking Pivka River, i.e. locality Planina Cave. Animals were sampled in spring, summer and autumn. We measured the activities of acetylcholinesterase (AChE) and glutathione S-transferase (GST) in individuals snap-frozen in the field immediately after collection. Acetylcholinesterase is likely related to animals' locomotor activity, while GST activity is related to the metabolic activity of an organism. Our study shows significantly lower AChE and GST activities in the cave population in comparison to both surface A. aquaticus populations. This confirms the assumption that cave A. aquaticus have lower locomotor and metabolic activity than surface A. aquaticus in their respective natural environments. In surface A. aquaticus populations, seasonal fluctuations in GST activity were observed, while these were less pronounced in individuals from the more stable cave environment. On the other hand, AChE activity was generally season-independent in all populations. To our knowledge, this is the first study of its kind conducted in A. aquaticus. Our results show that among closely related cave and surface A. aquaticus populations also physiological differences are present besides the morphological and genetic. These findings contribute to a better understanding of the biology of A. aquaticus and cave crustaceans in general.	[Jemec, Anita; Skufca, David; Prevorcnik, Simona; Fiser, Ziga; Zidar, Primoz] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia	University of Ljubljana	Jemec, A (corresponding author), Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia.	anita.jemec@bf.uni-lj.si	Jemec Kokalj, Anita/F-9206-2019	Jemec Kokalj, Anita/0000-0003-3143-4461; Skufca, David/0000-0002-1832-7840; Fiser, Ziga/0000-0003-4576-5173	Slovenian Research Agency, through Research program "Integrative zoology and speleobiology" [P1-0184]	Slovenian Research Agency, through Research program "Integrative zoology and speleobiology"	Research presented in this paper was supported by the Slovenian Research Agency, through Research program "Integrative zoology and speleobiology (P1-0184)". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, ADAPTATION NATURAL S, DOI DOI 10.4159/HARVARD.9780674419070; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilandzija H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080823; Bouskill NJ, 2006, ECOTOX ENVIRON SAFE, V65, P342, DOI 10.1016/j.ecoenv.2005.07.027; Cajaraville MP, 2000, SCI TOTAL ENVIRON, V247, P295, DOI 10.1016/S0048-9697(99)00499-4; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Damasio JB, 2007, CHEMOSPHERE, V66, P1206, DOI 10.1016/j.chemosphere.2006.07.055; Dellali M, 2001, COMP BIOCHEM PHYS C, V130, P227, DOI 10.1016/S1532-0456(01)00245-9; Duboue ER, 2011, CURR BIOL, V21, P671, DOI 10.1016/j.cub.2011.03.020; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fanjul-Moles ML, 1998, COMP BIOCHEM PHYS A, V119, P263, DOI 10.1016/S1095-6433(97)00413-3; Fiser C, 2013, OIKOS, V122, P770, DOI 10.1111/j.1600-0706.2012.20644.x; Fiser Z, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-015-1329-9; Gismondi E, 2012, ENVIRON RES, V118, P47, DOI 10.1016/j.envres.2012.06.004; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Halliwell B., 2007, FREE RADICALS BIOL M; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hervant F, 1997, COMP BIOCHEM PHYS A, V118, P1277, DOI 10.1016/S0300-9629(97)00047-9; Hervant F, 1996, PHYSIOL ZOOL, V69, P1277, DOI 10.1086/physzool.69.6.30164261; Hervant F, 1996, CR ACAD SCI III-VIE, V319, P1071; Hervant F, 1999, HYDROBIOLOGIA, V392, P197, DOI 10.1023/A:1003511416509; Huppop K., 1987, International Journal of Speleology, V16, P59; Issartel J, 2005, J EXP BIOL, V208, P2923, DOI 10.1242/jeb.01737; IVERSEN TM, 1988, INT REV GES HYDROBIO, V73, P73, DOI 10.1002/iroh.19880730107; Janssens BJ, 2000, J EXP BIOL, V203, P3717; Jemec A, 2008, ENVIRON TOXICOL CHEM, V27, P1904, DOI 10.1897/08-036.1; Jemec A, 2010, ENVIRON SCI POLLUT R, V17, P571, DOI 10.1007/s11356-009-0112-x; Jensen CS, 1997, ENVIRON TOXICOL CHEM, V16, P1727, DOI [10.1897/1551-5028(1997)016&lt;1727:AIAALB&gt;2.3.CO;2, 10.1002/etc.5620160822]; Konec M, 2015, J EVOLUTION BIOL, V28, P864, DOI 10.1111/jeb.12610; Lawniczak M, 2013, COMP BIOCHEM PHYS A, V165, P299, DOI 10.1016/j.cbpa.2013.03.028; Leinio S, 2005, COMP BIOCHEM PHYS C, V140, P408, DOI 10.1016/j.cca.2005.04.005; Leser V, 2008, ZOOLOGY, V111, P419, DOI 10.1016/j.zool.2007.10.007; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; Mair P, 2016, WRS2 WILCOX ROBUST E, P9; Menezes S, 2006, J EXP MAR BIOL ECOL, V335, P114, DOI 10.1016/j.jembe.2006.03.009; MIGLIORE L, 1982, INT J INVER REP DEV, V4, P359; Mosslacher F, 1996, ARCH HYDROBIOL, V138, P187; O'Neill AJ, 2004, MAR ENVIRON RES, V58, P327, DOI 10.1016/j.marenvres.2004.03.076; Parzefall J., 2012, ENCY CAVES; POULSON THOMAS L., 1963, AMER MIDLAND NAT, V70, P257, DOI 10.2307/2423056; POULSON TL, 1964, HDB PHYSL 4, P749; Prevorcnik S, 2004, ARCH HYDROBIOL, V160, P193, DOI 10.1127/0003-9136/2004/0160-0193; Protas M, 2012, WIRES DEV BIOL, V1, P823, DOI 10.1002/wdev.61; Protas ME, 2011, P NATL ACAD SCI USA, V108, P5702, DOI 10.1073/pnas.1013850108; R Core Team, 2013, R LANG ENV STAT COMP; Raza H, 2011, FEBS J, V278, P4243, DOI 10.1111/j.1742-4658.2011.08358.x; Riesch R, 2013, AM NAT, V181, P78, DOI 10.1086/668597; Robillard S, 2003, COMP BIOCHEM PHYS C, V135, P49, DOI 10.1016/S1532-0456(03)00049-8; Scaps P, 2000, COMP BIOCHEM PHYS C, V125, P377, DOI 10.1016/S0742-8413(00)00087-6; Simcic T, 2005, FRESHWATER BIOL, V50, P494, DOI 10.1111/j.1365-2427.2005.01339.x; Simcic T, 2007, MAR FRESHW BEHAV PHY, V40, P141, DOI 10.1080/10236240701452465; SKET B, 1994, HYDROBIOLOGIA, V287, P39, DOI 10.1007/BF00006895; Stahl BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140484; STEEL E. A., 1961, PROC ZOOL SOC LONDON, V137, P71; STRUS J, 1983, Bioloski Vestnik, V31, P83; Sworobowicz L, 2015, FRESHWATER BIOL, V60, P1824, DOI 10.1111/fwb.12613; Taylor SJ, 2015, HERPETOL CONSERV BIO, V10, P740; Turk S, 1996, HYDROBIOLOGIA, V337, P161, DOI 10.1007/BF00028517; Verovnik R, 2004, MOL ECOL, V13, P1519, DOI 10.1111/j.1365-294X.2004.02171.x; Verovnik R, 2003, GENETICA, V119, P155, DOI 10.1023/A:1026085716777; Verovnik R, 2009, ZOOL ANZ, V248, P101, DOI 10.1016/j.jcz.2009.03.001; Welker AF, 2013, COMP BIOCHEM PHYS A, V165, P384, DOI 10.1016/j.cbpa.2013.04.003; Wilczek G, 2003, POL J ENVIRON STUD, V12, P765; Wilhelm FM, 2006, FRESHWATER BIOL, V51, P1162, DOI 10.1111/j.1365-2427.2006.01564.x; Xuereb B, 2009, AQUAT TOXICOL, V94, P114, DOI 10.1016/j.aquatox.2009.06.010; Xuereb B, 2009, AQUAT TOXICOL, V93, P225, DOI 10.1016/j.aquatox.2009.05.006; Yamamoto Y, 2009, DEV BIOL, V330, P200, DOI 10.1016/j.ydbio.2009.03.003; Yoshizawa M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-108; Yoshizawa M, 2010, CURR BIOL, V20, P1631, DOI 10.1016/j.cub.2010.07.017	69	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176746	10.1371/journal.pone.0176746	http://dx.doi.org/10.1371/journal.pone.0176746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486514	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000024
J	de Wit, M; Carvalho, B; Delis-van Diemen, PM; van Alphen, C; Belien, JAM; Meijer, GA; Fijneman, RJA				de Wit, Meike; Carvalho, Beatriz; Delis-van Diemen, Pien M.; van Alphen, Carolien; Bellen, Jeroen A. M.; Meijer, Gerrit A.; Fijneman, Remond J. A.			Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression	PLOS ONE			English	Article							CANCER-CELLS; COLON-CANCER; STAGE-II; TUMOR; OVEREXPRESSION; PATHWAYS; MATRIX; STROMA; GENES	Background One prominent event associated with colorectal adenoma-to-carcinoma progression is genomic instability. Approximately 85% of colorectal cancer cases exhibit chromosomal instability characterized by accumulation of chromosome copy number aberrations (CNAs). Adenomas with gain of chromosome 8q, 13q, and/or 20q are at high risk of progression to cancer. Tumor progression is also associated with expansion of the extracellular matrix (ECM) and the activation of non-malignant cells within the tumor stroma. The glycoproteins versican and lumican are overexpressed at the mRNA level in colon carcinomas compared to adenomas, and are associated with the formation of tumor stroma. Purpose The aim of this study was to characterize versican and lumican protein expression in tumor progression and investigate their association with CNAs commonly associated with adenoma-to-carcinoma progression. Methods Tissue microarrays were constructed with colon adenomas and carcinomas that were characterized for MSI-status and DNA copy number gains of chromosomes 8q, 13q and 20q. Sections were immunohistochemically stained for lumican and versican. Protein expression levels were evaluated using digitized slides, and scores were finally dichotomized into a positive or negative score per sample. Results Lumican and versican expression were both observed in neoplastic cells and in the tumor stroma of colon adenomas and carcinomas. Lumican expression was more frequently present in epithelial cells of carcinomas than adenomas (49% versus 18%; P = 0.0001) and in high-risk adenomas and carcinomas combined compared to low-risk adenomas (43% versus 16%; P = 0.005). Versican staining in the tumor stroma was more often present in high-risk adenomas combined with carcinomas compared to low-risk adenomas (57% versus 36%; P = 0.03) and was associated with the presence of gain of 13q (71% versus 44%; P = 0.04). Conclusion Epithelial lumican and stromal versican protein expression are increased during colorectal adenoma-to-carcinoma progression.	[de Wit, Meike; Carvalho, Beatriz; Delis-van Diemen, Pien M.; Meijer, Gerrit A.; Fijneman, Remond J. A.] Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands; [de Wit, Meike; Carvalho, Beatriz; Delis-van Diemen, Pien M.; Bellen, Jeroen A. M.; Meijer, Gerrit A.; Fijneman, Remond J. A.] Vrije Univ Amsterdam, Dept Pathol, Med Ctr, Amsterdam, Netherlands; [van Alphen, Carolien] Vrije Univ Amsterdam, Dept Med Oncol, Med Ctr, Amsterdam, Netherlands	Netherlands Cancer Institute; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Fijneman, RJA (corresponding author), Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands.; Fijneman, RJA (corresponding author), Vrije Univ Amsterdam, Dept Pathol, Med Ctr, Amsterdam, Netherlands.	r.fijneman@nki.nl	Fijneman, Remond/X-4199-2019; de wit, meike/N-5494-2015; Carvalho, Beatriz/GXA-0720-2022	Fijneman, Remond/0000-0003-2076-5521; de wit, meike/0000-0003-1850-0831; Meijer, Gerrit/0000-0003-0330-3130	DeCoDe project [030-101]	DeCoDe project	This work was performed within the framework of CTMM, the Center for Translational Molecular Medicine; DeCoDe project (grant 030-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogels M, 2012, ONCOIMMUNOLOGY, V1, P798, DOI 10.4161/onci.20427; Brezillon S, 2009, CANCER LETT, V283, P92, DOI 10.1016/j.canlet.2009.03.032; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; Carvalho B, 2012, CELL ONCOL, V35, P53, DOI 10.1007/s13402-011-0065-1; Crispino P, 2008, CANCER INVEST, V26, P419, DOI 10.1080/07357900701788155; Davies RJ, 2002, LANCET, V359, P1917, DOI 10.1016/S0140-6736(02)08739-1; de Wit M, 2013, ANN SURG ONCOL, V20, pS348, DOI 10.1245/s10434-012-2441-0; de Wit M, 2012, GUT, V61, P855, DOI 10.1136/gutjnl-2011-300511; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Droste JSTS, 2012, GASTROENTEROLOGY, V142, pS643; Fijneman RJA, 2007, CANCER LETT, V258, P223, DOI 10.1016/j.canlet.2007.09.013; Helmke BM, 2012, ANTICANCER RES, V32, P1589; Hermsen M, 2002, GASTROENTEROLOGY, V123, P1109, DOI 10.1053/gast.2002.36051; Ishiwata T, 2007, ONCOL REP, V18, P537; Kim MY, 2006, GASTROENTEROLOGY, V131, P1913, DOI 10.1053/j.gastro.2006.10.021; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kunz-Schughart LA, 2002, HISTOL HISTOPATHOL, V17, P599, DOI 10.14670/HH-17.599; LEBARON RG, 1992, J BIOL CHEM, V267, P10003; Mukaratirwa S, 2005, INT J EXP PATHOL, V86, P219, DOI 10.1111/j.0959-9673.2005.00425.x; Nikitovic D, 2011, INT J BIOCHEM CELL B, V43, P928, DOI 10.1016/j.biocel.2011.03.008; Ogunbiyi OA, 1997, GASTROENTEROLOGY, V113, P761, DOI 10.1016/S0016-5085(97)70169-0; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Radwanska A, 2012, EXP CELL RES, V318, P2312, DOI 10.1016/j.yexcr.2012.07.005; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; SHINYA H, 1979, ANN SURG, V190, P679, DOI 10.1097/00000658-197912000-00001; Sillars-Hardebol AH, 2011, GUT; Sillars-Hardebol AH, 2012, J PATHOL, V226, P1, DOI 10.1002/path.3012; Sillars-Hardebol AH, 2010, TUMOR BIOL, V31, P89, DOI 10.1007/s13277-009-0012-1; Societies DFOBS, COD PROP SEC US HUM; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Theocharis AD, 2002, BBA-MOL BASIS DIS, V1588, P165, DOI 10.1016/S0925-4439(02)00161-8; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wit M, 2012, ANN SURG ONCOL; Wu JJ, 2011, CANCER RES, V71, P349, DOI 10.1158/0008-5472.CAN-10-2550	35	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0174768	10.1371/journal.pone.0174768	http://dx.doi.org/10.1371/journal.pone.0174768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481899	Green Published, Green Submitted, gold			2022-12-27	WOS:000401313700002
J	Tsutsumi, J; Minai, K; Kawai, M; Ogawa, K; Inoue, Y; Morimoto, S; Tanaka, T; Nagoshi, T; Ogawa, T; Yoshimura, M				Tsutsumi, Joshi; Minai, Kosuke; Kawai, Makoto; Ogawa, Kazuo; Inoue, Yasunori; Morimoto, Satoshi; Tanaka, Toshikazu; Nagoshi, Tomohisa; Ogawa, Takayuki; Yoshimura, Michihiro			Manifold implications of obesity in ischemic heart disease among Japanese patients according to covariance structure analysis: Low reactivity of B-type natriuretic peptide as an intervening risk factor	PLOS ONE			English	Article							DIABETES-MELLITUS; RECEPTOR; INDIVIDUALS; HYPERTROPHY; MORTALITY; HYPOXIA; IMPACT; LEVEL	Background/Objectives Obesity is believed to be one of the major risk factors for cardiovascular disease in Western countries. However, the effects of obesity should be continuously examined in the Japanese population because the average bodily habitus differs among countries. In this study, we collectively examined the significance of obesity and obesity-triggered risk factors including the low reactivity of B-type natriuretic peptide (BNP), for ischemic heart disease (IHD) in Japanese patients. Methods and results The study patients consisted of 1252 subjects (IHD: n = 970; non-IHD: n = 282). Multiple logistic regression analysis revealed that dyslipidemia, hypertension, diabetes, and the low reactivity of BNP were significant risk factors for IHD, but body mass index (BMI) was not. A theoretical path model was proposed by positioning BMI at the top of the hierarchical model. Exploratory factor analysis revealed that BMI did not play a causative role in IHD (P = NS). BMI was causatively linked to other risk factors (P<0.001 for hypertension; P<0.001 for dyslipidemia; P<0.001 for HbA1c; P<0.001 for LogBNP), and these factors played a causative role in IHD (P<0.001 for hypertension; P<0.001 for dyslipidemia; P<0.001 for HbA1c; P<0.001 for LogBNP). The intrinsic power of the low reactivity of BNP induced by high BMI on the promotion of IHD was fairly potent. Conclusion This study demonstrated that obesity per se is not a strong risk factor for IHD in Japanese patients. However, several important risk factors triggered by obesity exhibited a causative role for IHD. The low reactivity of BNP is a substantial risk factor for IHD.	[Tsutsumi, Joshi; Minai, Kosuke; Kawai, Makoto; Ogawa, Kazuo; Inoue, Yasunori; Morimoto, Satoshi; Tanaka, Toshikazu; Nagoshi, Tomohisa; Ogawa, Takayuki; Yoshimura, Michihiro] Jikei Univ, Div Cardiol, Dept Internal Med, Sch Med, Tokyo, Japan	Jikei University	Minai, K (corresponding author), Jikei Univ, Div Cardiol, Dept Internal Med, Sch Med, Tokyo, Japan.	heart@jikei.ac.jp	Tanaka, Toshikazu D/K-5989-2018	Tanaka, Toshikazu D/0000-0002-0711-7880	Grants-in-Aid for Scientific Research [17K09531] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Clerico A, 2015, CLIN CHIM ACTA, V443, P17, DOI 10.1016/j.cca.2014.06.003; Clerico A, 2012, HEART FAIL REV, V17, P81, DOI 10.1007/s10741-011-9249-z; Clerico A, 2009, CLIN CHIM ACTA, V405, P1, DOI 10.1016/j.cca.2009.03.050; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Harada E, 1999, J MOL CELL CARDIOL, V31, P1997, DOI 10.1006/jmcc.1999.1030; HIRATA Y, 1988, FEBS LETT, V238, P415, DOI 10.1016/0014-5793(88)80523-4; Inoue Y, 2016, METABOLISM, V65, P38, DOI 10.1016/j.metabol.2015.09.019; Invitti C, 2004, NEW ENGL J MED, V351, P1147; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kalantar-Zadeh K, 2004, J AM COLL CARDIOL, V43, P1439, DOI 10.1016/j.jacc.2003.11.039; Kawai M, 2013, INTERNAL MED, V52, P171, DOI 10.2169/internalmedicine.52.8704; Kinoshita K, 2016, INT J CARDIOL, V215, P283, DOI 10.1016/j.ijcard.2016.04.111; Lanfear DE, 2014, J CARD FAIL, V20, P662, DOI 10.1016/j.cardfail.2014.06.357; Liang FQ, 2003, ENDOCRINOLOGY, V144, P4187, DOI 10.1210/en.2002-0217; Luo YX, 2006, MOL PHARMACOL, V69, P1953, DOI 10.1124/mol.105.017905; Meroufel DN, 2015, GENE, V567, P159, DOI 10.1016/j.gene.2015.04.073; Minai K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108983; Mizuno Y, 2013, ENDOCR J, V60, P87, DOI 10.1507/endocrj.EJ12-0239; Morales-Villegas E, 2014, CURR HYPERTENS REV; Morikis VA, 2015, BIORHEOLOGY, V52, P447, DOI 10.3233/BIR-15067; MORITA E, 1993, CIRCULATION, V88, P82, DOI 10.1161/01.CIR.88.1.82; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; Nakane T, 2012, INTERNAL MED, V51, P239, DOI 10.2169/internalmedicine.51.6206; Nanri H, 2017, CHILD CARE HLTH DEV; Nishikimi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053233; Nojiri T, 2015, P NATL ACAD SCI USA, V112, P4086, DOI 10.1073/pnas.1417273112; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Sacks FM, 2014, CIRCULATION, V129, P999, DOI 10.1161/CIRCULATIONAHA.113.002529; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Ueshima H, 2006, CIRC J, V70, P1249; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Weidemann A, 2008, BIOCHEM J, V409, P233, DOI 10.1042/BJ20070629; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195; Zeng K, 2013, J HUM HYPERTENS, V27, P271, DOI 10.1038/jhh.2012.25; Zois NE, 2014, NAT REV CARDIOL, V11, P403, DOI 10.1038/nrcardio.2014.64	39	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177327	10.1371/journal.pone.0177327	http://dx.doi.org/10.1371/journal.pone.0177327			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481950	Green Published, gold			2022-12-27	WOS:000401313700052
J	Vercillo, T; Tonelli, A; Gori, M				Vercillo, Tiziana; Tonelli, Alessia; Gori, Monica			Intercepting a sound without vision	PLOS ONE			English	Article							AUDITORY SPATIAL LOCALIZATION; OCCIPITAL CORTEX; BLIND; PLASTICITY; SPACE; ONSET; EXTRAPOLATION; ORGANIZATION; MEMORY; EYE	Visual information is extremely important to generate internal spatial representations. In the auditory modality, the absence of visual cues during early infancy does not preclude the development of some spatial strategies. However, specific spatial abilities might result impaired. In the current study, we investigated the effect of early visual deprivation on the ability to localize static and moving auditory stimuli by comparing sighted and early blind individuals' performance in different spatial tasks. We also examined perceptual stability in the two groups of participants by matching localization accuracy in a static and a dynamic head condition that involved rotational head movements. Sighted participants accurately localized static and moving sounds. Their localization ability remained unchanged after rotational movements of the head. Conversely, blind participants showed a leftward bias during the localization of static sounds and a little bias for moving sounds. Moreover, head movements induced a significant bias in the direction of head motion during the localization of moving sounds. These results suggest that internal spatial representations might be body-centered in blind individuals and that in sighted people the availability of visual cues during early infancy may affect sensory-motor interactions.	[Vercillo, Tiziana] Univ Nevada, Dept Psychol, Reno, NV 89557 USA; [Tonelli, Alessia; Gori, Monica] Fdn Ist Italiano Tecnol, Unit Visually Impaired People, U VIP, Genoa, Italy	Nevada System of Higher Education (NSHE); University of Nevada Reno; Istituto Italiano di Tecnologia - IIT	Vercillo, T (corresponding author), Univ Nevada, Dept Psychol, Reno, NV 89557 USA.	tiz.vercillo@gmail.com	Gori, Monica/AAS-9963-2021; Gori, Monica/A-1238-2014; Tonelli, Alessia/AAE-8909-2021	Gori, Monica/0000-0002-5616-865X; Tonelli, Alessia/0000-0003-0317-2599				Amedi A, 2005, CURR DIR PSYCHOL SCI, V14, P306, DOI 10.1111/j.0963-7214.2005.00387.x; Cappagli G., 2015, DEV SCI; Cattaneo Z, 2011, J EXP PSYCHOL HUMAN, V37, P1110, DOI 10.1037/a0023511; Collignon O, 2013, BRAIN, V136, P2769, DOI 10.1093/brain/awt176; Collignon O, 2011, P NATL ACAD SCI USA, V108, P4435, DOI 10.1073/pnas.1013928108; Collignon O, 2009, EXP BRAIN RES, V192, P343, DOI 10.1007/s00221-008-1553-z; Corazzini LL, 2010, PSYCHOL BELG, V50, P327, DOI 10.5334/pb-50-3-4-327; Desmurget M, 2003, BRADFORD BOOKS, P289; Doucet ME, 2005, EXP BRAIN RES, V160, P194, DOI 10.1007/s00221-004-2000-4; Finocchietti S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01357; FREYD JJ, 1984, J EXP PSYCHOL LEARN, V10, P126, DOI 10.1037/0278-7393.10.1.126; Getzmann S, 2005, HEARING RES, V210, P104, DOI 10.1016/j.heares.2005.08.003; Gori M, 2015, MULTISENS RES, V28, P71, DOI 10.1163/22134808-00002478; Gori M, 2014, BRAIN, V137, P288, DOI 10.1093/brain/awt311; Gori M, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00077; Heimler B, 2015, CURR OPIN NEUROBIOL, V35, P169, DOI 10.1016/j.conb.2015.09.001; Hubbard TL, 2005, PSYCHON B REV, V12, P822, DOI 10.3758/BF03196775; Iachini T, 2014, BEHAV BRAIN RES, V273, P73, DOI 10.1016/j.bbr.2014.07.032; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Kerzel D, 2003, VISION RES, V43, P2623, DOI 10.1016/S0042-6989(03)00466-8; Kolarik AJ, 2016, EXP BRAIN RES, P1; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Lewald J, 2002, NEUROPSYCHOLOGIA, V40, P1868, DOI 10.1016/S0028-3932(02)00071-4; Medendorp WP, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0006.2002; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; PERROTT DR, 1977, J ACOUST SOC AM, V62, P1463, DOI 10.1121/1.381675; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Schechtman E, 2012, J NEUROSCI, V32, P13501, DOI 10.1523/JNEUROSCI.1315-12.2012; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; ThinusBlanc C, 1997, PSYCHOL BULL, V121, P20, DOI 10.1037/0033-2909.121.1.20; Vercillo T, 2016, DEV PSYCHOL, V52, P847, DOI 10.1037/dev0000103; Vercillo T, 2015, NEUROPSYCHOLOGIA, V67, P35, DOI 10.1016/j.neuropsychologia.2014.12.001; Vliegen J, 2004, J NEUROSCI, V24, P9291, DOI 10.1523/JNEUROSCI.2671-04.2004; Voss P, 2004, CURR BIOL, V14, P1734, DOI 10.1016/j.cub.2004.09.051; Voss P, 2012, CURRENT BIOL, V22; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Zwiers MP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-09-j0002.2001	38	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177407	10.1371/journal.pone.0177407	http://dx.doi.org/10.1371/journal.pone.0177407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481939	Green Submitted, Green Published, gold			2022-12-27	WOS:000401313700059
J	Brathwaite, R; Addo, J; Kunst, AE; Agyemang, C; Owusu-Dabo, E; Aikins, AD; Beune, E; Meeks, K; Klipstein-Grobusch, K; Bahendeka, S; Mockenhaupt, FP; Amoah, S; Galbete, C; Schulze, MB; Danquah, I; Smeeth, L				Brathwaite, Rachel; Addo, Juliet; Kunst, Anton E.; Agyemang, Charles; Owusu-Dabo, Ellis; Aikins, Ama de-Graft; Beune, Erik; Meeks, Karlijn; Klipstein-Grobusch, Kerstin; Bahendeka, Silver; Mockenhaupt, Frank P.; Amoah, Stephen; Galbete, Cecilia; Schulze, Matthias B.; Danquah, Ina; Smeeth, Liam			Smoking prevalence differs by location of residence among Ghanaians in Africa and Europe: The RODAM study	PLOS ONE			English	Article							HEALTH; ACCULTURATION; POPULATIONS; IMMIGRANTS; PATTERNS; BEHAVIOR; ORIGIN; ADULTS	Background Although the prevalence of smoking is low in Ghana, little is known about the effect of migration on smoking. Comparing Ghanaians living in their country of origin to those living in Europe offers an opportunity to investigate smoking by location of residence and the associations between smoking behaviours and migration-related factors. Methods Data on a relatively homogenous group of Ghanaians living in London (n = 949), Amsterdam (n = 1400), Berlin (n = 543), rural Ghana (n = 973) and urban Ghana (n = 1400) from the cross-sectional RODAM (Research on Obesity & Diabetes in African Migrants) study were used. Age-standardized prevalence rates of smoking by location of residence and factors associated with smoking among Ghanaian men were estimated using prevalence ratios (PR: 95% CIs). Results Current smoking was non-existent among women in rural and urban Ghana and London but was 3.2% and 3.3% in women in Amsterdam and Berlin, respectively. Smoking prevalence was higher in men in Europe (7.8%) than in both rural and urban Ghana (4.8%): PR 1.91: 95% CI 1.27, 2.88, adjusted for age, marital status, education and employment. Factors associated with a higher prevalence of smoking among Ghanaian men included European residence, being divorced or widowed, living alone, Islam religion, infrequent attendance at religious services, assimilation (cultural orientation), and low education. Conclusion Ghanaians living in Europe are more likely to smoke than their counterparts in Ghana, suggesting convergence to European populations, although prevalence rates are still far below those in the host populations.	[Brathwaite, Rachel; Addo, Juliet; Smeeth, Liam] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England; [Kunst, Anton E.; Agyemang, Charles; Beune, Erik; Meeks, Karlijn] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands; [Owusu-Dabo, Ellis] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Owusu-Dabo, Ellis] KNUST, Sch Publ Hlth, Dept Global Hlth, Kumasi, Ghana; [Aikins, Ama de-Graft] Univ Ghana, Reg Inst Populat Studies, Legon, Ghana; [Klipstein-Grobusch, Kerstin] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands; [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa; [Bahendeka, Silver] Int Diabet Federat, Kampala, Uganda; [Mockenhaupt, Frank P.; Amoah, Stephen] Charite, Inst Trop Med & Int Hlth, Berlin, Germany; [Galbete, Cecilia; Schulze, Matthias B.; Danquah, Ina] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany	University of London; London School of Hygiene & Tropical Medicine; University of Amsterdam; Academic Medical Center Amsterdam; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; University of Ghana; Utrecht University; Utrecht University Medical Center; University of Witwatersrand; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Brathwaite, R (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England.	Rachel.Brathwaite@lshtm.ac.uk	Schulze, Matthias B/AAH-6906-2021; Mockenhaupt, Frank P/U-9824-2017; Klipstein-Grobusch, Kerstin/F-5555-2016; Smeeth, Liam/X-5862-2018; Galbete, Cecilia/M-1276-2013	Schulze, Matthias B/0000-0002-0830-5277; Mockenhaupt, Frank P/0000-0002-8117-5421; Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Kunst, Anton/0000-0002-3313-5273; Smeeth, Liam/0000-0002-9168-6022; Silver, Bahendeka/0000-0001-8080-7872; Danquah, Ina/0000-0003-3222-3498; Meeks, Karlijn/0000-0003-3032-405X; Galbete, Cecilia/0000-0002-2497-6791	European Commission under the Framework Programme [278901]	European Commission under the Framework Programme	The RODAM study was funded by the European Commission under the Framework Programme (grant number: 278901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Action on Smoking and Health, 2015, SMOK DIAB; Agyemang C, 2005, J EPIDEMIOL COMMUN H, V59, P1014, DOI 10.1136/jech.2005.035964; Agyemang C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004877; Agyemang C, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-7; [Anonymous], 2015, WHO REP GLOB TOB EP; Aspinall PJ, 2014, PUBLIC HEALTH, V128, P297, DOI 10.1016/j.puhe.2013.12.013; Berry JW, 1997, APPL PSYCHOL-INT REV, V46, P5, DOI 10.1111/j.1464-0597.1997.tb01087.x; Bosdriesz JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058654; Brathwaite R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132401; Castro FG, 2009, J PRIM PREV, V30, P265, DOI 10.1007/s10935-009-0174-z; ELKIND AK, 1985, SOC SCI MED, V20, P1269, DOI 10.1016/0277-9536(85)90380-6; Garrusi B, 2012, INT J PSYCHIAT MED, V43, P279, DOI 10.2190/PM.43.3.g; Ghouri N, 2006, BRIT MED J, V332, P291, DOI 10.1136/bmj.332.7536.291; Giovino G A, 1999, Nicotine Tob Res, V1 Suppl 1, pS31, DOI 10.1080/14622299050011571; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; Hald J, 2003, ACTA ONCOL, V42, P154, DOI 10.1080/02841860310005020; Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x; Hong-Jun C, 2008, SOC SCI MED, V66, P609; Jibaly M., 2005, SMOKING SOCIAL POISO; Klumbiene J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1525-8; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P802, DOI 10.1007/s00103-013-1698-1; Leung LA, 2014, HEALTH ECON, V23, P1411, DOI 10.1002/hec.2992; Mathur R, 2014, J PUBLIC HEALTH-UK, V36, P684, DOI 10.1093/pubmed/fdt116; Nierkens V, 2006, TOB CONTROL, V15, P385, DOI 10.1136/tc.2006.014902; Office of National Statistics, 2015, STAT B AD SMOK HAB U; Owusu-Dabo E, 2009, TOB CONTROL, V18, P365, DOI 10.1136/tc.2009.030635; Pearce JR, 2010, ANN ASSOC AM GEOGR, V100, P393, DOI 10.1080/00045601003595537; Reiss K, 2015, TOB INDUC DIS, V13, DOI 10.1186/s12971-015-0036-9; Reiss K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-844; Richard W, 2003, SOCIAL DETERMINANTS; Saari AJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003218; Schoeborn CA, 2004, MARITAL STATUS HLTH; SECKER-Walker R, 2002, COCHRANE DB SYST REV, V2008; Sreeramareddy CT, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0243-x; Stevens GWJM, 2004, J CROSS CULT PSYCHOL, V35, P689, DOI 10.1177/0022022104270111; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; Tafawa AO, 2012, CANCER CAUSE CONTROL, V23, P45, DOI 10.1007/s10552-012-9898-9; United States Department of H Human Services, 2016, SUBST MENT HLTH SERV; World Health Organization, 2016, DAT STAT WHO IS SMOK; World Health Organization Regional Office for Europe, 2014, EUR TOB CONTR STAT R; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP	41	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177291	10.1371/journal.pone.0177291	http://dx.doi.org/10.1371/journal.pone.0177291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475620	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000400649500058
J	Beza, E; Steinke, J; van Etten, J; Reidsma, P; Fadda, C; Mittra, S; Mathur, P; Kooistra, L				Beza, Eskender; Steinke, Jonathan; van Etten, Jacob; Reidsma, Pytrik; Fadda, Carlo; Mittra, Sarika; Mathur, Prem; Kooistra, Lammert			What are the prospects for citizen science in agriculture? Evidence from three continents on motivation and mobile telephone use of resource-poor farmers	PLOS ONE			English	Article							LAND-USE; PARTICIPATION; TECHNOLOGIES; KNOWLEDGE; SELECTION; NETWORK; SYSTEM; EBIRD	As the sustainability of agricultural citizen science projects depends on volunteer farmers who contribute their time, energy and skills, understanding their motivation is important to attract and retain participants in citizen science projects. The objectives of this study were to assess 1) farmers' motivations to participate as citizen scientists and 2) farmers' mobile telephone usage. Building on motivational factors identified from previous citizen science studies, a questionnaire based methodology was developed which allowed the analysis of motivational factors and their relation to farmers' characteristics. The questionnaire was applied in three communities of farmers, in countries from different continents, participating as citizen scientists. We used statistical tests to compare motivational factors within and among the three countries. In addition, the relations between motivational factors and farmers characteristics were assessed. Lastly, Principal Component Analysis (PCA) was used to group farmers based on their motivations. Although there was an overlap between the types of motivations, for Indian farmers a collectivistic type of motivation (i.e., contribute to scientific research) was more important than egoistic and altruistic motivations. For Ethiopian and Honduran farmers an egoistic intrinsic type of motivation (i.e., interest in sharing information) was most important. While fun has appeared to be an important egoistic intrinsic factor to participate in other citizen science projects, the smallholder farmers involved in this research valued 'passing free time' the lowest. Two major groups of farmers were distinguished: one motivated by sharing information (egoistic intrinsic), helping (altruism) and contribute to scientific research (collectivistic) and one motivated by egoistic extrinsic factors (expectation, expert interaction and community interaction). Country and education level were the two most important farmers' characteristics that explain around 20% of the variation in farmers motivations. For educated farmers, contributing to scientific research was a more important motivation to participate as citizen scientists compared to less educated farmers. We conclude that motivations to participate in citizen science are different for smallholders in agriculture compared to other sectors. Citizen science does have high potential, but easy to use mechanisms are needed. Moreover, gamification may increase the egoistic intrinsic motivation of farmers.	[Beza, Eskender; Kooistra, Lammert] Wageningen Univ, Lab Geoinformat Sci & Remote Sensing, Droevendaalsesteeg 3, Pb Wageningen, Netherlands; [Beza, Eskender; Reidsma, Pytrik] Wageningen Univ, Plant Prod Syst, Ak Wageningen, Netherlands; [Steinke, Jonathan] Humboldt Univ, Berlin, Germany; [Steinke, Jonathan; van Etten, Jacob] Biovers Int, Turrialba, Costa Rica; [Fadda, Carlo] Biovers Int, Addis Ababa, Ethiopia; [Mittra, Sarika] Univ Wisconsin Madison, Dept Forest & Wildlife Ecol, 1630 Linden Dr, Madison, WI USA; [Mittra, Sarika; Mathur, Prem] Biovers Int, NASC Complex,Pusa Campus, New Delhi, India	Wageningen University & Research; Wageningen University & Research; Humboldt University of Berlin; Alliance; Bioversity International; Alliance; Bioversity International; University of Wisconsin System; University of Wisconsin Madison; Alliance; Bioversity International	Beza, E (corresponding author), Wageningen Univ, Lab Geoinformat Sci & Remote Sensing, Droevendaalsesteeg 3, Pb Wageningen, Netherlands.; Beza, E (corresponding author), Wageningen Univ, Plant Prod Syst, Ak Wageningen, Netherlands.	eskender.beza@wur.nl	Kooistra, Lammert/AAW-2172-2020	Kooistra, Lammert/0000-0001-5549-5993; van Etten, Jacob/0000-0001-7554-2558; Fadda, Carlo/0000-0003-3075-6207; Reidsma, Pytrik/0000-0003-2294-809X; Steinke, Jonathan/0000-0001-5742-702X	Strategic Funds of Wageningen UR	Strategic Funds of Wageningen UR	This research was carried out in a PhD project and it is part of the Wageningen UR strategic program 'Mapping for sustainable intensification', 2012-2016, funded by the Strategic Funds of Wageningen UR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was carried out in a PhD project and it is part of the Wageningen UR strategic program 'Mapping for sustainable intensification', 2012-2016, funded by the Strategic Funds of Wageningen UR. The research is also a contribution to the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS). The views expressed in this document cannot be taken to reflect the official opinions of CGIAR or Future Earth. The authors also would like to thank all the farmers and project team members in the three countries who participated in this research.	Antonopoulou E, 2010, COMPUT ELECTRON AGR, V70, P292, DOI 10.1016/j.compag.2009.07.024; Batson CD, 2002, J SOC ISSUES, V58, P429, DOI 10.1111/1540-4560.00269; Bellon M.R., 2001, PARTICIPATORY RES ME; Bernet T, 2001, AGR SYST, V69, P183, DOI 10.1016/S0308-521X(01)00024-5; Beza E, 2017, EUR J AGRON, V82, P206, DOI 10.1016/j.eja.2016.06.016; Brabham DC, 2010, INFORM COMMUN SOC, V13, P1122, DOI 10.1080/13691181003624090; Brabham DC., 2008, 1 MONDAY, V13, DOI [10.5210/fm.v13i6.2159., DOI 10.5210/FM.V13I6.2159]; Brophy J., 2004, MOTIVATING STUDENTS, V2; Car NJ, 2012, COMPUT ELECTRON AGR, V84, P132, DOI 10.1016/j.compag.2012.03.003; Ceccarelli S, 2007, EUPHYTICA, V155, P349, DOI 10.1007/s10681-006-9336-8; Conrad CC, 2011, ENVIRON MONIT ASSESS, V176, P273, DOI 10.1007/s10661-010-1582-5; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Curtis V, 2015, SCI COMMUN, V37, P723, DOI 10.1177/1075547015609322; Deterding S., 2011, P CHI, P1; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Fitz-Walter Z, 2011, P 23 AUSTR COMP HUM; Flatla D.R., 2011, P 24 ANN ACM S US IN; Follett R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143687; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hand E, 2010, NATURE, V465, P673, DOI 10.1038/465673a; Hellin J, 2008, EXP AGR, V44, P81, DOI 10.1017/S0014479707005935; Herrick JE, 2013, J SOIL WATER CONSERV, V68, p5A, DOI 10.2489/jswc.68.1.5A; Hofstede G., 2001, CULTURES CONSEQUENCE; Hofstede G, 1984, CULTURES CONSEQUENCE; Holohan A, 2005, J COMPUT-MEDIAT COMM, V10; Johnson MF, 2014, GLOBAL ENVIRON CHANG, V29, P235, DOI 10.1016/j.gloenvcha.2014.10.006; Krebs V., 2010, 1 MONDAY; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Laffont J-J, 2001, THEORY INCENTIVES, VI; Land-Zandstra AM, 2016, JCOM-J SCI COMMUN, V15; Land-Zandstra AM, 2016, PUBLIC UNDERST SCI, V25, P45, DOI 10.1177/0963662515602406; McKight PE, 2010, THE CORSINI ENCYCLOP; Misiko M, 2013, AGR SYST, V119, P35, DOI 10.1016/j.agsy.2013.04.004; Mittra S, 2015, BIOVERSITY INT; Muhr, 1991, QUALITATIVE SOCIOLOG, V14, P349, DOI DOI 10.1007/BF00989645; Neef A, 2011, AGR HUM VALUES, V28, P179, DOI 10.1007/s10460-010-9272-z; Newman G, 2012, FRONT ECOL ENVIRON, V10, P298, DOI 10.1890/110294; Nov O., 2011, P ICONFERENCE 2011 F; Nov O, 2011, P AAAI INT C WEBL SO; Ogodo O., 2009, CASSAVA DIS MONITORI; Okali C, 1994, FARMER PARTICIPATORY; Raddick M. Jordan, 2010, Astronomy Education Review, V9, DOI 10.3847/AER2009036; Raddick M.J., 2013, ARXIV PREPRINT ARXIV; Reddy PK, 2005, CURR SCI INDIA, V88, P1905; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robinson A, 2016, USING MOBILE VOICE T; Rotman D., 2014, ICONFERENCE 2014 P; Rotman D, 2012, PROCEEDINGS OF THE A; Ryan RM, 2000, CONTEMP EDUC PSYCHOL, V25, P54, DOI 10.1006/ceps.1999.1020; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Schunko C, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/s13002-015-0032-4; Singh NJ, 2014, ECOL SOC, V19, DOI 10.5751/ES-06665-190407; Sullivan BL, 2014, BIOL CONSERV, V169, P31, DOI 10.1016/j.biocon.2013.11.003; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Sumberg J, 2003, AGR SYST, V76, P739, DOI 10.1016/S0308-521X(02)00153-1; Thom J., 2012, P ACM 2012 C COMP SU; Van Etten J, 2019, EXP AGR, V55, P275, DOI 10.1017/S0014479716000739; van Etten J, 2011, IDS BULL-I DEV STUD, V42, P102, DOI 10.1111/j.1759-5436.2011.00240.x; Villamor GB, 2017, LAND USE POLICY, V61, P53, DOI 10.1016/j.landusepol.2016.11.002; Wood C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001220; World Community Grid, 2013, MEMB STUD FIND NEXT	62	48	48	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175700	10.1371/journal.pone.0175700	http://dx.doi.org/10.1371/journal.pone.0175700			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472823	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500014
J	De Cesare, A; Sirri, F; Manfreda, G; Moniaci, P; Giardini, A; Zampiga, M; Meluzzi, A				De Cesare, Alessandra; Sirri, Federico; Manfreda, Gerardo; Moniaci, Paola; Giardini, Alberto; Zampiga, Marco; Meluzzi, Adele			Effect of dietary supplementation with Lactobacillus acidophilus D2/CSL (CECT 4529) on caecum microbioma and productive performance in broiler chickens	PLOS ONE			English	Article							GROWTH-PERFORMANCE; CAMPYLOBACTER-JEJUNI; BACTERIAL COMMUNITY; IMMUNE-RESPONSES; BETA-GLUCOSIDASE; PROBIOTICS; BIFIDOBACTERIUM; CULTURES; DATABASE; STRAINS	This study examines the effects of the dietary supplementation with Lactobacillus acidophilus D2/CSL (CECT 4529) (LA) on productive performances, incidence of foot pad dermatitis and caecum microbioma in broiler chickens. A total of 1,100 one-day old male Ross 308 chicks were divided into 2 groups of 16 replicates with 25 birds each and reared from 1-41 d. One group was fed a basal diet (CON) and the other group the same diet supplemented with LA. Caecum contents were collected from 4 selected birds at day one and 5 selected birds at the end of the rearing period. Then, they were submitted to DNA extraction and whole DNA shotgun metagenomic sequencing. Overall, the LA supplementation produced a significant beneficial effect on body weight gain between 15-28 d and improved feed conversion rate in the overall period. On the contrary, litter moisture, pH and incidence of the foot pad lesions were not affected by LA. Birds treated with LA showed a lower occurrence of pasty vent at both 14 and 28 d. At the end of the rearing period, Lachanospiraceae were significantly higher in LA birds in comparison to CON (17.07 vs 14.39%; P = 0.036). Moreover, Ruminococcus obeum, Clostridium clostridioforme, Roseburia intestinalis, Lachnospiraceae bacterium 14-2T and Coprococcus eutactus were significantly higher in LA birds in comparison to CON. The relative abundance of Lactobacillus acidophilus was comparable between LA and CON groups. However, a positive effect was observed in relation to the metabolic functions in the treated group, with particular reference to the higher abundance of beta-glucosidase. In conclusion, the LA supplementation improved broiler productive performances and metabolic functions promoting animal health.	[De Cesare, Alessandra; Sirri, Federico; Manfreda, Gerardo; Moniaci, Paola; Zampiga, Marco; Meluzzi, Adele] Univ Bologna, Alma Mater Studiorum, Dept Agr & Food Sci, Bologna, Italy; [Giardini, Alberto] Ctr Sperimentale Latte, Lodi, Italy	University of Bologna	Sirri, F (corresponding author), Univ Bologna, Alma Mater Studiorum, Dept Agr & Food Sci, Bologna, Italy.	federico.sirri@unibo.it	Zampiga, Marco/ABC-5257-2020	Zampiga, Marco/0000-0001-8074-7283; SIRRI, FEDERICO/0000-0002-4640-7346	Centro Sperimentale del Latte S.r.l	Centro Sperimentale del Latte S.r.l	The Centro Sperimentale del Latte S.r.l. provided support in the form of salary for Alberto Giardini, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelakis E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010463; Askelson TE, 2014, APPL ENVIRON MICROB, V80, P943, DOI 10.1128/AEM.03155-13; Awad WA, 2009, POULTRY SCI, V88, P49, DOI 10.3382/ps.2008-00244; BARNES EM, 1972, BRIT POULTRY SCI, V13, P311, DOI 10.1080/00071667208415953; Bjerrum L, 2006, POULTRY SCI, V85, P1151, DOI 10.1093/ps/85.7.1151; Bouzaine T, 2005, LETT APPL MICROBIOL, V40, P391, DOI 10.1111/j.1472-765X.2005.01684.x; Brisbin JT, 2011, CLIN VACCINE IMMUNOL, V18, P1447, DOI 10.1128/CVI.05100-11; Brouns F, 2002, FOOD RES INT, V35, P187, DOI 10.1016/S0963-9969(01)00182-X; Camaschella P, 1985, MICROBIOLOGIE ALIMEN, V3, P73; Chen CY, 2012, POULTRY SCI, V91, P2139, DOI 10.3382/ps.2012-02237; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Dalmasso G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002476; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dominguez-Bello MG, 2008, MICROBES INFECT, V10, P1072, DOI 10.1016/j.micinf.2008.07.036; Donkor ON, 2008, J FOOD SCI, V73, pM15, DOI 10.1111/j.1750-3841.2007.00547.x; Edelman S, 2002, APPL ENVIRON MICROB, V68, P5155, DOI 10.1128/AEM.68.10.5155-5159.2002; Ekstrand C, 1998, BRIT POULTRY SCI, V39, P318, DOI 10.1080/00071669888845; FAO/WHO, 2002, WORK GROUP REP DRAFT; Fernandez-Rubio C, 2009, POULTRY SCI, V88, P943, DOI 10.3382/ps.2008-00484; Fritz WA, 1998, CARCINOGENESIS, V19, P2151, DOI 10.1093/carcin/19.12.2151; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Gallazzi D, 2008, ITAL J ANIM SCI, V7, P27; Gaskins HR, 2002, ANIM BIOTECHNOL, V13, P29, DOI 10.1081/ABIO-120005768; Ghareeb K, 2012, POULTRY SCI, V91, P1825, DOI 10.3382/ps.2012-02168; Gong J, 2008, J APPL MICROBIOL, V104, P1372, DOI 10.1111/j.1365-2672.2007.03699.x; Gong JH, 2002, FEMS MICROBIOL LETT, V208, P1, DOI 10.1111/j.1574-6968.2002.tb11051.x; Gong JH, 2007, FEMS MICROBIOL ECOL, V59, P147, DOI 10.1111/j.1574-6941.2006.00193.x; Haghighi HR, 2005, CLIN DIAGN LAB IMMUN, V12, P1387, DOI 10.1128/CDLI.12.12.1387-1392.2005; HOSKINS LC, 1981, J CLIN INVEST, V67, P163, DOI 10.1172/JCI110009; Huang MK, 2004, POULTRY SCI, V83, P788, DOI 10.1093/ps/83.5.788; Huyghebaert G, 2011, VET J, V187, P182, DOI 10.1016/j.tvjl.2010.03.003; Ismail B, 2005, J AGR FOOD CHEM, V53, P4918, DOI 10.1021/jf0404694; Izumi T, 2000, J NUTR, V130, P1695, DOI 10.1093/jn/130.7.1695; Jin LZ, 1998, POULTRY SCI, V77, P1259, DOI 10.1093/ps/77.9.1259; Jin LZ, 1996, LETT APPL MICROBIOL, V22, P229, DOI 10.1111/j.1472-765X.1996.tb01149.x; Kalavathy R, 2003, BRIT POULTRY SCI, V44, P139, DOI 10.1080/0007166031000085445; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kenneth HW, 1997, CLIN INFECT DIS, V25, pS114; Kim JS, 2012, J ANIM PHYSIOL AN N, V96, P618, DOI 10.1111/j.1439-0396.2011.01187.x; La Ragione RM, 2004, LETT APPL MICROBIOL, V38, P197, DOI 10.1111/j.1472-765X.2004.01474.x; Loh TC, 2010, ANIM SCI J, V81, P205, DOI 10.1111/j.1740-0929.2009.00701.x; Lund M, 2010, POULTRY SCI, V89, P1217, DOI 10.3382/ps.2010-00653; Meluzzi A, 2008, BRIT POULTRY SCI, V49, P509, DOI 10.1080/00071660802290424; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mountzouris KC, 2007, POULTRY SCI, V86, P309, DOI 10.1093/ps/86.2.309; Neal-McKinney JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043928; Nousiainen J., 2004, Lactic acid bacteria: microbiology and functional aspects, P547; Oakley BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057190; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Patterson JA, 2003, POULTRY SCI, V82, P627, DOI 10.1093/ps/82.4.627; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Pineiro M, 2007, J NUTR, V137, p850S, DOI 10.1093/jn/137.3.850S; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qian LC, 2009, ASIAN AUSTRAL J ANIM, V22, P260, DOI 10.5713/ajas.2009.80416; Reese ET., 1977, STRUCTURE BIOSYNTHES, P311; Rekha CR, 2011, INT J FOOD SCI NUTR, V62, P111, DOI 10.3109/09637486.2010.513680; Roy A, 2010, VET MED INT; RUSELERVANEMBDEN JGH, 1995, SCAND J GASTROENTERO, V30, P675, DOI 10.3109/00365529509096312; SAS Institute, 1988, SAS STAT USERS GUIDE; Scupham AJ, 2007, FEMS MICROBIOL ECOL, V60, P136, DOI 10.1111/j.1574-6941.2006.00245.x; Shim YH, 2012, BRIT POULTRY SCI, V53, P482, DOI 10.1080/00071668.2012.690508; Souza MR, 2007, VET MICROBIOL, V120, P142, DOI 10.1016/j.vetmic.2006.10.019; TANNOCK GW, 1990, APPL ENVIRON MICROB, V56, P1310, DOI 10.1128/AEM.56.5.1310-1316.1990; Tannock GW, 2004, APPL ENVIRON MICROB, V70, P3189, DOI 10.1128/AEM.70.6.3189-3194.2004; Timmerman HM, 2006, POULTRY SCI, V85, P1383, DOI 10.1093/ps/85.8.1383; Van den Abbeele P, 2010, APPL ENVIRON MICROB, V76, P5237, DOI 10.1128/AEM.00759-10; Willis WL, 2008, POULTRY SCI, V87, P606, DOI 10.3382/ps.2006-00458; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Zhao RX, 2007, WORLD J MICROB BIOT, V23, P195, DOI 10.1007/s11274-006-9209-2; Zulkifli I, 2000, BRIT POULTRY SCI, V41, P593, DOI 10.1080/713654979	72	56	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176309	10.1371/journal.pone.0176309	http://dx.doi.org/10.1371/journal.pone.0176309			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472118	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500037
J	Guede, I; Ortega, LA; Zuluaga, MC; Alonso-Olazabal, A; Murelaga, X; Pina, M; Gutierrez, FJ; Iacumin, P				Guede, Iranzu; Angel Ortega, Luis; Cruz Zuluaga, Maria; Alonso-Olazabal, Ainhoa; Murelaga, Xabier; Pina, Miriam; Javier Gutierrez, Francisco; Iacumin, Paola			Isotope analyses to explore diet and mobility in a medieval Muslim population at Tauste (NE Spain)	PLOS ONE			English	Article							BIOLOGICALLY AVAILABLE STRONTIUM; BONE-COLLAGEN; OXYGEN ISOTOPES; STABLE NITROGEN; TROPHIC LEVEL; TOOTH ENAMEL; RATIOS; CARBON; SR-87/SR-86; PHOSPHATE	The Islamic necropolis discovered in Tauste (Zaragoza, Spain) is the only evidence that a large Muslim community lived in the area between the 8th and 10th centuries. A multi-isotope approach has been used to investigate the mobility and diet of this medieval Muslim population living in a shifting frontier region. Thirty-one individuals were analyzed to determine delta N-15, delta C-13, delta O-18 and Sr-87/Sr-86 composition. A combination of strontium and oxygen isotope analysis indicated that most individuals were of local origin although three females and two males were non-local. The non-local males would be from a warmer zone whereas two of the females would be from a more mountainous geographical region and the third from a geologically-different area. The extremely high delta(15) N baseline at Tauste was due to bedrock composition (gypsum and salt). High individual delta(15) N values were related to the manuring effect and consumption of fish. Adult males were the most privileged members of society in the medieval Muslim world and, as isotope data reflected, consumed more animal proteins than females and young males.	[Guede, Iranzu; Angel Ortega, Luis; Cruz Zuluaga, Maria; Alonso-Olazabal, Ainhoa] Univ Basque Country, UPV EHU, Fac Sci & Technol, Dept Mineral & Petr, Vizcaya, Spain; [Murelaga, Xabier] Univ Basque Country, UPV EHU, Fac Sci & Technol, Dept Stratig & Palaeontol, Vizcaya, Spain; [Pina, Miriam; Javier Gutierrez, Francisco] El Patiaz Cultural Assoc, Cuesta Camara 12, Zaragoza, Spain; [Iacumin, Paola] Univ Parma, Dept Phys & Earth Sci, Parma, Italy	University of Basque Country; University of Basque Country; University of Parma	Ortega, LA (corresponding author), Univ Basque Country, UPV EHU, Fac Sci & Technol, Dept Mineral & Petr, Vizcaya, Spain.	luis.ortega@ehu.eus	Ortega, Luis Angel/K-8453-2014; Murelaga, Xabier/O-2262-2019; Iacumin, Paola/AAV-8855-2021	Ortega, Luis Angel/0000-0002-8929-0328; Murelaga, Xabier/0000-0001-8049-4917; Pina, Miriam/0000-0003-1079-7984; ZULUAGA IBARGALLARTU, MARIA CRUZ/0000-0003-1290-4093; ALONSO OLAZABAL, AINHOA/0000-0002-6994-0098	University of the Basque [GIU15/34]; Basque Country Government [IT315-10]	University of the Basque; Basque Country Government(Basque Government)	Research Group GIU15/34 of the University of the Basque provided support to MO, XM, Country-UPV/EHU, http://www.ehu.eus/es/web/ikerkuntza. IT315-10 Research Group of the Basque Country Government provided support to IG LO MCZ, http://www.hezkuntza.ejgv.euskadi.eus/r43-5553/es/.	Alexander MM, 2015, AM J PHYS ANTHROPOL, V156, P263, DOI 10.1002/ajpa.22647; Ambrose S.H., 1993, INVESTIGATIONS ANCIE, P59; AMBROSE SH, 1991, J ARCHAEOL SCI, V18, P293, DOI 10.1016/0305-4403(91)90067-Y; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Anderson G. D., 2006, MEDIEVAL ISLAMIC CIV, P264; [Anonymous], 1989, CARNEGIE I WASH YR B; [Anonymous], 2015, GRIDDED MAPS ISOTOPI; Balter V, 2004, OECOLOGIA, V139, P83, DOI 10.1007/s00442-003-1476-0; Balter V, 2002, PALAEOGEOGR PALAEOCL, V186, P127, DOI 10.1016/S0031-0182(02)00448-0; Balter V, 2001, CR ACAD SCI II A, V332, P59, DOI 10.1016/S1251-8050(00)01490-7; Barrett ELB, 2002, J EVOLUTION BIOL, P571; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bentley RA, 2005, ARCHAEOMETRY, V47, P629, DOI 10.1111/j.1475-4754.2005.00223.x; Bentley RA, 2004, J ARCHAEOL SCI, V31, P365, DOI 10.1016/j.jas.2003.09.003; Bittel LM, 2002, WOMEN EARLY MEDIEVAL; Blum JD, 2000, BIOGEOCHEMISTRY, V49, P87, DOI 10.1023/A:1006390707989; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; BOCHERENS H, 1991, J HUM EVOL, V20, P481, DOI 10.1016/0047-2484(91)90021-M; Bogaard A, 2007, J ARCHAEOL SCI, V34, P335, DOI 10.1016/j.jas.2006.04.009; Bohlke JK, 2000, APPL GEOCHEM, V15, P599, DOI 10.1016/S0883-2927(99)00075-X; Bol R, 2005, RAPID COMMUN MASS SP, V19, P3216, DOI 10.1002/rcm.2156; BRYANT JD, 1995, GEOCHIM COSMOCHIM AC, V59, P4523; BURTON JH, 1990, J ARCHAEOL SCI, V17, P547, DOI 10.1016/0305-4403(90)90035-4; Burton JH, 1996, ACS SYM SER, V625, P327, DOI 10.1021/bk-1996-0625.ch023; Canada Juste Alberto, 1980, PRINCIPE VIANA, V48-49, P5; Capilla JE, 2011, FALL M AGU; Causape Valenzuela J., 2003, REV REAL ACAD CIENCI, V58, P7; Christian LN, 2011, CHEM GEOL, V282, P84, DOI 10.1016/j.chemgeo.2011.01.011; Coope JA, 2014, ESSAYS MEDIEVAL STUD, V29, P76; Coope JA., 2010, J MEDIEVAL MEDITERRA, V20, P171; Darling WG, 2006, DEV PALEOENVIRON RES, V10, P1; Daux V, 2008, J HUM EVOL, V55, P1138, DOI 10.1016/j.jhevol.2008.06.006; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Drucker D, 2004, INT J OSTEOARCHAEOL, V14, P162, DOI 10.1002/oa.753; Dufour E, 1999, J ARCHAEOL SCI, V26, P617, DOI 10.1006/jasc.1998.0379; Evans J, 2006, J ARCHAEOL SCI, V33, P265, DOI 10.1016/j.jas.2005.07.011; Evans JA, 2010, J GEOL SOC LONDON, V167, P1, DOI 10.1144/0016-76492009-090; Evans JA, 2006, ARCHAEOMETRY, V48, P309, DOI 10.1111/j.1475-4754.2006.00258.x; Faure G., 2005, ISOTOPES PRINCIPLES, VThird; Fraser RA, 2011, J ARCHAEOL SCI, V38, P2790, DOI 10.1016/j.jas.2011.06.024; Fuller BT, 2012, AM J PHYS ANTHROPOL, V149, P157, DOI 10.1002/ajpa.22100; Garcia de Cortazar JA, 2008, MANUAL HIST MEDIEVAL; Garcia Sanchez E., 1995, ZOCO VIDA EC ARTES T, P49; Garcia Sanchez E., 2002, PATTERNS EVERYDAY LI, P275; Garcia-Sanchez E., 2006, MUJERES SOC ISLAMICA, P201; Glick Th. F., 2005, ISLAMIC CHRISTIAN SP, V2nd; Global Network of Isotopes in Precipitation, 2015, GNIP DAT; Guede I, 2017, MICROCHEM J, V130, P287, DOI 10.1016/j.microc.2016.10.005; Gutierrez FJ, 2016, ACT 1 C AR ARQ PATR, P415; HEATON THE, 1987, OECOLOGIA, V74, P236, DOI 10.1007/BF00379365; Hedges REM, 2007, J ARCHAEOL SCI, V34, P1240, DOI 10.1016/j.jas.2006.10.015; Hillson S., 1986, TEETH; HILLSON S, 1996, DENT ANTHR; Hitchcock R., 2014, MUSLIM SPAIN RECONSI; Hoefs J., 2009, STABLE ISOTOPE GEOCH, V6th; Hoppe KA, 2003, INT J OSTEOARCHAEOL, V13, P20, DOI 10.1002/oa.663; Hoppe KA, 1999, GEOLOGY, V27, P439, DOI 10.1130/0091-7613(1999)027<0439:TMAMRO>2.3.CO;2; Hoppe KA, 2007, QUATERNARY RES, V68, P347, DOI 10.1016/j.yqres.2007.08.001; Iacumin P., 2015, EUR SCI J, V11, P221; James David, 2009, EARLY ISLAMIC SPAIN; Katzenberg M. A., 2008, BIOL ANTHR HUMAN SKE, V2, P413; Katzenberg MA, 1999, J ARCHAEOL SCI, V26, P651, DOI 10.1006/jasc.1998.0382; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4811, DOI 10.1016/S0016-7037(96)00240-2; Lee-Thorp JA, 2008, ARCHAEOMETRY, V50, P925, DOI 10.1111/j.1475-4754.2008.00441.x; Levinson A.A., 1987, APPL GEOCHEM, V2, P367, DOI DOI 10.1016/0883-2927(87)90021-7; Lightfoot E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153850; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; LUZ B, 1985, EARTH PLANET SC LETT, V75, P29, DOI 10.1016/0012-821X(85)90047-0; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; Malainey ME, 2011, CONSUMERS GUIDE TO ARCHAEOLOGICAL SCIENCE: ANALYTICAL TECHNIQUES, P3, DOI 10.1007/978-1-4419-5704-7; Maurer AF, 2012, SCI TOTAL ENVIRON, V433, P216, DOI 10.1016/j.scitotenv.2012.06.046; Meier-Augenstein W., 2010, STABLE ISOTOPE FOREN; Muldner G, 2007, AM J PHYS ANTHROPOL, V134, P162, DOI 10.1002/ajpa.20647; Mundee M. M., 2010, THESIS; Navas A, 1988, AULA DEI, V19, P345; Olcina Domenech MH, 2008, ANALES U ALICANTE PR, V27, P213; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Pazdur A, 1999, RADIOCARBON, V41, P81, DOI 10.1017/S0033822200019354; Petersen A., 2013, OXFORD HDB OFTHE ARC, P241, DOI [10.1093/oxfordhb/9780199569069.013.0014, DOI 10.1093/OXFORDHB/9780199569069.013.0014]; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Pina M, 2011, ACT 12 JORN HIST TAU, P67; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Castillo JAQ, 2013, HIST AGRAR, P13; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Robson HK, 2015, ENV ARCHAEOLOGY; Safran JM., 2013, EFINING BOUNDARIES A; Salas-Salvado J, 2006, BRIT J NUTR, V96, pS100, DOI 10.1079/BJN20061710; Sandford Mary K., 1993, INVESTIGATIONS ANCIE; SCHOENINGER MJ, 1992, J WORLD PREHIST, V6, P247, DOI 10.1007/BF00975551; SCHOENINGER MJ, 1983, SCIENCE, V220, P1381, DOI 10.1126/science.6344217; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; SCHWARCZ HP, 1991, YEARB PHYS ANTHROPOL, V34, P283; Serraro JL, 2000, INTERVENCION ARQUEOL; Shatzmiller M., 1994, LABOUR MEDIEVAL ISLA; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Stephan E, 2000, J ARCHAEOL SCI, V27, P523, DOI 10.1006/jasc.1999.0480; Stutz LN, 2013, OXFORD HDB ARCHAEOLO, P68; Tichomirowa M, 2010, CHEM GEOL, V276, P104, DOI 10.1016/j.chemgeo.2010.06.004; Tutken T, 2011, GEOCHIM COSMOCHIM AC, V75, P5951, DOI 10.1016/j.gca.2011.07.024; Voerkelius S, 2010, FOOD CHEM, V118, P933, DOI 10.1016/j.foodchem.2009.04.125; WALKER PL, 1986, AM J PHYS ANTHROPOL, V71, P51, DOI 10.1002/ajpa.1330710107; West JB, 2009, J FORENSIC SCI, V54, P1261, DOI 10.1111/j.1556-4029.2009.01171.x; White CD, 1998, J ARCHAEOL SCI, V25, P643, DOI 10.1006/jasc.1997.0259; White T.D., 1991, HUMAN OSTEOLOGY; White W. M, 2015, ISOTOPE GEOCHEMISTRY; White W.M., 2013, GEOCHEMISTRY	108	27	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176572	10.1371/journal.pone.0176572	http://dx.doi.org/10.1371/journal.pone.0176572			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	ET9SP	28472159	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500054
J	Kagan, P; Sultan, M; Tachlytski, I; Safran, M; Ben-Ari, Z				Kagan, Polina; Sultan, Maya; Tachlytski, Irina; Safran, Michal; Ben-Ari, Ziv			Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation	PLOS ONE			English	Article							LIVER FIBROSIS; OXIDATIVE-STRESS; MICE; INJURY; TRANSCRIPTION-3; INFLAMMATION; PROGRESSION; EXPRESSION; STEATOSIS; DISEASES	Background During liver injury, hepatic stellate cells (HSCs) can undergo activation and transform into alpha-smooth muscle actin (alpha SMA)-expressing contractile myofibroblast-like cells, leading to deposition of excessive scar matrix. We have recently demonstrated that depletion of adenosine deaminase acting on double-stranded RNA (ADAR1) from mouse hepatocytes leads to HSC activation and induction of inflammation and hepatic fibrosis that is mediated by interleukin 6 (IL-6). Our aim was to identify and characterize the molecular pathways involved in the direct, inflammation-independent activation of HSCs by IL-6. Methods Primary HSCs were isolated from mouse livers. mRNA levels of alpha SMA and Col1a were analyzed using qRT-PCR. Protein levels of alpha SMA, MAPK, p-MAPK, p38, p-p38, STAT3 and p-STAT3 were assessed by Western Blot analysis. The effect of specific signal transduction pathway inhibitors (i.e., SB203580 (P-38 inhibitor), U0126 (MAPK inhibitor), S3I-201 (STAT3 inhibitor) and Ruxolitinib (Jak1/2 inhibitor)) was also studied. Results Primary HSCs treated with IL-6 demonstrated upregulation of alpha SMA and Col1a mRNA levels as well as increased alpha SMA protein levels. Moreover, the phenotypic transition of quiescent HSCs toward myofibroblast-like cells was noted upon administration of IL-6 and not in untreated samples. In addition, the phosphorylation levels of p38, MAPK and STAT3 increased 30 minutes after treatment, and was followed by a decline in the phosphorylation levels 2-4 hours post-treatment. However, addition of specific signal transduction pathway inhibitors curbed this effect, and resulted in alpha SMA and Col1a expression levels similar to those measured in untreated control samples. Conclusion IL-6 can directly induce the transition of HSCs toward myofibroblast-like cells. The effect is mediated by the activation of both MAPK and JAK/STAT signaling pathways. Elimination of either MAPK or JAK/STAT signaling pathways inhibits HSC stimulation. These results might pave the road toward the development of potential therapeutic interventions for hepatic fibrosis.	[Kagan, Polina; Sultan, Maya; Tachlytski, Irina; Safran, Michal; Ben-Ari, Ziv] Sheba Med Ctr, Liver Res Lab, Ramat Gan, Israel; [Kagan, Polina; Ben-Ari, Ziv] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Ben-Ari, Ziv] Sheba Med Ctr, Liver Dis Ctr, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	Ben-Ari, Z (corresponding author), Sheba Med Ctr, Liver Res Lab, Ramat Gan, Israel.; Ben-Ari, Z (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.; Ben-Ari, Z (corresponding author), Sheba Med Ctr, Liver Dis Ctr, Ramat Gan, Israel.	ziv.ben-ari@sheba.health.gov.il		Kagan, Polina/0000-0001-8150-4494	Israel Cancer association	Israel Cancer association	This work was supported by Israel Cancer association (M. Safran and Z. Ben-Ari) http://en.cancer.org.il/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by Israel Cancer Association (M.S. and Z.B.).	Ben-Shoshan SO, 2016, RNA BIOL, P1; CHOI I, 1994, CLIN EXP IMMUNOL, V95, P530; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Kovalovich K, 2000, HEPATOLOGY, V31, P149, DOI 10.1002/hep.510310123; Kroy DC, 2010, HEPATOLOGY, V51, P463, DOI 10.1002/hep.23322; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Liu YD, 2011, ALCOHOL CLIN EXP RES, V35, P921, DOI 10.1111/j.1530-0277.2010.01422.x; Mair M, 2010, GASTROENTEROLOGY, V138, P2499, DOI 10.1053/j.gastro.2010.02.049; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Natsume M, 1999, J LEUKOCYTE BIOL, V66, P601, DOI 10.1002/jlb.66.4.601; Neubauer K, 2001, CAN J GASTROENTEROL, V15, P187, DOI 10.1155/2001/870205; Nieto N, 2006, HEPATOLOGY, V44, P1487, DOI 10.1002/hep.21427; Plum W, 2010, AM J PATHOL, V176, P2236, DOI 10.2353/ajpath.2010.090469; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Reeves HL, 2002, FRONT BIOSCI-LANDMRK, V7, pD808, DOI 10.2741/reeves; Schaper F, 1998, BIOCHEM J, V335, P557, DOI 10.1042/bj3350557; Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004; Shah R, 2013, ALCOHOL CLIN EXP RES, V37, P1838, DOI 10.1111/acer.12167; Shu M, 2016, BIOCHEM BIOPH RES CO, V471, P233, DOI 10.1016/j.bbrc.2016.01.119; Silver JS, 2010, J LEUKOCYTE BIOL, V88, P1145, DOI 10.1189/jlb.0410217; Sinha-Hikim I, 2011, EXP MOL PATHOL, V91, P419, DOI 10.1016/j.yexmp.2011.04.009; Starkel P, 2007, LAB INVEST, V87, P173, DOI 10.1038/labinvest.3700496; Streetz KL, 2003, HEPATOLOGY, V38, P218, DOI 10.1053/jhep.2003.50268; Wang H, 2011, AM J PATHOL, V179, P714, DOI 10.1016/j.ajpath.2011.05.005; Wang H, 2011, INT J BIOL SCI, V7, P536, DOI 10.7150/ijbs.7.536; Zauberman A, 1999, ONCOGENE, V18, P3886, DOI 10.1038/sj.onc.1202738	28	40	45	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176173	10.1371/journal.pone.0176173	http://dx.doi.org/10.1371/journal.pone.0176173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472150	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500026
J	Kim, MJ; Lee, SR; Lee, MY; Sohn, JW; Yun, HG; Choi, JY; Jeon, SW; Suh, TS				Kim, Min-Joo; Lee, Seu-Ran; Lee, Min-Young; Sohn, Jason W.; Yun, Hyong Geon; Choi, Joon Yong; Jeon, Sang Won; Suh, Tae Suk			Characterization of 3D printing techniques: Toward patient specific quality assurance spine-shaped phantom for stereotactic body radiation therapy	PLOS ONE			English	Article							BONE-MINERAL DENSITY; HOUNSFIELD UNITS; RADIOSURGERY; RADIOTHERAPY; ACCURACY; CORD; MRI; CT	Development and comparison of spine-shaped phantoms generated by two different 3D-printing technologies, digital light processing (DLP) and Polyjet has been purposed to utilize in patient-specific quality assurance (QA) of stereotactic body radiation treatment. The developed 3D-printed spine QA phantom consisted of an acrylic body phantom and a 3D-printed spine shaped object. DLP and Polyjet 3D printers using a high-density acrylic polymer were employed to produce spine-shaped phantoms based on CT images. Image fusion was performed to evaluate the reproducibility of our phantom, and the Hounsfield units (HUs) were measured based on each CT image. Two different intensity-modulated radio-therapy plans based on both CT phantom image sets from the two printed spine-shaped phantoms with acrylic body phantoms were designed to deliver 16 Gy dose to the planning target volume (PTV) and were compared for target coverage and normal organ-sparing. Image fusion demonstrated good reproducibility of the developed phantom. The HU values of the DLP-and Polyjet-printed spine vertebrae differed by 54.3 on average. The PTV D-max dose for the DLP-generated phantom was about 1.488 Gy higher than that for the Polyjet-generated phantom. The organs at risk received a lower dose for the 3D printed spine-shaped phantom image using the DLP technique than for the phantom image using the Polyjet technique. Despite using the same material for printing the spine-shaped phantom, these phantoms generated by different 3D printing techniques, DLP and Polyjet, showed different HU values and these differently appearing HU values according to the printing technique could be an extra consideration for developing the 3D printed spine-shaped phantom depending on the patient's age and the density of the spinal bone. Therefore, the 3D printing technique and materials should be carefully chosen by taking into account the condition of the patient in order to accurately produce 3D printed patient-specific QA phantom.	[Kim, Min-Joo; Lee, Seu-Ran; Lee, Min-Young; Suh, Tae Suk] Catholic Univ Korea, Coll Med, Res Inst Biomed Engn, Dept Biomed Engn, Seoul, South Korea; [Kim, Min-Joo] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea; [Sohn, Jason W.] Case Western Reserve Univ, Sch Med, Dept Radiat Oncol, Cleveland, OH USA; [Yun, Hyong Geon; Choi, Joon Yong; Jeon, Sang Won] DongGuk Univ Hosp, Coll Med, Dept Radiat Oncol, Goyang, South Korea	Catholic University of Korea; Yonsei University; Yonsei University Health System; Case Western Reserve University; Dongguk University	Suh, TS (corresponding author), Catholic Univ Korea, Coll Med, Res Inst Biomed Engn, Dept Biomed Engn, Seoul, South Korea.	suhsanta@catholic.ac.kr			National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning [2014R1A2A1A10050270, 2017R1C1B1011798]	National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning	This study was supported by the National Research Foundation (NRF) of Korea funded by the Ministry of Science, ICT & Future Planning (2014R1A2A1A10050270,2017R1C1B1011798).	Avanzo M, 2009, NEUROSURG REV, V32, P1, DOI 10.1007/s10143-008-0167-z; Bache ST, 2015, MED PHYS, V42, P846, DOI 10.1118/1.4905489; Bartels RHMA, 2008, CA-CANCER J CLIN, V58, P245, DOI 10.3322/CA.2007.0016; Batawil N, 2016, RADIOGRAPHY, V22, pE93, DOI 10.1016/j.radi.2015.11.004; Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; Burfeindt MJ, 2012, IEEE ANTENN WIREL PR, V11, P1610, DOI 10.1109/LAWP.2012.2236293; Cai J, 2007, RADIOTHER ONCOL, V84, P279, DOI 10.1016/j.radonc.2007.06.008; Crump SS., 1992, United States Patent, Patent No. [No. 5,121,329A, 5121329, 5,121,329]; Deckard CR, 1989, United States Patent, Patent No. [US4863538A, 4863538, 4,863,538]; Du JY, 2014, SPINE, V39, pE593, DOI 10.1097/BRS.0000000000000255; Ehler ED, 2014, PHYS MED BIOL, V59, P5763, DOI 10.1088/0031-9155/59/19/5763; Gagnon GJ, 2009, NEUROSURGERY, V64, P297, DOI 10.1227/01.NEU.0000338072.30246.BD; Gallo JJ, 2015, J APPL CLIN MED PHYS, V16, P170, DOI 10.1120/jacmp.v16i1.5120; Gear JI, 2014, MED PHYS, V41, P525, DOI 10.1118/1.4887854; Gerszten PC, 2004, NEUROSURGERY, V55, P89, DOI 10.1227/01.NEU.0000126873.00845.A7; Hattori K, 2013, MED PHYS, V40, DOI 10.1118/1.4790023; Heyns M, 2013, NORTHEAST BIOENGIN C, P171, DOI 10.1109/NEBEC.2013.75; Hull CW, 1986, US Patent, Patent No. [4575330A, 4575330, 4,575,330]; International Commission on Radiation Units and Measurements, 1999, PRESCR REC REP PHOT; Ionita CN, 2014, PROC SPIE, V9038, DOI 10.1117/12.2042266; Jung J, 2015, INT J RADIAT ONCOL, V92, P745, DOI 10.1016/j.ijrobp.2015.02.055; Kato H, 2005, MED PHYS, V32, P3199, DOI 10.1118/1.2047807; Khan R, 2015, PHYS MED IN PRESS; Kuijper IT, 2010, RADIOTHER ONCOL, V94, P224, DOI 10.1016/j.radonc.2009.12.027; 윤경준, 2014, [PROGRESS in MEDICAL PHYSICS, 의학물리], V25, P100, DOI 10.14316/pmp.2014.25.2.100; Leary M, 2015, MATER DESIGN, V86, P487, DOI 10.1016/j.matdes.2015.07.052; Lee S, 2013, J KOREAN NEUROSURG S, V54, P384, DOI 10.3340/jkns.2013.54.5.384; National Industrial Chemicals Notification and Assessment Scheme, 1996, MOD ACR POL; Ryu S, 2007, CANCER, V109, P628, DOI 10.1002/cncr.22442; Schreiber JJ, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.5.FOCUS1483; Solomon J, 2015, RADIOLOGY, V275, P735, DOI 10.1148/radiol.15142005; Solomon J, 2014, MED PHYS, V41, DOI 10.1118/1.4893497; Xu XG, 2014, PHYS MED BIOL, V59, pR233, DOI 10.1088/0031-9155/59/18/R233; Yamane M., 1991, brevet US, Patent No. [US 5,059,266, 5059266]	34	27	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176227	10.1371/journal.pone.0176227	http://dx.doi.org/10.1371/journal.pone.0176227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472175	gold, Green Published, Green Submitted			2022-12-27	WOS:000400648500031
J	Tongyoo, P; Avihingsanon, Y; Prom-On, S; Mutirangura, A; Mhuantong, W; Hirankarn, N				Tongyoo, Pumipat; Avihingsanon, Yingyos; Prom-On, Santhitham; Mutirangura, Apiwat; Mhuantong, Wuttichai; Hirankarn, Nattiya			EnHERV: Enrichment analysis of specific human endogenous retrovirus patterns and their neighboring genes	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; EMBRYONIC STEM-CELLS; LONG TERMINAL REPEAT; DNA METHYLATION; TRANSPOSABLE ELEMENTS; HERV-E; NONCODING RNAS; HUMAN GENOME; EXPRESSION; SEQUENCES	Human endogenous retroviruses (HERVs) are flanked by long terminal repeats (LTRs), which contain the regulation part of the retrovirus. Remaining HERVs constitute 7% to 8% of the present day human genome, and most have been identified as solo LTRs. The HERV sequences have been associated with several molecular functions as well as certain diseases in human, but their roles in human diseases are yet to be established. We designed EnHERV to make accessible the identified endogenous retrovirus repetitive sequences from Repbase Update (a database of eukaryotic repetitive elements) that are present in the human genome. Defragmentation process was done to improve the Repeat-Masker annotation output. The defragmented elements were used as core database in EnHERV. EnHERV is available at http://sysbio.chula.ac.th/enherv and can be searched using either gene lists of user interest or HERV characteristics. Besides the search function, EnHERV also provides an enrichment analysis function that allows users to perform enrichment analysis between selected HERV characteristics and user-input gene lists, especially genes with the expression profile of a certain disease. EnHERV will facilitate exploratory studies of specific HERV characteristics that control gene expression patterns related to various disease conditions. Here we analyzed 25 selected HERV groups/names from all four HERV superfamilies, using the sense and anti-sense directions of the HERV and gene expression profiles from 49 specific tissue and disease conditions. We found that intragenic HERVs were associated with down-regulated genes in most cancer conditions and in psoriatic skin tissues and associated with up-regulated genes in immune cells particularly from systemic lupus erythematosus (SLE) patients. EnHERV allowed the analysis of how different types of LTRs were differentially associated with specific gene expression profiles in particular disease conditions for further studies into their mechanisms and functions.	[Tongyoo, Pumipat] Chulalongkorn Univ, Fac Grad Sch, Interdept Program Biomed Sci, Bangkok, Thailand; [Avihingsanon, Yingyos; Hirankarn, Nattiya] Chulalongkorn Univ, Fac Med, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand; [Avihingsanon, Yingyos] Chulalongkorn Univ, Dept Med, Div Nephrol, Bangkok, Thailand; [Avihingsanon, Yingyos] King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Prom-On, Santhitham] King Mongkuts Univ Technol Thonburi, Fac Engn, Comp Engn Dept, Bangkok, Thailand; [Mutirangura, Apiwat] Chulalongkorn Univ, Fac Med, Ctr Excellence Mol Genet Canc & Human Dis, Dept Anat, Bangkok, Thailand; [Mhuantong, Wuttichai] Natl Ctr Genet Engn & Biotechnol BIOTEC, Enzyme Technol Lab, Microbial Biotechnol & Biochem Res Unit, Khlong Luang, Pathum Thani, Thailand; [Hirankarn, Nattiya] Chulalongkorn Univ, Fac Med, Dept Microbiol, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; King Mongkuts University of Technology Thonburi; Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University	Hirankarn, N (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand.; Hirankarn, N (corresponding author), Chulalongkorn Univ, Fac Med, Dept Microbiol, Bangkok, Thailand.	Nattiya.H@gmail.com		Tongyoo, Pumipat/0000-0002-3274-5475; Hirankarn, Nattiya/0000-0003-2224-6856	Thailand Research Fund; Chulalongkorn University [PHD/0200/2552, CU-58-001-HR]; Ratchadapisek Somphot Endowment Fund; International Research Integration, Chula Research Scholar, Ratchadapisek Somphot Endowment Fund	Thailand Research Fund(Thailand Research Fund (TRF)); Chulalongkorn University(Chulalongkorn University); Ratchadapisek Somphot Endowment Fund; International Research Integration, Chula Research Scholar, Ratchadapisek Somphot Endowment Fund	This work was supported by the Thailand Research Fund under Royal Golden Jubilee Ph.D. Program and Chulalongkorn University (PHD/0200/2552, to PT); the Ratchadapisek Sompoch Endowment Fund (2015), Chulalongkorn University (CU-58-001-HR, to NH); and the Grant for International Research Integration, Chula Research Scholar, Ratchadapisek Somphot Endowment Fund (to NH).	Absher DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003678; Aporntewan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017934; Babaian A, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0080-x; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bergman CM, 2007, BRIEF BIOINFORM, V8, P382, DOI 10.1093/bib/bbm048; Chen SH, 2016, CLIN EXP IMMUNOL; Chuong EB, 2017, NAT REV GENET, V18, P71, DOI 10.1038/nrg.2016.139; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; Nogueira MAD, 2015, ARCH DERMATOL RES, V307, P259, DOI 10.1007/s00403-014-1524-0; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; FEUCHTERMURTHY AE, 1993, NUCLEIC ACIDS RES, V21, P135, DOI 10.1093/nar/21.1.135; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Giordano J, 2007, PLOS COMPUT BIOL, V3, P1321, DOI 10.1371/journal.pcbi.0030137; Glinsky GV, 2015, GENOME BIOL EVOL, V7, P1432, DOI 10.1093/gbe/evv081; Goodier JL, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0070-z; Grandi N, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0301-x; Griffiths DJ, 2001, GENOME BIOL, V2; Haase K, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0146-5; Hubley R., 2013, REPEATMASKER OPEN 40; Johnson R, 2014, RNA, V20, P959, DOI 10.1261/rna.044560.114; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kapusta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003470; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Katoh I, 2011, NEOPLASIA, V13, P1081, DOI 10.1593/neo.11794; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Kronung SK, 2016, ONCOTARGET, V7, P33484, DOI 10.18632/oncotarget.9255; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le Dantec C, 2015, VIRUSES-BASEL, V7, P1238, DOI 10.3390/v7031238; Levy A, 2008, NUCLEIC ACIDS RES, V36, pD47, DOI 10.1093/nar/gkm949; Lock FE, 2014, P NATL ACAD SCI USA, V111, pE3534, DOI 10.1073/pnas.1405507111; Long H, 2016, J AUTOIMMUN; Lu XY, 2014, NAT STRUCT MOL BIOL, V21, P423, DOI 10.1038/nsmb.2799; Mameli G, 2015, J NEUROIMMUNOL, V280, P66, DOI 10.1016/j.jneuroim.2015.03.003; Mavragani CP, 2016, ARTHRITIS RHEUMATOL, V68, P2686, DOI 10.1002/art.39795; Miao CG, 2014, LUPUS, V23, P730, DOI 10.1177/0961203314527365; Nakkuntod J, 2013, J HUM GENET, V58, P241, DOI 10.1038/jhg.2013.6; Nakkuntod J, 2011, CLIN CHIM ACTA, V412, P1457, DOI 10.1016/j.cca.2011.04.002; Okada M, 2002, J RHEUMATOL, V29, P1678; Paces J, 2002, NUCLEIC ACIDS RES, V30, P205, DOI 10.1093/nar/30.1.205; Pereira V, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r79; Pereira Vini, 2008, BMC Genomics, V9, P614, DOI 10.1186/1471-2164-9-614; Perron H, 2005, J NEUROVIROL, V11, P23, DOI 10.1080/13550280590901741; Pi WH, 2010, P NATL ACAD SCI USA, V107, P12992, DOI 10.1073/pnas.1004139107; Piotrowski PC, 2005, CLIN RHEUMATOL, V24, P620, DOI 10.1007/s10067-005-1123-8; Renaudineau Y, 2005, GENES IMMUN, V6, P663, DOI 10.1038/sj.gene.6364253; Schmitt K, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0035-7; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; Sukapan P, 2014, J HUM GENET, V59, P178, DOI 10.1038/jhg.2013.140; Suntsova M, 2015, CELL MOL LIFE SCI, V72, P3653, DOI 10.1007/s00018-015-1947-6; Taruscio D, 2002, MAMM GENOME, V13, P216, DOI 10.1007/s00335-001-2118-7; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Wang JC, 2016, NAT PROTOC, V11, P327, DOI 10.1038/nprot.2016.016; Watanabe Y, 2000, GENE, V252, P163, DOI 10.1016/S0378-1119(00)00208-0; Wu ZW, 2015, J DERMATOL SCI, V77, P110, DOI 10.1016/j.jdermsci.2014.12.004; Yooyongsatit S, 2015, J HUM GENET, V60, P349, DOI 10.1038/jhg.2015.33	60	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177119	10.1371/journal.pone.0177119	http://dx.doi.org/10.1371/journal.pone.0177119			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472109	gold, Green Submitted, Green Published			2022-12-27	WOS:000400648500139
J	Wang, CL; Yang, Y; Sun, DL; Jiang, Y				Wang, Chenglin; Yang, Yu; Sun, Donglin; Jiang, Yong			Prognosis of hepatocellular carcinoma patients with bile duct tumor thrombus after hepatic resection or liver transplantation in Asian populations: A meta-analysis	PLOS ONE			English	Article							OBSTRUCTIVE-JAUNDICE; CLINICOPATHOLOGICAL CHARACTERISTICS; SURGICAL-TREATMENT; PROGENITOR CELLS; HEPATECTOMY; RECURRENCE; EXPERIENCE; DIAGNOSIS; OUTCOMES; SURGERY	Background Hepatocellular carcinoma (HCC) with bile duct tumor thrombus (BDTT) in the clinic is rare, and surgical treatment is currently considered the most effective treatment. However, the influence of BDTT on the prognosis of HCC patients who underwent surgery remains controversial in previous studies. Therefore, this paper uses meta-analysis method to elucidate this controversy. Methods In this study, we conducted a literature search on databases PubMed, Embase and Web of Science from inception until September 2016. Each study was evaluated with Newcastle-Ottawa Scale (NOS). The pooled effect was calculated, and the association between BDTT and overall survival (OS) or disease-free survival (DFS) was reevaluated using meta-analysis for hazard ratio (HR) and 95% confidence interval (CI). Results A total of 11 studies was included containing 5295 patients. The (HR) for OS and DFS was 3.21 and 1.81, 95% CI was 2.34-4.39 and 1.17-2.78 respectively. Conclusions The results showed that HCC patients with BDTT had a worse prognosis than those without BDTT after hepatic resection or liver transplantation (LT).	[Wang, Chenglin; Yang, Yu; Sun, Donglin; Jiang, Yong] Soochow Univ, Affiliated Hosp 3, Dept Hepatobiliary Surg, Changzhou, Peoples R China	Soochow University - China	Jiang, Y (corresponding author), Soochow Univ, Affiliated Hosp 3, Dept Hepatobiliary Surg, Changzhou, Peoples R China.	yjiang8888@hotmail.com			Major Technology Project of Changzhou City Health Bureau [ZD201305]; Schoow University of Tumor laboratory	Major Technology Project of Changzhou City Health Bureau; Schoow University of Tumor laboratory	This research was supported by the "Major Technology Project of Changzhou City Health Bureau (ZD201305)".; We would like to thank the Schoow University of Tumor laboratory, for technology support of this study.	Buonaguro L, 2013, J HEPATOL, V59, P897, DOI 10.1016/j.jhep.2013.05.031; Cha C, 2003, J AM COLL SURGEONS, V197, P753, DOI 10.1016/j.jamcollsurg.2003.07.003; CHEN MF, 1994, CANCER, V73, P1335, DOI 10.1002/1097-0142(19940301)73:5<1335::AID-CNCR2820730505>3.0.CO;2-M; Effendi K, 2010, ONCOLOGY-BASEL, V78, P157, DOI 10.1159/000312658; Huang JF, 2002, J GASTROEN HEPATOL, V17, P190, DOI 10.1046/j.1440-1746.2002.02677.x; Hwang S, 2010, TRANSPL INT, V23, P723, DOI 10.1111/j.1432-2277.2010.01103.x; Ikenaga N, 2009, J GASTROINTEST SURG, V13, P492, DOI 10.1007/s11605-008-0751-0; Kim JM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000450; KOJIRO M, 1982, CANCER, V49, P2144, DOI 10.1002/1097-0142(19820515)49:10<2144::AID-CNCR2820491026>3.0.CO;2-O; Lai ECH, 2006, ANZ J SURG, V76, P631, DOI 10.1111/j.1445-2197.2006.03794.x; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Liu C, 2004, LIVER INT, V24, P669, DOI 10.1111/j.1478-3231.2004.0971.x; Molina-Jimenez F, 2010, HEPATOLOGY, V51, P777, DOI 10.1002/hep.23468; Moon DB, 2013, WORLD J SURG, V37, P443, DOI 10.1007/s00268-012-1845-0; Narita R, 2002, J GASTROENTEROL, V37, P55, DOI 10.1007/s535-002-8134-0; Noda T, 2011, SURGERY, V149, P371, DOI 10.1016/j.surg.2010.08.006; Oba A, 2014, ANTICANCER RES, V34, P4367; Pang Q, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001431; Peng BG, 2005, WORLD J GASTROENTERO, V11, P3966; Peng SY, 2004, WORLD J SURG, V28, P43, DOI 10.1007/s00268-003-7079-4; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.3.CO;2-F; Qin LX, 2004, WORLD J GASTROENTERO, V10, P1397; Qin LX, 2003, WORLD J GASTROENTERO, V9, P385, DOI 10.3748/wjg.v9.i3.385; Satoh S, 2000, SURGERY, V128, P779, DOI 10.1067/msy.2000.108659; Shao WY, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-2; Shiomi M, 2001, SURGERY, V129, P692, DOI 10.1067/msy.2001.113889; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Uchima-Koecklin H, 2012, GASTROENT HEPAT-BARC, V35, P326, DOI 10.1016/j.gastrohep.2011.12.004; UEDA M, 1994, HEPATO-GASTROENTEROL, V41, P349; Wang YD, 2010, CHINESE MED J-PEKING, V123, P2163, DOI 10.3760/cma.j.issn.0366-6999.2010.16.001; Wong TCL, 2015, HPB, V17, P401, DOI 10.1111/hpb.12368; Yeh CN, 2004, WORLD J SURG, V28, P471, DOI 10.1007/s00268-004-7185-y; Yu XH, 2011, DIGEST DIS SCI, V56, P252, DOI 10.1007/s10620-010-1256-8; Zeng H, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000364; Zhang R, 2013, ONCOL REP, V29, P967, DOI 10.3892/or.2012.2189; Zhou YM, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-55	36	5	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176827	10.1371/journal.pone.0176827	http://dx.doi.org/10.1371/journal.pone.0176827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472122	gold, Green Submitted, Green Published			2022-12-27	WOS:000400648500078
J	Arnason, JW; Murphy, JC; Kooi, C; Wiehler, S; Traves, SL; Shelfoon, C; Maciejewski, B; Dumonceaux, CJ; Lewenza, WS; Proud, D; Leigh, R				Arnason, Jason W.; Murphy, James C.; Kooi, Cora; Wiehler, Shahina; Traves, Suzanne L.; Shelfoon, Christopher; Maciejewski, Barbara; Dumonceaux, Curtis J.; Lewenza, W. Shawn; Proud, David; Leigh, Richard			Human beta-defensin-2 production upon viral and bacterial co-infection is attenuated in COPD	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; AIRWAY BACTERIAL; PULMONARY; EXACERBATIONS; INFECTION; SYMPTOMS; DISEASE; SMOKERS; EXPRESSION; INDUCTION	Viral-bacterial co-infections are associated with severe exacerbations of COPD. Epithelial antimicrobial peptides, including human beta-defensin-2 (HBD-2), are integral to innate host defenses. In this study, we examined how co-infection of airway epithelial cells with rhinovirus and Pseudomonas aeruginosa modulates HBD-2 expression, and whether these responses are attenuated by cigarette smoke and in epithelial cells obtained by bronchial brushings from smokers with normal lung function or from COPD patients. When human airway epithelial cells from normal lungs were infected with rhinovirus, Pseudomonas aeruginosa, or the combination, co-infection with rhinovirus and bacteria resulted in synergistic induction of HBD-2 (p<0.05). The combination of virus and flagellin replicated this synergistic increase (p<0.05), and synergy was not seen using a flagella-deficient mutant Pseudomonas (p<0.05). The effects of Pseudomonas aeruginosa were mediated via interactions of flagellin with TLR5. The effects of HRV-16 depended upon viral replication but did not appear to be mediated via the intracellular RNA helicases, retinoic acid-inducible gene-I or melanoma differentiation-associated gene-5. Cigarette smoke extract significantly decreased HBD-2 production in response to co-infection. Attenuated production was also observed following co-infection of cells obtained from healthy smokers or COPD patients compared to healthy controls (p<0.05). We conclude that co-exposure to HRV-16 and Pseudomonas aeruginosa induces synergistic production of HBD-2 from epithelial cells and that this synergistic induction of HBD-2 is reduced in COPD patients. This may contribute to the more severe exacerbations these patients experience in response to viral-bacterial co-infections.	[Arnason, Jason W.; Kooi, Cora; Dumonceaux, Curtis J.; Leigh, Richard] Univ Calgary, Cumming Sch Med, Dept Med, Snyder Inst Chron Dis, Calgary, AB, Canada; [Arnason, Jason W.; Murphy, James C.; Kooi, Cora; Wiehler, Shahina; Traves, Suzanne L.; Shelfoon, Christopher; Maciejewski, Barbara; Dumonceaux, Curtis J.; Proud, David; Leigh, Richard] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Snyder Inst Chron Dis, Calgary, AB, Canada; [Lewenza, W. Shawn] Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Snyder Inst Chron Dis, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Leigh, R (corresponding author), Univ Calgary, Cumming Sch Med, Dept Med, Snyder Inst Chron Dis, Calgary, AB, Canada.; Leigh, R (corresponding author), Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Snyder Inst Chron Dis, Calgary, AB, Canada.	rleigh@ucalgary.ca		Murphy, James/0000-0003-2702-9463	Canadian Institutes of Health Research (CIHR) [82049, 43923]; GlaxoSmithKline-CIHR Professorship in Inflammatory Lung Diseases at the University of Calgary; Tier 1 Canada Research Chair in Inflammatory Airway Diseases	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); GlaxoSmithKline-CIHR Professorship in Inflammatory Lung Diseases at the University of Calgary; Tier 1 Canada Research Chair in Inflammatory Airway Diseases	Grant numbers 82049 (to RL) & 43923 (to DP) from the Canadian Institutes of Health Research (CIHR) supported this work. Dr. Leigh holds the GlaxoSmithKline-CIHR Professorship in Inflammatory Lung Diseases at the University of Calgary and Dr. Proud is the recipient of a Tier 1 Canada Research Chair in Inflammatory Airway Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Celli BR, 2007, EUR RESPIR J, V29, P1224, DOI 10.1183/09031936.00109906; CHURCHILL L, 1989, AM REV RESPIR DIS, V140, P449, DOI 10.1164/ajrccm/140.2.449; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Duits LA, 2003, FEMS IMMUNOL MED MIC, V38, P59, DOI 10.1016/S0928-8244(03)00106-8; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Gershon AS, 2013, AM J RESP CRIT CARE, V187, P596, DOI 10.1164/rccm.201211-2044OC; Global Initiative for Chronic Obstructive Lung Disease, 2016, GLOB STRAT DIAGN MAN; Guarascio AJ, 2013, CLINICOECONOMIC OUTC, V5, P235, DOI 10.2147/CEOR.S34321; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Herr C, 2009, THORAX, V64, P144, DOI 10.1136/thx.2008.102681; Hudy MH, 2010, EUR RESPIR J, V35, P1256, DOI 10.1183/09031936.00128809; Jarczak J, 2013, HUM IMMUNOL, V74, P1069, DOI 10.1016/j.humimm.2013.05.008; Lewenza S, 2005, GENOME RES, V15, P583, DOI 10.1101/gr.3513905; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Proud D, 2004, J IMMUNOL, V172, P4637, DOI 10.4049/jimmunol.172.7.4637; Proud D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040762; Regan EA, 2015, JAMA INTERN MED, V175, P1539, DOI 10.1001/jamainternmed.2015.2735; Sanders SP, 1998, J VIROL, V72, P934, DOI 10.1128/JVI.72.2.934-942.1998; Scharf S, 2010, AM J PHYSIOL-LUNG C, V298, pL687, DOI 10.1152/ajplung.00365.2009; Schlee M, 2007, INFECT IMMUN, V75, P2399, DOI 10.1128/IAI.01563-06; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Sethi Sanjay, 2008, N Engl J Med, V359, P2355, DOI 10.1056/NEJMra0800353; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Tan WC, 2014, THORAX, V69, P709, DOI 10.1136/thoraxjnl-2013-205048; Triantafilou K, 2011, VIRULENCE, V2, P22, DOI 10.4161/viru.2.1.13807; Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070; Wang R, 2012, J IMMUNOL, V189, P2217, DOI 10.4049/jimmunol.1101895; Wark PAB, 2013, RESPIROLOGY, V18, P996, DOI 10.1111/resp.12099; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wiehler S, 2007, AM J PHYSIOL-LUNG C, V293, pL505, DOI 10.1152/ajplung.00066.2007; Wilkinson TMA, 2006, CHEST, V129, P317, DOI 10.1378/chest.129.2.317; Wilkinson TMA, 2003, AM J RESP CRIT CARE, V167, P1090, DOI 10.1164/rccm.200210-1179OC; Woodruff PG, 2016, NEW ENGL J MED, V374, P1811, DOI 10.1056/NEJMoa1505971; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	40	13	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0175963	10.1371/journal.pone.0175963	http://dx.doi.org/10.1371/journal.pone.0175963			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489911	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314100010
J	Berendt, L; Petersen, LG; Bach, KF; Poulsen, HE; Dalhoff, K				Berendt, Louise; Petersen, Lene Grejs; Bach, Karin Friis; Poulsen, Henrik Enghusen; Dalhoff, Kim			Barriers towards the publication of academic drug trials. Follow-up of trials approved by the Danish Medicines Agency	PLOS ONE			English	Article							CLINICAL-TRIALS; RETROSPECTIVE COHORT; REPORTING BIAS; COMPLETION; TIME	Objective To characterize and quantify barriers towards the publication of academic drug trials. Study design We identified academic drug trials approved during a 3-year period (2004-2007) by the Danish Medicines Agency. We conducted a survey among the trial sponsors to describe the rates of initiation, completion, and publication, and the reasons for the failure to reach each of these milestones. Information on size and methodological characteristics of the trials was extracted from the EudraCT database, a prospective register of all approved clinical drug trials submitted to European medicines agencies since 2004. Results A total of 181 academic drug trials were eligible for inclusion, 139 of which participated in our survey (response rate: 77%). Follow-up time ranged from 5.1 to 7.9 years. Most trials were randomized controlled trials (73%, 95% CI 65-81%). Initiation and completion rates were 92% (95% CI: 88-97%) and 93% (95% CI: 89-97%) respectively. The publication rate of completed trials was 73% (95% CI: 62-79%). RCTs were published faster than non-RCTs (quartile time to publication 2.9 vs. 3.1 years, p = 0.0412). Conclusions Many academic drug trials are left unpublished. Main barriers towards publication were related to the process from completion to publication. Hence, there is much to gain by facilitating the process from analysis to publication. Research institutions and funders should actively influence this process, e.g. by requiring the publication of trial results within a given time after completion.	[Berendt, Louise; Bach, Karin Friis] Bispebjerg Hosp, GCP Unit, Copenhagen Univ Hosp, Copenhagen, Denmark; [Berendt, Louise; Petersen, Lene Grejs] Danish Med Agcy, Med Dev & Clin Trials, Copenhagen, Denmark; [Poulsen, Henrik Enghusen; Dalhoff, Kim] Bispebjerg Hosp, Dept Clin Pharmacol, Copenhagen, Denmark; [Poulsen, Henrik Enghusen] Rigshosp, Lab Clin Pharmacol, Copenhagen, Denmark; [Poulsen, Henrik Enghusen] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Berendt, Louise] Novo Nordisk AS, Soborg, Denmark; [Bach, Karin Friis] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Novo Nordisk; University of Copenhagen	Berendt, L (corresponding author), Bispebjerg Hosp, GCP Unit, Copenhagen Univ Hosp, Copenhagen, Denmark.; Berendt, L (corresponding author), Danish Med Agcy, Med Dev & Clin Trials, Copenhagen, Denmark.; Berendt, L (corresponding author), Novo Nordisk AS, Soborg, Denmark.	lbe@berendt.eu		Poulsen, Henrik Enghusen/0000-0003-4242-9924	GCP Unit at Copenhagen University Hospital; Danish Medicines Agency; Laboratory of Clinical Pharmacology at Rigshospitalet; Lundbeckfonden [R57-A4933]; University of Copenhagen [100280-XXX/632-01]	GCP Unit at Copenhagen University Hospital; Danish Medicines Agency; Laboratory of Clinical Pharmacology at Rigshospitalet; Lundbeckfonden(Lundbeckfonden); University of Copenhagen	The study was funded by the GCP Unit at Copenhagen University Hospital, Danish Medicines Agency and Laboratory of Clinical Pharmacology at Rigshospitalet. LB received a grant from Lundbeckfonden (www.lundbeckfonden.dk, grant no. R57-A4933) and a grant from the University of Copenhagen (www.sundphd.ku.dk, reference 100280-XXX/632-01). These funders had no role in the design and conduct of the study; the collection, management, analysis and interpretation of the data; or the preparation, review, and approval of the manuscript.	Antes G, 2003, LANCET, V361, P978, DOI 10.1016/S0140-6736(03)12838-3; Bardy AH, 1998, BRIT J CLIN PHARMACO, V46, P147, DOI 10.1046/j.1365-2125.1998.00759.x; Berendt L, 2008, BMJ-BRIT MED J, V336, P33, DOI 10.1136/bmj.39401.470648.BE; Berendt L, 2010, BRIT J CLIN PHARMACO, V70, P729, DOI 10.1111/j.1365-2125.2010.03755.x; Blumle A, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2008.024521; Callahan ML, 1998, BMJ-BRIT MED J, V316, P1536, DOI 10.1136/bmj.316.7143.1536; Chalmers I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f105; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Decullier E, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-165; Decullier E, 2009, PLOS MED, V6, P202, DOI 10.1371/journal.pmed.1000034; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Dickersin K, 2011, J ROY SOC MED, V104, P532, DOI 10.1258/jrsm.2011.11k042; Hole OP, 2009, EUR J CLIN PHARMACOL, V65, P315, DOI 10.1007/s00228-008-0601-8; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Ioannidis JPA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7089; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; Schmucker C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114023; Song FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110418; Song FJ, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-79; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Sune P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054583; van den Bogert CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167709; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; Weber EJ, 1998, JAMA-J AM MED ASSOC, V280, P257, DOI 10.1001/jama.280.3.257; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.281053	26	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0172581	10.1371/journal.pone.0172581	http://dx.doi.org/10.1371/journal.pone.0172581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486523	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000002
J	Jha, PK; Khan, MI; Mishra, A; Das, P; Sinha, KK				Jha, Pravin K.; Khan, Mohd. Imran; Mishra, Anshul; Das, Pradeep; Sinha, Kislay K.			HAT2 mediates histone H4K4 acetylation and affects micrococcal nuclease sensitivity of chromatin in Leishmania donovani	PLOS ONE			English	Article							NUCLEOSOME CORE PARTICLE; TRYPANOSOMA-CRUZI; MYST-FAMILY; POLYCISTRONIC TRANSCRIPTION; FUNCTIONAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; DEACETYLASE; CLONING; PROTEIN; DNA	Histone post-translational modifications (PTMs) such as acetylation and methylation are known to affect chromatin higher order structures. Primary targets of these modifications include basic residues present at N-terminus tail region of core histones. Four histone acetyltransferase (HAT) genes have been identified in trypanosomatids. HAT1, HAT3 and HAT4 of Leishmania donovani have been partially characterized. However, there is no report about HAT2 of Leishmania donovani. Lysine residues present on the N-terminal tail of Leishmania donovani histone H4 are conserved in other trypanosomatids and humans. PTMs of lysines modulate various functions at chromatin level. The four histone acetyltrans-ferases encoded in Leishmania genome were over-expressed to analyse their functional activity. All four HATs were found actively acetylating core histones H3/H4. Similar to L. donovani HAT3 and HAT4, HAT2 was found to be a member of MYST family protein and have SAS2 type domain. Over-expression of HAT2 significantly increases acetylation of H4K4. To analyse the effect of HAT2 over-expression on chromatin accessibility, micrococcal nuclease digestion assay was performed. MNase digestion resulted in a higher proportion of the mononucleosomes and dinucleosomes in HAT2 over-expressing cells as compared to WT L. donovani cells. Acetylation of lysine-4 neutralizes the amino terminal region of histone H4. This weakens its interaction with neighbouring nucleosomes and the linker DNA. HAT2 over-expression in L. donovani resulted in highly accessible chromatin suggesting chromatin decondensation. HAT2 may have an important role to play in global regulation of transcription in L. donovani. Better understanding of these epigenetic determinants of parasite would help in designing novel therapeutic strategies.	[Jha, Pravin K.; Khan, Mohd. Imran; Mishra, Anshul; Sinha, Kislay K.] Natl Inst Pharmaceut Educ & Res, Dept Biotechnol, Hajipur, Bihar, India; [Das, Pradeep] Rajendra Mem Res Inst Med Sci, Mol Biol Div, Patna, Bihar, India	National Institute of Pharmaceutical Education & Research (NIPER); Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI)	Sinha, KK (corresponding author), Natl Inst Pharmaceut Educ & Res, Dept Biotechnol, Hajipur, Bihar, India.	kksinha@gmail.com	Jha, Pravin/GOH-0811-2022	Sinha, Kislay/0000-0002-6978-4611	Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India	Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India	The authors received funding for this work from Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Alsford S, 2004, MOL MICROBIOL, V53, P365, DOI 10.1111/j.1365-2958.2004.04151.x; Avvakumov N, 2007, ONCOGENE, V26, P5395, DOI 10.1038/sj.onc.1210608; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Bonisch C, 2012, NUCLEIC ACIDS RES, V40, P10719, DOI 10.1093/nar/gks865; da Cunha JPC, 2006, MOL BIOCHEM PARASIT, V150, P268, DOI 10.1016/j.molbiopara.2006.08.012; CHAHAL SS, 1980, NATURE, V287, P76, DOI 10.1038/287076a0; Collepardo-Guevara R, 2014, P NATL ACAD SCI USA, V111, P8061, DOI 10.1073/pnas.1315872111; ElBashir R, 2015, ANAL CHEM, V87, P9939, DOI 10.1021/acs.analchem.5b02517; Eram MS, 2014, J BIOL CHEM, V289, P12177, DOI 10.1074/jbc.M113.523183; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; GARCIARAMIREZ M, 1995, J BIOL CHEM, V270, P17923, DOI 10.1074/jbc.270.30.17923; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Heitz E, 1928, JAHRB WISS BOT, V69, P762; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Janzen CJ, 2006, FEBS LETT, V580, P2306, DOI 10.1016/j.febslet.2006.03.044; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200; Kawahara T, 2008, MOL MICROBIOL, V69, P1054, DOI 10.1111/j.1365-2958.2008.06346.x; Krajewski WA, 1998, P NATL ACAD SCI USA, V95, P1540, DOI 10.1073/pnas.95.4.1540; Kumar D, 2015, NUCLEIC ACIDS RES, V43, P5423, DOI 10.1093/nar/gkv431; Kumar D, 2012, MICROBIOL-SGM, V158, P328, DOI 10.1099/mic.0.050211-0; de Jesus TCL, 2016, J PROTEOME RES, V15, P2039, DOI 10.1021/acs.jproteome.6b00208; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maity AK, 2012, FEMS MICROBIOL LETT, V336, P57, DOI 10.1111/j.1574-6968.2012.02656.x; Mandava V, 2007, MOL BIOCHEM PARASIT, V156, P41, DOI 10.1016/j.molbiopara.2007.07.005; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Park CS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-539; Ramos TCP, 2015, MOL BIOCHEM PARASIT, V204, P1, DOI 10.1016/j.molbiopara.2015.11.001; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Respuela P, 2008, J BIOL CHEM, V283, P15884, DOI 10.1074/jbc.M802081200; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Siegel TN, 2008, MOL MICROBIOL, V67, P762, DOI 10.1111/j.1365-2958.2007.06079.x; Singh J, 2015, MOL BIOSYST, V11, P1887, DOI 10.1039/c5mb00251f; Sklenar Amy R., 2004, BMC Biochemistry, V5, P11, DOI 10.1186/1471-2091-5-11; Sullivan WJ, 2000, GENE, V242, P193, DOI 10.1016/S0378-1119(99)00526-0; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P174, DOI 10.1093/nar/22.2.174; Thomas S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-152; Toth K, 2006, BIOCHEMISTRY-US, V45, P1591, DOI 10.1021/bi052110u; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Van den Wyngaert I, 2000, FEBS LETT, V478, P77, DOI 10.1016/S0014-5793(00)01813-5; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yang XH, 2011, MOL CELL, V44, P39, DOI 10.1016/j.molcel.2011.07.032; Zaret K., 2005, CURR PROTOC MOL BIOL, VChapter 21; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	51	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177372	10.1371/journal.pone.0177372	http://dx.doi.org/10.1371/journal.pone.0177372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486547	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000077
J	Sorenson, EC; Khanin, R; Bamboat, ZM; Cavnar, MJ; Kim, TS; Sadot, E; Zeng, S; Greer, JB; Seifert, AM; Cohen, NA; Crawley, MH; Green, BL; Klimstra, DS; DeMatteo, RP				Sorenson, Eric C.; Khanin, Raya; Bamboat, Zubin M.; Cavnar, Michael J.; Kim, Teresa S.; Sadot, Eran; Zeng, Shan; Greer, Jonathan B.; Seifert, Adrian M.; Cohen, Noah A.; Crawley, Megan H.; Green, Benjamin L.; Klimstra, David S.; DeMatteo, Ronald P.			Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation	PLOS ONE			English	Article							GENE-EXPRESSION; COPY-NUMBER; CANCER; LIVER; DIFFERENTIATION; HYBRIDIZATION; PROLIFERATION; PROGRESSION; ALGORITHM; SURVIVAL	Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare variant of HCC that most frequently affects young adults. Because of its rarity and an absence of preclinical models, our understanding of FL-HCC is limited. Our objective was to analyze chromosomal alterations and dysregulated gene expression in tumor specimens collected at a single center during two decades of experience with FL-HCC. We analyzed 38 specimens from 26 patients by array comparative genomic hybridiziation (aCGH) and 35 specimens from 15 patients by transcriptome sequencing (RNA-seq). All tumor specimens exhibited genomic instability, with a higher frequency of genomic amplifications or deletions in metastatic tumors. The regions encoding 71 microRNAs (miRs) were deleted in at least 25% of tumor specimens. Five of these recurrently deleted miRs targeted the insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) gene product, and a correlating 100-fold upregulation of IGF2BP1 mRNA was seen in tumor specimens. Transcriptome analysis demonstrated intrapatient tumor similarity, independent of recurrence site or time. The p53 tumor suppressor pathway was downregulated as demonstrated by both aCGH and RNA-seq analysis. Notch, EGFR, NRAS, and RB1 pathways were also significantly dysregulated in tumors compared with normal liver tissue. The findings illuminate the genomic and transcriptomic landscape of this rare disease and provide insight into dysregulated oncogenic pathways and potential therapeutic targets in FL-HCC.	[Sorenson, Eric C.; Bamboat, Zubin M.; Cavnar, Michael J.; Kim, Teresa S.; Sadot, Eran; Zeng, Shan; Greer, Jonathan B.; Seifert, Adrian M.; Cohen, Noah A.; Crawley, Megan H.; Green, Benjamin L.; DeMatteo, Ronald P.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Khanin, Raya] Mem Sloan Kettering Canc Ctr, Dept Computat Biol & Bioinformat Core, New York, NY 10021 USA; [Klimstra, David S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	DeMatteo, RP (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.	dematter@mskcc.org	Seifert, Adrian M./AAL-3453-2021; Kim, Teresa/AAC-2437-2021	Seifert, Adrian M./0000-0002-5329-3164; Kim, Teresa/0000-0002-6040-7748; Cohen, Noah/0000-0003-3947-2585; Cohen, Noah/0000-0003-3794-9642; Green, Benjamin/0000-0002-5772-198X	Fibrolamellar Cancer Foundation; RPD; U.S. National Institutes of Health [T32-CA09501]; ECS; NATIONAL CANCER INSTITUTE [T32CA009501] Funding Source: NIH RePORTER	Fibrolamellar Cancer Foundation; RPD; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ECS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: Fibrolamellar Cancer Foundation (http://fibrefoundation.org), Recipient: RPD; U.S. National Institutes of Health Grant T32-CA09501, Recipient: ECS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ang Celina S, 2013, Gastrointest Cancer Res, V6, P3; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Buckley AF, 2006, HUM PATHOL, V37, P410, DOI 10.1016/j.humpath.2005.12.009; COLLIER NA, 1984, LANCET, V1, P538; Cornella H, 2015, GASTROENTEROLOGY, V148, P806, DOI 10.1053/j.gastro.2014.12.028; Dar AA, 2008, CANCER RES, V68, P8998, DOI 10.1158/0008-5472.CAN-08-2658; Do RK, 2014, THE BRITISH JOURNAL, V87; EDMONDSON HA, 1956, AMA J DIS CHILD, V91, P168, DOI 10.1001/archpedi.1956.02060020170015; Eggert T, 2014, GUT, V63, P1524, DOI 10.1136/gutjnl-2013-306407; Eggert T, 2013, UNITED EUR GASTROENT, V1, P351, DOI 10.1177/2050640613501507; EHRENFRIED JA, 1994, ANN SURG, V220, P484, DOI 10.1097/00000658-199410000-00007; Gutschner T, 2014, HEPATOLOGY, V59, P1900, DOI 10.1002/hep.26997; Honda K, 1998, BRIT J CANCER, V77, P776, DOI 10.1038/bjc.1998.126; Honeyman JN, 2014, SCIENCE, V343, P1010, DOI 10.1126/science.1249484; Huang XD, 2014, DIGEST DIS SCI, V59, P795, DOI 10.1007/s10620-013-2969-2; Ieta K, 2007, INT J CANCER, V121, P33, DOI 10.1002/ijc.22605; Kakar S, 2009, MODERN PATHOL, V22, P134, DOI 10.1038/modpathol.2008.178; Kannan K, 2011, P NATL ACAD SCI USA, V108, P9172, DOI 10.1073/pnas.1100489108; Kannangai Rajesh, 2005, Int J Gastrointest Cancer, V35, P53, DOI 10.1385/IJGC:35:1:053; Kannangai R, 2007, HUM PATHOL, V38, P639, DOI 10.1016/j.humpath.2006.07.019; Kaseb AO, 2013, ONCOLOGY-BASEL, V85, P197, DOI 10.1159/000354698; KESSLER SM, 2013, AM J PHYSIOL-GASTR L, V304, pG3280; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Malouf GG, 2014, HEPATOLOGY, V59, P2228, DOI 10.1002/hep.27018; Marchio AS, 2000, ONCOGENE, V19, P3733, DOI 10.1038/sj.onc.1203713; Mayo SC, 2014, J AM COLL SURGEONS, V218, P196, DOI 10.1016/j.jamcollsurg.2013.10.011; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; Patt YZ, 2003, J CLIN ONCOL, V21, P421, DOI 10.1200/JCO.2003.10.103; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Scian MJ, 2008, ONCOGENE, V27, P2583, DOI 10.1038/sj.onc.1210898; Stipa F, 2006, CANCER-AM CANCER SOC, V106, P1331, DOI 10.1002/cncr.21703; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Torbenson M, 2004, AM J CLIN PATHOL, V122, P377, DOI 10.1309/YH0H3FKYM4RMU1JF; Trankenschuh W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013688; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Vivekanandan P, 2008, MODERN PATHOL, V21, P670, DOI 10.1038/modpathol.2008.32; Wang L, 2011, CELL PROLIFERAT, V44, P291, DOI 10.1111/j.1365-2184.2011.00752.x; Ward SC, 2010, MODERN PATHOL, V23, P1180, DOI 10.1038/modpathol.2010.105; Wilkens L, 2000, AM J CLIN PATHOL, V114, P867, DOI 10.1309/BMTT-JBPD-D13H-1UVD; Xu L, 2015, HUM MOL GENET, V24, P50, DOI 10.1093/hmg/ddu418; Zhou X, 2014, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2014-19	48	19	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176562	10.1371/journal.pone.0176562	http://dx.doi.org/10.1371/journal.pone.0176562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486549	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314000016
J	Wang, W; Zhang, TM; Wu, CY; Wang, SS; Wang, YX; Li, H; Wang, N				Wang, Wei; Zhang, Tianmu; Wu, Chunyan; Wang, Shanshan; Wang, Yuxiang; Li, Hui; Wang, Ning			Immortalization of chicken preadipocytes by retroviral transduction of chicken TERT and TR	PLOS ONE			English	Article							NORMAL HUMAN-CELLS; TELOMERASE ACTIVITY; ADIPOCYTE DIFFERENTIATION; SPECIES IDENTIFICATION; BROILER-CHICKENS; ADIPOSE-TISSUE; TUMOR-CELLS; AVIAN CELLS; LIFE-SPAN; IN-VITRO	The chicken is an important agricultural animal and model for developmental biology, immunology and virology. Excess fat accumulation continues to be a serious problem for the chicken industry. However, chicken adipogenesis and obesity have not been well investigated, because no chicken preadipocyte cell lines have been generated thus far. Here, we successfully generated two immortalized chicken preadipocyte cell lines through transduction of either chicken telomerase reverse transcriptase (chTERT) alone or in combination with chicken telomerase RNA (chTR). Both of these cell lines have survived >100 population doublings in vitro, display high telomerase activity and have no sign of replicative senescence. Similar to primary chicken preadipocytes, these two cell lines display a fibroblast-like morphology, retain the capacity to differentiate into adipocytes, and do not display any signs of malignant transformation. Isoenzyme analysis and PCR-based analysis confirmed that these two cell lines are of chicken origin and are free from inter-species contamination. To our knowledge, this is the first report demonstrating the generation of immortal chicken cells by introduction of chTERT and chTR. Our established chicken preadipocyte cell lines show great promise as an in vitro model for the investigation of chicken adipogenesis, lipid metabolism, and obesity and its related diseases, and our results also provide clues for immortalizing other avian cell types.	[Wang, Wei; Zhang, Tianmu; Wu, Chunyan; Wang, Shanshan; Wang, Yuxiang; Li, Hui; Wang, Ning] Minist Agr, Key Lab Chicken Genet & Breeding, Harbin, Peoples R China; [Wang, Wei; Zhang, Tianmu; Wu, Chunyan; Wang, Shanshan; Wang, Yuxiang; Li, Hui; Wang, Ning] Educ Dept Heilongjiang Prov, Key Lab Anim Genet Breeding & Reprod, Harbin, Peoples R China; [Wang, Wei; Zhang, Tianmu; Wu, Chunyan; Wang, Shanshan; Wang, Yuxiang; Li, Hui; Wang, Ning] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China	Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China	Li, H; Wang, N (corresponding author), Minist Agr, Key Lab Chicken Genet & Breeding, Harbin, Peoples R China.; Li, H; Wang, N (corresponding author), Educ Dept Heilongjiang Prov, Key Lab Anim Genet Breeding & Reprod, Harbin, Peoples R China.; Li, H; Wang, N (corresponding author), Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China.	lihui@neau.edu.cn; wangning@neau.edu.cn			National High-tech R&D Program (863 Program) [2013AA102501]; National Natural Science Foundation of China [30972086]; National Basic Research Program of China (973 Program) [2009CB941604]; China Agricultural Research System [CARS-42]	National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); China Agricultural Research System	This work was supported by the National High-tech R&D Program (863 Program) (No. 2013AA102501), the National Natural Science Foundation of China (No. 30972086), the National Basic Research Program of China (973 Program) (No. 2009CB941604) and the China Agricultural Research System (No. CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba Y, 1999, BRIT POULTRY SCI, V40, P701, DOI 10.1080/00071669987124; BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; Chbab N, 2010, VET RES, V41, DOI 10.1051/vetres/2010026; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; CHERINGTON V, 1988, MOL CELL BIOL, V8, P1380, DOI 10.1128/MCB.8.3.1380; Chiocca S, 1996, J VIROL, V70, P2939, DOI 10.1128/JVI.70.5.2939-2949.1996; Classon M, 2000, P NATL ACAD SCI USA, V97, P10826, DOI 10.1073/pnas.190343597; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Coursen JD, 1997, EXP CELL RES, V235, P245, DOI 10.1006/excr.1997.3670; Darimont C, 2003, BIOCHIMIE, V85, P1231, DOI 10.1016/j.biochi.2003.10.015; Darimont C, 2003, CELL DEATH DIFFER, V10, P1025, DOI 10.1038/sj.cdd.4401273; Delany ME, 2004, GENE, V339, P61, DOI 10.1016/j.gene.2004.05.024; Duesberg P, 2000, CELL MOTIL CYTOSKEL, V47, P81; Dupont J, 2012, GEN COMP ENDOCR, V176, P86, DOI 10.1016/j.ygcen.2011.12.030; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Fragnet L, 2005, J BIOL CHEM, V280, P23502, DOI 10.1074/jbc.M501163200; Freshney RI, 2005, CULTURE ANIMAL CELLS, p[270, 274, 292]; Gondret F, 2001, J LIPID RES, V42, P106; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Guan LS, 2001, INT J CANCER, V93, P333, DOI 10.1002/ijc.1338; GUILHOT C, 1993, ONCOGENE, V8, P619; Hahn WC, 2002, MOL CELLS, V13, P351; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Ji B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-441; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARTIN GS, 1970, NATURE, V227, P1021, DOI 10.1038/2271021a0; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Matsubara Y, 2005, COMP BIOCHEM PHYS A, V141, P108, DOI 10.1016/j.cbpb.2005.04.013; Matsubara Y, 2008, COMP BIOCHEM PHYS A, V151, P511, DOI 10.1016/j.cbpa.2008.07.002; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Meyerson M, 1998, TOXICOL LETT, V103, P41, DOI 10.1016/S0378-4274(98)00278-1; Michailidis G, 2005, BIOCHEM BIOPH RES CO, V335, P240, DOI 10.1016/j.bbrc.2005.07.058; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Na J, 2014, PROTEIN CELL, V5, P569, DOI 10.1007/s13238-014-0073-9; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nims RW, 1998, IN VITRO CELL DEV-AN, V34, P35; O'Hare TH, 2011, CYTOGENET GENOME RES, V135, P65, DOI 10.1159/000330125; O'Hare TH, 2005, AGE, V27, P257, DOI 10.1007/s11357-005-4558-6; Ono K, 2007, IN VITRO CELL DEV-AN, V43, P168, DOI 10.1007/s11626-007-9033-5; ORFAO A, 1995, SCAND J CLIN LAB INV, V55, P145, DOI 10.3109/00365519509090577; Parodi B, 2002, BIOTECHNIQUES, V32, P432, DOI 10.2144/02322rr05; QURESHI MA, 1990, VET IMMUNOL IMMUNOP, V26, P237, DOI 10.1016/0165-2427(90)90094-9; SAKSELA E, 1963, P NATL ACAD SCI USA, V50, P390, DOI 10.1073/pnas.50.2.390; Seki Y, 2003, GEN COMP ENDOCR, V133, P80, DOI 10.1016/S0016-6480(03)00145-X; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Shkreli M, 2007, J VIROL, V81, P4848, DOI 10.1128/JVI.02530-06; SIMON J, 1989, Critical Reviews in Poultry Biology, V2, P121; Steube KG, 2003, IN VITRO CELL DEV-AN, V39, P468; STYLES JA, 1977, BRIT J CANCER, V36, P558, DOI 10.1038/bjc.1977.231; Swanberg SE, 2003, CYTOGENET GENOME RES, V102, P318, DOI 10.1159/000075769; Swanberg SE, 2010, EXP GERONTOL, V45, P647, DOI 10.1016/j.exger.2010.04.002; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tchkonia T, 2006, DIABETES, V55, P2571, DOI 10.2337/db06-0540; Tokushima Y, 2003, BRIT POULTRY SCI, V44, P746, DOI 10.1080/00071660310001645758; TRAGANOS F, 1977, INT J CANCER, V20, P30, DOI 10.1002/ijc.2910200107; Trapp S, 2006, J EXP MED, V203, P1307, DOI 10.1084/jem.20052240; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Vu BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077988; Wang S, 2004, AM J CLIN PATHOL, V122, P774, DOI 10.1309/8B849FC6PHAP8FDD; Wong SCH, 2003, LIFE SCI, V73, P2749, DOI 10.1016/S0024-3205(03)00670-2; Xu YL, 2009, J EXP ZOOL PART B, V312B, P872, DOI 10.1002/jez.b.21302; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141	66	39	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177348	10.1371/journal.pone.0177348	http://dx.doi.org/10.1371/journal.pone.0177348			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486516	Green Submitted, Green Published, gold			2022-12-27	WOS:000401314000074
J	Jaramillo, E; Dugan, JE; Hubbard, DM; Contreras, H; Duarte, C; Acuna, E; Schoeman, DS				Jaramillo, Eduardo; Dugan, Jenifer E.; Hubbard, David M.; Contreras, Heraldo; Duarte, Cristian; Acuna, Emilio; Schoeman, David S.			Macroscale patterns in body size of intertidal crustaceans provide insights on climate change effects	PLOS ONE			English	Article							EMERITA-ANALOGA STIMPSON; EXPOSED SANDY BEACHES; LIFE-HISTORY; RANGE SHIFTS; EXCIROLANA-BRAZILIENSIS; LATITUDINAL VARIATION; GEOGRAPHIC-VARIATION; CHANGE IMPACTS; MARINE; RESPONSES	Predicting responses of coastal ecosystems to altered sea surface temperatures (SST) associated with global climate change, requires knowledge of demographic responses of individual species. Body size is an excellent metric because it scales strongly with growth and fecundity for many ectotherms. These attributes can underpin demographic as well as community and ecosystem level processes, providing valuable insights for responses of vulnerable coastal ecosystems to changing climate. We investigated contemporary macroscale patterns in body size among widely distributed crustaceans that comprise the majority of intertidal abundance and biomass of sandy beach ecosystems of the eastern Pacific coasts of Chile and California, USA. We focused on ecologically important species representing different tidal zones, trophic guilds and developmental modes, including a high-shore macroalga-consuming talitrid amphipod (Orchestoidea tuberculata), two mid-shore scavenging cirolanid isopods (Excirolana braziliensis and E. hirsuticauda), and a low-shore suspension-feeding hippid crab (Emerita analoga) with an amphitropical distribution. Significant latitudinal patterns in body sizes were observed for all species in Chile (21 degrees - 42 degrees S), with similar but steeper patterns in Emerita analoga, in California (32 degrees - 41 degrees N). Sea surface temperature was a strong predictor of body size (-4% to - 35% degrees C-1) in all species. Beach characteristics were subsidiary predictors of body size. Alterations in ocean temperatures of even a few degrees associated with global climate change are likely to affect body sizes of important intertidal ectotherms, with consequences for population demography, life history, community structure, trophic interactions, food-webs, and indirect effects such as ecosystem function. The consistency of results for body size and temperature across species with different life histories, feeding modes, ecological roles, and microhabitats inhabiting a single widespread coastal ecosystem, and for one species, across hemispheres in this space-for-time substitution, suggests predictions of ecosystem responses to thermal effects of climate change may potentially be generalised, with important implications for coastal conservation.	[Jaramillo, Eduardo; Acuna, Emilio] Univ Austral Chile, Inst Ciencias Tierra, Valdivia, Chile; [Dugan, Jenifer E.; Hubbard, David M.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Contreras, Heraldo] Inst Fomento Pesquero, Putemun, Chile; [Duarte, Cristian] Univ Andres Bello, Dept Ecol & Biodiversidad, Fac Ecol & Recursos Nat, Santiago, Chile; [Schoeman, David S.] Univ Sunshine Coast, Sch Sci & Engn, Sippy Downs, Qld, Australia; [Schoeman, David S.] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, South Africa	Universidad Austral de Chile; University of California System; University of California Santa Barbara; Instituto de Fomento Pesquero (Valparaiso); Universidad Andres Bello; University of the Sunshine Coast; Nelson Mandela University	Jaramillo, E (corresponding author), Univ Austral Chile, Inst Ciencias Tierra, Valdivia, Chile.	edojaramillo@gmail.com		Schoeman, David/0000-0003-1258-0885; Duarte, Cristian/0000-0002-7033-3551	CONICYT through Project FONDAP (Oceanografia AMP; Biologia Marina); Direccion de Investigacion y Desarrollo of Universidad Austral de Chile through a travel grant; Santa Barbara Coastal LTER - USA National Science Foundation [OCE-0620276, OCE-1232779]; Directorate For Geosciences [1232779] Funding Source: National Science Foundation	CONICYT through Project FONDAP (Oceanografia AMP; Biologia Marina); Direccion de Investigacion y Desarrollo of Universidad Austral de Chile through a travel grant; Santa Barbara Coastal LTER - USA National Science Foundation; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Financial support for field and laboratory work in Chile was provided by CONICYT through Project FONDAP (Oceanografia & Biologia Marina, Programa Mayor no 3). Financial support for analyses and manuscript preparation was provided by Direccion de Investigacion y Desarrollo of Universidad Austral de Chile through a travel grant (July 2009) to EJ and for JD by the Santa Barbara Coastal LTER funded by the USA National Science Foundation (Award #s OCE-0620276 and OCE1232779). The statements, findings, conclusions and recommendations are those of the authors and do not necessarily reflect the views of the National Science Foundation (USA).r The authors thank Marcia Gonzalez, Ana Maria Ojeda and Andrea Bollinger for their assistance during laboratory work and Pedro Rubilar for his helpful advice on the use and review of the outputs of the Akaike Information Criterion analyses. Financial support for field and laboratory work in Chile was provided by CONICYT through Project FONDAP (Oceanografia & Biologia Marina, Programa Mayor no 3). Financial support for analyses and manuscript preparation was provided by Direccion de Investigacion y Desarrollo of Universidad Austral de Chile through a travel grant (July 2009) to EJ and for JD by the Santa Barbara Coastal LTER funded by the USA National Science Foundation (Award #s OCE-0620276 and OCE-1232779). The statements, findings, conclusions and recommendations are those of the authors and do not necessarily reflect the views of the National Science Foundation (USA).	ANNALA JH, 1980, NEW ZEAL J MAR FRESH, V14, P217, DOI 10.1080/00288330.1980.9515864; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Ashton KG, 2004, INTEGR COMP BIOL, V44, P403, DOI 10.1093/icb/44.6.403; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; BASCOM W, 1964, WAVES BEACHES DYNAMI; Bates AE, 2014, GLOBAL ENVIRON CHANG, V26, P27, DOI 10.1016/j.gloenvcha.2014.03.009; Berke SK, 2013, GLOBAL ECOL BIOGEOGR, V22, P173, DOI 10.1111/j.1466-8238.2012.00775.x; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cardoso RS, 2004, ESTUAR COAST SHELF S, V61, P559, DOI 10.1016/j.ecss.2004.06.021; Celentano E, 2016, MAR ECOL PROG SER, V552, P211, DOI 10.3354/meps11768; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Contreras H, 2003, ESTUAR COAST SHELF S, V58, P117, DOI 10.1016/S0272-7714(03)00046-5; Contreras H, 1999, ESTUAR COAST SHELF S, V48, P101, DOI 10.1006/ecss.1998.0396; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DEMARCH BGE, 1978, CAN J ZOOL, V56, P1801, DOI 10.1139/z78-246; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Duarte C, 2010, HYDROBIOLOGIA, V651, P291, DOI 10.1007/s10750-010-0309-5; DUGAN JE, 1991, J EXP MAR BIOL ECOL, V150, P63, DOI 10.1016/0022-0981(91)90106-7; Dugan JE, 1996, REV CHIL HIST NAT, V69, P579; Dugan JE, 2003, ESTUAR COAST SHELF S, V58, P25, DOI 10.1016/S0272-7714(03)00045-3; DUGAN JE, 1994, J EXP MAR BIOL ECOL, V181, P255, DOI 10.1016/0022-0981(94)90132-5; Dugan JE, 1990, GEOGRAPHIC TEMPORAL; Dugan JE, 2013, GEOMORPHOLOGY, V199, P95, DOI 10.1016/j.geomorph.2013.04.043; Dugan JE, 2010, SCIENCE, V329, P1146, DOI 10.1126/science.329.5996.1146-a; Efford I.E, 1976, Crustaceana, V30, P169, DOI 10.1163/156854076X00558; EFFORD I E, 1970, Crustaceana (Leiden), V18, P293, DOI 10.1163/156854070X00248; EFFORD IE, 1965, J ANIM ECOL, V34, P63, DOI 10.2307/2369; Folk R. L, 1980, PETROLOGY SEDIMENTAR; Forster J, 2012, P NATL ACAD SCI USA, V109, P19310, DOI 10.1073/pnas.1210460109; FRANK PW, 1975, MAR BIOL, V31, P181, DOI 10.1007/BF00391630; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Garzke J, 2015, OECOLOGIA, V177, P849, DOI 10.1007/s00442-014-3130-4; Gaston KJ, 2008, J BIOGEOGR, V35, P483, DOI 10.1111/j.1365-2699.2007.01772.x; GIBBS RJ, 1971, J SEDIMENT PETROL, V41, P7; Gillson L, 2013, TRENDS ECOL EVOL, V28, P135, DOI 10.1016/j.tree.2012.10.008; GLYNN PW, 1975, J ZOOL, V175, P509; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hartnoll R.G., 1985, Crustacean Issues, V3, P101; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; JAMES FC, 1970, ECOLOGY, V51, P365, DOI 10.2307/1935374; Jansen JM, 2007, J EXP MAR BIOL ECOL, V344, P161, DOI 10.1016/j.jembe.2006.12.014; Jaramillo E, 2001, MAR ECOL-P S Z N I, V22, P323, DOI 10.1046/j.1439-0485.2001.01752.x; JARAMILLO E, 1993, ESTUAR COAST SHELF S, V37, P615, DOI 10.1006/ecss.1993.1077; JARAMILLO E, 1987, Vie et Milieu, V37, P165; Johnson MW, 1942, BIOL BULL-US, V83, P67, DOI 10.2307/1538014; JONES MB, 1983, B MAR SCI, V33, P656; Kelley AL, 2015, MAR BIOL, V162, P1625, DOI 10.1007/s00227-015-2698-5; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; Lastra M, 2008, MAR BIOL, V154, P163, DOI 10.1007/s00227-008-0913-3; Lester RE, 2014, GLOBAL CHANGE BIOL, V20, P3471, DOI 10.1111/gcb.12634; Lima F. P., 2012, NATURE COMMUNICATION, V3; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Manyak-Davis A, 2013, AM NAT, V182, P347, DOI 10.1086/671170; MARINCOVICH L, 1973, INTERTIDAL MOLLUSKS; Meiri S, 2003, J BIOGEOGR, V30, P331, DOI 10.1046/j.1365-2699.2003.00837.x; Meiri S, 2009, GLOBAL ECOL BIOGEOGR, V18, P240, DOI 10.1111/j.1466-8238.2008.00437.x; Millien V, 2006, ECOL LETT, V9, P853, DOI 10.1111/j.1461-0248.2006.00928.x; Molinos JG, 2016, NAT CLIM CHANGE, V6, P83, DOI [10.1038/NCLIMATE2769, 10.1038/nclimate2769]; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Osorio C, 1971, B MUS NAC HIST NAT S, V29, P61; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parmesan C, 2013, ECOL LETT, V16, P58, DOI 10.1111/ele.12098; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; PICKETT S T A, 1989, P110; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Poloczanska ES, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00062; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; R Core Team, 2021, R LANGUAGE ENV STAT; RAY CARLETON, 1960, JOUR MORPHOL, V106, P85, DOI 10.1002/jmor.1051060104; Reynolds RW, 2002, IMPROVED IN SITU SAT; Roy K, 2003, ECOL LETT, V6, P205, DOI 10.1046/j.1461-0248.2003.00419.x; Schlacher TA, 2007, DIVERS DISTRIB, V13, P556, DOI 10.1111/j.1472-4642.2007.00363.x; Schoeman DS, 2014, GLOBAL CHANGE BIOL, V20, P2383, DOI 10.1111/gcb.12505; SEWARDTHOMPSON BL, 1973, SEDIMENTOLOGY, V20, P161, DOI 10.1111/j.1365-3091.1973.tb01612.x; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Short A.D., 1983, SANDY BEACHES ECOSYS, P133, DOI DOI 10.1007/978-94-017-2938-3_8; Strickland J.D.H., 1972, PRACT HDB SEAWATER A, V167, P185; Sunday JM, 2015, ECOL LETT, V18, P944, DOI 10.1111/ele.12474; Sydeman WJ, 2014, SCIENCE, V345, P77, DOI [10.1126/science.1251635, 10.1126/science.1250830]; Thomas AC, 2001, GEOPHYS RES LETT, V28, P3421, DOI 10.1029/2001GL013368; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tomasovych A, 2015, GLOBAL ECOL BIOGEOGR, V24, P157, DOI 10.1111/geb.12242; VALENTINE JW, 1966, LIMNOL OCEANOGR, V11, P198, DOI 10.4319/lo.1966.11.2.0198; Varela AI, 2012, REV CHIL HIST NAT, V85, P495, DOI 10.4067/S0716-078X2012000400011; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weber MJ, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00435.1; WEINBERG JR, 1989, MAR BIOL, V103, P143, DOI 10.1007/BF00543341; WENNER AM, 1987, BIOL BULL, V172, P225, DOI 10.2307/1541795; Wethey DS, 2008, HYDROBIOLOGIA, V606, P139, DOI 10.1007/s10750-008-9338-8; Weymouth FW, 1931, J EXP BIOL, V8, P228; Yvon-Durocher G, 2011, GLOBAL CHANGE BIOL, V17, P1681, DOI 10.1111/j.1365-2486.2010.02321.x	98	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177116	10.1371/journal.pone.0177116	http://dx.doi.org/10.1371/journal.pone.0177116			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481897	gold, Green Published			2022-12-27	WOS:000401313700035
J	Qiu, ZW; Zhou, JS; Liu, F; Qin, XJ; Dai, YR; Ke, YH; Chen, ZH; Li, W; Ying, SM; Shen, HH				Qiu, Zhangwei; Zhou, Jiesen; Liu, Fang; Qin, Xuejun; Dai, Yuanrong; Ke, Yuehai; Chen, Zhihua; Li, Wen; Ying, Songmin; Shen, Huahao			Deletion of Shp2 in bronchial epithelial cells impairs IL-25 production in vitro, but has minor influence on asthmatic inflammation in vivo	PLOS ONE			English	Article							IMMUNE-RESPONSES; T-CELLS; KAPPA-B; PROTEIN; INTERLEUKIN-25; ACTIVATION; FAMILY; GAB1; PATHOLOGIES; CYTOKINES	Shp2 played an important role in cigarette-smoke-mediated inflammation, surfactant homeostasis and asthmatic airway remodeling. However, whether shp2 plays a key role in epithelium-associated allergic reaction is still unknown. In this study, LPS and OVA were observed to induce the production of IL-25 in bronchial epithelial cells in vitro via the activation of MAPK p38 and JNK. Furthermore, blockage of Shp2 by its specific inhibitor PHPS1 or by siRNA-mediated depletion was found to reduce the production of IL-25 in epithelial cells as well as the up-regulated LPS-triggered activation of JNK but not p38. To confirm the role of intra-bronchial epithelial Shp2 in OVA-induced allergic reaction, we generated CC10-rtTA/(tetO)7-Cre/Shp2(f/f) mice, where Shp2 was conditionally knocked out in bronchial epithelial cells. Surprisingly, specific deletion of Shp2 in bronchial epithelial cells showed a mild but insignificant effect on the expressions of epithelium-derived cytokines as well as TH2 and TH17 polarization following allergen-induced murine airway inflammation. Collectively, our data suggested that deletion of Shp2 impaired IL-25 production in bronchial epithelial cells in vitro, but might yet have minor influence on OVA-induced allergic reaction in vivo.	[Qiu, Zhangwei; Zhou, Jiesen; Liu, Fang; Qin, Xuejun; Chen, Zhihua; Li, Wen; Ying, Songmin; Shen, Huahao] Zhejiang Univ, Sch Med, Dept Resp & Crit Care Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China; [Qiu, Zhangwei; Dai, Yuanrong] Wenzhou Med Univ, Dept Pulm Med, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China; [Qiu, Zhangwei; Dai, Yuanrong] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China; [Ke, Yuehai] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Program Mol Cell Biol, Hangzhou, Zhejiang, Peoples R China; [Ke, Yuehai] Zhejiang Univ, Sch Med, Inst Resp Dis, Hangzhou, Zhejiang, Peoples R China; [Shen, Huahao] State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Zhejiang University; Wenzhou Medical University; Wenzhou Medical University; Zhejiang University; Zhejiang University; State Key Laboratory of Respiratory Disease	Shen, HH (corresponding author), Zhejiang Univ, Sch Med, Dept Resp & Crit Care Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China.; Shen, HH (corresponding author), State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	huahaoshen@163.com		Dai, Yuanrong/0000-0002-7146-3374	National Basic Research Program of China (973 Program) [2009CB522103]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (973 Program) grant 2009CB522103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Bard-Chapeau EA, 2006, MOL CELL BIOL, V26, P4664, DOI 10.1128/MCB.02253-05; Bartemes KR, 2012, CLIN IMMUNOL, V143, P222, DOI 10.1016/j.clim.2012.03.001; Ben S, 2008, ALLERGY, V63, P1164, DOI 10.1111/j.1398-9995.2008.01747.x; Caramori G, 2001, EUR RESPIR J, V18, P466, DOI 10.1183/09031936.01.00040701; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Ikeda K, 2003, BLOOD, V101, P3594, DOI 10.1182/blood-2002-09-2817; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kang CM, 2005, AM J RESP CELL MOL, V33, P290, DOI 10.1165/rcmb.2005-0003OC; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Lam HC, 2011, JOVE-J VIS EXP, DOI 10.3791/2513; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Li FF, 2012, J IMMUNOL, V189, P3159, DOI 10.4049/jimmunol.1200197; Li MG, 2003, J BIOL CHEM, V278, P12013, DOI 10.1074/jbc.M211474200; Montagner A, 2005, J BIOL CHEM, V280, P5350, DOI 10.1074/jbc.M410012200; Morimoto M, 2009, DEV BIOL, V325, P171, DOI 10.1016/j.ydbio.2008.10.013; Murai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030280; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Qin XJ, 2012, ALLERGY, V67, P1547, DOI 10.1111/all.12048; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Shen HHH, 2003, J IMMUNOL, V170, P3296, DOI 10.4049/jimmunol.170.6.3296; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Suzukawa M, 2012, J IMMUNOL, V189, P3641, DOI 10.4049/jimmunol.1200461; Tamachi T, 2006, J ALLERGY CLIN IMMUN, V118, P606, DOI 10.1016/j.jaci.2006.04.051; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Xia LX, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.74; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Yu LY, 2009, J BIOL CHEM, V284, P13481, DOI 10.1074/jbc.M809740200; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zhang X, 2012, FASEB J, V26, P2338, DOI 10.1096/fj.11-200139	42	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177334	10.1371/journal.pone.0177334	http://dx.doi.org/10.1371/journal.pone.0177334			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481957	Green Published, Green Submitted, gold			2022-12-27	WOS:000401313700053
J	Rehan, W; Antfolk, J; Johansson, A; Jern, P; Santtila, P				Rehan, Wail; Antfolk, Jan; Johansson, Ada; Jern, Patrick; Santtila, Pekka			Experiences of severe childhood maltreatment, depression, anxiety and alcohol abuse among adults in Finland	PLOS ONE			English	Article							SEXUAL-ABUSE; SUBSTANCE USE; EMOTIONAL MALTREATMENT; GENDER-DIFFERENCES; PHYSICAL ABUSE; RISK-FACTORS; PSYCHOPATHOLOGY; ASSOCIATIONS; TRAUMA; HOPELESSNESS	Childhood maltreatment increases the risk of subsequent depression, anxiety and alcohol abuse, but the rate of resilient victims is unknown. Here, we investigated the rate of victims that do not suffer from clinical levels of these problems after severe maltreatment in a population-based sample of 10980 adult participants. Compared to men, women reported more severe emotional and sexual abuse, as well as more severe emotional neglect. For both genders, severe emotional abuse (OR = 3.80 [2.22, 6.52]); severe physical abuse (OR = 3.97 [1.72, 9.16]); severe emotional neglect (OR = 3.36 [1.73, 6.54]); and severe physical neglect (OR = 11.90 [2.66, 53.22]) were associated with depression and anxiety while only severe physical abuse (OR = 3.40 [1.28, 9.03]) was associated with alcohol abuse. Looking at men and women separately, severe emotional abuse (OR = 6.05 [1.62, 22.60] in men; OR = 3.74 [2.06, 6.81] in women) and severe physical abuse (OR = 6.05 [1.62, 22.60] in men; OR = 3.03 [0.99, 9.33] in women) were associated with clinical levels of depression and anxiety. In addition, in women, severe sexual abuse (OR = 2.40 [1.10, 5.21]), emotional neglect (OR = 4.78 [2.40, 9.56]), and severe physical neglect (OR = 9.86 [1.99, 48.93]) were associated with clinical levels of depression and anxiety. Severe emotional abuse in men (OR = 3.86 [0.96, 15.48]) and severe physical abuse in women (OR = 5.18 [1.48, 18.12]) were associated with alcohol abuse. Concerning resilience, the majority of severely maltreated participants did not report clinically significant levels of depression or anxiety (72%), or alcohol abuse (93%) in adulthood. Although the majority of severely abused or neglected individuals did not show clinical levels of depression, anxiety or alcohol use, severe childhood maltreatment increased the risk for showing clinical levels of psychopathology in adulthood.	[Rehan, Wail; Antfolk, Jan; Johansson, Ada; Jern, Patrick; Santtila, Pekka] Abo Akad Univ, Dept Psychol, Turku, Finland; [Johansson, Ada; Jern, Patrick] Univ Turku, Dept Psychol & Speech Language Pathol, Turku, Finland	Abo Akademi University; University of Turku	Rehan, W (corresponding author), Abo Akad Univ, Dept Psychol, Turku, Finland.	wailabdulmalik.rehan@abo.fi	Antfolk, Jan/D-2926-2018	Antfolk, Jan/0000-0003-0334-4987; Johansson, Ada/0000-0003-1853-6981	Academy of Finland [210298]; Center of Excellence grant from the Stiftelsen for Abo Akademi Foundation [21/22/05]	Academy of Finland(Academy of Finland); Center of Excellence grant from the Stiftelsen for Abo Akademi Foundation	This research was supported by the Academy of Finland Grant No. 210298, a Center of Excellence grant from the Stiftelsen for Abo Akademi Foundation Grant No. 21/22/05.	Albrecht A., 2014, J SOCIAL SCI RES, V6, P915, DOI 10.24297/jssr.v6i1.3453; Amado BG, 2015, PSYCHOSOC INTERV, V24, P49, DOI 10.1016/j.psi.2015.03.002; Babar T. F., 2001, ALCOHOL USE DISORDER; Bensley LS, 2000, AM J PREV MED, V18, P151, DOI 10.1016/S0749-3797(99)00084-7; Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Bifulco A, 2002, B MENNINGER CLIN, V66, P241, DOI 10.1521/bumc.66.3.241.23366; Bulik CM, 2001, BRIT J PSYCHIAT, V179, P444, DOI 10.1192/bjp.179.5.444; Truffino JC, 2010, REV PSIQUIATR SALUD, V3, P145, DOI 10.1016/j.rpsm.2010.09.003; Collishaw S, 2007, CHILD ABUSE NEGLECT, V31, P211, DOI 10.1016/j.chiabu.2007.02.004; Davydov DM, 2010, CLIN PSYCHOL REV, V30, P479, DOI 10.1016/j.cpr.2010.03.003; Derogatis, 2001, BRIEF SYMPTOM INVENT; Dube S. R., 2006, Journal of Adolescent Health, V38, DOI 10.1016/j.jadohealth.2005.06.006; Evans SE, 2013, CHILD ABUSE NEGLECT, V37, P934, DOI 10.1016/j.chiabu.2013.03.005; Gamble SA, 2006, J NERV MENT DIS, V194, P382, DOI 10.1097/01.nmd.0000218058.96252.ac; Gibb BE, 2003, DEPRESS ANXIETY, V17, P226, DOI 10.1002/da.10111; Gibb BE, 2007, DEPRESS ANXIETY, V24, P256, DOI 10.1002/da.20238; Glover DA, 2010, J TRAUMA DISSOCIATIO, V11, P152, DOI 10.1080/15299730903502920; Haatainen KM, 2003, SOC PSYCH PSYCH EPID, V38, P12, DOI 10.1007/s00127-003-0598-3; Hamilton JL, 2013, J CLIN CHILD ADOLESC, V42, P332, DOI 10.1080/15374416.2013.777916; Harbin SJ, 2016, J GRADUATE RES CREAT, V8, P1; Higgins DJ, 2001, AGGRESS VIOLENT BEH, V6, P547, DOI 10.1016/S1359-1789(00)00030-6; Hussey JM, 2006, PEDIATRICS, V118, P933, DOI 10.1542/peds.2005-2452; Hyman SM, 2008, DRUG ALCOHOL DEPEN, V92, P208, DOI 10.1016/j.drugalcdep.2007.08.006; Jaffee SR, 2007, CHILD ABUSE NEGLECT, V31, P231, DOI 10.1016/j.chiabu.2006.03.011; Johansson A, 2013, TWIN RES HUM GENET, V16, P150, DOI 10.1017/thg.2012.108; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P953, DOI 10.1001/archpsyc.57.10.953; Klika JB, 2013, TRAUMA VIOLENCE ABUS, V14, P222, DOI 10.1177/1524838013487808; Laaksonen T, 2011, CHILD ABUSE NEGLECT, V35, P480, DOI 10.1016/j.chiabu.2011.03.004; Liu RT, 2012, CHILD ABUSE NEGLECT, V36, P323, DOI 10.1016/j.chiabu.2011.11.007; MacMillan HL, 2001, AM J PSYCHIAT, V158, P1878, DOI 10.1176/appi.ajp.158.11.1878; Magnusson A, 2012, PSYCHOL MED, V2, P381; McLaughlin KA, 2010, PSYCHOL MED, V40, P847, DOI 10.1017/S0033291709991115; Moran PB, 2004, CHILD ABUSE NEGLECT, V28, P565, DOI 10.1016/j.chiabu.2003.12.002; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Radford L., 2011, CHILD ABUSE NEGLECT; Rehan W, 2015, NORD PSYCHOL, V67, P301, DOI 10.1080/19012276.2015.1026922; Rothman EF, 2008, PEDIATRICS, V122, pE298, DOI 10.1542/peds.2007-3412; Sartor CE, 2008, J STUD ALCOHOL DRUGS, V69, P718, DOI 10.15288/jsad.2008.69.718; Schwandt ML, 2013, ALCOHOL CLIN EXP RES, V37, P984, DOI 10.1111/acer.12053; Shin SH, 2009, ADDICT BEHAV, V34, P277, DOI 10.1016/j.addbeh.2008.10.023; Spinhoven P, 2010, J AFFECT DISORDERS, V126, P103, DOI 10.1016/j.jad.2010.02.132; Teicher MH, 2006, AM J PSYCHIAT, V163, P993, DOI 10.1176/appi.ajp.163.6.993; Teicher MH, 2013, AM J PSYCHIAT, V170, P1114, DOI 10.1176/appi.ajp.2013.12070957; Thompson MP, 2004, AM J PUBLIC HEALTH, V94, P599, DOI 10.2105/AJPH.94.4.599; Wright MO, 2009, CHILD ABUSE NEGLECT, V33, P59, DOI 10.1016/j.chiabu.2008.12.007; Young-Wolff KC, 2011, PSYCHOL MED, V41, P59, DOI 10.1017/S0033291710000425	47	61	62	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177252	10.1371/journal.pone.0177252	http://dx.doi.org/10.1371/journal.pone.0177252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481912	gold, Green Published, Green Submitted			2022-12-27	WOS:000401313700043
J	Montesdeoca, N; Calabuig, P; Corbera, JA; Oros, J				Montesdeoca, Natalia; Calabuig, Pascual; Corbera, Juan A.; Oros, Jorge			A long-term retrospective study on rehabilitation of seabirds in Gran Canaria Island, Spain (2003-2013)	PLOS ONE			English	Article							PENGUINS SPHENISCUS-DEMERSUS; LIGHT-INDUCED MORTALITY; OIL-SPILL; ARTIFICIAL LIGHTS; CORYS SHEARWATER; SOUTH-AFRICA; WESTERN CAPE; PETRELS; ATTRACTION; SURVIVAL	Aims The aims of this study were to analyze the causes of morbidity and mortality in a large population of seabirds admitted to the Tafira Wildlife Rehabilitation Center (TWRC) in Gran Canaria Island, Spain, from 2003 to 2013, and to analyze the outcomes of the rehabilitation process. Methods We included 1,956 seabirds (133 dead on admission and 1,823 admitted alive) in this study. Causes of morbidity were classified into nine categories: light pollution (fallout), fishing gear interaction, crude oil, poisoning/intoxication, other traumas, metabolic/ nutritional disorder, orphaned young birds, other causes, and unknown/undetermined. The crude and stratified (by causes of admission) rates of the three final disposition categories (euthanasia Er, unassisted mortality M-r, and release R-r), the time until death, and the length of stay were also studied for the seabirds admitted alive. Results Yellow-legged Gull (Larus michahellis) was the species most frequently admitted (46.52%), followed by Cory's Shearwater (Calonectris diomedea borealis) (20.09%). The most frequent causes of morbidity were light pollution (fallout) (25.81%), poisoning/intoxication (24.69%), and other traumas (18.14%). The final disposition rates were: E-r = 15.35%, M-r = 16.29%, and R-r = 68.34%. The highest E-r was observed in the 'other traumas' category (58.08%). Seabirds admitted due to metabolic/ nutritional disorder had the highest M-r (50%). The highest R-r was observed in the light pollution (fallout) category (99.20%). Conclusions This survey provides useful information for the conservation of several seabird species. We suggest that at least the stratified analysis by causes of admission of the three final disposition rates, and the parameters time until death and length of stay at the center should be included in the outcome research of the rehabilitation of seabirds. The high release rate for seabirds (68.34%) achieved at the TWRC emphasizes the importance of wildlife rehabilitation centers for the conservation of seabirds.	[Montesdeoca, Natalia; Corbera, Juan A.] Univ Las Palmas Gran Canaria, Vet Fac, Dept Anim Pathol, Arucas, Las Palmas, Spain; [Calabuig, Pascual] Tafira Wildlife Rehabil Ctr, Cabildo Gran Canaria, Las Palmas Gran Canaria, Spain; [Oros, Jorge] Univ Las Palmas Gran Canaria, Vet Fac, Dept Morphol, Arucas, Las Palmas, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Oros, J (corresponding author), Univ Las Palmas Gran Canaria, Vet Fac, Dept Morphol, Arucas, Las Palmas, Spain.	jorge.oros@ulpgc.es	Corbera, Juan Alberto/K-2289-2014; Orós, Jorge/G-8824-2015; Calabuig, Pascual/AAB-1723-2019	Corbera, Juan Alberto/0000-0001-7812-2065; Orós, Jorge/0000-0002-8346-5393; 				Altwegg R, 2008, BIOL CONSERV, V141, P1924, DOI 10.1016/j.biocon.2008.04.030; [Anonymous], 2004, EFFECTS PETROLEUM EX; Balseiro A, 2005, J WILDLIFE DIS, V41, P371, DOI 10.7589/0090-3558-41.2.371; Camacho M, 2013, J WILDLIFE DIS, V49, P637, DOI 10.7589/2012-03-093; Cooper JE, 2006, IN PRACTICE, V28, P2, DOI 10.1136/inpract.28.1.2; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; De la Cruz SEW, 2013, MAR POLLUT BULL, V67, P100, DOI 10.1016/j.marpolbul.2012.11.027; Duerr Rebecca S., 2015, Marine Ornithology, V43, P11; Einoder LD, 2009, FISH RES, V95, P6, DOI 10.1016/j.fishres.2008.09.024; EURING, 1994, AN AV HERR CIENT GES; Fauquier DA, 2013, J WILDLIFE DIS, V49, P246, DOI 10.7589/2011-09-270; Fontaine R, 2011, BIOL CONSERV, V144, P1998, DOI 10.1016/j.biocon.2011.04.022; Haman KH, 2013, J WILDLIFE DIS, V49, P235, DOI 10.7589/2012-04-119; IUCN SSC, 2014, IUCN RED LIST THREAT; Joys AC, 2003, 234 BTO; Le Corre M, 2002, BIOL CONSERV, V105, P93, DOI 10.1016/S0006-3207(01)00207-5; Li Y, 2012, B MAR SCI, V88, P559, DOI 10.5343/bms.2011.1039; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.2307/3868314; Lorenzo J. A, 2007, ATLAS AVES NIDIFICAN; Martin A., 2001, AVES ARCHIPIELAGO CA; McNeil Raymond, 1993, Current Ornithology, V10, P187; Miles W, 2010, BIRD STUDY, V57, P244, DOI 10.1080/00063651003605064; Miller E.A., 2012, MINIMUM STANDARDS WI, V4th ed.; Molina-Lopez RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060242; Montesdeoca N, 2016, J WILDLIFE DIS, V52, P647, DOI 10.7589/2015-09-255; Neimanis A, 2007, J WILDLIFE DIS, V43, P327, DOI 10.7589/0090-3558-43.3.327; Newman SH, 2007, MAR ECOL PROG SER, V352, P299, DOI 10.3354/meps07076; Oro D, 2005, J ZOOL, V265, P421, DOI 10.1017/S0952836905006515; Oros J, 2005, DIS AQUAT ORGAN, V63, P13, DOI 10.3354/dao063013; Oros J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149398; Paleczny M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129342; Parsons N., 2016, SO AFRICAN SEABIRD C, P53; Parsons NJ, 2017, VET PARASITOL, V233, P52, DOI 10.1016/j.vetpar.2016.12.001; Parsons NJ, 2005, AFR J MAR SCI, V27, P289, DOI 10.2989/18142320509504087; Parsons NJ, 2015, DIS AQUAT ORGAN, V116, P149, DOI 10.3354/dao02907; Piatt JF, 2007, MAR ECOL PROG SER, V352, P199, DOI 10.3354/meps07070; REED JR, 1985, AUK, V102, P377, DOI 10.2307/4086782; Rodrigues P, 2012, EUR J WILDLIFE RES, V58, P147, DOI 10.1007/s10344-011-0555-5; Rodriguez A, 2012, ANIM CONSERV, V15, P519, DOI 10.1111/j.1469-1795.2012.00544.x; Rodriguez A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10670; Rodriguez A, 2012, IBIS, V154, P167, DOI 10.1111/j.1474-919X.2011.01175.x; Rodriguez A, 2009, IBIS, V151, P299, DOI 10.1111/j.1474-919X.2009.00925.x; Sherley RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110794; Shutt JL, 2014, J GREAT LAKES RES, V40, P58, DOI 10.1016/j.jglr.2014.01.001; Siebert U, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-43; Sleeman JM, 2003, J AVIAN MED SURG, V17, P33, DOI 10.1647/1082-6742(2003)017[0033:CWMANP]2.0.CO;2; Sleeman Jonathan M., 2008, P97; TELFER TC, 1987, WILDLIFE SOC B, V15, P406; van Deventer M, 2012, BOT MAR, V55, P31, DOI [10.1515/BOT.2011.122, 10.1515/bot.2011.122]; Weimerskirch H, 2004, POLAR BIOL, V27, P374, DOI 10.1007/s00300-004-0600-x; WERNHAM CV, 1997, 186 BTO; Woodford M.H., 2000, QUARANTINE HLTH SCRE; WORK TM, 1993, J ZOO WILDLIFE MED, V24, P54	53	10	10	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177366	10.1371/journal.pone.0177366	http://dx.doi.org/10.1371/journal.pone.0177366			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475653	Green Published, Green Submitted, gold			2022-12-27	WOS:000400649500065
J	Reynolds, TH; Soriano, RA; Obadi, OA; Murkland, S; Possidente, B				Reynolds, Thomas H.; Soriano, Rachelle A.; Obadi, Obadi A.; Murkland, Stanley; Possidente, Bernard			Long term rebaudioside A treatment does not alter circadian activity rhythms, adiposity, or insulin action in male mice	PLOS ONE			English	Article							WEIGHT-LOSS MAINTENANCE; METABOLIC SYNDROME; STEVIA-REBAUDIANA; OBESITY; BERTONI; RISK; CONSUMPTION; STEVIOSIDE; SACCHARIN; EXTRACT	Obesity is a major public health problem that is highly associated with insulin resistance and type 2 diabetes, two conditions associated with circadian disruption. To date, dieting is one of the only interventions that result in substantial weight loss, but restricting caloric intake is difficult to maintain long-term. The use of artificial sweeteners, particularly in individuals that consume sugar sweetened beverages (energy drinks, soda), can reduce caloric intake and possibly facilitate weight loss. The purpose of the present study was to examine the effects of the artificial sweetener, rebaudioside A (Reb-A), on circadian rhythms, in vivo insulin action, and the susceptibility to diet-induced obesity. Six month old male C57BL/6 mice were assigned to a control or Reb-A (0.1% Reb-A supplemented drinking water) group for six months. Circadian wheel running rhythms, body weight, caloric intake, insulin action, and susceptibility to diet-induced obesity were assessed. Time of peak physical activity under a 12: 12 light-dark (LD) cycle, mean activity levels, and circadian period in constant dark were not significantly different in mice that consumed Reb-A supplemented water compared to normal drinking water, indicating that circadian rhythms and biological clock function were unaltered. Although wheel running significantly reduced body weight in both Reb-A and control mice (P = 0.0001), consuming Reb-A supplemented water did not alter the changes in body weight following wheel running (P = 0.916). In vivo insulin action, as assessed by glucose, insulin, and pyruvate tolerance tests, was not different between mice that consumed Reb-A treated water compared to normal drinking water. Finally, Reb-A does not appear to change the susceptibility to diet-induced obesity as both groups of mice gained similar amounts of body weight when placed on a high fat diet. Our results indicate that consuming Reb-A supplemented water does not promote circadian disruption, insulin resistance, or obesity.	[Reynolds, Thomas H.] Skidmore Coll, Dept Hlth & Exercise Sci, Saratoga Springs, NY 12866 USA; Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA	Skidmore College; Skidmore College	Reynolds, TH (corresponding author), Skidmore Coll, Dept Hlth & Exercise Sci, Saratoga Springs, NY 12866 USA.	treynold@skidmore.edu		Reynolds, Thomas/0000-0002-0290-528X	Skidmore College Faculty Development	Skidmore College Faculty Development	This work was supported by a Skidmore College Faculty Development grant awarded to BP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported, in part, by a Skidmore College Faculty Development grant awarded to BP.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Atteh JO, 2008, J ANIM PHYSIOL AN N, V92, P640, DOI 10.1111/j.1439-0396.2007.00760.x; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Davidson TL, 2014, NEUROBIOL LEARN MEM, V108, P172, DOI 10.1016/j.nlm.2013.07.014; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Fowler SP, 2008, OBESITY, V16, P1894, DOI 10.1038/oby.2008.284; HORWITZ DL, 1988, DIABETES CARE, V11, P230, DOI 10.2337/diacare.11.3.230; Kim MJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1204; Kraschnewski JL, 2010, INT J OBESITY, V34, P1644, DOI 10.1038/ijo.2010.94; Laermans J, 2016, OBES REV, V17, P108, DOI 10.1111/obr.12351; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; MacLean PS, 2015, OBES REV, V16, P45, DOI 10.1111/obr.12255; Nettleton JA, 2009, DIABETES CARE, V32, P688, DOI 10.2337/dc08-1799; Ogden CL, 2014, JAMA-J AM MED ASSOC, V312, P189, DOI [10.1001/jama.2014.6228, 10.1001/jama.2014.6219]; Oishi K, 2016, NUTRITION, V32, P1159, DOI 10.1016/j.nut.2016.03.013; OLIVEIRAFILHO RM, 1989, GEN PHARMACOL-VASC S, V20, P187, DOI 10.1016/0306-3623(89)90013-X; Park JE, 2010, J SCI FOOD AGR, V90, P1099, DOI 10.1002/jsfa.3906; Pepino MY, 2013, DIABETES CARE, V36, P2530, DOI 10.2337/dc12-2221; Peplonska B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133761; Reiter RJ, 2012, ANN MED, V44, P564, DOI 10.3109/07853890.2011.586365; Sridhar GR, 2016, WORLD J DIABETES, V7, P515, DOI 10.4239/wjd.v7.i19.515; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Weiss EC, 2007, AM J PREV MED, V33, P34, DOI 10.1016/j.amepre.2007.02.040; Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366; Wheeler A, 2008, FOOD CHEM TOXICOL, V46, pS54, DOI 10.1016/j.fct.2008.04.041; Yadav SK, 2012, CRIT REV FOOD SCI, V52, P988, DOI 10.1080/10408398.2010.519447	27	3	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177138	10.1371/journal.pone.0177138	http://dx.doi.org/10.1371/journal.pone.0177138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475596	Green Published, gold, Green Submitted			2022-12-27	WOS:000400649500050
J	Celewicz-Goldyn, S; Kuczynska-Kippen, N				Celewicz-Goldyn, Sofia; Kuczynska-Kippen, Natalia			Ecological value of macrophyte cover in creating habitat for microalgae (diatoms) and zooplankton (rotifers and crustaceans) in small field and forest water bodies	PLOS ONE			English	Article							STRUCTURAL COMPLEXITY; EPIPHYTIC DIATOMS; SMALL LAKES; LAND-USE; PONDS; ASSEMBLAGES; DIVERSITY; GRADIENTS; COMMUNITY; PHYTOPLANKTON	Due to their small area and shallow depth ponds are usually treated as a single sampling unit, while various microhabitats offer different environmental conditions. Thus, we tested the effect of different habitat types typically found within small ponds on the microalgae and zooplankton communities. We found that submerged macrophytes have the strongest impact on microalgae and zooplankton communities out of all the analysed habitats. Some epontic diatoms (e.g. Fragilaria dilatata, Cymbella affinis) and littoral-associated zooplankton species (e.g. Simocephalus vetulus, Lecane bulla) were significantly related to elodeids. However, pelagic species (e.g. bosminids) preferred less complex helophytes, which suggests that the most heterogeneous elodeid habitats were not an anti-predator shelter for cladocerans. Selection of different macrophyte types by taxonomically various organisms suggests that it is not only macrophyte cover that is desired for healthy aquatic environment but that a level of habitat mosaic is required to ensure the well-being of aquatic food webs. Species-specific preferences for different types of macrophytes indicate the high ecological value of macrophyte cover in ponds and a potential direction for the management of small water bodies towards maintaining a great variation of aquatic plants. Moreover, the type of surrounding landscape, reflecting human-induced disturbance (28 field ponds) and natural catchment (26 forest ponds), significantly influenced only zooplankton, while diatoms were affected indirectly through the level of conductivity. Nutrient overload (higher content of TRP) and increased conductivity in the field landscape contributed to a rise in microalgae (e.g. Amphora pediculus, Gomphonema parvulum) and zooplankton (e.g. Thermocyclops oithonoides, Eubosmina coregoni) abundance. An awareness of the responses of both components of plankton communities to environmental factors is necessary for maintaining the good state of small water bodies in various types of landscape.	[Celewicz-Goldyn, Sofia] Poznan Univ Life Sci, Fac Hort & Landscape Architecture, Dept Bot, Poznan, Poland; [Kuczynska-Kippen, Natalia] Adam Mickiewicz Univ, Fac Biol, Dept Water Protect, Poznan, Poland	Poznan University of Life Sciences; Adam Mickiewicz University	Celewicz-Goldyn, S (corresponding author), Poznan Univ Life Sci, Fac Hort & Landscape Architecture, Dept Bot, Poznan, Poland.	celewicz@up.poznan.pl	Kuczyńska-Kippen, Natalia/AAC-1955-2022; Celewicz, Sofia/Q-9399-2018	Celewicz, Sofia/0000-0003-2033-2777	Department of Botany, Poznah University of Life Sciences; Department of Water Protection, Adam Mickiewicz University in Poznah	Department of Botany, Poznah University of Life Sciences; Department of Water Protection, Adam Mickiewicz University in Poznah	The study was supported by these Departments: Department of Botany, Poznah University of Life Sciences (SCG) and Department of Water Protection, Adam Mickiewicz University in Poznah (NKK).	Anas MUM, 2013, ECOL INDIC, V30, P90, DOI 10.1016/j.ecolind.2013.01.038; Barinova S, 2013, PLANT BIOSYST, V147, P397, DOI 10.1080/11263504.2012.749956; Biggs J, 2005, AQUAT CONSERV, V15, P693, DOI 10.1002/aqc.745; Blanco S, 2014, CLEAN-SOIL AIR WATER, V42, P229, DOI 10.1002/clen.201200630; CARPENTER SR, 1986, AQUAT BOT, V26, P341, DOI 10.1016/0304-3770(86)90031-8; Carrino-Kyker SR, 2007, WETLANDS, V27, P749, DOI 10.1672/0277-5212(2007)27[749:SPCOTN]2.0.CO;2; Cazzanelli M, 2008, HYDROBIOLOGIA, V605, P113, DOI 10.1007/s10750-008-9324-1; Cereghino R, 2008, HYDROBIOLOGIA, V597, P1, DOI 10.1007/s10750-007-9225-8; Cereghino R, 2014, HYDROBIOLOGIA, V723, P1, DOI 10.1007/s10750-013-1719-y; Davies B, 2008, AGR ECOSYST ENVIRON, V125, P1, DOI 10.1016/j.agee.2007.10.006; Della Bella V, 2009, HYDROBIOLOGIA, V634, P25, DOI 10.1007/s10750-009-9890-x; DENYS L., 1991, INTRO ECOLOGICAL COD, V246; Dodson SI, 2007, HYDROBIOLOGIA, V579, P393, DOI 10.1007/s10750-006-0392-9; Dominy JN, 2012, SOUTHEAST NAT, V11, P263, DOI 10.1656/058.011.0208; Downing JA, 2010, LIMNETICA, V29, P9; Elbanowska H, 1999, PHYSICO CHEM WATER A; Erhard D, 2006, AQUAT BOT, V85, P203, DOI 10.1016/j.aquabot.2006.04.002; Frutos SM, 2008, REV BIOL TROP, V56, P1135; Gautam S, 2017, ECOL INDIC, V72, P67, DOI 10.1016/j.ecolind.2016.08.002; George DG, 2000, FRESHWATER BIOL, V43, P557, DOI 10.1046/j.1365-2427.2000.00539.x; Goldyn B, 2015, LIMNOLOGICA, V54, P14, DOI 10.1016/j.limno.2015.07.002; HATANO H, 1981, HYDROBIOLOGIA, V85, P161, DOI 10.1007/BF00006626; Joniak T, 2017, HYDROBIOLOGIA, V793, P121, DOI 10.1007/s10750-016-2913-5; Kollar J, 2015, FOTTEA, V15, P259, DOI 10.5507/fot.2015.022; Kuczynska-Kippen N, 2016, HYDROBIOLOGIA, V774, P39, DOI 10.1007/s10750-015-2595-4; Kuczynska-Kippen N, 2014, INT REV HYDROBIOL, V99, P58, DOI 10.1002/iroh.201301704; Lemmens P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072538; Leps J, 2003, MULTIVARIATE ANALYSE; Manatunge J, 2000, ENVIRON BIOL FISH, V58, P425, DOI 10.1023/A:1007691425268; de Faria DM, 2014, BRAZ J BIOL, V73, P681, DOI 10.1590/S1519-69842013000400002; Michelutti N, 2013, J PHYCOL, V49, P41, DOI 10.1111/jpy.12024; Nessimian JL, 2008, HYDROBIOLOGIA, V614, P117, DOI 10.1007/s10750-008-9441-x; Oertli B., 2010, POND CONSERVATION EU; Pereira HM, 2012, ANNU REV ENV RESOUR, V37, P25, DOI 10.1146/annurev-environ-042911-093511; Ryden L., 2003, ENV SCI UNDERSTANDIN; Sagrario G, 2009, FRESHWATER BIOL, V54, P1042, DOI 10.1111/j.1365-2427.2008.02152.x; Semlitsch RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123055; Simkhada B, 2006, INT REV HYDROBIOL, V91, P574, DOI 10.1002/iroh.200610852; Simkhada B, 2006, ARCH HYDROBIOL, V166, P41, DOI 10.1127/0003-9136/2006/0166-0041; Soininen J, 2012, ECOL APPL, V22, P624, DOI 10.1890/11-1126.1; Sousa E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154440; Spoljar M, 2017, ECOL INDIC, V75, P145, DOI 10.1016/j.ecolind.2016.12.038; Spoljar M, 2013, J ENG RES-KUWAIT, V1, P29; Spoljar M, 2012, ANN LIMNOL-INT J LIM, V48, P161, DOI 10.1051/limn/2012005; Svanys A, 2014, HYDROBIOLOGIA, V737, P57, DOI 10.1007/s10750-013-1782-4; Tonno I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154526; Trigal C, 2014, AQUAT SCI, V76, P61, DOI 10.1007/s00027-013-0312-9; Vanderstukken M, 2011, FRESHWATER BIOL, V56, P1837, DOI 10.1111/j.1365-2427.2011.02624.x; Warfe DM, 2004, OECOLOGIA, V141, P171, DOI 10.1007/s00442-004-1644-x; Wen XL, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-00666-Y, 10.1038/s41598-017-00666-y]; Wetzel R.G., 2000, LIMNOLOGICAL ANAL, V3; Wood RJ, 2016, SCI TOTAL ENVIRON, V557, P636, DOI 10.1016/j.scitotenv.2016.03.142; Yerli SV, 2012, TURK J FISH AQUAT SC, V12, P91, DOI 10.4194/1303-2712-v12_1_12; Zhang YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23867; Zhou YW, 2017, SCI TOTAL ENVIRON, V580, P1421, DOI 10.1016/j.scitotenv.2016.12.108	55	37	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177317	10.1371/journal.pone.0177317	http://dx.doi.org/10.1371/journal.pone.0177317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472138	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500157
J	Chiang, KJ; Tsai, JC; Liu, D; Lin, CH; Chiu, HL; Chou, KR				Chiang, Kai-Jo; Tsai, Jui-Chen; Liu, Doresses; Lin, Chueh-Ho; Chiu, Huei-Ling; Chou, Kuei-Ru			Efficacy of cognitive-behavioral therapy in patients with bipolar disorder: A meta-analysis of randomized controlled trials	PLOS ONE			English	Article							PSYCHOSOCIAL INTERVENTIONS; GROUP PSYCHOEDUCATION; RELAPSE PREVENTION; EPIDEMIOLOGY; PREDICTORS; CAREGIVERS; DEPRESSION; PROGRAM; PROMISE; ILLNESS	Background Although cognitive behavioral therapy (CBT) is considered a promising adjuvant to pharmacotherapy for treating bipolar disorder (BD), its efficacy is unproven. The present review and meta-analysis evaluated the treatment outcomes of patients with BD treated with CBT plus medication and compared these data with the outcomes of those who received standard care alone. Methods Electronic searches from inception to July 31, 2016, were performed using PubMed, Medline OVID, Cochrane Library, EMBASE, CINAHL plus, and PsycINFO. In the extensive electronic literature search, keywords such as "bipolar disorder," "manic-depressive psychosis," "bipolar affective disorder," "bipolar depression," "cognitive therapy," "cognitive-behavioral therapy," and "psychotherapy" were transformed into MeSH terms, and only randomized controlled trials (RCTs) were included. The pooled odds ratios (ORs) of relapse rates and Hedges's g, along with 95% confidence intervals (CIs), for the mean differences in the levels of depression, mania, and psychosocial functioning were calculated. Further subgroup analyses were conducted according to the characteristics of the CBT approaches, patients, and therapists, if the data were available. Result A total of 19 RCTs comprising 1384 patients with type I or II BD were enrolled in our systematic review and meta-analysis. The main analysis revealed that CBT could lower the relapse rate (pooled OR = 0.506; 95% CI = 0.278-0.921) and improve depressive symptoms (g = -0.494; 95% CI = -0.963 to -0.026), mania severity ( g = -0.581; 95% CI = -1.127 to -0.035), and psychosocial functioning ( g = 0.457; 95% CI = 0.106-0.809). Conclusions CBT is effective in decreasing the relapse rate and improving depressive symptoms, mania severity, and psychosocial functioning, with a mild-to-moderate effect size. Subgroup analyses indicated that improvements in depression or mania are more potent with a CBT treatment duration of >= 90 min per session, and the relapse rate is much lower among patients with type I BD.	[Chiang, Kai-Jo; Tsai, Jui-Chen; Liu, Doresses; Lin, Chueh-Ho; Chiu, Huei-Ling; Chou, Kuei-Ru] Tri Serv Gen Hosp, Coll Nursing, Sch Nursing, Taipei, Taiwan; [Chiang, Kai-Jo] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Nursing, Taipei, Taiwan; [Tsai, Jui-Chen; Chou, Kuei-Ru] Taipei Med Univ, Shuang Ho Hosp, Dept Nursing, Taipei, Taiwan; [Liu, Doresses] Taipei Med Univ, Wan Fang Hosp, Dept Nursing, Taipei, Taiwan; [Lin, Chueh-Ho] Taipei Med Univ, Coll Nursing, Sch Gerontol Hlth Management, Taipei, Taiwan; [Lin, Chueh-Ho] Taipei Med Univ, Coll Nursing, Masters Program Long Term Care, Taipei, Taiwan; [Chou, Kuei-Ru] Taipei Med Univ Hosp, Psychiat Res Ctr, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Chou, KR (corresponding author), Tri Serv Gen Hosp, Coll Nursing, Sch Nursing, Taipei, Taiwan.; Chou, KR (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Nursing, Taipei, Taiwan.; Chou, KR (corresponding author), Taipei Med Univ Hosp, Psychiat Res Ctr, Taipei, Taiwan.	kueiru@tmu.edu.tw	Chiu, Huei-Ling/AAC-8161-2020	Chiu, Huei-Ling/0000-0002-5402-9234; chou, kueiru/0000-0002-4882-3503	Ministry of Science and Technology (National Science Council (NSC), Taiwan [NSC99-2627-B-038-001]	Ministry of Science and Technology (National Science Council (NSC), Taiwan	This study was supported by Ministry of Science and Technology (project no. National Science Council (NSC)-NSC99-2627-B-038-001), Taiwan. The findings and conclusions in this document are those of the authors, who are responsible for its contents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Ministry of Science and Technology (project no National Science Concil (NSC)-NSC99-2627-B-038-001), Taiwan. The findings and conclusions in this document are those of the authors, who are responsible for its contents.	Aaronson CJ, 2008, J CLIN PSYCHIAT, V69, P418, DOI 10.4088/JCP.v69n0312; Ball JR, 2006, J CLIN PSYCHIAT, V67, P277, DOI 10.4088/JCP.v67n0215; BEBBINGTON P, 1995, SOC PSYCH PSYCH EPID, V30, P279, DOI 10.1007/BF00805795; Beynon S, 2008, BRIT J PSYCHIAT, V192, P5, DOI 10.1192/bjp.bp.107.037887; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; Colom F, 2003, ARCH GEN PSYCHIAT, V60, P402, DOI 10.1001/archpsyc.60.4.402; Crump C, 2013, JAMA PSYCHIAT, V70, P931, DOI 10.1001/jamapsychiatry.2013.1394; Cuijpers P, 2008, J CLIN PSYCHIAT, V69, P1675, DOI 10.4088/JCP.v69n1102; da Costa RT, 2011, REV BRAS PSIQUIATR, V33, P144, DOI 10.1590/S1516-44462011000200009; Dilsaver SC, 2011, J AFFECT DISORDERS, V129, P79, DOI 10.1016/j.jad.2010.08.030; Gomes BC, 2011, PSYCHOTHER PSYCHOSOM, V80, P144, DOI 10.1159/000320738; Isasi AG, 2010, J AFFECT DISORDERS, V126, P80, DOI 10.1016/j.jad.2010.03.026; Gonzalez-Isasi A, 2010, PSYCHIAT RES, V176, P161, DOI 10.1016/j.psychres.2008.06.047; Green MF, 2006, J CLIN PSYCHIAT, V67, P3, DOI 10.4088/JCP.1006e12; Gregory VL, 2010, J EVID-INFORM SOC WO, V7, P269, DOI 10.1080/15433710903176088; Harvey AG, 2015, J CONSULT CLIN PSYCH, V83, P564, DOI 10.1037/a0038655; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Hunter J.E., 1990, METHODS META ANAL CO; Lam D, 2005, PSYCHOL MED, V35, P69, DOI 10.1017/S0033291704002910; Lam DH, 2000, COGNITIVE THER RES, V24, P503, DOI 10.1023/A:1005557911051; Lam DH, 2003, ARCH GEN PSYCHIAT, V60, P145, DOI 10.1001/archpsyc.60.2.145; Lam DH, 2009, BIPOLAR DISORD, V11, P474, DOI 10.1111/j.1399-5618.2009.00724.x; Lynch D, 2010, PSYCHOL MED, V40, P9, DOI 10.1017/S003329170900590X; Maczka G, 2014, PSYCHIATR POL, V48, P1237, DOI 10.12740/PP/24992; Meyer TD, 2012, PSYCHOL MED, V42, P1429, DOI 10.1017/S0033291711002522; Miklowitz DJ, 2008, AM J PSYCHIAT, V165, P1408, DOI 10.1176/appi.ajp.2008.08040488; Miklowitz DJ, 2007, AM J PSYCHIAT, V164, P1340, DOI 10.1176/appi.ajp.2007.07020311; Miklowitz David J, 2006, Curr Psychiatry Rep, V8, P498, DOI 10.1007/s11920-006-0057-4; Oud M, 2016, BRIT J PSYCHIAT, V208, P213, DOI 10.1192/bjp.bp.114.157123; Perich T, 2013, ACTA PSYCHIAT SCAND, V127, P333, DOI 10.1111/acps.12033; Perlick DA, 2010, BIPOLAR DISORD, V12, P627, DOI 10.1111/j.1399-5618.2010.00852.x; Perlis RH, 2006, AM J PSYCHIAT, V163, P217, DOI 10.1176/appi.ajp.163.2.217; Pompili M, 2013, BIPOLAR DISORD, V15, P457, DOI 10.1111/bdi.12087; Raghupathi W, 2014, HEALTH INF SCI SYST, V2, DOI 10.1186/2047-2501-2-3; Sanchez-Moreno J, 2009, PSYCHOTHER PSYCHOSOM, V78, P285, DOI 10.1159/000228249; Scott J, 2006, BRIT J PSYCHIAT, V188, P313, DOI 10.1192/bjp.188.4.313; Scott J, 2001, PSYCHOL MED, V31, P459, DOI 10.1017/S0033291701003373; Scott J, 2007, INT J NEUROPSYCHOPH, V10, P123, DOI 10.1017/S1461145706006900; Szentagotai A, 2010, J CLIN PSYCHIAT, V71, P66, DOI 10.4088/JCP.08r04559yel; Thase ME, 2014, WORLD PSYCHIATRY, V13, P244, DOI 10.1002/wps.20149; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Weiss RD, 2007, AM J PSYCHIAT, V164, P100, DOI 10.1176/appi.ajp.164.1.100; Weiss RD, 2009, DRUG ALCOHOL DEPEN, V104, P212, DOI 10.1016/j.drugalcdep.2009.04.018; Williams JMG, 2008, J AFFECT DISORDERS, V107, P275, DOI 10.1016/j.jad.2007.08.022; Ye BY, 2016, PSYCHIAT CLIN NEUROS, V70, P351, DOI 10.1111/pcn.12399; Zaretsky A, 2008, CAN J PSYCHIAT, V53, P441, DOI 10.1177/070674370805300709	47	40	40	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176849	10.1371/journal.pone.0176849	http://dx.doi.org/10.1371/journal.pone.0176849			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472082	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500085
J	Elhadyl, A; Gine, A; Topalovic, O; Jacquiod, S; Sorensen, SJ; Sorribas, FJ; Heuer, H				Elhadyl, Ahmed; Gine, Ariadna; Topalovic, Olivera; Jacquiod, Samuel; Sorensen, Soren J.; Javier Sorribas, Francisco; Heuer, Holger			Microbiomes associated with infective stages of root-knot and lesion nematodes in soil	PLOS ONE			English	Article							PLANT-PARASITIC NEMATODES; MELOIDOGYNE SPP. EGGS; SURFACE-COAT; PASTEURIA-PENETRANS; ESCHERICHIA-COLI; POPULATIONS; INCOGNITA; COMMUNITIES; ATTACHMENT; BIOCONTROL	Endoparasitic root-knot (Meloidogyne spp.) and lesion (Pratylenchus spp.) nematodes cause considerable damage in agriculture. Before they invade roots to complete their life cycle, soil microbes can attach to their cuticle or surface coat and antagonize the nematode directly or by induction of host plant defenses. We investigated whether the nematode-associated microbiome in soil differs between infective stages of Meloidogyne incognita and Pratylenchus penetrans, and whether it is affected by variation in the composition of microbial communities among soils. Nematodes were incubated in suspensions of five organically and two integrated horticultural production soils, recovered by sieving and analyzed for attached bacteria and fungi after washing off loosely adhering microbes. Significant effects of the soil type and nematode species on nematode-associated fungi and bacteria were revealed as analyzed by community profiling using denaturing gradient gel electrophoresis. Attached microbes represented a small specific subset of the soil microbiome. Two organic soils had very similar bacterial and fungal community profiles, but one of them was strongly suppressive towards root-knot nematodes. They were selected for deep amplicon sequencing of bacterial 16S rRNA genes and fungal ITS. Significant differences among the microbiomes associated with the two species in both soils suggested specific surface epitopes. Among the 28 detected bacterial classes, Betaproteobacteria, Bacilli and Actinobacteria were the most abundant. The most frequently detected fungal genera were Malassezia, Aspergillus and Cladosporium. Attached microbiomes did not statistically differ between these two soils. However, Malassezia globosa and four fungal species of the family Plectosphaerellaceae, and the bacterium Neorhizobium galegae were strongly enriched on M. incognita in the suppressive soil. In conclusion, the highly specific attachment of microbes to infective stages of phytonematodes in soil suggested an ecological role of this association and might be involved in soil suppressiveness towards them.	[Elhadyl, Ahmed; Topalovic, Olivera; Heuer, Holger] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Dept Epidemiol & Pathogen Diagnost, Braunschweig, Germany; [Elhadyl, Ahmed] Benha Univ, Fac Agr, Dept Plant Protect, Banha, Egypt; [Gine, Ariadna; Javier Sorribas, Francisco] Univ Politecn Cataluna, Dept Engn Agroalimentaria & Biotecnol, Castelldefels, Spain; [Jacquiod, Samuel; Sorensen, Soren J.] Univ Copenhagen, Dept Biol, Sect Microbiol, Copenhagen, Denmark	Julius Kuhn-Institut; Egyptian Knowledge Bank (EKB); Benha University; Universitat Politecnica de Catalunya; University of Copenhagen	Heuer, H (corresponding author), Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Dept Epidemiol & Pathogen Diagnost, Braunschweig, Germany.	holger.heuer@julius-kuehn.de	Elhady, Ahmed/AAJ-7013-2020; Jacquiod, Samuel/M-2259-2014; Topalović, Olivera/AAM-2208-2020; Sorribas, F Javier/L-4896-2017; Blasco, Ariadna Giné/AAA-5545-2020; Sørensen, Søren J/J-5015-2014; Sørensen, Søren Johannes/N-2120-2019	Jacquiod, Samuel/0000-0002-0713-7996; Blasco, Ariadna Giné/0000-0002-3598-4818; Sørensen, Søren J/0000-0001-6227-9906; Sørensen, Søren Johannes/0000-0001-6227-9906; Sorribas, Francisco Javier/0000-0001-7465-7353; Heuer, Holger/0000-0001-6044-8171; Topalovic, Olivera/0000-0003-3839-1839	German Research Foundation [DFG HE695/1-1]; Deutscher Akademischer Austauschdienst; Gisela und Hermann Stegemann Stiftung; Ministerio de Economia y Competitividad project [AGL2013-49040-C2-1]	German Research Foundation(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Gisela und Hermann Stegemann Stiftung; Ministerio de Economia y Competitividad project	OT was financed by the German Research Foundation (http://www.dfg.de) grant DFG HE695/1-1, AE by the Deutscher Akademischer Austauschdienst (https://www.daad.eg/de), AG by the 'Gisela und Hermann Stegemann Stiftung' (travel and daily allowance) and Ministerio de Economia y Competitividad (http://www.mineco.gob.es) project AGL2013-49040-C2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2014, APPL ENVIRON MICROB, V80, P2679, DOI 10.1128/AEM.03905-13; Agrios G. N., 2005, PLANT PATHOL; Ashbee HR, 2002, CLIN MICROBIOL REV, V15, P21, DOI 10.1128/CMR.15.1.21-57.2002; Atkins SD, 2003, APPL ENVIRON MICROB, V69, P4788, DOI 10.1128/AEM.69.8.4788-4793.2003; Back MA, 2002, PLANT PATHOL, V51, P683, DOI 10.1046/j.1365-3059.2002.00785.x; Bent E, 2008, J NEMATOL, V40, P109; BIRD A F, 1988, Revue de Nematologie, V11, P75; BIRD AF, 1989, INT J PARASITOL, V19, P235, DOI 10.1016/0020-7519(89)90134-3; Brown AMV, 2016, SCI REP-UK, V6, DOI 10.1038/srep34955; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cao Y, 2015, J BASIC MICROB, V55, P950, DOI 10.1002/jobm.201400816; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chen ZX, 1998, J NEMATOL, V30, P313; Cook RJ, 1983, THE NATURE AND PRACT; Davies KG, 2006, NEMATOLOGY, V8, P475, DOI 10.1163/156854106778493493; Davies KG, 2011, ANNU REV PHYTOPATHOL, V49, P135, DOI 10.1146/annurev-phyto-121310-111406; DAVIES KG, 1992, PARASITOLOGY, V105, P475, DOI 10.1017/S0031182000074655; Davies KG, 2001, PARASITOLOGY, V122, P111, DOI 10.1017/S0031182000006958; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Evans D., 2016, FIELD MYCOLOGY, V17, P51; Fatima N, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2138-2; Gine A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00164; Gine A, 2013, BIOCONTROL, V58, P407, DOI 10.1007/s10526-012-9495-6; Gotlieb D, 2003, PHYTOPARASITICA, V31, P217, DOI 10.1007/BF02980831; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7; Heuer H, 2002, APPL ENVIRON MICROB, V68, P1325, DOI 10.1128/AEM.68.3.1325-1335.2002; Hora R, 2005, J FOOD PROTECT, V68, P2506, DOI 10.4315/0362-028X-68.12.2506; Iglesias-Garcia AM, 2013, PLANT DIS, V97, P1457, DOI 10.1094/PDIS-01-13-0016-RE; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Jacquiod S, 2016, RES MICROBIOL, V167, P436, DOI 10.1016/j.resmic.2016.03.003; KERRY B, 1988, AGR ECOSYST ENVIRON, V24, P293, DOI 10.1016/0167-8809(88)90073-4; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; Maghodia AB, 2008, J APPL MICROBIOL, V105, P1810, DOI 10.1111/j.1365-2672.2008.03945.x; Nunes I, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw175; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Omarjee J, 2008, APPL SOIL ECOL, V39, P1, DOI 10.1016/j.apsoil.2007.11.001; Orion D, 2001, J NEMATOL, V33, P203; Page Antony P., 2001, P167, DOI 10.1079/9780851994239.0167; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; R Development Core team, 2014, R A LANGUAGE AND ENV; Renker C, 2003, BIOL FERT SOILS, V37, P70, DOI 10.1007/s00374-002-0556-3; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROCCUZZO G, 1993, FUND APPL NEMATOL, V16, P151; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siddiqui ZA, 2012, BACTERIA AGROBIOLOGY, DOI DOI 10.1007/978-3-642-27515-9_14; Siddiqui ZA, 2009, PEST MANAG SCI, V65, P943, DOI 10.1002/ps.1777; SKOTLAND CB, 1971, PHYTOPATHOLOGY, V61, P435, DOI 10.1094/Phyto-61-435; SPIEGEL Y, 1995, EXP PARASITOL, V80, P220, DOI 10.1006/expr.1995.1027; SPIEGEL Y, 1995, J NEMATOL, V27, P127; STIRLING GR, 1979, J NEMATOL, V11, P99; Stirling GR, 2011, AUSTRALAS PLANT PATH, V40, P416, DOI 10.1007/s13313-011-0059-5; Sun MH, 2006, J INVERTEBR PATHOL, V93, P22, DOI 10.1016/j.jip.2006.03.006; Verdejo-Lucas S, 2002, J NEMATOL, V34, P405; Vogel JL, 2002, PROC S AFR SUG TECHN; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Weisskopf L, 2011, APPL ENVIRON MICROB, V77, P7715, DOI 10.1128/AEM.05845-11; Westphal A, 1999, PHYTOPATHOLOGY, V89, P434, DOI 10.1094/PHYTO.1999.89.5.434; Zakir Hussain, 2009, Indian Journal of Nematology, V39, P41	66	50	50	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177145	10.1371/journal.pone.0177145	http://dx.doi.org/10.1371/journal.pone.0177145			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472099	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500145
J	Graumann, R; Di Capua, GA; Oyarzun, JE; Vasquez, MA; Liao, C; Branes, JA; Roa, I; Casanello, P; Corvalan, AH; Owen, GI; Delgado, I; Zangemeister-Wittke, U; Ziegler, A				Graumann, Rebecca; Di Capua, Gabriella A.; Oyarzun, Juan E.; Vasquez, Marcos A.; Liao, Christine; Branes, Jorge A.; Roa, Ivan; Casanello, Paola; Corvalan, Alejandro H.; Owen, Gareth I.; Delgado, Iris; Zangemeister-Wittke, Uwe; Ziegler, Annemarie			Expression of teneurins is associated with tumor differentiation and patient survival in ovarian cancer	PLOS ONE			English	Article							PAIR-RULE GENE; CELL-CELL ADHESION; BREAST-CANCER; CAENORHABDITIS-ELEGANS; TRANSMEMBRANE PROTEINS; INTRACELLULAR DOMAIN; NEURITE OUTGROWTH; VISUAL-SYSTEM; FGF RECEPTORS; ODZ GENE	Teneurins are a family of highly conserved pair-rule proteins involved in morphogenesis and development of the central nervous system. Their function in adult tissues and in disease is largely unknown. Recent evidence suggests a role for dysregulated expression of Teneurins in human tumors, but systematic investigations are missing. Here, we investigated Teneurin-2 and Teneurin-4 expression in various cancer cell lines and in ovarian tumor tissues. Teneurin-2 and Teneurin-4 were expressed in most of the breast cancer cell lines tested. Teneurin-4 was also detected in ovarian cancer cell lines, and throughout ovarian tumors and normal ovary tissue. Ovarian tumors with low Teneurin-4 expression showed less differentiated phenotypes and these patients had shorter mean overall survival. Similarly, Teneurin-2 expression correlated with overall survival as well, especially in patients with serous tumors. In the various cell lines, 5-Aza-cytidine-induced changes in DNA methylation did not alter expression of Teneurin-2 and Teneurin-4, despite the existence of predicted CpG islands in both genes. Interestingly, however, we found evidence for the control of Teneurin-2 expression by the oncogenic growth factor FGF8. Furthermore, we identified multiple transcript splicing variants for Teneurin-2 and Teneurin-4, indicating complex gene expression patterns in malignant cells. Finally, downregulation of Teneurin-4 expression using siRNA caused a cell-type dependent increase in proliferation and resistance to cisplatin. Altogether, our data suggest that low Teneurin-4 expression provides a growth advantage to cancer cells and marks an undifferentiated state characterized by increased drug resistance and clinical aggressiveness. We conclude that Teneurin-2 and Teneurin-4 expression levels could be of prognostic value in ovarian cancer.	[Graumann, Rebecca; Di Capua, Gabriella A.; Oyarzun, Juan E.; Vasquez, Marcos A.; Liao, Christine; Ziegler, Annemarie] Univ Desarrollo, Fac Med, Ctr Genet & Gen, Clin Alemana, Santiago, Chile; [Branes, Jorge A.] Pontificia Univ Catolica Chile, Sch Med, Div Obstet & Gynecol, Santiago, Chile; [Roa, Ivan] Clin Alemana Santiago, Div Pathol, Santiago, Chile; [Casanello, Paola] Pontificia Univ Catolica Chile, Sch Med, Perinatol Res Lab, Santiago, Chile; [Corvalan, Alejandro H.; Owen, Gareth I.] Pontificia Univ Catolica Chile, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Corvalan, Alejandro H.; Owen, Gareth I.] Pontificia Univ Catolica Chile, UC Ctr Invest Oncol CITO, Santiago, Chile; [Owen, Gareth I.] Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Physiol, Santiago, Chile; [Delgado, Iris] Univ Desarrollo, Clin Alemana, Fac Med, Ctr Epidemiol & Hlth Policies, Santiago, Chile; [Zangemeister-Wittke, Uwe] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Oyarzun, Juan E.] Pontificia Univ Catolica Chile, Sch Med, Dept Gastroenterol, Santiago, Chile; [Vasquez, Marcos A.] Ctr Appl Med Res CIMA, Program Immunol & Immunotherapy, Pamplona, Spain; [Roa, Ivan] Creat Biosci, Santiago, Chile	Clinica Alemana; Universidad del Desarrollo; Pontificia Universidad Catolica de Chile; Clinica Alemana; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Clinica Alemana; Universidad del Desarrollo; University of Bern; Pontificia Universidad Catolica de Chile	Ziegler, A (corresponding author), Univ Desarrollo, Fac Med, Ctr Genet & Gen, Clin Alemana, Santiago, Chile.	aziegler@udd.cl	Casanello, Paola/X-7443-2019	Casanello, Paola/0000-0002-2355-1476; Di Capua, Gabriella A/0000-0002-2525-2568; Oyarzun, Juan Esteban/0000-0002-9695-7207; Corvalan, Alejandro/0000-0001-5492-3853	"Fondo Nacional de Desarrollo Cientifico y Tecnologico" (Fondecyt) [1100605]; "Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias" (FONDAP) [15130011]; "Comision Nacional de Investigacion Cientifica y Tecnologica" (CONICYT), from the Government of Chile	"Fondo Nacional de Desarrollo Cientifico y Tecnologico" (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); "Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias" (FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); "Comision Nacional de Investigacion Cientifica y Tecnologica" (CONICYT), from the Government of Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by grant No 1100605 from the "Fondo Nacional de Desarrollo Cientifico y Tecnologico" (Fondecyt) (A.Z.), https://www.conicyt.cl/fondecyt/. The activities performed by A.H.C. were financed by a "Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias" (FONDAP) grant No 15130011, http://www.conicyt.cl/fondap/. Both funding sources depend from the "Comision Nacional de Investigacion Cientifica y Tecnologica" (CONICYT), from the Government of Chile (http://www.conicyt.cl/).	Aldahmesh MA, 2012, GENET MED, V14, P900, DOI 10.1038/gim.2012.71; Antinucci P, 2013, CELL REP, V5, P582, DOI 10.1016/j.celrep.2013.09.045; Bagutti C, 2003, J CELL SCI, V116, P2957, DOI 10.1242/jcs.00603; BAUMGARTNER S, 1993, MECH DEVELOP, V40, P165, DOI 10.1016/0925-4773(93)90074-8; BAUMGARTNER S, 1994, EMBO J, V13, P3728, DOI 10.1002/j.1460-2075.1994.tb06682.x; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Beckmann J, 2013, NANO LETT, V13, P2937, DOI 10.1021/nl4013248; Beckmann J, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-35; Ben-Zur T, 2000, DEV BIOL, V217, P107, DOI 10.1006/dbio.1999.9532; Birrer MJ, 2007, J CLIN ONCOL, V25, P2281, DOI 10.1200/JCO.2006.09.0795; Boeva V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072182; Broz DK, 2010, INT J DEV BIOL, V54, P1509, DOI 10.1387/ijdb.103139dk; Buys TPH, 2007, GENE CHROMOSOME CANC, V46, P1069, DOI 10.1002/gcc.20492; Byron SA, 2010, GYNECOL ONCOL, V117, P125, DOI 10.1016/j.ygyno.2009.12.002; Chaffer CL, 2007, DIFFERENTIATION, V75, P831, DOI 10.1111/j.1432-0436.2007.00210.x; Chand D, 2013, MOL CELL NEUROSCI, V52, P38, DOI 10.1016/j.mcn.2012.09.006; Chandler LA, 1999, INT J CANCER, V81, P451, DOI 10.1002/(SICI)1097-0215(19990505)81:3<451::AID-IJC20>3.3.CO;2-8; Chang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105524; Cheng S-P, 2016, CLIN EXP MED; Cole C, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12585; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; Dharmaratne N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043083; Drabikowski K, 2005, DEV BIOL, V282, P27, DOI 10.1016/j.ydbio.2005.02.017; Feng K, 2002, J BIOL CHEM, V277, P26128, DOI 10.1074/jbc.M203722200; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Hor H, 2015, HUM MOL GENET, V24, P5677, DOI 10.1093/hmg/ddv281; Kenzelmann D, 2007, CELL MOL LIFE SCI, V64, P1452, DOI 10.1007/s00018-007-7108-9; Kenzelmann D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-30; Kenzelmann-Broz D., 2008, TENEURINS DEV DIS; Kinel-Tahan Y, 2007, DEV DYNAM, V236, P2541, DOI 10.1002/dvdy.21284; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; LEVINE A, 1994, CELL, V77, P587, DOI 10.1016/0092-8674(94)90220-8; Li H, 2006, MOL CELL NEUROSCI, V33, P136, DOI 10.1016/j.mcn.2006.06.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Marsh SK, 1999, ONCOGENE, V18, P1053, DOI 10.1038/sj.onc.1202392; Mattila MA, 2007, CYTOKINE GROWTH F R, V18, P257, DOI 10.1016/j.cytogfr.2007.04.010; Mejstrikova E, 2012, PEDIATRICS, V129, pE523, DOI 10.1542/peds.2011-0870; Miyamoto N, 1997, DEVELOPMENT, V124, P1653; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Mott NN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010143; Noonan FC, 2001, GENOMICS, V76, P37, DOI 10.1006/geno.2001.6590; Nunes SM, 2005, EXP CELL RES, V305, P122, DOI 10.1016/j.yexcr.2004.12.020; Okamoto J, 2010, ONCOGENE, V29, P5969, DOI 10.1038/onc.2010.330; Petrini I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060572; Rubin BP, 2002, DEVELOPMENT, V129, P4697; Salah Z, 2012, FRONT BIOSCI-LANDMRK, V17, P331, DOI 10.2741/3930; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; Suzuki N, 2014, J ORTHOP RES, V32, P915, DOI 10.1002/jor.22616; Suzuki N, 2014, FASEB J, V28, P1386, DOI 10.1096/fj.13-241034; Suzuki N, 2012, J NEUROSCI, V32, P11586, DOI 10.1523/JNEUROSCI.2045-11.2012; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tommasi S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2233; Tran H, 2015, EUR J NEUROSCI, V41, P55, DOI 10.1111/ejn.12767; Trzebiatowska A, 2008, MOL BIOL CELL, V19, P3898, DOI 10.1091/mbc.E08-01-0028; Tucker RP, 2007, INT J BIOCHEM CELL B, V39, P292, DOI 10.1016/j.biocel.2006.09.012; Tucker RP, 2001, DEV DYNAM, V220, P27, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1084>3.0.CO;2-B; Valve E, 2000, INT J CANCER, V88, P718, DOI 10.1002/1097-0215(20001201)88:5<718::AID-IJC6>3.0.CO;2-F; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Vater I, 2015, LEUKEMIA, V29, P677, DOI 10.1038/leu.2014.264; Vinatzer U, 2008, CLIN CANCER RES, V14, P6426, DOI 10.1158/1078-0432.CCR-08-0702; Wang XZ, 1999, ONCOGENE, V18, P5718, DOI 10.1038/sj.onc.1202950; Wei W, 2013, J CLIN INVEST, V123, P4435, DOI 10.1172/JCI70625; Young TR, 2013, J NEUROSCI, V33, P12490, DOI 10.1523/JNEUROSCI.4708-12.2013; Young TR, 2009, INT J BIOCHEM CELL B, V41, P990, DOI 10.1016/j.biocel.2008.06.014; Yue DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132134; Zhang HT, 2013, J BIOL CHEM, V288, P20966, DOI 10.1074/jbc.M113.484535; Zhang W, 2014, MOL MED REP, V10, P113, DOI 10.3892/mmr.2014.2152; Zheng LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022956; Zhou XH, 2003, GENE EXPR PATTERNS, V3, P397, DOI 10.1016/S1567-133X(03)00087-5; Zhu Y, 2016, REPROD BIOMED ONLINE, V32, P388, DOI 10.1016/j.rbmo.2016.01.005; Ziegler A, 2012, CANCER LETT, V326, P1, DOI 10.1016/j.canlet.2012.07.021; Ziegler A, 2012, LUNG CANCER, V75, P189, DOI 10.1016/j.lungcan.2011.07.009	74	12	12	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177244	10.1371/journal.pone.0177244	http://dx.doi.org/10.1371/journal.pone.0177244			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472127	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500155
J	Kratzer, RF; Espenlaub, S; Hoffmeister, A; Kron, MW; Kreppel, F				Kratzer, Ramona F.; Espenlaub, Sigrid; Hoffmeister, Andrea; Kron, Matthias W.; Kreppel, Florian			Covalent decoration of adenovirus vector capsids with the carbohydrate epitope alpha Gal does not improve vector immunogenicity, but allows to study the in vivo fate of adenovirus immunocomplexes	PLOS ONE			English	Article							T-CELL RESPONSES; ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; HIV VACCINE; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSE; RECOMBINANT ADENOVIRUS; SEROTYPE 5; DC-SIGN; PROTEIN	Adenovirus-based vectors are promising tools for genetic vaccination. However, several obstacles have to be overcome prior to a routine clinical application of adenovirus-based vectors as efficacious vectored vaccines. The linear trisaccharide epitope alpha Gal (alpha-Gal) with the carbohydrate sequence galactose-alpha-1,3-galactosyl-beta-1,4-N-acetylglucosamine has been described as a potent adjuvant for recombinant or attenuated vaccines. Humans and alpha-1,3-galactosyltransferase knockout mice do not express this epitope. Upon exposure of alpha-1,3-galactosyltransferase-deficient organisms to alpha Gal in the environment, large amounts of circulating anti-Gal antibodies are produced consistently. Immunocomplexes formed between recombinant alpha Gal-decorated vaccines and anti-Gal antibodies exhibit superior immunogenicity. We studied the effects of the trisaccharide epitope on CD8 T cell responses that are directed specifically to vector-encoded transgenic antigens. For that, covalently alpha Gal-decorated adenovirus vectors were delivered to anti-Gal alpha-1,3-galactosyltransferase knockout mice. We generated replication-defective, E1-deleted adenovirus type 5 vectors that were decorated with aGal at the hexon hypervariable regions 1 or 5, at fiber knob, or at penton base. Surprisingly, none of the adenovirus immunocomplexes being formed from alpha Gal-decorated adenovirus vectors and anti-Gal immunoglobulins improved the frequencies of CD8 T cell responses against the transgenic antigen ovalbumin. Humoral immunity directed to the adenovirus vector was neither increased. However, our data indicated that decoration of Ad vectors with the aGal epitope is a powerful tool to analyze the fate of adenovirus immunocomplexes in vivo.	[Kratzer, Ramona F.; Espenlaub, Sigrid; Hoffmeister, Andrea; Kron, Matthias W.; Kreppel, Florian] Ulm Univ, Dept Gene Therapy, Ulm, Germany; [Kreppel, Florian] Herdecke Univ, Fac Hlth, Ctr Biomed Educ & Res ZBAF, Sch Med,Chair Biochem & Mol Med, Witten, Germany	Ulm University	Kreppel, F (corresponding author), Ulm Univ, Dept Gene Therapy, Ulm, Germany.; Kreppel, F (corresponding author), Herdecke Univ, Fac Hlth, Ctr Biomed Educ & Res ZBAF, Sch Med,Chair Biochem & Mol Med, Witten, Germany.	Forian.Kreppel@uni-wh.de			BMBF Go-Bio grant [0315562]; International Graduate School in Molecular Medicine Ulm (IGradU); International Graduate School in Molecular Medicine Ulm (Excellence Initiative of the German Federal and State Governments); ZBAF/Center for Biomedical Research and Education	BMBF Go-Bio grant(Federal Ministry of Education & Research (BMBF)); International Graduate School in Molecular Medicine Ulm (IGradU); International Graduate School in Molecular Medicine Ulm (Excellence Initiative of the German Federal and State Governments); ZBAF/Center for Biomedical Research and Education	Support was provided by BMBF Go-Bio grant #0315562, International Graduate School in Molecular Medicine Ulm (IGradU) (IGradU, and Excellence Initiative of the German Federal and State Governments). Additionally, the work was supported by ZBAF/Center for Biomedical Research and Education (to FK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Motal U, 2006, J VIROL, V80, P6943, DOI 10.1128/JVI.00310-06; Abdel-Motal UM, 2007, J VIROL, V81, P9131, DOI 10.1128/JVI.00647-07; Abdel-Motal UM, 2010, VACCINE, V28, P1758, DOI 10.1016/j.vaccine.2009.12.015; Abdel-Motal UM, 2009, VACCINE, V27, P3072, DOI 10.1016/j.vaccine.2009.03.019; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Brandao JG, 2003, VACCINE, V21, P2268, DOI 10.1016/S0264-410X(03)00050-1; Chaitra MG, 2007, VACCINE, V25, P7168, DOI 10.1016/j.vaccine.2007.07.026; Chiang TR, 2000, TRANSPLANTATION, V69, P2593, DOI 10.1097/00007890-200006270-00020; Curlin ME, 2011, AIDS, V25, P153, DOI 10.1097/QAD.0b013e328342115c; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; de Cassan SC, 2011, J IMMUNOL, V187, P2602, DOI 10.4049/jimmunol.1101004; De Geest BR, 2003, BLOOD, V101, P2551, DOI 10.1182/blood-2002-07-2146; Deriy L, 2005, CANCER GENE THER, V12, P528, DOI 10.1038/sj.cgt.7700812; Douglas AD, 2010, VACCINE, V28, P7167, DOI 10.1016/j.vaccine.2010.08.068; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; Fonseca JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154819; GALILI U, 1993, BLOOD, V82, P2485, DOI 10.1182/blood.V82.8.2485.bloodjournal8282485; GALILI U, 1988, J BIOL CHEM, V263, P17755; Galili U, 1998, TRANSPLANTATION, V65, P1129, DOI 10.1097/00007890-199804270-00020; GALILI U, 1991, P NATL ACAD SCI USA, V88, P7401, DOI 10.1073/pnas.88.16.7401; GALILI U, 1984, J EXP MED, V160, P1519, DOI 10.1084/jem.160.5.1519; GALILI U, 1987, P NATL ACAD SCI USA, V84, P1369, DOI 10.1073/pnas.84.5.1369; GALILI U, 1988, INFECT IMMUN, V56, P1730, DOI 10.1128/IAI.56.7.1730-1737.1988; Galili U., 1999, SUBCELLULAR BIOCH GA; Gray G, 2010, CURR OPIN HIV AIDS, V5, P357, DOI 10.1097/COH.0b013e32833d2d2b; Hesse C, 2013, EUR J IMMUNOL, V43, P2543, DOI 10.1002/eji.201343429; Hutnick NA, 2009, NAT MED, V15, P876, DOI 10.1038/nm.1989; Jooss K, 1998, J VIROL, V72, P4212, DOI 10.1128/JVI.72.5.4212-4223.1998; Kreppel F, 2005, MOL THER, V12, P107, DOI 10.1016/j.ymthe.2005.03.006; Kreppel F, 2002, HUM GENE THER, V13, P1151, DOI 10.1089/104303402320138934; Krutzke L, 2016, J CONTROL RELEASE, V235, P379, DOI 10.1016/j.jconrel.2016.06.022; LARSEN RD, 1990, J BIOL CHEM, V265, P7055; Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130; Ludwig SL, 1998, J INFECT DIS, V178, P1776, DOI 10.1086/314498; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Matthews QL, 2011, MOL PHARMACEUT, V8, P3, DOI 10.1021/mp100214b; Matthews QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011815; McKelvey T, 2004, GENE THER, V11, P791, DOI 10.1038/sj.gt.3302232; McKenzie IFC, 1998, TRANSPLANTATION, V66, P754, DOI 10.1097/00007890-199809270-00010; Molinier-Frenkel V, 2002, J VIROL, V76, P127, DOI 10.1128/JVI.76.1.127-135.2002; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; Palmetshofer A, 1998, TRANSPLANTATION, V65, P971, DOI 10.1097/00007890-199804150-00018; Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942; PREVEC L, 1989, J GEN VIROL, V70, P429, DOI 10.1099/0022-1317-70-2-429; Prill JM, 2011, MOL THER, V19, P83, DOI 10.1038/mt.2010.229; RIBI E, 1984, J BIOL RESP MODIF, V3, P1; Sapinoro R, 2007, J GENE MED, V9, P1033, DOI 10.1002/jgm.1112; Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417; Schirmbeck R, 2008, MOL THER, V16, P1609, DOI 10.1038/mt.2008.141; Suleman M, 2011, VACCINE, V29, P5892, DOI 10.1016/j.vaccine.2011.06.071; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Tearle RG, 1996, TRANSPLANTATION, V61, P13, DOI 10.1097/00007890-199601150-00004; Unger WWJ, 2012, J CONTROL RELEASE, V160, P88, DOI 10.1016/j.jconrel.2012.02.007; Yu B, 2012, J MED VIROL, V84, P1408, DOI 10.1002/jmv.23325	54	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176852	10.1371/journal.pone.0176852	http://dx.doi.org/10.1371/journal.pone.0176852			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472163	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500086
J	Losina, E; Yang, HY; Deshpande, BR; Katz, JN; Collins, JE				Losina, Elena; Yang, Heidi Y.; Deshpande, Bhushan R.; Katz, Jeffrey N.; Collins, Jamie E.			Physical activity and unplanned illness-related work absenteeism: Data from an employee wellness program	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; INTEGRATED HEALTH-PROGRAM; QUALITY-OF-LIFE; LOW-BACK-PAIN; SICKNESS ABSENCE; PROSPECTIVE COHORT; GRADED ACTIVITY; EXERCISE; CARE; ASSOCIATION	Background Illness-related absenteeism is a major threat to work productivity. Our objective was to assess the relationship between physical activity and unplanned illness-related absenteeism from work. Methods We implemented physical activity program for sedentary non-clinician employees of a tertiary medical center. Financial rewards were available for reaching accelerometermeasured ambulatory physical activity goals over a 24-week period. We categorized participants into three groups based on mean levels of physical activity: low (0 - 74 min/week), medium (75 - 149 min/week) and meeting CDC guidelines (>= 150 min/week). We built a multivariable Poisson regression model to evaluate the relationship between physical activity and rates of unplanned illness-related absenteeism. Results The sample consisted of 292 employees who participated in the program. Their mean age was 38 years (SD 11), 83% were female, and 38% were obese. Over the 24 intervention weeks, participants engaged in a mean of 90 min/week (SD 74) of physical activity and missed a mean of 14 hours of work (SD 38) due to illness. Unplanned absenteeism due to illness was associated with physical activity. As compared to the group meeting CDC guidelines, in multivariable analyses those in the medium physical activity group had a 2.4 (95% CI 1.3 - 4.5) fold higher rate of illness-related absenteeism and those in the lowest physical activity group had a 3.5 ( 95% CI 1.7 - 7.2) fold higher rate of illness-related absenteeism. Discussion Less physical activity was associated with more illness-related absenteeism. Workforce-based interventions to increase physical activity may thus be a promising vehicle to reduce unplanned illness-related absenteeism.	[Losina, Elena; Yang, Heidi Y.; Deshpande, Bhushan R.; Katz, Jeffrey N.; Collins, Jamie E.] Brigham & Womens Hosp, Orthopaed & Arthrit Ctr Outcomes Res OrACORe, Dept Orthopaed Surg, Boston, MA 02115 USA; [Losina, Elena; Yang, Heidi Y.; Deshpande, Bhushan R.; Katz, Jeffrey N.; Collins, Jamie E.] Brigham & Womens Hosp, Policy & Innovat EValuat Orthopaed Treatments PI, Dept Orthopaed Surg, Boston, MA 02115 USA; [Losina, Elena; Deshpande, Bhushan R.; Katz, Jeffrey N.; Collins, Jamie E.] Harvard Med Sch, Boston, MA 02115 USA; [Losina, Elena; Katz, Jeffrey N.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Katz, Jeffrey N.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Katz, Jeffrey N.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Losina, E (corresponding author), Brigham & Womens Hosp, Orthopaed & Arthrit Ctr Outcomes Res OrACORe, Dept Orthopaed Surg, Boston, MA 02115 USA.; Losina, E (corresponding author), Brigham & Womens Hosp, Policy & Innovat EValuat Orthopaed Treatments PI, Dept Orthopaed Surg, Boston, MA 02115 USA.; Losina, E (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Losina, E (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.; Losina, E (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	elosina@partners.org		Losina, ELENA/0000-0002-3424-0892; Deshpande, Bhushan/0000-0003-0918-6836	BWH Presidential Fund	BWH Presidential Fund	The B-Well program and this present analysis were sponsored by the BWH Presidential Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alharbi M, 2016, EUR J PREV CARDIOL, V23, P1476, DOI 10.1177/2047487316634883; Amlani NM, 2014, SPORTS MED, V44, P887, DOI 10.1007/s40279-014-0171-0; [Anonymous], 2015, EMPL BEN US MARCH 20; Baicker K, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0626; Baumgartel H, 2013, INT ORG HLTH, V1, P280; Bort-Roig J, 2014, SPORTS MED, V44, P671, DOI 10.1007/s40279-014-0142-5; Brox JI, 2005, OCCUP MED-OXFORD, V55, P558, DOI 10.1093/occmed/kqi153; Eriksen HR, 2002, OCCUP MED-OXFORD, V52, P383, DOI 10.1093/occmed/52.7.383; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Goodwin RD, 2003, PREV MED, V36, P698, DOI 10.1016/S0091-7435(03)00042-2; Hanebuth D, 2006, J OCCUP ENVIRON MED, V48, P28, DOI 10.1097/01.jom.0000195319.24750.f8; Hill HD, 2013, WORK OCCUPATION, V40, P143, DOI 10.1177/0730888413480893; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; King AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062613; Kooiman TJM, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0018-5; Kristensen TR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-643; Lahti J, 2010, SCAND J MED SCI SPOR, V20, P191, DOI 10.1111/j.1600-0838.2009.00886.x; Lahti J, 2012, PREV MED, V55, P618, DOI 10.1016/j.ypmed.2012.10.006; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; LINDSTROM I, 1992, PHYS THER, V72, P279, DOI 10.1093/ptj/72.4.279; Marshall SJ, 2009, AM J PREV MED, V36, P410, DOI 10.1016/j.amepre.2009.01.021; Mattke S, 2015, INCENTIVES WORKPLACE; Mattke S, 2013, WORKPLACE WELLNESS P; Melchior M, 2003, J EPIDEMIOL COMMUN H, V57, P285, DOI 10.1136/jech.57.4.285; Mitchell RJ, 2011, POPUL HEALTH MANAG, V14, P93, DOI 10.1089/pop.2010.0014; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; NORTH F, 1993, BRIT MED J, V306, P361, DOI 10.1136/bmj.306.6874.361; Nurminen E, 2002, SCAND J WORK ENV HEA, V28, P85, DOI 10.5271/sjweh.652; Patel MS, 2016, J GEN INTERN MED, V31, P746, DOI 10.1007/s11606-016-3627-0; Patel MS, 2016, ANN INTERN MED, V164, P385, DOI 10.7326/M15-1635; Patel MS, 2015, JAMA-J AM MED ASSOC, V313, P459, DOI 10.1001/jama.2014.14781; Peipins LA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-520; Quist HG, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1084; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Seidell JC, 1997, BRIT MED BULL, V53, P238, DOI 10.1093/oxfordjournals.bmb.a011611; Staal JB, 2004, ANN INTERN MED, V140, P77, DOI 10.7326/0003-4819-140-2-200401200-00007; Sumanen H, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1718-1; Sushames A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161224; Tudor-Locke C, 2005, CAN J APPL PHYSIOL, V30, P666, DOI 10.1139/h05-147; Tveito TH, 2009, J ADV NURS, V65, P110, DOI 10.1111/j.1365-2648.2008.04846.x; U.S. Department of Health and Human Services, 2018, PHYS ACT GUID AM; van Rhenen W, 2007, INT ARCH OCC ENV HEA, V80, P505, DOI 10.1007/s00420-006-0157-9; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351	44	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176872	10.1371/journal.pone.0176872	http://dx.doi.org/10.1371/journal.pone.0176872			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472084	gold, Green Submitted, Green Published			2022-12-27	WOS:000400648500091
J	Rah, H; Chung, KW; Ko, KH; Kim, ES; Kim, JO; Sakong, JH; Kim, JH; Lee, WS; Kim, NK				Rah, HyungChul; Chung, Ki Wha; Ko, Ki Han; Kim, Eun Sun; Kim, Jung Oh; Sakong, Jung Hyun; Kim, Ji Hyang; Lee, Woo Sik; Kim, Nam Keun			miR-27a and miR-449b polymorphisms associated with a risk of idiopathic recurrent pregnancy loss	PLOS ONE			English	Article							CHINESE POPULATION; BREAST-CANCER; GENE-GENE; MICRORNA; EXPRESSION; MISCARRIAGE; WOMEN; DISEASES	Objective MicroRNAs (miRNAs) regulate gene expression during the peri-implantation period. The purpose of this study was to investigate whether genetic polymorphisms in the four miRNAs associated with fetal or placental development play roles in the development of idiopathic recurrent pregnancy loss (RPL) in Korean females. Study design A case-control study involving 225 controls and 387 women with at least two consecutively recurrent pregnancy losses between 1999 and 2012 was performed. The genotypes of the four miRNA polymorphisms, including miR-27a rs895819, miR-423 rs6505162, miR-449b rs10061133, and miR-605 rs2043556, were analyzed by the polymerase chain reaction-restriction fragment length polymorphism assay. Odds ratios and 95% confidence intervals were estimated using multivariate analyses after maternal age adjustments. The relationships between each of the four microRNA genotypes and each of the six clinical parameters of the RPL patients (plasma homocysteine and folate levels, natural killer cell number, platelet count, prothrombin time, and, activated partial thromboplastin time) were analyzed using multiple linear regression analyses. Results Our results suggest that weak associations between decreased RPL risk and the genotypes of miR-27a (AG and AG+GG), combination genotype of miR-27a/miR-423 (AG/GC), and haplotypes of miR-27a/miR-423/miR-449b/miR-605 (G-C-A-G) and miR-27a/miR-449b/miR-605 (G-A-G), whereas weak associations between increased RPL risk and genotypes of miR-449b (GG and AG+GG), combination genotypes of miR-423/miR-449b (CC/GG and CA/AG), miR-449b/miR-605 (AG/AG), haplotypes of miR-27a/miR-423/miR-449b/miR-605 (A-C-G-A, A-A-A-G, and G-C-G-G), miR-27a/miR-423/miR-449b (A-C-G), miR-27a/miR-449b/miR-605 (A-A-G, A-G-A, and G-G-G), miR-423/miR-449b/miR-605 (C-G-G and A-A-G), and miR-423/miR-449b (C-G and A-A). The genotypes of miR-27a (AG and AG+GG) also showed significant contributions to the prediction of folate levels in RPL patients. Conclusions The study showed associations between miRNA polymorphisms (miR-27a rs895819 and miR-449b rs10061133) and RPL development, and between the miRNA polymorphism (miR-27a rs895819) and plasma folate levels.	[Rah, HyungChul] Chungbuk Natl Univ, Dept Business Data Convergence, Cheongju, South Korea; [Chung, Ki Wha] Kongju Natl Univ, Dept Biol Sci, Coll Nat Sci, Gongju, South Korea; [Ko, Ki Han; Kim, Eun Sun; Kim, Jung Oh; Sakong, Jung Hyun; Kim, Nam Keun] CHA Univ, Dept Biomed Sci, Coll Life Sci, Seongnam, South Korea; [Kim, Ji Hyang] CHA Univ, Dept Obstet & Gynecol, CHA Bundang Med Ctr, Seongnam, South Korea; [Kim, Ji Hyang] CHA Univ, Fertil Ctr, CHA Bundang Med Ctr, Seongnam, South Korea; [Lee, Woo Sik] CHA Univ, Fertil Ctr, CHA Gangnam Med Ctr, Seoul, South Korea; [Kim, Nam Keun] CHA Univ, Inst Clin Res, CHA Bundang Med Ctr, Seongnam, South Korea	Chungbuk National University; Kongju National University; Pochon Cha University; Pochon Cha University; Pochon Cha University; Pochon Cha University; Pochon Cha University	Kim, NK (corresponding author), CHA Univ, Dept Biomed Sci, Coll Life Sci, Seongnam, South Korea.; Kim, NK (corresponding author), CHA Univ, Inst Clin Res, CHA Bundang Med Ctr, Seongnam, South Korea.	nkkim@cha.ac.kr		Kim, Nam Keun/0000-0003-0541-3528; Kim, Jung Oh/0000-0002-4171-2034	Basic Science Research Programs through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2013R1A1A2009661, 2009-0093821, 2015R1D1A1A09057432]; Korea Healthcare technology RD Project [HI15C1972010015]; Ministry for Health, Welfare & Family Affairs, Republic of Korea	Basic Science Research Programs through the National Research Foundation of Korea - Ministry of Education, Science, and Technology; Korea Healthcare technology RD Project; Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was partly supported by Basic Science Research Programs through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (grants 2013R1A1A2009661, 2009-0093821 and 2015R1D1A1A09057432). This study was also partly supported by a grant of the Korea Healthcare technology R&D Project (HI15C1972010015), Ministry for Health, Welfare & Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Soc Reprod Med, 2008, FERTIL STERIL, V90, pS60, DOI 10.1016/j.fertnstert.2008.08.065; Amin-Beidokhti M, 2017, REPROD BIOMED ONLINE, V34, P325, DOI 10.1016/j.rbmo.2016.12.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bidarimath M, 2014, CELL MOL IMMUNOL, V11, P538, DOI 10.1038/cmi.2014.45; Braza-Boils A, 2014, HUM REPROD, V29, P978, DOI 10.1093/humrep/deu019; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; CLIFFORD K, 1994, HUM REPROD, V9, P1328, DOI 10.1093/oxfordjournals.humrep.a138703; De Felice B, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0131-z; Fraga LR, 2014, MOL BIOL REP, V41, P1871, DOI 10.1007/s11033-014-3036-6; Goossens K, 2013, STEM CELLS DEV, V22, P1907, DOI 10.1089/scd.2012.0708; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114781; Hu Y, 2011, RNA BIOL, V8, P861, DOI 10.4161/rna.8.5.16034; Jeon YJ, 2012, GENE, V494, P168, DOI 10.1016/j.gene.2011.12.026; Jung YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095803; Larsen EC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-154; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Mouillet JF, 2011, BIRTH DEFECTS RES A, V91, P737, DOI 10.1002/bdra.20782; O'Toole AS, 2006, NUCLEIC ACIDS RES, V34, P3338, DOI 10.1093/nar/gkl428; Pan H, 2016, MENOPAUSE, V23, P1009, DOI 10.1097/GME.0000000000000659; Quere I, 1998, FERTIL STERIL, V69, P152, DOI 10.1016/S0015-0282(97)00451-2; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Said BI, 2015, CANCER GENET-NY, V208, P47, DOI 10.1016/j.cancergen.2014.12.003; Santamaria X, 2014, FERTIL STERIL, V101, P1545, DOI 10.1016/j.fertnstert.2014.04.044; STIRRAT GM, 1990, LANCET, V336, P673, DOI 10.1016/0140-6736(90)92159-F; Su X, 2015, REPRODUCTION, V150, P65, DOI 10.1530/REP-15-0007; Sun QM, 2010, CANCER SCI, V101, P2241, DOI 10.1111/j.1349-7006.2010.01667.x; Wei WJ, 2015, ENDOCRINE, V49, P436, DOI 10.1007/s12020-014-0467-8; Wessels JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072264; Zhang M, 2012, EUR J CANCER CARE, V21, P274, DOI 10.1111/j.1365-2354.2011.01308.x; Zhao HH, 2015, TUMOR BIOL, V36, P4763, DOI 10.1007/s13277-015-3126-7; Zhao Z, 2013, CLIN BIOCHEM, V46, P953, DOI 10.1016/j.clinbiochem.2013.01.026	32	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177160	10.1371/journal.pone.0177160	http://dx.doi.org/10.1371/journal.pone.0177160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489914	Green Published, gold, Green Submitted			2022-12-27	WOS:000401314100051
J	Balsells, E; Guillot, L; Nair, H; Kyaw, MH				Balsells, Evelyn; Guillot, Laurence; Nair, Harish; Kyaw, Moe H.			Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis	PLOS ONE			English	Review							PNEUMOCOCCAL CONJUGATE VACCINE; POPULATION-BASED SURVEILLANCE; CHANGING EPIDEMIOLOGY; NASOPHARYNGEAL CARRIAGE; CLINICAL PRESENTATION; EMERGENCY-DEPARTMENT; OXFORDSHIRE REGION; DOSING SCHEDULES; UNITED-STATES; EARLY IMPACT	Background Routine immunisation with pneumococcal conjugate vaccines (PCV7/10/13) has reduced invasive pneumococcal disease (IPD) due to vaccine serotypes significantly. However, an increase in disease due to non-vaccine types, or serotype replacement, has been observed. Serotypes' individual contributions to IPD play a critical role in determining the overall effects of PCVs. This study examines the distribution of pneumococcal serotypes in children to identify leading serotypes associated with IPD post-PCV introduction. Methods A systematic search was performed to identify studies and surveillance reports (published between 2000 and December 2015) of pneumococcal serotypes causing childhood IPD post-PCV introduction. Serotype data were differentiated based on the PCV administered during the study period: PCV7 or higher valent PCVs (PCV10 or PCV13). Meta-analysis was conducted to estimate the proportional contributions of the most frequent serotypes in childhood IPD in each period. Results We identified 68 studies reporting serotype data among IPD cases in children. We analysed data from 38 studies (14 countries) where PCV7 was administered and 20 (24 countries) where PCV10 or PCV13 have been introduced. Studies reported early and late periods of PCV7 administration (range: 2001 -/+ 13). In these settings, serotype 19A was the most predominant cause of childhood IPD, accounting for 21.8% (95% CI 18.6 -/+ 25.6) of cases. In countries that have introduced higher valent PCVs, study periods were largely representative of the transition and early years of PCV10 or PCV13. In these studies, the overall sero-type-specific contribution of 19A was lower (14.2% 95% CI 11.1 -/+ 18.3). Overall, non-PCV13 serotypes contributed to 42.2% (95% CI 36.1 -/+ 49.5%) of childhood IPD cases. However, regional differences were noted (57.8% in North America, 71.9% in Europe, 45.9% in Western Pacific, 28.5% in Latin America, 42.7% in one African country, and 9.2% in one Eastern Mediterranean country). Predominant non-PCV13 serotypes overall were 22F, 12F, 33F, 24F, 15C, 15B, 23B, 10A, and 38 (descending order), but their rank order varied by region. Conclusion Childhood IPD is associated with a wide number of serotypes. In the early years after introduction of higher valent PCVs, non-PCV13 types caused a considerable proportion of childhood IPD. Serotype data, particularly from resource-limited countries with high burden of IPD, are needed to assess the importance of serotypes in different settings. The geographic diversity of pneumococcal serotypes highlights the importance of continued surveillance to guide vaccine design and recommendations.	[Balsells, Evelyn; Guillot, Laurence; Nair, Harish] Univ Edinburgh, Med Sch, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Kyaw, Moe H.] Sanofi Pasteur, Swiftwater, PA USA	University of Edinburgh; Sanofi-Aventis	Balsells, E (corresponding author), Univ Edinburgh, Med Sch, Usher Inst Populat Hlth Sci & Informat, Teviot Pl, Edinburgh, Midlothian, Scotland.	e.balsells@ed.ac.uk	Nair, Harish/E-7431-2010	Nair, Harish/0000-0002-9432-9100	Sanofi Pasteur	Sanofi Pasteur	This study was financially supported by Sanofi Pasteur. MK is an employee of Sanofi Pasteur and had a critical role in study design, data collection and analysis and preparation of the manuscript.	Aguiar SI, 2008, CLIN MICROBIOL INFEC, V14, P835, DOI 10.1111/j.1469-0691.2008.02031.x; Al-Sheikh YA, 2014, ANN LAB MED, V34, P411, DOI 10.3343/alm.2014.34.5.411; Alexandre C, 2010, ACTA PAEDIATR, V99, P1686, DOI 10.1111/j.1651-2227.2010.01914.x; Angoulvant F, 2014, CLIN INFECT DIS, V58, P918, DOI 10.1093/cid/ciu006; Aristegui J, 2007, EUR J CLIN MICROBIOL, V26, P303, DOI 10.1007/s10096-007-0294-4; Australian Goverment Department of Health, 2012, INV PNEUM DIS SURV A; Barricarte A, 2007, CLIN INFECT DIS, V44, P1436, DOI 10.1086/516779; Bettinger JA, 2010, VACCINE, V28, P2130, DOI 10.1016/j.vaccine.2009.12.026; Black S, 2007, PEDIATR INFECT DIS J, V26, P771, DOI 10.1097/INF.0b013e318124a494; Bruce MG, 2015, VACCINE, V33, P4813, DOI 10.1016/j.vaccine.2015.07.080; Brueggemann AB, 2004, TEMPORAL GEOGRAPHIC; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; Calbo E, 2006, CLIN MICROBIOL INFEC, V12, P867, DOI 10.1111/j.1469-0691.2006.1502_1.x; Camilli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076309; Ceyhan M, 2011, CLIN VACCINE IMMUNOL, V18, P1028, DOI 10.1128/CVI.00526-10; Chiba N, 2014, EMERG INFECT DIS, V20, P1132, DOI 10.3201/eid2007.131485; Corcoran M, 2016, 10 INT S PNEUM PNEUM; Croney CM, 2012, CLIN VACCINE IMMUNOL, V19, P891, DOI 10.1128/CVI.05671-11; De Wals P, 2012, VACCINE, V30, P6416, DOI 10.1016/j.vaccine.2012.08.017; del Amo E, 2015, EUR J CLIN MICROBIOL, V34, P705, DOI 10.1007/s10096-014-2280-y; del Amo E, 2014, CLIN MICROBIOL INFEC, V20, P684, DOI 10.1111/1469-0691.12422; Demczuk WHB, 2013, CAN J MICROBIOL, V59, P778, DOI 10.1139/cjm-2013-0614; Desai AP, 2015, PEDIATR INFECT DIS J, V34, P1168, DOI 10.1097/INF.0000000000000849; Doit C, 2010, DIAGN MICR INFEC DIS, V66, P332, DOI 10.1016/j.diagmicrobio.2009.10.012; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Fleming-Dutra KE, 2014, PEDIATR INFECT DIS J, V33, pS152, DOI 10.1097/INF.0000000000000083; Foster D, 2011, J MED MICROBIOL, V60, P91, DOI 10.1099/jmm.0.023135-0; Fry N, 2016, 10 INT S PNEUM PNEUM; Guevara M, 2014, VACCINE, V32, P2553, DOI 10.1016/j.vaccine.2014.03.054; Rodriguez MAG, 2011, VACCINE, V29, P5740, DOI 10.1016/j.vaccine.2011.05.099; Hausdorff WP, 2016, HUM VACC IMMUNOTHER, V12, P358, DOI 10.1080/21645515.2015.1118593; Herrero M, 2012, EUR J EMERG MED, V19, P89, DOI 10.1097/MEJ.0b013e3283484bbc; Herz AM, 2006, PEDIATR INFECT DIS J, V25, P293, DOI 10.1097/01.inf.0000207485.39112.bf; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Hsu K, 2005, PEDIATR INFECT DIS J, V24, P17, DOI 10.1097/01.inf.0000148891.32134.36; Hsu KK, 2010, PEDIATR INFECT DIS J, V29, P289, DOI 10.1097/INF.0b013e3181c15471; Imohl M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0787-1; Ishiwada N, 2014, VACCINE, V32, P5425, DOI 10.1016/j.vaccine.2014.07.100; IVAC) IVAC, 2016, STAT PCV US IMP EV J; Jaiswal N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108617; [Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center (IVAC)], VACC INF MAN SYST VI; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Kaplan SL, 2013, PEDIATR INFECT DIS J, V32, P203, DOI 10.1097/INF.0b013e318275614b; Kaplan SL, 2010, PEDIATRICS, V125, P429, DOI 10.1542/peds.2008-1702; Kellner JD, 2009, CLIN INFECT DIS, V49, P205, DOI 10.1086/599827; Kim L, 2016, CLIN MICROBIOL REV, V29, P525, DOI 10.1128/CMR.00058-15; Knol MJ, 2015, EMERG INFECT DIS, V21, P2040, DOI 10.3201/eid2111.140780; Lee GM, 2014, J PEDIATR INFECT DIS, V3, P23, DOI 10.1093/jpids/pit057; Lepoutre A, 2008, Euro Surveill, V13; Lepoutre A, 2015, VACCINE, V33, P359, DOI 10.1016/j.vaccine.2014.11.011; Levy C, 2014, PEDIATR INFECT DIS J, V33, P1216, DOI 10.1097/INF.0000000000000451; Levy C, 2011, PEDIATR INFECT DIS J, V30, P168, DOI 10.1097/INF.0b013e3181f4cf69; Loo JD, 2014, PEDIATR INFECT DIS J, V33, pS161, DOI 10.1097/INF.0000000000000084; Metcalf BJ, 2016, CLIN MICROBIOL INFEC, V22, DOI [10.1016/j.cmi.2015.08.027, 10.1016/j.cmi.2016.08.001]; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Ministry of Health Singapore, EP NEWS B LAB DAT SU; Mistry RD, 2013, J EMERG MED, V45, P813, DOI 10.1016/j.jemermed.2013.04.029; Moore CE, 2014, J INFECT DIS, V210, P1001, DOI 10.1093/infdis/jiu213; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Munoz-Almagro C, 2011, J INFECTION, V63, P151, DOI 10.1016/j.jinf.2011.06.002; Nakano S, 2016, VACCINE, V34, P67, DOI 10.1016/j.vaccine.2015.11.015; Torne AN, 2014, VACCINE, V32, P3644, DOI 10.1016/j.vaccine.2014.04.066; New Zealand Ministry of Health, INV PNEUM DIS REP 20; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Olarte L, 2015, CLIN INFECT DIS, V61, P767, DOI 10.1093/cid/civ368; Oligbu G, 2016, 10 INT S PNEUM PNEUM; Parra EL, 2013, VACCINE, V31, P4033, DOI 10.1016/j.vaccine.2013.04.074; Perez-Trallero E, 2009, EUR J CLIN MICROBIOL, V28, P731, DOI 10.1007/s10096-008-0693-1; Picazo J, 2011, CLIN VACCINE IMMUNOL, V18, P89, DOI 10.1128/CVI.00317-10; Pilishvili T, 2016, 10 INT S PNEUM PNEUM; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Rendi-Wagner P, 2009, VACCINE, V27, P3963, DOI 10.1016/j.vaccine.2009.04.044; Salleras L, 2009, CLIN MICROBIOL INFEC, V15, P997, DOI 10.1111/j.1469-0691.2009.02938.x; Schutze GE, 2004, PEDIATR INFECT DIS J, V23, P1125, DOI 10.1097/01.inf.0000145478.36236.1e; Sharma D, 2013, PEDIATR INFECT DIS J, V32, pE45, DOI 10.1097/INF.0b013e3182788fdd; Shibl AM, 2012, VACCINE, V30, pG32, DOI 10.1016/j.vaccine.2012.07.030; SIREVA II, 2012, INF REG SIREVA 2 200; Steens A, 2013, VACCINE, V31, P6232, DOI 10.1016/j.vaccine.2013.10.032; Suga S, 2015, VACCINE, V33, P6054, DOI 10.1016/j.vaccine.2015.07.069; Valenzuela MT, 2009, REV PANAM SALUD PUBL, V25, P270, DOI 10.1590/S1020-49892009000300011; van der Linden M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131494; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; Varon E, 2015, VACCINE, V33, P6178, DOI 10.1016/j.vaccine.2015.10.015; Vila-Corcoles A, 2013, INFECTION, V41, P439, DOI 10.1007/s15010-012-0345-3; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Weatherholtz R, 2010, CID; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Williams SR, 2011, MED J AUSTRALIA, V194, P116, DOI 10.5694/j.1326-5377.2011.tb04192.x; World Health Organization, 2008, EST HIB PNEU DEATHS; World Health Organization, 2015, WHO VACC PREV DIS MO; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032	92	190	207	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177113	10.1371/journal.pone.0177113	http://dx.doi.org/10.1371/journal.pone.0177113			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486544	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000045
J	Cai, MY; Yang, ST; Zhao, CS; Zhou, QW; Hou, LP				Cai, Mingyong; Yang, Shengtian; Zhao, Changsen; Zhou, Qiuwen; Hou, Lipeng			Insight into runoff characteristics using hydrological modeling in the data-scarce southern Tibetan Plateau: Past, present, and future	PLOS ONE			English	Article							REMOTE-SENSING APPLICATIONS; SNOW-COVER; UNGAUGED BASINS; RIVER-BASIN; PRECIPITATION; PREDICTIONS	Regional hydrological modeling in ungauged regions has attracted growing attention in water resources research. The southern Tibetan Plateau often suffers from data scarcity in watershed hydrological simulation and water resources assessment. This hinders further research characterizing the water cycle and solving international water resource issues in the area. In this study, a multi-spatial data based Distributed Time-Variant Gain Model (MS-DTVGM) is applied to the Yarlung Zangbo River basin, an important international river basin in the southern Tibetan Plateau with limited meteorological data. This model is driven purely by spatial data from multiple sources and is independent of traditional meteorological data. Based on the methods presented in this study, daily snow cover and potential evapotranspiration data in the Yarlung Zangbo River basin in 2050 are obtained. Future (2050) climatic data (precipitation and air temperature) from the Fifth Assessment Report of the Intergovernmental Panel on Climate Change (IPCC-AR5) are used to study the hydrological response to climate change. The result shows that river runoff will increase due to precipitation and air temperature changes by 2050. Few differences are found between daily runoff simulations from different Representative Concentration Pathway (RCP) scenarios (RCP2.6, RCP4.5 and RCP8.5) for 2050. Historical station observations (1960-2000) at Nuxia and model simulations for two periods (2006-2009 and 2050) are combined to study inter-annual and intra-annual runoff distribution and variability. The inter-annual runoff variation is stable and the coefficient of variation (CV) varies from 0.21 to 0.27. In contrast, the intra-annual runoff varies significantly with runoff in summer and autumn accounting for more than 80% of the total amount. Compared to the historical period (1960-2000), the present period (2006-2009) has a slightly uneven intra-annual runoff temporal distribution, and becomes more balanced in the future (2050).	[Cai, Mingyong] Satellite Environm Ctr MEP, Beijing, Peoples R China; [Yang, Shengtian; Zhao, Changsen] Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China; [Yang, Shengtian] Xinjiang Univ, Coll Resource & Environm Sci, Urumqi, Peoples R China; [Zhou, Qiuwen] Guizhou Normal Univ, Sch Geog & Environm Sci, Guiyang, Peoples R China; [Hou, Lipeng] China Ctr SCO Environm Cooperat MEP, China ASEAN Environm Cooperat Ctr, Beijing, Peoples R China	Beijing Normal University; Xinjiang University; Guizhou Normal University	Yang, ST (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China.; Yang, ST (corresponding author), Xinjiang Univ, Coll Resource & Environm Sci, Urumqi, Peoples R China.	yangshengtian@bnu.edu.cn	Zhou, Qiuwen/GLT-1798-2022		General Program of National Nature Science Foundation of China [41601471, U1603241, 41671362]; Science and Technology Fund of Guizhou Province, China [[2015]2118]; Chinese National Key Project for RD [2016YFC0402403, 2016YFC0402409]	General Program of National Nature Science Foundation of China; Science and Technology Fund of Guizhou Province, China; Chinese National Key Project for RD	The authors would like to thank all project participants, as well as the General Program of National Nature Science Foundation of China (41601471, U1603241, 41671362), the Science and Technology Fund of Guizhou Province, China ([2015]2118), Chinese National Key Project for R&D (No. 2016YFC0402403, 2016YFC0402409).; The authors would like to thank all project participants, as well as the General Program of National Nature Science Foundation of China (41601471, U1603241, 41671362), the Science and Technology Fund of Guizhou Province, China ([2015]2118), Chinese National Key Project for R&D (No. 2016YFC0402403, 2016YFC0402409). In addition, the authors thank the anonymous reviewers for their helpful and constructive comments.	AHSAN M, 1994, J HYDROL, V155, P151, DOI 10.1016/0022-1694(94)90163-5; AMOROCHO J, 1971, WATER RESOUR RES, V7, P1087, DOI 10.1029/WR007i005p01087; Andersen J, 2002, J HYDROL, V264, P34, DOI 10.1016/S0022-1694(02)00046-X; Andersen J, 2001, J HYDROL, V247, P200, DOI 10.1016/S0022-1694(01)00384-5; ASTON AR, 1979, J HYDROL, V42, P383, DOI 10.1016/0022-1694(79)90057-X; Bagrov N., 1953, METEOROG GIDROL, V10, P20; Bamzai AS, 1999, J CLIMATE, V12, P3117, DOI 10.1175/1520-0442(1999)012<3117:RBESCS>2.0.CO;2; Bastiaanssen WGM, 2000, J HYDROL, V229, P87, DOI 10.1016/S0022-1694(99)00202-4; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Cai M, 2013, J APPL REMOTE SENS, V7, P259; Cai MY, 2014, WATER RESOUR MANAG, V28, P2851, DOI 10.1007/s11269-014-0641-z; Cao JT, 2006, CHINESE SCI BULL, V51, P594, DOI 10.1007/s11434-006-0594-6; Chalise SR, 2003, J HYDROL, V282, P25, DOI 10.1016/S0022-1694(03)00250-6; Che T, 2004, J GLACIOLOGY GEOCRYO; Chen He, 2012, Ecohydrology & Hydrobiology, V12, P93, DOI 10.2478/v10104-012-0009-z; Collischonn B, 2008, J HYDROL, V360, P207, DOI 10.1016/j.jhydrol.2008.07.032; Courault D., 2005, Irrigation and Drainage Systems, V19, P223, DOI 10.1007/s10795-005-5186-0; Cutore P, 2007, EWRA INT C; Dankers R, 2004, INT J REMOTE SENS, V25, P2933, DOI 10.1080/01431160310001618374; Grayson R., 2001, SPATIAL PATTERNS CAT; Grayson RB, 2002, ADV WATER RESOUR, V25, P1313, DOI 10.1016/S0309-1708(02)00060-X; Grimes DIF, 2003, HYDROLOG SCI J, V48, P567, DOI 10.1623/hysj.48.4.567.51410; Hall DK, 2002, REMOTE SENS ENVIRON, V83, P181, DOI 10.1016/S0034-4257(02)00095-0; Huffman GJ, 1997, B AM METEOROL SOC, V78, P5, DOI 10.1175/1520-0477(1997)078<0005:TGPCPG>2.0.CO;2; Immerzeel WW, 2009, REMOTE SENS ENVIRON, V113, P40, DOI 10.1016/j.rse.2008.08.010; Immerzeel W, 2008, INT J CLIMATOL, V28, P243, DOI 10.1002/joc.1528; Kite GW, 1996, HYDROLOG SCI J, V41, P563, DOI 10.1080/02626669609491526; Kristensen KJ, 1975, J HYDROL, V309, P39; Lakshmi V, 2004, HYDROL PROCESS, V18, P1029, DOI 10.1002/hyp.5520; Li XB, 2003, ACTA BOT SIN, V45, P1146; McMichael CE, 2006, J HYDROL, V317, P307, DOI 10.1016/j.jhydrol.2005.05.023; Michaelides S, 2009, ATMOS RES, V94, P512, DOI 10.1016/j.atmosres.2009.08.017; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; NILSON T, 1971, AGR METEOROL, V8, P25, DOI 10.1016/0002-1571(71)90092-6; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Ritchie JC, 1996, HYDROLOG SCI J, V41, P429, DOI 10.1080/02626669609491518; Schultz GA, 1996, HYDROLOG SCI J, V41, P453, DOI 10.1080/02626669609491520; Shi Y, 2011, QUATERN INT, V244, P159, DOI 10.1016/j.quaint.2011.01.041; Sivapalan M, 2003, HYDROLOG SCI J, V48, P857, DOI 10.1623/hysj.48.6.857.51421; Sivapalan M, 2003, HYDROL PROCESS, V17, P3163, DOI 10.1002/hyp.5155; Sobrino JA, 2006, REMOTE SENS ENVIRON, V102, P99, DOI 10.1016/j.rse.2006.02.001; Stisen S, 2008, J HYDROL, V354, P131, DOI 10.1016/j.jhydrol.2008.03.006; Su Z, 2002, HYDROL EARTH SYST SC, V6, P85, DOI 10.5194/hess-6-85-2002; Sun DL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002422; Tahir AA, 2011, J HYDROL, V409, P104, DOI 10.1016/j.jhydrol.2011.08.035; Tang BH, 2008, GENERALIZED SPLIT WI; XIA J, 1991, WATER RESOUR RES, V27, P2415, DOI 10.1029/91WR01364; XIA J, 1989, HYDROLOG SCI J, V34, P1; Xia J, 2005, SCI CHINA SER D, V48, P713, DOI 10.1360/03yd0183; Xia J, 2002, WATER INT, V27, P87, DOI 10.1080/02508060208686981; Xie X., 1991, J REMOTE SENSING, V4; You QL, 2007, J GEOGR SCI, V17, P409, DOI 10.1007/s11442-007-0409-y; Zaksek K, 2009, ISPRS J PHOTOGRAMM, V64, P414, DOI 10.1016/j.isprsjprs.2009.02.006	53	9	9	9	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176813	10.1371/journal.pone.0176813	http://dx.doi.org/10.1371/journal.pone.0176813			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486483	Green Published, Green Submitted, gold			2022-12-27	WOS:000401314000026
J	Baruah, PS; Beauchemin, M; Parker, JA; Bertrand, R				Baruah, Prasamit Saurav; Beauchemin, Myriam; Parker, J. Alexander; Bertrand, Richard			Expression of human Bcl-xL (Ser49) and (Ser62) mutants in Caenorhabditis elegans causes germline defects and aneuploidy	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; POLO-LIKE KINASE; CHROMOSOME SEGREGATION; GENE; PHOSPHORYLATION; INHIBITOR; BCL-X(L); IDENTIFICATION; DOMAIN; CHECKPOINT	An interesting feature of Bcl-xL protein is the presence of an unstructured loop domain between alpha 1 and alpha 2 helices, a domain not essential for its anti-apoptotic function and absent in CED-9 protein. Within this domain, Bcl-xL undergoes dynamic phosphorylation and dephosphorylation at Ser49 and Ser62 during G2 and mitosis in human cells. Studies have revealed that when these residues are mutated, cells harbour mitotic defects, including chromosome mis-attachment, lagging, bridging and mis-segregation with, ultimately, chromosome instability and aneuploidy. We undertook genetic experiments in Caenorhabditis elegans to understand the importance of Bcl-xL (Ser49) and (Ser62) in vivo. Transgenic worms carrying single-site S49A, S62A, S49D, S62D and dual site S49/62A mutants were generated and their effects were analyzed in germlines of young adult worms. Worms expressing Bcl-xL variants showed decreased egg-laying and hatching potency, variations in the length of their mitotic regions but not of their transition zones, appearance of chromosomal abnormalities at their diplotene stages, and increased germline apoptosis, with the exception of the S62D variants. Some of these transgenic strains, particularly the Ser to Ala variants, also showed slight modulations of lifespan compared to their controls. In addition, RNAi experiments silencing expression of the various Bcl-xL variants reversed their effects in vivo. Our in vivo observations confirmed the importance of Ser49 and Ser62 within Bcl-xL loop domain in maintaining chromosome stability.	[Baruah, Prasamit Saurav; Beauchemin, Myriam; Parker, J. Alexander; Bertrand, Richard] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada; [Baruah, Prasamit Saurav; Beauchemin, Myriam; Bertrand, Richard] Inst Canc Montreal, Montreal, PQ, Canada; [Parker, J. Alexander] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Bertrand, Richard] Univ Montreal, Dept Med & Spec Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Bertrand, R (corresponding author), Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada.; Bertrand, R (corresponding author), Inst Canc Montreal, Montreal, PQ, Canada.; Bertrand, R (corresponding author), Univ Montreal, Dept Med & Spec Med, Montreal, PQ, Canada.	richard.bertrand@umontreal.ca	Parker, Alex/F-4953-2014	Parker, Alex/0000-0002-3333-2445; Beauchemin, Myriam/0000-0001-7700-8850	Canadian Institutes of Health Research [MOP-97913]; Natural Sciences and Engineering Research Council of Canada [328207]; Faculte des etudes superieures (Universite de Montreal, Canada); Fondation de l'Institut du cancer de Montreal (Canada)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Faculte des etudes superieures (Universite de Montreal, Canada); Fondation de l'Institut du cancer de Montreal (Canada)	This work was supported by the Canadian Institutes of Health Research (Grant MOP-97913) and the Natural Sciences and Engineering Research Council of Canada (Grant 328207) to RB. PSB received scholarships from the Faculte des etudes superieures (Universite de Montreal, Canada) and the Fondation de l'Institut du cancer de Montreal (Canada).	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Baruah PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159091; Basu A, 2003, FEBS LETT, V538, P41, DOI 10.1016/S0014-5793(03)00131-5; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Boyd WA, 2010, MUTAT RES-FUND MOL M, V683, P57, DOI 10.1016/j.mrfmmm.2009.10.008; Burri SH, INT J RAD ONCOL BIOL; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Charbonneau J, 2001, CYTOTECHNOLOGY, V37, P41, DOI 10.1023/A:1016148825633; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Degterev A, 2001, NAT CELL BIOL, V3, P173, DOI 10.1038/35055085; Denver DR, 2006, GENETICS, V174, P57, DOI 10.1534/genetics.106.059840; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Fang X, 2011, SEMIN CELL DEV BIOL, V22, P595, DOI 10.1016/j.semcdb.2011.03.002; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gems D, 2000, J GERONTOL A-BIOL, V55, pB215, DOI 10.1093/gerona/55.5.B215; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harper NC, 2011, DEV CELL, V21, P934, DOI 10.1016/j.devcel.2011.09.001; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Hisahara S, 1998, J CELL SCI, V111, P667; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Karczmarek-Borowska B, 2006, LUNG CANCER, V51, P61, DOI 10.1016/j.lungcan.2005.08.010; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kitagawa R, 2009, FRONT BIOSCI-LANDMRK, V14, P1529, DOI 10.2741/3323; Lawrence KS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005150; Lu N, 2009, METHODS MOL BIOL, V559, P357, DOI 10.1007/978-1-60327-017-5_25; Mallick S, 2013, HEAD NECK-J SCI SPEC, V35, P1448, DOI 10.1002/hed.23153; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Musacchio A, 2011, PHILOS T R SOC B, V366, P3595, DOI 10.1098/rstb.2011.0072; Nishi Y, 2008, DEVELOPMENT, V135, P687, DOI 10.1242/dev.013425; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Qian J, 2004, ANAL BIOCHEM, V328, P131, DOI 10.1016/j.ab.2003.12.034; Rahman MM, 2015, MOL BIOL CELL, V26, P4718, DOI 10.1091/mbc.E15-04-0244; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Schmitt E, 2007, ONCOGENE, V26, P5851, DOI 10.1038/sj.onc.1210396; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Tao ZF, 2014, ACS MED CHEM LETT, V5, P1088, DOI 10.1021/ml5001867; Tarailo M, 2007, GENETICS, V175, P1665, DOI 10.1534/genetics.106.067918; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; VAUX DL, 1992, SCIENCE, V258, P1955, DOI 10.1126/science.1470921; Wang JF, 2014, CELL CYCLE, V13, P1313, DOI 10.4161/cc.28293; Wang JF, 2012, CELL CYCLE, V11, P2159, DOI 10.4161/cc.20672; Wang JF, 2011, CELL SIGNAL, V23, P2030, DOI 10.1016/j.cellsig.2011.07.017; Watanabe J, 2004, SURGERY, V135, P604, DOI 10.1016/j.surg.2003.11.015; Yamaguchi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024102; Yamamoto TG, 2008, J CELL BIOL, V183, P187, DOI 10.1083/jcb.200805185; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061	59	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177413	10.1371/journal.pone.0177413	http://dx.doi.org/10.1371/journal.pone.0177413			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481930	Green Submitted, Green Published, gold			2022-12-27	WOS:000401313700060
J	van der Meer, Y; Gerrits, WJJ; Jansman, AJM; Kemp, B; Bolhuis, JE				van der Meer, Yvonne; Gerrits, Walter J. J.; Jansman, Alfons J. M.; Kemp, Bas; Bolhuis, J. Elizabeth			A link between damaging behaviour in pigs, sanitary conditions, and dietary protein and amino acid supply	PLOS ONE			English	Article							LAYING HENS; FEATHER PECKING; CRUDE PROTEIN; IMMUNE-RESPONSES; PLASMA-CORTISOL; TRYPTOPHAN; SEROTONIN; ENERGY; SELECTION; AGGRESSION	The tendency to reduce crude protein (CP) levels in pig diets to increase protein efficiency may increase the occurrence of damaging behaviours such as ear and tail biting, particularly for pigs kept under suboptimal health conditions. We studied, in a 2x2x2 factorial design, 576 tail-docked growing-finishing entire male pigs in 64 pens, subjected to low (LSC) vs. high sanitary conditions (HSC), and fed a normal CP (NP) vs. a low CP diet (LP, 80% of NP) ad libitum, with a basal amino acid (AA) profile or supplemented AA profile with extra threonine, tryptophan and methionine. The HSC pigs were vaccinated in the first nine weeks of life and received antibiotics at arrival at experimental farm at ten weeks, after which they were kept in a disinfected part of the farm with a strict hygiene protocol. The LSC pigs were kept on the same farm in non-disinfected pens to which manure from another pig farm was introduced fortnightly. At 15, 18, and 24 weeks of age, prevalence of tail and ear damage and of tail and ear wounds was scored. At 20 and 23 weeks of age, frequencies of biting behaviour and aggression were scored for 10x10 min per pen per week. The prevalence of ear damage during the finisher phase (47 vs. 32% of pigs, P < 0.0001) and the frequency of ear biting (1.3 vs. 1.2 times per hour, P = 0.03) were increased in LSC compared with HSC pigs. This effect on ear biting was diet dependent, however, the supplemented AA profile reduced ear biting only in LSC pigs by 18% (SC x AA profile, P < 0.01). The prevalence of tail wounds was lower for pigs in LSC (13 +/- 0.02) than for pigs in HSC (0.22 +/- 0.03) in the grower phase (P < 0.007). Regardless of AA profile or sanitary status, LP pigs showed more ear biting (+20%, P < 0.05), tail biting (+25%, P < 0.10), belly nosing (+152%, P < 0.01), other oral manipulation directed at pen mates (+13%, P < 0.05), and aggression (+30%, P < 0.01) than NP pigs, with no effect on ear or tail damage. In conclusion, both low sanitary conditions and a reduction of dietary protein increase the occurrence of damaging behaviours in pigs and therefore may negatively impact pig welfare. Attention should be paid to the impact of dietary nutrient composition on pig behaviour and welfare, particularly when pigs are kept under suboptimal (sanitary) conditions.	[van der Meer, Yvonne; Gerrits, Walter J. J.] Wageningen Univ, Dept Anim Sci, Anim Nutr Grp, Wageningen, Netherlands; [van der Meer, Yvonne] De Heus Anim Nutr, Ede, Netherlands; [Jansman, Alfons J. M.] Wageningen UR Livestock Res, Anim Nutr, Wageningen, Netherlands; [Kemp, Bas; Bolhuis, J. Elizabeth] Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	van der Meer, Y (corresponding author), Wageningen Univ, Dept Anim Sci, Anim Nutr Grp, Wageningen, Netherlands.; van der Meer, Y (corresponding author), De Heus Anim Nutr, Ede, Netherlands.	yvonne.vandermeer@wur.nl			Dutch Feed4Foodure consortium	Dutch Feed4Foodure consortium	This research was financed by the Dutch Feed4Foodure consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON GH, 1979, CAN J PHYSIOL PHARM, V57, P1043, DOI 10.1139/y79-158; Beattie VE, 2001, ANIM SCI, V72, P35, DOI 10.1017/S1357729800055533; BIKKER P, 1994, J NUTR, V124, P1961, DOI 10.1093/jn/124.10.1961; Bolhuis JE, 2009, PHYSIOL BEHAV, V97, P470, DOI 10.1016/j.physbeh.2009.03.021; BURKE KA, 1951, J BIOL CHEM, V188, P723; Camerlink I, 2015, BEHAV GENET, V45, P117, DOI 10.1007/s10519-014-9671-9; CASTAGNE V, 1993, LIFE SCI, V53, P1803, DOI 10.1016/0024-3205(93)90488-O; Centraal Veevoeder Bureau (CVB), 2011, CHEM COMP NUTR VAL F; CHAMBERLAIN B, 1987, PHARMACOL BIOCHEM BE, V28, P503, DOI 10.1016/0091-3057(87)90513-2; de Ridder K, 2012, J ANIM SCI, V90, P3485, DOI 10.2527/jas.2011-4830; Edwards SA, 2006, VET J, V171, P198, DOI 10.1016/j.tvjl.2005.04.010; Ettle T, 2005, PHYSIOL BEHAV, V85, P289, DOI 10.1016/j.physbeh.2005.04.017; Ettle T, 2004, J ANIM SCI, V82, P1115; Ettle T, 2009, LIVEST SCI, V122, P259, DOI 10.1016/j.livsci.2008.09.007; FRASER D, 1991, CAN J ANIM SCI, V71, P611, DOI 10.4141/cjas91-076; GIBBONS JL, 1979, BRAIN RES, V169, P139, DOI 10.1016/0006-8993(79)90380-9; Gloaguen M, 2014, J ANIM SCI, V92, P637, DOI 10.2527/jas.2013-6514; Goossens X, 2008, ANIM WELFARE, V17, P35; Harley S, 2014, ANIM WELFARE, V23, P275, DOI 10.7120/09627286.23.3.275; HARPER AE, 1989, J NUTR, V119, P677, DOI 10.1093/jn/119.5.677; Heinonen M, 2010, VET J, V184, P303, DOI 10.1016/j.tvjl.2009.02.021; International Organization for Standardization (ISO), 2005, 139042005 ISO; ISO, 2005, 59831 ISO; Jansman AJM, 2002, ANIM FEED SCI TECH, V98, P49, DOI 10.1016/S0377-8401(02)00015-9; JENSEN MB, 1993, APPL ANIM BEHAV SCI, V37, P211, DOI 10.1016/0168-1591(93)90112-3; JERICHO KWF, 1972, CANADIAN VET J, V13, P156; Kampman-van de Hoek E, 2015, BRIT J NUTR, V113, P414, DOI 10.1017/S0007114514003821; Karlsson F, 2013, VET MICROBIOL, V165, P402, DOI 10.1016/j.vetmic.2013.03.031; KERR BJ, 1995, J ANIM SCI, V73, P3000; Kim JC, 2012, J ANIM SCI, V90, P362, DOI 10.2527/jas.53821; Koopmans SJ, 2005, PHYSIOL BEHAV, V85, P469, DOI 10.1016/j.physbeh.2005.05.010; Kops MS, 2014, BEHAV BRAIN RES, V268, P81, DOI 10.1016/j.bbr.2014.03.050; Kops MS, 2013, PHYSIOL BEHAV, V120, P77, DOI 10.1016/j.physbeh.2013.07.007; Kritas SK, 2007, VET REC, V160, P149, DOI 10.1136/vr.160.5.149; LARSEN C, 1983, NEW ZEAL VET J, V31, P105, DOI 10.1080/00480169.1983.34985; Le Bellego L, 2002, LIVEST PROD SCI, V76, P45, DOI 10.1016/S0301-6226(02)00008-8; Le Floc'h N, 2008, J ANIM SCI, V86, P3473, DOI 10.2527/jas.2008-0999; Le Floc'h N, 2012, P NUTR SOC, V71, P425, DOI 10.1017/S0029665112000560; Lepage O, 2002, J EXP BIOL, V205, P3679; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Marques BMFPP, 2012, PESQUI VET BRASIL, V32, P967, DOI 10.1590/S0100-736X2012001000003; Martinez-Trejo G, 2009, J ANIM VET ADV, V8, P608; Massey KA, 1998, AMINO ACIDS, V14, P271, DOI 10.1007/BF01318848; McIntyre J, 2002, APPL ANIM BEHAV SCI, V77, P93, DOI 10.1016/S0168-1591(02)00044-8; Melchior D, 2004, J ANIM SCI, V82, P1091; Moinard C, 2003, APPL ANIM BEHAV SCI, V81, P333, DOI 10.1016/S0168-1591(02)00276-9; Moughan PJ, 1998, QUANTITATIVE BIOL PI, P299; Munsterhjelm C, 2013, ANIMAL, V7, P814, DOI 10.1017/S1751731112002194; National Research Council, 2012, NUTR REQ SWIN, V11th, DOI DOI 10.17226/13298; Parmentier HK, 2009, POULTRY SCI, V88, P536, DOI 10.3382/ps.2008-00424; Petersen DL, 2001, TAIL BITING PIGS J, V162, P196; Pringle M, 2009, VET MICROBIOL, V139, P279, DOI 10.1016/j.vetmic.2009.05.018; Purves D, 2001, ACETYLCHOLINE NEUROS; Rakhshandeh A, 2010, LIVEST SCI, V134, P21, DOI 10.1016/j.livsci.2010.06.085; Ren M, 2014, ANIM FEED SCI TECH, V195, P67, DOI 10.1016/j.anifeedsci.2014.05.013; Rodenburg TB, 2007, APPL ANIM BEHAV SCI, V103, P205, DOI 10.1016/j.applanim.2006.05.024; Rodwell VW, 2003, HARPERS ILLUSTRATED, P264; Roth FX, 2006, J ANIM SCI, V84, P379, DOI 10.2527/2006.842379x; SALOMON RM, 1994, BIOL PSYCHIAT, V35, P570, DOI 10.1016/0006-3223(94)90105-8; Sutherland MA, 2011, APPL ANIM BEHAV SCI, V135, P179, DOI 10.1016/j.applanim.2011.10.015; Taylor NR, 2010, VET J, V186, P137, DOI 10.1016/j.tvjl.2009.08.028; Ursinus WW, 2014, J ANIM SCI, V92, P5193, DOI 10.2527/jas.2014-7918; Ursinus WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107040; Valros A., 2015, PORCINE HEALTH MANAG, V1, P1, DOI DOI 10.1186/2055-5660-1-1; Van de Weerd HA, 2003, APPL ANIM BEHAV SCI, V84, P101, DOI 10.1016/S0168-1591(03)00150-3; van der Meer Y, 2016, J ANIMAL SCI; van Hierden YM, 2004, BEHAV NEUROSCI, V118, P575, DOI 10.1037/0735-7044.118.3.575; Winberg S, 2001, J EXP BIOL, V204, P3867; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; WURTMAN RJ, 1975, AM J CLIN NUTR, V28, P638, DOI 10.1093/ajcn/28.6.638; Zonderland JJ, 2008, APPL ANIM BEHAV SCI, V110, P269, DOI 10.1016/j.applanim.2007.04.005; Zonderland JJ, 2010, LIVEST SCI, V129, P151, DOI 10.1016/j.livsci.2010.01.018	72	20	21	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0174688	10.1371/journal.pone.0174688	http://dx.doi.org/10.1371/journal.pone.0174688			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481880	Green Published, gold, Green Submitted			2022-12-27	WOS:000401313700001
J	Li, L; Hu, W; Zhu, HH; Li, Y; Zhang, H				Li, Lin; Hu, Wei; Zhu, Haihong; Li, You; Zhang, Hang			Tiled vector data model for the geographical features of symbolized maps	PLOS ONE			English	Article							PROGRESSIVE TRANSMISSION; REPRESENTATION; COMPRESSION; SUPPORT; WORLD	Electronic maps (E-maps) provide people with convenience in real-world space. Although web map services can display maps on screens, a more important function is their ability to access geographical features. An E-map that is based on raster tiles is inferior to vector tiles in terms of interactive ability because vector maps provide a convenient and effective method to access and manipulate web map features. However, the critical issue regarding rendering tiled vector maps is that geographical features that are rendered in the form of map symbols via vector tiles may cause visual discontinuities, such as graphic conflicts and losses of data around the borders of tiles, which likely represent the main obstacles to exploring vector map tiles on the web. This paper proposes a tiled vector data model for geographical features in symbolized maps that considers the relationships among geographical features, symbol representations and map renderings. This model presents a method to tailor geographical features in terms of map symbols and 'addition' (join) operations on the following two levels: geographical features and map features. Thus, these maps can resolve the visual discontinuity problem based on the proposed model without weakening the interactivity of vector maps. The proposed model is validated by two map data sets, and the results demonstrate that the rendered (symbolized) web maps present smooth visual continuity.	[Li, Lin; Hu, Wei; Zhu, Haihong; Li, You; Zhang, Hang] Wuhan Univ, Sch Resource & Environm Sci, Wuhan, Peoples R China; [Li, Lin] Wuhan Univ, Spatial Informat Sci Collaborat Innovat Ctr, Wuhan, Peoples R China; [Li, Lin] Minist Educ, Key Lab Geog Informat Syst, Wuhan, Peoples R China	Wuhan University; Wuhan University	Li, L; Zhu, HH (corresponding author), Wuhan Univ, Sch Resource & Environm Sci, Wuhan, Peoples R China.; Li, L (corresponding author), Wuhan Univ, Spatial Informat Sci Collaborat Innovat Ctr, Wuhan, Peoples R China.; Li, L (corresponding author), Minist Educ, Key Lab Geog Informat Syst, Wuhan, Peoples R China.	lilin@whu.edu.cn; hhzhu@whu.edu.cn		Hu, Wei/0000-0002-3744-8357	national Natural Science Foundation of China [41271453]; Scientific and Technological Leading Talent Fund of National Administration of Surveying, mapping and geo-information; Wuhan 'Yellow Crane Excellence' (Science and Technology) program; Doctoral Independent Scientific Research Project in Wuhan University [2012205020211]	national Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Leading Talent Fund of National Administration of Surveying, mapping and geo-information; Wuhan 'Yellow Crane Excellence' (Science and Technology) program; Doctoral Independent Scientific Research Project in Wuhan University	The article was supported by the national Natural Science Foundation of China under grant No.41271453 and url is http://www.nsfc.gov.cn/,The Scientific and Technological Leading Talent Fund of National Administration of Surveying, mapping and geo-information (2014), Wuhan 'Yellow Crane Excellence' (Science and Technology) program (2014) and the Doctoral Independent Scientific Research Project in Wuhan University (2012205020211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is funded by the National Natural Science Foundation of China (41271453); the Scientific and Technological Leading Talent Fund of National Administration of Surveying, mapping and geo-information (2014); the Wuhan 'Yellow Crane Excellence' (Science and Technology) program (2014); and the Doctoral Independent Scientific Research Project in Wuhan University (2012205020211).	Andrienko GL, 1999, INT J GEOGR INF SCI, V13, P355, DOI 10.1080/136588199241247; Anguelov D, 2010, COMPUTER, V43, P32, DOI 10.1109/MC.2010.170; Batty M., 2010, ANN GIS, V16, P1, DOI [10.1080/19475681003700831, DOI 10.1080/19475681003700831]; Bertolotto M, 2001, GEOINFORMATICA, V5, P345, DOI 10.1023/A:1012745819426; Butler H, 2008, GEOJSON FORMAT SPECI, P67; Chadil N, 2008, ECTI-CON 2008: PROCEEDINGS OF THE 2008 5TH INTERNATIONAL CONFERENCE ON ELECTRICAL ENGINEERING/ELECTRONICS, COMPUTER, TELECOMMUNICATIONS AND INFORMATION TECHNOLOGY, VOLS 1 AND 2, P393, DOI 10.1109/ECTICON.2008.4600454; Coors V, 1998, P 6 ACM INT S ADV GE; Deng W, 2000, GIS2000; Edsall R, 2008, ASPRS MANUAL OF GIS; Garcia Martin R, 2013, INT J GEOGR INF SCI, V27, P614, DOI 10.1080/13658816.2012.721555; Gleason Greasley, 2006, 19117REV NWIP ISO; Goodchild MF, 2007, INT J GEOGR INF SCI, V21, P239, DOI 10.1080/13658810600965271; Grajales FJ, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2912; Guo H, 2016, GEO-SPAT INF SCI, V19, P140, DOI 10.1080/10095020.2016.1182808; Han H, 2003, P 6 AGILE LYON FRANC, P103; Huang HS, 2011, INT J GEOGR INF SCI, V25, P1561, DOI 10.1080/13658816.2010.532133; Huang YX, 2006, GISCI REMOTE SENS, V43, P197, DOI 10.2747/1548-1603.43.3.197; Jang BJ, 2014, INT J GEOGR INF SCI, V28, P763, DOI 10.1080/13658816.2013.872249; [李霖 Li Lin], 2011, [测绘学报, Acta Geodetica et Cartographica Sinica], V40, P373; Li WW, 2015, COMPUT ENVIRON URBAN, V54, P314, DOI 10.1016/j.compenvurbsys.2015.04.003; Li XY, 2010, COMPUT GEOSCI-UK, V36, P1060, DOI 10.1016/j.cageo.2010.03.004; LIANG YD, 1984, ACM T GRAPHIC, V3, P1, DOI 10.1145/357332.357333; Liu PC, 2016, CARTOGR GEOGR INF SC, V43, P454, DOI 10.1080/15230406.2015.1088799; Lu Z, 2016, WEB3D S P; Lu Z, 2013, IEEE IJCNN; Lv ZH, 2016, IEEE ACCESS, V4, P407, DOI 10.1109/ACCESS.2016.2517076; Mac Aoidh E, 2008, INFORM VISUAL, V7, P275, DOI 10.1057/ivs.2008.24; Maso J., 2010, OPENGIS WEB MAP TILE, P4; Nossum AS, 2011, CARTOGR GEOGR INF SC, V38, P193, DOI 10.1559/15230406382193; Ormsby T., 2010, GETTING KNOW ARCGIS; Paiva AC, 2004, 15TH INTERNATIONAL WORKSHOP ON DATABASE AND EXPERT SYSTEMS APPLICATIONS, PROCEEDINGS, P809, DOI 10.1109/DEXA.2004.1333575; Pan B., 2007, INFORM COMMUNICATION, P503, DOI DOI 10.1007/978-3-211-69566-1_; Patterson TC, 2007, J GEOGR, V106, P145, DOI 10.1080/00221340701678032; Poplin A, 2015, CARTOGR GEOGR INF SC, V42, P358, DOI 10.1080/15230406.2014.991427; Pridal P., 2008, E PERIMETRON, V3, P10; Robinson AC, 2013, CARTOGR GEOGR INF SC, V40, P415, DOI 10.1080/15230406.2013.803833; Shekhar S, 2002, P 10 ACM INT S ADV G, P74; Sukaphat S., 2009, 10 ACIS INT C SOFTW; Tang AY, 1996, INT J GEOGR INF SYST, V10, P643, DOI 10.1080/026937996137927; Thomas J.J., 2005, ILLUMINATING PATH RE; Ting-Hua AI, 2004, REV ACTA GEODAETICA, V1; Tu S, 2001, P 9 ACM INT S ADV GE; Wartell ZJ, 2003, TECH REP; Wei ZK, 1999, P 2 INT WORKSH WEB I; Wenjue J., 2004, GEO-SPAT INF SCI, V7, P148, DOI DOI 10.1007/BF02826653; Yang BS, 2009, GEO-SPAT INF SCI, V12, P13, DOI 10.1007/s11806-009-0181-5; Yang BS, 2005, COMPUT GEOSCI-UK, V31, P569, DOI 10.1016/j.cageo.2004.11.011; Yang C, 2005, INT J GEOGR INF SCI, V19, P319, DOI 10.1080/13658810412331280202; Yong-Kyoon Kang, 2001, Advances in Databases and Information Systems. 5th East European Conference, ADBIS 2001. Proceedings (Lecture Notes in Computer Science Vol.2151), P127; Yue SS, 2016, INT J GEOGR INF SCI, V30, P143, DOI 10.1080/13658816.2015.1077964; Zhang J, 2014, CARTOGR GOEGR INFOR, V42, P44; Zhou MY, 2016, INT J DIGIT EARTH, V9, P230, DOI 10.1080/17538947.2015.1016558; Zhu XY, 2009, IEEC 2009: FIRST INTERNATIONAL SYMPOSIUM ON INFORMATION ENGINEERING AND ELECTRONIC COMMERCE, PROCEEDINGS, P730, DOI 10.1109/IEEC.2009.159	53	7	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176387	10.1371/journal.pone.0176387	http://dx.doi.org/10.1371/journal.pone.0176387			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475578	gold, Green Published, Green Submitted			2022-12-27	WOS:000400649500008
J	Bekalu, ZE; Madsen, CK; Dionisio, G; Brinch-Pedersen, H				Bekalu, Zelalem Eshetu; Madsen, Claus Krogh; Dionisio, Giuseppe; Brinch-Pedersen, Henrik			Aspergillus ficuum phytase activity is inhibited by cereal grain components	PLOS ONE			English	Article							PURIFICATION; RESISTANCE; PATHOGENS; CELLULASE; DEFENSES; ENZYMES; MAIZE; NIGER	In the current study, we report for the first time that grain components of barley, rice, wheat and maize can inhibit the activity of Aspergillus ficuum phytase. The phytase inhibition is dose dependent and varies significantly between cereal species, between cultivars of barley and cultivars of wheat and between Fusarium graminearum infected and non-infected wheat grains. The highest endpoint level of phytase activity inhibition was 90%, observed with grain protein extracts (GPE) from F. graminearum infected wheat. Wheat GPE from grains infected with F. graminearum inhibits phytase activity significantly more than GPE from non-infected grains. For four barley cultivars studied, the IC50 value ranged from 0.978 +/- 0.271 to 3.616 +/- 0.087 mgxml(-1). For two non-infected wheat cultivars investigated, the IC50 values were varying from 2.478 +/- 0.114 to 3.038 +/- 0.097 mgxml(-1). The maize and rice cultivars tested gaveIC(50) values on 0.983 +/- 0.205 and 1.972 +/- 0.019 mgxml(-1), respectively. After purifying the inhibitor from barley grains via Superdex G200, an approximately 30-35 kDa protein was identified. No clear trend for the mechanism of inhibition could be identified via Michaelis-Menten kinetics and Lineweaver-Burk plots. However, testing of the purified phytase inhibitor together with the A. ficuum phytase and the specific protease inhibitors pepstatin A, E64, EDTA and PMSF revealed that pepstatin A repealed the phytase inhibition. This indicates that the observed inhibition of A. ficuum phytase by cereal grain extracts is caused by protease activity of the aspartic proteinase type.	[Bekalu, Zelalem Eshetu; Madsen, Claus Krogh; Dionisio, Giuseppe; Brinch-Pedersen, Henrik] Aarhus Univ, Res Ctr Flakkebjerg, Dept Mol Biol & Genet, Slagelse, Denmark	Aarhus University	Brinch-Pedersen, H (corresponding author), Aarhus Univ, Res Ctr Flakkebjerg, Dept Mol Biol & Genet, Slagelse, Denmark.	hbp@mbg.au.dk	Madsen, Claus/AAC-2154-2022; Brinch-Pedersen, Henrik/AAY-8420-2021	Madsen, Claus/0000-0002-8921-3920; Brinch-Pedersen, Henrik/0000-0002-9773-8903; Dionisio, Giuseppe/0000-0003-4416-0519				Abul H JU, 1988, ANN NY ACAD SCI, V542, P102; BIRK Y, 1989, RECENT ADVANCES OF RESEARCH IN ANTINUTRITIONAL FACTORS IN LEGUME SEEDS, P83; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinch-Pedersen H, 2014, J CEREAL SCI, V59, P373, DOI 10.1016/j.jcs.2013.10.003; Dionisio G, 2007, PLANT BIOTECHNOL J, V5, P325, DOI 10.1111/j.1467-7652.2007.00244.x; ENGELEN AJ, 1994, J AOAC INT, V77, P760; GIBSON DM, 1988, ARCH BIOCHEM BIOPHYS, V260, P503, DOI 10.1016/0003-9861(88)90475-4; GIBSON DM, 1990, PLANT BIOL, V9, P77; GOEL M, 1979, PHYTOCHEMISTRY, V18, P939, DOI 10.1016/S0031-9422(00)91453-5; GREINER R, 1993, ARCH BIOCHEM BIOPHYS, V303, P107, DOI 10.1006/abbi.1993.1261; Greiner R, 1997, ARCH BIOCHEM BIOPHYS, V341, P201, DOI 10.1006/abbi.1997.9942; Gusakov AV, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1185, DOI 10.1134/S0006297910100019; Heil M, 2002, ANN BOT-LONDON, V89, P503, DOI 10.1093/aob/mcf076; Howarth EB, 2000, IMPROVING HUMAN NUTR; Huang ZY, 1997, PHYTOPATHOLOGY, V87, P622, DOI 10.1094/PHYTO.1997.87.6.622; Hubel F, 1996, PLANT PHYSIOL, V112, P1429, DOI 10.1104/pp.112.4.1429; Huma H., 2007, BIOTECHNOLOGY MOL BI, V2; HURST PL, 1977, BIOCHEM J, V165, P33, DOI 10.1042/bj1650033; Kostrewa D, 1997, NAT STRUCT BIOL, V4, P185, DOI 10.1038/nsb0397-185; Lott JNA., 1984, SEED PHYSL, P139; Nelson HE, 2014, BIOCONTROL, V59, P625, DOI 10.1007/s10526-014-9593-8; ODELL BL, 1972, J AGR FOOD CHEM, V20, P718, DOI 10.1021/jf60181a021; Palencia ER, 2010, TOXINS, V2, P399, DOI 10.3390/toxins2040399; Perrone G, 2007, STUD MYCOL, P53, DOI 10.3114/sim.2007.59.07; Ponte PIP, 2004, J APPL POULTRY RES, V13, P660, DOI 10.1093/japr/13.4.660; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sami AJ, 2011, J MED PLANTS RES, V5, P184; SEGUEILHA L, 1992, J FERMENT BIOENG, V74, P7, DOI 10.1016/0922-338X(92)90259-W; Slusarenko AJ, 2000, SYSTEMIC INDUCED RES; ULLAH AHJ, 1987, PREP BIOCHEM, V17, P63, DOI 10.1080/00327488708062477; Valueva TA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1305, DOI 10.1007/s10541-005-0015-5; VANHARTINGSVELDT W, 1993, GENE, V127, P87, DOI 10.1016/0378-1119(93)90620-I; Verhoeven T, 2005, HGCA RES REV; Yanke LJ, 1999, LETT APPL MICROBIOL, V29, P20, DOI 10.1046/j.1365-2672.1999.00568.x	35	13	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176838	10.1371/journal.pone.0176838	http://dx.doi.org/10.1371/journal.pone.0176838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472144	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500082
J	Bentley, SV; Greenaway, KH; Haslam, SA				Bentley, Sarah V.; Greenaway, Katharine H.; Haslam, S. Alexander			An online paradigm for exploring the self-reference effect	PLOS ONE			English	Article							MEMORY BIASES; COGNITION; RECALL; ADOLESCENTS; INFORMATION; DEPRESSION; PSYCHOLOGY; STABILITY; TURK	People reliably encode information more effectively when it is related in some way to the self -a phenomenon known as the self-reference effect. This effect has been recognized in psychological research for almost 40 years, and its scope as a tool for investigating the self-concept is still expanding. The self-reference effect has been used within a broad range of psychological research, from cultural to neuroscientific, cognitive to clinical. Traditionally, the self-reference effect has been investigated in a laboratory context, which limits its applicability in non-laboratory samples. This paper introduces an online version of the self-referential encoding paradigm that yields reliable effects in an easy-to-administer procedure. Across four studies (total N = 658), this new online tool reliably replicated the traditional self-reference effect: in all studies self-referentially encoded words were recalled significantly more than semantically encoded words (d = 0.63). Moreover, the effect sizes obtained with this online tool are similar to those obtained in laboratory samples, and are robust to experimental variations in encoding time (Studies 1 and 2) and recall procedure (Studies 3 and 4), and persist independent of primacy and recency effects (all studies).	[Bentley, Sarah V.; Greenaway, Katharine H.; Haslam, S. Alexander] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia	University of Queensland	Bentley, SV (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	s.bentley@uq.edu.au	Bentley, Sarah/K-7396-2018; Haslam, Alex/AAA-2512-2019; Greenaway, Katharine/A-9269-2015	Bentley, Sarah/0000-0002-7771-1631; Haslam, Alex/0000-0001-9523-7921; Greenaway, Katharine/0000-0002-0271-5312	Australian Research Council [FL110100199]	Australian Research Council(Australian Research Council)	This work was funded by the Australian Research Council Laureate Fellowship, http://www.arc.gov.au/, FL110100199, to SAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; ARON A, 1991, J PERS SOC PSYCHOL, V60, P241, DOI 10.1037/0022-3514.60.2.241; Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; Auerbach Randy P, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P335, DOI 10.1016/j.bpsc.2016.04.004; Auerbach RP, 2016, PSYCHOPHYSIOLOGY, V53, P1398, DOI 10.1111/psyp.12686; Auerbach RP, 2015, J ABNORM PSYCHOL, V124, P233, DOI 10.1037/abn0000023; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BARGH JA, 1988, J PERS SOC PSYCHOL, V54, P925, DOI 10.1037/0022-3514.54.6.925; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baumeister R. F., 1998, HDB SOCIAL PSYCHOL, V1-2, P680; Boduroglu A, 2015, MEMORY, V23, P736, DOI 10.1080/09658211.2014.925927; BOWER GH, 1979, J RES PERS, V13, P420, DOI 10.1016/0092-6566(79)90005-9; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Carver C.S., 2012, ATTENTION SELF REGUL; Chiao JY, 2010, J COGNITIVE NEUROSCI, V22, P1, DOI 10.1162/jocn.2009.21192; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Cunningham SJ, 2014, CHILD DEV, V85, P808, DOI 10.1111/cdev.12144; Cunningham SJ, 2013, CONSCIOUS COGN, V22, P237, DOI 10.1016/j.concog.2012.12.005; D'Argembeau A, 2005, BRIT J PSYCHOL, V96, P457, DOI 10.1348/000712605X53218; DAVIS H, 1979, COGNITIVE THER RES, V3, P97, DOI 10.1007/BF01172724; DENNY EB, 1992, J ABNORM PSYCHOL, V101, P575, DOI 10.1037/0021-843X.101.3.575; Fiske SusanT., 1991, SOCIAL COGNITION 2; Goldstein BL, 2015, COGNITION EMOTION, V29, P1445, DOI 10.1080/02699931.2014.990358; Grilli MD, 2011, J INT NEUROPSYCH SOC, V17, P929, DOI 10.1017/S1355617711000737; HALPIN JA, 1984, B PSYCHONOMIC SOC, V22, P87, DOI 10.3758/BF03333770; James W, 1950, PRINCIPLES PSYCHOL; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Kim K, 2015, SOC COGN AFFECT NEUR, V10, P494, DOI 10.1093/scan/nsu078; KLEIN SB, 1986, J EXP PSYCHOL GEN, V115, P26, DOI 10.1037/0096-3445.115.1.26; KUIPER NA, 1982, J PERS, V50, P67, DOI 10.1111/j.1467-6494.1982.tb00746.x; Lewin K., 1940, THE BACKGROUND OF CO, P68; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; Macrae CN, 1998, J PERS SOC PSYCHOL, V74, P578, DOI 10.1037/0022-3514.74.3.578; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Meade AW, 2012, PSYCHOL METHODS, V17, P437, DOI 10.1037/a0028085; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Peer E, 2017, J EXP SOC PSYCHOL, V70, P153, DOI 10.1016/j.jesp.2017.01.006; PRIETO SL, 1992, COGNITIVE THER RES, V16, P521, DOI 10.1007/BF01175139; PULLYBLANK J, 1985, CHILD DEV, V56, P1447, DOI 10.2307/1130464; ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037/0022-3514.35.9.677; Sanz J, 1996, COGNITION EMOTION, V10, P87, DOI 10.1080/026999396380402; Sedikides C, 2000, J PERS SOC PSYCHOL, V79, P906, DOI 10.1037/0022-3514.79.6.906; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Sul S, 2012, SOC NEUROSCI-UK, V7, P280, DOI 10.1080/17470919.2011.614001; Symons CS, 1997, PSYCHOL BULL, V121, P371, DOI 10.1037/0033-2909.121.3.371; Toichi M, 2002, AM J PSYCHIAT, V159, P1422, DOI 10.1176/appi.ajp.159.8.1422; Turk DJ, 2008, CONSCIOUS COGN, V17, P1040, DOI 10.1016/j.concog.2008.02.004; Turner J.C., 1989, PSYCHOL GROUP INFLUE, P233; TURNER JC, 1994, PERS SOC PSYCHOL B, V20, P454, DOI 10.1177/0146167294205002; Zhao Y, 2014, PSYCHOL MED, V44, P477, DOI 10.1017/S0033291713001177; Zhu Y, 2007, NEUROIMAGE, V34, P1310, DOI 10.1016/j.neuroimage.2006.08.047	57	11	11	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176611	10.1371/journal.pone.0176611	http://dx.doi.org/10.1371/journal.pone.0176611			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472160	Green Published, gold			2022-12-27	WOS:000400648500058
J	Bloemen, S; Zwaveling, S; ten Cate, H; ten Cate-Hoek, A; de Laat, B				Bloemen, Saartje; Zwaveling, Suzanne; ten Cate, Hugo; ten Cate-Hoek, Anna; de laat, Bas			Prediction of bleeding risk in patients taking vitamin K antagonists using thrombin generation testing	PLOS ONE			English	Article							INTERNATIONAL NORMALIZED RATIO; HAS-BLED SCORES; ATRIAL-FIBRILLATION; ANTICOAGULATED PATIENTS; THROMBOGRAM; MANAGEMENT; WARFARIN; THERAPY; PLASMA	Until recently, vitamin K antagonists (VKAs) were the mainstay of oral anticoagulant treatment with bleeding as the most prevalent adverse effect. One to four percent of patients experience major bleeding episodes, while clinically relevant bleeding occurs in up to 20%. At this moment no laboratory assays are available to identify patients at risk for bleeding. With this study we aimed to investigate whether thrombin generation tests might identify a bleeding risk in patients taking VKAs. This prospective cohort study included 129 patients taking VKAs for more than three months. Calibrated automated thrombinography (CAT) was performed in whole blood, platelet rich and platelet poor plasma. Hematocrit, hemoglobin concentrations and the International Normalized Ratio (INR) were defined and coagulation factor levels were measured. Forty clinically relevant bleeding episodes were registered in 26 patients during follow-up. No differences were found in plasma CAT parameters or INR values. Bleeding was not associated with age, sex, hematocrit, hemoglobin levels or coagulation factor levels. In whole blood a significantly lower endogenous thrombin potential (ETP) and peak were found in patients with bleeding (median ETP: 182.5 versus 256.2 nM. min, p = 0.002; peak: 23.9 versus 39.1 nM, p = 0.029). Additionally, the area under the receiver operating curve (AUC ROC) was significantly associated with bleeding (ETP: 0.700, p = 0.002; peak: 0.642, p = 0.029). HAS-BLED scores were also significantly higher in bleeding patients (3 versus 2, p = 0.003), with an AUC ROC 0.682 (p = 0.004). In conclusion, bleeding in patients taking VKAs is associated with a decreased whole blood ETP and peak as well as with an increased HAS-BLED score.	[Bloemen, Saartje; Zwaveling, Suzanne; de laat, Bas] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Synapse Res Inst, Maastricht, Netherlands; [Bloemen, Saartje; Zwaveling, Suzanne; de laat, Bas] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands; [ten Cate, Hugo; ten Cate-Hoek, Anna] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Internal Med,Lab Clin Thrombosis & Hemostasi, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Bloemen, S (corresponding author), Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Synapse Res Inst, Maastricht, Netherlands.; Bloemen, S (corresponding author), Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands.	s.bloemen@thrombin.com	Cate, Hugo ten/AAM-4000-2021	Bloemen, Saartje/0000-0003-3297-8196; ten Cate, Hugo/0000-0001-7796-4463				Al Dieri R, 2002, THROMB HAEMOSTASIS, V88, P576, DOI 10.1055/s-0037-1613258; Al Dieri R, 2012, BLOOD REV, V26, P197, DOI 10.1016/j.blre.2012.06.001; Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; Apostolakis S, 2013, THROMB HAEMOSTASIS, V110, P1074, DOI 10.1160/TH13-07-0552; Bloemen S, 2013, HAEMATOLOGICA, V98, P549, DOI 10.3324/haematol.2012.073601; Bosch Y, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-154; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dargaud Y, 2005, THROMB HAEMOSTASIS, V93, P475, DOI 10.1160/TH04-10-0706; Dargaud Y, 2013, J THROMB HAEMOST, V11, P1043, DOI 10.1111/jth.12244; Gallego P, 2012, CIRC-ARRHYTHMIA ELEC, V5, P312, DOI 10.1161/CIRCEP.111.967000; Halbritter K, 2013, J THROMB HAEMOST, V11, P651, DOI 10.1111/jth.12148; Hallas J, 2006, BMJ-BRIT MED J, V333, P726, DOI 10.1136/bmj.38947.697558.AE; Hemker HC, 2009, THROMB HAEMOSTASIS, V101, P171, DOI 10.1160/TH08-09-0562; Hemker HC, 2013, THROMB RES, V131, P3, DOI 10.1016/j.thromres.2012.10.011; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Lane DA, 2012, CIRCULATION, V126, P860, DOI 10.1161/CIRCULATIONAHA.111.060061; Levine MN, 2004, CHEST, V126, p287S, DOI 10.1378/chest.126.3_suppl.287S; Lip GYH, 2015, STROKE, V46, P143, DOI 10.1161/STROKEAHA.114.007199; Luna-Zaizar H, 2015, THROMB RES, V136, P1291, DOI 10.1016/j.thromres.2015.10.026; Ninivaggi M, 2012, CLIN CHEM, V58, P1252, DOI 10.1373/clinchem.2012.184077; Olesen JB, 2011, J THROMB HAEMOST, V9, P1460, DOI 10.1111/j.1538-7836.2011.04378.x; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Poli D, 2011, CIRCULATION, V124, P824, DOI 10.1161/CIRCULATIONAHA.110.007864; Rothberg MB, 2005, ANN INTERN MED, V143, P241, DOI 10.7326/0003-4819-143-4-200508160-00005; Sanden P, 2017, THROMB HAEMOSTASIS, V117, P27, DOI 10.1160/TH16-06-0489; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; van der Meijden PEJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064112; van Rein N, 2016, J THROMB HAEMOST, V14, P948, DOI 10.1111/jth.13306; Veeger NJGM, 2011, BRIT J HAEMATOL, V153, P508, DOI 10.1111/j.1365-2141.2011.08656.x; Vlieg AV, 2007, BRIT J HAEMATOL, V138, P769, DOI 10.1111/j.1365-2141.2007.06738.x; Whelihan MF, 2013, THROMB RES, V131, P377, DOI 10.1016/j.thromres.2013.01.023	32	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176967	10.1371/journal.pone.0176967	http://dx.doi.org/10.1371/journal.pone.0176967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472104	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500106
J	Welle, PD; Small, MJ; Doney, SC; Azevedo, IL				Welle, Paul D.; Small, Mitchell J.; Doney, Scott C.; Azevedo, Ines L.			Estimating the effect of multiple environmental stressors on coral bleaching and mortality	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; OCEAN ACIDIFICATION; GLOBAL ASSESSMENT; TEMPERATURE; RESILIENCE; IMPACTS; ADAPTATION; SCIENCE; LIMITS	Coral cover has been declining in recent decades due to increased temperatures and environmental stressors. However, the extent to which different stressors contribute both individually and in concert to bleaching and mortality is still very uncertain. We develop and use a novel regression approach, using non-linear parametric models that control for unobserved time invariant effects to estimate the effects on coral bleaching and mortality due to temperature, solar radiation, depth, hurricanes and anthropogenic stressors using historical data from a large bleaching event in 2005 across the Caribbean. Two separate models are created, one to predict coral bleaching, and the other to predict near-term mortality. A large ensemble of supporting data is assembled to control for omitted variable bias and improve fit, and a significant improvement in fit is observed from univariate linear regression based on temperature alone. The results suggest that climate stressors (temperature and radiation) far outweighed direct anthropogenic stressors (using distance from shore and nearby human population density as a proxy for such stressors) in driving coral health outcomes during the 2005 event. Indeed, temperature was found to play a role similar to 4 times greater in both the bleaching and mortality response than population density across their observed ranges. The empirical models tested in this study have large advantages over ordinary-least squares-they offer unbiased estimates for censored data, correct for spatial correlation, and are capable of handling more complex relationships between dependent and independent variables. The models offer a framework for preparing for future warming events and climate change; guiding monitoring and attribution of other bleaching and mortality events regionally and around the globe; and informing adaptive management and conservation efforts.	[Welle, Paul D.; Small, Mitchell J.; Azevedo, Ines L.] Carnegie Mellon Univ, Dept Engn & Publ Policy, 5000 Forbes Ave, Pittsburgh, PA 15213 USA; [Small, Mitchell J.] Carnegie Mellon Univ, Dept Civil & Environm Engn, 5000 Forbes Ave, Pittsburgh, PA 15213 USA; [Doney, Scott C.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, MS 25, Woods Hole, MA 02543 USA	Carnegie Mellon University; Carnegie Mellon University; Woods Hole Oceanographic Institution	Azevedo, IL (corresponding author), Carnegie Mellon Univ, Dept Engn & Publ Policy, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.	iazevedo@cmu.edu	Doney, Scott C/F-9247-2010	Doney, Scott C/0000-0002-3683-2437	center for Climate and Energy Decision Making through National Science Foundation [SES-0949710]; center for Climate and Energy Decision Making through Carnegie Mellon University [SES-0949710]; National Science Foundation Graduate Research Fellowship [DGE-1252522]; Direct For Social, Behav & Economic Scie [1463492] Funding Source: National Science Foundation	center for Climate and Energy Decision Making through National Science Foundation; center for Climate and Energy Decision Making through Carnegie Mellon University; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by the center for Climate and Energy Decision Making (SES-0949710), through a cooperative agreement between the National Science Foundation and Carnegie Mellon University. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. (DGE-1252522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P1798, DOI 10.1111/j.1365-2486.2010.02364.x; Berkelmans R, 1999, CORAL REEFS, V18, P219, DOI 10.1007/s003380050186; Brown BE, 2002, CORAL REEFS, V21, P119, DOI 10.1007/s00338-002-0215-z; Cesar H., 2003, EC WORLDWIDE CORAL R; Christie P, 2007, CORAL REEFS, V26, P1047, DOI 10.1007/s00338-007-0235-9; Claudet, 2015, AQUATIC FUNCTIONAL B, P211, DOI DOI 10.1016/B978-0-12-417015-5.00009-8; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; DeBose JL, 2013, CORAL REEFS, V32, P255, DOI 10.1007/s00338-012-0971-3; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Dunne RP, 2001, CORAL REEFS, V20, P201; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Fabricius KE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P493, DOI 10.1007/978-94-007-0114-4_28; Fisk D. A, 1985, P 5 INT COR REEF C; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O., 2000, P 9 INT COR REEF S B, V2, P23; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jameson SC, 1999, CORAL REEFS, V18, P333, DOI 10.1007/s003380050208; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; LESSER MP, 1990, CORAL REEFS, V8, P225, DOI 10.1007/BF00265015; Maina J, 2008, ECOL MODEL, V212, P180, DOI 10.1016/j.ecolmodel.2007.10.033; Maire E, 2016, ECOL LETT, V19, P351, DOI 10.1111/ele.12577; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McWilliams JP, 2005, ECOLOGY, V86, P2055, DOI 10.1890/04-1657; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Mumby PJ, 2001, MAR BIOL, V139, P183; Nagelkerken I, 2015, P NATL ACAD SCI USA, V112, P13272, DOI 10.1073/pnas.1510856112; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Rehr AP, 2012, ENVIRON MANAGE, V50, P1204, DOI 10.1007/s00267-012-9941-3; Richmond RH, 2007, BIOSCIENCE, V57, P598, DOI 10.1641/B570710; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Wilkinson C, 2008, STATUS CARIBBEAN COR; WILLIAMS E H JR, 1990, Atoll Research Bulletin, P1; Williams EH, 1988, P 6 INT COR REEF S, V3, P313; Yee SH, 2008, ECOL MODEL, V218, P162, DOI 10.1016/j.ecolmodel.2008.06.037; Yee SH, 2010, ENVIRON MONIT ASSESS, V161, P423, DOI 10.1007/s10661-009-0758-3	49	13	13	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175018	10.1371/journal.pone.0175018	http://dx.doi.org/10.1371/journal.pone.0175018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472031	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500007
J	Doppler, C; Arnhard, K; Dumfarth, J; Heinz, K; Messner, B; Stern, C; Koal, T; Klavins, K; Danzl, K; Pitterl, F; Grimm, M; Oberacher, H; Bernhard, D				Doppler, Christian; Arnhard, Kathrin; Dumfarth, Julia; Heinz, Katharina; Messner, Barbara; Stern, Christian; Koal, Therese; Klavins, Kristaps; Danzl, Katarina; Pitterl, Florian; Grimm, Michael; Oberacher, Herbert; Bernhard, David			Metabolomic profiling of ascending thoracic aortic aneurysms and dissections - Implications for pathophysiology and biomarker discovery	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; ACID SPHINGOMYELINASE; VALVE; PLASMA; CELLS; SPHINGOLIPIDS; INFLAMMATION; VIRUS	Objective Our basic understanding of ascending thoracic aortic aneurysm (ATAA) pathogenesis is still very limited, hampering early diagnosis, risk prediction, and development of treatment options. "Omics"-technologies, ideal to reveal tissue alterations from the normal physiological state due to disease have hardly been applied in the field. Using a metabolomic approach, with this study the authors seek to define tissue differences between controls and various forms of ATAAs. Methods Using a targeted FIA-MS/MS metabolomics approach, we analysed and compared the metabolic profiles of ascending thoracic aortic wall tissue of age-matched controls (n = 8), bicuspid aortic valve-associated aneurysms (BAV-A; n = 9), tricuspid aortic valve-associated aneurysms (TAV-A; n = 14), and tricuspid aortic valve-associated aortic dissections (TAV-Diss; n = 6). Results With sphingomyelin (SM) (OH) C22:2, SM C18:1, SM C22:1, and SM C24:1 only 4 out of 92 detectable metabolites differed significantly between controls and BAV-A samples. Between controls and TAV-Diss samples only phosphatidylcholine (PC) ae C32:1 differed. Importantly, our analyses revealed a general increase in the amount of total sphingomyelin levels in BAV-A and TAV-Diss samples compared to controls. Conclusions Significantly increased levels of sphingomyelins in BAV-A and TAV-Diss samples compared to controls may argue for a repression of sphingomyelinase activity and the sphingomyelinase-ceramide pathway, which may result in an inhibition of tissue regeneration; a potential basis for disease initiation and progression.	[Doppler, Christian; Dumfarth, Julia; Heinz, Katharina; Danzl, Katarina; Grimm, Michael; Bernhard, David] Innsbruck Med Univ, Univ Clin Cardiac Surg, Cardiac Surg Res Lab, Innsbruck, Austria; [Doppler, Christian; Bernhard, David] Johannes Kepler Univ Linz, Fac Med, Cardiac Vasc & Thorac Surg, Linz, Austria; [Arnhard, Kathrin; Pitterl, Florian; Oberacher, Herbert] Innsbruck Med Univ, Inst Legal Med & Core Facil Metabol, Innsbruck, Austria; [Messner, Barbara; Stern, Christian] Vienna Med Univ, Dept Cardiac Surg, Vienna, Austria; [Koal, Therese; Klavins, Kristaps] Biocrates Life Sci AG, Innsbruck, Austria	Medical University of Innsbruck; Johannes Kepler University Linz; Medical University of Innsbruck; Medical University of Vienna	Bernhard, D (corresponding author), Innsbruck Med Univ, Univ Clin Cardiac Surg, Cardiac Surg Res Lab, Innsbruck, Austria.; Bernhard, D (corresponding author), Johannes Kepler Univ Linz, Fac Med, Cardiac Vasc & Thorac Surg, Linz, Austria.	david.bernhard@i-med.ac.at	Klavins, Kristaps/AAJ-1644-2020; Dumfarth, Julia/ABE-4935-2020; Messner, Barbara/GLS-8150-2022; Parson, Walther/AAD-6845-2020	Klavins, Kristaps/0000-0001-9577-9990; Messner, Barbara/0000-0001-8331-6497; Oberacher, Herbert/0000-0002-0963-8268; Bernhard, David/0000-0002-2383-6607	Austrian National Bank [14745, 14590]; Tiroler Wissenschaftsfonds (TWF) [TWF-2016-1-9]; Biocrates Life Sciences AG, Tirol, Austria	Austrian National Bank; Tiroler Wissenschaftsfonds (TWF); Biocrates Life Sciences AG, Tirol, Austria	This work was supported by the Austrian National Bank [14745 to DB, and 14590 to BM], and the Tiroler Wissenschaftsfonds (TWF) [TWF-2016-1-9 to CD] Further, this study was supported by the Biocrates Life Sciences AG, Tirol, Austria in the form of salaries of the following authors (TK, KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adada M, 2016, CHEM PHYS LIPIDS, V197, P45, DOI 10.1016/j.chemphyslip.2015.07.008; Bao JX, 2016, FRONT BIOSCI-LANDMRK, V21, P1168, DOI 10.2741/4448; Berntorp E, 2016, HAEMOPHILIA OFFICIAL; Bienias K, 2016, PHARMACOL REP, V68, P570, DOI 10.1016/j.pharep.2015.12.008; Blaas I, 2016, J THROMBOSIS HAEMOST; Black KM, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000138; BRADY RO, 1966, P NATL ACAD SCI USA, V55, P366, DOI 10.1073/pnas.55.2.366; Chakravarthy H, 2016, STEM CELLS, V34, P972, DOI 10.1002/stem.2259; Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006; Chen Y, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0137-8; Ciborowski Michal, 2013, Methods Mol Biol, V1000, P103, DOI 10.1007/978-1-62703-405-0_9; Ciborowski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031982; Ciborowski M, 2011, J PROTEOME RES, V10, P1374, DOI 10.1021/pr101138m; Edsfeldt A, 2016, ARTERIOSCL THROM VAS, V36, P1132, DOI 10.1161/ATVBAHA.116.305675; El-Hamamsy I, 2009, NAT REV CARDIOL, V6, P771, DOI 10.1038/nrcardio.2009.191; Elefteriades JA, 2013, PROG CARDIOVASC DIS, V56, P57, DOI 10.1016/j.pcad.2013.06.002; Ellison JW, 2007, J SURG RES, V142, P28, DOI 10.1016/j.jss.2006.04.040; Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8; Foffa I, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-44; Gabande-Rodriguez E, 2014, CELL DEATH DIFFER, V21, P864, DOI 10.1038/cdd.2014.4; Goldfinger JZ, 2014, J AM COLL CARDIOL, V64, P1725, DOI 10.1016/j.jacc.2014.08.025; Grewal N, 2016, HEART VESSELS, V31, P795, DOI 10.1007/s00380-015-0703-z; Guo DC, 2006, ANN NY ACAD SCI, V1085, P339, DOI 10.1196/annals.1383.013; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Holzinger A, 2016, METHODS MOL BIOL, V1365, P243, DOI 10.1007/978-1-4939-3124-8_13; Iakoubova OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091437; Ikonomidis JS, 2013, J THORAC CARDIOV SUR, V145, P1326, DOI 10.1016/j.jtcvs.2012.12.027; Kirsch E W Matthias, 2006, Asian Cardiovasc Thorac Ann, V14, P254; Matt Peter, 2007, Asian Cardiovasc Thorac Ann, V15, P185; Otahal A, 2015, J VIROL, V89, P11723, DOI 10.1128/JVI.01869-15; Othman A, 2015, ATHEROSCLEROSIS, V240, P216, DOI 10.1016/j.atherosclerosis.2015.03.011; Peters DG, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e39; Pillai PS, 2012, INFLAMMATION, V35, P98, DOI 10.1007/s10753-011-9294-8; Puck Alexander, 2015, Results Immunol, V5, P23, DOI 10.1016/j.rinim.2015.10.001; Ruperez FJ, 2012, ANAL BIOANAL CHEM, V403, P1651, DOI 10.1007/s00216-012-5982-y; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Slebos DJ, 2015, RESPIRATION, V90, P136, DOI 10.1159/000431384; STCRAWFORD E, 1982, ARCH SURG-CHICAGO, V117, P1393; Tadros TM, 2009, CIRCULATION, V119, P880, DOI 10.1161/CIRCULATIONAHA.108.795401; Tung WS, 2001, J VASC SURG, V34, P143, DOI 10.1067/mva.2001.113310; van den Elzen S, 2016, IEEE T VIS COMPUT GR, V22, P1, DOI 10.1109/TVCG.2015.2468078; van den Elzen S, 2014, IEEE T VIS COMPUT GR, V20, P1087, DOI 10.1109/TVCG.2013.263; Weiss VU, 2015, ANAL CHEM, V87, P8709, DOI 10.1021/acs.analchem.5b01450; Zack F, 2016, INT J LEGAL MED, V130, P173, DOI 10.1007/s00414-015-1287-y; Zilz C, 2016, MULTIDISCIP RESP MED, V11, DOI 10.1186/s40248-016-0041-8	45	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176727	10.1371/journal.pone.0176727	http://dx.doi.org/10.1371/journal.pone.0176727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467501	gold, Green Submitted, Green Published			2022-12-27	WOS:000400647000070
J	Ian, E; Kirkerud, NH; Galizia, CG; Berg, BG				Ian, Elena; Kirkerud, Nicholas H.; Galizia, C. Giovanni; Berg, Bente G.			Coincidence of pheromone and plant odor leads to sensory plasticity in the heliothine olfactory system	PLOS ONE			English	Article							MOTH MANDUCA-SEXTA; ANTENNAL LOBE; RECEPTOR NEURONS; BOMBYX-MORI; REPRESENTATION; VIRESCENS; RESPONSES; BRAIN; DISCRIMINATION; DROSOPHILA	Male moths possess a highly specialized olfactory system comprised of two segregated sub-arrangements dedicated to processing information about plant odors and pheromones, respectively. Communication between these two sub-systems has been described at the peripheral level, but relatively little is known about putative interactions at subsequent synaptic relays. The male moth faces the challenge of seeking out the conspecific female in a highly dynamic odor world. The female-produced pheromone blend, which is a limited resource serving as guidance for the male, will reach his antennae in intermittent pockets of odor filaments mixed with volatiles from various plants. In the present study we performed calcium imaging for measuring odor-evoked responses in the uni-glomerular antennal-lobe projection neurons (analog to mitral cells in the vertebrate olfactory bulb) of Helicoverpa armigera. In order to investigate putative interactions between the two sub-systems tuned to plant volatiles and pheromones, respectively, we performed repeated stimulations with a selection of biologically relevant odors. We found that paired stimulation with a plant odor and the pheromone led to suppressed responses in both sub-systems as compared to those evoked during initial stimulation including application of each odor stimulus alone. The fact that the suppression persisted also after pairing, indicates the existence of a Hebbian-like plasticity in the primary olfactory center established by temporal pairing of the two odor stimulation categories.	[Ian, Elena; Kirkerud, Nicholas H.; Berg, Bente G.] Norwegian Univ Sci & Technol NTNU, Dept Psychol, Trondheim, Norway; [Kirkerud, Nicholas H.; Galizia, C. Giovanni] Univ Konstanz, Fachbereich Biol, Constance, Germany	Norwegian University of Science & Technology (NTNU); University of Konstanz	Berg, BG (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Psychol, Trondheim, Norway.	bente.berg@ntnu.no	; Galizia, C Giovanni/A-1771-2009	Berg, Bente Gunnveig/0000-0003-4035-9125; Kirkerud, Nicholas/0000-0002-8310-5523; Galizia, C Giovanni/0000-0001-8292-6031				Badeke E, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00143; Berg BG, 2009, CELL TISSUE RES, V335, P593, DOI 10.1007/s00441-008-0744-z; Berg BG, 1998, J COMP PHYSIOL A, V183, P669, DOI 10.1007/s003590050290; Biergans SD, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00082; Biergans SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039349; Chaffiol A, 2014, CHEM SENSES, V39, P451, DOI 10.1093/chemse/bju017; Deisig N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033159; Deng JY, 2004, J CHEM ECOL, V30, P2037, DOI 10.1023/B:JOEC.0000045593.62422.73; Dickens Joseph C., 1993, Chemoecology, V4, P175, DOI 10.1007/BF01256553; Galizia CG, 2014, EUR J NEUROSCI, V39, P1784, DOI 10.1111/ejn.12558; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Galizia CG, 2000, J COMP PHYSIOL A, V186, P1049, DOI 10.1007/s003590000156; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hillier NK, 2011, CHEM SENSES, V36, P93, DOI 10.1093/chemse/bjq102; HOMBERG U, 1988, CELL TISSUE RES, V254, P255; HOSKINS SG, 1986, CELL TISSUE RES, V244, P243; Ian E, 2016, CELL TISSUE RES; Kanzaki R, 2003, CHEM SENSES, V28, P113, DOI 10.1093/chemse/28.2.113; Light Douglas M., 1993, Chemoecology, V4, P145, DOI 10.1007/BF01256549; Namiki S, 2008, J COMP PHYSIOL A, V194, P501, DOI 10.1007/s00359-008-0325-3; Ochieng SA, 2002, J COMP PHYSIOL A, V188, P325, DOI 10.1007/s00359-002-0308-8; Olsen SR, 2008, TRENDS NEUROSCI, V31, P512, DOI 10.1016/j.tins.2008.07.006; Pregitzer P, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00042; Reisenman CE, 2008, J NEUROPHYSIOL, V100, P554, DOI 10.1152/jn.90231.2008; Reisenman CE, 2011, J COMP PHYSIOL A, V197, P653, DOI 10.1007/s00359-011-0625-x; Riffell Jeffrey A, 2009, Proc Natl Acad Sci U S A, V106, P19219, DOI 10.1073/pnas.0910592106; Rostelien T, 2005, CHEM SENSES, V30, P443, DOI 10.1093/chemse/bji039; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Sachse S, 1999, EUR J NEUROSCI, V11, P3970, DOI 10.1046/j.1460-9568.1999.00826.x; Schmidt-Busser D, 2009, J COMP PHYSIOL A, V195, P853, DOI 10.1007/s00359-009-0464-1; Seki Y, 2008, J COMP NEUROL, V506, P93, DOI 10.1002/cne.21528; Silbering AF, 2007, J NEUROSCI, V27, P11966, DOI 10.1523/JNEUROSCI.3099-07.2007; Silbering AF, 2008, J NEUROSCI, V28, P13075, DOI 10.1523/JNEUROSCI.2973-08.2008; Skiri HT, 2004, CHEM SENSES, V29, P253, DOI 10.1093/chemse/bjh026; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Trona F, 2010, J EXP BIOL, V213, P4291, DOI 10.1242/jeb.047365; Vickers NJ, 1998, J COMP NEUROL, V400, P35; Wilson DA, 2003, NEUROSCI BIOBEHAV R, V27, P307, DOI 10.1016/S0149-7634(03)00050-2; Wu H, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00206; Wu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070078; Zhao X-C, 2014, FRONTIERS SYSTEMS NE, P8	42	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175513	10.1371/journal.pone.0175513	http://dx.doi.org/10.1371/journal.pone.0175513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467500	Green Published, Green Submitted, gold			2022-12-27	WOS:000400647000015
J	Sato, Y; Tanino, Y; Wang, XT; Nikaido, T; Sato, S; Misa, K; Togawa, R; Frevert, CW; Munakata, M				Sato, Yuki; Tanino, Yoshinori; Wang, Xintao; Nikaido, Takefumi; Sato, Suguru; Misa, Kenichi; Togawa, Ryuichi; Frevert, Charles W.; Munakata, Mitsuru			Baseline serum syndecan-4 predicts prognosis after the onset of acute exacerbation of idiopathic interstitial pneumonia	PLOS ONE			English	Article							ACUTE LUNG INJURY; PULMONARY-FIBROSIS; RISK-FACTORS; BIOMARKER; LIPOPOLYSACCHARIDE; CLASSIFICATION; INFLAMMATION; OSTEOPONTIN; GUIDELINES; FEATURES	Background Patients with idiopathic interstitial pneumonia can experience acute respiratory worsening, also known as acute exacerbation, with a large deterioration on prognosis. The precise mechanism remains unclear; however, syndecan-4 may be involved. Syndecan-4, a transmembrane heparan sulfate proteoglycan expressed in a variety of cells (e.g., epithelial cells, macrophages, fibroblasts, etc.), performs various biological roles by binding to several proteins through its heparan sulfate glycosaminoglycan side chains. The goal of this study was to clarify the role of syndecan-4 in acute exacerbation of idiopathic interstitial pneumonia. Methods Patients with idiopathic interstitial pneumonia who had been sequentially admitted to our hospital due to acute exacerbation were retrospectively analyzed. First, serum syndecan-4 levels in the acute exacerbation and clinically stable phases were compared. Second, the relationship between serum syndecan-4 levels and clinical parameters was analyzed. Third, the relationship between serum syndecan-4 levels and prognosis was evaluated. Results Serum syndecan-4 levels were significantly lower in patients with acute exacerbation of idiopathic interstitial pneumonia than in patients in the clinically stable phase. Serum syndecan-4 levels also showed a significant positive correlation with white blood cell count and a weak positive tendency with KL-6 and baseline %VC. Prognosis was significantly worse in patients with idiopathic interstitial pneumonia with high baseline serum syndecan-4 levels than with low baseline levels. Multiple logistic analysis indicated baseline serum syndecan-4 level as the only prognostic predictor following acute exacerbation. Conclusions Baseline serum syndecan-4 is a possible prognostic biomarker after the onset of acute exacerbation of idiopathic interstitial pneumonia.	[Sato, Yuki; Tanino, Yoshinori; Wang, Xintao; Nikaido, Takefumi; Sato, Suguru; Misa, Kenichi; Togawa, Ryuichi; Munakata, Mitsuru] Fukushima Med Univ, Sch Med, Dept Pulm Med, Fukushima, Fukushima, Japan; [Frevert, Charles W.] Univ Washington, Dept Comparat Med, Div Pulm Crit Care Med, Seattle, WA 98195 USA; [Frevert, Charles W.] Univ Washington, Dept Comparat Med, Comparat Pathol Program, Seattle, WA 98195 USA; [Frevert, Charles W.] Univ Washington, Ctr Lung Biol, Seattle, WA 98195 USA	Fukushima Medical University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Tanino, Y (corresponding author), Fukushima Med Univ, Sch Med, Dept Pulm Med, Fukushima, Fukushima, Japan.	ytanino@fmu.ac.jp	TANINO, YOSHINORI/AAF-8773-2019	Sato, Yuki/0000-0002-8986-8388; Tanino, Yoshinori/0000-0003-2384-601X				Akira M, 1997, AM J ROENTGENOL, V168, P79, DOI 10.2214/ajr.168.1.8976924; Akira M, 2008, AM J RESP CRIT CARE, V178, P372, DOI 10.1164/rccm.200709-1365OC; Ambrosini V, 2003, EUR RESPIR J, V22, P821, DOI 10.1183/09031936.03.00022703; Antoniou KM, 2013, RESPIRATION, V86, P265, DOI 10.1159/000355485; Bensadoun ES, 1996, AM J RESP CRIT CARE, V154, P1819, DOI 10.1164/ajrccm.154.6.8970376; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Churg A, 2007, AM J SURG PATHOL, V31, P277, DOI 10.1097/01.pas.0000213341.70852.9d; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Collard HR, 2016, AM J RESP CRIT CARE, V194, P265, DOI 10.1164/rccm.201604-0801CI; Collard HR, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-73; Collard HR, 2010, AM J PHYSIOL-LUNG C, V299, pL3, DOI 10.1152/ajplung.90637.2008; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Fujimoto K, 2012, EUR RADIOL, V22, P83, DOI 10.1007/s00330-011-2211-6; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Guiot J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171344; Inokoshi Y, 2013, RESPIROLOGY, V18, P1236, DOI 10.1111/resp.12144; Ishiguro K, 2001, J BIOL CHEM, V276, P47483, DOI 10.1074/jbc.M106268200; Jenkins RG, 2015, LANCET RESP MED, V3, P462, DOI 10.1016/S2213-2600(15)00048-X; Jiang DH, 2010, J CLIN INVEST, V120, P2049, DOI 10.1172/JCI38644; Johannson KA, 2014, EUR RESPIR J, V43, P1124, DOI 10.1183/09031936.00122213; Kim DS, 2006, EUR RESPIR J, V27, P143, DOI 10.1183/09031936.06.00114004; Kishaba T, 2014, LUNG, V192, P141, DOI 10.1007/s00408-013-9530-0; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kon S, 2008, J EXP MED, V205, P25, DOI 10.1084/jem.20071324; KONDO A, 1989, INTERSTITIAL PNEUMON, P33; Kondoh Y, 2005, EUR RESPIR J, V25, P528, DOI 10.1183/09031936.05.00071004; Kondoh Y, 2010, SARCOIDOSIS VASC DIF, V27, P103; KONDOH Y, 1993, CHEST, V103, P1808, DOI 10.1378/chest.103.6.1808; Kondoh Y, 2015, RESPIR INVESTIG, V53, P271, DOI 10.1016/j.resinv.2015.04.005; Kubo H, 2005, CHEST, V128, P1475, DOI 10.1378/chest.128.3.1475; Kurosu K, 2008, J IMMUNOL, V181, P756, DOI 10.4049/jimmunol.181.1.756; Ley B, 2011, AM J RESP CRIT CARE, V37, P356; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Nagata K, 2013, RESPIROLOGY, V18, P439, DOI 10.1111/resp.12018; Natsuizaka M, 2014, AM J RESP CRIT CARE, V190, P773, DOI 10.1164/rccm.201403-0566OC; Nikaido T, 2015, J INFECT DIS, V212, P1500, DOI 10.1093/infdis/jiv234; Papiris SA, 2014, EXPERT REV RESP MED, V8, P271, DOI 10.1586/17476348.2014.896206; Parambil JG, 2005, CHEST, V128, P3310, DOI 10.1378/chest.128.5.3310; Park IN, 2007, CHEST, V132, P214, DOI 10.1378/chest.07-0323; Pruessmeyer J, 2010, J BIOL CHEM, V285, P555, DOI 10.1074/jbc.M109.059394; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rapraeger AC, 2000, J CELL BIOL, V149, P995, DOI 10.1083/jcb.149.5.995; Rice AJ, 2003, AM J CLIN PATHOL, V119, P709, DOI 10.1309/UVARMDY8FE9FJDKU; Richeldi L, 2015, ANN AM THORAC SOC, V12, pS181, DOI 10.1513/AnnalsATS.201504-210AW; Ryerson CJ, 2015, EUR RESPIR J, V46, P512, DOI 10.1183/13993003.00419-2015; Santoso A, 2016, MOL THER, V24, P41, DOI 10.1038/mt.2015.153; Schmidt EP, 2016, AM J RESP CRIT CARE, V194, P439, DOI 10.1164/rccm.201511-2281OC; Schupp JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116775; Song JW, 2011, EUR RESPIR J, V37, P356, DOI 10.1183/09031936.00159709; Tanino Y, 2012, AM J RESP CELL MOL, V47, P196, DOI 10.1165/rcmb.2011-0294OC; Tiitto L, 2006, THORAX, V61, P1091, DOI 10.1136/thx.2005.055814; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Usui Y, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002971; Vuga LJ, 2014, AM J RESP CRIT CARE, V189, P966, DOI 10.1164/rccm.201309-1592OC; White ES, 2016, AM J RESP CRIT CARE, V194, P1242, DOI 10.1164/rccm.201505-0862OC	56	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176789	10.1371/journal.pone.0176789	http://dx.doi.org/10.1371/journal.pone.0176789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467516	Green Submitted, Green Published, gold			2022-12-27	WOS:000400647000075
J	Duan, LM; Yang, SP; Zhang, G; Feng, F; Gu, MH				Duan, Liming; Yang, Shangpeng; Zhang, Gui; Feng, Fei; Gu, Minghui			A shape-based inter-layer contours correspondence method for ICT-based reverse engineering	PLOS ONE			English	Article							SYSTEM	The correspondence of a stack of planar contours in ICT (industrial computed tomography)based reverse engineering, a key step in surface reconstruction, is difficult when the contours or topology of the object are complex. Given the regularity of industrial parts and similarity of the inter-layer contours, a specialized shape-based inter-layer contours correspondence method for ICT-based reverse engineering was presented to solve the above problem based on the vectorized contours. In this paper, the vectorized contours extracted from the slices consist of three graphical primitives: circles, arcs and segments. First, the correspondence of the inter-layer primitives is conducted based on the characteristics of the primitives. Second, based on the corresponded primitives, the inter-layer contours correspond with each other using the proximity rules and exhaustive search. The proposed method can make full use of the shape information to handle industrial parts with complex structures. The feasibility and superiority of this method have been demonstrated via the related experiments. This method can play an instructive role in practice and provide a reference for the related research.	[Duan, Liming; Yang, Shangpeng; Zhang, Gui; Gu, Minghui] Chongqing Univ, Educ Minist China, Key Lab Optoelect Technol & Syst, ICT Res Ctr, Chongqing, Peoples R China; [Duan, Liming; Yang, Shangpeng; Zhang, Gui; Gu, Minghui] Chongqing Univ, Educ Minist China, Engn Res Ctr Ind Computed Tomog Nondestruct Testi, Chongqing, Peoples R China; [Duan, Liming; Yang, Shangpeng; Zhang, Gui; Feng, Fei; Gu, Minghui] Chongqing Univ, Coll Mech Engn, Chongqing, Peoples R China	Chongqing University; Chongqing University; Chongqing University	Duan, LM (corresponding author), Chongqing Univ, Educ Minist China, Key Lab Optoelect Technol & Syst, ICT Res Ctr, Chongqing, Peoples R China.; Duan, LM (corresponding author), Chongqing Univ, Educ Minist China, Engn Res Ctr Ind Computed Tomog Nondestruct Testi, Chongqing, Peoples R China.; Duan, LM (corresponding author), Chongqing Univ, Coll Mech Engn, Chongqing, Peoples R China.	duanliming163@163.com			Ministry of Science and Technology of the People's Republic of China [2013YQ030629]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by Ministry of Science and Technology of the People's Republic of China, http://www.mostgov.cn/, Grant Number: 2013YQ030629, Fund Recipient: Mr. Liming Duan.	Au K, 2008, P ACM SIGGRAPH T GRA, V27; Barequet G, 1996, COMPUT VIS IMAGE UND, V63, P251, DOI 10.1006/cviu.1996.0018; BRESLER Y, 1989, IEEE T PATTERN ANAL, V11, P840, DOI 10.1109/34.31446; Burguet J, 2011, I S BIOMED IMAGING, P602, DOI 10.1109/ISBI.2011.5872479; Chen YC, 2007, COMPUT METH PROG BIO, V86, P141, DOI 10.1016/j.cmpb.2007.01.011; Duan Li-ming, 2008, High Power Laser and Particle Beams, V20, P666; EKOULE AB, 1991, ACM T GRAPHIC, V10, P182, DOI 10.1145/108360.108363; Koh W, 2009, IEEE T MED IMAGING, V28, P555, DOI 10.1109/TMI.2008.2007821; [李安波 Li Anbo], 2016, [中国矿业大学学报. 自然科学版, Journal of China University of Mining & Technology], V45, P1050; [李安波 Li Anbo], 2015, [中国矿业大学学报. 自然科学版, Journal of China University of Mining & Technology], V44, P747; Liu F., 2011, GLOBAL J RES ENG, V11, P9; MEYERS D, 1992, ACM T GRAPHIC, V11, P228, DOI 10.1145/130881.131213; Owada S, 2003, INT J IMAGE GRAPHICS, V3, P609; Park Choi K, 1994, VISUAL COMPUT, V10, P372; Shih MY, 2000, P ANN INT IEEE EMBS, V22, P2910, DOI 10.1109/IEMBS.2000.901484; Volkau I, 2008, IEEE T MED IMAGING, V27, P745, DOI 10.1109/TMI.2007.911004; [王静 Wang Jing], 2002, [计算机工程与应用, Computer Engineering and Application], V38, P38; Wang SR, 2004, LECT NOTES COMPUT SC, V3150, P286; Xiao YJ, 2003, FOURTH INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P378; Yang Z, 2016, INT J MIN SCI TECHNO, V26, P361, DOI 10.1016/j.ijmst.2015.12.025; Zhang JW, 2017, INT J MIN SCI TECHNO, V27, P221, DOI 10.1016/j.ijmst.2017.01.001; Zheng J, 2010, COMPUTER APPL SOFTWA, V27, P36; Zheng J, 2010, COMPUTER APPL SOFTWA, V27, P4	23	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176383	10.1371/journal.pone.0176383	http://dx.doi.org/10.1371/journal.pone.0176383			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489867	Green Submitted, gold, Green Published			2022-12-27	WOS:000401314100022
J	Stanley, CR; Mettke-Hofmann, C; Preziosi, RF				Stanley, Christina R.; Mettke-Hofmann, Claudia; Preziosi, Richard F.			Personality in the cockroach Diploptera punctata: Evidence for stability across developmental stages despite age effects on boldness	PLOS ONE			English	Article							LIFE-HISTORY; ANIMAL PERSONALITY; INDIVIDUAL-DIFFERENCES; BEHAVIORAL SYNDROME; SEX-DIFFERENCES; SOCIAL-CONTEXT; ONTOGENY; EVOLUTION; TRAITS; METAMORPHOSIS	Despite a recent surge in the popularity of animal personality studies and their wide-ranging associations with various aspects of behavioural ecology, our understanding of the development of personality over ontogeny remains poorly understood. Stability over time is a central tenet of personality; ecological pressures experienced by an individual at different life stages may, however, vary considerably, which may have a significant effect on behavioural traits. Invertebrates often go through numerous discrete developmental stages and therefore provide a useful model for such research. Here we test for both differential consistency and age effects upon behavioural traits in the gregarious cockroach Diploptera punctata by testing the same behavioural traits in both juveniles and adults. In our sample, we find consistency in boldness, exploration and sociality within adults whilst only boldness was consistent in juveniles. Both boldness and exploration measures, representative of risk-taking behaviour, show significant consistency across discrete juvenile and adult stages. Age effects are, however, apparent in our data; juveniles are significantly bolder than adults, most likely due to differences in the ecological requirements of these life stages. Size also affects risk-taking behaviour since smaller adults are both bolder and more highly explorative. Whilst a behavioural syndrome linking boldness and exploration is evident in nymphs, this disappears by the adult stage, where links between other behavioural traits become apparent. Our results therefore indicate that differential consistency in personality can be maintained across life stages despite age effects on its magnitude, with links between some personality traits changing over ontogeny, demonstrating plasticity in behavioural syndromes.	[Stanley, Christina R.; Preziosi, Richard F.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Stanley, Christina R.] Univ Chester, Dept Biol Sci, Chester, Cheshire, England; [Mettke-Hofmann, Claudia] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England; [Preziosi, Richard F.] Manchester Metropolitan Univ, Sch Sci & Environm, Manchester, Lancs, England	University of Manchester; University of Chester; Liverpool John Moores University; Manchester Metropolitan University	Stanley, CR (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.; Stanley, CR (corresponding author), Univ Chester, Dept Biol Sci, Chester, Cheshire, England.	c.stanley@cantab.net	Preziosi, Richard F/A-8626-2010	Preziosi, Richard F/0000-0003-0468-6655; Stanley, Christina/0000-0002-5053-4831	Faculty of Life Sciences at the University of Manchester	Faculty of Life Sciences at the University of Manchester	This work was funded by the Faculty of Life Sciences at the University of Manchester.	Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bell AM, 2004, ANIM BEHAV, V68, P1339, DOI 10.1016/j.anbehav.2004.05.007; Benson-Amram S, 2012, P ROY SOC B-BIOL SCI, V279, P4087, DOI 10.1098/rspb.2012.1450; Bergman TJ, 2009, ANIM COGN, V12, P63, DOI 10.1007/s10071-008-0171-2; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; Brodin T, 2009, BEHAV ECOL, V20, P30, DOI 10.1093/beheco/arn111; Brown C, 2004, ANIM BEHAV, V68, P1325, DOI 10.1016/j.anbehav.2004.04.004; Carter AJ, 2013, BIOL REV, V88, P465, DOI 10.1111/brv.12007; Clary D, 2014, ETHOLOGY, V120, P1101, DOI 10.1111/eth.12283; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Conradt L, 2009, PHILOS T R SOC B, V364, P807, DOI 10.1098/rstb.2008.0257; Costa J., 2006, OTHER INSECT SOC; Curley JP., 2013, ANIMAL PERSONALITIES; Dangles O, 2007, J EXP BIOL, V210, P3165, DOI 10.1242/jeb.004648; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Dyer JRG, 2009, BEHAV ECOL, V20, P165, DOI 10.1093/beheco/arn129; Favati A, 2014, P R SOC LOND B, V281; Favati A, 2016, BEHAV ECOL, V27, P484, DOI 10.1093/beheco/arv177; Favati A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103535; Favreau FR, 2014, ANIM BEHAV, V92, P175, DOI 10.1016/j.anbehav.2014.04.003; Fidler AE, 2007, P ROY SOC B-BIOL SCI, V274, P1685, DOI 10.1098/rspb.2007.0337; Godin JGJ, 1996, P NATL ACAD SCI USA, V93, P10262, DOI 10.1073/pnas.93.19.10262; Groothuis TGG, 2011, DEV PSYCHOBIOL, V53, P641, DOI 10.1002/dev.20574; Gyuris E, 2011, P ROY SOC B-BIOL SCI, V278, P628, DOI 10.1098/rspb.2010.1326; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Hedrick AV, 2012, BEHAV ECOL SOCIOBIOL, V66, P407, DOI 10.1007/s00265-011-1286-z; ISHII S, 1967, Applied Entomology and Zoology, V2, P203; Jolles JW, 2014, BEHAV ECOL, V25, P1395, DOI 10.1093/beheco/aru146; Keiser CN, 2014, P R SOC LOND B, V281; Kralj-Fiser S, 2014, ANIM BEHAV, V91, P41, DOI 10.1016/j.anbehav.2014.02.016; Krause J, 2010, PHILOS T R SOC B, V365, P4099, DOI 10.1098/rstb.2010.0216; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; Lihoreau M, 2009, BEHAV PROCESS, V82, P81, DOI 10.1016/j.beproc.2009.03.008; Logue DM, 2009, BEHAV ECOL, V20, P781, DOI 10.1093/beheco/arp061; Lovlie H, 2014, P R SOC LOND B, V281; Magnhagen C, 2005, BEHAV ECOL SOCIOBIOL, V57, P295, DOI 10.1007/s00265-004-0834-1; Marchal E, 2013, GEN COMP ENDOCR, V188, P85, DOI 10.1016/j.ygcen.2013.04.018; Mather JA, 2013, ANIMAL PERSONALITIES; McDermott DR, 2014, BEHAV ECOL SOCIOBIOL, V68, P425, DOI 10.1007/s00265-013-1657-8; Mettke-Hofmann C, 2012, ETHOLOGY, V118, P906, DOI 10.1111/j.1439-0310.2012.02079.x; Mishra S, 2011, J COMP PSYCHOL, V125, P40, DOI 10.1037/a0020656; Mueller T, 2015, FRONTIERS ZOOLOGY, V12; Niemela PT, 2012, FUNCT ECOL, V26, P450, DOI 10.1111/j.1365-2435.2011.01939.x; Niemela PT, 2015, BEHAV ECOL, V26, P936, DOI 10.1093/beheco/arv036; Nilsson ALK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163213; Pinheiro J, NLME LINEAR NONLINEA, V3, P1; Planas-Sitja I, 2015, P R SOC LOND B, V282; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reale D, 2000, ANIM BEHAV, V60, P589, DOI 10.1006/anbe.2000.1530; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rivault C, 1998, J INSECT PHYSIOL, V44, P909, DOI 10.1016/S0022-1910(98)00062-6; Rodel HG, 2011, DEV PSYCHOBIOL, V53, P601, DOI 10.1002/dev.20522; ROTH LOUIS M., 1960, SMITHSONIAN MISC COLL, V141, P1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuett W, 2009, ANIM BEHAV, V77, P1041, DOI 10.1016/j.anbehav.2008.12.024; Sih A, 2003, ANIM BEHAV, V65, P29, DOI 10.1006/anbe.2002.2025; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sinn DL, 2008, ANIM BEHAV, V75, P433, DOI 10.1016/j.anbehav.2007.05.008; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Stamps JA, 2010, PHILOS T R SOC B, V365, P4029, DOI 10.1098/rstb.2010.0218; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Webster MM, 2011, BIOL REV, V86, P759, DOI 10.1111/j.1469-185X.2010.00169.x; Williams LJ, 2012, ANIM BEHAV, V84, P159, DOI 10.1016/j.anbehav.2012.04.025; Wilson ADM, 2013, BEHAV ECOL SOCIOBIOL, V67, P163, DOI 10.1007/s00265-012-1428-y; Wilson ADM, 2012, BEHAV ECOL, V23, P1316, DOI 10.1093/beheco/ars123; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	72	31	32	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176564	10.1371/journal.pone.0176564	http://dx.doi.org/10.1371/journal.pone.0176564			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UN	28489864	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000401314100026
J	Chae, YK; Kim, SH; Markley, JL				Chae, Young Kee; Kim, Seol Hyun; Markley, John L.			Relationship between recombinant protein expression and host metabolome as determined by two-dimensional NMR spectroscopy	PLOS ONE			English	Article							ESCHERICHIA-COLI CYTOPLASM; SACCHAROMYCES-CEREVISIAE; DISULFIDE BONDS; E. COLI; IDENTIFICATION; SOLUBILITY; PATHWAYS; BACTERIA; DATABASE; SPECTRA	Escherichia coli has been the most widely used host to produce large amounts of heterologous proteins. However, given an input plasmid DNA, E. coli may produce soluble protein, produce only inclusion bodies, or yield little or no protein at all. Many efforts have been made to surmount these problems, but most of them have involved time-consuming and labor-intensive trial-and-error. We hypothesized that different metabolomic fingerprints might be associated with different protein production outcomes. If so, then it might be possible to change the expression pattern by manipulating the metabolite environment. As a first step in testing this hypothesis, we probed a subset of the intracellular metabolites by partially labeling it with C-13-glucose. We tested 71 genes and identified 17 metabolites by employing the two-dimensional NMR spectroscopy. The statistical analysis showed that there existed the metabolite compositions favoring protein production. We hope that this work would help devise a systematic and predictive approach to the recombinant protein production.	[Chae, Young Kee; Kim, Seol Hyun] Sejong Univ, Dept Chem, Seoul, South Korea; [Markley, John L.] Univ Wisconsin Madison, Dept Biochem, Madison, WI USA	Sejong University; University of Wisconsin System; University of Wisconsin Madison	Chae, YK (corresponding author), Sejong Univ, Dept Chem, Seoul, South Korea.	ykchae@sejong.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A1A2053392, NRF-2016K2A9A1A01947329]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	Authors thank Ms. Hyosun Kim, Dongmin Kim, and Yoonjin Um for their technical assistance. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2014R1A1A2053392 and NRF-2016K2A9A1A01947329).	Akiyama Kenji, 2008, In Silico Biology, V8, P339; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Blommel Paul G., 2009, V498, P55, DOI 10.1007/978-1-59745-196-3_4; Brown BL, 2008, PROTEIN EXPRES PURIF, V62, P9, DOI 10.1016/j.pep.2008.07.003; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Chae YK, 2015, CHEM BIODIVERS, V12, P925, DOI 10.1002/cbdv.201400200; Chae YK, 2015, B KOREAN CHEM SOC, V36, P66, DOI 10.1002/bkcs.10016; Chae YK, 2013, B KOREAN CHEM SOC, V34, P3602, DOI 10.5012/bkcs.2013.34.12.3602; Chae YK, 2013, CHEM BIODIVERS, V10, P1816, DOI 10.1002/cbdv.201300016; Chae YK, 2012, B KOREAN CHEM SOC, V33, P4041, DOI 10.5012/bkcs.2012.33.12.4041; Chen Y, 2003, PROTEIN EXPRES PURIF, V32, P221, DOI 10.1016/S1046-5928(03)00233-X; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; De Marco V, 2004, BIOCHEM BIOPH RES CO, V322, P766, DOI 10.1016/j.bbrc.2004.07.189; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson MR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-32; Gopal GJ, 2013, PROTEIN J, V32, P419, DOI 10.1007/s10930-013-9502-5; Guo AC, 2013, NUCLEIC ACIDS RES, V41, pD625, DOI 10.1093/nar/gks992; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hoffmann F, 2004, ADV BIOCHEM ENG BIOT, V89, P73; Kang CM, 2015, CHEM BIODIVERS, V12, P1696, DOI 10.1002/cbdv.201400431; Kang CM, 2015, B KOREAN CHEM SOC, V36, P1328, DOI 10.1002/bkcs.10252; Kang WY, 2012, FEMS YEAST RES, V12, P608, DOI 10.1111/j.1567-1364.2012.00811.x; Kang WY, 2009, J KOREAN MAGN RESON, V13, P7, DOI 10.6564/JKMRS.2009.13.1.007; Lewis IA, 2007, ANAL CHEM, V79, P9385, DOI 10.1021/ac071583z; Lewis IA, 2009, MAGN RESON CHEM, V47, pS123, DOI 10.1002/mrc.2526; Mahalik S, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0177-1; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Niiranen L, 2007, PROTEIN EXPRES PURIF, V52, P210, DOI 10.1016/j.pep.2006.09.005; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Sahu SK, 2009, BIOTECHNOL LETT, V31, P1745, DOI 10.1007/s10529-009-0073-7; Sajed T, 2016, NUCLEIC ACIDS RES, V44, pD495, DOI 10.1093/nar/gkv1060; Sakurai T, 2013, PLANT CELL PHYSIOL, V54, pE5, DOI 10.1093/pcp/pcs184; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Spraul M, 2009, MAGN RESON CHEM, V47, pS130, DOI 10.1002/mrc.2528; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tegel Hanna, 2009, Biotechnology Journal, V4, P51, DOI 10.1002/biot.200800183; Thao Sandy, 2004, Journal of Structural and Functional Genomics, V5, P267, DOI 10.1007/s10969-004-7148-4; Volonte F, 2008, PROTEIN EXPRES PURIF, V61, P131, DOI 10.1016/j.pep.2008.05.010; Wang YH, 2006, BIOCHEM BIOPH RES CO, V346, P606, DOI 10.1016/j.bbrc.2006.05.180; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Zhang YB, 2004, PROTEIN EXPRES PURIF, V36, P207, DOI 10.1016/j.pep.2004.04.020	44	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177233	10.1371/journal.pone.0177233	http://dx.doi.org/10.1371/journal.pone.0177233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486539	gold, Green Published, Green Submitted			2022-12-27	WOS:000401314000061
J	Castilho, SRA; Godoy, CSDM; Guilarde, AO; Cardoso, JL; Andre, MCP; Junqueira-Kipnis, AP; Kipnis, A				Araujo Castilho, Suellen Rocha; de Miranda Godoy, Cassia Silva; Guilarde, Adriana Oliveira; Cardoso, Juliana Lamaro; Porfirio Andre, Maria Claudia; Junqueira-Kipnis, Ana Paula; Kipnis, Andre			Acinetobacter baumannii strains isolated from patients in intensive care units in Goiania, Brazil: Molecular and drug susceptibility profiles	PLOS ONE			English	Article							CARBAPENEM-RESISTANT; STENOTROPHOMONAS-MALTOPHILIA; ANTIMICROBIAL SUSCEPTIBILITY; LATIN-AMERICA; POLYMYXIN-B; OUTBREAK; BIOFILM; OXA-23; TIGECYCLINE; PREVALENCE	Resistance to antimicrobial agents is increasing worldwide and imposes significant life-threatening risks to several different populations, especially those in intensive care units (ICUs). Bacteria can quickly develop or acquire resistance to antimicrobial drugs, and combined with their intrinsic potential to cause disease in humans, these bacteria can become deadly. Among Gram-negative bacteria, Acinetobacter baumannii is notorious as a frequent opportunistic pathogen associated with critically ill patients, and understanding the genetic basis of A. baumannii resistance to beta-lactams among patients in ICUs will result in better protocols to prevent the development of resistance as well as improved treatment regimens. In this study, we assessed 1333 patients in five ICUs, 56 of whom developed A. baumannii infections. Most of the A. baumannii isolates were resistant to beta-lactam antimicrobial drugs, specifically, 3rd-and 4th-generation cephalosporins and carbapenems, and 91.1% of the isolates were multi-drug resistant (MDR). The most frequent OXA gene present was OXA-23 (55.1%), which is significantly associated with MDR strains. Most of the A. baumannii isolates (76.8%) were capable of forming a biofilm. The antimicrobial drug classes that were effective against most of these isolates were polymyxins and tigecycline. The molecular profile of the isolates allowed detection of 12 different clusters comprising 2 to 8 isolates each. In conclusion, our data indicate a high incidence of resistance to carbapenems as well as MDR strains among the observed A. baumannii isolates, most of which exhibited a high prevalence of OXA-23 gene expression. Only a few selective drugs were effective, reinforcing the notion that bacterial resistance is an emerging problem that should be prioritized in every healthcare facility.	[Araujo Castilho, Suellen Rocha; de Miranda Godoy, Cassia Silva; Guilarde, Adriana Oliveira; Cardoso, Juliana Lamaro; Porfirio Andre, Maria Claudia; Junqueira-Kipnis, Ana Paula; Kipnis, Andre] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil; [de Miranda Godoy, Cassia Silva; Guilarde, Adriana Oliveira] Hosp Trop Dis Dr Anuar Auad, Goiania, Go, Brazil	Universidade Federal de Goias	Kipnis, A (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.	andre.kipnis@gmail.com	Kipnis, Andre/ABG-5707-2020; Kipnis, Andre/M-7485-2017; Junqueira-Kipnis, Ana Paula/I-5534-2012	Kipnis, Andre/0000-0001-5950-106X; Kipnis, Andre/0000-0001-5950-106X; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [307186/2013-0]; Fundacao de Apoio a Pesquisa de Goias (FAPEG) [200910267000398]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa de Goias (FAPEG)	This work was financially supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, #307186/2013-0) and Fundacao de Apoio a Pesquisa de Goias (FAPEG, #200910267000398).	Azizun Nahar, 2013, Journal of Medicine, V14, P28; Badave GK, 2015, J CLIN DIAGN RES, V9, pDC8, DOI 10.7860/JCDR/2015/11014.5398; Barchitta M, 2009, INT J HYG ENVIR HEAL, V212, P330, DOI 10.1016/j.ijheh.2008.07.001; Chan JZM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-302; Dalla-Costa LM, 2003, J CLIN MICROBIOL, V41, P3403, DOI 10.1128/JCM.41.7.3403-3406.2003; Dias VC, 2016, J INFECT DEV COUNTR, V10, P544, DOI 10.3855/jidc.6640; Dizbay M, 2008, INT J ANTIMICROB AG, V32, P29, DOI 10.1016/j.ijantimicag.2008.02.016; Duarte A, 2016, COMP IMMUNOL MICROB, V45, P29, DOI 10.1016/j.cimid.2016.02.002; European Centre for Disease Prevention and Control, 2013, ANN EP REP 2013; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Gales AC, 2001, CLIN INFECT DIS, V32, pS104, DOI 10.1086/320183; Gales AC, 2001, J CLIN MICROBIOL, V39, P183, DOI 10.1128/JCM.39.1.183-190.2001; Gales AC, 2012, DIAGN MICR INFEC DIS, V73, P354, DOI 10.1016/j.diagmicrobio.2012.04.007; Gusatti CD, 2012, BRAZ J MICROBIOL, V43, P243, DOI [10.1590/S1517-83822012000100027, 10.1590/S1517-838220120001000027]; Hagihara M, 2014, ANTIMICROB AGENTS CH, V58, P874, DOI 10.1128/AAC.01624-13; Jeon BC, 2005, J CLIN MICROBIOL, V43, P2241, DOI 10.1128/JCM.43.5.2241-2245.2005; Kim DH, 2013, ANTIMICROB AGENTS CH, V57, P5239, DOI 10.1128/AAC.00633-13; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Martins AF, 2009, INFECTION, V37, P474, DOI 10.1007/s15010-009-9003-9; Moradi Jale, 2015, Osong Public Health Res Perspect, V6, P79, DOI 10.1016/j.phrp.2014.12.006; Naas T, 2005, J CLIN MICROBIOL, V43, P4826, DOI 10.1128/JCM.43.9.4826-4829.2005; Oliveira MS, 2008, J ANTIMICROB CHEMOTH, V61, P1369, DOI 10.1093/jac/dkn128; Pagano M, 2013, EPIDEMIOL INFECT, V141, P330, DOI 10.1017/S095026881200074X; Park SY, 2013, INFECT CHEMOTHER, V45, P325, DOI 10.3947/ic.2013.45.3.325; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Ruiz M, 2007, CLIN MICROBIOL INFEC, V13, P1192, DOI 10.1111/j.1469-0691.2007.01825.x; Sanchez CJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-47; Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005; Sohrabi N, 2012, MICROB DRUG RESIST, V18, P385, DOI 10.1089/mdr.2011.0077; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Tendolkar PM, 2004, INFECT IMMUN, V72, P6032, DOI 10.1128/IAI.72.10.6032-6039.2004; Tognim MCB, 2004, INT J INFECT DIS, V8, P284, DOI 10.1016/j.ijid.2003.11.009; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; Turton JF, 2006, FEMS MICROBIOL LETT, V258, P72, DOI 10.1111/j.1574-6968.2006.00195.x; VANSOOLINGEN D, 1994, METHOD ENZYMOL, V235, P196; Viehman JA, 2014, DRUGS, V74, P1315, DOI 10.1007/s40265-014-0267-8; Villegas MV, 2003, INFECT CONT HOSP EP, V24, P284, DOI 10.1086/502205; Villoria-Gonzalez AM, 2016, J PATHOG, V2016; Walther-Rasmussen J, 2006, J ANTIMICROB CHEMOTH, V57, P373, DOI 10.1093/jac/dki482; World Health Organization, 2016, UN HIGH LEV M ANT RE	42	25	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176790	10.1371/journal.pone.0176790	http://dx.doi.org/10.1371/journal.pone.0176790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475585	Green Published, gold, Green Submitted			2022-12-27	WOS:000400649500014
J	Cybulsky, AV; Guillemette, J; Papillon, J; Abouelazm, NT				Cybulsky, Andrey V.; Guillemette, Julie; Papillon, Joan; Abouelazm, Nihad T.			Regulation of Ste20-like kinase, SLK, activity: Dimerization and activation segment phosphorylation	PLOS ONE			English	Article							FOCAL ADHESION TURNOVER; GERMINAL CENTER KINASE; STE20-RELATED KINASE; MICROTUBULE ORGANIZATION; PROTEIN-PHOSPHORYLATION; DEPENDENT ACTIVATION; ACTIN CYTOSKELETON; SIGNALING PATHWAYS; GLOMERULAR INJURY; CELL-MIGRATION	The Ste20-like kinase, SLK, has diverse cellular functions. SLK mediates organ development, cell cycle progression, cytoskeletal remodeling, cytokinesis, and cell survival. Expression and activity of SLK are enhanced in renal ischemia-reperfusion injury, and overexpression of SLK was shown to induce apoptosis in cultured glomerular epithelial cells (GECs) and renal tubular cells, as well as GEC/podocyte injury in vivo. The SLK protein consists of a N-terminal catalytic domain and an extensive C-terminal domain, which contains coiled-coils. The present study addresses the regulation of SLK activity. Controlled dimerization of the SLK catalytic domain enhanced autophosphorylation of SLK at T183 and S189, which are located in the activation segment. The full-length ectopically- and endogenously-expressed SLK was also autophosphorylated at T183 and S189. Using ezrin as a model SLK substrate (to address exogenous kinase activity), we demonstrate that dimerized SLK 1-373 or full-length SLK can effectively induce activation-specific phosphorylation of ezrin. Mutations in SLK, including T183A, S189A or T193A reduced T183 or S189 autophosphorylation, and showed a greater reduction in ezrin phosphorylation. Mutations in the coiled-coil region of full-length SLK that impair dimerization, in particular I848G, significantly reduced ezrin phosphorylation and tended to reduce autophosphorylation of SLK at T183. In experimental membranous nephropathy in rats, proteinuria and GEC/podocyte injury were associated with increased glomerular SLK activity and ezrin phosphorylation. In conclusion, dimerization via coiled-coils and phosphorylation of T183, S189 and T193 play key roles in the activation and signaling of SLK, and provide targets for novel therapeutic approaches.	[Cybulsky, Andrey V.; Guillemette, Julie; Papillon, Joan; Abouelazm, Nihad T.] McGill Univ, Hlth Ctr, Res Inst, Dept Med, Montreal, PQ, Canada; [Abouelazm, Nihad T.] Alexandria Univ, Fac Med, Dept Clin Pharmacol, Alexandria, Egypt	McGill University; Egyptian Knowledge Bank (EKB); Alexandria University	Cybulsky, AV (corresponding author), McGill Univ, Hlth Ctr, Res Inst, Dept Med, Montreal, PQ, Canada.	andrey.cybulsky@mcgill.ca	Cybulsky, Andrey V./AAG-8238-2020	Cybulsky, Andrey V./0000-0003-4348-2348	Canadian Institutes of Health Research [MOP-125988, MOP-133492]; Catherine McLaughlin Hakim Chair	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Catherine McLaughlin Hakim Chair	This work was supported by Research Grants from the Canadian Institutes of Health Research MOP-125988, MOP-133492 (www.cihr-irsc.gc.ca/e/193.html), and the Catherine McLaughlin Hakim Chair (AVC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zahrani KN, 2014, DEV DYNAM, V243, P640, DOI 10.1002/dvdy.24106; Al-Zahrani KN, 2013, CELL ADHES MIGR, V7, P1, DOI 10.4161/cam.22495; Baron KD, 2015, BBA-MOL CELL RES, V1853, P1683, DOI 10.1016/j.bbamcr.2015.04.003; Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78; Coers W, 1996, EXP NEPHROL, V4, P184; Conradt L, 2011, NEOPLASIA, V13, P1026, DOI 10.1593/neo.111016; Cybulsky AV, 2007, AM J PHYSIOL-RENAL, V292, pF845, DOI 10.1152/ajprenal.00234.2006; Cybulsky AV, 2011, CONTRIB NEPHROL, V169, P107, DOI 10.1159/000313948; Cybulsky AV, 2010, AM J PATHOL, V177, P2290, DOI 10.2353/ajpath.2010.100263; Cybulsky AV, 2004, AM J PHYSIOL-RENAL, V286, pF16, DOI 10.1152/ajprenal.00144.2003; Cybulsky AV, 2015, J AM SOC NEPHROL, V26, p435A; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Delarosa S, 2011, AM J PHYSIOL-RENAL, V301, pF554, DOI 10.1152/ajprenal.00062.2011; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Elimam H, 2016, J BIOL CHEM, V291, P14468, DOI 10.1074/jbc.M115.696781; Ellinger-Ziegelbauer H, 2000, GENES CELLS, V5, P491, DOI 10.1046/j.1365-2443.2000.00337.x; Fokin AI, 2016, CYTOSKELETON, V73, P83, DOI 10.1002/cm.21276; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Guilluy C, 2008, CIRC RES, V102, P1265, DOI 10.1161/CIRCRESAHA.107.164764; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Hao W, 2006, J BIOL CHEM, V281, P3075, DOI 10.1074/jbc.M511744200; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hugo C, 1998, KIDNEY INT, V54, P1934, DOI 10.1046/j.1523-1755.1998.00195.x; Hugo C, 1996, J CLIN INVEST, V97, P2499, DOI 10.1172/JCI118697; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jaberi A, 2015, BBA-MOL CELL RES, V1853, P2539, DOI 10.1016/j.bbamcr.2015.06.005; Kim Y, 2015, MOL CANCER RES, V13, P765, DOI 10.1158/1541-7786.MCR-14-0326; Lee SJ, 2009, PROTEIN SCI, V18, P304, DOI 10.1002/pro.27; Luhovy AY, 2012, J BIOL CHEM, V287, P5446, DOI 10.1074/jbc.M111.302018; Machicoane M, 2014, J CELL BIOL, V205, P791, DOI 10.1083/jcb.201401049; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Muller S, 2015, NAT CHEM BIOL, V11, P818, DOI 10.1038/nchembio.1938; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; O'Reilly PG, 2005, J BIOL CHEM, V280, P42383, DOI 10.1074/jbc.M510763200; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Orlando RA, 2001, J AM SOC NEPHROL, V12, P1589, DOI 10.1681/ASN.V1281589; Panneton V, 2015, J BIOL CHEM, V290, P20960, DOI 10.1074/jbc.M115.645952; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Quizi JL, 2013, ONCOGENE, V32, P4656, DOI 10.1038/onc.2012.488; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Sabourin LA, 2000, MOL CELL BIOL, V20, P684, DOI 10.1128/MCB.20.2.684-696.2000; Sabourin LA, 1999, ONCOGENE, V18, P7566, DOI 10.1038/sj.onc.1203119; SALANT DJ, 1988, METHOD ENZYMOL, V162, P421; Storbeck CJ, 2009, MOL BIOL CELL, V20, P4174, DOI 10.1091/mbc.E08-07-0707; Storbeck CJ, 2004, MUSCLE NERVE, V29, P553, DOI 10.1002/mus.20000; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Viswanatha R, 2012, J CELL BIOL, V199, P969, DOI 10.1083/jcb.201207047; Wagner S, 2002, J BIOL CHEM, V277, P37685, DOI 10.1074/jbc.M205899200; Wagner S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001868; Weintz G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.29; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Yamada E, 2000, BBA-MOL CELL RES, V1495, P250, DOI 10.1016/S0167-4889(99)00164-0; Yi TF, 2014, P NATL ACAD SCI USA, V111, pE2182, DOI 10.1073/pnas.1404943111; Zhapparova ON, 2013, MOL BIOL CELL, V24, P3205, DOI 10.1091/mbc.E13-03-0137	55	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177226	10.1371/journal.pone.0177226	http://dx.doi.org/10.1371/journal.pone.0177226			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475647	Green Published, Green Submitted, gold			2022-12-27	WOS:000400649500055
J	Honorio, ICG; Bertoni, BW; Telles, MPD; Braga, RD; Franca, SD; Coppede, JD; Correa, VSC; Diniz, JAF; Pereira, AMS				Gomes Honorio, Isabela Cristina; Bertoni, Bianca Waleria; de Campos Telles, Mariana Pires; Braga, Ramilla dos Santos; Franca, Suzelei de Castro; Coppede, Juliana da Silva; Conde Correa, Valeria Siero; Felizola Diniz Filho, Jose Alexandre; Soares Pereira, Ana Maria			Genetic and chemical diversity of Uncaria tomentosa (Willd. ex. Schult.) DC. in the Brazilian Amazon	PLOS ONE			English	Article							SOLAR UV-RADIATION; ALKALOID PROFILE; POPULATION; SOFTWARE; GUIANENSIS; NUMBER; SRAP	Uncaria tomentosa (Willd. ex Schult.) DC., a plant native to the Amazon region, is used widely in popular medicine and by the pharmaceutical industry because of its anti-inflammatory activity. However, the survival of this species is endangered by deforestation and indiscriminate collection, and a preservation plan is urgently required. The objectives of this study were to determine the genetic and chemical variability between and within eight populations of U. tomentosa from the Brazilian states of Acre, Para and Amapa, and to investigate possible correlations between genetic and geographical distances, and between geographical distances or altitude and the accumulation of bioactive oxindole alkaloids. Three sequence-related amplified polymorphism (SRAP) markers were employed to fingerprint genomic DNA, and the amounts of mitraphylline and isomitraphylline in leaf samples were established by high-performance liquid chromatography. Although significant divergence existed between the tested populations (F-ST = 0.246), the largest genetic diversity and the highest percentage of polymorphism (95.68%) was found within the population from Mancio Lima, Acre. Gene flow was considered rather limited (Nm = 1.57), and no correlations between genetic and geographical distances were detected, suggesting that population structure followed an island model. Accumulations of mitraphylline and isomitraphylline varied in the range 32.94 to 0.57 and 3.75 to 0.36 mg g(-1) dry weight, respectively. The concentration of isomitraphylline was positively influenced by altitude, such that the population collected at the site with the highest elevation (Tarauaca, Acre) exhibited the greatest alkaloid content. SRAP markers were very efficient in fingerprinting genomic DNA from U. tomentosa populations and clearly showed that genetic variability within populations was greater than between populations. A conservation and management plan should prioritize the creation of germplasm banks to prevent the loss of existing genetic variability, particularly within alkaloid-rich populations such as those of Tarauaca	[Gomes Honorio, Isabela Cristina] Univ Estadual Paulista, Campus Lageado, Botucatu, SP, Brazil; [Bertoni, Bianca Waleria; Franca, Suzelei de Castro; Coppede, Juliana da Silva; Soares Pereira, Ana Maria] Univ Ribeirao Preto, Unidade Biotecnol, Ribeirao Preto, SP, Brazil; [de Campos Telles, Mariana Pires] Pontificia Univ Catolica Goias, Escola Ciencias Agr & Biol, Goiania, Go, Brazil; [de Campos Telles, Mariana Pires; Braga, Ramilla dos Santos] Univ Fed Goias, Lab Genet & Biodiversidade, Goiania, Go, Brazil; [Conde Correa, Valeria Siero] Reserva EcoCerrado Brasil, Araxa, MG, Brazil; [Felizola Diniz Filho, Jose Alexandre] Univ Fed Goias, Dept Ecol, ICB, Goiania, Go, Brazil	Universidade Estadual Paulista; Universidade de Ribeirao Preto; Pontificia Universidade Catolica de Goias; Universidade Federal de Goias; Universidade Federal de Goias	Pereira, AMS (corresponding author), Univ Ribeirao Preto, Unidade Biotecnol, Ribeirao Preto, SP, Brazil.	apereira@unaerp.br	Honório, Isabela Cristina ICGH Gomes/M-1391-2016; de Campos Telles, Mariana Pires/I-2670-2012; Braga, Ramilla/AAS-1010-2021; Franca, Suzelei C/E-4069-2013; Diniz-Filho, José Alexandre Felizola/D-9405-2013; Soares Pereira, Ana Maria/P-5646-2014	Honório, Isabela Cristina ICGH Gomes/0000-0002-5029-2238; Diniz-Filho, José Alexandre Felizola/0000-0002-0967-9684; Soares Pereira, Ana Maria/0000-0002-3478-4718	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [405167/2013-0]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by a grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Process No 405167/2013-0).; The authors would like to thank Dr. Piero Giuseppe Delprete for botanical identification of Uncaria tomentosa. Authors also thank Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPq) Proc. No 405167/2013-0 for financial support.	Pereira RDA, 2006, CIENC AGROTEC, V30, P637, DOI 10.1590/S1413-70542006000400007; Andola HC, 2010, CHEM BIODIVERS, V7, P415, DOI 10.1002/cbdv.200900041; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bertol G, 2012, PHYTOCHEM ANALYSIS, V23, P143, DOI 10.1002/pca.1335; Blumthaler M, 1997, J PHOTOCH PHOTOBIO B, V39, P130, DOI 10.1016/S1011-1344(96)00018-8; Cardoso SRS, 2000, MOL ECOL, V9, P1753, DOI 10.1046/j.1365-294x.2000.01056.x; Ceylan A, 2014, BIOCHEM SYST ECOL, V54, P219, DOI 10.1016/j.bse.2014.01.014; CHANDRA P, 1980, BIOCHEM SYST ECOL, V8, P379, DOI 10.1016/0305-1978(80)90040-X; Penaloza EMC, 2015, QUIM NOVA, V38, P378, DOI 10.5935/0100-4042.20150007; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; Cruz CD, 2013, ACTA SCI-AGRON, V35, P271, DOI 10.4025/actasciagron.v35i3.21251; da Silva MD, 2013, BIOCHEM SYST ECOL, V51, P189, DOI 10.1016/j.bse.2013.08.032; Dandrea A, 1995, 9 REUN COM CIENT TEC; Diniz JAF, 2013, GENET MOL BIOL, V36, P475, DOI 10.1590/S1415-47572013000400002; Domínguez Torrejón Gilberto, 2010, Rev. Soc. Quím. Perú, V76, P271; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falk DA., 2001, INTRO RESTORATION GE; Falkiewicz B, 2001, AM J CASE REP, V2, P305; Frankham R., 2008, FUNDAMENTOS GENETICA; Ganga Rita Maria Devós, 2004, Rev. Bras. Frutic., V26, P494, DOI 10.1590/S0100-29452004000300029; Honorio ICG, 2016, CIENC RURAL, V46, P1401, DOI 10.1590/0103-8478cr20150138; Gregianini TS, 2003, PHOTOCHEM PHOTOBIOL, V78, P470, DOI 10.1562/0031-8655(2003)078<0470:TABIIB>2.0.CO;2; Hu Y, 2007, BIOMED CHROMATOGR, V21, P967, DOI 10.1002/bmc.841; Laus G, 1997, PHYTOCHEMISTRY, V45, P855, DOI 10.1016/S0031-9422(97)00061-7; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; LINHART YB, 1981, HEREDITY, V46, P407, DOI 10.1038/hdy.1981.49; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Luna-Palencia GR, 2013, BIOTECHNOL LETT, V35, P791, DOI 10.1007/s10529-012-1128-8; Lydon J, 2009, PHOTOCHEM PHOTOBIOL, V85, P1156, DOI 10.1111/j.1751-1097.2009.00562.x; Marcon G, 1988, THESIS; Ministerio da Saude do Brasil, 2014, REL MED ESS RENAME 2; NEI M, 1978, GENETICS, V89, P583; Nejadhabibvash F., 2012, Australian Journal of Crop Science, V6, P1428; Ouwerkerk PBF, 1999, MOL GEN GENET, V261, P610, DOI 10.1007/s004380050003; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pereira RCA, 2006, ASPECTOS BOTANICOS E; Pritchard JK, 2000, GENETICS, V155, P945; Seoane CRS., 2000, SCI FOR, V57, P123; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; TEMPLETON A. R., 2011, GENETICA POPULACOES; Ter Steege Hans, 2015, Sci Adv, V1, pe1500936, DOI 10.1126/sciadv.1500936; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Zhang F, 2011, EUPHYTICA, V177, P15, DOI 10.1007/s10681-010-0239-3; Zhang Q, 2015, J ETHNOPHARMACOL, V173, P48, DOI 10.1016/j.jep.2015.06.011	46	9	9	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177103	10.1371/journal.pone.0177103	http://dx.doi.org/10.1371/journal.pone.0177103			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475604	Green Submitted, gold, Green Published			2022-12-27	WOS:000400649500048
J	Kashkooli, OB; Groger, J; Nunez-Riboni, I				Kashkooli, Omid Beyraghdar; Groeger, Joachim; Nunez-Riboni, Ismael			Qualitative assessment of climate-driven ecological shifts in the Caspian Sea	PLOS ONE			English	Article							GOLDEN GREY MULLET; CTENOPHORE MNEMIOPSIS-LEIDYI; IRANIAN COASTAL WATERS; REGIME SHIFTS; ANCHOVY KILKA; LIZA-AURATA; LEVEL CHANGES; BALTIC SEA; VARIABILITY; MARINE	The worldwide occurrence of complex climate-induced ecological shifts in marine systems is one of the major challenges in sustainable bio-resources management. The occurrence of ecological environment-driven shifts was studied in the Southern Caspian Sea using the "shiftogram" method on available fisheries-related (i.e. commercially important bentho-pelagic fish stocks) ecological and climatic variables. As indicators of potential environmentally driven shift patterns we used indices for the North Atlantic Oscillation, the Southern Oscillation, the Siberian High, the East Atlantic-West Russia pattern, as well as Sea Surface Temperature and surface chlorophyll-a concentration. Given the explorative findings from the serial shift analyses, the cascading and serial order of multiple shift events in climatic-ecologic conditions of the southern Caspian Sea suggested a linkage between external forces and dynamics of ecosystem components and structures in the following order: global-scale climate forces lead to local environmental processes, which in turn lead to biological components dynamics. For the first time, this study indicates that ecological shifts are an integral component of bentho-pelagic subsystem regulatory processes and dynamics. Qualitative correspondence of biological responses of bentho-pelagic stocks to climatic events is one of the supporting evidences that overall Caspian ecosystem structures and functioning might have-at least partially-been impacted by global-scale climatic or local environmental shifts. These findings may help to foster a regional Ecosystem-based Approach to Management (EAM) as an integral part of bentho-pelagic fisheries management plans.	[Kashkooli, Omid Beyraghdar; Groeger, Joachim; Nunez-Riboni, Ismael] Thunen Inst Sea Fisheries, Hamburg, Germany; [Kashkooli, Omid Beyraghdar; Groeger, Joachim] Univ Rostock, Inst Biosci, Rostock, Germany; [Kashkooli, Omid Beyraghdar] Isfahan Univ Technol, Dept Nat Resources, Esfahan, Iran	Johann Heinrich von Thunen Institute; University of Rostock; Isfahan University of Technology	Kashkooli, OB (corresponding author), Thunen Inst Sea Fisheries, Hamburg, Germany.; Kashkooli, OB (corresponding author), Univ Rostock, Inst Biosci, Rostock, Germany.; Kashkooli, OB (corresponding author), Isfahan Univ Technol, Dept Nat Resources, Esfahan, Iran.	omid.kashkooli@thuenen.de	Nunez-Riboni, Ismael/HGB-9167-2022		Ministry of Science, Research and Technology (MSRT) of Iran	Ministry of Science, Research and Technology (MSRT) of Iran	OBK was supported by the Ministry of Science, Research and Technology (MSRT) of Iran with a PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sincere thanks are expressed to the Ministry of Science, Research and Technology (MSRT) of Iran for granting Omid Beyraghdar Kashkooli a PhD scholarship for studying in Germany. This work was achieved in partial fulfillment of the requirements of Omid Beyraghdar Kashkooli's PhD degree submitted to the University of Rostock. Thunen Institute (TI) of Sea Fisheries in Hamburg and University of Rostock are acknowledged for providing all the scientific facilities and requirements during the course of this work. Authors would like to express their thanks to the Caspian Sea Ecology Research Center, Iranian Fisheries Research Organization for providing the regional fisheries datasets and information. Omid Beyraghdar Kashkooli would like thank his co-supervisor Dr. Hasan Fazli (Caspian Sea Ecology Research Center, Iranian Fisheries Research Organization) for providing the fisheries-derived data, his support and scientific guidance during his doctoral research. We are grateful to Dr. Boris Cisewski (TI) for his help with the chlorophyll-a data series. Dr. Maria Shahgedanova (University of Reading) is acknowledged for providing the relevant information regarding the calculation of the Siberian High Index.	Abdolmalaki S, 2007, ICES J MAR SCI, V64, P973, DOI 10.1093/icesjms/fsm062; Afraei Bandpei Mohammad Ali, 2010, International Aquatic Research, V2, P25; Allan RJ, 1996, SO OSCILLATION CLIMA; Arpe K, 2000, GEOPHYS RES LETT, V27, P2693, DOI 10.1029/1999GL002374; Arula T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091304; Askarova MA, 2014, PROCD SOC BEHV, V120, P455, DOI 10.1016/j.sbspro.2014.02.124; Barale V, 2008, REMOTE SENSING EUROP, P3, DOI [10.1007/978-1-4020-6772-3_1, DOI 10.1007/978-1-4020-6772-3_1]; Blenckner T, 2002, GLOBAL CHANGE BIOL, V8, P203, DOI 10.1046/j.1365-2486.2002.00469.x; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Daskalov GM, 2007, ICES J MAR SCI, V64, P503, DOI 10.1093/icesjms/fsl047; de Mora S, 2004, MAR POLLUT BULL, V48, P30, DOI 10.1016/j.marpolbul.2003.10.001; Deyle ER, 2013, P NATL ACAD SCI USA, V110, P6430, DOI 10.1073/pnas.1215506110; deYoung B, 2004, PROG OCEANOGR, V60, P143, DOI 10.1016/j.pocean.2004.02.017; Dippner JW, 2012, J MARINE SYST, V105, P115, DOI 10.1016/j.jmarsys.2012.07.001; Elguindi N, 2006, CLIM DYNAM, V26, P167, DOI 10.1007/s00382-005-0077-5; Fazli H, 2008, J APPL ICHTHYOL, V24, P610, DOI 10.1111/j.1439-0426.2008.01098.x; Fazli H, 2012, STOCK ASSESSMENT REP; Fazli H, 2007, FISHERIES SCI, V73, P285, DOI 10.1111/j.1444-2906.2007.01334.x; Fazli H, 2012, CYBIUM, V36, P545; Fendereski F, 2014, BIOGEOSCIENCES, V11, P6451, DOI 10.5194/bg-11-6451-2014; Finenko GA, 2006, MAR ECOL PROG SER, V314, P171, DOI 10.3354/meps314171; Ghaninejad D, 2010, IRAN J FISH SCI, V9, P402; Groger JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087525; Groger JP, 2010, ICES J MAR SCI, V67, P454, DOI 10.1093/icesjms/fsp259; Groger JP, 2011, ECOL INDIC, V11, P1084, DOI 10.1016/j.ecolind.2010.12.008; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hurrell J. W., 2003, N ATLANTIC OSCILLATI, V134, P1, DOI [10.1029/134GM01, DOI 10.1029/134GM01]; Hurrell JW, 2004, MARINE ECOSYSTEMS AND CLIMATE VARIATION, P15; Hurvich CM., 1993, J TIME SER ANAL, V14, P271, DOI DOI 10.1111/J.1467-9892.1993.TB00144.X; Ibrayev RA, 2010, OCEAN SCI, V6, P311, DOI 10.5194/os-6-311-2010; Jeong JH, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015904; Jiao Y, 2009, REV FISH BIOL FISHER, V19, P177, DOI 10.1007/s11160-008-9096-8; Johnson JE, 2010, REV FISH SCI, V18, P106, DOI 10.1080/10641260903434557; Karpinsky MG, 2005, HANDB ENVIRON CHEM, V5, P191, DOI 10.1007/698_5_010; Khodorevskaya RP, 1999, J APPL ICHTHYOL, V15, P106, DOI 10.1111/j.1439-0426.1999.tb00218.x; Kideys AE, 2003, MAR BIOL, V142, P163, DOI 10.1007/s00227-002-0932-4; Kideys Ahmet Erkan, 2005, Oceanography, V18, P76; King JR, 2006, FISHERIES MANAG ECOL, V13, P93, DOI 10.1111/j.1365-2400.2006.00480.x; Krichak SO, 2005, INT J CLIMATOL, V25, P183, DOI 10.1002/joc.1124; Lees K, 2006, FISH FISH, V7, P104, DOI 10.1111/j.1467-2979.2006.00215.x; Lehodey P, 2006, J CLIMATE, V19, P5009, DOI 10.1175/JCLI3898.1; Leonov AV, 2001, WATER RESOUR, V28, P535; Levin PS, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0275; Lim YK, 2015, CLIM DYNAM, V44, P3211, DOI 10.1007/s00382-014-2381-4; Lindegren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038410; Lydolph P.E., 1977, WORLD SURV CLIMATOL, V7, P1; Mackenzie BR, 2007, GLOBAL CHANGE BIOL, V13, P1348, DOI 10.1111/j.1365-2486.2007.01369.x; Mathews CP, 2006, J APPL ICHTHYOL, V22, P132, DOI 10.1111/j.1439-0426.2007.00941.x; Mollmann C, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0260; Mollmann C, 2012, ADV ECOL RES, V47, P303, DOI 10.1016/B978-0-12-398315-2.00004-1; Mollmann C, 2009, GLOBAL CHANGE BIOL, V15, P1377, DOI 10.1111/j.1365-2486.2008.01814.x; Nasrollahzadeh HS, 2008, CONT SHELF RES, V28, P1153, DOI 10.1016/j.csr.2008.02.015; Nazemosadat MJ, 2004, J CLIMATE, V17, P4005, DOI 10.1175/1520-0442(2004)017<4005:QTESIT>2.0.CO;2; Nezlin NP, 2005, HANDB ENVIRON CHEM, V5, P143; Ottersen G, 2004, MARINE ECOSYSTEMS AND CLIMATE VARIATION, P73; Ottersen G, 2010, J MARINE SYST, V79, P343, DOI 10.1016/j.jmarsys.2008.12.013; Panagiotopoulos F, 2005, J CLIMATE, V18, P1411, DOI 10.1175/JCLI3352.1; Panin GN, 2014, IZV ATMOS OCEAN PHY+, V50, P266, DOI 10.1134/S000143381402008X; Philander S.G, 1989, NINO NINA SO OSCILLA, V46; Pourkazemi M, 2006, J APPL ICHTHYOL, V22, P12, DOI 10.1111/j.1439-0426.2007.00923.x; RASMUSSON EM, 1983, SCIENCE, V222, P1195, DOI 10.1126/science.222.4629.1195; Renssen H, 2007, EARTH PLANET SC LETT, V261, P685, DOI 10.1016/j.epsl.2007.07.037; Ricel JC, 2011, ICES J MAR SCI, V68, P1343, DOI 10.1093/icesjms/fsr041; Roessig JM, 2004, REV FISH BIOL FISHER, V14, P251, DOI 10.1007/s11160-004-6749-0; Roohi A, 2010, BIOL INVASIONS, V12, P2343, DOI 10.1007/s10530-009-9648-4; Ruban GI, 2011, J APPL ICHTHYOL, V27, P199, DOI 10.1111/j.1439-0426.2011.01725.x; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Sissenwine M, 2004, MAR ECOL PROG SER, V274, P291; Stolberg F, 2006, CASPIAN SEA GIWA REG; TRENBERTH KE, 1980, MON WEATHER REV, V108, P855, DOI 10.1175/1520-0493(1980)108<0855:TNHSLP>2.0.CO;2; Ustarbekova DA, 2014, ARID ECOSYST, V4, P44, DOI 10.1134/S2079096114010077; Valipour A, 2006, KUTUM JEWEL CASPIAN; Wilsey CB, 2013, J FISH WILDL MANAG, V4, P220, DOI 10.3996/062012-JFWM-055; Yousefian M, 2008, ASIAN J ANIM VET ADV, V3, P437, DOI 10.3923/ajava.2008.437.442; ZHANG CI, 1988, T AM FISH SOC, V117, P180, DOI 10.1577/1548-8659(1988)117<0180:BBCATI>2.3.CO;2; Zorriehzahra Mohammad Jalil, 2014, VirusDisease, V25, P430, DOI 10.1007/s13337-014-0238-4	77	10	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176892	10.1371/journal.pone.0176892	http://dx.doi.org/10.1371/journal.pone.0176892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475609	Green Published, Green Submitted, gold			2022-12-27	WOS:000400649500024
J	Yu, H; Zhang, YL; Wang, ZF; Liu, LS; Chen, Z; Qi, W				Yu, Haibin; Zhang, Yili; Wang, Zhaofeng; Liu, Linshan; Chen, Zhao; Qi, Wei			Diverse range dynamics and dispersal routes of plants on the Tibetan Plateau during the late Quaternary	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; DNA-SEQUENCE VARIATION; COMPARATIVE PHYLOGEOGRAPHY; EVOLUTIONARY HISTORY; MOLECULAR PHYLOGEOGRAPHY; PICEA-LIKIANGENSIS; POPULATION-GROWTH; ADJACENT REGIONS; GLACIAL REFUGIA; ALPINE PLANTS	Phylogeographical studies have suggested that several plant species on the Tibetan Plateau (TP) underwent recolonization during the Quaternary and may have had distinct range dynamics in response to the last glacial. To further test this hypothesis and locate the possible historical dispersal routes, we selected 20 plant species from different parts of the TP and modeled their geographical distributions over four time periods using species distribution models (SDMs). Furthermore, we applied the least-cost path method together with SDMs and shared haplotypes to estimate their historical dispersal corridors. We identified three general scenarios of species distribution change during the late Quaternary: the 'contraction-expansion' scenario for species in the northeastern TP, the 'expansion-contraction' scenario for species in the southeast and the 'stable' scenario for widespread species. During the Quaternary, we identified that these species were likely to recolonize along the low-elevation valleys, huge mountain ranges and flat plateau platform (e.g. the Yarlung Zangbo Valley and the Himalaya). We inferred that Quaternary cyclic glaciations along with the various topographic and climatic conditions of the TP could have resulted in the diverse patterns of range shift and dispersal of Tibetan plant species. Finally, we believe that this study would provide valuable insights for the conservation of alpine species under future climate change.	[Yu, Haibin; Zhang, Yili; Wang, Zhaofeng; Liu, Linshan; Qi, Wei] Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, Key Lab Land Surface Pattern & Simulat, Beijing, Peoples R China; [Yu, Haibin] Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Zhang, Yili] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Zhao] Guangdong Inst Ecoenvironm Sci & Technol, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Sun Yat Sen University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangdong Academy of Sciences; Institute of Eco-environmental & Soil Sciences, Guangdong Academy of Sciences	Zhang, YL (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, Key Lab Land Surface Pattern & Simulat, Beijing, Peoples R China.; Zhang, YL (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	zhangyl@igsnrr.ac.cn	Qi, Wei/S-7651-2017	Qi, Wei/0000-0003-4898-6350; zhang, yili/0000-0002-9474-1664	Open Foundation of Key Laboratory of Land Surface Pattern and Simulation (CAS); Strategic Priority Research Program of the Chinese Academy of Sciences [XDB03030500]; National Natural Science Foundation of China [41271068, 41371120]	Open Foundation of Key Laboratory of Land Surface Pattern and Simulation (CAS); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Open Foundation of Key Laboratory of Land Surface Pattern and Simulation (CAS), the Strategic Priority Research Program of the Chinese Academy of Sciences (No.XDB03030500) and the National Natural Science Foundation of China (No.41271068, No.41371120).	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; [Anonymous], 2021, LANG ENV STAT COMP; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Chan LM, 2011, MOL PHYLOGENET EVOL, V59, P523, DOI 10.1016/j.ympev.2011.01.020; Chen JM, 2014, J SYST EVOL, V52, P313, DOI 10.1111/jse.12093; Chen JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060948; Chen SY, 2008, BOT J LINN SOC, V157, P125, DOI 10.1111/j.1095-8339.2008.00785.x; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; Du FK, 2017, J BIOGEOGR, V44, P294, DOI 10.1111/jbi.12836; Du ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20883; Duan YZ, 2011, NORD J BOT, V29, P615, DOI 10.1111/j.1756-1051.2011.00999.x; Etherington TR, 2013, LANDSCAPE ECOL, V28, P1223, DOI 10.1007/s10980-013-9880-2; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Fu YX, 1997, GENETICS, V147, P915; Gao QB, 2012, BOT J LINN SOC, V168, P204, DOI 10.1111/j.1095-8339.2011.01193.x; Gao YD, 2015, SCI REP-UK, V5, DOI 10.1038/srep11698; Hampe A, 2003, MOL ECOL, V12, P3415, DOI 10.1046/j.1365-294X.2003.02006.x; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; Ho T.N., 2001, WORLDWIDE MONOGRAPH; Li B., 1991, MAP QUATERNARY GLACI; Li HL, 2010, ECOL MODEL, V221, P944, DOI 10.1016/j.ecolmodel.2009.12.006; Li L, 2013, MOL ECOL, V22, P5237, DOI 10.1111/mec.12466; Liang H, 1995, ACTA BOT YUNN, V17, P380; Lin Z-Y, 1990, GEOGRAPHICAL RES, V9, P33; Liu JQ, 2014, J SYST EVOL, V52, P241, DOI 10.1111/jse.12094; Liu J, 2013, NEW PHYTOL, V199, P1093, DOI 10.1111/nph.12336; Liu YP, 2015, BIOCHEM SYST ECOL, V59, P159, DOI 10.1016/j.bse.2015.01.014; Liu Z, 2001, ACTA ECOL SIN, V22, P715; LUEBERT F, 2014, FRONTIERS ECOLOGY EV, V2, P27, DOI DOI 10.3389/FEVO.2014.00027; Matuszak S, 2016, J BIOGEOGR, V43, P580, DOI 10.1111/jbi.12617; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; Opgenoorth L, 2010, NEW PHYTOL, V185, P332, DOI 10.1111/j.1469-8137.2009.03007.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Shi Y.F., 1998, UPLIFT ENV CHANGES Q; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Song Z, 1982, EARLY TERTIARY PALYN; Sun YS, 2010, PLANT ECOL DIVERS, V3, P249, DOI 10.1080/17550874.2010.516279; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; Tang L, 1995, ACTA MICROPALAEONTOL, V13, P321; Tang LY, 1998, J GLACIOL GEOCRYOL, V20, P133; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Vignieri SN, 2005, MOL ECOL, V14, P1925, DOI 10.1111/j.1365-294X.2005.02568.x; Wan DS, 2016, ECOL EVOL, V6, P1977, DOI 10.1002/ece3.2019; [万和文 Wan Hewen], 2008, [第四纪研究, Quaternary Sciences], V28, P112; Wang GN, 2014, J SYST EVOL, V52, P289, DOI 10.1111/jse.12089; Wang IJ, 2009, MOL ECOL, V18, P1365, DOI 10.1111/j.1365-294X.2009.04122.x; Wen J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00004; Wu LL, 2010, MOL ECOL, V19, P1691, DOI 10.1111/j.1365-294X.2010.04613.x; Wu Z. Y., 1988, THE FLORA OF TIBET; Yan YJ, 2013, ECOL EVOL, V3, P4584, DOI 10.1002/ece3.847; Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI [10.1038/NCLIMATE1580, 10.1038/nclimate1580]; Yu G, 2000, J BIOGEOGR, V27, P635, DOI 10.1046/j.1365-2699.2000.00431.x; Yu Hai-bin, 2014, Yingyong Shengtai Xuebao, V25, P1669; Yu HB, 2015, ECOL EVOL, V5, pS781, DOI 10.1002/ece3.1840; Yu Haibin, 2013, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V33, P1268; Yue LL, 2014, J SYST EVOL, V52, P326, DOI 10.1111/jse.12038; Yue LL, 2012, AM J BOT, V99, P1726, DOI 10.3732/ajb.1100506; Zhang DC, 2016, J BIOGEOGR, V43, P2465, DOI 10.1111/jbi.12819; Zhang FQ, 2012, J SYST EVOL, V50, P276, DOI 10.1111/j.1759-6831.2012.00194.x; Zhang JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112923; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x; Zhang XM, 2013, J SYST EVOL, V51, P564, DOI 10.1111/jse.12026; [张镱锂 Zhang Yili], 2002, [地理研究, Geographical Research], V21, P1; Zhao C, 2013, J SYST EVOL, V51, P382, DOI 10.1111/jse.12005; Zou JB, 2012, J SYST EVOL, V50, P341, DOI 10.1111/j.1759-6831.2012.00207.x	75	17	20	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177101	10.1371/journal.pone.0177101	http://dx.doi.org/10.1371/journal.pone.0177101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475607	Green Submitted, Green Published, gold			2022-12-27	WOS:000400649500046
J	Iwamoto, N; Tsuji, S; Takatani, A; Shimizu, T; Fukui, S; Umeda, M; Nishino, A; Horai, Y; Koga, T; Kawashiri, SY; Aramaki, T; Ichinose, K; Hirai, Y; Tamai, M; Nakamura, H; Terada, K; Origuchi, T; Eguchi, K; Ueki, Y; Kawakami, A				Iwamoto, Naoki; Tsuji, Sosuke; Takatani, Ayuko; Shimizu, Toshimasa; Fukui, Shoichi; Umeda, Masataka; Nishino, Ayako; Horai, Yoshiro; Koga, Tomohiro; Kawashiri, Shin-ya; Aramaki, Toshiyuki; Ichinose, Kunihiro; Hirai, Yasuko; Tamai, Mami; Nakamura, Hideki; Terada, Kaoru; Origuchi, Tomoki; Eguchi, Katsumi; Ueki, Yukitaka; Kawakami, Atsushi			Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis	PLOS ONE			English	Article							METHOTREXATE; CP-690,550; PLACEBO; COMBINATION; INHIBITION; ADALIMUMAB; OUTCOMES	Objective We evaluated the efficacy and safety of tofacitinib in patients with rheumatoid arthritis (RA) in a real-world setting. Methods Seventy consecutive patients, for whom tofacitinib was initiated between November 2013 and May 2016, were enrolled. All patients fulfilled the 2010 ACR/EULAR classification criteria for RA. All patients received 5 mg of tofacitinib twice daily and were followed for 24 weeks. Clinical disease activity indicated by disease activity score (DAS) 28-ESR, the simplified disease activity index, and the clinical disease activity index as well as adverse events (AEs) were evaluated. Statistical analysis was performed to determine which baseline variables influenced the efficacy of tofacitinib at 24 weeks. Results Fifty-eight patients (82.9%) continued tofacitinib at 24 weeks. Clinical disease activity rapidly and significantly decreased, and this efficacy continued throughout the 24 weeks: i.e., DAS28-ESR decreased from 5.04 +/- 1.33 at baseline to 3.83 +/- 1.11 at 4 weeks and 3.53 +/- 1.17 at 24 weeks (P<0.0001, vs. baseline). 15 AEs including 5 herpes zoster infection occurred during tofacitinib treatment. The efficacy of tofacitinib was not changed in patients without concomitant use of methotrexate (MTX) or patients whose treatment with tocilizumab (TCZ) failed. Multivariable logistic analysis showed that the number of biologic DMARDs (bDMARDs) previously used was independently associated with achievement of DAS-low disease activity. Conclusions Our present study suggests that tofacitinib is effective in real-world settings even without concomitant MTX use or after switching from TCZ. Our results also suggest that its efficacy diminishes if started after use of multiple bDMARDs.	[Iwamoto, Naoki; Takatani, Ayuko; Shimizu, Toshimasa; Fukui, Shoichi; Umeda, Masataka; Nishino, Ayako; Horai, Yoshiro; Koga, Tomohiro; Ichinose, Kunihiro; Hirai, Yasuko; Tamai, Mami; Nakamura, Hideki; Kawakami, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Unit Adv Prevent Med Sci, Nagasaki, Japan; [Tsuji, Sosuke; Aramaki, Toshiyuki; Terada, Kaoru; Eguchi, Katsumi; Ueki, Yukitaka] Sasebo Chuo Hosp, Dept Rheumatol, Sasebo, Japan; [Kawashiri, Shin-ya] Nagasaki Univ, Grad Sch Biomed Sci, Dept Community Med, Unit Adv Prevent Med Sci, Nagasaki, Japan; [Origuchi, Tomoki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Phys Therapy, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Iwamoto, N (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Unit Adv Prevent Med Sci, Nagasaki, Japan.	naoki-iwa@nagasaki-u.ac.jp	Koga, Tomohiro/V-9397-2019; Umeda, Masataka/GVT-5444-2022; Ichinose, Kunihiro/I-2126-2019; Koga, Tomohiro/AAU-9697-2020	Umeda, Masataka/0000-0002-6647-7130; Ichinose, Kunihiro/0000-0001-8794-7106; Koga, Tomohiro/0000-0003-2077-4428	Grants-in-Aid for Scientific Research [16K19605, 17K16210] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aletaha D, 2005, CLIN EXP RHEUMATOL, V23, pS100; Burmester GR, 2013, LANCET, V381, P451, DOI 10.1016/S0140-6736(12)61424-X; Conklyn M, 2004, J LEUKOCYTE BIOL, V76, P1248, DOI 10.1189/jlb.0504282; Curtis JR, 2016, ANN RHEUM DIS, V75, P831, DOI 10.1136/annrheumdis-2014-205847; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Emery P, 2015, ANN RHEUM DIS, V74, P979, DOI 10.1136/annrheumdis-2013-203993; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Hyrich KL, 2007, ARTHRITIS RHEUM-US, V56, P13, DOI 10.1002/art.22331; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Karisson JA, 2008, RHEUMATOLOGY, V47, P507, DOI 10.1093/rheumatology/ken034; Keystone E, 2009, ANN RHEUM DIS, V68, P216, DOI 10.1136/ard.2007.085787; Kiltz U, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-209467; Kremer J, 2013, ANN INTERN MED, V159, P253, DOI 10.7326/0003-4819-159-4-201308200-00006; Lee EB, 2014, NEW ENGL J MED, V370, P2377, DOI 10.1056/NEJMoa1310476; Lee YH, 2015, RHEUMATOL INT, V35, P1965, DOI 10.1007/s00296-015-3291-4; Maeshima K, 2012, ARTHRITIS RHEUM-US, V64, P1790, DOI 10.1002/art.34329; Malmgaard L, 2004, J INTERF CYTOK RES, V24, P439, DOI 10.1089/1079990041689665; Paniagua R, 2005, TRANSPLANTATION, V80, P1283, DOI 10.1097/01.tp.0000177643.05739.cd; SCOTT DL, 2010, ANN RHEUM DIS, V69, DOI DOI 10.1016/S0140-6736(10)60826-4; Singh JA, 2016, ARTHRIT CARE RES, V68, P1, DOI 10.1002/acr.22783; Takeuchi T, 2012, MOD RHEUMATOL, V22, P327, DOI 10.1007/s10165-011-0516-6; van der Heijde D, 2013, ARTHRITIS RHEUM-US, V65, P559, DOI 10.1002/art.37816; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Winthrop KL, 2014, ARTHRITIS RHEUMATOL, V66, P2675, DOI 10.1002/art.38745	24	18	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177057	10.1371/journal.pone.0177057	http://dx.doi.org/10.1371/journal.pone.0177057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472115	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500131
J	Kim, HJ; Jo, MJ; Kim, BR; Kim, JL; Jeong, YA; Na, YJ; Park, SH; Lee, SY; Lee, DH; Lee, HS; Kim, BH; Lee, SI; Min, BW; Do Yoo, Y; Oh, SC				Kim, Hong Jun; Jo, Min Jee; Kim, Bo Ram; Kim, Jung Lim; Jeong, Yoon A.; Na, Yoo Jin; Park, Seong Hye; Lee, Suk-young; Lee, Dae-Hee; Lee, Hye Seung; Kim, Beek-hui; Lee, Sun Il; Min, Byung Wook; Do Yoo, Young; Oh, Sang Cheul			Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients	PLOS ONE			English	Article							NF-KAPPA-B; III COLON-CANCER; LYMPH-NODE RATIO; OXIDATIVE STRESS; ADJUVANT TREATMENT; VASCULAR INVASION; STAGE-II; TUMOR; FLUOROURACIL; OXALIPLATIN	Background Reactive oxygen species modulator-1 (Romo1) is a novel protein that has been reported to be crucial for cancer cell proliferation and invasion. However, its clinical implications in colorectal cancer patients are not well-known. For the first time, we investigated the association between Romo1 and the clinical outcomes of colorectal cancer patients. Study We examined Romo1 expression in resected tumor tissues immunohistochemically and assessed it with histological scores. We conducted survival analyses for patients who had curative resection (n = 190) in accordance with clinical parameters including level of Romo1 expression, and we examined the association between Romo1 expression and cell invasion using Matrigel invasion assay in colorectal cancer cells. Results We observed significantly longer mean disease-free survival in the low Romo1 group compared with the high Romo1 group (161 vs 127.6 months, p = 0.035), and the median overall survival of the low Romo1 group was significantly longer than that of the high Romo1 group (196.9 vs 171.3 months, p = 0.036). Cell invasiveness decreased in the Romo1 knockdown colorectal cancer cells in contrast to the controlled cells. Romo1 overexpression in tumor tissue was associated with a high lymph node ratio between the metastatic and examined lymph nodes (p = 0.025). Conclusions Romo1 overexpression in tumor tissue was significantly associated with survival in curatively resected colorectal cancer patients, suggesting Romo1 expression as a potential adverse prognostic marker. Increased Romo1 expression was found to be associated with high lymph node ratio. Cancer invasiveness appeared to be a key reason for the poor survival related to highly expressed Romo1.	Korea Univ, Coll Med, Dept Internal Med, Div Oncol Hematol, Seoul, South Korea; [Jo, Min Jee; Kim, Bo Ram; Kim, Jung Lim; Jeong, Yoon A.; Na, Yoo Jin; Park, Seong Hye; Lee, Dae-Hee; Oh, Sang Cheul] Korea Univ, Korea Univ Coll Med, Grad Sch Med, Seoul, South Korea; [Lee, Hye Seung; Kim, Beek-hui] Korea Univ, Korea Univ Guro Hosp, Coll Med, Dept Pathol, Seoul, South Korea; [Lee, Sun Il; Min, Byung Wook] Korea Univ, Korea Univ Guro Hosp, Coll Med, Dept Surg, Seoul, South Korea; [Do Yoo, Young] Korea Univ, Grad Sch Med, Lab Mol Cell Biol, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Oh, SC (corresponding author), Korea Univ, Korea Univ Coll Med, Grad Sch Med, Seoul, South Korea.	sachoh@korea.ac.kr		Yoo, Doo-Yeol/0000-0003-2814-5482; Min, Byung Wook/0000-0002-3621-5113	Business for Cooperative RAMP;D between Industry, Academy, and Research Institute [C0421445]; Brain Korea (BK) 21 Plus Program	Business for Cooperative RAMP;D between Industry, Academy, and Research Institute; Brain Korea (BK) 21 Plus Program	This work was supported (Grants No. C0421445) by Business for Cooperative R&D between Industry, Academy, and Research Institute funded Korea Small and Medium Business Administration in 20. This research was supported by the Brain Korea (BK) 21 Plus Program also.	Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Benedix F, 2010, DIS COLON RECTUM, V53, P57, DOI 10.1007/DCR.0b013e3181c703a4; Chung JS, 2014, BIOCHEM BIOPH RES CO, V450, P1656, DOI 10.1016/j.bbrc.2014.07.059; Chung JS, 2012, GASTROENTEROLOGY, V143, P1084, DOI 10.1053/j.gastro.2012.06.038; Chung YM, 2006, BIOCHEM BIOPH RES CO, V347, P649, DOI 10.1016/j.bbrc.2006.06.140; Dua RS, 2005, EJSO-EUR J SURG ONC, V31, P824, DOI 10.1016/j.ejso.2005.05.015; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fujii T, 2014, ANTICANCER RES, V34, P1255; Hwang IT, 2007, BIOCHEM BIOPH RES CO, V359, P304, DOI 10.1016/j.bbrc.2007.05.088; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Karkkainen MJ, 2002, NAT CELL BIOL, V4, pE2, DOI 10.1038/ncb0102-e2; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; Ladas EJ, 2004, J CLIN ONCOL, V22, P517, DOI 10.1200/JCO.2004.03.086; Lee HY, 2007, ANN SURG ONCOL, V14, P1712, DOI 10.1245/s10434-006-9322-3; Lee SH, 2015, LUNG CANCER, V87, P45, DOI 10.1016/j.lungcan.2014.11.004; Lee SH, 2014, LUNG CANCER, V85, P175, DOI 10.1016/j.lungcan.2014.05.023; Lee SH, 2016, CANC RES TREATMENT O; Lee S, 2015, INT J ONCOL, V46, P2021, DOI 10.3892/ijo.2015.2889; Lupinacci RM, 2014, WORLD J SURG, V38, P2089, DOI 10.1007/s00268-014-2511-5; Na AR, 2008, BIOCHEM BIOPH RES CO, V369, P672, DOI 10.1016/j.bbrc.2008.02.098; O'Connor ES, 2011, J CLIN ONCOL; Park YJ, 1999, WORLD J SURG, V23, P721, DOI 10.1007/PL00012376; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Sasaki N, 2001, CLIN CANCER RES, V7, P4136; Shyamsunder P, 2015, CANCER LETT, V361, P33, DOI 10.1016/j.canlet.2015.02.020; Sosa V, 2013, AGEING RES REV, V12, P376, DOI 10.1016/j.arr.2012.10.004; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Ushio-Fukai M, 2007, ANTIOXID REDOX SIGN, V9, P731, DOI 10.1089/ars.2007.1556; Wang JP, 2008, ANN SURG ONCOL, V15, P1600, DOI 10.1245/s10434-007-9716-x; Wang ZB, 2001, BIOCHEM BIOPH RES CO, V285, P669, DOI 10.1006/bbrc.2001.5232; Wolpin BM, 2008, GASTROENTEROLOGY, V134, P1296, DOI 10.1053/j.gastro.2008.02.098; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Yamaki S, 2013, SURG TODAY, V43, P901, DOI 10.1007/s00595-012-0378-3; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497	43	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176834	10.1371/journal.pone.0176834	http://dx.doi.org/10.1371/journal.pone.0176834			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472059	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500081
J	Perez-Padilla, R; Fernandez-Plata, R; de Oca, MM; Lopez-Varela, MV; Jardim, JR; Muino, A; Valdivia, G; Menezes, AMB				Perez-Padilla, Rogelio; Fernandez-Plata, Rosario; Montes de Oca, Maria; Victorina Lopez-Varela, Maria; Jardim, Jose R.; Muino, Adriana; Valdivia, Gonzalo; Menezes, Ana Maria B.		PLATINO Grp	Lung function decline in subjects with and without COPD in a population-based cohort in Latin-America	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; FEV1 DECLINE; SPIROMETRY; CITIES; RISK; TUBERCULOSIS; ASSOCIATION; DIAGNOSIS; PHENOTYPE	Background Lung-function decline is one of the possible mechanisms leading to Chronic Obstructive Pulmonary Disease (COPD). Methods We analyzed data obtained from two population-based surveys of adults (n = 2026) conducted in the same individuals 5-9 years (y) after their baseline examination in three Latin-American cities. Post BronchoDilator (postBD) FEV1 decline in mL/y, as % predicted/y (% P/y) and % of baseline/y (% B/y) was calculated and the influence of age, gender, BMI, baseline lung function, BD response, exacerbations rate evaluated using multivariate models. Results Expressed in ml/y, the mean annual postBD FEV1 decline was 27 mL (0.22%P, 1.32%B) in patients with baseline COPD and 36 (0.14%P, 1.36%B) in those without. Faster decline (in mL/y) was associated with higher baseline lung function, with significant response to bron-chodilators, older age and smoking at baseline, also in women with chronic cough and phlegm, or >= 2 respiratory exacerbations in the previous year, and in men with asthma. Conclusions Lung function decline in a population- based cohort did not differ in obstructed and nonobstructed individuals, it was proportional to baseline FEV1, and was higher in smokers, elderly, and women with respiratory symptoms.	[Perez-Padilla, Rogelio; Fernandez-Plata, Rosario] Natl Inst Resp Dis, Mexico City, DF, Mexico; [Montes de Oca, Maria] Univ Cent Venezuela, Hosp Univ Caracas, Pulm Div, Caracas, Venezuela; [Victorina Lopez-Varela, Maria; Muino, Adriana] Univ Republica, Fac Med, Montevideo, Uruguay; [Jardim, Jose R.] Univ Fed Sao Paulo, Sch Med, Pelotas, Brazil; [Menezes, Ana Maria B.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil	University of Central Venezuela; Universidad de la Republica, Uruguay; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Pelotas	Perez-Padilla, R (corresponding author), Natl Inst Resp Dis, Mexico City, DF, Mexico.	perezpad@gmail.com	Menezes, Ana MB/G-7266-2012; de, Maria Montes/AAP-7687-2021	Menezes, Ana MB/0000-0002-2996-9427; Perez-Padilla, Rogelio/0000-0002-1132-5308; Reis, AlessanRSS/0000-0001-8486-7469; Valdivia, Gonzalo/0000-0001-5368-6745	ALAT; Boehringer; GSK; Novartis	ALAT; Boehringer(Boehringer Ingelheim); GSK(GlaxoSmithKline); Novartis(Novartis)	The study was sponsored by ALAT, Boehringer, GSK, and Novartis. This does not alter our adherence to PLUS ONE policies on sharing data and materials, in a public repository.	Allwood BW, 2013, RESPIRATION, V86, P76, DOI 10.1159/000350917; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Casanova C, 2011, AM J RESP CRIT CARE, V184, P1015, DOI 10.1164/rccm.201105-0831OC; Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146; Grol MH, 1999, AM J RESP CRIT CARE, V160, P1830, DOI 10.1164/ajrccm.160.6.9812100; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Menezes Ana M B, 2004, BMC Med Res Methodol, V4, P15, DOI 10.1186/1471-2288-4-15; Menezes AMB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109732; Menezes AMB, 2014, CHEST, V145, P297, DOI 10.1378/chest.13-0622; Menezes AMB, 2014, ARCH BRONCONEUMOL, V50, P10, DOI 10.1016/j.arbres.2013.07.014; de Oca MM, 2012, EUR RESPIR J, V40, P28, DOI 10.1183/09031936.00141611; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Perez-Padilla Rogelio, 2007, COPD, V4, P113, DOI 10.1080/15412550701341012; Perez-Padilla R, 2006, ARCH BRONCONEUMOL, V42, P317, DOI 10.1157/13090581; Perez-Padilla R, 2012, ARCH MED RES, V43, P159, DOI 10.1016/j.arcmed.2012.03.007; Postma DS, 2015, LANCET, V385, P899, DOI 10.1016/S0140-6736(14)60446-3; Ramirez-Venegas A, 2014, AM J RESP CRIT CARE, V190, P996, DOI 10.1164/rccm.201404-0720OC; Skloot GS, 2009, CHEST, V135, P492, DOI 10.1378/chest.08-1391; Tantucci C, 2012, INT J CHRONIC OBSTR, V7, P95, DOI 10.2147/COPD.S27480; Thomsen LH, 2014, COPD, V11, P96, DOI 10.3109/15412555.2013.830096; Vestbo J, 1996, AM J RESP CRIT CARE, V153, P1530, DOI 10.1164/ajrccm.153.5.8630597; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Vollmer WM, 2009, EUR RESPIR J, V34, P588, DOI 10.1183/09031936.00164608	27	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177032	10.1371/journal.pone.0177032	http://dx.doi.org/10.1371/journal.pone.0177032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472184	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500124
J	Rios-Anjos, RM; Camandona, VDL; Bleicher, L; Ferreira, JR				Rios-Anjos, Rafaela Maria; Camandona, Vittoria de Lima; Bleicher, Lucas; Ferreira-Junior, Jose Ribamar			Structural and functional mapping of Rtg2p determinants involved in retrograde signaling and aging of Saccharomyces cerevisiae	PLOS ONE			English	Article							REPLICATIVE LIFE-SPAN; MITOCHONDRIAL DYSFUNCTION; ESCHERICHIA-COLI; DEPENDENT MITOCHONDRIA; STRUCTURE PREDICTION; RESPONSE PATHWAY; GENE-EXPRESSION; YEAST LONGEVITY; PROTEIN; NUCLEUS	In Saccharomyces cerevisiae mitochondrial dysfunction induces retrograde signaling, a pathway of communication from mitochondria to the nucleus that promotes a metabolic remodeling to ensure sufficient biosynthetic precursors for replication. Rtg2p is a positive modulator of this pathway that is also required for cellular longevity. This protein belongs to the ASKHA superfamily, and contains a putative N-terminal ATP-binding domain, but there is no detailed structural and functional map of the residues in this domain that accounts for their contribution to retrograde signaling and aging. Here we use Decomposition of Residue Correlation Networks and site-directed mutagenesis to identify Rtg2p structural determinants of retrograde signaling and longevity. We found that most of the residues involved in retrograde signaling surround the ATP-binding loops, and that Rtg2p N-terminus is divided in three regions whose mutants have different aging phenotypes. We also identified E137, D158 and S163 as possible residues involved in stabilization of ATP at the active site. The mutants shown here may be used to map other Rtg2p activities that crosstalk to other pathways of the cell related to genomic stability and aging.	[Rios-Anjos, Rafaela Maria; Camandona, Vittoria de Lima; Ferreira-Junior, Jose Ribamar] Univ Sao Paulo, Escola Aries Ciencias & Humanidades, Sao Paulo, Brazil; [Bleicher, Lucas] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil	Universidade de Sao Paulo; Universidade Federal de Minas Gerais	Ferreira, JR (corresponding author), Univ Sao Paulo, Escola Aries Ciencias & Humanidades, Sao Paulo, Brazil.	zeribajr@usp.br	Bleicher, Lucas/AAH-9397-2021; Bleicher, Lucas/R-5153-2019; Ferreira-Junior, Jose Ribamar S/B-6951-2012; Bleicher, Lucas/B-7967-2013	Bleicher, Lucas/0000-0001-7121-4952; Ferreira-Junior, Jose Ribamar S/0000-0001-5539-5298; Bleicher, Lucas/0000-0001-7121-4952	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br) to JRFJ.	AKIYAMA M, 1993, J BIOL CHEM, V268, P633; Alvarado J, 2006, STRUCTURE, V14, P1263, DOI 10.1016/j.str.2006.06.009; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bhattacharya D, 2013, PROTEINS, V81, P119, DOI 10.1002/prot.24167; Bhattacharyya S, 2002, GENETICS, V162, P579; Bleicher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027786; Borghouts C, 2004, GENETICS, V166, P765, DOI 10.1534/genetics.166.2.765; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486; CONRADWEBB H, 1995, MOL CELL BIOL, V15, P2420; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Ferreira JR, 2005, GENE, V354, P2, DOI 10.1016/j.gene.2005.03.048; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Giannattasio S, 2005, J BIOL CHEM, V280, P42528, DOI 10.1074/jbc.M509187200; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GLAB N, 1993, MOL GEN GENET, V236, P299, DOI 10.1007/BF00277126; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jazwinski SM, 2005, FEMS YEAST RES, V5, P1253, DOI 10.1016/j.femsyr.2005.07.001; Jia YK, 1997, MOL CELL BIOL, V17, P1110, DOI 10.1128/MCB.17.3.1110; Jiang JC, 2016, GENETICS, V204, P659, DOI 10.1534/genetics.116.188086; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kirchman PA, 1999, GENETICS, V152, P179; KOONIN EV, 1994, TRENDS BIOCHEM SCI, V19, P156, DOI 10.1016/0968-0004(94)90275-5; Kristensen O, 2004, BIOCHEMISTRY-US, V43, P8894, DOI 10.1021/bi049083c; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; LIAO XS, 1991, MOL CELL BIOL, V11, P38, DOI 10.1128/MCB.11.1.38; Liu ZC, 2003, MOL CELL, V12, P401, DOI 10.1016/S1097-2765(03)00285-5; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Liu ZC, 2001, EMBO J, V20, P7209, DOI 10.1093/emboj/20.24.7209; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; Rangarajan ES, 2006, J MOL BIOL, V359, P1249, DOI 10.1016/j.jmb.2006.04.031; Rupp S, 2002, METHOD ENZYMOL, V350, P112, DOI 10.1016/S0076-6879(02)50959-9; Schuler H, 2001, BBA-PROTEIN STRUCT M, V1549, P137, DOI 10.1016/S0167-4838(01)00255-2; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Sekito T, 2002, MOL BIOL CELL, V13, P795, DOI 10.1091/mbc.01-10-0473; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 2013, METHODS MOL BIOL, V1048, P49, DOI 10.1007/978-1-62703-556-9_5; Sippl MJ, 2012, STRUCTURE, V20, P718, DOI 10.1016/j.str.2012.01.024; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Wiederstein M, 2014, STRUCTURE, V22, P1063, DOI 10.1016/j.str.2014.05.005; Wykoff DD, 2001, GENETICS, V159, P1491; Zhang F, 2013, GENES-BASEL, V4, P86, DOI 10.3390/genes4010086; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	55	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177090	10.1371/journal.pone.0177090	http://dx.doi.org/10.1371/journal.pone.0177090			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472157	Green Submitted, gold, Green Published			2022-12-27	WOS:000400648500133
J	Tabori, H; Arnold, C; Jaudszus, A; Mentzel, HJ; Renz, DM; Reinsch, S; Lorenz, M; Michl, R; Gerber, A; Lehmann, T; Mainz, JG				Tabori, Harold; Arnold, Christin; Jaudszus, Anke; Mentzel, Hans-Joachim; Renz, Diane M.; Reinsch, Steffen; Lorenz, Michael; Michl, Ruth; Gerber, Andrea; Lehmann, Thomas; Mainz, Jochen G.			Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings	PLOS ONE			English	Article							QUALITY-OF-LIFE; G551D MUTATION; LIVER-DISEASE; INTESTINAL INFLAMMATION; SCHOOL-CHILDREN; CHRONIC PAIN; CFTR; ADOLESCENTS; MANIFESTATIONS; CIPROFLOXACIN	Background & aims Abdominal symptoms ( AS) are a hallmark of the multiorgan-disease cystic fibrosis CF). However, the abdominal involvement in CF is insufficiently understood and, compared to the pulmonary manifestation, still receives little scientific attention. Aims were to assess and quantify AS and to relate them to laboratory parameters, clinical findings, and medical history. Methods A total of 131 patients with CF of all ages were assessed with a new CF-specific questionnaire JenAbdomen- CF score 1.0) on abdominal pain and non-pain symptoms, disorders of appetite, eating, and bowel movements as well as symptom-related quality of life. Results were metrically dimensioned and related to abdominal manifestations, history of surgery, P. aeruginosa and S. aureus colonization, genotype, liver enzymes, antibiotic therapy, lung function, and nutritional status. Results AS during the preceding 3 months were reported by all of our patients. Most common were lack of appetite 130/131) and loss of taste 119/131) followed by abdominal pain 104/131), flatulence 102/131), and distention 83/131). Significantly increased AS were found in patients with history of rectal prolapse p = 0.013), distal intestinal obstruction syndrome p = 0.013), laparotomy p = 0.022), meconium ileus p = 0.037), pancreas insufficiency p = 0.042), or small bowel resection p = 0.048) as well as in patients who have been intermittently colonized with P. aeruginosa p = 0.006) compared to patients without history of these events. In contrast, no statistically significant associations were found to CF-associated liver disease, chronic pathogen colonization, lung function, CF-related diabetes, and nutritional status. Conclusion As the complex abdominal involvement in CF is still not fully understood, the assessment of the common AS is of major interest. In this regard, symptom questionnaires like the herein presented are meaningful and practical tools facilitating a wider understanding of the abdominal symptoms in CF. Furthermore, they render to evaluate possible abdominal effects of novel modulators of the underlying cystic fibrosis transmembrane (conductance) regulator (CFTR) defect.	[Tabori, Harold; Arnold, Christin; Jaudszus, Anke; Lorenz, Michael; Michl, Ruth; Gerber, Andrea; Mainz, Jochen G.] Jena Univ Hosp, Cyst Fibrosis Ctr, Jena, Germany; [Mentzel, Hans-Joachim; Renz, Diane M.] Jena Univ Hosp, Pediat Radiol, Jena, Germany; [Reinsch, Steffen] Jena Univ Hosp, Pediat Gastroenterol, Jena, Germany; [Lehmann, Thomas] Jena Univ Hosp, Inst Med Stat, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Mainz, JG (corresponding author), Jena Univ Hosp, Cyst Fibrosis Ctr, Jena, Germany.	Jochen.Mainz@med.uni-jena.de	Mainz, Jochen G/AFO-0929-2022	Lorenz, Michael/0000-0001-6153-2068; Mainz, Jochen G./0000-0003-3780-7759	German Academic Exchange Service (DAAD) [57130097]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This research was supported by the German Academic Exchange Service (DAAD, Grant: 57130097) to HT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APLEY J, 1958, ARCH DIS CHILD, V33, P165, DOI 10.1136/adc.33.168.165; Blackwell LS, 2015, PEDIATR PULM, V50, P244, DOI 10.1002/ppul.23091; Borowitz D, 2002, J PEDIATR GASTR NUTR, V35, P246, DOI 10.1097/00005176-200209000-00004; Borzio M, 1997, ITAL J GASTROENTEROL, V29, P262; Britto MT, 2002, CHEST, V121, P64, DOI 10.1378/chest.121.1.64; Bruzzese E, 2004, ALIMENT PHARM THER, V20, P813, DOI 10.1111/j.1365-2036.2004.02174.x; Bruzzese E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087796; Chaudry G, 2006, PEDIATR RADIOL, V36, P233, DOI 10.1007/s00247-005-0049-2; Chumpitazi BP, 2010, J PEDIATR-US, V157, P594, DOI 10.1016/j.jpeds.2010.04.040; Colombo C, 2007, CURR OPIN PULM MED, V13, P529, DOI 10.1097/MCP.0b013e3282f10a16; Comer DM, 2009, QJM-INT J MED, V102, P793, DOI 10.1093/qjmed/hcp120; Davies JC, 2013, AM J RESP CRIT CARE, V187, P1219, DOI 10.1164/rccm.201301-0153OC; Debray D, 2011, J CYST FIBROS, V10, pS29, DOI 10.1016/S1569-1993(11)60006-4; Dhaliwal J, 2015, J PEDIATR GASTR NUTR, V60, P521, DOI 10.1097/MPG.0000000000000683; Dray X, 2004, CLIN GASTROENTEROL H, V2, P498, DOI 10.1016/S1542-3565(04)00169-7; Festini Filippo, 2004, J Cyst Fibros, V3, P51, DOI 10.1016/j.jcf.2003.12.001; Food and Drug Administration U.S. Department of Health and Human Services, 2009, GUID IND PAT REP OUT; Fraquelli M, 2016, DIGEST LIVER DIS, V48, P271, DOI 10.1016/j.dld.2015.09.010; Gu YH, 2015, J PEDIATR-US, V166, P897, DOI 10.1016/j.jpeds.2014.12.063; Harland NJ, 2015, PHYSIOTHERAPY, V101, P50, DOI 10.1016/j.physio.2014.06.004; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Kainzwaldner V, 2013, ANAESTHESIST, V62, P453, DOI 10.1007/s00101-013-2177-7; Kelly T, 2015, DIGEST DIS SCI, V60, P1903, DOI 10.1007/s10620-015-3546-7; Koh JL, 2005, PEDIATR PULM, V40, P330, DOI 10.1002/ppul.20292; Kromeyer-Hauschild K, 1999, INT J OBESITY, V23, P1143, DOI 10.1038/sj.ijo.0801044; Lane MM, 2011, J PEDIATR-US, V159, P437, DOI 10.1016/j.jpeds.2011.03.002; Lee AL, 2016, CHRON RESP DIS, V13, P102, DOI 10.1177/1479972316631135; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Li L, 2014, CLIN NUTR, V33, P571, DOI 10.1016/j.clnu.2014.04.004; MCGRATH PA, 1987, PAIN, V31, P147, DOI 10.1016/0304-3959(87)90033-9; McKay K, 2015, J CYST FIBROS, V14, pS117; Modi AC, 2006, J CYST FIBROS, V5, P177, DOI 10.1016/j.jcf.2006.03.002; Munck A, 2014, INT J BIOCHEM CELL B, V52, P180, DOI 10.1016/j.biocel.2014.02.005; Munck A, 2012, J CYST FIBROS, V11, P46, DOI 10.1016/j.jcf.2011.07.010; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Ooi CY, 2016, NAT REV GASTRO HEPAT, V13, P175, DOI 10.1038/nrgastro.2015.226; Ooi CY, 2012, J CYST FIBROS, V11, P355, DOI 10.1016/j.jcf.2012.05.001; Ooi CY, 2011, GASTROENTEROLOGY, V140, P153, DOI 10.1053/j.gastro.2010.09.046; Palermo TM, 2006, CLIN J PAIN, V22, P532, DOI 10.1097/01.ajp.0000210996.45459.76; Parad RB, 1996, J MED GENET, V33, P711, DOI 10.1136/jmg.33.8.711; Perquin CW, 2000, PAIN, V87, P51, DOI 10.1016/S0304-3959(00)00269-4; Quittner AL, 2005, CHEST, V128, P2347, DOI 10.1378/chest.128.4.2347; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ravilly S, 1996, PEDIATRICS, V98, P741; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robertson MB, 2006, RADIOGRAPHICS, V26, P679, DOI 10.1148/rg.263055101; ROTH PL, 1994, PERS PSYCHOL, V47, P537, DOI 10.1111/j.1744-6570.1994.tb01736.x; SAVEDRA MC, 1989, RES NURS HEALTH, V12, P307, DOI 10.1002/nur.4770120506; Schmidt A, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-97; Sermet-Gaudelus I, 2009, J PAIN SYMPTOM MANAG, V38, P281, DOI 10.1016/j.jpainsymman.2008.08.009; Shoff SM, 2013, J CYST FIBROS, V12, P746, DOI 10.1016/j.jcf.2013.01.006; Staufer K, 2014, INT J MOL SCI, V15, P13529, DOI 10.3390/ijms150813529; Stenekes SJ, 2009, J PAIN SYMPTOM MANAG, V38, P837, DOI 10.1016/j.jpainsymman.2009.04.029; Sullivan A, 2001, Lancet Infect Dis, V1, P101, DOI 10.1016/S1473-3099(01)00066-4; Uusijarvi A, 2014, NEUROGASTROENT MOTIL, V26, P841, DOI 10.1111/nmo.12340; van der Doef Hubert P J, 2011, Curr Gastroenterol Rep, V13, P265, DOI 10.1007/s11894-011-0185-9; Venuti E, 2015, J CYST FIBROS, V14, pS51, DOI DOI 10.1016/s1569-1993(15)30165-x; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Werlin SL, 2010, J PEDIATR GASTR NUTR, V51, P304, DOI 10.1097/MPG.0b013e3181d1b013; WISTROM J, 1992, J ANTIMICROB CHEMOTH, V30, P693, DOI 10.1093/jac/30.5.693	60	33	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0174463	10.1371/journal.pone.0174463	http://dx.doi.org/10.1371/journal.pone.0174463			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472055	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500005
J	Wu, YY; Ni, JT; Cai, X; Lian, FZ; Ma, HY; Xu, LW; Yang, L				Wu, Yinyin; Ni, Juntao; Cai, Xiao; Lian, Fuzhi; Ma, Haiyan; Xu, Liangwen; Yang, Lei			Positive association between ALDH2 rs671 polymorphism and essential hypertension: A case-control study and meta-analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALDEHYDE DEHYDROGENASE; BLOOD-PRESSURE; ALCOHOL-CONSUMPTION; GLU504LYS POLYMORPHISM; GENETIC POLYMORPHISMS; JAPANESE; RISK; POPULATION; STATEMENT	Background and objective Several studies have been conducted to examine the association between aldehyde dehydrogenase 2 family (ALDH2) rs671 polymorphism and essential hypertension (EH). However, the results remain inconsistent. This study aimed to clarify the association between ALDH2 rs671 polymorphism and EH susceptibility. Methods One thousand and ninety-four cases and 1236 controls who were ethnic Han Chinese were collected for this population-based case-control study. A meta-analysis was performed to calculate the pooled odds ratio and 95% confidence interval, using allele contrast, dominant, recessive, and co-dominant models using fixed or random-effect models. Results Significant differences were observed between EH cases and controls at the level of both genotype (X-2 = 6.656, P<0.05) and alleles (X-2 = 6.314, P<0.05). An additional meta-analysis using 4204 cases and 5435 controls established that rs671 was significantly associated with EH (P<0.00001). Conclusion The results of our case-control study and meta-analysis showed that there is a significant association between ALDH2 rs671 polymorphism and EH susceptibility. In addition, the results of the breakdown analysis by gender suggest a male-specific association between the ALDH2 rs671 polymorphism and EH.	[Wu, Yinyin; Ni, Juntao; Cai, Xiao; Lian, Fuzhi; Ma, Haiyan; Xu, Liangwen; Yang, Lei] Hangzhou Normal Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University	Xu, LW; Yang, L (corresponding author), Hangzhou Normal Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China.	13588118965@163.com; yanglei62@hznu.edu.cn	Lian, Fuzhi/F-9083-2015; ma, haiyan/GWQ-7425-2022	Lian, Fuzhi/0000-0002-0733-579X; 	Program for Zhejiang Leading Team of Science and Technology Innovation [2011R50021]; Zhejiang Provincial Natural Science Foundation of China [LQ16H260002]	Program for Zhejiang Leading Team of Science and Technology Innovation; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the Program for Zhejiang Leading Team of Science and Technology Innovation (No. 2011R50021) and the Zhejiang Provincial Natural Science Foundation of China (No. LQ16H260002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amamoto K, 2002, HYPERTENS RES, V25, P857; Chang YC, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-58; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667; Fuchs FD, 2001, HYPERTENSION, V37, P1242, DOI 10.1161/01.HYP.37.5.1242; Gu Dong-feng, 2003, Zhonghua Yufang Yixue Zazhi, V37, P84; Hao PP, 2010, ATHEROSCLEROSIS, V212, P213, DOI 10.1016/j.atherosclerosis.2010.05.024; HARADA S, 1982, LANCET, V2, P827, DOI 10.1016/s0140-6736(82)92722-2; Hashimoto Y, 2002, CLIN CHEM, V48, P1043; Hasi T, 2011, GENET MOL RES, V10, P537, DOI 10.4238/vol10-1gmr1056; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hiura Y, 2010, CIRC J, V74, P2353, DOI 10.1253/circj.CJ-10-0353; Jaubert MP, 2014, AM J HYPERTENS, V27, P688, DOI 10.1093/ajh/hpt235; Jia K, 2015, INT J CLIN EXP MED, V8, P10767; Kakar P, 2006, J HUM HYPERTENS, V20, P833, DOI 10.1038/sj.jhh.1002082; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Krzesinski J-M, 2012, Rev Med Liege, V67, P279; Lagranha CJ, 2010, CIRC RES, V106, P1681, DOI 10.1161/CIRCRESAHA.109.213645; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Ma X, 2016, INTERN MED J, V46, P608, DOI 10.1111/imj.12983; Moher D, 2009, PHYS THER, V89, P873, DOI 10.1093/ptj/89.9.873; Nakagawa T, 2013, PHARMACOGENET GENOM, V23, P18323; Ota M, 2016, ENVIRON HEALTH PREV, V21, P1, DOI 10.1007/s12199-015-0490-2; Peng GS, 2007, GENOMICS, V17, P845; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; Saito K, 2003, J HYPERTENS, V21, P1097, DOI 10.1097/00004872-200306000-00009; Takagi S, 2001, HYPERTENS RES, V24, P365, DOI 10.1291/hypres.24.365; TAKESHITA T, 1993, LANCET, V341, P837, DOI 10.1016/0140-6736(93)90620-V; Wang Y, 2013, J HUM HYPERTENS, V27, P181, DOI 10.1038/jhh.2012.15; WEINER CP, 1994, P NATL ACAD SCI USA, V91, P5212, DOI 10.1073/pnas.91.11.5212; Yokoyama A, 2013, ALCOHOL CLIN EXP RES, V37, P1391, DOI 10.1111/acer.12108; Zhang SY, 2015, HERZ, V40, P203, DOI 10.1007/s00059-014-4166-2	33	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177023	10.1371/journal.pone.0177023	http://dx.doi.org/10.1371/journal.pone.0177023			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472173	gold, Green Submitted, Green Published			2022-12-27	WOS:000400648500122
J	Xu, TS; Gu, LH; Huang, W; Xia, WL; Zhang, YS; Zhang, YG; Rong, G; Schachtschneider, K; Hou, SS				Xu, Tie-Shan; Gu, Li-Hong; Huang, Wei; Xia, Wan-Liang; Zhang, Yun-Sheng; Zhang, Ya-Ge; Rong, Guang; Schachtschneider, Kyle; Hou, Shui-Sheng			Gene expression profiling in Pekin duck embryonic breast muscle	PLOS ONE			English	Article							RNA-SEQ; PECTORALIS-MUSCLE; SKELETAL; ADIPOGENESIS; HYPERTROPHY; MYOGENESIS; PROTEINS; ATROPHY; TOOL	Lean-type Pekin duck is a breed gained through long-term selection and great effort has been exerted to understand the mechanisms underlying increased muscle yields. However, the genes involved in Pekin duck embryonic breast muscle development have not been explored to date. In this study, we investigated gene expression profiles in Pekin Duck embryonic breast muscle at hatched day 13 (E13), E19, and E27 using RNA-seq. In total, we produced 519,312,178 raw reads resulting in 497,348,158 high-quality reads after filtering. The mapping, distribution of reads along annotated genes, and consistency across replicates demonstrates the high quality of the RNA-seq data used in this study, allowing us to continue with the downstream analysis. Significantly fewer differentially expressed genes (DEGs) were identified between E13 and E19 (203 DEGs) compared to E27 and E19 (2,797 DEGs). Many DEGs highly expressed in E19 are involved in metabolic processes and cell division. KEGG analysis showed many pathways associated with fat development were significantly enriched for DEGs highly expressed in E27. These results provide a basis for the further investigation of the mechanisms involved in Pekin duck embryonic breast muscle development.	[Xu, Tie-Shan; Xia, Wan-Liang; Zhang, Ya-Ge; Rong, Guang] Chinese Acad Trop Agr Sci, Trop Crop Genet Resource Res Inst, Danzhou, Hainan, Peoples R China; [Gu, Li-Hong] Inst Anim Sci Vet, Hainan Acad Agr Sci, Haikou, Peoples R China; [Huang, Wei; Zhang, Yun-Sheng; Hou, Shui-Sheng] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [Schachtschneider, Kyle] Univ Illinois, Dept Radiol, Chicago, IL USA	Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hou, SS (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China.	houss2010@163.com	zhang, yunsheng/AAP-8347-2021	Schachtschneider, Kyle/0000-0002-7293-8642	earmarked fund for China Agriculture Research System [CARS-43-1, CARS-43-42]	earmarked fund for China Agriculture Research System	Financial support of this work was provided by the earmarked fund for China Agriculture Research System (grant numbers: CARS-43-1, CARS-43-42). This grant is awarded to Shui-Sheng Hou, who is engaged in the Institute of Animal Science, Chinese Academy of Agricultural Sciences. In this study, Shui-Sheng Hou conformed the conceptualization and designed the study.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Chen W, 2012, EXP PHYSIOL, V97, P861, DOI 10.1113/expphysiol.2011.01083.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fan RW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-389; Garin-Shkolnik T, 2014, DIABETES, V63, P900, DOI 10.2337/db13-0436; Goswami SC, 2014, J PAIN, V15, P1338, DOI 10.1016/j.jpain.2014.09.010; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grifone R, 2007, DEV BIOL, V302, P602, DOI 10.1016/j.ydbio.2006.08.059; Gu LH, 2013, GENET MOL RES, V12, P6733, DOI 10.4238/2013.December.13.6; Gu LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086150; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Himes BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099625; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kazantzis M, 2012, BBA-MOL CELL BIOL L, V1821, P852, DOI 10.1016/j.bbalip.2011.09.010; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Moore DT., 2005, INFLUENCE EARLY NUTR; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Patel K, 2002, RES PRO CEL, V38, P163; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Smith S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-375; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Velleman S. G., 2010, International Journal of Poultry Science, V9, P417; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Wu WJ, 2014, INT J BIOL SCI, V10, P983, DOI 10.7150/ijbs.9442; Xu TS, 2015, GENET MOL RES, V14, P4448, DOI 10.4238/2015.May.4.2; Xu T. S., 2013, Journal of Animal and Veterinary Advances, V12, P852; Xu TS, 2013, GENET MOL RES, V12, P3166, DOI 10.4238/2013.February.28.18; Xu TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107574; Xu TS, 2012, MOL BIOL REP, V39, P7647, DOI 10.1007/s11033-012-1599-7; Zhang B, 2016, LIPIDS HLTH DIS, V15, P1; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	39	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0174612	10.1371/journal.pone.0174612	http://dx.doi.org/10.1371/journal.pone.0174612			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472139	Green Submitted, Green Published, gold			2022-12-27	WOS:000400648500006
J	Yang, M; Guo, WW; Yang, CS; Tang, JQ; Huang, Q; Feng, SX; Jiang, AJ; Xu, XF; Jiang, G				Yang, Ming; Guo, WenWen; Yang, ChunSheng; Tang, JianQin; Huang, Qian; Feng, ShouXin; Jiang, AiJun; Xu, XiFeng; Jiang, Guan			Mobile phone use and glioma risk: A systematic review and meta-analysis	PLOS ONE			English	Review							MALIGNANT BRAIN-TUMORS; LONG-TERM USE; CORDLESS PHONES; CELLULAR TELEPHONES; INTRACRANIAL TUMORS; POOLED ANALYSIS; HETEROGENEITY; CANCER	Objective Many studies have previously investigated the potential association between mobile phone use and the risk of glioma. However, results from these individual studies are inconclusive and controversial. The objective of our study was to investigate the potential association between mobile phone use and subsequent glioma risk using meta-analysis. Methods We performed a systematic search of the Science Citation Index Embase and PubMed databases for studies reporting relevant data on mobile phone use and glioma in 1980-2016. The data were extracted and measured in terms of the odds ratio (OR) and 95% confidence interval (CI) using the random effects model. Subgroup analyses were also carried out. This meta-analysis eventually included 11 studies comprising a total 6028 cases and 11488 controls. Results There was a significant positive association between long-term mobile phone use (minimum, 10 years) and glioma (OR = 1.44, 95% CI = 1.08-1.91). And there was a significant positive association between long-term ipsilateral mobile phone use and the risk of glioma (OR = 1.46, 95% CI = 1.12-1.92). Long-term mobile phone use was associated with 2.22 times greater odds of low-grade glioma occurrence (OR = 2.22, 95% CI = 1.69-2.92). Mobile phone use of any duration was not associated with the odds of high-grade glioma (OR = 0.81, 95% CI = 0.72-0.92). Contralateral mobile phone use was not associated with glioma regardless of the duration of use. Similarly, this association was not observed when the analysis was limited to high-grade glioma. Conclusions Our results suggest that long-term mobile phone use may be associated with an increased risk of glioma. There was also an association between mobile phone use and low-grade glioma in the regular use or long-term use subgroups. However, current evidence is of poor quality and limited quantity. It is therefore necessary to conduct large sample, high quality research or better characterization of any potential association between long-term ipsilateral mobile phone use and glioma risk.	[Yang, Ming; Feng, ShouXin; Jiang, AiJun; Xu, XiFeng] Affiliated Hosp Xuzhou Med Univ, Dept Stereotact Radiosurg, Xuzhou, Peoples R China; [Guo, WenWen; Huang, Qian] Affiliated Hosp Xuzhou Med Univ, Dept Radiotherapy, Xuzhou, Peoples R China; [Yang, ChunSheng] Affiliated Huaian Hosp Xuzhou Med Univ, Dept Dermatol, Huaian, Peoples R China; [Tang, JianQin; Jiang, Guan] Affiliated Hosp Xuzhou Med Univ, Dept Dermatol, Xuzhou, Peoples R China		Feng, SX (corresponding author), Affiliated Hosp Xuzhou Med Univ, Dept Stereotact Radiosurg, Xuzhou, Peoples R China.; Jiang, G (corresponding author), Affiliated Hosp Xuzhou Med Univ, Dept Dermatol, Xuzhou, Peoples R China.	Fengshouxin@sina.com; dr.guanjiang@gmail.com			Jiangsu Province's Key Provincial Talents Program; Xuzhou Medical Young Talents Project	Jiangsu Province's Key Provincial Talents Program; Xuzhou Medical Young Talents Project	This manuscript is supported by Jiangsu Province's Key Provincial Talents Program and Xuzhou Medical Young Talents Project. We would like to thank the native English speaking scientists of Elixigen Company (Huntington Beach, California) for editing our manuscript.	[Anonymous], 2013, IARC MONOGR EVAL CAR, V1, P102; Belpomme D, 2007, ENVIRON RES, V105, P414, DOI 10.1016/j.envres.2007.07.002; Cardis E, 2008, PHYS MED BIOL, V53, P2771, DOI 10.1088/0031-9155/53/11/001; Cardis E, 2010, INT J EPIDEMIOL, V39, P675, DOI 10.1093/ije/dyq079; Carlberg M, 2014, INT J ENV RES PUB HE, V11, P10790, DOI 10.3390/ijerph111010790; Christensen HC, 2005, NEUROLOGY, V64, P1189, DOI 10.1212/01.WNL.0000156351.72313.D3; Cota GF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002195; Coureau G, 2014, OCCUP ENVIRON MED, V71, P514, DOI 10.1136/oemed-2013-101754; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Gale BD, 2006, NEUROLOGY, V66, P781, DOI 10.1212/01.wnl.0000205131.20290.46; Gong Xiu, 2014, Zhonghua Yi Xue Za Zhi, V94, P3102; Hardell L, 1999, INT J ONCOL, V15, P113; Hardell L, 2006, INT ARCH OCC ENV HEA, V79, P630, DOI 10.1007/s00420-006-0088-5; Hardell L, 2007, OCCUP ENVIRON MED, V64, P626, DOI 10.1136/oem.2006.029751; Hardell Lennart, 2015, Pathophysiology, V22, P1, DOI 10.1016/j.pathophys.2014.10.001; Hardell L, 2013, INT J ONCOL, V43, P1833, DOI 10.3892/ijo.2013.2111; Hardell L, 2011, INT J EPIDEMIOL, V40, P1126, DOI 10.1093/ije/dyq246; Hardell L, 2011, INT J ONCOL, V38, P1465, DOI 10.3892/ijo.2011.947; Hardell L, 2009, INT J ONCOL, V35, P5, DOI 10.3892/ijo_00000307; Hepworth SJ, 2006, BMJ-BRIT MED J, V332, P883, DOI 10.1136/bmj.38720.687975.55; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Inskip PD, 2001, NEW ENGL J MED, V344, P79, DOI 10.1056/NEJM200101113440201; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Kan P, 2008, J NEURO-ONCOL, V86, P71, DOI 10.1007/s11060-007-9432-1; Klaeboe L, 2007, EUR J CANCER PREV, V16, P158, DOI 10.1097/01.cej.0000203616.77183.4c; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Lagorio S, 2014, BIOELECTROMAGNETICS, V35, P79, DOI 10.1002/bem.21829; Lahkola A, 2007, INT J CANCER, V120, P1769, DOI 10.1002/ijc.22503; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lonn S, 2005, AM J EPIDEMIOL, V161, P526, DOI 10.1093/aje/kwi091; Marumoto T, 2012, ADV EXPT MED BIOL, V746, P2; Repacholi MH, 2012, BIOELECTROMAGNETICS, V33, P187, DOI 10.1002/bem.20716; Schuz J, 2006, AM J EPIDEMIOL, V163, P512, DOI 10.1093/aje/kwj068; Takebayashi T, 2008, BRIT J CANCER, V98, P652, DOI 10.1038/sj.bjc.6604214; Vijayalaxmi, 2012, MUTAT RES-GEN TOX EN, V749, P1, DOI 10.1016/j.mrgentox.2012.09.007; Vrijheid M, 2006, J EXPO SCI ENV EPID, V16, P371, DOI 10.1038/sj.jes.7500509; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Yoon S, 2015, ENV HLTH TOXICOLOGY	38	50	53	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175136	10.1371/journal.pone.0175136	http://dx.doi.org/10.1371/journal.pone.0175136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472042	Green Published, gold, Green Submitted			2022-12-27	WOS:000400648500009
J	Islam, MJ; Broidy, L; Baird, K; Mazerolle, P				Islam, Md. Jahirul; Broidy, Lisa; Baird, Kathleen; Mazerolle, Paul			Intimate partner violence around the time of pregnancy and postpartum depression: The experience of women of Bangladesh	PLOS ONE			English	Article							MATERNAL DEPRESSION; POSTNATAL DEPRESSION; RISK-FACTORS; DOMESTIC VIOLENCE; PHYSICAL VIOLENCE; MENTAL-HEALTH; PERINATAL DEPRESSION; PERCEIVED STRESS; SOCIAL SUPPORT; MARRIED-WOMEN	Background and objectives Intimate partner violence (IPV) around the time of pregnancy is a serious public health concern and is known to have an adverse effect on perinatal mental health. In order to craft appropriate and effective interventions, it is important to understand how the association between IPV and postpartum depression (PPD) may differ as a function of the type and timing of IPV victimization. Here we evaluate the influence of physical, sexual and psychological IPV before, during and after pregnancy on PPD. Methods Cross-sectional survey data was collected between October 2015 and January 2016 in the Chandpur District of Bangladesh from 426 new mothers, aged 15-49 years, who were in the first six months postpartum. Multivariate logistic regression models were used to estimate the association between IPV and PPD, adjusted for socio-demographic, reproductive and psychosocial confounding factors. Results Approximately 35.2% of women experienced PPD within the first six months following childbirth. Controlling for confounders, the odds of PPD was significantly greater among women who reported exposure to physical (AOR: 1.79, 95% CI [1.25, 3.43]), sexual (AOR: 2.25, 95% CI [1.14, 4.45]) or psychological (AOR: 6.92, 95% CI [1.71, 28.04]) IPV during pregnancy as opposed to those who did not. However, both before and after pregnancy, only physical IPV evidences a direct effect on PPD. Results highlight the mental health consequences of IPV for women of Bangladesh, as well as the influence of timing and type of IPV on PPD outcomes. Conclusions and implications The findings confirm that exposure to IPV significantly increases the odds of PPD. The association is particularly strong for physical IPV during all periods and psychological IPV during pregnancy. Results reinforce the need to conduct routine screening during pregnancy to identify women with a history of IPV who may at risk for PPD and to offer them necessary support.	[Islam, Md. Jahirul; Broidy, Lisa; Mazerolle, Paul] Griffith Univ Brisbane, Sch Criminol & Criminal Justice, Brisbane, Qld, Australia; [Islam, Md. Jahirul] Bangladesh Planning Commiss, Minist Planning, Dhaka, Bangladesh; [Broidy, Lisa] 1 Univ New Mexico, Dept Sociol, Albuquerque, NM USA; [Baird, Kathleen] Griffith Univ, Sch Nursing & Midwifery, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia	Griffith University; University of New Mexico; Griffith University; Menzies Health Institute Queensland	Islam, MJ (corresponding author), Griffith Univ Brisbane, Sch Criminol & Criminal Justice, Brisbane, Qld, Australia.; Islam, MJ (corresponding author), Bangladesh Planning Commiss, Minist Planning, Dhaka, Bangladesh.	mdjahirul.islam@griffithuni.edu.au	Baird, Kathleen/AAP-1894-2021; Islam, Dr Md Jahirul/J-4093-2019	Baird, Kathleen/0000-0003-0142-6962; Islam, Dr Md Jahirul/0000-0001-6409-6724; Hossain, Mohammad/0000-0003-4615-5086; Mazerolle, Paul/0000-0002-5894-996X; Islam, Mohammad Mainul/0000-0002-0937-5082	Joint Donors Technical Assistance Fund (JDTAF) at the Ministry of Health and Family Welfare, Bangladesh	Joint Donors Technical Assistance Fund (JDTAF) at the Ministry of Health and Family Welfare, Bangladesh	The study was partially funded by the Joint Donors Technical Assistance Fund (JDTAF) at the Ministry of Health and Family Welfare, Bangladesh. The funding authority had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript. The corresponding author had full access to all data in the study and had final responsibility for the decision to submit for publication.	Adesina O, 2011, J OBSTET GYNAECOL, V31, P232, DOI 10.3109/01443615.2010.547954; Ahmed A M, 2005, East Mediterr Health J, V11, P164; Almond P, 2009, PERSPECT PUBLIC HEAL, V129, P221, DOI 10.1177/1757913909343882; Annagur A, 2013, BREASTFEED MED, V8, P53, DOI 10.1089/bfm.2012.0036; Azziz-Baumgartner E, 2014, VIOLENCE AGAINST WOM, V20, P59; Bangladesh Bureau of Statistics (BBS), 2013, VIOL WOM SURV 2011; Beck CT, 2008, MCN-AM J MATERN-CHIL, V33, P151, DOI 10.1097/01.NMC.0000318349.70364.1c; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; Beydoun HA, 2012, SOC SCI MED, V75, P959, DOI 10.1016/j.socscimed.2012.04.025; Beydoun HA, 2010, ANN EPIDEMIOL, V20, P575, DOI 10.1016/j.annepidem.2010.05.011; Bondas T, 2001, QUAL HEALTH RES, V11, P824, DOI 10.1177/104973201129119415; Brownridge DA, 2011, VIOLENCE AGAINST WOM, V17, P858, DOI 10.1177/1077801211412547; Cerulli C, 2010, BREASTFEED MED, V5, P225, DOI 10.1089/bfm.2010.0054; Chambliss LR, 2008, CLIN OBSTET GYNECOL, V51, P385, DOI 10.1097/GRF.0b013e31816f29ce; Chan KL, 2011, J INTERPERS VIOLENCE, V26, P1478, DOI 10.1177/0886260510369134; Chandran M, 2002, BRIT J PSYCHIAT, V181, P499, DOI 10.1192/bjp.181.6.499; Chibanda D, 2010, ARCH WOMEN MENT HLTH, V13, P201, DOI 10.1007/s00737-009-0073-6; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Craig M, 2009, CLIN EVIDENCE, V1, P1407; Dalal K, 2009, J BIOSOC SCI, V41, P561, DOI 10.1017/S0021932009990046; Desmarais SL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-132; Devries KM, 2010, REPROD HEALTH MATTER, V18, P158, DOI 10.1016/S0968-8080(10)36533-5; Edwards GD, 2006, INT J MENT HEALTH, V35, P62, DOI 10.2753/IMH0020-7411350105; Ege E, 2008, J OBSTET GYNAECOL RE, V34, P585, DOI 10.1111/j.1447-0756.2008.00718.x; Ellsberg M, 2001, STUD FAMILY PLANN, V32, P1, DOI 10.1111/j.1728-4465.2001.00001.x; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Faisal-Cury A, 2013, MATERN CHILD HLTH J, V17, P1297, DOI 10.1007/s10995-012-1127-3; Farid M, 2008, INT J GYNECOL OBSTET, V101, P141, DOI 10.1016/j.ijgo.2007.11.015; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Fisher JRW, 2004, BJOG-INT J OBSTET GY, V111, P1353, DOI 10.1111/j.1471-0528.2004.00394.x; Garabedian MJ, 2011, J WOMENS HEALTH, V20, P447, DOI 10.1089/jwh.2010.1960; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gausia K, 2009, PSYCHOL MED, V39, P999, DOI 10.1017/S0033291708004455; Gausia K, 2007, J REPROD INFANT PSYC, V25, P308, DOI 10.1080/02646830701644896; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Glover V, 2014, BEST PRACT RES CL OB, V28, P25, DOI 10.1016/j.bpobgyn.2013.08.017; Gomez-Beloz A, 2009, VIOLENCE VICTIMS, V24, P380, DOI 10.1891/0886-6708.24.3.380; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Gulamani SS, 2013, J PERINAT NEONAT NUR, V27, P52, DOI 10.1097/JPN.0b013e31827fcf24; Hegarty K, 2011, BRIT J PSYCHIAT, V198, P169, DOI 10.1192/bjp.bp.110.083758; Henderson JJ, 2003, BIRTH-ISS PERINAT C, V30, P175, DOI 10.1046/j.1523-536X.2003.00242.x; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Howard LM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001452; Husain N, 2011, ARCH WOMEN MENT HLTH, V14, P395, DOI 10.1007/s00737-011-0233-3; Illanes E, 2007, REV MED CHILE, V135, P326; Islam MJ, 2017, MIDWIFERY, V47, P43, DOI 10.1016/j.midw.2017.02.002; Islam MJ, 2017, ARCH WOMEN MENT HLTH, V20, P173, DOI 10.1007/s00737-016-0692-7; Isomaa R, 2013, HEALTH EDUC BEHAV, V40, P392, DOI 10.1177/1090198112445481; James L, 2013, VIOLENCE VICTIMS, V28, P359, DOI 10.1891/0886-6708.VV-D-12-00034; Jeanjot I, 2008, J WOMENS HEALTH, V17, P557, DOI 10.1089/jwh.2007.0639; Johnson PL, 2007, PSYCHIAT ANN, V37, P404; Kabir ZN, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24725; Kan ML, 2012, J FAM ISSUES, V33, P115, DOI 10.1177/0192513X11412037; Kantor G. K., 1999, REPORT USAF FAMILY N; Kendall-Tackett KA, 2007, TRAUMA VIOLENCE ABUS, V8, P344, DOI 10.1177/1524838007304406; Klainin P, 2009, INT J NURS STUD, V46, P1355, DOI 10.1016/j.ijnurstu.2009.02.012; Krug E. G., 2002, WORLD HLTH REPORT VI; Leung SSK, 2005, RES NURS HEALTH, V28, P27, DOI 10.1002/nur.20053; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Ludermir AB, 2010, LANCET, V376, P903, DOI 10.1016/S0140-6736(10)60887-2; Malta LA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-153; Marcotte D, 2002, J EMOT BEHAV DISORD, V10, P29, DOI 10.1177/106342660201000104; Martin SL, 2006, VIOLENCE AGAINST WOM, V12, P221, DOI 10.1177/1077801205285106; Martin SL, 2004, J FAM VIOLENCE, V19, P201, DOI 10.1023/B:JOFV.0000032630.50593.93; Milgrom J, 2006, STRESS HEALTH, V22, P229, DOI 10.1002/smi.1101; Moraes CL, 2011, PUBLIC HEALTH NUTR, V14, P2148, DOI 10.1017/S1368980011000802; Naved RT, 2013, ARCH SEX BEHAV, V42, P595, DOI 10.1007/s10508-012-0045-1; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Patel M, 2012, J HEALTH CARE POOR U, V23, P534, DOI 10.1353/hpu.2012.0037; Peedicayil A, 2004, BJOG-INT J OBSTET GY, V111, P682, DOI 10.1111/j.1471-0528.2004.00151.x; Quelopana AM, 2012, WOMEN HEALTH, V52, P437, DOI 10.1080/03630242.2012.687443; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Rahman A, 2008, TROP MED INT HEALTH, V13, P579, DOI 10.1111/j.1365-3156.2008.02036.x; Rahman M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-913; Righetti-Veltema M, 2002, J AFFECT DISORDERS, V70, P291, DOI 10.1016/S0165-0327(01)00367-6; Rodriguez MA, 2010, VIOLENCE AGAINST WOM, V16, P543, DOI 10.1177/1077801210366959; Romito P, 2009, J PSYCHOSOM OBST GYN, V30, P115, DOI 10.1080/01674820802545834; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Saito A, 2012, NURS HEALTH SCI, V14, P345, DOI 10.1111/j.1442-2018.2012.00735.x; Sambisa W, 2010, STUD FAMILY PLANN, V41, P165, DOI 10.1111/j.1728-4465.2010.00241.x; Savarimuthu RJS, 2010, INT J SOC PSYCHIATR, V56, P94, DOI 10.1177/0020764008097756; Scribano PV, 2013, MATERN CHILD HLTH J, V17, P307, DOI 10.1007/s10995-012-0986-y; Shah M, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-2; Shamu S, 2016, GEN HOSP PSYCHIAT, V38, P109, DOI 10.1016/j.genhosppsych.2015.10.005; Silverman JG, 2006, J WOMENS HEALTH, V15, P934, DOI 10.1089/jwh.2006.15.934; Sorbo MF, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-316; Stewart RC, 2008, MATERN CHILD NUTR, V4, P209, DOI 10.1111/j.1740-8709.2008.00147.x; Stewart RC, 2007, MATERN CHILD NUTR, V3, P94, DOI 10.1111/j.1740-8709.2007.00088.x; Swapan G, 2013, J OBSTET GYN INDIA, V63, P223, DOI 10.1007/s13224-013-0399-x; Taveras EM, 2003, PEDIATRICS, V112, P108, DOI 10.1542/peds.112.1.108; Tiwari A, 2008, BJOG-INT J OBSTET GY, V115, P377, DOI 10.1111/j.1471-0528.2007.01593.x; Tsai AC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001943; Uddin MK, 2012, J BEHAV SCI, V22, P26; Urquia ML, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-42; Valentine JM, 2011, ARCH WOMEN MENT HLTH, V14, P135, DOI 10.1007/s00737-010-0191-1; Verreault N, 2014, J PSYCHOSOM OBST GYN, V35, P84, DOI 10.3109/0167482X.2014.947953; Vizcarra Beatriz, 2004, Inj Control Saf Promot, V11, P125, DOI 10.1080/15660970412331292351; Wachs TD, 2009, CHILD DEV PERSPECT, V3, P51, DOI 10.1111/j.1750-8606.2008.00077.x; Wang SY, 2006, J PSYCHOSOM RES, V60, P303, DOI 10.1016/j.jpsychores.2005.08.012; Wang SY, 2003, AM J OBSTET GYNECOL, V189, P1407, DOI 10.1067/S0002-9378(03)00673-2; White RS, 2014, J AM GERIATR SOC, V62, P2350, DOI 10.1111/jgs.13135; WHO, 2013, RESPONDING INTIMATE; WHO, 2012, WORLD FED MENT HLTH; WHO UNFPA, 2009, MENT HLTH ASP WOM PE; Woolhouse H, 2012, BJOG-INT J OBSTET GY, V119, P315, DOI 10.1111/j.1471-0528.2011.03219.x; World Health Organization & Pan American Health Organization, 2012, UNDERSTANDING ADDRES; Zlotnick C, 2006, J INTERPERS VIOLENCE, V21, P262, DOI 10.1177/0886260505282564	111	65	67	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176211	10.1371/journal.pone.0176211	http://dx.doi.org/10.1371/journal.pone.0176211			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472056	Green Published, Green Submitted, gold			2022-12-27	WOS:000400648500029
